PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Fukuda, M; Kawabe, M; Takehara, M; Iwano, S; Kuwabara, K; Kikuchi, C; Wakamoto, H; Morimoto, T; Suzuki, Y; Ishii, E				Fukuda, Mitsumasa; Kawabe, Mika; Takehara, Makoto; Iwano, Sachiko; Kuwabara, Kozue; Kikuchi, Chiya; Wakamoto, Hiroyuki; Morimoto, Takehiko; Suzuki, Yuka; Ishii, Eiichi			Carnitine deficiency: Risk factors and incidence in children with epilepsy	BRAIN & DEVELOPMENT			English	Article						Carnitine deficiency; Childhood epilepsy; Tube feeding; Antiepileptic drugs; Intellectual disability; Estimated formula	VALPROIC ACID; CEREBRAL-PALSY; ESI-MS/MS; ACYLCARNITINES; HYPERAMMONEMIA; DRUGS; SERUM	Background: Carnitine deficiency is relatively common in epilepsy; risk factors reportedly include combination antiepileptic drug (AED) therapy with valproic acid (VPA), young age, intellectual disability, diet and enteral or parenteral feeding. Few studies have examined the correlation between each risk factor and carnitine deficiency in children with epilepsy. We examined the influence of these risk factors on carnitine deficiency, and identified a formula to estimate plasma free carnitine concentration in children with epilepsy. Methods: Sixty-five children with epilepsy and 26 age-matched controls were enrolled. Plasma carnitine concentrations were measured using an enzyme cycling assay, and correlations were sought with patients' other clinical characteristics. Results: Carnitine deficiency was found in approximately 17% of patients with epilepsy and was significantly associated with carnitine-free enteral formula only by tube feeding, number of AEDs taken (independent of VPA use), body weight (BW), body height and Gross Motor Function Classification System (GMFCS) score. Stepwise multiple linear regression analysis indicated that carnitine concentration (in mu mol/L) could be accurately estimated from a formula that does not require blood testing: 42.44 + 0.14 x (BW in kg) - 18.16 x (feeding) - 3.19 x (number of AEDs), where feeding was allocated a score of 1 for carnitine-free enteral formula only by tube feeding and 0 for taking food orally (R-2 = 0.504, P < 0.001). Conclusions: Carnitine-free enteral formula only by tube feeding, multiple AED treatment and low BW are risk factors for carnitine deficiency in children with epilepsy. L-carnitine should be administered to children at risk of deficiency to avoid complications. Treatment decisions can be informed using an estimation formula that does not require blood tests. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Fukuda, Mitsumasa; Kawabe, Mika; Takehara, Makoto; Iwano, Sachiko; Ishii, Eiichi] Ehime Univ, Grad Sch Med, Dept Pediat, Toon, Ehime 7910295, Japan; [Kuwabara, Kozue; Kikuchi, Chiya; Wakamoto, Hiroyuki; Morimoto, Takehiko; Suzuki, Yuka] Ehime Rehabil Ctr Children, Toon, Ehime, Japan	Fukuda, M (reprint author), Ehime Univ, Grad Sch Med, Dept Pediat, 454 Shitsukawa, Toon, Ehime 7910295, Japan.	fukumits@m.ehime-u.ac.jp			Osaka Foundation for Promotion of Fundamental Medical Research	This study was supported by a Setsuro Fujii Memorial Grant, from the Osaka Foundation for Promotion of Fundamental Medical Research. We are grateful to Prof. Isao Saito for help with statistical analysis.	De Vivo DC, 1998, EPILEPSIA, V39, P1216; COULTER DL, 1991, J CHILD NEUROL, V6, P7, DOI 10.1177/088307389100600102; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214; Castro-Gago M, 1998, J CHILD NEUROL, V13, P546; Verrotti A, 1999, INT J CLIN LAB RES, V29, P36, DOI 10.1007/s005990050060; Maeda Y, 2007, RAPID COMMUN MASS SP, V21, P799, DOI 10.1002/rcm.2905; Nakajima Y, 2011, BRAIN DEV-JPN, V33, P816, DOI 10.1016/j.braindev.2010.12.003; Graham HK, 2005, J PEDIATR ORTHOPED, V25, P127, DOI 10.1097/00004694-200501000-00026; REBOUCHE CJ, 1992, FASEB J, V6, P3379; BEGHI E, 1990, EPILEPSIA, V31, P346, DOI 10.1111/j.1528-1157.1990.tb05387.x; CASTROGAGO M, 1992, J PEDIATR-US, V120, P496, DOI 10.1016/S0022-3476(05)80931-X; Coulter D L, 1995, J Child Neurol, V10 Suppl 2, pS32; De Vivo DC, 1990, INT PEDIATR, V5, P134; Hamed SA, 2009, EPILEPSY RES, V86, P32, DOI 10.1016/j.eplepsyres.2009.04.002; Hiraoka A, 1997, BIOL PHARM BULL, V20, P91; OPALA G, 1991, AM J DIS CHILD, V145, P999; Pons R, 1997, PEDIATR RES, V42, P583, DOI 10.1203/00006450-199711000-00005; Silva MFB, 2001, CLIN BIOCHEM, V34, P635, DOI 10.1016/S0009-9120(01)00272-7; TAKAHASHI M, 1994, CLIN CHEM, V40, P817; Takeda Y, 2015, BRAIN DEV-JPN, V37, P94, DOI 10.1016/j.braindev.2014.03.012; Tanaka Shin-ichiro, 2003, J Atheroscler Thromb, V10, P321; Werner T, 2007, EPILEPSIA, V48, P72, DOI 10.1111/j.1528-1167.2006.00833.x	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					790	796		10.1016/j.braindev.2014.12.004		7	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800008		
J	Nishimura, T; Inaba, Y; Nakazawa, Y; Omata, T; Akasaka, M; Shirai, I; Ichikawa, M				Nishimura, Takafumi; Inaba, Yuji; Nakazawa, Yozo; Omata, Taku; Akasaka, Manami; Shirai, Ikuko; Ichikawa, Motoki			Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis	BRAIN & DEVELOPMENT			English	Article						Childhood; Myasthenia gravis; Ocular type; Regulatory T cell (Treg); Relapse; Th17 cell	IMMUNOLOGICAL SELF-TOLERANCE; FLOW-CYTOMETRY; TACROLIMUS; PROLIFERATION; LYMPHOCYTES; THYMOMA; T(H)17; THYMUS	Objective: Myasthenia gravis (MG) is a T-cell dependent and antibody mediated autoimmune disease. Recent studies of adult patients and animal models have shown that regulatory T cells (Tregs) play an important role in the pathogenesis of MG, but little is known about MG in children. This study evaluated the role of peripheral blood Tregs in childhood ocular MG and assessed if Tregs could be an index for estimating immunological status. Patients and methods: Clinical data and peripheral lymphocytes were obtained from 13 children with serum AChR antibody-positive ocular type MG and 18 age-matched controls. Committed cells from MG patients were divided into two clinical stages: active (n= 12) and remission (n=11). Tregs and Th17 cells were analyzed by flow cytometric analysis based on CD4(+)CD25(+) intracellular Foxp3(+) and CD4(+) intracellular IL-17A(+) fractions, respectively. Results: The percentage of Tregs among peripheral blood CD4(+) T cells in active stage, remission stage, and control groups was 3.3 +/- 1.3%, 4.8 +/- 1.7%, and 5.0 +/- 0.6%, respectively. The Treg population was significantly lower in the active stage than in the remission stage and controls. Furthermore, Treg percentage was significantly lower during relapse of myasthenia symptoms. We witnessed no remarkable associations between the percentage of Tregs and immune suppressant dosages. Conclusions: A significant reduction in the peripheral Treg population is considered to contribute to the pathophysiology of ocular type childhood MG and may be a marker of immunological state in these patients. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Nishimura, Takafumi; Inaba, Yuji; Nakazawa, Yozo] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan; [Omata, Taku] Chiba Childrens Hosp, Div Child Neurol, Chiba, Japan; [Akasaka, Manami] Iwate Med Univ, Sch Med, Dept Pediat, Morioka, Iwate 020, Japan; [Shirai, Ikuko] Tokyo Metropolitan Neurol Hosp, Dept Neuropediat, Tokyo, Japan; [Ichikawa, Motoki] Shinshu Univ, Grad Sch Med, Child & Womens Hlth Sci, Matsumoto, Nagano 390, Japan	Inaba, Y (reprint author), Shinshu Univ, Sch Med, Dept Pediat, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	inabay@shinshu-u.ac.jp					Bai Y, 2008, EUR J IMMUNOL, V38, P1877, DOI 10.1002/eji.200737973; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; Luther C, 2009, J IMMUNOL, V183, P841, DOI 10.4049/jimmunol.0802046; Aricha R, 2008, J IMMUNOL, V180, P2132; Grindebacke H, 2009, J IMMUNOL, V183, P4360, DOI 10.4049/jimmunol.0901091; Wang Z, 2012, SCAND J IMMUNOL, V76, P54, DOI 10.1111/j.1365-3083.2012.02703.x; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Bonelli M, 2008, INT IMMUNOL, V20, P861, DOI 10.1093/intimm/dxn044; Miroux C, 2012, TRANSPLANTATION, V94, P123, DOI 10.1097/TP.0b013e3182590d8f; Jaretzki A, 2000, NEUROLOGY, V55, P16; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Chiang LM, 2009, MUSCLE NERVE, V39, P423, DOI 10.1002/mus.21195; Shi YH, 2011, CHINESE MED J-PEKING, V124, P1951, DOI 10.3760/cma.j.issn.0366-6999.2011.13.006; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shinomiya N, 2004, CLIN IMMUNOL, V110, P154, DOI 10.1016/j.clim.2003.10.004; Liu RL, 2010, EUR J IMMUNOL, V40, P1577, DOI 10.1002/eji.200939792; Fattorossi A, 2005, IMMUNOLOGY, V116, P134, DOI 10.1111/j.1365-2567.2005.02220.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Balandina A, 2005, BLOOD, V105, P735, DOI 10.1182/blood-2003-11-3900; Masuda M, 2010, J NEUROIMMUNOL, V225, P123, DOI 10.1016/j.jneuroim.2010.03.016; Thiruppathi M, 2012, CLIN IMMUNOL, V145, P209, DOI 10.1016/j.clim.2012.09.012; Battaglia A, 2005, J BIOL REG HOMEOS AG, V19, P54; Dokai H, 2007, J NEUROIMMUNOL, V187, P192, DOI 10.1016/j.jneuroim.2007.04.021; Finnis MF, 2011, AUTOIMMUNE DIS, V2011; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; Kogina K, 2009, MOL CELLS, V28, P125, DOI 10.1007/s10059-009-0114-z; Luther C, 2005, J NEUROIMMUNOL, V164, P124, DOI 10.1016/j.jneuroim.2005.03.011; Matsui N, 2010, NEUROLOGY, V74, P816, DOI 10.1212/WNL.0b013e3181d31e47; Minami N, 2011, J NEUROL SCI, V300, P59, DOI 10.1016/j.jns.2010.09.033; Mu LL, 2009, IMMUNOLOGY, V128, pe826, DOI 10.1111/j.1365-2567.2009.03089.x; ROSES AD, 1981, NEUROLOGY, V31, P220; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakuma H, 2011, BRAIN DEV-JPN, V33, P442, DOI 10.1016/j.braindev.2010.08.002; Shen Z, 2011, MED HYPOTHESES, V76, P178, DOI 10.1016/j.mehy.2010.09.011; SOMMER N, 1991, NEUROLOGY, V41, P1270; Xu WH, 2012, J CLIN IMMUNOL, V32, P975, DOI 10.1007/s10875-012-9685-0; Yahikozawa H, 1995, No To Shinkei, V47, P585	37	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					808	816		10.1016/j.braindev.2014.12.007		9	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800011		
J	Ohno, K; Saito, Y; Togawa, M; Shinohara, Y; Ito, T; Sugano, H; Itamura, S; Nishimura, Y; Tamasaki, A; Maegaki, Y				Ohno, Koyo; Saito, Yoshiaki; Togawa, Masami; Shinohara, Yuki; Ito, Takamichi; Sugano, Hidenori; Itamura, Shinji; Nishimura, Yoko; Tamasaki, Akiko; Maegaki, Yoshihiro			Evolution of a symptomatic diffuse developmental venous anomaly with progressive cerebral atrophy in an atypical case of Sturge-Weber syndrome	BRAIN & DEVELOPMENT			English	Article						Developmental venous anomaly; Phakomatosis; Sturge Weber syndrome; Susceptibility-weighted imaging	PIGMENTOVASCULARIS TYPE IIB; PHAKOMATOSIS-PIGMENTOVASCULARIS; ABNORMALITIES; ASSOCIATION	A 2-year-old boy had glaucoma, bilateral facial haemangioma and widespread blue nevi on the trunk and extremities since birth. Dilated medullary veins were detected in the left cerebral periventricular white matter on magnetic resonance imaging (MRI). Macrocephaly and delayed psychomotor development were observed during late infancy, and susceptibility-weighted angiography revealed an extensive developmental venous anomaly with multiple caput medusae throughout bilateral hemispheres, accompanied by periventricular hyperintense alterations on MRI and progressive diffuse atrophy of the cerebral mantle with left-sided predominance. Hypoperfusion in the left cerebral and cerebellar hemisphere was also uncovered. No meningeal haemangioma was observed. This patient may represent a novel subgroup of phakomatosis cases that can be regarded as a variant of Sturge Weber syndrome. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ohno, Koyo; Saito, Yoshiaki; Togawa, Masami; Itamura, Shinji; Nishimura, Yoko; Tamasaki, Akiko; Maegaki, Yoshihiro] Tottori Univ, Fac Med, Inst Neurol Sci, Div Child Neurol, Yonago, Tottori 6838504, Japan; [Togawa, Masami] Tottori Prefectural Cent Hosp, Dept Paediat, Tottori, Japan; [Shinohara, Yuki] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, Yonago, Tottori 683, Japan; [Ito, Takamichi] Tottori Univ, Fac Med, Dept Med Sensory & Motor Organs, Div Dermatol, Yonago, Tottori 683, Japan; [Sugano, Hidenori] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan	Ohno, K (reprint author), Tottori Univ, Fac Med, Inst Neurol Sci, Div Child Neurol, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	oonok@med.tottori-u.ac.jp					Griffiths PD, 2003, AM J NEURORADIOL, V24, P719; Toelle SP, 2011, NEUROPEDIATRICS, V42, P234, DOI 10.1055/s-0031-1291243; Fujima N, 2011, NEUROIMAGE, V54, P344, DOI 10.1016/j.neuroimage.2010.08.020; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Santucci GM, 2008, AM J NEURORADIOL, V29, P1317, DOI 10.3174/ajnr.A1090; Ruiz DSM, 2007, NEURORADIOLOGY, V49, P987, DOI 10.1007/s00234-007-0279-0; Happle R, 2005, ARCH DERMATOL, V141, P385, DOI 10.1001/archderm.141.3.385; Camacho DLA, 2004, AM J NEURORADIOL, V25, P1549; Casey Michael A, 2011, J Radiol Case Rep, V5, P10, DOI 10.3941/jrcr.v5i5.769; Chhajed M, 2010, J PEDIAT NEUROSCI, V5, P138; Cho S, 2001, PEDIATR DERMATOL, V18, P263; Dillon WP, 1997, AM J NEURORADIOL, V18, P1839; Finklea LB, 2010, PEDIATR DERMATOL, V27, P303, DOI 10.1111/j.1525-1470.2010.01144.x; Iv M, 2014, J NEUROIMAGING; Jung AK, 2013, NEUROLOGY, V80, P1718, DOI 10.1212/WNL.0b013e3182904fbb; Uchino A, 2001, CLIN IMAG, V25, P82, DOI 10.1016/S0899-7071(01)00254-6	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					817	821		10.1016/j.braindev.2014.12.003		5	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800012		
J	Chong, PF; Ogata, R; Kobayashi, H; Koizumi, A; Kira, R				Chong, Pin Fee; Ogata, Reina; Kobayashi, Hatasu; Koizumi, Akio; Kira, Ryutaro			Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K	BRAIN & DEVELOPMENT			English	Article						Moyamoya syndrome; Down syndrome; RNF213; Pediatric stroke	R4810K RS112735431; DISEASE; PREVALENCE	Moyamoya syndrome is a unique progressive occlusive cerebrovascular disease that predisposes affected patients to stroke. We describe the case of a 2-year-old girl presenting with early onset of moyamoya syndrome with concurrent Down syndrome. Genetic testing revealed a heterozygous missense variant of RNF213. RNF213 was recently identified as the first susceptibility gene for moyamoya disease in patients with no known associated risk factors. The reported median age at the onset of idiopathic moyamoya disease with a heterozygous RNF213 risk variant is 7 years, while, the average age at onset of moyamoya syndrome in Down syndrome is 7-16 years. Down syndrome and RNF213 variant contribute to the development of moyamoya vasculopathy in different ways. Although the underlying mechanism is not fully understood, an additive effect was observed with the early-onset seen in this patient. Little is known about the potential association between RNF213 and moyamoya syndrome. Based on these observations, we hypothesize that the RNF213 risk variant has a modifier effect in steno-occlusive vasculopathy, even in medical conditions known to be associated with moyamoya syndrome. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Chong, Pin Fee; Ogata, Reina; Kira, Ryutaro] Fukuoka Childrens Hosp, Dept Pediat Neurol, Fukuoka 8130017, Japan; [Kobayashi, Hatasu; Koizumi, Akio] Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto, Japan	Chong, PF (reprint author), Fukuoka Childrens Hosp, Dept Pediat Neurol, Higashi Ku, 5-1-1 Kashii Teriha, Fukuoka 8130017, Japan.	chong.p.f@fcho.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25253047]	We thank the patient's family for their participation. This work is partly supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. Kiban Kenkyu A: 25253047 to A.K.).	Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Kainth DS, 2013, NEUROSURGERY, V72, P210, DOI 10.1227/NEU.0b013e31827b9beb; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V438, P13, DOI 10.1016/j.bbrc.2013.07.004; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Dai AI, 2000, J CHILD NEUROL, V15, P696, DOI 10.1177/088307380001501012; FUKUSHIMA Y, 1986, EUR J PEDIATR, V144, P516, DOI 10.1007/BF00441756; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V439, P419, DOI 10.1016/j.bbrc.2013.08.067; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					822	824		10.1016/j.braindev.2014.12.006		3	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800013		
J	Ide, M; Kato, T; Nakata, M; Saito, K; Yoshida, T; Awaya, T; Heike, T				Ide, Minako; Kato, Takeo; Nakata, Masatoshi; Saito, Keiko; Yoshida, Takeshi; Awaya, Tomonari; Heike, Toshio			A granulocytosis associated with rufinamide: A case report	BRAIN & DEVELOPMENT			English	Article						Drug-induced agranulocytosis; Rufinamide; Hypersensitivity reactions; Lennox-Gastaut syndrome	DRUG-INDUCED AGRANULOCYTOSIS; PEDIATRIC EPILEPSY; SAFETY	Background: Rufinamide, a triazole derivative, is a novel antiepileptic drug (AED) chemically unrelated to other current AEDs. Previous studies on pediatric epilepsy treatment with rufinamide have demonstrated a frequency of leukopenia as an adverse event of 0.5%, and there has been no report of the development of agranulocytosis. Here, we report a patient with Lennox Gastaut syndrome (LGS) who developed agranulocytosis associated with fever and skin rash with rufinamide. To the best of our knowledge, this is the first reported case of agranulocytosis induced by rufinamide. Patient: A 10-year-old boy with a history of herpes encephalitis at the age of 1 year developed LGS, and was administered rufinamide as add-on therapy to valproate, lamotrigine, and clonazepam because of difficulties in controlling tonic seizures. Eighteen days after initiation of rufinamide, agranulocytosis developed associated with high fever and skin rash, all of which resolved after withdrawal of rufinamide. Bone marrow aspiration demonstrated normo-cellular marrow with selective decrease of mature myeloid series, and suggested that agranulocytosis was not related to malignancy or serious infection. Conclusion: This case suggests that rufinamide may induce the potentially serious adverse effect of agranulocytosis. Patients should be monitored for clinical signs of agranulocytosis and consideration should be given to routine blood count determination for early detection of this. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ide, Minako; Kato, Takeo; Nakata, Masatoshi; Saito, Keiko; Yoshida, Takeshi; Awaya, Tomonari; Heike, Toshio] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan	Kato, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	takeo819@kuhp.kyoto-u.ac.jp	Awaya, Tomonari/O-2757-2015	Awaya, Tomonari/0000-0002-9004-3172			Andres E, 2008, CURR OPIN HEMATOL, V15, P15; Flanagan RJ, 2008, HUM PSYCHOPHARM CLIN, V23, P27, DOI 10.1002/hup.917; Lu W, 2008, DRUG METAB DISPOS, V36, P1624, DOI 10.1124/dmd.107.019554; Wheless JW, 2009, J CHILD NEUROL, V24, P1520, DOI 10.1177/0883073809350508; Hsieh DT, 2013, THER ADV NEUROL DISO, V6, P189, DOI 10.1177/1756285613481083; Stubner S, 2004, PHARMACOPSYCHIATRY, V37, pS70, DOI 10.1055/s-2004-815513; Tesfa D, 2009, AM J HEMATOL, V84, P428, DOI 10.1002/ajh.21433; Thome-Souza S, 2014, EPILEPSIA, V55, P1235, DOI 10.1111/epi.12689; Ural AU, 2005, EPILEPTIC DISORD, V7, P33	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					825	828		10.1016/j.braindev.2014.12.010		4	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800014		
J	Yamamoto, S; Takahashi, S; Tanaka, R; Okayama, A; Araki, A; Katano, H; Tanaka-Taya, K; Azuma, H				Yamamoto, Shiho; Takahashi, Satoru; Tanaka, Ryosuke; Okayama, Akie; Araki, Akiko; Katano, Harutaka; Tanaka-Taya, Keiko; Azuma, Hiroshi			Human herpesvirus-6 infection-associated acute encephalopathy without skin rash	BRAIN & DEVELOPMENT			English	Article						Diffusion-weighted imaging; Encephalitis; Encephalopathy; Exanthema subitum; Human herpesvirus-6; Magnetic resonance imaging; Periventricular white matter	EXANTHEM-SUBITUM; HUMAN-HERPESVIRUS-6 INFECTION	Background: Human herpesvirus-6 (HHV-6) is the etiological agent of exanthema subitum-associated encephalopathy, which usually occurs in children younger than 3 years. Brain imaging shows various abnormalities. Patient: A previously healthy 4-year-old girl developed acute encephalopathy with clinical features consisting of fever, repetitive seizures, and a disturbance of consciousness. The patient did not show skin rash suggestive of exanthema subitum during the course of her illness. The primary HHV-6 infection was diagnosed based on the absence of IgG against HHV-6 and identification of the virus DNA in the acute phase serum and a significant increase of the anti-HHV-6 IgG titers in the convalescent phase sera. Diffusion-weighted images showed transient high signal intensity in the bilateral periventricular white matter and splenium of the corpus callosum and in the gray matter structures such as the bilateral basal ganglia and thalami. Upon therapy with steroid and gamma-globulin, the patient recovered without any neurological deficits. Conclusion: Primary HHV-6 infection can cause acute encephalopathy without exanthema subitum. The etiological diagnosis is possible only by examining the blood and cerebrospinal fluid, when the patient shows no skin rash. This condition should be included in the differential diagnosis of acute encephalopathy even in patients older than 3 years. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Yamamoto, Shiho; Takahashi, Satoru; Tanaka, Ryosuke; Okayama, Akie; Araki, Akiko; Azuma, Hiroshi] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido 0788510, Japan; [Katano, Harutaka] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan; [Tanaka-Taya, Keiko] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo 1628640, Japan	Takahashi, S (reprint author), Asahikawa Med Univ, Dept Pediat, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	satoru5p@asahikawa-med.ac.jp			Ministry of Health, Labour and Welfare, Japan [H25-Shinko-Shitei-006]	This work was supported in part by a research grant from The Ministry of Health, Labour and Welfare, Japan (Grant Number H25-Shinko-Shitei-006).	Kawamura Y, 2011, J CLIN VIROL, V51, P12, DOI 10.1016/j.jcv.2011.02.002; Provenzale JM, 2008, RADIOLOGY, V249, P955, DOI 10.1148/radiol.2492071917; Yoshikawa T, 2009, PEDIATR NEUROL, V41, P353, DOI 10.1016/j.pediatrneurol.2009.05.012; Akasaka M, 2005, BRAIN DEV-JPN, V27, P30, DOI 10.1016/j.braindev.2004.03.009; YAMANISHI K, 1988, LANCET, V1, P1065; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207; Bozzola E, 2012, INFECTION, V40, P563, DOI 10.1007/s15010-012-0295-9; Katano H, 2011, J MED VIROL, V83, P322, DOI 10.1002/jmv.21962; Novoa LJ, 1997, J MED VIROL, V52, P301, DOI 10.1002/(SICI)1096-9071(199707)52:3<301::AID-JMV11>3.0.CO;2-L; OKI J, 1995, BRAIN DEV-JPN, V17, P356, DOI 10.1016/0387-7604(95)00077-O; TAKAHASHI K, 1992, PEDIATR INFECT DIS J, V11, P369, DOI 10.1097/00006454-199205000-00006	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	SEP	2015	37	8					829	832		10.1016/j.braindev.2014.12.005		4	Clinical Neurology	Neurosciences & Neurology	CQ8PV	WOS:000360871800015		
J	Toh, U; Iwakuma, N; Mishima, M; Okabe, M; Nakagawa, S; Akagi, Y				Toh, U.; Iwakuma, N.; Mishima, M.; Okabe, M.; Nakagawa, S.; Akagi, Y.			Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer	BREAST CANCER RESEARCH AND TREATMENT			English	Article						Breast cancer; Sentinel lymph node; Indocyanine green (ICG); Near-infrared fluorescence	STANDARD AXILLARY TREATMENT; QUALITY-OF-LIFE; AMERICAN-SOCIETY; BIOPSY; DISSECTION; TRIAL; FEASIBILITY; MORBIDITY	A new sensitive fluorescence imaging system was developed for the real-time identification of sentinel lymph nodes (SLNs) in patients with early breast cancer. The purpose of this study was to evaluate the utility of a color charge-coupled device camera system for the intraoperative detection of SLNs and to determine its clinical efficacy and sensitivity in patients with operable breast cancer. We assessed a total of 168 patients diagnosed with or suspected of having early-stage breast cancer without metastasis in SLNs. The intraoperative detection of SLNs was performed using the conventional Indigo Carmine dye (indigotindisulfonate sodium) technique combined with a new Indocyanine green (ICG) imaging system (HyperEye Medical System: HEMS, MIZUHO IKAKOGYO, Japan) to map SLNs, in which the lymphatic vessels and SLNs were visualized transcutaneously with illuminating ICG fluorescence. Between January 2012 and May 2013, SLNs were successfully identified in all 168 patients (detection rate: 100 %). By histopathology, the sensitivity was 93.8 % for the detection of the metastatic involvement of SLNs (15 of 16 nodal-positive patients). After a median follow-up of 30.5 months, none of the patients presented with axillary recurrence. These results suggest that the HEMS imaging system is a feasible and effective method for the detection of SLNs in breast cancer. Furthermore, the HEMS device permitted the transcutaneous visualization of lymphatic vessels under light conditions, thus facilitating the identification and detection of SLNs without affecting the surgical procedure, together with a high sensitivity and specificity.	[Toh, U.; Iwakuma, N.; Mishima, M.; Okabe, M.; Nakagawa, S.; Akagi, Y.] Kurume Univ, Dept Surg, Sch Med, Kurume, Fukuoka 8300011, Japan	Toh, U (reprint author), Kurume Univ, Dept Surg, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	utoh@med.kurume-u.ac.jp			Japanese Society for the Promotion of Science	This study was partially supported by research funding from the Japanese Society for the Promotion of Science.	Crane LMA, 2011, MOL IMAGING BIOL, V13, P1043, DOI 10.1007/s11307-010-0425-7; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Turner RR, 1997, ANN SURG, V226, P271, DOI 10.1097/00000658-199709000-00006; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Murawa D, 2009, BRIT J SURG, V96, P1289, DOI 10.1002/bjs.6721; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Stratmann SL, 1999, AM J SURG, V178, P454, DOI 10.1016/S0002-9610(99)00230-5; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Verbelen H, 2014, BREAST CANCER RES TR, V144, P21, DOI 10.1007/s10549-014-2846-5; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Rutgers EJT, 2005, EJSO, V31, P568, DOI 10.1016/j.ejso.2005.02.008; Temple LKF, 2002, ANN SURG ONCOL, V9, P654, DOI 10.1007/BF02574481; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; Wishart GC, 2012, EJSO-EUR J SURG ONC, V38, P651, DOI 10.1016/j.ejso.2012.05.007; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Wilke LG, 2006, ANN SURG ONCOL, V13, P491, DOI 10.1245/ASO.2006.05.013; Abe H, 2011, SURG TODAY, V41, P197, DOI 10.1007/s00595-009-4254-8; Fleissig A, 2006, BREAST CANCER RES TR, V95, P279, DOI 10.1007/s10549-005-9025-7; Bass SS, 1999, BREAST J, V5, P288, DOI 10.1046/j.1524-4741.1999.00001.x; De Gournay E, 2013, BRIT J CANCER, V109, P2783, DOI 10.1038/bjc.2013.658; Galimberti V, 2014, EJSO-EUR J SURG ONC, V40, P1203, DOI 10.1016/j.ejso.2014.07.041; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Giuliano AE, 1994, ANN SURG, V220, P398; Handa Takemi, 2009, Interact Cardiovasc Thorac Surg, V9, P150, DOI 10.1510/icvts.2008.201418; Handa Takemi, 2010, Gen Thorac Cardiovasc Surg, V58, P68, DOI 10.1007/s11748-009-0536-8; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Morton DL, 1999, ANN SURG ONCOL, V6, P12, DOI 10.1007/s10434-999-0012-9; Ram R, 2014, INT J BREAST CANC, V2014; Sandrucci S, 1999, TUMORI, V85, P425; Sardi A, 2002, AM SURGEON, V68, P24; van der Ploeg IMC, 2008, ANN SURG ONCOL, V15, P1025, DOI 10.1245/s10434-007-9760-6	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	SEP	2015	153	2					337	344		10.1007/s10549-015-3542-9		8	Oncology	Oncology	CQ5TU	WOS:000360669400010		
J	Akechi, T; Momino, K; Iwata, H				Akechi, Tatsuo; Momino, Kanae; Iwata, Hiroji			Brief screening of patients with distressing fear of recurrence in breast cancer survivors	BREAST CANCER RESEARCH AND TREATMENT			English	Letter									[Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Momino, Kanae] Nagoya City Univ, Grad Sch Nursing, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan	Akechi, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Mizuho Ku, Mizuho Cho, Nagoya, Aichi 4678601, Japan.	takechi@med.nagoya-cu.ac.jp					Mitchell AJ, 2013, LANCET ONCOL, V14, P721, DOI 10.1016/S1470-2045(13)70244-4; Akechi T, 2014, BREAST CANCER RES TR, V145, P205, DOI 10.1007/s10549-014-2929-3; Momino K, 2014, JPN J CLIN ONCOL, V44, P456, DOI 10.1093/jjco/hyu032	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	SEP	2015	153	2					475	476		10.1007/s10549-015-3537-6		2	Oncology	Oncology	CQ5TU	WOS:000360669400025		
J	Kondo, T; Uehara, T; Ikegami, A; Hirota, Y; Ikusaka, M				Kondo, Takeshi; Uehara, Takanori; Ikegami, Akiko; Hirota, Yusuke; Ikusaka, Masatomi			Bilateral Trapezius Ridge Pain With Sustained Low-Grade Fever Caused by Aortic Dissection	CANADIAN JOURNAL OF CARDIOLOGY			English	Editorial Material								Aortic dissection generally causes severe chest pain and ischemic symptoms related to branch vessel occlusion, but patients with this disease might present with unexpected symptoms. We report a case of a man with pain extending from the nuchal region to both shoulders and fever for 3 weeks. Bilateral trapezius ridge pain, which is characteristically associated with pericarditis, and persistent fever were the only diagnostic clues to aortic dissection. This case also emphasizes that aortic dissection should be considered as a cause of unexplained persistent fever.	[Kondo, Takeshi; Uehara, Takanori; Ikegami, Akiko; Hirota, Yusuke; Ikusaka, Masatomi] Chiba Univ Hosp, Dept Gen Med, Chiba, Chiba 2608677, Japan	Kondo, T (reprint author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608677, Japan.	reds_liverpool_2005@yahoo.co.jp					Spodick DH, 2003, JAMA-J AM MED ASSOC, V289, P1150, DOI 10.1001/jama.289.9.1150; Park SW, 2004, MAYO CLIN PROC, V79, P1252; Bains SR, 2008, AM J EMERG MED, V26, p[e3, 379]; Scawn NDA, 2001, ANESTH ANALG, V93, P260, DOI 10.1097/00000539-200108000-00004; Shimada S, 2007, CIRC J, V71, P766, DOI 10.1253/circj.71.766	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	SEP	2015	31	9							1204.e17	10.1016/j.cjca.2015.02.017		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CQ4GC	WOS:000360561400019		
J	Genest, VX; Miki, H; Vinet, L; Zhedanov, A				Genest, Vincent X.; Miki, Hiroshi; Vinet, Luc; Zhedanov, Alexei			Spin lattices, state transfer, and bivariate Krawtchouk polynomials	CANADIAN JOURNAL OF PHYSICS			English	Article								The quantum state transfer properties of a class of two-dimensional spin lattices on a triangular domain are investigated. Systems for which the 1-excitation dynamics is exactly solvable are identified. The exact solutions are expressed in terms of the bivariate Krawtchouk polynomials that arise as matrix elements of the unitary representations of the rotation group on the states of the three-dimensional harmonic oscillator.	[Genest, Vincent X.; Vinet, Luc] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada; [Miki, Hiroshi] Doshisha Univ, Dept Elect, Kyoto 6100394, Japan; [Zhedanov, Alexei] Donetsk Inst Phys & Technol, UA-340114 Donetsk, Ukraine	Genest, VX (reprint author), Univ Montreal, Ctr Rech Math, POB 6128,Ctr Ville Stn, Montreal, PQ H3C 3J7, Canada.	vincent.genest@umontreal.ca					Albanese C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.230502; Genest VX, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/4/045207; Miki H, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/12/125207; Bose S, 2007, CONTEMP PHYS, V48, P13, DOI 10.1080/00107510701342313; Genest VX, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/50/505203; Kay A, 2010, INT J QUANTUM INF, V8, P641, DOI 10.1142/S0219749910006514; Genest VX, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/21/215204; Vinet L, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.012323; Chakrabarti R, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/8/085302; Diaconis P, 2014, J STAT PLAN INFER, V154, P39, DOI 10.1016/j.jspi.2014.02.004; Genest VX, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/2/025202; Griffiths B.C., 1971, AUST J STAT, V13, P27, DOI [10.1111/j.1467-842X.1971.tb01239.x, DOI 10.1111/J.1467-842X.1971.TB01239.X.]; Grunbaum FA, 2011, SYMMETRY INTEGR GEOM, V7, DOI 10.3842/SIGMA.2011.119; Grunbaum FA, 2007, SYMMETRY INTEGR GEOM, V3, DOI 10.3842/SIGMA.2007.065; Iliev P, 2012, T AM MATH SOC, V364, P4225; KOEKOEK R, 2010, SPRINGER MONOGR MATH, P1; Miki H, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062306; Post S, 2015, ACTA APPL MATH, V135, P209, DOI 10.1007/s10440-014-9953-5; Vinet L, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.052319	19	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4204	1208-6045		CAN J PHYS	Can. J. Phys.	SEP	2015	93	9					979	984		10.1139/cjp-2014-0568		6	Physics, Multidisciplinary	Physics	CQ5RQ	WOS:000360663700011		
J	Ali, MA; Siddiki, SMAH; Kon, K; Shimizu, K				Ali, Md. Ayub; Siddiki, S. M. A. Hakim; Kon, Kenichi; Shimizu, Ken-ichi			A Heterogeneous Niobium(V) Oxide Catalyst for the Direct Amidation of Esters	CHEMCATCHEM			English	Article						amidation; amines; esters; heterogeneous catalysis; Lewis acids	SOLVENT-FREE CONDITIONS; CARBOXYLIC-ACIDS; AMINO-ALCOHOLS; AMIDE FORMATION; TRANSAMIDATION	This study reports the first example of a heterogeneous catalytic system for the direct amidation of various esters with amines. Of 25 types of catalyst, Nb2O5 shows the highest activity in the amidation of methyl benzoate with aniline. Nb2O5 gives high yields in the amidation of various esters and amines under solvent-free conditions, is reusable, and shows higher turnover numbers than previously reported homogeneous catalysts such as La(OTf)(3). IR spectroscopic studies of ethyl acetate adsorbed on the catalysts show a strong acid-base interaction between the Nb5+ Lewis acid site and carbonyl oxygen, which can result in high reactivity of the ester with a nucleophile (amine) and, thus, high activity of Nb2O5. Kinetic results show that the activity of Nb2O5 does not markedly decrease with increasing aniline concentration, in contrast to reference catalysts TiO2 and La(OTf)(3). The relatively low negative impact of basic molecules on the Lewis acid catalysis of Nb2O5 also enables its high activity.	[Ali, Md. Ayub; Kon, Kenichi; Shimizu, Ken-ichi] Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 0010021, Japan; [Siddiki, S. M. A. Hakim; Shimizu, Ken-ichi] Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries, Katsura, Kyoto 6158520, Japan	Shimizu, K (reprint author), Hokkaido Univ, Catalysis Res Ctr, N-21,W-10, Sapporo, Hokkaido 0010021, Japan.	kshimizu@cat.hokudai.ac.jp			MEXT (Japan) [26289299]; MEXT program "Elements Strategy Initiative to Form Core Research Center"; JSPS [25106010]	This work was supported by Grant-in-Aids for Scientific Research B (26289299) from MEXT (Japan), the MEXT program "Elements Strategy Initiative to Form Core Research Center", and a Grant-in-Aid for Scientific Research on Innovative Areas "Nano Informatics" (25106010) from JSPS.	de Oliveira VM, 2011, CHEMCATCHEM, V3, P1911, DOI 10.1002/cctc.201100221; Gnanaprakasam B, 2011, J AM CHEM SOC, V133, P1682, DOI 10.1021/ja109944n; Lanigan RM, 2013, EUR J ORG CHEM, V2013, P7453, DOI 10.1002/ejoc.201300573; Han C, 2005, J AM CHEM SOC, V127, P10039, DOI 10.1021/ja0527976; Constable DJC, 2007, GREEN CHEM, V9, P411, DOI 10.1039/b703488c; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Movassaghi M, 2005, ORG LETT, V7, P2453, DOI 10.1021/ol050773y; Carey JS, 2006, ORG BIOMOL CHEM, V4, P2337, DOI 10.1039/b602413k; Nakajima K, 2011, J AM CHEM SOC, V133, P4224, DOI 10.1021/ja110482r; Lundberg H, 2014, CHEM SOC REV, V43, P2714, DOI 10.1039/c3cs60345h; Caldwell N, 2013, ORG LETT, V15, P2506, DOI 10.1021/ol400987p; Dimitrijevic E, 2013, ACS CATAL, V3, P945, DOI 10.1021/cs4000848; Sabot C, 2007, TETRAHEDRON LETT, V48, P3863, DOI 10.1016/j.tetlet.2007.03.146; Morimoto H, 2014, ORG LETT, V16, P2018, DOI 10.1021/ol500593v; Tamura M, 2012, APPL CATAL A-GEN, V433, P135, DOI 10.1016/j.apcata.2012.05.008; Caldwell N, 2013, ACS SUSTAIN CHEM ENG, V1, P1339, DOI 10.1021/sc400204g; Ali MA, 2014, CHEM-EUR J, V20, P14256, DOI 10.1002/chem.201404538; Ali MA, 2014, TETRAHEDRON LETT, V55, P1316, DOI 10.1016/j.tetlet.2013.12.111; Tamura M, 2012, GREEN CHEM, V14, P717, DOI 10.1039/c2gc16316k; Ohshima T, 2012, CHEM COMMUN, V48, P5434, DOI 10.1039/c2cc32153j; Ishihara K, 2009, TETRAHEDRON, V65, P1085, DOI 10.1016/j.tet.2008.11.004; Bundesmann MW, 2010, TETRAHEDRON LETT, V51, P3879, DOI 10.1016/j.tetlet.2010.05.075; Caldwell N, 2014, J ORG CHEM, V79, P9347, DOI 10.1021/jo501929c; Guo ZR, 2001, TETRAHEDRON LETT, V42, P1843, DOI 10.1016/S0040-4039(01)00079-X; Jackson D., 2010, CHEM COMMUN, V46, P1813; Kim K, 2015, J ORG CHEM, V80, P4152, DOI 10.1021/acs.joc.5b00101; Kuroki Y, 1998, B CHEM SOC JPN, V71, P1221, DOI 10.1246/bcsj.71.1221; Lee J, 2014, ADV SYNTH CATAL, V356, P2653, DOI 10.1002/adsc.201400319; Novak A, 2006, TETRAHEDRON LETT, V47, P5767, DOI 10.1016/j.tetlet.2006.06.004; Sun HF, 2014, CATAL SCI TECHNOL, V4, P3870, DOI 10.1039/c3cy00799e; Valeur K., 2009, CHEM SOC REV, V38, P606; Varma RS, 1999, TETRAHEDRON LETT, V40, P6177, DOI 10.1016/S0040-4039(99)01209-5; Wali A, 1998, J CATAL, V173, P84, DOI 10.1006/jcat.1997.1896	33	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	SEP 1	2015	7	17					2705	2710		10.1002/cctc.201500601		6	Chemistry, Physical	Chemistry	CQ7XX	WOS:000360821200021		
J	Yanai, H				Yanai, Hikaru			Chemistry of Fluorinated Carbon Acids: Synthesis, Physicochemical Properties, and Catalysis	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Review						Bronsted acid; acidity; carbanion; catalyst; triflyl group	KETENE SILYL ACETALS; MUKAIYAMA-MICHAEL REACTION; GAS-PHASE ACIDITIES; CLAISEN CONDENSATION; BRONSTED ACIDS; ALDOL REACTION; AB-INITIO; LACTONES; KETONES; DERIVATIVES	The bisktrifluoromethyl)sulfonyllmethyl (Tf2CH; Tf=SO2CF3) group is known to be one of the strongest carbon acid functionalities. The acidity of such carbon acids in the gas phase is stronger than that of sulfuric acid. Our recent investigations have demonstrated that this type of carbon acids work as novel acid catalysts. In this paper, recent achievements in carbon acid chemistry by our research group, including synthesis, physicochemical properties, and catalysis, are summarized.	Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Yanai, H (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yanai@toyaku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Mitsubishi Gas Chemical Co., Ltd.; Asahi Glass Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Hoansha Foundation	The author expresses sincere appreciation to Professor Emeritus Takeo Taguchi (Tokyo University of Pharmacy and Life Sciences, TUPLS) and Professor Takashi Matsumoto (TUPLS) for their continued support and useful discussions. The author is also grateful to Professor Emeritus Fumiyo Kusu (TUPLS), Dr. Akira Kotani (TUPLS), Professor Emeritus Masaaki Mishima (Kyushu University), and Professor Emeritus Takaaki Sonoda (Kyushu University) for acidity measurements. The research reported here was made possible by the contributions of several collaborators, including students whose names are acknowledged in the publications cited. Central Glass Co., Ltd. kindly provided us Tf<INF>2</INF>CH<INF>2</INF> 1 as the gift. The present work was supported in part by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Scientific Research (C) and for Innovative Area "Advanced Molecular Transformation by Organocatalysis" from the Japan Society for the Promotion of Science, as well as Grants from Mitsubishi Gas Chemical Co., Ltd., Asahi Glass Foundation, Kurata Memorial Hitachi Science and Technology Foundation, and Hoansha Foundation.	Alcaide B, 2015, CHEM COMMUN, V51, P6992, DOI 10.1039/c5cc01223f; Alcaide B, 2015, CHEM COMMUN, V51, P3395, DOI 10.1039/c4cc10111a; Kim HS, 2001, J ELECTROANAL CHEM, V498, P209, DOI 10.1016/S0022-0728(00)00413-7; HOMMA K, 1990, B CHEM SOC JPN, V63, P1898, DOI 10.1246/bcsj.63.1898; Gutowski KE, 2006, J PHYS CHEM A, V110, P12044, DOI 10.1021/jp065243d; Lopez CS, 2005, J ORG CHEM, V70, P3654, DOI 10.1021/jo0501339; Waller FJ, 1999, J ORG CHEM, V64, P2910, DOI 10.1021/jo9800917; Yanai H, 2013, ASIAN J ORG CHEM, V2, P989, DOI 10.1002/ajoc.201300157; Chen JW, 2012, ANGEW CHEM INT EDIT, V51, P5897, DOI 10.1002/anie.201200378; Ishihara K, 2001, ANGEW CHEM INT EDIT, V40, P4077, DOI 10.1002/1521-3773(20011105)40:21<4077::AID-ANIE4077>3.0.CO;2-1; KOPPEL IA, 1994, J AM CHEM SOC, V116, P3047, DOI 10.1021/ja00086a038; Yanai H, 2010, CHEM COMMUN, V46, P8728, DOI 10.1039/c0cc02438d; FOROPOULOS J, 1984, INORG CHEM, V23, P3720, DOI 10.1021/ic00191a011; Nishimoto Y, 2011, ANGEW CHEM INT EDIT, V50, P8623, DOI 10.1002/anie.201104140; Boxer MB, 2006, J AM CHEM SOC, V128, P48, DOI 10.1021/ja054725k; Hasegawa A, 2006, ORG LETT, V8, P3175, DOI 10.1021/ol060939a; BROWN HC, 1955, J AM CHEM SOC, V77, P3752, DOI 10.1021/ja01619a022; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Brice T. J, 1956, U. S. Patent, Patent No. [2 732 398, 2732398]; Corey EJ, 1998, J AM CHEM SOC, V120, P12777, DOI 10.1021/ja983041s; Engelbrecht V. A., 1977, Z ANORGANISCHE ALLGE, V433, P19; GRAMSTAD T, 1957, J CHEM SOC, P4069, DOI 10.1039/jr9570004069; Hasegawa A, 2005, B CHEM SOC JPN, V78, P1401, DOI 10.1246/bcsj.78.1401; HASZELDINE RN, 1954, J CHEM SOC, P4228, DOI 10.1039/jr9540004228; HENDRICK.JB, 1974, J AM CHEM SOC, V96, P2275, DOI 10.1021/ja00814a061; Hiraiwa Y, 2006, EUR J ORG CHEM, P1837, DOI 10.1002/ejoc.200500845; Iida A, 2005, CHEM COMMUN, P3171, DOI 10.1039/b504750a; Ishihara K, 2002, SYNLETT, P1296; Ishihara K, 2002, SYNLETT, P1299; Iwata S, 2007, CHEM LETT, V36, P538, DOI 10.1246/cl.2007.538; Kong K, 2006, ORG LETT, V8, P2909, DOI 10.1021/ol060534q; Koppel IA, 2000, J AM CHEM SOC, V122, P5114, DOI 10.1021/ja0000753; Koshar R. J., 1977, U.S. Patent, Patent No. [4,053,519, 4053519, 4 053 519]; Koshar R. J., 1976, U.S. Patent, Patent No. [3 962 346, 3962346]; KOSHAR RJ, 1973, J ORG CHEM, V38, P3358, DOI 10.1021/jo00959a026; Leito I, 2009, J PHYS CHEM A, V113, P8421, DOI 10.1021/jp903780k; Mathieu B, 2002, TETRAHEDRON, V58, P8219, DOI 10.1016/S0040-4020(02)00971-7; Mathieu B, 2000, TETRAHEDRON LETT, V41, P9561, DOI 10.1016/S0040-4039(00)01694-4; Olah G. A., 2009, SUPERACID CHEM; ONAKA M, 1989, TETRAHEDRON LETT, V30, P6341, DOI 10.1016/S0040-4039(01)93889-4; Robins J., 1985, ACS SYM SER, V286, P263; Takahashi A, 2008, CHEM COMMUN, P2385, DOI 10.1039/b800815a; Takahashi A, 2010, J ORG CHEM, V75, P1259, DOI 10.1021/jo902641g; Takamura K, 1999, J ELECTROANAL CHEM, V468, P53, DOI 10.1016/S0022-0728(99)00049-2; TUROWSKY L, 1988, INORG CHEM, V27, P2135, DOI 10.1021/ic00285a025; WENKE G, 1983, SYNTHETIC COMMUN, V13, P449, DOI 10.1080/00397918308081822; Yamamoto H., 2008, ACID CATALYSIS MODER, V1, P35; Yanai H, 2011, CHEM COMMUN, V47, P7245, DOI 10.1039/c1cc12093j; Yanai H, 2010, J ORG CHEM, V75, P5375, DOI 10.1021/jo100915e; Yanai H, 2014, ASIAN J ORG CHEM, V3, P556, DOI 10.1002/ajoc.201402010; Yanai H, 2013, ANGEW CHEM INT EDIT, V52, P1560, DOI 10.1002/anie.201208809; Yanai H, 2015, J FLUORINE CHEM, V174, P108, DOI 10.1016/j.jfluchem.2014.11.006; Yanai H, 2013, TETRAHEDRON LETT, V54, P2160, DOI 10.1016/j.tetlet.2013.02.039; Yanai H, 2013, MOLECULES, V18, P15531, DOI 10.3390/molecules181215531; Yanai H, 2011, CHEM-EUR J, V17, P11747, DOI 10.1002/chem.201102023; Yanai H, 2012, CHEM COMMUN, V48, P8967, DOI 10.1039/c2cc33606e; Yanai H, 2014, J SYN ORG CHEM JPN, V72, P158; Zhang M, 2015, J PHYS ORG CHEM, V28, P181, DOI 10.1002/poc.3304; ZHU SZ, 1994, SYNTHESIS-STUTTGART, P261	59	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	SEP	2015	63	9					649	662				14	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CQ4TY	WOS:000360598700001		
J	Koide, T; Yamamoto, Y; Fukami, T; Katori, N; Okuda, H; Hiyama, Y				Koide, Tatsuo; Yamamoto, Yoshihisa; Fukami, Toshiro; Katori, Noriko; Okuda, Haruhiro; Hiyama, Yukio			Analysis of Distribution of Ingredients in Commercially Available Clarithromyein Tablets Using Near-Infrared Chemical Imaging with Principal Component Analysis and Partial Least Squares	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						near-infrared; chemical imaging; clarithromycin; principal component analysis; partial least squares	INFORMATION; MICROSCOPY; INTERNET	The aim of this study was to evaluate pharmaceuticals using a near-infrared chemical imaging (NIR-CI) technique for visualizing the distribution of ingredients in solid dosage forms of commercially available clarithromycin tablets. The cross section of a tablet was measured using the NIR-CI system for evaluating the distribution of ingredients in the tablet. The chemical images were generated by performing multivariate analysis methods: principal component analysis (PCA) and partial least squares (PLS) with normalized near-infrared (NIR) spectral data. We gained spectral and distributional information related to clarithromycin, cornstarch, and magnesium stearate by using PCA analysis. On the basis of this information, the distribution images of these ingredients were generated using PLS analysis. The results of PCA analysis enabled us to analyze individual components by using PLS even if sufficient information on the products was not available. However, some ingredients such as binder could not be detected using NIR-CI, because their particle sizes were smaller than the pixel size (approximately 25x25x50 mu m) and they were present in low concentrations. The combined analysis using both PCA and PLS with NIR-CI was useful to analyze the distribution of ingredients in a commercially available pharmaceutical even when sufficient information on the product is not available.	[Koide, Tatsuo; Katori, Noriko; Okuda, Haruhiro; Hiyama, Yukio] Natl Inst Hlth Sci, Div Drugs, Setagaya Ku, Tokyo 1588501, Japan; [Yamamoto, Yoshihisa] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Fukami, Toshiro] Meiji Pharmaceut Univ, Dept Mol Pharmaceut, Kiyose, Tokyo 2048588, Japan	Koide, T (reprint author), Natl Inst Hlth Sci, Div Drugs, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	koide@nihs.go.jp					Westenberger BJ, 2005, INT J PHARM, V306, P56, DOI 10.1016/j.ijpharm.2005.08.027; Gendrin C, 2008, J PHARMACEUT BIOMED, V48, P533, DOI 10.1016/j.jpba.2008.08.014; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Clarke F, 2004, VIB SPECTROSC, V34, P25, DOI 10.1016/j.vibspec.2003.08.005; Cairos C, 2009, TALANTA, V79, P657, DOI 10.1016/j.talanta.2009.04.042; Gowen AA, 2008, EUR J PHARM BIOPHARM, V69, P10, DOI 10.1016/j.ejpb.2007.10.013; Clarke FC, 2002, APPL SPECTROSC, V56, P1475, DOI 10.1366/00037020260377797; Dubois J, 2007, SPECTROSCOPY, V22, P40; Hammond S. V., 2002, HDB VIBRATIONAL SPEC, V2, P1405; Hilden LR, 2008, INT J PHARM, V353, P283, DOI 10.1016/j.ijpharm.2007.11.032; Kimura K, 2010, PHARM TECH JPN, V26, P353; Koide T, 2013, INT J PHARMACEUT, V441, P135, DOI 10.1016/j.ijpharm.2012.12.005; Miura S., 2008, J JPN SOC HOSP PHARM, V44, P719; MROSO PV, 1982, J PHARM SCI, V71, P1096, DOI 10.1002/jps.2600711004; Nakajima Y., 2009, JPN J CLIN PHARM THE, V40, P295; Toda K, 2010, PHARM TECH JPN, V26, P347; Veronin MA, 2004, SCIENCE, V305, P481, DOI 10.1126/science.1097355; Yonemochi E., 2013, PHARM TECH JPN, V29, P37	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	SEP	2015	63	9					663	668				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CQ4TY	WOS:000360598700002		
J	Sakakibara, N; Igarashi, J; Takata, M; Demizu, Y; Misawa, T; Kurihara, M; Konishi, R; Kato, Y; Maruyama, T; Tsukamoto, I				Sakakibara, Norikazu; Igarashi, Junsuke; Takata, Maki; Demizu, Yosuke; Misawa, Takashi; Kurihara, Masaaki; Konishi, Ryoji; Kato, Yoshihisa; Maruyama, Tokumi; Tsukamoto, Ikuko			Synthesis and Evaluation of Novel Carbocyclic Oxetanocin A (COA-Cl) Derivatives as Potential Tube Formation Agents	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						2-chloro-carbocyclic oxetanocin A; 2-chloro-C center dot OXT-A; nucleoside derivative; angiogenic activity	SPHINGOSINE 1-PHOSPHATE; ENDOTHELIAL-CELLS; THERAPEUTIC ANGIOGENESIS; ANTIVIRAL ACTIVITY; RECEPTOR AGONISTS; ANALOGS; NUCLEOSIDE; MIGRATION	Six novel carbocyclic oxetanocin A analogs (2-chloro-C center dot OXT-A; COA-Cl) with various hydroxy-methylated or spiro-conjugated cyclobutane rings at the N-9-position of the 2-chloropurine moiety were synthesized and evaluated using human umbilical vein endothelial cells. All prepared compounds (2a-f) showed good to moderate activity with angiogenic potency. Among these compounds, 100 mu M cis-trans-2',3'-bis(hydroxymethyl)cyclobutyl derivative (2b), trans-3'-hydroxymethylcyclobutyl analog (2d), and 3',3'-bis(hydroxymethyl)cyclobutyl derivative (2e) had greater angiogenic activity, with relative tube areas of 3.43 +/- 0.44, 3.32 +/- 0.53, and 3.59 +/- 0.83 (mean +/- standard deviation (S.D.)), respectively, which was comparable to COA-Cl (3.91 +/- 0.78). These data may be important for further development of this class of compounds as potential tube formation agents.	[Sakakibara, Norikazu; Kato, Yoshihisa; Maruyama, Tokumi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan; [Igarashi, Junsuke] Kagawa Univ, Fac Med, Dept Cardiovasc Physiol, Kita Ku, Miki, Kagawa 7610793, Japan; [Takata, Maki; Konishi, Ryoji; Tsukamoto, Ikuko] Kagawa Univ, Fac Med, Dept Pharm BioInformat, Kita Ku, Miki, Kagawa 7610793, Japan; [Demizu, Yosuke; Misawa, Takashi; Kurihara, Masaaki] Natl Inst Hlth Sci, Div Organ Chem, Setagaya Ku, Tokyo 1588501, Japan	Sakakibara, N (reprint author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa Campus,1314-1 Shido, Sanuki, Kagawa 7692193, Japan.	bara@kph.bunri-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24790123]	This research was partially supported by a Grant-in-Aid for Young Scientists (B), No. 24790123, from the Japan Society for the Promotion of Science (JSPS).	Okabe N, 2013, BRAIN RES, V1506, P115, DOI 10.1016/j.brainres.2013.02.009; Tsukamoto I, 2010, BIOCHEM BIOPH RES CO, V399, P699, DOI 10.1016/j.bbrc.2010.08.003; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Sakakibara N, 2012, HETEROCYCLES, V85, P1105, DOI 10.3987/COM-12-12441; Rikitake Y, 2002, ARTERIOSCL THROM VAS, V22, P108, DOI 10.1161/hq0102.101843; Biswas K, 2013, J BIOL CHEM, V288, P2325, DOI 10.1074/jbc.M112.409656; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Bobek V, 2006, VASC PHARMACOL, V44, P395, DOI 10.1016/j.vph.2006.03.009; Radchenko DS, 2008, TETRAHEDRON-ASYMMETR, V19, P2924, DOI 10.1016/j.tetasy.2008.12.016; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yonesu K, 2009, BIOCHEM PHARMACOL, V77, P1011, DOI 10.1016/j.bcp.2008.12.007; Sakakibara N, 2013, BIOORGAN MED CHEM, V21, P5900, DOI 10.1016/j.bmc.2013.06.061; Singh J, 1998, ORG PROCESS RES DEV, V2, P393, DOI 10.1021/op970214+; SLUSARCHYK WA, 1989, TETRAHEDRON LETT, V30, P6453, DOI 10.1016/S0040-4039(01)88992-9; BISACCHI GS, 1991, J MED CHEM, V34, P1415, DOI 10.1021/jm00108a026; Wong MLH, 2009, J CLIN NEUROSCI, V16, P1119, DOI 10.1016/j.jocn.2009.02.009; Collinson DJ, 2004, EUR J VASC ENDOVASC, V28, P9, DOI 10.1016/j.ejvs.2004.03.021; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Buzard DJ, 2008, EXPERT OPIN THER PAT, V18, P1141, DOI 10.1517/13543770802390324; Crosignani S, 2010, BIOORG MED CHEM LETT, V20, P1516, DOI 10.1016/j.bmcl.2010.01.102; HENLIN JM, 1992, HELV CHIM ACTA, V75, P589, DOI 10.1002/hlca.19920750216; Igarashi J, 2007, AM J PHYSIOL-CELL PH, V292, pC740, DOI 10.1152/ajpcell.00117.2006; Igarashi J., 2014, PERSPECTIVES, V2; MARUYAMA T, 1990, CHEM PHARM BULL, V38, P2719; O'Toole G., 2000, BR J PLAST SURG, V54, P1; Shimizu H, 2005, CIRCULATION, V111, P222, DOI 10.1161/01.CIR.0000152101.41037.AB; Slusarchyk W. A., 1994, U.S. Patent, Patent No. [U.S. 5369098A 19941129, 5369098]; Tokunaga T., 2007, PCT Int. Appl., Patent No. [WO 2007032371 A1 20070322, 2007032371]; Tsukamoto I., 2010, PCT Int. Appl., Patent No. [WO 2010061931 A1 20100603, 2010061931]	29	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	SEP	2015	63	9					701	709				9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CQ4TY	WOS:000360598700007		
J	Tsukano, C; Yamamoto, S; Takemoto, Y				Tsukano, Chihiro; Yamamoto, Sho; Takemoto, Yoshiji			Synthesis of alpha-Acyloxyketone Derivatives via the Platinum-Catalyzed Migration of Propargylic Esters	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						platinum; propargylic ester migration; alpha-acyloxyketone	MIGRATION/INTRAMOLECULAR 3+2 CYCLOADDITION; GOLD CATALYSIS; STEREOSELECTIVE REDUCTION; SUBSTITUTED ALKANONES; ENYNYL ESTERS; KETONES; REARRANGEMENT; ACCESS; HYDROSILANES; CARBOXYLATES	The synthesis of alpha-acyloxyketones via the migration of a propargylic ester followed by the intramolecular nucleophilic addition of the resulting allene was achieved using a cationic platinum catalyst. The optimized conditions for this transformation were determined to be 3 mol% of Pt(cod)Cl-2, 3 mol% of AgNTf2, and 3 eq of water in toluene at 100 degrees C, and these conditions were successfully applied to the synthesis of a wide variety of alpha-aryl-alpha-acyloxyketones. The mechanism of this reaction was evaluated in detail based on the results of isotope labeling experiments using (H2O)-O-18.	[Tsukano, Chihiro; Yamamoto, Sho; Takemoto, Yoshiji] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Yoshida, Kyoto 6068501, Japan	Takemoto, Y (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Yoshida, Kyoto 6068501, Japan.	takemoto@pharm.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25105727]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Activation Directed toward Straightforward Synthesis" (25105727) and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Zheng HJ, 2010, J AM CHEM SOC, V132, P1788, DOI 10.1021/ja910346m; Buzas A, 2006, ORG LETT, V8, P515, DOI 10.1021/ol053100o; Husain SM, 2011, ADV SYNTH CATAL, V353, P2359, DOI 10.1002/adsc.201100150; Nishimoto Y, 2012, ORG LETT, V14, P1846, DOI 10.1021/ol300450j; Shiroodi RK, 2013, CHEM SOC REV, V42, P4991, DOI 10.1039/c3cs35514d; Lu L, 2009, J ORG CHEM, V74, P474, DOI 10.1021/jo802043z; Patil AS, 2012, ANGEW CHEM INT EDIT, V51, P7799, DOI 10.1002/anie.201202704; Yu Y, 2013, ANGEW CHEM INT EDIT, V52, P7586, DOI 10.1002/anie.201302402; Zhang GZ, 2007, J AM CHEM SOC, V129, P11358, DOI 10.1021/ja074536x; Correa A, 2008, ANGEW CHEM INT EDIT, V47, P718, DOI 10.1002/anie.200703769; Wang DW, 2012, J AM CHEM SOC, V134, P9012, DOI 10.1021/ja303862z; FUJITA M, 1988, J ORG CHEM, V53, P5405, DOI 10.1021/jo00258a003; Ji KG, 2013, ANGEW CHEM INT EDIT, V52, P6508, DOI 10.1002/anie.201301601; Shu XZ, 2008, CHEM-EUR J, V14, P10556, DOI 10.1002/chem.200801591; ZHU ZL, 1995, J ORG CHEM, V60, P7728, DOI 10.1021/jo00129a010; Rettenmeier E, 2013, ANGEW CHEM INT EDIT, V52, P5880, DOI 10.1002/anie.201301382; Hazra CK, 2012, ORG LETT, V14, P4010, DOI 10.1021/ol301827t; Davidson D, 1937, J ORG CHEM, V2, P328, DOI 10.1021/jo01227a005; Lifchits O, 2011, ANGEW CHEM INT EDIT, V50, P9680, DOI 10.1002/anie.201104244; Marco-Contelles J, 2007, CHEM-EUR J, V13, P1350, DOI 10.1002/chem.200601522; Tellitu I, 2007, J ORG CHEM, V72, P1526, DOI 10.1021/jo062320s; FUJITA M, 1988, J ORG CHEM, V53, P5415, DOI 10.1021/jo00258a004; Cai SY, 2011, ANGEW CHEM INT EDIT, V50, P11133, DOI 10.1002/anie.201104028; Chaudhuri R, 2012, ADV SYNTH CATAL, V354, P2241, DOI 10.1002/adsc.201200187; Cho EJ, 2008, ADV SYNTH CATAL, V350, P2719, DOI 10.1002/adsc.200800544; Fernandez C, 2005, SYNTHESIS-STUTTGART, P1701, DOI 10.1055/s-2005-869895; Hiett NP, 2011, J ORGANOMET CHEM, V696, P378, DOI 10.1016/j.jorganchem.2010.10.001; Kinoshita T, 1996, CHEM PHARM BULL, V44, P1208; Loner CM, 2012, TETRAHEDRON LETT, V53, P5641, DOI 10.1016/j.tetlet.2012.08.032; MAHRWALD R, 1991, ANGEW CHEM INT EDIT, V30, P593, DOI 10.1002/anie.199105931; Marion N, 2007, ANGEW CHEM INT EDIT, V46, P2750, DOI 10.1002/anie.200604773; Mokar B. D., 2014, J CHEM SOC CHEM COMM, V50, P8966; Nadkarni D, 2003, J ORG CHEM, V68, P594, DOI 10.1021/jo0260544; Oh CH, 2009, J ORG CHEM, V74, P370, DOI 10.1021/jo802103g; Pei WW, 1998, SYNTHESIS-STUTTGART, P1298; Sakaguchi K, 2008, TETRAHEDRON LETT, V49, P25, DOI 10.1016/j.tetlet.2007.11.023; Steck W., 1972, CAN J CHEM, V50, P443; TAKAHASHI T, 1985, TETRAHEDRON LETT, V26, P5139, DOI 10.1016/S0040-4039(00)98885-3; Vijaykumar D, 2002, J ORG CHEM, V67, P4904, DOI 10.1021/jo020190r; Wang SZ, 2010, SYNLETT, P692, DOI 10.1055/s-0029-1219527; Yang J. S., 1984, HUAXUE XUEBAO, V42, P1308; Zhang B, 2013, TETRAHEDRON, V69, P2033, DOI 10.1016/j.tet.2012.12.046; Zheng HJ, 2011, ORG LETT, V13, P6448, DOI 10.1021/ol202746s	43	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	SEP	2015	63	9					710	719				10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CQ4TY	WOS:000360598700008		
J	Goto, T; Amano, Y; Machida, M; Imazeki, F				Goto, Tatsuru; Amano, Yoshimasa; Machida, Motoi; Imazeki, Fumio			Effect of Polarity of Activated Carbon Surface, Solvent and Adsorbate on Adsorption of Aromatic Compounds from Liquid Phase	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						aromatic compound; adsorption; activated carbon; surface; oxidation; polarity	FUNCTIONAL-GROUPS; NONAQUEOUS MEDIA; OXIDATION; NITROBENZENE; MOLECULES; BENZENE; WATER	In this study, introduction of acidic functional groups onto a carbon surface and their removal were carried out through two oxidation methods and outgassing to investigate the adsorption mechanism of aromatic compounds which have different polarity (benzene and nitrobenzene). Adsorption experiments for these aromatics in aqueous solution and n-hexane solution were conducted in order to obtain the adsorption isotherms for commercial activated carbon (BAC) as a starting material, its two types of oxidized BAC samples (0Xs), and their outgassed samples at 900 degrees C (OGs). Adsorption and desorption kinetics of nitrobenzene for the BAC, OXs and OGs in aqueous solution were also examined. The results showed that the adsorption of benzene molecules was significantly hindered by abundant acidic functional groups in aqueous solution, whereas the adsorbed amount of nitrobenzene on OXs gradually increased as the solution concentration increased, indicating that nitrobenzene can adsorb favourably on a hydrophilic surface due to its high dipole moment, in contrast to benzene. In n-hexane solution, it was difficult for benzene to adsorb on any sample owing to the high affinity between benzene and n-hexane solvent. On the other hand, adsorbed amounts of nitrobenzene on OXs were larger than those of OGs in n-hexane solution, implying that nitrobenzene can adsorb two adsorption sites, graphene layers and surface acidic functional groups. The observed adsorption and desorption rate constants of nitrobenzene on the OXs were lower than those on the BAC due to disturbance of diffusion by the acidic functional groups.	[Goto, Tatsuru; Amano, Yoshimasa; Machida, Motoi] Chiba Univ, Grad Sch Engn, Inage Ku, Chiba 2638522, Japan; [Amano, Yoshimasa; Machida, Motoi; Imazeki, Fumio] Chiba Univ, Safety & Hlth Org, Inage Ku, Chiba 2638522, Japan	Goto, T (reprint author), Chiba Univ, Grad Sch Engn, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	aaaa2614@chiba-u.jp			Japan Society for the Promotion of Science (JSPS) [26340058]	This study was funded in part by the Japan Society for the Promotion of Science (JSPS) under Grant-in-Aid for Scientific Research (C) (No. 26340058).	Rangel-Mendez JR, 2002, WATER RES, V36, P1244, DOI 10.1016/S0043-1354(01)00343-8; Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8; Song XL, 2010, DESALINATION, V255, P78, DOI 10.1016/j.desal.2010.01.011; Coasne B, 2009, LANGMUIR, V25, P10648, DOI 10.1021/la900984z; Li DJ, 2012, BIORESOURCE TECHNOL, V113, P121, DOI 10.1016/j.biortech.2012.02.130; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Ahnert F, 2003, ADSORPTION, V9, P311, DOI 10.1023/A:1026271830072; Shafeeyan MS, 2010, J ANAL APPL PYROL, V89, P143, DOI 10.1016/j.jaap.2010.07.006; Chen JL, 2012, J COLLOID INTERF SCI, V370, P32, DOI 10.1016/j.jcis.2011.12.073; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Boehm HP, 2002, CARBON, V40, P145, DOI 10.1016/S0008-6223(01)00165-8; Radovic LR, 1997, CARBON, V35, P1339, DOI 10.1016/S0008-6223(97)00072-9; Dean J. A., 1998, LANGES HDB CHEM, VV, P105; Derylo-Marczewska A, 2004, CARBON, V42, P301, DOI 10.1016/j.carbon.2003.10.031; Derylo-Marczewska A, 2008, COLLOID SURFACE A, V327, P1, DOI 10.1016/j.colsurfa.2008.05.026; Dowaidar AM, 2007, SEPAR SCI TECHNOL, V42, P3609, DOI 10.1080/01496390701626537; Kato Y, 2008, J COLLOID INTERF SCI, V322, P394, DOI 10.1016/j.jcis.2008.03.027; Machida M., 2011, TANSO, V247, P62; Mourao PAM, 2011, FUEL PROCESS TECHNOL, V92, P241, DOI 10.1016/j.fuproc.2010.04.013; Oskouie AK, 2002, CARBON, V40, P1199, DOI 10.1016/S0008-6223(01)00264-0; RAMIS G, 1993, J ELECTRON SPECTROSC, V64-5, P297, DOI 10.1016/0368-2048(93)80091-Y; Tarasevich YI, 2003, COLLOID SURFACE A, V215, P285, DOI 10.1016/S0927-7757(02)00491-0	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	SEP	2015	63	9					726	730				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CQ4TY	WOS:000360598700010		
J	Funakoshi, Y; Iwao, Y; Noguchi, S; Itai, S				Funakoshi, Yuka; Iwao, Yasunori; Noguchi, Shuji; Itai, Shigeru			Effect of Alkyl Chain Length and Unsaturation of the Phospholipid on the Physicochemical Properties of Lipid Nanoparticles	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						lipid nanoparticle; poorly water-soluble drug; phospholipid; alkyl chain	WATER-SOLUBLE DRUG; ORAL ABSORPTION; NIFEDIPINE; DISSOLUTION; STABILITY	Previously, we developed lipid nanoparticles (LNs) containing poorly water-soluble drugs using two types of phospholipids, a neutral phospholipid (hydrogenated soybean phosphatidylcholine) and a negatively-charged phospholipid (dipalmitoylphosphatidylglycerol), with mean particle sizes of less than 100 am. Here, we studied the effects of alkyl chain length and unsaturation of neutral and negatively-charged phospholipids on the physicochemical properties of LNs. Three neutral phospholipids, dimyristoylphosphatidylcholine, dipalmitoylphosphatidylcholine and distearoylphosphatidylcholine, having different alkyl chain lengths, were compared. The mean particle size of the LNs increased with the alkyl chain length, while the concentration of the drug entrapped in the LNs decreased. The particle size of all of the LNs could be maintained at less than 100nm for 1 month in cool and dark conditions, with the LNs with longer alkyl chain lipids showing greater stability. In the unsaturated phospholipids, the double bond in the alkyl chain of dioleoylphosphatidylcholine and dierucoylphosphatidylcholine did not affect the physicochemical properties of the LNs. The negatively-charged phospholipids dipalmitoylphosphatidylglycerol and distearoylphosphatidylglycerol were also compared; LNs with longer alkyl chain lipids had larger particle sizes and lower drug concentrations, similar to the results for neutral phospholipids. We concluded that although some changes in physicochemical properties were observed among LNs with different phospholipid alkyl chain lengths, this methodology was general. LNs with suitable physicochemical properties could be prepared irrespective of the type of phospholipids used.	[Funakoshi, Yuka; Iwao, Yasunori; Noguchi, Shuji; Itai, Shigeru] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Pharmaceut Engn, Suruga Ku, Shizuoka 4228526, Japan	Itai, S (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Pharmaceut Engn, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	s-itai@u-shizuoka-ken.ac.jp					Ohshima H, 2009, INT J PHARMACEUT, V377, P180, DOI 10.1016/j.ijpharm.2009.05.004; Law D, 2003, J PHARM SCI, V92, P505, DOI 10.1002/jps.10324; Hecq J, 2005, INT J PHARM, V299, P167, DOI 10.1016/j.ijpharm.2005.05.014; Jinno J, 2006, J CONTROL RELEASE, V111, P56, DOI 10.1016/j.jconrel.2005.11.013; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Mohammed AR, 2004, INT J PHARM, V285, P23, DOI 10.1016/j.ijpharm.2004.07.010; Verma S, 2011, INT J PHARMACEUT, V406, P145, DOI 10.1016/j.ijpharm.2010.12.027; Barman R. K., 2014, PHARM PHARM, V5, P455; Barman RK, 2014, CHEM PHARM BULL, V62, P399; Chen CYC, 2009, J TAIWAN INST CHEM E, V40, P380, DOI 10.1016/j.jtice.2008.10.006; Funakoshi Y, 2013, INT J PHARMACEUT, V451, P92, DOI 10.1016/j.ijpharm.2013.04.050; Kamiya S, 2006, CHEM PHARM BULL, V54, P181, DOI 10.1248/cpb.54.181; Kamiya S, 2008, INT J PHARM, V354, P242, DOI 10.1016/j.ijpharm.2007.10.049; Mehnert W, 2012, ADV DRUG DELIVER REV, V64, P83, DOI 10.1016/j.addr.2012.09.021	15	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	SEP	2015	63	9					731	736				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CQ4TY	WOS:000360598700011		
J	Kawashima, H; Kimura, H; Nakaya, Y; Tomatsu, K; Arimitsu, K; Nakanishi, H; Ozeki, E; Kuge, Y; Saji, H				Kawashima, Hidekazu; Kimura, Hiroyuki; Nakaya, Yuta; Tomatsu, Kenji; Arimitsu, Kenji; Nakanishi, Hiroaki; Ozeki, Eiichi; Kuge, Yuji; Saji, Hideo			Application of Microreactor to the Preparation of C-11-Labeled Compounds via O-[C-11]Methylation with [C-11]CH3I: Rapid Synthesis of [C-11]Raclopride	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						microreactor; [C-11]raclopride; O-[C-11]methylation; [C-11]CH3I; positron emission tomography	MICRO-REACTORS; RECEPTORS; PET; BINDING	A new radiolabeling method using a microreactor was developed for the rapid synthesis of [C-11]raclopride. A chip bearing a Y-shaped mixing junction with a 200 mu m (width)X20 mu m (depth)x250 mm (length) flow channel was designed, and the efficiency of O-[C-11]methylation was evaluated. Dimethyl sulfoxide solutions containing the O-desmethyl precursor or [C-11]CH3I were introduced into separate injection ports by infusion syringes, and the radiochemical yields were measured under various conditions. The decay-corrected radiochemical yield of microreactor-derived [C-11]raclopride reached 12% in 20s at 25 degrees C, which was observed to increase with increasing temperature. In contrast, batch synthesis at 25 degrees C produced a yield of 5%: this indicates that this device could effectively achieve O-[C-11]methylation in a shorter period of time. The microreactor technique may facilitate simple and efficient routine production of C-11-labeled compounds via O-[C-11]methylation with [C-11]CH3I.	[Kawashima, Hidekazu; Kimura, Hiroyuki; Nakaya, Yuta; Tomatsu, Kenji; Arimitsu, Kenji; Kuge, Yuji; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Kawashima, Hidekazu] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Tobetsu, Hokkaido 0610293, Japan; [Nakanishi, Hiroaki; Ozeki, Eiichi] Shimadzu Co Ltd, Technol Res Lab, Seika, Kyoto 6190237, Japan; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Kita Ku, Sapporo, Hokkaido 0600815, Japan	Saji, H (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	hsaji@pharm.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18659345]	This research was partially supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan through a Grant-in-Aid for Exploratory Research (Award number 18659345).	Fletcher PDI, 2002, TETRAHEDRON, V58, P4735, DOI 10.1016/S0040-4020(02)00432-5; Gillies JM, 2006, APPL RADIAT ISOTOPES, V64, P325, DOI [10.1016/j.apradiso.2005.08.007, 10.1016/j.apradiso.2005.05.007]; FARDE L, 1988, PSYCHOPHARMACOLOGY, V94, P471, DOI 10.1007/BF00212840; Mizrahi R, 2009, INT J NEUROPSYCHOPH, V12, P715, DOI 10.1017/S1461145709000327; Pascali G, 2010, NUCL MED BIOL, V37, P547, DOI 10.1016/j.nucmedbio.2010.03.006; Johnson TJ, 2002, ANAL CHEM, V74, P45, DOI 10.1021/ac010895d; Langer O, 1999, J LABELLED COMPD RAD, V42, P1183; Lee CC, 2005, SCIENCE, V310, P1793, DOI 10.1126/science.1118919; Milozic N, 2014, CHEM BIOCHEM ENG Q, V28, P215; McCreedy T, 2001, ANAL CHIM ACTA, V427, P39, DOI 10.1016/S0003-2670(00)01174-0; Haroun S, 2013, CAN J CHEM, V91, P326, DOI 10.1139/cjc-2012-0331; Capretto L, 2011, TOP CURR CHEM, V304, P27, DOI 10.1007/128_2011_150; Lu SY, 2004, LAB CHIP, V4, P523, DOI 10.1039/b407938h; EHRIN E, 1987, J LABELLED COMPD RAD, V24, P931, DOI 10.1002/jlcr.2580240808; Bhagat Ali Asgar S, 2008, Journal of Micromechanics and Microengineering, V18, DOI 10.1088/0960-1317/18/8/085005; Hooper J, 2007, J LABELLED COMPD RAD, V50, P189, DOI 10.1002/jlcr.1254; Ikoma Y, 2009, NEUROIMAGE, V47, P1639, DOI 10.1016/j.neuroimage.2009.05.099; Ishiwata K, 1999, ANN NUCL MED, V13, P195; MAZIERE B, 1992, NUCL MED BIOL, V19, P497	19	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	SEP	2015	63	9					737	740				4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CQ4TY	WOS:000360598700012		
J	Yutani, R; Teraoka, R; Kitagawa, S				Yutani, Reiko; Teraoka, Reiko; Kitagawa, Shuji			Microemulsion Using Polyoxyethylene Sorbitan Trioleate and Its Usage for Skin Delivery of Resveratrol to Protect Skin against UV-Induced Damage	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						resveratrol; microemulsion; polyoxyethylene sorbitan trioleate; skin delivery; photoprotection; phase diagram	POLYPHENOLS; PREVENTION; CELLS	We examined the phase behavior of various polyoxyethylene sorbitan fatty acid ester (polysorbates)/ethanol/isopropyl myristate (IPM)/150mM NaCl solution (NaClaq) systems in order to prepare a microemulsion containing a low ratio of ethanol, which is more suitable for in vivo application. Using polyoxyethylene sorbitan trioleate (Tween 85), which has a large lipophilic moiety, as a surfactant component, single-phase domain of the phase diagram was the largest of all the polysorbates examined, and in particular a large oil-rich single-phase domain was obtained. When the ratio of Tween 85 to ethanol was changed from 1:1 to 3 :1, the oil-rich single-phase domain further expanded, which led to a reduced ethanol concentration in the preparation. Thus, we determined the composition of the microemulsion to be Tween 85: ethanol:IPM:NaClaq=30:10:53 :7, and used it for skin delivery of resveratrol. Microemulsion gel was also prepared by adding 6.5% Aerosil (R) 200 into the microemulsion for ease of topical application. When applied with each vehicle, delivery of resveratrol into guinea pig skin in vitro was significantly enhanced compared with that by IPM, and resveratrol incorporated into the skin by microemulsion gel decreased lipid peroxidation to 29.5% compared with that of the control. Pretreatment of guinea pig dorsal skin with the microemulsion gel containing resveratrol almost completely prevented UV-B-induced erythema formation in vivo. These findings demonstrate that the microemulsion using Tween 85 containing a minimal concentration of ethanol enhanced the skin delivery of resveratrol and the incorporated resveratrol exhibited a protective effect against UV-induced oxidative damage.	[Yutani, Reiko; Teraoka, Reiko; Kitagawa, Shuji] Kobe Pharmaceut Univ, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Yutani, R (reprint author), Kobe Pharmaceut Univ, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	r-yutani@kobepharma-u.ac.jp					Bisht K, 2010, TOXICOLOGY, V278, P88, DOI 10.1016/j.tox.2009.11.008; Kitagawa S, 2011, CHEM PHARM BULL, V59, P793; Kitagawa S, 2009, J PHARM PHARMACOL, V61, P855, DOI [10.1211/jpp/61.07.0003, 10.1211/jpp.61.07.0003]; Udenigwe CC, 2008, NUTR REV, V66, P445, DOI 10.1111/j.1753-4887.2008.00076.x; Afaq F, 2006, EXP DERMATOL, V15, P678, DOI 10.1111/j.0906-6705.2006.00466.x; Kreilgaard M, 2002, ADV DRUG DELIVER REV, V54, pS77, DOI 10.1016/S0169-409X(02)00116-3; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Caddeo C, 2008, INT J PHARMACEUT, V363, P183, DOI 10.1016/j.ijpharm.2008.07.024; Kitagawa S, 2010, CHEM PHARM BULL, V58, P398, DOI 10.1248/cpb.58.398; Pappinen S., 2006, PERCUTANEOUS PENETRA, V2nd, P109; Park K, 2008, ONCOL REP, V19, P413; Yutani R, 2012, CHEM PHARM BULL, V60, P989	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	SEP	2015	63	9					741	745				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CQ4TY	WOS:000360598700013		
J	Pan, CJ; Zhao, CH; Takeuchi, M; Sugiyasu, K				Pan, Chengjun; Zhao, Chunhui; Takeuchi, Masayuki; Sugiyasu, Kazunori			Conjugated Oligomers and Polymers Sheathed with Designer Side Chains	CHEMISTRY-AN ASIAN JOURNAL			English	Review						conjugated polymers; fluorescent materials; molecular wires; organic electronics; -stacking	INSULATED MOLECULAR WIRES; AMPLIFIED SPONTANEOUS EMISSION; LINKED PORPHYRIN ARRAYS; CHARGE-CARRIER MOBILITY; SENSITIZED SOLAR-CELLS; CARBON DOUBLE HELICES; RADICAL CATIONS; CONDUCTING POLYMERS; SOLID-STATE; THIN-FILMS	Conjugated polymers (CPs) are often referred to as molecular wires because of their quasi one-dimensional electronic wavefunctions delocalized along the polymer chains. However, in the solid state, CPs tend to self-assemble through -stacking, which greatly attenuates the one-dimensional nature. By molecular design, CPs can be molecularly insulated just like electric power cords, resulting in so-called insulated molecular wires (IMWs). In this Focus Review, we will discuss their unique photophysical, electronic, and mechanical properties which originate from the absence of -stacking.	[Pan, Chengjun; Takeuchi, Masayuki; Sugiyasu, Kazunori] Natl Inst Mat Sci, Organ Mat Grp, Polymer Mat Unit, Tsukuba, Ibaraki 3050047, Japan; [Zhao, Chunhui; Takeuchi, Masayuki] Univ Tsukuba, Dept Mat Sci & Engn, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan	Takeuchi, M (reprint author), Natl Inst Mat Sci, Organ Mat Grp, Polymer Mat Unit, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	TAKEUCHI.Masayuki@nims.go.jp; SUGIYASU.Kazunori@nims.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23655108, 25620101, 26102009]; Shorai Foundation for Science and Technology; Association for the Progress of New Chemistry	The authors thank KAKENHI grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (No. 23655108, No. 25620101, No. 26102009), Shorai Foundation for Science and Technology, and The Association for the Progress of New Chemistry.	Anderson H. L., 2007, ANGEW CHEM, V119, P1046, DOI 10.1002/ange.200601780; Kobayashi M, 2010, J AM CHEM SOC, V132, P15162, DOI 10.1021/ja108094m; Masai H, 2014, J AM CHEM SOC, V136, P1742, DOI 10.1021/ja411665k; Terao J, 2014, J INCL PHENOM MACRO, V80, P165, DOI 10.1007/s10847-014-0381-y; Rose A, 2005, NATURE, V434, P876, DOI 10.1038/nature03438; Wakamiya A, 2003, J ORG CHEM, V68, P8305, DOI 10.1021/jo034754i; Terao J, 2009, J AM CHEM SOC, V131, P16004, DOI 10.1021/ja9074437; Wu SM, 2008, NAT NANOTECHNOL, V3, P569, DOI 10.1038/nnano.2008.237; Mroz MM, 2013, ADV MATER, V25, P4347, DOI 10.1002/adma.201301703; Frolov SV, 1997, PHYS REV LETT, V78, P729, DOI 10.1103/PhysRevLett.78.729; Li C, 2005, J AM CHEM SOC, V127, P4548, DOI 10.1021/ja050168q; Frampton MJ, 2007, ANGEW CHEM INT EDIT, V46, P1028, DOI 10.1002/anie.200601780; Brovelli S, 2012, ADV FUNCT MATER, V22, P4284, DOI 10.1002/adfm.201200786; Izumi T, 2003, J AM CHEM SOC, V125, P5286, DOI 10.1021/ja034333i; Fukazawa A, 2007, J AM CHEM SOC, V129, P14164, DOI 10.1021/ja0764207; Terao J, 2010, CHEM LETT, V39, P518, DOI 10.1246/cl.2010.518; Salleo A, 2010, ADV MATER, V22, P3812, DOI 10.1002/adma.200903712; Nishinaga T, 2004, J AM CHEM SOC, V126, P3163, DOI 10.1021/ja039434v; Tsuda S, 2009, CHEM LETT, V38, P76, DOI 10.1246/cl.2009.76; Sheina EE, 2004, MACROMOLECULES, V37, P3526, DOI 10.1021/ma0357063; Yamada R, 2008, NANO LETT, V8, P1237, DOI 10.1021/nl0732023; Nishinaga T, 2010, MATERIALS, V3, P2037, DOI 10.3390/ma3032037; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Otani T, 2011, CHEM-ASIAN J, V6, P350, DOI 10.1002/asia.201000619; Malenfant PRL, 2000, MACROMOLECULES, V33, P3634, DOI 10.1021/ma000003w; Terao J, 2012, CHEM LETT, V41, P652, DOI 10.1246/cl.2012.652; Liu J, 2013, J MATER CHEM A, V1, P10889, DOI 10.1039/c3ta12368e; Seki S, 2014, PHYS CHEM CHEM PHYS, V16, P11093, DOI 10.1039/c4cp00473f; Terao J, 2011, CHEM REC, V11, P269, DOI 10.1002/tcr.201100009; Liu J, 2013, CHEM COMMUN, V49, P7587, DOI 10.1039/c3cc41861h; Chiavarone L, 1999, APPL PHYS LETT, V75, P2053, DOI 10.1063/1.124913; Ouchi Y, 2012, CHEM-ASIAN J, V7, P75, DOI 10.1002/asia.201100524; Wang ZS, 2008, CHEM MATER, V20, P3993, DOI 10.1021/cm8003276; Cacialli F, 2002, NAT MATER, V1, P160, DOI 10.1038/nmat750; Yang JS, 1998, J AM CHEM SOC, V120, P11864, DOI 10.1021/ja982293q; Lee D, 2003, J AM CHEM SOC, V125, P6870, DOI 10.1021/ja034894+; Yokoyama A, 2004, MACROMOLECULES, V37, P1169, DOI 10.1021/ma035396o; Kobayashi M, 2014, CHEM LETT, V43, P432, DOI 10.1246/cl.131043; Sugiyasu K, 2010, J AM CHEM SOC, V132, P14754, DOI 10.1021/ja107444m; de Quadras L, 2007, J AM CHEM SOC, V129, P8296, DOI 10.1021/ja071612n; Yamazaki D, 2006, J AM CHEM SOC, V128, P14470, DOI 10.1021/ja065995l; Fujiwara Y, 2013, J ORG CHEM, V78, P2206, DOI 10.1021/jo302621k; SCHLUTER AD, 1994, NATURE, V368, P831, DOI 10.1038/368831a0; Tsuda S, 2009, CHEM LETT, V38, P190, DOI 10.1246/cl.2009.190; Pan C, 2014, ANGEW CHEM INT EDIT, V53, P8870, DOI 10.1002/anie.201402813; Terao J, 2011, CHEM COMMUN, V47, P6816, DOI 10.1039/c1cc12231b; Lafferentz L, 2009, SCIENCE, V323, P1193, DOI 10.1126/science.1168255; Terao J, 2009, J AM CHEM SOC, V131, P18046, DOI 10.1021/ja908783f; Bao ZN, 1998, MACROMOLECULES, V31, P8647, DOI 10.1021/ma981161e; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Yang JS, 1998, J AM CHEM SOC, V120, P5321, DOI 10.1021/ja9742996; Matsuo T, 2011, B CHEM SOC JPN, V84, P1178, DOI 10.1246/bcsj.20110090; Masai H, 2014, J AM CHEM SOC, V136, P14714, DOI 10.1021/ja508636z; Becker K, 2010, CHEM COMMUN, V46, P4686, DOI 10.1039/c0cc00670j; Masai H, 2014, TETRAHEDRON LETT, V55, P4035, DOI 10.1016/j.tetlet.2014.05.078; Mishchenko A, 2010, NANO LETT, V10, P156, DOI 10.1021/nl903084b; Saeki A, 2012, ACCOUNTS CHEM RES, V45, P1193, DOI 10.1021/ar200283b; Terao J, 2012, CHEM COMMUN, V48, P1577, DOI 10.1039/c1cc13012a; Tamao K, 2012, CHEM COMMUN, V48, P1030, DOI 10.1039/c1cc16067b; Osterbacka R, 2000, SCIENCE, V287, P839, DOI 10.1126/science.287.5454.839; Cornil J, 2001, ADV MATER, V13, P1053, DOI 10.1002/1521-4095(200107)13:14<1053::AID-ADMA1053>3.0.CO;2-7; Shiraki T, 2014, CHEM-ASIAN J, V9, P218, DOI 10.1002/asia.201301216; Tsuda S, 2009, TETRAHEDRON LETT, V50, P1146, DOI 10.1016/j.tetlet.2008.12.087; Kiguchi M, 2012, SMALL, V8, P726, DOI 10.1002/smll.201102075; Venkataraman L, 2006, NATURE, V442, P904, DOI 10.1038/nature05037; Zalewski L, 2011, ADV FUNCT MATER, V21, P834, DOI 10.1002/adfm.201001135; Shomura R, 2012, MACROMOLECULES, V45, P3759, DOI 10.1021/ma300373n; Taylor PN, 2000, ANGEW CHEM INT EDIT, V39, P3456, DOI 10.1002/1521-3773(20001002)39:19<3456::AID-ANIE3456>3.0.CO;2-0; Kiguchi M, 2014, J AM CHEM SOC, V136, P7327, DOI 10.1021/ja413104g; Gonzalez SR, 2011, J AM CHEM SOC, V133, P16350, DOI 10.1021/ja2061903; Sahoo D, 2014, CHEM MATER, V26, P4867, DOI 10.1021/cm5021959; Li BL, 2009, J AM CHEM SOC, V131, P13222, DOI 10.1021/ja9051153; Sirringhaus H, 2005, ADV MATER, V17, P2411, DOI 10.1002/adma.200501152; Koumura N, 2006, J AM CHEM SOC, V128, P14256, DOI 10.1021/ja0645640; Tanaka S, 2001, SYNTHETIC MET, V119, P67, DOI 10.1016/S0379-6779(00)00673-1; Ikeda T, 2009, CHEM-ASIAN J, V4, P1248, DOI 10.1002/asia.200900125; Nishinaga T, 2005, ORG BIOMOL CHEM, V3, P561, DOI 10.1039/b418872a; Bryan ZJ, 2013, MACROMOLECULES, V46, P8395, DOI 10.1021/ma401314x; Pan CJ, 2013, ANGEW CHEM INT EDIT, V52, P10775, DOI 10.1002/anie.201305728; Morisaki Y, 2012, CHEM-EUR J, V18, P11251, DOI 10.1002/chem.201201513; Choi SH, 2008, SCIENCE, V320, P1482, DOI 10.1126/science.1156538; Terao J, 2014, CHEM COMMUN, V50, P658, DOI 10.1039/c3cc47105e; Yokoyama A, 2007, MACROMOLECULES, V40, P4093, DOI 10.1021/ma061357b; Tateno M, 2013, CHEM-EUR J, V19, P5457, DOI 10.1002/chem.201204332; Terao J, 2010, MACROMOL SY, V297, P54, DOI 10.1002/masy.200900053; Becker K, 2007, ANGEW CHEM INT EDIT, V46, P3450, DOI 10.1002/anie.200605072; Becker K., 2007, ANGEW CHEM, V119, P3520, DOI 10.1002/ange.200605072; Brovelli S, 2008, NANO LETT, V8, P4546, DOI 10.1021/nl802775a; Brovelli S, 2010, SMALL, V6, P2796, DOI 10.1002/smll.201001881; Brovelli S, 2010, ADV MATER, V22, P3690, DOI 10.1002/adma.201000895; Brown PJ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.064203; Cardin DJ, 2002, ADV MATER, V14, P553, DOI 10.1002/1521-4095(20020418)14:8<553::AID-ADMA553>3.0.CO;2-F; de Quadras L, 2007, NEW J CHEM, V31, P1594, DOI 10.1039/b708690n; Endou M, 2012, CHEM COMMUN, V48, P540, DOI 10.1039/c1cc14994f; Fiesel R, 1997, MACROMOL CHEM PHYSIC, V198, P2623, DOI 10.1002/macp.1997.021980901; Fiesel R., 1996, ANGEW CHEM, V108, P2233; Fiesel R, 1996, ANGEW CHEM INT EDIT, V35, P2111, DOI 10.1002/anie.199621111; Fu DK, 1997, TETRAHEDRON, V53, P15487, DOI 10.1016/S0040-4020(97)00975-7; Fukuhara G, 2003, CHEM LETT, V32, P536; Ie Y, 2012, PURE APPL CHEM, V84, P931, DOI 10.1351/PAC-CON-11-10-26; Ie Y., 2011, ANGEW CHEM, V123, P12186; Ie Yutaka, 2011, Angew Chem Int Ed Engl, V50, P11980, DOI 10.1002/anie.201104700; Ie Y, 2009, CHEM COMMUN, P3020, DOI 10.1039/b901354g; Ikeda T, 2006, EUR J ORG CHEM, P3193, DOI 10.1002/ejoc.200600289; Karakaya B, 1997, J AM CHEM SOC, V119, P3296, DOI 10.1021/ja963943y; Latini G, 2008, ADV FUNCT MATER, V18, P2419, DOI 10.1002/adfm.200800120; Lee D, 2005, CHEM MATER, V17, P4622, DOI 10.1021/cm050803r; Lee SK, 2012, ACS NANO, V6, P5078, DOI 10.1021/nn3006976; Ma X, 2007, CHEM COMMUN, P1409, DOI 10.1039/b615900a; Mangalum A, 2014, MACROMOL CHEM PHYS, V215, P351, DOI 10.1002/macp.201300630; Mangalum A, 2010, CHEM COMMUN, V46, P5136, DOI 10.1039/c0cc00247j; Marsitzky D, 2001, J AM CHEM SOC, V123, P6965, DOI 10.1021/ja010020g; Morgan BP, 2009, MACROMOL RAPID COMM, V30, P1399, DOI 10.1002/marc.200900160; Mroz MM, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3179689; Pan C., 2013, ANGEW CHEM, V125, P10975; Perepichka I. F., 2009, HDB THIOPHENE BASED; Reynolds J. R., 2007, HDB CONJUGATED POLYM; Sato T, 1999, J AM CHEM SOC, V121, P10658, DOI 10.1021/ja9922983; Simpkins SME, 2006, J ORGANOMET CHEM, V691, P5517, DOI 10.1016/j.jorganchem.2006.07.021; Smith RC, 2009, MACROMOL RAPID COMM, V30, P2067, DOI 10.1002/marc.200900387; Sugiyasu K, 2009, CHEM-EUR J, V15, P6350, DOI 10.1002/chem.200900576; Swager T, 2002, NAT MATER, V1, P151, DOI 10.1038/nmat760; Lee DW, 2004, SYNLETT, P149, DOI 10.1055/s-2003-44963; Swager TM, 2008, ACCOUNTS CHEM RES, V41, P1181, DOI 10.1021/ar800107v; Pan CJ, 2014, CHEM COMMUN, V50, P11814, DOI 10.1039/c4cc03594a; Tanaka S, 1999, SYNTHETIC MET, V101, P532, DOI 10.1016/S0379-6779(98)00549-9; Taylor P. N., 2000, ANGEW CHEM, V112, P3598, DOI 10.1002/1521-3757(20001002)112:19<3598::AID-ANGE3598>3.0.CO;2-T; Terao J, 2014, CHEM LETT, V43, P1289, DOI 10.1246/c1.140365; Terao J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2707; Terao J, 2011, POLYM CHEM-UK, V2, P2444, DOI 10.1039/c1py00243k; Thomas SW, 2007, CHEM REV, V107, P1339, DOI 10.1021/cr0501339; WOITELLIER S, 1989, CHEM PHYS, V131, P481, DOI 10.1016/0301-0104(89)80193-4; Yamada R, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.025002; Zhao XM, 2005, INORG CHEM, V44, P2619, DOI 10.1021/ic048961s	134	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	SEP	2015	10	9					1820	1835		10.1002/asia.201500452		16	Chemistry, Multidisciplinary	Chemistry	CQ4QI	WOS:000360589300002		
J	Ohyama, T; Uchida, M; Kusama, H; Iwasawa, N				Ohyama, Tomoya; Uchida, Masako; Kusama, Hiroyuki; Iwasawa, Nobuharu			Total Synthesis of Proposed Structure of Yuremamine and All Diastereomers Using [3+2]-Cycloaddition of Platinum-Containing Azomethine Ylide	CHEMISTRY-AN ASIAN JOURNAL			English	Article						[3+2] cycloaddition; azomethine ylide; platinum; total synthesis; yuremamine	HIGHLY EFFICIENT SYNTHESIS; INHIBITOR JTT-010; MITOSENE SKELETON; 3+2 CYCLOADDITION; ALLYLATION; CORE	Total synthesis of the proposed structure of yuremamine has been achieved for the first time based on the intermolecular [3+2]-cycloaddition reaction of the platinum-containing azomethine ylide. All the possible diastereomers of yuremamine were also synthesized via the common intermediate. Through these syntheses, it was confirmed that the proposed structure of yuremamine and the diastereomers differ from the natural product.	[Ohyama, Tomoya; Uchida, Masako; Iwasawa, Nobuharu] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan; [Kusama, Hiroyuki] Gakushuin Univ, Fac Sci, Dept Chem, Toshima Ku, Tokyo 1718588, Japan	Iwasawa, N (reprint author), Tokyo Inst Technol, Dept Chem, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528551, Japan.	niwasawa@chem.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	We are grateful to Professor Jouko Vepsalainen (Univ. of Eastern Finland) for providing us with the <SUP>1</SUP>H and <SUP>13</SUP>C NMR spectra and an authentic sample of yuremamine. We would like to thank Prof. Kitamura (Univ. of Nagoya) for providing the ruthenium catalyst and giving important suggestions on the reaction conditions for the deallylation reaction using this catalyst. This research was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Fernandez LS, 2009, ORG LETT, V11, P329, DOI 10.1021/ol802506n; HATA T, 1956, J ANTIBIOT, V9, P141; Dethe DH, 2013, CHEM COMMUN, V49, P3260, DOI 10.1039/c3cc40617b; Wilson RM, 2006, ORG LETT, V8, P1745, DOI 10.1021/ol060485h; Kusama H, 2002, J AM CHEM SOC, V124, P11592, DOI 10.1021/ja027589h; Kusama H, 2006, ORG LETT, V8, P289, DOI 10.1021/ol052610f; VISHWAKARMA LC, 1988, ORG SYNTH, V66, P203; Vepsalainen JJ, 2005, PLANTA MED, V71, P1053, DOI 10.1055/s-2005-873131; Liu WB, 2012, ANGEW CHEM INT EDIT, V51, P5183, DOI 10.1002/anie.201200649; Hong L, 2010, CHEM-EUR J, V16, P440, DOI 10.1002/chem.200902638; BRADSHAW DP, 1991, J CHEM SOC PERK T 1, P19, DOI 10.1039/p19910000019; Calvert MB, 2015, CHEM COMMUN, V51, P6202, DOI 10.1039/c5cc00380f; DESSOLIN M, 1995, TETRAHEDRON LETT, V36, P5741, DOI 10.1016/00404-0399(50)1147A-; Johansen MB, 2008, ORG LETT, V10, P3497, DOI 10.1021/ol8012777; Liu W.-B., 2012, ANGEW CHEM, V124, P5273; POUSSET JL, 1977, J CHEM SOC CHEM COMM, P261, DOI 10.1039/c39770000261; Saburi H, 2005, ANGEW CHEM INT EDIT, V44, P1730, DOI 10.1002/anie.200462513; Saburi H., 2005, ANGEW CHEM, V117, P1758, DOI 10.1002/ange.200462513; Sasase T, 2005, DIABETES OBES METAB, V7, P586, DOI 10.1111/j.1463-1326.2004.00447.x; Takaya J, 2004, CHEM LETT, V33, P16, DOI 10.1246/cl.2004.16; Takaya J, 2011, TETRAHEDRON, V67, P4455, DOI 10.1016/j.tet.2011.04.017; Tanaka M, 2007, ORG LETT, V9, P3331, DOI 10.1021/ol071336h; Tanaka S, 2006, ADV SYNTH CATAL, V348, P375, DOI 10.1002/adsc.200505401	23	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	SEP	2015	10	9					1850	1853		10.1002/asia.201500491		4	Chemistry, Multidisciplinary	Chemistry	CQ4QI	WOS:000360589300004		
J	Tsukada, S; Sagawa, T; Gunji, T				Tsukada, Satoru; Sagawa, Takuya; Gunji, Takahiro			Carbon Monoxide Addition to Ruthenium-Dithiolene Complex and Polysiloxane Hybrid Film Formation	CHEMISTRY-AN ASIAN JOURNAL			English	Article						carbonyl ligands; electron-deficient compounds; ruthenium; sol-gel processes; solid-state reactions	TRIPODAL (POLYPHOSPHINE)METAL COMPLEXES; STATE ORGANOMETALLIC CHEMISTRY; SOLID-GAS REACTIONS; TOPOLOGICAL INSULATOR; CO; CARBONYLATION; NANOSHEET; PHOSPHINE; NH3	The addition of carbon monoxide to the ruthenium center of [((6)-C6Me6)Ru(S2C6H4)] (1) has been investigated. [((6)-C6Me6)Ru(CO)(S2C6H4)] (2) was obtained by the addition of CO gas to the ruthenium center of 1 in both solution and solid states. 1 was reproduced by treating 2 with an oxidant. A 1/polysiloxane self-standing hybrid film was also prepared and showed a dramatic color change upon transformation of 1 to 2 in polysiloxane hybrid film.	[Tsukada, Satoru; Sagawa, Takuya; Gunji, Takahiro] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan	Tsukada, S (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	tsukada@rs.tus.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24102008A02, 2401]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks (no. 2401)" (24102008A02) from The Ministry of Education, Culture, Sports, Science, and Technology, Japan.	AIME S, 1994, ORGANOMETALLICS, V13, P4232, DOI 10.1021/om00023a028; AIME S, 1995, ORGANOMETALLICS, V14, P3224, DOI 10.1021/om00007a024; Kambe T, 2013, J AM CHEM SOC, V135, P2462, DOI 10.1021/ja312380b; Wang K, 2001, SCIENCE, V291, P106, DOI 10.1126/science.291.5501.106; Kambe T, 2014, J AM CHEM SOC, V136, P14357, DOI 10.1021/ja507619d; Wang ZF, 2013, NANO LETT, V13, P2842, DOI 10.1021/nl401147u; [Anonymous], 1979, ADV INORG CHEM; Aritake Y, 2011, POLYHEDRON, V30, P886, DOI 10.1016/j.poly.2010.12.015; Aritake Y., 2012, RSC ADV, V2, P2975; Begum A, 2014, CHEM-EUR J, V20, P16657, DOI 10.1002/chem.201404461; BIANCHINI C, 1993, ORGANOMETALLICS, V12, P4757, DOI 10.1021/om00036a015; BIANCHINI C, 1993, J AM CHEM SOC, V115, P1753, DOI 10.1021/ja00058a021; BIANCHINI C, 1991, ORGANOMETALLICS, V10, P3415, DOI 10.1021/om00056a002; BONNET JJ, 1973, J AM CHEM SOC, V95, P2141, DOI 10.1021/ja00788a011; CHIN CS, 1993, ORGANOMETALLICS, V12, P1462, DOI 10.1021/om00028a077; Eisenberg R., 1970, PROGR INORG CHEM, V12, P295, DOI 10.1002/9780470166130.ch4; Fourmigue M, 1998, COORDIN CHEM REV, V178, P823, DOI 10.1016/S0010-8545(98)00104-0; GILLIAM OR, 1950, PHYS REV, V78, P140, DOI 10.1103/PhysRev.78.140; Gunji T, 2007, J POLYM SCI POL CHEM, V45, P3273, DOI 10.1002/pola.22076; Gunji T, 2004, J SOL-GEL SCI TECHN, V32, P43, DOI 10.1007/s10971-004-5762-z; Gunji T, 2001, J SOL-GEL SCI TECHN, V22, P219, DOI 10.1023/A:1012243902181; Gunji T, 2014, J SOL-GEL SCI TECHN, V72, P80, DOI 10.1007/s10971-014-3413-6; Hariu N., 2015, CONT ENG SCI, V8, P57; HATANO H, 1990, CHEM LETT, P1089, DOI 10.1246/cl.1990.1089; Ito M., 2014, CONT ENG SCI, V7, P869; Itoh T., 2010, POLYHEDRON, V29, P477; KAJITANI M, 1995, J ORGANOMET CHEM, V485, P31, DOI 10.1016/0022-328X(94)24762-8; Mashima K, 1997, J ORGANOMET CHEM, V545, P345, DOI 10.1016/S0022-328X(97)00378-1; Mashima K, 1997, ORGANOMETALLICS, V16, P1016, DOI 10.1021/om960759c; Nomura M, 2008, INORG CHEM, V47, P1301, DOI 10.1021/ic700778b; Olivan M, 1997, J AM CHEM SOC, V119, P8389, DOI 10.1021/ja971608j; Osakada K, 2004, INORG CHIM ACTA, V357, P3007, DOI 10.1016/j.ica.2004.02.030; Sakamoto R, 2012, DALTON T, V41, P10123, DOI 10.1039/c2dt30787a; Sheldrick G. M., 1996, SADABS PROGRAM SIEME; Sheldrick G. M., 1997, SHELXS 97 PROGRAM CR; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; Stiefel E. I., 2004, PROGR INORGANIC CHEM, V52; Sugimori A, 1999, B CHEM SOC JPN, V72, P879, DOI 10.1246/bcsj.72.879; Yu R, 2007, INORG CHEM, V46, P5131, DOI 10.1021/ic0624569	39	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	SEP	2015	10	9					1881	1883		10.1002/asia.201500617		3	Chemistry, Multidisciplinary	Chemistry	CQ4QI	WOS:000360589300010		
J	El-Safty, SA; Sakai, M; Selim, MM; Alhamid, AA				El-Safty, Sherif A.; Sakai, Masaru; Selim, Mahmoud M.; Alhamid, Abdulaziz A.			Mesotubular-Structured Hybrid Membrane Nanocontainer for Periodical Monitoring, Separation, and Recovery of Cobalt Ions from Water	CHEMISTRY-AN ASIAN JOURNAL			English	Article						cobalt; membranes; mesoscale tubular structures; nanocontainers; selective ion filtration	ATOMIC-ABSORPTION-SPECTROMETRY; TOXIC METAL-IONS; MESOPOROUS SILICA; AQUEOUS-SOLUTIONS; OPTICAL SENSORS; ICP-MS; NANOTUBES; REMOVAL; EXTRACTION; MONOLITHS	Exposure to toxins can cause deleterious effects even at very low concentrations. We have developed an optical sensor, filter, and extractor (i.e., containerlike) in a nanoscale membrane (NSM) for the ultratrace sensing, separation, and recovery of Co2+ ions from water. The design of the NSM is successfully controlled by dense decoration of a hydrophobic oil-hydrophilic receptor onto mesoscale tubular-structured silica nanochannels made of a hybrid anodic alumina membrane. The particular structure of the nanocontainer is ideal to control the multiple functions of the membrane, such as the optical detection/recognition, rejection/permeation, and recovery of Co2+ species in a single step. A typical sensor, filter, and extractor assessment experiment was performed by using a benchtop contact time technique and a flow-through cell detector to allow for precise control of the optical detection and exclusive rejection of target ions and the permeation of nontarget metal ions in water. This nanocontainer membrane has great potential to meet the increasing needs of purification and separation of Co2+ ions.	[El-Safty, Sherif A.] Natl Inst Mat Sci, Tsukuba, Ibaraki 050047, Japan; [El-Safty, Sherif A.] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Sakai, Masaru] Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tsukuba, Ibaraki 3050076, Japan; [Selim, Mahmoud M.] Prince Sattam AbdulAziz Univ, Al Aflaj Coll Sci & Human Studies, Dept Math & Phys, Al Aflaj 71011912, Saudi Arabia; [Alhamid, Abdulaziz A.] Prince Sattam AbdulAziz Univ, Alkharj 11942, Saudi Arabia	El-Safty, SA (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 050047, Japan.	sherif.elsafty@nims.go.jp					Meoto S, 2014, J MATER CHEM A, V2, P5640, DOI 10.1039/c3ta15330d; Shenashen MA, 2014, PART PART SYST CHAR, V31, P293, DOI 10.1002/ppsc.201300181; Khodakov AY, 2007, CHEM REV, V107, P1692, DOI 10.1021/cr050972v; Shenashen MA, 2013, SEP PURIF TECHNOL, V116, P73, DOI 10.1016/j.seppur.2013.05.011; El-Safty SA, 2009, ADSORPTION, V15, P227, DOI 10.1007/s10450-009-9171-z; Freschi GPG, 2012, FOOD ANAL METHOD, V5, P861, DOI 10.1007/s12161-011-9323-0; Yuan X, 2013, CHEM-ASIAN J, V8, P858, DOI 10.1002/asia.201201236; Deng XY, 2013, LANGMUIR, V29, P6815, DOI 10.1021/la400690p; Han WS, 2009, CHEM SOC REV, V38, P1904, DOI 10.1039/b818893a; Madathil BK, 2010, J ORTHOP RES, V28, P1360, DOI 10.1002/jor.21133; Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h; Cauda V, 2009, MICROPOR MESOPOR MAT, V118, P435, DOI 10.1016/j.micromeso.2008.09.022; El-Safty SA, 2013, ADV HEALTHC MATER, V2, P854, DOI 10.1002/adhm.201200326; Climent E, 2009, ANGEW CHEM INT EDIT, V48, P8519, DOI 10.1002/anie.200904243; Ding KL, 2009, J MATER CHEM, V19, P3725, DOI 10.1039/b821386k; Hill JJ, 2009, CHEM MATER, V21, P1841, DOI 10.1021/cm803083s; El-Safty SA, 2011, SMALL, V7, P62, DOI 10.1002/smll.201001303; El-Safty SA, 2008, J PHYS CHEM C, V112, P5476, DOI 10.1021/jp0760096; El-Safty SA, 2012, TRAC-TREND ANAL CHEM, V38, P98, DOI 10.1016/j.trac.2012.05.002; Bhatnagar A, 2010, BIOCHEM ENG J, V48, P181, DOI 10.1016/j.bej.2009.10.005; Balaji T, 2006, ANGEW CHEM INT EDIT, V45, P7202, DOI 10.1002/anie.200602453; El-Safty S, 2011, J MATER CHEM, V21, P5593, DOI 10.1039/c0jm03269g; Monier M, 2013, J HAZARD MATER, V250, P122, DOI 10.1016/j.jhazmat.2013.01.056; Mitchell DT, 2002, J AM CHEM SOC, V124, P11864, DOI 10.1021/ja027247b; von Berlepsch H, 2002, J PHYS CHEM B, V106, P3146, DOI 10.1021/jp0143701; El-Safty SA, 2010, CHEM COMMUN, V46, P3917, DOI 10.1039/c001654c; Wang Q, 2011, CHEM ENG J, V174, P126, DOI 10.1016/j.cej.2011.08.059; Yang YK, 2009, J MATER SCI, V44, P4539, DOI 10.1007/s10853-009-3687-1; Yang FY, 2014, FOOD CHEM, V147, P215, DOI 10.1016/j.foodchem.2013.09.141; Wu YY, 2004, NAT MATER, V3, P816, DOI 10.1038/nmat1230; El-Safty S, 2011, ANAL CHIM ACTA, V694, P151, DOI 10.1016/j.aca.2011.03.035; Diniz KM, 2014, CHEM ENG J, V239, P233, DOI 10.1016/j.cej.2013.11.027; El-Safty SA, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/37/375603; O'Sullivan JE, 2013, TALANTA, V115, P999, DOI 10.1016/j.talanta.2013.06.054; El-Safty SA, 2013, SENSOR ACTUAT B-CHEM, V176, P1015, DOI 10.1016/j.snb.2012.09.040; El-Safty SA, 2012, ADV FUNCT MATER, V22, P3013, DOI 10.1002/adfm.201200393; Khairy M, 2013, NANOSCALE, V5, P7920, DOI 10.1039/c3nr02403b; Wu YZ, 2011, CHEM-ASIAN J, V6, P2725, DOI 10.1002/asia.201100534; El-Safty SA, 2013, SMALL, V9, P2288, DOI 10.1002/smll.201202407; Zhao GX, 2011, ENVIRON SCI TECHNOL, V45, P10454, DOI 10.1021/es203439v; Luz MS, 2013, TALANTA, V115, P409, DOI 10.1016/j.talanta.2013.05.034; El-Safty S, 2011, COLLOID SURFACE A, V377, P44, DOI 10.1016/j.colsurfa.2010.12.015; Lin HP, 1996, SCIENCE, V273, P765, DOI 10.1126/science.273.5276.765; Li W, 2013, ADV MATER, V25, P5129, DOI 10.1002/adma.201302184; Keilbach A, 2010, CHEM MATER, V22, P5430, DOI 10.1021/cm100349c; Liu WF, 2011, CHEM ENG J, V175, P24, DOI 10.1016/j.cej.2011.09.004; Mekawy MM, 2011, J COLLOID INTERF SCI, V355, P348, DOI 10.1016/j.jcis.2010.11.056; Aragay G, 2011, CHEM REV, V111, P3433, DOI 10.1021/cr100383r; Shenashen MA, 2013, J HAZARD MATER, V260, P833, DOI 10.1016/j.jhazmat.2013.06.025; El-Safty SA, 2012, CHEM COMMUN, V48, P9652, DOI 10.1039/c2cc34788a; Balaji T., 2006, ANGEW CHEM, V118, P7360, DOI 10.1002/ange.200602453; Climent E., 2009, ANGEW CHEM, V121, P8671; Davis R. J., NICKEL COBALT THEIR, P354; Duman O, 2010, J HAZARD MATER, V176, P231, DOI 10.1016/j.jhazmat.2009.11.018; El-Safty SA, 2012, EUR J INORG CHEM, P5439, DOI 10.1002/ejic.201200629; El-Safty SA, 2011, TRAC-TREND ANAL CHEM, V30, P447, DOI 10.1016/j.trac.2011.01.004; Hasanpour F, 2013, J SERB CHEM SOC, V78, P717, DOI 10.2298/JSC120305070H; Ho W.S.W., 1992, MEMBRANE HDB; Khairy M, 2014, TRAC-TREND ANAL CHEM, V62, P56, DOI 10.1016/j.trac.2014.06.013; Kumari N, 2014, CHEM-ASIAN J, V9, P3174, DOI 10.1002/asia.201402635; Kursunlu AN, 2009, APPL SURF SCI, V255, P8798, DOI 10.1016/j.apsusc.2009.06.055; Liang Q., 2010, J MATER CHEM, V20, P8236; Manohar D.M., 2006, APPL CLAY SCI, V31, P194, DOI 10.1016/j.clay.2005.08.008; Shi W, 2010, J MEMBRANE SCI, V349, P333, DOI 10.1016/j.memsci.2009.11.066; [陶慧林 Tao Huilin], 2013, [理化检验. B, 化学分册, Physical Testing and Chemical Analysis], V49, P413; Wang S., 2013, J SPECTROSC N Y NY U; Yu JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3719; Zein R, 2010, J HAZARD MATER, V181, P52, DOI 10.1016/j.jhazmat.2010.04.076; Zhang YH, 2011, ACS APPL MATER INTER, V3, P3272, DOI 10.1021/am200908t	69	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	SEP	2015	10	9					1909	1918		10.1002/asia.201500421		10	Chemistry, Multidisciplinary	Chemistry	CQ4QI	WOS:000360589300015		
J	Nishitani, N; Hirose, T; Matsuda, K				Nishitani, Nobuhiko; Hirose, Takashi; Matsuda, Kenji			Investigation on the Surface-Confined Self-Assembly Stabilized by Hydrogen Bonds of Urea and Amide Groups: Quantitative Analysis of Concentration Dependence of Surface Coverage	CHEMISTRY-AN ASIAN JOURNAL			English	Article						hydrogen bond; scanning tunneling microscopy; self-assembled monolayer; thermodynamic model; urea	COOPERATIVE SUPRAMOLECULAR POLYMERIZATION; NUCLEATION-ELONGATION; SOLID INTERFACE; MECHANISM; NETWORKS; STM; DIARYLETHENE; MONOLAYERS; PATHWAY; DRIVEN	Formation of a hydrogen-bond network via an amide group is a key driving force for the nucleation-elongation-type self-assembly that is often seen in biomolecules and artificial supramolecular assemblies. In this work, rod-coil-like aromatic compounds bearing an amide (1a-3a) or urea group (1u-3u) were synthesized, and their self-assemblies on a 2-D surface were investigated by scanning tunneling microscopy (STM). According to the quantitative analysis of the concentration dependence of the surface coverage, it was revealed that the strength of the hydrogen bond (i.e., amide or urea) and the number of non-hydrogen atoms in a molecular component (i.e., size of core and length of alkyl side chain) play a primary role in determining the stabilization energy during nucleation and elongation processes of molecular ordering on the HOPG surface.	[Nishitani, Nobuhiko; Hirose, Takashi; Matsuda, Kenji] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol, Nishikyo Ku, Kyoto 6158510, Japan	Matsuda, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol, Nishikyo Ku, Kyoto 6158510, Japan.	kmatsuda@sbchem.kyoto-u.ac.jp	Hirose, Takashi/M-9764-2014	Hirose, Takashi/0000-0002-5351-2101	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26107008]; Japan Society for the Promotion of Science (JSPS), Japan [25810048]	This research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Photosynergetics" (No. 26107008) and the Program for Leading Graduate Schools "Training Program of Leaders for Integrated Medical System for Fruitful Healthy-Longevity Society" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). This work was also supported by a Grant-in-Aid for Young Scientists (B) (No. 25810048) from the Japan Society for the Promotion of Science (JSPS), Japan.	van Gorp JJ, 2002, J AM CHEM SOC, V124, P14759, DOI 10.1021/ja020984n; [Anonymous], 2001, ANGEW CHEM, V113, P2446; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c; Mayoral MJ, 2013, J AM CHEM SOC, V135, P2148, DOI 10.1021/ja312628g; Jonkheijm P, 2006, SCIENCE, V313, P80, DOI 10.1126/science.1127884; Bonifazi D, 2009, CHEM-EUR J, V15, P7004, DOI 10.1002/chem.200900900; Otte FL, 2014, J AM CHEM SOC, V136, P11248, DOI 10.1021/ja505563e; Zhang ZY, 1997, SCIENCE, V276, P377, DOI 10.1126/science.276.5311.377; Yan XZ, 2013, P NATL ACAD SCI USA, V110, P15585, DOI 10.1073/pnas.1307472110; Ciesielski A, 2010, ADV MATER, V22, P3506, DOI 10.1002/adma.201001582; Fischer L, 2010, ORG BIOMOL CHEM, V8, P3101, DOI 10.1039/c001090a; Kouwer PHJ, 2013, NATURE, V493, P651, DOI 10.1038/nature11839; [Anonymous], 2009, ANGEW CHEM, V121, P7434; Gutzler R, 2011, CHEM SCI, V2, P2290, DOI 10.1039/c1sc00531f; Korevaar PA, 2012, NATURE, V481, P492, DOI 10.1038/nature10720; Kaiser TE, 2009, J AM CHEM SOC, V131, P6719, DOI 10.1021/ja900684h; De Feyter S, 2003, CHEM SOC REV, V32, P139, DOI 10.1039/b206566p; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; Ajayaghosh A, 2007, ACCOUNTS CHEM RES, V40, P644, DOI 10.1021/ar7000364; Elemans JAAW, 2009, ANGEW CHEM INT EDIT, V48, P7298, DOI 10.1002/anie.200806339; Mazur U, 2015, CHEM COMMUN, V51, P4737, DOI 10.1039/c4cc09840d; [Anonymous], 2013, ANGEW CHEM, V125, P322; Lackinger M, 2005, LANGMUIR, V21, P4984, DOI 10.1021/la0467640; Ogi S, 2014, NAT CHEM, V6, P188, DOI [10.1038/nchem.1849, 10.1038/NCHEM.1849]; Kim K, 2005, J AM CHEM SOC, V127, P4879, DOI 10.1021/ja0403028; Filot IAW, 2010, J PHYS CHEM B, V114, P13667, DOI 10.1021/jp1072928; Prins LJ, 2001, ANGEW CHEM INT EDIT, V40, P2382, DOI 10.1002/1521-3773(20010702)40:13<2382::AID-ANIE2382>3.0.CO;2-G; Hirose T, 2013, ANGEW CHEM INT EDIT, V52, P304, DOI 10.1002/anie.201205085; Zhang XM, 2013, RSC ADV, V3, P11351, DOI 10.1039/c3ra40473k; Bleger D, 2010, CHEM-EUR J, V16, P14256, DOI 10.1002/chem.201002834; Ciesielski A, 2011, SMALL, V7, P342, DOI 10.1002/smll.201001419; De Feyter S, 1998, J PHYS CHEM B, V102, P8981, DOI 10.1021/jp973177x; Dreger K, 2006, LANGMUIR, V22, P1619, DOI 10.1021/la052370c; GUO ZY, 1995, BIOPOLYMERS, V36, P83, DOI 10.1002/bip.360360108; Heller LE, 2012, LANGMUIR, V28, P14855, DOI 10.1021/la3031733; Kang J, 2015, SCIENCE, V347, P646, DOI 10.1126/science.aaa4249; LINDSEY JS, 1991, NEW J CHEM, V15, P153; Sakano T, 2013, CHEM LETT, V42, P1537, DOI 10.1246/cl.130705; Schuurmans N, 2004, J AM CHEM SOC, V126, P13884, DOI 10.1021/ja046124j; Yokoyama S, 2014, CHEM COMMUN, V50, P5964, DOI 10.1039/c3cc48895k	40	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	SEP	2015	10	9					1926	1931		10.1002/asia.201500453		6	Chemistry, Multidisciplinary	Chemistry	CQ4QI	WOS:000360589300017		
J	Nakamoto, H; Aihara, Y; Yamaguchi, K; Kawamata, T; Okada, Y				Nakamoto, Hidetoshi; Aihara, Yasuo; Yamaguchi, Koji; Kawamata, Takakazu; Okada, Yoshikazu			Efficacy, safety, and outcomes in 17 pediatric cases treated with the free radical scavenger edaravone	CHILDS NERVOUS SYSTEM			English	Article						Pediatric; Brain infarction; Edaravone	ISCHEMIC BRAIN-DAMAGE; CEREBRAL-ARTERY OCCLUSION; MOYAMOYA-DISEASE; NEONATAL-RATS; MCI-186; INJURY; HYPERPERFUSION; ANTIOXIDANT; INVOLVEMENT; EDEMA	Edaravone is a free radical scavenger with brain protection properties and is recommended by "The Japanese Guidelines for the Management of Stroke 2009" for administration to adult patients, in whom it has been shown to improve neurological deficits after cerebral infarction. However, its dosage and effects have not yet been established in children. Seventeen pediatric patients with cerebral ischemia were administered edaravone at a dose based on body weight from the standard dose given to adults. Functional outcomes were evaluated using mRS and PSOM (modified ranking scale and pediatric stroke outcome scale, respectively). Immediate post-treatment results were mostly positive, with no liver or renal complications. In some cases, neurological symptoms markedly improved after the administration of edaravone. The efficacy of edaravone has not yet been examined in pediatric patients. The results of the present study suggest that edaravone has potential in the treatment of children safely with promising results similar to those in adults.	[Nakamoto, Hidetoshi; Aihara, Yasuo; Yamaguchi, Koji; Kawamata, Takakazu; Okada, Yoshikazu] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan; [Aihara, Yasuo] Tokyo Womens Med Univ, Neurol Inst, Dept Neurosurg, Shinjuku Ku, Tokyo 1628666, Japan	Aihara, Y (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan.	yaihara@nij.twmu.ac.jp			Department of Neurosurgery, Tokyo Women's Medical University	This study was supported by research funds from the Department of Neurosurgery, Tokyo Women's Medical University.	ABE K, 1988, STROKE, V19, P480; ANDOH K, 1994, ARZNEIMITTEL-FORSCH, V44-1, P715; Shinohara Y, 2009, CEREBROVASC DIS, V27, P485, DOI 10.1159/000210190; Yamamoto T, 1997, BRAIN RES, V762, P240, DOI 10.1016/S0006-8993(97)00490-3; Kaku Y, 2012, J CEREBR BLOOD F MET, V32, P2066, DOI 10.1038/jcbfm.2012.110; NISHI H, 1989, STROKE, V20, P1236; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; Chan PH, 1996, STROKE, V27, P1124; Anderson BJ, 2008, ANNU REV PHARMACOL, V48, P303, DOI 10.1146/annurev.pharmtox.48.113006.094708; Fujimura M, 2005, NEUROCRIT CARE, V2, P59, DOI 10.1385/NCC:2:1:059; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Ohta Y, 2009, INTERNAL MED, V48, P593, DOI 10.2169/internalmedicine.48.1871; Fujimura M, 2007, CHILD NERV SYST, V23, P1195, DOI 10.1007/s00381-007-0361-2; Kawashima H, 2011, J CLIN PHARM THER, V36, P412, DOI 10.1111/j.1365-2710.2011.01267.x; Mahmood I, 2006, BRIT J CLIN PHARMACO, V61, P545, DOI 10.1111/j.1365-2125.2006.02622.x; Masaoka N, 2006, J MATERN-FETAL NEO M, V19, P625, DOI 10.1080/14767050600850472; Mizuno A, 1998, GEN PHARMACOL-VASC S, V30, P575, DOI 10.1016/S0306-3623(97)00311-X; Noor JI, 2005, AM J OBSTET GYNECOL, V193, P1703, DOI 10.1016/j.ajog.2005.03.069; Ogasawara K, 2004, NEUROSURGERY, V55, P1060, DOI 10.1227/01.NEU.0000140838.27450.63; WATANABE T, 1988, PROSTAG LEUKOTR ESS, V33, P81, DOI 10.1016/0952-3278(88)90127-5; Yasuoka N, 2004, DEV BRAIN RES, V151, P129, DOI 10.1016/j.devbrainres.2004.04.006	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	SEP	2015	31	9					1533	1540		10.1007/s00381-015-2814-3		8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CQ8FI	WOS:000360841500014		
J	Torikai, K; Kijima, T; Hirakawa, T; Naganishi, H; Ishiwata, Y; Fukawa, T; Funaki, J; Nagaoka, R; Suzuki, K; Sano, T				Torikai, Katsuyuki; Kijima, Takeshi; Hirakawa, Takashi; Naganishi, Hiroki; Ishiwata, Yasuo; Fukawa, Toshihiko; Funaki, Junzo; Nagaoka, Ryosuke; Suzuki, Keiko; Sano, Tsuguo			Primary Palatoplasty for Unilateral Cleft Lip and Palate Using Mucosal Grafts and Flaps	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						cleft lip and palate; palatoplasty; mucosal grafts and flaps	REPAIR; CLOSURE; TEAM	The mucosal graft and flaps method (MG method) is a palatoplasty technique that was developed for the purpose of improving maxillary growth in patients with cleft palate. In the MG method, full-thickness buccal mucosa is grafted onto the raw surface created by pushback palatoplasty. The method is unlikely to result in severe scarring and has a favorable effect on maxillary growth. In addition, it is unlikely to result in oronasal fistula and provides good speech results. Overall, postive long-term treatment results have been obtained. Although the MG method is technically difficult and requires a lengthy surgery, the technique is considered to be effective for palate closure in terms of speech and maxillary growth.	[Torikai, Katsuyuki; Nagaoka, Ryosuke] Fureai Yokohama Hosp, Dept Plast & Reconstruct Surg, Yokohama, Kanagawa 2310031, Japan; [Torikai, Katsuyuki] Yokohama City Univ, Yokohama, Kanagawa, Japan; [Kijima, Takeshi; Sano, Tsuguo] Tokyo Nishi Tokushukai Hosp, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Hirakawa, Takashi] Hirakawa Orthodont Off, Hirakawa, Kanagawa, Japan; [Naganishi, Hiroki] Yokohama City Univ, Med Ctr, Dept Plast & Reconstruct Surg, Yokohama, Kanagawa, Japan; [Ishiwata, Yasuo] Ishiwata Orthodont Off, Ishiwata, Kanagawa, Japan; [Fukawa, Toshihiko] Fukawa Orthodont Off, Fukawa, Kanagawa, Japan; [Funaki, Junzo] Funaki Orthodont Off, Tokyo, Japan; [Suzuki, Keiko] Kitasato Univ, Sch Allied Hlth Sci, Speech Therapy Course, Tokyo, Japan	Torikai, K (reprint author), Fureai Yokohama Hosp, Dept Esthet & Plast Surg, Naka Ku, 2-3-3 Mandai Cho, Yokohama, Kanagawa 2310031, Japan.	ktori47@yahoo.co.jp					Abe M., 1980, ONSEIGENGO IGAKU, V21, P48; FURLOW LT, 1986, PLAST RECONSTR SURG, V78, P724; Calonge WM, 2011, ANN CHIR PLAST ESTH, V56, P315, DOI 10.1016/j.anplas.2010.09.003; Gillies HD, 1921, BRIT MED J, V1921, P335; HUDSON JW, 1995, ORAL SURG ORAL MED O, V80, P24, DOI 10.1016/S1079-2104(95)80011-5; Izuka T, 1957, NIPPON KYOSEI SHIKA, V16, P4; Kumai K, 1984, ONSEIGENGO IGAKU, V25, P169; LINDGREN V V, 1965, Plast Reconstr Surg, V35, P540, DOI 10.1097/00006534-196505000-00010; McGrattan K, 2013, CLEFT PALATE-CRAN J, V50, P13, DOI 10.1597/11-137; Ohira S, 1993, ONSEIGENGO IGAKU, V34, P298; PERKO MA, 1979, J MAXILLOFAC SURG, V7, P76, DOI 10.1016/S0301-0503(79)80015-6; PERKO MA, 1974, J MAXILLOFAC SURG, V2, P40, DOI 10.1016/S0301-0503(74)80012-3; PRUZANSKY S, 1955, J Int Coll Surg, V24, P370; Salyer K E, 1992, J Craniofac Surg, V3, P55, DOI 10.1097/00001665-199209000-00002; Suzuki K, 2012, J JPN CLEFT PALATE A, V37, P197; THALLER SR, 1995, J CRANIOFAC SURG, V6, P375, DOI 10.1097/00001665-199509000-00008; Torikai K, 2006, PEPARS, V11, P31; Torikai K, 2009, J CRANIOFAC SURG, V20, P1729, DOI 10.1097/SCS.0b013e3181b3efda; Wardell WEM, 1937, BRIT J SURG, V25, P117, DOI 10.1002/bjs.1800259715; Widmaier E., 1959, CHIRURG, V30, P274	20	0	0	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1545-1569	1055-6656		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	SEP	2015	52	5					532	542		10.1597/13-323		11	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CQ7XH	WOS:000360819200010		
J	Shintaku, Y; Tanikawa, C; Iida, S; Aikawa, T; Kogo, M; Yamashiro, T				Shintaku, Yuko; Tanikawa, Chihiro; Iida, Seiji; Aikawa, Tomonao; Kogo, Mikihiko; Yamashiro, Takashi			Maxillary Expansion and Midline Correction by Asymmetric Transverse Distraction Osteogenesis in a Patient With Unilateral Cleft Lip/Palate: A Case Report	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						asymmetric transverse distraction osteogenesis; narrow dental arch; unilateral cleft lip and palate	PALATE; LIP; DEFORMITIES; CHILDREN	This case report presents the management of a female patient with unilateral cleft lip and palate presenting with skeletal Class III malocclusion and a narrow upper dental arch with a midline deviation. The treatment plan involved asymmetric transverse distraction osteogenesis of the maxilla to make the upper dental midline coincident with the facial midline. After the treatment, a good facial profile and a close intercuspation of teeth were achieved. Occlusion remained stable with normal overjet and overbite after 2-year retention.	[Shintaku, Yuko; Aikawa, Tomonao; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Tanikawa, Chihiro; Yamashiro, Takashi] Osaka Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Suita, Osaka, Japan; [Iida, Seiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Reconstruct Surg, Okayama 7008530, Japan	Tanikawa, C (reprint author), 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ctanika@gmail.com					Vyas RM, 2009, J CRANIOFAC SURG, V20, P733, DOI 10.1097/SCS.0b013e3181a2d9aa; Heintze SD, 2010, INT J PROSTHODONT, V23, P129; Braumann B, 2002, CLEFT PALATE-CRAN J, V39, P1, DOI 10.1597/1545-1569(2002)039<0001:TDAOMC>2.0.CO;2; GRECO JM, 1990, INT J ORAL MAX SURG, V19, P103, DOI 10.1016/S0901-5027(05)80204-8; Scolozzi P, 2008, J CRANIOFAC SURG, V19, P1199, DOI 10.1097/SCS.0b013e318184365d; MARS M, 1987, CLEFT PALATE J, V24, P314; Vichi M, 1995, J DENT CHILD, V62, P412; DeLuke DM, 1997, J ORAL MAXIL SURG, V55, P694, DOI 10.1016/S0278-2391(97)90579-6; Figueroa AA, 2004, PLAST RECONSTR SURG, V114, P1382, DOI 10.1097/01.PRS.0000138593.89303.1B; COHEN SR, 1995, PLAST RECONSTR SURG, V96, P267, DOI 10.1097/00006534-199508000-00003; EPKER BN, 1976, J ORAL SURG, V34, P324; Iida S, 2008, ORAL SURG ORAL MED O, V105, pE8, DOI 10.1016/j.tripleo.2007.08.022; Kokich Vincent O Jr, 2005, J Esthet Restor Dent, V17, P5, DOI 10.1111/j.1708-8240.2005.tb00076.x; Losee JE, 2008, COMPREHENSIVE CLEFT; Mars M, 1990, CLEFT PALATE J, V1, P7; SCHWARZ C, 1976, Journal of Maxillofacial Surgery, V4, P40, DOI 10.1016/S0301-0503(76)80007-0; Turnbull N R, 2000, J Orthod, V27, P235; Wada K, 1977, J OSAKA U DENT SOC, V22, P239	18	0	0	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1545-1569	1055-6656		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	SEP	2015	52	5					618	624		10.1597/13-278		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CQ7XH	WOS:000360819200019		
J	Ling, FH; Tamura, M; Yasuhara, K; Ajima, K; Trinh, C				Ling, Frank Hiroshi; Tamura, Makoto; Yasuhara, Kazuya; Ajima, Kiyotake; Cong Van Trinh			Reducing flood risks in rural households: survey of perception and adaptation in the Mekong delta	CLIMATIC CHANGE			English	Article							SEA-LEVEL RISE; CLIMATE-CHANGE; VULNERABILITY; VIETNAM; VARIABILITY; EVENTS; IMPACT; RICE	The Mekong Delta, one of the most vulnerable regions to climate change, is the focus of international action for adaptation. Improved understanding of the exposures and perceptions at the local level will help residents to cope with natural disasters and future climate disruptions. In this study, we assess the exposure to floods that rural communities across the Mekong Delta are facing. Among the various natural disasters threatening the delta, extreme flooding is by far the most prevailing concern. By carrying out a field survey on 1350 residents, we characterize the flooding patterns and vulnerabilities of households in three geographically diverse provinces. The aim of this study is to assess the effectiveness of current flood adaptation in these households in conditions of regular flooding, as well as to extreme flooding events, which become more intense and frequent due to climate change. While the findings suggest varying degrees of coping with seasonal flooding by raising the ground floors of their homes, their capacity to prepare for extreme floods is limited in spite of the residents' awareness of the changing dynamics of natural disasters in their locality. We also examine their perception to the effects of climate change and identify factors that influence their awareness.	[Ling, Frank Hiroshi; Tamura, Makoto; Yasuhara, Kazuya; Ajima, Kiyotake] Ibaraki Univ, Inst Global Change Adaptat Sci, Mito, Ibaraki 3108512, Japan; [Cong Van Trinh] Water Resources Univ, Ho Chi Minh City, Vietnam	Ling, FH (reprint author), Ibaraki Univ, Inst Global Change Adaptat Sci, 2-1-1 Bunkyo, Mito, Ibaraki 3108512, Japan.	tomiro@gmail.com			Environment Research and Technology Development Fund S-8 "Comprehensive Research on Climate Change Impact Assessment and Adaptation Policies" of the Ministry of the Environment of Japan;  [23254004];  [24510047]	This study was partly supported by the Environment Research and Technology Development Fund S-8 "Comprehensive Research on Climate Change Impact Assessment and Adaptation Policies" of the Ministry of the Environment of Japan and the Grant-in-Aid for Scientific Research (ID: 23254004, 24510047). The authors would also like to thank Duong Vu, Vo Cong Hoang, and the students of the WRU, Vietnam for their support in conducting the survey.	ADB, 2012, SOC REP VIETNAM CLIM, P1; ADB AusAid, 2011, CLIM CHANG IMP AD A, P1; Adger WN, 1999, WORLD DEV, V27, P249, DOI 10.1016/S0305-750X(98)00136-3; Adger W. N., 2003, Progress in Development Studies, V3, P179, DOI 10.1191/1464993403ps060oa; Dasgupta S, 2009, CLIMATIC CHANGE, V93, P379, DOI 10.1007/s10584-008-9499-5; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Wassmann R, 2004, CLIMATIC CHANGE, V66, P89, DOI 10.1023/B:CLIM.0000043144.69736.b7; Dolan AH, 2006, J COASTAL RES, P1316; Pielke RA, 2012, GEOPHYS MONOGR SER, V196, P345, DOI 10.1029/2011GM001086; Dang HL, 2014, ENVIRON SCI POLICY, V41, P11, DOI 10.1016/j.envsci.2014.04.002; [Anonymous], 2011, MEK FLOOD CAUS WIS D; Kuenzer C, 2013, REMOTE SENS-BASEL, V5, P687, DOI 10.3390/rs5020687; Birkmann J, 2012, ENVIRON SCI ENG, P245, DOI 10.1007/978-94-007-3962-8_10; CARE Australia, 2012, ICAM INT COMM BAS AD, P1; Dang HL, 2014, MITIG ADAPT STRAT GL, V19, P531, DOI 10.1007/s11027-012-9447-6; Danh VT, 2011, ADV GLOB CHANGE RES, V45, P181, DOI 10.1007/978-94-007-0934-8_11; DTI News, 2012, DTI NEWS; DWF, 2011, SURV PERC RISKS CAN; Francisco H, 2008, EC ENV PROGR SE AS E; Ha T. T. P., 2013, MAR POLICY, V38, P417, DOI DOI 10.1016/J.MARP0L.2012.06.021; Klein R, 2000, MITIG ADAPT STRAT GL, V4, P1; Kobayashi H, 2012, J ASIAN ARCHIT BUILD, V11, P79; Laprise R., 2007, CLIMATE CHANGE 2007, P849; Le T. V. H., 2007, ESTUARINE COASTAL SH, V71, P110, DOI [10.1016/j.ecss.2006.08.21, DOI 10.1016/J.ECSS.2006.08.21]; Linh LH, 2012, INT J PLANT GENOM, V2012, DOI [10.1155/2012/949038, DOI 10.1155/2012/949038]; MONRE, 2010, VIETN NETH MEK DELT, P1; MRC, 2011, LIV EDG RIS SEA; Nguyen HH, 2007, UNDP 1 24, P1; Nguyen KV, 2013, ECOL SOC, V18, DOI 10.5751/ES-05427-180313; Nhan DK, 2011, ADV GLOB CHANGE RES, V45, P437, DOI 10.1007/978-94-007-0934-8_24; SIWRP, 2009, STUD CLIM SCEN ASS C, P1; Smithers J, 1997, GLOBAL ENVIRON CHANG, V7, P129, DOI 10.1016/S0959-3780(97)00003-4; Tamura M, 2014, CLIMATE CHNAGE ADAPT, P314; Tamura M, CLIMATE DEV; Tang PG, 2013, SOC T COMMUNITY PREO; Tinh BD, 2010, COMM ENV DISAST RISK, V5, P393, DOI 10.1108/S2040-7262(2010)0000005025; Truong TNC, 2011, OMONRICE, V18, P149; Tuan LA, 2008, FOOD SALINITY MANAGE, P1; Tuan LA, 2011, ADV GLOB CHANGE RES, V45, P207, DOI 10.1007/978-94-007-0934-8_12; UNDP, 2008, FLOOD PROOF POOR COA; Van TC, 2011, IDENTIFICATION SEA L; Vu D, 2014, 19 IAHR APD CONGR 20, DOI 10.13140/2.1.5153.9842; World Bank, 2010, EC NUCL POW, P1; World Bank, 2010, STEELST YB, P1; Yusuf A, 2009, CLIMATE CHANGE VULNE, P1	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-0009	1573-1480		CLIMATIC CHANGE	Clim. Change	SEP	2015	132	2					209	222		10.1007/s10584-015-1416-0		14	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CQ3YW	WOS:000360541800004		
J	Kajiwara, A; Kita, A; Saruwatari, J; Oniki, K; Morita, K; Yamamura, M; Murase, M; Koda, H; Hirota, S; Ishizuka, T; Nakagawa, K				Kajiwara, Ayami; Kita, Ayana; Saruwatari, Junji; Oniki, Kentaro; Morita, Kazunori; Yamamura, Masato; Murase, Motoji; Koda, Haruo; Hirota, Seisuke; Ishizuka, Tadao; Nakagawa, Kazuko			Higher Risk of Sulfonylurea-associated Hypoglycemic Symptoms in Women with Type 2 Diabetes Mellitus	CLINICAL DRUG INVESTIGATION			English	Article							1ST-LINE ADD-ON; CARDIOVASCULAR EVENTS; METFORMIN THERAPY; BLOOD-GLUCOSE; NATIONWIDE; COMBINATION; PREDICTORS; MORTALITY; INSULIN; PEOPLE	Background Although some evidence suggests that women may be at greater risk for hypoglycemia, no conclusion has been reached, and female sex has not been taken into account in antidiabetic drug-induced hypoglycemia. This study aimed to determine whether females are at a higher risk of sulfonylurea (SU)-associated hypoglycemia in daily clinical practice. Methods The incidence of adverse reactions of SU was investigated in 2119 Japanese patients who participated in the Drug Event Monitoring project of the Japan Pharmaceutical Association, which was conducted in Kumamoto prefecture. A multiple logistic regression analysis was used to determine the association between the incidence of hypoglycemic symptoms and female sex, with adjusted odds ratios (ORs) and 95 % confidence intervals (95 % CIs). Results Female sex was found to be significantly associated with hypoglycemic symptoms (female vs. male; OR 2.04; 95 % CI 1.22-3.41; p = 0.007). The concomitant use of other antihyperglycemic agents (>= 2 vs. 0 concomitant drug; OR 2.80; 95 % CI 1.17-6.67; p = 0.021), a shorter duration of diabetes medication (< 3 vs. >= 24 months; OR 4.14; 95 % CI 1.06-16.14; p = 0.041) and a longer follow-up period (OR 1.02; 95 % CI 1.00-1.04; p = 0.041) were identified as risk factors for hypoglycemia that were specific to females. Conclusion To the best of our knowledge, this is the first report to focus on female sex as a potential risk factor for SU-associated hypoglycemia. Our results support the importance of individualized therapy, which may be effective not only for reducing the risk of hypoglycemia in females but also the risk of its consequences, such as cardiovascular disease, dementia and increased mortality.	[Kajiwara, Ayami; Kita, Ayana; Saruwatari, Junji; Oniki, Kentaro; Morita, Kazunori; Nakagawa, Kazuko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Chuo Ku, Kumamoto 8620973, Japan; [Yamamura, Masato; Murase, Motoji; Koda, Haruo; Hirota, Seisuke] Kumamoto Pharmaceut Assoc, Kumamoto, Japan; [Ishizuka, Tadao] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Mol Design, Kumamoto 8620973, Japan; [Ishizuka, Tadao; Nakagawa, Kazuko] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan	Nakagawa, K (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	kazukon@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23510348, 26360049]	This work was supported by a grant-in-aid for scientific research: KAKENHI(C) No. 23510348 and 26360049 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abrahamson MJ, 2015, DIABETES CARE, V38, P166, DOI 10.2337/dc14-1945; Aung PP, 2012, DIABETIC MED, V29, P328, DOI 10.1111/j.1464-5491.2011.03505.x; Isacson D, 2008, ANN PHARMACOTHER, V42, P347, DOI 10.1345/aph.1K488; Lin CH, 2013, J INTERN MED, V273, P102, DOI 10.1111/joim.12000; Barnett AH, 2010, INT J CLIN PRACT, V64, P1121, DOI 10.1111/j.1742-1241.2009.02332.x; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; Hirst JA, 2013, DIABETOLOGIA, V56, P973, DOI 10.1007/s00125-013-2856-6; Cryer PE, 2014, DIABETES, V63, P2188, DOI 10.2337/db14-0059; Deusenberry CM, 2012, PHARMACOTHERAPY, V32, P613, DOI 10.1002/j.1875-9114.2011.01088.x; Vexiau P, 2008, DIABETES OBES METAB, V10, P16, DOI 10.1111/j.1463-1326.2008.00883.x; Seufert J, 2014, DIABETES OBES METAB, V16, P248, DOI 10.1111/dom.12211; Pietraszek A, 2010, NUTR METAB CARDIOVAS, V20, P366, DOI 10.1016/j.numecd.2010.05.001; Simeone JC, 2012, ANN PHARMACOTHER, V46, P157, DOI 10.1345/aph.1Q352; Faerch K, 2010, DIABETOLOGIA, V53, P858, DOI 10.1007/s00125-010-1673-4; ASPLUND K, 1983, DIABETOLOGIA, V24, P412; Association The Japan Pharmaceutical, 2011, J JPN PHARM ASS, V63, P1259; Chiu CJ, 2011, ANN BEHAV MED, V41, P71, DOI 10.1007/s12160-010-9226-0; Erhardt W, 2012, CLIN DRUG INVEST, V32, P189, DOI 10.2165/11597060-000000000-00000; Franconi Flavia, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P179; Genuth S, 2015, DIABETES CARE, V38, P170, DOI 10.2337/dc14-0565; Hakobyan L, 2011, DRUG SAFETY, V34, P1191, DOI 10.2165/11593810-000000000-00000; Hara Yoriko, 2014, Biopsychosoc Med, V8, P16, DOI 10.1186/1751-0759-8-16; Horton TJ, 2006, J APPL PHYSIOL, V100, P1883, DOI 10.1152/japplphysiol.01431.2005; Kajiwara A, 2013, DRUG SAFETY, V36, P981, DOI 10.1007/s40264-013-0077-z; Li YP, 2014, DIABETES CARE, V37, P3106, DOI 10.2337/dc14-1306; Miller ME, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5444; Mogensen UM, 2015, DIABETOLOGIA, V58, P50, DOI 10.1007/s00125-014-3372-z; Schejter YD, 2012, J AM MED DIR ASSOC, V13, P234, DOI 10.1016/j.jamda.2010.07.014; Sheu WHH, 2012, DIABETES RES CLIN PR, V96, P141, DOI 10.1016/j.diabres.2011.12.027; Sumida Ken D, 2007, Clin Med Res, V5, P193, DOI 10.3121/cmr.2007.729; Szalat Auryan, 2008, Diabetes Obes Metab, V10, P1135, DOI 10.1111/j.1463-1326.2008.00896.x; Vlckova V, 2009, DRUG SAFETY, V32, P409, DOI 10.2165/00002018-200932050-00004	34	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-2563	1179-1918		CLIN DRUG INVEST	Clin. Drug Invest.	SEP	2015	35	9					593	600		10.1007/s40261-015-0314-6		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ5UF	WOS:000360670500007		
J	Othman, AA; Chatamra, K; Mohamed, MEF; Dutta, S; Benesh, J; Yanagawa, M; Nagai, M				Othman, Ahmed A.; Chatamra, Krai; Mohamed, Mohamed-Eslam F.; Dutta, Sandeep; Benesh, Janet; Yanagawa, Masayoshi; Nagai, Masahiro			Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel Versus Oral Administration of Levodopa-Carbidopa Tablets in Japanese Subjects with Advanced Parkinson's Disease: Pharmacokinetics and Pilot Efficacy and Safety	CLINICAL PHARMACOKINETICS			English	Article							MOTOR FLUCTUATIONS; DOUBLE-BLIND; ABSORPTION	Background and Objective Oral levodopa-carbidopa (LC-oral) treatment in advanced Parkinson's disease (PD) is associated with motor complications due to large fluctuations in levodopa plasma concentrations. Levodopa-carbidopa intestinal gel (LCIG) provides individualized continuous levodopa-carbidopa delivery through intrajejunal infusion. This study evaluated the pharmacokinetics, safety, and efficacy of LCIG relative to LC-oral in Japanese subjects with advanced PD. Methods Subjects with advanced PD were converted from their anti-PD medications to individually optimized doses of LC-oral (10:1 levodopa:carbidopa ratio) for 28 days (baseline; period 1) followed by switching to intrajejunal infusion of LCIG (4:1 ratio) for 21 days (period 2). Pharmacokinetics, adverse events (AEs), and efficacy were assessed. Results Eight patients were enrolled. Six received LCIG and four reported at least one AE [most common: fall (33.3 %), dyskinesia (33.3 %)]; one discontinued due to an AE. The average daily dose was 1230/123 and 1370/342 mg levodopa/carbidopa for LC-oral and LCIG, respectively, at the end of each period. The degree of fluctuation and intra-subject variability of levodopa plasma concentrations were 5.5- and 4-fold lower, respectively, with LCIG than with LC-oral. Levodopa bioavailability was 99 % for LCIG relative to LC-oral. Compared with baseline, LCIG decreased "Off" time (2.68 h, P = 0.002) and increased "On" time without troublesome dyskinesia (2.35 h, P = 0.006) in the PD Diary((c)). With the small sample size, no statistically significant changes were seen on other efficacy endpoints. Conclusions In Japanese subjects with advanced PD, LCIG resulted in an improved pharmacokinetic profile that appeared to be associated with reduced motor complications compared with LC-oral. These results extend previous findings in mainly Caucasian populations.	[Othman, Ahmed A.; Mohamed, Mohamed-Eslam F.; Dutta, Sandeep] AbbVie, Clin Pharmacol & Pharmacometr, N Chicago, IL 60064 USA; [Othman, Ahmed A.] Cairo Univ, Fac Pharm, Dept Pharmaceut, Cairo, Egypt; [Chatamra, Krai; Benesh, Janet] AbbVie, Dept Neurosci, N Chicago, IL 60064 USA; [Yanagawa, Masayoshi] AbbVie GK, Tokyo, Japan; [Nagai, Masahiro] Ehime Univ Hosp, Clin Therapeut Trial Ctr, Toon, Ehime, Japan	Othman, AA (reprint author), AbbVie, Clin Pharmacol & Pharmacometr, 1 North Waukegan Rd,Bldg AP13A-3, N Chicago, IL 60064 USA.	ahmed.othman@abbvie.com			AbbVie	This study was sponsored by AbbVie. AbbVie contributed to the study design, research, and interpretation of data, writing, reviewing, and approving the manuscript. Drs. Othman, Chatamra, Mohamed, Dutta, and Benesh and Mr. Yanagawa are employees and shareholders of AbbVie. Dr. Nagai of Ehime University Hospital, Ehime, Japan was an investigator for the study. LCIG (Duodopa (R); Duopa (R); carbidopa-levodopa enteral suspension) is marketed by AbbVie in more than 40 countries and is currently being evaluated in clinical trials in Japan. The authors declare no other relationships or activities that could appear to have influenced the submitted work.	Abbott Japan Co. Ltd, NCT01479127 US NIH C; AbbVie, NCT01960842 US NIH C; Nyholm D, 2003, CLIN NEUROPHARMACOL, V26, P156, DOI 10.1097/00002826-200305000-00010; Olanow CW, 2014, LANCET NEUROL, V13, P141, DOI 10.1016/S1474-4422(13)70293-X; NUTT JG, 1994, NEUROLOGY, V44, P913; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Hauser RA, 2009, EUR NEUROL, V62, P1, DOI 10.1159/000215875; NUTT JG, 1984, CLIN NEUROPHARMACOL, V7, P35; WOOD AJJ, 1991, CLIN PHARMACOKINET, V20, P350, DOI 10.2165/00003088-199120050-00002; Hauser RA, 2000, CLIN NEUROPHARMACOL, V23, P75, DOI 10.1097/00002826-200003000-00003; KURLAN R, 1988, NEUROLOGY, V38, P419; Nyholm D, 2013, AAPS J, V15, P316, DOI 10.1208/s12248-012-9439-1; NUTT JG, 1984, NEW ENGL J MED, V310, P483, DOI 10.1056/NEJM198402233100802; Nyholm D, 2005, NEUROLOGY, V64, P216; Hardoff R, 2001, MOVEMENT DISORD, V16, P1041, DOI 10.1002/mds.1203; Fernandez HH, 2015, MOVEMENT DISORD, V30, P500, DOI 10.1002/mds.26123; LENNERNAS H, 1993, BRIT J CLIN PHARMACO, V35, P243; Nyholm D, 2007, PARKINSONISM RELAT D, V13, pS13, DOI 10.1016/j.parkreldis.2007.06.005; Nyholm D, 2004, CLIN NEUROPHARMACOL, V27, P245, DOI 10.1097/01.wnf.0000144041.28224.b7; Othman AA, 2014, BRIT J CLIN PHARMACO, V78, P94, DOI 10.1111/bcp.12324; RIVERACALIMLIM L, 1984, CLIN PHARMACOL THER, V35, P804; Slevin JT, 2015, J PARKINSON DIS, V5, P165, DOI 10.3233/JPD-140456; YEH KC, 1989, NEUROLOGY, V39, P25	23	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	SEP	2015	54	9					975	984		10.1007/s40262-015-0265-3		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ6FE	WOS:000360699000009		
J	Makino, A; Shintomi, M				Makino, Atsushi; Shintomi, Masahito			Critical condition related to the activation of solid fuel particles; comparisons with experimental results for char combustion in a quiescent environment	COMBUSTION AND FLAME			English	Article						Heterogeneous combustion; Particle combustion; Activation of solid fuel particles; Char combustion; Combustion rate; Critical particle size	BURNING CARBON PARTICLES; STAGNANT BOUNDARY-LAYER; DEGREES K; INTERACTIVE PROCESSES; KINETIC-PARAMETERS; COAL; TEMPERATURE; SIZE; GASIFICATION; DIFFUSION	In order to verify appropriateness and/or usefulness of the critical condition related to the activation of solid fuel particles, being derived in the previous work, an attempt has been made for conducting comparisons by use of such experimental data in the literature as are reported to be burned in a quiescent environment. Use has been made of various carbonaceous solid fuels, from anthracite to low-rank coal char, as well as petroleum coke, after having confirmed kinetic parameters for the surface reaction that are indispensable for estimating combustion rate. Specifically, particle sizes examined in the present comparisons are those from 4 lam to 25 mm; ambient temperatures are those, higher than 1000 K. Use has also been made of the Arrhenius plot of the comprehensive parameter, consisting of frequency factor for the surface C-O-2 reaction, particle diameter, oxygen mass-fraction, and pressure ratio, upper half of which, separated by the critical condition, corresponds to that for particle burn-out with the surface reaction being activated. In general, a fair degree of agreement has been demonstrated in the present comparisons, as far as the trend and approximate magnitude are concerned, suggesting that the formulation used has captured the essential feature of the particle combustion, which has never been elucidated. Furthermore, it has been confirmed that the reduction in particle size does not necessarily favor the particle combustion and that the surface reaction ceases to be activated when the particle size is reduced below the critical one. (C) 2015 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Makino, Atsushi] Japan Aerosp Explorat Agcy, Aeronaut Technol Directorate, Chofu, Tokyo 1828522, Japan; [Shintomi, Masahito] Numazu Natl Coll Technol, Dept Mech Engn, Shizuoka, Japan	Makino, A (reprint author), Japan Aerosp Explorat Agcy, Aeronaut Technol Directorate, 7-44-1 Jindaiji Higashi, Chofu, Tokyo 1828522, Japan.	amakino@chofu.jaxa.jp					ANNAMALAI K, 1994, PROG ENERG COMBUST, V20, P487, DOI 10.1016/0360-1285(94)90002-7; Annamalai K., 2007, COMBUSTION SCI ENG, P608; Annamalai K., 2007, COMBUSTION SCI ENG, P331; CARAM HS, 1977, IND ENG CHEM FUND, V16, P171, DOI 10.1021/i160062a001; ANNAMALAI K, 1993, PROG ENERG COMBUST, V19, P383, DOI 10.1016/0360-1285(93)90010-C; FIELD MA, 1970, COMBUST FLAME, V14, P237, DOI 10.1016/S0010-2180(70)80035-9; ARTHUR JR, 1951, T FARADAY SOC, V47, P164, DOI 10.1039/tf9514700164; FIELD MA, 1969, COMBUST FLAME, V13, P237, DOI 10.1016/0010-2180(69)90002-9; HAMOR RJ, 1973, COMBUST FLAME, V21, P153, DOI 10.1016/S0010-2180(73)80020-3; BANDYOPA.S, 1972, COMBUST FLAME, V18, P411, DOI 10.1016/S0010-2180(72)80192-5; BATCHELDER HR, 1953, IND ENG CHEM, V45, P1856, DOI 10.1021/ie50525a021; Blake TR, 2002, COMBUST FLAME, V129, P87, DOI 10.1016/S0010-2180(01)00360-1; Cassel H.M., 1956, P COMBUST INST, V6, P602; Chung P.M., 1965, ADV HEAT TRANSFER, V2, P109, DOI 10.1016/S0065-2717(08)70262-4; Clark T.J., 1962, NUCL GRAPHITE, P387; Essenhigh R.H., 1981, CHEM COAL UTILIZAT S, P1153; Essenhigh R.H., 1976, P COMBUST INST, V16, P353; Field M.A., 1967, MONTHLY B BRIT COAL, V31, P285; Frank-Kamenetsukii D.A., 1969, DIFFUSION HEAT TRANS, Vsecond, P349; Gerstein M., 1956, COMBUSTION PROCESSES, P444; Glassman I., 1996, COMBUSTION, Vthird, P468; Glassman I., 1996, COMBUSTION, Vthird, P330; Glassman I., 1996, COMBUSTION, Vthird, P462; Goetz G.J., 1982, EPRIAP2601; Golovina E.S., 1962, P COMBUST INST, V8, P784; Gray M.D., 1967, MONTHLY B BRIT COAL, V31, P285; Howard J.B., 1967, P COMBUST INST, V11, P399; Ivanova I.P., 1966, THERM ENG, V13, P70; KARCZ A, 1982, COMBUST FLAME, V45, P95, DOI 10.1016/0010-2180(82)90035-9; KARCZ H, 1980, FUEL, V59, P799, DOI 10.1016/0016-2361(80)90259-8; Katsnel'son B.D., 1964, TEPLOENERGETIKA, V11, P11; Khitrin L.N., 1962, PHYS COMBUSTION EXPL, P353; Khitrin L.N., 1964, HIGH TEMPERATURE TEC, P485; LIBBY PA, 1981, COMBUST FLAME, V41, P123, DOI 10.1016/0010-2180(81)90047-X; LIBBY PA, 1979, COMBUST FLAME, V36, P139, DOI 10.1016/0010-2180(79)90056-7; Maahs H.G., 1971, D6310 NASA TN; Makino A, 2009, P COMBUST INST, V32, P2067, DOI 10.1016/j.proci.2008.07.036; Makino A., 2011, MASS TRANSFER CHEM E, P251; Makino A., 2013, J COMBUST, V2013; Makino A, 2013, COMBUST FLAME, V160, P742, DOI 10.1016/j.combustflame.2012.12.001; MAKINO A, 1992, COMBUST FLAME, V90, P143, DOI 10.1016/0010-2180(92)90116-7; MAKINO A, 1994, COMBUST FLAME, V96, P261, DOI 10.1016/0010-2180(94)90013-2; Makino A., 1986, P COMBUST INST, V21, P183; Makino A, 2014, COMBUST FLAME, V161, P1537, DOI 10.1016/j.combustflame.2013.12.003; Makino A., 1997, T JPN SOC MECH ENG-B, V63, P1049; Mitchell R.E., 1990, P COMBUST INST, V23, P1169; MON E, 1978, IND ENG CHEM FUND, V17, P313, DOI 10.1021/i160068a017; MULCAHY MFR, 1969, REV PURE APPL CHEM, V19, P81; Parker AS, 1936, IND ENG CHEM, V28, P1334, DOI 10.1021/ie50323a024; Rosner D. E., 1972, ANN REV MATERIALS SC, V2, P573, DOI 10.1146/annurev.ms.02.080172.003041; Schlichting H., 2000, BOUNDARY LAYER THEOR, P110; Sherman R.A., 1934, ASME T, V56, P401; Smith DF, 1931, IND ENG CHEM, V23, P277, DOI 10.1021/ie50255a014; Smith I. W., 1982, P COMBUST INST, V19, P1045, DOI DOI 10.1016/S0082-0784(82)80281-6; SMITH IW, 1971, COMBUST FLAME, V17, P303, DOI 10.1016/S0010-2180(71)80052-4; SMITH IW, 1971, COMBUST FLAME, V17, P421, DOI 10.1016/S0010-2180(71)80065-2; Spalding D.B., 1951, Fuel, V30; Tu CM, 1934, IND ENG CHEM, V26, P749, DOI 10.1021/ie50295a014; UBHAYAKAR SK, 1976, J ELECTROCHEM SOC, V123, P747, DOI 10.1149/1.2132920; Visser W., 1984, P COMBUST INST, V20, P1845; WALKER PL, 1959, ADV CATAL, V11, P133, DOI 10.1016/S0360-0564(08)60418-6; Young B. C., 1981, P COMBUST INST, V18, P1249	62	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	SEP	2015	162	9					3156	3165		10.1016/j.combustflame.2015.05.001		10	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	CQ7JK	WOS:000360779100003		
J	Inoue, H; Suzuki, T; Inoue, T; Hattori, T; Nejima, R; Todokoro, D; Hoshi, S; Eguchi, H; Miyamoto, H; Ohashi, Y				Inoue, Hidenori; Suzuki, Takashi; Inoue, Tomoyuki; Hattori, Takaaki; Nejima, Ryohei; Todokoro, Daisuke; Hoshi, Saichi; Eguchi, Hiroshi; Miyamoto, Hitoshi; Ohashi, Yuichi			Clinical Characteristics and Bacteriological Profile of Moraxella Keratitis	CORNEA			English	Article						Moraxella; contact lens; diabetes mellitus; keratitis	CORNEAL ULCERS; PREDISPOSING FACTORS; BACTERIAL KERATITIS; INFECTION; SUSCEPTIBILITY; COMBINATION; POPULATION; ARTHRITIS	Purpose:Moraxella species are rare causative pathogens of severe sight-threatening keratitis. The aim of this study was to analyze the clinical presentation, predisposing risk factors, in vitro antimicrobial susceptibility, and treatment associated with Moraxella keratitis.Methods:We retrospectively reviewed 30 culture-proven cases of Moraxella keratitis from multiple centers in Japan.Results:The mean age of the patients was 58.4 23.4 years. The most common ocular conditions were contact lens wearing (5 patients, 16.7%) and trauma (3 patients, 10.0%). Seven patients had diabetes mellitus. Sixteen patients exhibited hypopyon in association with the corneal focus. Ring-shaped infiltration was found in 9 patients (30.0%), and irregular or amoebic-shaped infiltration was observed in 13 patients (43.3%). Eight patients (26.7%) showed small round infiltrates. All Moraxella isolates were sensitive to fluoroquinolones and aminoglycosides. All were treated with a combination ophthalmic solution containing a fluoroquinolone, tobramycin, and cefmenoxime. Although no patients developed corneal perforation, the response to treatment was slow in all cases; the mean treatment period was 41.9 days.Conclusions:In Japan, Moraxella keratitis occurs in patients with contact lens wear, trauma, and diabetes mellitus. It presents as a small, round, ring-shaped, irregularly shaped, or amoebic-shaped focus. Moraxella species exhibit good susceptibility to fluoroquinolones and aminoglycosides. Because the treatment response may be very slow, these agents should be continued for a long period of time.	[Inoue, Hidenori; Suzuki, Takashi; Inoue, Tomoyuki; Hattori, Takaaki; Nejima, Ryohei; Todokoro, Daisuke; Hoshi, Saichi] Ehime Univ, Grad Sch Med, OMIC Ocular Microbiol & Infect Conf Working Grp, Toon, Ehime 7910295, Japan; [Inoue, Hidenori; Suzuki, Takashi; Inoue, Tomoyuki; Ohashi, Yuichi] Ehime Univ, Grad Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan; [Hattori, Takaaki] Tokyo Med Univ, Dept Ophthalmol, Tokyo 1608402, Japan; [Nejima, Ryohei] Miyata Eye Hosp, Miyakonojo, Japan; [Todokoro, Daisuke] Gunma Univ, Sch Med, Dept Ophthalmol, Maebashi, Gumma 371, Japan; [Hoshi, Saichi] Natl Ctr Geriatr & Gerontol, Dept Ophthalmol, Obu, Japan; Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Ophthalmol, Tokushima 770, Japan; [Miyamoto, Hitoshi] Ehime Univ Hosp, Dept Clin Lab, Toon, Japan	Suzuki, T (reprint author), Ehime Univ, Grad Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan.	t-suzuki@m.ehime-u.ac.jp			Department of Bioscience, INCS, Ehime University	Supported by the Department of Bioscience, INCS, Ehime University.	Bharathi MJ, 2010, INDIAN J OPHTHALMOL, V58, P497, DOI 10.4103/0301-4738.71678; [Anonymous], 2006, NIHON GANKA GAKKAI Z, V110, P961; Loh RS, 2009, OPHTHALMOLOGY, V116, P2348, DOI 10.1016/j.ophtha.2009.05.004; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Ly CN, 2006, CLIN EXP OPHTHALMOL, V34, P44, DOI 10.1111/j.1442-9071.2006.1143.x; Kowalski RP, 2013, CORNEA, V32, P830, DOI 10.1097/ICO.0b013e318268d6f4; Patel R, 2015, CLIN CHEM, V61, P100, DOI 10.1373/clinchem.2014.221770; BAUM J, 1980, AM J OPHTHALMOL, V90, P476; COBO LM, 1981, BRIT J OPHTHALMOL, V65, P683, DOI 10.1136/bjo.65.10.683; Das S, 2006, BRIT J OPHTHALMOL, V90, P1236, DOI 10.1136/bjo.2006.095182; Garg P, 1999, CORNEA, V18, P176, DOI 10.1097/00003226-199903000-00006; HEIDEMANN DG, 1987, AM J OPHTHALMOL, V103, P576; MARIONEAUX SJ, 1991, CORNEA, V10, P21; Masaki T, 2012, J INFECT CHEMOTHER, V18, P386, DOI 10.1007/s10156-011-0311-5; Mian SI, 2011, ACTA OPHTHALMOL, V89, pE208, DOI 10.1111/j.1755-3768.2009.01780.x; Nakayama A, 2014, J INFECT CHEMOTHER, V20, P61, DOI 10.1016/j.jiac.2013.06.002; RINGVOLD A, 1985, ACTA OPHTHALMOL, V63, P427; Schreckenberger PC, 2003, MANUAL CLIN MICROBIO, V8th, P749; Srinivasan M, 2012, ARCH OPHTHALMOL-CHIC, V130, P151, DOI 10.1001/archophthalmol.2011.303; STERN GA, 1982, ANN OPHTHALMOL, V14, P295; Suzuki T, 2013, CORNEA, V32, pE156, DOI 10.1097/ICO.0b013e31828ffe0e; Whitman WB, 2012, BERGEYS MANUAL SYSTE, V5	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	SEP	2015	34	9					1105	1109		10.1097/ICO.0000000000000470		5	Ophthalmology	Ophthalmology	CQ1HT	WOS:000360348600020		
J	Futamura, K; Sekino, M; Hata, A; Ikebuchi, R; Nakanishi, Y; Egawa, G; Kabashima, K; Watanabe, T; Furuki, M; Tomura, M				Futamura, Koji; Sekino, Masashi; Hata, Akihiro; Ikebuchi, Ryoyo; Nakanishi, Yasutaka; Egawa, Gyohei; Kabashima, Kenji; Watanabe, Takeshi; Furuki, Motohiro; Tomura, Michio			Novel full-spectral flow cytometry with multiple spectrally-adjacent fluorescent proteins and fluorochromes and visualization of in vivo cellular movement	CYTOMETRY PART A			English	Article						spectral flow cytometry; separation of spectrally-adjacent fluoroprobes; photoconvertible fluorescent protein; immune cell movement	LIVING CELLS; HYPERSPECTRAL CYTOMETRY; GREEN; MICROSCOPY; MICE; COMPENSATION; LIMITATIONS; PRECURSORS; INDICATORS; DYNAMICS	Flow cytometric analysis with multicolor fluoroprobes is an essential method for detecting biological signatures of cells. Here, we present a new full-spectral flow cytometer (spectral-FCM). Unlike conventional flow cytometer, this spectral-FCM acquires the emitted fluorescence for all probes across the full-spectrum from each cell with 32 channels sequential PMT unit after dispersion with prism, and extracts the signals of each fluoroprobe based on the spectral shape of each fluoroprobe using unique algorithm in high speed, high sensitive, accurate, automatic and real-time. The spectral-FCM detects the continuous changes in emission spectra from green to red of the photoconvertible protein, KikGR with high-spectral resolution and separates spectrally-adjacent fluoroprobes, such as FITC (Emission peak (Em) 519 nm) and EGFP (Em 507 nm). Moreover, the spectral-FCM can measure and subtract autofluorescence of each cell providing increased signal-to-noise ratios and improved resolution of dim samples, which leads to a transformative technology for investigation of single cell state and function. These advances make it possible to perform 11-color fluorescence analysis to visualize movement of multilinage immune cells by using KikGR-expressing mice. Thus, the novel spectral flow cytometry improves the combinational use of spectrally-adjacent various FPs and multicolor fluorochromes in metabolically active cell for the investigation of not only the immune system but also other research and clinical fields of use. (c) 2015 International Society for Advancement of Cytometry	[Futamura, Koji; Furuki, Motohiro] Sony Corp, Life Sci Business Div, FCM Business Dept, Med Business Unit,Minato Ku, Tokyo 1080075, Japan; [Sekino, Masashi] Sony Corp, Concept Dev Dept, Applicat Technol Dev Div, Syst R&D Grp,RDS Platform,Shinagawa Ku, Tokyo 1080075, Japan; [Hata, Akihiro; Ikebuchi, Ryoyo; Nakanishi, Yasutaka; Watanabe, Takeshi; Tomura, Michio] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto 6068501, Japan; [Egawa, Gyohei; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068501, Japan	Tomura, M (reprint author), Osaka Ohtani Univ, Fac Pharm, Immunol Lab, 3-11-1 Nishikiorikita, Tondabayashi City, Osaka 5848540, Japan.	michio.tomura@gmail.com			"Analysis and Synthesis of Multidimensional Immune Organ Network" of the Ministry of Education, Culture, Sports, Science, and Technology, Japan [24111007];  [23113506]	Grant sponsor: Grant-in-Aid for Scientific Research for Scientific Research on Innovative Areas "Florescence Live Imaging", Grant number: 23113506; Grant sponsor: "Analysis and Synthesis of Multidimensional Immune Organ Network" of the Ministry of Education, Culture, Sports, Science, and Technology, Japan, Grant number: 24111007.	Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Liu BF, 2007, MOL VIS, V13, P854; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; Kotani M, 2013, J IMMUNOL, V190, P605, DOI 10.4049/jimmunol.1201345; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Novo D, 2013, CYTOM PART A, V83A, P508, DOI 10.1002/cyto.a.22272; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Miyawaki A, 1997, NATURE, V388, P882; McCombs JE, 2008, METHODS, V46, P152, DOI 10.1016/j.ymeth.2008.09.015; Kremers GJ, 2011, J CELL SCI, V124, P157, DOI 10.1242/jcs.072744; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Tomura M, 2009, INT IMMUNOL, V21, P1145, DOI 10.1093/intimm/dxp080; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Chattopadhyay PK, 2012, CYTOM PART A, V81A, P456, DOI 10.1002/cyto.a.22043; Bernstein HS, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt108; Chapman S, 2005, CURR OPIN PLANT BIOL, V8, P565, DOI 10.1016/j.pbi.2005.09.011; DesRosa SC, 2003, NAT MED, V9, P112; Goddard G, 2006, CYTOM PART A, V69A, P842, DOI 10.1002/cyto.a.20320; Gregori G, 2012, CYTOM PART A, V81A, P35, DOI 10.1002/cyto.a.21120; Gregori G, 2014, CURR TOP MICROBIOL, V377, P191, DOI 10.1007/82_2013_359; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Haraguchi T, 2002, GENES CELLS, V7, P881, DOI 10.1046/j.1365-2443.2002.00575.x; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Maecker Holden, 2009, Postepy Biochem, V55, P461; Muller-Taubenberger A, 2007, APPL MICROBIOL BIOT, V77, P1, DOI 10.1007/s00253-007-1131-5; Neumann M, 2002, J HISTOCHEM CYTOCHEM, V50, P437; Nolan JP, 2013, CYTOM PART A, V83A, P253, DOI 10.1002/cyto.a.22241; Nolan JP, 2013, CURR PROTOC CYTOM; Nowotschin S, 2009, TRENDS BIOTECHNOL, V27, P266, DOI 10.1016/j.tibtech.2009.02.006; PAWLEY J.B., 2006, HDB BIOL CONFOCAL MI; Press W. H., 2007, NUMERICAL RECIPES; Roederer M, 2002, CURR PROTOC IMMUNOL; Sakai K, 1995, BIOCHEM BIOPH RES CO, V217, P393, DOI 10.1006/bbrc.1995.2789; Sanders CK, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.037004; Tomura Michio, 2013, Methods Mol Biol, V961, P279, DOI 10.1007/978-1-62703-227-8_18; Tomura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073801; Tomura M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06030; Tomura M, 2010, J IMMUNOL, V184, P4646, DOI 10.4049/jimmunol.0903946	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4922	1552-4930		CYTOM PART A	Cytom. Part A	SEP	2015	87A	9					830	842		10.1002/cyto.a.22725		13	Biochemical Research Methods; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CQ4QU	WOS:000360590500010		
J	Liu, XD; Kakeda, S; Watanabe, K; Yoshimura, R; Abe, O; Ide, S; Hayashi, K; Katsuki, A; Umeno-Nakano, W; Watanabe, R; Ueda, I; Moriya, J; Nakamura, J; Korogi, Y				Liu, Xiaodan; Kakeda, Shingo; Watanabe, Keita; Yoshimura, Reiji; Abe, Osamu; Ide, Satoru; Hayashi, Kenji; Katsuki, Asuka; Umeno-Nakano, Wakako; Watanabe, Rieko; Ueda, Issei; Moriya, Junji; Nakamura, Jun; Korogi, Yukunori			RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAiVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY	DEPRESSION AND ANXIETY			English	Article						Hypothalamic-pituitary-adrenal (HPA) axis; voxel-based morphometry (VBM); Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV-TR; 17-item Hamilton Rating Scale for Depression (HAMD 17); glucocorticoid receptor	MEDIAL PREFRONTAL CORTEX; HUMAN CEREBRAL-CORTEX; ANTERIOR CINGULATE; ENDOGENOUS-DEPRESSION; ORBITOFRONTAL CORTEX; VOLUME; MRI; STRESS; PATHOPHYSIOLOGY; SCHIZOPHRENIA	ObjectiveIn major depressive disorder (MDD) patients, higher morning cortisol levels due to a hyperactive hypothalamic-pituitary-adrenal (HPA) axis have been reported. The aim of the present study was to evaluate the relationship between cortical thinning and the serum cortisol levels during the first depressive episode in drug-naive MDD patients using an automated surface-based morphometry (SBM) method. MethodsThe institutional review board approved this prospective study. MR imaging data were obtained using a 3T scanner by a three-dimensional fast-spoiled gradient recalled acquisition with steady state (3D-FSPGR). Thirty drug-naive patients with MDD and 41 age- and gender-matched healthy subjects (controls) were enrolled. We then used the SBM method (Freesurfer) to generate cortical thickness maps, and measured the cortical thickness in each subject. Morning blood samples were drawn from all participants for cortisol measurements. ResultsWe found the serum cortisol levels were significantly higher in the MDD patients than in the controls. The MDD patients manifested significant thinning of the left lateral orbitofrontal cortex compared with the controls. There was a significant negative linear correlation between the thickness of the left lateral orbitofrontal cortex and the serum cortisol levels in the MDD patients. ConclusionsIn the early stage of MDD, the thickness of the lateral orbitofrontal cortex was significantly reduced, and also showed a significant inverse correlation with the serum cortisol levels. Since the lateral orbitofrontal cortex contains a high concentration of glucocorticoid receptor, glucocorticoid receptor-mediated signaling transductions could contribute to neurotoxicity, which might occur when there are high cortisol levels in patients with MDD.	[Liu, Xiaodan; Kakeda, Shingo; Watanabe, Keita; Ide, Satoru; Watanabe, Rieko; Ueda, Issei; Moriya, Junji; Korogi, Yukunori] Univ Occupat & Environm Hlth, Dept Radiol, Fukuoka, Japan; [Yoshimura, Reiji; Hayashi, Kenji; Katsuki, Asuka; Umeno-Nakano, Wakako; Nakamura, Jun] Univ Occupat & Environm Hlth, Dept Psychiat, Fukuoka, Japan; [Abe, Osamu] Nihon Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Liu, Xiaodan] Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China	Watanabe, K (reprint author), Univ Occupat & Environm Hlth, Dept Radiol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 807, Japan.	sapient@med.uoeh-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	This work was supported by a grant-in-aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan. We extremely thank to all the subjects and coauthors who took part in this study.	Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneune.2005.02.010; Hucklebridge F, 1998, INT J PSYCHOPHYSIOL, V31, P69, DOI 10.1016/S0167-8760(98)00042-7; Northoff G, 2013, CURR OPIN NEUROBIOL, V23, P133, DOI 10.1016/j.conb.2012.08.004; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; HALBREICH U, 1985, ARCH GEN PSYCHIAT, V42, P904; Peterson BS, 2009, P NATL ACAD SCI USA, V106, P6273, DOI 10.1073/pnas.0805311106; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kuhn S, 2010, BIOL PSYCHIAT, V68, P1061, DOI 10.1016/j.biopsych.2010.08.004; Lim HK, 2012, NEUROPSYCHOPHARMACOL, V37, P838, DOI 10.1038/npp.2011.264; Mizoguchi K, 2003, NEUROSCIENCE, V119, P887, DOI 10.1016/S0306-4522(03)00105-2; Webster MJ, 2002, MOL PSYCHIATR, V7, P985, DOI 10.1038/sj.mp.4001139; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Herbert J, 2013, PSYCHOL MED, V43, P449, DOI 10.1017/S0033291712000955; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; RUBIN RT, 1987, ARCH GEN PSYCHIAT, V44, P328; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; PFOHL B, 1985, ARCH GEN PSYCHIAT, V42, P897; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Scheuerecker J, 2010, J PSYCHIATR NEUROSCI, V35, P311, DOI 10.1503/jpn.090076; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stokes PE, 1995, EUR NEUROPSYCHOPHARM, V5, P77, DOI 10.1016/0924-977X(95)00039-R; Young EA, 2001, NEUROPSYCHOPHARMACOL, V25, P267, DOI 10.1016/S0893-133X(00)00236-0; AHIMA RS, 1990, NEUROSCIENCE, V39, P579, DOI 10.1016/0306-4522(90)90244-X; DIORIO D, 1993, J NEUROSCI, V13, P3839; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; BRIDGES PK, 1966, BRIT J PSYCHIAT, V112, P1257, DOI 10.1192/bjp.112.493.1257; Carroll, 1976, ARCH GEN PSYCHIAT, V33, P1039, DOI 10.1001/archpsyc.1976.01770090029002; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Heckmann M, 1999, ARCH DIS CHILD, V81, pF171; Kroob G., 1988, SCIENCE, V242, P715; Lee S, 2013, PSYCHIAT INVEST, V10, P266, DOI 10.4306/pi.2013.10.3.266; Sorrells SF, 2014, NEUROENDOCRINOLOGY, V100, P129, DOI 10.1159/000367849; Treadway MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004887; Tu PC, 2011, PSYCHIAT RES, V202, P206; vansEijndhoven P, 2013, AM J PSYCHIAT, V170, P1477; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1091-4269	1520-6394		DEPRESS ANXIETY	Depress. Anxiety	SEP	2015	32	9					702	708		10.1002/da.22401		7	Psychology, Clinical; Psychiatry; Psychology	Psychology; Psychiatry	CQ8AD	WOS:000360827400008		
J	Hashimoto, M; Sato, T; Muroyama, Y; Fujimura, L; Hatano, M; Saito, T				Hashimoto, Masakazu; Sato, Tatsuya; Muroyama, Yuko; Fujimura, Lisa; Hatano, Masahiko; Saito, Tetsuichiro			Nepro is localized in the nucleolus and essential for preimplantation development in mice	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						Nepro; Notch; nucleolus; preimplantation development; ribosome biogenesis	IN-VIVO ELECTROPORATION; RIBOSOME BIOGENESIS; MOUSE; NOTCH; EMBRYOS; CELLS; RNA; APOPTOSIS; OOCYTES; PROTEIN	We generated knockout (KO) mice of Nepro, which has been shown to be necessary to maintain neural progenitor cells downstream of Notch in the mouse developing neocortex by using knockdown experiments, to explore its function in embryogenesis. Nepro KO embryos were morphologically indistinguishable from wild type (WT) embryos until the morula stage but failed in blastocyst formation, and many cells of the KO embryos resulted in apoptosis. We found that Nepro was localized in the nucleolus at the blastocyst stage. The number of nucleolus precursor bodies (NPBs) and nucleoli per nucleus was significantly higher in Nepro KO embryos compared with WT embryos later than the 2-cell stage. Furthermore, at the morula stage, whereas 18S rRNA and ribosomal protein S6 (rpS6), which are components of the ribosome, were distributed to the cytoplasm in WT embryos, they were mainly localized in the nucleoli in Nepro KO embryos. In addition, in Nepro KO embryos, the amount of the mitochondria-associated p53 protein increased, and Cytochrome c was distributed in the cytoplasm. These findings indicate that Nepro is a nucleolus-associated protein, and its loss leads to the apoptosis before blastocyst formation in mice.	[Hashimoto, Masakazu; Sato, Tatsuya; Muroyama, Yuko; Saito, Tetsuichiro] Chiba Univ, Grad Sch Med, Dept Dev Biol, Chuo Ku, Chiba 2608670, Japan; [Fujimura, Lisa; Hatano, Masahiko] Chiba Univ, Biomed Res Ctr, Chuo Ku, Chiba 2608670, Japan; [Hatano, Masahiko] Chiba Univ, Grad Sch Med, Dept Biomed Sci, Chuo Ku, Chiba 2608670, Japan	Saito, T (reprint author), Chiba Univ, Grad Sch Med, Dept Dev Biol, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.	tesaito@faculty.chiba-u.jp			JSPS KAKENHI [26840075, 24300116, 26640026]; MEXT, Japan [25123701]	We thank A. Miyawaki (RIKEN BSI, Japan) for Venus cDNA and S. Aizawa (RIKEN CDB, Japan) for the targeting vector DT-ApA/Neo and S. Yoshida and N. Kinoshita (National Institute for Basic Biology, Japan) for Neurogenin3-Cre mice and pCS2-EGFP plasmid, respectively. We also thank M. Kitagawa (Chiba University, Japan) for discussions, N. Sasano, K. Akimaru, and M. Tanaka (Chiba University) for technical assistance. This study was supported by JSPS KAKENHI grants 26840075 to M.H., and a Grant-in-Aid for Scientific Research on Innovative Areas 'Neural Diversity and Neocortical Organization' 25123701 from MEXT, Japan, and JSPS KAKENHI grants 24300116 and 26640026 to T.S.	Adachi K, 2007, MOL CELL BIOL, V27, P2202, DOI 10.1128/MCB.01908-06; Aguirre-Lavin T, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-30; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Lafontaine DLJ, 2010, TRENDS BIOCHEM SCI, V35, P267, DOI 10.1016/j.tibs.2009.12.006; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/nmeth.1315, 10.1038/NMETH.1315]; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; OKA C, 1995, DEVELOPMENT, V121, P3291; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Gallenberger M, 2011, HUM MOL GENET, V20, P422, DOI 10.1093/hmg/ddq478; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Rayon T, 2014, DEV CELL, V30, P410, DOI 10.1016/j.devcel.2014.06.019; Souilhol C, 2006, MOL CELL BIOL, V26, P4769, DOI 10.1128/MCB.00319-06; Newton K, 2003, MOL CELL BIOL, V23, P8519, DOI 10.1128/MCB.23.23.8519-8527.2003; Flechon JE, 1998, ZYGOTE, V6, P183, DOI 10.1017/S0967199498000112; Harlow E.D., 1988, ANTIBODIES LAB MANUA; Hatano M, 1997, J CLIN INVEST, V100, P795, DOI 10.1172/JCI119593; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Muroyama Y, 2009, DEVELOPMENT, V136, P3889, DOI 10.1242/dev.039180; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043748; Romanova LG, 2006, BIOL REPROD, V75, P690, DOI 10.1095/biolreprod.106.054072; TAKEUCHI IK, 1986, J ELECTRON MICROSC, V35, P280; WOOD SA, 1993, P NATL ACAD SCI USA, V90, P4582, DOI 10.1073/pnas.90.10.4582; Wu XL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-99; Zatsepina O, 2003, DEV BIOL, V253, P66, DOI 10.1006/dbio.2002.0865; Zatsepina OV, 2000, DEV BIOL, V223, P354, DOI 10.1006/dbio.2000.9762; Zhang J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-115	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	SEP	2015	57	7					529	538		10.1111/dgd.12232		10	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CQ7GD	WOS:000360770100004		
J	Gotoh, H; Hust, JA; Miura, T; Niimi, T; Emlen, DJ; Lavine, LC				Gotoh, Hiroki; Hust, James A.; Miura, Toru; Niimi, Teruyuki; Emlen, Douglas J.; Lavine, Laura C.			The Fat/Hippo signaling pathway links within-disc morphogen patterning to whole-animal signals during phenotypically plastic growth in insects	DEVELOPMENTAL DYNAMICS			English	Editorial Material						Fat; Hippo Signaling; phenotypic plasticity; insect development; appendage patterning; polyphenism	ORGAN SIZE CONTROL; JUVENILE-HORMONE; HIPPO PATHWAY; DEVELOPMENTAL REGULATION; ENDOCRINE REGULATION; CELL-PROLIFERATION; CONTACT INHIBITION; SEXUAL-DIMORPHISM; APIS-MELLIFERA; IMAGINAL DISC	Background: Insects exhibit a diversity of environmentally sensitive phenotypes that allow them to be an extraordinarily successful group. For example, mandible size in male stag beetles is exquisitely sensitive to the larval nutritional environment and is a reliable signal of male condition. Results: To date, studies of how such phenotypically plastic traits develop have focused on two types of mechanistic processes. Local, tissue-specific genetic mechanisms specify the shape and approximate final size of structures, whereas whole-animal hormonal signaling mechanisms modulate trait growth in response to environmental circumstance, including the body size and nutritional state of each individual. Hormones such as juvenile hormone, ecdysteroids, and/or ligands of the insulin-signaling pathway specify whether traits grow and regulate how much growth occurs across a diversity of insect groups. What remains to be shown is how the local, tissue-specific developmental genetic pathways interact with these whole animal hormonal signaling pathways during development to yield phenotypically plastic patterns of trait growth. Conclusions: Because the Fat/Hippo signaling pathway coordinates trait growth and development through its interactions with morphogens and hormonal pathways, we propose that Fat/Hippo signaling is a missing mechanistic link coordinating environmentally sensitive trait development in insects. (C) 2015 Wiley Periodicals, Inc.	[Gotoh, Hiroki; Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hust, James A.; Lavine, Laura C.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Emlen, Douglas J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Lavine, LC (reprint author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	lavine@wsu.edu					Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; Warren IA, 2013, BIOESSAYS, V35, P889, DOI 10.1002/bies.201300031; Mahfooz NS, 2004, P NATL ACAD SCI USA, V101, P4877, DOI 10.1073/pnas.0401216101; Matis M, 2013, GENE DEV, V27, P2207, DOI 10.1101/gad.228098.113; Clark RM, 2015, J EXP BIOL, V218, P298, DOI 10.1242/jeb.112888; Refki PN, 2014, DEV BIOL, V392, P441, DOI 10.1016/j.ydbio.2014.05.021; Fry CL, 2006, EVOL DEV, V8, P191, DOI 10.1111/j.1525-142X.2006.00089.x; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Emlen DJ, 2007, P NATL ACAD SCI USA, V104, P8661, DOI 10.1073/pnas.0701209104; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Cotton S, 2004, EVOLUTION, V58, P1038; RACHINSKY A, 1990, J INSECT PHYSIOL, V36, P189, DOI 10.1016/0022-1910(90)90121-U; Serrano N, 1997, CURR BIOL, V7, pR186, DOI 10.1016/S0960-9822(97)70085-X; Yi CL, 2010, GENE DEV, V24, P1673, DOI 10.1101/gad.1964810; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Johns A, 2014, INTEGR COMP BIOL, V54, P614, DOI 10.1093/icb/icu041; Wartlick O, 2011, NAT REV MOL CELL BIO, V12, P594, DOI 10.1038/nrm3169; Miura T, 2005, EVOL DEV, V7, P122, DOI 10.1111/j.1525-142X.2005.05014.x; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Kojima T, 2004, DEV GROWTH DIFFER, V46, P115; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Irvine KD, 2012, SEMIN CELL DEV BIOL, V23, P812, DOI 10.1016/j.semcdb.2012.04.006; Day SJ, 2000, DEVELOPMENT, V127, P2977; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Lawrence PA, 2008, NAT CELL BIOL, V10, P1379, DOI 10.1038/ncb1208-1379; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Emlen DJ, 2005, EVOLUTION, V59, P1060; Bando T, 2011, DEV DYNAM, V240, P1028, DOI 10.1002/dvdy.22590; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Okada K, 2006, J INSECT BEHAV, V19, P457, DOI 10.1007/s10905-006-9038-z; Bossuyt W, 2014, ONCOGENE, V33, P1218, DOI 10.1038/onc.2013.82; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Brisson JA, 2010, PHILOS T R SOC B, V365, P605, DOI 10.1098/rstb.2009.0255; CAMPBELL G, 1993, CELL, V74, P1113, DOI 10.1016/0092-8674(93)90732-6; REMBOLD H, 1974, J INSECT PHYSIOL, V20, P1193, DOI 10.1016/0022-1910(74)90225-X; Shingleton AW, 2010, ORGANOGENESIS, V6, P76, DOI 10.4161/org.6.2.10375; Brittle AL, 2010, CURR BIOL, V20, P803, DOI 10.1016/j.cub.2010.03.056; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Tu MP, 2005, GEN COMP ENDOCR, V142, P347, DOI 10.1016/j.ygcen.2005.02.009; Lavine L, 2015, ANNU REV ENTOMOL, V60, P453, DOI 10.1146/annurev-ento-010814-021045; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Stern DL, 1999, DEVELOPMENT, V126, P1091; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Shelby JA, 2007, J EXP ZOOL PART B, V308B, P417, DOI 10.1002/jez.b.21165; HARDIE J, 1980, NATURE, V286, P602, DOI 10.1038/286602a0; Parker J, 2011, EVOL DEV, V13, P304, DOI 10.1111/j.1525-142X.2011.00481.x; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI [10.1016/j.devcel.2013.01.020, 10.1016/j.devce1.2013.01.020]; Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Restrepo S, 2014, CURR BIOL, V24, pR245, DOI 10.1016/j.cub.2014.01.055; Bando T, 2009, DEVELOPMENT, V136, P2235, DOI 10.1242/dev.035204; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; Hattori A, 2013, J EXP ZOOL PART B, V320B, P295, DOI 10.1002/jez.b.22501; Clemmons D, 2010, IGFS LOCAL REPAIR SU; Cohen SM, 1993, DEV DROSOPHILA MELAN, VII, P747; desAzevedo SV, 2008, J INSECT PHYSL, V54, P1064; Emlen DJ, 2004, INTEGR COMP BIOL, V634, P617; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; GARCIA-BELLIDO A., 1965, J INSECT PHYSIOL, V11, P1071, DOI 10.1016/0022-1910(65)90179-4; Gotoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021139; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Hardie J., 1985, COMPREHENSIVE INSECT, V8, P441; Hartfelder K, 2011, INSECT ENDOCRINOLOGY, P464; Khila A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000583; Koyama T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00263; Lawrence PA, 1976, INSECT DEV, P132; Lenz M., 1976, P73; Mahfooz N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000866; Mirth Christen Kerry, 2012, Front Endocrinol (Lausanne), V3, P49, DOI 10.3389/fendo.2012.00049; Nijhout H. Frederik, 2014, Annual Review of Entomology, V60, P141; Nijhout HF, 1994, INSECT HORMONES; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Yoshida H, 2014, SCI REP, V4; Zera AJ, 2003, INTEGR COMP BIOL, V43, P607, DOI 10.1093/icb/43.5.607	94	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	SEP	2015	244	9			SI		1039	1045		10.1002/DVDY.24296		7	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CQ1OI	WOS:000360366700002		
J	Asai, A; Nagao, M; Sugihara, H; Oikawa, S				Asai, A.; Nagao, M.; Sugihara, H.; Oikawa, S.			Spontaneous high fat diet overeating and body weight gain in selectively bred mice for diet-induced glucose intolerance: possible role of leptin	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Asai, A.; Nagao, M.; Sugihara, H.; Oikawa, S.] Nippon Med Sch, Dept Endocrinol Diabet & Metab, Tokyo 113, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1204	S579	S579				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903171		
J	Atageldiyeva, KK; Fujita, Y; Yanagimachi, T; Honjo, J; Abiko, A; Takiyama, Y; Makino, Y; Haneda, M				Atageldiyeva, K. K.; Fujita, Y.; Yanagimachi, T.; Honjo, J.; Abiko, A.; Takiyama, Y.; Makino, Y.; Haneda, M.			Low carbohydrate diet and SGLT-2 inhibitors dissimilarly influenced on body weight and adiposity in normal mice	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Atageldiyeva, K. K.; Fujita, Y.; Yanagimachi, T.; Honjo, J.; Abiko, A.; Takiyama, Y.; Makino, Y.; Haneda, M.] Asahikawa Med Univ, Dept Med, Devis Metab & Biosyst Sci, Asahikawa, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		760	S365	S366				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902018		
J	Chae, H; Gomez-Ruiz, A; Lai, B; Antoine, N; Seino, S; Gilon, P				Chae, H.; Gomez-Ruiz, A.; Lai, B.; Antoine, N.; Seino, S.; Gilon, P.			Distinct roles of somatostatin in the control of glucagon secretion by glucose and K-ATP channel blockers from the perfused mouse pancreas	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Chae, H.; Gomez-Ruiz, A.; Lai, B.; Antoine, N.; Gilon, P.] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Endocrinol Diabet & Nutr, B-1200 Brussels, Belgium; [Seino, S.] Kobe Univ, Kobe Biotechnol Res & Human Resource Dev Ctr, Kobe, Hyogo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		549	S268	S268				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901239		
J	Din, MU; Raiko, J; Saari, T; Kudomi, N; Parkkola, R; Nuutila, P; Virtanen, KA				Din, M. U.; Raiko, J.; Saari, T.; Kudomi, N.; Parkkola, R.; Nuutila, P.; Virtanen, K. A.			Human brown adipose tissue oxygen consumption after meal is similar to cold activated consumption	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Din, M. U.; Raiko, J.; Saari, T.; Nuutila, P.; Virtanen, K. A.] Turku Univ Hosp, Turku PET Ctr, Turku, Finland; [Din, M. U.; Raiko, J.; Saari, T.; Nuutila, P.; Virtanen, K. A.] Univ Turku, SF-20500 Turku, Finland; [Kudomi, N.] Kagawa Univ, Fac Med, Dept Med Phys, Takamatsu, Kagawa 760, Japan; [Parkkola, R.] Med Imaging Ctr Southwest Finland, Turku, Finland; [Nuutila, P.] Turku Univ Hosp, Dept Endocrinol, Turku, Finland								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		691	S331	S331				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901380		
J	Fujioka, K; Asano, M; Ishizuka, T; Okada, H; Mori, I; Kajita, K; Morita, H				Fujioka, K.; Asano, M.; Ishizuka, T.; Okada, H.; Mori, I.; Kajita, K.; Morita, H.			Analysis of anti-insulin receptor antibody in two patients with rheumatoid arthritis and systemic lupus erythematosus	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Fujioka, K.; Asano, M.; Ishizuka, T.] Gifu Municipal Hosp, Gen Internal Med, Gifu, Japan; [Okada, H.] Gifu Prefectual Gen Med Ctr, Gen Internal Med, Gifu, Japan; [Mori, I.; Kajita, K.; Morita, H.] Gifu Univ, Grad Sch Med, Gen Internal Med, Gifu, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		623	S300	S300				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901312		
J	Fushimi, N; Shibuya, T; Takeishi, S; Itou, S; Kawai, H; Mori, A				Fushimi, N.; Shibuya, T.; Takeishi, S.; Itou, S.; Kawai, H.; Mori, A.			Hepatic fat deposition is improved more with SGLT2 inhibitor luseogliflozin compared with sitagliptin: a randomised, crossover, controlled study using computed tomography	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Fushimi, N.; Shibuya, T.; Takeishi, S.; Itou, S.; Kawai, H.; Mori, A.] Ichinomiyanishi Hosp, Diabet & Endocrinol, Ichinomiya City, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		815	S392	S392				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902073		
J	Garg, S; Jinnouchi, H; Dreyer, M; Mou, J; Hartman, ML; Rosilio, M; Bastyr, EJ				Garg, S.; Jinnouchi, H.; Dreyer, M.; Mou, J.; Hartman, M. L.; Rosilio, M.; Bastyr, E. J., III		IMAGINE 1 Study Grp	Greater HbA(1c) reduction with basal insulin peglispro (BIL) vs insulin glargine (GL) in an open-label, randomised study in type 1 diabetic patients: IMAGINE 1	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Garg, S.] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Jinnouchi, H.] Jinnouchi Hosp, Diabet Care Ctr, Kumamoto, Japan; [Dreyer, M.] Zentrum Innere Med, Hamburg, Germany; [Mou, J.; Hartman, M. L.; Bastyr, E. J., III] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Rosilio, M.] Lilly France, Neuilly Sur Seine, France								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		3	S2	S2				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900004		
J	Gmitrov, J				Gmitrov, J.			Baroreceptor stimulation enhanced vessel sensitivity to nitric oxide-mediated vasodilation, implications for treatment of diabetes and the metabolic syndrome	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Gmitrov, J.] Natl Inst Publ Hlth, Tokyo, Japan; [Gmitrov, J.] Agel SK Inc, Pro Vitae & Krompachy Hosp, Gelnica, Slovakia								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1137	S546	S546				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903104		
J	Hammar, N; Charbonnel, B; Fenici, P; Garcia-Alvarez, L; Gomes, MB; Hashigami, K; Hiller, J; Ji, L; Khunti, K; Nicolucci, A; Pocock, S; Shestakova, MV; Shimomura, I; Surmont, FA; Medina, J				Hammar, N.; Charbonnel, B.; Fenici, P.; Garcia-Alvarez, L.; Gomes, M. B.; Hashigami, K.; Hiller, J.; Ji, L.; Khunti, K.; Nicolucci, A.; Pocock, S.; Shestakova, M. V.; Shimomura, I.; Surmont, F. A.; Medina, J.			DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Hammar, N.] AstraZeneca AZ, Sodertalje, Sweden; [Charbonnel, B.] Univ Nantes, F-44035 Nantes, France; [Fenici, P.] AZ, Melbourne, Vic, Australia; [Garcia-Alvarez, L.; Hiller, J.] IMS Hlth, London, England; [Gomes, M. B.] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil; [Hashigami, K.] AZ, Tokyo, Japan; [Ji, L.] Peking Univ, Peoples Hosp, Ctr Diabet, Beijing 100871, Peoples R China; [Khunti, K.] Univ Leicester, Leicester LE1 7RH, Leics, England; [Nicolucci, A.] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy; [Pocock, S.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Shestakova, M. V.] Endocrinol Res Ctr, Moscow, Russia; [Shimomura, I.] Osaka Univ, Suita, Osaka 565, Japan; [Surmont, F. A.] AZ, Shanghai, Peoples R China; [Medina, J.] AZ, Madrid, Spain								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		373	S188	S188				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901063		
J	Hara, A; Fujitani, Y; Ogihara, T; Miyatsuka, T; Watada, H				Hara, A.; Fujitani, Y.; Ogihara, T.; Miyatsuka, T.; Watada, H.			Human IAPP impairs the success of islet transplantation	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Hara, A.; Fujitani, Y.; Ogihara, T.; Miyatsuka, T.; Watada, H.] Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan; [Hara, A.; Watada, H.] Juntendo Univ, Grad Sch Med, Ctr Therapeut Innovat Diabet, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		512	S252	S252				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901202		
J	Hasegawa, Y; Hori, M; Nakagami, T; Shiba, MH; Uchigata, Y				Hasegawa, Y.; Hori, M.; Nakagami, T.; Shiba, M. H.; Uchigata, Y.			Glucagon-Like Peptide-1 (GLP-1) and its receptor agonist, exendin-4, affect cholesterolmetabolism by regulating SREBP2 in hepatocyte	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Hasegawa, Y.; Nakagami, T.; Uchigata, Y.] Tokyo Womens Med Univ, Sch Med, Diabet Ctr, Tokyo, Japan; [Hasegawa, Y.; Hori, M.; Shiba, M. H.] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Innovat Lipidol, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		82	S41	S41				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900083		
J	Hatakeyama, H; Kanzaki, M				Hatakeyama, H.; Kanzaki, M.			AS160 vs Tbc1d1: cooperative determination of insulin-responsive GLUT4 trafficking activity after exercise-mimetic stimuli	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Hatakeyama, H.] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan; [Hatakeyama, H.; Kanzaki, M.] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		540	S264	S264				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901230		
J	Hatanaka, T; Ogawa, D; Terami, N; Nishii, N; Nakatsuka, A; Eguchi, J; Wada, J				Hatanaka, T.; Ogawa, D.; Terami, N.; Nishii, N.; Nakatsuka, A.; Eguchi, J.; Wada, J.			SGLT2 inhibitor dapagliflozin ameriorates diabetic nephropathy by inhibiting high-glucose-induced oxidative stress in a mouse model of type 1 diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med, Okayama 7008530, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Sci, Okayama 7008530, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		163	S83	S83				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900164		
J	Heianza, Y; Arase, Y; Kodama, S; Tsuji, H; Tanaka, S; Kobayashi, T; Hara, S; Sone, H				Heianza, Y.; Arase, Y.; Kodama, S.; Tsuji, H.; Tanaka, S.; Kobayashi, T.; Hara, S.; Sone, H.			Longitudinal trajectories of insulin sensitivity and beta cell function before the development of type 2 diabetes in Japanese individuals	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Heianza, Y.; Kodama, S.; Sone, H.] Niigata Univ, Fac Med, Dept Internal Med, Tokyo, Japan; [Arase, Y.; Tsuji, H.; Kobayashi, T.; Hara, S.] Toranomon Gen Hosp, Hlth Management Ctr, Tokyo, Japan; [Tanaka, S.] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Niigata, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		43	S21	S21				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900044		
J	Hira, T; Kanehira, A; Hara, H				Hira, T.; Kanehira, A.; Hara, H.			Changes in postprandial glucagon-like peptide-1 secretion during the development of diet-induced obesity in rats	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Hira, T.; Kanehira, A.; Hara, H.] Hokkaido Univ, Sapporo, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		557	S271	S271				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901247		
J	Hiromura, M; Nohtomi, K; Terasaki, M; Mori, Y; Kuwata, H; Hirano, T				Hiromura, M.; Nohtomi, K.; Terasaki, M.; Mori, Y.; Kuwata, H.; Hirano, T.			Dipeptidyl peptidase-4 inhibitor suppresses inflammation in U937 monocytes by inhibiting phosphorylation of caveolin-1 through CD26	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Hiromura, M.; Nohtomi, K.; Terasaki, M.; Mori, Y.; Hirano, T.] Showa Univ, Sch Med, Diabet Metab & Endocrinol, Tokyo 142, Japan; [Kuwata, H.] Showa Univ, Sch Dent, Oral Microbiol & Immunol, Tokyo 142, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		68	S34	S34				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900069		
J	Hirose, A; Goto, A; Yamaguchi, N; Kitano, S; Uchigata, Y				Hirose, A.; Goto, A.; Yamaguchi, N.; Kitano, S.; Uchigata, Y.			Cumulative excess HbA(1c) index may substantially predict retinopathy in type 1 diabetes patients, if we use HbA(1c) data of total diabetes duration - a DCCT/EDIC subgroup analysis	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Hirose, A.; Kitano, S.] Tokyo Womens Med Univ, Ctr Diabet, Diabet Ophthalmol, Tokyo, Japan; [Goto, A.; Yamaguchi, N.] Tokyo Womens Med Univ, Publ Hlth, Tokyo, Japan; [Uchigata, Y.] Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		233	S117	S117				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900234		
J	Honka, H; Koffert, J; Kauhanen, S; Kudomi, N; Linden, J; Teuho, J; Lindqvist, A; Wierup, N; Groop, L; Nuutila, P				Honka, H.; Koffert, J.; Kauhanen, S.; Kudomi, N.; Linden, J.; Teuho, J.; Lindqvist, A.; Wierup, N.; Groop, L.; Nuutila, P.			Bariatric surgery normalises splanchnic vascular responses to a mixed-meal and to GIP infusion	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Honka, H.; Koffert, J.; Linden, J.; Teuho, J.; Nuutila, P.] Univ Turku, Turku PET Ctr, Turku, Finland; [Koffert, J.] Turku Univ Hosp, Dept Gastroenterol, FIN-20520 Turku, Finland; [Kauhanen, S.] Turku Univ Hosp, Div Digest Surg & Urol, FIN-20520 Turku, Finland; [Kudomi, N.] Kagawa Univ, Dept Med Phys, Takamatsu, Kagawa 760, Japan; [Lindqvist, A.; Wierup, N.; Groop, L.] Lund Univ, Lund, Sweden; [Nuutila, P.] Turku Univ Hosp, Dept Endocrinol, FIN-20520 Turku, Finland								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		102	S50	S50				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900103		
J	Hosokawa, K; Tsunekawa, S; Seino, Y; Hamada, Y; Oiso, Y				Hosokawa, K.; Tsunekawa, S.; Seino, Y.; Hamada, Y.; Oiso, Y.			Familial clustering of Japanese patients with adult-onset type 1 diabetes mellitus from the database of "Tokai Clinical Study Group of Diabetes"	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Hosokawa, K.; Tsunekawa, S.; Oiso, Y.] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan; [Seino, Y.; Hamada, Y.] Nagoya Univ, Grad Sch Med, Dept Metab Med, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		286	S144	S145				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900287		
J	Imamura, M; Maeda, S; Yamauchi, T; Hara, K; Iwata, M; Hirose, H; Yasuda, K; Watada, H; Maegawa, H; Ito, C; Tanaka, Y; Tobe, K; Kaku, K; Kawamori, R; Kadowaki, T				Imamura, M.; Maeda, S.; Yamauchi, T.; Hara, K.; Iwata, M.; Hirose, H.; Yasuda, K.; Watada, H.; Maegawa, H.; Ito, C.; Tanaka, Y.; Tobe, K.; Kaku, K.; Kawamori, R.; Kadowaki, T.			A meta-analysis of Japanese genome-wide association studies identified seven novel susceptibility loci to type 2 diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Imamura, M.; Maeda, S.] RIKEN, Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan; [Maeda, S.] Univ Ryukyus, Nishihara, Okinawa 90301, Japan; [Yamauchi, T.; Kadowaki, T.] Univ Tokyo, Tokyo 1138654, Japan; [Hara, K.] Tokyo Med Univ, Tokyo 1608402, Japan; [Iwata, M.; Tobe, K.] Toyama Univ, Toyama, Japan; [Hirose, H.] Keio Univ, Tokyo, Japan; [Yasuda, K.] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Watada, H.; Kawamori, R.] Juntendo Univ, Tokyo, Japan; [Maegawa, H.] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan; [Ito, C.] Grand Tower Med Court, Hiroshima, Japan; [Tanaka, Y.] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan; [Kaku, K.] Kawasaki Med Univ, Kurashiki, Okayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		176	S89	S89				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900177		
J	Inaishi, J; Saisho, Y; Kou, K; Sato, S; Murakami, R; Yamada, T; Kitago, M; Kitagawa, Y; Itoh, H				Inaishi, J.; Saisho, Y.; Kou, K.; Sato, S.; Murakami, R.; Yamada, T.; Kitago, M.; Kitagawa, Y.; Itoh, H.			Effects of obesity and diabetes on alpha and beta cell mass in surgically removed human pancreas	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Inaishi, J.; Saisho, Y.; Kou, K.; Sato, S.; Murakami, R.; Itoh, H.] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Yamada, T.] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Kitago, M.; Kitagawa, Y.] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		488	S241	S241				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901178		
J	Kanazawa, I; Takeno, A; Tanaka, KI; Notsu, M; Yokomoto, M; Yamaguchi, T; Sugimoto, T				Kanazawa, I.; Takeno, A.; Tanaka, K. -I.; Notsu, M.; Yokomoto, M.; Yamaguchi, T.; Sugimoto, T.			Metformin protects against homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by activation of AMP-activated protein kinase	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kanazawa, I.; Takeno, A.; Tanaka, K. -I.; Notsu, M.; Yokomoto, M.; Yamaguchi, T.; Sugimoto, T.] Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane, Japan			Kanazawa, Ippei/F-8609-2010					0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1144	S549	S550				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903111		
J	Kaneko, S; Adachi, R; Ueda, Y; Tahara, Y				Kaneko, S.; Adachi, R.; Ueda, Y.; Tahara, Y.			Sustainable effects of basal insulin have favourable outcomes on fasting blood glucose control in patients with type 2 diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kaneko, S.; Adachi, R.; Ueda, Y.; Tahara, Y.] Takatsuki Red Cross Hosp, Diabet Endocrinol & Life Related Dis, Takatsuki, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		976	S472	S473				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902234		
J	Kawamura, M; Watanabe, T; Sakamoto, K; Ashidate, K; Kohro, T; Tanaka, A; Mori, Y; Tagami, M; Hirano, T; Yamazaki, T; Shiba, T				Kawamura, M.; Watanabe, T.; Sakamoto, K.; Ashidate, K.; Kohro, T.; Tanaka, A.; Mori, Y.; Tagami, M.; Hirano, T.; Yamazaki, T.; Shiba, T.		RES Study Grp	RESEARCH: superior effect of ezetimibe was sustained on LDL-C level and the rate of achievement of target value in a 52-week analysis	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kawamura, M.] Tokyo Teishin Hosp, Endocrinol & Meatabolism, Tokyo, Japan; [Watanabe, T.] Yokohama City Minato Red Cross Hosp, Internal Med, Tokyo, Japan; [Sakamoto, K.; Shiba, T.] Toho Univ, Ohashi Med Ctr, Dept Diabet & Metab, Tokyo, Japan; [Ashidate, K.] Kudanzaka Hosp, Internal Med, Tokyo, Japan; [Kohro, T.] Jichi Med Univ, Clin Informat Cardiol, Shimono, Japan; [Tanaka, A.] Kagawa Nutr Univ, Nutr Clin, Tokyo, Japan; [Mori, Y.] Toranomon Gen Hosp, Endocrinol & Meatabolism, Tokyo, Japan; [Tagami, M.] Sanraku Hosp, Life Style Related Dis Clin, Tokyo, Japan; [Hirano, T.] Showa Univ, Diabet Endocrinol & Meatabolism, Tokyo, Japan; [Yamazaki, T.] Tokyo Univ Hosp, Clin Res Support Ctr, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		161	S82	S82				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900162		
J	Kiminori, S; Nishikawa, T; Kukidome, D; Kajiwara, N; Motoshima, H; Matsumura, T; Araki, E				Kiminori, S.; Nishikawa, T.; Kukidome, D.; Kajiwara, N.; Motoshima, H.; Matsumura, T.; Araki, E.			Cellular hypoxia and mitochondrial reactive oxygen species may promote hyperglycaemic damage in a coordinated manner	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kiminori, S.; Kukidome, D.; Kajiwara, N.; Motoshima, H.; Matsumura, T.; Araki, E.] Kumamoto Univ, Metab Med, Kumamoto 860, Japan; [Nishikawa, T.] Kumamoto Univ, Mol Diabetol, Kumamoto 860, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		30	S15	S15				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900031		
J	Kim-Mitsuyama, S; Ma, M; Koibuchi, N; Nakagawa, T; Lin, B; Hasegawa, Y				Kim-Mitsuyama, S.; Ma, M.; Koibuchi, N.; Nakagawa, T.; Lin, B.; Hasegawa, Y.			Linagliptin, independently of blood glucose control, ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischaemia in type 2 diabetic mice	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kim-Mitsuyama, S.; Ma, M.; Koibuchi, N.; Nakagawa, T.; Lin, B.; Hasegawa, Y.] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		820	S394	S395				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902078		
J	Kimura, T; Sakurai, K; Morino, K; Shimizu, M; Ishikawa, T; Shiobara, K; Suzuki, S; Taneda, M; Yamamoto, M				Kimura, T.; Sakurai, K.; Morino, K.; Shimizu, M.; Ishikawa, T.; Shiobara, K.; Suzuki, S.; Taneda, M.; Yamamoto, M.			Pharmacokinetics, pharmacodynamics and tolerability of a novel glucokinase activator TMG-123, after single oral ascending doses in Japanse healthy subjects	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kimura, T.; Sakurai, K.; Morino, K.; Shimizu, M.; Ishikawa, T.; Shiobara, K.; Suzuki, S.; Taneda, M.; Yamamoto, M.] Teijin Pharma Ltd, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		37	S18	S18				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900038		
J	Kimura, T; Shimoda, M; Okauchi, S; Obata, A; Hirukawa, H; Kohara, K; Hiraoka, A; Tamura, K; Chikazawa, G; Yoshitaka, H; Shimizu, I; Kaku, K; Kaneto, H				Kimura, T.; Shimoda, M.; Okauchi, S.; Obata, A.; Hirukawa, H.; Kohara, K.; Hiraoka, A.; Tamura, K.; Chikazawa, G.; Yoshitaka, H.; Shimizu, I.; Kaku, K.; Kaneto, H.			Down-regulation of vascular GLP-1 receptor expression in subjects with obesity	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kimura, T.; Shimoda, M.; Okauchi, S.; Obata, A.; Hirukawa, H.; Kohara, K.; Kaku, K.; Kaneto, H.] Kawasaki Med Univ, Diabet Endocrinol & Metab, Kurashiki, Okayama, Japan; [Hiraoka, A.; Tamura, K.; Chikazawa, G.; Yoshitaka, H.; Shimizu, I.] Sakakibara Heart Inst, Okayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1183	S569	S569				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903150		
J	Kira, Y; Tomita, T; Odori, S; Fujikura, J; Hosoda, K; Nakao, K; Inagaki, N				Kira, Y.; Tomita, T.; Odori, S.; Fujikura, J.; Hosoda, K.; Nakao, K.; Inagaki, N.			Regulation of GPR40 gene expression in pancreatic islets of non-obese and obese glucose-intolerant rat models, Goto-Kakizaki rat and Koletsky rat	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kira, Y.; Tomita, T.; Odori, S.; Fujikura, J.; Hosoda, K.; Inagaki, N.] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto 6068501, Japan; [Nakao, K.] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto 6068501, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		573	S278	S278				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901263		
J	Kondo, T; Matsuyama, R; Kitano, S; Goto, R; Ono, K; Igata, M; Kawashima, J; Motoshima, H; Matsumura, T; Kai, H; Araki, E				Kondo, T.; Matsuyama, R.; Kitano, S.; Goto, R.; Ono, K.; Igata, M.; Kawashima, J.; Motoshima, H.; Matsumura, T.; Kai, H.; Araki, E.			The roles of heat shock protein 72 in hepatic glucose metabolism in mice model of type 2 diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kondo, T.; Matsuyama, R.; Kitano, S.; Goto, R.; Ono, K.; Igata, M.; Kawashima, J.; Motoshima, H.; Matsumura, T.; Araki, E.] Kumamoto Univ, Metab Med, Kumamoto 860, Japan; [Kai, H.] Kumamoto Univ, Mol Med, Kumamoto 860, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		607	S293	S293				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901296		
J	Kondo, Y; Toyoda, T; Funato, M; Hosokawa, Y; Sudo, T; Zhuang, X; Ohta, A; Inagaki, N; Osafune, K				Kondo, Y.; Toyoda, T.; Funato, M.; Hosokawa, Y.; Sudo, T.; Zhuang, X.; Ohta, A.; Inagaki, N.; Osafune, K.			A small molecule that facilitates the differentiation into pancreatic endocrine cells from human ES/iPS cells	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kondo, Y.; Toyoda, T.; Funato, M.; Hosokawa, Y.; Sudo, T.; Ohta, A.; Osafune, K.] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068501, Japan; [Kondo, Y.; Zhuang, X.; Inagaki, N.] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Kyoto 6068501, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		231	S116	S116				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900232		
J	Kondo, Y; Satoh, S; Osada, UN; Terauchi, Y				Kondo, Y.; Satoh, S.; Osada, U. N.; Terauchi, Y.			A pre-obese state accelerates beta cell dysfunction in patients with type 2 diabetes: a glucagon stimulation test-based cross-sectional study	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kondo, Y.; Terauchi, Y.] Yokohama City Univ, Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Kondo, Y.; Satoh, S.] Chigasaki Municipal Hosp, Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Osada, U. N.] Saiseikai Yokohama Shi Nanbu Hosp, Endocrinol & Diabet, Yokohama, Kanagawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		440	S218	S219				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901130		
J	Koya, D; Srivastava, SP; Kanasaki, M; Nagai, T; Shi, S; Kanasaki, K				Koya, D.; Srivastava, S. P.; Kanasaki, M.; Nagai, T.; Shi, S.; Kanasaki, K.			The antifibrotic microRNA crosstalk in the action of N-acetyl-seryl-aspartyl-lysyl-proline on kidney fibrosis in diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Koya, D.; Srivastava, S. P.; Kanasaki, M.; Nagai, T.; Shi, S.; Kanasaki, K.] Kanazawa Med Univ, Endocrinol & Metab, Kahoku Dist, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1125	S540	S540				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903092		
J	Kubo, F; Miyatsuka, T; Sasaki, S; Takahara, M; Yamamoto, Y; Shimo, N; Kaneto, H; Matsuoka, TA; Shimomura, I				Kubo, F.; Miyatsuka, T.; Sasaki, S.; Takahara, M.; Yamamoto, Y.; Shimo, N.; Kaneto, H.; Matsuoka, T. -A.; Shimomura, I.			Preserving expression of GLP-1 receptor in beta cells of db/db mice increases insulin secretion	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kubo, F.; Miyatsuka, T.; Sasaki, S.; Takahara, M.; Yamamoto, Y.; Shimo, N.; Matsuoka, T. -A.; Shimomura, I.] Osaka Univ, Grad Sch Med, Dept Metab Med, Tokyo, Japan; [Miyatsuka, T.] Juntendo Univ, Grad Sch Med, Dept Med Metab & Endocrinol, Tokyo, Japan; [Kaneto, H.] Kawasaki Med Univ, Dept Diabet Endocrinol & Metab, Okayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		556	S271	S271				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901246		
J	Kukidome, D; Sato, M; Shimoda, S; Nishikawa, T; Araki, E				Kukidome, D.; Sato, M.; Shimoda, S.; Nishikawa, T.; Araki, E.			Impaired balance ability, particularly one-leg stand evaluation, is associated with diabetic complications even in younger adults with type 2 diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kukidome, D.; Sato, M.; Shimoda, S.; Nishikawa, T.; Araki, E.] Kumamoto Univ, Sch Med, Fac Life Sci, Metab Med, Kumamoto 860, Japan; [Nishikawa, T.] Kumamoto Univ, Sch Med, Community Medicinec, Kumamoto 860, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1147	S551	S551				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903114		
J	Kurita, M; Nakagami, T; Oya, J; Isago, C; Tanaka, Y; Hasegawa, Y; Ito, A; Endo, Y; Uchigata, Y				Kurita, M.; Nakagami, T.; Oya, J.; Isago, C.; Tanaka, Y.; Hasegawa, Y.; Ito, A.; Endo, Y.; Uchigata, Y.			Energy expenditure from daily physical activity and risk of developing diabetes and change in cardiovascular risk factors	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kurita, M.; Nakagami, T.; Oya, J.; Isago, C.; Tanaka, Y.; Hasegawa, Y.; Ito, A.; Uchigata, Y.] Tokyo Womens Med Univ, Sch Med, Tokyo, Japan; [Endo, Y.] Saitama Ken Saiseikai Kurihashi Hosp, Hlth & Community Med, Saitama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		525	S258	S258				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901215		
J	Kusunoki, M; Natsume, Y; Sato, D; Tsutsui, H; Sasaki, H; Nakamura, T; Miyata, T; Oshida, Y				Kusunoki, M.; Natsume, Y.; Sato, D.; Tsutsui, H.; Sasaki, H.; Nakamura, T.; Miyata, T.; Oshida, Y.			Efficacy of SGLT2 inhibitors on bone mineral density in Japanese patients with type 2 diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Kusunoki, M.; Natsume, Y.; Oshida, Y.] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan; [Sato, D.; Sasaki, H.; Nakamura, T.] Yamagata Univ, Dept Biomed Informat Engn, Yamagata 990, Japan; [Tsutsui, H.] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo, Tokyo, Japan; [Miyata, T.] Sanno Med Ctr, Vasc Ctr, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		767	S369	S369				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902025		
J	Makino, Y; Atageldiyeva, KK; Kitsunai, H; Mizumoto, K; Yanagimachi, T; Fujita, Y; Abiko, A; Takiyama, Y; Haneda, M				Makino, Y.; Atageldiyeva, K. K.; Kitsunai, H.; Mizumoto, K.; Yanagimachi, T.; Fujita, Y.; Abiko, A.; Takiyama, Y.; Haneda, M.			High glucose induces membrane-bound transcription factor peptidase site1 via carbohydrate response element binding protein to modulate ER stress in mesangial cells	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Makino, Y.; Atageldiyeva, K. K.; Kitsunai, H.; Mizumoto, K.; Yanagimachi, T.; Fujita, Y.; Abiko, A.; Takiyama, Y.; Haneda, M.] Asahikawa Med Univ, Dept Med, Asahikawa, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1120	S538	S538				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903087		
J	Masuda, K; Kanno, A; Asahara, SI; Yoshitomi, R; Matsuda, T; Kimura-Koyanagi, M; Shibutani, Y; Yokoi, N; Kasuga, M; Seino, S; Kido, Y				Masuda, K.; Kanno, A.; Asahara, S-I.; Yoshitomi, R.; Matsuda, T.; Kimura-Koyanagi, M.; Shibutani, Y.; Yokoi, N.; Kasuga, M.; Seino, S.; Kido, Y.			GCN2, a type 2 diabetes mellitus susceptibility gene, is associated with the regulation of pancreatic beta cell mass	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Masuda, K.; Yoshitomi, R.; Kido, Y.] Kobe Univ, Grad Sch Hlth Sci, Tokyo, Japan; [Kanno, A.; Asahara, S-I.; Matsuda, T.; Kimura-Koyanagi, M.; Shibutani, Y.] Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Tokyo, Japan; [Yokoi, N.; Seino, S.] Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Tokyo, Japan; [Kasuga, M.] Natl Ctr Global Hlth & Med, Res Inst, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		486	S240	S240				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901176		
J	Matsuhisa, M; Koyama, M; Cheng, X; Sumi, M; Hirose, T				Matsuhisa, M.; Koyama, M.; Cheng, X.; Sumi, M.; Hirose, T.		EDITION JP 1 Study Grp	Sustained glycaemic control and less nocturnal hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml over 1 year in Japanese people with type 1 diabetes mellitus	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Matsuhisa, M.] Univ Tokushima, Tokushima 770, Japan; [Koyama, M.; Sumi, M.] Sanofi, Tokyo, Japan; [Cheng, X.] Sanofi, Beijing, Peoples R China; [Hirose, T.] Toho Univ, Sch Med, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		4	S2	S3				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900005		
J	Mifune, H; Tajiri, Y; Hara, K; Iwata, S; Nishi, Y; Kojima, M; Yamada, K				Mifune, H.; Tajiri, Y.; Hara, K.; Iwata, S.; Nishi, Y.; Kojima, M.; Yamada, K.			A disrupted rhythm of appetite-regulating hormone is relevant to abnormal feeding behaviour in high fat diet induced obese mice	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Mifune, H.] Kurume Univ, Sch Med, Inst Anim Expt, Kurume, Fukuoka, Japan; [Tajiri, Y.; Hara, K.; Iwata, S.; Yamada, K.] Kurume Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kurume, Fukuoka, Japan; [Nishi, Y.] Kurume Univ, Sch Med, Dept Physiol, Kurume, Fukuoka, Japan; [Kojima, M.] Kurume Univ, Kurume, Fukuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		640	S308	S308				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901329		
J	Miya, A; Nakamura, A; Miyoshi, H; Takano, Y; Sunagoya, K; Hayasaka, K; Shimizu, C; Terauchi, Y; Atsumi, T				Miya, A.; Nakamura, A.; Miyoshi, H.; Takano, Y.; Sunagoya, K.; Hayasaka, K.; Shimizu, C.; Terauchi, Y.; Atsumi, T.			Impact of glucose-loading on the variation of CD4+and CD8+T cells	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Miya, A.; Nakamura, A.; Miyoshi, H.; Takano, Y.; Atsumi, T.] Hokkaido Univ, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan; [Sunagoya, K.; Hayasaka, K.; Shimizu, C.] Hokkaido Univ, Div Lab & Transfus Med, Sapporo, Hokkaido, Japan; [Terauchi, Y.] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		680	S326	S326				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901369		
J	Miyake, H; Kanazawa, I; Sugimoto, T				Miyake, H.; Kanazawa, I.; Sugimoto, T.			Severe vertebral fracture and low osteocalcin level increase the mortality in postmenopausal women with type 2 diabetes mellitus	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Miyake, H.; Kanazawa, I.; Sugimoto, T.] Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane, Japan			Kanazawa, Ippei/F-8609-2010					0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1148	S551	S551				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903115		
J	Mizukami, H; Inaba, W; Xing, A; Yoshida, T; Takeuchi, Y; Yagihashi, S				Mizukami, H.; Inaba, W.; Xing, A.; Yoshida, T.; Takeuchi, Y.; Yagihashi, S.			Robust amyloid deposition with M1 macrophage infiltration in the islets in super-elderly Japanese type 2 diabetic subjects	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Mizukami, H.; Inaba, W.; Xing, A.; Yoshida, T.; Takeuchi, Y.; Yagihashi, S.] Hirosaki Univ, Pathol & Mol Med, Aomori, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		478	S236	S236				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901168		
J	Morita, M; Yamamoto, M; Takahashi, T; Sugimoto, T				Morita, M.; Yamamoto, M.; Takahashi, T.; Sugimoto, T.			Dipeptidly peptide-4 (DPP-4) inhibitors did not increase the incidence of infection in immune-compromised patients under chemotherapy	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Morita, M.; Yamamoto, M.; Sugimoto, T.] Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane, Japan; [Takahashi, T.] Shimane Univ Hosp, Oncol & Hematol, Izumo, Shimane, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		809	S389	S389				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902067		
J	Nagashimada, M; Ni, Y; Xu, L; Nagata, N; Kaneko, S; Ota, T				Nagashimada, M.; Ni, Y.; Xu, L.; Nagata, N.; Kaneko, S.; Ota, T.			MIP-1 alpha ablation prevents insulin resistance induced by high-fat feeding or leptin deficiency	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Nagashimada, M.; Ni, Y.; Xu, L.; Nagata, N.; Kaneko, S.; Ota, T.] Kanazawa Univ, Brain Liver Interface Med Res Ctr, Kanazawa, Ishikawa 9201192, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		676	S324	S325				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901365		
J	Nakamura, A; Iwami, D; Miyoshi, H; Morita, K; Shinohara, N; Terauchi, Y; Atsumi, T				Nakamura, A.; Iwami, D.; Miyoshi, H.; Morita, K.; Shinohara, N.; Terauchi, Y.; Atsumi, T.			Impact of renal transplantation on glucose tolerance in Japanese recipients with impaired glucose tolerance	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Nakamura, A.; Iwami, D.; Miyoshi, H.; Morita, K.; Shinohara, N.; Atsumi, T.] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Terauchi, Y.] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		405	S203	S203				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901095		
J	Nishimura, A; Usui, S; Kumashiro, N; Uchino, H; Yamato, A; Yasuda, D; Okubo, M; Mori, Y; Hirose, T				Nishimura, A.; Usui, S.; Kumashiro, N.; Uchino, H.; Yamato, A.; Yasuda, D.; Okubo, M.; Mori, Y.; Hirose, T.			Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: a randomised 24 week open-label trial	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Nishimura, A.; Usui, S.; Kumashiro, N.; Uchino, H.; Hirose, T.] Toho Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Nishimura, A.; Yamato, A.; Yasuda, D.; Okubo, M.; Mori, Y.] Toranomon Gen Hosp, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		723	S345	S345				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901412		
J	Nunoi, K; Sato, Y; Kaku, K; Suganami, H				Nunoi, K.; Sato, Y.; Kaku, K.; Suganami, H.			The effect of SGLT-2 inhibitor, tofogliflozin on the urinary albumin excretion rate by the degree of albuminuria in Japanese type 2 diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Nunoi, K.; Sato, Y.] St Marys Hosp, Div Endocrinol & Metab, Kurume, Fukuoka, Japan; [Kaku, K.] Kawasaki Med Univ, Dept Internal Med, Okayama, Japan; [Suganami, H.] Kowa Co Ltd, Clin Data Sci Dept, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		164	S84	S84				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900165		
J	Ohkuma, T; Hirakawa, Y; Nakamura, U; Kiyohara, Y; Kitazono, T; Ninomiya, T				Ohkuma, T.; Hirakawa, Y.; Nakamura, U.; Kiyohara, Y.; Kitazono, T.; Ninomiya, T.			Association between eating rate and obesity: a systematic review and meta-analysis	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Ohkuma, T.; Ninomiya, T.] Kyushu Univ, Ctr Cohort Studies, Fukuoka 812, Japan; [Hirakawa, Y.; Kiyohara, Y.] Kyushu Univ, Dept Environm Med, Fukuoka 812, Japan; [Nakamura, U.; Kitazono, T.] Kyushu Univ, Dept Med & Clin Sci, Fukuoka 812, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		707	S338	S338				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901396		
J	Oikawa, S; Nagao, M; Harada, T; Tanimura-Inagaki, K; Sugihara, H; Moritani, S; Sasaki, J; Kono, S				Oikawa, S.; Nagao, M.; Harada, T.; Tanimura-Inagaki, K.; Sugihara, H.; Moritani, S.; Sasaki, J.; Kono, S.		STREAM Study Investigators	Sitagliptin effect on lipid and glucose metabolism (SLIM) study	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Oikawa, S.] Fukujuji Hosp, Fukuoka, Japan; [Nagao, M.; Harada, T.; Tanimura-Inagaki, K.; Sugihara, H.] Nippon Med Sch, Dept Endocrinol Diabet & Metab, Fukuoka, Japan; [Moritani, S.] Moritani Clin, Tokyo, Japan; [Sasaki, J.] Int Univ Hlth & Welf, Fukuoka, Japan; [Kono, S.] Natl Inst Hlth & Nutr, Tokyo 162, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		818	S393	S394				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902076		
J	Ota, H; Itaya-Hironaka, A; Yamauchi, A; Sakuramoto-Tsuchida, S; Fujimura, T; Tsujinaka, H; Tomoda, K; Yoshikawa, M; Kimura, H; Takasawa, S				Ota, H.; Itaya-Hironaka, A.; Yamauchi, A.; Sakuramoto-Tsuchida, S.; Fujimura, T.; Tsujinaka, H.; Tomoda, K.; Yoshikawa, M.; Kimura, H.; Takasawa, S.			Up-regulation of selenoprotein P, a diabetes-associated hepatokine, and HIP/PAP, a mitogenic factor for the liver, in hepatocytes by intermittent hypoxia	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Ota, H.; Tomoda, K.; Yoshikawa, M.; Kimura, H.] Nara Med Univ, Dept Internal Med 2, Kashihara, Nara 634, Japan; [Itaya-Hironaka, A.; Yamauchi, A.; Sakuramoto-Tsuchida, S.; Fujimura, T.; Tsujinaka, H.; Takasawa, S.] Nara Med Univ, Dept Biochem, Kashihara, Nara 634, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		598	S289	S289				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901287		
J	Ota, T; Zhuge, F; Ni, Y; Xu, L; Nagashimada, M; Nagata, N; Kaneko, S				Ota, T.; Zhuge, F.; Ni, Y.; Xu, L.; Nagashimada, M.; Nagata, N.; Kaneko, S.			Linagliptin-mediated DPP4 inhibition controls both macrophage migration and alternative activation and improves insulin resistance in diet-induced obese mice	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Ota, T.; Zhuge, F.; Ni, Y.; Xu, L.; Nagashimada, M.; Nagata, N.; Kaneko, S.] Kanazawa Univ, Brain Liver Interface Med Res Ctr, Kanazawa, Ishikawa 9201192, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		674	S323	S324				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901363		
J	Reiko, A; Eguchi, H; Ueda, Y; Tahara, Y; Kaneko, S				Reiko, A.; Eguchi, H.; Ueda, Y.; Tahara, Y.; Kaneko, S.			Deterioration of glycaemic control as a clue to finding occult cancer	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Reiko, A.; Eguchi, H.; Ueda, Y.; Tahara, Y.; Kaneko, S.] Takatsuki Red Cross Hosp, Diabet Endocrinol & Life Related Dis, Takatsuki, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		694	S332	S332				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901383		
J	Saiki, R; Imai, H; Hashizume, M; Kigawa, Y; Koizumi, G; Tadokoro, R; Sato, S; Otsuka, F; Taniyama, M				Saiki, R.; Imai, H.; Hashizume, M.; Kigawa, Y.; Koizumi, G.; Tadokoro, R.; Sato, S.; Otsuka, F.; Taniyama, M.			Rosuvastatin 5 mg improved carotid atherosclerotic changes regardless of LDL cholesterol level in Japanese diabetic patients: a 2-year prospective study	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Saiki, R.; Imai, H.; Hashizume, M.; Kigawa, Y.; Koizumi, G.; Tadokoro, R.; Sato, S.; Otsuka, F.; Taniyama, M.] Showa Univ, Fujigaoka Hosp, Endocrinol & Metab, Yokohama, Kanagawa 227, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1179	S566	S567				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903146		
J	Saito, T; Shimoda, Y; Tagaya, Y; Osaki, A; Yamada, E; Okada, S; Yamada, M				Saito, T.; Shimoda, Y.; Tagaya, Y.; Osaki, A.; Yamada, E.; Okada, S.; Yamada, M.			APPL1 promotes mechanical stretch induced glucose uptake through PKC zeta-Myosin IIa pathway in C2C12 myotubes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Saito, T.; Shimoda, Y.; Tagaya, Y.; Osaki, A.; Yamada, E.; Okada, S.; Yamada, M.] Gunma Univ, Mol Sci & Internal Med, Maebashi, Gumma 371, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		614	S296	S296				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901303		
J	Sakai, Y; Nagashimada, M; Nagata, N; Ni, Y; Kaneko, S; Ota, T				Sakai, Y.; Nagashimada, M.; Nagata, N.; Ni, Y.; Kaneko, S.; Ota, T.			OP 12 Effects of novel therapies on the vasculature	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Sakai, Y.; Nagashimada, M.; Nagata, N.; Ni, Y.; Kaneko, S.; Ota, T.] Kanazawa Univ, Brain Liver Interface Med Res Ctr, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		67	S33	S33				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900068		
J	Sakamoto, K; Takemoto, M; Ishikawa, T; Ishibashi, R; He, P; Hattori, A; Yamaga, M; Shoji, M; Ide, S; Ide, K; Kawamura, H; Kobayashi, K; Tokuyama, H; Maezawa, Y; Yokote, K				Sakamoto, K.; Takemoto, M.; Ishikawa, T.; Ishibashi, R.; He, P.; Hattori, A.; Yamaga, M.; Shoji, M.; Ide, S.; Ide, K.; Kawamura, H.; Kobayashi, K.; Tokuyama, H.; Maezawa, Y.; Yokote, K.			A novel gene, R3h domain containing-like, might play a role in muscle regeneration	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Sakamoto, K.; Takemoto, M.; Ishikawa, T.; Ishibashi, R.; He, P.; Hattori, A.; Yamaga, M.; Shoji, M.; Ide, S.; Ide, K.; Kawamura, H.; Kobayashi, K.; Tokuyama, H.; Maezawa, Y.; Yokote, K.] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		347	S174	S174				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901037		
J	Sasaki, D; Koto, J; Watadani, R; Seto, Y; Tanida, A; Honda, K; Matumoto, K				Sasaki, D.; Koto, J.; Watadani, R.; Seto, Y.; Tanida, A.; Honda, K.; Matumoto, K.			New animal models reveal that two genes are candidates for the onset of type 2 diabetes associated with obesity in rats	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Sasaki, D.; Koto, J.; Watadani, R.; Seto, Y.; Tanida, A.; Honda, K.; Matumoto, K.] Kyoto Sangyo Univ, Kyoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		343	S172	S172				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901033		
J	Sasaki, H; Ogawa, K; Tanaka, H; Kurisu, S; Furuta, H; Nishi, M; Akamizu, T; Nanjo, K				Sasaki, H.; Ogawa, K.; Tanaka, H.; Kurisu, S.; Furuta, H.; Nishi, M.; Akamizu, T.; Nanjo, K.			Atrophy of both extensor digitorum brevis muscle may be a useful sign for diagnosis of diabetic symmetric polyneuropathy in Japanese diabetic men	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Sasaki, H.; Ogawa, K.; Tanaka, H.; Kurisu, S.] Wakayama Med Univ, Dept Med, Katsuragi, Japan; [Kurisu, S.; Furuta, H.; Nishi, M.; Akamizu, T.] Wakayama Med Univ, Dept Med 1, Katsuragi, Japan; [Nanjo, K.] Wakayama Rosai Hosp, Wakayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1038	S501	S502				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903005		
J	Shiozaki, M; Fujimoto, K; Sasaki, T; Yoshida, K; Utsunomiya, K				Shiozaki, M.; Fujimoto, K.; Sasaki, T.; Yoshida, K.; Utsunomiya, K.			PKCdelta is a key regulator of palmitate-induced beta cell death	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Shiozaki, M.; Fujimoto, K.; Utsunomiya, K.] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Sasaki, T.] Jikei Univ, Sch Med, Inst Clin Med & Res, Tokyo, Japan; [Yoshida, K.] Jikei Univ, Dept Biochem, Sch Med, Tokyo 105, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		472	S233	S234				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901162		
J	Shiramoto, M; Nishida, T; Hansen, A; Haahr, H				Shiramoto, M.; Nishida, T.; Hansen, A.; Haahr, H.			Higher early insulin exposure and greater early glucose-lowering effect with faster-acting insulin aspart vs insulin aspart in Japanese patients with type 1 diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Shiramoto, M.] SOUSEIKAI Global Clin Res Ctr, Tokyo, Japan; [Nishida, T.] Novo Nordisk Pharma Ltd, Tokyo, Japan; [Hansen, A.; Haahr, H.] Novo Nordisk AS, Soborg, Denmark								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		837	S403	S403				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902095		
J	Sugimoto, K; Hoshino, T; Tamura, A; Yabe, R; Yamazaki, T; Suzuki, S				Sugimoto, K.; Hoshino, T.; Tamura, A.; Yabe, R.; Yamazaki, T.; Suzuki, S.			One-leg standing time correlates with peripheral and cardiac autonomic nerve function in Japanese patients with type 2 diabetes	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Sugimoto, K.; Tamura, A.; Yabe, R.; Yamazaki, T.; Suzuki, S.] Ohta Nishinouchi Hosp, Ctr Diabet, Koriyama, Fukushima, Japan; [Hoshino, T.] Ohta Nishinouchi Hosp, Dept Phys Training & Sci, Koriyama, Fukushima, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1037	S501	S501				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903004		
J	Sumita, T; Hosaka, T; Iuchi, T; Sakai, G; Yasuda, S; Katayama, S; Inoue, I				Sumita, T.; Hosaka, T.; Iuchi, T.; Sakai, G.; Yasuda, S.; Katayama, S.; Inoue, I.			The rapid subcutaneous injection of heparin plus insulin lispro improved dramatically blood glucose of a patient with subcutaneous insulin resistance	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Sumita, T.; Iuchi, T.; Sakai, G.; Yasuda, S.; Katayama, S.; Inoue, I.] Saitama Med Univ, Tokyo, Japan; [Hosaka, T.] Kyorin Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		517	S254	S254				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901207		
J	Takahashi, H; Nishimura, R; Onda, Y; Tsujino, D; Ando, K; Utsunomiya, K				Takahashi, H.; Nishimura, R.; Onda, Y.; Tsujino, D.; Ando, K.; Utsunomiya, K.			Comparison of glycaemic variations in Japanese patients with type 1 diabetes receiving insulin detemir vs insulin degludec as assessed by Continuous Glucose Monitoring (CGM)	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Takahashi, H.; Nishimura, R.; Onda, Y.; Tsujino, D.; Ando, K.; Utsunomiya, K.] Jikei Univ, Sch Med, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		978	S473	S474				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902236		
J	Takako, IA; Shin, T; Atsushi, I; Kaori, H; Yasuhiro, N; Ryuya, M; Yusuke, S; Yoji, H; Yutaka, O				Takako, I-A.; Shin, T.; Atsushi, I.; Kaori, H.; Yasuhiro, N.; Ryuya, M.; Yusuke, S.; Yoji, H.; Yutaka, O.			The co-transplantation of islets with dental pulp stem cells improved survival and function of transplanted beta cells in streptozotocin-induced diabetic mice	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Takako, I-A.; Shin, T.; Atsushi, I.; Kaori, H.; Yasuhiro, N.; Ryuya, M.; Yutaka, O.] Nagoya Univ, Grad Sch Med, Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan; [Takako, I-A.] Nagoya Univ, Grad Sch Med, Oral & Maxillofacial Surg, Nagoya, Aichi 4648601, Japan; [Yusuke, S.; Yoji, H.] Nagoya Univ, Grad Sch Med, Metab Med, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		507	S250	S250				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901197		
J	Tanaka, K; Otabe, S; Kakino, S; Soejima, E; Yuan, X; Nakayama, H; Nakashima, O; Hara, K; Ohki, T; Wada, N; Hashinaga, T; Egashira, T; Tajiri, Y; Yamada, K				Tanaka, K.; Otabe, S.; Kakino, S.; Soejima, E.; Yuan, X.; Nakayama, H.; Nakashima, O.; Hara, K.; Ohki, T.; Wada, N.; Hashinaga, T.; Egashira, T.; Tajiri, Y.; Yamada, K.			Differential expression of the E2F family in the carcinogenesis accelerated by liver steatosis	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Tanaka, K.; Otabe, S.; Kakino, S.; Soejima, E.; Yuan, X.; Nakayama, H.; Hara, K.; Wada, N.; Hashinaga, T.; Egashira, T.; Tajiri, Y.; Yamada, K.] Kurume Univ, Endocrinol & Metab, Kurume, Fukuoka, Japan; [Nakashima, O.; Ohki, T.] Kurume Univ, Clin Lab Med, Kurume, Fukuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		696	S333	S333				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901385		
J	Tanaka, S; Kanazawa, I; Notsu, M; Sugimoto, T				Tanaka, S.; Kanazawa, I.; Notsu, M.; Sugimoto, T.			Visceral fat obesity and metabolic syndrome increase serum DPP-4 levels in type 2 diabetes mellitus	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Tanaka, S.; Kanazawa, I.; Notsu, M.; Sugimoto, T.] Shimane Univ, Fac Med, Izumo, Shimane, Japan			Kanazawa, Ippei/F-8609-2010					0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		651	S313	S313				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901340		
J	Tanizawa, Y; Ohta, Y; Taguchi, A; Akiyama, M; Nakabayashi, H; Matsumura, T; Suetomi, R; Yanai, A; Shinoda, K				Tanizawa, Y.; Ohta, Y.; Taguchi, A.; Akiyama, M.; Nakabayashi, H.; Matsumura, T.; Suetomi, R.; Yanai, A.; Shinoda, K.			DBP and Nfil3/E4BP4 play pivotal roles in circadian regulation of beta cell function	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Tanizawa, Y.; Ohta, Y.; Taguchi, A.; Akiyama, M.; Nakabayashi, H.; Matsumura, T.; Suetomi, R.] Yamaguchi Univ, Grad Sch Med, Dept Biosignal Anal, Ube, Yamaguchi 755, Japan; [Yanai, A.; Shinoda, K.] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Ube, Yamaguchi 755, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		453	S224	S225				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901143		
J	Terasaki, M; Hiromura, M; Kohashi, K; Kushima, H; Nagashima, M; Mori, Y; Hirano, T				Terasaki, M.; Hiromura, M.; Kohashi, K.; Kushima, H.; Nagashima, M.; Mori, Y.; Hirano, T.			Amelioration of hyperglycaemia with SGLT2i prevents atherosclerosis through suppression of macrophage form cell formation in diabetic mice independent of insulin action	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Terasaki, M.; Hiromura, M.; Kohashi, K.; Kushima, H.; Nagashima, M.; Mori, Y.; Hirano, T.] Showa Univ, Sch Med, Dept Med, Tokyo 142, Japan; [Terasaki, M.] Ebara Hosp, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		72	S35	S36				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900073		
J	Terauchi, Y; Koyama, M; Cheng, X; Sumi, M; Hirose, T				Terauchi, Y.; Koyama, M.; Cheng, X.; Sumi, M.; Hirose, T.		EDITION JP 2 Study Grp	Sustained glycaemic control and less hypoglycaemia over 1y with new insulin glargine 300 U/ml vs glargine 100 U/ml in Japanese type 2 diabetes mellitus people on basal insulin plus OAD(s) (EDITION JP 2)	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Terauchi, Y.] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan; [Koyama, M.; Sumi, M.] Sanofi, Tokyo, Japan; [Cheng, X.] Sanofi, Beijing, Peoples R China; [Hirose, T.] Toho Univ, Sch Med, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		959	S463	S463				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902217		
J	Tsujinaka, H; Itaya-Hironaka, A; Yamauchi, A; Sakuramoto-Tsuchida, S; Ota, H; Fujimura, T; Shobatake, R; Ogata, N; Takasawa, S				Tsujinaka, H.; Itaya-Hironaka, A.; Yamauchi, A.; Sakuramoto-Tsuchida, S.; Ota, H.; Fujimura, T.; Shobatake, R.; Ogata, N.; Takasawa, S.			Hydroquinone-damaged human retinal pigment epithelial cell proliferation by advanced glycation end-products via up-regulation of VEGF gene	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Tsujinaka, H.; Itaya-Hironaka, A.; Yamauchi, A.; Sakuramoto-Tsuchida, S.; Ota, H.; Fujimura, T.; Shobatake, R.; Takasawa, S.] Nara Med Univ, Dept Biochem, Kashihara, Nara 634, Japan; [Ogata, N.] Nara Med Univ, Dept Ophthalmol, Kashihara, Nara 634, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		1073	S517	S517				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820903040		
J	Yabe, D; Kuwata, H; Nishikino, R; Kaneko, M; Ito, C; Murotani, K; Kurose, T; Seino, Y				Yabe, D.; Kuwata, H.; Nishikino, R.; Kaneko, M.; Ito, C.; Murotani, K.; Kurose, T.; Seino, Y.			Use of the Japanese health insurance claims database to assess durability of DPP-4 inhibitors in patients with diabetes: comparison with other anti-diabetic drugs	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Yabe, D.; Kuwata, H.; Kurose, T.; Seino, Y.] Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, Osaka, Japan; [Nishikino, R.; Kaneko, M.; Ito, C.] Japan Med Data Ctr Co Ltd, Tokyo, Japan; [Murotani, K.] Aichi Med Univ, Ctr Clin Res, Nagakute, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		808	S389	S389				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902066		
J	Yada, T; Iwasaki, Y; Maejima, Y; Suyama, S; Yoshida, M; Arai, T; Katsurada, K; Kumari, P; Kakei, M				Yada, T.; Iwasaki, Y.; Maejima, Y.; Suyama, S.; Yoshida, M.; Arai, T.; Katsurada, K.; Kumari, P.; Kakei, M.			Peripheral oxytocin administration activates vagal afferent nerves to suppress feeding, ameliorating hyperphagia and obesity in diabetic db/db mice	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Yada, T.; Iwasaki, Y.; Maejima, Y.; Suyama, S.; Arai, T.; Katsurada, K.; Kumari, P.] Jichi Med Univ, Physiol, Shimotsuke, Tochigi, Japan; [Yada, T.] Natl Inst Physiol Sci, Dev Physiol, Okazaki, Aichi, Japan; [Yoshida, M.; Kakei, M.] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		659	S317	S317				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901348		
J	Yahagi, A; Hira, T; Nishimura, S; Sakaino, M; Yamashita, T; Hara, H				Yahagi, A.; Hira, T.; Nishimura, S.; Sakaino, M.; Yamashita, T.; Hara, H.			Luminal trans, trans-2,4-decadienal reduces gastric emptying in rats	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Yahagi, A.] Hokkaido Univ, Div Appl Biosci, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Hira, T.; Hara, H.] Hokkaido Univ, Res Fac Agr, Div Appl Biosci, Sapporo, Hokkaido, Japan; [Nishimura, S.; Sakaino, M.; Yamashita, T.] J Oil Mills Inc, Div Res & Dev, Fundamental Res Lab, Yokohama, Kanagawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		635	S305	S305				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820901324		
J	Yamada, H; Yoshida, M; Ito, K; Dezaki, K; Kawakami, M; Ishikawa, SE; Yada, T; Kakei, M				Yamada, H.; Yoshida, M.; Ito, K.; Dezaki, K.; Kawakami, M.; Ishikawa, S. -E.; Yada, T.; Kakei, M.			Potentiation of glucose-stimulated insulin secretion by GPR40-PLC-TRPC pathway in pancreatic beta cells	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Yamada, H.; Yoshida, M.; Ito, K.; Kawakami, M.; Ishikawa, S. -E.; Kakei, M.] Jichi Med Univ, Saitama Med Ctr, Dept Comprehens Med 1, Shimotsuke, Tochigi, Japan; [Dezaki, K.; Yada, T.] Jichi Med Univ, Dept Physiol, Shimotsuke, Tochigi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		171	S87	S87				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820900172		
J	Yamada, T; Shojima, N; Hara, K; Yamauchi, T; Kadowaki, T				Yamada, T.; Shojima, N.; Hara, K.; Yamauchi, T.; Kadowaki, T.			Excessive daytime sleepiness, daytime napping, and risk of type 2 diabetes: a meta-analysis	DIABETOLOGIA			English	Meeting Abstract	51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 14-18, 2015	Stockholm, SWEDEN	European Assoc Study Diabet					[Yamada, T.; Shojima, N.; Hara, K.; Yamauchi, T.; Kadowaki, T.] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo 1138654, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2015	58			1		940	S454	S454				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CP3ZE	WOS:000359820902198		
J	Bhuiyan, MAH; Kumamoto, T; Suzuki, S				Bhuiyan, Mohammad A. H.; Kumamoto, Takashi; Suzuki, Shigeyuki			Application of remote sensing and GIS for evaluation of the recent morphological characteristics of the lower Brahmaputra-Jamuna River, Bangladesh	EARTH SCIENCE INFORMATICS			English	Article						Remote sensing; GIS; Brahmaputra-Jamuna River; Channel planform	BANK EROSION; CHANNEL CHANGE; IMAGE-ANALYSIS; DYNAMICS; USA; PHOTOGRAPHS; DOWNSTREAM; ADJUSTMENT; RESERVOIR; STREAM	This paper deals with the morphological changes of the lower Brahmaputra-Jamuna River (BJR) in Bangladesh. Within few decades, the planform of the river has been changed abruptly by the combined effect of natural process and human interventions. Morphological features observing in this study were river planform, channel width, bankline migration and channel bed elevation. Eighteen sets of remote sensing data series from 1973 to 2011were analyzed using ERDAS/Imagine and GIS to document the variation of geomorphic elements of the lower BJR. GIS analysis of remote sensing data showed that the changes of channel planform were quite significant over the past 40 years, occurring two major phases of channel development. The changing patterns in the first phase (i.e., between 1973 and 1992) were quite irregular. However, the second phase ranging between 1992 and 2011 was unidirectional (mostly eastward). In general, the studied river reach was widened and the average rate of migration was 225 m y(-1) that was three-folds the values of the first phase. The height and slope of sand bars were gradually increasing, showing the highest value around the Jamuna Multipurpose Bridge (JMB) section. The planform characteristics of BJR at the downstream of JMB showed that the river reach was gradually widening and shifting eastwards. However, the reach at the upstream of the JMB showed westward migration. The recent trends of channel changes suggest that the river planform has lost it's naturally condition and it may, therefore, be predicted that increasing nature of channel width likely to continue in the immediate future.	[Bhuiyan, Mohammad A. H.; Kumamoto, Takashi; Suzuki, Shigeyuki] Okayama Univ, Dept Earth Sci, Okayama 7008530, Japan; [Bhuiyan, Mohammad A. H.] Jahangirnagar Univ, Dept Environm Sci, Dhaka 1342, Bangladesh	Bhuiyan, MAH (reprint author), Jahangirnagar Univ, Dept Environm Sci, Dhaka 1342, Bangladesh.	amirhb75@yahoo.com			Japanese Government Monbukagakusho Scholarship program	This research paper is a part of further development of the first author's Ph. D. work which was financed by Japanese Government Monbukagakusho Scholarship program 2010. Sincere gratitude to the Australia-NZ Geomorphology Group and organizing committee of the "7th International Conference on Geomorphology 2009", Melbourne, Australia for giving me the opportunity to present part of this paper in the large rivers session. Authors also greatly acknowledge Professor Auvijit Gupta, chair of the large river session for his valuable suggestion for developing the manuscript.	Akhtar MP, 2011, INT J SEDIMENT RES, V26, P431, DOI 10.1016/S1001-6279(12)60003-1; ANDREWS ED, 1986, GEOL SOC AM BULL, V97, P1012, DOI 10.1130/0016-7606(1986)97<1012:DEOFGR>2.0.CO;2; Mount NJ, 2013, GEOMORPHOLOGY, V183, P82, DOI 10.1016/j.geomorph.2012.07.017; Takagi T, 2007, GEOMORPHOLOGY, V85, P294, DOI 10.1016/j.geomorph.2006.03.028; Alabyan AM, 1998, EARTH SURF PROC LAND, V23, P467, DOI 10.1002/(SICI)1096-9837(199805)23:5<467::AID-ESP861>3.0.CO;2-T; LEEDER MR, 1975, NATURE, V253, P338, DOI 10.1038/253338a0; GREGORY KJ, 1974, WATER RESOUR RES, V10, P870, DOI 10.1029/WR010i004p00870; Barker R, 1997, EARTH SURF PROC LAND, V22, P1217, DOI 10.1002/(SICI)1096-9837(199724)22:13<1217::AID-ESP819>3.0.CO;2-U; Kondolf GM, 1997, ENVIRON MANAGE, V21, P533, DOI 10.1007/s002679900048; Ollero A, 2010, GEOMORPHOLOGY, V117, P247, DOI 10.1016/j.geomorph.2009.01.015; MARSTON RA, 1995, GEOMORPHOLOGY, V13, P121, DOI 10.1016/0169-555X(95)00066-E; Gurnell AM, 1997, REGUL RIVER, V13, P13, DOI 10.1002/(SICI)1099-1646(199701)13:1<13::AID-RRR420>3.0.CO;2-W; Graf WL, 2000, ENVIRON MANAGE, V25, P321, DOI 10.1007/s002679910025; Leigh DS, 2004, QUATERNARY SCI REV, V23, P65, DOI 10.1016/S0277-3791(03)00211-X; Mount NJ, 2003, GEOMORPHOLOGY, V56, P65, DOI 10.1016/S0169-555X(03)00046-1; Ashworth PJ, 2000, SEDIMENTOLOGY, V47, P533, DOI 10.1046/j.1365-3091.2000.00305.x; Bagnold R. A., 1960, 282E US GEOL SURV; Bak L, 2013, GEOMORPHOLOGY, V191, P51, DOI 10.1016/j.geomorph.2013.03.002; Billi P, 1997, IAHS-AISH P, P301; Boruah S, 2008, RIVER RES APPL, V24, P650, DOI 10.1002/rra.1132; Buckingham SE, 2007, J AM WATER RESOUR AS, V43, P888, DOI 10.1111/j.1752-1688.2007.00073.x; Carson EC, 2006, GEOMORPHOLOGY, V75, P368, DOI 10.1016/j.geomorph.2005.07.022; Castiglioni GB, 1981, P IAHS S FLOR 22 26, P223; Church M, 2009, EARTH SURF PROC LAND, V34, P1422, DOI 10.1002/esp.1831; Coleman J.M., 1969, SEDIMENT GEOL, V3, P129, DOI DOI 10.1016/0037-0738(69)90010-4; Croke JC, 2008, INT ASS HYDROLOGICAL, V325, P200; Dale PER, 1996, J AM MOSQUITO CONTR, V12, P316; Downward S.R., 1994, INT ASS HYDROLOGICAL, V224, P449; Dutto F, 1994, ESEMPI PIANURA PADAN, V7, P381; EGIS (Environment and GIS Support Project for Water Sector Planning), 1997, MORPH DYN BRAHM JAM; Gilvear DJ, 2003, TOOLS FLUVIAL GEOMOR, P211; GILVEAR DJ, 1995, FRESHWATER BIOL, V34, P389, DOI 10.1111/j.1365-2427.1995.tb00897.x; GOUDIE A., 1990, GEOMORPHOLOGICAL TEC; Gupta A, 1995, GEOPHYS MONOGR SER, V89, P125; Gupta A, 2002, GEOMORPHOLOGY, V44, P221, DOI 10.1016/S0169-555X(01)00176-3; Gurnell AM, 1994, REGUL RIVER, V7, P247; Hooke J. M., 1987, INT GEOMORPHOLOGY 1, P591; Islam AS, 1999, HYDROLOGIC CHARACTER; KNIGHTON AD, 1989, EARTH SURF PROCESSES, V14, P333, DOI 10.1002/esp.3290140408; Koppen W, 1936, GEOGRAPHISCHE SYSTEM; Milton EJ, 1995, CHANGING RIVER CHANN, P276; MULLER E, 1993, FRESHWATER BIOL, V29, P301, DOI 10.1111/j.1365-2427.1993.tb00766.x; Petts GE, 1977, RIVER CHANNEL CHANGE, P145; Piegay H, 2006, SPEC PUBL INT ASS SE, V36, P257; Rahman MM, 2002, INT J SEDIMENT RES, V17, P124; Sarker MH, 2014, GEOMORPHOLOGY, V215, P45, DOI 10.1016/j.geomorph.2013.07.025; Surian N, 1999, EARTH SURF PROC LAND, V24, P1135; Teisseyre AK, 1980, GEOL SUDETICA, V15, P67; Thorne C.R., 1992, LOWLAND FLOODPLAIN R, P95; Thorne C.R., 1993, GEOLOGICAL SOC SPECI, V75, P257, DOI 10.1144/GSL.SP.1993.075.01.16; Williams GP, 1978, US GEOLOGICAL SURVEY, P48; Williams G.P., 1984, REGUL RIVER, V1, P83; Yang X., 1999, JAG, V1, P146	53	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1865-0473	1865-0481		EARTH SCI INFORM	Earth Sci. Inform.	SEP	2015	8	3			SI		551	568		10.1007/s12145-014-0180-4		18	Computer Science, Interdisciplinary Applications; Geosciences, Multidisciplinary	Computer Science; Geology	CQ6CW	WOS:000360693000008		
J	Ichinokawa, M; Okamura, H; Watanabe, C; Kawabata, A; Oozeki, Y				Ichinokawa, Momoko; Okamura, Hiroshi; Watanabe, Chikako; Kawabata, Atsushi; Oozeki, Yoshioki			Effective time closures: quantifying the conservation benefits of input control for the Pacific chub mackerel fishery	ECOLOGICAL APPLICATIONS			English	Article						chub mackerel; generalized autoregressive state-space model; generalized linear model; input control; management strategy evaluation; Scomber japonicus; time closures	MARINE RESERVES; HIERARCHICAL MODEL; FACTORY TRAWLERS; MANAGEMENT; STOCK; CATCH; DYNAMICS; BEHAVIOR; LINE; CATCHABILITY	Restricting human access to a specific wildlife species, community, or ecosystem, i.e., input control, is one of the most popular tools to control human impacts for natural resource management and wildlife conservation. However, quantitative evaluations of input control are generally difficult, because it is unclear how much human impacts can actually be reduced by the control. We present a model framework to quantify the effectiveness of input control using day closures to reduce actual fishing impact by considering the observed fishery dynamics. The model framework was applied to the management of the Pacific stock of the chub mackerel (Scomber japonicus) fishery, in which fishing was suspended for one day following any day when the total mackerel catch exceeded a threshold level. We evaluated the management measure according to the following steps: (1) we fitted the daily observed catch and fishing effort data to a generalized linear model (GLM) or generalized autoregressive state-space model (GASSM), (2) we conducted population dynamics simulations based on annual catches randomly generated from the parameters estimated in the first step, (3) we quantified the effectiveness of day closures by comparing the results of two simulation scenarios with and without day closures, and (4) we conducted additional simulations based on different sets of explanatory variables and statistical models (sensitivity analysis). In the first step, we found that the GASSM explained the observed data far better than the simple GLM. The model parameterized with the estimates from the GASSM demonstrated that the day closures implemented from 2004 to 2009 would have decreased exploitation fractions by; similar to 10% every year and increased the 2009 stock biomass by 37-46% (median), relative to the values without day closures. The sensitivity analysis revealed that the effectiveness of day closures was particularly influenced by autoregressive processes in the fishery data and by positive relationships between fishing effort and total biomass. Those results indicated the importance of human behavioral dynamics under input control in quantifying the conservation benefit of natural resource management and the applicability of our model framework to the evaluation of the input controls that are actually implemented.	[Ichinokawa, Momoko; Okamura, Hiroshi; Watanabe, Chikako; Kawabata, Atsushi] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; [Oozeki, Yoshioki] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Shiogama, Miyagi 9850001, Japan	Ichinokawa, M (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	ichimomo@affrc.go.jp			Fishery Agency of Japan; JST-CREST; National Research Institute of Fisheries Science	We are very grateful to the North Pacific Federation of Purse Seiners, who kindly provided daily catch and effort data. Our sincere thanks are extended to Hiroyuki Kurota, Ray Hilborn, two reviewers, and the associate editor Eric Ward for useful and constructive comments that improved the manuscript greatly. Funding for this research was provided by the Fishery Agency of Japan, JST-CREST projects, and a research project at the National Research Institute of Fisheries Science.	Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Isaacs JC, 2000, WILDLIFE SOC B, V28, P61; Thorson JT, 2013, CAN J FISH AQUAT SCI, V70, P1829, DOI 10.1139/cjfas-2013-0280; Thorson JT, 2014, CAN J FISH AQUAT SCI, V71, P973, DOI 10.1139/cjfas-2013-0645; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; EDWARDS D, 1987, OIKOS, V50, P95, DOI 10.2307/3565405; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; Watanabe C, 2006, FISH RES, V78, P323, DOI 10.1016/j.fishres.2006.01.001; Dorn MW, 2001, ICES J MAR SCI, V58, P238, DOI 10.1006/jmsc.2000.1006; Clark John H., 2006, ALASKA FISHERY RESEARCH BULLETIN, V12, P1; Kawai H, 2002, FISHERIES SCI, V68, P963, DOI 10.1046/j.1444-2906.2002.00520.x; Swartz W, 2014, FISHERIES SCI, V80, P643, DOI 10.1007/s12562-014-0754-6; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Perry RI, 2000, FISH OCEANOGR, V9, P50, DOI 10.1046/j.1365-2419.2000.00121.x; van der Lee A, 2013, CAN J FISH AQUAT SCI, V70, P973, DOI 10.1139/cjfas-2012-0341; Pope JG, 2009, FISHERY MANAGERS GUIDEBOOK, 2ND EDITION, P220, DOI 10.1002/9781444316315.ch9; HILBORN R, 1987, CAN J FISH AQUAT SCI, V44, P1366, DOI 10.1139/f87-163; Dorn MW, 1998, CAN J FISH AQUAT SCI, V55, P180, DOI 10.1139/cjfas-55-1-180; Watanabe C, 2012, NIPPON SUISAN GAKK, V78, P15, DOI 10.2331/suisan.78.15; Bunnefeld N, 2011, TRENDS ECOL EVOL, V26, P441, DOI 10.1016/j.tree.2011.05.003; Maron M, 2013, CONSERV LETT, V6, P359, DOI 10.1111/conl.12007; Nielsen JR, 2006, DEV AQUAC FISH SCI, V36, P163; Punt AE, 2007, ICES J MAR SCI, V64, P603, DOI 10.1093/icesjms/fsm035; Prista N, 2011, FISH B-NOAA, V109, P170; van Oostenbrugge HJAE, 2008, AQUAT LIVING RESOUR, V21, P265, DOI 10.1051/alr:2008035; Skaug HJ, 2006, COMPUT STAT DATA AN, V51, P699, DOI 10.1016/j.csda.2006.03.005; Leos RR, 1998, CAL COOP OCEAN FISH, V39, P204; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Borchers DL, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P115; Burnham K. P., 2002, MODEL SELECTION MULT; Dunn DC, 2014, FISH FISH, V15, P359, DOI 10.1111/faf.12019; Eales J., 1986, MAR RES EC, V2, P331; Hanson PJ, 2006, N AM J FISH MANAGE, V26, P753, DOI 10.1577/M04-096.1; Hilborn R, 1992, QUANTITATIVE FISHERI; Kawabata A., 2013, MARINE FISHERIES STO, P133; Makino M., 2011, FISHERIES MANAGEMENT; Melnychuk MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056684; Pope J. G., 1972, RES B INT COMM NW AT, V9, P65; R Development Core Team, 2014, R LANG ENV STAT COMP; Raichev E., 2012, Trakia Journal of Sciences, V10, P48; Wilberg MJ, 2010, REV FISH SCI, V18, P7, DOI 10.1080/10641260903294647; Williams BK, 2002, ANAL MANAGEMENT ANIM	48	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	1051-0761	1939-5582		ECOL APPL	Ecol. Appl.	SEP	2015	25	6					1566	1584		10.1890/14-1216.1		19	Ecology; Environmental Sciences	Environmental Sciences & Ecology	CQ7VI	WOS:000360813100011		
J	Sarker, A; Ikeda, T; Abe, T; Inoue, K				Sarker, Ashutosh; Ikeda, Toru; Abe, Takaki; Inoue, Ken			Design principles for managing coastal fisheries commons in present-day Japan	ECOLOGICAL ECONOMICS			English	Article						Fisheries commons; Design principles; User self-governance; Japan	POOL RESOURCES; COLLECTIVE ACTION; GOVERNANCE; COMANAGEMENT; MANAGEMENT; SUSTAINABILITY; CONSERVATION; GOVERNMENT; LESSONS; SYSTEMS	Ostrom (1990) challenged the traditional belief that commons management inevitably requires state ownership or privatization and instead established the notion of user self-governance. This notion, a third policy option for managing the commons, entails little or no state involvement. Under this notion, Ostrom developed eight design principles to which self-governing institutional arrangements adhere, while the role of the state is minimal. This article seeks to establish whether design principles characterize such institutional arrangements when the role of the state is accommodated explicitly within the principles. Drawing on a case study of present-day management of Japan's community-based coastal fisheries commons, our study shows that the design principles can better characterize self-governing institutional arrangements when the state adopts a pro-user self-governance role that provides strategic support for users, but neither takes ownership of the commons nor participates in engineering the institutional arrangements. (C) 2015 Elsevier B.V. All rights reserved.	[Sarker, Ashutosh] Monash Univ Malaysia, Sch Business, Dept Econ, Sunway 46150, Selangor, Malaysia; [Ikeda, Toru] Niigata Prefectural Fisheries & Marine Res Inst, Nishi Ward, Niigata, Niigata 9502171, Japan; [Abe, Takaki; Inoue, Ken] Fukushima Univ, Fac Econ & Business Adm, Fukushima 9601296, Japan	Sarker, A (reprint author), Monash Univ Malaysia, Sch Business, Dept Econ, Sunway 46150, Selangor, Malaysia.	asarker@yahoo.com			Japanese Society for the Promotion of Science [23651033]	We thank three anonymous reviewers for thoughtful suggestions and insights, which have greatly enriched the quality of the manuscript. The Japanese Society for the Promotion of Science provided financial support for this research (Research Grant Number 23651033).	Abe T., 2007, J CENT REG AFF FUKUS, V19, P91; Acheson JM, 2013, CONSERV SOC, V11, P60, DOI 10.4103/0972-4923.110936; Cooke SJ, 2013, FISH FISH, V14, P439, DOI 10.1111/j.1467-2979.2012.00477.x; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Wilson DS, 2013, J ECON BEHAV ORGAN, V90, pS21, DOI 10.1016/j.jebo.2012.12.010; OSTROM V, 1961, AM POLIT SCI REV, V55, P831, DOI 10.2307/1952530; Basurto X, 2013, GLOBAL ENVIRON CHANG, V23, P1366, DOI 10.1016/j.gloenvcha.2013.08.001; McCay BJ, 2014, MAR POLICY, V44, P49, DOI 10.1016/j.marpol.2013.08.001; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641; Makino M, 2005, MAR POLICY, V29, P441, DOI 10.1016/j.marpol.2004.07.005; Agrawal A, 2013, ENVIRON SCI POLICY, V25, P138, DOI 10.1016/j.envsci.2012.08.004; HARDIN G, 1968, SCIENCE, V162, P1243; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Sarker A, 2008, ECOL ECON, V68, P461, DOI 10.1016/j.ecolecon.2008.05.001; Toonen T, 2010, PUBLIC ADMIN REV, V70, P193; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Shimada D, 2014, INT J COMMONS, V8, P207; BERKES F, 1989, NATURE, V340, P91, DOI 10.1038/340091a0; Schreiber MA, 2013, ECOL SOC, V18, DOI 10.5751/ES-05319-180212; Asada Y., 1983, 238 FAO; Bell S, 2012, PUBLIC ADMIN, V90, P144, DOI 10.1111/j.1467-9299.2011.01954.x; Berkes F., 1989, COMMON PROPERTY RESO; Cox M, 2010, ECOL SOC, V15; Feeny D., 1990, MANAGING THE COMMONS; Gjertsen H, 2004, LAND ECON, V80, P321, DOI 10.2307/3654724; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Higashida K., 2006, J CENT REG AFF FUKUS, V18, P55; Inoue K., 2008, J CENT REG AFF FUKUS, V19, P48; Inoue K., 2009, J CENT REG AFF FUKUS, V21, P83; Kahui V, 2014, ECOL ECON, V102, P1, DOI 10.1016/j.ecolecon.2014.03.006; Kojima A., 2006, ANN REP FUKUSHIMA U, V2, P19; Makino M., 2013, I ANAL FISHERIES MAN; Makino M., 2011, FISHERIES MANAGEMENT; Makino M., 2005, GLOBAL ENV RES, V7, P95; Mansbridge J, 2010, PERSPECT POLIT, V8, P590, DOI 10.1017/S153759270000040X; Matsushima H., 2012, THESIS U CALIFORNIA; McCay BJ, 1987, QUESTION COMMONS CUL; McKean M. A., 1982, ENVIRON REV, V6, P63, DOI 10.2307/3984155; Ministry of Agriculture Forestry and Fisheries (MAFF), 2010, FISH CENS 2008; Murota T., 2013, LOCAL COMMONS DEMOCR; North DC, 2005, PRINC ECON HIST W WO, P1; OLSON JR MANCUR, 1965, LOGIC COLLECTIVE ACT; Ostrom E, 2011, IMPROVING IRRIGATION IN ASIA: SUSTAINABLE PERFORMANCE OF AN INNOVATIVE INTERVENTION IN NEPAL, P1; Ostrom E, 2012, EUR POLIT SCI, V11, P128, DOI 10.1057/eps.2011.37; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E., 1992, CRAFTING I SELF GOVE; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Ostrom Elinor, 1994, RULES GAMES COMMON P; Ostrom V., 1977, ALTERNATIVES DELIVER, P7; Pinkerton E., 1992, SOC APPL ANTHROPOLOG, V51, P330; Plummer R, 2009, ECOL SOC, V14; Popescu I., 2013, FISHERIES JAPAN; Ruddle K., 1987, FAO FISHERIES TECHNI; Sarker A, 2009, WATER POLICY, V11, P598, DOI 10.2166/wp.2009.076; Sarker A., 2014, J HYDROL, V510, P246; Sarker A, 2008, HUM ECOL, V36, P821, DOI 10.1007/s10745-008-9206-1; Sarker A., 2013, PUBLIC ADM, V91, P727; Sarker A, 2001, AGR WATER MANAGE, V48, P89, DOI 10.1016/S0378-3774(00)00125-6; Sarker A, 2003, SOC NATUR RESOUR, V16, P159, DOI 10.1080/08941920390174265; Sorensen E., 2008, GOVERNANCE NETWORK R; Sumaila UR, 2010, FISH FISH, V11, P278, DOI 10.1111/j.1467-2979.2010.00377.x; Tokrisna R., 2004, J INT COOP STUD, V12, P1; Uchida H., 2007, THESIS U CALIFORNIA; Uchida H., 2008, CASE STUDIES FISHERI; WADE R, 1987, CAMBRIDGE J ECON, V11, P95; Yamamoto T., 1995, MAR RES EC, V10, P21	67	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8009	1873-6106		ECOL ECON	Ecol. Econ.	SEP	2015	117						32	38		10.1016/j.ecolecon.2015.06.019		7	Ecology; Economics; Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology; Business & Economics	CQ3OU	WOS:000360512800004		
J	Jin, Y; Yuan, Q; Zhang, J; Manabe, T; Tan, W				Jin, Ya; Yuan, Qi; Zhang, Jun; Manabe, Takashi; Tan, Wen			Proteomic analysis of cellular soluble proteins from human bronchial smooth muscle cells by combining nondenaturing micro 2DE and quantitative LC-MS/MS. 2. Similarity search between protein maps for the analysis of protein complexes	ELECTROPHORESIS			English	Article						Cellular proteins; Native protein map; Nondenaturing micro 2DE; Protein complex; Quantitative LC-MS; MS	MASS-SPECTROMETRY; ESCHERICHIA-COLI; MALDI-MS; SUBUNITS; PHOSPHORYLATION; HETERODIMER; ASSOCIATION; ACTIVATION; COMPONENTS; FRAMEWORK	Human bronchial smooth muscle cell soluble proteins were analyzed by a combined method of nondenaturing micro 2DE, grid gel-cutting, and quantitative LC-MS/MS and a native protein map was prepared for each of the identified 4323 proteins [1]. A method to evaluate the degree of similarity between the protein maps was developed since we expected the proteins comprising a protein complex would be separated together under nondenaturing conditions. The following procedure was employed using Excel macros; (i) maps that have three or more squares with protein quantity data were selected (2328 maps), (ii) within each map, the quantity values of the squares were normalized setting the highest value to be 1.0, (iii) in comparing a map with another map, the smaller normalized quantity in two corresponding squares was taken and summed throughout the map to give an overlap score, (iv) each map was compared against all the 2328 maps and the largest overlap score, obtained when a map was compared with itself, was set to be 1.0 thus providing 2328 overlap factors, (v) step (iv) was repeated for all maps providing 2328 x 2328 matrix of overlap factors. From the matrix, protein pairs that showed overlap factors above 0.65 from both protein sides were selected (431 protein pairs). Each protein pair was searched in a database (UniProtKB) on complex formation and 301 protein pairs, which comprise 35 protein complexes, were found to be documented. These results demonstrated that native protein maps and their similarity search would enable simultaneous analysis of multiple protein complexes in cells.	[Jin, Ya; Yuan, Qi; Zhang, Jun; Tan, Wen] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Jin, Ya] S China Univ Technol, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China; [Jin, Ya; Tan, Wen] S China Univ Technol, Key Lab Ind Biotechnol, Guangdong Higher Educ Inst, Guangzhou 510006, Guangdong, Peoples R China; [Manabe, Takashi] Ehime Univ, Fac Sci, Matsuyama, Ehime 790, Japan	Tan, W (reprint author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.	went@scut.edu.cn			National Natural Science Foundation of China [31400798]; Fundamental Research Funds for the Central Universities [2013ZM0048]; Science and Technology Program of Guangzhou, China [2014J4100022]; Guangdong Province Key Laboratory of Fermentation and Enzyme Engineering Open Fund, China [FJ2013002]; Ministry of Science and Technology of Guangdong Province, China [2012A080204001]	The mass spectrometry proteomic data have been deposited to the ProteomeXchange Consortium (http://www.proteomexchange.org) via the PRIDE partner repository [49] with the dataset identifier PXD001471. The authors would like to thank the PRIDE team for their great help with the data deposition process. This work is financially supported by "National Natural Science Foundation of China 31400798," "The Fundamental Research Funds for the Central Universities 2013ZM0048," "Science and Technology Program of Guangzhou, China 2014J4100022," "Guangdong Province Key Laboratory of Fermentation and Enzyme Engineering Open Fund, China FJ2013002," and "Ministry of Science and Technology of Guangdong Province, China 2012A080204001."	ADACHI I, 1990, J BIOL CHEM, V265, P960; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105; Fang L, 2008, J PROTEOME RES, V7, P4914, DOI 10.1021/pr800574c; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Richter R, 2010, EMBO J, V29, P1116, DOI 10.1038/emboj.2010.14; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI [10.1038/nmeth.1280, 10.1038/NMETH.1280]; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Zhao XF, 2000, GENOMICS, V63, P145, DOI 10.1006/geno.1999.6064; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Manabe T, 2010, ELECTROPHORESIS, V31, P2740, DOI 10.1002/elps.201000165; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; AROSIO P, 1978, J BIOL CHEM, V253, P4451; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Jarrous N, 1999, RNA, V5, P153, DOI 10.1017/S135583829800185X; Jin Y, 2015, ELECTROPHORESIS, V36, P1711, DOI 10.1002/elps.201400573; Jin Y, 2014, ELECTROPHORESIS, V35, P2055, DOI 10.1002/elps.201300628; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lowe M, 1996, J BIOL CHEM, V271, P30725; Manabe T, 2011, ELECTROPHORESIS, V32, P300, DOI 10.1002/elps.201000443; Manabe T, 2007, ELECTROPHORESIS, V28, P843, DOI 10.1002/elps.200600389; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MIRANDE M, 1985, EXP CELL RES, V156, P91, DOI 10.1016/0014-4827(85)90264-2; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Paytubi S, 2008, BIOCHEM J, V409, P223, DOI 10.1042/BJ20070811; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; ROMMELAERE H, 1993, P NATL ACAD SCI USA, V90, P11975, DOI 10.1073/pnas.90.24.11975; Schmidt DR, 1999, BIOCHEMISTRY-US, V38, P14711, DOI 10.1021/bi991614n; Schmidt F, 2003, J AM SOC MASS SPECTR, V14, P943, DOI 10.1016/S1044-0305(03)00345-3; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Sheu GT, 1997, J BIOL CHEM, V272, P33290, DOI 10.1074/jbc.272.52.33290; Vizcaino J. A., 2014, NAT BIOTECHNOL, V30, P223, DOI [10.1038/nbt.2839, DOI 10.1038/NBT.2839]; Wessels HJCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068340	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	SEP	2015	36	17					1991	2001		10.1002/elps.201400574		11	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CQ6UD	WOS:000360738600001		
J	Jiang, R; Hatano, R; Hill, R; Kuramochi, K; Jiang, T; Zhao, Y				Jiang, Rui; Hatano, Ryusuke; Hill, Robert; Kuramochi, Kanta; Jiang, Tao; Zhao, Ying			Water connectivity in hillslope of upland-riparian zone and the implication for stream nitrate-N export during rain events in an agricultural and forested watershed	ENVIRONMENTAL EARTH SCIENCES			English	Article						Shallow groundwater; Hillslope of upland-riparian zone; Water connectivity; Nitrate-N; Conceptual model	LAND-USE ANALYSIS; BIOGEOCHEMICAL CONTROLS; SPATIAL-PATTERNS; NITROGEN; CATCHMENTS; RUNOFF; GRASSLAND; MECHANISM; HYDROLOGY; QUALITY	Water connectivity in the hillslopes of the upland-riparian zone has environmental implications for stream nitrate-N (NO3 (-)-N) export during rain events. This study was conducted to measure the shallow groundwater table over a hillslope with upland, interface, and riparian forest components and measure the stream NO3 (-)-N concentrations in a 36.6 km(2) agricultural and forested watershed (AFW) in the Shibetsu area of northern Japan from July to November 2009. The groundwater and stream hydrographs at seasonal and rain event scales indicated that the hillslope water connectivity was first established from the riparian forest, and then expanded to the upland after several rain events. The hillslope water connectivity has important implications for NO3 (-)-N export in the watershed since the NO3 (-)-N export may primarily be explained by a flushing mechanism. The NO3 (-)-N export only flushed from riparian forest during the early water connection stage. While in the well water connection stage, the flush of NO3 (-)-N occurred with the subsurface flow from the upland which had a high shallow groundwater table and displayed higher stream NO3 (-)-N concentrations. However, lower stream NO3 (-)-N concentrations occurred during the late water connection stage and indicated that the N source in the upland might be limited due to denitrification and NO3 (-)-N leaching processes. Nevertheless, it was decided that the hydrology and biogeochemical reactions occurring in the upland controlled the stream NO3 (-)-N export. A conceptual model was formulated that explained the impacts of the hillslope water connectivity on the watershed stream NO3 (-)-N export during rain events in early, well, and late water connection stages within the AFW.	[Jiang, Rui; Zhao, Ying] Northwest A&F Univ, Coll Nat Resources & Environm, Key Lab Plant Nutr & Agrienvironm Northwest China, Minist Agr, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Rui; Hatano, Ryusuke; Kuramochi, Kanta] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Hill, Robert] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA; [Jiang, Tao] Southwest Univ, Coll Resources & Environm, Chongqing 400716, Peoples R China	Jiang, R (reprint author), Northwest A&F Univ, Coll Nat Resources & Environm, Key Lab Plant Nutr & Agrienvironm Northwest China, Minist Agr, 3 Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	haixia992000@hotmail.com; yzhao@nwsuaf.edu.cn			National Natural Science Foundation of China [41201279, 41371234]; Fundamental Research Funds for Central Universities [QN2013076]; Ph.D. Start-up Fund of Northwest AF University; Strategic International Cooperative Program "Comparative Study of Nitrogen Cycling and Its Impact on Water Quality in Agricultural Watersheds in Japan and China" by the Japan Science and Technology Agency	This study was supported by the National Natural Science Foundation of China (41201279), the Fundamental Research Funds for Central Universities (QN2013076), the Ph.D. Start-up Fund of Northwest A&F University, National Natural Science Foundation of China (41371234), and the Strategic International Cooperative Program "Comparative Study of Nitrogen Cycling and Its Impact on Water Quality in Agricultural Watersheds in Japan and China" by the Japan Science and Technology Agency.	Agricultural Department of Hokkaido Government, 2002, STAND FERT APPL HOKK; Anderson M. G., 1990, Process studies in hillslope hydrology., P365; Hill AR, 1999, WATER RESOUR RES, V35, P811, DOI 10.1029/1998WR900083; Woli KP, 2004, SCI TOTAL ENVIRON, V329, P61, DOI 10.1016/j.scitotenv.2004.03.006; Hill AR, 1996, J ENVIRON QUAL, V25, P743; Ocampo CJ, 2006, J HYDROL, V331, P643, DOI 10.1016/j.jhydrol.2006.06.010; Creed IF, 1996, WATER RESOUR RES, V32, P3337, DOI 10.1029/96WR02399; Hayakawa A, 2012, ECOL ENG, V47, P92, DOI 10.1016/j.ecoleng.2012.06.034; Schade JD, 2005, J N AM BENTHOL SOC, V24, P19, DOI 10.1899/0887-3593(2005)024<0019:HEANUB>2.0.CO;2; McNamara JP, 2008, HYDROL PROCESS, V22, P3294, DOI 10.1002/hyp.6920; Creed IF, 1998, WATER RESOUR RES, V34, P3105, DOI 10.1029/98WR01924; Burt TP, 2005, PROG PHYS GEOG, V29, P297, DOI 10.1191/0309133305pp450ra; Ocampo CJ, 2006, HYDROL PROCESS, V20, P4269, DOI 10.1002/hyp.6311; Vidon PGF, 2004, J HYDROL, V292, P210, DOI 10.1016/j.jhydrol.2004.01.005; Creed IF, 1998, WATER RESOUR RES, V34, P3079, DOI 10.1029/98WR02102; GERRITSE RG, 1995, WATER RES, V29, P2055, DOI 10.1016/0043-1354(95)00023-E; Hayakawa A, 2006, J ENVIRON QUAL, V35, P617, DOI 10.2134/jeq2005.0343; Inamdar SP, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004212; James AL, 2007, HYDROL PROCESS, V21, P3391, DOI 10.1002/hyp.6554; Jiang R, 2012, CATENA, V97, P1, DOI 10.1016/j.catena.2012.04.015; Jiang R, 2010, SOIL SCI PLANT NUTR, V56, P72, DOI 10.1111/j.1747-0765.2010.00456.x; Lexartza-Artzal Wainwright J, 2009, CATENA, V79, P146; McGlynn BL, 2002, J HYDROL, V257, P1, DOI 10.1016/S0022-1694(01)00559-5; McHale M, 2002, WATER RESOUR RES, V38; Ohrui K, 1998, HYDROL PROCESS, V12, P1433, DOI 10.1002/(SICI)1099-1085(199807)12:9<1433::AID-HYP646>3.0.CO;2-N; Shoji S, 1993, VOLCANIC ASH SOILS G, P1; Tachibana H, 2003, WATER ANAL, P362; Western AW, 2001, WATER RESOUR RES, V37, P83, DOI 10.1029/2000WR900241; Wood E. F., 1999, Integrating hydrology, ecosystems dynamics and biogeochemistry in complex landscapes. Dahlem Workshop, Berlin, Germany, January 18-23 1998., P197	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	SEP	2015	74	5					4535	4547		10.1007/s12665-015-4516-2		13	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CQ2AJ	WOS:000360401400071		
J	Basaham, AS; El Sayed, MA; Ghandour, IM; Masuda, H				Basaham, Ali S.; El Sayed, Mohamed A.; Ghandour, Ibrahim M.; Masuda, Harue			Geochemical background for the Saudi Red Sea coastal systems and its implication for future environmental monitoring and assessment	ENVIRONMENTAL EARTH SCIENCES			English	Article						Geochemical background; Environmental monitoring; Saudi Red Sea coastal lagoons; Calcareous sediments	TRACE-ELEMENTS; SURFACE SEDIMENTS; BASE-LINES; AL-KHARRAR; ARABIA; CONTAMINATION; LAGOON; LEVEL; SOILS	The present study aims at determining a geochemical background for the Red Sea to be a base for future environmental studies along the Saudi Red Sea coastal systems. Eighty-nine bottom sediment samples were collected from three coastal lagoons; Sharm Al-Kharar (47 samples) at the northern terminal of Wadi Rabigh, Al-Shuaiba Lagoon (22 samples) a fossil lagoon about 80 km south of Jeddah and Al-Mejarma Lagoon (20 samples) a back-barrier lagoon about 40 km south of Al-Shuaiba. The mud fraction (< 0.063 mm) was analysed to determine the concentrations of Al, Fe, Mn, V, Cr, Ni, Cu and Zn. The sediments of Sharm Al-Kharar yielded higher elemental concentrations than the other two lagoons. Aluminium (Al) displays significant correlation (r > 0.8) with Fe, Mn, V, Cr, Ni and Zn indicating that these elements are closely associated with the detrital influx. The geochemical background was determined after eliminating the outlier values using the equation median +/- A 2MAD (median absolute deviation) and then calculated descriptive statistics. Minimum values define lower limit of the background, the 98 percentiles define the upper limit and the geometric rather than arithmetic mean was used to define the average value. The calculation of environmental assessment indices using upper continental crust or average shale as background yields low values compared to the values calculated using estimated mean in the present study.	[Basaham, Ali S.; Ghandour, Ibrahim M.] King Abdulaziz Univ, Fac Marine Sci, Marine Geol Dept, Jeddah 21589, Saudi Arabia; [El Sayed, Mohamed A.] King Abdulaziz Univ, Fac Marine Sci, Marine Chem Dept, Jeddah 21589, Saudi Arabia; [Ghandour, Ibrahim M.] Tanta Univ, Fac Sci, Dept Geol, Tanta 31527, Egypt; [Masuda, Harue] Osaka City Univ, Grad Sch Sci, Dept Geosci, Sumiyoshi Ku, Osaka 5588585, Japan	Ghandour, IM (reprint author), King Abdulaziz Univ, Fac Marine Sci, Marine Geol Dept, POB 80207, Jeddah 21589, Saudi Arabia.	ighandour@kau.edu.sa	Ghandour, Ibrahim/H-8101-2012		Deanship of Scientific Research (DSR) King Abdulaziz University, Jeddah [347/150/1433]; DSR	This work was funded by the Deanship of Scientific Research (DSR) King Abdulaziz University, Jeddah, under Grant No. (347/150/1433). The authors therefore, acknowledge with thanks DSR technical and financial support. The authors would like to thank Mr. A. Zubairy, B. Zahrany and S. Anthony (King Abdulaziz University) for their assistance during field works.	Ahmed F, 1992, JKAU MARINE SCI, V3, P3; Ahmed FC, 2002, MULTIDISCIPLINARY OC, P82; Al-Barakati A.M.A., 2010, CANADIAN J COMPUTING, V1, P9; Al-Najjar T., 2011, Natural Science, V3, P775, DOI 10.4236/ns.2011.39102; Al-Sayari SS, 1978, QUATERNARY PERIOD SA; Abu-Zied Ramadan H., 2011, Journal of King Abdulaziz University Marine Sciences, V22, P159, DOI 10.4197/Mar.22-2.9; Pan K, 2011, MAR POLLUT BULL, V62, P1140, DOI 10.1016/j.marpolbul.2011.02.043; Basaham AS, 2008, OCEANOLOGIA, V50, P557; Covelli S, 1997, ENVIRON GEOL, V30, P34; Abu-Zied RH, 2013, ENVIRON EARTH SCI, V68, P451, DOI 10.1007/s12665-012-1751-7; Idris AM, 2008, MICROCHEM J, V90, P159, DOI 10.1016/j.microc.2008.05.004; Savvides C, 1995, WATER SCI TECHNOL, V32, P65, DOI 10.1016/0273-1223(96)00077-7; Ghandour IM, 2014, ENVIRON MONIT ASSESS, V186, P1465, DOI 10.1007/s10661-013-3467-x; Pekey H, 2004, MAR POLLUT BULL, V48, P946, DOI 10.1016/j.marpolbul.2003.11.023; Badr NBE, 2009, ENVIRON MONIT ASSESS, V155, P509, DOI 10.1007/s10661-008-0452-x; Hernandez L, 2003, SCI TOTAL ENVIRON, V312, P195, DOI 10.1016/S0048-9697(03)00223-7; Reimann C, 2005, SCI TOTAL ENVIRON, V350, P12, DOI 10.1016/j.scitotenv.2005.01.047; Basaham AS, 1998, ESTUAR COAST SHELF S, V46, P185, DOI 10.1006/ecss.1997.0278; Reimann C, 2005, SCI TOTAL ENVIRON, V346, P1, DOI 10.1016/j.scitotenv.2004.11.023; Abu-Zied RH, 2013, MAR MICROPALEONTOL, V103, P51, DOI 10.1016/j.marmicro.2013.07.005; Galan E, 2008, J GEOCHEM EXPLOR, V98, P89, DOI 10.1016/j.gexplo.2008.01.001; Basaham AS, 2006, J KING ABDULAZIZ U M, V17, P129, DOI 10.4197/mar.17-1.8; Campbell PGC, 1996, ECOTOXICOLOGY HIERAR, P11; Duplay J, 2012, ENVIRON EARTH SCI, V67, P1201, DOI 10.1007/s12665-012-1566-6; El Sayed M., 2004, J ENVIRON SCI, V27, P57; ELABD YI, 1991, MAR GEOL, V97, P137; El-Sayed MA, 2002, J KING ABDULAZIZ U M, V13, P21, DOI 10.4197/mar.13-1.2; Fedo CM, 1996, GEOCHIM COSMOCHIM AC, V60, P1751, DOI 10.1016/0016-7037(96)00058-0; Furuyama K, 2001, GONDWANA RES, V4, P427, DOI 10.1016/S1342-937X(05)70342-7; Garcia A, 2013, SCI MAR, V77, P91, DOI 10.3989/scimar.03725.27H; Garver J. I., 1993, GEOL SOC AM ABSTR, V25, P17; Mrvic´ V. V., 2010, Journal of Agricultural Sciences, Belgrade, V55, P157, DOI 10.2298/JAS1002157M; Papastergios G, 2010, WATER AIR SOIL POLL, V209, P323, DOI 10.1007/s11270-009-0201-y; Rencz AN, 2011, 6645 GEOL SURV CAN, P40; Rollinson H.R, 1993, USING GEOCHEMICAL DA, P352; Rudnick RL, 2003, TREATISE GEOCHEMISTR, V3, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Sagheer AAA, 2013, J ENV RES, V4, P0242; Salomons W, 1984, METALS HYDROCYCLE, P63; Siegel FR, 2002, ENV GEOCHEMISTRY POT; Skipwith P, 1973, TR1073I DIECT GEN MI; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; Turki A.J., 2007, J KING ABDULAZIZ U M, V18, P191, DOI 10.4197/mar.18-1.11	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	SEP	2015	74	5					4561	4570		10.1007/s12665-015-4477-5		10	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CQ2AJ	WOS:000360401400073		
J	Shin, WS; Fujibayashi, M; Nishimura, O				Shin, Woo-Seok; Fujibayashi, Megumu; Nishimura, Osamu			Spatio-temporal characteristics of the fatty acid compositions of two macrobenthos (Nuttallia olivacea and Hediste sp.) in the Nanakita River estuary, Japan	ENVIRONMENTAL EARTH SCIENCES			English	Article						Fatty acids; Food selectivity; Food web; Macrobenthos; Sediment; Spatial and seasonal variation	ORGANIC-MATTER; FOOD-WEB; TROPHIC INTERACTIONS; ISOTOPE ANALYSES; STABLE-ISOTOPES; FLAT ECOSYSTEM; SEDIMENT; BAY; PHYTOPLANKTON; BIOMARKERS	This study examined species-specific, dietary responses of two benthic macroinvertebrate species, Nuttllia olivacea and Hediste sp., to spatial and seasonal variations of resource composition in an estuarine tidal flat system of north-eastern Japan. This study measured fatty acid (FA) composition of sedimentary organic matter and macroinvertebrate tissue to estimate relative contributions of organic matter originating from different sources. N. olivacea and Hediste sp. are predominated in macrobenthos communities of sandy and muddy sediments in the studied estuary, respectively. The total FA of sedimentary organic matter was significantly related positively to the total organic carbon (TOC) content of sediment. FAs of diatom, bacteria, and terrestrial-plant origins were found higher values in the sediments with higher TOC. The dietary composition of N. olivacea showed both spatial and seasonal variations, but was consistently linked with diatom, bacteria and dinoflagellates in the sediments. Meanwhile, the FA composition of Hediste sp. demonstrated that the diets of this species depended heavily on diatom, bacteria and terrestrial plant. From these results it was revealed that Hediste sp. was more tightly linked with sedimentary organic matter composition compared with N. olivacea. This result indicates that Hediste sp. has a euryphagic diet and is possible to feed on sedimentary organic matter of various sources in natural environments. Both macroinvertebrate species showed different characteristics in terms of using of food resources and its spatial and seasonal variation. It is considered that the difference in feeding dietary habit of macroinvertebrates is one of the important factors which decide the sediment suitability for macrobenthos.	[Shin, Woo-Seok] Hankyong Natl Univ, Inst Marine Sci & Technol Res, Anseong 456749, Gyeonggi Do, South Korea; [Fujibayashi, Megumu; Nishimura, Osamu] Tohoku Univ, Grad Sch Engn, Dept Ecol Engn, Sendai, Miyagi 9808579, Japan	Shin, WS (reprint author), Hankyong Natl Univ, Inst Marine Sci & Technol Res, Anseong 456749, Gyeonggi Do, South Korea.	swooseok@hknu.ac.kr			KAKENHI [21360249]; Environmental Research and Technology Development Fund of Ministry of the Environment, Japan [B-1004]; GRRC program of Gyeonggi province	We also appreciate the help of H. NOMURA, Takashi Sakamaki and Y. NAGAHAMA for preparing and analyzing the fatty acid samples. This research was supported by KAKENHI(21360249) and the Environmental Research and Technology Development Fund(B-1004) of the Ministry of the Environment, Japan. This work was supported by the GRRC program of Gyeonggi province. [(GRRC HANKYONG 2012-B02), Development of An Automatic Picking System with Traveling Dispensers using Linear Motors].	ADMIRAAL W, 1988, ECOL STUD, V71, P105; Akutsu M, 2010, ENV ENG RES, V47, P237; Meyers PA, 1997, ORG GEOCHEM, V27, P213, DOI 10.1016/S0146-6380(97)00049-1; Meziane T, 2000, MAR ECOL PROG SER, V200, P49, DOI 10.3354/meps200049; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; Boschker HTS, 2005, LIMNOL OCEANOGR, V50, P70; VOLKMAN JK, 1980, GEOCHIM COSMOCHIM AC, V44, P1133, DOI 10.1016/0016-7037(80)90067-8; NAPOLITANO GE, 1994, J PHYCOL, V30, P943, DOI 10.1111/j.0022-3646.1994.00943.x; Alfaro AC, 2006, ESTUAR COAST SHELF S, V70, P271, DOI 10.1016/j.ecss.2006.06.017; Yamanaka T, 2013, ESTUAR COAST SHELF S, V126, P87, DOI 10.1016/j.ecss.2013.04.011; Kasai A, 2004, FISHERIES SCI, V70, P11, DOI 10.1111/j.1444-2906.2003.00764.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Meziane T, 1997, J SEA RES, V38, P47, DOI 10.1016/S1385-1101(97)00035-X; Kang CK, 2003, MAR ECOL PROG SER, V259, P79, DOI 10.3354/meps259079; Shi W, 2001, ORG GEOCHEM, V32, P453, DOI 10.1016/S0146-6380(00)00189-3; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; DYE AH, 1986, MAR ECOL PROG SER, V32, P259, DOI 10.3354/meps032259; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Napolitano GE, 1997, BIOCHEM SYST ECOL, V25, P739, DOI 10.1016/S0305-1978(97)00053-7; Yokoyama H, 2005, MAR ECOL PROG SER, V304, P101, DOI 10.3354/meps304101; Doi H, 2005, ESTUAR COAST SHELF S, V64, P316, DOI 10.1016/j.ecss.2005.02.028; Dubois S, 2007, MAR ECOL PROG SER, V336, P151, DOI 10.3354/meps336151; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Meziane T, 2002, J SEA RES, V47, P1, DOI 10.1016/S1385-1101(01)00092-2; Hawkins AJS, 1996, MAR ECOL PROG SER, V131, P179, DOI 10.3354/meps131179; Bhinu VS, 2005, J MOL MICROB BIOTECH, V10, P15, DOI 10.1159/000090344; Cook PLM, 2004, MAR ECOL PROG SER, V280, P55, DOI 10.3354/meps280055; Flemming BW, 2000, CONT SHELF RES, V20, P1179, DOI 10.1016/S0278-4343(00)00018-2; Freites L, 2002, J EXP MAR BIOL ECOL, V268, P185, DOI 10.1016/S0022-0981(01)00377-X; HOPKINSON CS, 1995, ESTUARIES, V18, P598, DOI 10.2307/1352380; Kemp P. F., 1990, AQUAT SCI, V12, P109; Korinkova Tereza, 2011, Malacologica Bohemoslovaca, V10, P1; Prins T. C., 1998, AQUAT ECOL, V31, P349, DOI DOI 10.1023/A:1009924624259; RAJENDRAN N, 1993, MAR CHEM, V42, P39, DOI 10.1016/0304-4203(93)90248-M; Sakamaki T, 2008, CAN J FISH AQUAT SCI, V65, P38, DOI 10.1139/F07-151; Sakamaki T, 2010, ECOSYSTEMS, V13, P328, DOI 10.1007/s10021-010-9321-x; Shin Woo-Seok, 2012, Environmental Engineering Research, V17, P77; Shin WS, 2013, ENV ENG RES, V18, P259; Smith S, 1995, REV GEOPHYS, V31, P75; VISHER GS, 1974, J SEDIMENT PETROL, V44, P502	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	SEP	2015	74	6					5283	5293		10.1007/s12665-015-4602-5		11	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CQ3XM	WOS:000360537700053		
J	Harada, J; Inoue, T; Kato, K; Uraie, N; Sakuragi, H				Harada, June; Inoue, Takashi; Kato, Kunihiko; Uraie, Nana; Sakuragi, Hiroaki			Performance evaluation of hybrid treatment wetland for six years of operation in cold climate	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Hybrid subsurface constructed wetland; Non-domestic sewage; High organic matter; Livestock industry; Dairy milking parlor wastewater; Long term monitoring	FLOW CONSTRUCTED WETLANDS; WASTE-WATER TREATMENT; HORIZONTAL SUBSURFACE FLOW; VERTICAL FLOW; DANISH GUIDELINES; DOMESTIC SEWAGE; SYSTEMS; REMOVAL; DESIGN	In Hokkaido, northern Japan, there are 12 hybrid subsurface constructed wetlands (HSCWs) and most of them are treating high concentrated organic wastewater. One of these systems is an HSCW situated in Embetsu, northern Hokkaido, and it has been in operation since November of 2006 to treat dairy milking parlor wastewater. The system is composed of two vertical flow beds and a horizontal flow bed. The influent and the effluent flow rates and pollutant concentrations and loads were extremely variable. Throughout its 6 years of operation, most of the pollutant removals were decently high. Removal efficiencies for COD, BOD5, and SS were ranging in the 90 %. Removal efficiencies for TN, NH4-N, and BOD5 were improving because of the development of the soil ecosystem and the Phragmites australis community. However, the removal efficiencies of TP were decreasing, presumably because of the declining adsorption ability. The accumulation of TP in the first and the second vertical beds had reached its plateau. Vertical beds had high removal efficiencies for TN, COD, BOD5, and SS. These high removal efficiencies of the first vertical bed may be caused from the efficient removal of solid material that is deposited as an organic layer of the first vertical bed. High NH4-N removal efficiencies exerted by the second vertical bed may be due to the recycling of wastewater. In conclusion, the HSCW was working excellently for its 6 years of operation, and it could be concluded that it has not reached its life yet.	[Harada, June; Inoue, Takashi; Uraie, Nana; Sakuragi, Hiroaki] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Kato, Kunihiko] Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan	Inoue, T (reprint author), Hokkaido Univ, Grad Sch Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	tino@env.agr.hokudai.ac.jp; katokuni@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries, Japan	We would like to express our sincere appreciation to the Ministry of Agriculture, Forestry and Fisheries, Japan for their financial support and the owner of the dairy farm in Embetsu in order to carry out our research.	O'Hogain S, 2003, WATER SCI TECHNOL, V48, P119; Arias CA, 2001, WATER RES, V35, P1159, DOI 10.1016/S0043-1354(00)00368-7; Sharma PK, 2013, ECOL ENG, V57, P216, DOI 10.1016/j.ecoleng.2013.04.031; Vymazal J, 2011, ECOL ENG, V37, P90, DOI 10.1016/j.ecoleng.2010.03.004; Brix H, 2005, WATER SCI TECHNOL, V51, P1; Comino E, 2013, ECOL ENG, V54, P165, DOI 10.1016/j.ecoleng.2013.01.027; Brix H, 2005, ECOL ENG, V25, P491, DOI 10.1016/j.ecoleng.2005.07.009; Molle P, 2005, WATER SCI TECHNOL, V51, P11; Ayaz SC, 2012, ECOL ENG, V40, P1, DOI 10.1016/j.ecoleng.2011.12.028; Vymazal J, 2005, ECOL ENG, V25, P478, DOI 10.1016/j.ecoleng.2005.07.010; Kato K, 2013, WATER SCI TECHNOL, V68, P1468, DOI 10.2166/wst.2013.364; Molle P, 2008, ECOL ENG, V34, P23, DOI 10.1016/j.ecoleng.2008.05.016; Platzer C, 1999, WATER SCI TECHNOL, V40, P257, DOI 10.1016/S0273-1223(99)00420-5; Comino E, 2011, ECOL ENG, V37, P1673, DOI 10.1016/j.ecoleng.2011.06.048; Vymazal J, 2007, SCI TOTAL ENVIRON, V380, P48, DOI 10.1016/j.scitotenv.2006.09.014; [Anonymous], 1992, STANDARD METHODS EXA; Reeb G, 2005, NATURAL AND CONSTRUCTED WETLANDS: NUTRIENTS, METALS AND MANAGEMENT, P43; Tanner CC, 2001, WATER SCI TECHNOL, V44, P9; Drizo A, 1999, WATER RES, V33, P3595, DOI 10.1016/S0043-1354(99)00082-2; Carvalho OE, 2013, BIORESOURCE TECHNOL, V134, P412, DOI [10.1016/j.biortech.2013.02.027, DOI 10.1016/J.BIORTECH.2013.02.027]; FAO, 2006, LIV LONG SHAD; IWA Specialist Group on use of Macrophytes inWater Pollution Control, 2000, CONSTR WETL POLL CON; Kantawanichkul S, 2003, WATER SCI TECHNOL, V48, P199; Mantovi P, 2003, BIORESOURCE TECHNOL, V88, P85, DOI 10.1016/S0960-8524(02)00291-2; Ministry of Agriculture Forestry and Fisheries, 2010, STAT NUMB COMPL REL; Molle P, 2014, WATER SCI TECHNOL, V69, P106, DOI 10.2166/wst.2013.561; Obarska-Pempkowiak H, 2003, POL J ENVIRON STUD, V12, P739; Sharma PK, 2011, WATER PRACTICE TECHN, V6, DOI [10.2166/wpt.2011.052, DOI 10.2166/WPT.2011.052]	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	SEP	2015	22	17					12861	12869		10.1007/s11356-014-3843-2		9	Environmental Sciences	Environmental Sciences & Ecology	CQ0TZ	WOS:000360311500008		
J	Li, XD; Yang, Z; Fu, PQ; Yu, J; Lang, YC; Liu, D; Ono, K; Kawamura, K				Li, Xiao-dong; Yang, Zhou; Fu, Pingqing; Yu, Jing; Lang, Yun-chao; Liu, Di; Ono, Kaori; Kawamura, Kimitaka			High abundances of dicarboxylic acids, oxocarboxylic acids, and alpha-dicarbonyls in fine aerosols (PM2.5) in Chengdu, China during wintertime haze pollution	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Dicarboxylic acids; Oxocarboxylic acids; alpha-dicarbonyls; Urban aerosols; Sichuan Basin	CARBON ISOTOPIC COMPOSITIONS; PARTICULATE ORGANIC-MATTER; AROMATIC-HYDROCARBONS PAHS; KETOCARBOXYLIC ACIDS; SIZE-DISTRIBUTIONS; AIR-POLLUTION; OXALIC-ACID; AMBIENT AIR; LOS-ANGELES; HONG-KONG	Daytime and nighttime fine aerosol (PM2.5) samples were collected during a haze episode in January 2013 within the urban area of Chengdu, southwest China. Aerosol samples were analyzed for low-molecular-weight homologous dicarboxylic acids, oxocarboxylic acids and alpha-dicarbonyls, as well as organic carbon and elemental carbon. Concentration ranges of diacids, oxoacids, and alpha-dicarbonyls were 1,400-5,250, 272-1,380, and 88-220 ng m(-3), respectively. Molecular distributions of diacids (mean 3,388 +/- 943 ng m(-3)) were characterized by a predominance of oxalic acid (C-2; 1,373 +/- 427 ng m(-3)), followed by succinic (C-4), terephthalic (tPh), and phthalic (Ph) acids. Such high levels of tPh and Ph were different from those in other Asian cities where malonic acid (C-3) is the second or third highest species, mostly owing to significant emissions from coal combustion and uncontrolled waste incineration. High contents of diacids, oxoacids, and alpha-dicarbonyls were detected on hazy days, suggesting an enhanced emission and/or formation of these organics during such a weather condition. Concentrations of unsaturated aliphatic diacids (e.g., maleic acid) and phthalic acids were higher in nighttime than in daytime. Good positive correlations of C-2 with C-3, C-4, ketomalonic (kC(3)), pyruvic (Pyr), and glyoxylic (E center dot C-2) acids in daytime suggest secondary production of C-2 via the photooxidation of longer chain diacids and E center dot C-2. This study demonstrated that both primary emissions and secondary production are important sources of dicarboxylic acids and related compounds in atmospheric aerosols in the Sichuan Basin.	[Li, Xiao-dong; Yang, Zhou; Lang, Yun-chao] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang 550002, Peoples R China; [Fu, Pingqing] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing 100029, Peoples R China; [Yu, Jing] Chengdu Univ Technol, State Key Lab Geohazard Prevent & Geoenvironm, Chengdu 610059, Peoples R China; [Liu, Di] Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochem, Guangzhou 510640, Guangdong, Peoples R China; [Ono, Kaori; Kawamura, Kimitaka] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Yang, Zhou] Grad Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Fu, PQ (reprint author), Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing 100029, Peoples R China.	fupingqing@mail.iap.ac.cn	Fu, Pingqing/G-4863-2013; Kawamura, Kimitaka/B-3839-2011	Fu, Pingqing/0000-0001-6249-2280; 	National Natural Science Foundation of China [41173022, 41175106]; West Light Foundation of the Chinese Academy of Sciences; Chinese Academy of Sciences [XDB05030305]; Japan Society for the Promotion of Science (JSPS) [24221001]; "One Hundred Talents" program of the Chinese Academy of Sciences	This work was financially supported by the National Natural Science Foundation of China (Grant No. 41173022, 41175106), the West Light Foundation of the Chinese Academy of Sciences, and the "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences (Grant No. XDB05030305). This study was also in part supported by Grant-in-aid No. 24221001 from the Japan Society for the Promotion of Science (JSPS). P.F. appreciates the financial support from the "One Hundred Talents" program of the Chinese Academy of Sciences. The authors thank Mr. Lv Long for his help during sample collection. All data presented in this paper are freely available upon request.	Alier M, 2014, ENVIRON SCI POLLUT R, V21, P11649, DOI 10.1007/s11356-013-2460-9; Robinson AL, 2006, ENVIRON SCI TECHNOL, V40, P7820, DOI 10.1021/es060781p; Perrone MG, 2013, ENVIRON POLLUT, V176, P215, DOI 10.1016/j.envpol.2013.01.012; Huang XF, 2005, ATMOS ENVIRON, V39, P2819, DOI 10.1016/j.atmosenv.2004.08.038; Mkoma SL, 2013, ATMOS CHEM PHYS, V13, P2235, DOI 10.5194/acp-13-2235-2013; Jung JS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014339; Jung J, 2009, J ENVIRON MANAGE, V90, P3231, DOI 10.1016/j.jenvman.2009.04.021; Wang Y, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037181; Crahan KK, 2004, ATMOS ENVIRON, V38, P3757, DOI 10.1016/j.atmosenv.2004.04.009; Huebert BJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003550; Wang Y, 2007, ATMOS RES, V84, P169, DOI 10.1016/j.atmosres.2006.07.001; Kawamura K, 1996, ATMOS ENVIRON, V30, P1709, DOI 10.1016/1352-2310(95)00395-9; Liu YJ, 2001, ENVIRON SCI TECHNOL, V35, P840, DOI 10.1021/es001354t; Narukawa M, 1999, GEOPHYS RES LETT, V26, P3101, DOI 10.1029/1999GL010810; Bunce NJ, 1997, ENVIRON SCI TECHNOL, V31, P2252, DOI 10.1021/es960813g; Kawamura K, 2005, ATMOS ENVIRON, V39, P1945, DOI 10.1016/j.atmosenv.2004.12.014; Huang XF, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007408; Kawamura K, 2013, ATMOS CHEM PHYS, V13, P8285, DOI 10.5194/acp-13-8285-2013; KAWAMURA K, 1993, ANAL CHEM, V65, P3505, DOI 10.1021/ac00071a030; He LY, 2004, ATMOS ENVIRON, V38, P6557, DOI 10.1016/j.atmosenv.2004.08.034; Carlton AG, 2007, ATMOS ENVIRON, V41, P7588, DOI 10.1016/j.atmosenv.2007.05.035; Fu PQ, 2010, ATMOS CHEM PHYS, V10, P2663; Kawamura K, 1999, J GEOPHYS RES-ATMOS, V104, P3501, DOI 10.1029/1998JD100041; Watson JG, 2001, CHEMOSPHERE, V43, P1141, DOI 10.1016/S0045-6535(00)00171-5; KAWAMURA K, 1993, ENVIRON SCI TECHNOL, V27, P2227, DOI 10.1021/es00047a033; Wang G, 2009, ATMOS CHEM PHYS, V9, P8869; ROGGE WF, 1991, ENVIRON SCI TECHNOL, V25, P1112, DOI 10.1021/es00018a015; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Guo S, 2010, ATMOS CHEM PHYS, V10, P947; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Ebelt ST, 2005, EPIDEMIOLOGY, V16, P396, DOI 10.1097/01.ede.0000158918.57071.3e; Ho KF, 2006, ATMOS ENVIRON, V40, P3030, DOI 10.1016/j.atmosenv.2005.11.069; Ma SX, 2010, ATMOS RES, V98, P176, DOI 10.1016/j.atmosres.2010.07.003; Miyazaki Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014439; SINGH HB, 1985, ATMOS ENVIRON, V19, P1911, DOI 10.1016/0004-6981(85)90017-4; KAWAMURA K, 1987, ENVIRON SCI TECHNOL, V21, P105, DOI 10.1021/es00155a014; Kim HS, 2007, ATMOS ENVIRON, V41, P6762, DOI 10.1016/j.atmosenv.2007.04.060; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Jung J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010337; Li YC, 2010, ENVIRON CHEM, V7, P338, DOI 10.1071/EN09167; Kundu S, 2010, ATMOS CHEM PHYS, V10, P2209; Saarikoski S, 2008, ATMOS CHEM PHYS, V8, P6281; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Sandradewi J, 2008, ENVIRON SCI TECHNOL, V42, P3316, DOI 10.1021/es702253m; Ho KF, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013304; Cao JJ, 2013, ATMOS CHEM PHYS, V13, P803, DOI 10.5194/acp-13-803-2013; Wang GH, 2012, ENVIRON SCI TECHNOL, V46, P4783, DOI 10.1021/es204322c; Pavuluri CM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012661; Buxton GV, 1997, J CHEM SOC FARADAY T, V93, P2889, DOI 10.1039/a701468f; Ye BM, 2003, ATMOS ENVIRON, V37, P499, DOI 10.1016/S1352-2310(02)00918-4; Aggarwal SG, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009365; Chen Bingheng, 2008, Environmental Health and Preventive Medicine, V13, P94, DOI 10.1007/s12199-007-0018-5; [Anonymous], 2004, J GEOPHYS RES, DOI DOI 10.1029/2003JD004387; Yang F, 2011, ATMOS CHEM PHYS, V11, P7893, DOI 10.5194/acp-11-7893-2011; Rinaldi M, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015659; Yu JZ, 2005, ENVIRON SCI TECHNOL, V39, P128, DOI 10.1021/es049559f; Schlesinger RB, 2007, INHAL TOXICOL, V19, P811, DOI 10.1080/08958370701402382; Liggio J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005113; Suh I, 2003, J AM CHEM SOC, V125, P12655, DOI 10.1021/ja0350280; Beckerman BS, 2013, ENVIRON SCI TECHNOL, V47, P7233, DOI 10.1021/es400039u; Zhao YL, 2007, ENVIRON SCI TECHNOL, V41, P99, DOI 10.1021/es0614518; Warneck P, 2003, ATMOS ENVIRON, V37, P2423, DOI 10.1016/S1352-2310(03)00136-5; Hegde P, 2012, ATMOS CHEM PHYS, V12, P6645, DOI 10.5194/acp-12-6645-2012; Jang MS, 2002, SCIENCE, V298, P814, DOI 10.1126/science.1075798; CACHIER H, 1989, NATURE, V340, P371, DOI 10.1038/340371a0; Charbouillot T, 2012, ATMOS ENVIRON, V56, P1, DOI 10.1016/j.atmosenv.2012.03.079; Cheng CL, 2013, ATMOS ENVIRON, V81, P443, DOI 10.1016/j.atmosenv.2013.09.013; Deng Li-qun, 2012, China Environmental Science, V32; Fisseha R, 2004, ANAL CHEM, V76, P6535, DOI 10.1021/ac048975f; Fu P, 2013, MAR CHEM, V148, P22, DOI 10.1016/j.marchem.2012.11.002; GROSJEAN D, 1984, JAPCA J AIR WASTE MA, V34, P537; Ho KF, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008011; Ho KF, 2011, ATMOS CHEM PHYS, V11, P2197, DOI 10.5194/acp-11-2197-2011; Kawamura K, 1996, ATMOS ENVIRON, V30, P1035, DOI 10.1016/1352-2310(95)00404-1; Kawamura K, 2005, ATMOS ENVIRON, V39, P599, DOI 10.1016/j.atmosenv.2004.10.020; Kawamura K, 2010, ATMOS ENVIRON, V44, P5320, DOI 10.1016/j.atmosenv.2010.09.016; Kroll JH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006004; Lee SC, 2001, ATMOS ENVIRON, V35, P5949, DOI 10.1016/S1352-2310(01)00374-0; Lei HC, 1997, ATMOS ENVIRON, V31, P851; Li Y., 2003, BASIN RES, V15, P117, DOI DOI 10.1046/J.1365-2117.2003.00197.X; Miyazaki Y, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011790; Miyazaki Y, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011736; Nirmalkar J, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-11014-13416-11354, DOI 10.1007/S11356-11014-13416-11354]; Osborne JM, 2014, NATURE CLIMATE CHANG; [陶俊 Tao Jun], 2011, [环境科学学报, Acta Scientiae Circumstantiae], V31, P2756; Volkamer R, 2001, J PHYS CHEM A, V105, P7865, DOI 10.1021/jp010152w; Wang GH, 2002, ATMOS ENVIRON, V36, P1941, DOI 10.1016/S1352-2310(02)00180-2; Wang GH, 2009, ENVIRON SCI TECHNOL, V43, P6493, DOI 10.1021/es803086g; Wang GH, 2005, ENVIRON SCI TECHNOL, V39, P7430, DOI 10.1021/es051055+; [王淑兰 Wang Shulan], 2004, [地理科学, Scientia Geographica Sinica], V24, P488; Yao XH, 2003, ATMOS ENVIRON, V37, P3001, DOI 10.1016/S1352-2310(03)00256-5; Zimmermann J, 1996, ATMOS ENVIRON, V30, P1255, DOI 10.1016/1352-2310(95)00417-3	92	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	SEP	2015	22	17					12902	12918		10.1007/s11356-015-4548-x		17	Environmental Sciences	Environmental Sciences & Ecology	CQ0TZ	WOS:000360311500013		
J	Ohba, C; Kato, M; Takahashi, N; Osaka, H; Shiihara, T; Tohyama, J; Nabatame, S; Azuma, J; Fujii, Y; Hara, M; Tsurusawa, R; Inoue, T; Ogata, R; Watanabe, Y; Togashi, N; Kodera, H; Nakashima, M; Tsurusaki, Y; Miyake, N; Tanaka, F; Saitsu, H; Matsumoto, N				Ohba, Chihiro; Kato, Mitsuhiro; Takahashi, Nobuya; Osaka, Hitoshi; Shiihara, Takashi; Tohyama, Jun; Nabatame, Shin; Azuma, Junji; Fujii, Yuji; Hara, Munetsugu; Tsurusawa, Reimi; Inoue, Takahito; Ogata, Reina; Watanabe, Yoriko; Togashi, Noriko; Kodera, Hirofumi; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Tanaka, Fumiaki; Saitsu, Hirotomo; Matsumoto, Naomichi			De novo KCNT1 mutations in early-onset epileptic encephalopathy	EPILEPSIA			English	Article						KCNT1; De novo mutation; Epilepsy of infancy with migrating focal seizures; Early onset epileptic encephalopathies	MIGRATING PARTIAL SEIZURES; INFANCY; GENES; SLACK; GAIN	KCNT1 mutations have been found in epilepsy of infancy with migrating focal seizures (EIMFS; also known as migrating partial seizures in infancy), autosomal dominant nocturnal frontal lobe epilepsy, and other types of early onset epileptic encephalopathies (EOEEs). We performed KCNT1-targeted next-generation sequencing (207 samples) and/or whole-exome sequencing (229 samples) in a total of 362 patients with Ohtahara syndrome, West syndrome, EIMFS, or unclassified EOEEs. We identified nine heterozygous KCNT1 mutations in 11 patients: nine of 18 EIMFS cases (50%) in whom migrating foci were observed, one of 180 West syndrome cases (0.56%), and one of 66 unclassified EOEE cases (1.52%). KCNT1 mutations occurred de novo in 10 patients, and one was transmitted from the patient's mother who carried a somatic mosaic mutation. The mutations accumulated in transmembrane segment 5 (2/9, 22.2%) and regulators of K+ conductance domains (7/9, 77.8%). Five of nine mutations were recurrent. Onset ages ranged from the neonatal period (<1month) in five patients (5/11, 45.5%) to 1-4months in six patients (6/11, 54.5%). A generalized attenuation of background activity on electroencephalography was seen in six patients (6/11, 54.5%). Our study demonstrates that the phenotypic spectrum of de novo KCNT1 mutations is largely restricted to EIMFS.	[Ohba, Chihiro; Kodera, Hirofumi; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Ohba, Chihiro; Tanaka, Fumiaki] Yokohama City Univ, Dept Clin Neurol & Stroke Med, Yokohama, Kanagawa 2360004, Japan; [Kato, Mitsuhiro; Takahashi, Nobuya] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Div Neurol, Clin Res Inst, Yokohama, Kanagawa, Japan; [Osaka, Hitoshi] Jichi Med Sch, Dept Pediat, Shimotsuke, Tochigi, Japan; [Shiihara, Takashi] Gunma Childrens Med Ctr, Dept Neurol, Shibukawa, Japan; [Tohyama, Jun] Nishi Niigata Chuo Natl Hosp, Dept Pediat, Epilepsy Ctr, Niigata, Japan; [Nabatame, Shin; Azuma, Junji] Osaka Univ, Grad Sch Med, Dept Pediat, Osaka, Japan; [Fujii, Yuji] Hiroshima Univ Hosp, Dept Pediat, Hiroshima, Japan; [Hara, Munetsugu] St Marys Hosp, Med Ctr Maternal & Child Hlth, Dept Neonatol, Kurume, Fukuoka, Japan; [Hara, Munetsugu; Watanabe, Yoriko] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan; [Tsurusawa, Reimi; Inoue, Takahito] Fukuoka Univ, Chikushi Hosp, Dept Pediat, Fukuoka 81401, Japan; [Ogata, Reina] Fukuoka Childrens Hosp, Dept Pediat Neurol, Fukuoka, Japan; [Togashi, Noriko] Miyagi Childrens Hosp, Dept Neurol, Sendai, Miyagi, Japan	Saitsu, H (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hsaitsu@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp			Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science [25293085, 25293235, 13313587, 24591500]; Takeda Science Foundation; Fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; Strategic Research Program for Brain Sciences [11105137]; Ministry of Education, Culture, Sports, Science and Technology of Japan [12024421]	We are grateful to the patients and their families for their participation in this study. We thank Nobuko Watanabe, Kiyomi Masuko, and Sayaka Sasamoto for their excellent technical assistance. This work was supported by the Ministry of Health, Labour and Welfare of Japan; the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (B) from (25293085, 25293235), Grant-in-Aid for Scientific Research (A) (13313587), and Grant-in-Aid for Scientific Research (C) (24591500)]; the Takeda Science Foundation; the Fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems (N. Matsumoto) from the Japan Science and Technology Agency; the Strategic Research Program for Brain Sciences (11105137); and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (12024421).	Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Mastrangelo M, 2012, PEDIATR NEUROL, V46, P24, DOI 10.1016/j.pediatrneurol.2011.11.003; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Milligan CJ, 2014, ANN NEUROL, V75, P581, DOI 10.1002/ana.24128; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Ishii A, 2013, GENE, V531, P467, DOI 10.1016/j.gene.2013.08.096; Igelstrom KM, 2013, NEUROSCIENTIST, V19, P248, DOI 10.1177/1073858412446311; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; McTague A, 2013, BRAIN, V136, P1578, DOI 10.1093/brain/awt073; Berg AT, 2005, EPILEPSIA, V51, P676, DOI DOI 10.1111/J.1528-1167.2010; Kaczmarek LK, 2013, ISRN NEUROSCI, V2013; Vanderver A, 2014, PEDIATR NEUROL, V50, P112, DOI 10.1016/j.pediatrneurol.2013.06.024	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	SEP	2015	56	9					E121	E128		10.1111/epi.13072		8	Clinical Neurology	Neurosciences & Neurology	CQ7PF	WOS:000360795400002		
J	Tian, FJ; Li, CY; Wang, X; Ren, SX; Li, N; Liu, Q; Zhou, SF; Lu, Y; Zhao, D; Chen, XJ				Tian, Fengjie; Li, Cuiyun; Wang, Xin; Ren, Shuangxia; Li, Ning; Liu, Qi; Zhou, Sufeng; Lu, Yang; Zhao, Di; Chen, Xijing			Comparative study on pharmacokinetics of a series of anticholinergics, atropine, anisodamine, anisodine, scopolamine and tiotropium in rats	EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Pharmacokinetics; Anticholinergics; Atropine-like drugs; Tiotropium	TANDEM MASS-SPECTROMETRY; OBSTRUCTIVE PULMONARY-DISEASE; LIQUID-CHROMATOGRAPHY; METABOLITES; ALKALOIDS; BROMIDE; PLASMA; DOG	The compound series of traditional anticholinergics [atropine (Atr), anisodamine (Ani), anisodine (AT3), and scopolamine (Sco)], naturally occurring belladonna alkaloid, have been approved for numerous therapeutic uses since 1970s. Tiotropium, a novel M receptor antagonist for the treatment of chronic obstructive pulmonary disease, was structurally modified based on atropine-like drugs. Clinical phenomena suggested that the changes of substituent group were related to the pharmacokinetic and pharmacodynamic characteristics of the agents. In an attempt to compare the pharmacokinetics of the series of anticholinergics and investigate the subsets motivating selective anticholinergic potencies, a sensitive LC-MS/MS method was established to analyze the differences of pharmacokinetic parameters. In this paper, we determined the pharmacokinetics of atropine, anisodamine, anisodine, scopolamine, and tiotropium after i.v. and i.g. single dose administration. After i.v. administration, the maximum drug plasma concentrations (C (max)) of Atr, Ani, AT3, and Sco were 274.25 +/- A 53.66, 267.50 +/- A 33.16, 340.50 +/- A 44.52, and 483.75 +/- A 78.13 ng/mL. Tiotropium had a slightly higher area under the curve with a significant increase of C (max) value. Because of their partial solubility, Atr, Ani, AT3, and Sco had different bioavailability in rats of 21.62, 10.78, 80.45 and 2.52 %, respectively. Following i.g. administration of tiotropium, the C (max) value below 20 ng/mL revealed the very low oral absorption. The urinary excretion rates of Atr, Ani, AT3, Sco and tiotropium were 11.33, 54.86, 32.67, 8.69 and 73.91 %. This work provided relatively comprehensive preclinical data on the series of anticholinergics, which may be used to explain the clinical adverse effects and applications.	[Tian, Fengjie; Li, Cuiyun; Wang, Xin; Ren, Shuangxia; Li, Ning; Liu, Qi; Zhou, Sufeng; Zhao, Di; Chen, Xijing] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China; [Lu, Yang] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa 9201192, Japan	Zhao, D (reprint author), China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China.	zhaodihehe@126.com; chenxj-lab@hotmail.com					Abdine HH, 2003, PROFILES DRUG SUBST, V30, P117; Poupko JM, 2007, J APPL TOXICOL, V27, P116, DOI 10.1002/jat.1154; Koumis T, 2005, CLIN THER, V27, P377, DOI 10.1016/j.clinthera.2005.04.006; Cardillo AB, 2010, PLANTA MED, V76, P402, DOI 10.1055/s-0029-1186164; [陈怀侠 Chen Huixia], 2006, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V26, P1369; Chen H, 2007, J CHIN MASS SPECTROM, V67, P984; [陈怀侠 CHEN Huai-xia], 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P719; Chen H, 2006, YAO XUE XUE BAO, V41, P1178; Chen HX, 2005, J CHROMATOGR B, V824, P21, DOI 10.1016/j.jchromb.2005.07.036; Chen HX, 2007, J PHARMACEUT BIOMED, V44, P773, DOI 10.1016/j.jpba.2007.01.038; Ding L, 2008, J CHROMATOGR SCI, V46, P445; Duan Yu-xiang, 2011, Zhongguo Xinyao yu Linchuang Zazhi, V30, P809; Gaire Bhakta Prasad, 2013, J Integr Med, V11, P73, DOI 10.3736/jintegrmed2013016; Gombar VK, 2013, J CHEM INF MODEL, V53, P948, DOI 10.1021/ci400001u; [黄莹 HUANG Ying], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P1214; Jiang B, 2010, BIOMED CHROMATOGR, V24, P490, DOI 10.1002/bmc.1316; Leusch A, 2001, BIOPHARM DRUG DISPOS, V22, P199, DOI 10.1002/bdd.280; Mittra S, 2001, ACTA PHARMACOL SIN, V22, P37; Pan SY, 2000, ACTA PHARMACOL SIN, V21, P124; Scullion Jane E, 2007, Int J Chron Obstruct Pulmon Dis, V2, P33, DOI 10.2147/copd.2007.2.1.33; Sun L, 2012, ACTA PHARMACOL SIN, V33, P761, DOI 10.1038/aps.2012.26; WANG PY, 1993, FEBS LETT, V332, P193, DOI 10.1016/0014-5793(93)80511-R; Xu ZP, 2011, INT IMMUNOPHARMACOL, V11, P260, DOI 10.1016/j.intimp.2010.12.001; Zhang WW, 2008, NEUROSCI LETT, V443, P241, DOI 10.1016/j.neulet.2008.07.048	24	1	1	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0378-7966	2107-0180		EUR J DRUG METAB PH	Eur. J. Drug Metabol. Pharmacokinet.	SEP	2015	40	3					245	253		10.1007/s13318-014-0192-y		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4IU	WOS:000360569100001		
J	Miyazaki, M; Kawase, T; Nishimura, C; Kitamura, T; Iwanaga, K; Kakemi, M				Miyazaki, Makoto; Kawase, Tomoko; Nishimura, Chisako; Kitamura, Tomoko; Iwanaga, Kazunori; Kakemi, Masawo			Pharmacokinetics and toxicity of repeated oral etoposide is altered by morphine coadministration in rats	EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Drug-drug interaction; Etoposide; Morphine; P-glycoprotein; Repeated oral dose; Bioavailability	P-GLYCOPROTEIN; INTESTINAL-ABSORPTION; EFFLUX; MODEL	The influence of morphine (MOR) on the pharmacokinetics and toxicity of repeated etoposide (ETP) oral administration was evaluated in rats. A decrease in the number of leukocytes in blood was observed by 5 days of treatment with ETP (30 mg/kg/day), which was prolonged by oral MOR coadministration (30 mg/kg/day). Furthermore, MOR significantly decreased animal viability. During the dosing period, the individual plasma ETP concentrations decreased at every dose. These doses were used to estimate the individual pharmacokinetic parameters by the Bayesian method using a linear 2-compartment model with a first-order kinetic absorption and the population parameters reported in our previous study. As a result, repeated ETP dosing without MOR showed a significant decrease in the intestinal absorption rate constant (ka), and single MOR coadministration induced an increase in bioavailability (F) and decrease in ka. However, repeated coadministration of ETP suppressed the increase of F by MOR, and the dose-normalized area under the concentration-time curve was not significantly decreased. The estimated trough concentration in the final day of coadministration was significantly higher than that of the control treatment and indicated a prolonged exposure time. These changes in the absorption of ETP may be closely related to variation in P-glycoprotein (P-gp) activity in the intestine and indicate that the pharmacokinetics and toxicity of ETP are altered by repeated oral coadministration of MOR.	[Miyazaki, Makoto; Kawase, Tomoko; Nishimura, Chisako; Kitamura, Tomoko; Iwanaga, Kazunori; Kakemi, Masawo] Osaka Univ Pharmaceut Sci, Dept Pharmaceut, Takatsuki, Osaka 5691094, Japan	Miyazaki, M (reprint author), Osaka Univ Pharmaceut Sci, Dept Pharmaceut, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	miyazaki@gly.oups.ac.jp			"High-Tech Research Center" Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by a "High-Tech Research Center" Project for Private Universities and a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Friberg LE, 2000, J PHARMACOL EXP THER, V295, P734; SLEVIN ML, 1989, J CLIN ONCOL, V7, P1333; Krzyzanski W, 2002, J PHARMACOKINET PHAR, V29, P311, DOI 10.1023/A:1020984823092; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277; Fujita-Hamabe W, 2012, J PHARM PHARMACOL, V64, P496, DOI 10.1111/j.2042-7158.2011.01426.x; Machavaram KK, 2004, PHARMAZIE, V59, P957; Miyazaki M, 2014, BIOL PHARM BULL, V37, P371; Nishimura T, 2008, PHARM RES-DORDR, V25, P2467, DOI 10.1007/s11095-008-9658-4; Okura T, 2009, BIOL PHARM BULL, V32, P1571; Wandel C, 2002, ANESTHESIOLOGY, V96, P913, DOI 10.1097/00000542-200204000-00019	10	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0378-7966	2107-0180		EUR J DRUG METAB PH	Eur. J. Drug Metabol. Pharmacokinet.	SEP	2015	40	3					335	341		10.1007/s13318-014-0212-y		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4IU	WOS:000360569100011		
J	Ishino, T; Takeno, S; Hirakawa, K				Ishino, Takashi; Takeno, Sachio; Hirakawa, Katsuhiro			Novel NOG mutation in Japanese patients with stapes ankylosis with broad thumbs and toes	EUROPEAN JOURNAL OF MEDICAL GENETICS			English	Article						NOG; Mutation; Conformation; Phenotype; p.C228G; SYNS1; SABTT	MULTIPLE-SYNOSTOSIS SYNDROME; AUDIO-SYMPHALANGISM SYNDROME; TEUNISSEN-CREMERS-SYNDROME; GENE-ENCODING NOGGIN; PROXIMAL SYMPHALANGISM; OTOSCLEROSIS; NONSENSE; FAMILY; GROWTH	Human noggin (NOG) gene mutation causes multiple bony disorders showing up as stapes ankylosis with broad thumbs and toes (SABTT), proximal symphalangism (SYM1), multiple synostoses syndrome 1 (SYNS1), tarsal-carpal coalition syndrome (TCC) and brachydactyly type B2 (BDB2). These phenotypes are defined as NOG-related syndromes with the same mutation. Some of these syndromes feature stapes ankylosis as one of the several bony symptoms. Here, we report a Japanese family with conductive hearing loss due to congenital stapes ankylosis. This family showed multiple features and was diagnosed with SABTT. We performed analysis of the NOG in the family by direct sequence analysis, and found a novel NOG mutation: c.682 T> G (p.C228G). Our results and a review of previous cases with NOG protein conformation suggest that this mutated NOG protein lead to a change in antagonist activity in BMPs and/or a haploinsufficiency that likely impaired finger 2 structure. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Ishino, Takashi; Takeno, Sachio; Hirakawa, Katsuhiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Otorhinolaryngol Head & Neck Surg, Minami Ku, Hiroshima, Hiroshima 7348551, Japan	Ishino, T (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Otorhinolaryngol Head & Neck Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan.	takashiishino@hotmail.com					Kosaki K, 2004, FERTIL STERIL, V81, P1137, DOI 10.1016/j.fertnstert.2003.08.054; Hwang CH, 2008, HUM MOL GENET, V17, P844, DOI 10.1093/hmg/ddm356; Dixon ME, 2001, GENET MED, V3, P349, DOI 10.1097/00125817-200109000-00004; DASILVA EO, 1984, AM J MED GENET, V18, P237, DOI 10.1002/ajmg.1320180208; Potti TA, 2011, HUM MUTAT, V32, P877, DOI 10.1002/humu.21515; Dawson K, 2006, AM J HUM GENET, V78, P708, DOI 10.1086/503204; Krause C, 2011, INT J BIOCHEM CELL B, V43, P478, DOI 10.1016/j.biocel.2011.01.007; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; Gong YQ, 1999, NAT GENET, V21, P302; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Debeer P, 2004, AM J MED GENET A, V128A, P439, DOI 10.1002/agmj.a.30152; Lehmann K, 2007, AM J HUM GENET, V81, P388, DOI 10.1086/519697; Takahashi T, 2001, CLIN GENET, V60, P447, DOI 10.1034/j.1399-0004.2001.600607.x; Brown DJ, 2002, AM J HUM GENET, V71, P618, DOI 10.1086/342067; Csomor P, 2012, ACTA OTO-LARYNGOL, V132, P624, DOI 10.3109/00016489.2011.653669; Cushing H, 1915, P NATL ACAD SCI USA, V1, P621, DOI 10.1073/pnas.1.12.621; Emery SB, 2009, OTOL NEUROTOL, V30, P1204, DOI 10.1097/MAO.0b013e31819e6398; Hirakawa Katsuhiro, 1988, PRACT OTOL KYOTO, V27, P71; Hirshoren N, 2008, EUR J MED GENET, V51, P351, DOI 10.1016/j.ejmg.2008.02.008; HURVITZ SA, 1985, CLIN GENET, V28, P61; Mangino M, 2002, Hum Mutat, V19, P308, DOI 10.1002/humu.9016; Oxley CD, 2008, HORM RES, V69, P221, DOI 10.1159/000113022; Rudnik-Schoneborn S, 2010, AM J MED GENET A, V152A, P1540, DOI 10.1002/ajmg.a.33387; TEUNISSEN B, 1990, LARYNGOSCOPE, V100, P380; Thomeer HGXM, 2011, OTOL NEUROTOL, V32, P632, DOI 10.1097/MAO.0b013e318211fada; Usami S, 2012, CLIN GENET, V82, P514, DOI 10.1111/j.1399-0004.2011.01831.x; van den Ende JJ, 2005, CLIN DYSMORPHOL, V14, P73, DOI 10.1097/00019605-200504000-00004; Vessel E. S., 1960, NEW ENGL J MED, V263, P839; Weekamp HH, 2005, OTOL NEUROTOL, V26, P38, DOI 10.1097/00129492-200501000-00008	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1769-7212	1878-0849		EUR J MED GENET	Eur. J. Med. Genet.	SEP	2015	58	9					427	432		10.1016/j.ejmg.2015.06.005		6	Genetics & Heredity	Genetics & Heredity	CQ4FT	WOS:000360560500001		
J	Gupta, D; Bijarnia-Mahay, S; Saxena, R; Kohli, S; Dua-Puri, R; Verma, J; Thomas, E; Shigematsu, Y; Yamaguchi, S; Deb, R; Verma, IC				Gupta, Deepti; Bijarnia-Mahay, Sunita; Saxena, Renu; Kohli, Sudha; Dua-Puri, Ratna; Verma, Jyotsna; Thomas, E.; Shigematsu, Yosuke; Yamaguchi, Seiji; Deb, Roumi; Verma, Ishwar Chander			Identification of mutations, genotype-phenotype correlation and prenatal diagnosis of maple syrup urine disease in Indian patients	EUROPEAN JOURNAL OF MEDICAL GENETICS			English	Article						Maple syrup urine disease; BCKDHA; BCKDHB; DBT; Mutation; Genotype-phenotype; Prenatal diagnosis; Modeling; Genetics; Indian	RESPONSIVE PHENOTYPE; BIOCHEMICAL BASIS; FOUNDER MUTATION; PROTEIN; GENE; SUBSTITUTIONS; POPULATION; COMMUNITY; E1-ALPHA	Maple syrup urine disease (MSUD) is caused by mutations in genes BCKDHA, BCKDHB, DBT encoding E1 alpha, E1 beta, and E2 subunits of enzyme complex, branched-chain alpha-ketoacid dehydrogenase (BCKDH). BCKDH participates in catabolism of branched-chain amino acids (BCAAs) - leucine, isoleucine and valine in the energy production pathway. Deficiency or defect in the enzyme complex causes accumulation of BCAAs and keto-acids leading to toxicity. Twenty-four patients with MSUD were enrolled in the study for molecular characterization and genotype-phenotype correlation. Molecular studies were carried out by sequencing of the 3 genes by Sanger method. Bioinformatics tools were employed to classify novel variations into pathogenic or benign. The predicted effects of novel changes on protein structure were elucidated by 3D modeling. Mutations were detected in 22 of 24 patients (11, 7 and 4 in BCKDHB, BCKDHA and DBT genes, respectively). Twenty mutations including 11 novel mutations were identified. Protein modeling in novel mutations showed alteration of structure and function of these subunits. Mutations, c.1065 delT (BCKDHB gene) and c.939G > C (DBT gene) were noted to be recurrent, identified in 6 of 22 alleles and 5 of 8 alleles, respectively. Two-third patients were of neonatal classical phenotype (16 of 24). BCKDHB gene mutations were present in 10 of these 16 patients. Prenatal diagnoses were performed in 4 families. Consanguinity was noted in 37.5% families. Although no obvious genotype - phenotype correlation could be found in our study, most cases with mutation in BCKDHB gene presented in neonatal period. Large number of novel mutations underlines the heterogeneity and distinctness of gene pool from India. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Gupta, Deepti; Bijarnia-Mahay, Sunita; Saxena, Renu; Kohli, Sudha; Dua-Puri, Ratna; Verma, Jyotsna; Thomas, E.; Verma, Ishwar Chander] Sir Ganga Ram Hosp, Ctr Med Genet, New Delhi, India; [Gupta, Deepti; Deb, Roumi] Amity Univ, Amity Inst Biotechnol, Noida, UP, India; [Shigematsu, Yosuke] Univ Fukui, Fac Med Sci, Dept Hlth Sci, Matsuoka, Fukui, Japan; [Yamaguchi, Seiji] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane, Japan	Bijarnia-Mahay, S (reprint author), Sir Ganga Ram Hosp, Ctr Med Genet, New Delhi, India.	bijarnia@gmail.com			Research Development Board of Sir Ganga Ram Hospital (SGRH)	The authors wish to acknowledge the contribution of our colleagues at Center of Medical Genetics - Dr Udhaya Kotecha, Dr Pratima Dash, Dr Swasti Pal, Dr Prahlad Balakrishnan, Dr Sireesha Movva, Dr Pratibha Bhai, Dr Sudhisha Dubey, Mr. Prashant Bhaskar, Mr Naresh Kashyap, Mr Rajendra Mishra; colleagues from other institutions for referring cases - Dr Bijoy Balakrishnan and Dr Riyas PK (Edappal Hospital, Kerala), Dr Rachna Gupta (Apollo hospital, Indore), Dr Sheela Nampoothiri (Amrita Institute of Medical Genetics, Cochin), Dr Chaitanya Datar (Sahaydri Medical Genetics and Tissue Engineering Facility, Pune), Dr Pritesh Pandya, (Sanjeevani Hospital, Rajkot), Dr Suvasini Sharma (Kalawati Saran Children's Hospital, New Delhi), Dr Jaspreet Kaur & Dr Sharad Sharma (Cocoon Hospital, Jaipur), Dr Neelam Kler, Dr Satish Saluja, Dr Pankaj Garg and Dr Arun Soni (Neonatology, SGRH, New Delhi). We would also like to thank our technical staff- Jyoti Singh, Deepika Babbar, Devender Prasad, Geetika Jhingan, Sandeepika Sharma, Azad Singh and other lab mates. The study was partially funded by Research Development Board of Sir Ganga Ram Hospital (SGRH). Our sincere thanks to all the patients and their families for their kind support.	Ankala A, 2015, HUM MUTAT, V36, P1, DOI 10.1002/humu.22704; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; AEvarsson A, 2000, STRUCT FOLD DES, V8, P277; Nellis MM, 2001, AM J HUM GENET, V68, P232, DOI 10.1086/316950; Flaschker N, 2007, J INHERIT METAB DIS, V30, P903, DOI 10.1007/s10545-007-0579-x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Quental S, 2008, MOL GENET METAB, V94, P148, DOI 10.1016/j.ymgme.2008.02.008; Dalal A, 2012, AM J MED GENET A, V158A, P2820, DOI 10.1002/ajmg.a.35620; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Edelmann L, 2001, AM J HUM GENET, V69, P863, DOI 10.1086/323677; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bittles AH, 2002, J GENET, V81, P91, DOI 10.1007/BF02715905; Bashyam MD, 2012, J CELL BIOCHEM, V113, P3122, DOI 10.1002/jcb.24189; Brodtkorb E, 2010, MOL GENET METAB, V100, P324, DOI 10.1016/j.ymgme.2010.04.017; Chuang D. T., 2001, THE METABOLIC AND MO, P1250; Chuang DT, 2006, J NUTR, V136, p243S; Chuang DT, 1998, J PEDIATR-US, V132, pS17, DOI 10.1016/S0022-3476(98)70523-2; Chuang JL, 2004, J BIOL CHEM, V279, P17792, DOI 10.1074/jbc.M313879200; CHUANG JL, 1995, J CLIN INVEST, V95, P954, DOI 10.1172/JCI117804; Chuang JL, 1997, J CLIN INVEST, V100, P736, DOI 10.1172/JCI119586; Doering C. B., 1998, FRONT BIOSCI, V3, P517; Gorzelany K, 2009, TURKISH J PEDIATR, V51, P97; Henneke Marco, 2003, Hum Mutat, V22, P417, DOI 10.1002/humu.9187; Matthews B. W., 2001, ENCYCLOPEDIA OF LIFE; Nagaraja D, 2010, CLIN BIOCHEM, V43, P581, DOI 10.1016/j.clinbiochem.2009.12.009; Narayanan MP, 2013, INDIAN J BIOCHEM BIO, V50, P442; POTASHNIK R, 1987, ISRAEL J MED SCI, V23, P886; Ramalho AS, 2009, CELL PHYSIOL BIOCHEM, V24, P335, DOI 10.1159/000257426; Rodriguez-Pombo P, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9428; Stenson PD, 2008, GENOME MED, V1, P13, DOI DOI 10.1186/GM13; Strauss K. A., 2013, GENEREVIEWS, P1993; Tammachote R, 2009, J INHERIT METAB DIS, V32, pS33, DOI 10.1007/s10545-009-1022-2; Wolf A, 2011, HUM MUTAT, V32, P1137, DOI 10.1002/humu.21547	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1769-7212	1878-0849		EUR J MED GENET	Eur. J. Med. Genet.	SEP	2015	58	9					471	478		10.1016/j.ejmg.2015.08.002		8	Genetics & Heredity	Genetics & Heredity	CQ4FT	WOS:000360560500007		
J	Yamamoto, T; Shimada, S; Shimojima, K; Sangu, N; Ninomiya, S; Kubota, M				Yamamoto, Toshiyuki; Shimada, Shino; Shimojima, Keiko; Sangu, Noriko; Ninomiya, Shinsuke; Kubota, Masaya			Leukoencephalopathy associated with 11q24 deletion involving the gene encoding hepatic and glial cell adhesion molecule in two patients	EUROPEAN JOURNAL OF MEDICAL GENETICS			English	Article						Megalencephalic leukoencephalopathy with subcortical cysts type 2 (MLC2); Hepatic and glial cell adhesion molecule (HEPACAM); 11q24; Microdeletion; Jacobsen syndrome	MEGALENCEPHALIC LEUKOENCEPHALOPATHY; SUBCORTICAL CYSTS; JACOBSEN-SYNDROME; MUTATIONS; MLC1; ABNORMALITIES; DISORDER	Leukoencephalopathies are heterogeneous entities with white matter abnormalities. Mutations of the gene encoding hepatic and glial cell adhesion molecule (HEPACAM) located on 11q24 are related to one of the leukoencephalopathies: megalencephalic leukoencephalopathy with subcortical cysts type 2 (MLC2). Genomic copy number aberrations were analyzed by microarray comparative hybridization for two patients. One patient who presented with abnormal intensity of the white matter had been previously been diagnosed with the typical genotype and phenotype of Jacobsen syndrome due to an 11q sub-telomere deletion, which was further characterized here. In a second patient who exhibited the characteristic finding of leukoencephalopathy, an interstitial deletion of 11q24 was also identified. HEPACAM was involved in both deletions. We therefore suggest that haploinsufficiency of HEPACAM, a gene previously associated with the features of MLC2 and located on the overlapping deletion region between the two patients, might be related to the observed white matter abnormalities. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Yamamoto, Toshiyuki; Shimada, Shino; Shimojima, Keiko; Sangu, Noriko] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan; [Yamamoto, Toshiyuki; Shimada, Shino] Tokyo Womens Med Univ, Dept Pediat, Tokyo 1628666, Japan; [Ninomiya, Shinsuke] Kurashiki Cent Hosp, Dept Clin Genet, Kurashiki, Okayama, Japan; [Kubota, Masaya] Natl Ctr Child Hlth & Dev, Div Neurol, Tokyo, Japan	Yamamoto, T (reprint author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ward, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yamamoto.toshiyuki@twmu.ac.jp			Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan	We thank the patients and their families for cooperation in this study. We would like to acknowledge the Collaborative Research Supporting Committee of the Japanese Society of Child Neurology (14-3) for promoting this study. This work was supported by a Grant-in-Aid for Scientific Research from Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan (T.Y.).	Mattina T, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-9; VANDERKNAAP MS, 1995, ANN NEUROL, V37, P324, DOI 10.1002/ana.410370308; Yamamoto T, 2011, AM J MED GENET A, V155A, P113, DOI 10.1002/ajmg.a.33735; Lopez-Hernandez T, 2011, HUM MOL GENET, V20, P3266, DOI 10.1093/hmg/ddr238; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Arnedo T, 2014, NEUROGENETICS, V15, P41, DOI 10.1007/s10048-013-0381-x; van der Knaap MS, 2012, LANCET NEUROL, V11, P973, DOI 10.1016/S1474-4422(12)70192-8; Shimada S, 2012, AM J MED GENET A, V158A, P1771, DOI 10.1002/ajmg.a.35431; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Capdevila-Nortes X, 2013, HUM MOL GENET, V22, P4405, DOI 10.1093/hmg/ddt290; Lopez-Hernandez T, 2011, AM J HUM GENET, V88, P422, DOI 10.1016/j.ajhg.2011.02.009; Grossfeld PD, 2004, AM J MED GENET A, V129A, P51, DOI 10.1002/ajmg.a.30090; Coldren CD, 2009, NEUROGENETICS, V10, P89, DOI 10.1007/s10048-008-0157-x; ONO J, 1994, CLIN GENET, V45, P325; Shimada S, 2015, BRAIN DEV-JPN, V37, P960, DOI 10.1016/j.braindev.2015.03.003; Shimada S, 2014, HUM GENOME VAR, V1, P14019; Takahashi I, 2012, AM J MED GENET A, V158A, P220, DOI 10.1002/ajmg.a.34382; Wenger SL, 2006, AM J MED GENET A, V140A, P704, DOI 10.1002/ajma.a.31146; Yamamoto T, 2014, J HUM GENET, V59, P300, DOI 10.1038/jhg.2014.21	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1769-7212	1878-0849		EUR J MED GENET	Eur. J. Med. Genet.	SEP	2015	58	9					492	496		10.1016/j.ejmg.2015.06.008		5	Genetics & Heredity	Genetics & Heredity	CQ4FT	WOS:000360560500010		
J	Hongo, Y; Ogawa, K; Takahara, Y; Takasu, K; Royer, S; Hasegawa, M; Sakaguchi, G; Ikegaya, Y				Hongo, Yoshie; Ogawa, Koichi; Takahara, Yuji; Takasu, Keiko; Royer, Sebastien; Hasegawa, Minoru; Sakaguchi, Gaku; Ikegaya, Yuji			Topological organization of CA3-to-CA1 excitation	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						calcium imaging; epilepsy; hippocampus; network; rat; sequence	CA3 PYRAMIDAL CELLS; HIPPOCAMPAL; NEURONS; RAT; REGION; MEMORY; RIPPLES; NETWORK; OUTPUT	The CA1-projecting axons of CA3 pyramidal cells, called Schaffer collaterals, constitute one of the major information flow routes in the hippocampal formation. Recent anatomical studies have revealed the non-random structural connectivity between CA3 and CA1, but little is known regarding the functional connectivity (i.e. how CA3 network activity is functionally transmitted downstream to the CA1 network). Using functional multi-neuron calcium imaging of rat hippocampal slices, we monitored the spatiotemporal patterns of spontaneous CA3 and CA1 burst activity under pharmacological GABAergic blockade. We found that spatially clustered CA3 activity patterns were transformed into layered CA1 activity sequences. Specifically, synchronized bursts initiated from multiple hot spots in CA3 ensembles, and CA1 neurons located deeper in the pyramidal cell layer were recruited during earlier phases of the burst events. The order of these sequential activations was maintained across the bursts, but the sequence velocity varied depending on the inter-burst intervals. Thus, CA3 axons innervate CA1 neurons in a highly topographical fashion.	[Hongo, Yoshie; Ogawa, Koichi; Takahara, Yuji; Takasu, Keiko; Hasegawa, Minoru; Sakaguchi, Gaku] Shionogi & Co Ltd, Pain & Neurosci, Discovery Res Lab Core Therapeut Areas, Toyonaka, Osaka, Japan; [Royer, Sebastien] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Ikegaya, Yuji] Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan	Ikegaya, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ikegaya@mol.f.u-tokyo.ac.jp			Kakenhi [25119004]; Health and Labour Sciences Research Grants for Research on Regulatory Science of Pharmaceuticals and Medical Devices from MHLW (iNCENS)	We thank Mr Takeyuki Miyawaki for his comments on an early version of this article. This work was supported by Kakenhi (25119004) and Health and Labour Sciences Research Grants for Research on Regulatory Science of Pharmaceuticals and Medical Devices from MHLW (iNCENS).	Amaral D., 2007, HIPPOCAMPUS BOOK, P37; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Druckmann S, 2014, NEURON, V81, P629, DOI 10.1016/j.neuron.2013.11.026; SORENSEN JC, 1993, ANAT EMBRYOL, V188, P107; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Slomianka L, 2011, BRAIN STRUCT FUNCT, V216, P301, DOI 10.1007/s00429-011-0322-0; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; BAIMBRIDGE KG, 1991, SYNAPSE, V7, P269, DOI 10.1002/syn.890070404; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; desLavilleon G., 2015, NAT NEUROSCI, V18, P493; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Kendall M. G., 1994, KENDALLS ADV THEORY; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Sasaki T, 2012, J PHYSIOL-LONDON, V590, P4869, DOI 10.1113/jphysiol.2012.237685; Scheffer-Teixeira R, 2012, CEREB CORTEX, V22, P2404, DOI 10.1093/cercor/bhr319; Schmidt H, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00025; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	SEP	2015	42	5					2135	2143		10.1111/ejn.12969		9	Neurosciences	Neurosciences & Neurology	CQ8JW	WOS:000360854900003		
J	Hayashi, Y; Yamazaki, T; Nakanishi, Y; Ono, T; Taniguchi, T; Monde, K; Uchimaru, T				Hayashi, Yujiro; Yamazaki, Tatsuya; Nakanishi, Yuki; Ono, Tsuyoshi; Taniguchi, Tohru; Monde, Kenji; Uchimaru, Tadafumi			Asymmetric Nitrocyclopropanation of -Substituted ,-Enals Catalyzed by Diphenylprolinol Silyl Ether for the Construction of All-Carbon Quaternary Stereogenic Centers	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Organocatalysis; Asymmetric synthesis; Small ring systems; Cyclopropanation; Chirality	VIBRATIONAL CIRCULAR-DICHROISM; ALPHA,BETA-UNSATURATED ALDEHYDES; ENANTIOSELECTIVE NITROCYCLOPROPANATION; ORGANOCATALYZED CYCLOPROPANATION; ANISOTROPIC DIELECTRICS; CHIRAL CYCLOPROPANES; ALKYLATION REACTIONS; RING-SYSTEM; DENSITY; EPOXIDATION	The diphenylprolinol silyl ether mediated asymmetric nitrocyclopropanation of -substituted ,-unsaturated aldehydes with bromonitromethane, followed by base-promoted isomerization was found to afford trans-nitrocyclopropanecarbaldehydes with all-carbon quaternary stereogenic centers with excellent diastereo- and enantioselectivities. DFT calculations indicated that the s-trans conformer of the iminium ion intermediate is more stable than the s-cis conformer. In addition, nucleophilic attack of the bromonitromethane anion to the iminium ion intermediate was calculated to occur preferentially from the opposite side of the bulky substituents of the pyrrolidine iminium intermediate.	[Hayashi, Yujiro; Nakanishi, Yuki; Ono, Tsuyoshi] Tohoku Univ, Dept Chem, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Yamazaki, Tatsuya] Tokyo Univ Sci, Dept Ind Chem, Fac Engn, Shinjuku Ku, Tokyo 1628601, Japan; [Taniguchi, Tohru; Monde, Kenji] Hokkaido Univ, Fac Adv Life Sci, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0010021, Japan; [Uchimaru, Tadafumi] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan	Hayashi, Y (reprint author), Tohoku Univ, Dept Chem, Grad Sch Sci, Aoba Ku, 6-3 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.	yhayashi@m.tohoku.ac.jp; t-uchimaru@aist.go.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23105010]	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research on Innovative Areas, Advanced Molecular Transformations by Organocatalysts, grant number 23105010. The authors thank Tsukuba Advanced Computing Center (TACC) for providing computational facilities.	Mielgo A, 2008, CHEM-ASIAN J, V3, P922, DOI 10.1002/asia.200700417; Papageorgiou CD, 2004, ANGEW CHEM INT EDIT, V43, P4641, DOI 10.1002/anie.200460234; Kunz RK, 2005, J AM CHEM SOC, V127, P3240, DOI 10.1021/ja042774b; Terrasson V, 2010, CHEM-EUR J, V16, P7875, DOI 10.1002/chem.201000334; Jensen KL, 2012, ACCOUNTS CHEM RES, V45, P248, DOI 10.1021/ar200149w; Stephens PJ, 2008, CHIRALITY, V20, P643, DOI 10.1002/chir.20477; Zhao YH, 2007, TETRAHEDRON-ASYMMETR, V18, P2462, DOI 10.1016/j.tetasy.2007.10.007; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Hayashi Y, 2005, ANGEW CHEM INT EDIT, V44, P4212, DOI 10.1002/anie.200500599; He YA, 2011, APPL SPECTROSC, V65, P699, DOI 10.1366/11-06321; Johansson CCC, 2006, ANGEW CHEM INT EDIT, V45, P6024, DOI 10.1002/anie.200602129; PARIKH JR, 1967, J AM CHEM SOC, V89, P5505, DOI 10.1021/ja00997a067; Martin-Vila M, 2000, TETRAHEDRON-ASYMMETR, V11, P3569, DOI 10.1016/S0957-4166(00)00297-4; Wessjohann LA, 2003, CHEM REV, V103, P1625, DOI 10.1021/cr0100188; Xie H, 2007, J AM CHEM SOC, V129, P10886, DOI 10.1021/ja073262a; Das JP, 2011, CHEM COMMUN, V47, P4593, DOI 10.1039/c0cc05222a; Zhang JM, 2009, TETRAHEDRON, V65, P802, DOI 10.1016/j.tet.2008.11.060; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Pellissier H, 2008, TETRAHEDRON, V64, P7041, DOI 10.1016/j.tet.2008.04.079; Hartikka A, 2007, J ORG CHEM, V72, P5874, DOI 10.1021/jo070519e; Taniguchi T, 2012, J AM CHEM SOC, V134, P3695, DOI 10.1021/ja3001584; KRAUS GA, 1980, J ORG CHEM, V45, P4825, DOI 10.1021/jo01312a004; Zhang JM, 2009, TETRAHEDRON-ASYMMETR, V20, P355, DOI 10.1016/j.tetasy.2009.01.003; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; Lifchits O, 2010, J AM CHEM SOC, V132, P10227, DOI 10.1021/ja1037935; Groselj U, 2009, HELV CHIM ACTA, V92, P1225; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; [Anonymous], SPARTAN 10; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Marigo M, 2005, ANGEW CHEM INT EDIT, V44, P794, DOI 10.1002/anie.200462101; Lebel H, 2003, CHEM REV, V103, P977, DOI 10.1021/cr010007e; GOTO H, 1989, J AM CHEM SOC, V111, P8950, DOI 10.1021/ja00206a046; Xu LW, 2010, ADV SYNTH CATAL, V352, P243, DOI 10.1002/adsc.200900797; Vesely J, 2008, TETRAHEDRON LETT, V49, P4209, DOI 10.1016/j.tetlet.2008.04.162; Aggarwal VK, 2004, ACCOUNTS CHEM RES, V37, P611, DOI 10.1021/ar030045f; Vreven T, 2006, J CHEM THEORY COMPUT, V2, P815, DOI 10.1021/ct050289g; Hawner C, 2010, CHEM COMMUN, V46, P7295, DOI 10.1039/c0cc02309d; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Scalmani G, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3359469; Bella M, 2009, SYNTHESIS-STUTTGART, P1583, DOI 10.1055/s-0029-1216796; Bondzic BP, 2010, ORG LETT, V12, P5434, DOI 10.1021/ol102269s; Mennucci B, 1997, J PHYS CHEM B, V101, P10506, DOI 10.1021/jp971959k; Companyo X, 2009, EUR J ORG CHEM, P3075, DOI 10.1002/ejoc.200900209; Dapprich S., 1999, J MOL STRUC-THEOCHEM, V462, P1, DOI DOI 10.1016/S0166-1280(98)00475-8; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Goto H., 1993, J CHEM SOC P2, P187; Goto H., 2012, CONFLEX 7; Gotoh H., 2013, SUSTAINABLE CATALYSI, P287; Hartikka A, 2007, TETRAHEDRON-ASYMMETR, V18, P1403, DOI 10.1016/j.tetasy.2007.05.030; Hayashi Y, 2014, CHEM-EUR J, V20, P17077, DOI 10.1002/chem.201403514; Hayashi Y., 2005, ANGEW CHEM, V117, P4284, DOI 10.1002/ange.200500599; Ibrahem I, 2008, CHEM-EUR J, V14, P7867, DOI 10.1002/chem.200800442; Inokuma T, 2009, SYNLETT, P1627, DOI 10.1055/s-0029-1217331; Jiang H, 2013, COMPREHENSIVE ENANTIOSELECTIVE ORGANOCATALYSIS: CATALYSTS, REACTIONS, AND APPLICATIONS, VOLS 1-3, P33; Johansson C. C. C., 2006, ANGEW CHEM, V118, P6170, DOI 10.1002/ange.200602129; KRAUS GA, 1980, J ORG CHEM, V45, P1175, DOI 10.1021/jo01294a058; Li WJ, 2011, TETRAHEDRON LETT, V52, P2715, DOI 10.1016/j.tetlet.2011.03.079; MaCooey S. H., 2006, J ORG CHEM, V71, P7494; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Marigo M., 2005, ANGEW CHEM, V117, P804, DOI 10.1002/ange.200462101; Papageorgiou C. D., 2004, ANGEW CHEM, V116, P4741, DOI 10.1002/ange.200460234; Wascholowski V, 2008, SYNTHESIS-STUTTGART, P1269, DOI 10.1055/s-2008-1042944	64	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	SEP	2015		26					5747	5754		10.1002/ejoc.201500838		8	Chemistry, Organic	Chemistry	CQ7DF	WOS:000360762400008		
J	Fujiwara, K; Kushibe, K; Sato, T; Norikura, T; Matsue, H; Iwai, K; Katoono, R; Suzuki, T				Fujiwara, Kenshu; Kushibe, Keisuke; Sato, Takuto; Norikura, Toshio; Matsue, Hajime; Iwai, Kunihisa; Katoono, Ryo; Suzuki, Takanori			Synthesis of Ganbajunins D and E and the Proposed Structure of Thelephantin D	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Total synthesis; Natural products; Cytotoxicity; Transesterification; Structure elucidation	P-TERPHENYL DERIVATIVES; MUSHROOM THELEPHORA-AURANTIOTINCTA; TNF-ALPHA PRODUCTION; 1ST TOTAL-SYNTHESIS; ANTIOXIDANT ACTIVITY; COUPLING REACTIONS; RADICAL SCAVENGER; PAXILLUS-CURTISII; ACYL MIGRATION; VIALININ-A	The syntheses of ganbajunins D and E and of the structure proposed for thelephantin D, as well as its regioisomer, were achieved in a divergent manner via a common monoester intermediate. The proposed structure of thelephantin D had NMR chemical shifts different from those of natural thelephantin D. This supported Takahashi's suggestion that the true structure of natural thelephantin D should be the same as that of terrestrin C, as was deduced from the similarities in their NMR spectra. The presence of isomerization equilibria between 2,5- and 2,6-diacyloxy-p-terphenyl derivatives in solution, which are the cause of the inseparability of these derivatives, was also demonstrated by monitoring the dynamic transition from a 2,6-diacyloxy-p-terphenyl-rich mixture of the derivatives to an equilibrium mixture. The results of biological and chemical property tests - such as cytotoxicity against cancer cells, affinity towards Fe2+ ion, and antioxidative activity - with the synthesized compounds are also described.	[Fujiwara, Kenshu; Kushibe, Keisuke; Sato, Takuto; Katoono, Ryo; Suzuki, Takanori] Hokkaido Univ, Dept Chem, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Norikura, Toshio; Matsue, Hajime; Iwai, Kunihisa] Aomori Univ Hlth & Welf, Dept Nutr, Fac Hlth Sci, Aomori 0308505, Japan	Fujiwara, K (reprint author), Hokkaido Univ, Dept Chem, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	fjwkn@sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The authors thank Dr. Eri Fukushi and Mr. Yusuke Takata (GC-MS and NMR Laboratory, Graduate School of Agriculture, Hokkaido University) for the measurements of mass spectra. This work was supported by Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Gordon MH, 2001, J AGR FOOD CHEM, V49, P2480, DOI 10.1021/jf000537w; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; REINAUD O, 1985, TETRAHEDRON LETT, V26, P3993, DOI 10.1016/S0040-4039(00)98706-9; Liu JK, 2004, CHEM BIODIVERS, V1, P601, DOI 10.1002/cbdv.200490050; Irlapati NR, 2004, TETRAHEDRON, V60, P9307, DOI 10.1016/j.tet.2004.07.035; Hu L, 2001, HELV CHIM ACTA, V84, P3342, DOI 10.1002/1522-2675(20011114)84:11<3342::AID-HLCA3342>3.0.CO;2-K; Liu JK, 2006, CHEM REV, V106, P2209, DOI 10.1021/cr050248c; Quang DN, 2006, CHEM REC, V6, P79, DOI 10.1002/tcr.20074; Kim EY, 2008, J NUTR, V138, P1647; ELIX JA, 1986, AUST J CHEM, V39, P613; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Norikura T, 2011, J AGR FOOD CHEM, V59, P6974, DOI 10.1021/jf200461j; BRANDWILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Barrero AF, 1998, TETRAHEDRON LETT, V39, P2425, DOI 10.1016/S0040-4039(98)00216-0; Donnelly DMX, 1999, SYNTHETIC COMMUN, V29, P2719, DOI 10.1080/00397919908086434; Elix JA, 1996, AUST J CHEM, V49, P1247; Fujiwara K, 2012, J ORG CHEM, V77, P5161, DOI 10.1021/jo300565s; IHARA M, 1990, J PHARM SCI, V79, P703, DOI 10.1002/jps.2600790811; LEE MW, 1992, PHYTOCHEMISTRY, V31, P2117; Shan YM, 2012, NAT PROD COMMUN, V7, P333; Norikura T, 2013, J AGR FOOD CHEM, V61, P1258, DOI 10.1021/jf3041098; Piettre SR, 1997, J MED CHEM, V40, P4208, DOI 10.1021/jm9701942; Quang DN, 2003, CHEM PHARM BULL, V51, P1064, DOI 10.1248/cpb.51.1064; Quang DN, 2003, PHYTOCHEMISTRY, V63, P919, DOI 10.1016/S0031-9422(03)00220-6; Quang DN, 2003, PLANTA MED, V69, P1063, DOI 10.1055/s-2003-45159; Radulovic N, 2005, PHYTOCHEMISTRY, V66, P1052, DOI 10.1016/j.phytochem.2005.03.008; Tsukamoto S, 2002, TETRAHEDRON, V58, P1103, DOI 10.1016/S0040-4020(01)01214-5; Xie C, 2005, BIOSCI BIOTECH BIOCH, V69, P2326, DOI 10.1271/bbb.69.2326; Ye YQ, 2009, J ORG CHEM, V74, P4642, DOI 10.1021/jo900638b; Ye YQ, 2007, ORG LETT, V9, P4131, DOI 10.1021/ol701590b; ZHANG SZ, 1990, CELL BIOL TOXICOL, V6, P219	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	SEP	2015		26					5798	5809		10.1002/ejoc.201500722		12	Chemistry, Organic	Chemistry	CQ7DF	WOS:000360762400014		
J	Kikushima, K; Nishina, Y				Kikushima, Kotaro; Nishina, Yuta			Synthesis of 2-Arylphenol Derivatives through a One-Pot Suzuki-Miyaura Coupling/Dehydrogenative Aromatization Sequence with Pd/C Catalysis	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Cross-coupling; Aromatization; Palladium; Phenols	AEROBIC DEHYDROGENATION; OXIDATIVE AROMATIZATION; MOLECULAR-OXYGEN; ORTHO-ARYLATION; 3,5-DIARYL PYRAZOLINES; O-ARYLPHENOLS; PHENOLS; DIBENZOFURANS; CYCLOHEXANONE; CYCLIZATION	One-pot synthesis of 2-arylphenols starting from 2-iodo-2-cyclohexen-1-one and arylboronic acids through sequential Suzuki-Miyaura coupling/dehydrogenative aromatization with Pd/C catalysis has been developed. A range of arylboronic acids serve as substrates, including those containing electron-donating or electron-withdrawing groups. Additionally, one-pot synthesis of di- or trisubstituted phenols bearing a phenyl group at the ortho position are also generated by using 2-iodo-2-cyclohexen-1-one derivatives as substrate. In the present method, commercially available and easily removable Pd/C was employed as a catalyst without any ligands. The operationally simple procedure and accessible conditions were used to provide modified phenols as the sole product in moderate to high yields.	[Kikushima, Kotaro; Nishina, Yuta] Okayama Univ, Res Core Interdisciplinary Sci, Kita Ku, Okayama 7008530, Japan; [Nishina, Yuta] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Nishina, Y (reprint author), Okayama Univ, Res Core Interdisciplinary Sci, Kita Ku, Okayama 7008530, Japan.	nisina-y@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Financial support for this study was provided by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through Special Coordination Funds for Promoting Science and Technology.	Jeong TS, 2004, BIOORG MED CHEM LETT, V14, P2719, DOI 10.1016/j.bmcl.2004.03.072; Hennings DD, 1997, J ORG CHEM, V62, P2, DOI 10.1021/jo961876k; Diao TN, 2013, J AM CHEM SOC, V135, P8205, DOI 10.1021/ja4031648; Kikushima K, 2013, RSC ADV, V3, P20150, DOI 10.1039/c3ra43071e; Bedford RB, 2009, ORG BIOMOL CHEM, V7, P3119, DOI 10.1039/b906119c; Zhao JJ, 2012, ORG LETT, V14, P5362, DOI 10.1021/ol302562a; Ishikawa S, 2007, CHEM LETT, V36, P1304, DOI 10.1246/cl.2007.1304; Bedford RB, 2003, ANGEW CHEM INT EDIT, V42, P112, DOI 10.1002/anie.200390037; Pun D, 2013, J AM CHEM SOC, V135, P8213, DOI 10.1021/ja403165u; Xiao B, 2011, J AM CHEM SOC, V133, P9250, DOI 10.1021/ja203335u; Simon MO, 2012, ANGEW CHEM INT EDIT, V51, P7537, DOI 10.1002/anie.201200698; Diao TN, 2011, J AM CHEM SOC, V133, P14566, DOI 10.1021/ja206575j; Zhao JJ, 2012, ORG LETT, V14, P1078, DOI 10.1021/ol203442a; Hong WP, 2013, J AM CHEM SOC, V135, P13664, DOI 10.1021/ja4073172; Girard SA, 2012, ORG LETT, V14, P5606, DOI 10.1021/ol3027279; Bedford RB, 2009, ORG BIOMOL CHEM, V7, P4853, DOI 10.1039/b916724m; Xiao B, 2010, J AM CHEM SOC, V132, P468, DOI 10.1021/ja909818n; Felpin FX, 2005, J ORG CHEM, V70, P8575, DOI 10.1021/jo051501b; Wei Y, 2011, ORG LETT, V13, P5504, DOI 10.1021/ol202229w; Zhao XD, 2010, J AM CHEM SOC, V132, P5837, DOI 10.1021/ja100783c; Izawa Y, 2011, SCIENCE, V333, P209, DOI 10.1126/science.1204183; Brunel JM, 2005, CHEM REV, V105, P857, DOI 10.1021/cr040079g; Benhida R, 1998, TETRAHEDRON LETT, V39, P6849, DOI 10.1016/S0040-4039(98)01494-4; Izawa Y, 2013, ANGEW CHEM INT EDIT, V52, P3672, DOI 10.1002/anie.201209457; Chen Y, 2003, CHEM REV, V103, P3155, DOI 10.1021/cr020025b; Oi S, 2003, TETRAHEDRON LETT, V44, P8665, DOI 10.1016/j.tetlet.2003.09.151; Manna K, 2014, J AM CHEM SOC, V136, P6566, DOI 10.1021/ja5018267; Hajra A, 2012, ORG LETT, V14, P5488, DOI 10.1021/ol302568b; He X, 2006, J MED CHEM, V49, P6308, DOI 10.1021/jm060715y; Bedford R. B., 2003, ANGEW CHEM, V115, P116, DOI 10.1002/ange.200390005; Bedford RB, 2008, CHEM COMMUN, P990, DOI 10.1039/b718128k; Ishikawa S, 2007, CHEM LETT, V36, P1302, DOI 10.1246/cl.2007.1302; Izawa Y., 2013, ANGEW CHEM, V125, P3760; Jeong TS, 2004, BIOORG MED CHEM LETT, V14, P2715, DOI 10.1016/j.bmcl.2004.03.079; Kawamura Y., 1997, CHEM LETT, P961; Kesler M. T., 2012, CHEMCATCHEM, V4, P326; Krafft ME, 2005, SYNLETT, P1263, DOI 10.1055/s-2005-868495; MILLION ME, 1995, J MED CHEM, V38, P4693, DOI 10.1021/jm00023a009; Moriuchi T, 2009, TETRAHEDRON LETT, V50, P7385, DOI 10.1016/j.tetlet.2009.10.070; Simon M. O., 2012, ANGEW CHEM, V124, P7655; Tyman J. H. P., 1996, SYNTHETIC NATURAL PH	41	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	SEP	2015		26					5864	5868		10.1002/ejoc.201500723		5	Chemistry, Organic	Chemistry	CQ7DF	WOS:000360762400020		
J	Chapple, CR; Osman, NI; Birder, L; van Koeveringe, GA; Oelke, M; Nitti, VW; Drake, MJ; Yamaguchi, O; Abrams, P; Smith, PP				Chapple, Christopher R.; Osman, Nadir I.; Birder, Lori; van Koeveringe, Gommert A.; Oelke, Matthias; Nitti, Victor W.; Drake, Marcus J.; Yamaguchi, Osamu; Abrams, Paul; Smith, Philip P.			The Underactive Bladder: A New Clinical Concept?	EUROPEAN UROLOGY			English	Article						Detrusor underactivity; Lower urinary tract symptoms; Underactive bladder	URINARY-TRACT SYMPTOMS; DETRUSOR UNDERACTIVITY; CONTRACTILITY; TERMINOLOGY; STRENGTH	Detrusor underactivity (DU) is an increasingly recognised cause of lower urinary tract symptoms in both men and women. There has been a lack of research into all aspects of this dysfunction, and as yet, no effective treatments exist. DU can be diagnosed at present only on the basis of an invasive urodynamic study. An international consensus group met at the International Consultation on Incontinence-Research Society and International Continence Society annual meetings in 2014 to consider the feasibility of developing a working definition of a symptom complex associated with DU. Drawing an analogy to detrusor overactivity (urodynamic diagnosis) and overactive bladder (symptom complex), the aim of this process is to help identify affected patients and facilitate further clinical and epidemiological research. Patient summary: Bladder underactivity is an underresearched but important cause of urinary symptoms in men and women. In this paper, an international expert group presents a working definition for the symptoms that characterise bladder underactivity, with the aim of facilitating further research in this area. (C) 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.	[Chapple, Christopher R.; Osman, Nadir I.] Royal Hallamshire Hosp, Dept Urol, Sheffield S10 2JF, S Yorkshire, England; [Birder, Lori] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [van Koeveringe, Gommert A.] Maastricht Univ, Med Ctr, Dept Urol, Maastricht, Netherlands; [Oelke, Matthias] Hannover Med Sch, Dept Urol, Hannover, Germany; [Nitti, Victor W.] NYU Med Ctr, Dept Urol, New York, NY 10016 USA; [Drake, Marcus J.; Abrams, Paul] Southmead Hosp, Bristol Urol Inst, Bristol, Avon, England; [Yamaguchi, Osamu] Nihon Univ, Sch Engn, Div Bioengn, Koriyama, Fukushima, Japan; [Yamaguchi, Osamu] Nihon Univ, Sch Engn, LUTD Res, Koriyama, Fukushima, Japan; [Smith, Philip P.] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT USA; [Smith, Philip P.] Univ Connecticut, Ctr Hlth, Ctr Aging, Farmington, CT USA	Chapple, CR (reprint author), Sheffield Teaching Hosp NHS Fdn Trust, Dept Urol, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	c.r.chapple@shef.ac.uk					van Koeveringe GA, 2011, NEUROUROL URODYNAM, V30, P723, DOI 10.1002/nau.21097; Abrams P, 1999, BJU INT, V84, P14; Smith PP, 2010, NEUROUROL URODYNAM, V29, P408, DOI 10.1002/nau.20765; van Koeveringe GA, 2014, NEUROUROL URODYNAM, V33, P591, DOI 10.1002/nau.22590; Smith PP, 2012, AM J PHYSIOL-REG I, V302, pR577, DOI 10.1152/ajpregu.00508.2011; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Abarbanel J, 2007, UROLOGY, V69, P436, DOI 10.1016/j.urology.2006.11.019; GRIFFITHS DJ, 1991, NEUROUROL URODYNAM, V10, P1, DOI 10.1002/nau.1930100102; Jeong Seong Jin, 2012, Korean J Urol, V53, P342, DOI 10.4111/kju.2012.53.5.342; Miyazato Minoru, 2013, Rev Urol, V15, P11; Oelke M, 2014, WORLD J UROL, V32, P1177, DOI 10.1007/s00345-014-1358-6; Osman NI, 2014, EUR UROL, V65, P389, DOI 10.1016/j.eururo.2013.10.015	12	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0302-2838	1873-7560		EUR UROL	Eur. Urol.	SEP	2015	68	3					351	353		10.1016/j.eururo.2015.02.030		3	Urology & Nephrology	Urology & Nephrology	CQ4JZ	WOS:000360572300009		
J	Deguchi, T; Yasuda, M; Ito, S				Deguchi, Takashi; Yasuda, Mitsuru; Ito, Shin			Re: Adrian Pilatz, Hamid Hossain, Rolf Kaiser, et al. Acute Epididymitis Revisited: Impact of Molecular Diagnostics on Etiology and Contemporary Guideline Recommendations. Eur Urol 2015;68:428-35	EUROPEAN UROLOGY			English	Letter							MYCOPLASMA-GENITALIUM		[Deguchi, Takashi; Yasuda, Mitsuru] Gifu Univ, Grad Sch Med, Dept Urol, Gifu, Gifu 5011194, Japan; [Ito, Shin] iClinic, Sendai, Miyagi, Japan	Deguchi, T (reprint author), Gifu Univ, Grad Sch Med, Dept Urol, 1-1 Yanagido, Gifu, Gifu 5011194, Japan.	deguchit@gifu-u.ac.jp					Ito S, 2012, INT J UROL, V19, P234, DOI 10.1111/j.1442-2042.2011.02917.x; Deguchi T, 2012, EXPERT REV ANTI-INFE, V10, P791, DOI [10.1586/eri.12.38, 10.1586/ERI.12.38]; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Hamasuna R., 2008, JPN J SEX TRANSM DIS, V19, P89; Pilatz A, 2015, EUR UROL, V68, P428, DOI 10.1016/j.eururo.2014.12.005	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0302-2838	1873-7560		EUR UROL	Eur. Urol.	SEP	2015	68	3					E59	E60		10.1016/j.eururo.2015.03.045		2	Urology & Nephrology	Urology & Nephrology	CQ4JZ	WOS:000360572300004		
J	Baba, Y; Aihara, Y; Watanabe, S				Baba, Yukihiro; Aihara, Yuko; Watanabe, Sumiko			MicroRNA-7a regulates Muller glia differentiation by attenuating Notch3 expression	EXPERIMENTAL EYE RESEARCH			English	Article						Mueller glia; miRNA; Explant culture; Mouse; Notch	MOUSE RETINA; RNA INTERFERENCE; CELLS; DICER; GENE; SPECIFICATION; MORPHOGENESIS; CANCER; FATE; HES1	miRNA-7a plays critical roles in various biological aspects in health and disease. We aimed to reveal roles of miR-7a in mouse retinal development by loss- and gain-of-function analyses of miR-7a. Plasmids encoding miR-7a or miR-7a-decoy (anti-sense miR-7a) were introduced into mouse retina at PO, and the retina was cultured as explant. Then, proliferation of retinal progenitors and differentiation of retinal subtypes were examined by immunostaining. miR-7a had no apparent effect on the proliferation of retinal progenitor cells. However, the expression of Miller glia marker, cyclin D3, was reduced by miR-7a overexpression and up-regulated by miR-7a decoy, suggesting that miR-7a negatively regulates differentiation of Muller glia. Targets of miR-7a, which were predicted by using a public program miRNA.org, and Notch3 was suggested to be one of candidate genes of miR-7a target. Notch3 3' UTR appeared to contain complementary sequence to the seed sequence of miR-7a. A reporter assay in NIH3T3 cells using a plasmid containing multiple repeats of potential target sequence of 3' Notch UTR showed that miR-7a suppress expression of reporter EGFP through 3'UTR region. Expression of sh-Notch3 and overexpression of NICD3 in retina suggested that miR-7a regulates Muller glia differentiation through attenuation of Notch3 expression. Taken together, we revealed that the miR-7a regulates the differentiation of Miller glia through the suppression of Notch3 expression. (C) 2015 Elsevier Ltd. All rights reserved.	[Baba, Yukihiro; Aihara, Yuko; Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo 1088639, Japan	Watanabe, S (reprint author), Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sumiko@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25118708]	We acknowledge Dr. Y Ouchi for discussion. This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (25118708).	Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Mouradian MM, 2012, NEUROBIOL DIS, V46, P279, DOI 10.1016/j.nbd.2011.12.046; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Usui A, 2013, DEVELOPMENT, V140, P740, DOI 10.1242/dev.090274; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Chan LWC, 2012, CURR TOP MED CHEM, V12, P920; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Hollensen AK, 2013, RNA BIOL, V10, P406, DOI 10.4161/rna.23543; Riesenberg AN, 2009, J NEUROSCI, V29, P12865, DOI 10.1523/JNEUROSCI.3382-09.2009; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Aparicio R., 2014, DEV DYNAM, V244, P21; Cooper N. G. F., 2014, INT J GENOMICS, P1; Cremisi F, 2013, FRONT CELL NEUROSCI, V7, P1; Da Ros VG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001554; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Dang L, 2006, DEV NEUROSCI-BASEL, V28, P58, DOI 10.1159/000090753; Deregowski V, 2006, J BONE MINER RES, V21, P1317, DOI 10.1359/JBMR.060505; Gonzalez-Vallinas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098556; Hibio N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00996; Pinter R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010021; Hojo M, 2000, DEVELOPMENT, V127, P2515; Karsy Michael, 2012, Genes Cancer, V3, P3, DOI 10.1177/1947601912448068; Lida A., 2011, INVEST OPHTH VIS SCI, V52, P3008; Otegi G., 2012, FRONT NEUROSCI, V5, P146; Satoh S, 2009, J NEUROSCI, V29, P12401, DOI 10.1523/JNEUROSCI.0951-09.2009; Tabata Y, 2004, MOL CELL BIOL, V24, P4513, DOI 10.1128/MCB.24.10.4513-4512.2004; Wang SL, 2000, NEURON, V27, P197, DOI 10.1016/S0896-6273(00)00028-3; Zhu MY, 2013, GENE EXPR PATTERNS, V13, P78, DOI 10.1016/j.gep.2012.12.001	37	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	SEP	2015	138						59	65		10.1016/j.exer.2015.06.022		7	Ophthalmology	Ophthalmology	CQ7IV	WOS:000360777100007		
J	Ono, T; Takada, S; Kinugawa, S; Tsutsui, H				Ono, Taisuke; Takada, Shingo; Kinugawa, Shintaro; Tsutsui, Hiroyuki			Curcumin ameliorates skeletal muscle atrophy in type 1 diabetic mice by inhibiting protein ubiquitination	EXPERIMENTAL PHYSIOLOGY			English	Article							LOWERED EXERCISE CAPACITY; KAPPA-B ACTIVATION; IMPAIRED MITOCHONDRIAL-FUNCTION; OXIDATIVE STRESS; TNF-ALPHA; PROTEASOME PATHWAY; GENE-EXPRESSION; CANCER CACHEXIA; ANGIOTENSIN-II; HEART-FAILURE	New Findings What is the central question of this study? We sought to examine whether curcumin could ameliorate skeletal muscle atrophy in diabetic mice by inhibiting protein ubiquitination, inflammatory cytokines and oxidative stress. What is the main finding and its importance? We found that curcumin ameliorated skeletal muscle atrophy in streptozotocin-induced diabetic mice by inhibiting protein ubiquitination without affecting protein synthesis. This favourable effect of curcumin was possibly due to the inhibition of inflammatory cytokines and oxidative stress. Curcumin may be beneficial for the treatment of muscle atrophy in type1 diabetes mellitus. Skeletal muscle atrophy develops in patients with diabetes mellitus (DM), especially in type1 DM, which is associated with chronic inflammation. Curcumin, the active ingredient of turmeric, has various biological actions, including anti-inflammatory and antioxidant properties. We hypothesized that curcumin could ameliorate skeletal muscle atrophy in mice with streptozotocin-induced type1 DM. C57BL/6J mice were injected with streptozotocin (200mgkg(-1) i.p.; DM group) or vehicle (control group). Each group of mice was randomly subdivided into two groups of 10 mice each and fed a diet with or without curcumin (1500mgkg(-1)day(-1)) for 2weeks. There were significant decreases in body weight, skeletal muscle weight and cellular cross-sectional area of the skeletal muscle in DM mice compared with control mice, and these changes were significantly attenuated in DM+Curcumin mice without affecting plasma glucose and insulin concentrations. Ubiquitination of protein was increased in skeletal muscle from DM mice and decreased in DM+Curcumin mice. Gene expressions of muscle-specific ubiquitin E3 ligase atrogin-1/MAFbx and MuRF1 were increased in DM and inhibited in DM+Curcumin mice. Moreover, nuclear factor-B activation, concentrations of the inflammatory cytokines tumour necrosis factor- and interleukin-1 and oxidative stress were increased in the skeletal muscle from DM mice and inhibited in DM+Curcumin mice. Curcumin ameliorated skeletal muscle atrophy in DM mice by inhibiting protein ubiquitination, inflammatory cytokines and oxidative stress. Curcumin may be beneficial for the treatment of muscle atrophy in type1 DM.	[Ono, Taisuke; Takada, Shingo; Kinugawa, Shintaro; Tsutsui, Hiroyuki] Hokkaido Univ, Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 060, Japan	Kinugawa, S (reprint author), Okkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	tuckahoe@med.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24390192, 25893005, 26350879, 26750331]; Banyu Life Science Foundation International; Suzuken Memorial Foundation; Takeda Science Foundation	This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24390192, 25893005, 26350879 and 26750331), Banyu Life Science Foundation International, Suzuken Memorial Foundation and Takeda Science Foundation.	Lu WT, 1998, TRANSPLANT P, V30, P609, DOI 10.1016/S0041-1345(97)01425-5; Chiu J, 2009, NUTRITION, V25, P964, DOI 10.1016/j.nut.2008.12.007; Jobin C, 1999, J IMMUNOL, V163, P3474; Takada S, 2014, EUR J PHARMACOL, V740, P690, DOI 10.1016/j.ejphar.2014.06.008; Anand P, 2007, MOL PHARM, V4, P807, DOI 10.1021/mp700113r; Frier BC, 2008, CELL STRESS CHAPERON, V13, P287, DOI 10.1007/s12192-008-0062-0; Sharma S, 2007, PHYTOTHER RES, V21, P278, DOI 10.1002/ptr.2070; Dehoux M, 2004, ENDOCRINOLOGY, V145, P4806, DOI 10.1210/en.2004-0406; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Liao P, 2010, AM J PHYSIOL-REG I, V298, pR599, DOI 10.1152/ajpregu.00480.2009; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Busquets S, 2007, CLIN NUTR, V26, P614, DOI 10.1016/j.clnu.2007.06.005; Tikoo K, 2008, BRIT J PHARMACOL, V153, P1225, DOI 10.1038/sj.bjp.0707666; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Du XJ, 2013, J ENDOCRINOL, V218, P75, DOI 10.1530/JOE-12-0568; Suga T, 2014, ENDOCRINOLOGY, V155, P68, DOI 10.1210/en.2013-1382; Plomgaard P, 2005, EXERC IMMUNOL REV, V11, P53; Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; Nishikawa M, 2015, NEPHROL DIAL TRANSPL, V30, P934, DOI 10.1093/ndt/gfv103; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Busquets S, 2001, CANCER LETT, V167, P33, DOI 10.1016/S0304-3835(01)00456-6; Bechara LRG, 2014, INT J CARDIOL, V175, P499, DOI 10.1016/j.ijcard.2014.06.046; Jin BW, 2007, J CELL BIOCHEM, V100, P960, DOI 10.1002/jcb.21060; Chen YW, 2009, BIOCHEM BIOPH RES CO, V388, P112, DOI 10.1016/j.bbrc.2009.07.129; NAIR KS, 1995, J CLIN INVEST, V95, P2926; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Hasselgren PO, 2002, BIOCHEM BIOPH RES CO, V290, P1, DOI 10.1006/bbrc.2001.5849; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Takada S, 2013, J APPL PHYSIOL, V114, P844, DOI 10.1152/japplphysiol.00053.2012; Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; Avci G, 2012, J SURG RES, V172, pE39, DOI 10.1016/j.jss.2011.08.021; Fukushima A, 2014, AM J PHYSIOL-ENDOC M, V307, pE503, DOI 10.1152/ajpendo.00449.2013; Griffiths RD, 1996, NUTRITION, V12, P456, DOI 10.1016/S0899-9007(96)00141-4; Kadoguchi T, 2015, EXP PHYSIOL, V100, P312, DOI 10.1113/expphysiol.2014.084095; Kelleher AR, 2010, ACTA DIABETOL, V47, P315, DOI 10.1007/s00592-010-0209-1; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Lecker SH, 1999, J NUTR, V129, p227S; Lesniewski LA, 2003, MUSCLE NERVE, V28, P493, DOI 10.1002/mus.10468; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Lv PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087254; Mastrocola R, 2008, FREE RADICAL BIO MED, V44, P584, DOI 10.1016/j.freeradbiomed.2007.10.047; Mitch WE, 1996, NEW ENGL J MED, V335, P1897; Pal R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5425; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Poylin V, 2008, MEDIAT INFLAMM, DOI 10.1155/2008/317851; vonsHaehling S, 2002, INT J CARDIOL, V85, P173; Wang Q, 2015, INT J BIOL SCI, V11, P199, DOI 10.7150/ijbs.10430; Wang XH, 2007, GENE THER, V14, P711, DOI 10.1038/sj.gt.3302927; Whitman SA, 2013, EXP CELL RES, V319, P2673, DOI 10.1016/j.yexcr.2013.07.015; Zuo L, 2014, AM J PHYSIOL-REG I, V306, pR75, DOI 10.1152/ajpregu.00425.2013	57	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	SEP 1	2015	100	9					1052	1063		10.1113/EP085049		12	Physiology	Physiology	CQ5EJ	WOS:000360625800009		
J	Yamanaka, H; Kato, K; Chimoto, K; Tsuno, S				Yamanaka, Hiroaki; Kato, Kei; Chimoto, Kosuke; Tsuno, Seiji			Estimation of surface-wave phase velocity from microtremor observation using an array with a reference station	EXPLORATION GEOPHYSICS			English	Article						array observation; cross correlation; microtremor exploration; multi-modal Rayleigh wave; phase velocity; S-wave velocity; seismic interferometry	AMBIENT SEISMIC NOISE; INVERSION; SPECTRUM	A procedure for estimation of Rayleigh wave phase velocities from microtremor observations, using an array with a reference station, is investigated in this study. Simultaneous observation of microtremors at a reference station and at a strong motion observation array in the Kanto Basin, Japan, was carried out. We first calculated cross correlations between records at the reference station and those at stations in the array using a seismic interferometric processing method on a 4300-h data series. After identifying dispersive Rayleigh waves from results of multiple filtering analysis of the cross correlations, semblance analysis of the cross correlations for different segments was carried out to estimate phase velocities for fundamental and higher-mode Rayleigh waves. The phase velocities from the proposed method are more appropriate than those from conventional methods at long periods as they avoid contamination by higher mode Rayleigh waves. The fundamental Rayleigh wave phase velocities were inverted to an S-wave velocity profile for deep sedimentary layers. We also examined the variations in the phase velocity with decreasing data duration. The phase velocities at periods less than 3 s from 6-h records are similar to those from 4300-h records, suggesting that our method is possibly applicable in microtremor exploration.	[Yamanaka, Hiroaki; Kato, Kei; Chimoto, Kosuke] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Tsuno, Seiji] Railway Tech Res Inst, Kokubunji, Tokyo 1858540, Japan	Yamanaka, H (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	yamanaka@depe.titech.ac.jp			Japan Society for the Promotion of Science [22310108]	The authors thank Nobuyuki Yamada and two reviewers for the comments that could improve the manuscript. We also acknowledge comments by Lindsay Thomas for useful suggestions to improve manuscript. A part of the study was supported with Grant-in-Aid for Scientific Research (No.22310108) by the Japan Society for the Promotion of Science.	Zaineh HE, 2012, SOIL DYN EARTHQ ENG, V39, P88, DOI 10.1016/j.soildyn.2012.03.003; Yamanaka H, 1996, B SEISMOL SOC AM, V86, P436; HORIKE M, 1985, J PHYS EARTH, V33, P59; NEIDELL NS, 1971, GEOPHYSICS, V36, P482, DOI 10.1190/1.1440186; Prieto GA, 2011, CR GEOSCI, V343, P600, DOI 10.1016/j.crte.2011.03.006; Shapiro NM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019491; Sabra KG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021862; Arai H, 2005, B SEISMOL SOC AM, V95, P1766, DOI 10.1785/0120040243; Kimman WP, 2012, B SEISMOL SOC AM, V102, P1388, DOI 10.1785/0120110069; CAPON J, 1969, P IEEE, V57, P1408, DOI 10.1109/PROC.1969.7278; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Snieder R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046610; Roberts J, 2005, EXPLOR GEOPHYS, V36, P34, DOI 10.1071/EG05034; Zhang SX, 2003, J APPL GEOPHYS, V53, P17, DOI 10.1016/S0926-9851(03)00014-4; Harmon N, 2007, B SEISMOL SOC AM, V97, P2009, DOI 10.1785/0120070050; Grutas R, 2012, EXPLOR GEOPHYS, V43, P255, DOI 10.1071/EG12031; Chimoto K., 2013, GEOPHYS EXPLORATION, V66, P179; Chimoto K, 2014, GEOPHYSICS, V79, pQ11, DOI 10.1190/GEO2013-0144.1; DZIEWONS.A, 1969, B SEISMOL SOC AM, V59, P427; Feng S., 2007, P 117 SEGJ C, P51; Gouedard P, 2008, GEOPHYS J INT, V172, P971, DOI 10.1111/j.1365-246X.2007.03654.x; Kitsunezaki C., 1990, J JSNDS, V9, P1; Okada H., 2003, GEOPHYS MONOGRAPH SE, V12; Yamanaka H, 2005, J ENVIRON ENG GEOPH, V10, P163, DOI 10.2113/JEEG10.2.163; Yamanaka H., 2006, BUTSURI TANSA, V59, P549, DOI [10.3124/segj.59.549., DOI 10.3124/SEGJ.59.549]; Yamanaka H., 2010, BUTSURI TANSA EXPLOR, V63, P409	26	0	0	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	0812-3985	1834-7533		EXPLOR GEOPHYS	Explor. Geophys.	SEP	2015	46	3					267	275		10.1071/EG14069		9	Geochemistry & Geophysics	Geochemistry & Geophysics	CQ5MK	WOS:000360648400006		
J	Zhang, BB; Xuan, C; Ji, YX; Zhang, WM; Wang, DG				Zhang, Beibei; Xuan, Chao; Ji, Yunxi; Zhang, Weiming; Wang, Daogang			Zebrafish xenotransplantation as a tool for in vivo cancer study	FAMILIAL CANCER			English	Review						Zebrafish; Xenotransplantation; Cancer	GENES-CONTROLLING DEVELOPMENT; STEM-LIKE CELL; TUMOR ANGIOGENESIS; TRANSGENIC ZEBRAFISH; CLONAL ZEBRAFISH; ADULT ZEBRAFISH; LIVER-TUMORS; DANIO-RERIO; MODEL; METASTASIS	Zebrafish represents a powerful model for cancer research. Particularly, the xenotransplantation of human cancer cells into zebrafish has enormous potential for further evaluation of cancer progression and drug discovery. Various cancer models have been established in adults, juveniles and embryos of zebrafish. This xenotransplantation zebrafish model provides a unique opportunity to monitor cancer proliferation, tumor angiogenesis, metastasis, self-renewal of cancer stem cells, and drug response in real time in vivo. This review summarizes the use of zebrafish as a model for cancer xenotransplantation, and highlights its advantages and disadvantages.	[Zhang, Beibei] Mie Univ, Grad Sch Med, Tsu, Mie 514, Japan; [Xuan, Chao] Qingdao Univ, Dept Clin Lab, Affiliated Hosp, Coll Med, Qingdao 266071, Peoples R China; [Ji, Yunxi; Wang, Daogang] Guangxi Univ Chinese Med, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China; [Zhang, Weiming] Binzhou Med Coll, Affiliated Hosp, Dept Oncol, Binzhou, Peoples R China	Wang, DG (reprint author), Guangxi Univ Chinese Med, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China.	gxcmuwdg@126.com					Tobia C, 2013, BBA-MOL BASIS DIS, V1832, P1371, DOI 10.1016/j.bbadis.2013.01.016; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Soroldoni Daniele, 2009, V546, P117, DOI 10.1007/978-1-60327-977-2_8; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Rouhi P, 2010, NAT PROTOC, V5, P1911, DOI 10.1038/nprot.2010.150; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Mizgirev I, 2010, NAT PROTOC, V5, P383, DOI 10.1038/nprot.2010.8; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; Love DR, 2004, CURR OPIN BIOTECH, V15, P564, DOI 10.1016/j.copbio.2004.09.004; Goessling W, 2007, NAT METHODS, V4, P551, DOI 10.1038/NMETH1059; Sun SY, 2010, BIOCHEM BIOPH RES CO, V396, P843, DOI 10.1016/j.bbrc.2010.04.170; Smith ACH, 2010, BLOOD, V115, P3296, DOI 10.1182/blood-2009-10-246488; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Lal S, 2012, J NEUROSCI RES, V90, P769, DOI 10.1002/jnr.22794; Stoletov K, 2008, ONCOGENE, V27, P4509, DOI 10.1038/onc.2008.95; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Tobia C, 2011, INT J DEV BIOL, V55, P505, DOI 10.1387/ijdb.103238ct; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Goldsmith P, 2004, CURR OPIN PHARMACOL, V4, P504, DOI 10.1016/j.coph.2004.04.005; Zhao CJ, 2011, CARCINOGENESIS, V32, P1143, DOI 10.1093/carcin/bgr076; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Liu NA, 2011, P NATL ACAD SCI USA, V108, P8414, DOI 10.1073/pnas.1018091108; Snaar-Jagalska BE, 2009, ZEBRAFISH, V6, P441, DOI 10.1089/zeb.2009.0614; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Yang LL, 2014, MOLECULES, V19, P2390, DOI 10.3390/molecules19022390; Mizgireuv IV, 2006, CANCER RES, V66, P3120, DOI 10.1158/0008-5472.CAN-05-3800; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Eguiara A, 2011, CELL CYCLE, V10, P3751, DOI 10.4161/cc.10.21.17921; Zhang L, 2012, CYTOM PART A, V81A, P176, DOI 10.1002/cyto.a.21167; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Patton EE, 2010, PIGM CELL MELANOMA R, V23, P314, DOI 10.1111/j.1755-148X.2010.00693.x; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Taylor AM, 2009, ZEBRAFISH, V6, P339, DOI 10.1089/zeb.2009.0607; Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Funfak A, 2007, LAB CHIP, V7, P1132, DOI 10.1039/b701116d; Granato M, 1996, CURR OPIN GENET DEV, V6, P461, DOI 10.1016/S0959-437X(96)80068-2; Harfouche R, 2009, ANGIOGENESIS, V12, P325, DOI 10.1007/s10456-009-9154-4; Ignatius MS, 2009, ZEBRAFISH, V6, P377, DOI 10.1089/zeb.2009.0610; Kalen M, 2009, CHEM BIOL, V16, P432, DOI 10.1016/j.chembiol.2009.02.010; Kuroyanagi J, 2014, FEBS LETT, V588, P3409, DOI 10.1016/j.febslet.2014.07.033; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Moshal Karni S, 2011, Cancers (Basel), V3, P4102, DOI 10.3390/cancers3044102; Nicoli S, 2008, BLOOD, V111, P4965, DOI 10.1182/blood-2007-10-118166; Payne E, 2009, BRIT J HAEMATOL, V146, P247, DOI 10.1111/j.1365-2141.2009.07705.x; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Shimada Y, 2014, METHODS MOL BIOL, V1165, P223, DOI 10.1007/978-1-4939-0856-1_15; Spitsbergen J, 2007, NAT METHODS, V4, P548, DOI 10.1038/nmeth0707-548; Stern HM, 2003, NAT REV CANCER, V3, P533, DOI 10.1038/nrc1126; Tamplin OJ, 2012, WIRES DEV BIOL, V1, P459, DOI 10.1002/wdev.37; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; Yang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061801; Zhang BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085439; Zhang BB, 2014, TUMOR BIOL, V35, P11861, DOI 10.1007/s13277-014-2417-8; Zon LI, 2010, ZEBRAFISH, V7, P1, DOI 10.1089/zeb.2010.9996	70	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1389-9600	1573-7292		FAM CANCER	Fam. Cancer	SEP	2015	14	3					487	493		10.1007/s10689-015-9802-3		7	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CQ6HV	WOS:000360706200018		
J	Sugawara, Y; Iwamori, M; Matsumura, T; Yutani, M; Amatsu, S; Fujinaga, Y				Sugawara, Yo; Iwamori, Masao; Matsumura, Takuhiro; Yutani, Masahiro; Amatsu, Sho; Fujinaga, Yukako			Clostridium botulinum type C hemagglutinin affects the morphology and viability of cultured mammalian cells via binding to the ganglioside GM3	FEBS JOURNAL			English	Article						botulinum toxin; ganglioside; GM3; hemagglutinin; sialic acid	INTESTINAL EPITHELIAL-CELLS; PROGENITOR TOXIN; CRYSTAL-STRUCTURE; HA PROTEINS; E-CADHERIN; ADHESION; COMPLEX; SUBCOMPONENT; MICRODOMAINS; RECOGNITION	Botulinum neurotoxin is conventionally divided into seven serotypes, designated A-G, and is produced as large protein complexes through associations with non-toxic components, such as hemagglutinin (HA) and non-toxic non-HA. These non-toxic proteins dramatically enhance the oral toxicity of the toxin complex. HA is considered to have a role in toxin transport through the intestinal epithelium by carbohydrate binding and epithelial barrier-disrupting activity. Type A and B HAs disrupt E-cadher-in-mediated cell adhesion, and, in turn, the intercellular epithelial barrier. Type C HA (HA/C) disrupts the barrier function by affecting cell morphology and viability, the mechanism of which remains unknown. In this study, we identified GM3 as the target molecule of HA/C. We found that sialic acid binding of HA is essential for the activity. It was abolished when cells were pre-treated with an inhibitor of ganglioside synthesis. Consistent with this, HA/C bound to a-series gangliosides in a glycan array. In parallel, we isolated clones resistant to HA/C activity from a susceptible mouse fibroblast strain. These cells lacked expression of ST-I, the enzyme that transfers sialic acid to lactosylceramide to yield GM3. These clones became sensitive to HA/C activity when GM3 was expressed by transfection with the ST-I gene. The sensitivity of fibroblasts to HA/C was reduced by expressing ganglioside synthesis genes whose products utilize GM3 as a substrate and consequently generate other a-series gangliosides, suggesting a GM3-specific mechanism. Our results demonstrate that HA/C affects cells in a GM3-dependent manner.	[Sugawara, Yo; Matsumura, Takuhiro; Yutani, Masahiro; Amatsu, Sho; Fujinaga, Yukako] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Infect Cell Biol, Suita, Osaka 5650871, Japan; [Iwamori, Masao] Kinki Univ, Fac Sci & Technol, Dept Biochem, Higashi Osaka, Osaka, Japan	Fujinaga, Y (reprint author), Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Infect Cell Biol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	yukafuji@biken.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) (KAKENHI) [25860319]	We are grateful to Masatoshi Takeichi (Riken Center for Developmental Biology, Kobe Japan) for providing cells and plasmids, and Shunji Kozaki (Department of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Japan) for providing the anti-type C L-PTC antiserum. We thank Daisuke Okuzaki (Research Institute for Microbial Diseases, Osaka University, Japan) for glycan array analysis, and Masanori Yagi and Toshihiro Horii (Research Institute for Microbial Diseases, Osaka University, Japan) for use of a lyophilizer. We also thank Yuki Sano, Asami Sano, Takayuki Yoshimura, Chiyoko Aoki and Yuriko Tanaka for technical assistance. This work was supported by the Japan Society for the Promotion of Science (JSPS) (KAKENHI grant number 25860319).	Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Arimitsu H, 2008, MICROB PATHOGENESIS, V45, P142, DOI 10.1016/j.micpath.2008.04.007; Nishikawa A, 2004, BIOCHEM BIOPH RES CO, V319, P327, DOI 10.1016/j.bbrc.2004.04.183; Oguma K, 1999, J TOXICOL-TOXIN REV, V18, P17; Amatsu S, 2013, J BIOL CHEM, V288, P35617, DOI 10.1074/jbc.M113.521179; Fujita A, 2009, BBA-MOL CELL BIOL L, V1791, P388, DOI 10.1016/j.bbalip.2009.01.008; Fujinaga Y, 1997, MICROBIOL-UK, V143, P3841; Fujinaga Y, 2000, FEBS LETT, V467, P179, DOI 10.1016/S0014-5793(00)01147-9; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Fujinaga Y, 2004, MICROBIOL-SGM, V150, P1529, DOI [10.1099/mic.0.26805-0, 10.1099/mic.0.026805-0]; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; Kiguchi K, 2006, CANCER SCI, V97, P1321, DOI 10.1111/j.1349-7006.2006.00326.x; Lee K, 2014, SCIENCE, V344, P1405, DOI 10.1126/science.1253823; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Yamashita S, 2012, FEBS LETT, V586, P2404, DOI 10.1016/j.febslet.2012.05.055; Nakamura T, 2008, J MOL BIOL, V376, P854, DOI 10.1016/j.jmb.2007.12.031; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Hakomori SI, 1998, ANN NY ACAD SCI, V845, P1, DOI 10.1111/j.1749-6632.1998.tb09657.x; Kouguchi H, 2002, J BIOL CHEM, V277, P2650, DOI 10.1074/jbc.M106762200; Simpson L, 2013, TOXICON, V68, P40, DOI 10.1016/j.toxicon.2013.02.014; Inoue K, 1999, MICROBIOL-UK, V145, P2533; Lee K, 2014, BIOCHEM BIOPH RES CO, V446, P568, DOI 10.1016/j.bbrc.2014.03.008; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; NORES GA, 1987, J IMMUNOL, V139, P3171; Chen Y, 2008, J LIPID RES, V49, P2268, DOI 10.1194/jlr.D800031-JLR200; Jin YJ, 2009, MICROBIOL-SGM, V155, P35, DOI 10.1099/mic.0.021246-0; Rossetto O, 2014, NAT REV MICROBIOL, V12, P535, DOI 10.1038/nrmicro3295; ZHENG MZ, 1993, J BIOL CHEM, V268, P2217; Inoue K, 2003, MICROBIOL-SGM, V149, P3361, DOI 10.1099/mic.0.26586-0; Inui K, 2010, J VET MED SCI, V72, P1251, DOI 10.1292/jvms.10-0090; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Jennemann R, 2013, PROG LIPID RES, V52, P231, DOI 10.1016/j.plipres.2013.02.001; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Daniotti Jose L, 2013, Front Oncol, V3, P306, DOI 10.3389/fonc.2013.00306; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Krengel U, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00325; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Sugawara Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111170	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	SEP	2015	282	17					3334	3347		10.1111/febs.13346		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CQ5FR	WOS:000360629200008		
J	Fujishiro, T; Ataka, K; Ermler, U; Shima, S				Fujishiro, Takashi; Ataka, Kenichi; Ermler, Ulrich; Shima, Seigo			Towards a functional identification of catalytically inactive [Fe]-hydrogenase paralogs	FEBS JOURNAL			English	Article						[Fe]-hydrogenase; Hmd paralogs; methanogenic archaea; sensor protein; tetrahydromethanopterin	CLUSTER-FREE HYDROGENASE; COMPLETE GENOME SEQUENCE; H-2-FORMING METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE; TRANSFER-RNA SYNTHETASE; ACYL-IRON LIGATION; METHANOGENIC ARCHAEA; ACTIVE-SITE; CRYSTAL-STRUCTURE; H-2 ACTIVATION; INFRARED-SPECTROSCOPY	[Fe]-hydrogenase (Hmd), an enzyme of the methanogenic energy metabolism, harbors an iron-guanylylpyridinol (FeGP) cofactor used for H-2 cleavage. The generated hydride is transferred to methenyl-tetrahydromethanopterin (methenyl-H4MPT+). Most hydrogenotrophic methanogens contain the hmd-related genes hmdII and hmdIII. Their function is still elusive. We were able to reconstitute the HmdII holoenzyme of Methanocaldococcus jannaschii with recombinantly produced apoenzyme and the FeGP cofactor, which is a prerequisite for in vitro functional analysis. Infrared spectroscopic and X-ray structural data clearly indicated binding of the FeGP cofactor. Methylene-H4MPT binding was detectable in the significantly altered infrared spectra of the HmdII holoenzyme and in the HmdII apoenzyme-methylene-H4MPT complex structure. The related binding mode of the FeGP cofactor and methenyl-H4MPT+ compared with Hmd and their multiple contacts to the polypeptide highly suggest a biological role in HmdII. However, holo-HmdII did not catalyze the Hmd reaction, not even in a single turnover process, as demonstrated by kinetic measurements. The found inactivity can be rationalized by an increased contact area between the C-and N-terminal folding units in HmdII compared with in Hmd, which impairs the catalytically necessary open-to-close transition, and by an exchange of a crucial histidine to a tyrosine. Mainly based on the presented data, a function of HmdII as Hmd isoenzyme, H2 sensor, FeGP-cofactor storage protein and scaffold protein for FeGP-cofactor biosynthesis could be excluded. Inspired by the recently found binding of HmdII to aminoacyl-tRNA synthetases and tRNA, we tentatively consider HmdII as a regulatory protein for protein synthesis that senses the intracellular methylene-H4MPT concentration.	[Fujishiro, Takashi; Shima, Seigo] Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany; [Ataka, Kenichi] Free Univ Berlin, Dept Phys, Berlin, Germany; [Ermler, Ulrich] Max Planck Inst Biophys, Frankfurt, Germany; [Shima, Seigo] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Shima, S (reprint author), Max Planck Inst Terr Mikrobiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	shima@mpi-marburg.mpg.de	Fujishiro, Takashi/F-4804-2013	Fujishiro, Takashi/0000-0001-7967-8380	Max Planck Society; Japan Science and Technology Agency	We thank Prof. Dr Rolf Thauer for discussions and helpful suggestions, Prof. Dr Hartmut Michel for continuous support, and the staff of the PXII beamline at the Swiss Light Source (Villigen) and Ulrike Demmer for help during data collection and X-ray structure analysis. We thank Prof. Ya-Ming Hou for kindly providing the expression plasmid for M. jannaschii HmdII. This work was supported by a grant of the Max Planck Society to R. Thauer and a grant of the PRESTO program from the Japan Science and Technology Agency to SS.	Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Tamura H, 2013, ANGEW CHEM INT EDIT, V52, P9656, DOI 10.1002/anie.201305089; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Shima S, 2005, J AM CHEM SOC, V127, P10430, DOI 10.1021/ja051895o; Lyon EJ, 2004, J AM CHEM SOC, V126, P14239, DOI 10.1021/ja046818s; Lie TJ, 2013, FEMS MICROBIOL LETT, V343, P156, DOI 10.1111/1574-6968.12141; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Shima S, 2012, DALTON T, V41, P767, DOI 10.1039/c1dt11093d; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walker CB, 2012, ISME J, V6, P2045, DOI 10.1038/ismej.2012.60; Afting C, 2000, ARCH MICROBIOL, V174, P225, DOI 10.1007/s002030000197; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Schick M, 2012, J AM CHEM SOC, V134, P3271, DOI 10.1021/ja211594m; Reeve JN, 1997, J BACTERIOL, V179, P5975; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Shima S, 2004, ANGEW CHEM INT EDIT, V43, P2547, DOI 10.1002/anie.200353763; Buurman G, 2000, FEBS LETT, V485, P200, DOI 10.1016/S0014-5793(00)02225-0; Smith DR, 1997, J BACTERIOL, V179, P7135; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Hiromoto T, 2009, FEBS LETT, V583, P585, DOI 10.1016/j.febslet.2009.01.017; Shima S, 2011, METHOD ENZYMOL, V494, P119, DOI 10.1016/B978-0-12-385112-3.00007-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shima S, 2011, EUR J INORG CHEM, P963, DOI 10.1002/ejic.201000955; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Hiromoto T, 2009, ANGEW CHEM INT EDIT, V48, P6457, DOI 10.1002/anie.200902695; Shima S, 2011, FEBS LETT, V585, P353, DOI 10.1016/j.febslet.2010.12.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Korbas M, 2006, J BIOL CHEM, V281, P30804, DOI 10.1074/jbc.M605306200; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Fujishiro T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7895; Fujishiro T, 2013, ANGEW CHEM INT EDIT, V52, P12555, DOI 10.1002/anie.201306745; Goker M, 2011, STAND GENOMIC SCI, V5, P407, DOI 10.4056/sigs.2465574; Goldman AD, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-199; Kamtekar S, 2003, P NATL ACAD SCI USA, V100, P1673, DOI 10.1073/pnas.0437911100; Lipman RSA, 2003, BIOCHEMISTRY-US, V42, P7487, DOI 10.1021/bi0344533; Lipman RSA, 2000, BIOCHEMISTRY-US, V39, P7792, DOI 10.1021/bi0004955; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oza JP, 2012, BIOCHEMISTRY-US, V51, P2378, DOI 10.1021/bi300106p; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; Pilak O, 2004, THESIS PHILLIPPS U M; SCHWORER B, 1991, ARCH MICROBIOL, V155, P459, DOI 10.1007/BF00244962; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shima S, 2010, ANGEW CHEM INT EDIT, V49, P9917, DOI 10.1002/anie.201006255; Shima S, 2001, METHOD ENZYMOL, V331, P317; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	SEP	2015	282	17					3412	3423		10.1111/febs.13351		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CQ5FR	WOS:000360629200012		
J	Teranishi, Y; Inoue, M; Yamamoto, NG; Kihara, T; Wiehager, B; Ishikawa, T; Winblad, B; Schedin-Weiss, S; Frykman, S; Tjernberg, LO				Teranishi, Yasuhiro; Inoue, Mitsuhiro; Yamamoto, Natsuko Goto; Kihara, Takahiro; Wiehager, Birgitta; Ishikawa, Taizo; Winblad, Bengt; Schedin-Weiss, Sophia; Frykman, Susanne; Tjernberg, Lars O.			Proton myo-inositol cotransporter is a novel gamma-secretase associated protein that regulates Ab production without affecting Notch cleavage	FEBS JOURNAL			English	Article						Alzheimer's disease; amyloid beta-peptide; Notch; proton myo-inositol cotransporter; gamma-secretase	BETA-PEPTIDE PRODUCTION; ALZHEIMERS-DISEASE; BRAIN; IDENTIFICATION; MODULATORS; INHIBITORS; COMPLEXES; A-BETA-43	gamma-Secretase is a transmembrane protease complex that is responsible for the processing of a multitude of type 1 transmembrane proteins, including the amyloid precursor protein and Notch. gamma-Secretase processing of amyloid precursor protein results in the release of the amyloid beta-peptide (A beta), which is involved in the pathogenesis in Alzheimer's disease. Processing of Notch leads to the release of its intracellular domain, which is important for cell development. gamma-Secretase associated proteins (GSAPs) could be of importance for substrate selection, and we have previously shown that affinity purification of gamma-secretase in combination with mass spectrometry can be used for finding such proteins. In the present study, we used this methodology to screen for novel GSAPs from human brain, and studied their effect on A beta production in a comprehensive gene knockdown approach. Silencing of probable phospholipid-transporting ATPase IIA, brain-derived neurotrophic factor/neurotrophin-3 growth factor receptor precursor and proton myo-inositol cotransporter (SLC2A13) showed a clear reduction of A beta and these proteins were selected for further studies on A beta production and Notch cleavage using small interfering RNA-mediated gene silencing, as well as an overexpression approach. Silencing of these reduced A beta secretion in a small interfering RNA dose-dependent manner. Interestingly, SLC2A13 had a lower effect on Notch processing. Furthermore, overexpression of SLC2A13 increased A beta 40 generation. Finally, the interaction between gamma-secretase and SLC2A13 was confirmed using immunoprecipitation and a proximity ligation assay. In summary, SLC2A13 was identified as a novel GSAP that regulates A beta production without affecting Notch cleavage. We suggest that SLC2A13 could be a target for A beta lowering therapy aimed at treating Alzheimer's disease.	[Teranishi, Yasuhiro; Inoue, Mitsuhiro; Yamamoto, Natsuko Goto; Kihara, Takahiro; Wiehager, Birgitta; Winblad, Bengt; Schedin-Weiss, Sophia; Frykman, Susanne; Tjernberg, Lars O.] Karolinska Inst, Ctr Alzheimer Res, Dept NVS, Div Neurogeriatr, S-14157 Huddinge, Sweden; [Teranishi, Yasuhiro; Inoue, Mitsuhiro; Yamamoto, Natsuko Goto] Dainippon Sumitomo Pharma Co Ltd, Drug Dev Res Labs, Osaka, Japan; [Kihara, Takahiro] Dainippon Sumitomo Pharma Co Ltd, Genom Sci Labs, Osaka, Japan; [Ishikawa, Taizo] Dainippon Sumitomo Pharma Co Ltd, Innovat Drug Discovery Res Labs, Osaka, Japan	Tjernberg, LO (reprint author), Karolinska Inst, Ctr Alzheimer Res, Dept NVS, Div Neurogeriatr, S-14157 Huddinge, Sweden.	lars.tjernberg@ki.se			Dainippon Sumitomo Pharma; Alzheimerfonden; Knut and Alice Wallenberg Foundation; Gun and Bertil Stohnes Foundation; Stiftelsen for Gamla Tjanarinnor	The HEK-APP cells were kindly provided by Dr Eirikur Benedikz (University of Southern Denmark) and the HEK-Notch Delta E cells were kindly provided by Dr Helena Karlstrom (Karolinska Institutet). The study was funded by Dainippon Sumitomo Pharma, Alzheimerfonden, Knut and Alice Wallenberg Foundation, Gun and Bertil Stohnes Foundation, and Stiftelsen for Gamla Tjanarinnor.	Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Wolfe MS, 2012, J NEUROCHEM, V120, P89, DOI 10.1111/j.1471-4159.2011.07501.x; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Uldry M, 2001, EMBO J, V20, P4467, DOI 10.1093/emboj/20.16.4467; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Wanngren J, 2012, J BIOL CHEM, V287, P32640, DOI 10.1074/jbc.M112.376541; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Teranishi Y, 2010, J CELL MOL MED, V14, P2675, DOI 10.1111/j.1582-4934.2009.00907.x; Frykman S, 2012, NEUROCHEM INT, V61, P108, DOI 10.1016/j.neuint.2012.03.016; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Hur JY, 2012, J BIOL CHEM, V287, P11991, DOI 10.1074/jbc.M111.246074; Inoue M, 2015, FEBS J, V282, P2587, DOI 10.1111/febs.13303; Schedin-Weiss S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063962; Lee J, 2011, BIOCHEMISTRY-US, V50, P4973, DOI 10.1021/bi200026m; Nilsson T, 2006, BIOCHEM BIOPH RES CO, V341, P1294, DOI 10.1016/j.bbrc.2006.01.096; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Teranishi Y, 2012, BIOCHEM BIOPH RES CO, V424, P476, DOI 10.1016/j.bbrc.2012.06.137; Ueda Y, 2014, MOL NEUROBIOL, V50, P821, DOI 10.1007/s12035-014-8768-8; Wolfe MS, 2007, CURR ALZHEIMER RES, V4, P571, DOI 10.2174/156720507783018299	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	SEP	2015	282	17					3438	3451		10.1111/febs.13353		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CQ5FR	WOS:000360629200014		
J	Sasaki, T				Sasaki, Takafumi			The Effects of Liquidity Shocks on Corporate Investments and Cash Holdings: Evidence from Actuarial Pension Gains/Losses	FINANCIAL MANAGEMENT			English	Article							RESEARCH-AND-DEVELOPMENT; FINANCING CONSTRAINTS; FLOW SENSITIVITY; DECISIONS; EQUITY; PLANS; DETERMINANTS; INFORMATION; FIRMS	This paper investigates how anticipated liquidity shocks affect corporate investment and cash holdings by examining the impacts of actuarial pension gains/losses that do not reduce current internal resources but will reduce those available in the future. Using a sample from Japanese manufacturing firms in which pension deficits had a huge impact on the internal resources of sponsoring firms, I show that pension losses significantly decrease the capital expenditures of sponsoring firms. Pension losses also increase corporate cash holdings, suggesting precautionary demands for cash prepared for future pension contributions. Overall, the results indicate that managers consider anticipated liquidity shocks in determining current investment and cash-saving policies.	Tokyo Univ Sci, Finance, Tokyo 162, Japan	Sasaki, T (reprint author), Tokyo Univ Sci, Finance, Tokyo 162, Japan.				Japan Society for the Promotion of Science (JSPS) [24330124, 22530370]	I appreciate the helpful comments from Raghavendra Rau (Editor), an anonymous referee, Hideki Hanaeda, Takato Hiraki, as well as seminar participants at NLI Research Institute and Waseda University. This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (B) Grant Number 24330124 and Grant-in-Aid for Scientific Research (C) Grant Number 22530370. All errors remain the sole responsibility of the author.	Aca S., 2008, J BANK FINANC, V32, P207; Opler T, 1999, J FINANC ECON, V52, P3, DOI 10.1016/S0304-405X(99)00003-3; Stein JC, 2003, HANDB ECON, V21, P111; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Bakke TE, 2012, J FINANC, V67, P1083, DOI 10.1111/j.1540-6261.2012.01742.x; Chang X, 2006, J FINANC, V61, P3009, DOI 10.1111/j.1540-6261.2006.01010.x; MYERS SC, 1984, J FINANC ECON, V13, P187, DOI 10.1016/0304-405X(84)90023-0; Bates TW, 2009, J FINANC, V64, P1985, DOI 10.1111/j.1540-6261.2009.01492.x; Rauh JD, 2006, J FINANC, V61, P33, DOI 10.1111/j.1540-6261.2006.00829.x; Brown JR, 2009, J BANK FINANC, V33, P971, DOI 10.1016/j.jbankfin.2008.10.009; Brown JR, 2009, J FINANC, V64, P151, DOI 10.1111/j.1540-6261.2008.01431.x; MYERS SC, 1977, J FINANC ECON, V5, P147, DOI 10.1016/0304-405X(77)90015-0; Almeida H, 2004, J FINANC, V59, P1777, DOI 10.1111/j.1540-6261.2004.00679.x; Bergstresser D, 2006, Q J ECON, V121, P157; Campbell JL, 2012, REV FINANC STUD, V25, P868, DOI 10.1093/rfs/hhr119; Campbell JL, 2010, CONTEMP ACCOUNT RES, V27, P469, DOI 10.1111/j.1911-3846.2010.01015.x; Fazzari S., 1988, BROOKINGS PAPERS EC, V1, P141, DOI DOI 10.2307/2534426; Franzoni F, 2009, J FINANC ECON, V92, P491, DOI 10.1016/j.jfineco.2008.06.004; Hubbard RG, 1998, J ECON LIT, V36, P193; Iskandar-Datta ME, 2012, J BANK FINANC, V36, P898, DOI 10.1016/j.jbankfin.2011.10.003; Kaplan SN, 1997, Q J ECON, V112, P169, DOI 10.1162/003355397555163; Lamont O, 1997, J FINANC, V52, P83, DOI 10.2307/2329557; McLellan S., 2005, BENEFITS Q, V21, P31; Phan HV, 2013, FINANC MANAGE, V42, P373, DOI 10.1111/j.1755-053X.2012.01218.x; Standard, 2006, CORP RAT CRIT; Towers/Watson, 2012, GLOB PENS STUD 2012; Yermo J., 2010, OECD WORKING PAPERS, V3	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0046-3892	1755-053X		FINANC MANAGE	Financ. Manage.	FAL	2015	44	3					685	707		10.1111/fima.12106		23	Business, Finance	Business & Economics	CQ7YU	WOS:000360823600007		
J	Chew, SH; Toyokuni, S				Chew, Shan Hwu; Toyokuni, Shinya			Malignant mesothelioma as an oxidative stress-induced cancer: An update	FREE RADICAL BIOLOGY AND MEDICINE			English	Review						Malignant mesothelioma; Asbestos; Iron; MicroRNA; Cancer stem cell	MEGAKARYOCYTE POTENTIATING FACTOR; GROWTH-FACTOR-RECEPTOR; NF-KAPPA-B; ASBESTOS-INDUCED ONCOGENESIS; DNA SINGLE-STRAND; PLEURAL MESOTHELIOMA; CROCIDOLITE ASBESTOS; CHRYSOTILE ASBESTOS; CARBON NANOTUBES; FERRIC NITRILOTRIACETATE	Malignant mesothelioma (MM) is a relatively rare cancer that occurs almost exclusively following respiratory exposure to asbestos in humans. Its pathogenesis is closely associated with iron overload and oxidative stress in mesothelial cells. On fiber exposure, mesothelial cells accumulate fibers simultaneously with iron, which either performs physical scissor function or catalyzes free radical generation, leading to oxidative DNA damage such as strand breaks and base modifications, followed by activation of intracellular signaling pathways. Chrysotile, per se without iron, causes massive hemolysis and further adsorbs hemoglobin. Exposure to indigestible foreign materials also induces chronic inflammation, involving consistent generation of free radicals and subsequent activation of NALP3 inflammasomes in macrophages. All of these contribute to mesothelial carcinogenesis. Genomic alterations most frequently involve homozygous deletion of INK4A/4B, and other pathways such as Hippo and TGF-beta pathways are also affected in MM. Recently, analyses of familial MM sorted out BAP] as a novel responsible tumor suppressor gene, whose function is not fully elucidated. Five-year survival of mesothelioma is still similar to 8%, and this cancer is increasing worldwide. Connective tissue growth factor, a secretory protein creating a vicious cycle mediated by beta-catenin, has been recognized as a hopeful target for therapy, especially in sarcomatoid subtype. Recent research outcomes related to microRNAs and cancer stem cells also offer additional novel targets for the treatment of MM. Iron reduction as chemoprevention of mesothelioma is helpful at least in an animal preclinical study. Integrated approaches to fiber-induced oxidative stress would be necessary to overcome this currently fatal disease. (C) 2015 Elsevier Inc. All rights reserved.	[Chew, Shan Hwu; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Showa Ku, Nagoya, Aichi 4668550, Japan	Toyokuni, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	toyokuni@med.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010	Toyokuni, Shinya/0000-0002-5757-1109	National Cancer Center Research and Development Fund [25-A-5]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24390094, 221S0001-04, 24108001]; Yasuda Medical Foundation	This work was supported in part by the National Cancer Center Research and Development Fund (25-A-5), a grant-in-aid for research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (24390094; 221S0001-04; 24108001), and the Yasuda Medical Foundation..	Aierken D, 2014, NAGOYA J MED SCI, V76, P149; Akatsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043403; Akatsuka S, 2010, J CLIN BIOCHEM NUTR, V47, P91, DOI 10.3164/jcbn.10-38R; Akatsuka S, 2006, AM J PATHOL, V169, P1328, DOI 10.2353/ajpath.2006.051280; Hollevoet K, 2012, J CLIN ONCOL, V30, P1541, DOI 10.1200/JCO.2011.39.6671; TOYOKUNI S, 1994, INT J CANCER, V57, P123, DOI 10.1002/ijc.2910570122; Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Jimenez LA, 1997, AM J PHYSIOL-LUNG C, V273, pL1029; Hu Q, 2010, LAB INVEST, V90, P360, DOI 10.1038/labinvest.2009.140; Tabata C, 2013, J CLIN GASTROENTEROL, V47, pE7, DOI 10.1097/MCG.0b013e31824e901b; Shi M, 2011, AM J SURG PATHOL, V35, P878, DOI 10.1097/PAS.0b013e318218985b; Vandermeers F, 2009, CLIN CANCER RES, V15, P2818, DOI 10.1158/1078-0432.CCR-08-1579; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Nagai H, 2011, P NATL ACAD SCI USA, V108, pE1330, DOI 10.1073/pnas.1110013108; Okazaki Y, 2013, CANCER SCI, V104, P989, DOI 10.1111/cas.12185; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jube S, 2012, CANCER RES, V72, P3290, DOI 10.1158/0008-5472.CAN-11-3481; Zanella CL, 1999, AM J PHYSIOL-LUNG C, V277, pL684; Jiang L, 2012, J PATHOL, V228, P366, DOI 10.1002/path.4075; MOSSMAN BT, 1990, SCIENCE, V247, P294, DOI 10.1126/science.2153315; Hanemann CO, 2008, BRAIN, V131, P606, DOI 10.1093/brain/awm249; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; WAGNER JC, 1988, BRIT J IND MED, V45, P305; REEVES AL, 1971, ENVIRON RES, V4, P496, DOI 10.1016/0013-9351(71)90010-7; Zacharski LR, 2008, J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209; Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014; Lee HB, 2007, J KOREAN MED SCI, V22, P943, DOI 10.3346/jkms.2007.22.6.943; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Qi F, 2013, AM J PATHOL, V183, P1654, DOI 10.1016/j.ajpath.2013.07.029; Pantazopoulos I, 2013, EUR RESPIR J, V41, P706, DOI 10.1183/09031936.00226111; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Benjamin H, 2010, J MOL DIAGN, V12, P771, DOI 10.2353/jmoldx.2010.090169; Yokoyama T, 2008, CARCINOGENESIS, V29, P2139, DOI 10.1093/carcin/bgn200; Ray M, 2009, CHEST, V136, P888, DOI 10.1378/chest.08-2665; Stecklein SR, 2012, P NATL ACAD SCI USA, V109, P13650, DOI 10.1073/pnas.1203326109; SEKIDO Y, 1995, CANCER RES, V55, P1227; Grigoriu B, 2009, CLIN BIOCHEM, V42, P1046, DOI 10.1016/j.clinbiochem.2009.03.007; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; MAPLES KR, 1992, CARCINOGENESIS, V13, P2035, DOI 10.1093/carcin/13.11.2035; Creaney J, 2007, CHEST, V132, P1239, DOI 10.1378/chest.07-0013; WAGNER JC, 1973, BRIT J CANCER, V28, P173, DOI 10.1038/bjc.1973.134; Yang HN, 2010, P NATL ACAD SCI USA, V107, P12611, DOI 10.1073/pnas.1006542107; Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; LANGER AM, 1982, LANCET, V2, P1101; Mutsaers SE, 2000, J PATHOL, V190, P86; MACNAB G, 1967, NATURE, V214, P522, DOI 10.1038/214522a0; Frei C, 2011, CARCINOGENESIS, V32, P1324, DOI 10.1093/carcin/bgr127; MCFADDEN D, 1986, AM J PATHOL, V123, P95; Takagi A, 2008, J TOXICOL SCI, V33, P105, DOI 10.2131/jts.33.105; Gee GV, 2010, INT J CANCER, V127, P2859, DOI 10.1002/ijc.25285; Boutin C, 1996, AM J RESP CRIT CARE, V153, P444; Kanarek MS, 2011, ANN EPIDEMIOL, V21, P688, DOI 10.1016/j.annepidem.2011.05.010; Nagai H, 2011, CANCER SCI, V102, P2118, DOI 10.1111/j.1349-7006.2011.02087.x; Shersher DD, 2013, SURG ONCOL CLIN N AM, V22, P345, DOI 10.1016/j.soc.2012.12.004; Illei PB, 2003, CANCER CYTOPATHOL, V99, P51, DOI 10.1002/cncr.10923; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Van Schil PE, 2014, EUR RESPIR J, V44, P754, DOI 10.1183/09031936.00207213; MacCorkle RA, 2006, CELL MOTIL CYTOSKEL, V63, P646, DOI 10.1002/cm.20151; Cortes-Dericks L, 2010, INT J ONCOL, V37, P437, DOI 10.3892/ijo_00000692; Cunniff B, 2013, J CELL PHYSIOL, V228, P835, DOI 10.1002/jcp.24232; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Haas AR, 2013, CLIN CHEST MED, V34, P99, DOI 10.1016/j.ccm.2012.12.005; Balatti V, 2011, J THORAC ONCOL, V6, P844, DOI 10.1097/JTO.0b013e31820db125; Kim MC, 2013, ASIAN PAC J CANCER P, V14, P3625, DOI 10.7314/APJCP.2013.14.6.3625; GOODGLICK LA, 1986, CANCER RES, V46, P5558; Toyokuni S, 2013, ADV DRUG DELIVER REV, V65, P2098, DOI 10.1016/j.addr.2013.05.011; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; TOYOKUNI S, 1995, INT J CANCER, V62, P309, DOI 10.1002/ijc.2910620313; Pache JC, 1998, AM J PATHOL, V152, P333; Wang YH, 2004, INT J ONCOL, V25, P173; Yang HN, 2006, P NATL ACAD SCI USA, V103, P10397, DOI 10.1073/pnas.0604008103; Hollevoet K, 2010, AM J RESP CRIT CARE, V181, P620, DOI 10.1164/rccm.200907-1020OC; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Sato A, 2010, MODERN PATHOL, V23, P1458, DOI 10.1038/modpathol.2010.134; Di Virgilio F, 2013, PHARMACOL REV, V65, P872, DOI 10.1124/pr.112.006171; Nagai H, 2013, CANCER PREV RES, V6, P1222, DOI 10.1158/1940-6207.CAPR-13-0244; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Zanella CL, 1996, CANCER RES, V56, P5334; Wiesner T, 2012, J CLIN ONCOL, V30, pE337, DOI 10.1200/JCO.2011.41.2965; Taniguchi T, 2007, CANCER SCI, V98, P438, DOI 10.1111/j.1349-7006.2006.00386.x; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Liu WH, 2000, AM J RESP CELL MOL, V23, P371; Aung W, 2007, CARCINOGENESIS, V28, P2047, DOI 10.1093/carcin/bgm090; Barchowsky A, 1998, TOXICOL APPL PHARM, V152, P388, DOI 10.1006/taap.1998.8462; BIANCHI AB, 1995, P NATL ACAD SCI USA, V92, P10854, DOI 10.1073/pnas.92.24.10854; BOYLAN AM, 1995, J CLIN INVEST, V96, P1987, DOI 10.1172/JCI118246; Brown DM, 1999, J PATHOL, V189, P258; CHENG JQ, 1994, CANCER RES, V54, P5547; Cheng NL, 1999, EXP MOL PATHOL, V66, P201, DOI 10.1006/exmp.1999.2268; Chew S. H., 2013, CARCINOGENESIS, V35, P164; CHURG A, 1982, HUM PATHOL, V13, P381, DOI 10.1016/S0046-8177(82)80227-X; Creaney J, 2014, THORAX, V69, P895, DOI 10.1136/thoraxjnl-2014-205205; Creaney J, 2011, LUNG CANCER, V74, P55, DOI 10.1016/j.lungcan.2011.02.007; Creaney J, 2013, DIS MARKERS, P119, DOI 10.1155/2013/874212; Cristaudo A, 2011, BIOMARK MED, V5, P261, DOI [10.2217/bmm.11.18, 10.2217/BMM.11.18]; Cui A., 2014, BMJ OPEN, V4; Cunniff B, 2014, REDOX BIOL, V3, P79, DOI 10.1016/j.redox.2014.11.003; Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5; DONG HY, 1994, CARCINOGENESIS, V15, P1251, DOI 10.1093/carcin/15.6.1251; DOPP E, 1995, ENVIRON HEALTH PERSP, V103, P268; FOTEV Z, 1987, J PATHOL, V151, P209, DOI 10.1002/path.1711510309; FREBOURG T, 1987, CANCER, V59, P2104, DOI 10.1002/1097-0142(19870615)59:12<2104::AID-CNCR2820591224>3.0.CO;2-I; Fukuoka K., 2013, MOL CLIN ONCOLOGY, V1, P942; Fung H, 1997, CARCINOGENESIS, V18, P825, DOI 10.1093/carcin/18.4.825; Grosse Y, 2014, LANCET ONCOL, V15, P1427, DOI 10.1016/S1470-2045(14)71109-X; HARDY JA, 1995, CARCINOGENESIS, V16, P319, DOI 10.1093/carcin/16.2.319; HARINGTO.JS, 1971, ENVIRON RES, V4, P95, DOI 10.1016/0013-9351(71)90038-7; HEINTZ NH, 1993, P NATL ACAD SCI USA, V90, P3299, DOI 10.1073/pnas.90.8.3299; Huncharek M, 2002, TUMORI, V88, P1; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Iwahori K, 2008, LUNG CANCER, V62, P45, DOI 10.1016/j.lungcan.2008.02.012; Jean D, 2011, AM J PATHOL, V178, P881, DOI 10.1016/j.ajpath.2010.10.039; Jensen CG, 1996, CARCINOGENESIS, V17, P2013, DOI 10.1093/carcin/17.9.2013; Jiang L, 2008, CANCER SCI, V99, P2142, DOI 10.1111/j.1349-7006.2008.00934.x; Jiang L, 2014, J PATHOL, V233, P402, DOI 10.1002/path.4377; KAMP DW, 1992, FREE RADICAL BIO MED, V12, P293, DOI 10.1016/0891-5849(92)90117-Y; Kovarova J, 2014, REDOX REP, V19, P16, DOI 10.1179/1351000213Y.0000000064; Kubo Y, 2012, J CLIN BIOCHEM NUTR, V51, P221, DOI 10.3164/jcbn.12-39; Levresse V, 2000, MUTAGENESIS, V15, P239, DOI 10.1093/mutage/15.3.239; MCDONALD AD, 1982, ANN OCCUP HYG, V26, P417, DOI 10.1093/annhyg/26.3.417; Mcdonald JC, 2010, ANN OCCUP HYG, V54, P851, DOI 10.1093/annhyg/meq076; Miller JM, 2014, CANCER PREV RES, V7, P330, DOI 10.1158/1940-6207.CAPR-13-0259; Miserocchi G, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-4; Morinaga K, 1989, IARC Sci Publ, P438; MOSSMAN BT, 1983, ENVIRON HEALTH PERSP, V51, P331, DOI 10.2307/3429773; Nagai H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01144; Newick K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039404; Ostroff RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046091; PETTERSSON T, 1988, CHEST, V94, P1037, DOI 10.1378/chest.94.5.1037; Poser I, 2004, MUTAT RES-GEN TOX EN, V559, P19, DOI 10.1016/j.mrgentox.2003.12.006; QUINLAN TR, 1995, AM J PATHOL, V147, P728; RAFTERY AT, 1973, J ANAT, V115, P375; Robinson Benjamin M, 2012, Ann Cardiothorac Surg, V1, P491, DOI 10.3978/j.issn.2225-319X.2012.11.04; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; SCHNITZER R J, 1970, Environmental Research, V3, P1, DOI 10.1016/0013-9351(70)90056-3; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Smith AH, 1996, AM J IND MED, V30, P252, DOI 10.1002/(SICI)1097-0274(199609)30:3<252::AID-AJIM2>3.0.CO;2-0; Stewart JH, 2007, J SURG RES, V141, P120, DOI 10.1016/j.jss.2007.03.048; Suzuki M, 2005, ONCOGENE, V24, P1302, DOI 10.1038/sj.onc.1208263; Tabata C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-205; Tatsuta T, 2013, INT J ONCOL, V43, P1402, DOI 10.3892/ijo.2013.2092; Teranishi S, 1977, Nihon Geka Hokan, V46, P361; Thompson JK, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-24; Tomasetti M, 2014, ANTIOXID REDOX SIGN, V21, P2109, DOI 10.1089/ars.2013.5215; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P859, DOI 10.1016/0891-5849(95)02184-1; Toyokuni S, 2009, NAGOYA J MED SCI, V71, P1; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; Toyokuni S, 2013, REDOX REP, V19, P1, DOI [10.1179/1351000213Y.0000000075, DOI 10.1179/1351000213Y.0000000075]; TOYOKUNI S, 1992, J INORG BIOCHEM, V47, P241, DOI 10.1016/0162-0134(92)84069-Y; TOYOKUNI S, 1993, CARCINOGENESIS, V14, P223, DOI 10.1093/carcin/14.2.223; Toyokuni S, 2011, FREE RADICAL RES, V45, P906, DOI 10.3109/10715762.2011.564170; Toyokuni S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00200; van der Bij S, 2011, BRIT J CANCER, V104, P1325, DOI 10.1038/bjc.2011.104; Varghese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052825; WAGNER J C, 1960, Br J Ind Med, V17, P260; Weber DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030221; Weber DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114483; WHITAKER D, 1985, J PATHOL, V145, P159, DOI 10.1002/path.1711450204; Xio S, 1995, Oncogene, V11, P511; Xu A, 2007, ENVIRON HEALTH PERSP, V115, P87, DOI 10.1289/ehp.9425; Yamashita K, 2015, LAB INVEST, V95, P749, DOI 10.1038/labinvest.2015.28; Yamazaki H, 2012, BIOCHEM BIOPH RES CO, V419, P529, DOI 10.1016/j.bbrc.2012.02.054; YEGLES M, 1993, AM J RESP CELL MOL, V9, P186; Yoshihara M, 2014, DNA RES, V21, P603, DOI 10.1093/dnares/dsu023; Yu Y, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00093	174	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	SEP	2015	86						166	178		10.1016/j.freeradbiomed.2015.05.002		13	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CQ4JA	WOS:000360569700016		
J	Minamiyama, Y; Takemura, S; Kodai, S; Kubo, S; Mizuguchi, S; Oka-Yamamoto, H; Ichikawa, H; Yoshikawa, T				Minamiyama, Yukiko; Takemura, Shigekazu; Kodai, Shintaro; Kubo, Shoji; Mizuguchi, Shinjiro; Oka-Yamamoto, Hiroko; Ichikawa, Hiroshi; Yoshikawa, Toshikazu			Liver fibrosis is improved by treatment of S-allyl cysteine, an aged-garlic extract, in CCl4-treated rats	FREE RADICAL BIOLOGY AND MEDICINE			English	Meeting Abstract	SFRR-E/SNFS Conference	SEP 02-04, 2015	Stuttgart, GERMANY	SFRR E, SNFS					[Minamiyama, Yukiko] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Food Hyg & Environm Hlth Div Appl Life Sci, Kyoto, Japan; [Takemura, Shigekazu; Kodai, Shintaro; Kubo, Shoji] Osaka City Univ, Grad Sch Med, Hepatobiliary Pancreat Surg, Osaka, Japan; [Mizuguchi, Shinjiro; Oka-Yamamoto, Hiroko] Osaka City Univ Hosp, Thorac Surg, Osaka, Japan; [Ichikawa, Hiroshi] Doshisha Univ, Fac Life & Med Sci, Med Life Syst, Kyoto, Japan; [Yoshikawa, Toshikazu] Kyoto Prefectural Univ, Grad Sch Med, Gastoroenterol, Kyoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	SEP	2015	86			1		PP26	S28	S28		10.1016/j.freeradbiomed.2015.07.101		1	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CQ4IQ	WOS:000360568700070		
J	Wang, SM; Ma, N; Kawanishi, S; Zhao, WL; Midorikawa, K; Hiraku, Y; Oikawa, SJ; Zhang, Z; Huang, GW; Murata, M				Wang, Shumin; Ma, Ning; Kawanishi, Shosuke; Zhao, Weilin; Midorikawa, Kaoru; Hiraku, Yusuke; Oikawa, Shinji; Zhang, Zhe; Huang, Guangwu; Murata, Mariko			Inflammation-related DNA damage in relation to the expression of cancer stemness markers in human nasopharyngeal carcinoma	FREE RADICAL BIOLOGY AND MEDICINE			English	Meeting Abstract	SFRR-E/SNFS Conference	SEP 02-04, 2015	Stuttgart, GERMANY	SFRR E, SNFS					[Wang, Shumin; Zhao, Weilin; Midorikawa, Kaoru; Hiraku, Yusuke; Oikawa, Shinji; Murata, Mariko] Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Suzuka, Japan; [Ma, Ning] Suzuka Univ Med Sci, Fac Nursing Sci, Suzuka, Mie, Japan; [Kawanishi, Shosuke] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Zhang, Zhe; Huang, Guangwu] Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Nanning, Peoples R China								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	SEP	2015	86			1		PP25	S27	S27		10.1016/j.freeradbiomed.2015.07.100		1	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CQ4IQ	WOS:000360568700069		
J	Yamamoto-Oka, H; Mizuguchi, S; Toda, M; Izumi, N; Okada, S; Minamiyama, Y; Takemura, S; Cepinskas, G; Nishiyama, N				Yamamoto-Oka, Hiroko; Mizuguchi, Shinjiro; Toda, Michihito; Izumi, Nobuhiro; Okada, Satoshi; Minamiyama, Yukiko; Takemura, Shigekazu; Cepinskas, Gediminas; Nishiyama, Noritoshi			Carbon monoxide releasing molecule-3 (CORM-3) modulates progression of M1/M2 phenotypes in alveolar macrophages	FREE RADICAL BIOLOGY AND MEDICINE			English	Meeting Abstract	SFRR-E/SNFS Conference	SEP 02-04, 2015	Stuttgart, GERMANY	SFRR E, SNFS					[Yamamoto-Oka, Hiroko; Mizuguchi, Shinjiro; Toda, Michihito; Izumi, Nobuhiro; Okada, Satoshi; Nishiyama, Noritoshi] Osaka City Univ, Thorac Surg, Osaka, Japan; [Minamiyama, Yukiko] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan; [Takemura, Shigekazu] Osaka City Univ, Hepatobiliary Pancreat Surg, Osaka, Japan; [Cepinskas, Gediminas] Lawson Hlth Res Inst, Ctr Crit Illness Resarch, London, ON, Canada								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	SEP	2015	86			1		PP4	S20	S20		10.1016/j.freeradbiomed.2015.07.079		1	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CQ4IQ	WOS:000360568700048		
J	Stott, I; Soga, M; Inger, R; Gaston, KJ				Stott, Iain; Soga, Masashi; Inger, Richard; Gaston, Kevin J.			Land sparing is crucial for urban ecosystem services	FRONTIERS IN ECOLOGY AND THE ENVIRONMENT			English	Article							BIODIVERSITY; ECOLOGY; GRADIENT	The world's cities must grow to accommodate an increasing urban population, and achieving this with minimal impact on ecosystem structures and functions is a major challenge. At opposite ends of a possible development spectrum are "land sharing" - extensive sprawling urbanization where built land and natural space are interspersed - and "land sparing" - intensive and extremely compact urbanization alongside separate, large, contiguous green space. Using case studies across urbanization gradients, we demonstrate that land sparing is crucial for sustaining a majority of ecosystem services. Conversely, some land sharing may also be necessary to ensure that people benefit from urban green space. Future urban development should carefully consider green space provision, to maximize the services provided by urban ecosystems. This can be achieved by optimizing distributions of development intensity across cities by means of top-down, policy-led approaches.	[Stott, Iain; Inger, Richard; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, England; [Soga, Masashi] Hokkaido Univ, Grad Sch Agr, Div Environm Resources, Sapporo, Hokkaido, Japan	Stott, I (reprint author), Univ Exeter, Environm & Sustainabil Inst, Penryn, England.	K.J.Gaston@exeter.ac.uk			EPSRC [EP/I002154/1]	This research was supported by EPSRC grant EP/I002154/1 under the Sustainable Urban Environments Program to the SECURE (Self Conserving Urban Environments) consortium. The consortium's four UK partners are Newcastle University, the University of Sheffield, Loughborough University, and the University of Exeter. We thank J Edmondson for providing carbon storage data and JA Harris for helpful comments on the original manuscript. OpenStreetMap data and cartography are (c) OpenStreetMap contributors: data are available under the Open Data Commons Open Database License (opendatacommons.org) and cartography under the Creative Commons Attribution-ShareAlike 2.0 License (creativecommons.org); for more information, see openstreetmap.org/copyright.	Fischer J, 2014, CONSERV LETT, V7, P149, DOI 10.1111/conl.12084; Lin BB, 2013, J APPL ECOL, V50, P1161, DOI 10.1111/1365-2664.12118; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Melo PC, 2009, REG SCI URBAN ECON, V39, P332, DOI 10.1016/j.regsciurbeco.2008.12.002; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; Ramalho CE, 2012, TRENDS ECOL EVOL, V27, P179, DOI 10.1016/j.tree.2011.10.008; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; Gaston KJ, 2013, J APPL ECOL, V50, P830, DOI 10.1111/1365-2664.12087; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Edmondson JL, 2014, SCI TOTAL ENVIRON, V472, P444, DOI 10.1016/j.scitotenv.2013.11.025; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Tyrvainen L, 2007, LANDSCAPE URBAN PLAN, V79, P5, DOI 10.1016/j.landurbplan.2006.03.003; Gold JR, 2013, EXPERIENCE MODERNISM; Henderson V., 2000, NATL BUREAU EC RES W, V7503; MA ( Millennium Ecosystem Assessment), 2005, SUMM DEC MAK; RIBA ( Royal Institute of British Architects), 2013, CIT HLTH CHECK DES C; Sassen Saskia, 1995, WORLD CITIES WORLD S; UNEP- WCMC ( United Nations Environment Programme- World Conservation Monitoring Centre), 2007, UK NAT EC ASS TECHN	27	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	1540-9295	1540-9309		FRONT ECOL ENVIRON	Front. Ecol. Environ.	SEP	2015	13	7					387	393		10.1890/140286		7	Ecology; Environmental Sciences	Environmental Sciences & Ecology	CQ4OB	WOS:000360583200018		
J	Umemura, H				Umemura, Hiroyuki			Independent effects of 2-D and 3-D locations of stimuli in a 3-D display on response speed in a Simon task	FRONTIERS IN PSYCHOLOGY			English	Article						Simon effect; 3-D; stimulus-response compatibility; reaction time; binocular disparity	S-R COMPATIBILITY; PREMOTOR THEORY; ATTENTION; DIMENSIONS; ACCOUNTS	The Simon Effect is a phenomenon in which reaction times are usually faster when the stimulus location and the response correspond, even if the stimulus location is irrelevant to the task. Recent studies have demonstrated the Simon effect in a three-dimensional (3-D) display. The present study examined whether two-dimensional (2-D) and 3-D locations simultaneously affected the Simon effect for stimuli in which a target and fixation were located on the same plane (ground or ceiling) at different 3-D depths, and the perspective effect produced a difference in the 2-D vertical location of the target stimulus relative to the fixation. The presence of the ground and ceiling plane was controlled to examine the contextual effects of background. The results showed that the 2-D vertical location and 3-D depth simultaneously affected the speed of responses, and they did not interact. The presence of the background did not affect the magnitude of either the 2-D or the 3-D Simon effect. These results suggest that 2-D vertical location and 3-D depth are coded simultaneously and independently, and both affect response selection in which 2-D and 3-D representations overlap.	Natl Inst Adv Ind Sci & Technol, Med & Biol Engn Res Grp, Biomed Res Inst, Ikeda, Osaka 5638577, Japan	Umemura, H (reprint author), Natl Inst Adv Ind Sci & Technol, Med & Biol Engn Res Grp, Biomed Res Inst, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	h.umemura@aist.go.jp			JSPS KAKENHI [24500335]	This study was supported by JSPS KAKENHI Grant Number 24500335.	Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Rigon J, 2011, AM J PSYCHOL, V124, P395; Valle-Inclan F, 2003, PSYCHOL RES-PSYCH FO, V67, P240, DOI 10.1007/s00426-003-0131-z; LAMBERTS K, 1992, ACTA PSYCHOL, V79, P115, DOI 10.1016/0001-6918(92)90028-C; Van der Lubbe RHJ, 2011, ACTA PSYCHOL, V136, P259, DOI 10.1016/j.actpsy.2010.09.007; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P208, DOI 10.1007/BF00419608; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; GAWRYSZEWSKI LD, 1987, NEUROPSYCHOLOGIA, V25, P19, DOI 10.1016/0028-3932(87)90040-6; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Rubichi S, 2006, PSYCHON B REV, V13, P201, DOI 10.3758/BF03193832; Chan AHS, 2010, APPL ERGON, V41, P840, DOI 10.1016/j.apergo.2010.03.005; HOMMEL B, 1995, PSYCHON B REV, V2, P370, DOI 10.3758/BF03210974; NICOLETTI R, 1994, PSYCHOL RES-PSYCH FO, V56, P144, DOI 10.1007/BF00419701; Proctor RW, 2003, PERCEPT PSYCHOPHYS, V65, P1318, DOI 10.3758/BF03194855; PROCTOR RW, 1994, PSYCHOL RES-PSYCH FO, V56, P185, DOI 10.1007/BF00419706; Stins JF, 1997, ECOL PSYCHOL, V9, P25, DOI 10.1207/s15326969eco0901_2; Umilta C., 1985, ATTENTION PERFORM, P457; Stoffer TH, 1997, ADV PSYCHOL, V118, P181; UMILTA C, 1991, European Journal of Cognitive Psychology, V3, P247, DOI 10.1080/09541449108406228	20	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	SEP 1	2015	6								1302	10.3389/fpsyg.2015.01302		8	Psychology, Multidisciplinary	Psychology	CQ3UZ	WOS:000360530500001		
J	Hiramoto, T; Tanaka, M; Ichikawa, T; Matsuura, Y; Hasegawa-Shiro, S; Shintani, T; Gomi, K				Hiramoto, Tetsuya; Tanaka, Mizuki; Ichikawa, Takanori; Matsuura, Yuka; Hasegawa-Shiro, Sachiko; Shintani, Takahiro; Gomi, Katsuya			Endocytosis of a maltose permease is induced when amylolytic enzyme production is repressed in Aspergillus oryzae	FUNGAL GENETICS AND BIOLOGY			English	Article						Aspergillus oryzae; Maltose transporter; Endocytosis; Ubiquitin ligase; alpha-Amylase; Carbon catabolite repression	CARBON CATABOLITE REPRESSION; GLUCOSE-INDUCED INACTIVATION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; GENE-EXPRESSION; BETA-GLUCURONIDASE; ESCHERICHIA-COLI; TAKA-AMYLASE; NIDULANS; PROTEIN	In the filamentous fungus Aspergillus oryzae, amylolytic enzyme production is induced by the presence of maltose. Previously, we identified a putative maltose permease (MalP) gene in the maltose-utilizing cluster of A. oryzae. malP disruption causes a significant decrease in alpha-amylase activity and maltose consumption, indicating that MalP is a maltose transporter required for amylolytic enzyme production in A. oryzae. Although the expression of amylase genes and malP is repressed by the presence of glucose, the effect of glucose on the abundance of functional MalP is unknown. In this study, we examined the effect of glucose and other carbon sources on the subcellular localization of green fluorescence protein (GFP)-tagged MalP. After glucose addition, GFP-MalP at the plasma membrane was internalized and delivered to the vacuole. This glucose-induced internalization of GFP-MalP was inhibited by treatment with latrunculin B, an inhibitor of actin polymerization. Furthermore, GFP-MalP internalization was inhibited by repressing the HECT ubiquitin ligase HulA (ortholog of yeast Rsp5). These results suggest that MalP is transported to the vacuole by endocytosis in the presence of glucose. Besides glucose, mannose and 2-deoxyglucose also induced the endocytosis of GFP-MalP and amylolytic enzyme production was inhibited by the addition of these sugars. However, neither the subcellular localization of GFP-MalP nor amylolytic enzyme production was influenced by the addition of xylose or 3-O-methylglucose. These results imply that MalP endocytosis is induced when amylolytic enzyme production is repressed. (C) 2015 Elsevier Inc. All rights reserved.	[Hiramoto, Tetsuya; Tanaka, Mizuki; Ichikawa, Takanori; Matsuura, Yuka; Hasegawa-Shiro, Sachiko; Shintani, Takahiro; Gomi, Katsuya] Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Lab Bioind Genom,Aoba Ku, Sendai, Miyagi 9818555, Japan	Gomi, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Lab Bioind Genom,Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	gomi@biochem.tohoku.ac.jp			JSPS KAKENHI [22248007, 25292044]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry	We thank Tetsuo Kobayashi and Osamu Mizutani for providing the plasmid pAGAR-F and the Delta ligD::loxP pyrG<SUP>-</SUP> strain, respectively. We thank Daisuke Miura for construction of promoterless GUS plasmid DNA. This study was supported by JSPS KAKENHI (Grant Nos: 22248007 and 25292044), Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry.	Machida M, 2008, DNA RES, V15, P173, DOI 10.1093/dnares/dsn020; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Yamada O, 1997, BIOSCI BIOTECH BIOCH, V61, P1367; Gomi K, 2000, BIOSCI BIOTECH BIOCH, V64, P816, DOI 10.1271/bbb.64.816; Higuchi Y, 2006, BIOCHEM BIOPH RES CO, V340, P784, DOI 10.1016/j.bbrc.2005.12.077; Petersen KL, 1999, MOL GEN GENET, V262, P668, DOI 10.1007/s004380051129; Mizutani O, 2012, APPL ENVIRON MICROB, V78, P4126, DOI 10.1128/AEM.00080-12; Ichinose S, 2014, APPL MICROBIOL BIOT, V98, P335, DOI 10.1007/s00253-013-5353-4; Valdez-Taubas J, 2004, FUNGAL GENET BIOL, V41, P42, DOI 10.1016/j.fgb.2003.09.003; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Tanaka M, 2012, APPL MICROBIOL BIOT, V96, P1275, DOI 10.1007/s00253-012-4169-y; Suzuki K, 2015, APPL MICROBIOL BIOT, V99, P1805, DOI 10.1007/s00253-014-6264-8; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Cortes S, 2003, PLANT PHYSIOL, V131, P824, DOI 10.1104/pp.010538; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Horak J, 1997, J BACTERIOL, V179, P1541; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Hasegawa S, 2010, FUNGAL GENET BIOL, V47, P1, DOI 10.1016/j.fgb.2009.10.005; Gaidarov I, 1999, NAT CELL BIOL, V1, P1; Sato H, 2011, APPL MICROBIOL BIOT, V92, P961, DOI 10.1007/s00253-011-3422-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Boase NA, 2004, MOL MICROBIOL, V53, P929, DOI 10.1111/j.1365-2958.2004.04172.x; Gournas C, 2010, MOL MICROBIOL, V75, P246, DOI 10.1111/j.1365-2958.2009.06997.x; Hervas-Aguilar A, 2010, EUKARYOT CELL, V9, P1504, DOI 10.1128/EC.00119-10; Higuchi Y, 2009, EUKARYOT CELL, V8, P37, DOI 10.1128/EC.00207-08; Horak J, 2002, J BIOL CHEM, V277, P8248, DOI 10.1074/jbc.M107255200; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; JEFFERSON RA, 1986, P NATL ACAD SCI USA, V83, P8447, DOI 10.1073/pnas.83.22.8447; Jiang H, 2000, J BACTERIOL, V182, P647, DOI 10.1128/JB.182.3.647-654.2000; Karachaliou M, 2013, MOL MICROBIOL, V88, P301, DOI 10.1111/mmi.12184; Kato M, 1996, BIOSCI BIOTECH BIOCH, V60, P1776; Lockington RA, 2001, MOL MICROBIOL, V40, P1311, DOI 10.1046/j.1365-2958.2001.02474.x; Lucero P, 1997, FEMS MICROBIOL LETT, V147, P273, DOI 10.1016/S0378-1097(96)00538-1; Makita T, 2009, BIOSCI BIOTECH BIOCH, V73, P391, DOI 10.1271/bbb.80654; Matsuo K, 2013, FUNGAL GENET BIOL, V56, P125, DOI 10.1016/j.fgb.2013.03.007; Medintz I, 1996, J BACTERIOL, V178, P2245; Minetoki T, 1996, CURR GENET, V30, P432, DOI 10.1007/s002940050153; Paiva S, 2009, J BIOL CHEM, V284, P19228, DOI 10.1074/jbc.M109.008318; TADA S, 1991, MOL GEN GENET, V229, P301, DOI 10.1007/BF00272170; Vongsangnak W, 2009, MICROBIOL-SGM, V155, P3893, DOI 10.1099/mic.0.031104-0	43	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	SEP	2015	82						136	144		10.1016/j.fgb.2015.05.015		9	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	CQ7JO	WOS:000360779600015		
J	Taga, M; Tanaka, K; Kato, S; Kubo, Y				Taga, Masatoki; Tanaka, Kaoru; Kato, Seiji; Kubo, Yasuyuki			Cytological analyses of the karyotypes and chromosomes of three Colletotrichum species, C. orbiculare, C. graminicola and C. higginsianum	FUNGAL GENETICS AND BIOLOGY			English	Article						Colletotrichum; Chromosome; Karyotype; Heterochromatin; Cytology	IN-SITU HYBRIDIZATION; FILAMENTOUS FUNGI; MOLECULAR KARYOTYPES; NECTRIA-HAEMATOCOCCA; MITOTIC CHROMOSOMES; PROTEIN-KINASE; FISSION YEAST; GENOME; REVEALS; FUSARIUM	In contrast to the recent accomplishments of genome projects, cytological information on chromosomes and genomes of the genus Colletotrichum is very scarce. In this study, we performed mitotic cytological karyotyping for the three species, C. orbiculare, C graminicola, and C higginsianum by fluorescence microscopy and compared the results with those from genome projects. Chromosome number (CN) of C. orbiculare was determined for the first time to be n = 10 with no minichromosomes (MCs) in the genome, while CNs of C graminicola and C higginsianum were consistent with those from their genome project including the number of MCs. Regarding chromosome features, C orbiculare was peculiar in that each chromosome was distinctly partitioned into a highly AT-rich pericentromeric region and the remaining highly GC-rich regions, and the pericentromeric region was judged to be constitutive heterochromatin. Integrating all the discernible morphological characteristics such as chromosome length, nucleolar organizing region, and DAPI-stained regions, idiograms were constructed for the three species. The overall cytological features of the chromosomes and genomes fit well with the data from the genome projects in terms of genome size, GC-content, and the occurrence of AT-rich regions. This study represents the most comprehensive and detailed mitotic cytological karyotyping of fungi ever reported. (C) 2015 Elsevier Inc. All rights reserved.	[Taga, Masatoki] Okayama Univ, Fac Sci, Dept Biol, Kita Ku, Okayama 7008530, Japan; [Tanaka, Kaoru; Kubo, Yasuyuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan; [Kato, Seiji; Kubo, Yasuyuki] Yamanashi Prefecture Agritechnol Ctr, Hokuto 4070201, Japan	Taga, M (reprint author), Okayama Univ, Fac Sci, Dept Biol, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	mtaga@cc.okayama-u.ac.jp; kao-tanaka@iskweb.co.jp; skato@olive.ocn.ne.jp; y_kubo@kpu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [24248009, 20140023]	We thank Richard C. O'Connell, Yoshitaka Takano and Lisa J. Vaillancourt for fungal strains. We also thank Beth E. Hazen for carefully reading the manuscript and giving valuable suggestions. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (Grant Nos. 24248009 and 20140023).	Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Takano Y, 2001, MOL PLANT MICROBE IN, V14, P1149, DOI 10.1094/MPMI.2001.14.10.1149; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Hiruma K, 2010, PLANT CELL, V22, P2429, DOI 10.1105/tpc.110.074344; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Taga M, 1998, MYCOL RES, V102, P1355, DOI 10.1017/S0953756298006455; Kubo Y, 2013, J GEN PLANT PATHOL, V79, P233, DOI 10.1007/s10327-013-0451-9; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Peterson DG, 1999, GENETICS, V152, P427; Tanaka S, 2009, PLANT CELL, V21, P2517, DOI 10.1105/tpc.109.068023; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Mehrabi R, 2007, MYCOLOGIA, V99, P868, DOI 10.3852/mycologia.99.6.868; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Andras SC, 2000, CHROMOSOME RES, V8, P387, DOI 10.1023/A:1009258719052; SHIRANE N, 1989, PHYTOPATHOLOGY, V79, P728, DOI 10.1094/Phyto-79-728; Smith KM, 2012, CHROMOSOME RES, V20, P635, DOI 10.1007/s10577-012-9290-3; Akamatsu H, 1999, CURR GENET, V35, P647, DOI 10.1007/s002940050464; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Crouch JA, 2014, GENOMICS PLANT ASS F, P69; Eusebio-Cope A, 2009, FUNGAL GENET BIOL, V46, P342, DOI 10.1016/j.fgb.2009.01.005; FINCHAM JRS, 1949, ANN BOT-LONDON, V13, P23; FORGERY WM, 1978, PLANT DIS REP, V62, P573; Garrido C, 2009, EUR J PLANT PATHOL, V125, P397, DOI 10.1007/s10658-009-9489-0; Hliscs R, 1997, CYTOGENET CELL GENET, V76, P167, DOI 10.1159/000134537; Hyde K. D., FUNGAL DIVERSITY, V39, P147; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; Kato S, 2003, GENES GENET SYST, V78, P155, DOI 10.1266/ggs.78.155; Kubo Y., 2012, TOPICS CURRENT GENET, V22, P115; LUCAS GB, 1946, AM J BOT, V33, P802, DOI 10.2307/2437277; Mahmoud AM, 2012, MYCOLOGIA, V104, P845, DOI 10.3852/11-306; MASEL A, 1990, CURR GENET, V18, P81, DOI 10.1007/BF00321120; MCCLINTOCK B, 1945, AM J BOT, V32, P671, DOI 10.2307/2437624; Narusaka M., 2009, PLANT J, V59, P672; O'Connell R, 2004, MOL PLANT MICROBE IN, V17, P272, DOI 10.1094/MPMI.2004.17.3.272; O'Sullivan D, 1998, CURR GENET, V33, P291, DOI 10.1007/s002940050339; Perkins D. D., 1992, DYNAMIC GENOME B MCC, P33; Prusky D., 2000, COLLETOTRICHUM HOST; Roca M. M. G., 2003, Fitopatologia Brasileira, V28, P367, DOI 10.1590/S0100-41582003000400004; Rollins J. A., 1996, THESIS PURDUE U W LA; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Schwartz DC, 1997, CURR OPIN BIOTECH, V8, P70, DOI 10.1016/S0958-1669(97)80160-7; SHIRAISH.Y, 1972, CHROMOSOMA, V37, P75, DOI 10.1007/BF00329559; SHIRANE N, 1988, PHYTOPATHOLOGY, V78, P1627, DOI 10.1094/Phyto-78-1627; SINGLETON JR, 1953, AM J BOT, V40, P124, DOI 10.2307/2438770; Taga M., 2011, 26 FUNG GEN C; Taga M, 2003, MYCOL RES, V107, P1012, DOI 10.1017/S0953756203008244; TAGA M, 1994, CHROMOSOMA, V103, P408, DOI 10.1007/BF00362285; Tags M., 2014, 16 INT C PLANT MICR; Tsuchiya D, 2002, FUNGAL GENET BIOL, V37, P22, DOI 10.1016/S1087-1845(02)00026-9; Tsuchiya D, 2010, METHODS MOL BIOL, V638, P235, DOI 10.1007/978-1-60761-611-5_18; Tsuchiya D, 2001, PHYTOPATHOLOGY, V91, P354, DOI 10.1094/PHYTO.2001.91.4.354; TSUGE T, 1989, CURR GENET, V16, P267, DOI 10.1007/BF00422113; UMESONO K, 1983, CURR GENET, V7, P123, DOI 10.1007/BF00365637; Yasumori H., 1962, B SHIMANE AGR COLL A, VA10, P26	62	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	SEP	2015	82						238	250		10.1016/j.fgb.2015.07.013		13	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	CQ7JO	WOS:000360779600024		
J	O'Donnell, K; Sink, S; Libeskind-Hadas, R; Hulcr, J; Kasson, MT; Ploetz, RC; Konkol, JL; Ploetz, JN; Carrillo, D; Campbell, A; Duncan, RE; Liyanage, PNH; Eskalen, A; Na, F; Geiser, DM; Bateman, C; Freeman, S; Mendel, Z; Sharon, M; Aoki, T; Cosse, AA; Rooney, AP				O'Donnell, Kerry; Sink, Stacy; Libeskind-Hadas, Ran; Hulcr, Jiri; Kasson, Matthew T.; Ploetz, Randy C.; Konkol, Joshua L.; Ploetz, Jill N.; Carrillo, Daniel; Campbell, Alina; Duncan, Rita E.; Liyanage, Pradeepa N. H.; Eskalen, Akif; Na, Francis; Geiser, David M.; Bateman, Craig; Freeman, Stanley; Mendel, Zvi; Sharon, Michal; Aoki, Takayuki; Cosse, Allard A.; Rooney, Alejandro P.			Discordant phylogenies suggest repeated host shifts in the Fusarium-Euwallacea ambrosia beetle mutualism	FUNGAL GENETICS AND BIOLOGY			English	Article						Cophylogeny; Fungiculture; Hybrid introgression; Molecular phylogenetics; Phylogenetic species; Symbiosis	FUNGUS-GROWING TERMITES; MITOCHONDRIAL-DNA; PATERNAL INHERITANCE; BARK BEETLES; SPECIES RECOGNITION; MOLECULAR PHYLOGENY; SYMBIOTIC FUNGUS; SCOLYTINAE; CURCULIONIDAE; TRANSMISSION	The mutualism between xyleborine beetles in the genus Euwallacea (Coleoptera: Curculionidae: Scolytinae) and members of the Ambrosia Fusarium Clade (AFC) represents one of 11 known evolutionary origins of fungiculture by ambrosia beetles. Female Euwallacea beetles transport fusarial symbionts in paired mandibular mycangia from their natal gallery to woody hosts where they are cultivated in galleries as a source of food. Native to Asia, several exotic Euwallacea species were introduced into the United States and Israel within the past two decades and they now threaten urban landscapes, forests and avocado production. To assess species limits and to date the evolutionary diversification of the mutualists, we reconstructed the evolutionary histories of key representatives of the Fusarium and Euwallacea clades using maximum parsimony and maximum likelihood methods. Twelve species-level lineages, termed AF 112, were identified within the monophyletic AFC and seven among the Fusarium-farming Euwallacea. Bayesian diversification-time estimates placed the origin of the Euwallacea-Fusarium mutualism near the Oligocene-Miocene boundary similar to 19-24 Mya. Most Euwallacea spp. appear to be associated with one species of Fusarium, but two species farmed two closely related fusaria. Euwallacea sp. #2 in Miami-Dade County, Florida cultivated Fusarium spp. AF-6 and AF-8 on avocado, and Euwallacea sp. #4 farmed Fusarium ambrosium AF-1 and Fusarium sp. AF-11 on Chinese tea in Sri Lanka. Cophylogenetic analyses indicated that the Euwallacea and Fusarium phylogenies were largely incongruent, apparently due to the beetles switching fusarial symbionts (i.e., host shifts) at least five times during the evolution of this mutualism. Three cospeciation events between Euwallacea and their AFC symbionts were detected, but randomization tests failed to reject the null hypothesis that the putative parallel cladogenesis is a stochastic pattern. Lastly, two collections of Euwallacea sp. #2 from Miami-Dade County, Florida shared an identical cytochrome oxidase subunit 1 (CO1) allele with Euwallacea validus, suggesting introgressive hybridization between these species and/or pseudogenous nature of this marker. Results of the present study highlight the importance of understanding the potential for and frequency of host-switching between Euwallacea and members of the AFC, and that these shifts may bring together more aggressive and virulent combinations of these invasive mutualists. Published by Elsevier Inc.	[O'Donnell, Kerry; Sink, Stacy] ARS, USDA, Bacterial Foodborne Pathogens & Mycol Res Unit, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA; [Libeskind-Hadas, Ran] Harvey Mudd Coll, Dept Comp Sci, Claremont, CA 91711 USA; [Hulcr, Jiri; Bateman, Craig] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Kasson, Matthew T.] W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; [Ploetz, Randy C.; Konkol, Joshua L.; Ploetz, Jill N.; Carrillo, Daniel; Campbell, Alina; Duncan, Rita E.] Univ Florida, Trop Res & Educ Ctr, Homestead, FL 33031 USA; [Liyanage, Pradeepa N. H.] Tea Res Inst Sri Lanka, St Coombs, Talawakelle, Sri Lanka; [Eskalen, Akif; Na, Francis] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Geiser, David M.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Freeman, Stanley; Mendel, Zvi] Volcani Ctr, ARO, Inst Plant Protect, IL-50250 Bet Dagan, Israel; [Aoki, Takayuki] Genet Resources Ctr, Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Cosse, Allard A.; Rooney, Alejandro P.] ARS, USDA, Crop Bioprotect Res Unit, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA	O'Donnell, K (reprint author), ARS, USDA, Bacterial Foodborne Pathogens & Mycol Res Unit, Natl Ctr Agr Utilizat Res, 1815 N Univ St, Peoria, IL 61604 USA.	kerry.odonnell@ars.usda.gov			USDA Forest Service; National Science Foundation; California Avocado Commission	The authors thank Nathane Orwig for running sequences in the NCAUR DNA Core Facility, Thomas White and Ronald Wideman for technical assistance in Homestead, CABI Biosciences for providing Fusarium isolates, Paul R. Campbell and Andrew D.W. Geering, The University of Queensland, Australia for collections of Euwallacea sp. #3, and Pat Nolan, County of San Diego, California for collections of Euwallacea sp. #5. The mention of firm names or trade products does not imply that they are endorsed or recommended by the US Department of Agriculture over other firms or similar products not mentioned. The USDA is an equal opportunity provider and employer. JH and CB were funded by the USDA Forest Service and the National Science Foundation, MK was funded by the USDA Forest Service's Forest Health Technology Enterprise Team, and AE and FN were supported by the USDA Forest Service and the California Avocado Commission.	Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Wolff JN, 2013, HEREDITY, V110, P57, DOI 10.1038/hdy.2012.60; Refregier G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-100; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Wild AL, 2008, MOL PHYLOGENET EVOL, V48, P877, DOI 10.1016/j.ympev.2008.05.023; O'Donnell K, 2008, J CLIN MICROBIOL, V46, P2477, DOI 10.1128/JCM.02371-07; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Bertheau C, 2011, MOL ECOL RESOUR, V11, P1056, DOI 10.1111/j.1755-0998.2011.03050.x; Zakharov EV, 2009, HEREDITY, V102, P590, DOI 10.1038/hdy.2009.26; Ballard JWO, 2000, MOL BIOL EVOL, V17, P1126; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Arunkumar KP, 2006, MOL PHYLOGENET EVOL, V40, P419, DOI 10.1016/j.ympev.2006.02.023; Dole SA, 2010, MOL PHYLOGENET EVOL, V54, P773, DOI 10.1016/j.ympev.2009.11.011; Eskalen A, 2013, PLANT DIS, V97, P938, DOI 10.1094/PDIS-11-12-1026-RE; Freeman S, 2013, MYCOLOGIA, V105, P1595, DOI 10.3852/13-066; Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; KOK LT, 1970, NATURE, V225, P661, DOI 10.1038/225661b0; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463; Cognato AI, 2011, ZOOL SCR, V40, P174, DOI 10.1111/j.1463-6409.2010.00466.x; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Kasson MT, 2013, FUNGAL GENET BIOL, V56, P147, DOI 10.1016/j.fgb.2013.04.004; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651; Mendel Z, 2012, PHYTOPARASITICA, V40, P235, DOI 10.1007/s12600-012-0223-7; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Carrillo D, 2014, PLANT PATHOL, V63, P54, DOI 10.1111/ppa.12073; Harrington TC, 2014, MYCOLOGIA, V106, P835, DOI 10.3852/13-354; Zhao X, 2004, HEREDITY, V93, P399, DOI 10.1038/sj.hdy.6800516; Ploetz RC, 2013, PLANT DIS, V97, P856, DOI 10.1094/PDIS-01-13-0056-FE; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Nobre T, 2011, MOL ECOL, V20, P2619, DOI 10.1111/j.1365-294X.2011.05090.x; Farrell BD, 2001, EVOLUTION, V55, P2011; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Alamouti SM, 2009, MYCOL RES, V113, P822, DOI 10.1016/j.mycres.2009.03.003; O'Donnell K, 2012, MYCOLOGIA, V104, P427, DOI 10.3852/11-179; Hulcr J, 2007, ECOL ENTOMOL, V32, P762, DOI 10.1111/j.1365-2311.2007.00939.x; MEUSEL MS, 1993, CURR GENET, V24, P539, DOI 10.1007/BF00351719; O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; Rabaglia RJ, 2006, ANN ENTOMOL SOC AM, V99, P1034, DOI 10.1603/0013-8746(2006)99[1034:ROAXCC]2.0.CO;2; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; Jordal BH, 2000, BIOL J LINN SOC, V71, P483, DOI 10.1006/bijl.2000.0457; Atkinson T.H., 2014, BARK AMBROSIA BEETLE; Battisti A, 1999, NATURWISSENSCHAFTEN, V86, P479, DOI 10.1007/s001140050658; Beaver R.A., 1989, P121; Biedermann PHW, 2009, ENVIRON ENTOMOL, V38, P1096, DOI 10.1603/022.038.0417; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BRAYFORD D, 1987, T BRIT MYCOL SOC, V89, P347; Bromham L, 2003, TRENDS ECOL EVOL, V18, P2, DOI 10.1016/S0169-5347(02)00009-5; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; DANTHANARAYANA W, 1968, Tea Quarterly, V39, P61; Six Diana L., 2012, Insects, V3, P339, DOI 10.3390/insects3010339; Eskalen A., 2012, PEST ALERT FUSARIUM; Eskalen A, 2012, PLANT DIS, V96, P1070, DOI 10.1094/PDIS-03-12-0276-PDN; Freeman S, 2012, SYMBIOSIS, V58, P245, DOI 10.1007/s13199-013-0222-6; Gadd C.H., 1947, T BR MYCOL SOC, V30, P13; Geib Scott M., 2012, Insects, V3, P141, DOI 10.3390/insects3010141; Gilmore SR, 2009, MOL ECOL RESOUR, V9, P90, DOI 10.1111/j.1755-0998.2009.02636.x; Hughes J, 2007, SYSTEMATIC BIOL, V56, P232, DOI 10.1080/10635150701311370; Hulcr J., 2015, BARK BEETLES; Jordal BH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-133; Jordal B.H., 2013, MOL ECOL RES, V14, P7; Kasson MT, 2014, PHYTOPATHOLOGY, V104, P282, DOI 10.1094/PHYTO-06-13-0148-R; Kawasaki Y, 2010, B ENTOMOL RES, V100, P231, DOI 10.1017/S000748530999023X; Kirkendall Lawrence R., 1993, P235; Kirkendall LR, 2007, ZOOTAXA, P53; Kolarik M., 2008, MYCOLOGICAL RES, V113, P44, DOI DOI 10.1016/J.MYCRES.2008.08.003; Kostovcik M., 2014, INT SOC MICROB ECOL; Libeskind-Hadas R., 2014, BIOINFORMATICS, V30, pi86; Mehdiabadi N.J., 2012, NAT COMMUN; Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60; New Pest Advisory Group (NPAG), 2013, EUW FORN EICHH TEA S; NIRENBERG HI, 1990, STUD MYCOL, P91; Norris D.M., 1980, APPL ENVIRON MICROB, V41, P376; NORRIS DM, 1967, SCIENCE, V156, P1120, DOI 10.1126/science.156.3778.1120; Rambaut A, 2007, TRACER V 1 4; Sherengul W, 2006, GENES GENET SYST, V81, P399, DOI 10.1266/ggs.81.399; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Thomas M.C., 2012, DACSP01647; Wingfield Michael J., 2010, New Zealand Journal of Forestry Science, V40, pS95; Wooding AL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0342; Zwickl D.J., 2006, THESIS U TEXAS AUSTI, P115	92	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	SEP	2015	82						277	290		10.1016/j.fgb.2014.10.014		14	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	CQ7JO	WOS:000360779600027		
J	Okimoto, S; Sun, JY; Fukuto, A; Horikoshi, Y; Matsuda, S; Matsuda, T; Ikura, M; Ikura, T; Machida, S; Kurumizaka, H; Miyamoto, Y; Oka, M; Yoneda, Y; Kiuchi, Y; Tashiro, S				Okimoto, Satoshi; Sun, Jiying; Fukuto, Atsuhiko; Horikoshi, Yasunori; Matsuda, Shun; Matsuda, Tomonari; Ikura, Masae; Ikura, Tsuyoshi; Machida, Shinichi; Kurumizaka, Hitoshi; Miyamoto, Yoichi; Oka, Masahiro; Yoneda, Yoshihiro; Kiuchi, Yoshiaki; Tashiro, Satoshi			hCAS/CSE1L regulates RAD51 distribution and focus formation for homologous recombinational repair	GENES TO CELLS			English	Article							STRAND BREAK REPAIR; SEGREGATION GENE CSE1; DNA-DAMAGE; CHROMOSOME SEGREGATION; NUCLEAR-LOCALIZATION; CAS PROTEIN; TRANSCRIPTIONAL REGULATION; HIGH EXPRESSION; IMPORTIN KPNA2; APOPTOSIS	Homologous recombinational repair (HR) is one of the major repair systems for DNA double-strand breaks. RAD51 is a key molecule in HR, and the RAD51 concentration in the cell nucleus increases after DNA damage induction. However, the mechanism that regulates the intracellular distribution of RAD51 is still unclear. Here, we show that hCAS/CSE1L associates with RAD51 in human cells. We found that hCAS/CSE1L negatively regulates the nuclear protein level of RAD51 under normal conditions. hCAS/CSE1L is also required to repress the DNA damage-induced focus formation of RAD51. Moreover, we show that hCAS/CSE1L plays roles in the regulation of the HR activity and in chromosome stability. These findings suggest that hCAS/CSE1L is responsible for controlling the HR activity by directly interacting with RAD51.	[Okimoto, Satoshi; Sun, Jiying; Fukuto, Atsuhiko; Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Hiroshima 7348551, Japan; [Okimoto, Satoshi; Fukuto, Atsuhiko; Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima 7348551, Japan; [Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Ctr Math Chromatin Live Dynam, Hiroshima 7348551, Japan; [Matsuda, Shun; Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga 5200811, Japan; [Ikura, Masae; Ikura, Tsuyoshi] Kyoto Univ, Ctr Radiat Biol, Dept Mutagenesis, Lab Chromatin Regulatory Network,Sakyo Ku, Kyoto 6068501, Japan; [Machida, Shinichi; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan; [Miyamoto, Yoichi; Oka, Masahiro; Yoneda, Yoshihiro] Natl Inst Biomed Innovat, Ibaraki, Osaka 5670085, Japan	Tashiro, S (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Hiroshima 7348551, Japan.	ktashiro@hiroshima-u.ac.jp	Matsuda, Shun/A-4017-2011	Matsuda, Shun/0000-0002-4181-2772	Platform for Dynamic Approaches to Living System, from the Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Hiromu Murakoshi for technical assistance with the in vitro pulldown assays. We also thank T.K. Kundu for valuable discussions. This work was supported by Grants-in-Aid and the Platform for Dynamic Approaches to Living System, from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Tseng SF, 2005, J BIOL CHEM, V280, P39594, DOI 10.1074/jbc.M508425200; Wellmann A, 1997, AM J PATHOL, V150, P25; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Wang HC, 1997, ONCOGENE, V15, P143, DOI 10.1038/sj.onc.1201252; Boni R, 1999, AM J DERMATOPATH, V21, P125, DOI 10.1097/00000372-199904000-00003; Teng SC, 2006, J MOL HISTOL, V37, P293, DOI 10.1007/s10735-006-9032-y; Henson SE, 2006, MUTAT RES-FUND MOL M, V601, P113, DOI 10.1016/j.mrfmmm.2006.06.016; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Sakamoto S, 2007, ONCOGENE, V26, P6002, DOI 10.1038/sj.onc.1210428; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Raderschall E, 2002, J CELL SCI, V115, P153; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Thompson ME, 2010, FEBS J, V277, P3072, DOI 10.1111/j.1742-4658.2010.07733.x; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Ogryzko VV, 1997, BIOCHEMISTRY-US, V36, P9493, DOI 10.1021/bi970236o; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Brinkmann U, 1996, BIOCHEMISTRY-US, V35, P6891, DOI 10.1021/bi952829+; Jeyasekharan AD, 2013, NAT STRUCT MOL BIOL, V20, P1191, DOI 10.1038/nsmb.2666; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; Atwell S, 2012, NUCLEIC ACIDS RES, V40, P11769, DOI 10.1093/nar/gks1131; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; Bennett BT, 2005, J CELL BIOCHEM, V96, P1095, DOI 10.1002/jcb.20640; Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7; Gildemeister OS, 2009, J BIOL CHEM, V284, P31945, DOI 10.1074/jbc.M109.024646; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; Hosoya N, 2012, EMBO REP, V13, P44, DOI 10.1038/embor.2011.221; Ishida T, 2008, GENES CELLS, V13, P91, DOI 10.1111/j.1365-2443.2007.01143.x; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; Kobayashi J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-34; Mladenov E, 2006, GENES CELLS, V11, P513, DOI 10.1111/j.1365-2443.2006.00958.x; Pierce Andrew J, 2005, Methods Mol Biol, V291, P373; San Filippo J., 2008, ANNU REV BIOCHEM, V77, P229, DOI DOI 10.1146/ANNUREV.BI0CHEM.77.061306.125255; Scherf U, 1998, BIOCHEM BIOPH RES CO, V250, P623, DOI 10.1006/bbrc.1998.9367; Scherf U, 1996, P NATL ACAD SCI USA, V93, P2670, DOI 10.1073/pnas.93.7.2670; Shima H, 2013, J CELL SCI, V126, P5284, DOI 10.1242/jcs.133744; Sun JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013554; Tai CJ, 2010, EXP CELL RES, V316, P2969, DOI 10.1016/j.yexcr.2010.07.019; Tashiro S, 1996, ONCOGENE, V12, P2165; Wellmann A, 2001, INT J MOL MED, V7, P489; Wyman C, 2004, CURR BIOL, V14, pR629, DOI 10.1016/j.cub.2004.07.049; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691; Yamamoto A, 1996, MOL GEN GENET, V251, P1	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	SEP	2015	20	9					681	694		10.1111/gtc.12262		14	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CQ7ZV	WOS:000360826500001		
J	Hu, LL; Fang, Y; Hayafuji, T; Ma, Y; Furuyashiki, T				Hu, Lingling; Fang, Yue; Hayafuji, Tsutomu; Ma, Yan; Furuyashiki, Tomoyuki			Azoles activate Atf1-mediated transcription through MAP kinase pathway for antifungal effects in fission yeast	GENES TO CELLS			English	Article							SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; PROLIFERATION INHIBITION; SIGNAL-TRANSDUCTION; SEXUAL DEVELOPMENT; MITOTIC REGULATOR; STY1; EXPRESSION; APOPTOSIS; GENES	Azole antifungals directly inhibit enzymes for ergosterol biosynthesis, and this direct action is thought to underlie antifungal actions of these drugs. Recent studies showed that azoles alter expression of genes for various cellular functions. However, transcription factors regulated by azoles and their roles in antifungal actions remain poorly characterized. Using luciferase assay, we found that miconazole increased luciferase activity under the promoter containing the cAMP response element (CRE) motif. This azole-induced activation of CRE reporter was abolished in Atf1-deficient cells, suggesting that azoles induce Atf1 activation. As Atf1 is activated by stress-activated MAP kinase Sty1 upon various stressors, we examined its involvement. Azoles increased phosphorylation of Sty1 for its activation, and Sty1 deletion impaired azole-induced CRE reporter activation. In contrast, deletion of Pyp1, a tyrosine phosphatase which negatively regulates Sty1, increased CRE reporter activation. In addition, cells deficient in Atf1 and stress-activated MAP kinase pathway showed resistance to azoles, whereas cells lacking Pyp1 increased azole susceptibility, suggesting a critical role for azole-induced activation of MAP kinase-Atf1 pathway in antifungal actions of azoles. Collectively, these results suggest that azoles activate stress-activated MAP kinase pathway, thereby facilitating Atf1-mediated transcription for antifungal effects.	[Hu, Lingling; Hayafuji, Tsutomu; Ma, Yan; Furuyashiki, Tomoyuki] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 6500017, Japan; [Fang, Yue] China Med Univ, Sch Pharm, Dept Biopharmaceut, Shenyang 110122, Peoples R China	Fang, Y (reprint author), China Med Univ, Sch Pharm, Dept Biopharmaceut, Shenyang 110122, Peoples R China.	fangyue@mail.cmu.edu.cn; mayan@med.kobe-u.ac.jp			Program for Liaoning Excellent Talents in University [LJQ2012067]; JSPS KAKENHI [26460339]	We thank Dr Takayoshi Kuno for generous supports, invaluable advice and encouragement to complete this study. We also thank Ms Misako Takizawa for secretarial help. This study was supported by the Program for Liaoning Excellent Talents in University (No. LJQ2012067) to Yue Fang and Grant-in-Aid for scientific Research (C) to Yan Ma (JSPS KAKENHI Grant Number 26460339).	Shieh JC, 1997, GENE DEV, V11, P1008, DOI 10.1101/gad.11.8.1008; Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045; Takeda T, 1995, EMBO J, V14, P6193; Liu H, 2010, ANTI-CANCER DRUG, V21, P841, DOI 10.1097/CAD.0b013e32833e8022; Denoyelle C, 2003, CELL SIGNAL, V15, P327, DOI 10.1016/S0898-6568(02)00124-9; Toone WM, 1998, GENES CELLS, V3, P485, DOI 10.1046/j.1365-2443.1998.00211.x; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764; Dimitroulakos J, 1999, BLOOD, V93, P1308; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Georgiadou SP, 2012, ANN NY ACAD SCI, V1272, P15, DOI 10.1111/j.1749-6632.2012.06795.x; Stettler S, 1996, J CELL SCI, V109, P1927; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Porter JR, 2010, J BIOL CHEM, V285, P41051, DOI 10.1074/jbc.M110.144337; Sanso M, 2011, MOL MICROBIOL, V82, P542, DOI 10.1111/j.1365-2958.2011.07851.x; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Buck V, 2001, MOL BIOL CELL, V12, P407; Samejima I, 1997, EMBO J, V16, P6162, DOI 10.1093/emboj/16.20.6162; Nguyen AN, 2002, MOL BIOL CELL, V13, P2651, DOI 10.1091/mbc.02-03-0043; Choi JW, 1999, J PHARMACOL EXP THER, V289, P572; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Fang Y, 2012, ANTIMICROB AGENTS CH, V56, P1949, DOI 10.1128/AAC.05126-11; Florio AR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-97; Hickman MJ, 2011, GENETICS, V188, P325, DOI 10.1534/genetics.111.128322; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Koyuturk M, 2004, NEUROSCI LETT, V370, P212, DOI 10.1016/j.neulet.2004.08.020; Morigasaki Susumu, 2013, Commun Integr Biol, V6, pe25020, DOI 10.4161/cib.25020; Oka A, 2002, GENES GENET SYST, V77, P383, DOI 10.1266/ggs.77.383; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; OTTILIE S, 1992, MOL CELL BIOL, V12, P5571; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; Samejima I, 1998, MOL BIOL CELL, V9, P2325; Santos J L, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.98.re1; Sartagul W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111936; Shieh JC, 1998, MOL BIOL CELL, V9, P311; Shiozaki K, 1997, MOL BIOL CELL, V8, P409; Zhou X, 2012, J BIOL CHEM, V287, P23434, DOI 10.1074/jbc.C111.338715	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	SEP	2015	20	9					695	705		10.1111/gtc.12263		11	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CQ7ZV	WOS:000360826500002		
J	Yamanishi, E; Yoon, K; Alberi, L; Gaiano, N; Mizutani, K				Yamanishi, Emiko; Yoon, Keejung; Alberi, Lavinia; Gaiano, Nicholas; Mizutani, Ken-ichi			NF-kappa B signaling regulates the generation of intermediate progenitors in the developing neocortex	GENES TO CELLS			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL IDENTITY; CEREBRAL-CORTEX; CROSS-TALK; NEURONAL DIFFERENTIATION; PRECURSOR CELLS; MOUSE-BRAIN; NOTCH; ACTIVATION	In addition to its well-established role during immune system function, NF-B regulates cell survival and synaptic plasticity in the mature nervous system. Here, we show that during mouse brain development, NF-B activity is present in the neocortical ventricular and subventricular zones (VZ and SVZ), where it regulates proliferative pool maintenance. Activation of NF-B signaling, by expression of p65 or an activated form of the IB kinase complex subunit IKK2, inhibited neuronal differentiation and promoted retention of progenitors in the VZ and SVZ. In contrast, blockade of the pathway with dominant negative forms of IKK2 and IB promoted neuronal differentiation both invivo and invitro. Furthermore, by modulating both the NF-B and Notch pathways, we show that in the absence of canonical Notch activity, after knockdown of the pathway effector CBF1, NF-B signaling promoted Tbr2 expression and intermediate neural progenitor fate. Interestingly, however, activation of NF-B invivo, with canonical Notch signaling intact, promoted expression of the radial glial marker Pax6. This work identifies NF-B signaling as a regulator of neocortical neurogenesis and suggests that the pathway plays roles in both the VZ and SVZ.	[Yamanishi, Emiko; Mizutani, Ken-ichi] Doshisha Univ, Grad Sch Brain Sci, Lab Neural Differentiat, Kyotanabe, Kyoto 6100394, Japan; [Yoon, Keejung; Alberi, Lavinia; Gaiano, Nicholas; Mizutani, Ken-ichi] Johns Hopkins Univ, Sch Med, Dept Neurol, Inst Cell Engn,Neuroregenerat Program, Baltimore, MD 21205 USA; [Mizutani, Ken-ichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Mizutani, K (reprint author), Doshisha Univ, Grad Sch Brain Sci, Lab Neural Differentiat, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 6100394, Japan.	kmizutan@mail.doshisha.ac.jp			National Institute of Mental Health [R21 MH073006]; JST, PRESTO 'Development and Function of Neural Networks'; MEXT of Japan; Mitsubishi foundation; Takeda Science Foundation	This work was supported by a grant from the National Institute of Mental Health (R21 MH073006) to N. G, JST, PRESTO 'Development and Function of Neural Networks', a Grant-in-Aid for Scientific Research on Innovative Areas 'Neurovascular' from the MEXT of Japan, The Mitsubishi foundation and the Takeda Science Foundation to K. M.	Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; NIWA H, 1991, GENE, V108, P193; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; De S, 2014, P NATL ACAD SCI USA, V111, P11721, DOI 10.1073/pnas.1412390111; Sun ZW, 2002, SHOCK, V18, P99, DOI 10.1097/00024382-200208000-00001; Shingo T, 2001, J NEUROSCI, V21, P9733; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Anton ES, 1997, DEVELOPMENT, V124, P3501; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Porcile C, 2002, ANN NY ACAD SCI, V973, P402; Li QT, 2000, GENE DEV, V14, P1729; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Ohkubo Y, 2004, J NEUROSCI, V24, P6057, DOI 10.1523/JNEUROSCI.1140-04.2004; Widera D, 2006, INT J DEV NEUROSCI, V24, P91, DOI 10.1016/j.ijdevneu.2005.11.017; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Denis-Donini S, 2005, DEV BRAIN RES, V154, P81, DOI 10.1016/j.devbraines.2004.10.010; Ang HL, 2007, BIOESSAYS, V29, P1039, DOI 10.1002/bies.20647; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Li WW, 1998, J NEUROSCI, V18, P8853; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Dickson KM, 2004, DEV DYNAM, V231, P122, DOI 10.1002/dvdy.20110; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Hayden Matthew S, 2006, Cell, V127, P1286; Inoue M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086356; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Pando MP, 2000, J BIOL CHEM, V275, P21278, DOI 10.1074/jbc.M002532200; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Young KM, 2006, J NEUROSCI RES, V83, P39, DOI 10.1002/jnr.20702	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	SEP	2015	20	9					706	719		10.1111/gtc.12267		14	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CQ7ZV	WOS:000360826500003		
J	Kitajima, K; Kawaguchi, M; Miyashita, K; Nakajima, M; Kanokoda, M; Hara, T				Kitajima, Kenji; Kawaguchi, Manami; Miyashita, Kazuya; Nakajima, Marino; Kanokoda, Mai; Hara, Takahiko			Efficient production of T cells from mouse pluripotent stem cells by controlled expression of Lhx2	GENES TO CELLS			English	Article							HOMEODOMAIN TRANSCRIPTION FACTORS; HEMATOPOIETIC PROGENITOR CELLS; IN-VITRO DIFFERENTIATION; LIM; VIVO; GENE; SPECIFICATION; ENDOTHELIUM; COMMITMENT; INDUCTION	LIM-homeobox transcription factor Lhx2 induces exvivo amplification of adult hematopoietic stem cells (HSCs) in mice. We previously showed that engraftable HSC-like cells are generated from mouse embryonic stem cells (ESCs) and induced pluripotent stem cells by enforced expression of Lhx2. However, when these HSC-like cells were transplanted into irradiated congenic mice, donor-derived T cells were barely detectable, whereas other lineages of hematopoietic cells were continuously produced. Here we investigated T-cell differentiation potential of the Lhx2-induced HSC-like cells using ESCs carrying doxycycline (dox)-inducible Lhx2 expression cassette. Dox-mediated over-expression of Lhx2 conferred a self-renewing activity to ESC-derived c-Kit(+)CD41(+) embryonic hematopoietic progenitor cells (HPCs), thereby converting them to HSC-like cells. When these HSC-like cells were transplanted into irradiated immunodeficient mice and they were supplied with a dox-containing water, CD4/8 double negative T cells were detected in their thymi. Once the Lhx2 expression was terminated, differentiation of CD4/8 double positive and single positive T cells was initiated in the thymi of transplanted mice and mature T cells were released in the peripheral blood. These results showed that engraftable HSC-like cells with full hematopoietic potential can be obtained from ESCs by the conditional expression of Lhx2.	[Kitajima, Kenji; Kawaguchi, Manami; Miyashita, Kazuya; Nakajima, Marino; Kanokoda, Mai; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Setagaya Ku, Tokyo 1568506, Japan; [Kawaguchi, Manami; Miyashita, Kazuya; Nakajima, Marino; Kanokoda, Mai; Hara, Takahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan	Kitajima, K (reprint author), Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	kitajima-kj@igakuken.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591415, 23390256]; Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare; SENSHIN Medical Research Foundation	We thank Drs Takao Nakata and Shinji Kamimura for their administrative support and Dr Michael Kyba for providing NSG/CD45.1 mice. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (24591415 to K.K. and 23390256 to K.K. and T.H.), a Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare, and the SENSHIN Medical Research Foundation. The authors declare no competing financial interests.	Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Hou PS, 2013, NUCLEIC ACIDS RES, V41, P7753, DOI 10.1093/nar/gkt567; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Robin C, 2011, BLOOD, V117, P5088, DOI 10.1182/blood-2011-01-329516; Oshima M, 2011, BLOOD, V117, pE142, DOI 10.1182/blood-2010-12-323212; Porter FD, 1997, DEVELOPMENT, V124, P2935; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Crompton JG, 2013, CELL STEM CELL, V12, P6, DOI 10.1016/j.stem.2012.12.009; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Kitajima K, 2011, BLOOD, V117, P3748, DOI 10.1182/blood-2010-07-298596; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Kitajima K, 2003, METHOD ENZYMOL, V365, P72; Tsai M, 2000, P NATL ACAD SCI USA, V97, P9186, DOI 10.1073/pnas.160254997; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Pfaff N, 2013, STEM CELLS, V31, P488, DOI 10.1002/stem.1316; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Chen M. J., 2012, CELL STEM CELL, V9, P541; Hashimoto K, 2007, DEV GROWTH DIFFER, V49, P287, DOI 10.1111/j.1440-169x.2007.00925.x; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Kitajima K, 2013, STEM CELLS, V31, P2680, DOI 10.1002/stem.1500; Kyba M, 2003, EXP HEMATOL, V31, P994, DOI 10.1016/j.exphem.2003.08.002; Lengerke C, 2007, ANN NY ACAD SCI, V1106, P197, DOI 10.1196/annals.1392.006; Matsumoto K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004820; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; Norrman K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012413; Pilat S, 2005, P NATL ACAD SCI USA, V102, P12101, DOI 10.1073/pnas.0505624102; Pinto do O P, 1998, EMBO J, V17, P5744; Pinto do P., 2002, BLOOD, V99, P3939; Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x; Thorsteinsdottir U, 1999, BLOOD, V94, P2605; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	SEP	2015	20	9					720	738		10.1111/gtc.12266		19	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CQ7ZV	WOS:000360826500004		
J	Kitamura, H; Ozono, E; Iwanaga, R; Bradford, AP; Okuno, J; Shimizu, E; Kurayoshi, K; Kugawa, K; Toh, H; Ohtani, K				Kitamura, Hodaka; Ozono, Eiko; Iwanaga, Ritsuko; Bradford, Andrew P.; Okuno, Junko; Shimizu, Emi; Kurayoshi, Kenta; Kugawa, Kazuyuki; Toh, Hiroyuki; Ohtani, Kiyoshi			Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts	GENES TO CELLS			English	Article							TUMOR-SUPPRESSOR; CELL-CYCLE; TRANSCRIPTION FACTOR; HOMOZYGOUS DELETIONS; PROAPOPTOTIC PROTEIN; BIM GENE; APOPTOSIS; EXPRESSION; CANCER; DEATH	The transcription factor E2F is the principal target of the tumor suppressor pRB. E2F plays crucial roles not only in cell proliferation by activating growth-related genes but also in tumor suppression by activating pro-apoptotic and growth-suppressive genes. We previously reported that, in human normal fibroblasts, the tumor suppressor genes ARF, p27(Kip1) and TAp73 are activated by deregulated E2F activity induced by forced inactivation of pRB, but not by physiological E2F activity induced by growth stimulation. In contrast, growth-related E2F targets are activated by both E2F activities, underscoring the roles of deregulated E2F in tumor suppression in the context of dysfunctional pRB. In this study, to further understand the roles of deregulated E2F, we explored new targets that are specifically activated by deregulated E2F using DNA microarray. The analysis identified nine novel targets (BIM, RASSF1, PPP1R13B, JMY, MOAP1, RBM38, ABTB1, RBBP4 and RBBP7), many of which are involved in the p53 and RB tumor suppressor pathways. Among these genes, the BIM gene was shown to be activated via atypical E2F-responsive promoter elements and to contribute to E2F1-mediated apoptosis. Our results underscore crucial roles of deregulated E2F in growth suppression to counteract loss of pRB function.	[Kitamura, Hodaka; Okuno, Junko; Shimizu, Emi; Kurayoshi, Kenta; Kugawa, Kazuyuki; Toh, Hiroyuki; Ohtani, Kiyoshi] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, Sanda, Hyogo 6691337, Japan; [Ozono, Eiko] Babraham Inst, Signalling Lab, Cambridge CB22 3AT, England; [Iwanaga, Ritsuko; Bradford, Andrew P.] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA	Ohtani, K (reprint author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	btm88939@kwansei.ac.jp					Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Feldstein O, 2012, MOL CANCER RES, V10, P1169, DOI 10.1158/1541-7786.MCR-12-0331; Fogal V, 2005, CELL DEATH DIFFER, V12, P369, DOI 10.1038/sj.cdd.4401562; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Gogada R, 2013, J BIOL CHEM, V288, P368, DOI 10.1074/jbc.M112.386102; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Iwanaga R, 2006, ONCOGENE, V25, P1786, DOI 10.1038/sj.onc.1209210; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Dimri GP, 2000, MOL CELL BIOL, V20, P273; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Gaviraghi M., 2008, BMC MOL BIOL, V9, P56; Iwanaga R, 2001, ONCOGENE, V20, P2055, DOI 10.1038/sj.onc.1204304; Matsui H, 2005, MOL BIOL REP, V32, P79, DOI 10.1007/s11033-004-7656-0; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Ozono E, 2009, GENES CELLS, V14, P89, DOI 10.1111/j.1365-2443.2008.01248.x; Ozono E, 2012, GENES CELLS, V17, P660, DOI 10.1111/j.1365-2443.2012.01617.x	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	SEP	2015	20	9					739	757		10.1111/gtc.12268		19	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CQ7ZV	WOS:000360826500005		
J	Inoue, M; Iwai, R; Yamanishi, E; Yamagata, K; Komabayashi-Suzuki, M; Honda, A; Komai, T; Miyachi, H; Kitano, S; Watanabe, C; Teshima, W; Mizutani, K				Inoue, Mayuko; Iwai, Ryota; Yamanishi, Emiko; Yamagata, Kazuyuki; Komabayashi-Suzuki, Mariko; Honda, Aya; Komai, Tae; Miyachi, Hitoshi; Kitano, Satsuki; Watanabe, Chisato; Teshima, Waka; Mizutani, Ken-ichi			Deletion of Prdm8 impairs development of upper-layer neocortical neurons	GENES TO CELLS			English	Article							CEREBRAL-CORTEX; SUBVENTRICULAR ZONE; STEM-CELLS; EXPRESSION; SPECIFICATION; PROGENITORS; RAT; DIFFERENTIATION; NEUROGENESIS; DISEASE	Upper-layer (UL) neocortical neurons are the most prominent distinguishing features of the mammalian neocortex compared with those of the avian dorsal cortex and are vastly expanded in primates. However, little is known about the identities of the genes that control the specification of UL neurons. Here, we found that Prdm8, a member of the PR (PRDI-BF1 and RIZ homology) domain protein family, was specifically expressed in the postnatal UL neocortex, particular those in late-born ROR ss-positive layer IV neurons. We generated homozygous Prdm8 knockout (Prdm8 KO) mice and found that the deletion of Prdm8 causes growth retardation and a reduced brain weight, although the brain weight-to-body weight ratio is unchanged at postnatal day 8 (P8). Immunohistochemistry showed that the relative UL thickness, but not the thickness of the deep layer (DL), was significantly reduced in Prdm8 KO mice compared with wild-type (WT) mice. In addition, we found that a number of late-born Brn2-positive UL neurons were significantly decreased in Prdm8 KO mice. To identify genes regulated by Prdm8 during neocortical development, we compared expression profiling analysis in Prdm8 KO and WT mice, and identified some candidate genes. These results suggest that the proper expression of Prdm8 is required for the normal development and construction of UL neurons in the mammalian neocortex.	[Inoue, Mayuko; Iwai, Ryota; Yamanishi, Emiko; Yamagata, Kazuyuki; Komabayashi-Suzuki, Mariko; Honda, Aya; Watanabe, Chisato; Teshima, Waka; Mizutani, Ken-ichi] Doshisha Univ, Grad Sch Brain Sci, Lab Neural Differentiat, Kyoto 6190225, Japan; [Inoue, Mayuko; Komai, Tae; Miyachi, Hitoshi; Kitano, Satsuki] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Mizutani, Ken-ichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Mizutani, K (reprint author), Doshisha Univ, Grad Sch Brain Sci, Lab Neural Differentiat, Kyoto 6190225, Japan.	kmizutan@mail.doshisha.ac.jp			JST, PRESTO 'Development and Function of Neural Networks'; MEXT of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Mitsubishi Foundation; Takeda Science Foundation	We thank Sarah E. Ross for antibody and Mika Matsumoto, Masaki Kato and Keiko Takemoto for excellent technical assistance. This research was supported by JST, PRESTO 'Development and Function of Neural Networks,' a Grant-in-Aid for Scientific Research on Innovative Areas 'Neurovascular' from the MEXT of Japan, Mochida Memorial Foundation for Medical and Pharmaceutical Research, The Mitsubishi Foundation and the Takeda Science Foundation.	AGMON A, 1993, J NEUROSCI, V13, P5365; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Komai T, 2009, GENE EXPR PATTERNS, V9, P503, DOI 10.1016/j.gep.2009.07.005; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Rajkowska G, 1998, ARCH GEN PSYCHIAT, V55, P215, DOI 10.1001/archpsyc.55.3.215; Ross SE, 2012, NEURON, V73, P292, DOI 10.1016/j.neuron.2011.09.035; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Hutsler JJ, 2005, BRAIN RES, V1052, P71, DOI 10.1016/j.brainres.2005.06.015; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Feitosa N. M., 2008, DEV BIOL, V369, P235; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Hattori Y, 1997, MOL BRAIN RES, V47, P262, DOI 10.1016/S0169-328X(97)00065-X; Inoue M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086356; Kinameri E., 2008, PLOS ONE, V3, P1; Levitt P, 1997, ANNU REV NEUROSCI, V20, P1, DOI 10.1146/annurev.neuro.20.1.1; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Takeuchi A, 2007, CEREB CORTEX, V17, P1531, DOI 10.1093/cercor/bhl064; Tarabykin V, 2001, DEVELOPMENT, V128, P1983	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	SEP	2015	20	9					758	770		10.1111/gtc.12274		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CQ7ZV	WOS:000360826500006		
J	Hamada, K; Yoshizawa, K				Hamada, K.; Yoshizawa, K.			Interstation phase speed and amplitude measurements of surface waves with nonlinear waveform fitting: application to USArray	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Inverse theory; Surface waves and free oscillations; Seismic tomography; North America	UPPER-MANTLE TOMOGRAPHY; WESTERN UNITED-STATES; NORTH-AMERICA; VELOCITY MAPS; AZIMUTHAL ANISOTROPY; STRUCTURE BENEATH; RAYLEIGH-WAVES; DISPERSION MEASUREMENTS; NEIGHBORHOOD ALGORITHM; TRANSPORTABLE ARRAY	A new method of fully nonlinear waveform fitting to measure interstation phase speeds and amplitude ratios is developed and applied to USArray. The Neighbourhood Algorithm is used as a global optimizer, which efficiently searches for model parameters that fit two observed waveforms on a common great-circle path by modulating the phase and amplitude terms of the fundamental-mode surface waves. We introduce the reliability parameter that represents how well the waveforms at two stations can be fitted in a time-frequency domain, which is used as a data selection criterion. The method is applied to observed waveforms of USArray for seismic events in the period from 2007 to 2010 with moment magnitude greater than 6.0. We collect a large number of phase speed data (about 75 000 for Rayleigh and 20 000 for Love) and amplitude ratio data (about 15 000 for Rayleigh waves) in a period range from 30 to 130 s. The majority of the interstation distances of measured dispersion data is less than 1000 km, which is much shorter than the typical average path-length of the conventional single-station measurements for source-receiver pairs. The phase speed models for Rayleigh and Love waves show good correlations on large scales with the recent tomographic maps derived from different approaches for phase speed mapping; for example, significant slow anomalies in volcanic regions in the western Unites States and fast anomalies in the cratonic region. Local-scale phase speed anomalies corresponding to the major tectonic features in the western United States, such as Snake River Plains, Basin and Range, Colorado Plateau and Rio Grande Rift have also been identified clearly in the phase speed models. The short-path information derived from our interstation measurements helps to increase the achievable horizontal resolution. We have also performed joint inversions for phase speed maps using the measured phase and amplitude ratio data of vertical component Rayleigh waves. These maps exhibit better recovery of phase speed perturbations, particularly where the strong lateral velocity gradient exists in which the effects of elastic focussing can be significant; that is, the Yellowstone hotspot, Snake River Plains, and Rio Grande Rift. The enhanced resolution of the phase speed models derived from the interstation phase and amplitude measurements will be of use for the better seismological constraint on the lithospheric structure, in combination with dense broad-band seismic arrays.	[Hamada, K.] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Yoshizawa, K.] Hokkaido Univ, Fac Sci, Dept Earth & Planetary Sci, Sapporo, Hokkaido 0600810, Japan	Hamada, K (reprint author), Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	kouta@mail.sci.hokudai.ac.jp	Yoshizawa, Kazunori/B-5631-2008	Yoshizawa, Kazunori/0000-0003-2282-3748	Ministry of Education, Culture, Sports, Science and Technology of Japan [22654053, 24740298, 26400443]	We thank the IRIS Data Management Center for the provision of seismic waveform data, particularly the networks TA and CI used in this study. We also thank Malcolm Sambridge for the provision of the Neighbourhood Algorithm code. Many constructive and critical comments by anonymous reviewers and the editor Gabi Laske were helpful for improving the manuscript. This study was partly supported by Grant-in-Aid for Scientific Research (Nos. 22654053, 24740298 and 26400443) to KY from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Lin FC, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009208; Kaviani A, 2007, GEOPHYS J INT, V171, P399, DOI 10.1111/j.1365-246X.2007.03535.X; Obrebski M, 2011, GEOPHYS J INT, V185, P1003, DOI 10.1111/j.1365-246X.2011.04990.x; Visser K, 2008, GEOPHYS J INT, V172, P1016, DOI 10.1111/j.1365-246X.2007.03685.x; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; Godfrey NJ, 1997, GEOL SOC AM BULL, V109, P1536, DOI 10.1130/0016-7606(1997)109<1536:OBTTGV>2.3.CO;2; Foster A, 2014, GEOPHYS J INT, V196, P1189, DOI 10.1093/gji/ggt454; Lin FC, 2011, GEOPHYS J INT, V186, P1104, DOI 10.1111/j.1365-246X.2011.05070.x; vanHeijst HJ, 1997, GEOPHYS J INT, V131, P209; Nettles M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004819; Lebedev S, 2008, GEOPHYS J INT, V173, P505, DOI 10.1111/j.1365-246X.2008.03721.x; Ekstrom G, 2005, PHYS EARTH PLANET IN, V148, P327, DOI 10.1016/j.pepi.2004.09.006; TRAMPERT J, 1995, GEOPHYS J INT, V122, P675, DOI 10.1111/j.1365-246X.1995.tb07019.x; Lin FC, 2009, GEOPHYS J INT, V177, P1091, DOI 10.1111/j.1365-246X.2009.04105.x; Ekstrom G, 2011, GEOPHYS J INT, V187, P1668, DOI 10.1111/j.1365-246X.2011.05225.x; WIELANDT E, 1993, GEOPHYS J INT, V113, P45, DOI 10.1111/j.1365-246X.1993.tb02527.x; Deschamps F, 2008, EARTH PLANET SC LETT, V274, P489, DOI 10.1016/j.epsl.2008.07.058; Burdick S, 2010, SEISMOL RES LETT, V81, P689, DOI 10.1785/gssrl.81.5.689; Yoshizawa K, 2010, PHYS EARTH PLANET IN, V183, P4, DOI 10.1016/j.pepi.2010.02.012; Julia J, 2000, GEOPHYS J INT, V143, P99, DOI 10.1046/j.1365-246x.2000.00217.x; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Bakirci T, 2012, GEOPHYS J INT, V190, P1058, DOI 10.1111/j.1365-246X.2012.05526.x; Laske G, 1996, J GEOPHYS RES-SOL EA, V101, P16059, DOI 10.1029/96JB00526; Waite GP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003867; Sambridge M, 1999, GEOPHYS J INT, V138, P479, DOI 10.1046/j.1365-246X.1999.00876.x; Yoshizawa K, 2002, GEOPHYS J INT, V149, P118, DOI 10.1046/j.1365-246X.2002.01634.x; Larson EWF, 2001, PURE APPL GEOPHYS, V158, P1377, DOI 10.1007/PL00001226; Forsyth DW, 2005, GEOPHYS MONOGR SER, V157, P81, DOI 10.1029/156GM06; Goes S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000049; Yang YJ, 2006, GEOPHYS J INT, V166, P1148, DOI 10.1111/j.1365-246X.2006.02972.x; BALDRIDGE WS, 1991, TECTONOPHYSICS, V197, P327, DOI 10.1016/0040-1951(91)90049-X; Baumont D, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000345; Boschi L, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025063; Dalton C. A., 2006, J GEOPHYS RES, V111, P1; Darbyshire FA, 2009, GEOPHYS J INT, V176, P215, DOI 10.1111/j.1365-246X.2008.03982.x; Debayle E., 2000, J GEOPHYS RES, V105, P25423; Debayle E, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009288; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Dziewonski A. M., 1972, B SEISMOL SOC AM, V47, P39; Ekstrom G, 1997, J GEOPHYS RES-SOL EA, V102, P8137, DOI 10.1029/96JB03729; Ekstrom G, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039131; Foster A, 2014, EARTH PLANET SC LETT, V402, P58, DOI 10.1016/j.epsl.2013.12.046; FRIEDERICH W, 1994, GEOPHYS J INT, V119, P931, DOI 10.1111/j.1365-246X.1994.tb04026.x; Godey S, 2003, GEOPHYS J INT, V152, P620, DOI 10.1046/j.1365-246X.2003.01866.x; Isse T, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003750; Isse T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026872; Lebedev S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2000JB000073; Li AB, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002259; Marone F, 2007, GEOPHYS J INT, V171, P206, DOI 10.1111/j.1365-246X.2007.03465.x; MONTAGNER JP, 1991, J GEOPHYS RES-SOL EA, V96, P20337, DOI 10.1029/91JB01890; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P43, DOI 10.1145/355984.355989; Pancha A, 2006, B SEISMOL SOC AM, V96, P11, DOI 10.1785/0120040166; Pedersen HA, 2006, GEOPHYS J INT, V165, P279, DOI 10.1111/j.1365-246X.2006.02893.x; Siebert L., 2002, VOLCANOES WORLD ILLU; Sine CR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033391; vanderLee S, 1997, J GEOPHYS RES-SOL EA, V102, P22815, DOI 10.1029/97JB01168; WOODHOUSE JH, 1986, GEOPHYS J INT, V87, P753, DOI 10.1111/j.1365-246X.1986.tb01970.x; Yang XN, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003193; Yoshizawa K, 2010, GEOPHYS J INT, V183, P1538, DOI 10.1111/j.1365-246X.2010.04814.x; Yoshizawa K, 1999, GEOPHYS J INT, V138, P205, DOI 10.1046/j.1365-246x.1999.00861.x; Yoshizawa K, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2002JB002254; Yoshizawa K, 2014, PHYS EARTH PLANET IN, V235, P33, DOI 10.1016/j.pepi.2014.07.008	62	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	SEP	2015	202	3					1463	1482		10.1093/gji/ggv213		20	Geochemistry & Geophysics	Geochemistry & Geophysics	CQ5EG	WOS:000360625500003		
J	Matsushima, M				Matsushima, Masaki			Core surface flow modelling with geomagnetic diffusion in a boundary layer	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Inverse theory; Dynamo: theories and simulations; Rapid time variations	SECULAR VARIATION; EARTHS CORE; MAGNETIC-FIELD; DYNAMO MODEL; HEAT-FLOW; FLUX; GEODYNAMO; MOTIONS	A new method of estimating fluid flows near the core-mantle boundary is presented. Both the geomagnetic diffusion and dynamics in a boundary layer are taken into account under the no-slip condition at the core-mantle boundary. Below the boundary layer, the tangentially geostrophic constraint is imposed on the flow to be estimated. The radial component of the geomagnetic field just within the core is calculated from the radial component and its partial derivatives with respect to the radius, first, derived from continuity of the solenoidal field across the finite jump in electrical conductivity and, second, the geomagnetic diffusion. Below the boundary layer, fluid motions thus derived show some features common to those estimated on the basis of the frozen-flux approximation, and their accompanying vortices at mid and high latitudes are well correlated with upwellings or downwellings inside the boundary layer. The positional relation of upwellings and downwellings in equatorial regions inside and below the boundary layer suggests existence of columnar convective cells there. Intense magnetic flux spots seen in equatorial regions are likely to be produced not by downwellings at tops of cyclonic columns but by flux expulsion due to upwellings between adjacent columnar flows. The present new method leads to a new insight on core surface flows that have not been noted so far.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Tokyo 1528551, Japan	Matsushima, M (reprint author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Tokyo 1528551, Japan.	mmatsush@geo.titech.ac.jp					Amit H, 2004, PHYS EARTH PLANET IN, V147, P1, DOI 10.1016/j.pepi.2004.02.006; Olson P, 2002, GEOPHYS J INT, V151, P809, DOI 10.1046/j.1365-246X.2002.01818.x; Amit H, 2008, GEOPHYS J INT, V175, P913, DOI 10.1111/j.1365-246X.2008.03948.x; WHALER KA, 1980, NATURE, V287, P528, DOI 10.1038/287528a0; LEMOUEL JL, 1984, NATURE, V311, P734, DOI 10.1038/311734a0; Amit H, 2013, GEOPHYS J INT, V194, P145, DOI 10.1093/gji/ggt077; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Takahashi F, 2005, SCIENCE, V309, P459, DOI 10.1126/science.1111831; Holme R, 2006, GEOPHYS J INT, V166, P518, DOI 10.1111/j.1365-246X.2006.03033.x; Amit H, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006542; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; Jackson A, 2003, NATURE, V424, P760, DOI 10.1038/nature01879; Aubert J, 2008, NATURE, V454, P758, DOI 10.1038/nature07109; Christensen UR, 2003, PHYS EARTH PLANET IN, V138, P39, DOI 10.1016/S0031-9201(03)00064-5; Finlay CC, 2010, SPACE SCI REV, V155, P177, DOI 10.1007/s11214-010-9691-6; Asari S, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008267; Gubbins D, 1996, PHYS EARTH PLANET IN, V98, P193, DOI 10.1016/S0031-9201(96)03187-1; Pais MA, 2008, GEOPHYS J INT, V173, P421, DOI 10.1111/j.1365-246X.2008.03741.x; BACKUS GE, 1968, PHILOS TR R SOC S-A, V263, P239, DOI 10.1098/rsta.1968.0014; BLOXHAM J, 1986, GEOPHYS J INT, V87, P669, DOI 10.1111/j.1365-246X.1986.tb06643.x; BRAGINSKY SI, 1991, GEOPHYS ASTRO FLUID, V60, P89, DOI 10.1080/03091929108219997; Chulliat A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006994; Davis RG, 1997, PHYS EARTH PLANET IN, V103, P181, DOI 10.1016/S0031-9201(97)00032-0; Gubbins D., 1987, GEOMAGN AERON, VII, P1; Gubbins D, 1996, GEOPHYS RES LETT, V23, P1825, DOI 10.1029/96GL01392; Holme R., 2007, TREATISE GEOPHYS, V8, P107; Hulot G, 2003, PHYS EARTH PLANET IN, V135, P47, DOI 10.1016/S0031-9201(02)00191-7; Kageyama A, 1997, PHYS PLASMAS, V4, P1569, DOI 10.1063/1.872287; Love JJ, 1999, GEOPHYS J INT, V138, P353, DOI 10.1046/j.1365-246x.1999.00895.x; Maus S, 2008, GEOPHYS J INT, V175, P853, DOI 10.1111/j.1365-246X.2008.03972.x; Olson P, 1999, J GEOPHYS RES-SOL EA, V104, P10383, DOI 10.1029/1999JB900013; Olson P, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000384; PEDLOSKY J., 1987, GEOPHYS FLUID DYNAMI; ROBERTS PH, 1965, J GEOMAGN GEOELECTR, V17, P137; Takahashi F, 2001, PHYS EARTH PLANET IN, V128, P149, DOI 10.1016/S0031-9201(01)00283-7; Takahashi F, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/s40623-014-0157-z; VOORHIES CV, 1993, GEOPH MONOG SERIES, V72, P113; VOORHIES CV, 1986, J GEOPHYS RES-SOLID, V91, P2444, DOI 10.1029/JB091iB12p12444; Voorhies C.V., 1984, THESIS U COLORADO BO; Wardinski I, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004401	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	SEP	2015	202	3					1495	1504		10.1093/gji/ggv233		10	Geochemistry & Geophysics	Geochemistry & Geophysics	CQ5EG	WOS:000360625500005		
J	Kobayashi, M; Takemura, S; Yoshimoto, K				Kobayashi, Manabu; Takemura, Shunsuke; Yoshimoto, Kazuo			Frequency and distance changes in the apparent P-wave radiation pattern: effects of seismic wave scattering in the crust inferred from dense seismic observations and numerical simulations	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Body waves; Computational seismology; Wave scattering and diffraction; Wave propagation	S-WAVE; HI-NET; DEPENDENT ATTENUATION; VOLCANIC FRONT; KIK-NET; JAPAN; EARTHQUAKE; LITHOSPHERE; REGION; MEDIA	Frequency and distance changes in the apparent P-wave radiation pattern (0.75-12 Hz) are investigated using velocity seismograms of shallow strike-slip earthquakes occurring in Chugoku region, southwestern Japan. Data from a dense seismic monitoring network revealed that the four-lobe apparent P-wave radiation pattern was gradually distorted with increasing frequency and propagation distance. Observed features suggest that seismic wave scattering due to small-scale velocity heterogeneity in the crust may be a major cause of this distortion. The effects of seismic wave scattering on apparent P-wave radiation pattern were investigated via 3-D finite difference simulation of seismic wave propagation. Our simulations demonstrated that the scattering of seismic waves modified the apparent P-wave radiation pattern from the original four-lobe shape, and that the small-scale velocity heterogeneity, characterized by the von Karman-type power spectral density function with correlation distance of 1 km, root-mean-square value of 0.03 and decay rate parameter of 0.5, might be adequate for modelling crustal heterogeneity in the target region. It was also found that the scattering attenuation of P wave expected from this heterogeneity is significantly smaller than the apparent P-wave attenuation and S-wave scattering attenuation reported by Multiple Lapse Time Window Analysis of previous studies in Japan. These results might imply that scattering attenuation is not the dominant mechanism of P-wave attenuation in the crust of Chugoku region.	[Kobayashi, Manabu] Yokohama City Univ, Div Sci, Int Coll Arts & Sci, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Takemura, Shunsuke; Yoshimoto, Kazuo] Yokohama City Univ, Grad Sch Nanobiosci, Dept Mat Syst Sci, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Takemura, Shunsuke] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Kobayashi, M (reprint author), Yokohama City Univ, Div Sci, Int Coll Arts & Sci, Kanazawa Ku, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan.	shunsuke@eri.u-tokyo.ac.jp					Aki K., 2002, QUANTITATIVE SEISMOL; Yoshimoto K, 2006, B SEISMOL SOC AM, V96, P637, DOI 10.1785/0120050085; Yabe S, 2014, J GEOPHYS RES-SOL EA, V119, P8171, DOI 10.1002/2014JB011383; Takahashi T, 2009, GEOPHYS J INT, V178, P1437, DOI 10.1111/j.1365-246X.2009.04227.x; Wu YM, 2008, SENSORS-BASEL, V8, P1, DOI 10.3390/s8010001; Kumagai H, 2013, J GEOPHYS RES-SOL EA, V118, P222, DOI 10.1029/2012JB009670; Takenaka H, 2003, PHYS EARTH PLANET IN, V137, P31, DOI 10.1016/S0031-9201(03)00006-2; Iio Y., 1986, Journal of Physics of the Earth, V34; Takemura S, 2013, GEOPHYS J INT, V193, P421, DOI 10.1093/gji/ggs127; OBARA K, 1995, J GEOPHYS RES-SOL EA, V100, P2103, DOI 10.1029/94JB02644; AKI K, 1980, PHYS EARTH PLANET IN, V21, P50, DOI 10.1016/0031-9201(80)90019-9; Nakahara H, 2004, GEOPHYS J INT, V157, P1255, DOI 10.1111/j.1365-246X.2004.02278.x; Takemura S, 2009, GEOPHYS J INT, V178, P950, DOI 10.1111/j.1365-246X.2009.04210.x; Pitarka A, 2000, B SEISMOL SOC AM, V90, P566, DOI 10.1785/0119990108; SATO H, 1984, J GEOPHYS RES, V89, P1221, DOI 10.1029/JB089iB02p01221; Yoshimoto K, 2009, EARTH PLANETS SPACE, V61, P1067; Satoh T, 2002, B SEISMOL SOC AM, V92, P1032, DOI 10.1785/0120010153; Sato H, 1997, PHYS EARTH PLANET IN, V104, P1, DOI 10.1016/S0031-9201(97)00050-2; Tajima R, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004941; Carcole E, 2010, GEOPHYS J INT, V180, P268, DOI 10.1111/j.1365-246X.2009.04394.x; Asano Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002761; Furumura T, 2004, CMES-COMP MODEL ENG, V6, P153; Takemura S, 2015, GEOPHYS J INT, V201, P459, DOI 10.1093/gji/ggv038; YOSHIMOTO K, 1993, GEOPHYS J INT, V114, P165, DOI 10.1111/j.1365-246X.1993.tb01476.x; Takemura S, 2014, GEOPHYS J INT, V197, P1016, DOI 10.1093/gji/ggu031; LIU HL, 1985, B SEISMOL SOC AM, V75, P689; Klimes L, 2002, PURE APPL GEOPHYS, V159, P1811, DOI 10.1007/s00024-002-8710-2; Ji C, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001764; FEHLER M, 1992, GEOPHYS J INT, V108, P787, DOI 10.1111/j.1365-246X.1992.tb03470.x; Imperatori W, 2013, GEOPHYS J INT, V192, P725, DOI 10.1093/gji/ggs041; Sawazaki K, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008182; Birch AF, 1961, J GEOPHYS RES, V66, P2199, DOI [10.1029/JZ065i004p01083, DOI 10.1029/JZ066I007P02199]; BOORE DM, 1984, B SEISMOL SOC AM, V74, P1615; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Fukuyama E., 1998, ZISIN, V51, P149; Gallovic F, 2015, J GEOPHYS RES-SOL EA, V120, P428, DOI 10.1002/2014JB011650; Graves RW, 1996, B SEISMOL SOC AM, V86, P1091; Hosoda T., 1995, JAP EARTH PLAN SCI J, P632; Maeda T, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008464; Nakamura Y, 1988, P 9 WORLD C EARTHQ E, VVII, P673; Okada Y, 2004, EARTH PLANETS SPACE, V56, pXV; Sato H, 2012, SEISMIC WAVE PROPAGA; Takemura M., 1998, ZISIN 2, V51, P211; WESSEL P, 1998, EOS T AGU, V0079	44	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	SEP	2015	202	3					1895	1907		10.1093/gji/ggv263		13	Geochemistry & Geophysics	Geochemistry & Geophysics	CQ5EG	WOS:000360625500033		
J	Hatano, T				Hatano, Takahiro			Friction laws from dimensional-analysis point of view	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Rheology and friction of fault zones; Mechanics; theory; and modelling	DEPENDENT FRICTION; STATE FRICTION; DRY-FRICTION; STICK-SLIP; STABILITY; BEHAVIOR; EARTHQUAKES; MECHANICS; SYSTEM; FAULTS	Friction laws, which are a key to the understanding of the diversity of earthquakes, are considered theoretically. Using dimensional analysis, the logarithmic dependence of the friction coefficient on the slip velocity and the state variable is derived without any knowledge of the underlying physical processes on the frictional surface. This is based on a simple assumption that the friction coefficient is expressed as the difference from a reference state. Therefore, the functional form of the rate and state dependent friction law itself does not necessarily mean that thermal activation processes dominate friction. It is also shown that if there are two (or more) state variables having the same dimension, we need not assume the logarithmic dependence on the state variables.	Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Hatano, T (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan.	hatano@eri.u-tokyo.ac.jp			JSPS	The author acknowledges Hiroyuki Noda for critical reading of the manuscript. He also acknowledges JSPS Grand-in-Aid for Scientific Research: 'New Perspective of the Great Subduction Zone Earthquake from the Super Deep Drilling'.	Han R, 2011, GEOLOGY, V39, P599, DOI 10.1130/G31842.1; Goldsby DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015240; DIETERICH JH, 1978, PURE APPL GEOPHYS, V116, P790, DOI 10.1007/BF00876539; Han R, 2007, SCIENCE, V316, P878, DOI 10.1126/science.1139763; Kuwano O, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048530; Bar-Sinai Y, 2014, J GEOPHYS RES-SOL EA, V119, P1738, DOI 10.1002/2013JB010586; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; KANAMORI H, 1994, ANNU REV EARTH PL SC, V22, P207, DOI 10.1146/annurev.ea.22.050194.001231; GU JC, 1984, J MECH PHYS SOLIDS, V32, P167, DOI 10.1016/0022-5096(84)90007-3; HESLOT F, 1994, PHYS REV E, V49, P4973, DOI 10.1103/PhysRevE.49.4973; Barenblatt G, 2003, SCALING; BLANPIED ML, 1986, PURE APPL GEOPHYS, V124, P415, DOI 10.1007/BF00877210; CHESTER FM, 1994, J GEOPHYS RES-SOL EA, V99, P7247, DOI 10.1029/93JB03110; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Nakatani M, 2001, J GEOPHYS RES-SOL EA, V106, P13347, DOI 10.1029/2000JB900453; Noda H, 2012, J STRUCT GEOL, V38, P234, DOI 10.1016/j.jsg.2011.08.012; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Ruina A. L., 1983, GEOPHYS RES LETT, V88, P359, DOI DOI 10.1029/JB088IB12P10359	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	SEP	2015	202	3					2159	2162		10.1093/gji/ggv280		4	Geochemistry & Geophysics	Geochemistry & Geophysics	CQ5EG	WOS:000360625500047		
J	Tamura, K; Sanada, Y; Shoji, A; Okumura, K; Uwatoko, N; Anzoua, KG; Sacks, EJ; Yamada, T				Tamura, Ken-ichi; Sanada, Yasuharu; Shoji, Atsushi; Okumura, Kenji; Uwatoko, Naohiro; Anzoua, Kossonou Guillaume; Sacks, Erik J.; Yamada, Toshihiko			DNA markers for identifying interspecific hybrids between Miscanthus sacchariflorus and Miscanthus sinensis	GRASSLAND SCIENCE			English	Article						DNA marker; interspecific hybrid; intron polymorphisms; Miscanthus; simple repeat sequence	SYMPATRIC POPULATIONS; M.-SACCHARIFLORUS; X-GIGANTEUS; CROP; POACEAE; GENOME; DISCOVERY; JAPAN	Interspecific hybrids between Miscanthus sacchariflorus and Miscanthus sinensis, such as Miscanthusxgiganteus, are promising biomass crops for temperate regions. A set of DNA markers to distinguish both species would be a powerful tool for interspecific hybrid breeding. Out of 85 intron-flanking primer pairs developed using genomic information from sugarcane (Saccharum hybrid) and Sorghum bicolor, seven were selected that showed polymorphisms between M.sacchariflorus and M.sinensis. Four simple sequence repeat primer pairs were also screened that showed polymorphisms between both species from 44 previously developed primer pairs. Of the polymerase chain reaction (PCR) products generated by the 11 primer pairs, nine amplified fragments were specific to M.sacchariflorus and two were specific to M.sinensis, based on 83 accessions mainly from Japan but also including Chinese and Korean ones. Fragments specific to two species were detected in three known hybrid plants. These results indicate that combinations of these PCR fragments could be good markers for identifying hybrids of M.sacchariflorus and M.sinensis obtained from breeding programs or from natural crosses between wild sympatric populations.	[Tamura, Ken-ichi; Sanada, Yasuharu; Shoji, Atsushi; Okumura, Kenji] Natl Agr & Food Res Org NARO, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan; [Uwatoko, Naohiro] Natl Agr & Food Res Org NARO, Kyushu Okinawa Agr Res Ctr, Koshi, Kumamoto, Japan; [Anzoua, Kossonou Guillaume; Yamada, Toshihiko] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Sapporo, Hokkaido, Japan; [Sacks, Erik J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	Tamura, K (reprint author), NARO Hokkaido Agr Res Ctr, 1 Hitsujigaoka, Sapporo, Hokkaido 0628555, Japan.	tamuken@affrc.go.jp	Yamada, Toshihiko/A-5111-2012	Yamada, Toshihiko/0000-0002-7845-6556			Adati S, 1958, B FACULTY AGR MIE U, V17, P1; GREEF JM, 1993, ANGEW BOT, V67, P87; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Zhou HF, 2011, AM J BOT, V98, pE195, DOI 10.3732/ajb.1100040; Robson P, 2013, J EXP BOT, V64, P4143, DOI 10.1093/jxb/ert225; Heaton EA, 2010, ADV BOT RES, V56, P75, DOI 10.1016/S0065-2296(10)56003-8; Kim C, 2012, THEOR APPL GENET, V124, P1325, DOI 10.1007/s00122-012-1790-1; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Nishiwaki A, 2011, AM J BOT, V98, P154, DOI 10.3732/ajb.1000258; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; Lyons LA, 1997, NAT GENET, V15, P47, DOI 10.1038/ng0197-47; Moon YH, 2013, EUPHYTICA, V193, P317, DOI 10.1007/s10681-013-0910-6; Cai HW, 2005, THEOR APPL GENET, V112, P158, DOI 10.1007/s00122-005-0118-9; Chae WB, 2014, GCB BIOENERGY, V6, P646, DOI 10.1111/gcbb.12101; Clifton-Brown John, 2008, P273, DOI 10.1007/978-0-387-70805-8_10; Dwiyanti MS, 2013, BIOENERG RES, V6, P486, DOI 10.1007/s12155-012-9274-3; Gowacka K, 2015, GCB BIOENERGY; Hirayoshi I, 1957, BULLETIN, P8; Honda M, 1939, BOT MAGAZINE, V53, P144; Jiang JX, 2013, PLANT SYST EVOL, V299, P1367, DOI 10.1007/s00606-013-0801-2; Kim C, 2014, PLANT CELL, V26, P2420, DOI 10.1105/tpc.114.125583; Kim JK, 2012, BIOPROC BIOSYST ENG, V35, P55, DOI 10.1007/s00449-011-0592-1; Nielsen PN, 1990, PFLUG SPATEN, V3, P1; Tamura K, 2012, MOL BREEDING, V30, P1, DOI 10.1007/s11032-011-9593-7; Tamura K, 2013, DIAGNOSTICS PLANT BR, P211; Tamura K, 2009, THEOR APPL GENET, V118, P1549, DOI 10.1007/s00122-009-1003-8; You FM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-331	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-6961	1744-697X		GRASSL SCI	Grassl. Sci.	SEP	2015	61	3					160	166		10.1111/grs.12089		7	Agriculture, Multidisciplinary; Agronomy	Agriculture	CQ6ME	WOS:000360717700004		
J	Mitsuhashi, S; Masunaka, A; Kikawada, T; Sugawara, K; Tsukiboshi, T; Tamaki, H; Sato, H				Mitsuhashi, Shohei; Masunaka, Akira; Kikawada, Tomohiro; Sugawara, Koya; Tsukiboshi, Takao; Tamaki, Hiroyuki; Sato, Hisashi			Evaluation of resistance to Pythium root rot by Pythium arrhenomanes in corn by using a toothpick inoculation method	GRASSLAND SCIENCE			English	Article						Pythium root rot; toothpick method; Zea mays L	PATHOGENICITY; VIRULENCE	A toothpick inoculation method was applied for evaluating the disease severity and infection frequency of Pythium root rot, which seriously restricts forage corn production in Japan. Seven corn hybrids were inoculated with toothpicks infested with Pythium arrhenomanes, the causal pathogen of the disease. Between 2011 and 2013, toothpicks were inserted into holes of the bottom stalks of corn plants just above the ground at the silking stage. At the inoculation plots throughout the experimental years, the infection frequencies of highly susceptible hybrids were stable even under suboptimal climate conditions. Therefore, we have concluded that the toothpick method is useful especially for discarding highly susceptible hybrids based on the data obtained from a single year. Further experiments will be required to overcome such problems as the low correlation between hybrids and their parental inbreds, and the development of more accurate screening systems for selecting resistant genotypes.	[Mitsuhashi, Shohei; Masunaka, Akira; Tsukiboshi, Takao; Tamaki, Hiroyuki] Natl Agr & Food Res Org NARO, Inst Livestock & Grassland Sci, Nasushiobara, Tochigi, Japan; [Kikawada, Tomohiro; Sato, Hisashi] Natl Agr & Food Res Org NARO, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan; [Sugawara, Koya] Natl Agr & Food Res Org NARO, Tohoku Agr Res Ctr, Morioka, Iwate, Japan	Mitsuhashi, S (reprint author), NARO Inst Livestock & Grassland Sci, 768 Senbonmatsu, Nasushiobara, Tochigi 3292793, Japan.	shouheim@affrc.go.jp					ABAD ZG, 1994, PHYTOPATHOLOGY, V84, P913, DOI 10.1094/Phyto-84-913; Deep IW, 1996, CROP PROT, V15, P85, DOI 10.1016/0261-2194(95)00120-4; Bruehl GW, 1953, TECHNICAL B USDA, V1084, P1; Craft CM, 1996, APPL ENVIRON MICROB, V62, P1550; DEWAN MM, 1988, SOIL BIOL BIOCHEM, V20, P801, DOI 10.1016/0038-0717(88)90085-5; Dickson JG, 1956, DIS FIELD CROPS, P1; Drechsler C, 1928, PHYTOPATHOLOGY, V18, P873; ERWIN D. C, 1957, PLANT DIS REPORTER, V41, P988; Funakubo T, 2010, ANN REP KANTO TOSAN, V57, P15; HOY JW, 1988, PHYTOPATHOLOGY, V78, P1688, DOI 10.1094/Phyto-78-1688; Mesterhazy A, 2000, GENETIKA, V32, P495; Nemoto K, 1987, BULLETIN, V77, P29; TODD LR, 1994, PLANT DIS, V78, P876; Tsukiboshi T, 2014, PLANT DIS, V98, P1155, DOI 10.1094/PDIS-01-14-0059-PDN; Young H.C., 1943, PHYTOPATHOLOGY, V33, P16	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-6961	1744-697X		GRASSL SCI	Grassl. Sci.	SEP	2015	61	3					181	184		10.1111/grs.12096		4	Agriculture, Multidisciplinary; Agronomy	Agriculture	CQ6ME	WOS:000360717700007		
J	Deguchi, S; Uozumi, S; Kaneko, M; Touno, E				Deguchi, Shin; Uozumi, Sunao; Kaneko, Makoto; Touno, Eiko			Organic cultivation system of corn-triticale rotation using white clover living mulch	GRASSLAND SCIENCE			English	Article						Corn; living mulch; organic cultivation; triticale; white clover	NITROGEN; YIELDS; WEEDS	We conducted an on-farm experiment to establish corn-triticale rotational cropping system for producing organic forage, using white clover living mulch (LM). A 2-ha experimental field has been managed according to the Japanese Agricultural Standard for organic feed production since 2003, and two cropping systems (LM and tillage cultivation [TC]) combined with two compost application methods (with and without compost application before planting) were tested as four corn cultivation treatments from 2008 to 2009. White clover was sown in the autumn of 2008, and corn was cultivated from June to October 2009 using the four treatments and without any application of chemical herbicides and fertilizers. After the corn harvest, the two treatments of compost application were set up again within each corn cultivation treatment, resulting in a total of eight treatments. Triticale was cultivated in those treatments from October 2009 to June 2010, without chemical herbicides or fertilizers. The results of the treatments showed that LM suppressed weed growth and increased nitrogen (N) uptake and yield of corn compared to the TC treatment. The dry matter yields of corn were the highest and the dry weight of the weeds were the lowest in the LM treatment with compost application before planting. Furthermore, the positive effect of LM on N supply was preserved during the cropping of triticale. Therefore, we concluded that the total dry matter yield of forage crops in corn-triticale rotation could be increased by using white clover LM with compost application to suppress weed growth and to increase the N uptake both of the main and succeeding crops. White clover LM is a useful cultivation technique for organic production of forage crops.	[Deguchi, Shin; Uozumi, Sunao; Kaneko, Makoto; Touno, Eiko] Natl Agr & Food Res Org NARO, Tohoku Agr Res Ctr, Morioka, Iwate, Japan	Deguchi, S (reprint author), NARO Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan.	deguchi@affrc.go.jp					ABE A, 1979, J ANIM SCI, V48, P1483; Rasmussen IA, 2004, WEED RES, V44, P12, DOI 10.1046/j.1365-3180.2003.00367.x; Hartwig NL, 2002, WEED SCI, V50, P688, DOI 10.1614/0043-1745(2002)050[0688:AIACCA]2.0.CO;2; Brandsaeter LO, 1998, BIOL AGRIC HORTIC, V16, P291; Association of Self-supply Feed Evaluation, 2001, GEN CROP STAND ASS O, P1; Deguchi S, 2014, SOIL SCI PLANT NUTR, V60, P183, DOI 10.1080/00380768.2014.890016; Japan Meteorological Agency, 2014, CLIM STAT; Kanazawa K, 2009, B NATL AGR RES CTR, V12, P27; Maeda A, 2006, BULLETIN, V129, P13; Ministry of Agriculture Forestry and Fisheries (MAFF), 2012, 86 STAT YB MIN AGR F, P1; Ministry of Agriculture Forestry and Fisheries (MAFF), 2005, JAP AGR STAND ORG LI; Nakui T, 1984, BULLETIN, V70, P85; Okumura T, 1986, BULLETIN, V19, P1; Uozumi S, 2006, B NATL AGR RES CENT, V106, P15; Uozumi S, 2004, B NATL AGR RES CENT, V102, P93; Uozumi S, 2005, SUSTAINABLE LIVESTOC, V59, P247; Uozumi S., 2012, Japanese Journal of Grassland Science, V58, P1, DOI 10.1111/j.1744-697X.2011.00239.x	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-6961	1744-697X		GRASSL SCI	Grassl. Sci.	SEP	2015	61	3					188	194		10.1111/grs.12091		7	Agriculture, Multidisciplinary; Agronomy	Agriculture	CQ6ME	WOS:000360717700009		
J	Tazuma, S				Tazuma, Susumu			Statins affect gallstone diseases: Underlying mechanism(s) are to be established	HEPATOLOGY RESEARCH			English	Editorial Material							CHOLESTEROL GALLSTONE; DISSOLUTION; POPULATION; REDUCTASE; RISK; CHOLECYSTECTOMY; PRAVASTATIN; LOVASTATIN; INHIBITOR		Univ Hosp, Dept Gen Internal Med, Hiroshima, Japan	Tazuma, S (reprint author), Univ Hosp, Dept Gen Internal Med, Hiroshima, Japan.						Caroli-Bosc FX, 2001, DIGEST DIS SCI, V46, P540, DOI 10.1023/A:1005643014395; Ruhl CE, 2011, GASTROENTEROLOGY, V140, P508, DOI 10.1053/j.gastro.2010.10.060; Erichsen R, 2011, AM J EPIDEMIOL, V173, P162, DOI 10.1093/aje/kwq361; Navarese EP, 2014, AM J CARDIOL, V113, P1753, DOI 10.1016/j.amjcard.2014.02.034; Bodmer M, 2009, JAMA-J AM MED ASSOC, V302, P2001, DOI 10.1001/jama.2009.1601; Chapman BA, 1998, DIGEST DIS SCI, V43, P349, DOI 10.1023/A:1018862507469; Chiu HF, 2012, EXPERT OPIN DRUG SAF, P14; Kan HP, 2015, HEPATOL RES, V45, P942, DOI 10.1111/hepr.12433; Merzon E, 2010, EXPERT OPIN DRUG SAF, V9, P539, DOI 10.1517/14740338.2010.485190; SAUNDERS KD, 1993, SURGERY, V113, P28; SAUNDERS KD, 1991, ANN SURG, V214, P149, DOI 10.1097/00000658-199108000-00009; SMIT JWA, 1992, GASTROENTEROLOGY, V103, P1068; TAZUMA S, 1992, DIGESTION, V51, P179; Tazuma S, 2013, J GASTROENTEROL H S4, P103; Tsai CJ, 2009, GASTROENTEROLOGY, V136, P1593, DOI 10.1053/j.gastro.2009.01.042; WALTER SD, 1991, BIOMETRICS, V47, P795, DOI 10.2307/2532640	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					939	941		10.1111/hepr.12472		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300001		
J	Terashima, T; Yamashita, T; Iida, N; Yamashita, T; Nakagawa, H; Arai, K; Kitamura, K; Kagaya, T; Sakai, Y; Mizukoshi, E; Honda, M; Kaneko, S				Terashima, Takeshi; Yamashita, Tatsuya; Iida, Noriho; Yamashita, Taro; Nakagawa, Hidetoshi; Arai, Kuniaki; Kitamura, Kazuya; Kagaya, Takashi; Sakai, Yoshio; Mizukoshi, Eishiro; Honda, Masao; Kaneko, Shuichi			Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy	HEPATOLOGY RESEARCH			English	Article						hepatic arterial infusion chemotherapy; hepatocellular carcinoma; neutrophil lymphocyte ratio; predictive factor; prognostic factor	TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-TRANSPLANTATION; PROGNOSTIC INDEX; PHASE-II; INFLAMMATION; CANCER; SORAFENIB; RECURRENCE; GUIDELINE; CRITERIA	AimInflammation plays a critical role in cancer. The aim of the present study was to investigate the impact of neutrophil to lymphocyte ratio (NLR) on patients with advanced hepatocellular carcinoma (HCC) treated with hepatic arterial infusion chemotherapy (HAIC). MethodsWe retrospectively evaluated 266 patients with advanced HCC treated with HAIC between March 2003 and December 2012. NLR was calculated from the differential leukocyte count by dividing the absolute neutrophil count by the absolute lymphocyte count. ResultsThe cut-off level of NLR was set as the median value of 2.87 among all patients in this study. The objective response rate in the patients with low NLR was 37.6%, which was significantly better than that of the patients with high NLR (21.1%; P<0.01). Multivariate analysis revealed that low NLR remained associated with the response to HAIC (P=0.024). Median progression-free survival and median overall survival in patients with high NLR were 3.2 and 8.0 months, respectively, which were significantly shorter than that of the patients with low NLR (5.6 and 20.7 months; P<0.01 and P<0.01, respectively). High NLR was an independent unfavorable prognostic factor in multivariate analysis. The patient outcome was stratified more clearly by NLR calculated after HAIC added to calculations before HAIC. Serum platelet-derived growth factor-BB level was positively correlated with NLR. ConclusionResults suggest that NLR is a useful predictor in patients with advanced HCC treated with HAIC. These findings may be useful in determining treatment strategies or in designing clinical chemotherapy trials in future.	[Terashima, Takeshi; Yamashita, Tatsuya; Iida, Noriho; Yamashita, Taro; Nakagawa, Hidetoshi; Arai, Kuniaki; Kitamura, Kazuya; Kagaya, Takashi; Sakai, Yoshio; Mizukoshi, Eishiro; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan	Yamashita, T (reprint author), Kanazawa Univ Hosp, Dept Gastroenterol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	ytatsuya@m-kanazawa.jp					Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Bertuzzo VR, 2011, TRANSPLANTATION, V91, P1279, DOI 10.1097/TP.0b013e3182187cf0; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Yamashita T, 2011, ONCOLOGY-BASEL, V81, P281, DOI 10.1159/000334439; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Arihara F, 2013, CANCER IMMUNOL IMMUN, V62, P1421, DOI 10.1007/s00262-013-1447-1; Lee JM, 2012, SEMIN ONCOL, V39, P399, DOI 10.1053/j.seminoncol.2012.05.010; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Pinato DJ, 2012, TRANSL RES, V160, P146, DOI 10.1016/j.trsl.2012.01.011; Lee MH, 2012, J GASTROEN HEPATOL, V27, P313, DOI 10.1111/j.1440-1746.2011.06867.x; Chen LP, 2012, EUR J CANCER, V48, P1977, DOI 10.1016/j.ejca.2012.01.015; Miyahara K, 2013, BRIT J CANCER, V109, P2072, DOI 10.1038/bjc.2013.554; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Oxnard GR, 2012, JNCI-J NATL CANCER I, V104, P1534, DOI 10.1093/jnci/djs353; Pinato DJ, 2012, J HEPATOL, V57, P1013, DOI 10.1016/j.jhep.2012.06.022; Inaba Y, 2013, EUR J CANCER, V49, P2832, DOI 10.1016/j.ejca.2013.05.011; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Takizawa D, 2007, DIGEST DIS SCI, V52, P3290, DOI 10.1007/s10620-007-9808-2; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Kaneko S, 2012, HEPATOL RES, V42, P523, DOI 10.1111/j.1872-034X.2012.00981.x; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; McNally ME, 2013, ANN SURG ONCOL, V20, P923, DOI 10.1245/s10434-012-2639-1; Morimoto M, 2012, ANTICANCER RES, V32, P619; Song DS, 2014, J GASTROENTEROL, DOI [10.1007/s00535-014-0978-3, DOI 10.1007/S00535-014-0978-3.]; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Terashima T, 2014, HEPATOL RES, V44, P1179, DOI 10.1111/hepr.12266; Wada Y, 2007, ONCOL REP, V17, P161	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					949	959		10.1111/hepr.12436		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300003		
J	Senoo, T; Ichikawa, T; Taura, N; Miyaaki, H; Miuma, S; Shibata, H; Honda, T; Takatsuki, M; Hidaka, M; Soyama, A; Eguchi, S; Nakao, K				Senoo, Takemasa; Ichikawa, Tatsuki; Taura, Naota; Miyaaki, Hisamitsu; Miuma, Satoshi; Shibata, Hidetaka; Honda, Takuya; Takatsuki, Mitsuhisa; Hidaka, Masaaki; Soyama, Akihiko; Eguchi, Susumu; Nakao, Kazuhiko			Incidence of and risk factors for bile duct stones after living donor liver transplantation: An analysis of 100 patients	HEPATOLOGY RESEARCH			English	Article						bile duct stone; complication; living donor liver transplantation; male sex; right lobe graft	PAPILLARY BALLOON DILATION; BILIARY-TRACT COMPLICATIONS; LONG-TERM OUTCOMES; ENDOSCOPIC SPHINCTEROTOMY; SINGLE-CENTER; RECONSTRUCTION; EXPERIENCE; MANAGEMENT; ANASTOMOSIS; RECIPIENTS	AimAlthough bile duct stone (BDS) is one of the biliary complications of liver transplantation, analytical studies, particularly on living donor liver transplantation (LDLT) cases, are rare. This study aimed to clarify the incidence of and risk factors for BDS following LDLT. MethodsWe retrospectively reviewed the medical records of 100 patients who underwent LDLT at our institute from August 2000 to May 2012, and analyzed their clinical characteristics and risk factors for BDS. ResultsOf these, 10 patients (10.0%) developed BDS during the observation period. The median follow-up period to BDS diagnosis was 45.5 months (range, 5-84) after LDLT. Univariate analysis revealed male sex, right lobe graft and bile duct strictures as factors that significantly correlated with BDS formation. Multivariate analysis revealed bile duct strictures (odds ratio, 7.17; P=0.011) and right lobe graft (odds ratio, 10.20; P=0.040) to be independent risk factors for BDS formation. One patient with BDS and biliary strictures succumbed to sepsis from cholangitis. ConclusionIn the present study, right lobe graft and bile duct strictures are independent risk factors for BDS formation after LDLT. More careful observation and monitoring are required in the patients with high-risk factors.	[Senoo, Takemasa; Ichikawa, Tatsuki; Taura, Naota; Miyaaki, Hisamitsu; Miuma, Satoshi; Shibata, Hidetaka; Honda, Takuya; Nakao, Kazuhiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, Nagasaki 8528501, Japan; [Takatsuki, Mitsuhisa; Hidaka, Masaaki; Soyama, Akihiko; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan	Ichikawa, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	ichikawa@nagasaki-u.ac.jp					Koivusalo A, 1996, SCAND J GASTROENTERO, V31, P506, DOI 10.3109/00365529609006773; Rerknimitr R, 2002, GASTROINTEST ENDOSC, V55, P224, DOI 10.1067/mge.2002.120813; Maheshwari A, 2007, LIVER TRANSPLANT, V13, P1645, DOI 10.1002/It.21212; Tsujino T, 2007, CLIN GASTROENTEROL H, V5, P130, DOI 10.1016/j.cgh.2006.10.013; Ohashi A, 2009, DIGEST ENDOSC, V21, P73, DOI 10.1111/j.1443-1661.2009.00835.x; Natsui M, 2011, EUR J GASTROEN HEPAT, V23, P818, DOI 10.1097/MEG.0b013e328348c0bf; Kasahara M, 2006, ANN SURG, V243, P559, DOI 10.1097/01.sla.0000206419.65678.2e; GREIF F, 1994, ANN SURG, V219, P40, DOI 10.1097/00000658-199401000-00007; Yasuda I, 2010, GASTROINTEST ENDOSC, V72, P1185, DOI 10.1016/j.gie.2010.07.006; Pascher A, 2005, TRANSPLANT INT, V18, P627, DOI 10.1111/j.1432-2277.2005.00123.x; Thethy S, 2004, CLIN TRANSPLANT, V18, P647, DOI 10.1111/j.1399-0012.2004.00254.x; Gondolesi GE, 2004, TRANSPLANTATION, V77, P1842, DOI 10.1097/01.tp.0000123077.78702.0c; Balderramo D, 2011, GASTROENT HEPAT-BARC, V34, P107, DOI 10.1016/j.gastrohep.2010.05.008; Doi S, 2013, J GASTROENTEROL, V48, P1090, DOI 10.1007/s00535-012-0707-8; Gor NV, 2008, LIVER TRANSPLANT, V14, P1466, DOI 10.1002/lt.21492; Hisatsune H, 2003, TRANSPLANTATION, V76, P810, DOI 10.1097/01.TP.0000083224.00756.8F; Khuroo MS, 2005, J GASTROEN HEPATOL, V20, P217, DOI 10.1111/j.1400-1746.2004.03490.x; Kirimlioglu V, 2011, TRANSPL P, V43, P917, DOI 10.1016/j.transproceed.2010.11.024; Maluf DG, 2005, AM J TRANSPLANT, V5, P149, DOI 10.1111/j.1600-6143.2004.00654.x; Martins FP, 2011, HEPATO-GASTROENTEROL, V58, P732; Na GH, 2014, HPB, V16, P312, DOI 10.1111/hpb.12151; Perrakis A, 2010, TRANSPL P, V42, P4154, DOI 10.1016/j.transproceed.2010.09.045; Polese L, 2007, TRANSPL P, V39, P1942, DOI 10.1016/j.transproceed.2007.05.053; Prat F, 1996, GASTROENTEROLOGY, V110, P894, DOI 10.1053/gast.1996.v110.pm8608900; Shah JN, 2003, AM J GASTROENTEROL, V98, P1861, DOI 10.1016/S0002-9270(03)00508-2; Sheng R, 1996, RADIOLOGY, V198, P243; Spier BJ, 2008, LIVER TRANSPLANT, V14, P1461, DOI 10.1002/lt.21511; Tanaka S, 2004, GASTROINTEST ENDOSC, V59, P614, DOI 10.1016/S0016-5107(04)00157-9; Yazumi S, 2005, J GASTROENTEROL, V40, P861, DOI 10.1007/s00535-005-1698-5	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					969	975		10.1111/hepr.12438		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300005		
J	Hidaka, H; Nakazawa, T; Fujii, S; Yanagihara, M; Minamino, T; Takada, J; Tanaka, Y; Okuwaki, Y; Shibuya, A; Koizumi, W				Hidaka, Hisashi; Nakazawa, Takahide; Fujii, Shigeru; Yanagihara, Michiko; Minamino, Tsutomu; Takada, Juichi; Tanaka, Yoshiaki; Okuwaki, Yusuke; Shibuya, Akitaka; Koizumi, Wasaburo			Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography	HEPATOLOGY RESEARCH			English	Article						congestion index; modified Response Evaluation Criteria in Solid Tumors; portal venous area; portal venous flow velocity	CONTRAST-ENHANCED ULTRASONOGRAPHY; ALPHA-FETOPROTEIN; ULTRASOUND; IMPEDANCE	AimEarly evaluation of the response to sorafenib for patients with hepatocellular carcinoma (HCC) remains unclear. This prospective study investigated the early evaluation of the efficacy of sorafenib in patients with advanced HCC using duplex Doppler ultrasonography (DDU). MethodsThirty-seven Child-Pugh class-A advanced HCC patients treated with sorafenib 400mg b.i.d. were enrolled. Changes in portal venous area (PVA) and portal venous flow velocity (PVV) revealed by DDU before and after 2 weeks of sorafenib treatment were evaluated. The relation between the congestion index (PVA/PVV), which reflects the pathophysiological hemodynamics of the portal venous system and the tumor response, according to the modified Response Evaluation Criteria in Solid Tumors (mRECIST), was also assessed. ResultsThe median progression-free survival and overall survival of all the patients was 2.8 months (95% confidence interval [CI], 2.6-3.2) and 12.8 months (95% CI, 8.7-17.0), respectively. Overall, three patients (8%) had a partial response (PR), 15 (41%) stable disease (SD) and 17 (46%) progressive disease, according to the mRECIST, and two patients (6%) could not be evaluated because of worsened conditions. The decrease in the congestion index was significantly larger in the disease control group (PR/SD) after the sorafenib treatment (P=0.035); furthermore, the congestion index was the only significant independent predictor of disease control (P=0.033; hazard ratio, 8.456; 95% CI, 1.182-60.484). ConclusionA decrease in the congestion index revealed by DDU provides an early evaluation of response in patients taking sorafenib for advanced HCC.	[Hidaka, Hisashi; Nakazawa, Takahide; Minamino, Tsutomu; Takada, Juichi; Tanaka, Yoshiaki; Okuwaki, Yusuke; Shibuya, Akitaka; Koizumi, Wasaburo] Kitasato Univ, East Hosp, Sch Med, Dept Gastroenterol,Internal Med, Sagamihara, Kanagawa 2520380, Japan; [Fujii, Shigeru; Yanagihara, Michiko] Kitasato Univ, East Hosp, Dept Ultrasonog, Sagamihara, Kanagawa 2520380, Japan	Hidaka, H (reprint author), Kitasato Univ, East Hosp, Sch Med, Dept Gastroenterol,Internal Med,Minami Ku, 2-1-1 Asamizodai, Sagamihara, Kanagawa 2520380, Japan.	hisashi7@kitasato-u.ac.jp			SRL	A. S. received funding from SRL. The other authors declare that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.	MORIYASU F, 1986, AM J ROENTGENOL, V146, P735; Ueshima K, 2011, DIGEST DIS, V29, P321, DOI 10.1159/000327570; Sugimoto K, 2013, LIVER INT, V33, P605, DOI 10.1111/liv.12098; Zocco MA, 2013, J HEPATOL, V59, P1014, DOI [10.1016/j.jhep.2013.06.011, 10.1016/j.jhep.2013.07.028]; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Personeni N, 2012, J HEPATOL, V57, P101, DOI 10.1016/j.jhep.2012.02.016; Ogasawara S, 2011, HEPATOL INT, V5, P850, DOI 10.1007/s12072-010-9249-4; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Frampas E, 2013, EUR J RADIOL, V82, pE205, DOI 10.1016/j.ejrad.2012.12.004; Hidaka H, 2012, J GASTROENTEROL, V47, P1030, DOI 10.1007/s00535-012-0563-6; Moschouris H, 2012, MED ULTRASON, V14, P87; Murata K, 2010, INT J ONCOL, V36, P161, DOI 10.3892/ijo_00000487; Nakazawa T, 2013, EUR J GASTROEN HEPAT, V25, P683, DOI 10.1097/MEG.0b013e32835d913b; Bintintan A, 2013, MED ULTRASON, V15, P116; Bolognesi M, 1996, HEPATOLOGY, V23, P1035; Coriat R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016978; OHNISHI K, 1985, RADIOLOGY, V154, P495; Piscaglia F, 1998, AM J GASTROENTEROL, V93, P1925; Shiozawa K, 2012, WORLD J GASTROENTERO, V18, P5753, DOI 10.3748/wjg.v18.i40.5753; The Liver Cancer Study Group of Japan, 2003, GEN RUL CLIN PATH ST, V2nd	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					976	985		10.1111/hepr.12440		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300006		
J	Miyahara, K; Nouso, K; Dohi, C; Morimoto, Y; Kinugasa, H; Wada, N; Takeuchi, Y; Kuwaki, K; Onishi, H; Ikeda, F; Miyake, Y; Nakamura, S; Shiraha, H; Takaki, A; Amano, M; Nishimura, SI; Yamamoto, K				Miyahara, Koji; Nouso, Kazuhiro; Dohi, Chihiro; Morimoto, Yuki; Kinugasa, Hideaki; Wada, Nozomu; Takeuchi, Yasuto; Kuwaki, Kenji; Onishi, Hideki; Ikeda, Fusao; Miyake, Yasuhiro; Nakamura, Shinichiro; Shiraha, Hidenori; Takaki, Akinobu; Amano, Maho; Nishimura, Shin-Ichiro; Yamamoto, Kazuhide			Alteration of N-glycan profiles in patients with chronic hepatitis and hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Article						biomarker; diagnosis; hepatocellular carcinoma; liver disease; N-glycan	SERUM ALPHA-FETOPROTEIN; HUMAN LIVER; B-VIRUS; TRANSFERRIN; DIAGNOSIS; CIRRHOSIS; CANCER; GLYCOSYLATION; FUCOSYLATION; EXPRESSION	AimMost of the modification of N-glycosylation reported in cancers including hepatocellular carcinoma (HCC) were based on the examinations of a small number of patients or particular proteins. The aim of this study is to reveal changes in whole serum N-glycan profiles systematically during the process of hepatocarcinogenesis and to elucidate their clinical application. MethodsWe analyzed sera from 105 patients with chronic hepatitis/liver cirrhosis (CH/LC) and age-/sex-matched healthy volunteers (HLT), as well as from 114 patients with HCC. Serum N-glycan profiles were measured comprehensively by a new, quantitative, high-throughput method and compared with clinical parameters. ResultsThe total amount of N-glycan expression was significantly higher in patients with CH/LC than in HLT; however, no differences were observed between CH/LC and HCC patients. In HCC patients, multi-antennary glycans with fucose residues, particularly m/z 3195, were increased compared with CH/LC patients. The expression of m/z 3195 was high, especially in patients with a high number of intrahepatic lesions (>3), large tumor size (>3cm), macroscopic vascular invasion or metastasis. The ratio of pairs of glycans on the same path of the biosynthesis pathway (m/z 3195/1914) showed a higher area under the receiver-operator curve of 0.810 than any other single glycan to distinguish HCC from CH/LC. ConclusionWe demonstrate the full spectrum of the alterations of serum N-glycans comprehensively in patients with liver disease, and elucidate the possible use of glycans as novel biomarkers of liver disease progression.	[Miyahara, Koji; Nouso, Kazuhiro; Dohi, Chihiro; Morimoto, Yuki; Kinugasa, Hideaki; Wada, Nozomu; Takeuchi, Yasuto; Kuwaki, Kenji; Onishi, Hideki; Ikeda, Fusao; Miyake, Yasuhiro; Nakamura, Shinichiro; Shiraha, Hidenori; Takaki, Akinobu; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Okayama 7008558, Japan; [Nouso, Kazuhiro; Onishi, Hideki; Ikeda, Fusao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Hepatol, Okayama, Okayama 7008558, Japan; [Amano, Maho; Nishimura, Shin-Ichiro] Hokkaido Univ, Fac Adv Life Sci, Field Drug Discovery Res, Sapporo, Hokkaido, Japan; [Amano, Maho; Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Amano, Maho; Nishimura, Shin-Ichiro] Med Chem Pharmaceut, Sapporo, Hokkaido, Japan	Nouso, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Hepatol, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	nouso@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 25220206, 23590976]	THIS WORK WAS supported by Grant-in-Aids for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 25220206, 23590976).	Dall'Olio F, 2004, GLYCOBIOLOGY, V14, P39, DOI 10.1093/glycob/cwh002; Nouso K, 2013, J GASTROENTEROL, V48, P1171, DOI 10.1007/s00535-012-0732-7; Kamiyama T, 2013, HEPATOLOGY, V57, P2314, DOI 10.1002/hep.26262; Padhya KT, 2013, CURR OPIN GASTROEN, V29, P285, DOI 10.1097/MOG.0b013e32835ff1cf; Nishimura SI, 2011, ADV CARBOHYD CHEM BI, V65, P219, DOI 10.1016/B978-0-12-385520-6.00005-4; Yanagi M, 2001, J GASTROEN HEPATOL, V16, P1282, DOI 10.1046/j.1440-1746.2001.02612.x; Klein A, 2010, PROTEOM CLIN APPL, V4, P372, DOI 10.1002/prca.200900151; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010; Bekesova S, 2012, J PROTEOMICS, V75, P2216, DOI 10.1016/j.jprot.2012.01.024; Alley WR, 2012, J PROTEOME RES, V11, P2282, DOI 10.1021/pr201070k; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Dimitroff CJ, 2004, CANCER RES, V64, P5261, DOI 10.1158/0008-5472.CAN-04-0691; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Yoshida H, 1999, ANN INTERN MED, V131, P174; Ang IL, 2006, J PROTEOME RES, V5, P2691, DOI 10.1021/pr060109r; TAKETA K, 1993, CANCER RES, V53, P5419; AOYAGI Y, 1985, BIOCHIM BIOPHYS ACTA, V830, P217, DOI 10.1016/0167-4838(85)90277-8; Cuchacovich M, 1996, J RHEUMATOL, V23, P44; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; MATSUMOTO K, 1994, CLIN CHIM ACTA, V224, P1, DOI 10.1016/0009-8981(94)90115-5; Miyahara K, 2014, HEPATOLOGY, V59, P355, DOI 10.1002/hep.26531; Moriwaki K, 2007, GLYCOBIOLOGY, V17, P1311, DOI 10.1093/glycob/cwm094; SEKINE C, 1987, BRIT J CANCER, V56, P371, DOI 10.1038/bjc.1987.205; SHAFRITZ DA, 1981, NEW ENGL J MED, V305, P1067, DOI 10.1056/NEJM198110293051807; Shinzaki S, 2008, AM J GASTROENTEROL, V103, P1173, DOI 10.1111/j.1572-0241.2007.01699.x; Suzuki Y, 1996, J GASTROEN HEPATOL, V11, P358, DOI 10.1111/j.1440-1746.1996.tb01384.x; Wei T, 2012, EXP MOL PATHOL, V93, P8, DOI 10.1016/j.yexmp.2012.01.011; Witz IP, 2006, IMMUNOL LETT, V104, P89, DOI 10.1016/j.imlet.2005.11.008; YAMASHITA K, 1993, CANCER RES, V53, P2970; YAMASHITA K, 1989, J BIOL CHEM, V264, P2415	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					986	993		10.1111/hepr.12441		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300007		
J	Hirano, H; Saito, M; Yano, Y; Momose, K; Yoshida, M; Tanaka, A; Azuma, T				Hirano, Hirotaka; Saito, Masaya; Yano, Yoshihiko; Momose, Kenji; Yoshida, Masaru; Tanaka, Atsushi; Azuma, Takeshi			Chronic Liver Disease Questionnaire would be a primary screening tool of neuropsychiatric test detecting minimal hepatic encephalopathy of cirrhotic patients	HEPATOLOGY RESEARCH			English	Article						health-related quality of life; L-carnitine; neurophysiological test; nomogram; taurine; zinc	QUALITY-OF-LIFE; ISHEN PRACTICE GUIDELINES; L-CARNITINE TREATMENT; PROGNOSTIC-SIGNIFICANCE; VERSION; DYSFUNCTION; PREVALENCE; DIAGNOSIS; VALIDITY; TAURINE	AimThe neuropsychiatric test (NP test) is a clinically available modality to confirm minimal hepatic encephalopathy (MHE), but it takes at least 30min for outpatients to complete. An easier primary screening tool of the NP test would be helpful to predict MHE in routine testing on the public. MethodsWe performed a prospective cohort study on 59 cirrhotic outpatients at Kobe University Hospital. Laboratory measurements, the NP test and the Chronic Liver Disease Questionnaire (CLDQ) were performed. As an indicator of MHE, cases with and without two abnormal subsets or more in the NP test were compared, and the independent risk factors were statistically examined. Predictive scoring systems of the risk of MHE were established using multivariate logistic regression. ResultsCLDQ worry (WO) was the best predictive factor of MHE diagnosed by the NP test (P=0.006). The predictive model using CLDQ WO discriminated well between patients with and without MHE (area under the curve, 0.714; 95% confidence interval, 0.582-0.824). The predictive scores of MHE enable the patient-specific probability to be easily looked up. ConclusionCLDQ WO was shown to be an independent factor associated with the NP test to diagnose MHE in cirrhotic patients. The easy predictive scoring system of the risk of MHE using CLDQ WO could become a primary screening tool before performing the NP test in a social setting.	[Hirano, Hirotaka; Saito, Masaya; Yano, Yoshihiko; Momose, Kenji; Yoshida, Masaru; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Div Gastroenterol, Kobe, Hyogo 6500017, Japan; [Yoshida, Masaru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Metabol Res, Kobe, Hyogo 6500017, Japan; [Yano, Yoshihiko] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo 6500017, Japan; [Tanaka, Atsushi] Teikyo Univ, Sch Med, Dept Med, Tokyo 173, Japan	Saito, M (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	masaya@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	WE GRATEFULLY APPRECIATE Dr Kiwamu Okita for invaluable suggestions in preparing our manuscript. We thank the nurses and our colleagues at the Department of Gastroenterology and the Gastroenterology Ward at Kobe University Hospital for their cooperation. This work was supported by a Grant-in-Aid for Young Scientists (B) (to M. S.) and grants for the Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. Y. and T. A.).	Narahara Y, 2011, J GASTROENTEROL, V46, P78, DOI 10.1007/s00535-010-0282-9; Sidhu SS, 2011, AM J GASTROENTEROL, V106, P307, DOI 10.1038/ajg.2010.455; Bustamante J, 1999, J HEPATOL, V30, P890, DOI 10.1016/S0168-8278(99)80144-5; Guerit JM, 2009, LIVER INT, V29, P789, DOI 10.1111/j.1478-3231.2009.02030.x; Romero-Gomez M, 2001, AM J GASTROENTEROL, V96, P2718, DOI 10.1016/S0002-9270(01)02692-2; Younossi ZM, 1999, GUT, V45, P295; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; DOLEZAL V, 1981, J NEUROCHEM, V36, P1323, DOI 10.1111/j.1471-4159.1981.tb00569.x; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Roman E, 2011, AM J GASTROENTEROL, V106, P476, DOI 10.1038/ajg.2010.413; Malaguarnera M, 2008, DIGEST DIS SCI, V53, P3018, DOI 10.1007/s10620-008-0238-6; SPAGNOLI A, 1991, NEUROLOGY, V41, P1726; Bajaj JS, 2010, GASTROENTEROLOGY, V138, P2332, DOI 10.1053/j.gastro.2010.02.015; Schomerus H, 2001, METAB BRAIN DIS, V16, P37, DOI 10.1023/A:1011610427843; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; Shimbo K, 2010, BIOMED CHROMATOGR, V24, P683, DOI 10.1002/bmc.1346; Randolph C, 2009, LIVER INT, V29, P629, DOI 10.1111/j.1478-3231.2009.02009.x; Sharma P, 2007, J HEPATOL, V47, P67, DOI 10.1016/j.jhep.2007.02.022; Hartmann IJC, 2000, AM J GASTROENTEROL, V95, P2029; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Tuerk MJ, 2009, CURR OPIN GASTROEN, V25, P136, DOI 10.1097/MOG.0b013e328321b395; Bajaj JS, 2008, CLIN GASTROENTEROL H, V6, P1135, DOI 10.1016/j.cgh.2008.05.025; Bajaj JS, 2007, AM J GASTROENTEROL, V102, P1903, DOI 10.1111/j.1572-0241.2007.01424.x; Bao ZJ, 2007, WORLD J GASTROENTERO, V13, P3003; Butterworth RF, 1996, ADV EXP MED BIOL, V403, P601; Chavez-Tapia NC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-74; Ferrer M, 2006, LIVER TRANSPLANT, V12, P95, DOI 10.1002/lt.20551; Groeneweg M, 2000, J HEPATOL, V32, P748, DOI 10.1016/S0168-8278(00)80243-3; Hauser W, 2004, EUR J GASTROEN HEPAT, V16, P599, DOI 10.1097/01.meg.000108324.52416.18; Kato A, 2013, HEPATOL RES, V43, P452, DOI 10.1111/j.1872-034X.2012.01092.x; Kato A, 2004, HEPATOL RES, V30, P71, DOI 10.1016/j.hepres.2004.07.001; Kharbanda Parampreet S, 2003, Indian J Gastroenterol, V22 Suppl 2, pS37; Mahmood S, 2008, OPEN GASTROENTEROL J, V2, P57, DOI 10.2174/1874259900802010057; Malaguarnera M, 2003, DIGEST DIS, V21, P271, DOI 10.1159/000073347; Maric D, 2011, ACTA CLIN CROAT, V50, P375; Michitaka K, 2008, HEPATOL RES, V38, P1069, DOI 10.1111/j.1872-034X.2008.00374.x; Moscucci F, 2011, LIVER INT, V31, P1505, DOI 10.1111/j.1478-3231.2011.02598.x; Roman E, 2013, EUR J GASTROEN HEPAT, V25, P77, DOI 10.1097/MEG.0b013e3283589f49; Rucci P, 2005, DIGEST LIVER DIS, V37, P850, DOI 10.1016/j.dld.2005.02.014; Sergeeva OA, 2007, J PHYSIOL-LONDON, V585, P539, DOI 10.1113/jphysiol.2007.141432; Wang JY, 2013, WORLD J GASTROENTERO, V19, P4984, DOI 10.3748/wjg.v19.i30.4984; Weissenborn K, 2002, HEPATOLOGY, V35, P494, DOI 10.1053/jhep.2002.31552; WEISSENBORN K, 1990, ELECTROEN CLIN NEURO, V75, P289, DOI 10.1016/0013-4694(90)90107-U; Wunsch E, 2011, LIVER INT, V31, P980, DOI 10.1111/j.1478-3231.2011.02465.x; Zhou YQ, 2009, J GASTROEN HEPATOL, V24, P408, DOI 10.1111/j.1440-1746.2008.05678.x	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					994	1003		10.1111/hepr.12442		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300008		
J	Namikawa, M; Kakizaki, S; Kaira, K; Tojima, H; Yamazaki, Y; Horiguchi, N; Sato, K; Oriuchi, N; Tominaga, H; Sunose, Y; Nagamori, S; Kanai, Y; Oyama, T; Takeyoshi, I; Yamada, M				Namikawa, Masashi; Kakizaki, Satoru; Kaira, Kyoichi; Tojima, Hiroki; Yamazaki, Yuichi; Horiguchi, Norio; Sato, Ken; Oriuchi, Noboru; Tominaga, Hideyuki; Sunose, Yutaka; Nagamori, Shushi; Kanai, Yoshikatsu; Oyama, Tetsunari; Takeyoshi, Izumi; Yamada, Masanobu			Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Article						ASCT2; hepatocellular carcinoma; LAT1; prognostic factor; xCT	NONSMALL CELL LUNG; PROGNOSTIC-SIGNIFICANCE; CD98 EXPRESSION; BREAST-CANCER; CLONING; MARKER	AimAmino acid transporters play an important role in tumor progression and survival of cancer cells. However, the prognostic significance of L-type amino acid transporter 1 (LAT1), system ASC amino acid transporter-2 (ASCT2) and xCT expression in patients with hepatocellular carcinoma (HCC) remains unclear. The aim of this study is to investigate the clinicopathological significance of these amino acid transporters in patients with HCC. MethodsWe examined 84 patients with surgically resected HCC. Tumor sections were stained by immunohistochemistry for LAT1, ASCT2, xCT, 4F2hc/CD98hc (4F2hc), Ki-67 and microvessel density (MVD) determined by CD34. ResultsLAT1, 4F2hc, ASCT2 and xCT were positively expressed in 61% (50/84), 77% (65/84), 63% (53/84) and 65% (55/84), respectively. Positive LAT1 expression was significantly associated with 4F2hc expression, Ki-67 and the serum albumin. By univariate analysis, LAT1 expression, disease stage and albumin had a significant relationship with overall survival. Tumor size, disease stage, portal vein invasion, albumin and -fetoprotein had a significant relationship with progression-free survival. Multivariate analysis confirmed that LAT1 expression is an independent and significant prognostic factor for predicting worse outcome after surgery. ConclusionLAT1 can serve as a significant prognostic marker for predicting negative prognosis after surgery.	[Namikawa, Masashi; Kakizaki, Satoru; Kaira, Kyoichi; Tojima, Hiroki; Yamazaki, Yuichi; Horiguchi, Norio; Sato, Ken; Yamada, Masanobu] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma, Japan; [Kaira, Kyoichi] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Gunma, Japan; [Oriuchi, Noboru] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Gunma, Japan; [Sunose, Yutaka; Takeyoshi, Izumi] Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Surg, Gunma, Japan; [Oyama, Tetsunari] Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Gunma, Japan; [Tominaga, Hideyuki] Fukushima Med Univ, Adv Clin Res Ctr, Fukushima, Japan; [Namikawa, Masashi] Kiryu Kosei Gen Hosp, Dept Internal Med, Kiryu, Gumma, Japan; [Nagamori, Shushi; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Div Biosyst Pharmacol, Osaka, Japan	Kaira, K (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, 3-39-22 Showamachi, Maebashi, Gunma 3718511, Japan.	kkaira1970@yahoo.co.jp			Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO)	THIS WORK WAS supported in part by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO). We also deeply appreciate Professor Masahiko Nishiyama of the Department of Molecular Pharmacology and Oncology, Professor Takayuki Asao of the Department of Oncology Clinical Development, Gunma University Graduate School of Medicine, for the critical review of this manuscript, and Ms Yuka Matsui for her technical assistance in manuscript submission.	Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Kaira K, 2009, ANN SURG ONCOL, V16, P3473, DOI 10.1245/s10434-009-0685-0; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kaira K, 2011, AM J TRANSL RES, V3, P468; Shimizu K, 2014, BRIT J CANCER, V110, P2030, DOI 10.1038/bjc.2014.88; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Imai H, 2010, ANTICANCER RES, V30, P4819; Kekuda R, 1996, J BIOL CHEM, V271, P18657; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; Kaira K, 2012, BRIT J CANCER, V107, P632, DOI 10.1038/bjc.2012.310; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Toyoda M, 2014, BRIT J CANCER, V110, P2506, DOI 10.1038/bjc.2014.178; Baek S, 2012, CLIN CANCER RES, V18, P5427, DOI 10.1158/1078-0432.CCR-12-0214; Kaira K, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-482; Li J, 2013, TUMOR BIOL, V34, P2977, DOI 10.1007/s13277-013-0861-5; Toyoda M, 2014, HEAD NECK	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					1014	1022		10.1111/hepr.12431		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300010		
J	Kawaguchi, T; Kodama, T; Hikita, H; Makino, Y; Saito, Y; Tanaka, S; Shimizu, S; Sakamori, R; Miyagi, T; Wada, H; Nagano, H; Hiramatsu, N; Tatsumi, T; Takehara, T				Kawaguchi, Tsukasa; Kodama, Takahiro; Hikita, Hayato; Makino, Yuki; Saito, Yoshinobu; Tanaka, Satoshi; Shimizu, Satoshi; Sakamori, Ryotaro; Miyagi, Takuya; Wada, Hiroshi; Nagano, Hiroaki; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo			Synthetic lethal interaction of combined CD26 and Bcl-xL inhibition is a powerful anticancer therapy against hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Article						ABT-737; apoptosis; CD26; cell cycle; hepatocellular carcinoma	DIPEPTIDYL PEPTIDASE-IV; ANTI-CD26 MONOCLONAL-ANTIBODY; CELL-CYCLE ARREST; PROLONGED SURVIVAL; CANCER; EXPRESSION; SORAFENIB; OVEREXPRESSION; MESOTHELIOMA; METASTASIS	AimCD26 is a membrane glycoprotein that has multiple functions, including dipeptidyl peptidase IV activity. CD26 expression varies in different tumor types, and its role in tumor growth in hepatocellular carcinoma (HCC) remains unclear. MethodsCD26 expression levels were examined in resected HCC and surrounding non-cancerous lesions. The effect of CD26 knockdown on the cellular proliferation of HepG2 or Huh7 cells, both of which highly express CD26, was studied in vitro. ResultsCD26 mRNA expression levels were significantly increased in HCC compared with their surrounding non-cancerous lesions. We confirmed that various HCC cell lines, especially HepG2 and Huh7 cells, showed high expression levels of CD26. siRNA-mediated knockdown of CD26 suppressed hepatoma cell growth in vitro. CD26 knockdown induced cell cycle arrest through the upregulation of Cip/Kip family proteins, p21 in HepG2 cells and p27 in Huh7 cells. CD26 knockdown did not affect apoptosis, but it increased expressions of the pro-apoptotic proteins Bim and Bak and the anti-apoptotic protein Bcl-xL, suggesting an addiction of CD26 knockdown cells to Bcl-xL for survival. We thus treated CD26 knockdown cells with ABT-737, a Bcl-xL/-2/-w inhibitor, and observed that the synthetic lethal interaction of combined Bcl-xL and CD26 inhibition induced significant apoptosis and impaired cellular viability. ConclusionCD26 mRNA was overexpressed in HCC, and its inhibition suppressed cellular proliferation through cell cycle arrest. The combined use of CD26 knockdown with a Bcl-xL inhibitor further elicited substantial apoptosis and therefore may serve as a powerful anticancer combination therapy against HCC.	[Kawaguchi, Tsukasa; Kodama, Takahiro; Hikita, Hayato; Makino, Yuki; Saito, Yoshinobu; Tanaka, Satoshi; Shimizu, Satoshi; Sakamori, Ryotaro; Miyagi, Takuya; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Wada, Hiroshi; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan	Takehara, T (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor and Welfare of Japan	This work was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to T. Takehara) and a Grant-in-Aid for Research on Hepatitis from the Ministry of Health, Labor and Welfare of Japan.	Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Stecca BA, 1997, J HEPATOL, V27, P337, DOI 10.1016/S0168-8278(97)80180-8; Inamoto T, 2006, CLIN CANCER RES, V12, P3470, DOI 10.1158/1078-0432.CCR-06-0361; Aoe K, 2012, CLIN CANCER RES, V18, P1447, DOI 10.1158/1078-0432.CCR-11-1990; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Kajiyama H, 2002, CANCER RES, V62, P2753; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Ho L, 2001, CLIN CANCER RES, V7, P2031; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Thompson MA, 2007, MINI-REV MED CHEM, V7, P253, DOI 10.2174/138955707780059853; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mentzel S, 1996, J HISTOCHEM CYTOCHEM, V44, P445; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Inamoto T, 2007, CLIN CANCER RES, V13, P4191, DOI 10.1158/1078-0432.CCR-07-0110; Itou M, 2013, WORLD J GASTROENTERO, V19, P2298, DOI 10.3748/wjg.v19.i15.2298; Pro B, 2004, HISTOL HISTOPATHOL, V19, P1345; Gaetaniello L, 1998, HEPATOLOGY, V27, P934, DOI 10.1002/hep.510270407; HARADA T, 1995, J GEN VIROL, V76, P1215, DOI 10.1099/0022-1317-76-5-1215; Hatano R, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-30; Hirai K, 1999, PATHOL INT, V49, P264, DOI 10.1046/j.1440-1827.1999.00859.x; Ishii T, 2001, P NATL ACAD SCI USA, V98, P12138, DOI 10.1073/pnas.211439098; JOHNSON RC, 1993, J CELL BIOL, V121, P1423, DOI 10.1083/jcb.121.6.1423; Koga H, 2001, HEPATOLOGY, V33, P1087, DOI 10.1053/jhep.2001.24024; Mares V, 2012, HISTOL HISTOPATHOL, V27, P931; Ohnuma K, 2002, IMMUNOLOGY, V107, P325, DOI 10.1046/j.1365-2567.2002.01510.x; Pethiyagoda C. L., 2000, Clinical and Experimental Metastasis, V18, P391, DOI 10.1023/A:1010930918055; Shen Ying-Chun, 2013, Liver Cancer, V2, P345, DOI 10.1159/000343850; Wilson MJ, 2000, J ANDROL, V21, P220	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					1023	1033		10.1111/hepr.12434		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300011		
J	Shimokobe, H; Sumida, Y; Tanaka, S; Mori, K; Kitamura, Y; Fukumoto, K; Kakutani, A; Ohno, T; Kanemasa, K; Imai, S; Hibino, S; Yoshikawa, T				Shimokobe, Hideto; Sumida, Yoshio; Tanaka, Saiyu; Mori, Kojiro; Kitamura, Yoko; Fukumoto, Kohei; Kakutani, Akira; Ohno, Tomoyuki; Kanemasa, Kazuyuki; Imai, Shunsuke; Hibino, Sawako; Yoshikawa, Toshikazu			Human placental extract treatment for non-alcoholic steatohepatitis non-responsive to lifestyle intervention: A pilot study	HEPATOLOGY RESEARCH			English	Article						human placental extract; liver biopsy; non-alcoholic steatohepatitis; transaminase	FATTY LIVER-DISEASE; INJURY; RATS; REGENERATION; VALIDATION; DIAGNOSIS; LAENNEC; JBP485	AimNo pharmacological therapies have been established for non-alcoholic steatohepatitis (NASH), which can lead to liver-related mortality. Human placental extract (HPE), which has anti-inflammatory effects, has been expected to be a promising treatment for chronic liver disease. This pilot study was conducted to evaluate the efficacy of HPE for biopsy-diagnosed NASH. MethodsAfter a lifestyle intervention for 12 weeks, 10 subjects with abnormal alanine aminotransferase (30IU/L) and biopsy-proven NASH (Non-Alcoholic Fatty Liver Disease Activity Score [NAS], 4) received i.m. injections of HPE (Laennec) at a dose of 4mL/day twice per week for 24 weeks, and seven of them underwent a second liver biopsy after the treatment. Liver biopsies were scored for NAS and fibrosis. Histological response was defined as a decrease of 2points or more in NAS and no increase in fibrosis. ResultsSerum transaminase activities were significantly lower at 8 weeks compared with pretreatment levels in nine patients who continued treatment for 24 weeks. One patient refused to continue the treatment soon after starting therapies. In seven patients undergoing post-treatment biopsies, NAS (mean [standard deviation]) mildly decreased from 5.29 (0.95) to 4.00 (1.83) without reaching statistical significance (P=0.078). Histological response was observed in all three obese patients and in only one of four non-obese ones. No significant changes were observed in body mass index, lipid profiles and diabetic control/insulin resistance. ConclusionIn NASH patients who received HPE treatment, significant reductions in serum liver enzymes were obtained after 8 weeks. Histological efficacy may be better in obese patients than in non-obese ones.	[Shimokobe, Hideto; Tanaka, Saiyu; Mori, Kojiro; Kitamura, Yoko; Fukumoto, Kohei; Kakutani, Akira; Ohno, Tomoyuki; Kanemasa, Kazuyuki] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan; [Imai, Shunsuke] Nara City Hosp, Dept Pathol, Nara, Japan; [Sumida, Yoshio] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto 6028566, Japan; [Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Kyoto 6028566, Japan; [Hibino, Sawako] Louis Pasteur Ctr Med Res, Basic Res Div, Antiaging Med Sci, Kyoto, Japan	Sumida, Y (reprint author), Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	sumida@koto.kpu-m.ac.jp					Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Liu KX, 1998, BIOL PHARM BULL, V21, P44; Yang T, 2009, J PHARM PHARMACOL, V61, P767, DOI [10.1211/jpp.61.06.0009, 10.1211/jpp/61.06.0009]; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Bohinc BN, 2012, CLIN LIVER DIS, V16, P549, DOI 10.1016/j.cld.2012.05.002; Wu JJ, 2008, BIOL PHARM BULL, V31, P2040, DOI 10.1248/bpb.31.2040; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Kong M, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/732915; Park SY, 2010, PLACENTA, V31, P873, DOI 10.1016/j.placenta.2010.07.010; Biswas TK, 2001, ACTA PHARMACOL SIN, V22, P1113; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Wu JJ, 2008, EUR J PHARMACOL, V589, P299, DOI 10.1016/j.ejphar.2008.04.066; Sumida Y, 2013, FREE RADICAL RES, V47, P869, DOI 10.3109/10715762.2013.837577; Jung J, 2011, INT IMMUNOPHARMACOL, V11, P976, DOI 10.1016/j.intimp.2011.02.012; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Banerjee K K, 1992, Riv Eur Sci Med Farmacol, V14, P361; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hjelkrem M, 2011, ALIMENT PHARM THER, V34, P214, DOI 10.1111/j.1365-2036.2011.04695.x; Japanese Society for the Study of Obesity, 2000, J JPN SOC STUDY OBES, V6, P18; Kong MH, 2008, MENOPAUSE, V15, P296, DOI 10.1097/gme.0b013e3181405b74; Lee KK, 2012, EVID-BASED COMPL ALT, V2012; Merriman RB, 2006, HEPATOLOGY, V44, P874, DOI 10.1002/hep.21346; NAKAYAMA S, 1989, FOLIA PHARMACOL JPN, V94, P137, DOI 10.1254/fpj.94.137; Nakayama S, 1998, NIPPON YAKURIGAKU ZA, V94, P289; Togashi SI, 2002, PLACENTA, V23, P497, DOI 10.1053/plac.2002.0833; Ueda H, 1974, KANZO, V15, P162	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					1034	1040		10.1111/hepr.12432		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300012		
J	Irei, T; Onoe, T; Das, LK; Tanimine, N; Ishiyama, K; Ide, K; Kobayashi, T; Tashiro, H; Ohdan, H				Irei, Toshimitsu; Onoe, Takashi; Das, Lalit Kumar; Tanimine, Naoki; Ishiyama, Kohei; Ide, Kentaro; Kobayashi, Tsuyoshi; Tashiro, Hirotaka; Ohdan, Hideki			Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases	HEPATOLOGY RESEARCH			English	Article						ABO-incompatible; hepatopulmonary syndrome; living donor liver transplantation	RITUXIMAB; IMPACT; OUTCOMES; DISEASE; CANDIDATES; MORTALITY; SURVIVAL; LIFE	Hepatopulmonary syndrome (HPS) is a severe complication in patients with chronic liver disease with poor prognosis. Liver transplantation (LT) is a promising treatment for HPS; however, very severe HPS, which is defined by an arterial oxygen pressure (PaO2) of less than 50mmHg and a right-left intrapulmonary shunt rate of more than 20%, may be a contraindication to LT, including living donor LT (LDLT). Here, we report two cases of decompensated liver cirrhosis with very severe HPS which were resolved after adult-to-adult LDLT including ABO-incompatible LDLT. Both patients required oxygen supportive therapy in combination with specialized respiratory care postoperatively, followed by improvement of oxygenation and substantial decreases of intrapulmonary shunt rate. These findings suggest very severe HPS can be resolved by LDLT, including ABO-incompatible LDLT, and reduced graft volume did not impede the reversal of intrapulmonary shunting. Our current report may indicate that adult-to-adult LDLT, including ABO-incompatible LDLT, is becoming an effective therapeutic method and prompt a review of previous reports as well as our own files with particular regard to the indication of LDLT for decompensated liver cirrhosis with very severe HPS.	[Irei, Toshimitsu; Onoe, Takashi; Das, Lalit Kumar; Tanimine, Naoki; Ishiyama, Kohei; Ide, Kentaro; Kobayashi, Tsuyoshi; Tashiro, Hirotaka; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Hiroshima, Hiroshima 7348551, Japan; [Irei, Toshimitsu; Onoe, Takashi] Natl Hosp Org Kure Med Ctr, Chugoku Canc Ctr, Inst Clin Res, Kure, Japan	Onoe, T (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan.	tonoemd@gmail.com			BSE from the Japanese Ministry of Health, Labor and Welfare	THIS WORK WAS supported by a Grant-in-Aid for the Research on Hepatitis and BSE from the Japanese Ministry of Health, Labor and Welfare.	Alexander J, 1997, Liver Transpl Surg, V3, P54, DOI 10.1002/lt.500030108; Liote H, 2010, EUR RESPIR J, V35, P681, DOI 10.1183/09031936.00080209; Irei T, 2007, BLOOD, V110, P4567, DOI 10.1182/blood-2007-04-082719; Swanson KL, 2005, HEPATOLOGY, V41, P1122, DOI 10.1002/hep.20658; Schenk P, 2003, GASTROENTEROLOGY, V125, P1042, DOI 10.1053/S0016-5085(03)01207-1; Gupta S, 2010, AM J TRANSPLANT, V10, P354, DOI 10.1111/j.1600-6143.2009.02822.x; Hadjinicolaou AV, 2012, RHEUMATOLOGY, V51, P653, DOI 10.1093/rheumatology/ker290; Iyer VN, 2013, HEPATOLOGY, V57, P2427, DOI 10.1002/hep.26070; Goldberg DS, 2014, GASTROENTEROLOGY, V146, P1256, DOI 10.1053/j.gastro.2014.01.005; Krowka MJ, 2000, GUT, V46, P1, DOI 10.1136/gut.46.1.1; Arguedas MR, 2003, HEPATOLOGY, V37, P192, DOI 10.1053/jhep.2003.50023; Schenk P, 2000, ANN INTERN MED, V133, P701; Fallon MB, 2008, GASTROENTEROLOGY, V135, P1168, DOI 10.1053/j.gastro.2008.06.038; Benitez C, 2009, ANN HEPATOL, V8, P71; Asthana S, 2010, TRANSPL INT, V23, P432, DOI 10.1111/j.1432-2277.2009.00998.x; Chihara Y, 2011, LIVER TRANSPLANT, V17, P144, DOI 10.1002/lt.22207; Egawa H, 2014, AM J TRANSPLANT, V14, P102, DOI 10.1111/ajt.12520; Egawa H, 1999, TRANSPLANTATION, V67, P712, DOI 10.1097/00007890-199903150-00012; Fleming GM, 2008, LIVER TRANSPLANT, V14, P966, DOI 10.1002/lt.21477; Ganzemueller J, 2011, MINERVA UROL NEFROL, V63, P263; Kohzuki M, 2000, ARCH PHYS MED REHAB, V81, P1527, DOI 10.1053/apmr.2000.9393; Martinez GP, 2001, J HEPATOL, V34, P651, DOI 10.1016/S0168-8278(00)00108-2; Meyers C, 1998, LIVER TRANSPLANT SUR, V4, P510, DOI 10.1002/lt.500040608; Molleston JP, 1999, J PEDIATR GASTR NUTR, V29, P225, DOI 10.1097/00005176-199908000-00024; Motomura T, 2011, SURG TODAY, V41, P436, DOI 10.1007/s00595-009-4260-x; Rodriguez-Roisin R, 2004, EUR RESPIR J, V24, P861, DOI 10.1183/09031936.04.00010904; STOLLER JK, 1995, WESTERN J MED, V163, P133	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	SEP	2015	45	9					1041	1046		10.1111/hepr.12445		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ8GA	WOS:000360843300013		
J	Takahashi, S; Kohashi, K; Yamamoto, H; Hirahashi, M; Kumagai, R; Takizawa, N; Nakamura, K; Maehara, Y; Tanaka, M; Takayanagi, R; Oda, Y				Takahashi, Shunsuke; Kohashi, Kenichi; Yamamoto, Hidetaka; Hirahashi, Minako; Kumagai, Reiko; Takizawa, Nobuyoshi; Nakamura, Kazuhiko; Maehara, Yoshihiko; Tanaka, Masao; Takayanagi, Ryoichi; Oda, Yoshinao			Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum	HUMAN PATHOLOGY			English	Article						Medullary carcinoma; Adhesion molecules; Epithelial-mesenchymal transition; Colorectum	POORLY DIFFERENTIATED ADENOCARCINOMA; MICROSATELLITE INSTABILITY; BETA-CATENIN; CANCER; COLON; METASTASIS; OVEREXPRESSION; PROGRESSION; SURVIVAL; INVASION	Medullary carcinoma (MC) of the colorectum is known as a rare variant with favorable prognosis despite its poorly differentiated morphology. The mechanism of its favorable behavior has been unclear. Here, we compared the expressions of adhesion molecules and epithelial-mesenchymal transition (EMT)-related proteins in the central portion and invasive front between 43 MCs and 30 poorly differentiated adenocarcinomas (PDAs). The expressions of membranous E-cadherin (P < .0001), P-catenin (P < .0001) and claudin 1 (P = .0036) were significantly preserved in the invasive front of the MCs compared to those in the invasive front of the PDAs. E-cadherin membranous expression was also significantly preserved in the central portion of the MCs (P = .0178). Nuclear beta-catenin expression in both the central portion (P = .0463) and invasive front (P = .0346) of the MCs was significantly less frequent compared to that in the PDAs. Snail (P = .0035) and Twist1 (P = .0463) expressions in the invasive front of the MCs were significantly less frequent compared to the PDAs, suggesting that the EMT phenomenon may occur rarely in colorectal MC. Reduced membranous E-cadherin expression in the MC central portion was significantly correlated with poor clinical outcome (P = .0086). Our immunohistochemical results indicate that preserved adhesion molecule protein and less frequent expression of EMT-related transcription factors in the invasive front contribute to the favorable prognosis of colorectal MCs. We suggest that a reduced expression of E-cadherin in the central portion might be a good biomarker for an unfavorable prognosis in cases of MC. (C) 2015 Elsevier Inc. All rights reserved.	[Takahashi, Shunsuke; Kohashi, Kenichi; Yamamoto, Hidetaka; Hirahashi, Minako; Kumagai, Reiko; Takizawa, Nobuyoshi; Oda, Yoshinao] Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Nakamura, Kazuhiko; Takayanagi, Ryoichi] Kyushu Univ, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Tanaka, Masao] Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Fukuoka 8128582, Japan	Oda, Y (reprint author), Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Pathol Sci,Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	oda@surgpath.med.kyushu-u.ac.jp					HALVORSEN TB, 1989, J CLIN PATHOL, V42, P162, DOI 10.1136/jcp.42.2.162; Ruschoff J, 1997, AM J PATHOL, V150, P1815; Lanza G, 1999, J CLIN ONCOL, V17, P2429; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Fujita K, 2011, AM J SURG PATHOL, V35, P295, DOI 10.1097/PAS.0b013e318205df36; Wick MR, 2005, AM J CLIN PATHOL, V123, P56, DOI 10.1309/1VFJ1C3LP52A4FP8; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Boland CR, 1998, CANCER RES, V58, P5248; Fan XJ, 2013, HUM PATHOL, V44, P173, DOI 10.1016/j.humpath.2012.03.029; Thirunavukarasu P, 2010, INT J ONCOL, V37, P901, DOI 10.3892/ijo_00000741; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Sipos F, 2012, WORLD J GASTROENTERO, V18, P601, DOI 10.3748/wjg.v18.i7.601; Arai T, 2007, PATHOL INT, V57, P205, DOI 10.1111/j.1440-1827.2007.02082.x; Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X; Winn B, 2009, HUM PATHOL, V40, P398, DOI 10.1016/j.humpath.2008.08.014; Edge S, 2010, AM JOINT COMMITTEE C; Fan F, 2012, CANCER MED-US, V1, P5, DOI 10.1002/cam4.4; Fiehn AMK, 2015, VIRCHOWS ARCH, V466, P13, DOI 10.1007/s00428-014-1675-6; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; Gao ZH, 2014, ONCOL LETT, V8, P2069, DOI 10.3892/ol.2014.2433; Georges R, 2012, J CELL MOL MED, V16, P260, DOI 10.1111/j.1582-4934.2011.01289.x; Hamilton SR, 2010, WHO CLASSIFICATION T, P131; Jover R, 2004, AM J CLIN PATHOL, V122, P389, DOI 10.1309/V9PGK2Y260VFVULR; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Markiewicz A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-226; Matsuoka T, 2011, J SURG ONCOL, V103, P674, DOI 10.1002/jso.21854; Ozguven BY, 2011, POL J PATHOL, V62, P19; Ueda J, 2007, PATHOBIOLOGY, V74, P32, DOI 10.1159/000101049; Valdes-Mora F, 2009, ANN SURG ONCOL, V16, P78, DOI 10.1245/s10434-008-0166-x	29	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	SEP	2015	46	9					1257	1266		10.1016/j.humpath.2015.05.023		10	Pathology	Pathology	CQ7JL	WOS:000360779200002		
J	Tekkouk, K; Hirokawa, J; Sauleau, R; Ettorre, M; Sano, M; Ando, M				Tekkouk, Karim; Hirokawa, Jiro; Sauleau, Ronan; Ettorre, Mauro; Sano, Makoto; Ando, Makoto			Dual-Layer Ridged Waveguide Slot Array Fed by a Butler Matrix With Sidelobe Control in the 60-GHz Band	IEEE TRANSACTIONS ON ANTENNAS AND PROPAGATION			English	Article						Butler matrix; diffusion bonding technique; hollow waveguide; millimeter-wave antenna; ridged waveguide; slot array	RECTANGULAR WAVEGUIDE; ANTENNA; POSTS	A novel multibeam antenna based on a 4 x 4 Butler matrix with sidelobe level (SLL) control is proposed in the 60-GHz band. The SLL is controlled using a dedicated circuit composed by four 90-degree couplers with different coupling factors and several cross couplers. This dual-layer antenna is made by hollow waveguides and is assembled using diffusion bonding technique. The radiating part is a compact array of ridged waveguides designed to avoid appearance of grating lobes in the visible range for large scanning angles. The antenna field of view is +/- 43 degrees. with sidelobes lower than -17.5 dB over the entire scanning range. The isolation between the input ports of the Butler matrix is better than 25 dB at the design frequency of 61.5 GHz. The reflection bandwidth for VSWR <2 is larger than 6.5%. At the design frequency, the measured conductor losses of the antenna are estimated lower than 0.64 dB for all ports.	[Tekkouk, Karim; Sauleau, Ronan; Ettorre, Mauro] Univ Rennes 1, IETR, UMR CNRS 6164, F-35042 Rennes, France; [Hirokawa, Jiro; Sano, Makoto; Ando, Makoto] Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1528552, Japan	Tekkouk, K (reprint author), IETR, Rennes, France.	karim.tekkouk@univ-rennes1.fr; jiro@antenna.ee.titech.ac.jp; ronan.sauleau@univ-rennes1.fr; mauro.ettorre@univ-rennes1.fr; msano@antenna.ee.titech.ac.jp; mando@antenna.ee.titech.ac.jp			Agence Nationale de la Recherche [ANR 2010 VERS 001301, ANR 12-EMMA-0041-01]; DGCIS (FUI) [10]; Matisse Doctoral School; GENCI-IDRIS [2014-050779]	This work was conducted in part by the Strategic Information and Communications R&D Promotion Programme, the Ministry of Internal Affairs and Communications in Japan. This work was supported by the Agence Nationale de la Recherche under Grant ANR 2010 VERS 001301, Grant ANR 12-EMMA-0041-01; DGCIS (FUI 10, DENOTEIC); and Matisse Doctoral School. Part of the work was performed using HPC resources from GENCI-IDRIS under Grant 2014-050779.	Miura Y, 2011, IEEE T ANTENN PROPAG, V59, P2844, DOI 10.1109/TAP.2011.2158784; Park S, 2006, IEEE T ANTENN PROPAG, V54, P1474, DOI 10.1109/TAP.2006.874310; Hirokawa J, 1998, IEEE T ANTENN PROPAG, V46, P625, DOI 10.1109/8.668903; Ettorre M, 2011, IEEE T ANTENN PROPAG, V59, P1093, DOI 10.1109/TAP.2011.2109695; HIROKAWA J, 1995, IEEE T VEH TECHNOL, V44, P749, DOI 10.1109/25.467958; Hayashi Y, 2011, IEEE T ANTENN PROPAG, V59, P398, DOI 10.1109/TAP.2010.2096180; Sauleau R, 2006, IEEE T ANTENN PROPAG, V54, P1122, DOI 10.1109/TAP.2006.872563; HALL PS, 1990, IEE PROC-H, V137, P293; LEVIATAN Y, 1983, IEEE T MICROW THEORY, V31, P806, DOI 10.1109/TMTT.1983.1131610; Li WR, 2004, ELECTRON LETT, V40, P290, DOI 10.1049/el:20040198; Kai T, 2005, IEICE T COMMUN, VE88B, P1298, DOI 10.1093/ietcom/e88-b.3.1298; AUDA H, 1984, IEEE T MICROW THEORY, V32, P606, DOI 10.1109/TMTT.1984.1132736; Butler J, 1961, ELECTRON DES, V9, P170; Chen P, 2009, IEEE T ANTENN PROPAG, V57, P1813, DOI 10.1109/TAP.2009.2019868; Elliott R. S., 1985, IEEE ANT PROP SOC NE, V29, P4; Gandini E., 2013, IEEE ANTENN WIREL PR, V11, P1572; Hao ZC, 2006, IEE P-MICROW ANTEN P, V153, P426, DOI 10.1049/ip-map:20050171; Hirokawa J., 2003, RADIO SCI, V38; Hirokawa J., 2007, P EUR C ANT PROP 11, P1; Marcuvitz N., 1951, WAVEGUIDE HDB; Nguyen N. T., 2010, IEEE T ANTENN PROPAG, V58, P2757; Nguyen NT, 2011, IEEE T ANTENN PROPAG, V59, P2152, DOI 10.1109/TAP.2011.2144550; Nguyen NT, 2013, IEEE T ANTENN PROPAG, V61, P1658, DOI 10.1109/TAP.2012.2220320; SAKAKIBARA K, 1994, IEICE T COMMUN, VE77B, P511; Sato J., 1998, P IEEE ANT PROP SOC, P1706; She YF, 2009, APMC: 2009 ASIA PACIFIC MICROWAVE CONFERENCE, VOLS 1-5, P2041; SHELTON JP, 1969, IEEE T ANTENN PROPAG, VAP17, P645, DOI 10.1109/TAP.1969.1139525; SHELTON JP, 1968, PR INST ELECTR ELECT, V56, P1818, DOI 10.1109/PROC.1968.6756; Tekkouk K., 2012, Proceedings of the 2012 6th European Conference on Antennas and Propagation (EuCAP), DOI 10.1109/EuCAP.2012.6206347; Webb W, 2001, IEEE COMMUN MAG, V39, P115, DOI 10.1109/35.948404; Yamamoto S, 2006, IEICE T ELECTRON, VE89C, P1080, DOI 10.1093/ietele/e89-c.7.1080	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-926X	1558-2221		IEEE T ANTENN PROPAG	IEEE Trans. Antennas Propag.	SEP	2015	63	9					3857	3867		10.1109/TAP.2015.2442612		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CQ7SE	WOS:000360803400008		
J	Miao, Y; Haneda, K; Kim, M; Takada, J				Miao, Yang; Haneda, Katsuyuki; Kim, Minseok; Takada, Jun-ichi			Antenna De-Embedding of Radio Propagation Channel With Truncated Modes in the Spherical Vector Wave Domain	IEEE TRANSACTIONS ON ANTENNAS AND PROPAGATION			English	Article						Antenna de-embedding; ideal spherical array; mode-to-mode mapping matrix; truncated modes; virtual spherical DRA array	EXPANSION; COEFFICIENTS	This paper proposes a novel approach to extracting the narrowband propagation channel from the communication link by de-embedding the impact of the antennas. In the proposed approach, the mode-to-mode mapping matrix M, which is the expression of the propagation channel in the spherical vector wave domain, is estimated by applying pseudo-inverse computation to the channel transfer functions with dedicated spherical arrays. The estimated M is truncated and only the dominant modes within the spatial bandwidth of the fields radiated from the finite volume of the spherical array are considered. Two types of spherical array are investigated: 1) an ideal array using tangential dipoles; and 2) a virtual array using dielectric resonator antenna (DRA). The ideal array is used for parameter investigation including the array radius and the spacing with regard to the size of M and the condition number of the excitation coefficient matrix, while the virtual DRA array is proposed as a practical implementation of the ideal array. The accuracy of the proposed approach has been validated numerically. The uncertainties of spherical array in practice, such as the influence of nonideally embedded array elements, cables, and fixtures, are considered in the validation. Moreover, the channel transfer functions reproduced by the de-embedded M are analyzed, given different target antennas at link ends. The gain and phase discrepancies as well as the antenna correlations of the reproduced channel transfer function are compared with the generated reference.	[Miao, Yang; Takada, Jun-ichi] Tokyo Inst Technol, Dept Int Dev Engn, Tokyo 1528552, Japan; [Haneda, Katsuyuki] Aalto Univ, Sch Sci & Technol, Dept Radio Sci & Engn, FI-00076 Aalto, Finland; [Kim, Minseok] Niigata Univ, Sch Engn, Dept Elect & Elect Engn, Niigata 9502181, Japan	Miao, Y (reprint author), Tokyo Inst Technol, Dept Int Dev Engn, Tokyo 1528552, Japan.	miao.y@ap.ide.titech.ac.jp					Poon ASY, 2005, IEEE T INFORM THEORY, V51, P523, DOI 10.1109/TIT.2004.840892; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Fleury BH, 1999, IEEE J SEL AREA COMM, V17, P434, DOI 10.1109/49.753729; Haneda K, 2013, IEEE T ANTENN PROPAG, V61, P5735, DOI 10.1109/TAP.2013.2279091; Steinbauer M, 2001, IEEE ANTENN PROPAG M, V43, P51, DOI 10.1109/74.951559; Bernland A, 2012, IEEE ANTENN WIREL PR, V11, P608, DOI 10.1109/LAWP.2012.2202870; Fisher N.I., 1993, STAT ANAL SPHERICAL; Glazunov A. A., 2008, P 29 URSI GEN ASS CH, P1; Glazunov AA, 2011, IEEE T ANTENN PROPAG, V59, P119, DOI 10.1109/TAP.2010.2090639; Glazunov AA, 2010, IET MICROW ANTENNA P, V4, P778, DOI 10.1049/iet-map.2009.0057; Glazunov AA, 2011, PR ELECTROMAGN RES S, P603; Glazunov AA, 2011, IEEE ANTENN WIREL PR, V10, P1112, DOI 10.1109/LAWP.2011.2170951; Glazunov AA, 2009, IEEE T ANTENN PROPAG, V57, P2055, DOI 10.1109/TAP.2009.2016686; Golub, 1996, MATRIX COMPUTATIONS, V3rd; Haneda K, 2013, IEEE T ANTENN PROPAG, V61, P890, DOI 10.1109/TAP.2012.2223431; Haneda K, 2013, PROC EUR CONF ANTENN, P2801; Hansen J., 1988, SPHERICAL NEAR FIELD, VPeter Peregrinus Ltd; Ishimiya K., 2008, P IEEE C COMP VIS PA, P1; Jensen F., 2004, P 26 ANN M ANT MEAS, P489; Khatun A., 2010, P IEEE INT C INT ADV, P1; Laitinen T., 2005, THESIS HELSINKI U TE; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Molina-Garcia-Pardo JM, 2008, IEEE T ANTENN PROPAG, V56, P3818, DOI 10.1109/TAP.2008.2005542; Naganawa J, 2015, IEEE T ANTENN PROPAG, V63, P2545, DOI 10.1109/TAP.2015.2414442; Xu H, 2004, IEEE T WIREL COMMUN, V3, P966, DOI 10.1109/TWC.2004.827736	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-926X	1558-2221		IEEE T ANTENN PROPAG	IEEE Trans. Antennas Propag.	SEP	2015	63	9					4100	4110		10.1109/TAP.2015.2443854		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CQ7SE	WOS:000360803400032		
J	Yamaguchi, Y; Ogawa, A; Takeda, A; Iwata, S				Yamaguchi, Yutaro; Ogawa, Anna; Takeda, Akiko; Iwata, Satoru			Cyber Security Analysis of Power Networks by Hypergraph Cut Algorithms	IEEE TRANSACTIONS ON SMART GRID			English	Article						False data injection; hypergraph; minimum cut; power network; security index; state estimation	FLOW	This paper presents exact solution methods for analyzing vulnerability of electric power networks to a certain kind of undetectable attacks known as false data injection attacks. We show that the problems of finding the minimum number of measurement points to be attacked undetectably reduce to minimum cut problems on hypergraphs, which admit efficient combinatorial algorithms. Experimental results indicate that our exact solution methods run as fast as the previous methods, most of which provide only approximate solutions. We also present an algorithm for enumerating all small cuts in a hypergraph, which can be used for finding vulnerable sets of measurement points.	[Yamaguchi, Yutaro; Ogawa, Anna; Takeda, Akiko; Iwata, Satoru] Univ Tokyo, Dept Math Informat, Tokyo 1138656, Japan; [Ogawa, Anna] Keio Univ, Dept Adm Engn, Yokohama, Kanagawa 2238522, Japan	Yamaguchi, Y (reprint author), Univ Tokyo, Dept Math Informat, Tokyo 1138656, Japan.	yutaro_yamaguchi@mist.i.u-tokyo.ac.jp			Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST); Japan Society for the Promotion of Science	This work was supported by the Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST). The work of Y. Yamaguchi was supported by the Japan Society for the Promotion of Science Fellowship for Young Scientists.	Yang HH, 1996, IEEE T COMPUT AID D, V15, P1533, DOI 10.1109/43.552086; Liu Y, 2009, CCS'09: PROCEEDINGS OF THE 16TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P21; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; NAGAMOCHI H, 1992, SIAM J DISCRETE MATH, V5, P54, DOI 10.1137/0405004; Zimmerman RD, 2011, IEEE T POWER SYST, V26, P12, DOI 10.1109/TPWRS.2010.2051168; Gomez-Exposito A., 2004, POWER SYSTEM STATE E; Hendrickx JM, 2014, IEEE T AUTOMAT CONTR, V59, P3194, DOI 10.1109/TAC.2014.2351625; Karger DR, 1999, MATH OPER RES, V24, P383, DOI 10.1287/moor.24.2.383; Sou KC, 2013, IEEE T SMART GRID, V4, P856, DOI 10.1109/TSG.2012.2230199; Klimmek R., 1996, B9602 FREIE U BERL; Lin J., 2007, P IEEE POW ENG SOC G, P1; Nagamochi H, 1997, SIAM J DISCRETE MATH, V10, P469, DOI 10.1137/S0895480194271323; Nagata M., 2013, P 2013 INT S NONL TH, P69; Orlin James B, 2013, P 45 ANN ACM S THEOR, P765; Pistorius J., 2003, International Transactions in Operational Research, V10, DOI 10.1111/1475-3995.00389; Sandberg H., 2010, P 1 WORKSH SEC CONTR; Sou KC, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P4054; Zonouz S, 2012, IEEE T SMART GRID, V3, P1790, DOI 10.1109/TSG.2012.2217762	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1949-3053	1949-3061		IEEE T SMART GRID	IEEE Trans. Smart Grid	SEP	2015	6	5					2189	2199		10.1109/TSG.2015.2394791		11	Engineering, Electrical & Electronic	Engineering	CQ2MW	WOS:000360435900002		
J	Tanaka, T; Kajiwara, T; Kutomi, G; Kurotaki, T; Saito, K; Kanaseki, T; Tsukahara, T; Hirohashi, Y; Torigoe, T; Hirata, K; Okamoto, Y; Sato, N; Tamura, Y				Tanaka, Tsutomu; Kajiwara, Toshimitsu; Kutomi, Goro; Kurotaki, Takehiro; Saito, Keita; Kanaseki, Takayuki; Tsukahara, Tomohide; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Hirata, Koichi; Okamoto, Yoshiharu; Sato, Noriyuki; Tamura, Yasuaki			CpG-A stimulates Hsp72 secretion from plasmacytoid dendritic cells, facilitating cross-presentation	IMMUNOLOGY LETTERS			English	Article						Antigen presentation/processing; Dendritic cells; Heat shock protein; T cells; Tumor immunity	HEAT-SHOCK PROTEINS; STATIC EARLY ENDOSOME; IN-VIVO; PATHWAY; PEPTIDE; INDUCTION; SURVIVIN; IMMUNITY; TARGETS; ANTIGEN	Plasmacytoid dendritic cells (pDCs) are the main producers of IFN-alpha in response to unmethylated DNA molecules, including cytosine guanine dinucleotide (CpG)-DNA in vivo. pDCs specifically express toll-like receptor (TLR) 9 and are therefore able to recognize the unmethylated DNAs. It has recently been shown that not only conventional DCs (cDCs) but also pDCs efficiently cross-present exogenous antigens after TLR9 activation. However, the precise molecular mechanism has remained unclear. Here, we show that pDCs secreted heat shock protein 72 (Hsp72) in response to CpG-A administration in a TLR9-dependent manner. Extracellular Hsp72 bound to an Hsp90-peptide complex and enhanced binding of Hsp90-peptide complex to pDC, resulting in efficient cross-presentation. Our experiments therefore suggest a mechanism for orchestration of immune responses by stimulation of pDCs with CpG-A. (C) 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.	[Tanaka, Tsutomu; Kajiwara, Toshimitsu; Kanaseki, Takayuki; Tsukahara, Tomohide; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Sato, Noriyuki; Tamura, Yasuaki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Tanaka, Tsutomu] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Kutomi, Goro; Kurotaki, Takehiro; Saito, Keita; Hirata, Koichi] Sapporo Med Univ, Sch Med, Dept Surg, Sapporo, Hokkaido, Japan; [Okamoto, Yoshiharu] Tottori Univ, Joint Dept Vet Med, Tottori 680, Japan; [Tamura, Yasuaki] Hokkaido Univ, Dept Mol Therapeut, Ctr Food & Med Innovat, Sapporo, Hokkaido, Japan	Tamura, Y (reprint author), Hokkaido Univ, Dept Mol Therapeut, Ctr Food & Med Innovat, Sapporo, Hokkaido, Japan.	ytamura@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan.	Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Idenoue S, 2005, CLIN CANCER RES, V11, P1474, DOI 10.1158/1078-0432.CCR-03-0817; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Calderwood SK, 2007, ANN NY ACAD SCI, V1113, P28, DOI 10.1196/annals.1391.019; Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Oura J, 2011, INT IMMUNOL, V23, P223, DOI 10.1093/intimm/dxq475; Kurotaki T, 2007, J IMMUNOL, V179, P1803; Mambula SS, 2006, J IMMUNOL, V177, P7849; Azuma M, 2012, ONCOIMMUNOLOGY, V1, P581; Schlecht G, 2004, BLOOD, V104, P1808, DOI 10.1182/blood-2004-02-0426; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Datta SK, 2005, SPRINGER SEMIN IMMUN, V26, P247, DOI 10.1007/s00281-004-0174-2; Datta S.K., 2003, J IMMUNOL, V170; Hirohashi Y, 2002, CLIN CANCER RES, V8, P1731; Okuya K, 2010, J IMMUNOL, V184, P7092, DOI 10.4049/jimmunol.1000490; Tamura Y, 2012, IMMUNOTHERAPY-UK, V4, P841, DOI [10.2217/imt.12.75, 10.2217/IMT.12.75]; Tanaka T, 2015, CANCER SCI, V106, P18, DOI 10.1111/cas.12570	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	SEP	2015	167	1					34	40		10.1016/j.imlet.2015.06.014		7	Immunology	Immunology	CQ4SZ	WOS:000360596200006		
J	Suzuki, Y; Matsui, T; Ito, H; Ashida, T; Nakamura, S; Motoya, S; Matsumoto, T; Sato, N; Ozaki, K; Watanabe, M; Hibi, T				Suzuki, Yasuo; Matsui, Toshiyuki; Ito, Hiroaki; Ashida, Toshifumi; Nakamura, Shiro; Motoya, Satoshi; Matsumoto, Takayuki; Sato, Noriko; Ozaki, Kunihiko; Watanabe, Mamoru; Hibi, Toshifumi			Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohn's Disease: A Prospective Clinical Trial	INFLAMMATORY BOWEL DISEASES			English	Article							INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; RANDOMIZED-TRIAL; SERUM INFLIXIMAB; INTENSIFICATION; PATHOGENESIS; ASSOCIATION	Background: We aimed to clarify the efficacy, safety, and factors associated with remission on dose escalation in patients with Crohn's disease showing loss of response (LOR) to infliximab treatment of 5 mg/kg at 8-week intervals in a clinical trial. Methods: Thirty-nine patients with LOR to 5 mg/kg infliximab therapy started treatment with 10 mg/kg per 8 weeks. LOR was defined as both a Crohn's Disease Activity Index of >= 175 at 8 weeks after infusion of 5 mg/kg infliximab and a Crohn's Disease Activity Index increase of >= 50 from 4 to 8 weeks after infusion. Results: At week 8 after the first infusion of 10 mg/kg, median (95% confidence interval) reduction in Crohn's Disease Activity Index of 33 patients evaluated was 95.0 (70.0-134.0), meeting the primary endpoint. Remission rate at week 40 was 41% (16 of 39), with correlation noted between remission achievement and serum infliximab level (P = 0.036). Univariate analysis revealed that "infliximab trough level >= 1 mu g/mL," "interleukin 6 level <= 2.41 pg/mL," and "albumin level >= 3.8 g/dL" before dose escalation were significantly associated with remission at week 40 (P = 0.017, P = 0.011, and P = 0.019, respectively), and these variables were correlated with each other (all: P < 0.001). The cutoff infliximab level for remission was 0.42 mu g/mL in receiver operating characteristic curve analysis. No adverse events related to dose escalation were observed. Conclusions: Doubling the infliximab dose safely led to remission in patients with Crohn's disease with LOR to 5 mg/kg treatment. Remission was associated with pre-escalation levels of infliximab, interleukin 6, and albumin. Our findings suggest that dose escalation while maintaining a certain level of infliximab is important in achieving remission.	[Suzuki, Yasuo] Toho Univ, Sakura Med Ctr, Dept Internal Med, Sakura 2858741, Japan; [Matsui, Toshiyuki] Fukuoka Univ, Dept Gastroenterol, Chikushi Hosp, Chikushino, Japan; [Ito, Hiroaki] Kinshukai Infus Clin, Osaka, Japan; [Ashida, Toshifumi] Sapporo Higashi Tokushukai Hosp, Ctr Inflammatory Bowel Dis, Sapporo, Hokkaido, Japan; [Nakamura, Shiro] Hyogo Coll Med, Div Lower Gastroenterol, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Motoya, Satoshi] Sapporo Kosei Gen Hosp, Ctr Inflammatory Bowel Dis, Sapporo, Hokkaido, Japan; [Matsumoto, Takayuki] Iwate Med Univ, Dept Internal Med, Div Gastroenterol, Morioka, Iwate 020, Japan; [Sato, Noriko; Ozaki, Kunihiko] Mitsubishi Tanabe Pharma Corp, Osaka, Japan; [Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Tokyo, Japan	Suzuki, Y (reprint author), Toho Univ, Sakura Med Ctr, Dept Internal Med, 564-1 Shimoshizu, Sakura 2858741, Japan.	yasuo-suzuki@sakura.med.toho-u.ac.jp			Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma; Zeria Pharmaceutical; AbbVie; Ajinomoto Pharmaceuticals; EN Otsuka Pharmaceutical; JIMRO; Kyorin Pharmaceutical; Otsuka Pharmaceutical; Otsuka Pharmaceutical Factory; UCB Japan; Janssen Pharmaceutical KK; Asahi Kasei Medical; Astellas Pharma; Eisai; Kyowa Hakko Kirin; Abbott Japan; AbbVie GK; Takeda Pharmaceutical; Chugai Pharmaceutical; GlaxoSmithKline; ONO Pharmaceutical; Pfizer Japan; Shionogi	This study was sponsored by Mitsubishi Tanabe Pharma Corporation. The authors thank the patients, investigators, and study personnel who made the trial possible.; Y. Suzuki has received lecture fees from Mitsubishi Tanabe Pharma. H. Ito is currently receiving consulting fees from Mitsubishi Tanabe Pharma and Zeria Pharmaceutical and has received lecture fees from AbbVie. T. Ashida has received lecture fees from Mitsubishi Tanabe Pharma. S. Nakamura is currently receiving grants/grants pending from AbbVie, Ajinomoto Pharmaceuticals, EN Otsuka Pharmaceutical, JIMRO, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Otsuka Pharmaceutical, Otsuka Pharmaceutical Factory, and UCB Japan; has received lecture fees from Mitsubishi Tanabe Pharma. S. Motoya is currently receiving grants/grants pending from Janssen Pharmaceutical KK and has received lecture fees from Mitsubishi Tanabe Pharma. T. Matsumoto has received lecture fees from Mitsubishi Tanabe Pharma. N. Sato and K. Ozaki are employees of Mitsubishi Tanabe Pharma. M. Watanabe is currently receiving grants from Ajinomoto Pharmaceuticals, Asahi Kasei Medical, Astellas Pharma, Eisai, JIMRO, Kyorin Pharmaceutical, Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, Otsuka Pharmaceutical, UCB Japan, and Zeria Pharmaceutical; received a grant from Abbott Japan; is currently receiving consulting fees from Abbott Japan, AbbVie GK, Ajinomoto Pharmaceuticals, Eisai, Kyorin Pharmaceutical, and Takeda Pharmaceutical; received consulting fees from Asahi Kasei Medical, Astellas Pharma, Chugai Pharmaceutical, JIMRO, Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, Otsuka Pharmaceutical, UCB Japan, Zeria Pharmaceutical, GlaxoSmithKline, ONO Pharmaceutical, Pfizer Japan, and Shionogi. The other authors have no conflicts of interest to disclose.	Charles P, 1999, J IMMUNOL, V163, P1521; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Gisbert JP, 2009, AM J GASTROENTEROL, V104, P760, DOI 10.1038/ajg.2008.88; Katz L, 2012, INFLAMM BOWEL DIS, V18, P2026, DOI 10.1002/ibd.22902; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Rutgeerts P, 2006, ALIMENT PHARM THERAP, V23, P451, DOI 10.1111/j.1365-2036.2006.02786.x; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P402, DOI 10.1053/j.gastro.2003.11.014; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Maser EA, 2006, CLIN GASTROENTEROL H, V4, P1248, DOI 10.1016/j.cgh.2006.06.025; Allez M, 2010, J CROHNS COLITIS, V4, P355, DOI 10.1016/j.crohns.2010.04.004; Afif W, 2010, AM J GASTROENTEROL, V105, P1133, DOI 10.1038/ajg.2010.9; Chaparro M, 2012, J CROHNS COLITIS, V6, P62, DOI 10.1016/j.crohns.2011.07.005; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Fasanmade AA, 2010, INT J CLIN PHARM TH, V48, P297; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1016/j.gastro.2006.01.048; Peyrin-Biroulet L, 2010, GUT, V59, P141, DOI 10.1136/gut.2009.187120; Hibi T, 2012, INFLAMM BOWEL DIS, V18, P1480, DOI 10.1002/ibd.21886; Hibi T, 2014, J GASTROENTEROL, V49, P254, DOI 10.1007/s00535-013-0807-0; Japanese Medicines Agency, 2011, ASS REP INFL; Kato K, 2011, GUT LIVER, V5, P37, DOI 10.5009/gnl.2011.5.1.37; Lin KK, 2012, DIGEST DIS SCI, V57, P1013, DOI 10.1007/s10620-011-1969-3	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-0998	1536-4844		INFLAMM BOWEL DIS	Inflamm. Bowel Dis.	SEP	2015	21	9					2114	2122		10.1097/MIB.0000000000000475		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CQ5GE	WOS:000360630500011		
J	Li, B; Zhao, ZH; Jiang, YJ; Jing, LR				Li, Bo; Zhao, Zhihong; Jiang, Yujing; Jing, Lanru			Contact mechanism of a rock fracture subjected to normal loading and its impact on fast closure behavior during initial stage of fluid flow experiment	INTERNATIONAL JOURNAL FOR NUMERICAL AND ANALYTICAL METHODS IN GEOMECHANICS			English	Article						rock fracture; fluid flow experiment; fast closure; contact mechanism; elastic; crushing	ELASTIC-PLASTIC CONTACT; PRESSURE-SOLUTION; ROUGH SURFACES; HYDROTHERMAL CONDITIONS; NATURAL FRACTURE; NET DISSOLUTION; NORMAL STRESS; SHEAR LOADS; MODEL; PERMEABILITY	Fast closure of rock fractures has been commonly observed in the initial stage of fluid flow experiments at environmental temperatures under low or moderate normal stresses. To fully understand the mechanisms that drive this fast closure, the evolution of local stresses acting on contacting asperities on the fracture surfaces prior to fluid flow tests needs to be evaluated. In this study, we modeled numerically the asperity deformation and failure processes during initial normal loading, by adopting both elastic and elastic-plastic deformation models for the asperities on a real rock fracture with measured surface topography data, and estimated their impact on initial conditions for fluid flow test performed under laboratory conditions. Compared with the previous models that simulate the normal contact of a fracture as the approach of two rigid surfaces without deformations, our models of deformable asperities yielded smaller contact areas and higher stresses on contacting asperities at a given normal stress or normal displacement. The results show that the calculated local stresses were concentrated on the contacts of a few major asperities, resulting in crushing of asperity tips. With these higher contact stresses, however, the predicted closure rates by pressure solution are still several orders of magnitude lower than that of the experimental measurements at the initial stage of fluid flow test. This indicates that single pressure solution may not likely to be the principal compaction mechanism for this fast closure, and that the damages on contacting asperities that occur during the initial normal loading stage may play an important role. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Li, Bo; Jiang, Yujing] Nagasaki Univ, Sch Engn, Nagasaki 8528521, Japan; [Zhao, Zhihong] Tsinghua Univ, Dept Civil Engn, Beijing 100084, Peoples R China; [Jiang, Yujing] Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Cofo, Qingdao 266590, Peoples R China; [Jiang, Yujing] Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266590, Peoples R China; [Jing, Lanru] Royal Inst Technol, Dept Land & Water Resources Engn, S-10044 Stockholm, Sweden	Li, B (reprint author), Nagasaki Univ, Sch Engn, Nagasaki 8528521, Japan.	libo@nagasaki-u.ac.jp			National Natural Science Foundation of China [51379117];  [24760690]	This study was partially funded by Grant-in-Aid for Young Scientists (B) (No. 24760690), Japan and National Natural Science Foundation of China (No. 51379117). The authors like to thank Dr. Hideaki Yasuhara in Ehime University, Japan for providing the laser scanned surface topography data of the rock fracture sample that was used in this study.	Ameli P, 2014, ROCK MECH ROCK ENG, V47, P1563, DOI 10.1007/s00603-014-0575-z; Jacq C, 2002, J TRIBOL-T ASME, V124, P653, DOI 10.1115/1.1467920; Brantut N, 2013, J STRUCT GEOL, V52, P17, DOI 10.1016/j.jsg.2013.03.007; Yasuhara H, 2008, PURE APPL GEOPHYS, V165, P1289, DOI 10.1007/s00024-008-0356-2; Yasuhara H, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002536; Bhushan B, 1998, TRIBOL LETT, V4, P1, DOI 10.1023/A:1019186601445; Revil A, 1999, GEOPHYS RES LETT, V26, P255, DOI 10.1029/1998GL900268; Shah KR, 1997, INT J ROCK MECH MIN, V34, P727, DOI 10.1016/S1365-1609(97)00007-7; Persson BNJ, 2006, SURF SCI REP, V61, P201, DOI 10.1016/j.surfrep.2006.04.001; BROWN SR, 1986, J GEOPHYS RES-SOLID, V91, P4939, DOI 10.1029/JB091iB05p04939; Polak A, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002717; CHIU YP, 1977, J APPL MECH-T ASME, V44, P587; Zimmerman RW, 1996, TRANSPORT POROUS MED, V23, P1; BANDIS SC, 1983, INT J ROCK MECH MIN, V20, P249, DOI 10.1016/0148-9062(83)90595-8; DERJAGUIN BV, 1975, J COLLOID INTERF SCI, V53, P314, DOI 10.1016/0021-9797(75)90018-1; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Yasuhara H, 2006, EARTH PLANET SC LETT, V244, P186, DOI 10.1016/j.epsl.2006.01.046; CHIU YP, 1978, J APPL MECH-T ASME, V45, P302; Yasuhara H, 2006, INT J NUMER ANAL MET, V30, P1039, DOI 10.1002/nag.513; BROWN SR, 1985, J GEOPHYS RES-SOLID, V90, P5531, DOI 10.1029/JB090iB07p05531; Drescher K, 2003, J S AFR I MIN METALL, V103, P325; EVANS B, 1984, J GEOPHYS RES, V89, P4213, DOI 10.1029/JB089iB06p04213; GREENWOO.JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI [10.1515/crll.1882.92.156., DOI 10.1515/CRLL.1882.92.156]; Johnson K.L., 1985, CONTACT MECH; Li B, 2008, INT J ROCK MECH MIN, V45, P362, DOI 10.1016/j.ijrmms.2007.06.004; Matsuki K, 2008, INT J ROCK MECH MIN, V45, P194, DOI 10.1016/j.ijrmms.2007.04.009; McGuire TP, 2013, TRANSPORT POROUS MED, V98, P15, DOI 10.1007/s11242-013-0123-4; Olsson R, 2001, INT J ROCK MECH MIN, V38, P317, DOI 10.1016/S1365-1609(00)00079-4; Polak A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017575; Pyrak-Nolte LJ, 2000, INT J ROCK MECH MIN, V37, P245, DOI 10.1016/S1365-1609(99)00104-5; Tian XF, 1996, J TRIBOL-T ASME, V118, P33, DOI 10.1115/1.2837089; Wang F, 2005, J TRIBOL-T ASME, V127, P494, DOI 10.1115/1.1924573; Wang ZJ, 2010, TRIBOL T, V53, P224, DOI 10.1080/10402000903177908; Xiong XB, 2011, INT J ROCK MECH MIN, V48, P1292, DOI 10.1016/j.ijrmms.2011.09.009; Yasuhara H, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002663; Yasuhara H, 2011, APPL GEOCHEM, V26, P2074, DOI 10.1016/j.apgeochem.2011.07.005; YOSHIOKA N, 1994, J GEOPHYS RES-SOL EA, V99, P15549, DOI 10.1029/94JB00938; YOSHIOKA N, 1989, J GEOPHYS RES-SOLID, V94, P17691, DOI 10.1029/JB094iB12p17691; YOSHIOKA N, 1994, J GEOPHYS RES-SOL EA, V99, P15561, DOI 10.1029/94JB00931; YOSHIOKA N, 1989, J GEOPHYS RES-SOLID, V94, P17681, DOI 10.1029/JB094iB12p17681; Zhang YJ, 2011, SCI CHINA TECHNOL SC, V54, P1748, DOI 10.1007/s11431-011-4437-6	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-9061	1096-9853		INT J NUMER ANAL MET	Int. J. Numer. Anal. Methods Geomech.	SEP	2015	39	13					1431	1449		10.1002/nag.2365		19	Engineering, Geological; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CQ7UK	WOS:000360810000003		
J	Li, YS; Hamamura, M				Li, Yingsong; Hamamura, Masanori			Zero-attracting variable-step-size least mean square algorithms for adaptive sparse channel estimation	INTERNATIONAL JOURNAL OF ADAPTIVE CONTROL AND SIGNAL PROCESSING			English	Article						least mean square; sparse channel estimation; compressed sensing; zero-point attracting; l(1)-penalized least mean square; variable-step-size; adaptive filtering	CONSTRAINT LMS ALGORITHM; SYSTEM-IDENTIFICATION	Recently, sparsity-aware least mean square (LMS) algorithms have been proposed to improve the performance of the standard LMS algorithm for various sparse signals, such as the well-known zero-attracting LMS (ZA-LMS) algorithm and its reweighted ZA-LMS (RZA-LMS) algorithm. To utilize the sparsity of the channels in wireless communication and one of the inherent advantages of the RZA-LMS algorithm, we propose an adaptive reweighted zero-attracting sigmoid functioned variable-step-size LMS (ARZA-SVSS-LMS) algorithm by the use of variable-step-size techniques and parameter adjustment method. As a result, the proposed ARZA-SVSS-LMS algorithm can achieve faster convergence speed and better steady-state performance, which are verified in a sparse channel and compared with those of other popular LMS algorithms. The simulation results show that the proposed ARZA-SVSS-LMS algorithm outperforms the standard LMS algorithm and the previously proposed sparsity-aware algorithms for dealing with sparse signals. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Li, Yingsong; Hamamura, Masanori] Kochi Univ Technol, Grad Sch Engn, Kami 7828502, Japan	Li, YS (reprint author), Kochi Univ Technol, Grad Sch Engn, Kami 7828502, Japan.	liyingsong@ieee.org					[Anonymous], 2011, P IEEE INT C AC SPEE; Aboulnasr T, 1997, IEEE T SIGNAL PROCES, V45, P631, DOI 10.1109/78.558478; Meng J, 2012, IEEE J-STSP, V6, P15, DOI 10.1109/JSTSP.2011.2169649; Chen YL, 2009, INT CONF ACOUST SPEE, P3125; Gu YT, 2009, IEEE SIGNAL PROC LET, V16, P774, DOI 10.1109/LSP.2009.2024736; Adachi F, 2007, WIREL COMMUN MOB COM, V7, P969, DOI [10.1002/wcm.507, 10.1002/wem.507]; Wu FY, 2013, SIGNAL PROCESS, V93, P967, DOI 10.1016/j.sigpro.2012.10.008; Godavarti M, 2005, IEEE T SIGNAL PROCES, V53, P2382, DOI 10.1109/TSP.2005.849167; Jin J, 2010, IEEE J-STSP, V4, P409, DOI 10.1109/JSTSP.2009.2039173; Li Y, 2000, IEEE T VEH TECHNOL, V49, P1207, DOI 10.1109/25.875230; Prodan I, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-315; Shi K, 2010, SIGNAL PROCESS, V90, P3289, DOI 10.1016/j.sigpro.2010.05.015; Eksioglu EM, 2011, IET SIGNAL PROCESS, V5, P480, DOI 10.1049/iet-spr.2010.0083; Vaswani N, 2008, IEEE IMAGE PROC, P893, DOI 10.1109/ICIP.2008.4711899; Wan F, 2011, IEEE T VEH TECHNOL, V60, P2569, DOI 10.1109/TVT.2011.2153218; Gui G, 2013, UEEE INT SYM PERS IN, P296; Candes EJ, 2008, J FOURIER ANAL APPL, V15, P877; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Douglas SC, 1997, IEEE T SIGNAL PROCES, V45, P2125, DOI 10.1109/78.611231; Gao Ying, 2001, Acta Electronica Sinica, V29; Gui G., 2013, EURASIP J WIREL COMM, V2013, P1; Haykin S., 2001, ADAPTIVE FILTER THEO; Hung YF, 2003, P 14 IEEE INT S PERS, V1, P17; Korowajczuk L, 2011, LTE, WIMAX AND WLAN NETWORK DESIGN, OPTIMIZATION AND PERFORMANCE ANALYSIS, P1, DOI 10.1002/9781119970460; Liu LG, 2010, IEICE T FUND ELECTR, VE93A, P972, DOI 10.1587/transfun.E93.A.972; Nie W, 2010, IEEE 72 VEH TECHN C, P1; Proakis J. G., 2001, DIGITAL COMMUNICATIO; Salman MS, 2012, P 20 INT C SOFTW TEL, P1; Shen B, 2013, IEEE T NEUR NET LEAR, V24, P2027, DOI 10.1109/TNNLS.2013.2271357; Taheri O, 2014, SIGNAL PROCESS, V104, P70, DOI 10.1016/j.sigpro.2014.03.048; Tan JF, 1997, J DATA ACQUISITION P, V12, P171; Wagner KT, 2009, INT CONF ACOUST SPEE, P3117, DOI 10.1109/ICASSP.2009.4960284; Wang Z, 2014, IEEE T AUTOMATIC CON, V57, P1431	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0890-6327	1099-1115		INT J ADAPT CONTROL	Int. J. Adapt. Control Signal Process.	SEP	2015	29	9					1189	1206		10.1002/acs.2536		18	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CQ7FI	WOS:000360768000008		
J	Wang, ZZ; Guo, J				Wang, Zhenzhong; Guo, Jiang			y Research on an optimized machining method for parallel grinding of f-theta optics	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						f-theta optics; Parallel grinding; Simultaneous 2-axis; Form accuracy	ASPHERICAL MOLD INSERTS; ERROR; COMPENSATION; SURFACE	Parallel grinding method has been widely used for advanced optics machining, especially f-theta optics. In order to reduce the dependence on high-precision machine tool with many degrees of freedom (DOF) and obtain high machining accuracy, in this paper, we propose a simultaneous 2-axis method to replace the conventional simultaneous 3-axis method in parallel grinding. Firstly, the algorithm of the simultaneous 2-axis method is explained. Then, the motion control errors and machining errors under simultaneous 3-axis and 2-axis methods are comparably analyzed, respectively. Finally, through grinding experiments, the feasibility of the simultaneous 2-axis method is verified.	[Wang, Zhenzhong] Xiamen Univ, Dept Mech & Elect Engn, Xiamen 361005, Peoples R China; [Guo, Jiang] RIKEN, Ultrahigh Precis Opt Technol Team, Ctr Adv Photon RAP, Wako, Saitama 3510198, Japan	Guo, J (reprint author), RIKEN, Ultrahigh Precis Opt Technol Team, Ctr Adv Photon RAP, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	guojiang3302@163.com			Laboratory of Precision Manufacturing Technology, CAEP [KF13011]	The authors would like to gratefully acknowledge the funding support from Laboratory of Precision Manufacturing Technology, CAEP (no. KF13011).	Liang ZQ, 2010, INT J MACH TOOL MANU, V50, P728, DOI 10.1016/j.ijmachtools.2010.04.005; Brinksmeier E, 2010, CIRP ANN-MANUF TECHN, V59, P652, DOI 10.1016/j.cirp.2010.05.001; Jiang X, 2007, CIRP ANN-MANUF TECHN, V56, P553, DOI 10.1016/j.cirp.2007.05.132; Chen FJ, 2010, INT J MACH TOOL MANU, V50, P480, DOI 10.1016/j.ijmachtools.2010.01.001; Fang FZ, 2013, CIRP ANN-MANUF TECHN, V62, P823, DOI 10.1016/j.cirp.2013.05.003; Brass M, 2010, HDB OPTICS, VIII; Chen WK, 2005, PRECIS ENG, V29, P315, DOI 10.1016/j.precisioneng.2004.11.002; Guo Yinbiao, 2004, Chinese Journal of Mechanical Engineering, V17, P149; Huang H, 2007, INT J MACH TOOL MANU, V47, P2237, DOI 10.1016/j.ijmachtools.2007.06.008; Hwang Y, 2006, INT J MACH TOOL MANU, V46, P1929, DOI 10.1016/j.ijmachtools.2006.01.030; Jiang C, 2013, INT J ADV MANUF TECH, V66, P537, DOI 10.1007/s00170-012-4347-1; Kuriyagawa T, 1996, J MATER PROCESS TECH, V62, P387, DOI 10.1016/S0924-0136(96)02440-5; Lin XH, 2014, INT J ADV MANUF TECH, V71, P233, DOI 10.1007/s00170-013-5430-y; Ohmori H, 1995, CIRP ANN-MANUF TECHN, V44, P287, DOI 10.1016/S0007-8506(07)62327-0; Sun X, 2006, PRECIS ENG, V30, P145, DOI 10.1016/j.precisioneng.2005.07.001; Syoji K, 2004, ULTRAPRECISION MACHI	16	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	SEP	2015	80	5-8					1411	1419		10.1007/s00170-015-7042-1		9	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	CQ6FW	WOS:000360700900056		
J	Shibata, N				Shibata, Nobuyuki			Subjective response of standing persons exposed to fore-aft, lateral and vertical whole-body vibration	INTERNATIONAL JOURNAL OF INDUSTRIAL ERGONOMICS			English	Article						Whole-body vibration; Discomfort; Standing posture; Seated posture; Psychophysics	DISCOMFORT	The aims of this study were to propose multiply scale factors for evaluation of discomfort of standing persons and to investigate whether there exist differences between multiplying factors used for evaluation of discomfort of standing persons and those of seated persons exposed to WBV. Twelve male subjects were exposed to twenty-seven stimuli that comprise three acceleration magnitudes (0.2, 0.4, and 0.8 m/s(2) r.m.s.) along fore-aft (x), lateral (y) or vertical (z) direction. The subjects with seated or standing posture on the platform of the vibration test rig rated the subjective discomfort for each stimulus that has frequency contents ranging from 1.0 Hz to 20 Hz with a constant power spectrum density. The order of presentation of the test stimuli was fully randomized and each stimulus was repeated three times. The subjective scale for discomfort was calculated by using the category judgment method. The best combinations of multiplying factors were determined by calculating correlation coefficients of regression curves in-between subjective ratings and vibration magnitudes. In all the directions, body posture significantly influenced on subjective discomfort scales. Particularly in the fore-aft and lateral direction, the upper limit of all the categories for the standing posture resulted in higher vibration acceleration magnitudes than those for the seated posture. In contrast, in the vertical direction, only the upper limit of category "1: Not uncomfortable" for standing posture was observed to be higher than that for seated posture. The best agreement for ISO-weighted vibration acceleration occurred at x factor of 1.8 and y factor of 1.8 in the standing posture and x factor of 2.8 and y factor of 1.8 in the seated posture. The results suggest that seated people respond more sensitively and severely in perception of discomfort to fore-aft and lateral vibration than standing people do while standing people respond more sensitively and severely to vertical vibration than seated people do. Thus the effects of body postures on multiplying factors should be considered in evaluation of discomfort caused by whole-body vibration. Relevance to industry: This study reports differences in subjective response of standing persons to foreaft, lateral and vertical whole-body vibration. The results obtained in this study propose the fundamental data on the sensitivity to whole-body vibration exposed with standing posture. (C) 2015 Elsevier B.V. All rights reserved.	Natl Inst Occupat Safety & Hlth, Human Engn & Risk Management Res Grp, Tama Ku, Kawasaki, Kanagawa 2148585, Japan	Shibata, N (reprint author), Natl Inst Occupat Safety & Hlth, Human Engn & Risk Management Res Grp, Tama Ku, 6-21-1 Nagao, Kawasaki, Kanagawa 2148585, Japan.	shibata@h.jniosh.go.jp			Japan Society for Promotion of Science (JSPS) [25420203]	This research has been partly funded by Grant-in-Aid for Scientific Research (C) (No. 25420203) of Japan Society for Promotion of Science (JSPS).	GRIFFIN MJ, 1977, J SOUND VIB, V54, P107, DOI 10.1016/0022-460X(77)90409-6; Thuong O, 2011, J SOUND VIB, V330, P816, DOI 10.1016/j.jsv.2010.08.040; MISTROT P, 1990, ERGONOMICS, V33, P1523, DOI 10.1080/00140139008925351; Gregory DE, 2008, GAIT POSTURE, V28, P86, DOI 10.1016/j.gaitpost.2007.10.005; Thuong O, 2012, APPL ERGON, V43, P902, DOI 10.1016/j.apergo.2011.12.011; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Atkinson RC, 1968, PSYCHOL LEARN MOTIV, V2, P89, DOI DOI 10.1016/S0079-7421(08)60422-3; Baker WDR, 2010, ERGONOMICS, V53, P365, DOI 10.1080/00140130903402242; Borg G., 1998, BORGS PERCEIVED EXER; Griffin M. J., 1990, HDB HUMAN VIBRATION; Guilford J. P., 1954, PSYCHOMETRIC METHODS; Hacaambwa TM, 2007, INT J IND ERGONOM, V37, P61, DOI 10.1016/j.ergon.2006.09.017; International Organization for Standardization, 1997, 26311 ISO; Kaneko C, 2005, IND HEALTH, V43, P221, DOI 10.2486/indhealth.43.221; Levitin A., 2006, INTRO DESIGN ANAL AL; Mansfield NJ, 2005, IND HEALTH, V43, P378, DOI 10.2486/indhealth.43.378; Mansfield NJ, 2011, J ACOUST SOC AM, V130, P3723, DOI 10.1121/1.3654014; Marjanen Y, 2010, IND HEALTH, V48, P519, DOI 10.2486/indhealth.MSWBVI-19; Matsumoto Y, 2000, J SOUND VIB, V238, P691, DOI 10.1006/jsvi.2000.3133; Shibata N, 2012, INT ARCH OCC ENV HEA, V85, P171, DOI 10.1007/s00420-011-0657-0	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-8141	1872-8219		INT J IND ERGONOM	Int. J. Ind. Ergon.	SEP	2015	49						116	123		10.1016/j.ergon.2015.01.012		8	Engineering, Industrial; Ergonomics	Engineering	CQ3OR	WOS:000360512500013		
J	Kumagai, M; Ogawa, S; Doe, A; Suzuki, K				Kumagai, Motoi; Ogawa, Shohei; Doe, Aya; Suzuki, Kenji			Cerebral oxygenation measured by near-infrared spectroscopy and jugular vein oxygen saturation during robotic-assisted laparoscopic radical prostatectomy under total intravenous anaesthesia	INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY			English	Article						jugular venous oxygen saturation (SjvO(2)); regional cerebral tissue oxygen saturation (rSO(2)); Trendelenburg position; pneumoperitoneum	STEEP TRENDELENBURG POSITION; BEACH CHAIR POSITION; HEMOGLOBIN CONCENTRATION; CO2 PNEUMOPERITONEUM; SHOULDER SURGERY; CARBON-DIOXIDE; NITROUS-OXIDE; BLOOD-VOLUME; SEVOFLURANE; PROPOFOL	BackgroundThe effects of total intravenous anaesthesia (TIVA) on cerebral oxygenation in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP) have not been investigated. We examined the changes in jugular venous oxygen saturation (SjvO(2)) and regional cerebral tissue oxygen saturation (rSO(2)) during RALP under TIVA. Whether rSO(2) could reflect SjvO(2) was also examined. MethodsForty patients (ASA 1-2) undergoing RALP were enrolled. Measurements were obtained at eight time points during the operation. ResultsSjvO(2) did not decrease at any measurement point, whereas rSO(2) fell significantly 120min after pneumoperitoneum in a steep Trendelenburg position (p <0.01). There was a weak correlation between SjvO(2) and rSO(2) (Pearson correlation coefficient =0.34; p <0.01). Bland-Altman analysis showed a wide interval for the limit of agreement (47%) between the two measurements. ConclusionsThese findings suggested that TIVA could be safely used for RALP. It was also demonstrated that rSO(2) did not accurately reflect SjvO(2) during RALP. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kumagai, Motoi; Ogawa, Shohei; Doe, Aya; Suzuki, Kenji] Iwate Med Univ, Sch Med, Dept Anaesthesiol, Morioka, Iwate 020, Japan	Kumagai, M (reprint author), Iwate Med Univ, Sch Med, Dept Anaesthesiol, Morioka, Iwate 020, Japan.	bear@kxd.biglobe.ne.jp					Park EY, 2009, ACTA ANAESTH SCAND, V53, P895, DOI 10.1111/j.1399-6576.2009.01991.x; Kalmar AF, 2010, BRIT J ANAESTH, V104, P433, DOI 10.1093/bja/aeq018; Falabella A, 2007, INT J MED ROBOT COMP, V3, P312, DOI 10.1002/rcs.165; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Choi SH, 2013, YONSEI MED J, V54, P225, DOI 10.3349/ymj.2013.54.1.225; Pollard V, 1996, ANESTH ANALG, V82, P278, DOI 10.1097/00000539-199602000-00011; Lestar M, 2011, ANESTH ANALG, V113, P1069, DOI 10.1213/ANE.0b013e3182075d1f; Yoshitani K, 2007, ANESTHESIOLOGY, V106, P458, DOI 10.1097/00000542-200703000-00009; Gainsburg DM, 2012, MINERVA ANESTESIOL, V78, P596; Jeong H, 2012, ANESTHESIOLOGY, V116, P1047, DOI 10.1097/ALN.0b013e31825154d2; ARTRU AA, 1983, ANESTHESIOLOGY, V58, P533, DOI 10.1097/00000542-198306000-00010; Danic MJ, 2007, J ROBOTIC SURG, V1, P119, DOI 10.1007/s11701-007-0024-z; Dunham CM, 2002, J TRAUMA, V52, P225; Fischer GW, 2009, PAIN PRACT, V9, P304, DOI 10.1111/j.1533-2500.2009.00282.x; Gasatis A, 2006, MINERVA ANESTHESIOL, V72, P605; Halversons A, 1988, SURG ENDOSC, V12, P266; Hasss S, 2011, INT J MED ROBOT, V7, P408; Herregods L, 1988, Anaesthesia, V43 Suppl, P107, DOI 10.1111/j.1365-2044.1988.tb09089.x; Koivusalo AM, 2000, ACTA ANAESTH SCAND, V44, P834, DOI 10.1034/j.1399-6576.2000.440709.x; Mavrocordatos P, 2000, J NEUROSURG ANESTH, V12, P10, DOI 10.1097/00008506-200001000-00003; Moon Hyun Soo, 2011, Korean J Anesthesiol, V61, P388, DOI 10.4097/kjae.2011.61.5.388; Murthy G, 1992, Physiologist, V35, pS184; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; Schramm P, 2014, ANAESTHESIA, V69, P58, DOI 10.1111/anae.12477; Struthers AD, 1998, LANCET, V352, P568, DOI 10.1016/S0140-6736(97)11478-7; Walsh Patrick C, 2003, J Urol, V170, P318; Watanabe Masanori, 2009, Masui, V58, P1232; Yoshitani K, 2005, BRIT J ANAESTH, V94, P341, DOI 10.1093/bja/aei046	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-5951	1478-596X		INT J MED ROBOT COMP	Int. J. Med. Robot. Comput. Assist. Surg.	SEP	2015	11	3					302	307		10.1002/rcs.1629		6	Surgery	Surgery	CQ8FT	WOS:000360842600006		
J	Tadano, K; Kawashima, K				Tadano, Kotaro; Kawashima, Kenji			A pneumatic laparoscope holder controlled by head movement	INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY			English	Article						laparoscopic surgery; camera holder; penumatically-driven robotic arm; control by head movement	MINIMALLY INVASIVE SURGERY; SYSTEM	BackgroundIn traditional laparoscopic surgery, the laparoscope is handled by a camera assistant according to verbal instructions from the surgeon. Thus there is a strong need for a laparoscope holder who intuitively provides the appropriate view with excellent stability. MethodsA pneumatically driven robotic arm was developed to hold and manipulate a laparoscope. The robotic arm is operated by the user's head movement, which is measured with gyroscopes attached to the operator's head and body. ResultsWe confirmed experimentally that head tracking can be performed accurately using the proposed method. The experimental results indicated that the robotic camera holder has sufficient dynamic characteristics to quickly follow the operator's head movement. ConclusionsA laparoscope holder control system has been developed. In this system, a laparoscope is held by a pneumatically driven robotic arm that is controlled to follow the operator's head movement. The experimental results prove the effectiveness of the system. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tadano, Kotaro; Kawashima, Kenji] Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tadano, K (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	tadano@pi.titech.ac.jp			Program for Creating Start-ups from Advanced Research and Technology by Ministry of Education, Culture, Sports, Science and Technology in Japan	This project was supported by the Program for Creating Start-ups from Advanced Research and Technology by the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Tadano K, 2010, ADV ROBOTICS, V24, P1763, DOI 10.1163/016918610X522559; Taylor RH, 2003, IEEE T ROBOTIC AUTOM, V19, P765, DOI 10.1109/TRA.2003.817058; Yavuz Y, 2000, SURG LAPARO ENDO PER, V10, P163; Hermans B, 2012, P 9 NAT C THEOR APPL; Herman B, 2009, INT J MED ROBOT COMP, V5, P319, DOI 10.1002/rcs.263; Kihara K, 2012, INT J UROL, V19, P886, DOI 10.1111/j.1442-2042.2012.03044.x; Kommu Sashi S, 2007, Journal of Robotic Surgery, V1, DOI 10.1007/s11701-007-0010-5; Long JA, 2007, J ENDOUROL, V21, P911, DOI 10.1089/end.2006.0328; Nebots P, 2003, ENDOSC PERCUTAN TECH, V13, P334; Ranes A, 2008, J ENDOUROL, V22, P129; SACKIER JM, 1994, SURG ENDOSC-ULTRAS, V8, P63, DOI 10.1007/BF02909496; Tadano K, 2010, J ROBOTICS MECHATRON, V22, P179; Tanoue K, 2006, SURG ENDOSC, V20, P753, DOI 10.1007/s00464-005-0177-7	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-5951	1478-596X		INT J MED ROBOT COMP	Int. J. Med. Robot. Comput. Assist. Surg.	SEP	2015	11	3					331	340		10.1002/rcs.1606		10	Surgery	Surgery	CQ8FT	WOS:000360842600009		
J	Mazel, J; Casas, P; Fontugne, R; Fukuda, K; Owezarski, P				Mazel, Johan; Casas, Pedro; Fontugne, Romain; Fukuda, Kensuke; Owezarski, Philippe			Hunting attacks in the dark: clustering and correlation analysis for unsupervised anomaly detection	INTERNATIONAL JOURNAL OF NETWORK MANAGEMENT			English	Article						unsupervised anomaly detection & characterization; clustering; outliers detection; anomaly correlation; filtering rules; MAWILab	TRAFFIC ANOMALIES; BACKBONE NETWORKS	Network anomalies and attacks represent a serious challenge to ISPs, who need to cope with an increasing number of unknown events that put their networks' integrity at risk. Most of the network anomaly detection systems proposed so far employ a supervised strategy to accomplish their task, using either signature-based detection methods or supervised-learning techniques. The former fails to detect unknown anomalies, exposing the network to severe consequences; the latter requires labeled traffic, which is difficult and expensive to produce. In this paper, we introduce a powerful unsupervised approach to detect and characterize network anomalies in the dark, that is, without relying on signatures or labeled traffic. Unsupervised detection is accomplished by means of robust clustering techniques, combining subspace clustering with correlation analysis to blindly identify anomalies. To alleviate network operator's post-processing tasks and to speed up the deployment of effective countermeasures, anomaly ranking and characterization are automatically performed on the detected events. The system is extensively tested with real traffic from the Widely Integrated Distributed Environment backbone network, spanning 6years of flows captured from a trans-Pacific link between Japan and the USA, using the MAWILab framework for ground-truth generation. We additionally evaluate the proposed approach with synthetic data, consisting of traffic from an operational network with synthetic attacks. Finally, we compare the performance of the unsupervised detection against different previously used unsupervised detection techniques, as well as against multiple anomaly detectors used in MAWILab. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Mazel, Johan; Fontugne, Romain; Fukuda, Kensuke] NII, Tokyo, Japan; [Casas, Pedro] Telecommun Res Ctr Vienna FTW, Vienna, Austria; [Owezarski, Philippe] CNRS, LAAS, F-31077 Toulouse 4, France; [Owezarski, Philippe] Univ Toulouse, UPS, INSA, ISAE,UTI,UTM,LAAS,INP, F-31077 Toulouse 4, France	Casas, P (reprint author), Telecommun Res Ctr Vienna, Donau City Str 1, A-1220 Vienna, Austria.	casas@ftw.at			European Commission [FP7-ICT-2007-2/223936]; Strategic International Collaborative R&D Promotion Project of the Ministry of Internal Affairs and Communication, Japan; European Union [608533]	This work has been carried out in the framework of the ECODE project, funded by the European Commission under grant FP7-ICT-2007-2/223936. The work has been supported by the Strategic International Collaborative R&D Promotion Project of the Ministry of Internal Affairs and Communication, Japan, and by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 608533 (NECOMA).	Agrawal R., 1998, SIGMOD Record, V27; Allman M, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P77; Lakhina A, 2004, ACM SIGCOMM COMP COM, V34, P219, DOI 10.1145/1030194.1015492; Dean J, 2008, COMMUN ACM, V51, P107, DOI 10.1145/1327452.1327492; [Anonymous], 2007, METROLOGY SECURITY Q; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Marnerides AK, 2014, COMPUT NETW, V73, P224, DOI 10.1016/j.comnet.2014.08.007; Mirkovic J, 2004, ACM SIGCOMM COMP COM, V34, P39, DOI 10.1145/997150.997156; Moise G, 2009, KNOWL INF SYST, V21, P299, DOI 10.1007/s10115-009-0226-y; Shon T, 2007, INFORM SCIENCES, V177, P3799, DOI 10.1016/j.ins.2007.03.025; Tellenbach B, 2011, COMPUT NETW, V55, P3485, DOI 10.1016/j.comnet.2011.07.008; Fred ALN, 2005, IEEE T PATTERN ANAL, V27, P835, DOI 10.1109/TPAMI.2005.113; Lakhina A, 2005, ACM SIGCOMM COMP COM, V35, P217, DOI 10.1145/1090191.1080118; Barford P., 2002, Proceedings of the Second Internet Measurement Workshop. IMW 2002; Barnett RJ, 2008, P 2008 ANN RES C S A, P1, DOI 10.1145/1456659.1456660; Bhuyan MH, 2014, COMPUT INFORM, V33, P1; Borgnat P, 2009, IEEE INFOCOM SER, P711, DOI 10.1109/INFCOM.2009.5061979; Brauckhoff D, 2012, IEEE ACM T NETWORK, V20, P1788, DOI 10.1109/TNET.2012.2187306; Brownlee N, 2012, LNCS, V7192, P179; Brutlag J. D., 2000, Proceedings of the Fourteenth Systems Administration Conference (LISA XIV); Casas P, 2011, P 4 IFIP INT C NEW T; Chandola V, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541882; Cho K., 2000, P ANN C USENIX ANN T, P51; Coluccia A, 2013, COMPUT NETW, V57, P3446, DOI 10.1016/j.comnet.2013.07.028; Dewaele G, 2007, P 2007 WORKSH LARG S, P145, DOI 10.1145/1352664.1352675; Duffield N, 2009, IEEE INFOCOM SER, P424, DOI 10.1109/INFCOM.2009.5061947; Eskin E., 2002, ADV INFORM SECURITY, V6, P77; Ester M, 1996, KDD, V96, P226; Fernandes G, 2009, L N INST COMP SCI SO, V19, P91; Fiadino P, 2014, 2014 6 INT TEL C ITC, P1; Fontugne R, 2010, P 6 INT C CONEXT 201; Fontugne R, 2015, P 40 IEEE INT C AC S; Fontugne R., 2011, ACM APPL COMPUTING R, V11, P41; Gamer T, 2012, COMPUT NETW, V56, P169, DOI 10.1016/j.comnet.2011.08.015; Glatz E, 2012, P INT MEAS C, P37; Kanda Y, 2013, COMPUT COMMUN, V36, P575, DOI 10.1016/j.comcom.2012.12.002; Krishnamurthy B., 2003, P 3 ACM SIGCOMM C IN, P234; Leung K., 2005, P 28 AUSTR C COMP SC, V38, P333; Mazel J, 2011, P 7 INT C NETW SERV, P1; Muller E., 2009, PVLDB, V2, P1270; Cormode G, 2005, IEEE ACM T NETWORK, V13, P1219, DOI 10.1109/TNET.2005.860096; Novakov Stevan, 2014, International Journal of Mobile Computing and Multimedia Communications, V6, DOI 10.4018/ijmcmc.2014010102; Parsons L., 2004, ACM SIGKDD EXPLORATI, V6, P90, DOI DOI 10.1145/1007730.1007731; Plonka D, 2009, 2009 47TH ANNUAL ALLERTON CONFERENCE ON COMMUNICATION, CONTROL, AND COMPUTING, VOLS 1 AND 2, P128, DOI 10.1109/ALLERTON.2009.5394858; Portnoy Leonid, 2001, P ACM CSS WORKSH DAT; Silveira F, 2010, P IEEE INFOCOM, P1; Silveira F, 2010, ACM SIGCOMM COMP COM, V40, P267, DOI 10.1145/1851275.1851215; Soule A, 2005, P INT MEAS C, P331; Strehl A., 2002, J MACHINE LEARNING R, V3, P583, DOI DOI 10.1162/153244303321897735; Xu K, 2008, IEEE ACM T NETWORK, V16, P1241, DOI 10.1109/TNET.2007.911438; Zhang Y., 2013, P 9 ACM C EM NETW EX, P25, DOI 10.1145/2535372.2535411	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1055-7148	1099-1190		INT J NETW MANAG	Int. J. Netw. Manag.	SEP-OCT	2015	25	5			SI		283	305		10.1002/nem.1903		23	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CQ8FO	WOS:000360842100003		
J	Ryu, H; Chung, WK				Ryu, Hyejeong; Chung, Wan Kyun			Local map-based exploration using a breadth-first search algorithm for mobile robots	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Exploration; Localization; Mapping; Mobile robot; Scan-matching	SLAM; ENVIRONMENTS	This paper describes a local map-based exploration strategy. Segmented frontiers and relative transformations constitute a tree structure. This frontier tree structure, which manages multiple local maps, effectively overcomes the limitations of conventional exploration methods, which maintain only a single global map. Although this method uses only local maps and adjacent node information, mapping completion and efficiency can be improved greatly by merging and updating the frontier nodes. In addition, a modified breadth-first search (BFS) algorithm is used to determine the next exploration target. BFS exploration is appropriate for large environments because it induces a loop-closing event from the root node, which is necessary to recover the estimation accuracy when the uncertainty of the robot's pose has become large. The proposed local map-based BFS exploration can construct an accurate map, even in large environments.	[Ryu, Hyejeong] Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi, Ishikawa 9231211, Japan; [Ryu, Hyejeong; Chung, Wan Kyun] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang 790784, Gyeongsangbuk D, South Korea	Ryu, H (reprint author), Japan Adv Inst Sci & Technol, Sch Informat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231211, Japan.	roohj@postech.ac.kr			Engineering Research Center [2011-0030075]; Industrial Source Technology Development Program [10043928]	This work was supported in part by the Engineering Research Center (no. 2011-0030075) and the Industrial Source Technology Development Programs (no. 10043928).	Ahn SH, 2008, AUTON ROBOT, V24, P315, DOI 10.1007/s10514-007-9083-2; Al khawaldah M., 2015, ADV ROBOTICS, P1; Pinies P, 2008, IEEE T ROBOT, V24, P1094, DOI 10.1109/TRO.2008.2004636; Yamauchi B, 1997, 1997 IEEE INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN ROBOTICS AND AUTOMATION - CIRA '97, PROCEEDINGS, P146; Cole DM, 2006, IEEE INT CONF ROBOT, P1556; Lu F, 1997, J INTELL ROBOT SYST, V18, P249, DOI 10.1023/A:1007957421070; Marinakis D, 2010, IEEE T ROBOT, V26, P1051, DOI 10.1109/TRO.2010.2081410; Estrada C, 2005, IEEE T ROBOT, V21, P588, DOI 10.1109/TRO.2005.844673; Carpin S, 2008, AUTON ROBOT, V25, P305, DOI 10.1007/s10514-008-9097-4; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Blanco JL, 2007, IEEE INT CONF ROBOT, P2061, DOI 10.1109/ROBOT.2007.363625; Blum A, 1997, SIAM J COMPUT, V26, P110, DOI 10.1137/S0097539791194931; Cabrera-Mora F, 2012, IEEE T SYST MAN CY B, V42, P850, DOI 10.1109/TSMCB.2011.2179799; Choi KS, 2010, INT J PRECIS ENG MAN, V11, P255, DOI 10.1007/s12541-010-0029-9; Deng XT, 1998, J ACM, V45, P215, DOI 10.1145/274787.274788; DUDEK G, 1991, IEEE T ROBOTIC AUTOM, V7, P859, DOI 10.1109/70.105395; Keidar M, 2014, INT J ROBOT RES, V33, P215, DOI 10.1177/0278364913494911; Lester P., PATHFINDING BEGINNER; Makarenko A., 2002, IEEE RSJ INT C INT R, V1, P534, DOI 10.1109/IRDS.2002.1041445; Martinez JL, 2006, J FIELD ROBOT, V23, P21, DOI 10.1002/rob.20104; Moravec H., 1985, ROB AUT P 1985 IEEE, V2, P116; Panaite P., 1998, P 9 ANN ACM SIAM S D, P316; Ryu H, 2015, ELECTRON LETT, V51, P686, DOI 10.1049/el.2014.4034; Ryu H, 2013, INTEL SERV ROBOT, V6, P199, DOI 10.1007/s11370-013-0137-3; Sim R., 2005, P IEEE INT C ROB AUT, P661, DOI 10.1109/ROBOT.2005.1570193; Stachniss C., 2005, P ROBOTICS SCI SYSTE, V2, P65; Valencia R, 2013, IEEE T ROBOT, V29, P1050, DOI 10.1109/TRO.2013.2257577; Vallve J, 2015, ROBOT AUTON SYST, V69, P68, DOI 10.1016/j.robot.2014.08.009; Yaakov B.-S., 2001, ESTIMATION APPL TRAC, P404	29	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	SEP	2015	16	10					2073	2080		10.1007/s12541-015-0269-9		8	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CQ4JL	WOS:000360570800003		
J	Li, X; Li, N; Tao, GL; Liu, H; Kagawa, T				Li, Xin; Li, Ning; Tao, Guoliang; Liu, Hao; Kagawa, Toshiharu			Experimental comparison of Bernoulli gripper and vortex gripper	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Bernoulli gripper; Vortex gripper; Experimental comparison; Suction; Pressure distribution; Stress		A Bernoulli gripper and a vortex gripper are types of pneumatic grippers that have similar functions but different working principles. They are widely used for performing gripping, transferring, and placing operations in automated production lines. This study systematically compares the two grippers and provides an objective reference to enable users to choose an appropriate gripper. First, we present the working principles of both grippers. Then, we measure the curves of suction force, air consumption, and upstream pressure; furthermore, we analyze and compare the energy consumption from the viewpoint of the entire pneumatic system. The results reveal the relationships with the air consumption and total energy consumption. Next, we measure the pressure distribution formed on the upper surface of the workpiece. From the experimental results, the principles of the two grippers are stated and compared. Furthermore, we use the pressure distribution data to estimate the deformation and inner stress of the workpiece. The influence of the grippers on the workpiece are analyzed and compared from a material mechanics viewpoint. Finally, we use three types of rough surfaces to qualitatively evaluate and compare the performance of the grippers when gripping a workpiece with a rough surface.	[Li, Xin; Li, Ning; Tao, Guoliang; Liu, Hao] Zhejiang Univ, State Key Lab Fluid Power Transmiss & Control, Hangzhou 310027, Zhejiang, Peoples R China; [Kagawa, Toshiharu] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan	Li, X (reprint author), Zhejiang Univ, State Key Lab Fluid Power Transmiss & Control, 38 Zheda Rd, Hangzhou 310027, Zhejiang, Peoples R China.	vortexdoctor@zju.edu.cn	Li, Xin/E-7846-2012		National Natural Science Foundation of China [51375441]; Science Fund for Creative Research Groups of National Natural Science Foundation of China [51221004]	This work is supported by the National Natural Science Foundation of China (No. 51375441) and the Science Fund for Creative Research Groups of National Natural Science Foundation of China (No. 51221004).	Li X, 2011, J ENG MECH-ASCE, V137, P400, DOI 10.1061/(ASCE)EM.1943-7889.0000237; Brun XF, 2009, SOL ENERG MAT SOL C, V93, P1238, DOI 10.1016/j.solmat.2009.01.016; Li X, 2008, EXP THERM FLUID SCI, V32, P1448, DOI 10.1016/j.expthermflusci.2008.03.010; Brun XF, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.3139222; Davis S, 2008, ROBOT CIM-INT MANUF, V24, P249, DOI 10.1016/j.rcim.2006.11.002; Dini G, 2009, CIRP ANN-MANUF TECHN, V58, P21, DOI 10.1016/j.cirp.2009.03.076; Isobe H, 2007, INT J PRECIS ENG MAN, V8, P44; Li X, 2014, J ENG MECH, V140, DOI 10.1061/(ASCE)EM.1943-7889.0000774; Lundstrom G., 1974, IND ROBOT, V1, P72, DOI 10.1108/eb004449; Mantriota G, 2007, MECH MACH THEORY, V42, P2, DOI 10.1016/j.mechmachtheory.2006.03.003; Xin L., 2014, IEEE T AUTOM SCI ENG, DOI [10.1109/TASE.2014.2361251, DOI 10.1109/TASE.2014.2361251]	11	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	SEP	2015	16	10					2081	2090		10.1007/s12541-015-0270-3		10	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CQ4JL	WOS:000360570800004		
J	Lee, SJ; Takahashi, M; Kawahito, Y; Katayama, S				Lee, Su-Jin; Takahashi, Makoto; Kawahito, Yousuke; Katayama, Seiji			Microstructural evolution and characteristics of weld fusion zone in high speed dissimilar welding of Ti and Al	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Ti; Al; Dissimilar welding; Single mode fiber laser; Intermetallic compound; TEM analysis	ALLOYS; METALS; LASER	The joining or welding of dissimilar metals is one of the effective measures to reduce structures weight of the production or to save rare metals and to save a manufacturing cost. In the weld fusion zone of Ti and Al, intermetallic compounds such as Ti3Al, TiAl, TiAl2 and TiAl3 are easily formed, and especially, brittle TiAl2 and TiAl3 makes such dissimilar metals joining very difficult. However, it was clarified that an ultra-high speed welding could suppress the formation of intermetallic compounds in the previous study.(1) Full penetration dissimilar lap welding of Ti and Al with single-mode fiber laser was tried at ultra-high welding speed in this study, and the microstructure of the welded zone, interface zone and base metals in the dissimilar Al and Ti weld bead was investigated. To confirm the formation of intermetallic compounds in the weld fusion zone, welded interface areas were observed and analyzed using scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX) and micro-probe X-ray diffractometer (XRD). Especially microstructural phases of Ti and Al dissimilar welds were confirmed using transmission electron microscopy (TEM) with EDX. It was consequently found that Ti3Al intermetallic compound phase existed in all the weld fusion zones produced under any conditions, but the formation areas of such intermetallic compounds could be reduced by the ultra-high welding speed of 50 m/min.	[Lee, Su-Jin] Korea Inst Machinery & Mat, Busan Laser Applicat Support Ctr, Busan 618230, South Korea; [Lee, Su-Jin; Takahashi, Makoto; Kawahito, Yousuke; Katayama, Seiji] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Lee, SJ (reprint author), Korea Inst Machinery & Mat, Busan Laser Applicat Support Ctr, 30,Gwahaksandan 1-Ro 60beon Gil, Busan 618230, South Korea.	mpmmu47@gmail.com					Meshram SD, 2007, J MATER PROCESS TECH, V184, P330, DOI 10.1016/j.jmatprotec.2006.11.123; Chen SH, 2011, J ALLOY COMPD, V509, P891, DOI 10.1016/j.jallcom.2010.09.125; Chen YC, 2009, MATER DESIGN, V30, P469, DOI 10.1016/j.matdes.2008.06.008; Katayama S., 2009, J JPN WELD SOC, V78, P124; Katayama S., 2009, J JPN WELD SOC, V78, P682; Lee SJ, 2013, J LASER MICRO NANOEN, V8, P149, DOI 10.2961/jlmn.2013.02.0006; Lee S.-J., 2014, J KOREAN SOC MARINE, V38, P133; Leyens C., 2015, TITANIUM TITANIUM AL; Shamoto H., 2009, P 72 LAS MAT PROC C, P31	9	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	SEP	2015	16	10					2121	2127		10.1007/s12541-015-0274-z		7	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CQ4JL	WOS:000360570800008		
J	Takakura, M				Takakura, Minoru			Relations of participation in organized activities to smoking and drinking among Japanese youth: contextual effects of structural social capital in high school	INTERNATIONAL JOURNAL OF PUBLIC HEALTH			English	Article						Social capital; Social participation; Multilevel modelling; High school; Japan	CROSS-SECTIONAL SURVEYS; MULTILEVEL ANALYSIS; YOUNG-PEOPLE; ADOLESCENT ALCOHOL; HEALTH EVIDENCE; DRUG-USE; PREVALENCE; ASSOCIATION; BEHAVIORS; DECREASE	This cross-sectional study examined the effect of school-level structural social capital on smoking and drinking among Japanese youth. Self-administered anonymous questionnaires were distributed to 3248 students at 29 high schools across Okinawa, Japan in 2008. Structural social capital was measured by students' participation in organized activities: student council, extracurricular activities, volunteer activities, community sports clubs, and youth associations. Contextual-level social capital was measured by aggregated school-level individual responses. At the individual level, extracurricular activity participation was negatively associated with smoking and drinking, whereas participation in youth associations was positively associated with smoking and drinking. School-level extracurricular activity participation was negatively associated with smoking among boys, whereas school-level participation in youth associations was positively associated with smoking among boys and girls and drinking among boys. This study suggests that structural social capital measured by participation in organized activities, especially extracurricular activities, might be an important way for youths to attain good health. This study also supports the idea that particular type of activities, such as youth associations, can lead to the so-called "dark side of social capital".	Univ Ryukyus, Sch Hlth Sci, Okinawa, Japan	Takakura, M (reprint author), Univ Ryukyus, Sch Hlth Sci, Okinawa, Japan.	minoru@med.u-ryukyu.ac.jp			KAKENHI from the Japan Society for the Promotion of Science (JSPS) [19500579, 23300246]; Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The author would like to thank all students and teachers who agreed to participate in this study. This study was supported by Grants-in-Aid for Scientific Research (KAKENHI Grant Number 19500579 and 23300246) from the Japan Society for the Promotion of Science (JSPS) and the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Snelgrove JW, 2009, SOC SCI MED, V68, P1993, DOI 10.1016/j.socscimed.2009.03.011; Denault AS, 2009, J YOUTH ADOLESCENCE, V38, P1199, DOI 10.1007/s10964-009-9437-5; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Moilanen KL, 2014, J YOUTH ADOLESCENCE, V43, P454, DOI 10.1007/s10964-013-0088-1; Sellstrom E, 2006, J EPIDEMIOL COMMUN H, V60, P149, DOI 10.1136/jech.2005.036707; Mahoney JL, 2000, J ADOLESCENCE, V23, P113, DOI 10.1006/jado.2000.0302; Chen CY, 2014, PREV MED, V62, P148, DOI 10.1016/j.ypmed.2013.11.003; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Zambon A, 2010, J EPIDEMIOL COMMUN H, V64, P89, DOI 10.1136/jech.2009.088443; De Clercq B, 2012, SOC SCI MED, V74, P202, DOI 10.1016/j.socscimed.2011.10.025; Murayama H, 2012, SOC SCI MED, V75, P2472, DOI 10.1016/j.socscimed.2012.09.027; Takakura M, 2011, SOC SCI MED, V72, P299, DOI 10.1016/j.socscimed.2010.11.003; Pavlova MK, 2014, SOC INDIC RES, V117, P29, DOI 10.1007/s11205-013-0332-9; Johansen A, 2006, SCAND J PUBLIC HEALT, V34, P32, DOI 10.1080/14034940510032158; Morrow V, 1999, SOCIOL REV, V47, P744, DOI 10.1111/1467-954X.00194; Bohnert AM, 2007, J ABNORM CHILD PSYCH, V35, P1021, DOI 10.1007/s10802-007-9152-1; Centers for Disease Control and Prevention (CDC), 2011, 2011 YOUTH RISK BEH; Diez R., 2002, J EPIDEMIOL COMMUNIT, V56, P588, DOI DOI 10.1136/JECH.56.8.588; Engstrom K, 2008, SOC SCI MED, V66, P2268, DOI [10.1016/j.socscimed.2008.01.019, DOI 10.1016/J.SOCSCIMED.2008.01.019]; Harpham T, 2008, SOCIAL CAPITAL HLTH, P51; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, P174; Kawachi I, 2008, SOCIAL CAPITAL HLTH, P1, DOI 10.1007/978-0-387-71311-3_1; Kim D., 2008, SOCIAL CAPITAL HLTH, P139, DOI 10.1007/978-0-387-71311-3_8; Lindstrom M., 2008, SOCIAL CAPITAL HLTH, P215, DOI DOI 10.1007/978-0-387-71311-3_10; McPherson KE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-971; Aslund C, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-33; Nyqvist F, 2013, SOCIAL INDICATORS RE, V116, P545, DOI DOI 10.1007/S11205-013-0288-9; OECD, 2008, EDUCATION AT A GLANC; Okinawa Prefectural Educational Board, 2008, OK PREF SCH BAS SURV; Osaki Y, 2009, ALCOHOL CLIN EXP RES, V33, P247, DOI 10.1111/j.1530-0277.2008.00822.x; Osaki Yoneatsu, 2008, Environmental Health and Preventive Medicine, V13, P219, DOI 10.1007/s12199-008-0033-1; Putnam RD, 1993, MAKING DEMOCRACY WOR; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Takakura M, 2014, JPN J SCH HLTH, V56, P347; Takakura M, 2003, RYUKYU MED J, V22, P95; Thorlindsson T, 2012, HEALTH PLACE, V18, P796, DOI 10.1016/j.healthplace.2012.03.013; Wada K, 1998, J STUD ALCOHOL, V59, P381; West P, 2004, RES PAPERS ED, V19, P261, DOI DOI 10.1080/0267152042000247972; Winstanley EL, 2008, DRUG ALCOHOL DEPEN, V92, P173, DOI 10.1016/j.drugalcdep.2007.07.012	40	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1661-8556	1661-8564		INT J PUBLIC HEALTH	Int. J. Public Health	SEP	2015	60	6					679	689		10.1007/s00038-015-0697-4		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CQ6HW	WOS:000360706300008		
J	Zhang, H; Chen, GQ; Zheng, L; Han, Z; Zhang, YB; Wu, YQ; Liu, SG				Zhang, Hong; Chen, Guangqi; Zheng, Lu; Han, Zheng; Zhang, Yingbin; Wu, YanQiang; Liu, Shuguang			Detection of contacts between three-dimensional polyhedral blocks for discontinuous deformation analysis	INTERNATIONAL JOURNAL OF ROCK MECHANICS AND MINING SCIENCES			English	Article						3-D DDA; Contact detection; Neighbor search; Contact type examination; Entrance candidate identification; Arbitrarily shaped polyhedral block	DISCRETE ELEMENT METHOD; ANALYSIS DDA METHOD; TO-FACE CONTACT; ROCK MASSES; DETECTION ALGORITHM; ANALYSIS FRAMEWORK; FLUID-FLOW; 3-D DDA; MODEL; STABILITY	A new algorithm to detect contacts between three-dimensional (3-D) arbitrarily shaped polyhedral blocks for the discontinuous deformation analysis (DDA) method is presented in this paper. The new algorithm includes three main steps, i.e. neighbor search, contact type examination, and entrance candidate identification, all of which are performed using the general features and relations of geometric elements of polyhedra. First, contact detection begins with searching neighbor blocks and vertices potential to be in contact in order to improve the computation efficiency. Then, pairs of neighbor blocks are examined in more detail for four basic contact types. Finally, corresponding contact points and planes for each contact type are identified by general entrance formulas, which is prepared for the subsequent contact force calculations in the program. The new algorithm has been implemented in the original 3-D DDA program and the extended 3-D DDA program can display the results using OpenGL. Three typical contact examples including concave blocks, i.e. vertex-to-concave-edge, convex-edge-to-concave-edge and vertex-to-concave-vertex contacts are provided to verify the new algorithm. Additionally, a practical example in rock engineering, sliding of a tetrahedral wedge, is also presented, and the 3-DDA results are compared with the analytical solutions. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhang, Hong; Chen, Guangqi; Han, Zheng] Kyushu Univ, Dept Civil & Struct Engn, Fukuoka 8190395, Japan; [Zhang, Hong; Liu, Shuguang] Tongji Univ, Coll Civil Engn, Dept Hydraul Engn, Shanghai 200092, Peoples R China; [Zheng, Lu] Sichuan Univ, Sichuan Univ Hong Kong Polytech Univ Inst Disaste, Chengdu 610207, Peoples R China; [Han, Zheng] Cent S Univ, Sch Civil Engn, Changsha 410075, Hunan, Peoples R China; [Zhang, Yingbin] Southwest Jiaotong Univ, Minist Educ, Key Lab Transportat Tunnel Engn, Chengdu 610031, Peoples R China; [Zhang, Yingbin] Southwest Jiaotong Univ, Sch Civil Engn, Dept Geotech Engn, Chengdu 610031, Peoples R China; [Wu, YanQiang] CEA, Crust Deformat Monitoring & Applicat Ctr 1, Tianjin 300180, Peoples R China	Zheng, L (reprint author), Sichuan Univ, Sichuan Univ Hong Kong Polytech Univ Inst Disaste, Chengdu 610207, Peoples R China.	zhenglu@scu.edu.cn			National Science & Technology Pillar Program of the Ministry of Science and Technology of China [2014BAL05801]; Japan Society for the Promotion of Science [15K12483]; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development	The authors thank Genhua Shi for his great contribution to DDA development and his diligent work on DDA programming. The program used in this study is extended from his latest version of the original code, 3-D DDA 2008. This study has received financial support from the project supported by National Science & Technology Pillar Program of the Ministry of Science and Technology of China (Grant no. 2014BAL05801). Also, this work was supported by Grant-in-Aid for challenging Exploratory Research (Grant no. 15K12483, G. Chen) from Japan Society for the Promotion of Science and Kyushu University Interdisciplinary Programs in Education and Projects in Research Development. These financial supports are gratefully acknowledged.	Ning YJ, 2011, ROCK MECH ROCK ENG, V44, P483, DOI 10.1007/s00603-010-0132-3; Nezami EG, 2004, COMPUT GEOTECH, V31, P575, DOI 10.1016/j.compgeo.2004.08.002; Beyabanaki SAR, 2008, COMPUT GEOTECH, V35, P346, DOI 10.1016/j.compgeo.2007.08.006; Ahn TY, 2011, INT J COMP METH-SING, V8, P171, DOI 10.1142/S0219876211002538; Zhang YB, 2014, INT J ROCK MECH MIN, V70, P533, DOI 10.1016/j.ijrmms.2014.06.005; Sitar N, 2005, J GEOTECH GEOENVIRON, V131, P716, DOI 10.1061/(ASCE)1090-0241(2005)131:6(716); Zhang YH, 2014, TUNN UNDERGR SP TECH, V40, P241, DOI 10.1016/j.tust.2013.10.012; Wu JH, 2007, INT J NUMER ANAL MET, V31, P649, DOI 10.1002/nag.548; Ning YJ, 2011, COMPUT GEOTECH, V38, P40, DOI 10.1016/j.compgeo.2010.09.003; Bakun-Mazor D, 2009, INT J ROCK MECH MIN, V46, P262, DOI 10.1016/j.ijrmms.2008.04.001; Hatzor YH, 2010, INT J ROCK MECH MIN, V47, P1289, DOI 10.1016/j.ijrmms.2010.09.014; Kamai R, 2008, INT J NUMER ANAL MET, V32, P1321, DOI 10.1002/nag.671; Keneti AR, 2008, COMPUT GEOTECH, V35, P746, DOI 10.1016/j.compgeo.2007.12.002; Pearce CJ, 2000, ENG FRACT MECH, V65, P283, DOI 10.1016/S0013-7944(99)00121-6; Wu JH, 2009, INT J ROCK MECH MIN, V46, P397, DOI 10.1016/j.ijrmms.2008.07.010; Zhang YB, 2013, ENG GEOL, V166, P216, DOI 10.1016/j.enggeo.2013.08.002; Morgan WE, 2015, INT J ROCK MECH MIN, V73, P82, DOI 10.1016/i.ijrmms.2014.09.021; Wu JH, 2005, INT J NUMER ANAL MET, V29, P971, DOI 10.1002/nag.429; Jiang QH, 2004, ROCK MECH ROCK ENG, V37, P95, DOI 10.1007/s00603-003-0008-x; Wu JH, 2004, INT J ROCK MECH MIN, V41, P731, DOI 10.1016/j.ijrmms.2004.01.010; Chen GQ, 2013, ROCK MECH ROCK ENG, V46, P527, DOI 10.1007/s00603-012-0360-9; Wu JH, 2010, COMPUT GEOTECH, V37, P594, DOI 10.1016/j.compgeo.2010.03.007; Wu JH, 2005, INT J NUMER METH ENG, V63, P876, DOI 10.1002/nme.1307; Yeung MR, 2007, COMPUT GEOTECH, V34, P175, DOI 10.1016/j.compgeo.2006.11.001; Jing LR, 2001, INT J ROCK MECH MIN, V38, P343, DOI 10.1016/S1365-1609(01)00005-3; Chen HM, 2013, TUNN UNDERGR SP TECH, V38, P506, DOI 10.1016/j.tust.2013.08.006; Tsesarsky M, 2006, TUNN UNDERGR SP TECH, V21, P29, DOI 10.1016/j.tust.2005.05.001; Tian Q, 2014, INT J NUMER ANAL MET, V38, P881, DOI 10.1002/nag.2237; Wu W, 2014, THEOR APPL FRACT MEC, V72, P136, DOI 10.1016/j.tafmec.2014.03.004; Wu JH, 2010, COMPUT GEOTECH, V37, P153, DOI 10.1016/j.compgeo.2009.08.009; Ahn TY, 2012, ADVANCES IN DISCONTINUOUS NUMERICAL METHODS AND APPLICATIONS IN GEOMECHANICS AND GEOENGINEERING, P101; Munjiza A, 1998, INT J NUMER METH ENG, V43, P131, DOI 10.1002/(SICI)1097-0207(19980915)43:1<131::AID-NME447>3.0.CO;2-S; YEUNG MR, 1993, INT J ROCK MECH MIN, V30, P1411, DOI 10.1016/0148-9062(93)90129-2; Cheng YM, 1998, COMPUT GEOTECH, V22, P153, DOI 10.1016/S0266-352X(98)00002-0; Nezami EG, 2006, INT J NUMER ANAL MET, V30, P783, DOI 10.1002/nag.500; Wu JH, 2011, COMPUT GEOTECH, V38, P741, DOI 10.1016/j.compgeo.2011.04.003; Hatzor YH, 2002, INT J ROCK MECH MIN, V39, P867, DOI 10.1016/S1365-1609(02)00071-0; Liu XL, 2001, ADV ENG SOFTW, V32, P409, DOI 10.1016/S0965-9978(00)00101-0; Rouainia M, 2006, ENG GEOL, V82, P222, DOI 10.1016/j.enggeo.2005.11.004; Kaidi S, 2012, OCEAN ENG, V55, P62, DOI 10.1016/j.oceaneng.2012.07.035; Kim YI, 1999, INT J ROCK MECH MIN, V36, P949, DOI 10.1016/S0148-9062(99)00046-7; Koyama T, 2011, INT J NUMER ANAL MET, V35, P1, DOI 10.1002/nag.890; Rizzi E, 2014, ENG STRUCT, V60, P241, DOI 10.1016/j.engstruct.2013.12.023; Law HK, 2003, J GEOTECH GEOENVIRON, V129, P575, DOI 10.1061/(ASCE)1090-0241(2003)129:7(575); Beyabanaki SAR, 2009, INT J ROCK MECH MIN, V46, P1223, DOI 10.1016/j.ijrmms.2008.12.001; Bicanic N, 2001, P 4 INT C AN DISC DE, P165; [Chen Guangqi 陈光齐], 2003, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V22, P926; CUNDALL PA, 1988, INT J ROCK MECH MIN, V25, P107, DOI 10.1016/0148-9062(88)92293-0; Goodman R. E., 1985, BLOCK THEORY ITS APP; Jing L, 2007, DEV GEOTECHNICAL ENG, P317; Keneti AR, 2008, GEOMECH GEOENG INT J, V3, P79, DOI 10.1080/17486020701730041; Kveldsvik V, 2009, ROCK MECH ROCK ENG, V42, P689, DOI 10.1007/s00603-008-0005-1; Ma GC, 2011, J ROCK MECH GEOTECH, V3, P57; MacLaughlin MM, 2002, GEOTECH SPEC PUBL, P329; Mikola RG, 2013, P 47 US ROCK MECH GE; Ning Y, 2010, FRONT ARCHIT CIV ENG, V4, P223; Perkins E, 2001, ENG COMPUTATION, V18, P48, DOI 10.1108/02644400110365770; Shi G., 1988, THESIS U CALIFORNIA; Shi G. H., 2014, Geomechanics & Geoengineering: An International Journal, V9, DOI 10.1080/17486025.2013.871065; Shi GH, 2001, P 4 INT C AN DISC DE, P1; Sitar N, 1997, P 2 PAN S LANDSL RIO; Wu J. H., 2008, ADV ENG SOFTWARE, V39, P15, DOI 10.1016/j.advengsoft.2006.11.007; Yeung MR, 1997, INT J ROCK MECH MIN, V34	63	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1365-1609	1873-4545		INT J ROCK MECH MIN	Int. J. Rock Mech. Min. Sci.	SEP	2015	78						57	73		10.1016/j.ijrmms.2015.05.008		17	Engineering, Geological; Mining & Mineral Processing	Engineering; Mining & Mineral Processing	CQ5IT	WOS:000360637800007		
J	Chiba, K; Kanazaki, M; Ariyarit, A; Yoda, H; Ito, S; Kitagawa, K; Shimada, T				Chiba, Kazuhisa; Kanazaki, Masahiro; Ariyarit, Atthaphon; Yoda, Hideyuki; Ito, Shoma; Kitagawa, Koki; Shimada, Toru			Multidisciplinary Design Exploration for Sounding Launch Vehicle using Hybrid Rocket Engine in View of Ballistic Performance	INTERNATIONAL JOURNAL OF TURBO & JET-ENGINES			English	Article						single-stage launch vehicle; hybrid rocket engine; ballistic performance; design informatics; evolutionary computations	SUPERSONIC TECHNOLOGY DEMONSTRATOR; GENETIC ALGORITHM; FLYBACK-BOOSTER; OPTIMIZATION	Conceptual design of a launch vehicle with a hybrid rocket engine (HRE) has been implemented using design informatics approach in order to investigate the feasibility of a single-stage hybrid rocket. Two test design problems were formulated by using two objective functions: maximization of downrange and minimization of initial gross weight, seven design variables which describe geometry and initial conditions, and one constraint relative to target altitude. The optimization result reveals the economical performance of hybrid rocket is limited with HRE in terms of the maximum downrange achievable. Moreover, the data-mining result indicates the mechanism of design-variable behavior.	[Chiba, Kazuhisa] Univ Electrocommun, Grad Sch Informat & Engn, Tokyo 1828585, Japan; [Kanazaki, Masahiro; Ariyarit, Atthaphon; Yoda, Hideyuki; Ito, Shoma] Tokyo Metropolitan Univ, Grad Sch Syst Design, Tokyo 1910065, Japan; [Kitagawa, Koki; Shimada, Toru] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan	Chiba, K (reprint author), Univ Electrocommun, Grad Sch Informat & Engn, Tokyo 1828585, Japan.	kazchiba@uec.ac.jp					Zitzler E, 2007, LECT NOTES COMPUT SC, V4403, P862; Keane AJ, 2006, AIAA J, V44, P879, DOI 10.2514/1.16875; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; WEGMAN EJ, 1990, J AM STAT ASSOC, V85, P664, DOI 10.2307/2290001; Jeong S, 2005, J AIRCRAFT, V42, P413, DOI 10.2514/1.6386; Arias-Montano A, 2012, IEEE T EVOLUT COMPUT, V16, P662, DOI 10.1109/TEVC.2011.2169968; Chiba K, 2008, J SPACECRAFT ROCKETS, V45, P975, DOI 10.2514/1.28511; Chiba K, 2008, J AIRCRAFT, V45, P1481, DOI 10.2514/1.33272; Chiba K, 2012, J AIRCRAFT, V49, P1200, DOI 10.2514/1.C031116; Chiba K, 2014, J ADV MECH DES SYST, V8, P1; Chiba K, 2006, J AIRCRAFT, V43, P832, DOI 10.2514/1.12782; Chiba K, 2007, J AIRCRAFT, V44, P1100, DOI 10.2514/1.17549; Gordon S., 1994, NASA REFERENCE PUBLI; Hirata K, 2011, 20115677 AIAA; Inselberg A, 1985, VISUAL COMPUT, V1, P69, DOI DOI 10.1007/BF01898350; Karabeyoglu MA, 2013, P 5 EUR C AER SPAC S; Kitagawa Y, 2012, T JPN SOC AERONAUT S, V55, P229, DOI 10.2322/tjsass.55.229; Kosugi Y, 2011, 20111634 AIAA; Nakagawa I, 2011, J PROPUL POWER, V27, P1276, DOI 10.2514/1.B34206; Simurda L, 2013, 20133635 AIAA; Sutton GP, 1978, ROCKET PROPULSION EL; Thicksten Z, 2008, 20115677 AIAA	22	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-0082	2191-0332		INT J TURBO JET ENG	Int. J. Turbo. Jet-Engines	SEP	2015	32	3					299	304		10.1515/tjj-2015-0038		6	Engineering, Aerospace	Engineering	CQ5FW	WOS:000360629700008		
J	Miyata, Y; Sakai, H				Miyata, Yasuyoshi; Sakai, Hideki			Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement	INTERNATIONAL JOURNAL OF UROLOGY			English	Review						angiogenesis; microvessel density; pathological features; prognosis; prostate cancer	RENAL-CELL CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; RADICAL PROSTATECTOMY; TUMOR ANGIOGENESIS; BREAST-CARCINOMA; ENDOGLIN CD105; PATHOLOGICAL STAGE; PANCREATIC-CANCER; POOR-PROGNOSIS; EXPRESSION	Angiogenesis plays important roles in tumor growth and cancer cell dissemination in almost all cancers. In prostate cancer, there is general agreement that increased angiogenesis is an important factor in determining tumor development and prognosis in these patients. Microvessel density is recognized as a useful marker for evaluating the angiogenic status of cancer tissues. Many investigators have reported that microvessel density is significantly associated with pathological features and outcomes in prostate cancer patients; however, some researchers have expressed opposing opinions. As the reason for such discrepancy, previous reports have suggested differences in the methodologies of measuring microvessel density in cancer tissues. In the present review, we focus on the variation in such methods, including the selected area and the method used for (semi)quantification. In particular, we discuss the relationship between malignancy potential, tumor progression, and survival and differences in the antibodies used for detection of endothelial cells in detail. We briefly compare the pathological significance and prognostic roles of microvessel density measured using von Willebrand factor, CD31, CD34, and CD105. Based on these analyses, the advantages and limitations of microvessel density measurements in prostate cancer tissues are clarified. Improved real and specific markers of cancer-related angiogenesis are necessary for better predictions of prognoses and for discussion of treatment strategies for patients with prostate cancer. However, establishment of a satisfactory cancer-related endothelial marker could take a long time. Therefore, knowledge regarding the pathological significance of microvessel density - based on understanding of the advantages and limitations of microvessel density determination methods - is important.	[Miyata, Yasuyoshi; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki 8528501, Japan	Miyata, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki 8528501, Japan.	int.doc.miya@m3.dion.ne.jp					Aki R, 2010, J CELL BIOCHEM, V110, P80, DOI 10.1002/jcb.22512; Rubatt JM, 2009, GYNECOL ONCOL, V112, P469, DOI 10.1016/j.ygyno.2008.11.030; Matsuda Y, 2013, WORLD J GASTROENTERO, V19, P42, DOI 10.3748/wjg.v19.i1.42; Eaton CL, 2010, PROSTATE, V70, P875, DOI 10.1002/pros.21121; Borre M, 2000, CLIN CANCER RES, V6, P1882; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; Miyazawa K, 2014, ONCOL LETT, V8, P985, DOI 10.3892/ol.2014.2274; Wikstrom P, 2002, PROSTATE, V51, P268, DOI 10.1002/pros.10083; Kumar P, 1996, J PATHOL, V178, P363, DOI 10.1002/(SICI)1096-9896(199604)178:4<363::AID-PATH491>3.0.CO;2-8; Mehta R, 2001, CLIN CANCER RES, V7, P81; Silberman MA, 1997, CANCER, V79, P772, DOI 10.1002/(SICI)1097-0142(19970215)79:4<772::AID-CNCR14>3.0.CO;2-X; Rubin MA, 1999, UROLOGY, V53, P542, DOI 10.1016/S0090-4295(98)00561-5; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; Hlobilkova A, 2009, NEOPLASMA, V56, P284, DOI 10.4149/neo_2009_04_284; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Takagi K, 2005, J GASTROENTEROL, V40, P402, DOI 10.1007/s00535-004-1556-x; Steiner I, 2012, ONCOL REP, V27, P389, DOI 10.3892/or.2011.1539; Miyata Y, 2013, CANCER SCI, V104, P681, DOI 10.1111/cas.12140; Ozawa MG, 2005, CANCER, V104, P2104, DOI 10.1002/cncr.21436; Tretiakova M, 2013, HUM PATHOL, V44, P495, DOI 10.1016/j.humpath.2012.06.009; Teranishi N, 2007, INT J ONCOL, V30, P593; Erbersdobler A, 2002, EUR UROL, V41, P40, DOI 10.1016/S0302-2838(01)00021-5; Gustavsson H, 2009, BJU INT, V104, P1786, DOI 10.1111/j.1464-410X.2009.08676.x; Chalkley HW, 1943, J NATL CANCER I, V4, P47; SPORN LA, 1985, J CLIN INVEST, V76, P1102, DOI 10.1172/JCI112064; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Bettencourt MC, 1998, J UROLOGY, V160, P459, DOI 10.1016/S0022-5347(01)62925-2; de la Taille A, 2000, AM J CLIN PATHOL, V113, P555; Woollard DJ, 2013, PROSTATE, V73, P563, DOI 10.1002/pros.22596; El-Gohary YM, 2007, AM J CLIN PATHOL, V127, P572, DOI 10.1309/X6NXYE57DLUE2NQ8; WEIDNER N, 1993, AM J PATHOL, V143, P401; Mucci LA, 2009, J CLIN ONCOL, V27, P5627, DOI 10.1200/JCO.2008.20.8876; FINA L, 1990, BLOOD, V75, P2417; LIOTTA LA, 1976, CANCER RES, V36, P889; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; Arakawa A, 1997, PROSTATE CANCER P D, V1, P32, DOI 10.1038/sj.pcan.4500204; BIGLER SA, 1993, HUM PATHOL, V24, P220, DOI 10.1016/0046-8177(93)90304-Y; Bodey B, 1998, ANTICANCER RES, V18, P3621; Bono AV, 2002, PROSTATE CANCER P D, V5, P123, DOI 10.1038/sj.pcan.4500572; Bostwick DG, 1996, UROLOGY, V48, P47, DOI 10.1016/S0090-4295(96)00149-5; Dhakal HP, 2009, HISTOL HISTOPATHOL, V24, P1049; Erbersdobler A, 2010, WORLD J UROL, V28, P68; Folkman J, 1990, JNCI-J NATL CANCER I, V3, P4, DOI DOI 10.1093/JNCI/82.1.4; FOX SB, 1995, J NATL CANCER I, V87, P1798, DOI 10.1093/jnci/87.23.1798; Hansen S, 1998, LAB INVEST, V78, P1563; Hasan J, 2002, BRIT J CANCER, V86, P1566, DOI 10.1038/sj/bjc/6600315; Heinrich E, 2011, PROSTATE, V71, P1752, DOI 10.1002/pros.21392; Herrmann E, 2007, ONCOL REP, V18, P133; Hyder CL, 2014, J CELL SCI, V127, P2161, DOI 10.1242/jcs.125062; Karashima T, 2013, INT J UROL, V20, P923, DOI 10.1111/iju.12084; Kaygusuz G, 2007, INT UROL NEPHROL, V39, P841, DOI 10.1007/s11255-006-9144-z; Li SL, 2007, WORLD J GASTROENTERO, V13, P6076, DOI 10.3748/wjg.13.6076; LINDENMAYER AE, 1995, VIRCHOWS ARCH, V426, P457; Lissbrant IF, 1997, PROSTATE, V33, P38; Maruta S, 2009, APMIS, V117, P791, DOI 10.1111/j.1600-0463.2009.02534.x; Mithal P, 2014, INT J UROL, V21, P1209, DOI 10.1111/iju.12571; Miyata Y, 2013, VIRCHOWS ARCH, V463, P673, DOI 10.1007/s00428-013-1463-8; Miyata Y, 2015, PROSTATE, V75, P84, DOI 10.1002/pros.22894; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; Offersen BV, 1998, APMIS, V106, P643; Offersen BV, 2002, APMIS, V110, P177, DOI 10.1034/j.1600-0463.2002.100209.x; Revelos K, 2007, ANTICANCER RES, V27, P3651; Sato M, 2014, INT J UROL, V21, P130, DOI 10.1111/iju.12231; Schiffer D, 2010, ANTICANCER RES, V30, P1977; St Croix B, 2000, SCIENCE, V289, P1197; Stawerski P, 2013, WSPOLCZESNA ONKOL, V17, P378, DOI 10.5114/wo.2013.37220; Tomisaki S, 1996, CANCER, V77, P1772; Trojan L, 2004, ANTICANCER RES, V24, P1651; vansNiekerk CG, 2009, PROSTATE, V69, P62; Westerhoff M, 2010, AM J SURG PATHOL, V34, P494, DOI 10.1097/PAS.0b013e3181d38f0a; Killingsworth MC, 2011, PATHOBIOLOGY, V78, P24, DOI 10.1159/000322739; Yamahatsu K, 2012, INT J ONCOL, V40, P1345, DOI 10.3892/ijo.2012.1333; Zhang B, 2014, TUMOR BIOL, V35, P2769, DOI 10.1007/s13277-013-1367-x	74	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	SEP	2015	22	9					806	815		10.1111/iju.12840		10	Urology & Nephrology	Urology & Nephrology	CQ7CR	WOS:000360760900002		
J	Yao, A; Sejima, T; Iwamoto, H; Masago, T; Morizane, S; Honda, M; Takenaka, A				Yao, Akihisa; Sejima, Takehiro; Iwamoto, Hideto; Masago, Toshihiko; Morizane, Shuichi; Honda, Masashi; Takenaka, Atsushi			High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						castration-resistant prostate cancer; docetaxel; neutrophil-to-lymphocyte ratio; overall survival; progression-free survival	SYSTEMIC INFLAMMATION; PROGNOSTIC SCORE; SURVIVAL; MEN; MITOXANTRONE; PREDNISONE; THERAPY; JAPAN	ObjectiveTo evaluate the prognostic significance of the neutrophil-to-lymphocyte ratio in patients receiving chemotherapy with docetaxel for castration-resistant prostate cancer. MethodsA total of 57 castration-resistant prostate cancer patients treated between 2009 and 2014 were included in the present retrospective study. All patient data, including clinicopathological factors, were assessed. Univariate and multivariate Cox regression models were used to predict overall survival and progression-free survival after chemotherapy initiation. ResultsThe median overall survival and progression-free survival were determined as 19.0months (range 1-61months) and 10.0months (range 1-56months), respectively. The cut-off level of the neutrophil-to-lymphocyte ratio was set as the median value of 3.5 among all patients in this study. In Kaplan-Meier analysis, the median overall survival and progression-free survival were shorter in patients with a high neutrophil-to-lymphocyte ratio compared with those with a low neutrophil-to-lymphocyte ratio (15 vs 20months, P=0.0125; and 9.5 vs 15months, P=0.0132, respectively). The overall survival and progression-free survival periods in patients with a high neutrophil-to-lymphocyte ratio were significantly shorter than those of patients with a low neutrophil-to-lymphocyte ratio (P=0.0178 and 0.0176, respectively). In the multivariate analysis, a high neutrophil-to-lymphocyte ratio was an independent predictor of overall survival and progression-free survival (hazard ratio 2.728, 95% confidence interval 1.05-7.09, P=0.039; and hazard ratio 2.376, 95% confidence interval 1.12-5.06, P=0.024, respectively). ConclusionThe present study results suggest that the neutrophil-to-lymphocyte ratio is a useful prognostic factor in patients with castration-resistant prostate cancer treated by docetaxel chemotherapy. These findings might be useful in determining treatment strategies in the future.	[Yao, Akihisa; Sejima, Takehiro; Iwamoto, Hideto; Masago, Toshihiko; Morizane, Shuichi; Honda, Masashi; Takenaka, Atsushi] Tottori Univ, Fac Med, Dept Surg, Div Urol, Yonago, Tottori 6838503, Japan	Sejima, T (reprint author), Tottori Univ, Fac Med, Dept Surg, Div Urol, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	sejimat@med.tottori-u.ac.jp					Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Leibowitz-Amit R, 2014, ANN ONCOL, V25, P657, DOI 10.1093/annonc/mdt581; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; George DJ, 2001, CLIN CANCER RES, V7, P1932; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P139, DOI 10.1093/jjco/hyq169; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Halabi S, 2003, J CLIN ONCOL, V21, P1232, DOI 10.1200/JCO.2003.06.100; Linton A, 2013, CLIN GENITOURIN CANC, V11, P423, DOI 10.1016/j.clgc.2013.04.020; Beer TM, 2008, CANCER, V112, P2377, DOI 10.1002/cncr.23461; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Armstrong AJ, 2010, EUR J CANCER, V46, P517, DOI 10.1016/j.ejca.2009.11.007; desBono JS, 2010, LANCET, V376, P1147; desBono JS, 2011, NEW ENGL J MED, V364, P1995; Donkena KV, 2010, CURR CANCER DRUG TAR, V10, P402; Lorente D, 2014, ANN ONCOL; Maekawa K, 2010, DRUG METAB DISPOS, V38, P2100, DOI 10.1124/dmd.110.034140; Miyake H, 2013, UROL ONCOL-SEMIN ORI, V31, P733, DOI 10.1016/j.urolonc.2011.06.006; Nuhn P, 2013, BJU INT, DOI [10.1111/bju.12531, DOI 10.1111/BJU.12531]; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Pond GR, 2012, BJU INT, V110, P461; Takechi H, 2008, UROLOGY, V72, P1111, DOI 10.1016/j.urology.2007.12.090; Templeton AJ, 2014, CANCER-AM CANCER SOC, V120, P3346, DOI 10.1002/cncr.28890; van SR, 2014, ANN ONCOL	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	SEP	2015	22	9					827	833		10.1111/iju.12839		7	Urology & Nephrology	Urology & Nephrology	CQ7CR	WOS:000360760900005		
J	Akiyama, Y; Nomiya, A; Niimi, A; Yamada, Y; Fujimura, T; Nakagawa, T; Fukuhara, H; Kume, H; Igawa, Y; Homma, Y				Akiyama, Yoshiyuki; Nomiya, Akira; Niimi, Aya; Yamada, Yukio; Fujimura, Tetsuya; Nakagawa, Tohru; Fukuhara, Hiroshi; Kume, Haruki; Igawa, Yasuhiko; Homma, Yukio			Botulinum toxin typeA injection for refractory interstitial cystitis: A randomized comparative study and predictors of treatment response	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						botulinum toxins typeA; hydrodistension; interstitial cystitis; intravesical administration; randomized controlled trial	EPIDERMAL-GROWTH-FACTOR; BLADDER SYNDROME; PAIN SYNDROME; SYNDROME/INTERSTITIAL CYSTITIS; OVERACTIVE BLADDER; INCREASED NUMBER; A INJECTIONS; HYDRODISTENTION; EFFICACY; 1-YEAR	ObjectivesTo determine whether botulinum toxin typeA can represent an alternative treatment option for patients with interstitial cystitis refractory to conventional therapies. MethodsThis is a single-center, prospective, open labeled, randomized comparative study. Patients with refractory interstitial cystitis were randomly divided into two groups: immediate injection (groupA) or 1-month delayed injection (groupB) of botulinum toxin typeA after allocation. The rate of treatment response (global response assessment+1: slightly improved), and changes in symptom scores and frequency volume chart variables were compared between groups 1month after allocation. Using subjects of both groups as a single cohort, predictive factors for treatment response at 1month post-injection and the duration of response were explored. ResultsA total of 34 patients (groupA n=18, groupB n=16) were allocated. The response rate was significantly higher in groupA than groupB (72.2% vs 25.0%, P=0.01). All symptom measures showed significant improvement in groupA than groupB. When both groups were combined as a single cohort, the response rate was 73.5% at 1month, 58.8% at 3months, 38.2% at 6months and 20.6% at 12months. The mean duration of response was 5.4months. Multivariate analysis showed that past exposure to hydrodistension more than three times correlated with better outcomes. ConclusionsBotulinum toxin typeA injection could be an alternative treatment option for patients with interstitial cystitis refractory to conventional therapies, especially for those who have received repeated hydrodistensions and transurethral fulguration.	[Akiyama, Yoshiyuki; Niimi, Aya; Yamada, Yukio; Fujimura, Tetsuya; Nakagawa, Tohru; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138655, Japan; [Akiyama, Yoshiyuki; Igawa, Yasuhiko] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138655, Japan; [Nomiya, Akira] Mitsui Mem Hosp, Dept Urol, Tokyo 101, Japan	Homma, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Urol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	homma-uro@umin.ac.jp			Japanese Health Labor Sciences Research grant [H22-047]	This study was financially supported by Japanese Health Labor Sciences Research grant (H22-047). The authors thank Dr Masayoshi Zaitsu and Dr Koji Ichihara for their helpful advice in data analysis and figure preparation.	Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Kuo HC, 2009, BJU INT, V104, P657, DOI 10.1111/j.1464-410X.2009.08495.x; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Giannantoni A, 2008, J UROLOGY, V179, P1031, DOI 10.1016/j.juro.2007.10.032; Glemain P, 2002, EUR UROL, V41, P79, DOI 10.1016/S0302-2838(01)00006-9; Apostolidis A, 2006, EUR UROL, V49, P644, DOI 10.1016/j.eururo.2005.12.010; Lamb K, 2004, J PAIN, V5, P150, DOI 10.1016/j.jpain.2004.01.001; GILLENWATER JY, 1988, J UROLOGY, V140, P203; Pinto R, 2013, J UROLOGY, V189, P548, DOI 10.1016/j.juro.2012.09.027; Yamada T, 2007, WORLD J UROL, V25, P407, DOI 10.1007/s00345-007-0174-7; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Smith CP, 2003, J UROLOGY, V169, P1896, DOI 10.1097/01.ju.0000049202.56189.54; Keay S, 2004, UROLOGY, V63, P22, DOI 10.1016/j.urology.2003.08.024; Smith CP, 2004, UROLOGY, V64, P871, DOI 10.1016/j.urology.2004.06.073; Manning J, 2014, INT UROGYNECOL J, V25, P593, DOI 10.1007/s00192-013-2267-8; Karsenty G, 2008, EUR UROL, V53, P275, DOI 10.1016/j.eururo.2007.10.013; Chai TC, 2000, J UROLOGY, V163, P1440, DOI 10.1016/S0022-5347(05)67638-0; Dupont MC, 2001, J UROLOGY, V166, P1111, DOI 10.1016/S0022-5347(05)65931-9; Homma Yukio, 2002, Nihon Hinyokika Gakkai Zasshi, V93, P669; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; MESSING E M, 1978, Urology, V12, P381, DOI 10.1016/0090-4295(78)90286-8; PANG X, 1995, BRIT J UROL, V75, P744, DOI 10.1111/j.1464-410X.1995.tb07384.x; Parsons CL, 1994, FEMALE UROLOGY, P421; Rofeim O, 2001, Urology, V57, P130, DOI 10.1016/S0090-4295(01)01103-7; Rosamilia A, 1999, J UROLOGY, V161, P1865, DOI 10.1016/S0022-5347(05)68830-1; SEHN J T, 1978, Urology, V11, P581, DOI 10.1016/0090-4295(78)90007-9; Tirumuru S, 2010, INT UROGYNECOL J, V21, P1285, DOI 10.1007/s00192-010-1162-9	27	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	SEP	2015	22	9					835	841		10.1111/iju.12833		7	Urology & Nephrology	Urology & Nephrology	CQ7CR	WOS:000360760900007		
J	Tomoe, H				Tomoe, Hikaru			Editorial Comment from Dr Tomoe to Botulinum toxin type A injection for refractory interstitial cystitis: A randomized comparative study and predictors of treatment response	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							BLADDER SYNDROME		Tokyo Womens Med Univ, Med Ctr East, Dept Urol & Pelv Reconstruct Surg, Tokyo, Japan	Tomoe, H (reprint author), Tokyo Womens Med Univ, Med Ctr East, Dept Urol & Pelv Reconstruct Surg, Tokyo, Japan.	tomoeur@dnh.twmu.ac.jp					Akiyama Y, 2015, INT J UROL, V22, P835, DOI 10.1111/iju.12833; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Hanno P, 2009, NEUROUROL URODYNAM, V28, P274, DOI 10.1002/nau.20687; Hanno PM, 2015, J UROLOGY, V193, P1545, DOI 10.1016/j.juro.2015.01.086; Chennamsetty A, 2015, UROLOGY, V85, P74, DOI 10.1016/j.urology.2014.09.012	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	SEP	2015	22	9					841	842		10.1111/iju.12846		2	Urology & Nephrology	Urology & Nephrology	CQ7CR	WOS:000360760900008		
J	Nishikawa, R; Goto, Y; Kurozumi, A; Matsushita, R; Enokida, H; Kojima, S; Naya, Y; Nakagawa, M; Ichikawa, T; Seki, N				Nishikawa, Rika; Goto, Yusuke; Kurozumi, Akira; Matsushita, Ryosuke; Enokida, Hideki; Kojima, Satoko; Naya, Yukio; Nakagawa, Masayuki; Ichikawa, Tomohiko; Seki, Naohiko			MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						centromere proteinF; microRNA; microRNA-205; prostate cancer; tumor suppressor	CENP-F; ONCOGENIC FUNCTION; TUMOR-SUPPRESSOR; MIR-205; MARKER; PROGRESSION; METASTASIS; ACTIVATION; PROGNOSIS; TARGETS	ObjectivesTo investigate the functional roles of microRNA-205 in the modulation of novel cancer pathways in prostate cancer cells. MethodsFunctional studies of microRNA-205 were carried out to investigate cell proliferation, migration and invasion in prostate cancer cell lines (PC3 and DU145) by restoration of mature microRNA. Insilico database and genome-wide gene expression analyses were carried out to identify molecular targets and pathways mediated by microRNA-205. Loss-of-function studies were applied to microRNA-205 target genes. ResultsRestoration of microRNA-205 in cancer cell lines significantly inhibited cancer cell migration and invasion. Our data showed that the centromere protein F gene was overexpressed in prostate cancer clinical specimens and was a direct target of microRNA-205 regulation. Silencing of centromere protein F significantly inhibited cancer cell migration and invasion. Furthermore, MCM7, an oncogenic gene functioning downstream of centromere protein F, was identified by si-centromere protein F transfectants in prostate cancer cells. ConclusionsLoss of tumor-suppressive microRNA-205 seems to enhance cancer cell migration and invasion in prostate cancer through direct regulation of centromere protein F. Our data describing pathways regulated by tumor-suppressive microRNA-205 provide new insights into the potential mechanisms of prostate cancer oncogenesis and metastasis.	[Nishikawa, Rika; Goto, Yusuke; Kurozumi, Akira; Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba 2608670, Japan; [Nishikawa, Rika; Goto, Yusuke; Kurozumi, Akira; Ichikawa, Tomohiko] Chiba Univ, Dept Urol, Grad Sch Med, Chiba 2608670, Japan; [Matsushita, Ryosuke; Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan; [Kojima, Satoko; Naya, Yukio] Teikyo Univ, Chiba Med Ctr, Dept Urol, Chiba, Japan	Seki, N (reprint author), Chiba Univ, Grad Sch Med, Dept Funct Genom, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	naoseki@faculty.chiba-u.jp			KAKENHI [24592590, 25293333]; Futaba Electronics Memorial Foundation	This study was supported by the KAKENHI, grant numbers (C) 24592590 and (B) 25293333, and by Futaba Electronics Memorial Foundation.	Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Qin AY, 2013, EUR J CELL BIOL, V92, P54, DOI 10.1016/j.ejcb.2012.11.002; Gandellini P, 2012, CELL DEATH DIFFER, V19, P1750, DOI 10.1038/cdd.2012.56; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Nishikawa R, 2014, CANCER SCI, V105, P802, DOI 10.1111/cas.12441; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Goto Y, 2014, ONCOTARGET, V5, P7748; Nishikawa R, 2014, INT J ONCOL, V45, P401, DOI 10.3892/ijo.2014.2437; Dai YD, 2013, BIOCHEM BIOPH RES CO, V436, P711, DOI 10.1016/j.bbrc.2013.06.021; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Goto Y, 2014, FEBS LETT, V588, P1973, DOI 10.1016/j.febslet.2014.04.020; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Fuse M, 2012, J HUM GENET, V57, P691, DOI 10.1038/jhg.2012.95; Padmanabhan V, 2004, J CLIN PATHOL, V57, P1057, DOI 10.1136/jcp.2004.016436; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Greene SB, 2010, RNA BIOL, V7, P300; Chi KN, 2009, EUR UROL, V56, P594, DOI 10.1016/j.eururo.2009.06.027; Chen WB, 2011, J CLIN PATHOL, V64, P751, DOI 10.1136/jcp.2011.089631; Goto Y, 2015, INT J UROL, V22, P242, DOI 10.1111/iju.12700; Hulf T, 2013, ONCOGENE, V32, P2891, DOI 10.1038/onc.2012.300; Kim HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043223; Kojima S, 2013, J HUM GENET, V59, P78; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	SEP	2015	22	9					867	877		10.1111/iju.12829		11	Urology & Nephrology	Urology & Nephrology	CQ7CR	WOS:000360760900015		
J	Kobayashi, T				Kobayashi, Takashi			Editorial Comment to MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Kyoto Univ, Dept Urol, Grad Sch Med, Kyoto, Japan	Kobayashi, T (reprint author), Kyoto Univ, Dept Urol, Grad Sch Med, Kyoto, Japan.	selecao@kuhp.kyoto-u.ac.jp					Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Nishikawa R, 2015, INT J UROL, V22, P867, DOI 10.1111/iju.12829; Zhuo YJ, 2015, INT J MOL MED, V35, P966, DOI 10.3892/ijmm.2015.2086	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	SEP	2015	22	9					877	877		10.1111/iju.12883		1	Urology & Nephrology	Urology & Nephrology	CQ7CR	WOS:000360760900016		
J	Inoue, H; Nishimura, K; Hara, T				Inoue, Hitoshi; Nishimura, Kensaku; Hara, Tsuneo			Postoperative prostate-specific antigen monitoring interval for radical prostatectomy patients with low recurrence risk	INTERNATIONAL JOURNAL OF UROLOGY			English	Letter							BIOCHEMICAL RECURRENCE		[Inoue, Hitoshi; Nishimura, Kensaku; Hara, Tsuneo] Ikeda Municipal Hosp, Dept Urol, Ikeda, Osaka, Japan	Inoue, H (reprint author), Ikeda Municipal Hosp, Dept Urol, Ikeda, Osaka, Japan.	hinokin2000@hotmail.co.jp					Briganti A, 2014, EUR UROL, V66, P479, DOI 10.1016/j.eururo.2013.11.045; Boorjian SA, 2012, EUR UROL, V61, P664, DOI 10.1016/j.eururo.2011.11.053; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Inoue H, 2015, INT J CLIN ONCOL, V20, P171, DOI 10.1007/s10147-014-0681-7	4	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	SEP	2015	22	9					884	884		10.1111/iju.12809		1	Urology & Nephrology	Urology & Nephrology	CQ7CR	WOS:000360760900018		
J	Kanayama, H; Fukumori, T; Fujimoto, H; Nakanishi, H; Ohyama, C; Suzuki, K; Nishiyama, H; Eto, M; Miki, T; Kamoi, K; Kubota, Y; Takahashi, S; Homma, Y; Naito, S				Kanayama, Hiro-omi; Fukumori, Tomoharu; Fujimoto, Hiroyuki; Nakanishi, Hiroyuki; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Miki, Tsuneharu; Kamoi, Kazumi; Kubota, Yoshinobu; Takahashi, Satoru; Homma, Yukio; Naito, Seiji			Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						epidemiology; Japanese; renal cell carcinoma; survival	NATIONWIDE SURVEY; KIDNEY CANCER; PREVALENCE; STATISTICS; OBESITY; RISK	ObjectivesTo describe the clinicopathological features and oncological outcomes of renal cell carcinoma diagnosed in Japan in 2007, the results of the large-scale renal cell carcinoma registration study carried out by the Japanese Urological Association are reported. MethodsThe renal cell carcinoma survey was carried out by the Japanese Urological Association in 2012 to register newly diagnosed renal cell carcinoma cases in 2007 from 340 institutions nationwide. The survey included clinicopathological details, such as sex, age, family history, past history, smoking history, body mass index, reason for diagnosis, TNM classification, stage, histopathology, treatment and clinical outcomes. ResultsA total of 3663 cases diagnosed in 2007 were registered in this renal cell carcinoma registry program from 340 institutions. A total of 15 patients with a final diagnosis of oncocytoma were excluded, and 3648 cases of renal cell carcinoma were analyzed to evaluate oncological outcomes. The patients' median age was 63.9years (range 5.9-95.1years). Clear cell renal cell carcinoma was the most common histological subtype (77.2%), followed by papillary (5.0%) and chromophobe (3.2%) renal cell carcinoma. The most common initial treatment was radical nephrectomy (72.6%), and the most common secondary treatment was cytokine therapy (13.1%). Five-year overall survival rates in stagesI, II, III, and IV were 94.8%, 90.2%, 78.8% and 39.6%, respectively. The 5-year overall survival rates for clear cell, papillary and chromophobe renal cell carcinomas, and carcinoma of the collecting ducts of Bellini were 88.6%, 79.8%, 93.0% and 40.0%, respectively. ConclusionsThe present report is the first nationwide large-scale study to describe the clinicopathological characteristics and oncological outcomes of patients with renal cell carcinoma in Japan. Oncological outcomes depend on the clinical stage and histological subtype. Further investigations will be required to show improved oncological outcomes in the molecular targeted therapy era using the results of the present study as a baseline.	[Kanayama, Hiro-omi; Fukumori, Tomoharu; Fujimoto, Hiroyuki; Nakanishi, Hiroyuki; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Miki, Tsuneharu; Kamoi, Kazumi; Kubota, Yoshinobu; Takahashi, Satoru; Homma, Yukio; Naito, Seiji] Japanese Urol Assoc, Canc Registrat Comm, Tokushima, Japan; [Kanayama, Hiro-omi; Fukumori, Tomoharu] Univ Tokushima, Inst Hlth Biosciences, Dept Urol, Grad Sch, Tokushima, Japan; [Fujimoto, Hiroyuki; Nakanishi, Hiroyuki] Natl Canc Ctr, Div Urol, Tokyo, Japan; [Ohyama, Chikara] Hirosaki Univ, Grad Sch Med, Dept Urol, Aomori, Japan; [Suzuki, Kazuhiro] Gunma Univ, Sch Med, Dept Urol, Maebashi, Gunma, Japan; [Nishiyama, Hiroyuki] Univ Tsukuba, Dept Urol, Fac Med, Tsukuba, Ibaraki, Japan; [Eto, Masatoshi] Kumamoto Univ, Dept Urol, Fac Life Sci, Kumamoto, Japan; [Miki, Tsuneharu; Kamoi, Kazumi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kyoto, Japan; [Kubota, Yoshinobu] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan; [Takahashi, Satoru] Nihon Univ, Dept Urol, Tokyo, Japan; [Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Naito, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka, Japan	Kanayama, H (reprint author), Univ Tokushima, Inst Hlth Biosciences, Dept Urol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	kanayama.hiroomi@tokushima-u.ac.jp					Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Naito S, 2010, EUR UROL, V57, P317, DOI 10.1016/j.eururo.2008.12.026; Miki T, 2014, INT J UROL, V21, pS1, DOI 10.1111/iju.12441; Chow WH, 2000, NEW ENGL J MED, V343, P1305, DOI 10.1056/NEJM200011023431804; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Marumo K, 2001, INT J UROL, V8, P359, DOI 10.1046/j.1442-2042.2001.00314.x; Marumo K, 2007, INT J UROL, V14, P479, DOI 10.1111/j.1442-2042.2007.01739.x; Jemal A, 2007, CA-CANCER J CLIN, V57, P43; Fujimoto H, 2014, INT J UROL, V21, P527, DOI 10.1111/iju.12367; Japanese Urological Association, 2009, 2009 ED REN CELL CAR; Sakai I, 2012, BJU INT, V109, P695, DOI 10.1111/j.1464-410X.2011.10451.x	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	SEP	2015	22	9					S1	S7		10.1111/iju.12826		7	Urology & Nephrology	Urology & Nephrology	CQ7CR	WOS:000360760900001		
J	Takamizawa, H				Takamizawa, Hideyuki			Predicting Interest Rate Volatility Using Information on the Yield Curve	INTERNATIONAL REVIEW OF FINANCE			English	Article							TERM-STRUCTURE MODELS; UNSPANNED STOCHASTIC VOLATILITY; INTEREST-RATE DERIVATIVES; CONTINUOUS-TIME MODELS; SPECIFICATION ANALYSIS; COVARIANCE-MATRIX; BOND YIELDS; TREASURY; MARKETS; HETEROSKEDASTICITY	This study examines whether information on the yield curve is useful for predicting volatility of the yield curve. The information is used within dynamic models by specifying the covariance matrix of changes in yield factors as nonlinear functions of the factors. Using such models, it is found that the information (i) is useful for predicting volatility of the slope factor, achieving the accuracy comparable with the GARCH model; (ii) has incremental value for predicting volatility of the curvature factor when combined with a volatility-specific factor; and (iii) does not much improve prediction of volatility of the level factor once the volatility-specific factor is introduced.	Hitotsubashi Univ, Grad Sch Commerce & Management, Kunitachi, Tokyo 1868601, Japan	Takamizawa, H (reprint author), Hitotsubashi Univ, Grad Sch Commerce & Management, Kunitachi, Tokyo 1868601, Japan.	hi.takamizawa@r.hit-u.ac.jp			JSPS KAKENHI [23730212]; SEIMEIKAI research grant; NOMURA Foundation	I am grateful to the anonymous referee for comments, which enabled me to significantly improve this manuscript. This work was supported by JSPS KAKENHI Grant Number 23730212, SEIMEIKAI research grant, and NOMURA Foundation research grant.	Andersen T. G., 1997, WORKING PAPER; Andersen TG, 1997, J ECONOMETRICS, V77, P343, DOI 10.1016/S0304-4076(96)01819-2; Longstaff FA, 2001, J FINANC, V56, P2067, DOI 10.1111/0022-1082.00399; Collin-Dufresne P, 2002, J FINANC, V57, P1685, DOI 10.1111/1540-6261.00475; Ghysels E, 2005, J FINANC ECON, V76, P509, DOI 10.1016/j.jfineco.2004.03.008; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Dai Q, 2007, REV FINANC STUD, V20, P1669, DOI 10.1093/rfs/hhm021; Jarrow R, 2007, J FINANC, V62, P345, DOI 10.1111/j.1540-6261.2007.01209.x; DIEBOLD FX, 1995, J BUS ECON STAT, V13, P253, DOI 10.2307/1392185; Hansen PR, 2005, J APPL ECONOM, V20, P873, DOI 10.1002/jae.800; Collin-Dufresne P, 2009, J FINANC ECON, V94, P47, DOI 10.1016/j.jfineco.2008.06.007; Andersen TG, 2010, J FINANC, V65, P603, DOI 10.1111/j.1540-6261.2009.01546.x; Duffee GR, 2011, REV FINANC STUD, V24, P2895, DOI 10.1093/rfs/hhr033; Duffee GR, 2002, J FINANC, V57, P405, DOI 10.1111/1540-6261.00426; Ghysels E, 2006, J ECONOMETRICS, V131, P59, DOI 10.1016/j.jeconom.2005.01.004; Li HT, 2006, J FINANC, V61, P341, DOI 10.1111/j.1540-6261.2006.00838.x; Dai Q, 2000, J FINANC, V55, P1943, DOI 10.1111/0022-1082.00278; Ait-Sahalia Y, 1996, REV FINANC STUD, V9, P385; Ball CA, 1999, J FINANC, V54, P2339, DOI 10.1111/0022-1082.00191; Bikbov R, 2011, J FINANC ECONOMET, V9, P66, DOI 10.1093/jjfinec/nbq019; Brenner RJ, 1996, J FINANC QUANT ANAL, V31, P85, DOI 10.2307/2331388; BROWN RH, 1994, PHILOS T R SOC A, V347, P563, DOI 10.1098/rsta.1994.0066; CHAN KC, 1992, J FINANC, V47, P1209, DOI 10.2307/2328983; Christiansen C., 2005, WORKING PAPER; Christiansen C, 2005, J BANK FINANC, V29, P1037, DOI 10.1016/j.jbankfin.2003.11.004; Christiansen C, 2004, J FUTURES MARKETS, V24, P315, DOI 10.1002/fut.10118; COX JC, 1985, ECONOMETRICA, V53, P385, DOI 10.2307/1911242; Durham GB, 2003, J FINANC ECON, V70, P463, DOI 10.1016/S0304-405X(03)00207-1; Fan R, 2003, J FINANC, V58, P2219, DOI 10.1111/1540-6261.00603; Gallant AR, 1998, J AM STAT ASSOC, V93, P10, DOI 10.2307/2669598; Han B, 2007, J FINANC, V62, P1491, DOI 10.1111/j.1540-6261.2007.01242.x; Heidari M, 2009, J FINANC QUANT ANAL, V44, P517, DOI 10.1017/S0022109009990093; Heidari M., 2003, J FIXED INCOME, P75, DOI 10.3905/jfi.2003.319347; Jacobs K, 2009, J FINANC ECON, V91, P288, DOI 10.1016/j.jfineco.2008.02.006; Joslin S., 2010, WORKING PAPER; Litterman Robert, 1991, J FIXED INCOME, V1, P54, DOI 10.3905/jfi.1991.692347; Littermann R., 1991, J FIXED INCOME, V1, P49, DOI 10.3905/jfi.1991.692346; Perignon C, 2006, J BUS, V79, P1535, DOI 10.1086/500684; Perignon C, 2007, J BANK FINANC, V31, P3125, DOI 10.1016/j.jbankfin.2006.11.016; Phoa W, 1997, J FIXED INCOME, V7, P43, DOI 10.3905/jfi.1997.408196; LONGSTAFF FA, 1992, J FINANC, V47, P1259, DOI 10.2307/2328939; Shoji I., 2002, INT J COMPUTATIONAL, V1, P163; Takamizawa H, 2009, J ECON DYN CONTROL, V33, P65, DOI 10.1016/j.jedc.2008.05.001; Thompson S, 2008, REV FINANC STUD, V21, P819, DOI 10.1093/rfs/hhm082	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1369-412X	1468-2443		INT REV FINANC	Int. Rev. Financ.	SEP	2015	15	3					347	386		10.1111/irfi.12053		40	Business, Finance	Business & Economics	CQ5TS	WOS:000360669200003		
J	Hosoi, J; Okada, M; Gokan, T; Amano, K; Martin, AJ				Hosoi, Jun; Okada, Makoto; Gokan, Tomohiro; Amano, Kazuo; Martin, Andrew James			Early to Middle Miocene rotational tectonics of the Ou Backbone Range, northeast Japan	ISLAND ARC			English	Article						counterclockwise rotation; Green Tuff; Miocene; northeast Japan; Ou Backbone Ranges; paleomagnetism; paleostress; tectonics	EXTENSIONAL TECTONICS; PALEOMAGNETIC EVIDENCE; PYRITE FORMATION; EASTERN MARGIN; EVOLUTION; SEDIMENTS; SEA; ARC; PREFECTURE; ANISOTROPY	It is well known that a counterclockwise rotation occurred in the Miocene in northeast Japan. However, the detailed timing and mechanism of the rotation has been debated. Moreover, there has been no research about the relationship between rotational tectonics and the evolution of sedimentary basins. We carried out paleomagnetic and rock magnetic analyses in Nishiwaga Town, Iwate Prefecture, northeast Japan, where the stratigraphy and sedimentary basin formation have previously been clarified. We found that there was a counterclockwise rotational movement of about 45 degrees at about 15 Ma. From our results and previous studies on the tectonics and sedimentary basin development, we are able to ascertain the following tectonic history and sedimentary basin evolution in this area: (i) before the rotational movement, sandstone and mudstone were deposited in a tranquil environment with no volcanic activity coupled with slow tectonic subsidence; (ii) between 16.4-15.1 Ma and 14 Ma, a counterclockwise rotation occurred with rapid tectonic subsidence and continuous explosive volcanism; (iii) at about 14Ma, the counterclockwise rotation ended and there was a reduction in both subsidence and volcanism. This result shows the impact that rotational tectonics can have on sedimentary basin formation.	[Hosoi, Jun] AIST, Inst Geol & Geoinformat, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Okada, Makoto; Amano, Kazuo] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan; [Gokan, Tomohiro] Moriya City Off, Moriya 3020198, Japan; [Martin, Andrew James] Natl Cooperat Disposal Radioact Waste NAGRA, CH-5430 Wettingen, Switzerland	Hosoi, J (reprint author), AIST, Inst Geol & Geoinformat, Geol Survey Japan, Higashi 1-1-1,Cent 7, Tsukuba, Ibaraki 3058567, Japan.	j.hosoi@aist.go.jp			Fukada Geological Institute	We thank Ms. Reiko Takahashi for accommodation in the study area. We also thank Dr. T. Nakajima (Geological Survey of Japan, AIST), an anonymous reviewer, Associate Editor Dr. Y. Yasuhiro (JAMSTEC) and Editor in Chief Prof. M. Ito (Chiba University) for their helpful reviews and comments. This study was partly supported by a Fukada Grant-in-Aid from the Fukada Geological Institute (Fukada Grant-in-Aid, 2012).	Rowan CJ, 2006, EARTH PLANET SC LETT, V241, P119, DOI 10.1016/j.epsl.2005.10.017; Sagnotti L, 1998, PHYS EARTH PLANET IN, V105, P73, DOI 10.1016/S0031-9201(97)00071-X; Benning LG, 2000, CHEM GEOL, V167, P25, DOI 10.1016/S0009-2541(99)00198-9; OTOFUJI YI, 1985, NATURE, V317, P603, DOI 10.1038/317603a0; OTOFUJI Y, 1994, EARTH PLANET SC LETT, V121, P503, DOI 10.1016/0012-821X(94)90087-6; Kano K, 2007, J ASIAN EARTH SCI, V30, P20, DOI 10.1016/j.jseaes.2006.07.003; ROBERTS AP, 1995, EARTH PLANET SC LETT, V134, P227, DOI 10.1016/0012-821X(95)00131-U; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Faccenna C, 2002, TECTONOPHYSICS, V356, P213, DOI 10.1016/S0040-1951(02)00287-1; Wilkin RT, 1996, GEOCHIM COSMOCHIM AC, V60, P4167, DOI 10.1016/S0016-7037(97)81466-4; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Mattei M, 1997, TECTONOPHYSICS, V271, P107, DOI 10.1016/S0040-1951(96)00244-2; Raffi I, 2006, QUATERNARY SCI REV, V25, P3113, DOI 10.1016/j.quascirev.2006.07.007; BERNER RA, 1984, GEOCHIM COSMOCHIM AC, V48, P605, DOI 10.1016/0016-7037(84)90089-9; Coxs A., 1960, GEOL SOC AM BULL, V71, P645; Days R., 1977, PHYS EARTH PLANETARY, V13, P260; Hoshi H., 1999, B GEOLOGICAL SURVEY, V50, P3; Hoshis H, 2002, J GEOL SOC JAPAN, V108, P510; Hoshis H, 2014, 121 ANN M GEOL SOC J, P25; Hoshi H, 1998, EARTH PLANETS SPACE, V50, P23; Hoshi H, 2007, EARTH PLANETS SPACE, V59, P871; Hosois J., 2013, J GEOL SOC JPN, V119, P630, DOI DOI 10.5575/geosoc.2013.0035; Jelinek V., 1981, TECTONOPHYSICS, V79, P63; Kaos S. J., 2004, CHEM GEOL, V203, P153; Kitamuras N., 1959, CONTR I GEOL PAL TOH, V49, P1; Kitamuras N., 1962, CONTRIBUTIONS I GEOL, V55, P1; Matsukumas T, 1969, PETROLOGISTS EC GEOL, P39; Mattei M, 1999, TECTONOPHYSICS, V307, P33, DOI 10.1016/S0040-1951(99)00117-1; Mino K, 2001, EARTH PLANETS SPACE, V53, P805; Nakajima T, 2006, PALAEOGEOGR PALAEOCL, V241, P28, DOI 10.1016/j.palaeo.2006.06.009; Nakajimas T., 2000, J GEOL SOC JPN, V106, P93, DOI [10.5575/geosoc.106.93., DOI 10.5575/GEOSOC.106.93]; Nakajimas T., 1999, J GEOL SOC JPN, V105, P668; Otofuji Y.-I., 1996, ISL ARC, V5, P229, DOI DOI 10.1111/J.1440-1738.1996.TB00029.X; Otofujis Y., 1985, EARTH PLANET SC LETT, V130, P95; Otsukis K., 1989, MEM SOC GEOL JPN, V32, P281; Porreca M, 2012, INT J EARTH SCI, V101, P863, DOI 10.1007/s00531-011-0670-2; Roberts AP, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000336; Saito T., 1963, Science Reports of the Tohoku University Ser 2 Geol, V35, P123; Satos H, 1994, J GEOPHYS RES, V99, P261; Satos H., 1986, CONTRIB I GEOL PALEO, V89, P1; Satos H., 1982, J TECTONIC RES GROUP, V27, P55; Sato T., 1991, Journal of the Japanese Association for Petroleum Technology, V56, P263; TOSHA T, 1988, TECTONICS, V7, P653, DOI 10.1029/TC007i003p00653; Vasiliev I, 2009, TECTONOPHYSICS, V473, P457, DOI 10.1016/j.tecto.2009.04.002; Yamaji A, 1999, EARTH PLANETS SPACE, V51, P81	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	SEP	2015	24	3					288	300		10.1111/iar.12109		13	Geosciences, Multidisciplinary	Geology	CQ4OK	WOS:000360584100002		
J	Kawahata, H; Nomura, R; Matsumoto, K; Nishi, H				Kawahata, Hodaka; Nomura, Ritsuo; Matsumoto, Katsumi; Nishi, Hiroshi			Linkage of deep sea rapid acidification process and extinction of benthic foraminifera in the deep sea at the Paleocene/Eocene transition	ISLAND ARC			English	Article						agglutinated foraminifera; benthic foraminifera; carbon cycle; ocean acidification; Ocean Drilling Program (ODP); The Paleocene; Eocene (P; E) transition	EOCENE THERMAL MAXIMUM; EQUATORIAL PACIFIC-OCEAN; CARBON-ISOTOPE EXCURSION; PLANKTONIC-FORAMINIFERA; METHANE HYDRATE; SOUTHERN TETHYS; BOUNDARY; SECTION; RECORDS; MARINE	Ocean Drilling Program Leg 199 Site 1220 provides a continuous sedimentary section across the Paleocene/Eocene (P/E) transition in the carbonate-bearing sediments on 56-57 Ma oceanic crust. The large negative C-13 shift in seawater is likely due to the disintegration of methane hydrate, which is expected to be rapidly changed to carbon dioxide in the atmosphere and well-oxygenated seawater, leading to a reduction in deep-sea pH. A pH decrease was very likely responsible for the emergence of agglutinated foraminiferal fauna as calcareous fauna was eliminated by acidification at the P/E transition at Site 1220. The absence of the more resistant calcareous benthic foraminifera and the presence of the planktonic foraminifera at Site 1220 is interesting and unique, which indicates that calcareous benthic foraminifera suffered greatly from living on the seafloor. Box model calculation demonstrates that, assuming the same mean alkalinity as today, pCO(2) must increase from 280ppm to about 410ppm for the calcite undersaturation in the deep ocean and for the oversaturation in the surface ocean during the P/E transition. The calculated increased pCO(2) coincides with paleo-botanical evidence. The current global emission rate (approximate to 7.3 peta (10(15)) gC/y) of anthropogenic carbon input is approximately 30 times of the estimate at the P/E transition. The results at the P/E transition give an implication that the deep sea benthic fauna will be threatened in future in combination with ocean acidification, increased sea surface temperature and more stratified surface water.	[Kawahata, Hodaka] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Nomura, Ritsuo] Shimane Univ, Fac Educ, Matsue, Shimane 6908504, Japan; [Matsumoto, Katsumi] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; [Nishi, Hiroshi] Tohoku Univ, Tohoku Univ Museum, Ctr Acad Resources & Arch, Sendai, Miyagi 9808578, Japan	Kawahata, H (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwanoha 5-1-5, Kashiwa, Chiba 2778564, Japan.	kawahata@aori.u-tokyo.ac.jp			Japan Society for Promotion of Science [22224009]	We thank K. Minoshima and N. Hokanishi for their technical support for inorganic chemical analysis at Geological Survey of Japan, National Institute of Advanced Industrial Science and Technology. This research was partly supported by Grants-in-Aids from the Japan Society for the Promotion of Science to H.K. (No. 22224009). We also acknowledge the constructive comments by Prof. Michael A. Kaminski and one anonymous reviewer.	Akimotos K., 1990, STUDIES IN BENTHIC, P211; Kelly DC, 1996, GEOLOGY, V24, P423; Inoue S, 2013, NAT CLIM CHANGE, V3, P683, DOI [10.1038/nclimate1855, 10.1038/NCLIMATE1855]; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Green MA, 2004, LIMNOL OCEANOGR, V49, P727; Erez J, 2003, REV MINERAL GEOCHEM, V54, P115, DOI 10.2113/0540115; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; Norris RD, 1999, NATURE, V401, P775, DOI 10.1038/44545; Kent DV, 2003, EARTH PLANET SC LETT, V211, P13, DOI 10.1016/S0012-821X(03)00188-2; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; Alegret L, 2006, MICROPALEONTOLOGY, V52, P433; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Raffi I, 2005, PALAEOGEOGR PALAEOCL, V226, P93, DOI 10.1016/j.palaeo.2005.05.006; Storey M, 2007, SCIENCE, V316, P587, DOI 10.1126/science.1135274; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Panchuk K, 2008, GEOLOGY, V36, P315, DOI 10.1130/G24474A.1; Zili L, 2009, REV MEX CIENC GEOL, V26, P729; John CM, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001465; Ernst SR, 2006, MAR MICROPALEONTOL, V60, P89, DOI 10.1016/j.marmicro.2006.03.002; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Bice KL, 2001, J GEOPHYS RES-OCEANS, V106, P11529, DOI 10.1029/2000JC000561; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; Pagani M, 2005, GEOCHIM COSMOCHIM AC, V69, P953, DOI 10.1016/j.gca.2004.07.029; GRIPP AE, 1990, GEOPHYS RES LETT, V17, P1109, DOI 10.1029/GL017i008p01109; Lemarchand D, 2000, NATURE, V408, P951, DOI 10.1038/35050058; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Bains S, 2000, NATURE, V407, P171, DOI 10.1038/35025035; Bakers S., 2002, SCIENCE, V297, P833; BRALOWER TJ, 1995, PALEOCEANOGRAPHY, V10, P841, DOI 10.1029/95PA01143; Bralower TJ, 1997, GEOLOGY, V25, P963, DOI 10.1130/0091-7613(1997)025<0963:HRROTL>2.3.CO;2; Bralowers T. J., 2002, PALEOCEANOGRAPHY, V17; Cushmans J. A., 1951, GEOLOGICAL SURVEY PR, V232, P1; Cushmans J. A., 1946, GEOLOGICAL SURVEY PR, V206, P1; Cushmans J. A., 1935, GEOL SURV PROF PAP U, V181, P1; Dayton P.K., 1990, P631; Dickens GR, 2004, NATURE, V429, P513, DOI 10.1038/429513a; Elliss B. F., 1940, SPEC PUBL AM MUS N S; Engebretson D. C., 1985, SPEC PAP GEOL SOC AM, V206, P1, DOI 10.1130/SPE206-p1; FINGER K L, 1981, Micropaleontology (New York), V27, P111, DOI 10.2307/1485283; Freiwalds A., 2004, BIODIVERSITY SERIES; Giusberti L, 2009, MAR MICROPALEONTOL, V70, P102, DOI 10.1016/j.marmicro.2008.11.003; Hikami M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048501; Kaiho K, 2006, PALAEOGEOGR PALAEOCL, V237, P456, DOI 10.1016/j.palaeo.2005.12.017; Kroons D., 2004, P OCEAN DRILLING PRO; Kuroyanagi A, 2013, MAR MICROPALEONTOL, V101, P28, DOI 10.1016/j.marmicro.2013.04.005; Kuroyanagi A, 2009, MAR MICROPALEONTOL, V73, P190, DOI 10.1016/j.marmicro.2009.09.003; Loeblichs A. R., 1987, FORAMINIFERAL GENERA; Lyles M. W., 1999, INITIAL REPORTS OCEA, P1; Maeda L, 2002, MAR GEOL, V189, P197, DOI 10.1016/S0025-3227(02)00405-X; Murrays J. W., 2008, ECOLOGY APPL BENTHIC; Nomura R., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V121, P3, DOI 10.2973/odp.proc.sr.121.138.1991; Nuness F., 2005, P OCEAN DRILLING PRO, P199; Orrs J. C., 2005, NATURE, V437, P681; Paks D., 1997, SCI RESULTS X OCEAN, V150X, P305; Pearsons P. N., 2000, SCIENCE, V284, P1824; Saidovas K. M., 1975, BENTHONIC FORAMINIFE; Scheibner C, 2008, EARTH-SCI REV, V90, P71, DOI 10.1016/j.earscirev.2008.07.002; Speijers R. P., 1994, GEOL ULTRIECTIN, V124, P1; Stassen P, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002323; Takashima R, 2009, PALAEOGEOGR PALAEOCL, V273, P61, DOI 10.1016/j.palaeo.2008.12.001; Thomass E., 2007, GEOL S AM S, V424, P1, DOI DOI 10.1130/2007.2424(01); Thomass E., 1996, SPECIAL PUBLICATION, V101, P401; Tjalsma R.C., 1983, MICROPALEONTOLOGY SP, V4, P1; Tripati AK, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000631; Widmark Joen G.V., 1997, Fossils and Strata, V43, P1; Xus W. Y., 2001, J GEOPHYS RES, V106, P26413; Yamamura M, 2007, PALAEOGEOGR PALAEOCL, V254, P477, DOI 10.1016/j.palaeo.2007.07.002; Zili L, 2010, TURK J EARTH SCI, V19, P385, DOI 10.3906/yer-0904-7	75	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	SEP	2015	24	3					301	316		10.1111/iar.12106		16	Geosciences, Multidisciplinary	Geology	CQ4OK	WOS:000360584100003		
J	Sone, T; Kano, A; Kashiwagi, K; Mori, T; Okumura, T; Shen, CC; Hori, M				Sone, Tomomi; Kano, Akihiro; Kashiwagi, Kenji; Mori, Taiki; Okumura, Tomoyo; Shen, Chuan-Chou; Hori, Masako			Two modes of climatic control in the Holocene stalagmite record from the Japan Sea side of the Japanese islands	ISLAND ARC			English	Article						East Asian winter monsoon; Holocene climate mode; Japan; Mg/Ca ratio; millennial-scale variation; oxygen and carbon isotopes; prior calcite precipitation; stalagmite	TRACE-ELEMENT VARIATIONS; CHINESE LOESS PLATEAU; TSUSHIMA WARM CURRENT; ASIAN SUMMER MONSOON; SOIL ORGANIC-MATTER; HIGH-RESOLUTION; SOUTHWESTERN JAPAN; ISOTOPIC COMPOSITION; VEGETATION HISTORY; SPELEOTHEM RECORD	The Holocene stalagmite FG01 collected at the Fukugaguchi Cave in Itoigawa, central Japan provides a unique high-resolution record of the East Asian winter monsoon. Because of the climate conditions on the Japan Sea side of the Japanese islands, the volume of precipitation during the winter is strongly reflected in the stalagmite O-18 signal. Examination of the carbon isotopes and the Mg/Ca ratio of FG01 provided additional information on the Holocene climate in Itoigawa, which is characterized by two different modes separated at 6.4 ka. Dripwater composition and the correlation between the C-13 and Mg/Ca data of FG01 indicate the importance of prior calcite precipitation (PCP), a process that selectively eliminated C-12 and calcium ions from infiltrating water from CO2 degassing and calcite precipitation. In an earlier period (10.0-6.4 ka), an increase in soil pCO(2) associated with warming and wetting climate trends was a critical factor that enhanced PCP, and resulted in an increasing trend in the Mg/Ca and C-13 data and a negative correlation between the C-13 and O-18 profiles. A distinct peak in the C-13 age profile at 6.8 ka could be a response to an increase of approximately 10% in C4 plants in the recharge area. At 6.4 ka, the climate mode changed to another, and correlation between O-18 and C-13 became positive. In addition, a millennial-scale variation in O-18 and pulsed changes in C-13 and Mg/Ca became distinct. Assuming that O-18 and PCP were controlled by moisture in the later period, the volume of precipitation was high during 6.0-5.2, 4.4-4.0, and 3.0-2.0 ka. In contrast, the driest interval in Itoigawa was during 0.2-0.4 ka, and broadly corresponds to the Little Ice Age.	[Sone, Tomomi] Marine Works Japan, Yokosuka, Kanagawa 2370063, Japan; [Kano, Akihiro; Mori, Taiki] Kyushu Univ, Grad Sch Social & Cultural Studies, Fukuoka 8190395, Japan; [Kashiwagi, Kenji] Toyama Univ, Fac Sci, Dept Earth Sci, Toyama 9308555, Japan; [Okumura, Tomoyo] Japan Agcy Marine Earth Sci & Technol, Lab Ocean Earth Life Evolut Res, Yokosuka, Kanagawa 2370061, Japan; [Shen, Chuan-Chou] Natl Taiwan Univ, Dept Geosci, High Precis Mass Spectrometry & Environm Change L, Taipei 106, Taiwan; [Hori, Masako] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Kano, A (reprint author), Kyushu Univ, Grad Sch Social & Cultural Studies, 744 Motooka, Fukuoka 8190395, Japan.	kano@scs.kyushu-u.ac.jp	Shen, Chuan-Chou/H-9642-2013		Japan Society for the Promotion of Science [21340149, 25287131]; Taiwan ROC MOST [103-2119-M-002-022]; NTU grant [101R7625]	We would like to thank Norio Iyota and Yoichi Kamikawa of the Taiheiyo Cement Co. for kindly accepting our research project and allowing access to the Fukugaguchi Cave in the limestone mine. Two anonymous reviewers provided constructive comments that improve the manuscript. Weather data were obtained from the website of the Japan Meteorological Agency (http://www.jma.go.jp/). This study was financially supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (21340149 and 25287131) to AK, Taiwan ROC MOST (103-2119-M-002-022), and NTU grant (101R7625) to CCS.	Dreybrodt W, 2008, GEOCHIM COSMOCHIM AC, V72, P4712, DOI 10.1016/j.gca.2008.07.022; Fohlmeister J, 2011, RADIOCARBON, V53, P99; MUCCI A, 1987, GEOCHIM COSMOCHIM AC, V51, P1977, DOI 10.1016/0016-7037(87)90186-4; Baker A, 1998, GEOCHIM COSMOCHIM AC, V62, P393, DOI 10.1016/S0016-7037(97)00343-8; Burns SJ, 2001, GEOLOGY, V29, P623, DOI 10.1130/0091-7613(2001)029<0623:SEFOFC>2.0.CO;2; Fairchild IJ, 2009, QUATERNARY SCI REV, V28, P449, DOI 10.1016/j.quascirev.2008.11.007; Genty D, 2001, GEOCHIM COSMOCHIM AC, V65, P3443, DOI 10.1016/S0016-7037(01)00697-4; Spotl C, 2005, GEOCHIM COSMOCHIM AC, V69, P2451, DOI 10.1016/j.gca.2004.12.009; Mickler PJ, 2006, GEOL SOC AM BULL, V118, P65, DOI 10.1130/B25698.1; Bar-Matthews M, 2000, CHEM GEOL, V169, P145, DOI 10.1016/S0009-2541(99)00232-6; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Fukudome K, 2010, J OCEANOGR, V66, P539; Genty D, 2003, NATURE, V421, P833, DOI 10.1038/nature01391; Broecker WS, 2010, QUATERNARY SCI REV, V29, P1078, DOI 10.1016/j.quascirev.2010.02.019; NESJE A, 1991, GEOLOGY, V19, P610, DOI 10.1130/0091-7613(1991)019<0610:HGACVI>2.3.CO;2; Koizumi I, 2008, MAR MICROPALEONTOL, V69, P263, DOI 10.1016/j.marmicro.2008.08.004; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Paulsen DE, 2003, QUATERNARY SCI REV, V22, P691, DOI 10.1016/S0277-3791(02)00240-8; Genty D, 1999, GEOCHIM COSMOCHIM AC, V63, P1537, DOI 10.1016/S0016-7037(99)00122-2; Fairchild IJ, 2006, EARTH-SCI REV, V75, P105, DOI 10.1016/j.earscirev.2005.08.003; Lachniet MS, 2009, QUATERNARY SCI REV, V28, P412, DOI 10.1016/j.quascirev.2008.10.021; Dorale JA, 1998, SCIENCE, V282, P1871, DOI 10.1126/science.282.5395.1871; Maher BA, 2006, HOLOCENE, V16, P309, DOI 10.1191/0959683606hl929rp; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Clemens SC, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001926; Roberts MS, 1998, EARTH PLANET SC LETT, V154, P237, DOI 10.1016/S0012-821X(97)00116-7; Kaufmann G, 2003, EARTH PLANET SC LETT, V214, P251, DOI 10.1016/S0012-821X(03)00369-8; Lachniet MS, 2004, GEOLOGY, V32, P957, DOI 10.1130/G20797.1; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Shen CC, 2012, GEOCHIM COSMOCHIM AC, V99, P71, DOI 10.1016/j.gca.2012.09.018; Hayashi R, 2010, QUATERNARY RES, V74, P91, DOI 10.1016/j.yqres.2010.04.008; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175; STOWE LG, 1978, AM NAT, V112, P609, DOI 10.1086/283301; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965; Uchida S, 2013, CHEM GEOL, V347, P59, DOI 10.1016/j.chemgeo.2013.04.006; Fairchild IJ, 2000, CHEM GEOL, V166, P255, DOI 10.1016/S0009-2541(99)00216-8; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; HARMON RS, 1978, QUATERNARY RES, V9, P54, DOI 10.1016/0033-5894(78)90082-0; McDermott F, 2004, QUATERNARY SCI REV, V23, P901, DOI 10.1016/j.quascirev.2003.06.021; Hori M, 2008, GEOCHIM COSMOCHIM AC, V72, P480, DOI 10.1016/j.gca.2007.10.025; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Griffiths ML, 2010, EARTH PLANET SC LETT, V292, P27, DOI 10.1016/j.epsl.2010.01.002; GASCOYNE M, 1983, J HYDROL, V61, P213, DOI 10.1016/0022-1694(83)90249-4; Bonds G., 1997, SCIENCE, V294, P2130; BUHMANN D, 1985, CHEM GEOL, V48, P189, DOI 10.1016/0009-2541(85)90046-4; Caley T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6371; Denniston RF, 2001, PALAEOGEOGR PALAEOCL, V176, P147, DOI 10.1016/S0031-0182(01)00334-0; Fukugaguchi Cave Research Committee, 1990, REP FUK CAV; Fukusawas H., 1998, SUMMARIES RES USING, V9, P5; Gascoynes M, 1993, QUATERNARY SCI REV, V75, P609; GOEDE A, 1991, PALAEOGEOGR PALAEOCL, V88, P121, DOI 10.1016/0031-0182(91)90018-M; Hirose N, 2006, SOLA, V2, P61, DOI 10.2151/sola.2006-016; Horis M., 2009, B GRADUATE SCH SOCIA, V15, P51; Hori M, 2013, CHEM GEOL, V347, P190, DOI 10.1016/j.chemgeo.2013.03.005; Huang YM, 2001, GEOCHIM COSMOCHIM AC, V65, P47, DOI 10.1016/S0016-7037(00)00513-5; Inoues J., 2001, DAIYONKI KENKYU, V40, P97; Kanos A., 2012, J GEOL SOC JPN, V118, P157, DOI DOI 10.5575/geosoc.2011.0025; Kijimas T., 2007, CHOJYAGABARA SITE; Koizumi I, 2006, PALAEOGEOGR PALAEOCL, V232, P36, DOI 10.1016/j.palaeo.2005.09.003; Kumons F., 2009, KYUSEKKIKENKYU, V5, P3; Kumons F., 2003, DAIYONKI KENKYU, V42, P13; Kurisaki K., 2006, CHIKYU KAGAKU, V40, P245; Maher BA, 2008, HOLOCENE, V18, P861, DOI 10.1177/0959683608095569; Matsushimas Y., 2010, DAIYONKI KENKYU, V49, P1; Moys C. M., 2002, NATURE, V420, P162; Nakazawa T, 2001, FACIES, V44, P183, DOI 10.1007/BF02668174; NESJE A, 1993, QUATERNARY SCI REV, V12, P255, DOI 10.1016/0277-3791(93)90081-V; OOMORI T, 1987, MAR CHEM, V20, P327, DOI 10.1016/0304-4203(87)90066-1; PAZDUR A, 1988, RADIOCARBON, V30, P7; Quinns J. A., 1988, B NATL SPELEOLOGY SO, V50, P59; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rozanski K., 1993, CLIMATE CHANGE CONTI, DOI [10.1029/GM078p0001, DOI 10.1029/GM078P0001]; Shen CC, 2010, QUATERNARY SCI REV, V29, P3327, DOI 10.1016/j.quascirev.2010.08.012; Sone T, 2013, QUATERNARY SCI REV, V75, P150, DOI 10.1016/j.quascirev.2013.06.019; Takadas H., 2006, DAIYONKI KENKYU, V45, P249; TAKAHARA H, 1992, ECOL RES, V7, P371, DOI 10.1007/BF02347104; Tans M., 2014, CLIM DYNAM, V42, P1067; Wang HP, 2014, QUATERN INT, V334, P155, DOI 10.1016/j.quaint.2014.03.013; Yang XL, 2014, HOLOCENE, V24, P1657, DOI 10.1177/0959683614551222; Yiou P., 1996, EOS T AM GEOGRAPH UN, V77, P379, DOI DOI 10.1029/96E000259	81	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	SEP	2015	24	3					342	358		10.1111/iar.12118		17	Geosciences, Multidisciplinary	Geology	CQ4OK	WOS:000360584100005		
J	Tee, KK; Kantor, R; Sungkanuparph, S; Takebe, Y; Li, P; Ditangco, R; Phanuphak, P; Sirisanthana, T; Sim, B; Ratanasuwan, W; Kantipong, P; Kamarulzaman, A				Tee, Kok Keng; Kantor, Rami; Sungkanuparph, Somnuek; Takebe, Yutaka; Li, Patrick; Ditangco, Rossana; Phanuphak, Praphan; Sirisanthana, Thira; Sim, Benedict; Ratanasuwan, Winai; Kantipong, Pacharee; Kamarulzaman, Adeeba		TREAT Asia Studies Evaluate	Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia	JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES			English	Letter							SUBTYPE B; INFECTION		[Tee, Kok Keng; Takebe, Yutaka; Kamarulzaman, Adeeba] Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Kantor, Rami] Brown Univ, Dept Med, Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA; [Sungkanuparph, Somnuek] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Toyama, Japan; [Li, Patrick] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China; [Ditangco, Rossana] Res Inst Trop Med, Manila, Philippines; [Phanuphak, Praphan] HIV NAT Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Sirisanthana, Thira] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Sim, Benedict] Hosp Sungai Buloh, Kuala Lumpur, Malaysia; [Ratanasuwan, Winai] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Kantipong, Pacharee] Chiangrai Prachanukroh Hosp, Chiang Rai, Thailand	Tee, KK (reprint author), Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.						Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Mayer KH, 2014, CLIN INFECT DIS, V58, P1760, DOI 10.1093/cid/ciu176; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Land S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18580; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Ng KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067286; PAUP, 2003, PHYLOGENETIC ANAL US; Sungkanuparph S, 2011, CLIN INFECT DIS, V52, P1053, DOI 10.1093/cid/cir107	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1525-4135	1077-9450		JAIDS-J ACQ IMM DEF	JAIDS	SEP 1	2015	70	1					E28	E30		10.1097/QAI.0000000000000614		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CQ1HO	WOS:000360348100006		
J	Fujii, N; Tsuji, B; Honda, Y; Kondo, N; Nishiyasu, T				Fujii, Naoto; Tsuji, Bun; Honda, Yasushi; Kondo, Narihiko; Nishiyasu, Takeshi			Effect of short-term exercise-heat acclimation on ventilatory and cerebral blood flow responses to passive heating at rest in humans	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						exercise training; control of breathing; respiratory alkalosis; cerebral perfusion; orthostatic tolerance	PROLONGED SUBMAXIMAL EXERCISE; HYPERTHERMIC HYPERVENTILATION; CORE TEMPERATURE; BODY-TEMPERATURE; STRESSED HUMANS; VELOCITY; HYPERPNEA; CO2; VASODILATION; COMPONENTS	Hyperthermia induces hyperventilation and cerebral hypoperfusion in resting humans. We tested the hypothesis that short-term exercise-heat acclimation would alleviate those effects. Twenty healthy male subjects were divided into two groups that performed exercise training in the heat (TR-HEAT, n = 10) or cold (TR-COLD, n = 10). Before and after the training, the subjects in both groups participated in passive-heat tests at rest. Training was performed at 37 degrees C (TR-HEAT) or 10 degrees C (TR-COLD) and entailed four 20-min bouts of cycling at 50% peak oxygen uptake separated by 10-min recoveries daily for 6 consecutive days. After TR-HEAT, esophageal temperature was lowered when measured before and during passive heating, as was the esophageal temperature threshold for cutaneous active vasodilation, whereas plasma volume was increased (all P < 0.05). These traditional indices of successful heat acclimation were not all induced by TR-COLD (all P > 0.05). TR-HEAT had no significant effect on passive heating-induced increases in minute ventilation, even when evaluated as the esophageal temperature threshold for increases in minute ventilation and the slope relating minute ventilation to esophageal temperature (all P > 0.05). By contrast, TR-HEAT attenuated the passive heating-induced reduction in the cerebral vascular conductance index (middle cerebral artery mean blood velocity/mean arterial pressure) (all P < 0.05). TR-COLD did not attenuate the increase in minute ventilation or the decrease in the cerebral vascular conductance index observed during passive heating (all P > 0.05). These data suggest that in resting heated humans, short-term heat acclimation achieved through moderate-intensity exercise training (i.e., 50% peak oxygen uptake) in the heat does not influence hyperthermia- induced hyperventilation, but it does potentially attenuate cerebral hypoperfusion.	[Fujii, Naoto; Tsuji, Bun; Honda, Yasushi; Nishiyasu, Takeshi] Univ Tsukuba, Inst Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Fujii, Naoto] Univ Ottawa, Sch Human Kinet, Human & Environm Physiol Res Unit, Ottawa, ON, Canada; [Kondo, Narihiko] Kobe Univ, Fac Human Dev, Kobe, Hyogo 657, Japan	Nishiyasu, T (reprint author), Univ Tsukuba, Inst Hlth & Sport Sci, Tsukuba, Ibaraki, Japan.	nisiyasu@taiiku.tsukuba.ac.jp			Center of Excellence projects; Ministry of Education, Science, and Culture of Japan; Japan Society for the Promotion of Science	This study was supported by grants from the Center of Excellence projects, and Ministry of Education, Science, and Culture of Japan. N. Fujii is the recipient of a research fellowship for young scientists from the Japan Society for the Promotion of Science.	Schlader ZJ, 2013, J APPL PHYSIOL, V114, P1730, DOI 10.1152/japplphysiol.00079.2013; WHITNEY RJ, 1953, J PHYSIOL-LONDON, V121, P1; Fujii N, 2012, EUR J APPL PHYSIOL, V112, P295, DOI 10.1007/s00421-011-1980-6; Carter R, 2006, J APPL PHYSIOL, V101, P1744, DOI 10.1152/japplphysiol.00200.2006; DILL DB, 1974, J APPL PHYSIOL, V37, P247; Boden AG, 2000, EXP PHYSIOL, V85, P527, DOI 10.1017/S0958067000020534; Tsuji B, 2012, J APPL PHYSIOL, V113, P1388, DOI 10.1152/japplphysiol.00335.2012; Nelson MD, 2011, J PHYSIOL-LONDON, V589, P4053, DOI 10.1113/jphysiol.2011.212118; Brothers RM, 2009, J PHYSIOL-LONDON, V587, P3921, DOI 10.1113/jphysiol.2009.172023; Wilson TE, 2006, AM J PHYSIOL-REG I, V291, pR1443, DOI 10.1152/ajpregu.00712.2005; Fujii N, 2008, J APPL PHYSIOL, V104, P998, DOI 10.1152/japplphysiol.00146.2007; White MD, 1996, J APPL PHYSIOL, V81, P1249; Hayashi K, 2006, J APPL PHYSIOL, V100, P414, DOI 10.1152/japplphysiol.00541.2005; Garrett AT, 2012, EUR J APPL PHYSIOL, V112, P1827, DOI 10.1007/s00421-011-2153-3; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Lorenzo S, 2010, J APPL PHYSIOL, V109, P1736, DOI 10.1152/japplphysiol.00725.2010; Patterson MJ, 2004, AM J PHYSIOL-REG I, V286, pR512, DOI 10.1152/ajpregu.00359.2003; Ross EZ, 2012, J APPL PHYSIOL, V112, P748, DOI 10.1152/japplphysiol.00988.2011; Thomas KN, 2010, J HUM HYPERTENS, V24, P458, DOI 10.1038/jhh.2009.93; White MD, 2006, J APPL PHYSIOL, V101, P655, DOI 10.1152/japplphysiol.00210.2006; Fujii N, 2008, EXP PHYSIOL, V93, P994, DOI 10.1113/expphysiol.2008.042143; Rasmussen P, 2006, EUR J APPL PHYSIOL, V96, P299, DOI 10.1007/s00421-005-0079-3; Bain AR, 2013, J APPL PHYSIOL, V115, P653, DOI 10.1152/japplphysiol.00394.2013; Takeno Y, 2001, J APPL PHYSIOL, V91, P1520; CABANAC M, 1995, EUR J APPL PHYSIOL O, V71, P71, DOI 10.1007/BF00511235; Beaudin AE, 2009, AM J PHYSIOL-REG I, V297, pR605, DOI 10.1152/ajpregu.90672.2008; Murrell CJ, 2013, AGE, V35, P905, DOI 10.1007/s11357-012-9414-x; Serrador JM, 2000, STROKE, V31, P1672; KELLOGG DL, 1995, CIRC RES, V77, P1222; BLAND JM, 1986, LANCET, V1, P307; Buono MJ, 1998, AM J PHYSIOL-REG I, V274, pR1295; COLTON JS, 1972, AM J PHYSIOL, V223, P1041; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; DETRY JMR, 1972, J APPL PHYSIOL, V32, P506; Hayashi K, 2011, J APPL PHYSIOL, V110, P1334, DOI 10.1152/japplphysiol.00010.2010; Hodge D, 2013, AUTON NEUROSCI-BASIC, V177, P101, DOI 10.1016/j.autneu.2013.02.017; JESSEN C, 1983, J APPL PHYSIOL, V54, P880; JOELS N, 1968, J PHYSIOL-LONDON, V197, P1; Kovtun LT, 2013, INT J CIRCUMPOL HEAL, V5, P72; Nybo L, 2001, J PHYSIOL-LONDON, V534, P279, DOI 10.1111/j.1469-7793.2001.t01-1-00279.x; Ogoh S, 2014, J APPL PHYSIOL, V117, P46, DOI 10.1152/japplphysiol.01078.2013; Pierau FK, 1994, THERMAL BALANCE HLTH, P31; Poirier MP, 2015, MED SCI SPORT EXER, V47, P390, DOI 10.1249/MSS.0000000000000401; RIEDEL W, 1973, PFLUG ARCH EUR J PHY, V340, P59, DOI 10.1007/BF00592197; Rowell LB, 1986, HUMAN CIRCULATION; Sancheti A, 2006, EUR J APPL PHYSIOL, V96, P495, DOI 10.1007/s00421-005-0101-9; SHVARTZ E, 1975, J APPL PHYSIOL, V39, P590; Taylor NAS, 2014, COMPR PHYSIOL, V4, P325, DOI 10.1002/cphy.c130022; TAYLOR WF, 1984, J APPL PHYSIOL, V57, P191; Tsuji B, 2012, AM J PHYSIOL-REG I, V302, pR94, DOI 10.1152/ajpregu.00048.2011; VANZETTI G, 1966, J LAB CLIN MED, V67, P116; Visocchi M, 1996, STEREOT FUNCT NEUROS, V66, P184, DOI 10.1159/000099687; WENGER CB, 1980, J APPL PHYSIOL, V48, P114; Wilsmore BR, 2006, SPINAL CORD, V44, P160, DOI 10.1038/sj.sc.3101823; Yamazaki F, 2003, J APPL PHYSIOL, V95, P1567, DOI 10.1152/japplphysiol.00063.2003	55	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	SEP 1	2015	119	5					435	444		10.1152/japplphysiol.01049.2014		10	Physiology; Sport Sciences	Physiology; Sport Sciences	CQ6DJ	WOS:000360694300002		
J	Tomoto, T; Sugawara, J; Nogami, Y; Aonuma, K; Maeda, S				Tomoto, Tsubasa; Sugawara, Jun; Nogami, Yoshie; Aonuma, Kazutaka; Maeda, Seiji			The influence of central arterial compliance on cerebrovascular hemodynamics: insights from endurance training intervention	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						cerebral hemodynamics; central arterial compliance; left ventricular contractility; endurance training; pulsatile component	SMALL-VESSEL DISEASE; PULSE-WAVE VELOCITY; CEREBRAL-BLOOD-FLOW; MICROVASCULAR DISEASE; INDEPENDENT PREDICTOR; HABITUAL EXERCISE; AEROBIC FITNESS; STIFFNESS; STROKE; PULSATILITY	Normally, central elastic arteries (e.g., aorta and common carotid artery) effectively buffer cardiac pulsation-induced flow/pressure fluctuations. With advancing age, arterial stiffening deteriorates this function and produces the greater cerebral hemodynamic pulsatility that impacts vulnerable brain tissue. It is well known that the buffering function of the central artery is improved by regular aerobic exercise, but the influence of endurance training on the pulsatile component of cerebral hemodynamics remains poorly understood. To characterize the functional role of the central artery at the heart-brain hemodynamic connection comprehensively, we assessed relations among the endurance training-induced changes in the left ventricle (LV), carotid arterial compliance, and cerebral hemodynamics. Thirteen collegiate tennis players (20 +/- 1 yr) underwent a 16-wk endurance training intervention designed for improving cardiovascular function. Expectedly, maximal oxygen uptake ((V) over dotO(2peak)), LV ejection velocity (via Doppler ultrasound), and the maximal rate of pressure increase of estimated aortic pressure waveform (via general transfer function) improved after the training intervention, whereas middle cerebral arterial (MCA) hemodynamics (via transcranial Doppler), such as mean and pulsatile flow velocities, remained unchanged. Carotid arterial compliance (via ultrasound and applanation tonometry) increased after the training intervention, and a larger increase in carotid arterial compliance was significantly associated with the greater attenuations of pulsatile MCA velocity (r = -0.621) normalized by mean MCA velocity. These results suggest that the training-induced improvement of carotid artery Windkessel function might offset the expected increase in the pulsatile component of cerebral perfusion induced by the enhanced LV systolic function.	[Tomoto, Tsubasa] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Tomoto, Tsubasa; Sugawara, Jun] Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tsukuba, Ibaraki, Japan; [Nogami, Yoshie] Shonan Inst Technol, Fac Engn, Fujisawa, Kanagawa 251, Japan; [Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Maeda, Seiji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan	Sugawara, J (reprint author), Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	jun.sugawara@aist.go.jp			Japanese Ministry of Education, Science, and Culture [26670116]	This study was supported, in part, by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, and Culture (grant no. 26670116).	O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Brown AD, 2010, NEUROBIOL AGING, V31, P2047, DOI 10.1016/j.neurobiolaging.2008.11.002; LEWIS JF, 1984, CIRCULATION, V70, P425; Hirata K, 2006, STROKE, V37, P2552, DOI 10.1161/01.STR.0000242289.20381.f4; Henskens LHG, 2008, HYPERTENSION, V52, P1120, DOI 10.1161/HYPERTENSIONAHA.108.119024; Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; Tarumi T, 2014, J CEREBR BLOOD F MET, V34, P971, DOI 10.1038/jcbfm.2014.44; Scuteri A, 2007, J HYPERTENS, V25, P1035, DOI 10.1097/HJH.0b013e3280895b55; Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Scolletta S, 2013, INTENS CARE MED, V39, P1025, DOI 10.1007/s00134-013-2861-8; Wohlfahrt P, 2014, J HYPERTENS, V32, P1097, DOI 10.1097/HJH.0000000000000137; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Spence AL, 2011, J PHYSIOL-LONDON, V589, P5443, DOI 10.1113/jphysiol.2011.217125; de la Torre JC, 2010, AGEING RES REV, V9, P218, DOI 10.1016/j.arr.2010.04.002; Sugawara J, 2009, INT J CARDIOL, V135, P346, DOI 10.1016/j.ijcard.2008.04.007; Pluim BM, 2000, CIRCULATION, V101, P336; Bruel A, 1998, ATHEROSCLEROSIS, V140, P135, DOI 10.1016/S0021-9150(98)00130-0; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Maeda S, 2009, ACTA PHYSIOL, V196, P223, DOI 10.1111/j.1748-1716.2008.01909.x; Tanaka H, 2000, CIRCULATION, V102, P1270; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64; Murrell CJ, 2013, AGE, V35, P905, DOI 10.1007/s11357-012-9414-x; Markus HS, 2004, J NEUROL NEUROSUR PS, V75, P353, DOI 10.1136/jnnp.2003.025825; Tarumi T, 2011, AM J HYPERTENS, V24, P1108, DOI 10.1038/ajh.2011.101; Caselli S, 2011, EUR J ECHOCARDIOGR, V12, P514, DOI 10.1093/ejechocard/jer071; Kim DH, 2010, EUR NEUROL, V64, P247, DOI 10.1159/000319923; Lee CD, 2002, MED SCI SPORT EXER, V34, P592; Nichols WW, 2011, MCDONALDS BLOOD FLOW; Tanahashi K, 2014, AM J HYPERTENS, V27, P415, DOI 10.1093/ajh/hpt217; Weissler A M, 1971, Mod Concepts Cardiovasc Dis, V40, P1	32	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	SEP 1	2015	119	5					445	451		10.1152/japplphysiol.00129.2015		7	Physiology; Sport Sciences	Physiology; Sport Sciences	CQ6DJ	WOS:000360694300003		
J	Matsukawa, K; Ishii, K; Liang, N; Endo, K; Ohtani, R; Nakamoto, T; Wakasugi, R; Kadowaki, A; Komine, H				Matsukawa, Kanji; Ishii, Kei; Liang, Nan; Endo, Kana; Ohtani, Ryo; Nakamoto, Tomoko; Wakasugi, Rie; Kadowaki, Akito; Komine, Hidehiko			Increased oxygenation of the cerebral prefrontal cortex prior to the onset of voluntary exercise in humans	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						regional cerebral blood flow; voluntary ergometer; motor-driven passive exercise; near-infrared spectroscopy	NEAR-INFRARED SPECTROSCOPY; TRANSCRANIAL MAGNETIC STIMULATION; EFFERENT NERVE ACTIVITY; CENTRAL COMMAND; BLOOD-FLOW; DECEREBRATE CATS; DYNAMIC EXERCISE; CARDIOVASCULAR-RESPONSES; OVERGROUND LOCOMOTION; ANTERIOR CINGULATE	To determine whether output from the forebrain (termed central command) may descend early enough to increase cardiac and renal sympathetic outflows at the onset of voluntary exercise, we examined the changes in regional tissue blood flows of bilateral prefrontal cortices with near-infrared spectroscopy, precisely identifying the onset of voluntary ergometer 30-s exercise at 41 +/- 2% of the maximal exercise intensity in humans. Prefrontal oxygenated-hemoglobin (Oxy-Hb) concentration was measured as index of regional blood flow unless deoxygenated-hemoglobin concentration remained unchanged. Prefrontal Oxy-Hb concentration increased significantly (P < 0.05) 5 s prior to the onset of exercise with arbitrary start, whereas such increase in prefrontal Oxy-Hb was absent before exercise abruptly started by a verbal cue. Furthermore, the increase in prefrontal Oxy-Hb observed at the initial 15-s period of exercise was greater with arbitrary start than cued start. The prefrontal Oxy-Hb, thereafter, decreased during the later period of exercise, irrespective of either arbitrary or cued start. The reduction in prefrontal Oxy-Hb had the same time course and response magnitude as that during motor-driven passive exercise. Cardiac output increased at the initial period of exercise, whereas arterial blood pressure and total peripheral resistance decreased. The depressor response was more pronounced (P < 0.05) with arbitrary start than cued start. Taken together, it is suggested that the increase in prefrontal Oxy-Hb observed prior to the onset of voluntary exercise may be in association with central command, while the later decrease in the Oxy-Hb during exercise may be in association with feedback stimulated by mechanical limb motion.	[Matsukawa, Kanji; Ishii, Kei; Liang, Nan; Endo, Kana; Ohtani, Ryo; Nakamoto, Tomoko; Wakasugi, Rie; Kadowaki, Akito] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Integrat Physiol, Hiroshima 7348551, Japan; [Komine, Hidehiko] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan	Matsukawa, K (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Integrat Physiol, Kasumi 1-2-3, Hiroshima 7348551, Japan.	matsuk@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Center of Innovation Program from Japan Science and Technology Agency (JST)	Support for this study was provided by Grants-in-Aid for Scientific Research (B) and for Exploratory Research from the Japan Society for the Promotion of Science (JSPS) and partially supported by the Center of Innovation Program from Japan Science and Technology Agency (JST). K. Ishii was supported as a JSPS research fellow.	Kovach CK, 2012, J NEUROSCI, V32, P8434, DOI 10.1523/JNEUROSCI.5468-11.2012; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657; GOODWIN GM, 1972, J PHYSIOL-LONDON, V226, P173; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Miyazawa T, 2013, EUR J APPL PHYSIOL, V113, P2841, DOI 10.1007/s00421-013-2723-7; Westerhaus MJ, 2001, BRAIN RES, V903, P117, DOI 10.1016/S0006-8993(01)02453-2; Rupp T, 2008, EUR J APPL PHYSIOL, V102, P153, DOI 10.1007/s00421-007-0568-7; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; HOSHI Y, 1993, J APPL PHYSIOL, V75, P1842; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740; Hassan SF, 2013, J PHYSIOL-LONDON, V591, P6069, DOI 10.1113/jphysiol.2013.262071; Thornton JM, 2002, J PHYSIOL-LONDON, V539, P615, DOI 10.1013/jphysiol.2001.014621; Williamson JW, 2003, J APPL PHYSIOL, V94, P1726, DOI 10.1152/japplphysiol.01152.2002; DECETY J, 1993, J PHYSIOL-LONDON, V461, P549; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Williamson JW, 2002, J APPL PHYSIOL, V92, P1317, DOI 10.1152/japplphysiol.00939.2001; Ishii K, 2012, J APPL PHYSIOL, V112, P1961, DOI 10.1152/japplphysiol.00075.2012; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; ELDRIDGE FL, 1981, SCIENCE, V211, P844, DOI 10.1126/science.7466362; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; ELWELL CE, 1994, J APPL PHYSIOL, V77, P2753; Endo K, 2013, J PHYSIOL SCI, V63, P287, DOI 10.1007/s12576-013-0267-6; Furubayashi T, 2013, J NEUROPHYSIOL, V109, P1626, DOI 10.1152/jn.00980.2011; GANDEVIA SC, 1993, J PHYSIOL-LONDON, V470, P85; Ishii K, 2013, PHYSL REP, V1; Ishii K, 2014, PHYSL REP, V2; Kadowaki A, 2011, AM J PHYSIOL-HEART C, V300, pH1373, DOI 10.1152/ajpheart.01296.2010; Liang N, 2011, J APPL PHYSIOL, V110, P670, DOI 10.1152/japplphysiol.00740.2010; Matsukawa K, 2012, EXP PHYSIOL, V97, P20, DOI 10.1113/expphysiol.2011.057661; Matsukawa K., 2001, EXERCISE NUTR ENV ST, V1, P39; Matsukawa K, 1998, AM J PHYSIOL-HEART C, V275, pH1115; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; MITCHELL JH, 1990, MED SCI SPORT EXER, V22, P141; Nowak M, 1999, J APPL PHYSIOL, V86, P819; Ogoh S, 2009, J APPL PHYSIOL, V106, P880, DOI 10.1152/japplphysiol.91292.2008; Rostrup E, 2002, BRAIN RES, V954, P183, DOI 10.1016/S0006-8993(02)03246-8; Sadamoto T, 1997, J APPL PHYSIOL, V83, P1454; Sander M, 2010, J APPL PHYSIOL, V108, P1691, DOI 10.1152/japplphysiol.91539.2008; Sato K, 2009, EXP PHYSIOL, V94, P1139, DOI 10.1113/expphysiol.2009.048587; Shoemaker JK, 2015, AUTON NEUROSCI-BASIC, V188, P5, DOI 10.1016/j.autneu.2014.10.022; VERBERNE AJM, 1987, BRAIN RES, V426, P243, DOI 10.1016/0006-8993(87)90878-X; Vianna LC, 2009, J APPL PHYSIOL, V107, P1113, DOI 10.1152/japplphysiol.00480.2009; Vianna LC, 2015, AM J PHYSIOL-REG I, V308, pR597, DOI 10.1152/ajpregu.00236.2014; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027	48	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	SEP 1	2015	119	5					452	462		10.1152/japplphysiol.00406.2015		11	Physiology; Sport Sciences	Physiology; Sport Sciences	CQ6DJ	WOS:000360694300004		
J	Ogoh, S; Hirasawa, A; Sugawara, J; Nakahara, H; Ueda, S; Shoemaker, JK; Miyamoto, T				Ogoh, Shigehiko; Hirasawa, Ai; Sugawara, Jun; Nakahara, Hidehiro; Ueda, Shinya; Shoemaker, J. Kevin; Miyamoto, Tadayoshi			The effect of an acute increase in central blood volume on the response of cerebral blood flow to acute hypotension	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						arterial pressure; dynamic regulation; cardiac output; transcranial Doppler; humans	OBSTRUCTIVE SLEEP-APNEA; AUTONOMIC NEURAL-CONTROL; VERTEBRAL ARTERIES; ORTHOSTATIC STRESS; DYNAMIC EXERCISE; CARBON-DIOXIDE; TRANSIENT HYPOTENSION; CONSCIOUS HUMANS; AUTOREGULATION; PRESSURE	The purpose of the present study was to examine whether the response of cerebral blood flow to an acute change in perfusion pressure is modified by an acute increase in central blood volume. Nine young, healthy subjects voluntarily participated in this study. To measure dynamic cerebral autoregulation during normocapnic and hypercapnic (5%) conditions, the change in middle cerebral artery mean blood flow velocity was analyzed during acute hypotension caused by two methods: 1) thigh-cuff occlusion release (without change in central blood volume); and 2) during the recovery phase immediately following release of lower body negative pressure (LBNP; -50 mmHg) that initiated an acute increase in central blood volume. In the thigh-cuff occlusion release protocol, as expected, hypercapnia decreased the rate of regulation, as an index of dynamic cerebral autoregulation (0.236 +/- 0.018 and 0.167 +/- 0.025 s(-1), P = 0.024). Compared with the cuff-occlusion release, the acute increase in central blood volume (relative to the LBNP condition) with LBNP release attenuated dynamic cerebral autoregulation (P = 0.009). Therefore, the hypercapnia-induced attenuation of dynamic cerebral autoregulation was not observed in the LBNP release protocol (P = 0.574). These findings suggest that an acute change in systemic blood distribution modifies dynamic cerebral autoregulation during acute hypotension.	[Ogoh, Shigehiko; Hirasawa, Ai] Toyo Univ, Kawagoe, Saitama 3508585, Japan; [Sugawara, Jun] Natl Inst Adv Ind Sci & Technol, Tsukuba, Japan; [Nakahara, Hidehiro; Ueda, Shinya; Miyamoto, Tadayoshi] Morinomiya Univ Med Sci, Osaka, Japan; [Shoemaker, J. Kevin] Western Univ, London, ON, Canada	Ogoh, S (reprint author), Toyo Univ, Dept Biomed Engn, 2100 Kujirai, Kawagoe, Saitama 3508585, Japan.	ogoh@toyo.jp			Japanese Ministry of Education, Culture, Sports, and Science [24300237]	This study was supported in part by a Grant-in-Aid for Scientific Research (no. 24300237) from the Japanese Ministry of Education, Culture, Sports, and Science.	Sugawara J, 2010, HYPERTENSION, V56, P920, DOI 10.1161/HYPERTENSIONAHA.110.160549; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Ogoh S, 2007, J PHYSIOL-LONDON, V581, P405, DOI 10.1113/jphysiol.2006.125112; TIECKS FP, 1995, STROKE, V26, P1014; Tzeng YC, 2010, HYPERTENSION, V56, P268, DOI 10.1161/HYPERTENSIONAHA.110.152066; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Shoemaker JK, 2002, CAN J PHYSIOL PHARM, V80, P1136, DOI 10.1139/Y02-148; Ogoh S, 2005, J PHYSIOL-LONDON, V569, P697, DOI 10.1113/jphysiol.2005.095836; SATO T, 1993, HYPERTENSION, V21, P866; Zhang R, 1998, J APPL PHYSIOL, V85, P1113; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; AASLID R, 1989, STROKE, V20, P45; Sato K, 2012, EXP PHYSIOL, V97, P1272, DOI 10.1113/expphysiol.2012.064774; Coverdale NS, 2015, AM J PHYSIOL-HEART C, V308, pH1030, DOI 10.1152/ajpheart.00761.2014; LASSEN NA, 1964, CIRC RES, V15, P201; Immink RV, 2004, CIRCULATION, V110, P2241, DOI 10.1161/01.CIR.0000144472.08647.40; Urbano F, 2008, J APPL PHYSIOL, V105, P1852, DOI 10.1152/japplphysiol.90900.2008; Fadel PJ, 2012, EXP PHYSIOL, V97, P39, DOI 10.1113/expphysiol.2011.057554; Panerai RB, 2010, J APPL PHYSIOL, V109, P1860, DOI 10.1152/japplphysiol.00857.2010; Lucas SJE, 2010, HYPERTENSION, V55, P698, DOI 10.1161/HYPERTENSIONAHA.109.146290; Ogoh S, 2013, J CEREBR BLOOD F MET, V33, P1915, DOI 10.1038/jcbfm.2013.149; Nasr N, 2009, EUR J NEUROL, V16, P386, DOI 10.1111/j.1468-1331.2008.02505.x; Ogoh S, 2003, J PHYSIOL-LONDON, V551, P601, DOI 10.1113/jphysiol.2003.046029; Tzeng YC, 2012, AM J PHYSIOL-HEART C, V303, pH658, DOI 10.1152/ajpheart.00328.2012; Lewis NCS, 2015, CLIN SCI, V129, P169, DOI 10.1042/CS20140751; Ogoh S, 2014, EXP PHYSIOL, V99, P849, DOI 10.1113/expphysiol.2013.076802; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; Sato K, 2011, J PHYSIOL-LONDON, V589, P2847, DOI 10.1113/jphysiol.2010.204461; Ogoh S, 2013, CLIN SCI, V125, P37, DOI 10.1042/CS20120335; Ogoh S, 2008, STROKE, V39, P1979, DOI 10.1161/STROKEAHA.107.510008; Ogoh S, 2006, J APPL PHYSIOL, V100, P51, DOI 10.1152/japplphysiol.00804.2005; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Serrador JM, 2000, STROKE, V31, P1672; Sato K, 2012, J PHYSIOL-LONDON, V590, P3277, DOI 10.1113/jphysiol.2012.230425; ELAM M, 1981, BRAIN RES, V222, P373, DOI 10.1016/0006-8993(81)91040-4; Ogoh S, 2005, AM J PHYSIOL-HEART C, V288, pH1461, DOI 10.1152/ajpheart.00948.2004; Ogoh S, 2006, J APPL PHYSIOL, V101, P68, DOI 10.1152/jappalphysiol.01452.2005; Cassaglia PA, 2008, SLEEP, V31, P1729; Castro PM, 2014, J APPL PHYSIOL, V117, P205, DOI 10.1152/japplphysiol.00893.2013; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Dineen NE, 2010, J APPL PHYSIOL, V108, P604, DOI 10.1152/japplphysiol.01157.2009; FITZGERA.RS, 1971, RESP PHYSIOL, V12, P218, DOI 10.1016/0034-5687(71)90054-5; GILLER CA, 1993, NEUROSURGERY, V32, P737; Gujic M, 2007, J PHYSIOL-LONDON, V585, P165, DOI 10.1113/jphysiol.2007.141002; Kimmerly DS, 2003, CLIN PHYSIOL FUNCT I, V23, P314, DOI 10.1046/j.1475-0961.2003.00507.x; LEE KD, 1964, Q J EXP PHYSIOL CMS, V49, P171; Ogoh S, 2015, EXP PHYSIOL, V100, P259, DOI 10.1113/expphysiol.2014.083964; Ogoh S, 2015, EXP PHYSIOL, V100, P109, DOI 10.1113/expphysiol.2014.084202; Ogoh S, 2010, J APPL PHYSIOL, V108, P538, DOI 10.1152/japplphysiol.01235.2009; Ogoh S, 2010, J PHYSIOL-LONDON, V588, P365, DOI 10.1113/jphysiol.2009.180844; Panerai RB, 2008, PHYSIOL MEAS, V29, P497, DOI 10.1088/0967-3334/29/4/006; Panerai RB, 2003, PHYSIOL MEAS, V24, P367, DOI 10.1088/0967-3334/24/2/312; Tsivgoulis G, 2009, EUR J NEUROL, V16, P283, DOI 10.1111/j.1468-1331.2008.02501.x; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Vianna LC, 2015, AM J PHYSIOL-HEART C, V308, pH681, DOI 10.1152/ajpheart.00343.2014	55	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	SEP 1	2015	119	5					527	533		10.1152/japplphysiol.00277.2015		7	Physiology; Sport Sciences	Physiology; Sport Sciences	CQ6DJ	WOS:000360694300012		
J	Ishihara, M; Kumano, I; Hattori, H; Nakamura, S				Ishihara, Masayuki; Kumano, Isao; Hattori, Hidemi; Nakamura, Shingo			Application of hydrogels as submucosal fluid cushions for endoscopic mucosal resection and submucosal dissection	JOURNAL OF ARTIFICIAL ORGANS			English	Review						Endoscopic mucosal resection (EMR); Endoscopic submucosal dissection (ESD); Photocrosslinked chitosan hydrogel (PCH); Submucosal fluid cushion (SFC); Tissue adhesive	PHOTOCROSSLINKABLE CHITOSAN HYDROGEL; FIBROBLAST GROWTH FACTOR-2; DMEM/F12 MEDIUM; INJECTION; ADHESIVE; BIOCOMPATIBILITY; NANOPARTICLES; ACCELERATION; DELIVERY; CANCER	Numerous new techniques have recently been reported and described for the endoscopic mucosal resection (EMR) of large superficial lesions of the gastrointestinal tract, using various natural, synthetic, and semi-synthetic materials such as chitin/chitosan and their derivatives. Although saline-assisted EMR is an established minimally invasive therapy, en bloc resection and histopathological analyses are required to determine its curative potential. In addition, complete resection of lesions of > 2 cm in diameter remains difficult, despite improved EMR techniques. The development of endoscopic submucosal dissection (ESD) has increased dissection rates for en bloc resection of large lesions, but perforation occurs more frequently during ESD than during EMR. Submucosal injections of those biomaterials which have high viscosity and hydrogelatinization ability as submucosal fluid cushions (SFC) may facilitate ESD as well as EMR for the treatment of superficial tumors of the alimentary tract. In this review, we describe the application of biomaterials such as chitosan derivatives, sodium hyaluronate, and 50 % glucose as a SFC for ESD, focusing photocrosslinked chitosan hydrogels (PCH) which we have originally developed.	[Ishihara, Masayuki; Hattori, Hidemi; Nakamura, Shingo] Natl Def Med Coll, Div Biomed Engn, Res Inst, Tokorozawa, Saitama 3598513, Japan; [Kumano, Isao] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan	Ishihara, M (reprint author), Natl Def Med Coll, Div Biomed Engn, Res Inst, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	ishihara@ndmc.ac.jp					Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013; Ono K, 2000, J BIOMED MATER RES, V49, P289; Obara K, 2005, WOUND REPAIR REGEN, V13, P390, DOI 10.1111/j.1067-1927.2005.130406.x; Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1; Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197; FRANK S, 1995, J BIOL CHEM, V270, P12607; Ishihara M, 2001, WOUND REPAIR REGEN, V9, P513, DOI 10.1046/j.1524-475x.2001.00513.x; Nagpal K, 2010, CHEM PHARM BULL, V58, P1423; Horio T, 2010, ARTIF ORGANS, V34, P342, DOI 10.1111/j.1525-1594.2009.00855.x; Chavakis T, 2004, FASEB J, V18, P1306, DOI 10.1096/fj.03-1009fje; Pedersen TB, 2012, ANN THORAC SURG, V94, P234, DOI 10.1016/j.athoracsur.2012.03.050; Fujishiro M, 2005, GASTROINTEST ENDOSC, V62, P933, DOI 10.1016/j.gie.2005.07.052; Kumano I, 2012, GASTROINTEST ENDOSC, V75, P841, DOI 10.1016/j.gie.2011.10.035; Inoue H, 1999, CAN J GASTROENTEROL, V13, P477; Feitoza AB, 2003, GASTROINTEST ENDOSC, V57, P41, DOI 10.1067/mge.2003.25; Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x; HIRAO M, 1988, GASTROINTEST ENDOSC, V34, P264, DOI 10.1016/S0016-5107(88)71327-9; VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270; Xu YM, 2003, INT J PHARM, V250, P215, DOI 10.1016/S0378-5173(02)00548-3; Ishizuka T, 2007, ENDOSCOPY, V39, P428, DOI 10.1055/s-2007-966393; ESCOTT GM, 1995, INFECT IMMUN, V63, P4770; Hattori H, 2013, ARTIF ORGANS, V37, P478; Hayashi T, 2004, J BIOMED MATER RES B, V71B, P367, DOI 10.1002/jbm.b.30099; Ishihara M, 2012, CHITOSAN BASED SYSTE, P93; Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0; Ishizuka T, 2009, ENDOSCOPY, V41, P25, DOI 10.1055/s-0028-1103483; Kaehler GFBA, 2007, EUR SURG RES, V39, P93, DOI 10.1159/000099597; Katsinelos P, 2008, GASTROINTEST ENDOSC, V68, P692, DOI 10.1016/j.gie.2008.02.063; Kiyozumi T, 2007, BURNS, V33, P642, DOI 10.1016/j.burns.2006.09.010; Kizilel Seda, 2005, Diabetes Technol Ther, V7, P968, DOI 10.1089/dia.2005.7.968; Masuoka K, 2005, BIOMATERIALS, V26, P3277, DOI 10.1016/j.biomaterials.2004.07.061; MOY OJ, 1988, J HAND SURG-AM, V13A, P273; No HK, 2000, REV ENVIRON CONTAM T, V163, P1; Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003; Otani Y, 1996, J Biomed Mater Res, V31, P158; Park MH, 2015, MACROMOL BIOSCI, V15, P464, DOI 10.1002/mabi.201400426; Suzuki H, 2001, Gastrointest Endosc Clin N Am, V11, P511; Tada M, 1996, GASTROINTEST ENDOSC, V44, P63, DOI 10.1016/S0016-5107(96)70231-6; TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U; VANHOLDER R, 1993, BIOMATERIALS, V14, P737, DOI 10.1016/0142-9612(93)90037-3; Vesselov LM, 2004, LASER SURG MED, V34, P348, DOI 10.1002/lsm.20031; Walker KJ, 2015, J BIOMED MATER RES B, V103, P1149, DOI 10.1002/jbm.b.33293; Yamamoto H, 1999, GASTROINTEST ENDOSC, V50, P251, DOI 10.1016/S0016-5107(99)70234-8	43	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					191	198		10.1007/s10047-015-0843-z		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700001		
J	Yamada, A; Shiraishi, Y; Miura, H; Hashem, HMO; Tsuboko, Y; Yamagishi, M; Yambe, T				Yamada, Akihiro; Shiraishi, Yasuyuki; Miura, Hidekazu; Hashem, Hashem Mohamed Omran; Tsuboko, Yusuke; Yamagishi, Masaaki; Yambe, Tomoyuki			Development of a thermodynamic control system for the Fontan circulation pulsation device using shape memory alloy fibers	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Fontan circulation; Congenital heart disease; Shape memory alloy fiber	TOTAL CAVOPULMONARY CONNECTION; ASSIST DEVICE; FLOW; OPERATION; FAILURE; SUPPORT; MODEL	The Fontan procedure is one of the common surgical treatments for circulatory reconstruction in pediatric patients with congenital heart disease. In Fontan circulation, low pulsatility may induce localized lung ischemia and may impair the development of pulmonary peripheral endothelial cells. To promote pulmonary circulation in Fontan circulation, we have been developing a pediatric pulmonary circulatory pulsation device using shape memory alloy fibers attached from the outside of total cavopulmonary connection. In this study, we developed a new thermal control system for the device and examined its functions. We mounted on the device 16 fibers connected in parallel around an ePTFE graft circumferentially. To provide optimized contraction, we designed the new thermal control system. The system consisted of a thermistor, a pressure sensor, and a regulator that was controlled by the adaptive thermodynamic transfer functions. We monitored the parameters and calculated heat transfer function as well as pressure distribution on the graft surface. Then we examined and compared the dynamic contractile pressure and changes in surface temperature. As a result, by the application of the control based on the new feedback system analysis, the circumferential contractile pressure increased by 35 %. The adaptive thermodynamic regulation was useful for the selection of alternative thresholds of the surface temperature of the graft. The system could achieve effective contraction for the pulsatile flow generation by the device.	[Yamada, Akihiro; Tsuboko, Yusuke; Yambe, Tomoyuki] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 9808575, Japan; [Yamada, Akihiro; Shiraishi, Yasuyuki; Miura, Hidekazu; Yambe, Tomoyuki] Tohoku Univ, Dept Med Engn & Cardiol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Hashem, Hashem Mohamed Omran] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Yamagishi, Masaaki] Kyoto Prefectural Univ Med, Pediat Cardiovasc Surg, Kyoto, Japan	Shiraishi, Y (reprint author), Tohoku Univ, Dept Med Engn & Cardiol, Inst Dev Aging & Canc, Aoba Ku, Seiryo Machi 4-1, Sendai, Miyagi 9808575, Japan.	akiyamada@idac.tohoku.ac.jp; shiraishi@idac.tohoku.ac.jp; yambe@idac.tohoku.ac.jp			JSPS KAKENHI [25282126, 26560199]; JSPS [26.6949]	This work was supported by JSPS KAKENHI Grant Number 25282126, 26560199, and JSPS Fellows Grant Number 26.6949.	ACCF Heart Failure and Transplant and Transplant Committee AHA Heart Failure and Transplantation Committee and Heart Failure Society of America, 2011, J AM COLL CARDIOL, V17, P349; Kogon BE, 2008, J THORAC CARDIOV SUR, V136, P1237, DOI 10.1016/j.jtcvs.2008.05.017; HUMES RA, 1988, J THORAC CARDIOV SUR, V96, P212; Henaine R, 2013, J THORAC CARDIOV SUR, V146, P522, DOI 10.1016/j.jtcvs.2012.11.031; Shiraishi Y, 2005, P ANN INT IEEE EMBS, P406, DOI 10.1109/IEMBS.2005.1616431; Tedford RJ, 2012, CIRCULATION, V125, P289, DOI 10.1161/CIRCULATIONAHA.111.051540; Hjortdal VE, 2003, CIRCULATION, V108, P1227, DOI 10.1161/01.CIR.0000087406.27922.6B; FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240; Bhavsar SS, 2009, ARTIF ORGANS, V33, P977, DOI 10.1111/j.1525-1594.2009.00940.x; Cochrane AD, 1997, EUR J CARDIO-THORAC, V12, P107, DOI 10.1016/S1010-7940(97)00112-7; de Leval MR, 1998, PEDIATR CARDIOL, V19, P316; Homma D, 2007, P INT C SHAP MEM SUP, P463; Kaza AK, 2015, EUR J CARDIO-THORAC, V47, P505, DOI 10.1093/ejcts/ezu198; Malhotra SP, 2008, CIRCULATION, V118, pS177, DOI 10.1161/CIRCULATIONAHA.107.751784; MARCELLETTI C, 1990, J THORAC CARDIOV SUR, V100, P228; Miura H, 2013, IEEE ENG MED BIO, P5723, DOI 10.1109/EMBC.2013.6610850; NORMAN JC, 1981, CARDIOVASC DIS, V8, P119; Riemer RK, 2005, J THORAC CARDIOV SUR, V130, P351, DOI 10.1016/j.jtcvs.2004.12.037; Rodefeld MD, 2003, SEMIN THORAC CARDIOV, V14, P45; SHERMAN C, 1984, T AM SOC ART INT ORG, V30, P143; Shiraishi Y, 2009, IEEE ENG MED BIO, P3047, DOI 10.1109/IEMBS.2009.5333627; Shiraishi Y, 2011, IEEE ENG MED BIO, P8353, DOI 10.1109/IEMBS.2011.6092060; ShumTim D, 1997, ANN THORAC SURG, V64, P1374, DOI 10.1016/S0003-4975(97)00901-6; Sidiropoulos A, 1998, J HEART LUNG TRANSPL, V17, P1172; TAMAKI S, 1992, BRIT HEART J, V67, P177; Voss B, 2002, EUR J CARDIO-THORAC, V21, P780, DOI 10.1016/S1010-7940(02)00063-5; Vukicevic M, 1992, ASAIO J, V59, P253; Yamada A, 2013, IEEE ENG MED BIO, P683, DOI 10.1109/EMBC.2013.6609592; Yamane T, 2002, J ARTIF ORGANS, V5, P149, DOI 10.1007/s100470200027	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					199	205		10.1007/s10047-015-0827-z		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700002		
J	Ishii, K; Hosoda, K; Nishida, M; Isoyama, T; Saito, I; Ariyoshi, K; Inoue, Y; Ono, T; Nakagawa, H; Sato, M; Hara, S; Lee, X; Wu, SY; Imachi, K; Abe, Y				Ishii, Kohei; Hosoda, Kyohei; Nishida, Masahiro; Isoyama, Takashi; Saito, Itsuro; Ariyoshi, Koki; Inoue, Yusuke; Ono, Toshiya; Nakagawa, Hidemoto; Sato, Masami; Hara, Sintaro; Lee, Xinyang; Wu, Sheng-Yuan; Imachi, Kou; Abe, Yusuke			Hydrodynamic characteristics of the helical flow pump	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Helical flow pump; Rotary blood pump; Flow visualization; Computational fluid dynamics analysis; Total artificial heart	TOTAL ARTIFICIAL-HEART; REPLACEMENT	The helical flow pump (HFP) was invented to be an ideal pump for developing the TAH and the helical flow TAH (HFTAH) using two HFPs has been developed. However, since the HFP is quite a new pump, hydrodynamic characteristics inside the pump are not clarified. To analyze hydrodynamic characteristics of the HFP, flow visualization study using the particle image velocimetry and computational fluid dynamics analysis were performed. The experimental and computational models were developed to simulate the left HFP of the HFTAH and distributions of flow velocity vectors, shear stress and pressure inside the pump were examined. In distribution of flow velocity vectors, the vortexes in the vane were observed, which indicated that the HFP has a novel and quite unique working principle in which centrifugal force rotates the fluid in the helical volutes and the fluid is transferred from the inlet to the outlet helical volutes according to the helical structure. In distribution of shear stress, the highest shear stress that was considered to be occurred by the shunt flow across the impeller was found around the entrance of the inlet helical volute. However, it was not so high to cause hemolysis. This shunt flow is thought to be improved by redesigning the inlet and outlet helical volutes. In distribution of pressure, negative pressure was found near the entrance of the inlet helical volute. However, it was not high. Negative pressure is thought to be reduced with an improvement in the design of the impeller or the vane shape.	[Ishii, Kohei; Hosoda, Kyohei; Isoyama, Takashi; Saito, Itsuro; Ariyoshi, Koki; Inoue, Yusuke; Ono, Toshiya; Nakagawa, Hidemoto; Sato, Masami; Hara, Sintaro; Lee, Xinyang; Wu, Sheng-Yuan; Imachi, Kou; Abe, Yusuke] Univ Tokyo, Dept Biomed Engn, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ishii, Kohei] Kagawa Natl Coll Technol, Dept Electromech Syst Engn, Takamatsu, Kagawa, Japan; [Nishida, Masahiro] Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Biomed Engn, Tsukuba, Ibaraki, Japan	Ishii, K (reprint author), Univ Tokyo, Dept Biomed Engn, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ishii@bme.gr.jp; abe@bme.gr.jp			JSPS KAKENHI [22249053, 22240054]	The study was supported in part by the JSPS KAKENHI (22249053) and (22240054).	Abe Y, 2008, J ARTIF ORGANS, V11, P191, DOI 10.1007/s10047-008-0434-3; Abe Y, 2013, IEEE ENG MED BIO, P2720, DOI 10.1109/EMBC.2013.6610102; Abe Y, 2012, J ARTIF ORGANS, V15, P331, DOI 10.1007/s10047-012-0659-z; Copeland JG, 2004, NEW ENGL J MED, V351, P859, DOI 10.1056/NEJMoa040186; Frazier OH, 2009, TEX HEART I J, V36, P568; Fukamachi K, 2010, J HEART LUNG TRANSPL, V29, P13, DOI 10.1016/j.healun.2009.05.034; Dowling RD, 2004, J THORAC CARDIOV SUR, V127, P131, DOI 10.1016/j.jtcvs.2003.07.023; BLUDSZUWEIT C, 1995, ARTIF ORGANS, V19, P590, DOI 10.1111/j.1525-1594.1995.tb02386.x; Arvand A, 2004, ARTIF ORGANS, V28, P892, DOI 10.1111/j.1525-1594.2004.07379.x; Chung MKH, 2004, ARTIF ORGANS, V28, P1089, DOI 10.1111/j.1525-1594.2004.07348.x; HASSAN YA, 1991, EXP FLUIDS, V12, P49; Ishii K, 2013, IEEE ENG MED BIO, P2724, DOI 10.1109/EMBC.2013.6610103; Kormos RL, 2001, ANN THORAC SURG S, V71, pS116	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					206	212		10.1007/s10047-015-0828-y		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700003		
J	Kakiuchi, K; Matsuda, K; Harii, N; Sou, K; Aoki, J; Takeoka, S				Kakiuchi, Kenta; Matsuda, Kenichi; Harii, Norikazu; Sou, Keitaro; Aoki, Junko; Takeoka, Shinji			Establishment of a total liquid ventilation system using saline-based oxygen micro/nano-bubble dispersions in rats	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Micro/nano-bubbles; Oxygen; Liquid ventilation; Lung	RESPIRATORY-DISTRESS-SYNDROME; DELIVERY	Micro/nano-bubbles are practical nanomaterials designed to increase the gas content in liquids. We attempted to use oxygen micro/nano-bubble dispersions as an oxygen-rich liquid as a means for total liquid ventilation. To determine the oxygen content in the bubble dispersion, a new method based on a spectrophotometric change between oxy- and deoxy-hemoglobin was established. The oxygen micro/nano-bubble dispersion was supplied to an experimental total ventilation liquid in anesthetic rats. Though the amount of dissolving oxygen was as low as 6 mg/L in physiological saline, the oxygen content in the oxygen micro/nano-bubble dispersion was increased to 45 mg/L. The positive correlation between the oxygen content and the life-saving time under liquid ventilation clearly indicates that the life-saving time is prolonged by increasing the oxygen content in the oxygen micro/nano-bubble dispersion. This is the first report indicating that the oxygen micro/nano-bubbles containing a sufficient amount of oxygen are useful in producing oxygen-rich liquid for the process of liquid ventilation.	[Kakiuchi, Kenta; Takeoka, Shinji] Waseda Univ TWIns, Dept Life Sci & Med Biosci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan; [Matsuda, Kenichi; Harii, Norikazu; Aoki, Junko] Univ Yamanashi, Sch Med, Dept Emergency & Crit Care Med, Chuo Chi, Yamanashi 4093898, Japan; [Sou, Keitaro] Waseda Biosci Res Inst Singapore WABIOS, Singapore 138667, Singapore; [Sou, Keitaro] Waseda Univ, Org Univ Res Initiat, Shinjuku Ku, Tokyo 1620041, Japan	Matsuda, K (reprint author), Univ Yamanashi, Sch Med, Dept Emergency & Crit Care Med, 1110 Shimokawahigashi, Chuo Chi, Yamanashi 4093898, Japan.	matsudak@yamanashi.ac.jp; takeoka@waseda.jp		Sou, Keitaro/0000-0002-5449-9084			Swanson EJ, 2010, LANGMUIR, V26, P15726, DOI [10.1021/la1029432, 10.1021/1a1029432]; Kacmarek RM, 2006, AM J RESP CRIT CARE, V173, P882, DOI 10.1164/rccm.200508-1196OC; CLARK LC, 1966, SCIENCE, V152, P1755, DOI 10.1126/science.152.3730.1755; Cavalli R, 2009, INT J PHARMACEUT, V381, P160, DOI 10.1016/j.ijpharm.2009.07.010; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Hirschl RB, 2002, AM J RESP CRIT CARE, V165, P781, DOI 10.1164/rccm.2003052; Bisazza A, 2008, IEEE ENG MED BIO, P2067, DOI 10.1109/IEMBS.2008.4649599; Cox CA, 2002, PEDIATR CRIT CARE ME, V3, P288, DOI 10.1097/00130478-200207000-00017; Ebina K, 2013, PLOS ONE, V8, P1; Funhrman BP, 1991, CRIT CARE MED, V19, P712; Jiang LJ, 2006, ANN THORAC SURG, V82, P124, DOI 10.1016/j.athoracsur.2006.02.018; Leanch CL, 1996, NEW ENGL J MED, V335, P761; Lowe KC, 1999, BLOOD REV, V13, P171, DOI 10.1054/blre.1999.0113; Matsuda K, 2003, CRIT CARE MED, V31, P2034, DOI 10.1097/01.CCM.0000075353.38441.45; Matsuki N, 2012, EUR BIOPHYS J BIOPHY, V41, P571, DOI 10.1007/s00249-012-0811-y; MOSKOWIT.GD, 1970, FED PROC, V29, P1751; Tamura M, 2001, SHINSHU MED J, V49, P239; Tawfic Qutaiba A, 2011, Oman Med J, V26, P4, DOI 10.5001/omj.2011.02; Tsagogiorgas C, 2011, PEDIATR PULM, V46, P964, DOI 10.1002/ppul.21461	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					220	227		10.1007/s10047-015-0835-z		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700005		
J	Funayama, M; Sumikura, H; Takewa, Y; Tatsumi, E; Nakayama, Y				Funayama, Marina; Sumikura, Hirohito; Takewa, Yoshiaki; Tatsumi, Eisuke; Nakayama, Yasuhide			Development of self-expanding valved stents with autologous tubular leaflet tissues for transcatheter valve implantation	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Biovalve; Stent; Heart valve; In vivo tissue engineering; Self-expanding	AORTIC-VALVE; HEART-VALVES; CONDUIT BIOVALVE; FLUID-MECHANICS; IN-VITRO; MODEL; SINUS; ARCHITECTURE; REPLACEMENT; SURGERY	In this study, self-expanding valved stents were prepared by in-body tissue architecture technology. As molds, plastic rods (outer diameter; 14 or 25 mm), mounted with specially designed self-expanding stents, whose strut was a combination of two wavy rings and three pillars, were embedded into the subcutaneous pouches of goats or beagles for 1 month. Upon harvesting, the molds were fully encapsulated with membranous connective tissues, in which the stent strut was completely embedded. The tubular tissues with the stents were obtained by removing the internal rods. About a half of the tubular tissues as a leaflet part was folded inside the remaining tubular tissues having ring strut as a conduit part. When the overlapped tubular tissues were fixed at the three pillars, two different-sized self-expanding valved stents (internal diameter; 14 or 25 mm) with autologous tubular leaflet tissues were obtained as Stent-Biovales. After shape formation of the leaflets at the closed form, regurgitation rate was approximately 5 and 22 % at pulmonary and aortic condition, respectively. The Stent-Biovalves developed here may be useful as a heart valve for patients undergoing transcatheter heart valve implantation.	[Funayama, Marina; Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr, Res Inst, Div Med Engn & Mat, Suita, Osaka 5658565, Japan; [Funayama, Marina] Nihon Univ, Coll Bioresource Sci, Tokyo, Kanagawa 102, Japan; [Sumikura, Hirohito; Takewa, Yoshiaki; Tatsumi, Eisuke] Natl Cerebral & Cardiovasc Ctr Res, Dept Artificial Organs, Osaka, Japan	Nakayama, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Div Med Engn & Mat, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	nakayama@ri.ncvc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors thank Ms. Manami Sone for her technical support in this study. This study was funded in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Dasi LP, 2009, CLIN EXP PHARMACOL P, V36, P225, DOI 10.1111/j.1440-1681.2008.05099.x; Sumikura H, 2014, ARTIF ORGANS, V38, P282, DOI 10.1111/aor.12173; Hayashida K, 2008, J BIOMED MATER RES B, V86B, P1, DOI 10.1002/jbm.b.30981; Yoganathan AP, 2004, ANNU REV BIOMED ENG, V6, P331, DOI 10.1146/annurev.bioeng.6.040803.140111; Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0; Dore A, 1997, AM J CARDIOL, V80, P906, DOI 10.1016/S0002-9149(97)00544-4; Marom G, 2013, J THORAC CARDIOV SUR, V146, P1227, DOI 10.1016/j.jtcvs.2013.01.030; Sun W, 2005, J BIOMECH ENG-T ASME, V127, P905, DOI 10.1115/1.2049337; Grande-Allen KJ, 2000, J THORAC CARDIOV SUR, V119, P753, DOI 10.1016/S0022-5223(00)70011-0; Mizuno T, 2014, J BIOMED MATER RES B, V102, P1038, DOI 10.1002/jbm.b.33086; Cribier A, 2012, ARCH CARDIOVASC DIS, V105, P146, DOI 10.1016/j.acvd.2012.01.005; THUBRIKAR MJ, 1986, ANN THORAC SURG, V42, P434; Yamanami M, 2010, CIRCULATION, V122, pS100, DOI 10.1161/CIRCULATIONAHA.109.922211; Takewa Y, 2013, J ARTIF ORGANS, V16, P176, DOI 10.1007/s10047-012-0679-8; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Katayama S, 2008, J THORAC CARDIOV SUR, V136, P1528, DOI 10.1016/j.jtcvs.2008.05.054; Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O; Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828; Hayashida K, 2007, J THORAC CARDIOV SUR, V134, P152, DOI 10.1016/j.jtcvs.2007.01.087; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Cox JL, 2005, J THORAC CARDIOV SUR, V130, P520, DOI 10.1016/j.jtcvs.2004.12.054; Nakayama Y, 2011, J BIOMED MATER RES B, V99B, P135, DOI 10.1002/jbm.b.31880; Nakayama Y, 2015, J BIOMED MATER RES B, V103, P1, DOI 10.1002/jbm.b.33186	24	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					228	235		10.1007/s10047-015-0820-6		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700006		
J	Yasuda, T; Obara, H; Hsu, HC; Mizunuma, H; Matsuno, N; Enosawa, S				Yasuda, Toshitaka; Obara, Hiromichi; Hsu, Huai-che; Mizunuma, Hiroshi; Matsuno, Naoto; Enosawa, Shin			Proposal of a novel evaluation index for the effects of shear stress and exposure time on hepatocyte damage	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Hepatocyte; Ratio of living cells; Viability; Shear stress; Rheoscope	TRANSPLANTATION	The purpose of this study was to propose a novel evaluation index for the effects of shear stress level and exposure time on hepatocyte damage. Suspensions of rat hepatocytes (0.5 mL) were subjected to shear stress from 1.2 to 3.1 Pa for 10 min (n = 3) using a rheoscope. We counted living and dead cells in photographs taken at 1-min intervals using a digital camera attached to the microscope. Living and dead cells were distinguished using a Trypan blue exclusion test. Under each level of shear stress, at each 1-min time interval, we measured the viability [living-cell number (t)/countable cell number (t)] and the ratio of living cells [RLC: living-cell number (t)/countable cell number in the initial condition]. The effects of shear stress and exposure time on viability and RLC were assessed by multiple regression analysis. As expected, we observed an increase in the number of dead cells and little change in the number of living cells when shear stress was increased. The coefficient of determination (R (2)) to predict the effectiveness of viability and RLC indicated a low to moderate correlation. Viability correlated with shear stress and exposure time (p < 0.001); however, RLC only correlated with exposure time of shear stress (p < 0.001). In this test condition, viability was strongly related not to living-cell damage but to dead-cell damage. Therefore, we propose RLC as a novel and effective index for investigating the effect of shear stress on living hepatocytes.	[Yasuda, Toshitaka] Tokyo Natl Coll Technol, Dept Elect Engn, Hachioji, Tokyo 1930997, Japan; [Obara, Hiromichi; Mizunuma, Hiroshi] Tokyo Metropolitan Univ, Dept Mech Engn, Hachioji, Tokyo 1920397, Japan; [Hsu, Huai-che; Matsuno, Naoto; Enosawa, Shin] Natl Ctr Child Hlth & Dev, Div Adv Med Sci, Tokyo 1578535, Japan	Yasuda, T (reprint author), Tokyo Natl Coll Technol, Dept Elect Engn, 1220-2 Kunugida Cho, Hachioji, Tokyo 1930997, Japan.	tyasuda@tokyo-ct.ac.jp			Precise Measurement Technology Promotion Foundation in Fuchu City, Tokyo; Tokyo National College of Technology; JSPS KAKENHI [24656129]; Foundation of the President of Tokyo Metropolitan University	This research was supported in part by a 2012 grant from the Precise Measurement Technology Promotion Foundation in Fuchu City, Tokyo, a 2012-2013 grant from Tokyo National College of Technology, a JSPS KAKENHI (Grant Number 24656129) and a special research grant from the Foundation of the President of Tokyo Metropolitan University.	Higgins GM, 1931, ARCH PATHOL, V12, P186; Fitzpatrick E, 2009, J INTERN MED, V266, P339, DOI 10.1111/j.1365-2796.2009.02152.x; Tanaka Y, 2006, MEAS SCI TECHNOL, V17, P3167, DOI 10.1088/0957-0233/17/12/S08; Enosawa S, 2014, LIVER TRANSPLANT, V20, P391, DOI 10.1002/lt.23800; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Meyburg J, 2009, CELL TRANSPLANT, V18, P77; Savins J. G., 1970, Rheologica Acta, V9, DOI 10.1007/BF01975403; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sumida T, 2012, MECH CHARACTERISTIC	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					236	242		10.1007/s10047-015-0834-0		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700007		
J	Hamada, C; Honda, K; Kawanishi, K; Nakamoto, H; Ito, Y; Sakurada, T; Tanno, Y; Mizumasa, T; Miyazaki, M; Moriishi, M; Nakayama, M				Hamada, Chieko; Honda, Kazuho; Kawanishi, Kunio; Nakamoto, Hirotaka; Ito, Yasuhiko; Sakurada, Tsutomu; Tanno, Yudo; Mizumasa, Toru; Miyazaki, Masanobu; Moriishi, Misaki; Nakayama, Masaaki			Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Peritoneal dialysis; Neutral PD solution; Pathological changes; Hybrid therapy; Peritoneal lavage	GLYCATION END-PRODUCTS; SCLEROSIS; MEMBRANE	Peritoneal dialysis solution (PDS) plays a role in functional and morphological damage to the peritoneum. This study aimed to clarify the effect of neutral PDS in preventing morphological changes by assessing peritoneal damage and comparing morphological alterations between PD patients treated with neutral PDS and acidic PDS. Sixty-one patients participated from seven hospitals. All patients were treated with neutral PDS excluding icodextrin, during their entire PD treatment, and experienced no episode of peritonitis. The thickness of submesothelial compact (SMC) zone and the presence of vasculopathy in the anterior parietal abdominal peritoneum were assessed. The impact of icodextrin, hybrid therapy, and peritoneal rest and lavage in morphological alterations were determined. There was no significant difference in the average SMC thickness between neutral and acidic PDS. The vessel patency in patients using neutral PDS was significantly higher compared to that in acidic PDS at any time during PD. There were no significant suppressive effects from interventions or use of icodextrin with respect to peritoneal morphological injury. A monolayer of mesothelial cell was observed in approximately half the patients, especially in their receiving lavage patients. Neutral PDS, accompanied by other preventive approaches against peritoneal injury, might suppress the development of peritoneal morphological alterations.	[Hamada, Chieko; Nakamoto, Hirotaka] Juntendo Univ, Fac Med, Div Nephrol, Bunkyo Ku, Tokyo, Japan; [Honda, Kazuho] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Kawanishi, Kunio] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo, Japan; [Ito, Yasuhiko] Nagoya Univ, Grad Sch Med, Dept Nephrol, Tokyo, Japan; St Marianna Univ, Sch Med, Div Nephrol & Hypertens, Tokyo, Japan; [Tanno, Yudo] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens, Tokyo, Japan; [Mizumasa, Toru] Fukuoka Red Cross Hosp, Nephrol & Dialysis Ctr, Tokyo, Japan; [Miyazaki, Masanobu] Miyazaki Clin, Tokyo, Japan; [Moriishi, Misaki] Tsuchiya Gen Hosp, Tokyo, Japan; [Nakayama, Masaaki] Fukushima Med Univ, Sch Med, Dept Nephrol, Tokyo, Japan	Hamada, C (reprint author), Juntendo Univ, Fac Med, Div Nephrol, Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan.	chieko@juntendo.ac.jp			Baxter Japan	The authors have no conflicts of interest to declare expect Dr. Yasuhiko Ito. He is a professor in endowed chair supported by Baxter Japan.	Jones S, 2001, KIDNEY INT, V59, P1529, DOI 10.1046/j.1523-1755.2001.0590041529.x; Shimaoka T, 2010, NEPHROL DIAL TRANSPL, V25, P3379, DOI 10.1093/ndt/gfq194; Yamamoto T, 2010, PERITON DIALYSIS INT, V30, P343, DOI 10.3747/pdi.2008.00273; Honda K, 2008, CLIN J AM SOC NEPHRO, V3, P720, DOI 10.2215/CJN.03630807; Kawanishi K, 2013, PERITON DIALYSIS INT, V33, P242, DOI 10.3747/pdi.2011.00270; Linden T, 1998, PERITON DIALYSIS INT, V18, P290; LIBEREK T, 1993, NEPHRON, V65, P260; Williams JD, 2002, J AM SOC NEPHROL, V13, P470; Mateijsen MAM, 1999, PERITON DIALYSIS INT, V19, P517; Ayuzawa N, 2012, PERITON DIALYSIS INT, V32, P159, DOI 10.3747/pdi.2010.00234; DOUVDEVANI A, 1995, J AM SOC NEPHROL, V6, P207; Grzegorzewska AE, 2009, POL ARCH MED WEWN, V119, P242; Jörres A, 1993, Perit Dial Int, V13 Suppl 2, pS291; Krishnan Murali, 2005, International Urology and Nephrology, V37, P409, DOI 10.1007/s11255-004-1392-1; Miyata T, 2000, KIDNEY INT, V58, P425, DOI 10.1046/j.1523-1755.2000.00182.x; Nakamura S, 2004, SEMIN NEPHROL, V24, P502, DOI 10.1016/j.semnephrol.2004.06.027; Topley N, 1994, Perit Dial Int, V14 Suppl 3, pS21; Nakayama M, 2010, THER APHER DIAL, V14, P489, DOI 10.1111/j.1744-9987.2010.00901.x	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					243	250		10.1007/s10047-015-0822-4		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700008		
J	Nishizawa, Y; Mizuiri, S; Yorioka, N; Hamada, C; Tomino, Y				Nishizawa, Yoshiko; Mizuiri, Sonoo; Yorioka, Noriaki; Hamada, Chieko; Tomino, Yasuhiko			Determinants of coronary artery calcification in maintenance hemodialysis patients	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Active vitamin D3; Coronary artery calcification score (CACS); Maintenance hemodialysis patients; Risk factors; Vascular calcification	CHRONIC KIDNEY-DISEASE; DOSE VITAMIN-D; VASCULAR CALCIFICATION; SECONDARY HYPERPARATHYROIDISM; AORTIC CALCIFICATION; COMPUTED-TOMOGRAPHY; PHOSPHATE BINDERS; CINACALCET HCL; DIALYSIS; CKD	In addition to the well-known traditional risk factors, uremia-related so-called novel risk factors and medications appear to affect coronary artery calcification in hemodialysis patients. This study was performed to evaluate coronary artery calcification score (CACS) in maintenance hemodialysis (MHD) patients, and to identify significantly related factors. We assessed CACS using Agatston Score by MDCT, sex, age, dialysis vintage, presence of diabetes mellitus, smoking history, presence of a parts per thousand yen100 ml urine volume/day, normalized protein catabolic rate, geriatric nutritional risk index, administration of active vitamin D3, cinacalcet, phosphate binders or antihypertensive agents, and circulation parameters including creatinine, albumin, corrected calcium and phosphate in 207 MHD patients. Coronary artery calcifications were observed in 192 patients (92.8 %). In multivariate analysis, CACS showed direct associations with age (p < 0.001), dialysis vintage (p < 0.001) and presence of diabetes mellitus (p < 0.01), and an inverse association only with active vitamin D3 administration (p < 0.001) in MHD patients. Patients with active vitamin D3 showed significantly lower CACS than in those without it (1349.6 +/- A 1635.0 vs. 2475.6 +/- A 2646.6 H, p < 0.05). Older age, longer duration of dialysis and diabetes mellitus are risk factors and administration of active vitamin D3 is protective factor for coronary artery calcification in MHD patients.	[Nishizawa, Yoshiko; Hamada, Chieko; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Nishizawa, Yoshiko; Mizuiri, Sonoo] Ichiyokai Harada Hosp, Div Nephrol, Saeki Ku, Hiroshima 7315134, Japan; [Yorioka, Noriaki] Hiroshima Kidney Org, Hiroshima, Japan	Nishizawa, Y (reprint author), Ichiyokai Harada Hosp, Div Nephrol, Saeki Ku, 7-10 Kairoyama Cho, Hiroshima 7315134, Japan.	y-nishizawa@icy.or.jp			Ichiyokai Harada Hospital	We thank Dr. Masahiro Ishine and Mr. Kenji Mizuno for the expert imaging techniques. This study was supported by the private foundation of Ichiyokai Harada Hospital.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827; Drueke TB, 2012, J AM SOC NEPHROL, V23, P1277, DOI 10.1681/ASN.2012060569; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Marz W, 2011, CLIN J AM SOC NEPHRO, V6, P1316, DOI 10.2215/CJN.09121010; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Ribeiro S, 1998, NEPHROL DIAL TRANSPL, V13, P2037, DOI 10.1093/ndt/13.8.2037; Shoji T, 2012, J ATHEROSCLER THROMB, V19, P299; Mathew S, 2008, J AM SOC NEPHROL, V19, P1509, DOI 10.1681/ASN.2007080902; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191; Fishbane S, 2008, CLIN J AM SOC NEPHRO, V3, P1718, DOI 10.2215/CJN.01040308; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Zittermann A, 2007, CURR OPIN LIPIDOL, V18, P41, DOI 10.1097/MOL.0b013e328011c6fc; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Lau WL, 2012, KIDNEY INT, V82, P1261, DOI 10.1038/ki.2012.322; Yamada K, 2008, AM J CLIN NUTR, V87, P106; Ohtake T, 2010, HEMODIAL INT, V14, P218, DOI 10.1111/j.1542-4758.2009.00423.x; Toussaint ND, 2011, NEPHROLOGY, V16, P290, DOI 10.1111/j.1440-1797.2010.01412.x; Torres PU, 2006, J RENAL NUTR, V16, P253, DOI 10.1053/j.jrn.2006.04.010; Floege Jürgen, 2004, Nephrol Dial Transplant, V19 Suppl 5, pV59, DOI 10.1093/ndt/gfh1058; Nitta K, 2011, THER APHER DIAL, V15, P513, DOI 10.1111/j.1744-9987.2011.00979.x; Nitta K, 2004, HYPERTENS RES, V27, P527, DOI 10.1291/hypres.27.527; Ogawa T, 2010, HEART VESSELS, V25, P1, DOI 10.1007/s00380-009-1151-4; Park MY, 2011, NEPHROLOGY, V16, P285, DOI 10.1111/j.1440-1797.2010.01393.x; Pencak P, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-10; Zheng CM, 2011, INT J NEPHROL, DOI [10.4061/2011/939613, DOI 10.4061/2011/939613]	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					251	256		10.1007/s10047-015-0823-3		6	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700009		
J	Kokubo, K; Kurihara, Y; Tsukao, H; Maruyama, N; Kobayashi, K; Shinbo, T; Hirose, M; Kobayashi, H				Kokubo, Kenichi; Kurihara, Yoshitaka; Tsukao, Hiroshi; Maruyama, Naoko; Kobayashi, Kozue; Shinbo, Toshihiro; Hirose, Minoru; Kobayashi, Hirosuke			Effects of increased surface coverage of polyvinylpyrrolidone over a polysulfone hemofilter membrane on permeability and cell adhesion during continuous hemofiltration	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Continuous hemofiltration; Polyvinylpyrrolidone; Sieving coefficient; Cell adhesion	FIBER DIALYSIS MEMBRANES; ACUTE KIDNEY INJURY; FILTER LIFE; CIRCUIT; RECOVERY; THERAPY; SYSTEM	The purpose of the present study was to evaluate the adhesiveness of blood cells and the solute removal performance change of modified polysulfone membranes which have increased polyvinylpyrrolidone (PVP) coverage over their surface. Continuous hemofiltration (CHF) experiments for 24 h were carried out using an ex vivo hemofilter evaluation system to compare a modified polysulfone hemofilter (SHG) with the conventional polysulfone hemofilter (SH). The 25 and 50 % cutoff values of the sieving coefficient of dextran after CHF and the protein concentration in the filtrate was higher in SHG, indicating that less fouling occurred in the SHG membrane. Adhesion of blood cells after 24 h of CHF was significantly higher in the case of SH than in the case of SHG. Blood cell adhesion and membrane fouling were reduced with the use of a polysulfone membrane modified with increased PVP coverage over the surface.	[Kokubo, Kenichi; Kurihara, Yoshitaka; Tsukao, Hiroshi; Maruyama, Naoko; Kobayashi, Kozue; Hirose, Minoru; Kobayashi, Hirosuke] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan; [Kokubo, Kenichi; Maruyama, Naoko; Kobayashi, Kozue; Shinbo, Toshihiro; Hirose, Minoru; Kobayashi, Hirosuke] Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Maruyama, Naoko] Saitama Med Univ, Fac Hlth & Med Care, Moroyama, Saitama, Japan	Kokubo, K (reprint author), Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan.	kokubo@kitasato-u.ac.jp			Toray Industry Inc.; Toray Medical Co., Ltd.	H. Kobayashi and K. Kokubo received research grants from Toray Industry Inc. and Toray Medical Co., Ltd. The other authors declare that they have no conflict of interest.	Tsunoda N, 1999, ASAIO J, V45, P418, DOI 10.1097/00002480-199909000-00010; Uchino S, 2003, NEPHRON CLIN PRACT, V94, pC94, DOI 10.1159/000072492; Ricci Z, 2011, CURR OPIN CRIT CARE, V17, P556, DOI 10.1097/MCC.0b013e32834cd360; Hayama M, 2004, BIOMATERIALS, V25, P1019, DOI 10.1016/S0142-9612(03)00629-X; Ochoa NA, 2001, J MEMBRANE SCI, V187, P227, DOI 10.1016/S0376-7388(01)00348-9; Nurmohamed SA, 2011, ASAIO J, V57, P48, DOI 10.1097/MAT.0b013e318201a599; Baldwin I, 2007, CONTRIB NEPHROL, V156, P178; Bellomo R, 1997, BLOOD PURIFICAT, V15, P354, DOI 10.1159/000170354; Bowry SK, 2001, INT J ARTIF ORGANS, V24, P757; Davenport A, 1997, AM J KIDNEY DIS, V30, pS20, DOI 10.1016/S0272-6386(97)90538-2; Glassford NJ, 2011, CURR OPIN CRIT CARE, V17, P562, DOI 10.1097/MCC.0b013e32834cd334; KELLER F, 1990, NEPHROL DIAL TRANSPL, V5, P802; Koga S, 2010, J MEMBRANE SCI, V355, P208, DOI 10.1016/j.memsci.2010.03.032; Krouzecky A, 2009, INTENS CARE MED, V35, P364, DOI 10.1007/s00134-008-1271-9; Nojiri C, 1989, ASAIO Trans, V35, P357, DOI 10.1097/00002480-198907000-00060; Schetz M, 2001, Curr Opin Anaesthesiol, V14, P143, DOI 10.1097/00001503-200104000-00004; Uchino S, 2008, CRIT CARE MED, V36, pS238, DOI 10.1097/CCM.0b013e318168e4a8; Zou YQ, 2010, MACROMOL BIOSCI, V10, P1432, DOI 10.1002/mabi.201000223	18	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					257	263		10.1007/s10047-015-0826-0		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700010		
J	Alamusi; Matsuo, T; Hosoya, O; Tsutsui, KM; Uchida, T				Alamusi; Matsuo, Toshihiko; Hosoya, Osamu; Tsutsui, Kimiko M.; Uchida, Tetsuya			Vision maintenance and retinal apoptosis reduction in RCS rats with Okayama University-type retinal prosthesis (OUReP (TM)) implantation	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Retinal prosthesis; Photoelectric dye; RCS rat; Apoptosis; Electroretinogram	RETINITIS-PIGMENTOSA; DEGENERATION; SAFETY	Photoelectric dye-coupled polyethylene film, designated Okayama University-type retinal prosthesis or OUReP (TM), generates light-evoked surface electric potentials and stimulates neurons. In this study, the vision was assessed by behavior tests in aged hereditary retinal dystrophic RCS rats with OUReP (TM), retinal apoptosis and electroretinographic responses were measured in dystrophic eyes with OUReP (TM). The dye-coupled films, or plain films as a control, were implanted in subretinal space of RCS rats. On behavior tests, RCS rats with dye-coupled films, implanted at the old age of 14 weeks, showed the larger number of head-turning, consistent with clockwise and anticlockwise rotation of a surrounding black-and-white-striped drum, compared with rats with plain films, under the dim (50 lux) and bright (150 lux) conditions in the observation period until the age of 22 weeks (n = 5, P < 0.05, repeated-measure ANOVA). The number of apoptotic cells in retinal sections at the site of dye-coupled film implantation was significantly smaller, compared with the other retinal sites, neighboring the film, or opposite to the film, 5 months after film implantation at the age of 6 weeks (P = 0.0021, Friedman test). The dystrophic eyes of RCS rats with dye-coupled films showed positive responses to maximal light stimulus at a significantly higher rate, compared with the eyes with no treatment (P < 0.05, Chi-square test). Electroretinograms in normal eyes of Wistar rats with dye-coupled or plain films showed significantly decreased amplitudes (n = 14, P < 0.05, repeated-measure ANOVA). In conclusions, vision was maintained in RCS rats with dye-coupled films implanted at the old age. The dystrophic eyes with dye-coupled films showed electroretinographic responses. Five-month film implantation caused no additional retinal changes.	[Alamusi; Matsuo, Toshihiko] Okayama Univ, Sch Med, Ophthalmol, Okayama 700, Japan; [Alamusi; Matsuo, Toshihiko; Hosoya, Osamu; Tsutsui, Kimiko M.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 700, Japan; [Hosoya, Osamu; Tsutsui, Kimiko M.] Okayama Univ, Sch Med, Neurogen, Okayama 700, Japan; [Uchida, Tetsuya] Okayama Univ, Polymer Mat Sci, Fac Engn, Okayama 700, Japan; [Uchida, Tetsuya] Grad Sch Nat Sci & Technol, Okayama, Japan	Matsuo, T (reprint author), Okayama Univ, Sch Med, Ophthalmol, Okayama 700, Japan.	matsuot@cc.okayama-u.ac.jp; tuchida@cc.okayama-u.ac.jp					Alamusi, 2013, J ARTIF ORGANS, V16, P343, DOI 10.1007/s10047-013-0697-1; Chow AY, 2004, ARCH OPHTHALMOL-CHIC, V122, P460, DOI 10.1001/archopht.122.4.460; Cuenca N, 2005, EUR J NEUROSCI, V22, P1057, DOI 10.1111/j.1460-9568.2005.04300.x; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996; Loewenstein JI, 2004, ARCH OPHTHALMOL-CHIC, V122, P587, DOI 10.1001/archopht.122.4.587; Matsuo T, 2009, J ARTIF ORGANS, V12, P213, DOI 10.1007/s10047-009-0471-6; Matsuo T, 2006, United States Patent. Patent, Patent No. [US 7,101,533 B2, 7101533]; Matsuo T, 2007, BRIT J OPHTHALMOL, V91, P888, DOI 10.1136/bjo.2007.114538; Matsuo T, 2003, ACTA MED OKAYAMA, V57, P257; Okamoto K, 2008, J ARTIF ORGANS, V11, P45, DOI 10.1007/s10047-008-0403-x; Pardue MT, 2005, INVEST OPHTH VIS SCI, V46, P674, DOI 10.1167/iovs.04-0515; Tamaki M, 2011, J ARTIF ORGANS, V14, P140, DOI 10.1007/s10047-011-0557-9; Tamaki T, 2008, J ARTIF ORGANS, V11, P38, DOI 10.1007/s10047-007-0398-8; Uchida T, 2005, MEMOIRS FACULTY ENG, V39, P16; Uji A, 2006, ARTIF ORGANS, V30, P695, DOI 10.1111/j.1525-1594.2006.00286.x; Uji A, 2005, ARTIF ORGANS, V29, P53, DOI 10.1111/j.1525-1594.2004.29010.x	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					264	271		10.1007/s10047-015-0825-1		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700011		
J	Imamura, T; Kinugawa, K; Nitta, D; Hatano, M; Kinoshita, O; Nawata, K; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Hatano, Masaru; Kinoshita, Osamu; Nawata, Kan; Ono, Minoru			Biventricular failure with low pulmonary vascular resistance was managed by left ventricular assist device alone without right-sided mechanical support	JOURNAL OF ARTIFICIAL ORGANS			English	Article						DuraHeart; Right ventricular failure; Sildenafil; Dilated cardiomyopathy	D HEART-FAILURE; CIRCULATORY SUPPORT; RISK SCORE; IMPLANTATION; INSERTION; DATABASE; PREDICTS	How to manage preoperative right ventricular dysfunction (RVD) in heart failure patients without cardiogenic shock remains as a matter to be debated because implantable biventricular assist device treatment has not been established thus far. We here presented a patient with significant RVD indicated by low RV stroke work index (0.3 g/m) and RV dilatation as well as low pulmonary vascular resistance (PVR, 0.8 Wood Unit), who was managed by the introduction of pimobendan and sildenafil after the implantation of DuraHeart and tricuspid annuloplasty without right VAD, although his New York Heart Association symptom remained class III. Preoperative low PVR may be a key for successful LVAD treatment alone without right VAD in patients with INTERMACS profile 3 suffering RVD.	[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, Tokyo 1138655, Japan; [Nitta, Daisuke; Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo 1138655, Japan	Imamura, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	imamurate-int@h.u-tokyo.ac.jp; kinugawa-tky@umin.ac.jp					Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Shiga T, 2012, CIRC J, V76, P2785, DOI 10.1253/circj.CJ-12-0231; Matthews JC, 2008, J AM COLL CARDIOL, V51, P2163, DOI 10.1016/j.jacc.2008.03.009; Imamura T, 2014, CIRC J, V78, P2259, DOI 10.1253/circj.CJ-14-0368; Cleveland JC, 2011, J HEART LUNG TRANSPL, V30, P862, DOI 10.1016/j.healun.2011.04.004; Kormos RL, 2010, J THORAC CARDIOV SUR, V139, P1316, DOI 10.1016/j.jtcvs.2009.11.020; Fitzpatrick JR, 2008, J HEART LUNG TRANSPL, V27, P1286, DOI 10.1016/j.healun.2008.09.006; Kinugawa K, 2011, CIRC J, V75, P2038, DOI 10.1253/circj.CJ-11-0621; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Fukamachi K, 1999, ANN THORAC SURG, V68, P2181, DOI 10.1016/S0003-4975(99)00753-5; Imamura T, 2014, CIRC J, V78, P625, DOI 10.1253/circj.CJ-13-1201; Imamura T, 2013, J ARTIF ORGANS, V16, P101, DOI 10.1007/s10047-012-0662-4; Ochiai Y, 2002, CIRCULATION, V106, pI198, DOI 10.1161/01.cir.0000032906.33237.1c; Santambrogio Luisa, 2006, Interact Cardiovasc Thorac Surg, V5, P379, DOI 10.1510/icvts.2006.128322; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					272	275		10.1007/s10047-015-0829-x		4	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700012		
J	Seguchi, O; Saito, K; Fukuma, K; Shimamoto, K; Sato, T; Nakajima, S; Sunami, H; Kuroda, K; Sato, T; Watanabe, T; Hata, H; Yanase, M; Fujita, T; Kobayashi, J; Nagatsuka, K; Nakatani, T				Seguchi, Osamu; Saito, Kozue; Fukuma, Kazuki; Shimamoto, Keiko; Sato, Takuma; Nakajima, Seiko; Sunami, Haruki; Kuroda, Kensuke; Sato, Takamasa; Watanabe, Takuya; Hata, Hiroki; Yanase, Masanobu; Fujita, Tomoyuki; Kobayashi, Junjiro; Nagatsuka, Kazuyuki; Nakatani, Takeshi			Evaluation of micro-emboli in a patient with ventricular assist device support with hemolysis	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Ventricular assist device; Transcranial Doppler; Micro-embolic signals; Hemolysis	INTENSITY TRANSIENT SIGNALS; MICROEMBOLI; THROMBOSIS; ULTRASOUND; RISK; LVAD	The clinical relevance of transcranial Doppler (TCD) detection of micro-embolic signals (MES) in patients with ventricular assist devices (VADs) has been described. However, all of the previous studies concerning TCD in patients with VADs were conducted in patients with old devices; the clinical relevance of TCD in patients with newer devices has not been fully elucidated. We recently encountered a patient with a continuous-flow VAD with hemolysis. TCD monitoring was useful for the direct evaluation of micro-emboli in this patient. A 50-year-old male who underwent HeartMate IIA (R) VAD (Thoratec Corporation; Pleasanton, CA) implantation with a diagnosis of ischemic cardiomyopathy 15 months prior was admitted to our institution because of findings suggestive of hemolysis, such as elevated lactate dehydrogenase (LDH) and total bilirubin. Unfractionated heparin was started after admission and hemolysis gradually improved. On admission, TCD detected 146 MES during 30 min of monitoring. During the hospital course, the MES count decreased to 20 signals on hospital day 4 and further decreased to 2 signals on hospital day 15 along with decreases in LDH and total bilirubin. Since hemolysis in VAD patients is thought to be associated with thromboembolic outcomes, MES detected by TCD indicate subclinical micro-emboli. TCD monitoring may be useful for assessing the risk of thromboembolic events in newer continuous-flow VAD patients through direct visualization of micro-emboli.	[Seguchi, Osamu; Shimamoto, Keiko; Sato, Takuma; Nakajima, Seiko; Sunami, Haruki; Kuroda, Kensuke; Sato, Takamasa; Watanabe, Takuya; Yanase, Masanobu; Nakatani, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, Suita, Osaka 5658565, Japan; [Saito, Kozue; Fukuma, Kazuki; Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Suita, Osaka 5658565, Japan; [Hata, Hiroki; Fujita, Tomoyuki; Kobayashi, Junjiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka 5658565, Japan	Seguchi, O (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	seguchi.osamu.hp@mail.ncvc.go.jp					Boyle AJ, 2009, J HEART LUNG TRANSPL, V28, P881, DOI 10.1016/j.healun.2009.05.018; Uriel N, 2012, J AM COLL CARDIOL, V60, P1764, DOI 10.1016/j.jacc.2012.07.052; Pagani FD, 2009, J AM COLL CARDIOL, V54, P312, DOI 10.1016/j.jacc.2009.03.055; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Whitson BA, 2014, ANN THORAC SURG, V97, P2097, DOI 10.1016/j.athoracsur.2014.02.041; John R, 2008, J THORAC CARDIOV SUR, V136, P1318, DOI 10.1016/j.jtcvs.2007.12.077; Schmid C, 1998, ANN THORAC SURG, V65, P1703, DOI 10.1016/S0003-4975(98)00299-9; AUSTEN WG, 1965, J SURG RES, V5, P283; BABIKIAN VL, 1994, STROKE, V25, P1570; Kaps M, 1997, STROKE, V28, P322; Moazami N, 1997, ASAIO J, V43, P177; Nabavi DG, 2003, J THORAC CARDIOV SUR, V126, P160, DOI 10.1016/S0022-5223(03)00019-9; Potapov EV, 2001, ASAIO J, V47, P249, DOI 10.1097/00002480-200105000-00018; Ravichandran AK, 2014, J HEART LUNG TRANSPL, V33, P44, DOI 10.1016/j.healun.2013.08.019; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; SLIWKA U, 1995, STROKE, V26, P2067; Thoennissen NH, 2006, ASAIO J, V52, P243, DOI 10.1097/01.mat.0000214682.95834.de; Toda Koichi, 2015, Gen Thorac Cardiovasc Surg, V63, P1, DOI 10.1007/s11748-014-0480-0; TONG DC, 1995, STROKE, V26, P1588	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					276	279		10.1007/s10047-015-0832-2		4	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700013		
J	Hieda, M; Seguchi, O; Mutara, Y; Sunami, H; Sato, T; Yanase, M; Hiroki, H; Fujita, T; Nakatani, T				Hieda, Michinari; Seguchi, Osamu; Mutara, Yoshihiro; Sunami, Haruki; Sato, Takuma; Yanase, Masanobu; Hiroki, Hata; Fujita, Tomoyuki; Nakatani, Takeshi			Acute response test to adaptive servo-ventilation, a possible modality to assessing the reversibility of pulmonary vascular resistance	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Adaptive servo-ventilation; Hemodynamics; Pulmonary hypertension; Pulmonary vascular resistance; Left ventricular assisted device	HEART-TRANSPLANT CANDIDATES; INTERNATIONAL SOCIETY; HYPERTENSION; FAILURE; PRESSURE	Since pulmonary hypertension (PH) due to left-sided heart failure (HF) with elevated pulmonary vascular resistance (PVR) is contraindication for heart transplantation (HTx), correct evaluation of reversibility in PVR is essential for adequate therapeutic decision-making. However, guidelines or recommended protocols for pharmacological testing to evaluate the reversibility of PVR have not been established yet. In this report, we presented a 34-year-old male with advanced HF complicated by severe PH with high PVR [5.93 Wood units (WU)] who was deemed eligible for HTx. To evaluate his HTx candidacy, oxygen inhalation test was applied during right heart catheterization (RHC) and PVR was drastically decreased to 2.29 WU. At that time, acute response test to adaptive servo-ventilation (ASV) was also applied and use of ASV temporarily but substantially decreased PVR to 2.15 WU. From the results of both oxygen inhalation test and acute response test to ASV, reversibility of PVR in this patient was confirmed, and the patient was approved as HTx candidate and received left ventricular assist device (LVAD) implantation for bridge to transplant. After LVAD implantation, PVR substantially and persistently decreased to 2.4 WU. These findings indicate that acute response test to ASV during RHC may be a possible modality to evaluate the reversibility of PVR in HF patients with PH complicated by elevated PVR.	[Hieda, Michinari; Seguchi, Osamu; Mutara, Yoshihiro; Sunami, Haruki; Sato, Takuma; Yanase, Masanobu; Nakatani, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, Suita, Osaka 5658565, Japan; [Hiroki, Hata; Fujita, Tomoyuki] Natl Cerebral & Cardiovasc Ctr, Dept Adult Cardiac Surg, Osaka, Japan	Hieda, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	hieda_michinari_0119@yahoo.co.jp					Mehra MR, 2006, J HEART LUNG TRANSPL, V25, P1024, DOI 10.1016/j.healun.2006.06.008; SEALS DR, 1990, CIRC RES, V67, P130; Haruki N, 2011, EUR J HEART FAIL, V13, P1140, DOI 10.1093/eurjhf/hfr103; Takama N, 2011, CIRC J, V75, P1164, DOI 10.1253/circj.CJ-10-0831; Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002; Guglin M, 2010, J CARD FAIL, V16, P461, DOI 10.1016/j.cardfail.2010.01.003; JOHNSTON WE, 1989, AM REV RESPIR DIS, V140, P1257; Yamada S, 2013, CIRC J, V77, P1214, DOI 10.1253/circj.CJ-12-1088; Givertz MM, 1996, J AM COLL CARDIOL, V28, P1775; Guazzi Marco, 2012, Eur Respir Rev, V21, P338, DOI 10.1183/09059180.00004612; Klotz S, 2003, EUR J HEART FAIL, V5, P645, DOI 10.1016/S1388-9842(03)00059-X; Radovancevic B, 2005, J HEART LUNG TRANSPL, V24, P690, DOI 10.1016/j.healun.2004.04.016; Roberts DH, 2001, CHEST, V120, P1547, DOI 10.1378/chest.120.5.1547; Teschler H, 2001, AM J RESP CRIT CARE, V164, P614	14	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					280	283		10.1007/s10047-015-0833-1		4	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700014		
J	Hieda, M; Seguchi, O; Mutara, Y; Sunami, H; Sato, T; Yanase, M; Hiroki, H; Fujita, T; Nakatani, T				Hieda, Michinari; Seguchi, Osamu; Mutara, Yoshihiro; Sunami, Haruki; Sato, Takuma; Yanase, Masanobu; Hiroki, Hata; Fujita, Tomoyuki; Nakatani, Takeshi			Acute response test to adaptive servo-ventilation, a possible modality to assessing the reversibility of pulmonary vascular resistance (vol 18, pg 280, 2015)	JOURNAL OF ARTIFICIAL ORGANS			English	Correction									[Hieda, Michinari; Seguchi, Osamu; Mutara, Yoshihiro; Sunami, Haruki; Sato, Takuma; Yanase, Masanobu; Nakatani, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, Suita, Osaka 5658565, Japan; [Hiroki, Hata; Fujita, Tomoyuki] Natl Cerebral & Cardiovasc Ctr, Dept Adult Cardiac Surg, Osaka, Japan	Hieda, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	hieda_michinari_0119@yahoo.co.jp					Hieda M, 2015, J ARTIF ORGANS, V18, P280, DOI 10.1007/s10047-015-0833-1	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					284	284		10.1007/s10047-015-0841-1		1	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700015		
J	Kobayashi, H; Abe, M; Murata, Y; Maruyama, T; Furukawa, T; Oikawa, O; Okada, K				Kobayashi, Hiroki; Abe, Masanori; Murata, Yusuke; Maruyama, Takashi; Furukawa, Tetsuya; Oikawa, Osamu; Okada, Kazuyoshi			Low-density lipoprotein apheresis for corticosteroid-resistant skin lesions caused by cholesterol crystal embolism: a case report and review of the literature	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Acute kidney injury; Cholesterol crystal embolism; Corticosteroids; Low-density lipoprotein apheresis		Cholesterol crystal embolism (CCE) is an arterio-arterial embolism originating from the breakdown of atherosclerotic plaques in the aortic wall. The embolism affects the skin and kidney particularly, as well as frequently affects the gastrointestinal tract and other organs. Although there are no clearly effective direct therapies for CCE, corticosteroid therapy and combination therapy with low-density lipoprotein apheresis (LDL-A) followed by corticosteroids were recently reported to be effective for renal manifestations in some cases. However, few cases offer suggestions for the treatment of skin lesions caused by CCE. We report here a case of a 58-year-old man diagnosed with CCE with skin manifestations and kidney dysfunction who achieved complete remission after LDL-A. LDL-A may be a useful treatment for CCE, particularly in cases with skin manifestations.	[Kobayashi, Hiroki; Abe, Masanori; Murata, Yusuke; Maruyama, Takashi; Furukawa, Tetsuya; Oikawa, Osamu; Okada, Kazuyoshi] Nihon Univ, Div Nephrol Hypertens & Endocrinol, Dept Internal Med, Sch Med,Itabashi Ku, Tokyo 1738610, Japan	Abe, M (reprint author), Nihon Univ, Div Nephrol Hypertens & Endocrinol, Dept Internal Med, Sch Med,Itabashi Ku, 30-1 Oyaguchi Kami Chou, Tokyo 1738610, Japan.	abe.masanori@nihon-u.ac.jp					Nakayama M, 2006, CLIN NEPHROL, V66, P232; Doty JR, 2003, ANN THORAC SURG, V75, P1221, DOI 10.1016/S0003-4975(02)04712-4; Daimon S, 2000, CLIN EXP NEPHROL, V4, P352, DOI 10.1007/s101570070015; Ehara T, 2005, NEPHROLOGY, V10, P90, DOI 10.1111/j.1440-1797.2005.00358.x; Enomae M, 2007, INTERNAL MED, V46, P1123, DOI 10.2169/internalmedicine.46.0102; Hirai K, 2014, J ARTIF ORGANS, V18, P72; Sato Kiyotaka, 2002, Masui, V51, P166; Sekine Yuji, 2011, Kyobu Geka, V64, P195; Tamai O, 1997, CIRCULATION, V95, P76; Tamura Kouichi, 2003, Clin Exp Nephrol, V7, P67, DOI 10.1007/s101570300010	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	SEP	2015	18	3					285	289		10.1007/s10047-015-0830-4		5	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CQ5VB	WOS:000360672700016		
J	Hong, ER; Ganz, JB; Ninci, J; Neely, L; Gilliland, W; Boles, M				Hong, Ee Rea; Ganz, Jennifer B.; Ninci, Jennifer; Neely, Leslie; Gilliland, Whitney; Boles, Margot			An Evaluation of the Quality of Research on Evidence-Based Practices for Daily Living Skills for Individuals with Autism Spectrum Disorder	JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS			English	Article						Autism spectrum disorder (ASD); Adaptive behavior skills; Daily living skills; Independent living skills; Video modeling; In vivo behavioral intervention; Single-case research; Single-subject research; Systematic literature review; What Works Clearinghouse	SINGLE-SUBJECT RESEARCH; SELF-HELP SKILLS; INTELLECTUAL DISABILITIES; DEVELOPMENTAL-DISABILITIES; ADAPTIVE-BEHAVIOR; PURCHASING SKILLS; YOUNG-ADULTS; INTERVENTION RESEARCH; WORKS CLEARINGHOUSE; VIDEO INSTRUCTION	This study presents a literature review of interventions for improving daily living skills of individuals with ASD. This review investigated the quality of the design and evidence of the literature base and determined the state of the evidence base related to interventions for improving daily living skills of individuals with ASD. Included studies were evaluated to determine the overall quality of the evidence for each design within each article, based on the What Works Clearinghouse standards for single-case experimental design (Kratochwill et al. 2010), adapted by Maggin et al. (Remedial Spec Educ 34(1):44-58, 2013. doi: 10.1177/0741932511435176). As a result, video modeling was found to be an evidence-based practice. Limitations and implications for future research and for practitioners are discussed.	[Hong, Ee Rea; Ganz, Jennifer B.; Ninci, Jennifer; Neely, Leslie; Gilliland, Whitney; Boles, Margot] Univ Tsukuba, Tsukuba, Ibaraki 3050044, Japan	Hong, ER (reprint author), Univ Tsukuba, 916-302 11 Banchi,Namiki 4 Chome, Tsukuba, Ibaraki 3050044, Japan.	ghdeerea@tamu.edu; jeniganz@tamu.edu; jninci@tamu.edu; leslie.cockerill@gmail.com; gillilandw@tamu.edu; margotb2011@gmail.com			U.S. Department of Education, Office of Special Education Programs [H325D110046]	The contents of this manuscript were developed under the Preparation of Leaders in Autism Across the Lifespan grant awarded by the U.S. Department of Education, Office of Special Education Programs (Grant No. H325D110046).	ALCANTARA PR, 1994, EXCEPT CHILDREN, V61, P40; Allen K. D., 2010, EDUC TREAT CHILD, V33, P339, DOI DOI 10.1353/ETC.0.0101; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Tomanik SS, 2007, J AUTISM DEV DISORD, V37, P921, DOI 10.1007/s10803-006-0227-6; Bennett KD, 2013, J AUTISM DEV DISORD, V43, P585, DOI 10.1007/s10803-012-1597-6; Rayner C, 2011, DEV NEUROREHABIL, V14, P339, DOI 10.3109/17518423.2011.606508; Goodson J, 2007, RES DEV DISABIL, V28, P458, DOI 10.1016/j.ridd.2006.06.002; Charlop-Christy MH, 2000, J AUTISM DEV DISORD, V30, P537, DOI 10.1023/A:1005635326276; Cannella-Malone HI, 2011, J POSIT BEHAV INTERV, V13, P144, DOI 10.1177/1098300710366593; Kemp DC, 1995, J ASSOC PERS SEVERE, V20, P229; Flynn L, 2012, RES AUTISM SPECT DIS, V6, P431, DOI 10.1016/j.rasd.2011.06.016; Cimera RE, 2009, AUTISM, V13, P285, DOI 10.1177/1362361309103791; Allen KD, 2012, J AUTISM DEV DISORD, V42, P2410, DOI 10.1007/s10803-012-1519-7; Tomanik S, 2004, J INTELLECT DEV DIS, V29, P16, DOI 10.1080/13668250410001662892; Mechling LC, 2009, J AUTISM DEV DISORD, V39, P1420, DOI 10.1007/s10803-009-0761-0; Bledsoe R, 2003, AUTISM, V7, P289, DOI 10.1177/1362361303007003005; Cannella-Malone H, 2006, EDUC TRAIN DEV DISAB, V41, P344; COLLINS BC, 1993, EDUC TRAIN MENT RET, V28, P128; Jasmin E, 2009, J AUTISM DEV DISORD, V39, P231, DOI 10.1007/s10803-008-0617-z; Gillham JE, 2000, J AUTISM DEV DISORD, V30, P269, DOI 10.1023/A:1005571115268; HARING TG, 1987, J APPL BEHAV ANAL, V20, P89, DOI 10.1901/jaba.1987.20-89; Odom SL, 2005, EXCEPT CHILDREN, V71, P137; Palmen A, 2012, RES AUTISM SPECT DIS, V6, P1377, DOI 10.1016/j.rasd.2012.05.010; Maggin DM, 2013, REM SPEC EDUC, V34, P44, DOI 10.1177/0741932511435176; Park CJ, 2012, J AUTISM DEV DISORD, V42, P2761, DOI 10.1007/s10803-012-1534-8; CARR EG, 1993, J APPL BEHAV ANAL, V26, P157, DOI 10.1901/jaba.1993.26-157; Lattimore LP, 2006, J APPL BEHAV ANAL, V39, P91, DOI 10.1901/jaba.2006.154-04; Bereznak S, 2012, J DEV PHYS DISABIL, V24, P269, DOI 10.1007/s10882-012-9270-8; Horner RH, 2005, EXCEPT CHILDREN, V71, P165; Allen KD, 2010, FOCUS AUTISM DEV DIS, V25, P186, DOI 10.1177/1088357610377318; Cannella-Malone HI, 2012, EDUC TRAIN AUTISM DE, V47, P332; Sutera S, 2007, J AUTISM DEV DISORD, V37, P98, DOI 10.1007/s10803-006-0340-6; Ganz JB, 2005, EDUC TRAIN DEV DISAB, V40, P24; Mechling LC, 2012, J AUTISM DEV DISORD, V42, P2364, DOI 10.1007/s10803-012-1484-1; Mays NM, 2011, RES AUTISM SPECT DIS, V5, P1351, DOI 10.1016/j.rasd.2011.01.017; Hauser-Cram P, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00151; Kratochwill TR, 2013, REM SPEC EDUC, V34, P26, DOI 10.1177/0741932512452794; Wolery M, 2013, REM SPEC EDUC, V34, P39, DOI 10.1177/0741932512468038; Parker D, 2011, FOCUS AUTISM DEV DIS, V26, P131, DOI 10.1177/1088357610376945; Van Laarhoven T, 2006, EDUC TRAIN DEV DISAB, V41, P365; Perry A, 2009, J AUTISM DEV DISORD, V39, P1066, DOI 10.1007/s10803-009-0704-9; Bennett K, 2010, FOCUS AUTISM DEV DIS, V25, P173, DOI 10.1177/1088357610371636; Bennett K. D., 2013, J BEHAV ED, V22, P103, DOI [10.1007/s10864-013-9168-2, DOI 10.1007/S10864-013-9168-2]; Bennett Teresa Ann, 2013, J Can Acad Child Adolesc Psychiatry, V22, P13; BLEW PA, 1985, J APPL BEHAV ANAL, V18, P337, DOI 10.1901/jaba.1985.18-337; Breen C. G., 1995, J BEHAV ED, V5, P29, DOI 10.1007/BF02110213; Burke R. V., 2013, J VOCATIONAL REHABIL, V38, P1; Camargo SPH, 2014, J AUTISM DEV DISORD, V44, P2096, DOI 10.1007/s10803-014-2060-7; Cavkaytar A, 2009, EDUC TRAIN DEV DISAB, V44, P381; Centers for Disease Control and Prevention (CDC), 2014, PREV AUT SPECTR DIS; Cihak David F, 2008, Journal of Special Education Technology, V23; Cihak DF, 2008, RES AUTISM SPECT DIS, V2, P716, DOI 10.1016/j.rasd.2008.02.006; Detweiler D. D., 2005, FOCUS AUTISM OTHER D, V20, P98, DOI DOI 10.1177/10883576050200020601; FANTUZZO J, 1984, EDUC TRAIN MENT RET, V19, P102; FANTUZZO JW, 1983, PSYCHOL REP, V53, P871; Freeman BJ, 1999, J AUTISM DEV DISORD, V29, P379, DOI 10.1023/A:1023078827457; Ganz JB, 2008, FOCUS AUTISM DEV DIS, V23, P79, DOI 10.1177/1088357607311447; Ganz JB, 2011, RES AUTISM SPECT DIS, V5, P1500, DOI 10.1016/j.rasd.2011.02.011; GARDILL MC, 1995, EDUC TRAIN MENT RET, V30, P254; Gast D. L., 2010, SINGLE SUBJECT RES M; Gray KM, 2014, J AUTISM DEV DISORD, V44, P3006, DOI 10.1007/s10803-014-2159-x; KAYSER JE, 1986, J ASSOC PERS SEVERE, V11, P28; Kellems R. O., 2012, CAREER DEV TRANSITIO, V35, P155, DOI DOI 10.1177/0885728812443082; Klin A., 2008, AUTISM SPECTRUM DISO, P141; Kratochwill T. R., 2010, SINGLE CASE DESIGNS; Lattimore L Perry, 2009, Behav Anal Pract, V2, P34; Lattimore L Perry, 2008, Behav Anal Pract, V1, P24; Liss M, 2001, J AUTISM DEV DISORD, V31, P219, DOI 10.1023/A:1010707417274; MATSON JL, 1990, RES DEV DISABIL, V11, P361, DOI 10.1016/0891-4222(90)90023-2; Mayer G. R., 2012, BEHAV ANAL LASTING C; Mechling L, 2010, EDUC TRAIN AUTISM DE, V45, P230; Mechling Linda C, 2008, Journal of Special Education Technology, V23; Mechling L. C., 2004, Journal of Special Education Technology, V19; Mechling LC, 2009, EDUC TRAIN DEV DISAB, V44, P218; Mechling LC, 2005, EDUC TRAIN DEV DISAB, V40, P47; Myles B. S., 1999, FOCUS AUTISM OTHER D, V14, P106, DOI DOI 10.1177/108835769901400206; Ninci J., 2015, J AUTISM DEV DISORD, P1, DOI [10.1007/s40489-014-0046-1, DOI 10.1007/S40489-014-0046-1]; Odom S. L., 2010, PREVENTING SCH FAILU, V54, P275, DOI DOI 10.1080/10459881003785506; Ozcan N, 2009, EDUC TRAIN DEV DISAB, V44, P237; Palmen A, 2012, DEV NEUROREHABIL, V15, P401, DOI 10.3109/17518423.2012.701240; Parrott K. A., 2000, J BEHAV ED, V10, P3, DOI 10.1023/A:1016639721684; PIERCE KL, 1994, J APPL BEHAV ANAL, V27, P471, DOI 10.1901/jaba.1994.27-471; Rayner CS, 2010, DEV NEUROREHABIL, V13, P225, DOI 10.3109/17518421003801489; Schwartz I. S., 2010, EDUC TREAT CHILD, V33, P443, DOI DOI 10.1353/ETC.0.0098; Sewell TJ, 1998, J EARLY INTERVENTION, V21, P132; Shipley-Benamou R, 2002, J POSIT BEHAV INTERV, V4, P166, DOI DOI 10.1177/10983007020040030501; Sigafoos J., 2005, J BEHAV ED, V14, P189, DOI DOI 10.1007/S10864-00506297-2; Sigafoos J., 2007, J BEHAV ED, V16, P93, DOI DOI 10.1007/S10864-006-9004-Z; SMITH MD, 1985, J AUTISM DEV DISORD, V15, P163, DOI 10.1007/BF01531602; Sparrow S, 2005, VINELAND ADAPTIVE BE; Van Laarhoven T., 2007, ASSIST TECHNOL, V14, P28; Wendt O., 2011, ASSISTIVE TECHNOLOGY, V4	93	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0162-3257	1573-3432		J AUTISM DEV DISORD	J. Autism Dev. Disord.	SEP	2015	45	9					2792	2815		10.1007/s10803-015-2444-3		24	Psychology, Developmental	Psychology	CQ4AH	WOS:000360545800012		
J	Kasai, T; Hamaguchi, T; Miyata, M				Kasai, Taishi; Hamaguchi, Tasuku; Miyata, Makoto			Gliding Motility of Mycoplasma mobile on Uniform Oligosaccharides	JOURNAL OF BACTERIOLOGY			English	Article							ELECTRON-MICROSCOPY; GLASS BINDING; MACHINERY; IDENTIFICATION; GLI349; ANTIBODIES; MORPHOLOGY; MOVEMENTS; CENTIPEDE; MUTANTS	The binding and gliding of Mycoplasma mobile on a plastic plate covered by 53 uniform oligosaccharides were analyzed. Mycoplasmas bound to and glided on only 21 of the fixed sialylated oligosaccharides (SOs), showing that sialic acid is essential as the binding target. The affinities were mostly consistent with our previous results on the inhibitory effects of free SOs and suggested that M. mobile recognizes SOs from the nonreducing end with four continuous sites as follows. (i and ii) A sialic acid at the nonreducing end is tightly recognized by tandemly connected two sites. (iii) The third site is recognized by a loose groove that may be affected by branches. (iv) The fourth site is recognized by a large groove that may be enhanced by branches, especially those with a negative charge. The cells glided on uniform SOs in manners apparently similar to those of the gliding on mixed SOs. The gliding speed was related inversely to the mycoplasma's affinity for SO, suggesting that the detaching step may be one of the speed determinants. The cells glided faster and with smaller fluctuations on the uniform SOs than on the mixtures, suggesting that the drag caused by the variation in SOs influences gliding behaviors. IMPORTANCE Mycoplasma is a group of bacteria generally parasitic to animals and plants. Some Mycoplasma species form a protrusion at a pole, bind to solid surfaces, and glide in the direction of the protrusion. These procedures are essential for parasitism. Usually, mycoplasmas glide on mixed sialylated oligosaccharides (SOs) derived from glycoprotein and glycolipid. Since gliding motility on uniform oligosaccharides has never been observed, this study gives critical information about recognition and interaction between receptors and SOs.	[Miyata, Makoto] Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, Osaka 558, Japan; Osaka City Univ, OCU Adv Res Inst Nat Sci & Technol OCARINA, Sumiyoshi Ku, Osaka 558, Japan	Miyata, M (reprint author), Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, Osaka 558, Japan.	miyata@sci.osaka-cu.ac.jp		MIYATA, Makoto/0000-0002-7478-7390	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24117002, 21249030, 24390107]	This study was supported by a Grant-in-Aid for Scientific Research in the Priority Area "Harmonized Supramolecular Motility Machinery and Its Diversity" (24117002 to M.M.) and by Grants-in-Aid for Scientific Research (A and B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (21249030 and 24390107 to M.M.).	Adan-Kubo J, 2006, J BACTERIOL, V188, P2821, DOI 10.1128/JB.188.8.2821-2828.2006; ALUOTTO B B, 1970, International Journal of Systematic Bacteriology, V20, P35; Hiratsuka Y, 2006, P NATL ACAD SCI USA, V103, P13618, DOI 10.1073/pnas.0604122103; Kinosita Y, 2014, P NATL ACAD SCI USA, V111, P8601, DOI 10.1073/pnas.1310355111; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Miura Y, 2008, MOL CELL PROTEOMICS, V7, P370, DOI 10.1074/mcp.M700377-MCP200; Kasai T, 2013, J BACTERIOL, V195, P429, DOI 10.1128/JB.01141-12; Uenoyama A, 2005, P NATL ACAD SCI USA, V102, P12754, DOI 10.1073/pnas.0506114102; Miyata M, 2000, MICROBIOL-UK, V146, P1311; Oda M, 2012, J BIOL CHEM, V287, P33070, DOI 10.1074/jbc.M112.393801; Miyata M, 2004, J BACTERIOL, V186, P4382, DOI 10.1128/JB.186.13.4382-4386.2004; Lesoil C, 2010, BIOCHEM BIOPH RES CO, V391, P1312, DOI 10.1016/j.bbrc.2009.12.023; Nakane D, 2012, J BACTERIOL, V194, P122, DOI 10.1128/JB.05857-11; Jaffe JD, 2004, J BACTERIOL, V186, P4254, DOI 10.1128/JB.186.13.4254-4261.2004; Metsugi S, 2005, BIOPHYSICS-USSR, V1, P33, DOI http://dx.doi.org/10.2142/biophysics.1.33; Miyata M, 2010, ANNU REV MICROBIOL, V64, P519, DOI 10.1146/annurev.micro.112408.134116; Miyata M, 2008, TRENDS MICROBIOL, V16, P6, DOI 10.1016/j.tim.2007.11.002; Miyata M, 2002, J BACTERIOL, V184, P1827, DOI 10.1028/JB.184.7.1827-1831.2002; Miyata M, 2013, MOL CELL BIOL MOLLIC, P237; Nakane D, 2011, J BACTERIOL, V193, P715, DOI 10.1128/JB.00796-10; Nakane D, 2009, J BACTERIOL, V191, P3256, DOI 10.1128/JB.01823-08; Nakane D, 2007, P NATL ACAD SCI USA, V104, P19518, DOI 10.1073/pnas.0704280104; Pereyre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038585; Quinn GP, 2002, EXPT DESIGN DATA ANA, P537; Razin S, 2010, BIOLOGICALS, V38, P183, DOI 10.1016/j.biologicals.2009.11.008; Seto S, 2005, J BACTERIOL, V187, P3502, DOI 10.1128/JB.187.10.3502-3510.2005; Seto S, 2005, J BACTERIOL, V187, P1875, DOI 10.1128/JB.187.5.1875-1877.2005; Takada W, 2013, ANAL BIOCHEM, V435, P123, DOI 10.1016/j.ab.2013.01.004; TOWNSEND RR, 1989, ANAL BIOCHEM, V182, P1; Tulum I, 2014, J BACTERIOL, V196, P1815, DOI 10.1128/JB.01418-13; Uenoyama A, 2005, J BACTERIOL, V187, P5578, DOI 10.1128/JB.187.16.5578-5584.2005; Uenoyama A, 2004, J BACTERIOL, V186, P1537, DOI 10.1128/JB.186.5.1537-1545.2004; Uenoyama A, 2009, J BACTERIOL, V191, P1982, DOI 10.1128/JB.01012-08; Yamada K, 2009, J PROTEOME RES, V8, P521, DOI 10.1021/pr800710f	34	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	SEP	2015	197	18					2952	2957		10.1128/JB.00335-15		6	Microbiology	Microbiology	CQ6KH	WOS:000360712700006		
J	Phan, NQ; Uebanso, T; Shimohata, T; Nakahashi, M; Mawatari, K; Takahashi, A				Ngoc Quang Phan; Uebanso, Takashi; Shimohata, Takaaki; Nakahashi, Mutsumi; Mawatari, Kazuaki; Takahashi, Akira			DNA-Binding Protein HU Coordinates Pathogenicity in Vibrio parahaemolyticus	JOURNAL OF BACTERIOLOGY			English	Article							SECRETION SYSTEM 1; ESCHERICHIA-COLI; GENES; GROWTH; TRANSCRIPTION; EXPRESSION; VIRULENCE; SURVIVAL; CELLS; NS	HU is one of the most abundant nucleoid-associated proteins in bacterial cells and regulates the expression of many genes involved in growth, motility, metabolism, and virulence. It is known that Vibrio parahaemolyticus pathogenicity is related to its characteristic rapid growth and that type III secretion system 1 (T3SS1) contributes to its cytotoxicity. However, it is not known if HU plays a role in the pathogenicity of V. parahaemolyticus. In the present study, we investigated the effect of HU proteins HU-2 (HU alpha) (V. parahaemolyticus 2911 [vp2911]) and HU beta (vp0920) on the pathogenicity of V. parahaemolyticus. We found that a deletion of both HU subunits (yielding the Delta HUs [Delta vp0920 Delta vp2911] strain), but not single deletions, led to a reduction of the growth rate. In addition, expression levels of T3SS1-related genes, including exsA (positive regulator), exsD (negative regulator), vp1680 (cytotoxic effector), and vp1671 (T3SS1 apparatus), were reduced in the Delta HUs strain compared to the wild type (WT). As a result, cytotoxicity to HeLa cells was decreased in the Delta HUs strain. The additional deletion of exsD in the Delta HUs strain restored T3SS1-related gene expression levels and cytotoxicity but not the growth rate. These results suggest that the HU protein regulates the levels of T3SS1 gene expression and cytotoxicity in a growth rate-independent manner. IMPORTANCE Nucleoid-binding protein HU regulates cellular behaviors, including nucleoid structuring, general recombination, transposition, growth, replication, motility, metabolism, and virulence. It is thought that both the number of bacteria and the number of virulence factors may affect the pathogenicity of bacteria. In the present study, we investigated which factor(s) has a dominant role during infection in one of the most rapidly growing bacterial species, Vibrio parahaemolyticus. We found that V. parahaemolyticus cytotoxicity is regulated, in a growth rate-independent manner, by the HU proteins through regulation of a number of virulence factors, including T3SS1 gene expression.	[Ngoc Quang Phan; Uebanso, Takashi; Shimohata, Takaaki; Nakahashi, Mutsumi; Mawatari, Kazuaki; Takahashi, Akira] Univ Tokushima, Dept Prevent Environm & Nutr, Inst Biomed Sci, Grad Sch, Tokushima 770, Japan	Uebanso, T (reprint author), Univ Tokushima, Dept Prevent Environm & Nutr, Inst Biomed Sci, Grad Sch, Tokushima 770, Japan.	uebanso@tokushima-u.ac.jp			Japan Science and Technology Agency (JST)/Japan International Cooperation Agency (JICA), Science and Technology Research Partnership for Sustainable Development (SATREPS); Support Center for Advanced Medical Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School	This work was supported by the Japan Science and Technology Agency (JST)/Japan International Cooperation Agency (JICA) as part of the Science and Technology Research Partnership for Sustainable Development (SATREPS). This study was also supported by the Support Center for Advanced Medical Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School.	Alberti-Segui C, 2010, J BACTERIOL, V192, P6217, DOI 10.1128/JB.00106-10; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Nakano M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-155; Kodama T, 2002, CELL MICROBIOL, V4, P213, DOI 10.1046/j.1462-5822.2002.00176.x; Zhou XH, 2008, MOL MICROBIOL, V69, P747, DOI 10.1111/j.1365-2958.2008.06326.x; Bi HK, 2009, CURR MICROBIOL, V58, P443, DOI 10.1007/s00284-008-9340-4; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Mangan MW, 2011, MICROBIOL-SGM, V157, P1075, DOI 10.1099/mic.0.046359-0; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; van Noort J, 2004, P NATL ACAD SCI USA, V101, P6969, DOI 10.1073/pnas.0308230101; Kodama T, 2010, FEMS MICROBIOL LETT, V311, P10, DOI 10.1111/j.1574-6968.2010.02066.x; Nydam SD, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00001; Burdette DL, 2009, MOL MICROBIOL, V73, P639, DOI 10.1111/j.1365-2958.2009.06798.x; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Honda T., 1993, REV MED MICROBIOL, V4, P106; Nackerdien ZE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001671; Nomura T, 2000, MICROB PATHOGENESIS, V28, P25, DOI 10.1006/mpat.1999.0321; Oberto J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004367; ROUVIEREYANIV J, 1975, P NATL ACAD SCI USA, V72, P3428, DOI 10.1073/pnas.72.9.3428; Schechter LM, 2003, INFECT IMMUN, V71, P5432, DOI 10.1128/IAI.71.9.5432-5435.2003; Shimohata T, 2011, J INFECT DIS, V203, P537, DOI 10.1093/infdis/jiq070; Shimohata T, 2012, CAN J MICROBIOL, V58, P1002, DOI [10.1139/w2012-081, 10.1139/W2012-081]; TWEDT RM, 1971, APPL MICROBIOL, V22, P593; Wang LM, 2014, VET MICROBIOL, V171, P165, DOI 10.1016/j.vetmic.2014.03.030; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; Zhou XH, 2009, MICROBIOL-SGM, V155, P837, DOI 10.1099/mic.0.024919-0	31	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	SEP	2015	197	18					2958	2964		10.1128/JB.00306-15		7	Microbiology	Microbiology	CQ6KH	WOS:000360712700007		
J	Lin, JY; Sun, XF; Wu, HX				Lin, Justin Y.; Sun, Xifang; Wu, Harry X.			Banking structure and industrial growth: Evidence from China	JOURNAL OF BANKING & FINANCE			English	Article						Banking structure; Banking development; Industrial growth	ECONOMIC-GROWTH; FINANCIAL DEVELOPMENT; CREDIT	The debate on the puzzling relationship between financial development and economic growth in China has remained inconclusive because the effects of banking ownership structure and size structure are highly intertwined in the existing studies. This paper addresses this problem by specifying an empirical model to disentangle the two structural effects. The analysis uses a data set that includes the banking sector and 28 manufacturing industries across 30 Chinese provinces over the period 1999-2007. In order to identify the channel through which banking structure affects industrial growth, two interactive variables are constructed to capture the interaction of the prevailing banking structure with labor intensity and the share of non-state-owned enterprises in each industry, respectively. The regression results are robust and make the case for the ongoing banking reforms to reduce state ownership and promote small banking institutions. (C) 2015 Elsevier B.V. All rights reserved.	[Lin, Justin Y.] Peking Univ, Natl Sch Dev, Beijing 100871, Peoples R China; [Sun, Xifang] S China Univ Technol, Sch Econ & Commerce, Guangzhou 510006, Guangdong, Peoples R China; [Wu, Harry X.] Hitotsubashi Univ, Inst Econ Res, Tokyo 1868603, Japan	Sun, XF (reprint author), S China Univ Technol, Sch Econ & Commerce, Guangzhou 510006, Guangdong, Peoples R China.	justinlin@nsd.pku.edu.cn; sunnyxfs@gmail.com; harry.wu@ier.hit-u.ac.jp			"Basic Asian Studies Support Program" at Seoul National University, South Korea; JSPS [24330076]	The authors thank the two referees for their insightful comments and suggestions. We are grateful to Robert J. Cull, Lixin Colin Xu, Xiaobo Zhang, Binkai Chen, Qiao Liu and participants at seminars at Seoul National University, Peking University, and Southwestern University of Finance and Economics for their constructive comments. Xifang Sun acknowledges the financial support provided by the "Basic Asian Studies Support Program" at Seoul National University, South Korea. Harry Wu would like to acknowledge the financial support from JSPS Grant No. 24330076 for data work on capital stock. However, the views expressed in this paper are solely the responsibility of the authors.	Chang PC, 2010, J BANK FINANC, V34, P2753, DOI 10.1016/j.jbankfin.2010.05.015; Allen F, 2005, J FINANC ECON, V77, P57, DOI 10.1016/j.jfineco.2004.06.010; Long C, 2011, J INT ECON, V84, P112, DOI 10.1016/j.jinteco.2011.03.002; Guariglia A, 2008, J COMP ECON, V36, P633, DOI 10.1016/j.jce.2007.12.003; Rajan RG, 1998, AM ECON REV, V88, P559; Ge Y, 2007, J BANK FINANC, V31, P513, DOI 10.1016/j.jbankfin.2006.07.009; Liang Q, 2006, CHINA ECON REV, V17, P395, DOI 10.1016/j.chieco.2005.09.003; Ayyagari M, 2010, REV FINANC STUD, V23, P3048, DOI 10.1093/rfs/hhq030; Zhang J, 2012, J COMP ECON, V40, P393, DOI 10.1016/j.jce.2012.01.001; Cull R, 2009, J FINANC INTERMED, V18, P173, DOI 10.1016/j.jfi.2008.08.004; Aziz J., 2002, 02194 INT MON FUND; Boyreau-Debray G., 2005, 11214 NBER; Boyreau-Debray G., 2003, 3027 WORLD BANK; Chong TTL, 2013, J BANK FINANC, V37, P3412, DOI 10.1016/j.jbankfin.2013.05.006; Demetriades P., 2008, DOES CHINESE B UNPUB; Dobson W., 2006, CONTRADICTION UNPUB; Ferri G, 2009, J BANK FINANC, V33, P131, DOI 10.1016/j.jbankfin.2007.06.013; Levine R., 2005, HDB EC GROWTH; Lin J. Y., 2009, EC RES J, V44, P4; Lin J. Y, 2008, EC RES J, V43, P31; Park A, 2001, J COMP ECON, V29, P608, DOI 10.1006/jcec.2001.1740; Podpiera R., 2006, WP0671 IMF; Wu H. X., 2008, 2008 WORLD C NAT ACC	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4266	1872-6372		J BANK FINANC	J. Bank Financ.	SEP	2015	58						131	143		10.1016/j.jbankfin.2015.02.012		13	Business, Finance; Economics	Business & Economics	CQ3NW	WOS:000360510300010		
J	Zabelina, V; Klymenko, V; Tamura, T; Doroshenko, K; Liang, HY; Sezutsu, H; Sehnal, F				Zabelina, Valeriya; Klymenko, Vyacheslav; Tamura, Toshiki; Doroshenko, Karina; Liang, Haoyuan; Sezutsu, Hideki; Sehnal, Frantisek			Genome engineering and parthenocloning in the silkworm, Bombyx mori	JOURNAL OF BIOSCIENCES			English	Review						Genomic cloning; genetic engineering; insect biotechnology; recombinant proteins; sex control; silk	TARGETED GENE-EXPRESSION; YELLOW-FEVER MOSQUITO; TRANSGENIC SILKWORMS; ARTIFICIAL PARTHENOGENESIS; MECHANICAL-PROPERTIES; TRANSPOSABLE ELEMENT; PROTEIN-PRODUCTION; AEDES-AEGYPTI; H-CHAIN; TRANSFORMATION	Genetic engineering of the silkworm, Bombyx mori, opens door to the production of new kinds of silk and to the use of silkworms as proteosynthetic bioreactors. The insertion of foreign genes into silkworm genome and the control of their expression by diverse promoters have become possible but are not yet efficient enough for commercial use. Several methods of gene targeting are being developed to minimize position effect on transgene expression and facilitate cloning. Parthenocloning can be exploited to conserve genetic traits and improve selection and amplification of clones containing genes of interest. Some silkworm clones have been bred for decades as genetically stable female stocks whose unfertilized eggs are induced to develop by heat-shock treatment. Any exclusively female generation contains exact copies of the maternal clone-founder genome. Ovaries transplanted in either direction between the standard and the parthenogenetic genotypes yield eggs capable of parthenocloning. In addition, use of male larvae as ovary recipients eliminates diapause in eggs produced in the implants. Unfertilized eggs of some silkworm clones respond also to the cold-shock treatment by producing homozygous fertile sons; cloned females can be crossed with their parthenogenetic sons to obtain progeny homozygous for the transgene in both sexes. Rational exploitation of available parthenozygous pools and the use of parthenocloning methods enable rapid fixation and maintenance of the desired genotypes.	[Zabelina, Valeriya; Doroshenko, Karina; Liang, Haoyuan] Kharkov Natl Univ, UA-61077 Kharkov, Ukraine; [Klymenko, Vyacheslav; Sehnal, Frantisek] CAS, Ctr Biol, Ceske Budejovice 37005, Czech Republic; [Tamura, Toshiki; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	Klymenko, V (reprint author), CAS, Ctr Biol, Ceske Budejovice 37005, Czech Republic.	stemway@gmail.com; ttamura@affrc.go.jp; sehnal@bc.cas.cz	Zabelina, Valeriya/L-1433-2015		Postdok_BIOGLOBE [CZ.1.07/2.3.00/30.0032]; European Social Fund; state budget of the Czech Republic [RVO 60077344]; Czech Science Foundation [P502/10/2382]	The working stay of VZ in the Biology Centre, Czech Academy of Sciences was supported by project Postdok_BIOGLOBE - CZ.1.07/2.3.00/30.0032 co-financed by the European Social Fund and the state budget of the Czech Republic (RVO 60077344). Most research expenditures were covered by grant P502/10/2382 from the Czech Science Foundation.	Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f; Takasu Y, 2014, METHODS, V69, P46, DOI 10.1016/j.ymeth.2014.02.014; Iizuka T, 2013, ADV FUNCT MATER, V23, P5232, DOI 10.1002/adfm.201300365; Grenier AM, 2004, J INSECT PHYSIOL, V50, P751, DOI 10.1016/j.jinsphys.2004.06.002; Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; BRAND AH, 1993, DEVELOPMENT, V118, P401; Kojima K, 2007, BIOSCI BIOTECH BIOCH, V71, P2943, DOI 10.1271/bbb.70353; Ito K, 2008, P NATL ACAD SCI USA, V105, P7523, DOI 10.1073/pnas.0711841105; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Kurihara H, 2007, BIOCHEM BIOPH RES CO, V355, P976, DOI 10.1016/j.bbrc.2007.02.055; Kludkiewicz B, 2009, INSECT BIOCHEM MOLEC, V39, P938, DOI 10.1016/j.ibmb.2009.11.005; Zhu ZH, 2010, J BIOMAT SCI-POLYM E, V21, P395, DOI 10.1163/156856209X423126; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Tomita M, 2011, BIOTECHNOL LETT, V33, P645, DOI 10.1007/s10529-010-0498-z; Tatematsu K, 2010, TRANSGENIC RES, V19, P473, DOI 10.1007/s11248-009-9328-2; ASTAUROV BL, 1973, GENETIKA+, V9, P93; Xu HF, 2014, TRANSGENIC RES, V23, P697, DOI 10.1007/s11248-014-9826-8; TERSKAYA ER, 1975, GENETIKA+, V11, P54; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Sturtevant AH, 1915, AM NAT, V49, P42, DOI 10.1086/279453; Tan A, 2005, P NATL ACAD SCI USA, V102, P11751, DOI 10.1073/pnas.0500954102; Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009; Tamura T, 2000, NAT BIOTECHNOL, V18, P81; Imamura M, 2003, GENETICS, V165, P1329; Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1; Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109; Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2; Sajwan S, 2013, INSECT BIOCHEM MOLEC, V43, P17, DOI 10.1016/j.ibmb.2012.10.011; Woltje M, 2014, APPL MICROBIOL BIOT, V98, P4571, DOI 10.1007/s00253-014-5543-8; Astaurov BL, 1936, DOKL AKAD NAUK SSSR, V2, P277; Astaurov B.L., 1940, ARTIFICIAL PARTHENOG; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Daimon T, 2012, PLOS GENET, V8; Doroshenko KA, 2010, SERICOLOGIA, V50, P187; Fedic Robert, 2002, Journal of Insect Biotechnology and Sericology, V71, P1; Fujii T, 2010, INSECT MOL BIOL, V19, P659, DOI 10.1111/j.1365-2583.2010.01020.x; Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743; Kawai S., 2012, BOMBYX MORI P NATL A, V109, pf591; KLIMENKO VV, 1979, TSITOLOGIYA+, V21, P793; KLIMENKO VV, 1977, DOKL AKAD NAUK SSSR+, V236, P740; Klymenko Vyacheslav V., 2001, Journal of Insect Biotechnology and Sericology, V70, P155; Klymenko V. V., 2012, Cell and Tissue Biology, V6, P280, DOI 10.1134/S1990519X12030054; Klymenko VV, 2013, ANIM BREED GENET UKR, V47, P40; Kuwana Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105325; LOUKERIS TG, 1995, SCIENCE, V270, P2002, DOI 10.1126/science.270.5244.2002; Lysenko NG, 2013, SCI TECHNOL B UKRAIN, V109, P165; Ma L, 2011, CELL RES, V21, P934, DOI 10.1038/cr.2011.36; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Michaille JJ, 1990, SERICOLOGIA, V30, P49; MICHAILLE JJ, 1990, GENE, V86, P177, DOI 10.1016/0378-1119(90)90277-X; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; RASMUSSEN SW, 1976, CHROMOSOMA, V54, P245, DOI 10.1007/BF00293453; ROTH DA, 1993, P NATL ACAD SCI USA, V90, P8372, DOI 10.1073/pnas.90.18.8372; Shaik AH, 2009, J INSECT PHYSL, V55, P781; Strunnikov V.A., 1987, GENETIC METHODS SELE; Takasu Y, 2013, PLOS ONE, V8, P73458; Tatematsu K, 2012, J BIOTECHNOL BIOMA S, V9, P1; Tichomiroff AA, 1886, ARCH ANAT PHYSL P S, P35; Tsubota T, 2014, INSECT MOL BIOL, V23, P165, DOI 10.1111/imb.12071; Uhlirova M, 2002, DEV GENES EVOL, V212, P145, DOI 10.1007/s00427-002-0221-8; Yonemura N, 2012, MOL GENET GENOMICS, V287, P731, DOI 10.1007/s00438-012-0711-y; Yonemura N, 2012, INSECT BIOCHEM MOLEC, V42, P371, DOI 10.1016/j.ibmb.2012.01.008; Yonemura N, 2013, APPL ENTOMOL ZOOL, V48, P265, DOI 10.1007/s13355-013-0182-6; Zabelina V, 2015, J INSECT PHYSIOL, V81, P28, DOI 10.1016/j.jinsphys.2015.06.011; Zabelina VY, 2008, SERICOLOGIA, V48, P123	68	0	0	INDIAN ACAD SCIENCES	BANGALORE	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA	0250-5991	0973-7138		J BIOSCIENCES	J. Biosci.	SEP	2015	40	3					645	655		10.1007/s12038-015-9548-y		11	Biology	Life Sciences & Biomedicine - Other Topics	CQ6DQ	WOS:000360695000016		
J	Fukumoto, S; Ozono, K; Michigami, T; Minagawa, M; Okazaki, R; Sugimoto, T; Takeuchi, Y; Matsumoto, T				Fukumoto, Seiji; Ozono, Keiichi; Michigami, Toshimi; Minagawa, Masanori; Okazaki, Ryo; Sugimoto, Toshitsugu; Takeuchi, Yasuhiro; Matsumoto, Toshio			Pathogenesis and diagnostic criteria for rickets and osteomalacia-proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Vitamin D; Hypophosphatemia; Hyopcalcemia; Fibroblast growth factor 23	HEREDITARY HYPOPHOSPHATEMIC RICKETS; VITAMIN-D; PHOSPHATE HOMEOSTASIS; MUTATIONS; GENE; FIBROBLAST-GROWTH-FACTOR-23; HYPERCALCIURIA; SLC34A3; DISEASE; FGF-23	Rickets and osteomalacia are diseases characterized by impaired mineralization of bone matrix. Recent investigations have revealed that the causes of rickets and osteomalacia are quite variable. Although these diseases can severely impair the quality of life of affected patients, rickets and osteomalacia can be completely cured or at least respond to treatment when properly diagnosed and treated according to the specific causes. On the other hand, there are no standard criteria to diagnose rickets or osteomalacia nationally and internationally. Therefore, we summarize the definition and pathogenesis of rickets and osteomalacia, and propose diagnostic criteria and a flowchart for the differential diagnosis of various causes of these diseases. We hope that these criteria and the flowchart are clinically useful for the proper diagnosis and management of these diseases.	[Fukumoto, Seiji; Matsumoto, Toshio] Univ Tokushima, Fujii Mem Inst Med Sci, Tokushima 7708503, Japan; [Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Michigami, Toshimi] Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Bone & Mineral Res, Izumi 5941101, Japan; [Minagawa, Masanori] Childrens Hosp, Dept Endocrinol, Chiba 2660007, Japan; [Okazaki, Ryo] Teikyo Univ, Chiba Med Ctr, Dept Med 3, Ichihara, Chiba 2990111, Japan; [Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane 6938501, Japan; [Takeuchi, Yasuhiro] Toranomon Gen Hosp, Endocrine Ctr, Div Endocrinol, Tokyo 1058470, Japan	Fukumoto, S (reprint author), Univ Tokushima, Fujii Mem Inst Med Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	fukumoto-tky@umin.ac.jp			Ministry of Health, Labour and Welfare of Japan	This study was supported in part by a grant from the Ministry of Health, Labour and Welfare of Japan.	Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; WEISS MJ, 1988, P NATL ACAD SCI USA, V85, P7666, DOI 10.1073/pnas.85.20.7666; Prentice A, 2013, J STEROID BIOCHEM, V136, P201, DOI 10.1016/j.jsbmb.2012.11.018; Fukumoto S, 2014, CURR OPIN NEPHROL HY, V23, P346, DOI 10.1097/01.mnh.0000447012.98357.da; Bendik I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00248; Endo I, 2008, BONE, V42, P1235, DOI 10.1016/j.bone.2008.02.014; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Collier J, 2007, HEPATOLOGY, V46, P1271, DOI 10.1002/hep21852; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; Kubota T, 2014, HORM RES PAEDIAT, V81, P251, DOI 10.1159/000357142; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Reginato AJ, 2003, BEST PRACT RES CL RH, V17, P1063, DOI 10.1016/S1521-6942(03)00112-8; TOVEY FI, 1992, J GASTROEN HEPATOL, V7, P639, DOI 10.1111/j.1440-1746.1992.tb01498.x; Whyte MP, 2009, MEDICINE, V37, P483	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	SEP	2015	33	5					467	473		10.1007/s00774-015-0698-7		7	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CQ6IA	WOS:000360706700001		
J	Kaneshiro, S; Ebina, K; Shi, KR; Yoshida, K; Otsuki, D; Yoshikawa, H; Higuchi, C				Kaneshiro, Shoichi; Ebina, Kosuke; Shi, Kenrin; Yoshida, Kiyoshi; Otsuki, Dai; Yoshikawa, Hideki; Higuchi, Chikahisa			Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Bruton tyrosine kinase (Btk); Osteoblastic differentiation; MAPK; NF kappa B; PKC alpha	X-LINKED AGAMMAGLOBULINEMIA; B-CELL; BONE-FORMATION; KAPPA-B; INHIBITION; EXPRESSION; PCI-32765; ARTHRITIS; OSTERIX; FAMILY	The Tec family of nonreceptor tyrosine kinases has been shown to play a key role in inflammation and bone destruction. Bruton tyrosine kinase (Btk) has been the most widely studied because of its critical role in B cells. Furthermore, recent evidence has demonstrated that blocking Btk signaling is effective in ameliorating lymphoma progression and experimental arthritis. The role of Btk in osteoblastic differentiation has not been well elucidated. In this study, we demonstrated the role of Btk in osteoblastic differentiation and investigated the effects of a Btk inhibitor on osteoblastic differentiation in mouse preosteoblastic MC3T3-E1 cells, primary calvarial osteoblasts, and bone marrow stromal ST2 cells. Btk expression was detected in all three cell lines. Btk inhibition stimulated mRNA expression of osteoblastic markers (alkaline phosphatase, osteocalcin, and osterix) and promoted mineralization of the extracellular matrix. In addition, Btk knockdown caused increased mRNA expression of osteoblastic markers. Furthermore, Btk inhibition suppressed the phosphorylation of mitogen-activated protein kinase (MAPK), nuclear factor kappa B (NF kappa B), and protein kinase C alpha (PKC alpha). Our results indicate that Btk may regulate osteoblastic differentiation through the MAPK, NF kappa B, and PKC alpha signaling pathways.	[Kaneshiro, Shoichi; Ebina, Kosuke; Shi, Kenrin; Yoshida, Kiyoshi; Otsuki, Dai; Yoshikawa, Hideki; Higuchi, Chikahisa] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan	Higuchi, C (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	c-higuchi@umin.ac.jp					Alles N, 2010, ENDOCRINOLOGY, V151, P4626, DOI 10.1210/en.2010-0399; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Lee SH, 2008, J BIOL CHEM, V283, P11526, DOI 10.1074/jbc.M708935200; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785; Chang BY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3400; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI [10.1038/nchembio.481, 10.1038/NCHEMBIO.481]; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Hendriks RW, 2011, NAT CHEM BIOL, V7, P4, DOI 10.1038/nchembio.502; Robak T, 2012, EXPERT OPIN INV DRUG, V21, P921, DOI 10.1517/13543784.2012.685650; Suzuki A, 2002, BONE, V30, P91, DOI 10.1016/S8756-3282(01)00660-3; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Tan SL, 2013, PHARMACOL THERAPEUT, V138, P294, DOI 10.1016/j.pharmthera.2013.02.001; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; Kaneshiro S, 2013, J BONE MINER METAB, P1; Liu LC, 2011, J PHARMACOL EXP THER, V338, P154, DOI 10.1124/jpet.111.181545; Nakura A, 2011, BONE, V48, P476, DOI 10.1016/j.bone.2010.09.238; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Weniger MA, 2011, SEMIN HEMATOL, V48, P214, DOI 10.1053/j.seminhematol.2011.05.001; Yoshida K, 2011, BIOCHEM BIOPH RES CO, V411, P774, DOI 10.1016/j.bbrc.2011.07.023	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	SEP	2015	33	5					486	495		10.1007/s00774-014-0612-8		10	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CQ6IA	WOS:000360706700003		
J	Tamiya, H; Miyakawa, M; Takeshita, A; Miura, D; Takeuchi, Y				Tamiya, Hiroyuki; Miyakawa, Megumi; Takeshita, Akira; Miura, Daishu; Takeuchi, Yasuhiro			Ultrasonographic evaluation of parathyroid hyperplasia in multiple endocrine neoplasia type 1: Positive correlation between parathyroid volume and circulating parathyroid hormone concentration	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Ultrasonography; Parathyroid hyperplasia; Parathyroid volume; MEN1	PRIMARY HYPERPARATHYROIDISM; ADENOMA WEIGHT; SERUM-CALCIUM; GLAND SIZE	There are few reports on parathyroid ultrasonography of multiple endocrine neoplasia type 1 (MEN1). This study investigated the ultrasonographic features of parathyroid glands in 10 patients with MEN1 who underwent preoperative neck ultrasonography and parathyroidectomy between 2006 and 2010 at Toranomon Hospital. We retrospectively analyzed clinical features, laboratory and ultrasonographic data, and pathological diagnosis. A total of 38 parathyroid glands were surgically removed (three to five glands from each patient). All removed parathyroids were pathologically diagnosed as hyperplasia. Seven cases (70.0 %) had adenomatous thyroid nodules. Twenty-five enlarged parathyroid glands (65.8 %) were detected by preoperative ultrasonography with a detection rate of 81.8 % (9/11) and 59.3 % (16/27) for patients without and with adenomatous nodules, respectively. Total parathyroid gland weight and potentially predictable total parathyroid volume by preoperative ultrasonography were significantly correlated with preoperative serum intact parathyroid hormone (iPTH) concentration (R = 0.97, P < 0.001 and R = 0.96, P < 0.001, respectively). The equation used for prediction of the total volume by ultrasonography was 15 x iPTH (pg/ml) - 1,000 and that for total weight was 20 x iPTH (pg/ml) - 1,400. Although adenomatous nodules often coexisted with MEN1 and made identification of enlarged parathyroid glands by ultrasonography difficult, the positive correlation between the predictable parathyroid volume by ultrasonography and serum iPTH suggests that their measurement is useful in the preoperative detection and localization of enlarged parathyroid glands in patients with MEN1. Furthermore, the presence of parathyroid glands that should be resected can be predicted before surgery using the equation proposed here.	[Tamiya, Hiroyuki; Miyakawa, Megumi; Takeshita, Akira; Takeuchi, Yasuhiro] Toranomon Gen Hosp, Endocrine Ctr, Div Endocrinol, Minato Ku, Tokyo 1058470, Japan; [Takeshita, Akira; Miura, Daishu; Takeuchi, Yasuhiro] Okinaka Mem Inst Med Res, Tokyo, Japan; [Miura, Daishu] Toranomon Gen Hosp, Div Breast & Endocrine Surg, Tokyo 1058470, Japan	Tamiya, H (reprint author), Toranomon Gen Hosp, Endocrine Ctr, Div Endocrinol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	tamiyatky@gmail.com		Tamiya, Hiroyuki/0000-0001-8283-070X	Okinaka Memorial Institute for Medical Research	This study was funded by a grant from Okinaka Memorial Institute for Medical Research (Y.T.). We thank all staff of the Toranomon Hospital Endocrine Center for their kind help with this study.	Trump D, 1996, QJM-MON J ASSOC PHYS, V89, P653; Barbaros U, 2009, AM J OTOLARYNG, V30, P239, DOI 10.1016/j.amjoto.2008.06.007; Berger AC, 1999, J AM COLL SURGEONS, V188, P382, DOI 10.1016/S1072-7515(98)00317-2; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; MARX SJ, 1986, MEDICINE, V65, P226; BENSON L, 1987, UPSALA J MED SCI, V92, P147; Bindlish V, 2002, HEAD NECK-J SCI SPEC, V24, P1000, DOI 10.1002/hed.10165; Doherty GM, 2004, WORLD J SURG, V28, P1139, DOI 10.1007/s00268-004-7560-8; Doherty GM, 2005, J SURG ONCOL, V89, P143, DOI 10.1002/jso.20181; Eberle F, 1981, Ergeb Inn Med Kinderheilkd, V46, P76; GOUGH IR, 1988, AUST NZ J SURG, V58, P381, DOI 10.1111/j.1445-2197.1988.tb01084.x; Hamidi S, 2006, ANZ J SURG, V76, P882, DOI 10.1111/j.1445-2197.2006.03896.x; Imaizumi M, 2006, JAMA-J AM MED ASSOC, V295, P1011, DOI 10.1001/jama.295.9.1011; MALLETTE LE, 1989, AM J MED SCI, V298, P51, DOI 10.1097/00000441-198907000-00010; Marx SJ, 2012, WILLIAMS TXB ENDOCRI, P1728; MARX SJ, 1991, CLIN ENDOCRINOL, V35, P521, DOI 10.1111/j.1365-2265.1991.tb00938.x; Moretz WH, 2007, LARYNGOSCOPE, V117, P1957, DOI 10.1097/MLG.0b013e31813c14fc; Mozes G, 2002, J AM COLL SURGEONS, V194, P126, DOI 10.1016/S1072-7515(01)01139-5; Nilubol N, 2012, WORLD J SURG, V36, P1368, DOI 10.1007/s00268-012-1451-1; Randhawa PS, 2007, CLIN OTOLARYNGOL, V32, P179, DOI 10.1111/j.1365-2273.2007.01447.x; RASTAD J, 1984, ACTA CHIR SCAND, V150, P199; Regal M, 1999, J ENDOCRINOL INVEST, V22, P191; RUTLEDGE R, 1985, SURGERY, V98, P1107; Sekiyama K, 2003, INT J UROL, V10, P7, DOI 10.1046/j.1442-2042.2003.00564.x; Tamiya H, 2013, ENDOCR J, V60, P709; Unluturk U, 2012, CLIN ENDOCRINOL, V76, P492, DOI 10.1111/j.1365-2265.2011.04241.x; WILLIAMS JG, 1992, AM J SURG, V163, P301, DOI 10.1016/0002-9610(92)90007-E	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	SEP	2015	33	5					523	529		10.1007/s00774-014-0614-6		7	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CQ6IA	WOS:000360706700007		
J	Miyakoshi, N; Aizawa, T; Sasaki, S; Ando, S; Maekawa, S; Aonuma, H; Tsuchie, H; Sasaki, H; Kasukawa, Y; Shimada, Y				Miyakoshi, Naohisa; Aizawa, Toshiaki; Sasaki, Satoshi; Ando, Shigeru; Maekawa, Shigeto; Aonuma, Hiroshi; Tsuchie, Hiroyuki; Sasaki, Hiroshi; Kasukawa, Yuji; Shimada, Yoichi			Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Bisphosphonate; Bone union; Femoral fracture; Teriparatide	BONE TURNOVER MARKERS; VITAMIN-D; ALENDRONATE THERAPY; PARATHYROID-HORMONE; DIAPHYSEAL; EFFICACY; QUALITY; UNIONS; FEMUR; HIP	Atypical femoral fracture (AFF) often appears with bisphosphonate use. Teriparatide (TPTD) treatment may promote AFF healing, but few controlled or comparative studies have examined the effects of TPTD on healing of bisphosphonate-associated AFF. We retrospectively reviewed the medical records of 45 consecutive AFFs in 34 Japanese patients who had received oral bisphosphonates (alendronate or risedronate) for osteoporosis before AFF and had been followed for a parts per thousand yen12 months (range, 12-90 months). Thirty-seven complete or incomplete AFFs (82 %) were treated surgically and eight incomplete AFFs (18 %) were treated conservatively. Bisphosphonates were stopped at diagnosis. Based on TPTD use after fracture, AFFs were divided into non-TPTD (n = 24) and TPTD (n = 21) groups. Time to fracture-healing and frequency of delayed healing or non-union were compared between groups. Because fracture type (complete or incomplete) differed significantly between groups, only subanalyses for all surgically treated AFFs (complete and incomplete), surgically treated complete AFFs, and conservatively treated incomplete AFFs were performed. In subanalyses for all AFFs treated surgically, mean (+/- A standard deviation) time to fracture healing was significantly better in the TPTD group (5.4 +/- A 1.5 months) than in the non-TPTD group (8.6 +/- A 4.7 months; P = 0.012), and the frequency of delayed healing or non-union was significantly lower in the TPTD group than in the non-TPTD group (P = 0.014). Subanalyses for surgically treated complete AFFs yielded similar results, but subanalyses for incomplete AFFs treated conservatively showed no significant differences between groups. TPTD treatment appears to significantly shorten the postoperative time to fracture healing and reduce rates of delayed healing or non-union after bisphosphonate-associated AFF.	[Miyakoshi, Naohisa; Kasukawa, Yuji; Shimada, Yoichi] Akita Univ, Sch Med, Dept Orthoped Surg, Akita 0108543, Japan; [Miyakoshi, Naohisa; Aizawa, Toshiaki; Sasaki, Satoshi; Ando, Shigeru; Maekawa, Shigeto; Aonuma, Hiroshi; Tsuchie, Hiroyuki; Sasaki, Hiroshi; Kasukawa, Yuji; Shimada, Yoichi] Akita Bone & Osteoporosis Network A BONE, Akita, Japan; [Aizawa, Toshiaki] Northern Akita Municipal Hosp, Dept Orthoped Surg, KitaAkita, Japan; [Sasaki, Satoshi] Higashinaruse Natl Hlth Insurance Clin, Higashinaruse, Japan; [Ando, Shigeru] Yamamoto Kumiai Gen Hosp, Dept Orthoped Surg, Noshiro, Akita, Japan; [Maekawa, Shigeto] Ogachi Cent Hosp, Dept Orthoped Surg, Yuzawa, Japan; [Aonuma, Hiroshi] Kakunodate Gen Hosp, Dept Orthoped Surg, Senboku, Japan; [Tsuchie, Hiroyuki] Nakadoori Gen Hosp, Dept Orthoped Surg, Akita, Japan; [Sasaki, Hiroshi] Akita Rosai Hosp, Dept Orthoped Surg, Odate, Japan	Miyakoshi, N (reprint author), Akita Univ, Sch Med, Dept Orthoped Surg, 1-1-1 Hondo, Akita 0108543, Japan.	miyakosh@doc.med.akita-u.ac.jp					Papadokostakis G, 2005, INJURY, V36, P813, DOI 10.1016/j.injury.2004.11.029; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Gomberg SJ, 2011, J CLIN ENDOCR METAB, V96, P1627, DOI 10.1210/jc.2010-2520; Weil YA, 2011, J TRAUMA, V71, P186, DOI 10.1097/TA.0b013e31821957e3; Rizzoli R, 2011, OSTEOPOROSIS INT, V22, P373, DOI 10.1007/s00198-010-1453-5; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Lee YK, 2013, J CLIN ENDOCR METAB, V98, P2742, DOI 10.1210/jc.2012-4322; McClung M, 2013, AM J MED, V126, P13, DOI 10.1016/j.amjmed.2012.06.023; Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; Thompson RN, 2012, J BONE JOINT SURG BR, V94B, P385, DOI 10.1302/0301-620X.94B3.27999; Sasaki S, 2012, J BONE MINER METAB, V30, P561, DOI 10.1007/s00774-012-0358-0; Chiang CY, 2013, BONE, V52, P360, DOI 10.1016/j.bone.2012.10.006; Sahota O, 1999, CLIN ENDOCRINOL, V51, P217, DOI 10.1046/j.1365-2265.1999.00764.x; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Iwamoto J, 2011, OSTEOPOROSIS INT, V22, P2735, DOI 10.1007/s00198-010-1495-8; Egol KA, 2013, CLIN ORTHOP RELAT RE; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; Gavaskar Ashok S, 2010, J Orthop Surg (Hong Kong), V18, P45; Huang HT, 2012, MENOPAUSE, V19, P1360, DOI 10.1097/gme.0b013e318260143d; Lin Tsung-Li, 2013, BMC Res Notes, V6, P11, DOI 10.1186/1756-0500-6-11; Miyakoshi N, 2004, CURR PHARM DESIGN, V10, P2615, DOI 10.2174/1381612043383737; Oh CW, 2013, SCI WORLD J, DOI 10.1155/2013/450148; Pietrogrande L, 2013, INJURY, V44, pS54, DOI 10.1016/S0020-1383(13)70013-5; Saleh Anas, 2012, HSS J, V8, P103, DOI 10.1007/s11420-012-9275-y; Watanabe Y, 2013, J ORTHOP SCI, V18, P803, DOI 10.1007/s00776-013-0415-0; Yamamoto T, 2013, J BONE MINER METAB, V31, P199, DOI 10.1007/s00774-012-0403-z	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	SEP	2015	33	5					553	559		10.1007/s00774-014-0617-3		7	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CQ6IA	WOS:000360706700011		
J	Kato, T; Niwa, M; Yamashita, T; Matumoto, M; Umemura, Y				Kato, Takeru; Niwa, Masato; Yamashita, Takenori; Matumoto, Minoru; Umemura, Yoshihisa			Past sporting activity during growth induces greater bone mineral content and enhances bone geometry in young men and women	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Osteogenic index; Prepuberty; Weight-bearing exercise; Bone geometry	PHYSICAL-ACTIVITY; JUMPING INTERVENTION; TENNIS PLAYERS; PROXIMAL FEMUR; SHORT BOUTS; STRENGTH; MASS; EXERCISE; GIRLS; SIZE	We aimed to determine the effect of past sporting activity on bone mineral content (BMC), areal bone mineral density (aBMD) in the lumbar spine and proximal femur, and bone geometry of the mid femur in young men and women. We assessed 142 subjects, comprising 79 young men (21.2 +/- A 0.8 years) and 63 premenopausal young women (21.4 +/- A 0.6 years). The subjects were classified into three groups, two on the basis of the age of starting to participate in sport [elementary school starters (6-12 years), junior high school to university starters (13-22 years)], and the third group had no participation in sport. We measured BMC and aBMD by dual-energy X-ray absorptiometry (DXA) in the lumbar spine and proximal femur, and bone geometric characteristics of the mid femur by magnetic resonance imaging (MRI), and calculated the osteogenic index (OI) of previous sporting activity. The OI correlated significantly with many MRI-determined measures of bone geometry; DXA-measured BMC and aBMD were effective indicators of previous sporting activity in both sexes. The female elementary school starters had significantly greater femoral mid-diaphyseal perimeters (vs the no-sport group), bone cross-sectional area (vs the 13-22-year-old starters and the no-sport group), and maximum and minimum second moment of area at the mid-diaphysis point of the femur (vs the no-sport group). The OI is a proven practicable and useful index. DXA- and MRI-determined geometric characteristics showed that high-impact, weight-bearing exercise before and in early puberty induces greater total proximal femur BMC and enhances femoral mid-diaphyseal size and shape, and that these benefits persisted in young adult women.	[Kato, Takeru] Suzuka Univ Med Sci, Fac Hlth Sci, Dept Clin Nutr, Suzuka 5100293, Japan; [Niwa, Masato] Natl Hosp Org, Mie Chuo Med Ctr, Tsu, Mie 5141101, Japan; [Yamashita, Takenori] Suzuka Univ Med Sci, Fac Hlth Sci, Dept Clin Radiat, Suzuka 5100293, Japan; [Matumoto, Minoru; Umemura, Yoshihisa] Chukyo Univ, Sch Hlth & Sport Sci, Lab Exercise Physiol & Biomech, Kaizu, Toyota 4700393, Japan	Kato, T (reprint author), Suzuka Univ Med Sci, Fac Hlth Sci, Dept Clin Nutr, Kishioka 1001-1, Suzuka 5100293, Japan.	t-kato@suzuka-u.ac.jp			(KAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science and Technology	This study was financially supported by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The Japanese Ministry of Education, Culture, Sports, Science and Technology does not have any involvement in study design, interpretation of data and in the decision to submit the paper for publication.	Seeman E, 2003, J APPL PHYSIOL, V95, P2142, DOI 10.1152/japplphysiol.00564.2003; Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101; Kohrt WM, 1997, J BONE MINER RES, V12, P1253, DOI 10.1359/jbmr.1997.12.8.1253; Lofgren B, 2011, J BONE MINER RES, V26, P1740, DOI 10.1002/jbmr.381; Macdonald HM, 2007, J BONE MINER RES, V22, P434, DOI 10.1359/JBMR.061205; Witzke KA, 2000, MED SCI SPORT EXER, V32, P1051, DOI 10.1097/00005768-200006000-00003; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; McKay HA, 2005, BRIT J SPORT MED, V39, P521, DOI 10.1136/bjsm.2004.014266; Bass SL, 2002, J BONE MINER RES, V17, P2274, DOI 10.1359/jbmr.2002.17.12.2274; Kim BT, 2003, J BONE MINER RES, V18, P150, DOI 10.1359/jbmr.2003.18.1.150; Szulc P, 2006, J BONE MINER RES, V21, P1856, DOI 10.1359/JBMR.060904; Kontulainen S, 2002, J BONE MINER RES, V17, P2281, DOI 10.1359/jbmr.2002.17.12.2281; MacKelvie KJ, 2002, J BONE MINER RES, V17, P834, DOI 10.1359/jbmr.2002.17.5.834; Petit MA, 2002, J BONE MINER RES, V17, P363, DOI 10.1359/jbmr.2002.17.3.363; Ducher G, 2011, J BONE MINER RES, V26, P1321, DOI 10.1002/jbmr.323; Nilsson M, 2009, J BONE MINER RES, V24, P125, DOI [10.1359/jbmr.080909, 10.1359/JBMR.080909]; Dolan SH, 2006, MED SCI SPORT EXER, V38, P1121, DOI 10.1249/01.mss.0000222841.96885.a8; Erlandson MC, 2011, J BONE MINER RES, V26, P1313, DOI 10.1002/jbmr.338; Faulkner RA, 2003, MED SCI SPORT EXER, V35, P513, DOI 10.1249/01.MSS.0000053724.33480.8B; Greene DA, 2012, J BONE MINER METAB, V30, P580, DOI 10.1007/s00774-012-0360-6; Kato T, 2009, BRIT J SPORT MED, V43, P932, DOI 10.1136/bjsm.2008.052308; Miyabara Y, 2007, J BONE MINER METAB, V25, P414, DOI 10.1007/s00774-007-0780-x; NIH, 2000, NIH CONSENSUS STATE, V17, P1; Proctor KL, 2002, MED SCI SPORT EXER, V34, P1830, DOI 10.1249/01.MSS.0000037094.71541.B9; Warden SJ, 2007, J BONE MINER RES, V22, P251, DOI 10.1359/JBMR.061107	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	SEP	2015	33	5					569	576		10.1007/s00774-014-0620-8		8	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CQ6IA	WOS:000360706700013		
J	Ohara, M; Imanishi, Y; Nagata, Y; Ishii, A; Kobayashi, I; Mori, K; Ito, M; Miki, T; Nishizawa, Y; Inaba, M				Ohara, Masaya; Imanishi, Yasuo; Nagata, Yuki; Ishii, Akira; Kobayashi, Ikue; Mori, Katsuhito; Ito, Manabu; Miki, Takami; Nishizawa, Yoshiki; Inaba, Masaaki			Clinical efficacy of oral risedronate therapy in Japanese patients with Paget's disease of bone	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Paget's disease of bone; Risedronate; Alkaline phosphatase (ALP); Bone-specific ALP (BAP); Type I procollagen N-terminal pro-peptide (PINP)	BISPHOSPHONATE THERAPY; BIOCHEMICAL MARKERS; ZOLEDRONIC ACID; TURNOVER; GUIDELINES; MANAGEMENT; RESORPTION; PAMIDRONATE; RESISTANCE; DIAGNOSIS	Paget's disease of bone (PDB) is a chronic disorder characterized by localized bone regions with excessive bone turnover. Although oral risedronate (17.5 mg daily for 8 weeks) was recently approved in Japan, its efficacy is not well understood. We retrospectively examined the efficacy of oral risedronate in PDB patients in a clinical setting. Eleven patients whose serum alkaline phosphatase (ALP) level exceeded the upper limit of the normal range were treated. Patients whose ALP levels normalized and remained so for 12 months after therapy initiation were defined as responders. Treatment was repeated if bone pain recurred or if serum ALP levels increased at least 25% above the nadir. Six patients (55%) were responsive to the therapy. A higher prevalence of skull lesions, higher serum calcium levels at treatment initiation and antecedent treatments of bisphosphonates were predictors of resistance against the therapy. Fresh frozen serum samples obtained from some treatment sessions were evaluated for metabolic bone markers such as bone-specific ALP (BAP), type I procollagen N-terminal pro-peptide (PINP), N-treminal crosslinking telopeptide of type I collagen and C-treminal crosslinking telopeptide of type I collagen (CTX). A significant reduction of P1NP preceded that of serum ALP levels in the responders, which was followed by a similar occurrence for BAP and osteocalcin (BGP) levels. A temporary decrease in CTX levels was noted. No significant changes in markers (including ALP level) were observed in non-responder and repeat-treatment groups. P1NP levels may be more useful than ALP levels in assessing treatment efficacy. Repeat treatment effectiveness for the repeat-treatment group was limited.	[Ohara, Masaya; Imanishi, Yasuo; Nagata, Yuki; Kobayashi, Ikue; Mori, Katsuhito; Nishizawa, Yoshiki; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, Osaka 5458585, Japan; [Ishii, Akira] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 5458585, Japan; [Ito, Manabu] Hokkaido Univ, Sch Med, Dept Orthopaed, Sapporo, Hokkaido 060, Japan; [Miki, Takami] Osaka City Univ, Grad Sch Med, Dept Geriatr & Neurol, Osaka 5458585, Japan	Imanishi, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	imanishi@med.osaka-cu.ac.jp			Ministry of Science, Education and Culture of Japan [24591235, 24591353]	We would like to express our appreciation to Ajinomoto Pharmaceuticals Co., Ltd. for permitting the use of part of the Phase III data for oral risedronate treatment. This work was supported in part by Grants-in-Aid Scientific Research (C) (No. 24591235 to YI) and (No. 24591353 to MI and YI) from the Ministry of Science, Education and Culture of Japan.	Alexandersen P, 2005, J BONE MINER RES, V20, P588, DOI 10.1359/JBMR.041212; Alvarez L, 2004, RHEUMATOLOGY, V43, P869, DOI 10.1093/rheumatology/keh185; Randall AG, 1996, J BONE MINER RES, V11, P1176; Reid IR, 2005, NEW ENGL J MED, V353, P898, DOI 10.1056/NEJMoa044241; Alvarez L, 1997, ARTHRITIS RHEUM, V40, P461, DOI 10.1002/art.1780400312; Ralston SH, 2012, CALCIFIED TISSUE INT, V91, P97, DOI 10.1007/s00223-012-9599-0; Reid IR, 2004, BONE, V35, P224, DOI 10.1016/j.bone.2004.03.023; Hosking D, 2007, J BONE MINER RES, V22, P142, DOI 10.1359/JBMR.061001; Miller PD, 1999, AM J MED, V106, P513, DOI 10.1016/S0002-9343(99)00062-5; BLUMSOHN A, 1995, CLIN CHEM, V41, P1592; Cacace E, 2004, CLIN EXP RHEUMATOL, V22, P502; Civitelli R, 2009, OSTEOPOROSIS INT, V20, P843, DOI 10.1007/s00198-009-0838-9; Falchetti A, 2010, CURR OPIN RHEUMATOL, V22, P410, DOI 10.1097/BOR.0b013e32833af61e; HARINCK HIJ, 1986, Q J MED, V58, P133; Hashimoto J, 2006, J BONE MINER METAB, V24, P186, DOI 10.1007/s00774-005-0670-z; Joshua F, 2003, ARTHRITIS RHEUM, V48, P2321, DOI 10.1002/art.11136; MEUNIER PJ, 1987, CLIN ORTHOP RELAT R, P37; Nishida Y, 2013, CLIN RHEUMATOL, V32, P241, DOI 10.1007/s10067-012-2109-y; Papapoulos SE, 2006, J BONE MINER RES, V21, pP88, DOI 10.1359/JBMR.06S216; Papapoulos SE, 1996, J CLIN ENDOCR METAB, V81, P3993, DOI 10.1210/jc.81.11.3993; PATEL S, 1993, J BONE MINER RES, V8, P1467; Peris P, 2006, CALCIFIED TISSUE INT, V79, P22, DOI 10.1007/s00223-005-0247-9; Selby PL, 2006, J BONE MINER RES, V21, pP92, DOI 10.1359/JBMR.06S217; Selby PL, 2002, BONE, V31, P366, DOI 10.1016/S8756-3282(02)00817-7; Singer FR, 2009, NAT REV RHEUMATOL, V5, P483, DOI 10.1038/nrrheum.2009.149; Takata S, 2006, J BONE MINER METAB, V24, P359, DOI 10.1007/s00774-006-0696-x; Tsujimoto M, 2011, BONE, V48, P798, DOI 10.1016/j.bone.2010.12.006; Walsh JP, 2004, BONE, V34, P747, DOI 10.1016/j.bone.2003.12.011; Woitge HW, 2000, CLIN CHEM, V46, P684; Yoh K, 2010, J BONE MINER METAB, V28, P468, DOI 10.1007/s00774-009-0152-9	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	SEP	2015	33	5					584	590		10.1007/s00774-014-0623-5		7	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CQ6IA	WOS:000360706700015		
J	Haruta, I; Fuku, Y; Kinoshita, K; Yoneda, K; Morinaga, A; Amitani, M; Amitani, H; Asakawa, A; Sugawara, H; Takeda, Y; Bowers, CY; Inui, A				Haruta, Izumi; Fuku, Yuki; Kinoshita, Kazuhisa; Yoneda, Koichi; Morinaga, Akinori; Amitani, Marie; Amitani, Haruka; Asakawa, Akihiro; Sugawara, Hideki; Takeda, Yasuo; Bowers, Cyril Y.; Inui, Akio			One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient	JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE			English	Article						GHRP-2; Anorexia nervosa; Body weight; Ghrelin; GH; IGF-1	FOOD-INTAKE; OLDER-ADULTS; GHRELIN; STOMACH	Background In Japan, growth hormone releasing peptide-2 (GHRP-2) is clinically used as a diagnostic agent for growth hormone secretion deficiency, but the therapeutic application of GHRP-2 has not been studied in anorexia nervosa. GHRP-2 reportedly exhibits agonistic action for ghrelin receptor and increases food intake. Methods We administered GHRP-2 to a patient with a 20-year history of anorexia nervosa to determine whether GHRP-2 treatment increases food intake and body weight. GHRP-2 was administered before every meal by an intranasal approach for 1 year. Results Although the patient reported a decreased fear of eating and decreased desire to be thin by our previous treatment, she was unable to increase food intake or body weight because of digestive tract dysfunction. Vomiting after meals caused by delayed gastric emptying and incurable constipation were prolonged, and sub-ileus and hypoglycemia were observed. GHRP-2 increased the feeling of hunger and food intake, decreased early satiety and improved hypoglycemia. The patient's body weight gradually increased by 6.7 kg (from 21.1 kg to 27.8 kg) in 14 months after starting GHRP-2 administration. The fatigability and muscle strength improved, and the physical and mental activities were also increased. No obvious side effects were observed after long-term intranasal administration of GHRP-2. Conclusions Patients with a long-term history of eating disorder occasionally recover from the psychological problems such as fear for obesity but remain emaciated. We believe that ghrelin agonists such as GHRP-2 may be promising agents for the effective treatments of severe anorexia nervosa in a chronic condition.	[Haruta, Izumi; Fuku, Yuki; Kinoshita, Kazuhisa; Yoneda, Koichi; Morinaga, Akinori; Amitani, Marie; Amitani, Haruka; Asakawa, Akihiro; Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 8908520, Japan; [Haruta, Izumi; Fuku, Yuki; Kinoshita, Kazuhisa; Yoneda, Koichi; Morinaga, Akinori; Amitani, Marie; Amitani, Haruka; Asakawa, Akihiro; Inui, Akio] Kagoshima Univ Hosp, Kagoshima 8908520, Japan; [Sugawara, Hideki; Takeda, Yasuo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, Kagoshima 8908520, Japan; [Bowers, Cyril Y.] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA	Inui, A (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	inui@m.kufm.kagoshima-u.ac.jp			 [24390182]	This study was supported by Grants-in-Aid for Scientific Research Project Number 24390182.	Inui A, 1999, CANCER RES, V59, P4493; White HK, 2009, J CLIN ENDOCR METAB, V94, P1198, DOI 10.1210/jc.2008-0632; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Suokas JT, 2013, PSYCHIAT RES, V210, P1101, DOI 10.1016/j.psychres.2013.07.042; BOWERS CY, 1984, ENDOCRINOLOGY, V114, P1537; Hotta M, 2009, ENDOCR J, V56, P1119, DOI 10.1507/endocrj.K09E-168; Inui A, 2001, MOL PSYCHIATR, V6, P620, DOI 10.1038/sj.mp.4000944; Khalil R.B., 2011, EAT WEIGHT DISORD-ST, V16, P300; Laferrere B, 2005, J CLIN ENDOCR METAB, V90, P611, DOI 10.1210/jc.2004-1719; Li RL, 2012, J BIOL CHEM, V287, P17942, DOI 10.1074/jbc.M112.358051; Miljic D, 2006, J CLIN ENDOCR METAB, V91, P1491, DOI 10.1210/jc.2005-2304; Nakahara T, 2007, J PSYCHIATR RES, V41, P814, DOI 10.1016/j.jpsychires.2006.07.021; Nass R, 2008, ANN INTERN MED, V149, P601; Ogiso K, 2011, NUTRITION, V27, P988, DOI 10.1016/j.nut.2011.05.005; Strasser F, 2012, CURR PHARM DESIGN, V18, P4800, DOI 10.2174/138161212803216870	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2190-5991	2190-6009		J CACHEXIA SARCOPENI	J. Caxhexia Sarcopenia Muscle	SEP	2015	6	3					237	241		10.1002/jcsm.12028		5	Medicine, General & Internal	General & Internal Medicine	CQ5EB	WOS:000360625000007		
J	Hopper, I; Skiba, M; von Lueder, TG; Watanabe, M; Funston, R; Tonkin, A; Krum, H				Hopper, Ingrid; Skiba, Marina; von Lueder, Thomas G.; Watanabe, Masataka; Funston, Robyn; Tonkin, Andrew; Krum, Henry			Digoxin Withdrawal Worsens Clinical Status in Stable Patients With Heart Failure Receiving Optimal Contemporaneous Therapy-A Randomized Controlled Trial	JOURNAL OF CARDIAC FAILURE			English	Letter							MANAGEMENT		[Hopper, Ingrid; Skiba, Marina; von Lueder, Thomas G.; Watanabe, Masataka; Tonkin, Andrew; Krum, Henry] Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Hopper, Ingrid; Skiba, Marina; Funston, Robyn; Krum, Henry] Alfred Hlth, Dept Clin Pharmacol, Melbourne, Vic, Australia; [von Lueder, Thomas G.] Oslo Univ Hosp, Dept Cardiol B, Oslo, Norway; [Watanabe, Masataka] Tokyo Med Univ, Dept Cardiol, Tokyo 1608402, Japan	Hopper, I (reprint author), Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia.	ingrid.hopper@monash.edu					Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Khand AU, 2003, J AM COLL CARDIOL, V42, P1944, DOI 10.1016/j.jacc.2003.07.020; Georgiopoulou VV, 2009, CIRC-HEART FAIL, V2, P90, DOI 10.1161/CIRCHEARTFAILURE.108.807032; Freeman JV, 2013, CIRC-CARDIOVASC QUAL, V6, P525, DOI 10.1161/CIRCOUTCOMES.111.000079; FERGUSON DW, 1989, CIRCULATION, V80, P65; Butler Javed, 2010, Congest Heart Fail, V16, P191, DOI 10.1111/j.1751-7133.2010.00161.x; Cleland JGF, 2009, CIRC-HEART FAIL, V2, P81, DOI 10.1161/CIRCHEARTFAILURE.109.859322; GHEORGHIADE M, 1987, J AM COLL CARDIOL, V9, P849; KRUM H, 1995, J AM COLL CARDIOL, V25, P289, DOI 10.1016/0735-1097(94)00417-O; PACKER M, 1993, NEW ENGL J MED, V329, P1, DOI 10.1056/NEJM199307013290101	11	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	SEP	2015	21	9					779	781		10.1016/j.cardfail.2015.07.003		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CQ7JD	WOS:000360778000014		
J	Saito, T; Makino, T; Hata, Y; Koezuka, S; Otsuka, H; Isobe, K; Tochigi, N; Shibuya, K; Homma, S; Iyoda, A				Saito, Takahiro; Makino, Takashi; Hata, Yoshinobu; Koezuka, Satoshi; Otsuka, Hajime; Isobe, Kazutoshi; Tochigi, Naobumi; Shibuya, Kazutoshi; Homma, Sakae; Iyoda, Akira			Giant thymoma successfully resected via anterolateral thoracotomy: a case report	JOURNAL OF CARDIOTHORACIC SURGERY			English	Article						Surgery; Giant thymoma; Thymoma; Anterolateral incision	MASS	The appropriate surgical approach for a large mediastinal tumor is controversial. Median sternotomy is the standard approach for thymomas. We herein report the case of a giant thymoma, 13 cm in diameter, surgically resected via anterolateral incision. Subsequent thymectomy was performed via thoracoscopy. The resected specimen was a WHO type AB thymoma, Masaoka stage I, without capsular invasion. The anterolateral incision was less invasive and more versatile in the present case, as the incision could be extended to a hemiclamshell or posterolateral incision depending on exposure and relationship to adjacent organs and vascular structures.	[Saito, Takahiro; Makino, Takashi; Hata, Yoshinobu; Koezuka, Satoshi; Otsuka, Hajime; Iyoda, Akira] Toho Univ, Sch Med, Div Chest Surg, Tokyo, Japan; [Isobe, Kazutoshi; Homma, Sakae] Toho Univ, Div Resp Med, Sch Med, Tokyo, Japan; [Tochigi, Naobumi; Shibuya, Kazutoshi] Toho Univ, Dept Surg Pathol, Sch Med, Tokyo, Japan	Iyoda, A (reprint author), Toho Univ, Sch Med, Div Chest Surg, Tokyo, Japan.	aiyoda@med.toho-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [15 K10272]; Toho University Graduate School of Medicine [15-02]	This study was supported in part by a Grant-in-aid for Scientific Research (C) 15 K10272 from the Japanese Ministry of Education, Culture, Sports, Science and Technology and The Research Promotion Grant from Toho University Graduate School of Medicine (No. 15-02 to A.I.).	Falkson CB, 2009, J THORAC ONCOL, V4, P911; Wright CD, 2005, J THORAC CARDIOV SUR, V130, P1413, DOI 10.1016/j.jtcvs.2005.07.026; Nakagawa K, 2003, J THORAC CARDIOV SUR, V126, P1134, DOI 10.1016/S0022-5223(03)00798-0; Fazliogullari O, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-14; Filosso PL, 2012, INTERACT CARDIOV TH, V15, P930, DOI 10.1093/icvts/ivs360; Gotte JM, 2007, THORAC CARDIOV SURG, V55, P336, DOI 10.1055/s-965106; Limmer S, 2010, INTERACT CARDIOV TH, V10, P451, DOI 10.1510/icvts.2009.225557; Santoprete S, 2007, ANN THORAC SURG, V83, P1526, DOI 10.1016/j.athoracsur.2006.10.016; SIM E K W, 1992, SMJ Singapore Medical Journal, V33, P407; Spartalis Eleftherios D, 2012, J Med Case Rep, V6, P99, DOI 10.1186/1752-1947-6-99; Takanami I, 1999, J THORAC CARDIOV SUR, V118, P1134, DOI 10.1016/S0022-5223(99)70120-0; Takenaka T, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-68; TSUBOTA N, 1993, TOHOKU J EXP MED, V171, P229, DOI 10.1620/tjem.171.229; Yamazaki K, 2007, ANN THORAC SURG, V83, P315, DOI 10.1016/j.athoracsur.2006.03.092	14	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1749-8090			J CARDIOTHORAC SURG	J. Cardiothorac. Surg.	SEP 1	2015	10								110	10.1186/s13019-015-0321-y		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CQ5VQ	WOS:000360674200001		
J	Miyazaki, S; Ichihara, N; Takagi, T; Iesaka, Y				Miyazaki, Shinsuke; Ichihara, Noboru; Takagi, Takamitsu; Iesaka, Yoshito			Coronary Artery Spasm During Cryothermal Cavotricuspid Isthmus Ablation	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Editorial Material						atrial flutter; atrial fibrillation; catheter ablation; cryoablation; coronary artery spasm			[Miyazaki, Shinsuke; Ichihara, Noboru; Takagi, Takamitsu; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Ibaraki, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Ctr Cardiovasc, Div Cardiol, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	SEP	2015	26	9					1019	1020		10.1111/jce.12657		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CQ7VM	WOS:000360813600016		
J	Miyazaki, S; Iwasawa, J; Kuroi, A; Iesaka, Y				Miyazaki, Shinsuke; Iwasawa, Jin; Kuroi, Akio; Iesaka, Yoshito			Iatrogenic Atrial Septal Defect After Cryoballoon Pulmonary Vein Isolation	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Editorial Material						atrial fibrillation; atrial septal defect; catheter ablation; cryoablation; cryoballoon			[Miyazaki, Shinsuke; Iwasawa, Jin; Kuroi, Akio; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Ibaraki, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Ctr Cardiovasc, Div Cardiol, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshin-suke@k3.dion.ne.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	SEP	2015	26	9					1021	1021		10.1111/jce.12676		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CQ7VM	WOS:000360813600017		
J	Makino, H; Hokamura, K; Natsume, T; Kimura, T; Kamio, Y; Magata, Y; Namba, H; Katoh, T; Sato, S; Hashimoto, T; Umemura, K				Makino, Hiroshi; Hokamura, Kazuya; Natsume, Takahiro; Kimura, Tetsuro; Kamio, Yoshinobu; Magata, Yasuhiro; Namba, Hiroki; Katoh, Takasumi; Sato, Shigehito; Hashimoto, Tomoki; Umemura, Kazuo			Successful serial imaging of the mouse cerebral arteries using conventional 3-T magnetic resonance imaging	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						animal model; intracranial aneurysm; magnetic resonance angiography (MRA); subarachnoid hemorrhage; T2-weighted magnetic resonance imaging (MRI)	SUBARACHNOID HEMORRHAGE; INTRACRANIAL ANEURYSMS; MICE; MODEL; HYPERTENSION; ISCHEMIA; INJURY	Serial imaging studies can be useful in characterizing the pathologic and physiologic remodeling of cerebral arteries in various mouse models. We tested the feasibility of using a readily available, conventional 3-T magnetic resonance imaging (MRI) to serially image cerebrovascular remodeling in mice. We utilized a mouse model of intracranial aneurysm as a mouse model of the dynamic, pathologic remodeling of cerebral arteries. Aneurysms were induced by hypertension and a single elastase injection into the cerebrospinal fluid. For the mouse cerebrovascular imaging, we used a conventional 3-T MRI system and a 40-mm saddle coil. We used non-enhanced magnetic resonance angiography (MRA) to detect intracranial aneurysm formation and T2-weighted imaging to detect aneurysmal subarachnoid hemorrhage. A serial MRI was conducted every 2 to 3 days. MRI detection of aneurysm formation and subarachnoid hemorrhage was compared against the postmortem inspection of the brain that was perfused with dye. The imaging times for the MRA and T2-weighted imaging were 3.7 +/- 0.5 minutes and 4.8 +/- 0.0 minutes, respectively. All aneurysms and subarachnoid hemorrhages were correctly identified by two masked observers on MRI. This MRI-based serial imaging technique was useful in detecting intracranial aneurysm formation and subarachnoid hemorrhage in mice.	[Makino, Hiroshi; Kimura, Tetsuro; Katoh, Takasumi; Sato, Shigehito] Hamamatsu Univ Sch Med, Dept Anesthesiol & Intens Care, Hamamatsu, Shizuoka 4313192, Japan; [Hokamura, Kazuya; Umemura, Kazuo] Hamamatsu Univ Sch Med, Dept Pharmacol, Hamamatsu, Shizuoka 4313192, Japan; [Natsume, Takahiro] Fujita Hlth Univ, Sch Hlth Sci, Fac Radiol Technol, Toyoake, Aichi, Japan; [Kamio, Yoshinobu; Namba, Hiroki] Hamamatsu Univ Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka 4313192, Japan; [Magata, Yasuhiro] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Hashimoto, Tomoki] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA	Makino, H (reprint author), Dept Anesthesiol & Intens Care, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313115, Japan.	hmakino@hama-med.ac.jp			Japan Society for the Promotion of Science KAKENHI [25861717, 24592120]; National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01NS055876, R01NS082280]	The project described was supported by Japan Society for the Promotion of Science KAKENHI (Grant Numbers 25861717 (HM), 24592120 (KH)) and the National Institute of Neurological Disorders and Stroke (NIH/NINDS; R01NS055876 and R01NS082280 (TH)).	Zhang ZG, 1997, J CEREBR BLOOD F MET, V17, P1081; Morimoto M, 2002, STROKE, V33, P1911, DOI 10.1161/01.STR.0000021000.19637.3D; YANG GY, 1994, STROKE, V25, P165; Tada Y, 2014, STROKE, V45, P579, DOI 10.1161/STROKEAHA.113.003072; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120; Nuki Y, 2009, HYPERTENSION, V54, P1337, DOI 10.1161/HYPERTENSIONAHA.109.138297; Verma RK, 2013, EUR J RADIOL, V82, P1539, DOI 10.1016/j.ejrad.2013.03.021; Baumbach GL, 2003, HYPERTENSION, V41, P50, DOI 10.1161/01.HYP.0000042427.05390.5C; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jeon H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-103; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; Makino H, 2012, STROKE, V43, P2450, DOI 10.1161/STROKEAHA.112.659821; Shimamura M, 2013, J CEREBR BLOOD F MET, V33, P1153, DOI 10.1038/jcbfm.2013.62; Tutino VM, 2014, J CEREBR BLOOD F MET, V34, P415, DOI 10.1038/jcbfm.2013.209; Weiss D, 2008, HYPERTENSION, V51, P218, DOI 10.1161/HYPERTENSIONAHA.107.095885	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2015	35	9					1523	1527		10.1038/jcbfm.2015.78		5	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CQ6BN	WOS:000360689500020		
J	Lee, Y; Takenaka, K; Kanosue, K				Lee, YingHua; Takenaka, Koji; Kanosue, Kazuyuki			An understanding of Japanese children's perceptions of fun, barriers, and facilitators of active free play	JOURNAL OF CHILD HEALTH CARE			English	Article						Focus groups; health promotion; primary care	PHYSICAL-ACTIVITY; SCHOOL; TIME; OUTDOORS; FITNESS; SAFETY	Physical activity contributes to children's physical and mental well-being. Research suggests that active free play helps to maintain and increase physical activity in children and also contributes to social and emotional well-being. To date, these studies have focused on Western countries. Thus, this study was conducted to gain insights into the factors of perceptions of fun, barriers, and facilitators affecting active free play from the perspective of Japanese children using focus group interviews. In Japan, 12 focus groups were conducted with 60 children aged 9-11 years. Children's perceptions of fun in active free play were categorized into socializing, achievement, emotions, and freedom. Additionally, active boys' groups were interested in free play and adventure play; girls' groups were interested in free play with less physical movement and challenges; inactive boys' groups were interested in relaxing and competitive play with bodily contact. However, children mentioned that busy schedules, weather, and health-related factors acted as main barriers. Lastly, children noted facilitators include setting schedules, having access to equipment and playgrounds, and holding special events. The findings provide insights into active free play-related factors for active and inactive Japanese children and also clarify the differences between Japanese and Western children. Such findings will contribute to designing interventions to increase active free play.	[Lee, YingHua; Takenaka, Koji; Kanosue, Kazuyuki] Waseda Univ, Tokorozawa, Saitama 3591192, Japan	Lee, Y (reprint author), Waseda Univ, 2-579-15 Mikashima, Tokorozawa, Saitama 3591192, Japan.	leeinka@ruri.waseda.jp			research fund on Sports Medicine and Science of the Japan Sports Association	This study was supported by the research fund on Sports Medicine and Science of the Japan Sports Association.	Brockman R, 2010, PREV MED, V51, P144, DOI 10.1016/j.ypmed.2010.05.012; Veitch J, 2006, HEALTH PLACE, V12, P383, DOI 10.1016/j.healthplace.2005.02.009; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Burdette HL, 2005, ARCH PEDIAT ADOL MED, V159, P46, DOI 10.1001/archpedi.159.1.46; Pellegrini AD, 1998, CHILD DEV, V69, P577, DOI 10.1111/j.1467-8624.1998.tb06226.x; Salvy SJ, 2009, J PEDIATR PSYCHOL, V34, P217, DOI 10.1093/jpepsy/jsn071; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037//0003-066X.55.1.68; Reilly JJ, 2004, LANCET, V363, P211, DOI 10.1016/S0140-6736(03)15331-7; Ridgers ND, 2007, PREV MED, V44, P393, DOI 10.1016/j.ypmed.2007.01.009; Ridgers ND, 2011, HEALTH EDUC RES, V26, P586, DOI 10.1093/her/cyr014; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; CHEN CS, 1989, CHILD DEV, V60, P551, DOI 10.1111/j.1467-8624.1989.tb02736.x; Valentine G, 1997, GEOFORUM, V28, P219, DOI 10.1016/S0016-7185(97)00010-9; Boreham C, 2001, J SPORT SCI, V19, P915, DOI 10.1080/026404101317108426; Cleland V, 2008, INT J OBESITY, V32, P1685, DOI 10.1038/ijo.2008.171; SMITH PK, 1981, INT J BEHAV DEV, V4, P421; Armitage M, 2001, PLAY TODAY PRIMARY S, P37; Armstrong N, 1997, YOUNG PEOPLE PHYS AC; Ashiabi GS, 2007, EARLY CHILDHOOD ED J, V35, P199, DOI DOI 10.1007/S10643-007-0165-8; Blatchford P., 1998, BRIT EDUC RES J, V24, P79, DOI DOI 10.1080/0141192980240106; Bray M., 2006, COMPARE, V36, P515, DOI 10.1080/03057920601024974; Brockman R, 2011, INT J BEHAV NUTR PHY, V11, P461, DOI DOI 10.1186/1471-2458-11-461; Brockman R, 2009, BMC PUBLIC HEALTH, V9, P1; Castellli DM, 2007, J TEACH PHYS EDUC, V26, P375; Cooper AR, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-31; Fox K, 1991, J PHYS ED RECREATION, V62, P290; Greenbaum T. L., 1988, PRACTICAL HDB GUIDE; Jago R, 2009, INT J BEHAV NUTR PHY, V6, P1; Jeanfreau Scharalda G, 2010, Health Promot Pract, V11, P612, DOI 10.1177/1524839910363537; Krueger RA, 2000, FOCUS GROUPS PRACTIC; Mandigo JL, 1996, AVANTE, V2, P56; Ministry of Education Culture Sports Science and Technology, 2010, SURV NAT PHYS FITN E; Ministry of Education Culture Sports Science and Technology (MEXT), 2008, SURV LEARN ACT SCH C; Myles BS, 1998, INTERV SCH CLIN, V33, P259; Nelson CM, 1997, EDUC TREAT CHILD, V20, P250; Peterson-Sweeney Kathleen, 2005, J Pediatr Health Care, V19, P104, DOI 10.1016/S0891-5245(04)00271-8; Ratey J. J., 2008, SPARK REVOLUTIONARY; Sallis J. F., 1994, PEDIATR EXERC SCI, V64, P302; Sallo M, 1997, PEDIATR EXERC SCI, V9, P44; Takenaka K, 2010, CHILD HLTH RES, V69, P603; Titman W, 1992, PLAY PLAYTIME PLAYGR; Uechi H, 2006, HLTH PROMOTION, V8, P142; Vaughn S, 1996, FOCUS GROUP INTERVIE; Weiss MR, 2000, PRESIDENTS COUNCIL P, V3, P1; Woolley Helen, 2006, CHILDRENS GEOGRAPHIE, V4, P45, DOI DOI 10.1080/14733280600577368	45	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1367-4935	1741-2889		J CHILD HEALTH CARE	J. Child Health Care	SEP	2015	19	3					334	344		10.1177/1367493513519294		11	Nursing; Pediatrics	Nursing; Pediatrics	CQ7YF	WOS:000360822100006		
J	Yamana, H; Matsui, H; Sasabuchi, Y; Fushimi, K; Yasunaga, H				Yamana, Hayato; Matsui, Hiroki; Sasabuchi, Yusuke; Fushimi, Kiyohide; Yasunaga, Hideo			Categorized diagnoses and procedure records in an administrative database improved mortality prediction	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Administrative data; Comorbidity; Severity; In-hospital mortality; Charlson; Elixhauser	CHARLSON COMORBIDITY INDEX; IN-HOSPITAL MORTALITY; RISK ADJUSTMENT; PERFORMANCE; ICD-9-CM; COMPLICATIONS; ELIXHAUSER; IMPACT; CARE	Objectives: Comorbidity measures are widely used in administrative databases to predict mortality. The Japanese Diagnosis Procedure Combination database is unique in that secondary diagnoses are recorded into subcategories, and procedures are precisely recorded. We investigated the influence of these features on the performance of mortality prediction models. Study Design and Setting: We obtained data of adult patients with main diagnosis of acute myocardial infarction, congestive heart failure, acute cerebrovascular disease, gastrointestinal hemorrhage, pneumonia, or septicemia during a I-year period. Multiple models were constructed representing different subcategories from which Charlson and Elixhauser comorbidities were extracted. Prevalence of comorbidities and C statistics of logistic regression models predicting in-hospital mortality was compared. Associations between four procedures (computed tomography, oxygen administration, urinary catheter, and vasopressors) and mortality were also evaluated. Results: C statistics of the model using all secondary diagnoses (Charlson: 0.717; Elixhauscr: 0.762) were greater than those using a limited subcategory to strictly specify comorbidities (Charlson: 0.708; Elixhauser: 0.744). However, misidentification of complications and main diagnoses as comorbidities was observed in the all-diagnosis model. The four procedures were associated with mortality. Conclusion: Subcategorized diagnoses allowed correct identification of comorbidities and procedures predicted mortality. Incorporation of these two features should be considered for other administrative databases. (C) 2015 Elsevier Inc. All rights reserved.	[Yamana, Hayato; Matsui, Hiroki; Sasabuchi, Yusuke; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, Tokyo 1130033, Japan; [Yamana, Hayato] Bunkyo City Publ Hlth Ctr, Bunkyo Ku, Tokyo 1128555, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Grad Sch Med, Bunkyo Ku, Tokyo 1138510, Japan	Yasunaga, H (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasunagah-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H26-Policy-011]	This study was supported by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number: H26-Policy-011).	Stukenborg GJ, 2001, MED CARE, V39, P727, DOI 10.1097/00005650-200107000-00009; Ghali WA, 2001, J GEN INTERN MED, V16, P519, DOI 10.1046/j.1525-1497.2001.016008519.x; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Lieffers JR, 2011, CANCER-AM CANCER SOC, V117, P1957, DOI 10.1002/cncr.25653; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Myers RP, 2009, HEPATOLOGY, V49, P568, DOI 10.1002/hep.22676; Sundararajan V, 2007, MED CARE, V45, P1210; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Johnston JA, 2002, MED CARE, V40, P929, DOI 10.1097/01.MLR.0000027367.95427.AA; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Holman CDJ, 2005, J CLIN EPIDEMIOL, V58, P1006, DOI 10.1016/j.jclinepi.2005.01.020; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chu YT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-140; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Healthcare Cost and Utilization Project (HCUP), 2012, CLIN CLASS SOFTW CCS; IEZZONI LI, 1992, JAMA-J AM MED ASSOC, V267, P2197, DOI 10.1001/jama.267.16.2197; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Martins M, 2006, J CLIN EPIDEMIOL, V59, P665, DOI 10.1016/j.jclinepi.2005.11.017; Quan H, 2004, J CLIN EPIDEMIOL, V57, P366, DOI 10.1016/j.jclinepi.2003.01.002; van Walraven C, 2009, MED CARE, V47, P626	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	SEP	2015	68	9					1028	1035		10.1016/j.jclinepi.2014.12.004		8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CQ4TK	WOS:000360597300009		
J	Kario, K; Hamasaki, H				Kario, Kazuomi; Hamasaki, Haruna			Nocturnal Blood Pressure Surge Behind Morning Surge in Obstructive Sleep Apnea Syndrome: Another Phenotype of Systemic Hemodynamic Atherothrombotic Syndrome	JOURNAL OF CLINICAL HYPERTENSION			English	Editorial Material							ORGAN DAMAGE; HYPERTENSIVE PATIENTS; RISK-FACTOR; J-HOP; HOME; MANAGEMENT		[Kario, Kazuomi; Hamasaki, Haruna] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi 3290498, Japan	Kario, K (reprint author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kkario@jichi.ac.jp					Hoshide S, 2014, AM J HYPERTENS, V27, P939, DOI 10.1093/ajh/hpt290; Ishikawa J, 2012, HYPERTENSION, V60, P921, DOI 10.1161/HYPERTENSIONAHA.112.198101; Kario K, 2006, HYPERTENS RES, V29, P581, DOI 10.1291/hypres.29.581; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273; Kario K, 2013, NAT REV NEPHROL, V9, P726, DOI 10.1038/nrneph.2013.224; Kuniyoshi FHS, 2008, J AM COLL CARDIOL, V52, P343, DOI 10.1016/j.jacc.2008.04.027; Amin R, 2008, HYPERTENSION, V51, P84, DOI 10.1161/HYPERTENSIONAHA.107.099762; Kario K, 2015, HYPERTENSION, V65, P1163, DOI 10.1161/HYPERTENSIONAHA.115.04800; Kario K, 2009, HYPERTENS RES, V32, P428, DOI 10.1038/hr.2009.56; Kario K, 2013, HYPERTENS RES, V36, P478, DOI 10.1038/hr.2013.19; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Kario K, 2014, J CLIN HYPERTENS, V16, P459, DOI 10.1111/jch.12327; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Cho JS, 2015, J CLIN HYPERTENS, V17, P675, DOI 10.1111/jch.12581; Kario K, 2015, J CLIN HYPERTENS, V17, P340, DOI 10.1111/jch.12500; Kario K, 2015, J CLIN HYPERTENS, V17, P328, DOI 10.1111/jch.12505; Kario K, 2009, HYPERTENS RES, V32, P537, DOI 10.1038/hr.2009.73; Kario K, 2015, ESSENTIAL MANUAL 24, P1; Shirasaki O, 2011, HYPERTENS RES, V34, P922, DOI 10.1038/hr.2011.52	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1524-6175	1751-7176		J CLIN HYPERTENS	J. Clin. Hypertens.	SEP	2015	17	9					682	685		10.1111/jch.12576		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CQ7EZ	WOS:000360767100006		
J	Yanai, H; Hirowatari, Y				Yanai, Hidekatsu; Hirowatari, Yuji			Association of Serum Uric Acid Concentration With Metabolic Risk Factors in Patients With Type 2 Diabetes	JOURNAL OF CLINICAL HYPERTENSION			English	Letter									[Yanai, Hidekatsu] Natl Ctr Global Hlth, Dept Internal Med, Chiba, Japan; [Yanai, Hidekatsu] Med Kohnodai Hosp, Chiba, Japan; [Hirowatari, Yuji] Tosoh Corp, Biosci Div, Kanagawa, Japan	Yanai, H (reprint author), Natl Ctr Global Hlth, Dept Internal Med, Chiba, Japan.						Jia ZT, 2013, DIABETES RES CLIN PR, V101, P88, DOI 10.1016/j.diabres.2013.03.026; Marotta T, 2015, J CLIN HYPERTENS, V17, P27, DOI 10.1111/jch.12434	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1524-6175	1751-7176		J CLIN HYPERTENS	J. Clin. Hypertens.	SEP	2015	17	9					741	741		10.1111/jch.12580		1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CQ7EZ	WOS:000360767100019		
J	Kure, K; Isago, T; Hirayama, T				Kure, Katsuhiro; Isago, Tsukasa; Hirayama, Takeshi			Changes in the sebaceous gland in patients with male pattern hair loss (androgenic alopecia)	JOURNAL OF COSMETIC DERMATOLOGY			English	Article						androgenic alopecia; sebaceous gland; follicular stem cell; immunohistochemistry; male pattern hair loss	FOLLICLE STEM-CELLS; CYTOKERATIN 15; HUMAN SKIN; PATHOGENESIS; DIFFERENTIATION; EXPRESSION	BackgroundThe sebaceous gland and the follicular bulge region have important role in biology of the hair. They initiate destruction of the hair follicle both in human and animal models in certain conditions. The morphometric feature of the sebaceous gland is not well understood so as the distribution of the bulge stem cells in pathological conditions of male pattern hair loss or androgenic alopecia (AGA). ObjectivesThe authors perform morphometric analysis of the sebaceous gland in AGA patients and also study distribution of the follicular stem cells in the bulge region in these populations. MethodsTwo hundred and fifty cases of glass slide specimen from Japanese patients with male pattern hair loss were reviewed. Among these, 23 cases of the longitudinal (vertical) sections of the scalp skin with diagnosis of AGA were found and analyzed for the morphometric characteristics. Each sebaceous gland area was measured using NIH imagej system and statistically analyzed. For the identification of the follicular bulge region, an immunohistochemistry using anticytokeratin 15 (C8/144B clone) was carried out in the cases of AGA. ResultsThe sebaceous gland area of the AGA group was noticeably increased, while the size of each sebaceous gland remains unchanged. It has more lobules in the hair follicular unit in the AGA population. In the immunohistochemistry, the follicular stem cells are present in the bulge regions in cases of AGA. ConclusionsThe overgrowth (multilobulation) of the sebaceous gland and relative preservation of the follicular stem cells suggest that the changes in the sebaceous gland could be an important factor in the pathology of AGA.	[Kure, Katsuhiro; Isago, Tsukasa] Tokyo Womens Med Univ, Dept Plast & Reconstruct Surg, Med Ctr East, Tokyo 1168567, Japan; [Hirayama, Takeshi] Mem Clin Hirayama, Tokyo, Japan	Kure, K (reprint author), Tokyo Womens Med Univ, Dept Plast & Reconstruct Surg, Med Ctr East, Arakawa Ku, 2-1-10 Nishioku, Tokyo 1168567, Japan.	info@plazaclinic.net					Al-Refu K, 2009, BRIT J DERMATOL, V160, P1188, DOI 10.1111/j.1365-2133.2009.09074.x; Al-Refu K, 2012, BRIT J DERMATOL, V167, P479, DOI 10.1111/j.1365-2133.2012.11018.x; Roh C, 2004, PHYSIOL GENOMICS, V19, P207, DOI 10.1152/physiolgenomics.00134.2004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thiedke CC, 2003, AM FAM PHYSICIAN, V67, P1007; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Springer K, 2003, AM FAM PHYSICIAN, V68, P93; Lyle S, 1998, J CELL SCI, V111, P3179; Pontiggia L, 2009, J INVEST DERMATOL, V129, P480, DOI 10.1038/jid.2008.254; Mounsey AL, 2009, AM FAM PHYSICIAN, V80, P356; Al-Zaid T, 2011, J AM ACAD DERMATOL, V65, P597, DOI 10.1016/j.jaad.2010.09.774; Stenn KS, 1999, ARCH DERMATOL, V135, P973, DOI 10.1001/archderm.135.8.973; Inui S, 2009, J DERMATOL, V36, P82, DOI 10.1111/j.1346-8138.2009.00593.x; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ashrafuzzaman M, 2010, ACTA HISTOCHEM CYTOC, V43, P9, DOI 10.1267/ahc.09032; Misago N, 2006, J DERMATOL, V33, P2, DOI 10.1111/j.1346-8138.2006.00001.x; Rasband WS, 1997, IMAGE; SAWAYA ME, 1989, J INVEST DERMATOL, V92, P91, DOI 10.1111/1523-1747.ep13071290; Sellheyer K, 2006, AM J DERMATOPATH, V28, P236, DOI 10.1097/00000372-200606000-00051; Sinclair R, 1998, BRIT MED J, V317, P865; Stenn KS, 2001, J CUTAN PATHOL, V28, P445, DOI 10.1034/j.1600-0560.2001.028009445.x	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1473-2130	1473-2165		J COSMET DERMATOL-US	J. Cosmet. Dermatol.	SEP	2015	14	3					178	184		10.1111/jocd.12153		7	Dermatology	Dermatology	CQ6PR	WOS:000360726900003		
J	Beresniak, A; Auray, JP; Duru, G; Aractingi, S; Krueger, GG; Talarico, S; Tsutani, K; Dupont, D; de Linares, Y				Beresniak, Ariel; Auray, Jean-Paul; Duru, Gerard; Aractingi, Selim; Krueger, Gerald G.; Talarico, Sergio; Tsutani, Kiichiro; Dupont, Danielle; de Linares, Yolaine			Quality of life assessment in cosmetics: specificity and interest of the international BeautyQol instrument	JOURNAL OF COSMETIC DERMATOLOGY			English	Article						quality of life; cosmetic outcome; cosmetic efficacy	PEDIATRIC DERMATOLOGY; VALIDATION	The wide use of cosmetics and their perceived benefits upon well-being imply objective descriptions of their effects upon the different dimensions contributing to the quality of life (QoL). Such a goal pleas for using relevant and validated scientific instruments with robust measurement methods. This paper discusses the interest of the new validated questionnaire BeautyQoL specifically designed to assess the effect of cosmetic products on physical appearance and QoL. After conducting a review of skin appearance and QoL, three phases of the international codevelopment have been carried out in the following sequence: semi-directed interviews (Phase 1), acceptability study (Phase 2), and validation study (Phase 3). Data collection and validation process have been carried out in 16 languages. This review confirms that QoL instruments developed in dermatology are not suitable to assess cosmetic products, mainly because of their lack of sensitivity. General acceptability of BeautyQol was very good. Forty-two questions have been structured in five dimensions that explained 76.7% of the total variance: Social Life, Self-confidence, Mood, Vitality, and Attractiveness. Cronbach's alpha coefficients are between 0.932 and 0.978, confirming the good internal consistency of the results. The BeautyQol questionnaire is the first international instrument specific to cosmetic products and physical appearance that has been validated in 16 languages and could be used in a number of clinical trials and descriptive studies to demonstrate the added value of these products on the QoL.	[Beresniak, Ariel] Data Min Int, CH-1215 Geneva 15, Switzerland; [Beresniak, Ariel; Aractingi, Selim] Paris Descartes Univ, Paris, France; [Auray, Jean-Paul; Duru, Gerard] Cyklad Grp, Lyon, France; [Krueger, Gerald G.] Univ Utah, Salt Lake City, UT USA; [Talarico, Sergio] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Tsutani, Kiichiro] Univ Tokyo, Tokyo, Japan; [Dupont, Danielle] Data Min Amer, Montreal, PQ, Canada; [de Linares, Yolaine] LOreal Res, Clichy, France	Beresniak, A (reprint author), Data Min Int, Route Aeroport 29-31,CP221, CH-1215 Geneva 15, Switzerland.	aberesniak@datamining-international.com			L'Oreal Research Innovation	The BeautyQol international project has been funded by an unrestrictive grant from L'Oreal Research Innovation.	Gandek B, 2004, HEALTH CARE FINANC R, V25, P5; Miniszewska J, 2013, ACTA DERM-VENEREOL, V93, P551, DOI 10.2340/00015555-1530; [Anonymous], 1951, PSYCHOMETRIKA; Taieb C, 2012, J COSMET LASER THER, V14, P18, DOI 10.3109/14764172.2011.634420; Both H, 2007, J INVEST DERMATOL, V127, P2726, DOI 10.1038/sj.jid.5701142; Balkrishnan R, 2006, INT J DERMATOL, V45, P111, DOI 10.1111/j.1365-4632.2004.02371.x; Tedeschi A, 2007, CUTIS, V79, P110; Basra MKA, 2008, BRIT J DERMATOL, V159, P997, DOI 10.1111/j.1365-2133.2008.08832.x; Battie C, 2011, ANN DERMATOL VENER, V138, P294, DOI 10.1016/j.annder.2011.01.028; Beresniak A, 2012, ARCH DERMATOL, V148, P1275, DOI 10.1001/archdermatol.2012.2696; Brown MM, 2013, DERMATOL CLIN, V31, P211, DOI 10.1016/j.det.2012.12.010; CDC, 2013, HLTH REL QUAL LIF; Finlay AY, 2004, INDIAN J DERMATOL VE, V70, P144; Graham HA, 1985, INT J COSMETIC SCI, V7, P85; Gregory D, 2009, QUALITY LIFE DICT HU, V5th; Hongbo Y, 2004, BRIT J DERMATOL, V151, P45; Juniper EF, 1996, QUALITY LIFE PHARMAC, P49; March H, 1998, PSYCHOL BULL, V103, P391; McHorney CA, 1999, ANNU REV PUBL HEALTH, V20, P309, DOI 10.1146/annurev.publhealth.20.1.309; Sadick Neil S, 2008, Dermatol Online J, V14, P2; WHO Definition of Health, 1946, PREV CONST WORLD HLT	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1473-2130	1473-2165		J COSMET DERMATOL-US	J. Cosmet. Dermatol.	SEP	2015	14	3					260	265		10.1111/jocd.12156		6	Dermatology	Dermatology	CQ6PR	WOS:000360726900013		
J	Furue, M; Kadono, T				Furue, Masutaka; Kadono, Takafumi			New therapies for controlling atopic itch	JOURNAL OF DERMATOLOGY			English	Editorial Material						atopic dermatitis; dorsal root ganglion; itch signal; new therapy; spinal cord	GASTRIN-RELEASING-PEPTIDE; DOUBLE-BLIND; SCRATCHING BEHAVIOR; DERMATITIS PATIENTS; CLINICAL-TRIAL; PARALLEL-GROUP; DORSAL-HORN; SPINAL-CORD; PRURITUS; MULTICENTER	Chronic itch in atopic dermatitis markedly diminishes the quality of life of affected individuals. Sleep disturbance and impaired productivity in work due to chronic itch impose a socioeconomic burden. Conventional therapies for atopic dermatitis are capable of reducing atopic itch. However, the majority of patients are not satisfied with the antipruritic capacity of conventional treatments. In this review, we summarize recent progress in itch signaling in the skin, dorsal root ganglion and spinal cord. New therapies for controlling atopic itch are also discussed.	[Furue, Masutaka] Kyushu Univ, Dept Dermatol, Fukuoka 8128582, Japan; [Kadono, Takafumi] St Marianna Univ, Sch Med, Dept Dermatol, Kawasaki, Kanagawa, Japan	Furue, M (reprint author), Kyushu Univ, Dept Dermatol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	furue@dermatol.med.kyushu-u.ac.jp					Akiyama T, 2015, ACTA DERM-VENEREOL, V95, P147, DOI 10.2340/00015555-1879; Akiyama T, 2014, PAIN, V155, P80, DOI 10.1016/j.pain.2013.09.011; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Maier E, 2014, J IMMUNOL, V193, P645, DOI 10.4049/jimmunol.1301836; Kumagai H, 2010, NEPHROL DIAL TRANSPL, V25, P1251, DOI 10.1093/ndt/gfp588; Solorzano C, 2015, J NEUROSCI, V35, P648, DOI 10.1523/JNEUROSCI.2955-14.2015; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Akiyama T, 2010, PAIN, V151, P378, DOI 10.1016/j.pain.2010.07.024; Akiyama T, 2013, NEUROSCIENCE, V250, P697, DOI 10.1016/j.neuroscience.2013.07.035; Kawashima M, 2003, BRIT J DERMATOL, V148, P1212, DOI 10.1046/j.1365-2133.2003.05293.x; Furue M, 2014, J DERMATOL, V41, P577, DOI 10.1111/1346-8138.12534; Rubel D, 2013, J DERMATOL, V40, P160, DOI 10.1111/1346-8138.12065; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Foster E, 2015, NEURON, V85, P1289, DOI 10.1016/j.neuron.2015.02.028; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Kamo A, 2011, J DERMATOL SCI, V62, P64, DOI 10.1016/j.jdermsci.2011.01.008; Chamlin SL, 2005, ARCH PEDIAT ADOL MED, V159, P745, DOI 10.1001/archpedi.159.8.745; Furue Masutaka, 2011, J Dermatol, V38, P310, DOI 10.1111/j.1346-8138.2011.01209.x; Gutierrez-Mecinas M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-79; Hachisuka J, 2010, J NEUROPHYSIOL, V104, P271, DOI 10.1152/jn.00938.2009; Hanifin JM, 1996, J INVEST DERMATOL, V107, P51, DOI 10.1111/1523-1747.ep12297888; Hawro T, 2014, ALLERGY, V69, P113, DOI 10.1111/all.12316; Kataoka Y, 2014, J DERMATOL, V41, P221, DOI 10.1111/1346-8138.12440; Kawakami T, 2011, J DERMATOL, V38, P531, DOI 10.1111/j.1346-8138.2010.01052.x; Mochizuki H, 2015, J DERMATOL, V42, P761, DOI 10.1111/1346-8138.12956; Moustafa Farah, 2014, Dermatol Online J, V20, P22608; Murata Y, 2015, J DERMATOL, V42, P129, DOI 10.1111/1346-8138.12726; Noro Y, 2014, J DERMATOL, V41, P233, DOI 10.1111/1346-8138.12405; Otsuka A, 2011, EUR J DERMATOL, V21, P816, DOI 10.1684/ejd.2011.1470; Roblin D, 2015, ACTA DERM-VENEREOL, V95, P542, DOI 10.2340/00015555-2047; Saeki H, 2009, J DERMATOL, V36, P563, DOI 10.1111/j.1346-8138.2009.00706.x; Takeuchi S, 2010, J DERMATOL SCI, V57, P44, DOI 10.1016/j.jdermsci.2009.09.008; Takeuchi S, 2014, J DERMATOL, V41, P200, DOI 10.1111/1346-8138.12331; Takeuchi S, 2012, ANN DERMATOL, V24, P144, DOI 10.5021/ad.2012.24.2.144; Tamari M, 2014, J DERMATOL, V41, P213, DOI 10.1111/1346-8138.12321; Tekatas A, 2014, J DERMATOL, V41, P98, DOI 10.1111/1346-8138.12340; Tominaga M, 2014, J DERMATOL, V41, P205, DOI 10.1111/1346-8138.12317; Woods MT, 2011, J DRUGS DERMATOL, V10, P171	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					847	850		10.1111/1346-8138.13060		4	Dermatology	Dermatology	CQ7EQ	WOS:000360766200001		
J	Horita, K; Tomita, C; Yasoshima, M; Matsunaga, K				Horita, Kotomi; Tomita, Chiaki; Yasoshima, Mitsue; Matsunaga, Kayoko			Optimal evaluation time point for patch testing to predict skin irritation of commercial topical drugs	JOURNAL OF DERMATOLOGY			English	Article						assessment at 24h; classified patch testing; patch testing; repeated application test; transient erythema	SODIUM LAURYL SULFATE; CONTACT-DERMATITIS; VISUAL ASSESSMENT; BLOOD-FLOW; SUSCEPTIBILITY; EXPOSURE	To develop patch testing (PT) that better reflects the skin irritation resulting from repeated applications, we methodically classified PT results and examined correlations between these results with results from repeated application tests. A total of 115 commercial topical drugs were used for patch testing. In two groups of 30 healthy individuals with normal back skin, 55 or 60 commercial topical drugs were applied to the back for 24h. Skin reactions were scored for each group at 2 and 24h after patch removal. Based on time-dependent changes in skin reaction at each evaluation time, PT results were classified into six different types. For repeated application testing, a total of 17 products with different types of PT results were selected. A total of 104 healthy individuals divided into three groups (n=22-52 each) received application of 6-7 test materials, differing for each group, for 3weeks on both arms. Incidences of positive symptoms induced by repeated drug application excluding transient erythema showed a greater correlation with reaction levels at 24h after patch removal than 2h after patch removal. Many test materials that triggered a high incidence of positive symptoms after repeated application also exhibited erythema or greater reaction up to 24h after patch removal. PT offers a useful test system for predicting skin irritation that develops after repeated application of topical drug. Moreover, assessment at 24h after patch removal is suggested as the optimal evaluation time point to reflect the results of repeated application tests.	[Horita, Kotomi; Matsunaga, Kayoko] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 47011, Japan; [Horita, Kotomi; Tomita, Chiaki; Yasoshima, Mitsue] Ikedamohando, Res Lab, Toyama 9300394, Japan	Horita, K (reprint author), Ikedamohando, Res Lab, 16 Jinden,Kamiichi Machi, Toyama 9300394, Japan.	horita.kt@ikedamohando.co.jp					YORK M, 1995, HUM EXP TOXICOL, V14, P729; Yosipovitch G, 1996, ARCH DERMATOL RES, V288, P245, DOI 10.1007/BF02530092; Slotosch CM, 2007, CONTACT DERMATITIS, V57, P235, DOI 10.1111/j.1600-0536.2007.01200.x; Loffler H, 2007, BRIT J DERMATOL, V157, P74, DOI 10.1111/j.1365-2133.2007.07944.x; Basketter D, 1997, CONTACT DERMATITIS, V37, P218, DOI 10.1111/j.1600-0536.1997.tb02438.x; Basketter DA, 1996, CONTACT DERMATITIS, V35, P208, DOI 10.1111/j.1600-0536.1996.tb02359.x; Basketter DA, 1997, FOOD CHEM TOXICOL, V35, P845, DOI 10.1016/S0278-6915(97)00053-7; BASKETTER DA, 1993, CONTACT DERMATITIS, V29, P185, DOI 10.1111/j.1600-0536.1993.tb03534.x; Basketter DA, 2004, CONTACT DERMATITIS, V51, P1, DOI 10.1111/j.0105-1873.2004.00385.x; Basketter DA, 1998, CONTACT DERMATITIS, V38, P253, DOI 10.1111/j.1600-0536.1998.tb05738.x; Brasch J, 1999, CONTACT DERMATITIS, V41, P150, DOI 10.1111/j.1600-0536.1999.tb06107.x; Clemmensen A, 2008, SKIN RES TECHNOL, V14, P277, DOI 10.1111/j.1600-0846.2008.00291.x; De jC, 2006, CONTACT DERMATITIS, V54, P325; Fartasch M, 2012, CONTACT DERMATITIS, V67, P217, DOI 10.1111/j.1600-0536.2012.02063.x; Foy V, 2001, CONTACT DERMATITIS, V45, P346, DOI 10.1034/j.1600-0536.2001.450605.x; HONG CZ, 1991, AM J PHYS MED REHAB, V70, P29, DOI 10.1097/00002060-199102000-00006; Horita K, 2014, J DERMATOL, V41, P505, DOI 10.1111/1346-8138.12505; Kanto H, 2013, J DERMATOL, V40, P363, DOI 10.1111/1346-8138.12004; Kawai K, 2004, VISUAL DERMATOLOGY, V3, P74; Kawamura T, 1970, JPN J DERMATOL, V80, P301; Magnusson BM, 1996, ACTA DERM-VENEREOL, V76, P129; Matsunaga K, 1983, SKIN RES, V25, P622; Mehling A, 2010, CONTACT DERMATITIS, V62, P157, DOI 10.1111/j.1600-0536.2009.01656.x; Nickoloff B J, 1998, Am J Contact Dermat, V9, P107, DOI 10.1016/S1046-199X(98)90006-9; Ohya U, 1988, DIGEST DIS SCI, V33, P883; Sugai T, 1985, SKIN RES, V27, P793; Sugai T, 1977, SKIN RES, V19, P210; Sugai T, 1976, HIFU, V18, P38; Tabata N, 1998, ACTA DERM-VENEREOL, V78, P244; Tupker RA, 1997, CONTACT DERMATITIS, V37, P53, DOI 10.1111/j.1600-0536.1997.tb00041.x	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					851	860		10.1111/1346-8138.12920		10	Dermatology	Dermatology	CQ7EQ	WOS:000360766200002		
J	Nakamura, Y; Ohara, K; Kishi, A; Teramoto, Y; Sato, S; Fujisawa, Y; Fujimoto, M; Otsuka, F; Hayashi, N; Yamazaki, N; Yamamoto, A				Nakamura, Yasuhiro; Ohara, Kuniaki; Kishi, Akiko; Teramoto, Yukiko; Sato, Sayuri; Fujisawa, Yasuhiro; Fujimoto, Manabu; Otsuka, Fujio; Hayashi, Nobukazu; Yamazaki, Naoya; Yamamoto, Akifumi			Effects of non-amputative wide local excision on the local control and prognosis of insitu and invasive subungual melanoma	JOURNAL OF DERMATOLOGY			English	Article						amputation; distal phalanx; local recurrence; subungual melanoma; wide local excision	NAIL APPARATUS MELANOMA; MOHS MICROGRAPHIC SURGERY; TO-BONE DISTANCE; SURGICAL-MANAGEMENT; MALIGNANT-MELANOMA; MATRIX; RECONSTRUCTION; UNIT	Subungual melanomas (SUM) are rare, and amputation is often required. Non-amputative wide local excision (WLE) of the nail unit with the periosteum of the distal phalanx, followed by skin graft, has been accepted for insitu or SUM of 0.5mm or less thickness. However, previous reports have included a limited number of cases, and not all more than 0.5-mm thick SUM exhibit invasion or attachment to the distal phalanx. The aim of the present study was to investigate the local recurrence and prognosis for insitu, minimally invasive and invasive SUM that were treated using WLE. We retrospectively reviewed 50 patients with insitu (n=48) or minimally invasive SUM (n=2) (insitu or minimally invasive group) and 12 patients with more than 0.5-mm thick invasive SUM (invasive group) who were treated using WLE. All patients survived the follow-up period (24-207months), although four patients with insitu SUM experienced local recurrence at the lateral margin and re-excision was required. In the invasive group, no patients experienced local recurrence, although one patient (8.3%) developed nodal metastasis at 86months and regional lymph node dissection was required. WLE may provide acceptable local control for insitu and intermediate thickness SUM, without compromising the vital prognosis. However, a larger randomized prospective study with long-term follow up is required to evaluate adequately the risks associated with a non-amputative WLE for insitu and invasive SUM.	[Nakamura, Yasuhiro; Teramoto, Yukiko; Sato, Sayuri; Yamamoto, Akifumi] Saitama Med Univ, Int Med Ctr, Dept Skin Oncol Dermatol, Saitama 3501298, Japan; [Ohara, Kuniaki; Kishi, Akiko; Hayashi, Nobukazu] Toranomon Gen Hosp, Dept Dermatol, Tokyo, Japan; [Yamazaki, Naoya] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan; [Fujisawa, Yasuhiro; Fujimoto, Manabu; Otsuka, Fujio] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki, Japan	Nakamura, Y (reprint author), Saitama Med Univ, Int Med Ctr, Dept Skin Oncol Dermatol, 1397-1 Yamane, Saitama 3501298, Japan.	ynakamur@saitama-med.co.jp			National Cancer Center Research and Development Fund [26-A-4]	This work was partly supported by the National Cancer Center Research and Development Fund (26-A-4).	Rayatt SS, 2007, J PLAST RECONSTR AES, V60, P635, DOI 10.1016/j.bjps.2006.10.014; PARK KGM, 1992, ANN SURG, V216, P692, DOI 10.1097/00000658-199212000-00012; Cohen T, 2008, AM J SURG, V195, P244, DOI 10.1016/j.amjsurg.2007.03.010; HEATON KM, 1994, ANN SURG, V219, P197, DOI 10.1097/00000658-199402000-00012; Moehrle M, 2003, DERMATOL SURG, V29, P366, DOI 10.1046/j.1524-4725.2003.29087.x; Ishihara K, 2008, INT J CLIN ONCOL, V13, P33, DOI 10.1007/s10147-007-0751-1; Smock ED, 2010, J PLAST RECONSTR AES, V63, pE36, DOI 10.1016/j.bjps.2009.05.010; Sureda N, 2011, BRIT J DERMATOL, V165, P852, DOI 10.1111/j.1365-2133.2011.10477.x; Banfield CC, 1999, J AM ACAD DERMATOL, V40, P98, DOI 10.1016/S0190-9622(99)70535-9; BLESSING K, 1991, HISTOPATHOLOGY, V19, P425, DOI 10.1111/j.1365-2559.1991.tb00232.x; Brodland DG, 2001, DERMATOL SURG, V27, P269, DOI 10.1046/j.1524-4725.2001.01911.x; Chow WTH, 2013, J PLAST RECONSTR AES, V66, P274, DOI 10.1016/j.bjps.2012.06.022; Clarkson JHW, 2002, BRIT J PLAST SURG, V55, P165, DOI 10.1054/bjps.2001.3782; Debarbieux S, 2012, BRIT J DERMATOL, V167, P828, DOI 10.1111/j.1365-2133.2012.11013.x; Duarte AF, 2010, DERMATOLOGY, V220, P173, DOI 10.1159/000266038; Haddock NT, 2014, ANN PLAS SURG, V73, P640, DOI 10.1097/SAP.0b013e318284ecb9; Haneke E, 2012, DERMATOL THER, V25, P510, DOI 10.1111/j.1529-8019.2012.01515.x; Hayashi K, 2012, DERMATOL SURG, V38, P692, DOI 10.1111/j.1524-4725.2011.02217.x; High WA, 2004, ARCH DERMATOL, V140, P1102, DOI 10.1001/archderm.140.9.1102; Imakado S, 2008, J DERMATOL, V35, P754, DOI 10.1111/j.1346-8138.2008.00557.x; Kim JY, 2011, DERMATOLOGY, V223, P122, DOI 10.1159/000329432; Lazar A, 2005, J HAND SURG-BRIT EUR, V30B, P194, DOI 10.1016/j.jhsb.2004.11.006; Nakamura Y, 2014, J DERMATOL, V41, P872, DOI 10.1111/1346-8138.12622; O'Leary JA, 2000, CLIN ORTHOP RELAT R, P206; TAKEMATSU H, 1985, CANCER, V55, P2725, DOI 10.1002/1097-0142(19850601)55:11<2725::AID-CNCR2820551134>3.0.CO;2-V	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					861	866		10.1111/1346-8138.12923		6	Dermatology	Dermatology	CQ7EQ	WOS:000360766200003		
J	Nomura, T; Moriuchi, R; Takeda, M; Suzuki, S; Kikuchi, K; Ito, T; Shimizu, H; Shimizu, S				Nomura, Toshifumi; Moriuchi, Reine; Takeda, Masae; Suzuki, Shotaro; Kikuchi, Kazuhiro; Ito, Takamasa; Shimizu, Hiroshi; Shimizu, Satoko			Low-dose etretinate shows promise in management of punctate palmoplantar keratoderma type 1: Case report and review of the published work	JOURNAL OF DERMATOLOGY			English	Article						AAGAB; adapalene; etretinate; punctate palmoplantar keratoderma type 1; retinoid	RECURRENT AAGAB MUTATIONS; BRAUER	Punctate palmoplantar keratoderma type 1 (PPKP1) is a rare autosomal dominant disorder of keratinization, clinically characterized by punctate keratotic papules affecting the palmoplantar skin. Loss-of-function mutations in AAGAB have recently been reported as a cause of PPKP1. Despite the discovery of the genetic cause of PPKP1, pathogenesis-based therapies are still unavailable. Moreover, little is known about the effectiveness of treatments for PPKP1. In this study, we analyzed a Japanese woman with PPKP1 and identified a novel frame-shift mutation c.195_198del4 (p.Lys66Phefs*43) in AAGAB. Moreover, low-dose etretinate was effective in improving the PPKP1 lesions in our patient. Our published work review identified only eight cases of PPKP1 with successful response to topical or systemic treatments. Notably, six of the cases were successfully treated with systemic retinoids. Thus, this study clearly provides further evidence that PPKP1 is caused by AAGAB mutations and that systemic retinoids are the most promising current treatment for PPKP1.	[Nomura, Toshifumi; Takeda, Masae; Suzuki, Shotaro; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan; [Moriuchi, Reine; Kikuchi, Kazuhiro; Ito, Takamasa; Shimizu, Satoko] Sapporo City Gen Hosp, Dept Dermatol, Sapporo, Hokkaido, Japan	Nomura, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	nomura@huhp.hokudai.ac.jp			Japan Society for the Promotion of Science [25860925]	We are grateful to the patient for her participation in this study. This work was supported by a Grant-in-Aid for Young Scientists (B) 25860925 (to T. N.) from the Japan Society for the Promotion of Science.	Al-Mutairi Nawaf, 2005, J Drugs Dermatol, V4, P627; Erkek E, 2006, ARCH DERMATOL, V142, P1076, DOI 10.1001/archderm.142.8.1076; Giehl KA, 2012, AM J HUM GENET, V91, P754, DOI 10.1016/j.ajhg.2012.08.024; Horikoshi M, 2004, J DERMATOL, V31, P469; Kiritsi D, 2013, J INVEST DERMATOL, V133, P2483, DOI 10.1038/jid.2013.171; Kong MS, 2004, CUTIS, V74, P173; Nomura T, 2015, ACTA DERM-VENEREOL, V95, P110, DOI 10.2340/00015555-1832; Piskin Suleyman, 2007, Ther Clin Risk Manag, V3, P621; Pohler E, 2014, BRIT J DERMATOL, V171, P433, DOI 10.1111/bjd.12927; Pohler E, 2012, NAT GENET, V44, P1272, DOI 10.1038/ng.2444; Pohler E, 2013, J INVEST DERMATOL, V133, P2805, DOI 10.1038/jid.2013.243; Raone B, 2014, J AM ACAD DERMATOL, V71, pE48, DOI 10.1016/j.jaad.2014.01.909	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					889	892		10.1111/1346-8138.12916		4	Dermatology	Dermatology	CQ7EQ	WOS:000360766200007		
J	Funakoshi, T; Sato, T; Hosokawa, R; Saito, M; Amagai, M; Ishiko, A; Ohyama, M				Funakoshi, Takeru; Sato, Tomotaka; Hosokawa, Ryoko; Saito, Masataka; Amagai, Masayuki; Ishiko, Akira; Ohyama, Manabu			Application of electron microscopic analysis and fluorescent insitu hybridization technique for the successful diagnosis of extraskeletal Ewing's sarcoma	JOURNAL OF DERMATOLOGY			English	Article						dense core granules; electron microscopy; extraskeletal Ewing's sarcoma; fluorescence insitu hybridization; peripheral primitive neuroectodermal tumor	MERKEL CELL-CARCINOMA; NEUROECTODERMAL TUMOR; EXPRESSION; REARRANGEMENT; FAMILY	The diagnosis of soft tissue tumors is often challenging. Immunohistochemical investigation, let alone routine histopathological investigation, may not allow definitive diagnosis in some cases. To overcome such difficulties, more advanced techniques need to be adopted. Herein, we report an extremely rare 56-year-old Japanese female case of extraskeletal Ewing's sarcoma (ES), successfully diagnosed by electron microscopy (EM) using formalin-fixed sections and fluorescence insitu hybridization (FISH). The patient had a 2-year history of a tumor growing on the leg. In routine histopathology, invasive proliferation of tumor cells was observed in the dermis. Tumor cells were round and uniform with large hyperchromatic nuclei, which were positively stained for CD56, VS38c, Ki-67, MIC2 and vimentin, but not for pan-keratin AE1+AE3, cytokeratin 20, chromogranin A, synaptophysin and neuron-specific enolase. As these findings were not conclusive to make the final diagnosis, EM specimens were prepared from formalin-fixed sections and subjected to investigation. Cell surface projections and dense core granules were detected, suggestive of either Merkel cell carcinoma or extraskeletal ES. Subsequent FISH analysis identified reciprocal translocation of the ESWR1 gene, enabling the final diagnosis of extraskeletal ES. This study provides useful information enabling the diagnosis of this uncommon soft tissue tumor.	[Funakoshi, Takeru; Sato, Tomotaka; Hosokawa, Ryoko; Saito, Masataka; Amagai, Masayuki; Ishiko, Akira; Ohyama, Manabu] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan	Funakoshi, T (reprint author), Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	takeruf@a8.keio.jp; manabuohy@z8.keio.jp					Iwamoto Y, 2007, JPN J CLIN ONCOL, V37, P79, DOI 10.1093/jjco/hyl142; Delaplace M, 2012, BRIT J DERMATOL, V166, P721, DOI 10.1111/j.1365-2133.2011.10743.x; Kurokawa M, 2003, J DERMATOL SCI, V31, P219, DOI 10.1016/S0923-1811(03)00029-X; Byrd-Gloster AL, 2000, HUM PATHOL, V31, P58, DOI 10.1016/S0046-8177(00)80199-9; Fernandez-Flores A, 2013, APPL IMMUNOHISTO M M, V21, P379, DOI 10.1097/PAI.0b013e318273a9e0; Omori M, 2014, EUR J DERMATOL, V24, P126, DOI 10.1684/ejd.2013.2247; Rajagopalan A, 2013, J CUTAN PATHOL, V40, P19, DOI 10.1111/cup.12049; Riley RD, 2003, EUR J CANCER, V39, P19, DOI 10.1016/S0959-8049(02)00500-2; Suh CH, 2002, ULTRASTRUCT PATHOL, V26, P67; TEFFT M, 1969, RADIOLOGY, V92, P1501; Yamaguchi U, 2005, J CLIN PATHOL, V58, P1051, DOI 10.1136/jcp.2004.025502; Yang DT, 2004, J CUTAN PATHOL, V31, P254, DOI 10.1111/j.0303-6987.2003.00175.x	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					893	896		10.1111/1346-8138.12930		4	Dermatology	Dermatology	CQ7EQ	WOS:000360766200008		
J	Tofuku, Y; Nobeyama, Y; Kamide, R; Moriwaki, S; Nakagawa, H				Tofuku, Yukari; Nobeyama, Yoshimasa; Kamide, Ryoichi; Moriwaki, Shinichi; Nakagawa, Hidemi			Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients	JOURNAL OF DERMATOLOGY			English	Article						carcinogenesis; complementation group F; cutaneous malignant tumors; hypersensitivity to sunlight; xeroderma pigmentosum	MUTATIONS	Xeroderma pigmentosum (XP) is an autosomal recessive genetic disorder characterized by extraordinary sensitivity to sunlight, resulting in cutaneous malignant tumors. Among XP, XP-F presents relatively uniquely in Japanese. To clarify the characteristics of this group, we describe a case of XP-F and review Japanese cases previously reported. A 50-year-old Japanese woman was referred to us with multiple, variously sized, light- or dark-brown macules on the face and sunlight-exposed extremities. She had experienced bulla formation with approximately 10min of sunlight exposure during her elementary school years. Her parents had been first cousins, and her mother and sister had photosensitivity. She showed no neurological or developmental abnormalities. Ultraviolet (UV) irradiation testing revealed normal levels for minimal erythema dose with UV-A and UV-B. Sensitivity to UV-C and DNA repair ability in the patient's fibroblasts were indicated between that in normal individuals and that in an XP-A patient. Complementation assay revealed that transfection of the XPF gene led most efficient DNA repair compared with the other XP genes. Therefore, the patient was diagnosed with XP-F. Twenty-three cases of Japanese patients (six males, 17 females) with XP-F have been reported, including the present case. Our review suggested a relatively high prevalence of 50% (11/22) for cutaneous malignant tumors. A significant difference was evident in the mean age at first medical consultation between patients with cutaneous malignant tumors (53.6years) and patients without such tumors (30.8years). This suggests that cutaneous malignant tumors could occur in the age range of 30-50years in XP-F patients.	[Tofuku, Yukari; Nobeyama, Yoshimasa; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo 1058461, Japan; [Kamide, Ryoichi] Hihuno Clin Ningyocho, Tokyo, Japan; [Moriwaki, Shinichi] Osaka Med Coll, Dept Dermatol, Osaka, Japan	Nobeyama, Y (reprint author), Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, 25-8 Nishi Shimbashi 3 Chome, Tokyo 1058461, Japan.	nobederm@jikei.ac.jp					Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Asai M, 2013, NISHINIHON J DERMATO, V75, P508; Ito T, 1995, JPN J DERMATOL, V105, P424; Kato Y, 2000, JPN J DERMATOL, V110, P301; Kondo S, 1990, NISHINIHON J DERMATO, V52, P279; Kraemer KH, 2014, XERODERMA PIGMENTOSU; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; Minamino Y, 2002, JPN J DERMATOL, V112, P866; MORIWAKI S, 1993, BRIT J DERMATOL, V128, P91, DOI 10.1111/j.1365-2133.1993.tb00154.x; Moriwaki S, 1999, CLIN DERMATOL, V53, P79; Sethi M, 2013, BRIT J DERMATOL, V169, P1279, DOI 10.1111/bjd.12523; Tamura D, 2010, J INVEST DERMATOL, V130, P1491, DOI 10.1038/jid.2010.76; Wolff K, 2007, FITZPATRICKS DERMATO, V7th, P1311; Yagi T, 1998, MUTAGENESIS, V13, P595, DOI 10.1093/mutage/13.6.595; Yasue T, 1998, JPN J DERMATOL, V108, P883	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					897	899		10.1111/1346-8138.12942		3	Dermatology	Dermatology	CQ7EQ	WOS:000360766200009		
J	Honma, M; Iinuma, S; Kanno, K; Komatsu, S; Minami-Hori, M; Ishida-Yamamoto, A				Honma, Masaru; Iinuma, Shin; Kanno, Kyoko; Komatsu, Shigetsuna; Minami-Hori, Masako; Ishida-Yamamoto, Akemi			Correlation of disease activity and serum level of carcinoembryonic antigen in acquired idiopathic generalized anhidrosis: A case report	JOURNAL OF DERMATOLOGY			English	Article						anhidrosis; carcinoembryonic antigen; carcinoembryonic antigen-related cell adhesion molecule; clinical marker; hypohidrosis; sweat gland		Hypohidrosis and anhidrosis are congenital or acquired conditions which are characterized by inadequate sweating. Acquired idiopathic generalized hypohidrosis/anhidrosis (AIGA) includes idiopathic pure sudomotor failure (IPSF), which has the following distinct features: sudden onset in youth, increased serum immunoglobulin E and responds favorably to systemic corticosteroid. No clinical markers reflecting the disease severity or activity have been established. Here, we report a case of AIGA in a Japanese patient successfully treated with repeated methylprednisolone pulse therapy. In this case, serum carcinoembryonic antigen (CEA) levels increased up to 19.8ng/mL along with aberrant CEA immunoreactivity of eccrine sweat glands. Interestingly, the serum CEA level normalized as sweating improved with repeated methylprednisolone pulse therapy. Therefore, serum CEA level may serve as a useful clinical marker of hypohidrosis or anhidrosis.	[Honma, Masaru; Iinuma, Shin; Kanno, Kyoko; Komatsu, Shigetsuna; Minami-Hori, Masako; Ishida-Yamamoto, Akemi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Honma, M (reprint author), Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	wanwan@asahikawa-med.ac.jp					Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Metze D, 1996, J INVEST DERMATOL, V106, P64, DOI 10.1111/1523-1747.ep12327258; Nagaishi T, 2008, MUCOSAL IMMUNOL, V1, pS39, DOI 10.1038/mi.2008.50; Nakazato Y, 2004, NEUROLOGY, V63, P1476; Ohshima Y, 2013, BRIT J DERMATOL, V168, P430, DOI 10.1111/j.1365-2133.2012.11112.x; Wilson APM, 1999, ANTICANCER RES, V19, P2749	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					900	902		10.1111/1346-8138.12926		3	Dermatology	Dermatology	CQ7EQ	WOS:000360766200010		
J	Takahashi, T; Fujisawa, T; Kimura, M; Ohnishi, H; Seishima, M				Takahashi, Tomoko; Fujisawa, Tomomi; Kimura, Masaki; Ohnishi, Hidenori; Seishima, Mariko			Familial Mediterranean fever variant with repeated atypical skin eruptions	JOURNAL OF DERMATOLOGY			English	Article						autoinflammatory disease; colchicine; erysipelas-like erythema; familial Mediterranean fever; MEFV	ERYSIPELAS-LIKE ERYTHEMA; CHILDREN	Familial Mediterranean fever (FMF) is characterized by self-limited bouts of fever and polyserositis. Skin involvement is not common in FMF, and erysipelas-like erythema is found to be the most frequent skin eruption which is often accompanied by arthritis and fever, and disappears within 12-72h. We report a 40-year-old Japanese woman who presented with a 2-year history of recurrent fever with general fatigue, polyarthralgia and transient maculopapular eruptions on her lower extremities and trunk. The histological findings of the maculopapular eruption showed lymphocyte infiltration around the capillaries in the entire dermis. Mutation analysis showed a heterozygous E148Q-P369S mutation of MEFV. These findings suggested a diagnosis of late-onset FMF variant with atypical skin eruptions. The patient was successfully treated with colchicine. Thus, we should pay attention to repeated atypical skin eruptions for the early detection of atypical FMF.	[Takahashi, Tomoko; Fujisawa, Tomomi; Seishima, Mariko] Gifu Univ, Grad Sch Med, Dept Dermatol, Gifu, Gifu 5011194, Japan; [Kimura, Masaki] Gifu Univ, Grad Sch Med, Dept Gen & Cardiothorac Surg, Gifu, Gifu 5011194, Japan; [Ohnishi, Hidenori] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Gifu 5011194, Japan	Seishima, M (reprint author), Gifu Univ, Grad Sch Med, Dept Dermatol, 1-1 Yanagido, Gifu, Gifu 5011194, Japan.	seimarik@gifu-u.ac.jp					Akin H, 2010, MOL BIOL REP, V37, P93, DOI 10.1007/s11033-009-9543-1; Migita K, 2014, MEDICINE, V93, P158, DOI 10.1097/MD.0000000000000029; Shimizu M, 2010, RHEUMATOLOGY, V49, P2221, DOI 10.1093/rheumatology/keq157; Migita K, 2012, MEDICINE, V91, P337, DOI 10.1097/MD.0b013e318277cf75; Ureten K, 2010, RHEUMATOL INT, V30, P911, DOI 10.1007/s00296-009-1073-6; Livneh A, 1997, ARTHRITIS RHEUM, V40, P1879, DOI 10.1002/art.1780401023; Barzilai A, 2000, J AM ACAD DERMATOL, V42, P791, DOI 10.1067/mjd.2000.103048; Kavukcu S, 2009, CLIN RHEUMATOL, V28, P857, DOI 10.1007/s10067-009-1138-7; MAJEED HA, 1990, Q J MED, V75, P607; Majeed HA, 1997, QJM-MON J ASSOC PHYS, V90, P37; Muhn CY, 1998, ARCH DERMATOL, V134, P929, DOI 10.1001/archderm.134.8.929; Radakovic S, 2013, J AM ACAD DERMATOL, V68, pE61, DOI 10.1016/j.jaad.2012.09.038; Satta R, 2007, ARCH DERMATOL, V143, P1080, DOI 10.1001/archderm.143.8.1080; Tamir N, 1999, AM J MED GENET, V87, P30, DOI 10.1002/(SICI)1096-8628(19991105)87:1<30::AID-AJMG6>3.3.CO;2-2	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					903	905		10.1111/1346-8138.12929		3	Dermatology	Dermatology	CQ7EQ	WOS:000360766200011		
J	Tanaka, M; Yang, LP; Wataya-Kaneda, M; Suzuki, T; Okamura, K; Hozumi, Y; Yang, F; Katayama, I				Tanaka, Mari; Yang, Liping; Wataya-Kaneda, Mari; Suzuki, Tamio; Okamura, Ken; Hozumi, Yutaka; Yang, Fei; Katayama, Ichiro			Case of Hermansky-Pudlak syndrome 1 in a Japanese infant	JOURNAL OF DERMATOLOGY			English	Letter							MUTATION; HPS1		[Tanaka, Mari; Yang, Liping; Wataya-Kaneda, Mari; Yang, Fei; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka 5650871, Japan; [Suzuki, Tamio; Okamura, Ken; Hozumi, Yutaka] Yamagata Univ, Fac Med, Dept Dermatol, Yamagata 990, Japan	Wataya-Kaneda, M (reprint author), Osaka Univ, Grad Sch Med, Dept Dermatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mkaneda@derma.med.osaka-u.ac.jp					Cullinane AR, 2011, AM J HUM GENET, V88, P778, DOI 10.1016/j.ajhg.2011.05.009; Natsuga K, 2005, J INVEST DERMATOL, V125, P154, DOI 10.1111/j.0022-202X.2005.23743.x; Nazarian R, 2003, P NATL ACAD SCI USA, V100, P8770, DOI 10.1073/pnas.1532040100; Okamura K, 2014, J DERMATOL SCI, V74, P173, DOI 10.1016/j.jdermsci.2013.12.011; Suzuki T, 2004, J DERMATOL SCI, V36, P106, DOI 10.1016/j.jdermsci.2004.08.008	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					906	907		10.1111/1346-8138.12937		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200012		
J	Yasuda, M; Kishi, C; Yokoyama, Y; Amano, H; Ishikawa, O				Yasuda, Masahito; Kishi, Chikako; Yokoyama, Yoko; Amano, Hiroo; Ishikawa, Osamu			Case of X-linked hypohidrotic ectodermal dysplasia with a novel EDA missense mutation	JOURNAL OF DERMATOLOGY			English	Letter									[Yasuda, Masahito; Kishi, Chikako; Yokoyama, Yoko; Amano, Hiroo; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gumma 3718511, Japan	Yasuda, M (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	myasuda@gunma-u.ac.jp					Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Dietz J, 2013, EUR J PEDIATR, V172, P1023, DOI 10.1007/s00431-013-1985-8; Gunadi, 2009, PEDIATR RES, V65, P453, DOI 10.1203/PDR.0b013e3181991229; Koguchi-Yoshioka H, 2015, ACTA DERM-VENEREOL, V95, P476, DOI 10.2340/00015555-1978	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					907	908		10.1111/1346-8138.12959		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200013		
J	Minakawa, S; Kaneko, T; Niizeki, H; Mizukami, H; Saito, Y; Nigawara, T; Kurose, R; Nakabayashi, K; Kabashima, K; Sawamura, D				Minakawa, Satoko; Kaneko, Takahide; Niizeki, Hironori; Mizukami, Hiroki; Saito, Yoko; Nigawara, Takeshi; Kurose, Rie; Nakabayashi, Kazuhiko; Kabashima, Kenji; Sawamura, Daisuke			Case of pachydermoperiostosis with solute carrier organic anion transporter family, member 2A1 (SLCO2A1) mutations	JOURNAL OF DERMATOLOGY			English	Letter							PRIMARY HYPERTROPHIC OSTEOARTHROPATHY; GENE		[Minakawa, Satoko; Kaneko, Takahide; Sawamura, Daisuke] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori 0368562, Japan; [Niizeki, Hironori] Natl Ctr Child Hlth & Dev, Dept Dermatol, Tokyo, Japan; [Mizukami, Hiroki] Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori 0368562, Japan; [Saito, Yoko] Hirosaki Univ, Grad Sch Med, Dept Radiol Life Sci, Hirosaki, Aomori 0368562, Japan; [Nigawara, Takeshi] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori 0368562, Japan; [Kurose, Rie] Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori 0368562, Japan; [Nakabayashi, Kazuhiko] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 606, Japan	Minakawa, S (reprint author), Hirosaki Univ, Grad Sch Med, Dept Dermatol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	minakawas@yahoo.co.jpand; smartdai@hirosaki-u.ac.jp					Cheng RH, 2013, EUR J DERMATOL, V23, P636, DOI 10.1684/ejd.2013.2154; Dias JACM, 2014, SEMIN ARTHRITIS RHEU, V43, P566, DOI 10.1016/j.semarthrit.2013.07.015; Zhang Z, 2013, GENE, V521, P191, DOI 10.1016/j.gene.2013.03.047; Niizeki H, 2014, J DERMATOL SCI, V75, P193, DOI 10.1016/j.jdermsci.2014.05.008; Sasaki T, 2012, J DERMATOL SCI, V68, P36, DOI 10.1016/j.jdermsci.2012.07.008	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					908	910		10.1111/1346-8138.12974		3	Dermatology	Dermatology	CQ7EQ	WOS:000360766200014		
J	Honma, M; Iinuma, S; Takahashi, H; Iizuka, H; Ishida-Yamamoto, A				Honma, Masaru; Iinuma, Shin; Takahashi, Hidetoshi; Iizuka, Hajime; Ishida-Yamamoto, Akemi			Accelerated nail elongation speed in psoriasis patients during treatment	JOURNAL OF DERMATOLOGY			English	Letter									[Honma, Masaru; Iinuma, Shin; Takahashi, Hidetoshi; Iizuka, Hajime; Ishida-Yamamoto, Akemi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Honma, M (reprint author), Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	wanwan@asahikawa-med.ac.jp					Wilson FC, 2009, ARTHRIT RHEUM-ARTHR, V61, P233, DOI 10.1002/art.24172; Sanchez-Regana M, 2011, J EUR ACAD DERMATOL, V25, P579, DOI 10.1111/j.1468-3083.2010.03938.x; Baran R, 2003, TEXT ATLAS NAIL DISO, V3rd; Crowley JJ, 2015, JAMA DERMATOL, V151, P87, DOI 10.1001/jamadermatol.2014.2983; Kyriakou A, 2014, SCI WORLD J, V2014	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					910	911		10.1111/1346-8138.12990		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200015		
J	Takahashi, M; Takeuchi, M; Matsunaga, K				Takahashi, Masayuki; Takeuchi, Makoto; Matsunaga, Kayoko			Infant with generalized pustular psoriasis who responded to cyclosporin A therapy	JOURNAL OF DERMATOLOGY			English	Letter									[Takahashi, Masayuki; Takeuchi, Makoto] Tsushima City Hosp, Dept Dermatol, Tsushima, Aichi 4968537, Japan; [Takahashi, Masayuki; Matsunaga, Kayoko] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 47011, Japan	Takahashi, M (reprint author), Tsushima City Hosp, Dept Dermatol, 3-73 Tachibana Cho, Tsushima, Aichi 4968537, Japan.	takahashimasayuki@k6.dion.ne.jp					Miyazaki Y, 2002, DERMATOLOGY, V204, P308, DOI 10.1159/000063371; Namba C, 2014, J DERMATOL, V41, P403, DOI 10.1111/1346-8138.12481; Posso-De Los Rios CJ, 2014, PEDIATR DERMATOL, V31, P430, DOI 10.1111/pde.12351; WYSOCKI GP, 1987, CLIN EXP DERMATOL, V12, P191, DOI 10.1111/j.1365-2230.1987.tb01893.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					911	913		10.1111/1346-8138.12960		3	Dermatology	Dermatology	CQ7EQ	WOS:000360766200016		
J	Okuhira, H; Matsunaka, H; Iwahashi, Y; Nakamura, Y; Furukawa, F; Yamamoto, Y				Okuhira, Hisako; Matsunaka, Hiroshi; Iwahashi, Yoshifumi; Nakamura, Yasushi; Furukawa, Fukumi; Yamamoto, Yuki			Case report of aquagenic wrinkling of the palms associated with impaired stratum corneum function	JOURNAL OF DERMATOLOGY			English	Letter									[Okuhira, Hisako; Matsunaka, Hiroshi; Furukawa, Fukumi; Yamamoto, Yuki] Wakayama Med Univ, Dept Dermatol, Wakayama, Wakayama 6410012, Japan; [Iwahashi, Yoshifumi; Nakamura, Yasushi] Wakayama Med Univ, Dept Clin Lab Med, Wakayama, Wakayama 6410012, Japan; [Yamamoto, Yuki] Wakayama Med Univ, Dept Cosmet Dermatol & Photomed, Wakayama, Wakayama 6410012, Japan	Okuhira, H (reprint author), Wakayama Med Univ, Dept Dermatol, 811-1 Kimiidera, Wakayama, Wakayama 6410012, Japan.	okuhisa@wakayama-med.ac.jp					Morita E, 2010, ALLERGY, V65, P1166, DOI 10.1111/j.1398-9995.2010.02361.x; Itin PH, 2002, DERMATOLOGY, V204, P8, DOI 10.1159/000051802; Kabasima K, 2008, J AM ACAD DERMATOL, V59, P28; Nadal M, 2015, ANN DERMATOL VENER, V142, P201, DOI 10.1016/j.annder.2015.01.012; Vale R, 2012, J DERMATOL, V39, P471, DOI 10.1111/j.1346-8138.2011.01387.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					913	914		10.1111/1346-8138.12953		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200017		
J	Ohata, C; Nii, S; Furumura, M; Nakama, T				Ohata, Chika; Nii, Saori; Furumura, Minao; Nakama, Takekuni			Vesicles and pustules on the fingers as an initial manifestation of eosinophilic pustular folliculitis	JOURNAL OF DERMATOLOGY			English	Letter									[Ohata, Chika; Nii, Saori; Furumura, Minao; Nakama, Takekuni] Kurume Univ, Dept Dermatol, Sch Med, Kurume, Fukuoka 8300011, Japan	Ohata, C (reprint author), Kurume Univ, Dept Dermatol, Sch Med, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	ohata@med.kurume-u.ac.jp					AOYAMA H, 1992, DERMATOLOGY, V185, P276; Fujiyama T, 2013, J DERMATOL, V40, P419, DOI 10.1111/1346-8138.12125; ISE S, 1965, ARCH DERMATOL, V92, P169, DOI 10.1001/archderm.92.2.169; SARUTA T, 1980, Journal of Dermatology (Tokyo), V7, P239; STEFFEN C, 1985, ARCH DERMATOL, V121, P921, DOI 10.1001/archderm.121.7.921	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					914	915		10.1111/1346-8138.12946		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200018		
J	Iijima, S; Ito, M; Makabe, K; Murakami, Y; Yokooji, T; Matsuo, H				Iijima, Shigeruko; Ito, Michiko; Makabe, Kaoru; Murakami, Yoshihiro; Yokooji, Tomoharu; Matsuo, Hiroaki			Case of food-dependent exercise-induced anaphylaxis due to Japanese apricot and peach: Detection of causative antigens	JOURNAL OF DERMATOLOGY			English	Letter									[Iijima, Shigeruko; Ito, Michiko; Makabe, Kaoru] Mito Saiseikai Gen Hosp, Dept Dermatol, Ibaraki, Japan; [Murakami, Yoshihiro; Yokooji, Tomoharu; Matsuo, Hiroaki] Hiroshima Univ, Dept Pathophysiol & Therapeut, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Iijima, S (reprint author), Hanamizuki Clin, Div Dermatol, 1-6-22 Chuo, Ushiku, Ibaraki 3001234, Japan.	imacintosh@poppy.ocn.ne.jp					Aihara Y, 2001, J ALLERGY CLIN IMMUN, V107, P1100, DOI 10.1067/mai.2001.115627; Bianchi A, 2011, Eur Ann Allergy Clin Immunol, V43, P122; Inomata N, 2014, ANN ALLERG ASTHMA IM, V112, P175, DOI 10.1016/j.anai.2013.11.003; Komoto K, 2003, JPN J DERMATOALLERGO, V11, P62; Sopo SM, 2013, ALLERGOL IMMUNOPATH, V41, P201, DOI 10.1016/j.aller.2012.07.009	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					916	917		10.1111/1346-8138.12951		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200019		
J	Yagami, A; Suzuki, K; Nakamura, M; Sano, A; Iwata, Y; Kobayashi, T; Suzuki, M; Hara, K; Teshima, R; Matsunaga, K				Yagami, Akiko; Suzuki, Kayoko; Nakamura, Masashi; Sano, Akiyo; Iwata, Yohei; Kobayashi, Tsukane; Suzuki, Mari; Hara, Kazuhiro; Teshima, Reiko; Matsunaga, Kayoko			Case of anaphylactic reaction to soy following percutaneous sensitization by soy-based ingredients in cosmetic products	JOURNAL OF DERMATOLOGY			English	Letter							ALLERGY		[Yagami, Akiko; Suzuki, Kayoko; Nakamura, Masashi; Sano, Akiyo; Iwata, Yohei; Kobayashi, Tsukane; Matsunaga, Kayoko] Fujita Hlth Univ, Dept Dermatol, Sch Med, Toyoake, Aichi 4701192, Japan; [Suzuki, Kayoko] Kariya Toyota Gen Hosp, Dept Dermatol, Kariya, Aichi, Japan; [Nakamura, Masashi; Hara, Kazuhiro] Gen Res & Dev Inst, Nagakute, Aichi, Japan; [Suzuki, Mari] Mari Skin Clin, Nagoya, Aichi, Japan; [Teshima, Reiko] Natl Inst Hlth Sci, Tokyo, Japan	Yagami, A (reprint author), Fujita Hlth Univ, Dept Dermatol, Sch Med, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	ayagami@fujita-hu.ac.jp					Holzhauser T, 2009, J ALLERGY CLIN IMMUN, V123, P452, DOI 10.1016/j.jaci.2008.09.034; Strid J, 2005, CLIN EXP ALLERGY, V35, P757, DOI 10.1111/j.1365-2222.2005.02260.x; Niinimaki A, 1998, ALLERGY, V53, P1078, DOI 10.1111/j.1398-9995.1998.tb03818.x; Yagami A, 2015, ALLERGOL INT, V64, P287, DOI 10.1016/j.alit.2015.03.005	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					917	918		10.1111/1346-8138.12966		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200020		
J	Arima, Y; Namiki, T; Kato, K; Ueno, M; Iikawa, M; Tokoro, S; Takayama, K; Miura, K; Yokozeki, H				Arima, Yumi; Namiki, Takeshi; Kato, Kohei; Ueno, Makiko; Iikawa, Madoka; Tokoro, Shown; Takayama, Kaoru; Miura, Keiko; Yokozeki, Hiroo			Pigmented squamous cell carcinoma of the cheek and its dermoscopic features	JOURNAL OF DERMATOLOGY			English	Letter									[Arima, Yumi; Namiki, Takeshi; Kato, Kohei; Ueno, Makiko; Iikawa, Madoka; Tokoro, Shown; Takayama, Kaoru; Yokozeki, Hiroo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Tokyo 1138510, Japan; [Miura, Keiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pathol, Tokyo 1138510, Japan	Namiki, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tnamderm@tmd.ac.jp					Zalaudek I, 2004, DERMATOL SURG, V30, P539, DOI 10.1111/j.1524-4725.2004.30172.x; Chung E, 2015, J AM ACAD DERMATOL, V72, pS64, DOI 10.1016/j.jaad.2014.08.044; Fraga-Braghiroli N, 2013, J AM ACAD DERMATOL, V69, pE161, DOI 10.1016/j.jaad.2013.04.024; Morgan MB, 2000, J CUTAN PATHOL, V27, P381, DOI 10.1034/j.1600-0560.2000.027008381.x; Satter EK, 2007, AM J DERMATOPATH, V29, P486	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					918	920		10.1111/1346-8138.12933		3	Dermatology	Dermatology	CQ7EQ	WOS:000360766200021		
J	Ito, K; Nakagawa, H				Ito, Keigo; Nakagawa, Hidemi			Diagnostically challenging case of low-fat spindle cell lipoma	JOURNAL OF DERMATOLOGY			English	Letter									[Ito, Keigo; Nakagawa, Hidemi] Jikei Univ, Dept Dermatol, Sch Med, Tokyo 1058461, Japan	Nakagawa, H (reprint author), Jikei Univ, Dept Dermatol, Sch Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	hidemi@jikei.ac.jp					ENZINGER FM, 1975, CANCER, V36, P1852, DOI 10.1002/1097-0142(197511)36:5<1852::AID-CNCR2820360542>3.0.CO;2-U; Chen BJ, 2012, AM J SURG PATHOL, V36, P1119, DOI 10.1097/PAS.0b013e31825d532d; Billings SD, 2007, AM J DERMATOPATH, V29, P437	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					921	923		10.1111/1346-8138.12947		3	Dermatology	Dermatology	CQ7EQ	WOS:000360766200023		
J	Takahashi, S; Hayama, K; Inadomi, T; Fujita, H; Suzuki, H; Terui, T				Takahashi, Shogo; Hayama, Koremasa; Inadomi, Toru; Fujita, Hideki; Suzuki, Hiroyuki; Terui, Tadashi			Electron microscopic observation of cholesterotic fibrous histiocytoma of the finger	JOURNAL OF DERMATOLOGY			English	Letter									[Takahashi, Shogo; Hayama, Koremasa; Inadomi, Toru; Fujita, Hideki; Suzuki, Hiroyuki; Terui, Tadashi] Nihon Univ, Div Cutaneous Sci, Dept Dermatol, Sch Med, Tokyo 1738610, Japan	Hayama, K (reprint author), Nihon Univ, Div Cutaneous Sci, Dept Dermatol, Sch Med,Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	hayama-nhn@umin.ac.jp					HUNT SJ, 1990, ARCH DERMATOL, V126, P506, DOI 10.1001/archderm.126.4.506; KLINKNER AM, 1995, J HISTOCHEM CYTOCHEM, V43, P1071; LeBoit PE, 2006, WHO CLASSIFICATION T, P261; Yu M, 2014, AM J DERMATOPATH, V36, P278, DOI 10.1097/DAD.0b013e3182817be2	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					923	924		10.1111/1346-8138.12952		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200024		
J	Watanabe, M; Ujiie, H; Saito, N; Abe, R; Shimizu, H				Watanabe, Mika; Ujiie, Hideyuki; Saito, Nao; Abe, Riichiro; Shimizu, Hiroshi			Kimura disease associated with severe visual dysfunction due to remarkable periorbital involvement	JOURNAL OF DERMATOLOGY			English	Letter									[Watanabe, Mika; Ujiie, Hideyuki; Saito, Nao; Abe, Riichiro; Shimizu, Hiroshi] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Ujiie, H (reprint author), Hokkaido Univ, Dept Dermatol, Grad Sch Med, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	h-ujiie@med.hokudai.ac.jp					Chen H, 2004, AM J SURG PATHOL, V28, P505, DOI 10.1097/00000478-200404000-00010; Requena L, 1998, J AM ACAD DERMATOL, V38, P143, DOI 10.1016/S0190-9622(98)70237-3; Buggage RR, 1999, SURV OPHTHALMOL, V44, P79, DOI 10.1016/S0039-6257(99)00064-8; Kimura T, 1948, T SOC PATH JAP, V37, P179; Yamazaki K, 2013, HUM IMMUNOL, V74, P1097, DOI 10.1016/j.humimm.2013.06.001	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					924	925		10.1111/1346-8138.12954		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200025		
J	Nakagawa, K; Okabayashi, A; Kishida, M; Kinoshita, R; Yoshida, Y; Imanishi, H; Tsuruta, D				Nakagawa, Koichi; Okabayashi, Aya; Kishida, Masaru; Kinoshita, Rie; Yoshida, Yasuhiko; Imanishi, Hisayoshi; Tsuruta, Daisuke			Case of pigmented eccrine poroma macroscopically simulated a malignant neoplasm with uptake of F-18-fluorodeoxyglucose on positron emission tomography/computed tomography	JOURNAL OF DERMATOLOGY			English	Letter							DERMATOFIBROMA		[Nakagawa, Koichi; Okabayashi, Aya; Kishida, Masaru; Kinoshita, Rie] Saiseikai Tondabayashi Hosp, Dept Dermatol, Osaka, Japan; [Yoshida, Yasuhiko] Saiseikai Tondabayashi Hosp, Dept Dermatol, Osaka, Japan; [Imanishi, Hisayoshi; Tsuruta, Daisuke] Osaka City Univ, Dept Dermatol, Grad Sch Med, Osaka 558, Japan	Nakagawa, K (reprint author), Saiseikai Tondabayashi Hosp, Dept Dermatol, 1-3-36 Koyodai, Tondabayashi City, Osaka 5840082, Japan.	yama_and_sawa@tonbyo.org					Germain M, 2002, J AM ACAD DERMATOL, V46, pS125, DOI 10.1067/mjd.2002.106356; Battistella M, 2008, EUR J DERMATOL, V18, P461, DOI 10.1684/ejd.2008.0445; Bingham BA, 2013, CLIN NUCL MED, V38, pE140, DOI 10.1097/RLU.0b013e318263869d; Hayashi Y, 2012, RINSHO HIFUKA, V66, P974; Ibusuki A, 2011, J DERMATOL, V38, P104, DOI 10.1111/j.1346-8138.2010.01051.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					926	927		10.1111/1346-8138.12963		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200026		
J	Matsushita, S; Krahenbuhl, L; Otsuka, A; Mihic-Probst, D; Cheng, P; Dummer, R; Goldinger, SM				Matsushita, Shigeto; Kraehenbuehl, Lukas; Otsuka, Atsushi; Mihic-Probst, Daniela; Cheng, Phil; Dummer, Reinhard; Goldinger, Simone M.			Histological evaluation of a "residual" metastasis after ipilimumab therapy in a patient with advanced melanoma	JOURNAL OF DERMATOLOGY			English	Letter							SURVIVAL		[Matsushita, Shigeto; Kraehenbuehl, Lukas; Otsuka, Atsushi; Cheng, Phil; Dummer, Reinhard; Goldinger, Simone M.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Matsushita, Shigeto] Kagoshima Med Ctr, Natl Hosp Org, Dept Dermatooncol Dermatol, Kagoshima, Japan; [Mihic-Probst, Daniela] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	Goldinger, SM (reprint author), Univ Zurich Hosp, Dept Dermatol, 31 Gloriastr, CH-8091 Zurich, Switzerland.	Simone.Goldinger@usz.ch					Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Wolchok JD, 2013, ANN ONCOL, V24, P2174, DOI 10.1093/annonc/mdt161; Robert C, 2013, CLIN CANCER RES, V19, P2232, DOI 10.1158/1078-0432.CCR-12-3080; McDermott D, 2014, CANCER TREAT REV, V40, P1056, DOI 10.1016/j.ctrv.2014.06.012; Tsaknakis B, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0813-3	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					927	928		10.1111/1346-8138.12964		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200027		
J	Fukuda, K; Funakoshi, T; Fukuyama, M; Kakuta, R; Sato, M; Nakamura, Y; Tanese, K; Masugi, Y; Amagai, M				Fukuda, Keitaro; Funakoshi, Takeru; Fukuyama, Masahiro; Kakuta, Risa; Sato, Misato; Nakamura, Yoshio; Tanese, Keiji; Masugi, Yohei; Amagai, Masayuki			Metastatic eccrine porocarcinoma successfully treated with carboplatin and epirubicin chemotherapy	JOURNAL OF DERMATOLOGY			English	Letter							DOCETAXEL; CANCER		[Fukuda, Keitaro; Funakoshi, Takeru; Fukuyama, Masahiro; Kakuta, Risa; Sato, Misato; Nakamura, Yoshio; Tanese, Keiji; Amagai, Masayuki] Keio Univ, Dept Dermatol, Sch Med, Tokyo 1608582, Japan; [Masugi, Yohei] Keio Univ, Dept Pathol, Sch Med, Tokyo 1608582, Japan	Funakoshi, T (reprint author), Keio Univ, Dept Dermatol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	takerufunakoshi@yahoo.co.jp					Robson A, 2001, AM J SURG PATHOL, V25, P710, DOI 10.1097/00000478-200106000-00002; Rossi A, 2012, J CLIN ONCOL, V30, P1692, DOI 10.1200/JCO.2011.40.4905; De Iuliis F, 2014, ANTICANCER RES, V34, P5263; O'Neill VJ, 2002, BRIT J CANCER, V86, P1385, DOI 10.1038/sj/bjc/6600259; Plunkett TA, 2001, ANN ONCOL, V12, P411, DOI 10.1023/A:1011196615177	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					928	930		10.1111/1346-8138.12977		3	Dermatology	Dermatology	CQ7EQ	WOS:000360766200028		
J	Miyagawa, F; Hirose, C; Fukumoto, T; Asai, H; Kobayashi, N; Asada, H				Miyagawa, Fumi; Hirose, Chiharu; Fukumoto, Takaya; Asai, Hideki; Kobayashi, Nobuhiko; Asada, Hideo			Cutaneous squamous cell carcinoma with extensive perineural invasion and perineural cyst formation without regional lymph node metastases	JOURNAL OF DERMATOLOGY			English	Letter									[Miyagawa, Fumi; Hirose, Chiharu; Fukumoto, Takaya; Kobayashi, Nobuhiko; Asada, Hideo] Nara Med Univ, Sch Med, Dept Dermatol, Kashihara, Nara 6348522, Japan; [Asai, Hideki] Nara Med Univ, Sch Med, Ctr Plast Surg, Kashihara, Nara 6348522, Japan	Miyagawa, F (reprint author), Nara Med Univ, Sch Med, Dept Dermatol, 840 Shijo, Kashihara, Nara 6348522, Japan.	fumim@naramed-u.ac.jp					Carter JB, 2013, JAMA DERMATOL, V149, P35, DOI 10.1001/jamadermatol.2013.746; GOEPFERT H, 1984, AM J SURG, V148, P542, DOI 10.1016/0002-9610(84)90385-4; Farasat S, 2011, J AM ACAD DERMATOL, V64, P1051, DOI 10.1016/j.jaad.2010.08.033; COTTEL WI, 1982, J DERMATOL SURG ONC, V8, P589; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P261, DOI 10.1016/j.jaad.2005.03.048	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					930	931		10.1111/1346-8138.12981		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200029		
J	Sato, Y; Hara, T; Okubo, Y; Utani, A				Sato, Yukie; Hara, Toshihide; Okubo, Yumi; Utani, Atsushi			Axillary syringomas misdiagnosed as pseudoxanthoma elasticum for years	JOURNAL OF DERMATOLOGY			English	Letter							SKIN		[Sato, Yukie; Hara, Toshihide; Okubo, Yumi; Utani, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki 8528501, Japan	Utani, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	utani@nagasaki-u.ac.jp					Demirkesen C, 1995, J CUTAN PATHOL, V22, P518, DOI 10.1111/j.1600-0560.1995.tb01147.x; Ghanadan Alireza, 2013, Indian J Dermatol, V58, P326, DOI 10.4103/0019-5154.113956; Heo YS, 2010, ANN DERMATOL, V22, P85, DOI 10.5021/ad.2010.22.1.85; Javier CNB, 2012, INT J DERMATOL, V51, P1313, DOI 10.1111/j.1365-4632.2011.05236.x; Mine Y, 2014, EUR J DERMATOL, V24, P401, DOI 10.1684/ejd.2014.2335	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					933	934		10.1111/1346-8138.12984		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200031		
J	Yamanaka, K; Kondo, M; Goto, H; Yamamoto, S; Taniguchi, Y; Mizutani, H				Yamanaka, Keiichi; Kondo, Makoto; Goto, Hiroyuki; Yamamoto, Shinya; Taniguchi, Yoshiki; Mizutani, Hitoshi			Band-like lipoatrophy on the forearm by injected triamcinolone acetonide to wrist joint	JOURNAL OF DERMATOLOGY			English	Letter									[Yamanaka, Keiichi; Kondo, Makoto; Mizutani, Hitoshi] Mie Univ, Dept Dermatol, Grad Sch Med, Tsu, Mie 5148507, Japan; [Goto, Hiroyuki; Yamamoto, Shinya; Taniguchi, Yoshiki] Yokkaichi Municipal Hosp, Dept Dermatol, Yokaichi, Japan	Yamanaka, K (reprint author), Mie Univ, Dept Dermatol, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	yamake@clin.medic.mie-u.ac.jp					Hugle B, 2009, ARTHRITIS RHEUM-US, V60, P3512, DOI 10.1002/art.24987; Avilés-Izquierdo J A, 2006, Dermatol Online J, V12, P17; Fardet L, 2007, RHEUMATOLOGY, V46, P1102, DOI 10.1093/rheumatology/kem062; Liang J, 2013, AM J PHYS MED REHAB, V92, P639, DOI 10.1097/PHM.0b013e318269ebdc	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					934	935		10.1111/1346-8138.12940		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200032		
J	Fujimura, Y; Natsuga, K; Abe, R; Morita, Y; Nomura, T; Shimizu, H				Fujimura, Yu; Natsuga, Ken; Abe, Riichiro; Morita, Yusuke; Nomura, Toshifumi; Shimizu, Hiroshi			Plasma cell cheilitis extending beyond vermillion border	JOURNAL OF DERMATOLOGY			English	Letter									[Fujimura, Yu; Natsuga, Ken; Abe, Riichiro; Morita, Yusuke; Nomura, Toshifumi; Shimizu, Hiroshi] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Natsuga, K (reprint author), Hokkaido Univ, Dept Dermatol, Grad Sch Med, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	natsuga@med.hokudai.ac.jp					Choi JW, 2009, J DERMATOL, V36, P669, DOI 10.1111/j.1346-8138.2009.00733.x; Fujimura Taku, 2013, Case Rep Dermatol, V5, P79, DOI 10.1159/000350184; Hanami Yuka, 2011, Dermatol Online J, V17, P6; Ito T, 2014, ACTA DERM-VENEREOL, V94, P593, DOI 10.2340/00015555-1795; Yang JH, 2005, J DERMATOL, V32, P987	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					935	936		10.1111/1346-8138.12985		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200033		
J	Yamada, K; Motegi, S; Amano, H; Ishikawa, O				Yamada, Kazuya; Motegi, Sei-ichiro; Amano, Hiroo; Ishikawa, Osamu			Epstein-Barr virus-related post-transplant lymphoproliferative disorder in the skin	JOURNAL OF DERMATOLOGY			English	Letter							PTLD		[Yamada, Kazuya; Motegi, Sei-ichiro; Amano, Hiroo; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gumma 3718511, Japan	Motegi, S (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showa, Maebashi, Gumma 3718511, Japan.	smotegi@gunma-u.ac.jp; hamano@gunma-u.ac.jp					Seckin D, 2013, AM J TRANSPLANT, V13, P2146, DOI 10.1111/ajt.12281; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P155, DOI 10.1016/j.critrevonc.2005.03.015; Al-Mansour Z, 2013, CURR HEMATOL MALIG R, V8, P173, DOI 10.1007/s11899-013-0162-5; Swerdlow SH, 2008, WHO CLASSIFICATION T, P343	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					936	937		10.1111/1346-8138.12965		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200034		
J	Inui, S; Itami, S				Inui, Shigeki; Itami, Satoshi			Contact immunotherapy-resistant alopecia areata totalis/universalis reactive to topical corticosteroid	JOURNAL OF DERMATOLOGY			English	Letter							MANAGEMENT		[Inui, Shigeki; Itami, Satoshi] Osaka Univ, Grad Sch Med, Dept Regenerat Dermatol, Suita, Osaka 5650871, Japan	Inui, S (reprint author), Osaka Univ, Grad Sch Med, Dept Regenerat Dermatol, 2-2 G2 Yamada Oka, Suita, Osaka 5650871, Japan.	inui@r-derma.med.osaka-u.ac.jp					Ito T, 2012, J DERMATOL, V39, P11, DOI 10.1111/j.1346-8138.2011.01476.x; Rokhsar CK, 1998, J AM ACAD DERMATOL, V39, P751, DOI 10.1016/S0190-9622(98)70048-9; Messenger AG, 2012, BRIT J DERMATOL, V166, P916, DOI 10.1111/j.1365-2133.2012.10955.x; Inui S, 2010, J DERMATOL, V37, P888, DOI 10.1111/j.1346-8138.2010.00903.x; Marhaba R, 2007, J IMMUNOL, V179, P5071	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					937	939		10.1111/1346-8138.12938		3	Dermatology	Dermatology	CQ7EQ	WOS:000360766200035		
J	Saito-Shono, T; Ito, A; Hatano, Y; Kumagi, M; Ishii, K; Fujiwara, S				Saito-Shono, Tomoko; Ito, Akiko; Hatano, Yutaka; Kumagi, Midori; Ishii, Koji; Fujiwara, Sakuhei			Case of alopecia areata accompanied by polymyalgia rheumatica	JOURNAL OF DERMATOLOGY			English	Letter									[Saito-Shono, Tomoko; Ito, Akiko; Hatano, Yutaka; Fujiwara, Sakuhei] Oita Univ, Sch Med, Dept Dermatol, Oita 87011, Japan; [Kumagi, Midori; Ishii, Koji] Oita Univ, Sch Med, Dept Rheumatol, Oita 87011, Japan	Saito-Shono, T (reprint author), Oita Univ, Sch Med, Dept Dermatol, Oita 87011, Japan.						Nakajima T, 2007, DERMATOLOGY, V215, P320, DOI 10.1159/000107626; Soriano A, 2012, BEST PRACT RES CL RH, V26, P91, DOI 10.1016/j.berh.2012.01.007; FAERGEMANN J, 1979, CUTIS, V23, P757; McElwee KJ, 2013, EXP DERMATOL, V22, P609, DOI 10.1111/exd.12209	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	SEP	2015	42	9					939	940		10.1111/1346-8138.12941		2	Dermatology	Dermatology	CQ7EQ	WOS:000360766200036		
J	Chiba, Y; Kimbara, Y; Kodera, R; Tsuboi, Y; Sato, K; Tamura, Y; Mori, S; Ito, H; Araki, A				Chiba, Yuko; Kimbara, Yoshiyuki; Kodera, Remi; Tsuboi, Yuki; Sato, Ken; Tamura, Yoshiaki; Mori, Seijiro; Ito, Hideki; Araki, Atsushi			Risk factors associated with falls in elderly patients with type 2 diabetes	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						Hypoglycemia; Falls; Elderly type 2 diabetes; Impaired balance; Sarcopenia; Frailty	OLDER-ADULTS; HYPOGLYCEMIC EVENTS; BODY-COMPOSITION; GLYCEMIC CONTROL; MUSCLE STRENGTH; MELLITUS; HEALTH; WOMEN; DEPRESSION; PEOPLE	Aims: This study investigated risk factors of falls in elderly patients with type 2 diabetes mellitus. Methods: A total of 211 patients aged >= 60 years (168 diabetic patients and 43 non-diabetic control subjects) were studied. Factors associated with falls in the past year were retrospectively examined using multiple logistic regression analysis. Results: The prevalence of patients who had a history of falls in the past year was twice as high as in diabetic patients compared in control subjects (36.9% vs. 18.6%, P < 0.05). When diabetic patients were exclusively analyzed, the presence of any level of hypoglycemia and the Timed Up and Go test (TUG) scores correlated with patients' falls. The presence of hypoglycemia (OR 3.62, 95% CI: 1.242-10.534, P = 0.018), cognitive impairment (OR 3.63, 95% CI: 1.227-10.727, P = 0.020), and high Fall Risk Index scores (OR 1.2, 95% CI: 1.010-1.425, P = 0.039) was independently correlated with the presence of multiple falls. When the diabetic patients were divided into three groups according to the frequency of hypoglycemia episodes, the prevalence of falls increased as the frequency of hypoglycemia increased. Conclusion: Hypoglycemia was a risk factor of falls in elderly type 2 diabetic patients. (C) 2015 Elsevier Inc. All rights reserved.	[Chiba, Yuko; Kimbara, Yoshiyuki; Kodera, Remi; Tsuboi, Yuki; Sato, Ken; Tamura, Yoshiaki; Mori, Seijiro; Ito, Hideki; Araki, Atsushi] Tokyo Metropolitan Geriatr Hosp, Dept Diabet Metab & Endocrinol, Itabashi Ku, Tokyo 1730015, Japan	Chiba, Y (reprint author), Tokyo Metropolitan Geriatr Hosp, Dept Diabet Metab & Endocrinol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	chibaytky2004@yahoo.co.jp			Health and Labour Science Research Grant [H21-Chouju-Ordinal-005]; Japan Foundation for Aging and Health	This study was supported by the Health and Labour Science Research Grant (H21-Chouju-Ordinal-005) and the Japan Foundation for Aging and Health.	Childs BP, 2005, DIABETES CARE, V28, P1245; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Morley JE, 1999, CLIN GERIATR MED, V15, P211; Strotmeyer ES, 2008, DIABETES CARE, V31, P1767, DOI 10.2337/dc08-0433; Engler B, 2011, EXP CLIN ENDOCR DIAB, V119, P59, DOI 10.1055/s-0030-1262874; Maurer MS, 2005, J GERONTOL A-BIOL, V60, P1157; Johnston SS, 2012, DIABETES OBES METAB, V14, P634, DOI 10.1111/j.1463-1326.2012.01583.x; Wang CP, 2011, DIABETES CARE, V34, P268, DOI 10.2337/dc10-1405; Derr R, 2003, DIABETES CARE, V26, P2728, DOI 10.2337/diacare.26.10.2728; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Andersen H, 2004, DIABETES, V53, P1543, DOI 10.2337/diabetes.53.6.1543; Nelson JM, 2007, J AM GERIATR SOC, V55, P2041, DOI 10.1111/j.1532-5415.2007.01430.x; Schwartz AV, 2008, DIABETES CARE, V31, P391, DOI 10.2337/dc07-1152; Nordin E, 2008, AGE AGEING, V37, P442, DOI 10.1093/ageing/afn101; Schwartz AV, 2002, DIABETES CARE, V25, P1749, DOI 10.2337/diacare.25.10.1749; Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183; Yau RK, 2013, DIABETES CARE, V36, P3985, DOI 10.2337/dc13-0429; Volpato S, 2005, J GERONTOL A-BIOL, V60, P1539; Whooley MA, 1999, ARCH INTERN MED, V159, P484, DOI 10.1001/archinte.159.5.484; Araki A, 2009, GERIATR GERONTOL INT, V9, P105, DOI 10.1111/j.1447-0594.2008.00495.x; Tilling LM, 2006, J DIABETES COMPLICAT, V20, P158, DOI 10.1016/j.jdiacomp.2005.06.004; Menz HB, 2004, ARCH PHYS MED REHAB, V85, P245, DOI 10.1016/j.apmr.2003.06.015; Araki A., 2015, JAPANESE J GERIATRIC, V52, P4; Araki A., 2012, GERIATR GERONTOL INT, V12, P8; Brown AF, 2003, J AM GERIATR SOC S, V51, P265; Duncan PW, 1990, J GERONTOL, V45, P192; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Kachroo Sumesh, 2015, J Manag Care Spec Pharm, V21, P243; Kim H., 2001, JPN J GERIATR, V38, P805; Roman de Mettelinge T., 2013, PLOS ONE, V8; Shao W, 2013, CURR MED RES OPIN, V29, P1609, DOI 10.1185/03007995.2013.830599; Shibata H, 2001, GERIATR GERONTOL INT, V1, P8, DOI 10.1046/j.1444-1586.2001.00004.x; Toba K., 2009, JMAJ - Japan Medical Association Journal, V52, P237; Yasumura S., 2009, JMAJ - Japan Medical Association Journal, V52, P231; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	36	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	SEP-OCT	2015	29	7					898	902		10.1016/j.jdiacomp.2015.05.016		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ4UG	WOS:000360599500008		
J	Onda, Y; Nishimura, R; Morimoto, A; Sano, H; Utsunomiya, K; Tajima, N				Onda, Yoshiko; Nishimura, Rimei; Morimoto, Aya; Sano, Hironari; Utsunomiya, Kazunori; Tajima, Naoko		Diabet Epidemiology Res Int DERI M	Causes of death in patients with childhood-onset type 1 diabetes receiving dialysis in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						Cause of death; Dialysis; Type 1 diabetes; Cardiovascular disease; Childhood-onset	STAGE RENAL-DISEASE; POPULATION-BASED COHORT; ALL-CAUSE MORTALITY; MAINTENANCE HEMODIALYSIS; REPLACEMENT THERAPY; TIME TRENDS; MELLITUS; NEPHROPATHY; IDDM; COMPLICATIONS	Aims: To investigate the causes of death and how they changed over time in patients with childhood-onset type 1 diabetes who were receiving dialysis. Methods: Of the 1384 patients who were diagnosed with type 1 diabetes at < 18 years of age between 1965 and 1979, 113 who were subsequently confirmed as having received dialysis and having died as of January 1, 2008 were found eligible for the study. The cause of death trends were expressed according to the duration of dialysis. Results: The leading causes of death were end-stage renal disease (ESRD) (36.3%), cardiovascular disease (CVD) (31.9%), and infections (203%). Among CVD, cerebral hemorrhage was the most frequent (38.9%) and showed a significant trend for an increase in the duration of dialysis (P = 0.01, the Cochran-Armitage trend test). The mortality from ESRD concentrated within 5 years of dialysis and that from CVD increased after 10 years of dialysis, while the mortality from infections peaked during 5 to 10 years from initiation of dialysis. Conclusions: The leading causes of death in dialysis patients with type 1 diabetes were ESRD, CVD, and infections. As the duration of dialysis increased, however, CVD contributed more to mortality. Special attention should be paid to CVD, particularly cerebral hemorrhage, to improve the long-term prognosis of patients. (C) 2015 Elsevier Inc. All rights reserved.	[Onda, Yoshiko; Nishimura, Rimei; Sano, Hironari; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Minato Ku, Tokyo 1058461, Japan; [Nishimura, Rimei] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Morimoto, Aya] Morimoto Hosp, Dept Internal Med, Musashino, Tokyo 1800004, Japan; [Tajima, Naoko] Jikei Univ, Sch Med, Minato Ku, Tokyo 1058461, Japan	Onda, Y (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Minato Ku, Tokyo 1058461, Japan.	morohoshy@gmail.com; rimei.nishimura@gmail.com; aya.morimoto@hoku.cc; hirosano@jikei.ac.jp; kazu-utsunomiya@jikei.ac.jp; naokopgh@gmail.com			National Institutes of Health [DK-35905]; Japan Child and Family Research Institute, Ministry of Health, Labor and Welfare [H10-Kodomo-022]; Ministry of Education, Culture, Sports, Science and Technology, Japan [Wakate-B 14770186, 16790328, 22790573]; Jikei Graduate School of Medicine, Tokyo, Japan; COSTCO Japan Diabetes Foundation	This study was supported by a research grant from the National Institutes of Health (DK-35905), a grant from the Japan Child and Family Research Institute, Ministry of Health, Labor and Welfare (H10-Kodomo-022), a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Wakate-B 14770186, 16790328, 22790573), a research grant from Jikei Graduate School of Medicine, Tokyo, Japan, and a grant from COSTCO Japan Diabetes Foundation.	ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; Freedman BI, 2007, CLIN J AM SOC NEPHRO, V2, P1306, DOI 10.2215/CJN.02560607; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Nakano T, 2010, AM J KIDNEY DIS, V55, P21, DOI 10.1053/j.ajkd.2009.06.034; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; BORCHJOHNSEN K, 1985, DIABETOLOGIA, V28, P590; Kawamura M, 1998, AM J KIDNEY DIS, V31, P991, DOI 10.1053/ajkd.1998.v31.pm9631844; Nassar GM, 2001, KIDNEY INT, V60, P1, DOI 10.1046/j.1523-1755.2001.00765.x; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; Morimoto A, 2013, DIABETOLOGIA, V56, P2171, DOI 10.1007/s00125-013-3001-2; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Toyoda K, 2005, AM J KIDNEY DIS, V45, P1058, DOI 10.1053/j.ajkd.2005.02.028; Soedamah-Muthu SS, 2006, DIABETOLOGIA, V49, P660, DOI 10.1007/s00125-005-0120-4; BOJESTIG M, 1994, NEW ENGL J MED, V330, P15, DOI 10.1056/NEJM199401063300103; Collins Allan J, 2008, Am J Kidney Dis, V51, pS1, DOI 10.1053/j.ajkd.2007.11.001; KITAGAWA T, 1995, AM J EPIDEMIOL, V142, P612; LAPORTE RE, 1991, DIABETES CARE, V14, P49; ORCHARD TJ, 1991, DIABETES CARE, V14, P55; European Best Practice Guidelines Expert Group on Hemodialysis European Renal Association, 2002, NEPHROL DIAL TRAN S7, V17, P7; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Haapio M, 2010, DIABETES CARE, V33, P1718, DOI 10.2337/dc10-0030; Harjutsalo V, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5364; Hemodialysis Adequacy 2006 Work Group, 2006, AM J KIDNEY DIS S, V48, pS2, DOI DOI 10.1053/J.AJKD.2006.03.051.MEDLINE; Hibi I., 1981, REPORT CHILDHOOD DIA; Jorgensen ME, 2013, DIABETOLOGIA, V56, P2401, DOI 10.1007/s00125-013-3025-7; Lazarus J., 1995, BRENNER RECTORS KIDN, V5th, P2453; MIKI E, 1972, Journal of the Japan Diabetes Society, V15, P38; Nakai S, 2006, THER APHER DIAL, V10, P476, DOI 10.1111/j.1744-9987.2006.00440.x; Nishimura R, 1996, DIABETES CARE, V19, P758, DOI 10.2337/diacare.19.7.758; Ritz E, 1999, DIABETES CARE, V22, pB80; Stel VS, 2010, NEPHROL DIAL TRANSPL, V25, P3315, DOI 10.1093/ndt/gfq209; U.S. Renal Data System Group, 2013, USRDS 2013 ANN DAT R, P249; Van Dijk PCW, 2005, KIDNEY INT, V67, P1489, DOI 10.1111/j.1523-1755.2005.00227.x; Wakasugi M, 2013, THER APHER DIAL, V17, P298, DOI 10.1111/j.1744-9987.2012.01144.x; Working Group Committee for the Preparation of Guidelines for Peritoneal Dialysis, 2010, THERAPEUTIC APHERESI, V14, P489; Yamagata K, 2012, THER APHER DIAL, V16, P54, DOI 10.1111/j.1744-9987.2011.01005.x; Yeun Y. J., 2011, HEMODIALYSIS, V9	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	SEP-OCT	2015	29	7					903	907		10.1016/j.jdiacomp.2015.05.014		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ4UG	WOS:000360599500009		
J	Fukami, K; Shibata, R; Nakayama, H; Yamada, K; Okuda, S; Koga, M				Fukami, Kei; Shibata, Ryo; Nakayama, Hitomi; Yamada, Kentaro; Okuda, Seiya; Koga, Masafumi			Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						Diabetic nephropathy; Glycated albumin; HbA1c; End-stage renal disease; Glycemic excursion	CARDIOVASCULAR EVENTS; GLUCOSE-TOLERANCE; HEMODIALYSIS; INDICATOR; MORTALITY; LESSONS; INDEX; DEATH; RISK	Objective: Diabetic patients with severe chronic kidney disease (CKD) not treated with dialysis falsely show low levels of HbA1c and GA due to renal anemia and proteinuria, respectively. Recently, we reported that serum albumin-adjusted GA (adjGA) accurately reflects mean plasma glucose (PG) in these patients. It is considered that GA reflects not only mean PG but also glycemic excursion; therefore, in the present study we investigated whether adjGA reflects glycemic excursion in these patients. Methods: Thirty type 2 diabetic patients with severe CKD not treated with dialysis were enrolled in the present study. PG was monitored by seven times a day, and indicators of glycemic excursion [SD, max PG, Delta PG, M value, J index, and mean amplitude of glucose excursion (MAGE)] were calculated. The correlations between HbA1c, GA or adjGA and indicators of glycemic excursion were investigated. Results: HbA1c showed no significant correlation with indicators of glycemic excursion. GA was significantly correlated with them except for Delta PG. adjGA was significantly and strongly associated with them except for MAGE. GA, but not adjGA, showed a significant positive correlation with serum albumin. Conclusion: adjGA was not influenced by serum albumin and showed a significant correlation with indicators of glycemic excursion in diabetic patients with severe CKD not treated with dialysis. These results suggest that adjGA could be useful for indicating glycemic control in diabetic patients with severe CKD not treated with dialysis. (C) 2015 Elsevier Inc. All rights reserved.	[Fukami, Kei; Shibata, Ryo; Okuda, Seiya] Kurume Univ, Sch Med, Dept Med, Div Nephrol, Fukuoka 8300011, Japan; [Nakayama, Hitomi; Yamada, Kentaro] Kurume Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Fukuoka 8300011, Japan; [Koga, Masafumi] Kawanishi City Hosp, Dept Internal Med, Kawanishi, Hyogo 6660915, Japan	Koga, M (reprint author), Kawanishi City Hosp, Dept Internal Med, 5-21-1 Higashi Uneno, Kawanishi, Hyogo 6660915, Japan.	m-koga@kawanishi-city-hospital.com					Koga M, 2014, CLIN CHIM ACTA, V433, P96, DOI 10.1016/j.cca.2014.03.001; Peacock TP, 2008, KIDNEY INT, V73, P1062, DOI 10.1038/ki.2008.25; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Freedman BI, 2011, CLIN J AM SOC NEPHRO, V6, P1635, DOI 10.2215/CJN.11491210; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Pugliese G, 2014, NUTR METAB CARDIOVAS, V24, P815, DOI 10.1016/j.numecd.2014.02.013; SERVICE FJ, 1970, DIABETES, V19, P644; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Moen MF, 2009, CLIN J AM SOC NEPHRO, V4, P1121, DOI 10.2215/CJN.00800209; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; Chujo Keiko, 2006, J Med Invest, V53, P223, DOI 10.2152/jmi.53.223; Fukami K, 2015, ANN CLIN BIOCHEM, V52, P488, DOI 10.1177/0004563214568162; Borch-Johnsen K, 1999, LANCET, V354, P617; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Inaba M, 2012, CLIN NEPHROL, V78, P273, DOI 10.5414/CN106940; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Kim HS, 2012, DIABETES-METAB RES, V28, P73, DOI 10.1002/dmrr.2346; National Kidney Foundation, 2012, AM J KIDNEY DIS, V60, P850, DOI DOI 10.1053/J.AJKD.2012.07.005; SCHLICHT.J, 1965, ACTA MED SCAND, V177, P95; Nathan DM, 2005, NEW ENGL J MED, V353, P2643; The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]; Tsutsumi C, 2013, DIABETOL INT, V4, P156; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6; WOJCICKI JM, 1995, HORM METAB RES, V27, P41, DOI 10.1055/s-2007-979906	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	SEP-OCT	2015	29	7					913	917		10.1016/j.jdiacomp.2015.06.003		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ4UG	WOS:000360599500011		
J	Koya, D				Koya, Daisuke			Epidermal growth factor receptor signaling and the progression of diabetic nephropathy	JOURNAL OF DIABETES INVESTIGATION			English	Editorial Material							ENDOPLASMIC-RETICULUM STRESS; KIDNEY-DISEASE; TGF-BETA; AUTOPHAGY; ACTIVATION; FIBROSIS; MICE		Kanazawa Med Univ, Diabetol & Endocrinol, Kanazawa, Ishikawa, Japan	Koya, D (reprint author), Kanazawa Med Univ, Diabetol & Endocrinol, Kanazawa, Ishikawa, Japan.	koya0516@kanazawa-med.ac.jp					Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Soldatos G, 2008, DIABETES RES CLIN PR, V82, pS75, DOI 10.1016/j.diabres.2008.09.042; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279; Chen JC, 2015, J AM SOC NEPHROL, V26, P1115, DOI 10.1681/ASN.2014020192; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kume S, 2012, DIABETES, V61, P23, DOI 10.2337/db11-0555; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Cunard R, 2011, AM J PHYSIOL-RENAL, V300, pF1054, DOI 10.1152/ajprenal.00021.2011; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Koya D, 2011, J DIABETES INVEST, V2, P248, DOI 10.1111/j.2040-1124.2011.00112.x; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					519	521		10.1111/jdi.12317		3	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800005		
J	Seino, Y; Ogata, H; Maekawa, R; Izumoto, T; Iida, A; Harada, N; Miki, T; Seino, S; Inagaki, N; Tsunekawa, S; Oiso, Y; Hamada, Y				Seino, Yusuke; Ogata, Hidetada; Maekawa, Ryuya; Izumoto, Takako; Iida, Atsushi; Harada, Norio; Miki, Takashi; Seino, Susumu; Inagaki, Nobuya; Tsunekawa, Shin; Oiso, Yutaka; Hamada, Yoji			Fructose induces glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and insulin secretion: Role of adenosine triphosphate-sensitive K+ channels	JOURNAL OF DIABETES INVESTIGATION			English	Article						Adenosine triphosphate-sensitive K+ channe; Fructose; Hormone secretion	ATP CHANNEL; GIP SECRETION; MICE; CELLS; GLP-1; INTOLERANCE	Adenosine triphosphate-sensitive K+ (K-ATP) channels play an essential role in glucose-induced insulin secretion from pancreatic -cells. It was recently reported that the K-ATP channel is also found in the enteroendocrine K-cells and L-cells that secrete glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), respectively. In the present study, we investigated the involvement of the K-ATP channel in fructose-induced GIP, GLP-1 and insulin secretion in mice. Fructose stimulated GIP secretion, but pretreatment with diazoxide, a K-ATP channel activator, did not affect fructose-induced GIP secretion under streptozotocin-induced hyperglycemic conditions. Fructose significantly stimulated insulin secretion in Kir6.2(+/+) mice, but not in mice lacking K-ATP channels (Kir6.2(-/-)), and fructose stimulated GLP-1 secretion in both Kir6.2(+/+) mice and Kir6.2(-/-) mice under the normoglycemic condition. In addition, diazoxide completely blocked fructose-induced insulin secretion in Kir6.2(+/+) mice and in MIN6-K8 -cells. These results show that fructose-induced GIP and GLP-1 secretion is K-ATP channel-independent and that fructose-induced insulin secretion is K-ATP channel-dependent.	[Seino, Yusuke; Hamada, Yoji] Nagoya Univ, Grad Sch Med, Dept Metabol Med, Nagoya, Aichi 4648601, Japan; [Ogata, Hidetada; Maekawa, Ryuya; Izumoto, Takako; Iida, Atsushi; Tsunekawa, Shin; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan; [Harada, Norio; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Miki, Takashi] Chiba Univ, Grad Sch Med, Dept Med Physiol, Chiba, Japan; [Seino, Susumu] Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Kobe, Hyogo 657, Japan	Seino, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Metabol Med, Nagoya, Aichi 4648601, Japan.	yusuke@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sport, Science and Technology, Japan	We thank Michiko Yamada and Mayumi Katagiri (Nagoya University Graduate School of Medicine) for their technical assistance, and Junichi Miyazaki (Osaka University) for providing MIN6-K8 beta-cells. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sport, Science and Technology, Japan.	Sakamoto E, 2012, J DIABETES INVEST, V3, P432, DOI 10.1111/j.2040-1124.2012.00208.x; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Rocca AS, 1999, ENDOCRINOLOGY, V140, P1687, DOI 10.1210/en.140.4.1687; Persson K, 2000, AM J PHYSIOL-ENDOC M, V279, pE956; ROBERGE JN, 1993, ENDOCRINOLOGY, V133, P233, DOI 10.1210/en.133.1.233; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Ferraris RP, 2001, BIOCHEM J, V360, P265, DOI 10.1042/0264-6021:3600265; BRUBAKER PL, 1991, ENDOCRINOLOGY, V128, P3175; FLATT PR, 1989, J NUTR, V119, P1300; Iwasaki M, 2010, J DIABETES INVEST, V1, P137, DOI 10.1111/j.2040-1124.2010.00026.x; Kuhre RE, 2014, AM J PHYSIOL-GASTR L, V306, pG622, DOI 10.1152/ajpgi.00372.2013; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Ogata H, 2014, J ENDOCRINOL, V222, P191, DOI 10.1530/JOE-14-0161; Seino Y, 2013, J ENDOCRINOL, V218, P25, DOI 10.1530/JOE-12-0579	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					522	526		10.1111/jdi.12356		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800006		
J	Sakashita, Y; Nakanishi, S; Yoneda, M; Nakashima, R; Yamane, K; Kohno, N				Sakashita, Yu; Nakanishi, Shuhei; Yoneda, Masayasu; Nakashima, Reiko; Yamane, Kiminori; Kohno, Nobuoki			Regardless of central obesity, metabolic syndrome is a significant predictor of type2 diabetes in Japanese Americans	JOURNAL OF DIABETES INVESTIGATION			English	Article						Central obesity; Metabolic syndrome; Type2 diabetes mellitus	CHOLESTEROL EDUCATION-PROGRAM; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; VISCERAL ADIPOSITY; INSULIN-RESISTANCE; NATIVE JAPANESE; LOS-ANGELES; MELLITUS; RISK; DEFINITIONS	Aims/IntroductionThe impact of metabolic syndrome (MetS) on the development of type2 diabetes has been reported in different ethnic populations. However, whether central obesity is an essential component as a diagnostic criterion for MetS remains a controversial topic. The aim of the present study was to investigate the association between MetS and the incidence of type2 diabetes with or without central obesity in a Japanese American population. Materials and MethodsWe examined whether MetS predicts incident type2 diabetes among 928 Japanese American participants who did not have diabetes enrolled in an ongoing medical survey between 1992 and 2007. MetS was defined on the basis of American Heart Association/National Heart, Lung, and Blood Institute criteria. The average follow-up period was approximately 6.8years. ResultsDuring the follow-up period, 116 new cases of diabetes were diagnosed. Compared to the participants without MetS, the hazard ratio (HR) for incident type2 diabetes was significantly higher in participants with MetS, after adjustment for sex, age and impaired glucose tolerance (HR 1.64, 95% CI 1.11-2.42). The risk of type2 diabetes was found to be significantly higher in participants with MetS but without central obesity (HR 2.07, 95% CI 1.25-3.41), as well as in participants with MetS and with central obesity (HR 2.46, 95% CI 1.51-4.01) than in participants with neither MetS nor central obesity, after adjustment for sex, age and impaired glucose tolerance. ConclusionsThese results show that the presence of MetS, with or without central obesity, could independently predict the development of type2 diabetes in Japanese Americans.	[Sakashita, Yu; Yoneda, Masayasu; Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan; [Nakanishi, Shuhei] Hiroshima Red Cross Hosp, Hiroshima, Japan; [Nakanishi, Shuhei] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Nakashima, Reiko] Senda Med Clin, Hiroshima, Japan; [Yamane, Kiminori] Nippon Telegraph & Tel NTT West Corp Chugoku Hlth, Hiroshima, Japan	Nakanishi, S (reprint author), Hiroshima Red Cross Hosp, Hiroshima, Japan.	n-shuhei@umin.net					Genuth S, 2003, DIABETES CARE, V26, P3160; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484; Cameron AJ, 2008, J INTERN MED, V264, P177, DOI 10.1111/j.1365-2796.2008.01935.x; Zeng P, 2011, DIABETES RES CLIN PR, V94, P299, DOI 10.1016/j.diabres.2011.08.020; [Anonymous], 2005, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.105.169404; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Mukai N, 2009, DIABETES CARE, V32, P2288, DOI 10.2337/dc09-0896; Yoneda M, 2008, DIABETES RES CLIN PR, V79, P518, DOI 10.1016/j.diabres.2007.10.012; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Hayashi T, 2008, DIABETES, V57, P1269, DOI 10.2337/db07-1378; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Committee to Evaluate Diagnostic Standards for Metabolic Syndrome, 2005, NIPPON NAIKA GAKKAI, V94, P794; Egusa Genshi, 2002, J Atheroscler Thromb, V9, P299; Ford ES, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-35; HARA H, 1994, DIABETES RES CLIN PR, V24, pS37, DOI 10.1016/0168-8227(94)90225-9; Ledoux M, 1997, CAN MED ASSOC J, V157, pS46; Ley SH, 2009, CAN MED ASSOC J, V180, P617, DOI 10.1503/cmaj.080972; Mamtani MR, 2005, ARCH MED RES, V36, P581, DOI 10.1016/j.arcmed.2005.03.049; Mannucci E, 2008, DIABETES OBES METAB, V10, P430, DOI 10.1111/j.1463-1326.2007.00724.x; Nakanishi S, 2004, BIOMED PHARMACOTHER, V58, P571, DOI 10.1016/j.biopha.2004.10.001; Nichols GA, 2010, DIABETES RES CLIN PR, V90, P115, DOI 10.1016/j.diabres.2010.06.011; Wang JJ, 2007, ATHEROSCLEROSIS, V192, P161, DOI 10.1016/j.atherosclerosis.2006.04.027	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					527	532		10.1111/jdi.12327		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800007		
J	Charvat, H; Goto, A; Goto, M; Inoue, M; Heianza, Y; Arase, Y; Sone, H; Nakagami, T; Song, X; Qiao, Q; Tuomilehto, J; Tsugane, S; Noda, M; Inoue, M				Charvat, Hadrien; Goto, Atsushi; Goto, Maki; Inoue, Machiko; Heianza, Yoriko; Arase, Yasuji; Sone, Hirohito; Nakagami, Tomoko; Song, Xin; Qiao, Qing; Tuomilehto, Jaakko; Tsugane, Shoichiro; Noda, Mitsuhiko; Inoue, Manami			Impact of population aging on trends in diabetes prevalence: A meta-regression analysis of 160,000 Japanese adults	JOURNAL OF DIABETES INVESTIGATION			English	Article						Diabetes; Population aging; Prevalence	IMPAIRED GLUCOSE-TOLERANCE; FASTING PLASMA-GLUCOSE; LIFE-STYLE; EPIDEMIOLOGIC EVIDENCE; DIAGNOSTIC-CRITERIA; GENERAL-POPULATION; METAANALYSIS; MELLITUS; CANCER; PREVENTION	Aims/IntroductionTo provide age- and sex-specific trends, age-standardized trends, and projections of diabetes prevalence through the year 2030 in the Japanese adult population. Materials and MethodsIn the present meta-regression analysis, we included 161,087 adults from six studies and nine national health surveys carried out between 1988 and 2011 in Japan. We assessed the prevalence of diabetes using a recorded history of diabetes or, for the population of individuals without known diabetes, either a glycated hemoglobin level of 6.5% (48mmol/mol) or the 1999 World Health Organization criteria (i.e., a fasting plasma glucose level of 126mg/dL and/or 2-h glucose level of 200mg/dL in the 75-g oral glucose tolerance test). ResultsFor both sexes, prevalence appeared to remain unchanged over the years in all age categories except for men aged 70years or older, in whom a significant increase in prevalence with time was observed. Age-standardized diabetes prevalence estimates based on the Japanese population of the corresponding year showed marked increasing trends: diabetes prevalence was 6.1% among women (95% confidence interval [CI] 5.5-6.7), 9.9% (95% CI 9.2-10.6) among men, and 7.9% (95% CI 7.5-8.4) among the total population in 2010, and was expected to rise by 2030 to 6.7% (95% CI 5.2-9.2), 13.1% (95% CI 10.9-16.7) and 9.8% (95% CI 8.5-12.0), respectively. In contrast, the age-standardized diabetes prevalence using a fixed population appeared to remain unchanged. ConclusionsThis large-scale meta-regression analysis shows that a substantial increase in diabetes prevalence is expected in Japan during the next few decades, mainly as a result of the aging of the adult population.	[Charvat, Hadrien; Tsugane, Shoichiro] Teikyo Univ, Epidemiol & Prevent Grp, Res Ctr Canc Prevent & Screening, Natl Canc Ctr, Tokyo, Japan; [Goto, Atsushi; Goto, Maki; Noda, Mitsuhiko] Teikyo Univ, Dept Diabet Res, Natl Ctr Global Hlth & Med, Tokyo, Japan; [Inoue, Machiko] Teikyo Univ, Gen Med Educ Ctr, Tokyo, Japan; [Arase, Yasuji] Toranomon Gen Hosp, Hlth Management Ctr, Tokyo, Japan; [Nakagami, Tomoko] Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan; [Heianza, Yoriko; Sone, Hirohito] Niigata Univ, Fac Med, Dept Internal Med, Niigata, Japan; [Song, Xin; Qiao, Qing] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Song, Xin; Qiao, Qing; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Qiao, Qing] R&D AstraZeneca AB, Molndal, Sweden; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Inoue, M (reprint author), Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan.	mnminoue@m.u-tokyo.ac.jp			JSPS [25460742]; Ministry of Health, Labor and Welfare of Japan [H22-019, H25-016]	We thank the following studies for their contribution of data to the collaborative the Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Asia study. The Hisayama study: Yasufumi Doi, Toshiharu Ninomiya and Yutaka Kiyohara, Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University. Funagata Study: Takeo Kato and Makoto Tominaga, Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University School of Medicine, Yamagata, Japan. Makoto Daimon, Department of Endocrinology and Metabolism, Hirosaki University, Hirosaki, Japan. Ojika Study: Masaki Nagai and Satomi Shibazaki, Department of Public Health, Saitama Medical University Faculty of Medicine, Saitama, Japan. This work was supported by JSPS KAKENHI (Grant-in-Aid for Scientific Research) grant number 25460742 and Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H22-019 and H25-016) from the Ministry of Health, Labor and Welfare of Japan.	American Diabetes Association, 2010, DIABETES CARE S1, V33, pS62, DOI DOI 10.2337/DC10-S062; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Inoue M, 2012, ENDOCR-RELAT CANCER, V19, pF1, DOI 10.1530/ERC-12-0142; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0; Kachi Y, 2012, SLEEP MED, V13, P307, DOI 10.1016/j.sleep.2011.04.008; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P176, DOI 10.1016/j.diabres.2013.11.003; Yano Y, 2012, DIABETES CARE, V35, P1310, DOI 10.2337/dc11-2245; Bando Y, 2009, DIABETES RES CLIN PR, V83, P341, DOI 10.1016/j.diabres.2008.11.033; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Tada N, 2011, J ATHEROSCLER THROMB, V18, P723; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Yazaki Y, 2006, NAT MED, V12, P73, DOI 10.1038/nm0106-73; Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275; Noto H, 2012, J DIABETES INVEST, V3, P24, DOI 10.1111/j.2040-1124.2011.00183.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gary TL, 2004, J GEN INTERN MED, V19, P1242, DOI 10.1111/j.1525-1497.2004.41002.x; Goto A, 2013, J EPIDEMIOL, V23, P295, DOI 10.2188/jea.JE20120221; Heianza Y, 2012, DIABETES RES CLIN PR, V95, P283, DOI 10.1016/j.diabres.2011.10.024; IDF Diabetes Atlas Group, 2013, DIABETES RES CLIN PR, V100, P277, DOI 10.1016/j.diabres.2013.02.00523506763; Inoue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040375; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ministry of Health, NAT DIAB SURV 1997; Ministry of Health, 1993, J HLTH WELFARE STAT, V40, P36; Ministry of Health Labour and Welfare, 2008, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2007, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2009, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2006, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2012, 2 HLTH JAP 21 PROJ; Ministry of Health Labour and Welfare, 2011, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2010, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2002, NAT DIAB SURV 2002; Miyashita M, 2008, J HIROSHIMA MED ASS, V61, P375; Nagai M, 1992, JPN J PUBLIC HLTH, V39, P907; Nakano Masahiro, 1998, Japanese Journal of Geriatrics, V35, P839; National Institute of Population and Social Security Research, 2013, PROP POP AG 65 INT C; National Statistics Center, 2013, POP DISTR EST 1990; National Statistics Center, 2013, POP DISTR PROJ 2013; National Statistics Center, 2013, POP DISTR EST 1995 2; Noda M, 2010, ENDOCR J, V57, P629; OHMURA T, 1993, DIABETOLOGIA, V36, P1198, DOI 10.1007/BF00401066; R Development Core Team, 2012, R LANG ENV STAT COMP; Sasazuki S, 2012, PREV MED, V54, P112, DOI 10.1016/j.ypmed.2011.11.003; SEKIKAWA A, 1993, DIABETES CARE, V16, P570, DOI 10.2337/diacare.16.4.570; Sugawara A, 2009, EPIDEMIOLOGY, V20, P464, DOI 10.1097/EDE.0b013e31819ed4ed; Takahashi Y, 2000, DIABETES CARE, V23, P1092, DOI 10.2337/diacare.23.8.1092; Tamakoshi A, 2009, PREV MED, V48, P486, DOI 10.1016/j.ypmed.2009.02.017; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; United Nations, 2012, WORLD POP PROSP 2012; Uthman OA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-226; World Health Organization, 2011, ACC WORK OV GLOB IMP, P1; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					533	542		10.1111/jdi.12333		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800008		
J	Yabe, SG; Iwasaki, N; Yasuda, K; Hamazaki, TS; Konno, M; Fukuda, S; Takeda, F; Kasuga, M; Okochi, H				Yabe, Shigeharu G.; Iwasaki, Naoko; Yasuda, Kazuki; Hamazaki, Tatsuo S.; Konno, Masamitsu; Fukuda, Satsuki; Takeda, Fujie; Kasuga, Masato; Okochi, Hitoshi			Establishment of maturity-onset diabetes of the young-induced pluripotent stem cells from a Japanese patient	JOURNAL OF DIABETES INVESTIGATION			English	Article						Diabetes; Maturity-onset diabetes of the young; Pluripotent stem cells	PREMATURE TERMINATION CODONS; NONSENSE-MEDIATED DECAY; GENE	Maturity-onset diabetes of the young (MODY) is a heterozygous monogenic diabetes; more than 13 disease genes have been identified. However, the pathogenesis of MODY is not fully understood, because the pancreatic -cells of the patients are inaccessable. Therefore, we attempted to establish MODY patient-derived induced pluripotent stem cells (MODY-iPS) cells to investigate the pathogenic mechanism of MODY by inducing pancreatic -cells. We established MODY5-iPS cells from a Japanese patient with MODY5 (R177X), and confirmed that MODY5-iPS cells possessed the characteristics of pluripotent stem cells. In the course of differentiation from MODY5-iPS cells into pancreatic -cells, we examined the disease gene, HNF1B messenger ribonucleic acid. We found that the amount of R177X mutant transcripts was much less than that of wild ones, but they increased after adding cycloheximide to the medium. These results suggest that these R177X mutant messenger ribonucleic acids are disrupted by nonsense-mediated messenger ribonucleic acid decay in MODY-iPS cells during the developmental stages of pancreatic -cells.	[Yabe, Shigeharu G.; Hamazaki, Tatsuo S.; Konno, Masamitsu; Fukuda, Satsuki; Takeda, Fujie; Okochi, Hitoshi] Tokyo Womens Med Univ, Res Inst, Dept Regenerat Med, Tokyo, Japan; [Yasuda, Kazuki] Tokyo Womens Med Univ, Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Metab Disorders, Tokyo, Japan; [Kasuga, Masato] Tokyo Womens Med Univ, Natl Ctr Global Hlth & Med, Tokyo, Japan; [Iwasaki, Naoko] Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan	Yabe, SG (reprint author), Tokyo Womens Med Univ, Res Inst, Dept Regenerat Med, Tokyo, Japan.	syabe@ri.ncgm.go.jp; hokochi@ri.ncgm.go.jp			National Center for Global Health and Medicine [24A115]; JSPS [26860272]; MEXT [22510214]	We thank Wataru Nishimura and Takao Nammo, Diabetes Research Center, National Center for Global Health and Medicine, for fruitful discussions. The authors are grateful to Dr BLS Pierce (University of Maryland University College) for editorial work in the preparation of this article. We also thank Professor Makoto Kawashima in the Department of Dermatology, Tokyo Women's Medical University, for carrying out the skin biopsies. This work was supported by a grant from the National Center for Global Health and Medicine (24A115) to HO, a Grant-in-Aid (26860272) for Young Scientists (B) from the JSPS to SGY, and was partially supported by a Grant-in-Aid (22510214) for Scientific Research from the MEXT to NI.	Hua H, 2013, J CLIN INVEST, V123, P3146, DOI 10.1172/JCI67638; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Teo AKK, 2013, J BIOL CHEM, V288, P5353, DOI 10.1074/jbc.C112.428979; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bonnefond A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037423; Cauvajal-Vergara X, 2010, NATURE, V465, P808; Harries LW, 2004, DIABETES, V53, P500, DOI 10.2337/diabetes.53.2.500; Harries LW, 2005, HUM GENET, V118, P214, DOI 10.1007/s00439-005-0023-y; Iwasaki N, 1998, DIABETES CARE, V21, P2144, DOI 10.2337/diacare.21.12.2144	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					543	547		10.1111/jdi.12334		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800009		
J	Iwahashi, H; Noguchi, M; Okauchi, Y; Morita, S; Imagawa, A; Shimomura, I				Iwahashi, Hiromi; Noguchi, Midori; Okauchi, Yukiyoshi; Morita, Sachiko; Imagawa, Akihisa; Shimomura, Iichiro			Extent of weight reduction necessary for minimization of diabetes risk in Japanese men with visceral fat accumulation and glycated hemoglobin of 5.6-6.4%	JOURNAL OF DIABETES INVESTIGATION			English	Article						Diabetes prevention; Visceral fat accumulation; Weight reduction	LIFE-STYLE INTERVENTION; FOLLOW-UP; PROGRAM; PREVENTION; MELLITUS	Aims/IntroductionWeight reduction improves glycemic control in obese men with glycated hemoglobin (HbA1c) of 5.6-6.4%, suggesting that it can prevent the development of diabetes in these patients. The aim of the present study was to quantify the amount of weight reduction necessary for minimization of diabetes risk in Japanese men with visceral fat accumulation. Materials and MethodsThe study participants were 482 men with an estimated visceral fat area of 100cm(2), HbA1c of 5.6-6.4%, fasting plasma glucose (FPG) of <126mg/dL or casual plasma glucose <200mg/dL. They were divided into two groups based on weight change at the end of the 3-year follow-up period (weight gain and weight loss groups). The weight loss group was classified into quartile subgroups (lowest group, 0 to <1.2%: second lowest group, 1.2 to <2.5%: second highest group, 2.5 to <4.3%: highest group, 4.3% weight loss). The development of diabetes at the end-point represented a rise in HbA1c to 6.5% or FPG 126mg/dL, or casual plasma glucose 200mg/dL. ResultsThe cumulative incidence of diabetes at the end of the 3-year follow-up period was 16.2% in the weight gain group and 10.1% in the weight loss group (P not significant). The incidence of diabetes was significantly lower in the highest weight loss group (3.1%), but not in the second highest, the second lowest and the lowest weight loss groups (9.7, 10.1 and 18.3%), compared with the weight gain group. ConclusionsMinimization of the risk of diabetes in Japanese men with visceral fat accumulation requires a minimum of 4-5% weight loss in those with HbA1c of 5.6-6.4%.	[Iwahashi, Hiromi; Okauchi, Yukiyoshi; Imagawa, Akihisa; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Noguchi, Midori; Morita, Sachiko] Amagasaki City Off, Gen Affairs Bur, Personal Dept, Payroll Sect,Employee Hlth Promot Sect, Amagasaki, Hyogo, Japan	Iwahashi, H (reprint author), Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan.	iwahashi@endmet.med.osaka-u.ac.jp					Okauchi Y, 2007, DIABETES CARE, V30, P2392, DOI 10.2337/dc07-0218; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Ryo M, 2005, DIABETES CARE, V28, P451, DOI 10.2337/diacare.28.2.451; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Muramoto A, 2014, OBES RES CLIN PRACT, V8, pE466, DOI 10.1016/j.orcp.2013.10.003; Okauchi Y, 2010, ATHEROSCLEROSIS, V212, P698, DOI 10.1016/j.atherosclerosis.2010.06.011; Okauchi Y, 2013, J DIABETES INVEST, V4, P454, DOI 10.1111/jdi.12084; Ryo M, 2011, INTERNAL MED, V50, P1643, DOI 10.2169/internalmedicine.50.5039; Matsuzawa Y, 2002, CIRC J, V66, P987	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					553	559		10.1111/jdi.12339		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800011		
J	Tanimoto, M; Kanazawa, A; Hirose, T; Yoshihara, T; Kobayashi-Kimura, S; Nakanishi, R; Tosaka, Y; Sasaki-Omote, R; Kudo-Fujimaki, K; Komiya, K; Ikeda, F; Someya, Y; Mita, T; Fujitani, Y; Watada, H				Tanimoto, Masumi; Kanazawa, Akio; Hirose, Takahisa; Yoshihara, Tomoaki; Kobayashi-Kimura, Saeko; Nakanishi, Risa; Tosaka, Yuka; Sasaki-Omote, Ruri; Kudo-Fujimaki, Kyoko; Komiya, Koji; Ikeda, Fuki; Someya, Yuki; Mita, Tomoya; Fujitani, Yoshio; Watada, Hirotaka			Comparison of sitagliptin with nateglinide on postprandial glucose and related hormones in drug-naive Japanese patients with type2 diabetes mellitus: A pilot study	JOURNAL OF DIABETES INVESTIGATION			English	Article						Dipeptidyl peptidase-4 inhibitor; Glinide; Glucagon	GLUCAGON-LIKE PEPTIDE-1; COMBINATION THERAPY; INSULIN-RESPONSE; IV ACTIVITY; INHIBITOR; CELLS; HYPERGLYCEMIA; EFFICACY; HUMANS; SAFETY	Aims/IntroductionDipeptidyl peptidase-4 inhibitors and glinides are effective in reducing postprandial hyperglycemia. However, little information is available on the comparative effects of the two drugs on the levels of postprandial glucose. The aim of the present study was to compare the effects of sitagliptin and nateglinide on meal tolerance tests in drug-naive patients with type2 diabetes mellitus. Materials and MethodsThe study participants were 19 patients with type2 diabetes mellitus, which was inadequately controlled by diet and exercise. An open-label, prospective, cross-over trial was carried out to compare the effects of single-dose sitagliptin and nateglinide on the postprandial glucose level and its related hormones during meal tests. ResultsThe change in area under the curve (AUC) of glucose from 0 to 180min (AUC(0-180min)) during the meal test by nateglinide was similar to that by sitagliptin. As expected, the change in active glucagon like peptide-1 was significantly higher after a single-dose of sitagliptin than nateglinide. Then, insulin secretion relative to glucose elevation (ISG) (ISG(0-180min): AUC(0-180min) insulin/AUC(0-180min) glucose) was significantly enhanced by nateglinide compared with sitagliptin. Conversely, glucagon level (AUC(0-180min) glucagon) was increased by administration of nateglinide, whereas the glucagon level was reduced by administration of sitagliptin. ConclusionsThe effects of sitagliptin on postprandial glucose levels were similar to those of nateglinide in drug-naive type2 diabetes patients. However, the induced changes in insulin, active glucagon-like peptide-1 and glucagon during meal loading suggest that reduction of postprandial hyperglycemia was achieved by the unique effect of each drug.	[Tanimoto, Masumi; Kanazawa, Akio; Hirose, Takahisa; Yoshihara, Tomoaki; Kobayashi-Kimura, Saeko; Nakanishi, Risa; Tosaka, Yuka; Sasaki-Omote, Ruri; Kudo-Fujimaki, Kyoko; Komiya, Koji; Ikeda, Fuki; Someya, Yuki; Mita, Tomoya; Fujitani, Yoshio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan; [Kanazawa, Akio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Therapeut Innovat Diabet, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Mol Diabetol, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan	Kanazawa, A (reprint author), Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan.	akana@juntendo.ac.jp			Kissei Pharma; Sanofi; Takeda Pharmaceutical Co.; Novartis Pharmaceuticals; Eli Lilly; MSD; Dainippon Sumitomo; Novo Nordisk Pharma; Sanofi-Aventis; Daiichi Sankyo; Kowa; Mochida; Sanwakagaku; Novartis; Boehringer Ingelheim; Tanabe Mitsubishi; Telmo; Sanofi Aventis; Roche; Ono; Asteras; Astrazeneca; Daiichi Sankyo Inc.; Eli Lilly and Company; Kissei Pharmaceutical Co.; Kowa Pharmaceutical CO.; Kyowa Hakko Kirin Co.; Ono Pharmaceutical Co.; Mitsubishi Tanabe Pharma; Sanwakagaku Kenkyusho; Bristol-Myers Squibb; Dainippon Sumitomo Pharma; Johnson and Johnson; Mochida Pharmaceutical Co.; Pfizer	AK has received lecture fees from Kissei Pharma, Sanofi and Takeda Pharmaceutical Co. YF has received lecture fees from Novartis Pharmaceuticals and Eli Lilly, and research funds from Novartis Pharmaceuticals, MSD and Takeda Pharmaceutical Co. TH has received lecture fees from MSD, Eli Lilly, Takeda Pharmaceutical Co., Novartis Pharmaceuticals, Dainippon Sumitomo, Novo Nordisk Pharma, Sanofi-Aventis and Daiichi Sankyo, and also research funds from MSD, Eli Lilly, Takeda Pharmaceutical Co., Kowa, Mochida, Sanwakagaku, Novo Nordisk Pharma, Kissei Pharma, Novartis, Boehringer Ingelheim, Tanabe Mitsubishi, Dainippon Sumitomo, Telmo, Sanofi Aventis, Roche, Ono and Daiichi Sankyo. TM has received lecture fees from MSD, Takeda Pharmaceutical Co., and Eli Lilly. HW has received lecture fees from Asteras, Astrazeneca, Boehringer Ingelheim, Daiichi Sankyo Inc., Eli Lilly and Company, Kissei Pharmaceutical Co., Kowa Pharmaceutical CO., Kyowa Hakko Kirin Co., MSD, Novartis Pharmaceuticals, Novo Nordisk Pharma, Ono Pharmaceutical Co., Mitsubishi Tanabe Pharma, Sanofi-Aventis, Sanwakagaku Kenkyusho, and Takeda Pharmaceutical Co., and research funds from Asteras, Astrazeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo Inc., Dainippon Sumitomo Pharma, Eli Lilly, Johnson and Johnson, Kissei Pharmaceutical Co., Kowa Pharmaceutical CO., Kyowa Hakko Kirin Co. MSD, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co., Novartis Pharmaceuticals, Novo Nordisk Pharma, Pfizer, Sanwakagaku Kenkyusho, Sanofi, and Takeda Pharmaceutical Co. All the other authors declare no conflict of interest.	Hare KJ, 2010, DIABETES, V59, P1765, DOI 10.2337/db09-1414; Fadini GP, 2013, ATHEROSCLEROSIS, V229, P23, DOI 10.1016/j.atherosclerosis.2013.04.007; Hsieh J, 2010, DIABETOLOGIA, V53, P552, DOI 10.1007/s00125-009-1611-5; Vincent SH, 2007, DRUG METAB DISPOS, V35, P533, DOI 10.1124/dmd.106.013136; ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; Ervinna N, 2013, ENDOCRINOLOGY, V154, P1260, DOI 10.1210/en.2012-1855; Choudhury S, 2000, J CLIN PHARMACOL, V40, P634; Bak MJ, 2014, EUR J ENDOCRINOL, V170, P529, DOI 10.1530/EJE-13-0941; Arnolds S, 2010, DIABETES CARE, V33, P1509, DOI 10.2337/dc09-2191; Tanaka Y, 1998, DIABETES CARE, V21, P1133, DOI 10.2337/diacare.21.7.1133; Bell PM, 2011, DIABETES RES CLIN PR, V91, pE68, DOI 10.1016/j.diabres.2010.11.033; Bokvist K, 1999, EUR J PHARMACOL, V386, P105, DOI 10.1016/S0014-2999(99)00754-2; Cheng-Xue Rui, 2013, Diabetes, V62, P1612, DOI 10.2337/db12-0347; Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society, 2012, DIABETOL INT, V3, P8; DelsPrato S, 2003, DIABETOLOGIA S1, V46, pM2; Duffy NA, 2007, EUR J PHARMACOL, V568, P278, DOI 10.1016/j.ejphar.2007.05.010; Fonseca VA, 2004, METABOLISM, V53, P1331, DOI 10.1016/j.metabol.2004.05.009; Kitahara Y, 2011, BIOL PHARM BULL, V34, P671; Kudo-Fujimaki K, 2014, J DIABETES INVEST, V5, P400, DOI 10.1111/jdi.12160; McKillop AM, 2009, EUR J ENDOCRINOL, V161, P877, DOI 10.1530/EJE-09-0547; Ohta A, 2013, EXPERT OPIN PHARMACO, V14, P2315, DOI 10.1517/14656566.2013.842554; Tanaka T, 2014, J DIABETES INVEST, V5, P199, DOI 10.1111/jdi.12140; Terasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070933; Uchino H, 2000, ENDOCR J, V47, P639, DOI 10.1507/endocrj.47.639; Yoshino Gen, 2006, Journal of the Japan Diabetes Society, V49, P361	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					560	566		10.1111/jdi.12338		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800012		
J	Sakane, N; Kotani, K; Tsuzaki, K; Nishi, M; Takahashi, K; Murata, T; Yamada, K; Okazaki, K; Yanagisawa, K; Yamada, K; Kuribayashi, N; Totsuka, Y; Hiyoshi, T; Naka, M; Sugimoto, M; Aoki, Y; Waki, M; Furuya, M; Kitaoka, H; Oishi, M; Shimizu, I; Miyaoka, H; Okada, A; Yamamoto, T				Sakane, Naoki; Kotani, Kazuhiko; Tsuzaki, Kokoro; Nishi, Masami; Takahashi, Kaoru; Murata, Takashi; Yamada, Kazunori; Okazaki, Kentaro; Yanagisawa, Katsuyuki; Yamada, Kenichi; Kuribayashi, Nobuichi; Totsuka, Yasuo; Hiyoshi, Toru; Naka, Motoji; Sugimoto, Masatake; Aoki, Yuji; Waki, Masako; Furuya, Miyuki; Kitaoka, Haruko; Oishi, Mariko; Shimizu, Ikki; Miyaoka, Hiroaki; Okada, Akira; Yamamoto, Toshikazu			Fear of hypoglycemia and its determinants in insulin-treated patients with type2 diabetes mellitus	JOURNAL OF DIABETES INVESTIGATION			English	Article						Fear; Hypoglycemia; Insulin; Type2 diabetes	QUALITY-OF-LIFE; MARITAL-STATUS; BASE-LINE; RISK; MORTALITY; CHILDREN; BURDEN; COSTS	The aim of the present study was to investigate the prevalence of fear of hypoglycemia, in association with severe hypoglycemia and social factors, in insulin-treated patients with type2 diabetes mellitus. A questionnaire survey on hypoglycemia and patient-physician communication was carried out in 355 patients with insulin-treated type2 diabetes mellitus patients at 16 hospitals and clinics. A fear of hypoglycemia was reported by 27.7% of patients. A stepwise logistic regression analysis found that severe hypoglycemia during the past 1year was a significant determinant of fear of hypoglycemia (odds ratio 2.16, 95% confidence interval 1.06-4.41; P=0.034), and age (odds ratio 1.02, 95% confidence interval 1.00-1.05, P=0.038) and living alone (odds ratio 1.93, 95% confidence interval 1.00-3.73, P<0.05) were significantly higher in patients with fear of hypoglycemia than in those without it.	[Sakane, Naoki; Kotani, Kazuhiko; Tsuzaki, Kokoro; Nishi, Masami; Takahashi, Kaoru] Natl Hosp, Org Kyoto Med Ctr, Div Prevent Med, Clin Res Inst, Kyoto, Japan; [Murata, Takashi; Yamada, Kazunori] Natl Hosp, Org Kyoto Med Ctr, Ctr Diabet, Kyoto, Japan; [Oishi, Mariko] Oishi Clin, Kyoto, Japan; [Kotani, Kazuhiko] Juichi Med Univ, Dept Clin Lab Med, Shimotsuke, Tochigi, Japan; [Nishi, Masami; Okada, Akira] Okada Clin, Fukuoka, Japan; [Takahashi, Kaoru] Hyogo Hlth Serv Assoc, Kobe, Hyogo, Japan; [Okazaki, Kentaro] Nagoya Univ, Grad Sch Med, Dept Dev Community Oriented Healthcare Syst, Nagoya, Aichi 4648601, Japan; [Yanagisawa, Katsuyuki] Souen Diabet Clin, Sapporo, Hokkaido, Japan; [Yamada, Kenichi] Kenichi Yamada Internal Med Clin, Okinawa, Miyagi, Japan; [Kuribayashi, Nobuichi] Misakinaika Clin, Chiba, Japan; [Totsuka, Yasuo] Chofu Tozan Hosp, Chofu, Tokyo, Japan; [Sugimoto, Masatake] Tokyo Adventist Hosp, Tokyo, Japan; [Hiyoshi, Toru] Japanese Red Cross Med Ctr, Tokyo, Japan; [Naka, Motoji] Asama Gen Hosp, Dept Internal Med, Saku, Nagano, Japan; [Aoki, Yuji] Natl Hosp, Org Matsumoto Med Ctr, Dept Internal Med, Nagano, Japan; [Waki, Masako] Shizuoka City Shizuoka Hosp, Shizuoka, Japan; [Furuya, Miyuki] Tenri Hosp, Dept Endocrinol, Nara, Japan; [Kitaoka, Haruko] Seikeikai Hosp, Dept Internal Med, Osaka, Japan; [Shimizu, Ikki] Sakakibara Heart Inst Okayama, Dept Diabet, Okayama, Japan; [Miyaoka, Hiroaki] Saiseikai Matsuyama Hosp, Matsuyama, Ehime, Japan; [Yamamoto, Toshikazu] Kariyushikai Heartlife Hosp, Okinawa, Japan	Sakane, N (reprint author), Natl Hosp, Org Kyoto Med Ctr, Div Prevent Med, Clin Res Inst, Kyoto, Japan.	nsakane@kyotolan.hosp.go.jp			National Hospital Organization; Ministry of Health, Welfare and Labor of Japan	The study was supported by a grant from the National Hospital Organization (multicenter clinical studies) and the Ministry of Health, Welfare and Labor of Japan.	Eaker ED, 2007, PSYCHOSOM MED, V69, P509, DOI 10.1097/PSY.0b013e3180f62357; Johnson SR, 2013, DIABETIC MED, V30, P1126, DOI 10.1111/dme.12247; Anderbro T, 2010, DIABETIC MED, V27, P1151, DOI 10.1111/j.1464-5491.2010.03078.x; Turchin A, 2009, DIABETES CARE, V32, P1153, DOI 10.2337/dc08-2127; Willis WD, 2013, EXPERT REV PHARM OUT, V13, P123, DOI [10.1586/erp.12.80, 10.1586/ERP.12.80]; Molloy GJ, 2009, SOC SCI MED, V69, P223, DOI 10.1016/j.socscimed.2009.05.010; Fidler Carrie, 2011, J Med Econ, V14, P646, DOI 10.3111/13696998.2011.610852; Schopman JE, 2010, DIABETES RES CLIN PR, V87, P64, DOI 10.1016/j.diabres.2009.10.013; Hajos TRS, 2014, DIABETES CARE, V37, P102, DOI 10.2337/dc13-0971; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074699; Ikeda A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-73; Ishii H., 2005, Journal of the Japan Diabetes Society, V48, P19; Kawamori R, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-131; Miller ME, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5444; Moghissi Etie, 2013, Diabetes Ther, V4, P239, DOI 10.1007/s13300-013-0039-6; Nakayama K, 1997, Environ Health Prev Med, V2, P11, DOI 10.1007/BF02931223; Nordfeldt S, 2005, J PEDIATR ENDOCR MET, V18, P83; Oyer David S, 2013, Curr Diabetes Rev, V9, P195; Uemura K, 2012, GERONTOLOGY, V58, P413, DOI 10.1159/000336988; Williams SA, 2012, J DIABETES COMPLICAT, V26, P399, DOI 10.1016/j.jdiacomp.2012.05.002	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					567	570		10.1111/jdi.12340		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800013		
J	Tanaka, M; Imai, J; Satoh, M; Hashimoto, T; Izumi, T; Sawada, S; Uno, K; Hasegawa, Y; Kaneko, K; Yamada, T; Ishigaki, Y; Imai, Y; Katagiri, H				Tanaka, Mamiko; Imai, Junta; Satoh, Michihiro; Hashimoto, Takanao; Izumi, Tomohito; Sawada, Shojiro; Uno, Kenji; Hasegawa, Yutaka; Kaneko, Keizo; Yamada, Tetsuya; Ishigaki, Yasushi; Imai, Yutaka; Katagiri, Hideki			Impacts of the Great East Japan Earthquake on diabetic patients	JOURNAL OF DIABETES INVESTIGATION			English	Article						Glycemic control; Natural disaster; Sympathetic activation	QUALITY-OF-LIFE; GLYCEMIC CONTROL; WEIGHT-LOSS; INSULIN SENSITIVITY; NEURONAL SIGNALS; GLUCOSE; MELLITUS; STRESS; HYPERTENSION; RESTRICTION	Aims/IntroductionWe investigated impacts of the Great East Japan Earthquake on diabetic patients and characterized those with disaster-susceptible diabetes. Materials and MethodsWe enrolled 497 diabetic patients who had been followed at hospitals in devastated areas. We collected metabolic parameters prospectively, 1 and 3months after the earthquake, and retrospectively for pre-earthquake time-points. Questionnaire surveys were carried out regarding earthquake-related damage and post-earthquake lifestyle alterations. Available data were analyzed to examine associations with post-earthquake glycosylated hemoglobin alterations. ResultsThe mean glycosylated hemoglobin level of the participants was not elevated at 1month, and was significantly decreased at 3months as compared with the pre-earthquake glycosylated hemoglobin. There were no significant differences in earthquake-related damage or lifestyle alterations between the improved and worsened glycemic control groups according to the data obtained from the questionnaire survey. As reported, fasting serum C-peptide levels were significantly lower in the worsened glycemic control group (P<0.05). Notably, plasma noradrenaline levels were significantly higher in the worsened glycemic control group (P<0.05). Furthermore, at 1month after the earthquake, the plasma noradrenaline level was significantly higher in the low C-peptide group (fasting serum C-peptide <1.0ng/mL) than in the high C-peptide group (fasting serum C-peptide 1.0ng/mL), but this difference had disappeared by 3months after the earthquake. These findings show that post-earthquake plasma noradrenaline levels were temporarily increased in the low C-peptide group. ConclusionsSympathetic nerve activation might be elicited more easily in subjects with lower endogenous insulin secretory capacity, and could be involved in the mechanism underlying post-earthquake worsening of glycemic control.	[Tanaka, Mamiko; Imai, Junta; Izumi, Tomohito; Sawada, Shojiro; Uno, Kenji; Hasegawa, Yutaka; Kaneko, Keizo; Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ Hosp, Dept Diabet & Metab, Tokyo, Japan; [Satoh, Michihiro] Tohoku Univ Hosp, Dept Pharm, Tokyo, Japan; [Hashimoto, Takanao; Imai, Yutaka] Tohoku Univ, Grad Sch Med & Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Ishigaki, Yasushi] Iwate Med Univ Hosp, Dept Diabet & Metab, Morioka, Iwate, Japan	Imai, J (reprint author), Tohoku Univ Hosp, Dept Diabet & Metab, Tokyo, Japan.	imai@med.tohoku.ac.jp			Global-COE Programs for 'Network Medicine'; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a grant from the Global-COE Programs for 'Network Medicine' to M Tanaka, J Imai, and H Katagiri from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank the doctors of Tohoku Pharmaceutical University Hospital, Osaki Citizen Hospital, Minami Tohoku Hospital, South Miyagi Medical Center, Sendai Teisin Hospital, JR Sendai Hospital, Kurihara Central Hospital, Izumi Hospital, Shiogama City Hospital, Saka General Hospital, Kanagami Hospital, Marumori Hospital, Ayashi Heart Clinic, Sendai Red Cross Hospital, Iwate Prefectural Iwai Hospital, Soma Central Hospital and Ohta General Hospital for providing the data from medical records maintained at their institutions.	Jones AG, 2013, DIABETIC MED, V30, P803, DOI 10.1111/dme.12159; Heilbronn LK, 1999, DIABETES CARE, V22, P889, DOI 10.2337/diacare.22.6.889; Mancia G, 2007, J HYPERTENS, V25, P909, DOI 10.1097/HJH.0b013e328048d004; Satoh M, 2011, HYPERTENSION, V58, pE193, DOI 10.1161/HYPERTENSIONAHA.111.184077; HUGHES TA, 1984, AM J MED, V77, P7, DOI 10.1016/0002-9343(84)90429-7; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006; Fujihara K, 2012, EXP CLIN ENDOCR DIAB, V120, P560, DOI 10.1055/s-0032-1314873; Thorens B, 2011, DIABETES OBES METAB, V13, P82, DOI 10.1111/j.1463-1326.2011.01453.x; Festa A, 2000, DIABETES CARE, V23, P624, DOI 10.2337/diacare.23.5.624; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.106.151621; BIRGERSTAM G, 1985, SCAND J CLIN LAB INV, V45, P707, DOI 10.3109/00365518509155284; DEVRIES A, 1949, AM J MED, V6, P51, DOI 10.1016/0002-9343(49)90006-6; HENRY RR, 1986, DIABETES, V35, P990, DOI 10.2337/diabetes.35.9.990; Inui A, 1998, ARCH INTERN MED, V158, P274, DOI 10.1001/archinte.158.3.274; Ishii C, 2001, DIABETES RES CLIN PR, V54, P137, DOI 10.1016/S0168-8227(01)00261-3; Kamoi K, 2006, DIABETES RES CLIN PR, V74, P141, DOI 10.1016/j.diabres.2006.03.028; Kannan A, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0447-7; Kirizuka K, 1997, DIABETES RES CLIN PR, V36, P193, DOI 10.1016/S0168-8227(97)00030-2; Masuo Kazuko, 2010, Curr Diabetes Rev, V6, P58; Ng J, 2011, DIABETIC MED, V28, P519, DOI 10.1111/j.1464-5491.2011.03228.x; Ogawa S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000830; Salman S, 2001, PSYCHIAT CLIN NEUROS, V55, P165, DOI 10.1046/j.1440-1819.2001.00807.x; Sengul A, 2004, ENDOCR J, V51, P407, DOI 10.1507/endocrj.51.407; SULLIVAN P, 1981, HYPERTENSION, V3, P119; Tanaka M, 2014, DIABETES CARE, V37, pE212, DOI 10.2337/dc14-1479; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					577	586		10.1111/jdi.12336		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800015		
J	Hayami, T; Kato, Y; Kamiya, H; Kondo, M; Naito, E; Sugiura, Y; Kojima, C; Sato, S; Yamada, Y; Kasagi, R; Ando, T; Noda, S; Nakai, H; Takada, E; Asano, E; Motegi, M; Watarai, A; Kato, K; Nakamura, J				Hayami, Tomohide; Kato, Yoshiro; Kamiya, Hideki; Kondo, Masaki; Naito, Ena; Sugiura, Yukako; Kojima, Chika; Sato, Sami; Yamada, Yuichiro; Kasagi, Rina; Ando, Toshihito; Noda, Saeko; Nakai, Hiromi; Takada, Eriko; Asano, Emi; Motegi, Mikio; Watarai, Atsuko; Kato, Koichi; Nakamura, Jiro			Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet	JOURNAL OF DIABETES INVESTIGATION			English	Article						Ketoacidosis; Low-carbohydrate diet; Sodium-glucose cotransporter2 inhibitor	INSULIN SENSITIVITY; DAPAGLIFLOZIN	We present a case of a 32-year-old diabetic woman with Prader-Willi syndrome who developed severe ketoacidosis caused by a sodium-glucose cotransporter2 (SGLT2) inhibitor, a novel class of antihyperglycemic agents, during a strict low-carbohydrate diet. At admission, a serum glucose level of 191mg/dL was relatively low, though laboratory evaluations showed severe ketoacidosis. This is the first report of ketoacidosis caused by a SGLT2 inhibitor. It is necessary to not only pay attention when using a SGLT2 inhibitor in patients following a low-carbohydrate diet, but also to start a low-carbohydrate diet in patients treated with a SGLT2 inhibitor because of a high risk for developing ketoacidosis.	[Hayami, Tomohide; Kato, Yoshiro; Kamiya, Hideki; Kondo, Masaki; Naito, Ena; Sugiura, Yukako; Kojima, Chika; Sato, Sami; Yamada, Yuichiro; Kasagi, Rina; Ando, Toshihito; Noda, Saeko; Nakai, Hiromi; Takada, Eriko; Asano, Emi; Motegi, Mikio; Nakamura, Jiro] Aichi Med Univ, Sch Med, Dept Internal Med, Div Diabet, Nagakute, Aichi 48011, Japan; [Watarai, Atsuko] Chubu Rosai Hosp, Ctr Prevent Med, Nagoya, Aichi, Japan; [Kato, Koichi] Aichi Gakuin Univ, Sch Pharm, Lab Med, Nagoya, Aichi 464, Japan	Kato, Y (reprint author), Aichi Med Univ, Sch Med, Dept Internal Med, Div Diabet, Nagakute, Aichi 48011, Japan.	ykato4@aichi-med-u.ac.jp					Bravata DM, 2003, JAMA-J AM MED ASSOC, V289, P1837, DOI 10.1001/jama.289.14.1837; Seino Y, 2014, EXPERT OPIN PHARMACO, V15, P2741, DOI 10.1517/14656566.2014.978290; Mudaliar S, 2014, DIABETES TECHNOL THE, V16, P137, DOI 10.1089/dia.2013.0167; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Kitabchi AE, 2001, DIABETES CARE, V24, P131, DOI 10.2337/diacare.24.1.131; Fujita Y, 2014, J DIABETES INVEST, V5, P265, DOI 10.1111/jdi.12214; Chen TY, 2006, LANCET, V367, P958, DOI 10.1016/S0140-6736(06)68394-3; Shah P, 2006, NEW ENGL J MED, V354, P97, DOI 10.1056/NEJMc052709; Tanaka K, 1999, DIABETES RES CLIN PR, V44, P137, DOI 10.1016/S0168-8227(99)00023-6	9	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	SEP	2015	6	5					587	590		10.1111/jdi.12330		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ7UQ	WOS:000360810800016		
J	Suzuki, Y; Miyajima, M; Ohta, K; Yoshida, N; Okumura, M; Nakamura, M; Sasano, T; Kawara, T; Matsuura, M; Matsushima, E				Suzuki, Yoko; Miyajima, Miho; Ohta, Katsuya; Yoshida, Noriko; Okumura, Masaki; Nakamura, Mitsuru; Sasano, Tetsuo; Kawara, Tokuhiro; Matsuura, Masato; Matsushima, Eisuke			A Triphasic Change of Cardiac Autonomic Nervous System During Electroconvulsive Therapy	JOURNAL OF ECT			English	Article						heart rate variability; sympathetic nervous system; parasympathetic nervous system; depression; electroconvulsive therapy	HEART-RATE-VARIABILITY; MAJOR DEPRESSIVE DISORDER; QT INTERVAL; ECT STIMULUS; STIMULATION; PROPOFOL	Objectives Dynamic autonomic activity changes have been repeatedly reported during electroconvulsive therapy (ECT). However, the specific timing of these changes remains unclear. To clarify whether sympathetic or parasympathetic nervous activity contributes separately to the second stage and the third stage during and after induced seizures by ECT, we examined heart rate (HR) and spectral analysis of variability (HRV) during ECT. Methods Seventeen patients with depression participated in the study and underwent ECT. The R-R intervals (RRI) were recorded and analyzed sequentially for the HRV indices high-frequency (HF) (an index of parasympathetic activity) and low-frequency (LF)/high-frequency (an index of sympathetic activity) for 4 minutes before and after stimulus onset by the maximum entropy method. Averaged HRs were compared between 3 heart beats prestimulus and poststimulus onset. The HRV power in the range of 30 to 80 and 80 to 130 seconds after a seizure was compared between the HF and LF/HF components. Results There was a significant reduction of the averaged HR over 3 HRs just after stimulus onset, suggesting parasympathetic dominance in the first phase. The LF/HF power significantly increased in the 30 to 80 s range after stimulus onset, whereas the HF power significantly increased in the 80 to 130 s range after stimulus onset, reflecting sympathetic activation in the second phase and parasympathetic activation in the third phase, respectively. Conclusions The evaluation of HR and HRV revealed a triphasic change from parasympathetic to sympathetic to parasympathetic cardiac autonomic activity after ECT stimulus onset in depression patients.	[Suzuki, Yoko; Miyajima, Miho; Ohta, Katsuya; Yoshida, Noriko; Matsushima, Eisuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Liaison Psychiat & Palliat Med, Tokyo 1138519, Japan; [Ohta, Katsuya; Sasano, Tetsuo; Matsuura, Masato] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Sect Life Sci & Biofunct Informat, Tokyo 1138519, Japan; [Ohta, Katsuya] Onda Daini Hosp, Chiba, Japan; [Yoshida, Noriko; Okumura, Masaki; Nakamura, Mitsuru] Tokyo Metropolitan Hlth & Med Corp, Toshima Hosp, Tokyo, Japan; [Kawara, Tokuhiro] Bunkyo Gakuin Univ, Grad Sch Hlth Care Sci, Tokyo, Japan	Suzuki, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Liaison Psychiat & Palliat Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	snchld.lppm@tmd.ac.jp					Abrams R., 2002, ELECTROCONVULSIVE TH; Agelink WM, 2001, J AFFECT DISORDERS, V62, P187; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Nahshoni E, 2004, J PSYCHOSOM RES, V56, P89, DOI 10.1016/S0022-3999(03)00037-0; Rasmussen KG, 2006, J ECT, V22, P116, DOI 10.1097/00124509-200606000-00008; Ebert A, 2010, PROG NEURO-PSYCHOPH, V34, P1174, DOI 10.1016/j.pnpbp.2010.06.012; Bar KJ, 2010, J AFFECT DISORDERS, V125, P323, DOI 10.1016/j.jad.2010.02.110; Folkerts HW, 1997, ACTA PSYCHIAT SCAND, V96, P334, DOI 10.1111/j.1600-0447.1997.tb09926.x; Schultz SK, 1997, J AFFECT DISORDERS, V44, P13, DOI 10.1016/S0165-0327(97)01443-2; Riznyk L, 2005, PHARMACOL REP, V57, P128; Yuuki N, 2005, ACTA PSYCHIAT SCAND, V112, P257, DOI 10.1111/j.1600-0447.2005.00625.x; Erdil F, 2009, J ECT, V25, P174, DOI 10.1097/YCT.0b013e3181903fa5; Boettger S, 2008, BIPOLAR DISORD, V10, P276, DOI 10.1111/j.1399-5618.2007.00503.x; McCall WV, 1996, J CLIN PSYCHIAT, V57, P199; Bar KJ, 2004, J AFFECT DISORDERS, V82, P245, DOI 10.1016/j.jad.2003.12.016; Sackeim HA, 1999, J ECT, V15, P5; Karpyak VM, 2004, J ECT, V20, P81, DOI 10.1097/00124509-200406000-00002; Bozkurt A, 2013, ISR J PSYCHIATR REL, V50, P40; Takano H, 2011, EPILEPSY RES, V97, P225, DOI 10.1016/j.eplepsyres.2011.08.007; Venables P H, 1991, Ann N Y Acad Sci, V620, P191, DOI 10.1111/j.1749-6632.1991.tb51584.x; TROUP PJ, 1978, PACE, V1, P172, DOI 10.1111/j.1540-8159.1978.tb03461.x; Azuma H, 2007, PSYCHIAT CLIN NEUROS, V61, P290, DOI 10.1111/j.1440-1819.2007.01665.x; Tezuka N, 2010, J ECT, V26, P41, DOI 10.1097/YCT.0b013e3181a95dbe; Zarate CA, 2001, ARCH GEN PSYCHIAT, V58, P1168, DOI 10.1001/archpsyc.58.12.1168; Koschke M, 2009, PSYCHOSOM MED, V71, P852, DOI 10.1097/PSY.0b013e3181b8bb7a; WELCH CA, 1989, CONVULSIVE THER, V5, P35; Swartz CM, 2000, PSYCHIAT RES, V97, P229, DOI 10.1016/S0165-1781(00)00234-1; ABRAMS R, 1976, BRIT J PSYCHIAT, V129, P482, DOI 10.1192/bjp.129.5.482; Schulz S, 2010, PHYSIOL MEAS, V31, P303, DOI 10.1088/0967-3334/31/3/003; Delamont RS, 2011, EPILEPSY RES, V97, P267, DOI 10.1016/j.eplepsyres.2011.10.016; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Udupa K, 2007, J AFFECT DISORDERS, V100, P137, DOI 10.1016/j.jad.2006.10.007; Beyer JL, 1998, ELECTROCONVULSIVE TH, P111; Castro VM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f288; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kogut Christopher, 2013, Ther Adv Drug Saf, V4, P189, DOI 10.1177/2042098613492366; Mankad MV, 2010, CLIN MANUAL ELECTROC; Rottenberg J, 2007, PSYCHOPHYSIOLOGY, V44, P450, DOI 10.1111/j.1469-8986.2007.00509.x; SACKEIM HA, 1994, CONVULSIVE THER, V10, P140; Stahl SM, 2008, NEUROSCIENTIFIC BASI, P185; Camm AJ, 1996, CIRCULATION, V93, P1043; Zyl LT, 2008, BIOPSYCHOSOC MED, V2, P12	43	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1095-0680	1533-4112		J ECT	J. ECT	SEP	2015	31	3					186	191		10.1097/YCT.0000000000000227		6	Behavioral Sciences; Psychiatry	Behavioral Sciences; Psychiatry	CQ5MO	WOS:000360648900013		
J	Inoue, T; Murota, T; Okada, S; Hamamoto, S; Muguruma, K; Kinoshita, H; Matsuda, T				Inoue, Takaaki; Murota, Takashi; Okada, Shinsuke; Hamamoto, Shuzo; Muguruma, Kouei; Kinoshita, Hidefumi; Matsuda, Tadashi		SMART Study Grp	Influence of Pelvicaliceal Anatomy on Stone Clearance After Flexible Ureteroscopy and Holmium Laser Lithotripsy for Large Renal Stones	JOURNAL OF ENDOUROLOGY			English	Article							SHOCK-WAVE LITHOTRIPSY; NONCONTRAST COMPUTED-TOMOGRAPHY; RETROGRADE INTRARENAL SURGERY; SINGLE-CENTER EXPERIENCE; LOWER POLE STONES; 2 CM; INFUNDIBULOPELVIC ANATOMY; FOLLOW-UP; SUCCESS; CALCULI	Purpose: This study was performed to evaluate the impact of pelvicaliceal anatomy on stone clearance in patients with remnant fragments in the lower pole after flexible ureteroscopy and holmium laser lithotripsy (fURSL) for renal stones >15mm. Patients and Methods: This retrospective study included 67 patients with radiopaque residual fragments (>2mm) in the lower pole after fURSL for large renal stones (>15mm). The preoperative infundibular length (IL), infundibular width (IW), infundibulopelvic angle (IPA), and caliceal pelvic height (CPH) were measured using intravenous urography. Multivariate analysis was performed to determine whether any of these measurements affected stone clearance. Results: Of the 67 patients, 55 (82.1%) were stone free (SF) 3 months after fURSL. The anatomic factors significantly favorable for an SF status were a short IL, broad IW, wide IPA, and low CPH. On multivariate analysis, the IPA had a significant influence on an SF status after fURSL (p=0.010). An IPA <30 degrees was a negative risk factor (p=0.019). Postoperative complications occurred in nine patients (13.4%), including Clavien grade I complications in two patients (2.9%), grade II in six patients (8.9%), and grade IIIa in one patient (1.8%). Almost all complications were minor. Conclusions: An IPA <30 degrees is the only negative risk factor for stone clearance after fURSL for large renal stones according to our multivariate analysis. Additional studies are required to further evaluate the characteristics of the pelvicaliceal anatomy influencing stone clearance.	[Inoue, Takaaki; Murota, Takashi; Muguruma, Kouei] Kansai Med Univ, Takii Hosp, Dept Urol, Moriguchi, Osaka 570, Japan; [Inoue, Takaaki; Murota, Takashi; Muguruma, Kouei] Kansai Med Univ, Takii Hosp, Stone Ctr, Moriguchi, Osaka 570, Japan; [Okada, Shinsuke] Gyotoku Gen Hosp, Dept Urol, Ichikawa, Japan; [Hamamoto, Shuzo] Toyota Kousei Hosp, Dept Urol, Toyota, Japan; [Kinoshita, Hidefumi; Matsuda, Tadashi] Kansai Med Univ, Hirakata Hosp, Dept Urol, Hirakata, Osaka 5731191, Japan	Matsuda, T (reprint author), Kansai Med Univ, Hirakata Hosp, Dept Urol, Hirakata Shinmachi 2,Chome 3-1, Hirakata, Osaka 5731191, Japan.	matsudat@hirakata.kmu.ac.jp					Resorlu B, 2012, UROLOGY, V79, P61, DOI 10.1016/j.urology.2011.06.031; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Aboumarzouk OM, 2012, J ENDOUROL, V26, P1257, DOI 10.1089/end.2012.0217; Perks AE, 2008, UROLOGY, V72, P765, DOI 10.1016/j.urology.2008.05.046; Sahinkanat T, 2008, UROLOGY, V71, P801, DOI 10.1016/j.urology.2007.11.052; Breda A, 2009, EUR UROL, V55, P1190, DOI 10.1016/j.eururo.2008.06.019; SAMPAIO FJB, 1992, J UROLOGY, V147, P322; Perlmutter AE, 2008, UROLOGY, V71, P214, DOI 10.1016/j.urology.2007.09.023; Sampaio FJB, 1997, J ENDOUROL, V11, P157, DOI 10.1089/end.1997.11.157; Breda A, 2008, J UROLOGY, V179, P981, DOI 10.1016/j.juro.2007.10.083; Streem SB, 1996, J UROLOGY, V155, P1186, DOI 10.1016/S0022-5347(01)66208-6; Schoenthaler M, 2012, J ENDOUROL, V26, P1425, DOI 10.1089/end.2012.0227; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; Auge BK, 2001, J ENDOUROL, V15, P835, DOI 10.1089/089277901753205852; GRAFF J, 1988, J UROLOGY, V140, P479; Huang ZC, 2012, UROLOGY, V80, P800, DOI 10.1016/j.urology.2012.05.013; Gupta NP, 2000, J UROLOGY, V163, P24, DOI 10.1016/S0022-5347(05)67964-5; Assmy EI- A, 2008, J ENDOUROL, V9, P2175; Cracco CM, 2011, CURR OPIN UROL, V21, P154, DOI 10.1097/MOU.0b013e3283436d32; Elbahnasy AM, 1998, J ENDOUROL, V12, P113, DOI 10.1089/end.1998.12.113; Ghoneim IA, 2005, EUR UROL, V48, P296, DOI 10.1016/j.eururo.2005.02.017; Grasso M, 1998, J UROLOGY, V160, P346, DOI 10.1016/S0022-5347(01)62892-1; Ito H, 2012, J ENDOUROL, V26, P1125, DOI 10.1089/end.2012.0154; Jessen JP, 2014, J ENDOUROL, V28, P146, DOI 10.1089/end.2013.0401; Kumar A, 2015, J UROLOGY, V193, P160, DOI 10.1016/j.juro.2014.07.088; Kupeli B, 2007, J ENDOUROL, V21, P18, DOI 10.1089/end.2006.0156; PSIHRAMIS KE, 1992, J UROLOGY, V147, P1006; Sampaio FJ, 1994, J ENDOUROL, V4, P241; Sampaio F J, 2001, Curr Opin Urol, V11, P359, DOI 10.1097/00042307-200107000-00004; Sozen S, 2008, J ENDOUROL, V22, P877, DOI 10.1089/end.2007.0277; Symes A, 2005, UROL RES, V33, P297, DOI 10.1007/s00240-005-0476-4; Tuckey J, 2000, J ENDOUROL, V14, P475; Turk C, 2014, GUIDELINES UROLITHIA, P13; Wiener SV, 2012, UROLOGY, V80, P790, DOI 10.1016/j.urology.2012.05.040	34	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0892-7790	1557-900X		J ENDOUROL	J. Endourol.	SEP 1	2015	29	9					998	1005		10.1089/end.2015.0071		8	Urology & Nephrology	Urology & Nephrology	CQ4RA	WOS:000360591100004		
J	Haga, N; Yanagida, T; Yabe, M; Akaihata, H; Hata, J; Sato, Y; Ogawa, S; Ishibashi, K; Kojima, Y				Haga, Nobuhiro; Yanagida, Tomohiko; Yabe, Michihiro; Akaihata, Hidenori; Hata, Junya; Sato, Yuichi; Ogawa, Soichiro; Ishibashi, Kei; Kojima, Yoshiyuki			Timing of Urinary Pad Exchanges Was the Most Important Factor Affecting Quality of Life in the Early Postoperative Period After Robot-Assisted Laparoscopic Radical Prostatectomy	JOURNAL OF ENDOUROLOGY			English	Article							JAPANESE MEN; INCONTINENCE; CONTINENCE; PATIENT; CANCER; PERCEPTION	Purpose: The aim of the present study is to investigate the effect of pad use for postprostatectomy incontinence on urinary quality of life (QoL) after robot-assisted laparoscopic radical prostatectomy (RARP) in the early postoperative period. Methods: Ninety patients underwent RARP simultaneously completed International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and modified pad use questionnaire that evaluated pad use and urinary QoL and a 24-hour pad test. Pad use was also assessed by pad form, pad size, the number of pad exchanges per day, and the timing of pad exchanges (i.e., to what extent the pad was wet when the patients exchanged it.). The investigation involved patients visiting the outpatient clinic for the first time after RARP. The association between pad use and urinary QoL was investigated. Results: The mean frequency of pad exchanges was 22/day. The mean 24-hour pad test was 139 +/- 193g/day. Multivariate analyses revealed the timing of pad exchanges was significantly associated with QoL on the ICIQ-SF and the modified pad use questionnaire (P=0.007 and P<0.001, respectively) and the number of pad exchanges per day was significantly associated with QoL on the ICIQ-SF (P=0.01); QoL worsened with pad wetness and increasing frequency of pad exchange. The other factors relating to pad use were not significantly associated with aggravation of QoL. Conclusions: In the early postoperative period after RARP, the timing of pad exchanges was the most important factor affecting QoL. Namely, patients with postprostatectomy incontinence should wear the appropriate size of pad according to the volume of urinary incontinence and exchange pads when the pad is not too wet. On the other hand, pad form, pad size, and volume of urinary incontinence were not associated with decreased QoL.	[Haga, Nobuhiro; Yanagida, Tomohiko; Yabe, Michihiro; Akaihata, Hidenori; Hata, Junya; Sato, Yuichi; Ogawa, Soichiro; Ishibashi, Kei; Kojima, Yoshiyuki] Fukushima Med Univ, Sch Med, Dept Urol, Fukushima 9601295, Japan	Haga, N (reprint author), Fukushima Med Univ, Sch Med, Dept Urol, 1 Hikarigaoka, Fukushima 9601295, Japan.	pessoco@fmu.ac.jp					Porpiglia F, 2013, EUR UROL, V63, P606, DOI 10.1016/j.eururo.2012.07.007; Sammon JD, 2013, J ENDOUROL, V27, P442, DOI 10.1089/end.2012.0312; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Nitti VW, 2014, J UROLOGY, V192, P836, DOI 10.1016/j.juro.2014.03.031; Wallerstedt A, 2012, J UROLOGY, V187, P196, DOI 10.1016/j.juro.2011.09.030; Van Velthoven RF, 2003, UROLOGY, V61, P699, DOI 10.1016/S0090-4295(02)02543-8; Dylewski DA, 2007, NEUROUROL URODYNAM, V26, P3, DOI 10.1002/nau.20352; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Rocco F, 2006, J UROLOGY, V175, P2201, DOI 10.1016/S0022-5347(06)00262-X; Di Pierro GB, 2011, EUR UROL, V59, P1, DOI 10.1016/j.eururo.2010.10.026; Liss MA, 2010, J UROLOGY, V183, P1464, DOI 10.1016/j.juro.2009.12.009; Rocco B, 2007, EUR UROL, V51, P996, DOI 10.1016/j.eururo.2006.10.014; Bochove-Overgaauw DM, 2011, J UROLOGY, V185, P1363, DOI 10.1016/j.juro.2010.11.075; Fader M, 2008, COCHRANE DB SYST REV, V4; Kakehi Y, 2007, J UROLOGY, V177, P1856, DOI 10.1016/j.juro.2007.01.066; Kowalik CG, 2013, NEUROUROL URODYNAM, V34, P251; Lebret T, 2008, UROLOGY, V71, P256, DOI 10.1016/j.urology.2007.08.062; Lee SR, 2010, YONSEI MED J, V51, P883, DOI 10.3349/ymj.2010.51.6.883; Macaulay M, 2014, BJU INT; Namiki S, 2010, J CANCER RES CLIN, V136, P379, DOI 10.1007/s00432-009-0665-6; Namiki S, 2009, INT J UROL, V16, P75, DOI 10.1111/j.1442-2042.2008.02197.x; Seweryn J, 2012, J UROLOGY, V187, P956, DOI 10.1016/j.juro.2011.10.138; Tsui JF, 2013, J UROLOGY, V190, P1787, DOI 10.1016/j.juro.2013.05.055	23	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0892-7790	1557-900X		J ENDOUROL	J. Endourol.	SEP 1	2015	29	9					1044	1051		10.1089/end.2015.0326		8	Urology & Nephrology	Urology & Nephrology	CQ4RA	WOS:000360591100012		
J	Yoshida, K; Yokomizo, A; Matsuda, T; Hamasaki, T; Kondo, Y; Yamaguchi, K; Kanayama, H; Wakumoto, Y; Horie, S; Naito, S				Yoshida, Kenji; Yokomizo, Akira; Matsuda, Tadashi; Hamasaki, Tsutomu; Kondo, Yukihiro; Yamaguchi, Kunihisa; Kanayama, Hiro-omi; Wakumoto, Yoshiaki; Horie, Shigeo; Naito, Seiji			The Advantage of a Ureteroscopic Navigation System with Magnetic Tracking in Comparison with Simulated Fluoroscopy in a Phantom Study	JOURNAL OF ENDOUROLOGY			English	Article							UNILATERAL URETEROSCOPY; RADIATION; TIME	Purpose: To assess whether our ureteroscopic real-time navigation system has the possibility to reduce radiation exposure and improve performance of ureteroscopic maneuvers in surgeons of various ages and experience levels. Materials and Methods: Our novel ureteroscopic navigation system used a magnetic tracking device to detect the position of the ureteroscope and display it on a three-dimensional image. We recruited 31 urologists from five institutions to perform two tasks. Task 1 consisted of finding three internal markings on the phantom calices. Task 2 consisted of identifying all calices by ureteroscopy. In both tasks, participants performed with simulated fluoroscopy first, followed by our navigation system. Accuracy rates (AR) for identification, required time (T) for completing the task, migration length (ML), and time exposed to simulated fluoroscopy were recorded. Results: The AR, T, and ML for both tasks were significantly better with the navigation system than without it (Task 1 with simulated fluoroscopy vs with navigation: AR 87.1 % vs 98.9%, P=0.003; T 355s vs 191s, P<0.0001; ML 4627mm vs 2701mm, P<0.0001. Task 2: AR 88.2% vs 96.7%, P=0.011; T 394s vs 333s, P=0.027; ML 5966mm vs 5299mm, P=0.0006). In both tasks, the participants used the simulated fluoroscopy about 20% of the total task time. Conclusions: Our navigation system, while still under development, could help surgeons of all levels to achieve better performances for ureteroscopic maneuvers compared with using fluoroscopic guidance. It also has the potential to reduce radiation exposure during fluoroscopy.	[Yoshida, Kenji; Matsuda, Tadashi] Kansai Med Univ, Dept Urol & Androl, Osaka, Japan; [Yokomizo, Akira; Naito, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 8128525, Japan; [Hamasaki, Tsutomu; Kondo, Yukihiro] Nippon Med Sch, Dept Urol, Tokyo, Japan; [Yamaguchi, Kunihisa; Kanayama, Hiro-omi] Univ Tokushima, Grad Sch, Inst HBS, Dept Urol, Tokushima 770, Japan; [Wakumoto, Yoshiaki; Horie, Shigeo] Juntendo Univ, Dept Urol, Tokyo, Japan	Naito, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128525, Japan.	naito@uro.med.kyushu-u.ac.jp					Andonian S, 2009, AUA UPDATE SERIES, V28; Hughes-Hallett A, 2014, UROLOGY, V83, P266, DOI 10.1016/j.urology.2013.08.049; Kokorowski PJ, 2013, J UROLOGY, V190, P1474, DOI 10.1016/j.juro.2013.03.006; Greene DJ, 2011, UROLOGY, V78, P286, DOI 10.1016/j.urology.2010.11.020; Hsi RS, 2013, J ENDOUROL, V27, P432, DOI 10.1089/end.2012.0478; Weld LR, 2014, UROLOGY, V84, P520, DOI 10.1016/j.urology.2014.03.035; Weld LR, 2015, WORLD J UROL, V33, P119, DOI 10.1007/s00345-014-1264-y; Yoshida K, 2014, J ENDOUROL, V28, P1053, DOI 10.1089/end.2013.0757	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0892-7790	1557-900X		J ENDOUROL	J. Endourol.	SEP 1	2015	29	9					1059	1064		10.1089/end.2015.0054		6	Urology & Nephrology	Urology & Nephrology	CQ4RA	WOS:000360591100014		
J	Asai, T; Dodo, S; Karishuku, M; Yagi, N; Akiyama, Y; Hayashi, A				Asai, Tomohiro; Dodo, Satoschi; Karishuku, Mitsuhiro; Yagi, Nobuo; Akiyama, Yasuhiro; Hayashi, Akinori			Performance of Multiple-Injection Dry Low-NOx Combustors on Hydrogen-Rich Syngas Fuel in an IGCC Pilot Plant	JOURNAL OF ENGINEERING FOR GAS TURBINES AND POWER-TRANSACTIONS OF THE ASME			English	Article								The successful development of coal-based integrated gasification combined cycle (IGCC) technology requires gas turbines capable of achieving the dry low nitrogen oxides (NOx) combustion of hydrogen-rich syngas fuels for low emissions and high plant efficiency. Mitsubishi Hitachi Power Systems, Ltd. (MHPS) has been developing a "multipleinjection burner" to achieve the dry low-NOx (DLN) combustion of hydrogen-rich syngas fuels. The purposes of this paper are to present the test results of a multican combustor equipped with multiple-injection burners in an IGCC pilot plant, and evaluate combustor performance by focusing on the effects of flame shapes. The syngas fuel produced in the plant contained approximately 50% carbon monoxide, 20% hydrogen, and 20% nitrogen by volume. In the tests, the combustor with slenderer flames achieved lower NOx emissions of 10.9 ppm (at 15% oxygen), reduced combustor liner and burner plate metal temperatures, and lowered combustion efficiency at the maximum gas turbine load. The test results showed that the slenderer flames were more effective in reducing NOx emissions and liner/burner plate metal temperatures. A comparison with the diffusion-flame combustor demonstrated that the multiple-injection combustors achieved the dry low-NOx combustion of the syngas fuel in the plant.	[Asai, Tomohiro; Akiyama, Yasuhiro; Hayashi, Akinori] Mitsubishi Hitachi Power Syst Ltd, Ctr Res & Dev, Hitachinaka, Ibaraki 3120034, Japan; [Dodo, Satoschi; Karishuku, Mitsuhiro; Yagi, Nobuo] Mitsubishi Hitachi Power Syst Ltd, Hitachi Gas Turbine Engn Dept, Hitachi, Ibaraki 3178511, Japan	Asai, T (reprint author), Mitsubishi Hitachi Power Syst Ltd, Ctr Res & Dev, 832-2 Horiguchi, Hitachinaka, Ibaraki 3120034, Japan.	tomohiro3_asai@mhps.com; satoshi_dodo@mhps.com; mitsuhiro_karishuku@mhps.com; nobuo_yagi@mhps.com; yasuhiro_akiyama@mhps.com; akinori_hayashi@mhps.com			NEDO	This work was performed under the "Innovative Zero-Emission Coal Gasification Power Generation Project: Development of Low NO<INF>x</INF> Combustion Technology for High-Hydrogen Syngas in IGCC" managed by the New Energy and Industrial Technology Development Organization (NEDO). The authors sincerely appreciate the valuable guidance and financial support provided by NEDO. The authors are most grateful to the Wakamatsu Research Institute of Electric Power Development Co., Ltd. (J-POWER) for supporting the tests in the EAGLE plant.	Alavandi S. K., 2012, GT201268128 ASME; Chiesa P, 2005, J ENG GAS TURB POWER, V127, P73, DOI 10.1115/1.1787513; Asai T., 2011, GT201145295 ASME; Asai T., 2013, POWER201398122 ASME; Asai T., 2010, GT201022286 ASME; Bolanos F., 2013, GT201394420 ASME; Dodo S., 2011, GT201145459 ASME; Dodo S, 2013, J ENG GAS TURB POWER, V135, DOI 10.1115/1.4006691; Funke H. H.-W., 2012, GT201269421 ASME; Gazzani M., 2013, GT201394701 ASME; Glassman I, 2008, COMBUSTION, 4TH EDITION, P1; Hollon B., 2011, GT201145929 ASME; IPCC, 2005, IPCC SPECIAL REPORT; Kimura N., 2005, APEC CLEAN FOSS EN T, P1; Lefebvre AH, 2010, GAS TURBINE COMBUSTION ALTERNATIVE FUELS AND EMISSIONS, THIRD EDITION, P1, DOI 10.1201/9781420086058-f; Lieuwen T, 2009, SYNTHESIS GAS COMBUS; Amato A, 2013, CAMB AERO SER, P209; Nagasaki N., 2010, HITACHI REV, V59, P77; Nagasaki N., 2014, THERM NUCL POWER J, V65, P759; Nagasaki N., 2013, HITACHI REV, V62, P39; NEDO and Japan Coal Energy Center (JCOAL), 2006, CLEAN COAL TECHN JAP; New Energy and Industrial Technology Development Organization (NEDO), 2005, 100005208 NEDO; Omata K., 2014, J JPN I ENERGY, V93, P624; Reiss F., 2002, GT200230108 ASME; Roediger T., 2012, GT201269006 ASME; Therkelsen P. L., 2012, GT201268436 ASME; Wu J., 2007, GT200728337 ASME; York WD, 2013, J ENG GAS TURB POWER, V135, DOI 10.1115/1.4007733	28	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0742-4795	1528-8919		J ENG GAS TURB POWER	J. Eng. Gas. Turbines Power-Trans. ASME	SEP	2015	137	9							091504	10.1115/1.4029614		11	Engineering, Mechanical	Engineering	CQ4BH	WOS:000360548600005		
J	Ikeda, M; Inui, T				Ikeda, Masahiro; Inui, Takahisa			Small data blow-up of L (2) or H (1)-solution for the semilinear Schrodinger equation without gauge invariance	JOURNAL OF EVOLUTION EQUATIONS			English	Article						Critical exponent; Nonlinear Schrodinger equation; Nongauge invariance; L-2-subcritical; Strauss exponent	CAUCHY-PROBLEM; CRITICAL EXPONENTS; WAVE-EQUATION; DIMENSIONS; EXISTENCE; THEOREMS	We consider the initial value problem for the semilinear Schrodinger equation: i partial derivative(t)u + Delta u = lambda vertical bar u vertical bar(p,) (t, d) is an element of [0, T)x R-n, (NLS) where p > 1, lambda is an element of C\. {0}. In this paper, we will prove a small data blow-up result of L-2 and H-1-solution for (NLS) in 1 < p < 1 + 4/n. Also, an upper bound of the life span will be given (Theorem 2.2).	[Ikeda, Masahiro; Inui, Takahisa] Kyoto Univ, Grad Sch Sci, Dept Math, Kyoto, Kyoto 6068502, Japan	Ikeda, M (reprint author), Kyoto Univ, Grad Sch Sci, Dept Math, Kyoto, Kyoto 6068502, Japan.	mikeda@math.kyoto-u.ac.jp; inui@math.kyoto-u.ac.jp					GINIBRE J, 1979, J FUNCT ANAL, V32, P1, DOI 10.1016/0022-1236(79)90076-4; Yordanov BT, 2006, J FUNCT ANAL, V231, P361, DOI 10.1016/j.jfa.2005.03.012; Ozawa T, 2013, J MATH ANAL APPL, V399, P147, DOI 10.1016/j.jmaa.2012.10.003; STRAUSS WA, 1981, J FUNCT ANAL, V41, P110, DOI 10.1016/0022-1236(81)90063-X; Kato T, 1995, J ANAL MATH, V67, P281, DOI 10.1007/BF02787794; Deng K, 2000, J MATH ANAL APPL, V243, P85, DOI 10.1006/jmaa.1999.6663; GLASSEY RT, 1977, J MATH PHYS, V18, P1794, DOI 10.1063/1.523491; Todorova G, 2001, J DIFFER EQUATIONS, V174, P464, DOI 10.1006/jdeq.2000.3933; Galaktionov VA, 2002, INDIANA U MATH J, V51, P1321, DOI 10.1512/iumj.2002.51.2131; CAZENAVE T, 1990, NONLINEAR ANAL-THEOR, V14, P807, DOI 10.1016/0362-546X(90)90023-A; Cazenave T., 2003, COURANT LECT NOTES M, V10; Chaves M, 2001, EUR J APPL MATH, V12, P601; Germain P, 2012, J MATH PURE APPL, V97, P505, DOI 10.1016/j.matpur.2011.09.008; GINIBRE J, 1995, MATH Z, V219, P119, DOI 10.1007/BF02572354; Ikeda M, 2013, DIFFER INTEGRAL EQU, V26, P1275; Ikeda M., ARXIV12116928; Ikeda M, 2015, J MATH ANAL APPL, V425, P758, DOI 10.1016/j.jmaa.2015.01.003; Ikeda M, 2015, P AM MATH SOC, V143, P163; KATO T, 1987, ANN I H POINCARE-PHY, V46, P113; Kuiper H., 2003, ELECT J DIFFERENTIAL, V2003, P1; LEVINE HA, 1990, SIAM REV, V32, P262, DOI 10.1137/1032046; OGAWA T, 1991, P AM MATH SOC, V111, P487, DOI 10.2307/2048340; OGAWA T, 1991, J DIFFER EQUATIONS, V92, P317, DOI 10.1016/0022-0396(91)90052-B; Oh T, 2012, CR MATH, V350, P389, DOI 10.1016/j.crma.2012.04.009; Oh T., 2012, COMMUNICATION; Raphael P., COMMUNICATION; Sun F., 2010, ELECTRON J DIFFER EQ, V2010, P1; Tsutsumi Y., 1987, FUNK EKVA, V30, P115	28	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1424-3199	1424-3202		J EVOL EQU	J. Evol. Equ.	SEP	2015	15	3					571	581		10.1007/s00028-015-0273-7		11	Mathematics, Applied; Mathematics	Mathematics	CQ8MX	WOS:000360863000004		
J	Valle, S; Carpentier, E; Vu, B; Tsutsui, K; Deviche, P				Valle, Shelley; Carpentier, Elodie; Vu, Bethany; Tsutsui, Kazuyoshi; Deviche, Pierre			Food restriction negatively affects multiple levels of the reproductive axis in male house finches, Haemorhous mexicanus	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Luteinizing hormone; Gonadal development; Gonadotropin-releasing hormone; Hypothalamic-pituitary-gonadal axis; Seasonal reproduction; Testosterone	STARLINGS STURNUS-VULGARIS; GONADOTROPIN-RELEASING-HORMONE; JUNCOS JUNCO-HYEMALIS; NEUROPEPTIDE-Y; CARPODACUS-MEXICANUS; LUTEINIZING-HORMONE; JAPANESE-QUAIL; PHOTOPERIODIC CONTROL; TESTICULAR DEVELOPMENT; OPPORTUNISTIC BREEDER	Nutrition influences reproductive functions across vertebrates, but the effects of food availability on the functioning of the hypothalamic-pituitary-gonadal (HPG) axis in wild birds and the mechanisms mediating these effects remain unclear. We investigated the influence of chronic food restriction on the HPG axis of photostimulated house finches, Haemorhous mexicanus. Food-restricted birds had underdeveloped testes with smaller seminiferous tubules than ad libitum-fed birds. Baseline plasma testosterone increased in response to photostimulation in ad libitum-fed but not in food-restricted birds. Food availability did not, however, affect the plasma testosterone increase resulting from a gonadotropin-releasing hormone-I (GnRH) or a luteinizing hormone (LH) challenge. The number of hypothalamic GnRH immunoreactive (ir) but not proGnRH-ir perikarya was higher in food-restricted than in ad libitum-fed finches, suggesting inhibited secretion of GnRH. Hypothalamic gonadotropin-inhibitory hormone (GnIH)-ir and neuropeptide Y (NPY)-ir were not affected by food availability. Plasma corticosterone (CORT) was also not affected by food availability, indicating that the observed HPG axis inhibition did not result from increased activity of the hypothalamic-pituitary-adrenal (HPA) axis. This study is among the first to examine multilevel functional changes in the HPG axis in response to food restriction in a wild bird. The results indicate that food availability affects both hypothalamic and gonadal function, but further investigations are needed to clarify the mechanisms by which nutritional signals mediate these effects.	[Valle, Shelley; Vu, Bethany; Deviche, Pierre] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Carpentier, Elodie] Univ Poitiers, Fac Sci Fondament & Appl, F-86022 Poitiers, France; [Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Shinjuku Ku, Tokyo 1628480, Japan	Valle, S (reprint author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	shelley.valle@asu.edu			National Science Foundation [IOB 1026620]; School of Life Sciences at Arizona State University	The project was supported by National Science Foundation Award IOB 1026620 to P.D., and a grant from the School of Life Sciences at Arizona State University to S.V.	Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Jawor JM, 2006, GEN COMP ENDOCR, V149, P182, DOI 10.1016/j.ygcen.2006.05.013; Clarke IJ, 2012, NEUROENDOCRINOLOGY, V95, P305, DOI 10.1159/000332822; Tsutsui K, 2012, GEN COMP ENDOCR, V177, P305, DOI 10.1016/j.ygcen.2012.02.013; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Wade GN, 1996, AM J PHYSIOL-ENDOC M, V270, pE1; HAMNER WM, 1968, ECOLOGY, V49, P211, DOI 10.2307/1934450; TANABE Y, 1981, GEN COMP ENDOCR, V43, P392, DOI 10.1016/0016-6480(81)90299-9; Dawson A, 1997, J REPROD FERTIL, V111, P1; Davies S, 2014, HORM BEHAV, V66, P41, DOI 10.1016/j.yhbeh.2014.04.003; Bungo T, 2011, J POULT SCI, V48, P1, DOI 10.2141/jpsa.010117; DAWSON A, 1986, IBIS, V128, P572, DOI 10.1111/j.1474-919X.1986.tb02709.x; Wingfield JC, 2012, GEN COMP ENDOCR, V178, P485, DOI 10.1016/j.ygcen.2012.07.007; MEIJER T, 1991, IBIS, V133, P80, DOI 10.1111/j.1474-919X.1991.tb04814.x; RICHARDSON RD, 1995, AM J PHYSIOL-REG I, V268, pR1418; Perfito N, 2008, HORM BEHAV, V53, P567, DOI 10.1016/j.yhbeh.2008.01.002; SALDANHA CJ, 1994, GEN COMP ENDOCR, V93, P128; Deviche P, 2000, GEN COMP ENDOCR, V117, P8, DOI 10.1006/gcen.1999.7361; [Anonymous], 2015, J EXP BIOL, V218, P2694, DOI [10.1242/jeb.123323, DOI 10.1242/JEB.123323]; Schoech SJ, 2009, GEN COMP ENDOCR, V163, P201, DOI 10.1016/j.ygcen.2008.09.009; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Perez-Rodriguez L, 2006, ANIM BEHAV, V72, P97, DOI 10.1016/j.anbehav.2005.09.021; KUENZEL WJ, 1987, PEPTIDES, V8, P823, DOI 10.1016/0196-9781(87)90066-0; Tsutsui K, 2009, PROG NEUROBIOL, V88, P76, DOI 10.1016/j.pneurobio.2009.02.003; HAHN TP, 1995, J EXP ZOOL, V272, P213, DOI 10.1002/jez.1402720306; MEIJER T, 1990, BEHAVIOUR, V114, P117, DOI 10.1163/156853990X00077; Small TW, 2008, BRAIN BEHAV EVOLUT, V71, P127, DOI 10.1159/000111459; Walsh KM, 1997, BRAIN RES BULL, V44, P707, DOI 10.1016/S0361-9230(97)00268-2; SHARP PJ, 1990, J ENDOCRINOL, V124, P291, DOI 10.1677/joe.0.1240291; Fokidis HB, 2012, J EXP BIOL, V215, P2920, DOI 10.1242/jeb.071043; Young KA, 2001, BIOL REPROD, V64, P706, DOI 10.1095/biolreprod64.2.706; Parry DM, 1997, J NEUROENDOCRINOL, V9, P235, DOI 10.1046/j.1365-2826.1997.00575.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Cho RN, 1998, GEN COMP ENDOCR, V109, P244, DOI 10.1006/gcen.1997.7027; Deviche P, 2005, J EXP BIOL, V208, P1287, DOI 10.1242/jeb.01531; RODENHOUSE NL, 1992, ECOLOGY, V73, P357, DOI 10.2307/1938747; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Ball GF, 2008, PHILOS T R SOC B, V363, P231, DOI 10.1098/rstb.2007.2137; Fraley GS, 2013, GEN COMP ENDOCR, V184, P103, DOI 10.1016/j.ygcen.2012.11.026; Perfito N, 2011, GEN COMP ENDOCR, V173, P20, DOI 10.1016/j.ygcen.2011.04.016; DUTLOW CM, 1992, J CLIN INVEST, V90, P2496, DOI 10.1172/JCI116142; O'Brien S, 2005, J ORNITHOL, V146, P332, DOI 10.1007/s10336-005-0013-9; Caro SP, 2009, FUNCT ECOL, V23, P172, DOI 10.1111/j.1365-2435.2008.01486.x; Deviche P, 2012, HORM BEHAV, V61, P741, DOI 10.1016/j.yhbeh.2012.03.012; Salvante KG, 2007, J EXP BIOL, V210, P1325, DOI 10.1242/jeb.02745; Perfito N, 2005, GEN COMP ENDOCR, V143, P121, DOI 10.1016/j.ygcen.2005.03.004; Lynn SE, 2010, HORM BEHAV, V58, P214, DOI 10.1016/j.yhbeh.2010.03.015; WINGFIELD JC, 1982, CONDOR, V84, P399, DOI 10.2307/1367443; WINGFIELD JC, 1987, AM SCI, V75, P602; Deviche P, 2006, GEN COMP ENDOCR, V147, P167, DOI 10.1016/j.ygcen.2005.12.024; Kwok AHY, 2007, POULTRY SCI, V86, P423; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Clarke IJ, 2011, FRONT NEUROENDOCRIN, V32, P367, DOI 10.1016/j.yfrne.2011.01.001; FOLLETT BK, 1977, J ENDOCRINOL, V74, P449, DOI 10.1677/joe.0.0740449; HATTORI A, 1986, GEN COMP ENDOCR, V64, P446, DOI 10.1016/0016-6480(86)90082-1; Dawson A, 2007, GEN COMP ENDOCR, V153, P378, DOI 10.1016/j.ygcen.2007.01.043; Bechtold DA, 2013, TRENDS NEUROSCI, V36, P74, DOI 10.1016/j.tins.2012.12.007; CONTIJOCH AM, 1993, NEUROENDOCRINOLOGY, V57, P135, DOI 10.1159/000126353; Bruggeman V, 1998, J REPROD FERTIL, V114, P267; Hau M, 2000, J EXP ZOOL, V286, P494, DOI 10.1002/(SICI)1097-010X(20000401)286:5<494::AID-JEZ7>3.0.CO;2-3; Kobayashi M, 2002, ZOOL SCI, V19, P449, DOI 10.2108/zsj.19.449; Burns CMB, 2014, HORM BEHAV, V65, P179, DOI 10.1016/j.yhbeh.2013.10.006; Caro SP, 2012, GEN COMP ENDOCR, V176, P1, DOI 10.1016/j.ygcen.2011.12.021; Davies S, 2015, J EXP ZOOL PART A, V323, P478, DOI 10.1002/jez.1943; Davies S., 2015, FUNCT ECOL; Davies S, 2015, J EXP BIOL, V218, P2685, DOI 10.1242/jeb.123042; DAWSON A, 1983, GEN COMP ENDOCR, V49, P286, DOI 10.1016/0016-6480(83)90146-6; Dawson A, 2015, FRONT NEUROENDOCRIN, V37, P52, DOI 10.1016/j.yfrne.2014.08.004; Deviche P, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 4: BIRDS, P27; Duckworth RA, 2001, P ROY SOC B-BIOL SCI, V268, P2467, DOI 10.1098/rspb.2001.1827; Farner D. S., 1980, AVIAN ENDOCRINOLOGY, P331; Farner D. S., 1979, HORMONES EVOLUTION, P829; FOSTER RG, 1988, CELL TISSUE RES, V253, P327; Garrel G, 2011, ENDOCRINOLOGY, V152, P3905, DOI 10.1210/en.2011-1167; Hahn T.P., 2005, FUNCTIONAL AVIAN END, P167; HAHN TP, 1995, GEN COMP ENDOCR, V99, P349, DOI 10.1006/gcen.1995.1119; HAMNER WM, 1966, GEN COMP ENDOCR, V7, P224, DOI 10.1016/0016-6480(66)90043-8; Helms C., 1960, BIRDBANDING, V31, P1, DOI DOI 10.2307/4510793; Hirschenhauser K, 2000, GEN COMP ENDOCR, V118, P262, DOI 10.1006/gcen.2000.7463; Horak D, 2015, GLOBAL ECOL BIOGEOGR, V24, P437, DOI 10.1111/geb.12261; Kirby John D., 2000, P597, DOI 10.1016/B978-012747605-6/50024-9; Klingerman Candice M, 2011, Front Endocrinol (Lausanne), V2, P101, DOI 10.3389/fendo.2011.00101; Kriegsfeld LJ, 2015, FRONT NEUROENDOCRIN, V37, P65, DOI 10.1016/j.yfrne.2014.12.001; Lack D., 1968, ECOLOGICAL ADAPTATIO; LEE WS, 1990, P NATL ACAD SCI USA, V87, P5163, DOI 10.1073/pnas.87.13.5163; McGuire NL, 2013, PEERJ, V1, DOI 10.7717/peerj.139; MCSHANE TM, 1992, BIOL REPROD, V46, P1151, DOI 10.1095/biolreprod46.6.1151; Murton R.K., 1977, AVIAN BREEDING CYCLE; Nager RG, 2006, ARDEA, V94, P323; Ohkura S, 2000, ENDOCRINOLOGY, V141, P4472, DOI 10.1210/en.141.12.4472; Olsson M, 1997, J EVOLUTION BIOL, V10, P369, DOI 10.1007/s000360050030; Pyle P., 1997, IDENTIFICATION GUI 1; ROBERTS JL, 1989, MOL BRAIN RES, V6, P127, DOI 10.1016/0169-328X(89)90046-6; Ruffino L, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0080-y; Stevenson TJ, 2012, J NEUROENDOCRINOL, V24, P267, DOI 10.1111/j.1365-2826.2011.02245.x; Wingfield J.C., 1983, P265; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P406, DOI 10.1016/0016-6480(84)90083-2	98	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	SEP	2015	218	17					2694	2704		10.1242/jeb.123323		11	Biology	Life Sciences & Biomedicine - Other Topics	CQ5PT	WOS:000360658500012		
J	Watanabe, YY; Baranov, EA; Miyazaki, N				Watanabe, Yuuki Y.; Baranov, Eugene A.; Miyazaki, Nobuyuki			Drift dives and prolonged surfacing periods in Baikal seals: resting strategies in open waters?	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Diving behavior; Food processing; Predator avoidance; Accelerometer	NORTHERN ELEPHANT SEALS; CRAB-EATER SEALS; PHOCA SIBIRICA; PATTERNS; BEHAVIOR; CLASSIFICATION; MOVEMENTS; MAMMALS; STROKE; DEPTH	Many pinnipeds frequently rest on land or ice, but some species remain in open waters for weeks or months, raising the question of how they rest. A unique type of dive, called drift dives, has been reported for several pinnipeds with suggested functions of rest, food processing and predator avoidance. Prolonged surfacing periods have also been observed in captive seals and are thought to aid food processing. However, information from other species in a different environment would be required to better understand the nature and function of this behavior. In this study, we attached multi-sensor tags to Baikal seals Pusa sibirica, a rare, freshwater species that has no aquatic predators and few resting grounds during the ice-free season. The seals exhibited repeated drift dives (mean depth, 116 m; duration, 10.1 min) in the daytime and prolonged periods at the surface (mean duration, 1.3 h) mainly around dawn. Drift dives and prolonged surfacing periods were temporally associated and observed between a series of foraging dives, suggesting a similar function, i.e. a combination of resting and food processing. The maximum durations of both drift and foraging dives were 15.4 min, close to the aerobic dive limit of this species; therefore, metabolic rates might not be significantly depressed during drift dives, further supporting the function of food processing rather than purely resting. Our results also show that drift diving can occur in a predator-free environment, and thus predator avoidance is not a general explanation of drift dives in pinnipeds.	[Watanabe, Yuuki Y.] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Watanabe, Yuuki Y.] SOKENDAI, Dept Polar Sci, Tachikawa, Tokyo 1908518, Japan; [Baranov, Eugene A.] Baikal Seal Aquarium, Irkutsk 664005, Russia; [Miyazaki, Nobuyuki] Japan Marine Sci Fdn, Taito Ku, Tokyo 1100008, Japan	Watanabe, YY (reprint author), Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan.	watanabe.yuuki@nipr.ac.jp			Japan Society for the Promotion of Science [05J11533, 13460082]	This work was funded by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (05J11533 to Y.Y.W. and 13460082 to N.M.).	Andersen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103072; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Watanabe Y, 2006, J EXP BIOL, V209, P3269, DOI 10.1242/jeb.02402; Secor SM, 2009, J COMP PHYSIOL B, V179, P1, DOI 10.1007/s00360-008-0283-7; LEBOEUF BJ, 1989, CAN J ZOOL, V67, P2514; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; Ponganis PJ, 1997, CAN J ZOOL, V75, P1323, DOI 10.1139/z97-756; Watanabe Y, 2004, MAR ECOL PROG SER, V279, P283, DOI 10.3354/meps279283; Page B, 2005, CAN J ZOOL, V83, P293, DOI 10.1139/Z05-013; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Mitani Y, 2010, BIOL LETTERS, V6, P163, DOI 10.1098/rsbl.2009.0719; Bengtson JL, 2004, POLAR BIOL, V27, P344, DOI 10.1007/s00300-004-0597-1; FALKE KJ, 1985, SCIENCE, V229, P556, DOI 10.1126/science.4023700; BENGTSON JL, 1992, POLAR BIOL, V12, P635; Burkanov V., 2008, PUSA SIBIRICA IUCN R; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; Meir JU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083248; Narazaki T., 2010, RECONSTRUCTION 3 D P; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sparling CE, 2007, BIOL LETT-UK, V3, P94, DOI 10.1098/rsbl.2006.0566; Stewart BS, 1996, MAR MAMMAL SCI, V12, P528	26	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	SEP	2015	218	17					2793	2798		10.1242/jeb.125898		6	Biology	Life Sciences & Biomedicine - Other Topics	CQ5PT	WOS:000360658500023		
J	Nishio, M; Kawamoto, T; Kawakami, R; Edo, K; Yamazaki, Y				Nishio, M.; Kawamoto, T.; Kawakami, R.; Edo, K.; Yamazaki, Y.			Life history and reproductive ecology of the endangered Itasenpara bitterling Acheilognathus longipinnis (Cyprinidae) in the Himi region, central Japan	JOURNAL OF FISH BIOLOGY			English	Article						conservation; floodplain; freshwater mussel; growth; oviposition; paddy field	RHODEUS-OCELLATUS-KURUMEUS; HOST MUSSEL UTILIZATION; LOACH LEPTOBOTIA-CURTA; HABITAT USE; SPATIAL UTILIZATION; OVIPOSITOR LENGTH; FLOODPLAIN SYSTEM; TEMPORARY WATERS; SEASONAL-CHANGE; PRESENT STATE	The life history, reproductive ecology and habitat utilization of the Itasenpara (deepbody) bitterling Acheilognathus longipinnis were investigated in a lowland segment of the Moo River in Toyama Prefecture, central Honshu, Japan. Analysis of 1285 individuals revealed that the study population comprised a single size class, an age at maturation of 3 months and a life span of 1 year. On the basis of the growth pattern, the life cycle was divided into two stages: the juvenile stage, characterized by rapid growth, and the adult stage at which growth ceased. Spawning by A. longipinnis was recorded between early September and late October. Female A. longipinnis in the 0+ year age class began to mature when they reached a standard length (L-S) of 564 mm. Mature females had a large clutch size (maximum 273 eggs) and deposited highly adhesive and relatively large eggs (255 mm(3); major axis, 312 mm; minor axis, 122 mm) via a short ovipositor (mean length, 215 mm) into freshwater mussels. The embryos remained in the gill cavities of the freshwater mussels (used as a spawning substratum) and emerged as juveniles (L-S, 9 mm). Habitat utilization during spawning was analysed using a generalized linear model. The best-fit model showed that three environmental factors (freshwater mussel availability, water depth and vegetation cover) were important variables for habitat utilization by A. longipinnis. Shallow areas (water depth, 250-330 mm) created for rice paddy management and areas with an abundance of cover were particularly effective for predator avoidance. These results suggest that maintenance of water level fluctuations corresponding with rice cultivation and the abundance of vegetation on the river bank (particularly avoidance of concrete revetments) is essential for conservation of this species under current practices for rice cultivation in Japan.	[Nishio, M.; Kawakami, R.] Board Educ Himi City, Himi, Toyama 9358686, Japan; [Nishio, M.; Yamazaki, Y.] Toyama Univ, Grad Sch Sci & Engn Res, Toyama 9308555, Japan; [Kawamoto, T.] Kyushu Univ, Fishery Res Lab, Fukutsu, Fukuoka 8113304, Japan; [Edo, K.] Agcy Cultural Affairs, Chiyoda Ward, Tokyo 1008959, Japan	Nishio, M (reprint author), Board Educ Himi City, Himi, Toyama 9358686, Japan.	masaki.nishio@city.himi.lg.jp			River Fund in charge of the River Foundation, Japan; National Treasure Investigation Fund (Agency for Cultural Affairs)	The authors thank R. Nakatake, S. Ishida, N. Sugino, Y. Ebata and M. Nakajin (Board of Education, Himi City) for their generous research support, and C. Smith (Gatty Marine Laboratory, School of Biology, University of St Andrews) for comments and reviewing of the English text. This study was supported in part by the River Fund in charge of the River Foundation, Japan, and the National Treasure Investigation Fund (Agency for Cultural Affairs). This research was conducted as part of a collaborative project with the Faculty of Science, University of Toyama, and Himi Collaborative Research Laboratory, Himi City. The research was conducted with permission from the Agency for Cultural Affairs and the Ministry of the Environment.	Abe T, 2007, ZOOL SCI, V24, P922, DOI 10.2108/zsj.24.922; Abe T, 2007, ZOOL SCI, V24, P850, DOI 10.2108/zsj.24.850; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldridge D. C., 1997, THESIS CAMBRIDGE U C; Gibbs JP, 2000, CONSERV BIOL, V14, P314, DOI 10.1046/j.1523-1739.2000.98608.x; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00289.x; Negishi JN, 2012, FRESHWATER BIOL, V57, P1500, DOI 10.1111/j.1365-2427.2012.02803.x; Buijse AD, 2002, FRESHWATER BIOL, V47, P889, DOI 10.1046/j.1365-2427.2002.00915.x; Kobori H, 2003, AMBIO, V32, P307, DOI 10.1639/0044-7447(2003)032[0307:PCAFST]2.0.CO;2; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Armitage PD, 2003, AQUAT CONSERV, V13, P165, DOI 10.1002/aqc.549; Washitani I, 2001, POPUL ECOL, V43, P189, DOI 10.1007/s10144-001-8182-8; Katayama N, 2011, AQUAT CONSERV, V21, P146, DOI 10.1002/aqc.1169; Chang CH, 2014, MOL PHYLOGENET EVOL, V81, P182, DOI 10.1016/j.ympev.2014.08.026; Chipps SR, 2006, WETLANDS, V26, P497, DOI 10.1672/0277-5212(2006)26[497:ABWDAB]2.0.CO;2; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Kitamura J, 2005, POPUL ECOL, V47, P41, DOI 10.1007/s10144-004-0201-0; BALTZ DM, 1984, ENVIRON BIOL FISH, V10, P101, DOI 10.1007/BF00001666; Kitamura J, 2012, J EVOLUTION BIOL, V25, P566, DOI 10.1111/j.1420-9101.2011.02453.x; Tockner K, 1998, AQUAT CONSERV, V8, P71; Yoshimura C, 2005, RIVER RES APPL, V21, P93, DOI 10.1002/rra.835; Kato N, 2010, WETLANDS, V30, P1171, DOI 10.1007/s13157-010-0103-1; King AJ, 2003, CAN J FISH AQUAT SCI, V60, P773, DOI 10.1139/F03-057; Smith C, 2004, J ZOOL, V262, P107, DOI 10.1017/S0952836903004497; Apostolidis C, 2014, J APPL ICHTHYOL, V30, P189, DOI 10.1111/jai.12303; Bambaradeniya C. N. B., 2003, BIODIVERSITY ASS RIC; Billman EJ, 2006, WEST N AM NATURALIST, V66, P434, DOI 10.3398/1527-0904(2006)66[434:EOTOTS]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT; COLEMAN RM, 1991, COPEIA, P1092, DOI 10.2307/1446105; CONOVER DO, 1992, J FISH BIOL, V41, P161, DOI 10.1111/j.1095-8649.1992.tb03876.x; Craig JF, 2004, FISH RES, V66, P271, DOI 10.1016/S0165-7836(03)00196-6; Davis SR, 2007, J ANIM ECOL, V76, P276, DOI 10.1111/j.1365-2656.2006.01209.x; DEVORE PW, 1978, T AM FISH SOC, V107, P763, DOI 10.1577/1548-8659(1978)107<763:DROBTS>2.0.CO;2; Grift RE, 2001, J FISH BIOL, V59, P1033, DOI 10.1006/jfbi.2001.1716; Halls AS, 1999, FISHERIES MANAG ECOL, V6, P261; HALYK LC, 1983, CAN J ZOOL, V61, P2446; Hayashi K, 2013, ICHTHYOL RES, V60, P218, DOI 10.1007/s10228-013-0335-1; HELFMAN GS, 1981, COPEIA, P392, DOI 10.2307/1444228; Jones MJ, 2006, BIODIVERS CONSERV, V15, P1993, DOI 10.1007/s10531-005-4316-1; JONSSON B, 1979, Environmental Biology of Fishes, V4, P43, DOI 10.1007/BF00005927; Kass G. V, 1980, APPL STATIST, V20, P119, DOI DOI 10.2307/2986296; Kawanishi R, 2011, ICHTHYOL RES, V58, P202, DOI 10.1007/s10228-011-0208-4; Kitamura J, 2006, J FISH BIOL, V68, P594, DOI 10.1111/j.1095-8649.2005.00949.x; Kitamura Jyun-ichi, 2011, Japanese Journal of Ichthyology, V58, P195; Kitamura J, 2006, ICHTHYOL RES, V53, P216, DOI 10.1007/s10228-006-0336-4; Kitamura J, 2009, ICHTHYOL RES, V56, P296, DOI 10.1007/s10228-008-0082-x; Kitamura J, 2006, J FISH BIOL, V69, P263, DOI 10.1111/j.1095-8649.2006.01099.x; Kitamura Jyun-ichi, 2010, Japanese Journal of Ichthyology, V57, P35; Kitamura JI, 2007, ENVIRON BIOL FISH, V78, P37, DOI 10.1007/s10641-006-9076-6; Kitanishi S, 2013, CONSERV GENET, V14, P901, DOI 10.1007/s10592-013-0470-2; Kitanishi S., 2012, ENVIRON BIOL FISH, V96, P567; Kondo Takaki, 1993, Biology of Inland Waters, V8, P1; Konecna M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1069, DOI 10.1007/s00265-010-0921-4; KWAK TJ, 1988, AM MIDL NAT, V120, P241, DOI 10.2307/2425995; Lucas M. C., 2001, MIGRATION FRESHWATER; Matthews W. J., 1998, PATTERNS FRESHWATER; MCMAHON TE, 1989, CAN J FISH AQUAT SCI, V46, P1551, DOI 10.1139/f89-197; Nakajima J, 2010, ADV RIVER ENG, V16, P449; Nakamura F, 2007, FOREST ECOL MANAG, V241, P28, DOI 10.1016/j.foreco.2006.12.022; Nakamura M., 1969, CYPRINID FISHES JAPA; Nishio Masaki, 2012, Japanese Journal of Ichthyology, V59, P147; Ogawa R., 2008, JPN J ICHTHYOL, V55, P144; Ogawa Rikiya, 2011, P49; Ogle D. H., 2012, FSA PACKAGE R FUNCTI; Onikura N, 2007, J JPN SOC WATER ENV, V30, P277, DOI DOI 10.2965/JSWE.30.277; Onikura N, 2009, ZOOL SCI, V26, P375, DOI 10.2108/zsj.26.375; Paunovic Momir, 2006, Aquatic Invasions, V1, P154; Przybylski M, 2007, BEHAVIOUR, V144, P1403, DOI 10.1163/156853907782418204; Reichard M, 2002, ECOL FRESHW FISH, V11, P112, DOI 10.1034/j.1600-0633.2002.00002.x; SAITOH K, 1988, Japanese Journal of Ecology (Tokyo), V38, P35; Sommer TR, 2002, T AM FISH SOC, V131, P966, DOI 10.1577/1548-8659(2002)131<0966:SAROSI>2.0.CO;2; Takaki Yoshihide, 2008, Ornithological Science, V7, P93, DOI 10.2326/1347-0558(2008)7[93:SCAICO]2.0.CO;2; Tojo Hitoshi, 1996, Japanese Journal of Ornithology, V45, P141, DOI 10.3838/jjo.45.141; Tuner T. F., 1994, COPEIA, V1994, P174; Uehara K., 2007, THESIS KINKI U NARA; Uehara K, 2006, J EXP ZOOL PART A, V305A, P823, DOI 10.1002/jez.a.325; Vie J.-C., 2009, WILDLIFE CHANGING WO; Washitani I., 2008, GLOBAL ENV RES, V12, P119; WILLIAMS DD, 1979, INT REV GES HYDROBIO, V64, P501; Wootton R. J., 2015, REPROD BIOL TELEOST; Yamazaki Y, 2014, CONSERV GENET, V15, P921, DOI 10.1007/s10592-014-0589-9; Yamazaki Y., 2009, JAPANESE J ICHTHYOLO, V56, P76	82	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1112	1095-8649		J FISH BIOL	J. Fish Biol.	SEP	2015	87	3					616	633		10.1111/jfb.12739		18	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CQ5TX	WOS:000360669700006		
J	Gaither, MR; Bernal, MA; Fernandez-Silva, I; Mwale, M; Jones, SA; Rocha, C; Rocha, LA				Gaither, M. R.; Bernal, M. A.; Fernandez-Silva, I.; Mwale, M.; Jones, S. A.; Rocha, C.; Rocha, L. A.			Two deep evolutionary lineages in the circumtropical glasseye Heteropriacanthus cruentatus (Teleostei, Priacanthidae) with admixture in the south-western Indian Ocean	JOURNAL OF FISH BIOLOGY			English	Article						barcode; bigeyes; Caribbean; circumglobal; divergent lineages; reef fish	POPULATION GENETIC-STRUCTURE; TUNA KATSUWONUS-PELAMIS; ATLANTIC BIGEYE TUNA; MITOCHONDRIAL-DNA; CONTROL REGION; INDO-PACIFIC; REEF FISH; HAPLOTYPE RECONSTRUCTION; ACANTHOCYBIUM-SOLANDRI; GLOBAL PHYLOGEOGRAPHY	A phylogeographic study of the circumtropical glasseye Heteropriacanthus cruentatus was conducted. Molecular analyses indicate two mitochondrial cytochrome c oxidase subunit I (coI) lineages that are 104% divergent: one in the western Atlantic (Caribbean) and another that was detected across the Indo-Pacific. A fixed single nucleotide polymorphism (SNP) was detected at a nuclear locus (S7 ribosomal protein) and is consistent with this finding. There is evidence of recent dispersal from the Atlantic to the Indian Ocean with individuals of mixed lineages detected in South Africa and the Mozambique Channel. Using coalescent analyses of the mitochondrial dataset, time of divergence between lineages was estimated to be c. 153 million years. The deep divergence between these two lineages indicates distinct evolutionary units, however, due to the lack of morphological differences and evidence of hybridization between lineages, taxonomic revision is not suggested at this time.	[Gaither, M. R.; Bernal, M. A.; Fernandez-Silva, I.; Jones, S. A.; Rocha, C.; Rocha, L. A.] Calif Acad Sci, San Francisco, CA 94118 USA; [Gaither, M. R.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Bernal, M. A.] Univ Texas Richardson, Inst Marine Sci, Port Aransas, TX 78373 USA; [Fernandez-Silva, I.] Univ Ryukyus, Grad Sch Engn & Sci, Mol Invertebrate Systemat & Ecol Lab, Okinawa 9030213, Japan; [Mwale, M.] South African Inst Aquat Biodivers, ZA-6140 Grahamstown, South Africa; [Mwale, M.] Natl Zool Gardens South Africa, ZA-001 Pretoria, South Africa	Gaither, MR (reprint author), Calif Acad Sci, 55 Mus Concourse Dr, San Francisco, CA 94118 USA.	michellergaither@gmail.com	Mwale, Monica/C-2556-2012	Mwale, Monica/0000-0003-2180-8917	California Academy of Sciences; South African Institute for Aquatic Biodiversity; Japanese Society for the Promotion of Science	This project was funded by the California Academy of Sciences, the South African Institute for Aquatic Biodiversity and a fellowship to I.F.-S. by the Japanese Society for the Promotion of Science. We would like to thank the staff at the Center for Comparative Genomics, the Department of Ichthyology and the Diving Safety Programmes at CAS and at the University of Hawai'i at Manoa for their support throughout this project. We would also like to acknowledge M. J. A. Vermeij and the staff of CARMABI for logistical support in Curacao, to J. Reimer, O. Masami, S. Nakachi, Yamada-san and members of the Marine Station at Kuroshio as well as members of the MISE and Tachihara's laboratory at the University of the Ryukyus for scientific advice and logistic support during the collection of Japanese specimens. Thanks to B. Bowen, R. Coleman, J. Copus, R. Kosaki, M. Roger, J. Troller, K. Gleason, D. Wagner and the crew of the Hi'ialakai, the staff at the Papahanaumokuakea Marine National Monument and the Hawai'i Institute of Marine Biology for making the collection of Hawaiian specimens possible. Kansas University Natural History Museum, the Museum National d'Histoire Naturelle, the South African Institute for Aquatic Biodiversity [the R.V. Dr Fridtjof Nansen, FAO and the Agulhas and Somali Current Large Marine Ecosystems Project (ASCLME) research cruise (28 November to 17 December 2008)], the Smithsonian National Museum of Natural History, A. Bentley, R. Bills, E. Delrieu-Trottin, B. Konqobe, M. Lisher, V. Messmer, C. Meyer, S. Planes and J. Williams greatly facilitated the collection of tissues.	Durand JD, 2012, MOL PHYLOGENET EVOL, V64, P73, DOI 10.1016/j.ympev.2012.03.006; Bowen Brian W., 2008, V9, P147; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Craig MT, 2006, J BIOGEOGR, V33, P969, DOI 10.1111/j.1365-2699.2006.01467.x; Graves JE, 2003, MAR FRESHWATER RES, V54, P287, DOI 10.1071/MF01290; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Montes I, 2012, MAR ECOL PROG SER, V471, P183, DOI 10.3354/meps09991; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Diaz-Jaimes P, 2010, MOL PHYLOGENET EVOL, V57, P1209, DOI 10.1016/j.ympev.2010.10.005; Miya M, 1997, NATURE, V389, P803, DOI 10.1038/39774; Gasparini JL, 2001, J NAT HIST, V35, P1639, DOI 10.1080/002229301317092379; Garber AF, 2005, MAR BIOL, V147, P205, DOI 10.1007/s00227-004-1533-1; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; Portnoy DS, 2010, MOL ECOL, V19, P1994, DOI 10.1111/j.1365-294X.2010.04626.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Durand JD, 2005, MAR BIOL, V147, P313, DOI 10.1007/s00227-005-1564-2; Rosel PE, 1996, MAR BIOL, V125, P11, DOI 10.1007/BF00350756; Buonaccorsi VP, 2001, MOL ECOL, V10, P1179, DOI 10.1046/j.1365-294X.2001.01270.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Bowen BW, 2006, J HERED, V97, P1, DOI 10.1093/jhered/esj006; Hidaka K, 2008, ICHTHYOL RES, V55, P53, DOI 10.1007/s10228-007-0010-5; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Gonzalez EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-252; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Schmiedl G, 1997, PALAEOGEOGR PALAEOCL, V130, P43, DOI 10.1016/S0031-0182(96)00137-X; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; Brendtro KS, 2008, MAR BIOL, V155, P11, DOI 10.1007/s00227-008-0997-9; Briggs J. C., 1960, COPEIA, V1960, P171; Caldwell D. K., 1962, Copeia, V1962, P417, DOI 10.2307/1440910; Chow S, 1998, MOL ECOL, V7, P1247; Craig MT, 2004, J BIOGEOGR, V31, P1085, DOI 10.1111/j.1365-2699.2004.01035.x; Ely B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-19; FITCH J E, 1984, Proceedings of the California Academy of Sciences, V43, P301; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2014, MOL PHYLOGENET EVOL, V74, P38, DOI 10.1016/j.ympev.2014.01.017; GRAVES JE, 1984, MAR BIOL, V79, P315, DOI 10.1007/BF00393264; Gray KN, 2009, B MAR SCI, V84, P25; Griffiths AM, 2010, P ROY SOC B-BIOL SCI, V277, P1497, DOI 10.1098/rspb.2009.2111; Harzhauser M, 2007, ZOOL ANZ, V246, P241, DOI 10.1016/j.jcz.2007.05.001; Kon T, 2007, MOL PHYLOGENET EVOL, V44, P53, DOI 10.1016/j.ympev.2006.12.007; Quattro JM, 2013, ZOOTAXA, V3702, P159; Randall J. E., 2007, REEF SHORE FISHES HA; Ritchie H, 2013, DEEP-SEA RES PT II, V98, P431, DOI 10.1016/j.dsr2.2013.06.014; Rocha LA, 2005, MOL ECOL, V14, P3921, DOI 10.1111/j.1365-294X.2005.02698.x; STARNES WC, 1988, B MAR SCI, V43, P117	60	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1112	1095-8649		J FISH BIOL	J. Fish Biol.	SEP	2015	87	3					715	727		10.1111/jfb.12754		13	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CQ5TX	WOS:000360669700012		
J	Yaegashi, H; Shimizu, T; Ito, T; Kanematsu, S				Yaegashi, Hajime; Shimizu, Takeo; Ito, Tsutae; Kanematsu, Satoko			Biolistic transformation of the violet root rot fungus Helicobasidium mompa	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Basidiomycete; Helicobasidium mompa; Hygromycin; Mitotic stability; Particle bombardment; Transformation	TUMEFACIENS-MEDIATED TRANSFORMATION; MICROPROJECTILE BOMBARDMENT; AGROBACTERIUM-TUMEFACIENS; PARTICLE BOMBARDMENT; TRANSIENT TRANSFORMATION; SACCHAROMYCES-CEREVISIAE; GENETIC-TRANSFORMATION; ASPERGILLUS-NIDULANS; DNA; STRAINS	The violet root rot fungus, Helicobasidium mompa, is agriculturally important, but development of a genetic transformation system for the fungus has been limited. In this study, H. mompa V17 and V664 isolates were biolistically transformed with a plasmid expressing the hygromycin B phosphotransferase (hph) gene. Hygromycin-resistant strains were obtained from both isolates. Various numbers of copies of the hph gene expression cassette were integrated into the H. mompa genome. Most transformants grew stably on selective and nonselective media, suggesting that biolistic transformation is an efficient method to generate mitotically stable H. mompa transformants.	[Yaegashi, Hajime; Shimizu, Takeo; Ito, Tsutae; Kanematsu, Satoko] Natl Agr & Food Res Org NARO, Apple Res Stn Inst Fruit Tree Sci, Morioka, Iwate 0200123, Japan	Yaegashi, H (reprint author), Natl Agr & Food Res Org NARO, Apple Res Stn Inst Fruit Tree Sci, 92 Shimokuriyagawa, Morioka, Iwate 0200123, Japan.	hyae@affrc.go.jp	Shimizu, Takeo/O-2787-2015		Program for the Promotion of Basic and Applied Research for Innovation in Bio-Oriented Industries	We thank Drs. Tsutomu Morinaga and Dr. Sanae Kano (Prefectural University of Hiroshima) for kindly providing plasmid pBGgHg-Hihg and Dr. Noriko Yamagishi (Iwate University) for helpful advice on particle bombardment. This work was supported by the Program for the Promotion of Basic and Applied Research for Innovation in Bio-Oriented Industries.	de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; ARMALEO D, 1990, CURR GENET, V17, P97, DOI 10.1007/BF00312852; BUNDOCK P, 1995, EMBO J, V14, P3206; JOHNSTON SA, 1988, SCIENCE, V240, P1538, DOI 10.1126/science.2836954; Fitzgerald AM, 2003, MYCOL RES, V107, P803, DOI 10.1017/S0953756203008086; Hazell BW, 2000, LETT APPL MICROBIOL, V30, P282, DOI 10.1046/j.1472-765X.2000.00715.x; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Ikeda K, 2004, MYCOL RES, V108, P626, DOI 10.1017/s0953756204000061; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Kilaru S, 2009, APPL ENVIRON MICROB, V75, P7196, DOI 10.1128/AEM.01151-09; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; Rodriguez-Tovar AV, 2005, J MICROBIOL METH, V63, P45, DOI 10.1016/j.mimet.2005.02.016; BILLS SN, 1995, MYCOL RES, V99, P557, DOI 10.1016/S0953-7562(09)80713-2; CASE ME, 1979, P NATL ACAD SCI USA, V76, P5259, DOI 10.1073/pnas.76.10.5259; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; Djulic A, 2011, FUNGAL BIOL-UK, V115, P633, DOI 10.1016/j.funbio.2011.03.007; FUNGARO MHP, 1995, FEMS MICROBIOL LETT, V125, P293; Herzog RW, 1996, APPL MICROBIOL BIOT, V45, P333, DOI 10.1007/s002530050692; Ito K, 1949, B GOVT FOREST EXPT S, V43, P1; Kano S, 2011, MYCOSCIENCE, V52, P24, DOI 10.1007/s10267-010-0067-2; Kano S, 2011, MYCOSCIENCE, V52, P333, DOI 10.1007/s10267-010-0103-2; LORITO M, 1993, CURR GENET, V24, P349, DOI 10.1007/BF00336788; Pliego C, 2009, FUNGAL GENET BIOL, V46, P137, DOI 10.1016/j.fgb.2008.11.009; Sasaki A, 2002, MOL PLANT MICROBE IN, V15, P780, DOI 10.1094/MPMI.2002.15.8.780; Schillberg S, 2000, MOL GEN GENET, V262, P911, DOI 10.1007/PL00008658; Segawa K, 1990, COMPENDIUM APPLE PEA, P52; Sunagawa M, 2007, BIOSCI BIOTECH BIOCH, V71, P47, DOI 10.1271/bbb.60328; Sunagawa M, 2002, FEMS MICROBIOL LETT, V211, P143, DOI 10.1016/S0378-1097(02)00635-3	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	SEP	2015	81	5					351	357		10.1007/s10327-015-0604-0		7	Plant Sciences	Plant Sciences	CQ6IV	WOS:000360708900002		
J	Kurose, D; Misawa, T; Suzui, T; Ichikawa, K; Kisaki, G; Hoang, LH; Furuya, N; Tsuchiya, K; Tsushima, S; Sato, T				Kurose, Daisuke; Misawa, Tomoo; Suzui, Takahito; Ichikawa, Kazunori; Kisaki, Gan; Long H. Hoang; Furuya, Naruto; Tsuchiya, Kenichi; Tsushima, Seiya; Sato, Toyozo			Taxonomic re-examination of several Japanese Stemphylium strains based on morphological and molecular phylogenetic analyses	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Conidial morphology; Multi-gene; Molecular phylogeny; Pleospora	SEQUENCE-DATA; LYCOPERSICI; FUNGI; CHINA	Most of the many Stemphylium species on record as plant pathogens in Japan have been identified by morphology. Using molecular phylogenetic analysis of four loci (rDNA-ITS, EF-1 alpha, GPD, and vmaA-vpsA) combined, we re-examined the taxonomy of 31 Stemphylium strains that had been identified morphologically before or after their deposit in the NIAS Genebank, Japan. In the present study, these Japanese strains were separated into three groups (Groups A, C, and E). Sixteen Japanese strains formed a new subgroup (designated Subgroup C2) that contained no type or ex-type strains of existing species. Four of the strains had been identified correctly, whereas the other 27 strains appear to have been misidentified based on our phylogenetic analysis. We examined the conidial morphology of four representative misidentified strains selected from each clade. While the morphological characteristics of a strain isolated from Welsh onion resembles those of the S. vesicarium type, this strain belongs to Subgroup C2 rather than Subgroup C1 and, therefore, could not be identified at the species level. Conversely, three pathogenic strains isolated from aster, asparagus, and Chinese chive were re-identified based on our combined morphological and phylogenetic data. We propose the scientific names of the aster leaf spot pathogen as S. lycopersici, and the asparagus Stemphylium leaf spot and Chinese chive brown leaf blight pathogens as S. herbarum.	[Kurose, Daisuke; Tsushima, Seiya] Nat Resources Inventory Ctr, Natl Inst Agro Environm Sci, Tsukuba, Ibaraki 3058604, Japan; [Misawa, Tomoo] Hokkaido Res Org, Donan Agr Expt Stn, Hokuto, Hokkaido 0411201, Japan; [Suzui, Takahito] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3008602, Japan; [Ichikawa, Kazunori] Yamanashi Prefectural Agritechnol Ctr, Kai, Yamanashi 4000105, Japan; [Kisaki, Gan] Kagawa Prefectural Agr Expt Stn, Ayauta, Kagawa 7612306, Japan; [Long H. Hoang] Agr Genet Inst, Dept Mol Plant Pathol, Hanoi, Vietnam; [Furuya, Naruto; Tsuchiya, Kenichi] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Sato, Toyozo] Genet Resources Ctr, Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	Sato, T (reprint author), Genet Resources Ctr, Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan.	s1043@affrc.go.jp					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Wang Y, 2010, MYCOLOGIA, V102, P708, DOI 10.3852/09-208; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Inderbitzin P, 2009, MYCOLOGIA, V101, P329, DOI [10.3052/08-071, 10.3852/08-071]; Shenoy BD, 2007, FUNGAL DIVERS, V26, P1; Camara MPS, 2002, MYCOLOGIA, V94, P660, DOI 10.2307/3761717; LEACH CM, 1970, MYCOLOGIA, V62, P1071, DOI 10.2307/3757622; MILLER PM, 1955, PHYTOPATHOLOGY, V45, P461; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; SIMMONS EG, 1969, MYCOLOGIA, V61, P1, DOI 10.2307/3757341; Deng JX, 2014, MYCOL PROG, V13, P477, DOI 10.1007/s11557-013-0929-z; Enjoji S, 1931, J PLANT PROT, V18, P48; Farr DF, 2014, FUNGAL DATABASES SYS; Hosen M. I., 2009, World Journal of Agricultural Sciences, V5, P94; Ichikawa Kazunori, 1994, Annals of the Phytopathological Society of Japan, V60, P523; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kubota M, 2010, MAFF MICROORG GENET, V30, P1; Kurose D, 2015, J GEN PLANT PATHOL, V81, P169, DOI 10.1007/s10327-015-0578-y; Kurose D, 2014, J GEN PLANT PATHOL, V80, P147, DOI 10.1007/s10327-013-0501-3; Minegishi N, 1991, P KANTO TOSAN PLANT, V38, P113; Misawa T, 2009, JPN J PHYTOPATHOL, V75, P87; Misawa T, 2009, ANN REPT PLANT PROT, V60, P55; Moralejo E, 2008, MYCOLOGIA, V100, P310, DOI 10.3852/mycologia.100.2.310; Nishi N, 2009, J GEN PLANT PATHOL, V75, P80, DOI 10.1007/s10327-008-0133-1; Nishihara N, 1961, MISCELLANEOUS PUBLIC, P54; Pei YF, 2011, MYCOL PROG, V10, P163, DOI 10.1007/s11557-010-0686-1; Phytopathological Society of Japan (PSJ) National Institute of Agrobiological Sciences (NIAS), 2012, COMM NAM PLANT DIS J, V2nd; Shibata S, 2000, ANN REPT PLANT PROT, V51, P62; SIMMONS E G, 1985, Sydowia, V38, P284; Simmons Emory G., 2001, Harvard Papers in Botany, V6, P199; SUZUI T, 1973, Annals of the Phytopathological Society of Japan, V39, P364; Tomioka Keisuke, 1997, Annals of the Phytopathological Society of Japan, V63, P337; Tomioka K, 2011, J GEN PLANT PATHOL, V77, P342, DOI 10.1007/s10327-011-0337-7; Wang Y, 2009, MYCOL PROG, V8, P301, DOI 10.1007/s11557-009-0600-x; Wang Y, 2006, MYCOTAXON, V96, P77; Watanabe T, 1989, T MYCOLOGICAL SOC JA, V30, P427; WILTSHIRE S. P., 1938, Transactions of the British Mycological Society, V21, P211; Yu SH, 2001, KOREAN SPECIES ALTER, P159	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	SEP	2015	81	5					358	367		10.1007/s10327-015-0607-x		10	Plant Sciences	Plant Sciences	CQ6IV	WOS:000360708900003		
J	Ishikawa, K; Maejima, K; Netsu, O; Fukuoka, M; Nijo, T; Hashimoto, M; Takata, D; Yamaji, Y; Namba, S				Ishikawa, Kazuya; Maejima, Kensaku; Netsu, Osamu; Fukuoka, Misato; Nijo, Takamichi; Hashimoto, Masayoshi; Takata, Daisuke; Yamaji, Yasuyuki; Namba, Shigetou			Rapid detection of fig mosaic virus using reverse transcription loop-mediated isothermal amplification	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Fig mosaic virus (FMV); Negative-strand RNA virus; Fig mosaic disease (FMD); Common fig; Reverse transcription loop-mediated isothermal amplification (RT-LAMP) detection	SENSE RNA VIRUS; SEQUENCE; MULTIPARTITE; SEGMENTS; FICUS; GENE	Fig mosaic virus (FMV), a negative-strand RNA virus, is a causal agent of fig mosaic disease, which occurs in almost all countries where figs are grown and severely affects worldwide fig production. Reverse transcription-polymerase chain reaction (RT-PCR) using FMV-specific primers has typically been used to detect FMV, but faster and easier detection methods for FMV are required because RT-PCR requires multiple steps and special equipment. In this study, we established a reverse transcription loop-mediated isothermal amplification (RT-LAMP) method to detect FMV. We designed LAMP primer sets based on sequence conservation among FMV isolates. The RT-LAMP reaction using a primer set targeting RNA3 in total RNA extracted from FMV-infected fig leaves resulted in rapid detection within 15 min. In addition, we established a fast and simple method of direct sampling from fig leaves using a wooden toothpick. The RT-LAMP reaction specificity and reactivity when using the direct sampling method were almost comparable to those obtained using isolated total RNA. Moreover, geographically and phylogenetically distinct FMV isolates were detectable using the FMV RT-LAMP assay. The assay presented here provides a practical method to detect FMV.	[Ishikawa, Kazuya; Maejima, Kensaku; Netsu, Osamu; Fukuoka, Misato; Nijo, Takamichi; Hashimoto, Masayoshi; Yamaji, Yasuyuki; Namba, Shigetou] Univ Tokyo, Grad Sch Agr & Life Sci, Plant Pathol Lab, Dept Agr & Environm Biol,Bunkyo Ku, Tokyo 1138657, Japan; [Takata, Daisuke] Univ Tokyo, Grad Sch Agr & Life Sci, Inst Sustainable Agroecosyst Serv, Nishi Tokyo, Tokyo 1880002, Japan	Namba, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Plant Pathol Lab, Dept Agr & Environm Biol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	anamba@mail.ecc.u-tokyo.ac.jp	Netsu, Osamu/O-1225-2015		Japan Society for the Promotion of Science	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. We thank Bojan Duduk (Institute of Pesticides and Environmental Protection, Belgrade-Zemun, Serbia), Shimane Agricultural Technology Center (Shimane, Japan) and Fukuoka Prefectural Plant Protection Office (Fukuoka, Japan) for kindly providing FMV-infected fig samples.	Elbeaino T, 2009, ARCH VIROL, V154, P1719, DOI 10.1007/s00705-009-0509-3; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Ishikawa K, 2013, J GEN VIROL, V94, P682, DOI 10.1099/vir.0.047860-0; Fukuta S, 2004, J VIROL METHODS, V121, P49, DOI 10.1016/j.viromet.2004.05.016; Fukuta S, 2003, J VIROL METHODS, V112, P35, DOI 10.1016/S0166-0934(03)00187-3; Boubourakas IN, 2009, J VIROL METHODS, V160, P63, DOI 10.1016/j.jviromet.2009.04.021; Ishikawa K, 2012, J GEN VIROL, V93, P1612, DOI 10.1099/vir.0.042663-0; BLODGETT EARLE C, 1967, PLANT DIS REP, V51, P893; Caglayan K, 2010, PLANT DIS, V94, P1448, DOI 10.1094/PDIS-11-09-0771; Condit IJ, 1933, PHYTOPATHOLOGY, V23, P887; Elbeaino T, 2009, J GEN VIROL, V90, P1281, DOI 10.1099/vir.0.008649-0; FLOCK RA, 1955, PHYTOPATHOLOGY, V45, P52; Ishikawa K, 2012, J GEN PLANT PATHOL, V78, P136, DOI 10.1007/s10327-012-0359-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Okuda M, 2005, PLANT DIS, V89, P705, DOI 10.1094/PD-89-0705; Sugawara K, 2012, J GEN PLANT PATHOL, V78, P389, DOI 10.1007/s10327-012-0403-9; Walia JJ, 2009, PLANT DIS, V93, P4, DOI 10.1094/PDIS-93-1-0004	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	SEP	2015	81	5					382	389		10.1007/s10327-015-0603-1		8	Plant Sciences	Plant Sciences	CQ6IV	WOS:000360708900005		
J	Komatsu, T; Kondo, N				Komatsu, Tsutomu; Kondo, Norio			Efficacy of a copper-based bactericide in controlling bacterial blight of grapevines caused by Xylophilus ampelinus	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Bacterial blight; Copper agent; Meta-analysis; Overwintering; Xylophilus ampelinus	CLINICAL-TRIALS; PLANT PATHOLOGY; VITIS-VINIFERA; METAANALYSIS; AGENT; NECROSIS; SPOT	We investigated the efficacy of a microbial copper agent to protect against bacterial blight of grapevine caused by Xylophilus ampelinus from 2012 to 2014 in Hokkaido, Japan. A solution of the basic copper wettable powder sulfate was sprayed at 10-day intervals in two processing plots, using two application protocols: seven rounds of application immediately after leaf development and three or four applications at the initial onset of the disease. Due to the low disease incidence for the duration of the study, symptoms were only observed on leaves, not on spikes or fruits. The disease incidence in plots that were treated at the initial stage of the disease was significantly lower than in untreated plots. This protective effect improved as the number of applications was increased. After overwintering of these vines, X. ampelinus was detected in the axillary buds of untreated vines, but it was seldom detected in vines treated at the initial onset of the disease. Thus, the copper agent controlled the extent of infection during the year of treatment and reduced the quantity of bacteria surviving overwintering. Our findings indicate that three or four applications of the agent at the initial stage of the disease should be effective to prevent bacterial blight of grapevines.	[Komatsu, Tsutomu; Kondo, Norio] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Komatsu, Tsutomu] Hokkaido Res Org, Cent Agr Expt Stn, Naganuma, Hokkaido 0691395, Japan	Komatsu, T (reprint author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	komatsu-tsutomu@hro.or.jp	Kondo, Norio/A-4358-2012				Madden LV, 2011, PHYTOPATHOLOGY, V101, P16, DOI 10.1094/PHYTO-03-10-0069; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Grall S, 2005, APPL ENVIRON MICROB, V71, P8292, DOI 10.1128/AEM.71.12.8292-8300.2005; Grall S, 2003, APPL ENVIRON MICROB, V69, P1904, DOI 10.1128/AEM.69.4.1904-1912.2003; GRASSO S, 1979, RIV PATOL VEG, V15, P91; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawaguchi A, 2014, J GEN PLANT PATHOL, V80, P158, DOI 10.1007/s10327-014-0506-6; Komatsu T, 2015, J GEN PLANT PATHOL, V81, P237, DOI 10.1007/s10327-015-0581-3; Lopez M. M., 1987, OEPP EPPO B, V17, P231; PANAGOPOULOS C G, 1987, Bulletin OEPP, V17, P225; PANAGOPOULOS C G, 1969, Annales de l'Institut Phytopathologique Benaki, V9, P59; Rosenberg MS, 2004, PHYTOPATHOLOGY, V94, P1013, DOI 10.1094/PHYTO.2004.94.9.1013; Sawada H., 2011, Japanese Journal of Phytopathology, V77, P7; Shinmura A, 2012, JPN J PHYTOPATHOL, V78, P60; Tango T, 2002, GUIDE METAANALYSIS; WILLEMS A, 1987, Bulletin OEPP, V17, P237	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	SEP	2015	81	5					409	414		10.1007/s10327-015-0609-8		6	Plant Sciences	Plant Sciences	CQ6IV	WOS:000360708900008		
J	Minami, T; Minami, T; Shimizu, N; Yamamoto, Y; De Velasco, M; Nozawa, M; Yoshimura, K; Harashima, N; Harada, M; Uemura, H				Minami, Takafumi; Minami, Tomoko; Shimizu, Nobutaka; Yamamoto, Yutaka; De Velasco, Marco; Nozawa, Masahiro; Yoshimura, Kazuhiro; Harashima, Nanae; Harada, Mamoru; Uemura, Hirotsugu			Identification of Programmed Death Ligand 1-derived Peptides Capable of Inducing Cancer-reactive Cytotoxic T Lymphocytes From HLA-A24(+) Patients With Renal Cell Carcinoma	JOURNAL OF IMMUNOTHERAPY			English	Article						renal cell carcinoma; PD-L1; HLA-A24; peptide; CTL	PHASE-I TRIAL; VACCINATION; B7-H1; INTERLEUKIN-2; VACCINES; ANTIBODY; TARGET; SAFETY	Molecular therapy targeting tumor angiogenesis has been the standard treatment for metastatic renal cell carcinoma (mRCC). However, despite their significant antitumor effects, most of patients with mRCC have not been cured. Under such circumstances, anticancer immunotherapy has been considered a promising treatment modality for mRCC, and cancer-reactive cytotoxic T lymphocytes (CTLs) are the most powerful effectors among several immune cells. However, anticancer CTLs can be inhibited by several immune inhibitory mechanisms, including the interaction between programmed death 1 (PD-1) and its ligand PD-L1, on T cells and cancer cells, respectively. Alternatively, this also means that PD-L1 could be a promising target for anticancer immunotherapy. Therefore, we searched for PD-L1-derived peptides that are applicable for anticancer vaccine for HLA-A24(+) RCC patients. Among 5 peptides derived from PD-L1, which were prepared based on the binding motif to the HLA-A24 allele, both PD-L1(11-19) and PD-L1(41-50) peptides induced peptide-specific CTLs from peripheral blood mononuclear cells of HLA-A24(+) RCC patients. Such PD-L1 peptide-stimulated CD8(+) T cells showed cytotoxicity against HLA-A24(+) and PD-L1-expressing RCC cells. Although IFN- treatment increased PD-L1 expression on PD-L1(low) RCC cells, their sensitivity to cytotoxicity of PD-L1 peptide-stimulated CD8(+) T cells varied between patients. Altogether, these results indicate that both PD-L1(11-19) and PD-L1(41-50) peptides could be candidates for peptide-based anticancer vaccines for HLA-A24(+) mRCC patients.	[Minami, Takafumi; Minami, Tomoko; Shimizu, Nobutaka; Yamamoto, Yutaka; De Velasco, Marco; Nozawa, Masahiro; Yoshimura, Kazuhiro; Uemura, Hirotsugu] Kinki Univ, Dept Urol, Sch Med, Osaka 5898511, Japan; [Harashima, Nanae; Harada, Mamoru] Shimane Univ, Sch Med, Dept Immunol, Izumo, Shimane, Japan	Minami, T (reprint author), Kinki Univ, Dept Urol, Sch Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	minami@med.kindai.ac.jp			KAKENHI (from the Ministry of Education, Culture, Sports, Science, and Technology of Japan) [22390305]	Supported in part by KAKENHI (Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan) (No. 22390305 to H.U.).	Abiko K, 2012, CLIN CANCER RES, V19, P1363; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; PARKER KC, 1994, J IMMUNOL, V152, P163; Munir S, 2013, CANCER RES, V73, P1764, DOI 10.1158/0008-5472.CAN-12-3507; Yoshimura K, 2013, BRIT J CANCER, V108, P1260, DOI 10.1038/bjc.2013.90; Ljungberg B, 2007, EUR UROL, V51, P1502, DOI 10.1016/j.eururo.2007.03.035; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Uemura H, 2006, CLIN CANCER RES, V12, P1768, DOI 10.1158/1078-0432.CCR-05-2253; Suekane S, 2007, CANCER SCI, V98, P1965, DOI 10.1111/j.1349-7006.2007.00631.x; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Hida N, 2002, CANCER IMMUNOL IMMUN, V51, P219, DOI 10.1007/s00262-002-0273-7; Imanishi T., 1992, HLA 1991, V1, P1065; Minami T, 2014, INT IMMUNOPHARMACOL, V20, P59, DOI 10.1016/j.intimp.2014.02.018; Munir S, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23991; Naota H, 2006, J IMMUNOL METHODS, V314, P54, DOI 10.1016/j.jim.2006.05.009; Noman MZ, J EXP MED, V211, P781; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Shimizu K, 2003, ONCOL REP, V10, P1307; Toplalian SL, 2012, CURR OPIN IMMUNOL, V24, P207; Torikai H, 2007, BONE MARROW TRANSPL, V40, P165, DOI 10.1038/sj.bmt.1705689; Uemura H, 1999, BRIT J CANCER, V81, P741, DOI 10.1038/sj.bjc.6690757; Uemura H, 2008, WORLD J UROL, V26, P147, DOI 10.1007/s00345-008-0246-3	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1524-9557	1537-4513		J IMMUNOTHER	J. Immunother.	SEP	2015	38	7					285	291		10.1097/CJI.0000000000000090		7	Oncology; Immunology; Medicine, Research & Experimental	Oncology; Immunology; Research & Experimental Medicine	CQ4QB	WOS:000360588600004		
J	Dorre, K; Olczak, M; Wada, Y; Sosicka, P; Gruneberg, M; Reunert, J; Kurlemann, G; Fiedler, B; Biskup, S; Hortnagel, K; Rust, S; Marquardt, T				Doerre, K.; Olczak, M.; Wada, Y.; Sosicka, P.; Grueneberg, M.; Reunert, J.; Kurlemann, G.; Fiedler, B.; Biskup, S.; Hoertnagel, K.; Rust, S.; Marquardt, T.			A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach	JOURNAL OF INHERITED METABOLIC DISEASE			English	Article							NUCLEOTIDE SUGAR TRANSPORTERS; GDP-FUCOSE TRANSPORTER; CONGENITAL DISORDERS; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN SYNDROME; X-CHROMOSOME; GLYCOSYLATION; INACTIVATION; MUTATION; DISEASE	Congenital disorders of glycosylation (CDG) are a group of hereditary metabolic diseases characterized by abnormal glycosylation of proteins and lipids. Often, multisystem disorders with central nervous system involvement and a large variety of clinical symptoms occur. The main characteristics are developmental delay, seizures, and ataxia. In this paper we report the clinical and biochemical characteristics of a 5-year-old girl with a defective galactosylation of N-glycans, resulting in developmental delay, muscular hypotonia, epileptic seizures, inverted nipples, and visual impairment. Next generation sequencing revealed a de novo mutation (c.797G > T, p.G266V) in the X-chromosomal gene SLC35A2 (solute carrier family 35, UDP-galactose transporter, member A2; MIM 300896). While this mutation was found heterozygous, random X-inactivation of the normal allele will lead to loss of normal SLC35A2 activity in respective cells. The functional relevance of the mutation was demonstrated by complementation of UGT-deficient MDCK-RCA(r) and CHO-Lec8 cells by normal UGT-expression construct but not by the mutant version. The effect of dietary galactose supplementation on glycosylation was investigated, showing a nearly complete normalization of transferrin glycosylation.	[Doerre, K.; Grueneberg, M.; Reunert, J.; Kurlemann, G.; Fiedler, B.; Rust, S.; Marquardt, T.] Univ Klinikum Munster, Klin Kinder & Jugendmed, D-48149 Munster, Germany; [Olczak, M.; Sosicka, P.] Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50138 Wroclaw, Poland; [Wada, Y.] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Biskup, S.; Hoertnagel, K.] Praxis Humangenet & CeGaT GmbH, Tubingen, Germany	Marquardt, T (reprint author), Univ Klinikum Munster, Klin Kinder & Jugendmed, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	marquat@uni-muenster.de					Sprong H, 2003, MOL BIOL CELL, V14, P3482, DOI 10.1091/mbc.E03-03-0130; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/88289; Marquardt T, 1999, BLOOD, V94, P3976; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Ng BG, 2013, AM J HUM GENET, V92, P632, DOI 10.1016/j.ajhg.2013.03.012; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Biffi S, 2007, CLIN BIOCHEM, V40, P1431, DOI 10.1016/j.clinbiochem.2007.08.015; Biskup S, 2010, LABORATORIUMSMEDIZIN, V34, P305, DOI 10.1515/JLM.2010.056; CLAYTON P, 1993, LANCET, V341, P956, DOI 10.1016/0140-6736(93)91244-G; Ferrari MC, 2001, EUR J ENDOCRINOL, V144, P409, DOI 10.1530/eje.0.1440409; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Kabuss R, 2005, GLYCOBIOLOGY, V15, P905, DOI 10.1093/glycob/cwi085; Kniffin CL, 2013, SOLUTE CARRIER FAMIL; Kodera H, 2013, HUMU; Mandato C, 2006, PEDIATR RES, V59, P293, DOI 10.1203/01.pdr.0000196378.30165.26; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Martinez-Duncker I, 2005, BLOOD, V105, P2671, DOI 10.1182/blood-2004-09-3509; Maszczak-Seneczko D, 2011, GLYCOCONJUGATE J, V28, P481, DOI 10.1007/s10719-011-9348-z; Olczak M, 2013, BIOCHEM BIOPH RES CO, V434, P473, DOI 10.1016/j.bbrc.2013.03.098; Olczak M, 2006, BBA-MOL CELL RES, V1763, P82, DOI 10.1016/j.bbamcr.2005.12.006; Song ZW, 2013, MOL ASPECTS MED, V34, P590, DOI 10.1016/j.mam.2012.12.004; STANLEY P, 1989, MOL CELL BIOL, V9, P377; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; Vallot C, 2013, M S-MED SCI, V29, P223, DOI 10.1051/medsci/2013292024	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-8955	1573-2665		J INHERIT METAB DIS	J. Inherit. Metab. Dis.	SEP	2015	38	5					931	940		10.1007/s10545-015-9828-6		10	Endocrinology & Metabolism; Genetics & Heredity	Endocrinology & Metabolism; Genetics & Heredity	CQ2NC	WOS:000360436700018		
J	Saito, M; Toth, G; Okabe, Y				Saito, M.; Toth, G.; Okabe, Y.			DIFFERENT ATTITUDES TOWARDS PEOPLE WITH INTELLECTUAL DISABILITIES BETWEEN EARLY CHILDHOOD CARE AND EDUCATION TEACHERS AND UNDERGRADUATE STUDENTS	JOURNAL OF INTELLECTUAL DISABILITY RESEARCH			English	Meeting Abstract									[Saito, M.] Nippon Sport Sci Univ, Tokyo, Japan; [Toth, G.] Sagami Womens Univ, Sagamihara, Kanagawa, Japan; [Okabe, Y.] Hamamatsu Gakuin Univ, Shizuoka, Japan		saitou.ma@nittai.ac.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0964-2633	1365-2788		J INTELL DISABIL RES	J. Intell. Disabil. Res.	SEP	2015	59			1	SI		41	41				1	Education, Special; Genetics & Heredity; Clinical Neurology; Psychiatry; Rehabilitation	Education & Educational Research; Genetics & Heredity; Neurosciences & Neurology; Psychiatry; Rehabilitation	CQ3KI	WOS:000360500500093		
J	Yang, J; Sun, SS; Li, WH; Du, HP; Alici, G; Nakano, M				Yang, Jian; Sun, Shuaishuai; Li, Weihua; Du, Haiping; Alici, Gursel; Nakano, Masami			Development of a linear damper working with magnetorheological shear thickening fluids	JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES			English	Article						Magnetorheological shear thickening fluid; linear damper; shear thickening effect; magnetorheological effect	ELECTRORHEOLOGICAL FLUID; DYNAMIC PROPERTIES; HAPTIC DEVICE; SUSPENSIONS; SYSTEMS; BRAKE	Magnetorheological shear thickening fluid is a smart material that exhibits both magnetorheological and shear thickening effects. This study focuses on the design and development of a novel magnetorheological shear thickening fluid-based linear damper. First, micron-sized carbonyl iron particles, at a 20% and 80% weight fraction, were immersed among the shear thickening fluid base and thoroughly mixed under a high shear condition to produce the magnetorheological shear thickening fluid. Then, a monotube damper with a bypass was designed and fabricated. The testing results using an MTS machine show that the influence of incorporating shear thickening fluid allows the 20% magnetorheological shear thickening fluid-filled damper to work in different dynamic loading velocities with the stiffness and damping changed, while, simultaneously, the dynamics of the damper depend on the variations in the magnetic field. The measured responses of the 20% magnetorheological shear thickening fluid-filled damper prove that the dampers have both the MR effect and shear thickening effect. In contrast, the 80% magnetorheological shear thickening fluid-filled damper behaves more like a conventional magnetorheological fluid-filled damper because its shear thickening effect is restrained and the MR effect becomes more obvious with higher iron volume.	[Yang, Jian; Sun, Shuaishuai; Li, Weihua; Alici, Gursel] Univ Wollongong, Sch Mech Mat & Mechatron Engn, Wollongong, NSW 2522, Australia; [Du, Haiping] Univ Wollongong, Sch Elect Comp & Telecommun Engn, Wollongong, NSW 2522, Australia; [Nakano, Masami] Tohoku Univ, Inst Fluid Sci, Intelligent Fluid Control Syst Lab, Sendai, Miyagi 980, Japan	Li, WH (reprint author), Univ Wollongong, Sch Mech Mat & Mechatron Engn, Northfields Ave, Wollongong, NSW 2522, Australia.	weihuali@uow.edu.au	Li, Weihua/G-3605-2012	Li, Weihua/0000-0002-6190-8421	ARC [DP150102636]; University of Wollongong-China Scholarship Council joint PhD scholarships; JSPS Invitation Fellowship	This research was supported by the ARC Discovery Grant (DP150102636) and University of Wollongong-China Scholarship Council joint PhD scholarships. This research was also partially supported by the JSPS Invitation Fellowship 2014.	Franks GV, 2000, J RHEOL, V44, P759, DOI 10.1122/1.551111; Fischer C, 2006, SMART MATER STRUCT, V15, P1467, DOI 10.1088/0964-1726/15/5/036; Hasanzadeh M, 2014, J MATER ENG PERFORM, V23, P1182, DOI 10.1007/s11665-014-0870-6; Popp KM, 2010, J INTEL MAT SYST STR, V21, P1471, DOI 10.1177/1045389X09355666; Wereley NM, 2004, SMART MATER STRUCT, V13, P743, DOI [10.1088/0964-1726/13/4/012, 10.1088/1726/13/4/012]; Zhang XZ, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/3/035027; Lee YS, 2003, RHEOL ACTA, V42, P199, DOI 10.1007/s00397-002-0290-7; Liu B, 2006, SMART MATER STRUCT, V15, P1960, DOI 10.1088/0964-1726/15/6/052; Wang DH, 2009, VEHICLE SYST DYN, V47, P1305, DOI 10.1080/00423110802538328; Zhang XZ, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/12/125012; Yoshioka H, 2002, J ENG MECH-ASCE, V128, P540, DOI 10.1061/(ASCE)0733-9399(2002)128:5(540); BONNECAZE RT, 1992, J CHEM PHYS, V96, P2183, DOI 10.1063/1.462070; Carlson J D, 1996, P 3 INT C MOT VIBR C, V3, P35; Du HP, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/10/105016; Han YM, 2006, SMART MATER STRUCT, V15, P1438, DOI 10.1088/0964-1726/15/5/033; John S, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/2/025023; Jung HJ, 2004, STRUCT ENG MECH, V17, P493; Li WH, 2003, INT J ADV MANUF TECH, V21, P508, DOI 10.1007/s001700300060; Soutrenon M, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/3/035022; STANWAY R, 1987, J ELECTROSTAT, V20, P167, DOI 10.1016/0304-3886(87)90056-8; Zhang XZ, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/1/015051	21	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1045-389X	1530-8138		J INTEL MAT SYST STR	J. Intell. Mater. Syst. Struct.	SEP	2015	26	14					1811	1817		10.1177/1045389X15577653		7	Materials Science, Multidisciplinary	Materials Science	CQ7DI	WOS:000360762700008		
J	Jeong, SH; Tanaka, Y; Morito, K				Jeong, Seok-Hwan; Tanaka, Yu; Morito, Ken			1 x 4 Channel Si-Nanowire Microring-Assisted Multiple Delayline-Based Optical MUX/DeMUX	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Microring resonator; optical demultiplexer; optical interconnect; optical waveguide; silicon photonics; wavelength division multiplexing	MACH-ZEHNDER INTERFEROMETER; PERIODIC MULTI/DEMULTIPLEXER; CMOS TECHNOLOGY; RING-RESONATOR; WAVE-GUIDES; COUPLER; INTERLEAVER; PASSBAND; FILTERS	We proposed theoretically analyzed and experimentally demonstrated novel 1 x 4 channel flatband optical multiplexer/demultiplexer (MUX/DeMUX) that is based on Si-nanowire microring-assisted multiple delaylines. The proposed optical MUX/DeMUX scheme, which includes all-pass microring-type phase controllers and a Banyan-type 4 x 4 coupler, exhibits superior spectral flatness to any Si-nanowire optical DeMUXs that have previously been experimentally demonstrated.	[Jeong, Seok-Hwan; Tanaka, Yu; Morito, Ken] Photon Elect Technol Res Assoc, Tsukuba, Ibaraki 3058563, Japan	Jeong, SH (reprint author), Photon Elect Technol Res Assoc, Tsukuba, Ibaraki 3058563, Japan.	s-jeong@petra-jp.org; tanaka@petra-jp.org; k-morito@petra-jp.org			New Energy and Industrial Technology Development Organization	This work was supported in part by the New Energy and Industrial Technology Development Organization.	Miller DAB, 2009, P IEEE, V97, P1166, DOI 10.1109/JPROC.2009.2014298; Jeong SH, 2014, OPT LETT, V39, P3702, DOI 10.1364/OL.39.003702; Bogaerts W, 2010, IEEE J SEL TOP QUANT, V16, P33, DOI 10.1109/JSTQE.2009.2039680; Luo LW, 2010, OPT EXPRESS, V18, P23079, DOI 10.1364/OE.18.023079; Halir R, 2012, OPT EXPRESS, V20, P13470, DOI 10.1364/OE.20.013470; Vlasov YA, 2012, IEEE COMMUN MAG, V50, pS67, DOI 10.1109/MCOM.2012.6146487; Park S, 2011, OPT EXPRESS, V19, P13531, DOI 10.1364/OE.19.013531; Zhang Y, 2013, IEEE PHOTONIC TECH L, V25, P422, DOI 10.1109/LPT.2013.2241049; Kim DW, 2008, OPT LETT, V33, P530, DOI 10.1364/OL.33.000530; Assefa S., 2012, P IEEE INT EL DEV M; Fohn T., 2014, OPT FIB COMM C SAN F; Halir R, 2011, OPT LETT, V36, P178, DOI 10.1364/OL.36.000178; Horst F., 2010, OPT FIB COMM C SAN D; Jeong S.-H., 2014, EUR C OPT COMM CANN; Jeong S.-H., 2013, OPT EXP, V20, P26000; Kim DJ, 2008, IEEE PHOTONIC TECH L, V20, P1615, DOI 10.1109/LPT.2008.2002731; Kohtoku M, 2000, IEEE PHOTONIC TECH L, V12, P1174, DOI 10.1109/68.874226; Leick L, 2002, OPT LETT, V27, P1318, DOI 10.1364/OL.27.001318; Roeloffzen CGH, 2003, P SOC PHOTO-OPT INS, V4947, P84, DOI 10.1117/12.468252; Sanchis P, 2009, OPT LETT, V34, P2760, DOI 10.1364/OL.34.002760; Sheng Z, 2012, IEEE PHOTONICS J, V4, P2272, DOI 10.1109/JPHOT.2012.2230320; Tsuchizawa T, 2006, JPN J APPL PHYS 1, V45, P6658, DOI 10.1143/JJAP.45.6658; Wang ZP, 2007, IEEE PHOTONIC TECH L, V19, P1072, DOI 10.1109/LPT.2007.899815	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	SEP 1	2015	33	17					3736	3743		10.1109/JLT.2015.2457431		8	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CQ3LO	WOS:000360504000029		
J	Kawaguchi, T; Ogawa, Y; Watanabe, M; Tominaga, T				Kawaguchi, Tomohiro; Ogawa, Yoshikazu; Watanabe, Mika; Tominaga, Teiji			Craniopharyngiomas Presenting with Nonobstructive Hydrocephalus: Underlying Influence of Subarachnoidal Hemorrhage. Two Case Reports	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						craniopharyngioma; communicating hydrocephalus; subarachnoid hemorrhage; cerebrospinal fluid; malabsorption	OF-THE-LITERATURE; INTRATUMORAL HEMORRHAGE; BRAIN-TUMORS; CHILDREN; MANAGEMENT; CHILDHOOD; ANEURYSMS; ADULTS	Nonobstructive hydrocephalus in craniopharyngioma patients is rare, and the etiology is not known. We report two cases of patients with craniopharyngioma who presented with nonobstructive hydrocephalus. Repeated subarachnoidal hemorrhage (SAH) was considered as the underlying mechanism of hydrocephalus development. The first case was a 67-year-old woman presenting with deteriorated consciousness. Head computed tomography (CT) and magnetic resonance (MR) imaging demonstrated a solid suprasellar tumor with subarachnoidal and intraventricular hematoma with ventricle dilatation but no cerebrospinal fluid (CSF) obstruction. The extended transsphenoidal approach achieved gross total removal. Because of persistent ventricle dilatation, ventriculoperitoneal shunt was required. The second case was a 35-year-old woman presenting with persistent headache. Head CT and MR imaging demonstrated a solid suprasellar tumor with ventricular dilatation but no CSF obstruction. The extended transsphenoidal approach achieved gross total removal. The postoperative course was uneventful, and a ventriculoperitoneal shunt was not required. In both cases, histologic examination of the tumors revealed squamous-papillary type craniopharyngioma with remarkable inflammatory cell infiltrations in the perivascular space. CSF cytology revealed hemosiderin-laden phagocytes, indicative of previous SAH causing CSF malabsorption. These cases suggested that surgery should be indicated for patients with craniopharyngiomas with nonobstructive hydrocephalus, even if the tumors are not associated with neurologic and/or endocrinologic deficits.	[Kawaguchi, Tomohiro; Ogawa, Yoshikazu] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi 9828523, Japan; [Watanabe, Mika] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan	Ogawa, Y (reprint author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, 4-20-1 Nagamachiminami, Sendai, Miyagi 9828523, Japan.	yogawa@kohnan-sendai.or.jp					VANGIJN J, 1985, J NEUROSURG, V63, P355; DeVile CJ, 1996, J NEUROSURG, V85, P73, DOI 10.3171/jns.1996.85.1.0073; Puget S, 2007, J NEUROSURG, V106, P3, DOI 10.3171/ped.2007.106.1.3; Van Effenterre R, 2002, J NEUROSURG, V97, P3, DOI 10.3171/jns.2002.97.1.0003; CINALLI G, 1995, J NEUROSURG, V83, P480, DOI 10.3171/jns.1995.83.3.0480; HOFFMAN HJ, 1992, J NEUROSURG, V76, P47, DOI 10.3171/jns.1992.76.1.0047; Duff JM, 2000, NEUROSURGERY, V46, P291, DOI 10.1097/00006123-200002000-00007; Karavitaki N, 2006, ENDOCR REV, V27, P371, DOI 10.1210/er.2006-0002; [Anonymous], 2003, J NEUROSURG SCI, V47, P210; WEINER HL, 1994, NEUROSURGERY, V35, P1001; Tomita T, 2005, CHILD NERV SYST, V21, P729, DOI 10.1007/s00381-005-1202-9; Karavitaki N, 2005, CLIN ENDOCRINOL, V62, P397, DOI 10.1111/j.1365-2265.2005.02231.x; Wong TT, 2011, CHILD NERV SYST, V27, P1723, DOI 10.1007/s00381-011-1523-9; Licata B, 2003, J Neurosurg Sci, V47, P201; Bloch J, 2003, ACTA NEUROCHIR, V145, P73, DOI 10.1007/s00701-002-1021-7; Celli P, 1993, J Neurosurg Sci, V37, P97; Dario A, 1993, J Neurosurg Sci, V37, P179; Duff J, 2000, NEUROSURGERY, V46, P302, DOI DOI 10.1097/00006123-200002000-00007; FINCHER EF, 1951, J NEUROSURG, V8, P576, DOI 10.3171/jns.1951.8.6.0576; Lai L, 2013, J CLIN NEUROSCI, V20, P1134, DOI 10.1016/j.jocn.2012.09.033; Lin LL, 2008, J NEUROS-PEDIATR, V1, P126, DOI 10.3171/PED/2008/1/2/126; LOCKSLEY HB, 1966, J NEUROSURG, V24, P1034, DOI 10.3171/jns.1966.24.6.1034; Nishioka H, 2000, NEUROL MED-CHIR, V40, P324, DOI 10.2176/nmc.40.324; Nomura K, 2003, NEUROL MED CHIR TOKY, V40, P1; OHTA K, 1990, ANN NEUROL, V27, P441, DOI 10.1002/ana.410270414; Shibao S, 2012, BRAIN TUMOR PATHOL, V29, P96, DOI 10.1007/s10014-011-0068-7; Vanhauwaert D, 2013, J NEUROL SURG PART A, V74, P307, DOI 10.1055/s-0033-1341413; Weiner HL, 1994, NEUROSURGERY, V69, P643, DOI DOI 10.1227/00006123-199412000-00001; Yamashita S, 2004, NEUROL MED-CHIR, V44, P43, DOI 10.2176/nmc.44.43; YOKOTA A, 1987, CHILD NERV SYST, V3, P65, DOI 10.1007/BF00271124	30	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	SEP	2015	76	5					418	423		10.1055/s-0034-1382784		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CQ1TY	WOS:000360383600012		
J	Zanou, N; Mondin, L; Fuster, C; Seghers, F; Dufour, I; de Clippele, M; Schakman, O; Tajeddine, N; Iwata, Y; Wakabayashi, S; Voets, T; Allard, B; Gailly, P				Zanou, Nadege; Mondin, Ludivine; Fuster, Clarisse; Seghers, Francois; Dufour, Ines; de Clippele, Marie; Schakman, Olivier; Tajeddine, Nicolas; Iwata, Yuko; Wakabayashi, Shigeo; Voets, Thomas; Allard, Bruno; Gailly, Philippe			Osmosensation in TRPV2 dominant negative expressing skeletal muscle fibres	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							RAT SOLEUS MUSCLE; CA2+ RELEASE; VENTRICULAR MYOCYTES; HYPERTONIC SOLUTIONS; HYPEROSMOTIC STRESS; DANTROLENE SODIUM; VOLUME REGULATION; OSMOTIC-STRESS; PROTEIN-KINASE; BLOOD-PRESSURE	Increased plasma osmolarity induces intracellular water depletion and cell shrinkage followed by activation of a regulatory volume increase (RVI). In skeletal muscle, this is accompanied by transverse tubule (TT) dilatation and by a membrane depolarization responsible for a release of Ca2+ from intracellular pools. We observed that both hyperosmotic shock-induced Ca2+ transients and RVI were inhibited by Gd3+, ruthenium red and GsMTx4 toxin, three inhibitors of mechanosensitive ion channels. The response was also completely absent in muscle fibres overexpressing a non-permeant, dominant negative (DN) mutant of the transient receptor potential, V2 isoform (TRPV2) ion channel, suggesting the involvement of TRPV2 or of a TRP isoform susceptible to heterotetramerization with TRPV2. The release of Ca2+ induced by hyperosmotic shock was increased by cannabidiol, an activator of TRPV2, and decreased by tranilast, an inhibitor of TRPV2, suggesting a role for the TRPV2 channel itself. Hyperosmotic shock-induced membrane depolarization was impaired in TRPV2-DN fibres, suggesting that TRPV2 activation triggers the release of Ca2+ from the sarcoplasmic reticulum by depolarizing TTs. RVI requires the sequential activation of STE20/SPS1-related proline/alanine-rich kinase (SPAK) and NKCC1, a Na+-K+-Cl- cotransporter, allowing ion entry and driving osmotic water flow. In fibres overexpressing TRPV2-DN as well as in fibres in which Ca2+ transients were abolished by the Ca2+ chelator BAPTA, the level of P-SPAK(Ser373) in response to hyperosmotic shock was reduced, suggesting a modulation of SPAK phosphorylation by intracellular Ca2+. We conclude that TRPV2 is involved in osmosensation in skeletal muscle fibres, acting in concert with P-SPAK-activated NKCC1.	[Zanou, Nadege; Mondin, Ludivine; Seghers, Francois; Dufour, Ines; de Clippele, Marie; Schakman, Olivier; Tajeddine, Nicolas; Gailly, Philippe] Catholic Univ Louvain, Inst Neurosci, Lab Cell Physiol, B-1200 Brussels, Belgium; [Fuster, Clarisse; Allard, Bruno] Univ Lyon 1, CNRS, UMR 5534, Ctr Genet & Physiol Cellulaire & Mol, F-69622 Villeurbanne, France; [Iwata, Yuko; Wakabayashi, Shigeo] Natl Cardiovasc Ctr, Res Inst, Dept Mol Physiol, Suita, Osaka 5658565, Japan; [Voets, Thomas] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Ion Channel Res, B-3000 Louvain, Belgium	Gailly, P (reprint author), Catholic Univ Louvain, Inst Neurosci, Lab Cell Physiol, Ave Mounier,B1-53-17, B-1200 Brussels, Belgium.	philippe.gailly@uclouvain.be			"Association francaise contre les myopathies" (AFM) [16738]; "Association belge contre les maladies neuro-musculaires" (ABMM); Concerted Research Action from the General Direction of Scientific Research of the French Community of Belgium [ARC10/15-029]; Interuniversity Poles of Attraction Belgian Science Policy [P7/13]	The work was funded by the "Association francaise contre les myopathies" (AFM grant 16738), the "Association belge contre les maladies neuro-musculaires" (ABMM), by a Concerted Research Action from the General Direction of Scientific Research of the French Community of Belgium (ARC10/15-029) and the Interuniversity Poles of Attraction Belgian Science Policy (P7/13). L.M. was post-doctoral fellow and N.Z. is postdoctoral researcher of the Fonds de la Recherche Scientifique (FNRS, Belgium).	Kawai M, 1999, AM J PHYSIOL-HEART C, V277, pH603; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Gailly P, 2012, CURR OPIN PHARMACOL, V12, P326, DOI 10.1016/j.coph.2012.01.018; Hoffmann EK, 2001, COMP BIOCHEM PHYS A, V130, P355, DOI 10.1016/S1095-6433(01)00419-6; SJOGAARD G, 1985, AM J PHYSIOL, V248, pR190; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JC131766; Zhao FY, 2001, J BIOL CHEM, V276, P13810; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; BRATUSCHMARRAIN PR, 1983, DIABETES, V32, P1028, DOI 10.2337/diabetes.32.11.1028; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Kanzaki M, 1999, NAT CELL BIOL, V1, P165; Dulhunty AF, 2006, CLIN EXP PHARMACOL P, V33, P763, DOI 10.1111/j.1440-1681.2006.04441.x; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Ho TC, 2012, CHANNELS, V6, P246, DOI 10.4161/chan.20719; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Apostol S, 2009, J MUSCLE RES CELL M, V30, P97, DOI 10.1007/s10974-009-9179-8; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Pickering JD, 2009, J GEN PHYSIOL, V133, P511, DOI 10.1085/jgp.200910191; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; HAUSSINGER D, 1993, LANCET, V341, P1330, DOI 10.1016/0140-6736(93)90828-5; Szentesi P, 2001, J GEN PHYSIOL, V118, P355, DOI 10.1085/jgp.118.4.355; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Russell JM, 2000, PHYSIOL REV, V80, P211; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Caterina MJ, 1999, NATURE, V398, P436; Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571; Brinkmeier H, 2011, ADV EXP MED BIOL, V704, P749, DOI 10.1007/978-94-007-0265-3_39; BRUTON JD, 1989, Q J EXP PHYSIOL CMS, V74, P565; Chawla S, 2001, J PHYSIOL-LONDON, V536, P351, DOI 10.1111/j.1469-7793.2001.0351c.xd; CLAUSEN T, 1979, J PHYSIOL-LONDON, V292, P505; DREWNOWSKA K, 1991, AM J PHYSIOL, V260, pC122; ELLIS KO, 1972, N-S ARCH PHARMACOL, V274, P107, DOI 10.1007/BF00501011; ELLIS KO, 1972, N-S ARCH PHARMACOL, V275, P83, DOI 10.1007/BF00505069; Foster D W, 1974, Adv Intern Med, V19, P159; Foppen RJG, 2004, PFLUG ARCH EUR J PHY, V447, P416, DOI 10.1007/s00424-003-1165-1; Gosmanov AR, 2003, NEWS PHYSIOL SCI, V18, P196, DOI 10.1152/nips.01446.2003; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; GULATI J, 1986, BIOPHYS J, V49, P949; Hattori T, 2006, INT J NEUROSCI, V116, P1501, DOI 10.1080/00207450600553000; HERMSMEY.K, 1972, J GEN PHYSIOL, V59, P779, DOI 10.1085/jgp.59.6.779; Ikemoto T, 2001, BRIT J PHARMACOL, V134, P729, DOI 10.1038/sj.bjp.0704307; Klein MG, 1996, NATURE, V379, P455, DOI 10.1038/379455a0; Liedtke CM, 2002, BBA-MOL CELL RES, V1589, P77, DOI 10.1016/S0167-4889(01)00189-6; Marino A, 2007, COMP BIOCHEM PHYS A, V147, P196, DOI 10.1016/j.cbpa.2006.12.030; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Ponce-Coria J, 2012, AM J PHYSIOL-CELL PH, V303, pC1198, DOI 10.1152/ajpcell.00284.2012; Pouvreau Sandrine, 2007, V403, P185, DOI 10.1007/978-1-59745-529-9_12; Sid B, 2010, J PHYSIOL-LONDON, V588, P2315, DOI 10.1113/jphysiol.2009.185900; SITDIKOV R F, 1989, Byulleten' Eksperimental'noi Biologii i Meditsiny, V108, P563; vanMil HGJ, 1997, BRIT J PHARMACOL, V120, P39, DOI 10.1038/sj.bjp.0700887; Vassort G, 2008, M S-MED SCI, V24, P163, DOI 10.1051/medsci/2008242163; Wang Z, 2011, CELL PHYSIOL BIOCHEM, V28, P703, DOI 10.1159/000335764; WATSON PD, 1993, AM J PHYSIOL, V264, pR790; Wehner F, 2003, Rev Physiol Biochem Pharmacol, V148, P1, DOI 10.1007/s10254-003-0009-x; Weisleder N, 2006, ACTA PHARMACOL SIN, V27, P791, DOI 10.1111/j.1745-7254.2006.00384.x; WILDENTHAL K, 1975, AM J PHYSIOL, V229, P1505; Willerson J T, 1975, Recent Adv Stud Cardiac Struct Metab, V8, P219; Wormser C, 2011, FISH PHYSIOL BIOCHEM, V37, P745, DOI 10.1007/s10695-011-9474-3; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	66	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	SEP 1	2015	593	17					3849	3863		10.1113/JP270522		15	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CQ7GB	WOS:000360769900014		
J	Gram, M; Vigelso, A; Yokota, T; Helge, JW; Dela, F; Hey-Mogensen, M				Gram, Martin; Vigelso, Andreas; Yokota, Takashi; Helge, Jorn Wulff; Dela, Flemming; Hey-Mogensen, Martin			Skeletal muscle mitochondrial H2O2 emission increases with immobilization and decreases after aerobic training in young and older men	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							TARGETED ANTIOXIDANTS PROTECT; OXIDATIVE STRESS; MECHANICAL VENTILATION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; DISUSE ATROPHY; BED REST; HUMANS; CAPACITY; DYSFUNCTION	Mitochondrial dysfunction, defined as increased oxidative stress and lower capacity for energy production, may be seen with ageing and may cause frailty, or it could be that it is secondary to physical inactivity. We studied the effect of 2weeks of one-leg immobilization followed by 6weeks of supervised cycle training on mitochondrial function in 17 young (mean +/- SEM: 23 +/- 1years) and 15 older (68 +/- 1years) healthy men. Submaximal H2O2 emission and respiration were measured simultaneously at a predefined membrane potential in isolated mitochondria from skeletal muscle using two protocols: pyruvate+malate (PM) and succinate+rotenone (SR). This allowed measurement of leak and ATP generating respiration from which the coupling efficiency can be calculated. The protein content of the anti-oxidants manganese superoxide dismuthase (MnSOD), CuZn superoxide dismuthase, catalase and gluthathione peroxidase 1 was measured by western blotting. Immobilization decreased ATP generating respiration using PM and increased H2O2 emission using both PM and SR similarly in young and older men. Both were restored to baseline after the training period. Furthermore, MnSOD and catalase content increased with endurance training. The young men had a higher leak respiration at inclusion using PM and a higher membrane potential in State 3 using both substrate combinations. Collectively, the findings of the present study support the notion that increased mitochondrial reactive oxygen species mediates the detrimental effects seen after physical inactivity. Age, on the other hand, was not associated with impairments in anti-oxidant protein levels, mitochondrial respiration or H2O2 emission using either protocol.	[Gram, Martin; Vigelso, Andreas; Yokota, Takashi; Helge, Jorn Wulff; Dela, Flemming; Hey-Mogensen, Martin] Univ Copenhagen, Dept Biomed Sci, Ctr Hlth Aging, Xlab,Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Yokota, Takashi] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan	Dela, F (reprint author), Univ Copenhagen, Dept Biomed Sci, Ctr Hlth Aging, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	fdela@sund.ku.dk	Helge, Jorn/I-7096-2012; Vigelso, Andreas/A-5269-2015; 	Helge, Jorn/0000-0001-9724-5423; Vigelso, Andreas/0000-0003-2309-7768; Gram, Martin/0000-0002-0350-3506	UNIK research program: Food, Fitness & Pharma for Health and Disease (Danish Ministry of Science, Technology and Innovation); Nordea Foundation; Aase and Ejnar Danielsens Foundation; Kathrine and Vigo Skovgaards Foundation; Simon Fougner Hartmann Family Foundation; Torben and Alice Frimodts Foundation; Odaand Hans Svenningsens Foundation; Mampei Suzuki Diabetes Foundation	This work was supported by the UNIK research program: Food, Fitness & Pharma for Health and Disease (Danish Ministry of Science, Technology and Innovation), The Nordea Foundation, Aase and Ejnar Danielsens Foundation, Kathrine and Vigo Skovgaards Foundation, Simon Fougner Hartmann Family Foundation, Torben and Alice Frimodts Foundation, Odaand Hans Svenningsens Foundation and the Mampei Suzuki Diabetes Foundation.	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Eriksen L, 2011, SCAND J PUBLIC HEALT, V39, P203, DOI 10.1177/1403494810393557; Capel F, 2004, MECH AGEING DEV, V125, P367, DOI 10.1016/j.mad.2004.02.005; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bejma J, 1999, J APPL PHYSIOL, V87, P465; Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072; Tonkonogi M, 1997, ACTA PHYSIOL SCAND, V161, P345, DOI 10.1046/j.1365-201X.1997.00222.x; Ghosh S, 2011, DIABETES, V60, P2051, DOI 10.2337/db11-0121; Marzani B, 2005, EXP GERONTOL, V40, P959, DOI 10.1016/j.exger.2005.08.010; Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957; Glover EI, 2010, APPL PHYSIOL NUTR ME, V35, P125, DOI 10.1139/H09-137; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Hutter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x; Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011; KONDO H, 1991, ACTA PHYSIOL SCAND, V142, P527, DOI 10.1111/j.1748-1716.1991.tb09191.x; Whidden MA, 2009, J APPL PHYSIOL, V106, P385, DOI 10.1152/japplphysiol.91106.2008; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2; HARMAN D, 1972, J AM GERIATR SOC, V20, P145; Brocca L, 2012, J PHYSIOL-LONDON, V590, P5211, DOI 10.1113/jphysiol.2012.240267; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Reihmane D, 2013, EXP PHYSIOL, V98, P778, DOI 10.1113/expphysiol.2012.069211; McClung JM, 2009, CRIT CARE MED, V37, P1373, DOI 10.1097/CCM.0b013e31819cef63; Anisimov VN, 2011, AGING-US, V3, P1110; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Johannsen DL, 2012, J CLIN ENDOCR METAB, V97, P242, DOI 10.1210/jc.2011-1798; Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002; Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001; Conley KE, 2013, EXP PHYSIOL, V98, P768, DOI 10.1113/expphysiol.2012.067314; Dalla Libera L, 2009, J APPL PHYSIOL, V107, P549, DOI 10.1152/japplphysiol.00280.2009; desOliveira VN, 2012, APPL PHYSIOL NUTR ME, V37, P334; Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002; Gouspillou G, 2010, BBA-BIOENERGETICS, V1797, P143, DOI 10.1016/j.bbabio.2009.09.004; Gram M, 2014, EXP GERONTOL, V58, P269, DOI 10.1016/j.exger.2014.08.013; Hey-Mogensen M, 2015, J PHYSIOL-LONDON, V593, P3991, DOI 10.1113/JP270204; Hey-Mogensen M, 2010, DIABETOLOGIA, V53, P1976, DOI 10.1007/s00125-010-1813-x; Iossa S, 2004, DIABETES, V53, P2861, DOI 10.2337/diabetes.53.11.2861; Larsen S, 2015, SCAND J MED SCI SPOR, V25, pE59, DOI 10.1111/sms.12252; Moriggi M, 2010, PROTEOMICS, V10, P3756, DOI 10.1002/pmic.200900817; NOrregaard J, 2014, J AGING PHYS ACTIV, DOI [10.1123/japa.2014-007, DOI 10.1123/JAPA.2014-007]; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; Venditti P, 1999, ARCH BIOCHEM BIOPHYS, V372, P315, DOI 10.1006/abbi.1999.1494; Vigelso A, 2015, J REHABIL MED, V47, P552, DOI 10.2340/16501977-1961; Zoll J, 2002, J PHYSIOL-LONDON, V543, P191, DOI 10.1113/jphysiol.2002.019661	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	SEP 1	2015	593	17					4011	4027		10.1113/JP270211		17	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CQ7GB	WOS:000360769900024		
J	Shimizu, F; Ooatari, M; Uehara, M; Takahashi, Y; Kawano, K				Shimizu, Fumiaki; Ooatari, Miwako; Uehara, Miyuki; Takahashi, Yoshihiro; Kawano, Kenji			Effect of concurrent mental nerve reconstruction at the same time as mandibular reconstruction using a fibula osteoseptocutaneous flap	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Free fibula flap; Mental nerve; Nerve graft	INFERIOR ALVEOLAR; OSTEORADIONECROSIS	The damage of inferior alveolar nerve causes some functional problem including numbness of lower lip and drooling. During segmental mandibulectomy, inferior alveolar nerve commonly resected, therefore, it is ideal to reconstruct the nerve to get better functional result. Sensory recovery was assessed after mandibular reconstruction using free fibula osteoseptocutaneous flap in thirteen cases. In six cases, the mental nerve reconstruction was performed simultaneously, and in seven cases, the mental nerve reconstruction was not performed. In the case that the mental nerve was reconstructed simultaneously, unilateral mental nerve reconstruction was performed in five cases, and bilateral mental nerve reconstruction was performed in one cases. More than one year after the reconstruction, sensory recovery was assessed and compared between the group that the mental nerve was reconstructed and the group that was not reconstructed. Our results showed almost a normal sensory recovery of the lips on the reconstructed side more than one year after the reconstruction in reconstructed group. In contrast, sensory recovery was poor in nonreconstructed group and non-reconstructed side. These results showed that mental nerve reconstruction at the same time as mandibular reconstruction affects the postoperative mandibular function. The sural nerve can be harvested from the same donor site of the free fibula osteoseptocutaneous flap and such mental nerve reconstruction with nerve grafting can be completed within an hour. Most cases of mandibular reconstruction using a free fibula osteoseptocutaneous flap transfer can therefore be candidates for mental nerve reconstruction at the time of mandibular reconstruction. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Shimizu, Fumiaki; Ooatari, Miwako; Uehara, Miyuki] Oita Univ Hosp, Dept Plast Surg, Oita, Japan; [Takahashi, Yoshihiro; Kawano, Kenji] Oita Univ Hosp, Dept Oral & Maxillofacial Surg, Oita, Japan	Shimizu, F (reprint author), Oita Univ, Fac Med, Dept Plast Surg, Oita, Japan.	fumi@med.oita-u.ac.jp					Strauss ER, 2006, J ORAL MAXIL SURG, V64, P1767, DOI 10.1016/j.joms.2005.11.111; Chang YM, 2011, PLAST RECONSTR SURG, V128, P1220, DOI 10.1097/PRS.0b013e318230c6a9; Wei FC, 1997, J CRANIOFAC SURG, V8, P512, DOI 10.1097/00001665-199711000-00018; Pogrel MA, 2002, J ORAL MAXIL SURG, V60, P485, DOI 10.1053/joms.2002.31841; Celik N, 2002, PLAST RECONSTR SURG, V109, P1875, DOI 10.1097/00006534-200205000-00014; Santamaria E, 1998, PLAST RECONSTR SURG, V101, P921, DOI 10.1097/00006534-199804040-00006; Bagberi SC, 2010, J ORAL MAXILLOFAC SU, V68, P2770; Bagberi SC, 2009, J ORAL MAXILLOFAC SU, V67, P1791; Chang TM, 2012, J PLAST RECONSTR AES, V65, P757; WEI FC, 1994, BRIT J PLAST SURG, V47, P544, DOI 10.1016/0007-1226(94)90137-6	10	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	SEP	2015	68	9					1228	1234		10.1016/j.bjps.2015.05.010		7	Surgery	Surgery	CQ4GQ	WOS:000360563000009		
J	Maeda, T; Kimura, C; Murao, N; Takahashi, K				Maeda, Taku; Kimura, Chu; Murao, Naoki; Takahashi, Kikuko			Promising long-term outcomes of the reused skin-graft technique for chronic gluteal hidradenitis suppurativa	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Reused skin-graft technique; Chronic gluteal hidradenitis suppurativa; Recurrence; Long-term outcomes; Hurley classification system	CONTROLLED CROSSOVER TRIAL; SURGICAL-TREATMENT; DOUBLE-BLIND; CLINDAMYCIN; MANAGEMENT; THERAPY	Background: The reused skin-graft technique can be used to treat chronic gluteal hidradenitis suppurativa, but long-term outcomes and the reliability of the technique have not been reported. Methods: In a retrospective review of 18 men with chronic gluteal hidradenitis suppurativa (age range, 18-68 years) treated with a reused skin graft between June 2004 and March 2012, we evaluated disease severity (Hurley classification system), skin-graft thickness, the need for an additional normal skin graft, histological findings and recurrence rate at the surgical site. Results: The mean duration of follow-up was 61.3 months (range, 17-113 months). Five cases were classified into severity group I, 12 cases into severity group II and one case into severity group III. The range of skin-graft thicknesses was 0.013-0.020 inches. An additional donor site was unnecessary in 10 cases (three cases in group I (60%) and seven cases in group II (58.3%)). Histological examination indicated that a buried epidermal cyst could cause chronic gluteal hidradenitis suppurativa recurrence, although none of the patients experienced recurrence at the surgical site during follow-up. Conclusion: The reused skin-graft technique is reliable for chronic gluteal hidradenitis suppurativa resection, and it shows promising long-term outcomes. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Maeda, Taku; Murao, Naoki] Hokkaido Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kimura, Chu; Takahashi, Kikuko] Hosp Hakodate, Hakodate Gen Cent, Dept Plast & Reconstruct Surg, Hakodate, Hokkaido 0410011, Japan	Maeda, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.	takumaeda1105@yellow.plala.or.jp					Alikhan A, 2009, J AM ACAD DERMATOL, V60, P62; Adani R, 1998, PLAST RECONSTR SURG, V101, P1544, DOI 10.1097/00006534-199805000-00018; Alikhan A, 2009, J AM ACAD DERMATOL, V60, P539, DOI 10.1016/j.jaad.2008.11.911; Lapins J, 2001, ARCH DERMATOL, V137, P730; Ellis LZ, 2012, DERMATOL SURG, V38, P517, DOI 10.1111/j.1524-4725.2011.02186.x; Miller I, 2011, BRIT J DERMATOL, V165, P391, DOI 10.1111/j.1365-2133.2011.10339.x; Mandal A, 2005, SURG-J R COLL SURG E, V3, P23; Gener G, 2009, DERMATOLOGY, V219, P148, DOI 10.1159/000228334; Kuo HW, 2003, DERMATOL SURG, V29, P173, DOI 10.1046/j.1524-4725.2003.29044.x; Jemec GBE, 1998, J AM ACAD DERMATOL, V39, P971, DOI 10.1016/S0190-9622(98)70272-5; Bohn J, 2001, SCAND J PLAST RECONS, V35, P305; Endo Y, 1998, BRIT J DERMATOL, V139, P906; Grant A, 2010, J AM ACAD DERMATOL, V62, P205, DOI 10.1016/j.jaad.2009.06.050; CLEMMENSEN OJ, 1983, INT J DERMATOL, V22, P325, DOI 10.1111/j.1365-4362.1983.tb02150.x; Von der Werth JM, 2001, BRIT J DERMATOL, V144, P809, DOI 10.1046/j.1365-2133.2001.04137.x; Mendonca CO, 2006, BRIT J DERMATOL, V154, P977, DOI 10.1111/j.1365-2133.2006.07155.x; Jemec GBE, 1996, CLIN EXP DERMATOL, V21, P419, DOI 10.1111/j.1365-2230.1996.tb00145.x; Revuz J, 2009, J EUR ACAD DERMATOL, V23, P985, DOI 10.1111/j.1468-3083.2009.03356.x; Chen YE, 2014, PLAST RECONSTR SURG, V133, p370E, DOI 10.1097/PRS.0000000000000080; Honda T, 2002, J DERMATOL, V29, P96; Ishizawa T, 2000, J Dermatol, V27, P734; MCGROUTHER DA, 1980, BRIT J PLAST SURG, V33, P9, DOI 10.1016/0007-1226(80)90046-6; MORTIMER PS, 1986, BRIT J DERMATOL, V115, P263, DOI 10.1111/j.1365-2133.1986.tb05740.x; PALETTA F X, 1963, Plast Reconstr Surg, V31, P307, DOI 10.1097/00006534-196304000-00001; PEREZDIAZ D, 1995, INT J COLORECTAL DIS, V10, P225, DOI 10.1007/BF00346224; SILVERBERG B, 1987, PLAST RECONSTR SURG, V79, P555, DOI 10.1097/00006534-198704000-00007; WATSON JD, 1985, BRIT J PLAST SURG, V38, P567, DOI 10.1016/0007-1226(85)90022-0; Yamada N, 2002, BRIT J PLAST SURG, V55, P358, DOI 10.1054/bjps.2002.3855	28	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	SEP	2015	68	9					1268	1275		10.1016/j.bjps.2015.05.025		8	Surgery	Surgery	CQ4GQ	WOS:000360563000015		
J	Ishiura, R; Yoshimatsu, H; Yamamoto, T; Iida, T				Ishiura, Ryohei; Yoshimatsu, Hidehiko; Yamamoto, Takumi; Iida, Takuya			Near-infrared fluorescent angiography for demarcation of infected ulcer debridement	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							INDOCYANINE GREEN LYMPHOGRAPHY; LOWER-EXTREMITY LYMPHEDEMA; DERMAL BACKFLOW PATTERNS		[Ishiura, Ryohei; Yoshimatsu, Hidehiko; Yamamoto, Takumi; Iida, Takuya] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Ishiura, R (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2014, J PLAST RECONSTR AES, V67, P1573, DOI 10.1016/j.bjps.2014.06.007	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	SEP	2015	68	9					1315	1317		10.1016/j.bjps.2015.04.017		4	Surgery	Surgery	CQ4GQ	WOS:000360563000025		
J	Yoshimatsu, H; Yamamoto, T; Iwamoto, T; Haragi, M; Narushima, M; Iida, T; Koshima, I				Yoshimatsu, Hidehiko; Yamamoto, Takumi; Iwamoto, Taku; Haragi, Makiko; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao			Pedicle-in-a-trench technique for lower extremity reconstruction	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter									[Yoshimatsu, Hidehiko; Yamamoto, Takumi; Iwamoto, Taku; Haragi, Makiko; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao] Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yoshimatsu, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hidehiko.yoshimatsu@gmail.com					DeFranzo AJ, 2001, PLAST RECONSTR SURG, V108, P1184, DOI 10.1097/00006534-200110000-00013	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	SEP	2015	68	9					1318	1319		10.1016/j.bjps.2015.05.002		3	Surgery	Surgery	CQ4GQ	WOS:000360563000027		
J	Mori, M; Arai, S; Miyazaki, T; Arck, PC				Mori, M.; Arai, S.; Miyazaki, T.; Arck, P. C.			DEDD (death-effector domain-containing, DNA-binding protein) is required for decidual and vascular remodeling to sustain early pregnancy in mice	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the European-Society-for-Reproductive-Immunology	SEP 21-24, 2015	Magdalen Coll, Oxford, ENGLAND	European Soc Reprod Immunol	Magdalen Coll				[Mori, M.; Arck, P. C.] Univ Med Ctr Hamburg, Dept Obstet & Fetal Med, Hamburg, Germany; [Arai, S.; Miyazaki, T.] Univ Tokyo, Fac Med, Tokyo 1138654, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	SEP	2015	111					O12	14	14		10.1016/j.jri.2015.06.082		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CQ7HZ	WOS:000360774900029		
J	Takahashi, H; Yamamoto, T; Matsuno, T; Murase, T; Yamazaki, M; Chishima, F				Takahashi, H.; Yamamoto, T.; Matsuno, T.; Murase, T.; Yamazaki, M.; Chishima, F.			Changes of natural cytotoxicity receptors in decidual NK cells at term pregnancy	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the European-Society-for-Reproductive-Immunology	SEP 21-24, 2015	Magdalen Coll, Oxford, ENGLAND	European Soc Reprod Immunol	Magdalen Coll				[Takahashi, H.; Yamamoto, T.; Matsuno, T.; Murase, T.; Yamazaki, M.; Chishima, F.] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	SEP	2015	111					P27	29	29		10.1016/j.jri.2015.06.031		1	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CQ7HZ	WOS:000360774900064		
J	Kokubo, K; Suzuki, K; Hattori, N; Miyai, I; Mori, E				Kokubo, Kae; Suzuki, Kyoko; Hattori, Noriaki; Miyai, Ichiro; Mori, Etsuro			Executive Dysfunction in Patients with Putaminal Hemorrhage	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Putaminal hemorrhage; the frontal-subcortical circuits; executive dysfunction; Wisconsin Card Sorting Test; working memory	FRONTAL-SUBCORTICAL CIRCUITS; BASAL GANGLIA LESIONS; CAUDATE LESIONS; HUMAN STRIATUM; APHASIA; PERFORMANCE; RELEVANCE; PROFILES; DEMENTIA; BEHAVIOR	Background: The frontal-subcortical circuits link the specific areas of the frontal cortex to the striatum, basal ganglia, and thalamus. Disruption of the frontal-subcortical circuits may lead to cognitive impairment with frontal lobe features. The putamen is a central component of frontal-subcortical circuits. Although putaminal lesions presumably lead to cognitive and behavioral changes, studies on frontal lobe dysfunctions after putaminal stroke are scarce. There are no previous studies that systematically examined frontal lobe functions with a focal putaminal lesion. The objective of this study is to demonstrate whether putaminal hemorrhage causes frontal lobe dysfunction. Methods: Cognitive functions, including various aspects of frontal lobe functions, were systematically assessed in 15 patients with left-or right-sided putaminal hemorrhage 2 months after the onset and compared with healthy controls. Results: Patients did not have signs of aphasia, apraxia, or spatial neglect. They performed significantly worse on tests of frontal lobe function, including Letter-Number Sequencing (U = 22, P < .001), lexical fluency (U = 30, P < .001), and motor series subtest (U = 45, P < .004) of the Frontal Assessment Battery. On the Wisconsin Card Sorting Test, patients performed significantly worse for "categories achieved'' (U = 29.5, P < .001), "perseverative errors'' (U = 25, P < .001), and "set loss'' (U = 49, P < .008). None showed behavioral impairment. Conclusions: Isolated putaminal hemorrhage causes modest frontal lobe dysfunction without behavioral symptoms. Our findings indicate that isolated putaminal hemorrhage disrupts the dorsolateral-striato-pallido-thalamic circuits and causes executive dysfunction. (C) 2015 by National Stroke Association	[Kokubo, Kae] Kobegakuin Univ, Dept Psychol, Kobe, Hyogo 6512180, Japan; [Kokubo, Kae; Hattori, Noriaki; Miyai, Ichiro] Morinomiya Hosp, Neurorehabil Res Inst, Osaka, Japan; [Suzuki, Kyoko] Yamagata Univ, Grad Sch Med, Dept Clin Neurosci, Yamagata 990, Japan; [Kokubo, Kae; Mori, Etsuro] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan	Kokubo, K (reprint author), Kobegakuin Univ, Dept Psychol, Nishi Ku, 518 Arise Ikawadani Cho, Kobe, Hyogo 6512180, Japan.	kokubo@human.kobegakuin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26350602, 200200004]; Global COE program (Basic and Translational Research Center for Global Brain Science, Ministry of Education, Culture, Sports, Science and Technology of Japan)	N.H. was supported by Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant 26350602). E.M. was supported by Grant-in-Aid for Scientific Research on priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant 200200004) and Global COE program (Basic and Translational Research Center for Global Brain Science, Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abe Mitsuyo, 2004, No To Shinkei, V56, P567; Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; Benke T, 2003, NEUROCASE, V9, P70, DOI 10.1076/neur.9.1.70.14374; ALEXANDER MP, 1987, BRAIN, V110, P961, DOI 10.1093/brain/110.4.961; Kumral E, 1999, STROKE, V30, P100; Cools R, 2006, J COGNITIVE NEUROSCI, V18, P1973, DOI 10.1162/jocn.2006.18.12.1973; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873; CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133; MENDEZ MF, 1989, NEUROLOGY, V39, P349; MARAGANORE DM, 1991, MOVEMENT DISORD, V6, P358, DOI 10.1002/mds.870060418; LAPLANE D, 1989, BRAIN, V112, P699, DOI 10.1093/brain/112.3.699; DESPOSITO M, 1995, NEUROLOGY, V45, P38; Burgaleta M, 2014, HUM BRAIN MAPP, V35, P1957, DOI 10.1002/hbm.22305; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Bokura H, 1997, STROKE, V28, P970; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giroud M, 1997, J NEUROL NEUROSUR PS, V63, P611, DOI 10.1136/jnnp.63.5.611; Hiebert NM, 2014, NEUROIMAGE, V101, P448, DOI 10.1016/j.neuroimage.2014.07.013; Ishiai S., 1999, BEHAV INATTENTION TE; Ishiai S, 2000, NEUROLOGY, V55, P364; Kailash PB, 1994, BRAIN, V117, P856; Kashima H, 1995, NO TO SEISHIN NO IGA, V6, P209; Kugo A, 2007, PSYCHIAT RES, V153, P69, DOI 10.1016/j.psychres.2006.04.004; Mori E, 2002, ANN NY ACAD SCI, V977, P141; NAESER MA, 1982, ARCH NEUROL-CHICAGO, V39, P2; SLTA Committee, 1977, STAND LANG TEST APH; Toyokura M, 2003, ARCH PHYS MED REHAB, V84, P691, DOI 10.1016/S0003-9993(03)04904-3; WAB committee, 1986, W APH BATT JAP VERS; Wechsler D, 1997, WECHSLER ADULT INTEL; Wechsler D., 1987, WECHSLER MEMORY SCAL	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	SEP	2015	24	9					1978	1985		10.1016/j.jstrokecerebrovasdis.2015.04.047		8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CQ5MP	WOS:000360649000015		
J	Kato, Y; Hayashi, T; Nagamine, Y; Tanahashi, N; Kobayashi, S				Kato, Yuji; Hayashi, Takeshi; Nagamine, Yuito; Tanahashi, Norio; Kobayashi, Shotai		Japan Standard Stroke Registry	Antithrombotic Drugs Play a Significant Role in Intracerebral Hemorrhage in the Elderly Patients	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Age stratification; intracerebral hemorrhage; epidemiology; Japanese	STANDARD STROKE REGISTRY; CARDIOVASCULAR-DISEASE; ISCHEMIC-STROKE; RISK-FACTORS; THERAPY BAT; JAPANESE; MICROBLEEDS; MORTALITY; HISAYAMA; TRENDS	Background: Japan has the fastest aging society in the world. Compared with younger patients, older ones have a different stroke risk profile and different stroke features. The aim of this study was to examine the risk factor profiles, stroke severities, and functional outcomes of hypertensive intracerebral hemorrhage (ICH) in different age groups. Methods: A total of 14,599 patients with hypertensive ICH were included in a multicenter, hospital-based registration study using a computerized database involving 95 Japanese institutes from 2000 to 2012. Results: The frequencies of atrial fibrillation, previous stroke, and coronary artery disease peaked in patients in their 80s and decreased thereafter. The frequency of the use of antithrombotic agents increased with age and reached its peak (26.7%) in patients in their 80s and sustained 18.6% in patients aged 90 years or older. More severe symptoms on admission and worse functional outcomes were observed with an increase in age, which might be related with the increased rate of antithrombotic therapy. Conclusions: The rate of use of antithrombotic agents increases with age. The role of these agents in ICH becomes larger in aged people, which may be one of the causes of poorer outcome in aged patients with ICH. Given that the population is rapidly aging, the use of antithrombotic agents should be considered an emerging risk factor. (C) 2015 by National Stroke Association	[Kato, Yuji; Hayashi, Takeshi; Nagamine, Yuito; Tanahashi, Norio] Saitama Med Univ, Saitama Int Med Ctr, Dept Neurol & Cerebrovasc Med, Saitama 3501298, Japan; [Kobayashi, Shotai] Shimane Univ, Dept Neurol, Matsue, Shimane, Japan	Kato, Y (reprint author), Saitama Med Univ, Saitama Int Med Ctr, Dept Neurol & Cerebrovasc Med, 1397-1 Yamane, Saitama 3501298, Japan.	yujik@saitama-med.ac.jp			Japanese Ministry of Welfare	JSSRS was developed with the support ("21st Century Type Promoting Development of Clinical Research Fund'') from the Japanese Ministry of Welfare during 1999 to 2001.	van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Bokura H, 2011, STROKE, V42, P1867, DOI 10.1161/STROKEAHA.110.601922; Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278; Toyoda K, 2007, CEREBROVASC DIS, V24, P289, DOI 10.1159/000105682; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Kobayashi S, 2006, AM J PREV MED, V31, pS240, DOI 10.1016/j.amepre.2006.08.011; Toyoda K, 2009, CEREBROVASC DIS, V27, P151, DOI 10.1159/000177924; Toyoda K, 2010, STROKE, V41, P1440, DOI 10.1161/STROKEAHA.110.580506; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Hosomi N, 2009, CEREBROVASC DIS, V27, P67, DOI 10.1159/000172636; KASE CS, 1995, BAILLIERE CLIN NEUR, V4, P247; Kato Y, 2015, J STROKE CEREBROVASC, V24, P811, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.019; Yamaguchi S, 2014, JPN J STROKE, V36, P378	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	SEP	2015	24	9					1986	1990		10.1016/j.jstrokecerebrovasdis.2015.04.046		5	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CQ5MP	WOS:000360649000016		
J	Nomura, S; Kunitsugu, I; Ishihara, H; Koizumi, H; Yoneda, H; Shirao, S; Oka, F; Suzuki, M				Nomura, Sadahiro; Kunitsugu, Ichiro; Ishihara, Hideyuki; Koizumi, Hiroyasu; Yoneda, Hiroshi; Shirao, Satoshi; Oka, Fumiaki; Suzuki, Michiyasu			Relationship between Aging and Enlargement of Intracranial Aneurysms	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Subarachnoid hemorrhage; intracranial aneurysm; community-based study; aging; aneurysmal size; aneurysmal location	NATURAL-HISTORY; RISK-FACTORS; RUPTURE; SIZE; AGE; EPIDEMIOLOGY; SMALLER; JAPAN	Background: To predict possible enlargement of cerebral aneurysms with aging, we retrospectively analyzed aneurysm size in relation to patient age and aneurysm site. Methods: We included 1332 unruptured and 2362 ruptured aneurysms detected in patients from the Yamaguchi Prefecture, Japan, from 1995 to 2005. Results: Age-specific site distribution was not found in the unruptured aneurysms. In the ruptured aneurysms, the incidence of anterior communicating artery (AComA) aneurysms was higher than that of internal carotid posterior communicating (ICPC) artery aneurysms among the patients aged 40-49 years (32.6% versus 14.4%), whereas the difference was small among the elderly patients aged 70-79 years (25.8% versus 24.9%). In the AComA aneurysms, either in the unruptured or ruptured cases, no age-related change in size was found. In the ICPC aneurysms, either in the unruptured or in the ruptured cases, the size of the aneurysms 7 mm or larger increased with age. Conclusions: The sizes of AComA aneurysms may remain stable with aging. Therefore, the risk of rupture may be similar in young and elderly patients. Meanwhile, ICPC artery aneurysms may continue to grow throughout the patient's life, with an increasing risk of rupture. (C) 2015 by National Stroke Association	[Nomura, Sadahiro; Ishihara, Hideyuki; Koizumi, Hiroyasu; Yoneda, Hiroshi; Shirao, Satoshi; Oka, Fumiaki; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Nomura, Sadahiro; Ishihara, Hideyuki; Koizumi, Hiroyasu; Yoneda, Hiroshi; Shirao, Satoshi; Oka, Fumiaki; Suzuki, Michiyasu] Yamaguchi Neurosurg Assoc, Ube, Yamaguchi, Japan; [Kunitsugu, Ichiro] Yamaguchi Univ, Sch Med, Dept Publ Hlth, Ube, Yamaguchi 7558505, Japan	Nomura, S (reprint author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	snomura@yamaguchi-u.ac.jp					Amenta PS, 2012, NEUROSURGERY, V70, P693, DOI 10.1227/NEU.0b013e3182354d68; Carter BS, 2006, NEUROSURGERY, V58, P217, DOI 10.1227/01.NEU.0000194639.37803.F8; You SH, 2010, J NEUROL NEUROSUR PS, V81, P479, DOI 10.1136/jnnp.2008.169573; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Rinkel GJE, 2008, J NEURORADIOLOGY, V35, P99, DOI 10.1016/j.neurad.2007.11.004; Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Inagawa T, 2010, WORLD NEUROSURG, V73, P84, DOI 10.1016/j.surneu.2009.07.001; Wiebers D, 1998, NEW ENGL J MED, V339, P1725; Ishihara H, 2013, NEUROEPIDEMIOLOGY, V41, P7, DOI 10.1159/000345247; Joo SW, 2009, J KOREAN NEUROSURG S, V45, P85, DOI 10.3340/jkns.2009.45.2.85; Kamitani H, 2000, SURG NEUROL, V54, P59, DOI 10.1016/S0090-3019(00)00265-2; Mehan WA, 2014, J NEUROINTERV SURG, V6, P761, DOI 10.1136/neurintsurg-2013-010944; So TY, 2010, J CLIN NEUROSCI, V17, P29, DOI 10.1016/j.jocn.2009.04.010	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	SEP	2015	24	9					2049	2053		10.1016/j.jstrokecerebrovasdis.2015.04.039		5	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CQ5MP	WOS:000360649000024		
J	Araki, Y; Takagi, Y; Fushimi, Y; Arakawa, Y; Funaki, T; Kikuchi, T; Takahashi, JC; Togashi, K; Miyamoto, S				Araki, Yoshio; Takagi, Yasushi; Fushimi, Yasutaka; Arakawa, Yoshiki; Funaki, Takeshi; Kikuchi, Takayuki; Takahashi, Jun C.; Togashi, Kaori; Miyamoto, Susumu			Apparent Diffusion Coefficient and Transient Neurological Deficit after Revascularization Surgery in Moyamoya Disease	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Adult; diffusion; moyamoya disease; revascularization surgery; transient neurological deficit	SYMPTOMATIC CEREBRAL HYPERPERFUSION; APPEARING WHITE-MATTER; EXTRACRANIAL-INTRACRANIAL BYPASS; CLINICAL-FEATURES; OXYGEN EXTRACTION; BLOOD-VOLUME; ENDARTERECTOMY; HYPOPERFUSION; DETERIORATION; TOMOGRAPHY	Background: Transient neurological deficits are relatively common after direct revascularization surgery for moyamoya disease (MMD). Although recent evidence has revealed the clinical features and pathophysiology, preoperative predictors have remained unclear. This study investigated whether the apparent diffusion coefficient (ADC) in normal-appearing white matter (NAWM) on magnetic resonance imaging could offer a predictor of postoperative transient neurological deficits. Methods: This study included adult patients with MMD who underwent superficial temporal artery-middle cerebral artery bypass. Preoperative ADCs were measured in NAWM on ipsilateral hemisphere. Single photon emission computed tomography (SPECT) with I-123-iodoamphetamine was performed on postoperative days 2-6. Relationships between mean ADC and postoperative transient neurological deficits were assessed. Results: Twenty of the 26 subjects (76.9%) experienced transient neurological deficits. Focal hyperemia on postoperative SPECT appeared in 11 of the 20 subjects with postoperative transient neurological deficits and 1 of the 6 subjects without (P = .12). Mean ADCs in patients with and without postoperative transient neurological deficits were 748.3 +/- 12 mm(2)/second x 10(-6) and 679.7 +/- 21.9 mm(2)/second x 10(-6), respectively (P = .0091). Conclusions: Preoperative ADC elevation in NAWM may indicate postoperative transient neurological deficits not only in patients with postoperative hyperemia on SPECT, but also in patients with this pathology. (C) 2015 by National Stroke Association	[Araki, Yoshio; Takagi, Yasushi; Arakawa, Yoshiki; Funaki, Takeshi; Kikuchi, Takayuki; Takahashi, Jun C.; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Fushimi, Yasutaka; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan	Araki, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	yaraki@kuhp.kyoto-u.ac.jp					SUZUKI J, 1983, STROKE, V14, P104; Hayashi K, 2012, WORLD NEUROSURG, V78, P447, DOI 10.1016/j.wneu.2011.10.041; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Fujimura M, 2012, NEUROL MED-CHIR, V52, P327; Conklin J, 2010, STROKE, V41, P1610, DOI 10.1161/STROKEAHA.110.579540; Pandey P, 2011, STROKE, V42, P3304, DOI 10.1161/STROKEAHA.110.598565; Fujimura M, 2012, CEREBROVASC DIS, V33, P436, DOI 10.1159/000336765; Uchino H, 2012, STROKE, V43, P2610, DOI 10.1161/STROKEAHA.112.654723; O'Sullivan M, 2001, NEUROLOGY, V57, P2307; Miyamoto S, 2014, STROKE, V45, P1415, DOI 10.1161/STROKEAHA.113.004386; Fukuda T, 2007, AM J NEURORADIOL, V28, P737; Derdeyn CP, 2002, BRAIN, V125, P595, DOI 10.1093/brain/awf047; Kurumatani T, 1998, STROKE, V29, P1058; Calviere L, 2012, J NEUROL NEUROSUR PS, V83, P591, DOI 10.1136/jnnp-2011-301388; Engelter ST, 2000, AM J ROENTGENOL, V175, P425; Fujimura M, 2009, SURG NEUROL, V71, P442, DOI 10.1016/j.surneu.2008.02.031; Fujimura M, 2011, NEUROSURGERY, V68, P957, DOI 10.1227/NEU.0b013e318208f1da; Hayashi T, 2010, J NEUROSURG-PEDIATR, V6, P73, DOI 10.3171/2010.4.PEDS09478; Hokari M, 2008, J NUCL MED, V49, P1922, DOI 10.2967/jnumed.108.054379; Jeong H, 2011, AM J NEURORADIOL, V32, P1893, DOI 10.3174/ajnr.A2683; Kuroda Satoshi, 1994, Neurologia Medico-Chirurgica, V34, P15, DOI 10.2176/nmc.34.15; Nakamizo A, 2013, J STROKE CEREBROVASC, V23, P457; Ohue S, 2008, SURG NEUROL, V69, P281, DOI 10.1016/j.surneu.2007.01.047; Soinne L, 2003, NEUROLOGY, V61, P1061	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	SEP	2015	24	9					2054	2059		10.1016/j.jstrokecerebrovasdis.2015.04.026		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CQ5MP	WOS:000360649000025		
J	Takizawa, S; Tanaka, F; Nishiyama, K; Hasegawa, Y; Nagata, E; Mizuma, A; Yutani, S; Nakayama, T; Kobayashi, H; Yanagimachi, N; Okazaki, T; Kitagawa, K				Takizawa, Shunya; Tanaka, Fumiaki; Nishiyama, Kazutoshi; Hasegawa, Yasuhiro; Nagata, Eiichiro; Mizuma, Atsushi; Yutani, Sachiko; Nakayama, Taira; Kobayashi, Hiroyuki; Yanagimachi, Noriharu; Okazaki, Takashi; Kitagawa, Kazuo		CMB-NOW Study Investigators	Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Acute ischemic stroke; anticoagulant; cerebral microbleeds; MRI; NOACs; warfarin	INTRACEREBRAL HEMORRHAGE; ISCHEMIC-STROKE; ANTITHROMBOTIC THERAPY; RISK-FACTORS	Rationale: Anticoagulants are widely used to prevent recurrence of ischemic stroke in patients with nonvalvular atrial fibrillation, but in some patients, they also cause bleeding, particularly intracranial hemorrhage. One of the independent predictors of intracerebral hemorrhage is the presence of cerebral microbleeds (CMBs); a high incidence of intracerebral hemorrhage is reported in warfarin-treated patients with multiple CMBs. Longitudinal study suggested that the presence of CMBs at baseline is a predictor of new CMBs in warfarin-treated patients. However, there has been no study on the progression of CMBs in patients receiving the non-vitamin K antagonist oral anticoagulants (NOACs). Aims: This study tests the hypothesis that the incidence of hemorrhagic stroke is lower in patients receiving NOACs (dabigatran, rivaroxaban, apixaban, and edoxaban) than in those receiving warfarin, and this difference reflects the difference in the effects of warfarin and NOACs on the progression of CMBs. Design: We will enroll 200 patients with at least 1 CMB detected by 1.5 T magnetic resonance imaging (T*(2) -weighted imaging) at baseline and who have received NOACs or warfarin for at least 12 months. Primary end point is the proportion of subjects with an increased number of CMBs at month 12 of treatment with NOACs or warfarin. If the results of this study support the efficacy of NOACs for preventing increase of CMBs, this would be of great interest to domestic and overseas clinicians, in view of the potential therapeutic impact, including that on primary prevention of ischemic stroke. (C) 2015 by National Stroke Association	[Takizawa, Shunya; Nagata, Eiichiro; Mizuma, Atsushi; Yutani, Sachiko; Nakayama, Taira] Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa 2591193, Japan; [Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 232, Japan; [Nishiyama, Kazutoshi] Kitasato Univ, Sch Med, Dept Neurol, Sagamihara, Kanagawa 228, Japan; [Hasegawa, Yasuhiro] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan; [Kobayashi, Hiroyuki] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa 2591193, Japan; [Yanagimachi, Noriharu; Okazaki, Takashi] Tokai Univ, Sch Med, Dept Diagnost Radiol, Isehara, Kanagawa 2591193, Japan; [Kitagawa, Kazuo] Tokyo Womens Med Univ, Dept Neurol, Tokyo, Japan	Takizawa, S (reprint author), Tokai Univ, Sch Med, Dept Neurol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	shun@is.icc.u-tokai.ac.jp			Daiichi-Sankyo [14A067]	This work was supported by funding from Daiichi-Sankyo (14A067).	Akoudad S, 2014, STROKE, V45, P3436, DOI 10.1161/STROKEAHA.114.007112; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Lovelock CE, 2010, STROKE, V41, P1222, DOI 10.1161/STROKEAHA.109.572594; Fan YH, 2003, STROKE, V34, P2459, DOI 10.1161/01.STR.0000090841.90286.81; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Lee SH, 2009, NEUROLOGY, V72, P171, DOI 10.1212/01.wnl.0000339060.11702.dd; Orken DN, 2013, CLIN NEUROL NEUROSUR, V115, P1682, DOI 10.1016/j.clineuro.2013.03.004; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Offenbacher H, 1996, AM J NEURORADIOL, V17, P573; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Greenberg SM, 2004, STROKE, V35, P1415, DOI 10.1161/01.STR.0000126807.69758.0e; Soo YOY, 2008, J NEUROL, V255, P1679, DOI 10.1007/s00415-008-0967-7; Song TJ, 2013, EUR J NEUROL, V20, P502, DOI 10.1111/ene.12003; Charidimou Andreas, 2012, Front Neurol, V3, P133; Imaizumi T, 2013, J STROKE CEREBROVASC, V22, P869, DOI 10.1016/j.jstrokecerebrovasdis.2012.08.003; Ogawa S, 2010, CIRC J, V74, P2479, DOI 10.1253/circj.CJ-88-0001; LEVINE MN, 2001, CHEST, V119, P108; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	SEP	2015	24	9					2143	2148		10.1016/j.jstrokecerebrovasdis.2015.05.032		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CQ5MP	WOS:000360649000038		
J	Imaizumi, T; Inamura, S; Nomura, T; Kanno, A; Kim, SN				Imaizumi, Toshio; Inamura, Shigeru; Nomura, Tatsufumi; Kanno, Aya; Kim, Sang Nyon			The Severity of White Matter Lesions Possibly Influences Stroke Recurrence in Patients with Histories of Lacunar Infarctions	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						White matter lesions; stroke recurrences; lacunar infarction; intracerebral hemorrhage; cerebral microbleeds	CHRONIC CEREBRAL HYPOPERFUSION; VASCULAR COGNITIVE IMPAIRMENT; INTRACEREBRAL HEMORRHAGE; BRAIN MICROBLEEDS; ISCHEMIC-STROKE; MOUSE MODEL; LEUKOARAIOSIS; PREDICTOR; DISEASE; HYPERINTENSITY	Background: To investigate the recurrent stroke types associated with white matter lesions (WMLs), we prospectively observed recurrences in patients with histories of lacunar infarctions (LIs). Methods: We prospectively analyzed the types of stroke recurrences in 305 patients (138 women, 70.2 +/- 11.7 years old) consecutively admitted to our hospital with LIs from April 2004 to December 2011. WMLs were graded using Fazekas' grades (Gr). Recurrence-free rate curves were generated by the Kaplan-Meier method using the log-rank test. Results: The follow-up period was 50.7 +/- 32.8 (.25-114) months. During this period, 62 strokes recurred. The incidences of strokes (all types), LIs, and deep intracerebral hemorrhages (ICHs) presenting as recurrences in 112 patients with Gr 2-3 were 6.2, 2.0, and 1.5 %/year, respectively, values that were significantly greater than those seen in 79 patients with Gr 0 (2.1 [P=.0001],.6 [P=.014], and.5 %/year [P=.016], respectively), and in 114 patients with Gr 1 (2.8 [P=.003],.9 [P=.009], and.6 %/year [P=.043], respectively). There was no significant difference among Gr 0, 1, and 2-3 in incidences of recurrences presenting as lobar ICHs, atherothrombotic infarctions, or cardioembolic infarctions. Multivariate analyses demonstrated that Gr 2-3 significantly and independently elevated the rate of deep ICHs or LIs presenting as recurrences after adjustment for risk factors. Conclusions: The presence of high-grade WMLs elevated the rate of stroke recurrences presenting as LIs and deep ICHs, but not other types.	[Imaizumi, Toshio; Inamura, Shigeru; Nomura, Tatsufumi; Kanno, Aya; Kim, Sang Nyon] Kushiro City Gen Hosp, Dept Neurosurg, Kushiro, Hokkaido 0850822, Japan	Imaizumi, T (reprint author), Kushiro City Gen Hosp, Dept Neurosurg, 1-12 Shunkodai, Kushiro, Hokkaido 0850822, Japan.	timaizum@d9.dion.ne.jp					Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Henneman WJP, 2009, STROKE, V40, P492, DOI 10.1161/STROKEAHA.108.516286; Taheri S, 2011, STROKE, V42, P2158, DOI 10.1161/STROKEAHA.110.611731; HEISTAD DD, 1990, BLOOD VESSELS, V27, P258; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Roob G, 2000, STROKE, V31, P2665; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Kuller LH, 2004, STROKE, V35, P1821, DOI 10.1161/01.STR.0000132193.35955.69; Black S, 2009, STROKE, V40, pS48, DOI 10.1161/STROKEAHA.108.537704; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Arsava EM, 2009, NEUROLOGY, V72, P1403, DOI 10.1212/WNL.0b013e3181a18823; Liew G, 2014, INT J STROKE, V9, P921, DOI 10.1111/j.1747-4949.2012.00865.x; Topakian R, 2010, J NEUROL NEUROSUR PS, V81, P192, DOI 10.1136/jnnp.2009.172072; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Manolio TA, 1999, ARTERIOSCL THROM VAS, V19, P356; Palumbo V, 2007, NEUROLOGY, V68, P1020, DOI 10.1212/01.wnl.0000257817.29883.48; Henon H, 2003, STROKE, V34, P2935, DOI 10.1161/01.STR.0000103747.58719.59; de Groot JC, 2002, ANN NEUROL, V52, P335, DOI 10.1002/ana.10294; Fu JH, 2005, J NEUROL NEUROSUR PS, V76, P793, DOI 10.1136/jnnp.2003.032771; Imaizumi T, 2014, J STROKE CEREBROVASC, V23, P520, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.035; Imaizumi T, 2014, J STROKE CEREBROVASC, V23, P1897, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.011; Imaizumi T, 2004, J NEUROSURG, V101, P915, DOI 10.3171/jns.2004.101.6.0915; Imaizumi T, 2014, J STROKE CEREBROVASC, V23, P610, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.011; MIYAO S, 1992, STROKE, V23, P1434; Moody DM, 2004, RADIOLOGY, V233, P883, DOI 10.1148/radiol.2333020981; Naka H, 2006, AM J NEURORADIOL, V27, P830; Schulz UG, 2013, J AM HEART ASSOC, V2, P1; Smith EE, 2010, STROKE, V41, pS139, DOI 10.1161/STROKEAHA.110.596056; van der Grond J, 2004, NEUROLOGY, V63, P1452	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	SEP	2015	24	9					2154	2160		10.1016/j.jstrokecerebrovasdis.2015.05.023		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CQ5MP	WOS:000360649000040		
J	Kono, M; Takahashi, S; Kamamoto, D; Emoto, K; Yoshida, K				Kono, Maya; Takahashi, Satoshi; Kamamoto, Dai; Emoto, Katsura; Yoshida, Kazunari			Twenty-Year Follow-up of Chronic Encapsulated Intracerebral Hematoma	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Chronic encapsulated intracerebral hematoma; collagenous membrane; hematoma; intracerebral hemorrhage; cerebral cavernous malformation		This is the first case report of a patient with chronic encapsulated intracerebral hematoma who developed excessive perifocal edema and symptoms 20 years after his initial diagnosis. (C) 2015 by National Stroke Association. (C) 2015 by National Stroke Association	[Kono, Maya; Takahashi, Satoshi; Kamamoto, Dai; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Tokyo 1608582, Japan; [Emoto, Katsura] Keio Univ Hosp, Div Diagnost Pathol, Tokyo, Japan	Kono, M (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	maya@keio.jp					HIRSH LF, 1981, NEUROSURGERY, V9, P169; Greiner-Perth R, 1997, NEUROSURG REV, V20, P231, DOI 10.1007/BF01105893; Nishiyama Akira, 2014, Surg Neurol Int, V5, P88, DOI 10.4103/2152-7806.134076	3	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	SEP	2015	24	9					E255	E256		10.1016/j.jstrokecerebrovasdis.2015.04.043		2	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CQ5MP	WOS:000360649000004		
J	Vogeli, B; Olsson, S; Riek, R; Guntert, P				Voegeli, Beat; Olsson, Simon; Riek, Roland; Guentert, Peter			Complementarity and congruence between exact NOEs and traditional NMR probes for spatial decoding of protein dynamics	JOURNAL OF STRUCTURAL BIOLOGY			English	Article						Exact NOE; eNOE; Protein ensemble; Structure determination; GB3	NUCLEAR-MAGNETIC-RESONANCE; RESIDUAL DIPOLAR COUPLINGS; LIQUID-CRYSTALLINE MEDIUM; CONSERVATIVE MUTAGENESIS; MOLECULAR-DYNAMICS; CROSS-VALIDATION; BACKBONE; SPECTROSCOPY; MOTION; RELAXATION	The study of the spatial sampling of biomolecules is essential to understanding the structure-dynamics-function relationship. We have established a protocol for the determination of multiple-state ensembles based on exact measurements of the nuclear Overhauser effect (eNOE). The protocol is practical since it does not require any additional data, while all other NMR data sets must be supplemented by NOE restraints. The question arises as to how much structural and dynamics information is shared between the eNOEs and other NMR probes. We compile one of the largest and most diverse NMR data sets of a protein to date consisting of eNOEs, RDCs and J couplings for GB3. We show that the eNOEs improve the back-prediction of RDCs and J couplings, either upon use of more than one state, or in comparison to conventional NOEs. Our findings indicate that the eNOE data is self-consistent, consistent with other data, and that the structural representation with multiple states is warranted. (C) 2015 Elsevier Inc. All rights reserved.	[Voegeli, Beat; Olsson, Simon; Riek, Roland; Guentert, Peter] ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Olsson, Simon] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Guentert, Peter] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Guentert, Peter] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany; [Guentert, Peter] Tokyo Metropolitan Univ, Grad Sch Sci, Hachioji, Tokyo 1920397, Japan	Vogeli, B (reprint author), ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, HCI F217, CH-8093 Zurich, Switzerland.	beat.voegeli@phys.chem.ethz.ch	Olsson, Simon/J-5757-2014	Olsson, Simon/0000-0002-3927-7897	Swiss National Science Foundation [140214]; ETH Research Grant [ETH-04 13-1]; Danish Council for Independent Research\Natural Sciences [DFF-4002-00151]; Lichtenberg program of the Volkswagen Foundation	B.V. was supported by the Swiss National Science Foundation with Grant 140214 and the by ETH Research Grant ETH-04 13-1. S.O. is funded by an Independent Postdoc grant from The Danish Council for Independent Research vertical bar Natural Sciences (ID: DFF-4002-00151). P.G. gratefully acknowledges financial support by the Lichtenberg program of the Volkswagen Foundation.	KESSLER H, 1988, J AM CHEM SOC, V110, P3393, DOI 10.1021/ja00219a008; Perez C, 2001, J AM CHEM SOC, V123, P7081, DOI 10.1021/ja003724j; Orts J, 2012, J CHEM THEORY COMPUT, V8, P3483, DOI 10.1021/ct3002249; BRUSCHWEILER R, 1994, J AM CHEM SOC, V116, P11199; Yao L, 2008, J PHYS CHEM B, V112, P6045, DOI 10.1021/jp0772124; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Orts J, 2013, J BIOMOL NMR, V57, P211, DOI 10.1007/s10858-013-9780-4; Ban D, 2013, MOLECULES, V18, P11904, DOI 10.3390/molecules181011904; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; KARPLUS M, 1963, J AM CHEM SOC, V85, P2870, DOI 10.1021/ja00901a059; Vogeli B, 2007, J AM CHEM SOC, V129, P9377, DOI 10.1021/ja070324o; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; BRUSCHWEILER R, 1992, J AM CHEM SOC, V114, P2289; Yao LS, 2007, J AM CHEM SOC, V129, P11326, DOI 10.1021/ja073937+; Fenwick RB, 2011, J AM CHEM SOC, V133, P10336, DOI 10.1021/ja200461n; Wang B, 2013, J CHEM THEORY COMPUT, V9, P4653, DOI 10.1021/ct400631b; Hu JS, 1997, J AM CHEM SOC, V119, P6360, DOI 10.1021/ja970067v; Olsson S, 2014, J CHEM THEORY COMPUT, V10, P3484, DOI 10.1021/ct5001236; Sabo TM, 2014, J BIOMOL NMR, V58, P287, DOI 10.1007/s10858-013-9775-1; Ottiger M, 1999, J AM CHEM SOC, V121, P4690, DOI 10.1021/ja984484z; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Vogeli B, 2013, MOL PHYS, V111, P437, DOI 10.1080/00268976.2012.728257; Vogeli B, 2012, CHIMIA, V66, P787, DOI 10.2533/chimia.2012.787; Yao LS, 2008, J AM CHEM SOC, V130, P16518, DOI 10.1021/ja805654f; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; CONSTANTINE KL, 1995, J AM CHEM SOC, V117, P10841, DOI 10.1021/ja00149a007; Clore GM, 2004, J AM CHEM SOC, V126, P2923, DOI 10.1021/ja0386804; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Vogeli B, 2014, J MAGN RESON, V241, P53, DOI 10.1016/j.jmr.2013.11.016; Vogeli B, 2012, NAT STRUCT MOL BIOL, V19, P1053, DOI 10.1038/nsmb.2355; Vogeli B, 2009, J AM CHEM SOC, V131, P17215, DOI 10.1021/ja905366h; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; Anthis NJ, 2015, Q REV BIOPHYS, V48, P35, DOI 10.1017/S0033583514000122; BELL RA, 1970, CAN J CHEMISTRY, V48, P1114, DOI 10.1139/v70-184; BONVIN AMJJ, 1995, J MOL BIOL, V250, P80, DOI 10.1006/jmbi.1995.0360; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; BRUSCHWEILER R, 1991, Journal of Biomolecular NMR, V1, P3, DOI 10.1007/BF01874565; Chi CN, 2015, J BIOMOL NMR, V62, P63, DOI 10.1007/s10858-015-9917-8; Chou JJ, 2003, J AM CHEM SOC, V125, P8959, DOI 10.1021/ja029972s; Clore GM, 2006, J MOL BIOL, V355, P879, DOI 10.1016/j.jmb.2005.11.042; FESIK SW, 1986, J AM CHEM SOC, V108, P3165, DOI 10.1021/ja00272a002; Fletcher CM, 1996, J BIOMOL NMR, V8, P292, DOI 10.1007/BF00410328; Guntert P., 2015, J BIOMOL NMR; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; LIAN LY, 1992, J MOL BIOL, V228, P1219, DOI 10.1016/0022-2836(92)90328-H; Miclet E, 2005, J BIOMOL NMR, V31, P201, DOI 10.1007/s10858-005-0175-z; Olsson S, 2015, J AM CHEM SOC, V137, P6270, DOI 10.1021/jacs.5b01289; Olsson S, 2011, J MAGN RESON, V213, P182, DOI 10.1016/j.jmr.2011.08.039; Shapiro YE, 2013, PROG BIOPHYS MOL BIO, V112, P58, DOI 10.1016/j.pbiomolbio.2013.05.001; Torchia DA, 2015, PROG NUCL MAG RES SP, V84, P14, DOI 10.1016/j.pnmrs.2014.11.001; Vogeli B, 2014, PROG NUCL MAG RES SP, V78, P1, DOI 10.1016/j.pnmrs.2013.11.001; Vogeli B., 2015, DATA BRIEF COM UNPUB; Vogeli B, 2011, J BIOMOL NMR, V50, P315, DOI 10.1007/s10858-011-9519-z; Vogeli B, 2008, J BIOMOL NMR, V41, P17, DOI 10.1007/s10858-008-9237-3	57	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1047-8477	1095-8657		J STRUCT BIOL	J. Struct. Biol.	SEP	2015	191	3					306	317		10.1016/j.jsb.2015.07.008		12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CQ4UD	WOS:000360599200006		
J	Moriya, T; Fukatsu, K; Iwaya, K; Noguchi, M; Saitoh, D; Miyazaki, M; Hase, K; Yamamoto, J				Moriya, Tomoyuki; Fukatsu, Kazuhiko; Iwaya, Keiichi; Noguchi, Midori; Saitoh, Daizoh; Miyazaki, Masaru; Hase, Kazuo; Yamamoto, Junji			The influence of dietary restriction on hepatic mononuclear cell numbers and functions in mice	JOURNAL OF SURGICAL RESEARCH			English	Article						Nutrition; Liver; Immunity; Cytokine response; Immunoglobulin	FOOD-INTAKE; SURGICAL-PATIENTS; LIVER; MALNUTRITION; PERITONITIS; COMPLICATIONS; CHALLENGE; NUTRITION; APOPTOSIS; AUTOPHAGY	Background: Surgical patients with gastrointestinal malignancies are at increased risk for malnutrition. However, the mechanism by which dietary restriction (DR), one form of malnutrition, impairs hepatic immunity remains to be clarified. The present study was designed to examine the influence of DR on hepatic mononuclear cell (MNC) numbers, subpopulations, and cytokine productions (tumor necrosis factor alpha [TNF-alpha], interferon gamma [IFN-gamma], and interleukin 10 [IL-10]) in response to lipopolysaccharide (LPS) in mice. Immunoglobulin (Ig) A levels in the gallbladder and histopathologic changes in the liver were also assessed. Material and methods: Male Institute of Cancer Research mice were randomly assigned to three dietary groups: ad libitum (AD), mild restriction (MR), and severe restriction (SR). The AD, MR, and SR groups received daily mouse chow in amounts of 190, 133, and 76 g/kg, respectively, for 7 d. After the mice had been fed for 7 d, hepatic MNCs were isolated. Total hepatic MNCs were counted and subpopulations were determined by flow cytometry. Cytokine productions (TNF-alpha, IFN-gamma, and IL-10) by hepatic MNCs in response to LPS were measured. Blood samples were analyzed for hepatobiliary biochemical parameters. IgA levels in gallbladder bile were measured with enzyme-linked immunosorbent assay. In addition, liver histologies were examined. Results: Hepatic MNC numbers were significantly lower in the MR and SR groups than in the AD group, with no significant difference between the MR and SR groups. The percentage of B cells was significantly lower in the SR group than in the MR and AD groups, whereas the T-cell percentage was higher in the SR group than in the MR and AD groups. The percentage of Kupffer cells was significantly lower in the SR group than in the AD group, whereas that in the MR group was midway between those in the SR and AD groups. TNF-alpha and IL-10 levels in hepatic MNC culture supernatants were increased LPS-dose dependently in the AD group. However, the increase was slight in the MR group and absent in the SR group. The IgA levels in gallbladder bile were significantly lower in the SR and MR groups than in the AD group. On the basis of hematoxylin and eosin staining of hepatic sections, livers from the SR group showed atrophic hepatocytes and sinusoidal dilatation, whereas these changes were absent in the AD group. Conclusions: DR decreases hepatic MNC number with subpopulation changes, reduces IgA levels in gallbladder bile, blunts cytokine production by hepatic MNCs, and induces pathologic damage in the liver, which may be an important mechanism underlying the impaired host defense associated with malnutrition. (C) 2015 Elsevier Inc. All rights reserved.	[Moriya, Tomoyuki; Hase, Kazuo; Yamamoto, Junji] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Fukatsu, Kazuhiko] Univ Tokyo, Surg Ctr, Tokyo, Japan; [Iwaya, Keiichi] Natl Def Med Coll, Dept Pathol, Tokorozawa, Saitama 3598513, Japan; [Noguchi, Midori; Saitoh, Daizoh] Natl Def Med Coll, Div Traumatol, Res Inst, Tokorozawa, Saitama 3598513, Japan; [Miyazaki, Masaru] Chiba Univ, Dept Surg, Chiba, Japan	Moriya, T (reprint author), Natl Def Med Coll, Dept Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	tmoriya@ndmc.ac.jp					Beattie AH, 2000, GUT, V46, P813, DOI 10.1136/gut.46.6.813; Ono S, 2003, SURGERY, V134, P92, DOI 10.1067/msy.2003.189; Ikeda S, 2001, ARCH SURG-CHICAGO, V136, P297, DOI 10.1001/archsurg.136.3.297; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Schiesser M, 2009, SURGERY, V145, P519, DOI 10.1016/j.surg.2009.02.001; Iyer SS, 2012, J IMMUNOL, V188, P77, DOI 10.4049/jimmunol.1004027; Sungurtekin H, 2004, J AM COLL NUTR, V23, P227; Burggraaf J, 1996, BRIT J CLIN PHARMACO, V42, P499, DOI 10.1046/j.1365-2125.1996.44115.x; DANON YL, 1983, J PEDIATR GASTR NUTR, V2, P663, DOI 10.1097/00005176-198311000-00016; ECHTENACHER B, 1990, J IMMUNOL, V145, P3762; Gershwin ME, 2003, LIVER IMMUNOLOGY; Kang WD, 2003, JPEN-PARENTER ENTER, V27, P193, DOI 10.1177/0148607103027003193; Kono H, 2006, J LEUKOCYTE BIOL, V79, P809, DOI 10.1189/jlb.0405179; Laichalk LL, 1996, INFECT IMMUN, V64, P5211; Mackay IR, 2002, IMMUNOL CELL BIOL, V80, P36, DOI 10.1046/j.1440-1711.2002.01063.x; Moriya T, 2012, SURGERY, V151, P745, DOI 10.1016/j.surg.2011.12.003; Moriya T, 2007, ANN SURG, V245, P642, DOI 10.1097/01.sla.0000251516.20755.6c; MULLEN JL, 1979, ARCH SURG-CHICAGO, V114, P121; NAGURA H, 1981, J IMMUNOL, V126, P587; Navaneethan U, 2011, Minerva Gastroenterol Dietol, V57, P97; Omata J, 2009, JPEN-PARENTER ENTER, V33, P618, DOI 10.1177/0148607109336598; RICH MW, 1989, AM J CARDIOL, V63, P714, DOI 10.1016/0002-9149(89)90257-9; Rivadeneira DE, 2001, SURGERY, V129, P617, DOI 10.1067/msy.2001.112963; Shimamatsu K, 1997, HEPATOLOGY, V26, P343, DOI 10.1002/hep.510260214; SHIMURA F, 1983, J NUTR SCI VITAMINOL, V29, P429; Teichgraber UKM, 1997, J ULTRAS MED, V16, P549; Tochio H, 2001, AM J ROENTGENOL, V177, P1109; Torosian MH, 1999, WORLD J SURG, V23, P565, DOI 10.1007/PL00012348; Ueno C, 2005, JPEN-PARENTER ENTER, V29, P345, DOI 10.1177/0148607105029005345; Wanless IR, 2002, PATHOLOGY LIVER, P539; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025	31	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2015	198	1					120	126		10.1016/j.jss.2015.05.061		7	Surgery	Surgery	CQ6IG	WOS:000360707300020		
J	Zeniya, M; Morimoto, N; Takahashi, D; Mori, Y; Mori, T; Ando, F; Araki, Y; Yoshizaki, Y; Inoue, Y; Isobe, K; Nomura, N; Oi, K; Nishida, H; Sasaki, S; Sohara, E; Rai, T; Uchida, S				Zeniya, Moko; Morimoto, Nobuhisa; Takahashi, Daiei; Mori, Yutaro; Mori, Takayasu; Ando, Fumiaki; Araki, Yuya; Yoshizaki, Yuki; Inoue, Yuichi; Isobe, Kiyoshi; Nomura, Naohiro; Oi, Katsuyuki; Nishida, Hidenori; Sasaki, Sei; Sohara, Eisei; Rai, Tatemitsu; Uchida, Shinichi			Kelch-Like Protein 2 Mediates Angiotensin II-With No Lysine 3 Signaling in the Regulation of Vascular Tonus	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							DISEASE-CAUSING MUTATIONS; PHOSPHORYLATION CASCADE; HUMAN HYPERTENSION; CL COTRANSPORTER; WNK KINASES; IN-VIVO; AUTOPHAGY; DEGRADATION; KEAP1; KLHL3	Recently, the kelch-like protein 3 (KLHL3)-Cullin3 complex was identified as an E3 ubiquitin ligase for with no lysine (WNK) kinases, and the impaired ubiquitination of WNK4 causes pseudohypoaldosteronism type II (PHAII), a hereditary hypertensive disease. However, the involvement of WNK kinase regulation by ubiquitination in situations other than PHAII has not been identified. Previously, we identified the WNK3-STE20/SPS1-related proline/alanine-rich kinase-Na/K/Cl cotransporter isoform 1 phosphorylation cascade in vascular smooth muscle cells and found that it constitutes an important mechanism of vascular constriction by angiotensin II (AngII). In this study, we investigated the involvement of KLHL proteins in AngII-induced WNK3 activation of vascular smooth muscle cells. In the mouse aorta and mouse vascular smooth muscle (MOVAS) cells, KLHL3 was not expressed, but KLHL2, the closest homolog of KLHL3, was expressed. Salt depletion and acute infusion of AngII decreased KLHL2 and increased WNK3 levels in the mouse aorta. Notably, the AngII-induced changes in KLHL2 and WNK3 expression occurred within minutes in MOVAS cells. Results of KLHL2 overexpression and knockdown experiments in MOVAS cells confirmed that KLHL2 is the major regulator of WNK3 protein abundance. The AngII-induced decrease in KLHL2 was not caused by decreased transcription but increased autophagy-mediated degradation. Furthermore, knockdown of sequestosome 1/p62 prevented the decrease in KLHL2, suggesting that the mechanism of KLHL2 autophagy could be selective autophagy mediated by sequestosome 1/p62. Thus, we identified a novel component of signal transduction in AngII-induced vascular contraction that could be a promising drug target.	[Zeniya, Moko; Morimoto, Nobuhisa; Takahashi, Daiei; Mori, Yutaro; Mori, Takayasu; Ando, Fumiaki; Araki, Yuya; Yoshizaki, Yuki; Inoue, Yuichi; Isobe, Kiyoshi; Nomura, Naohiro; Oi, Katsuyuki; Nishida, Hidenori; Sasaki, Sei; Sohara, Eisei; Rai, Tatemitsu; Uchida, Shinichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nephrol, Tokyo, Japan	Uchida, S (reprint author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan.	suchida.kid@tmd.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare Health and Labor Sciences Research Grant; Salt Science Research Foundation [1422]; Takeda Science Foundation; Banyu Foundation Research Grant; Vehicle Racing Commemorative Foundation	This study was supported, in part, by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (S, A); a Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-Aid for Young Scientists (B); a Ministry of Health, Labor, and Welfare Health and Labor Sciences Research Grant; Salt Science Research Foundation Grant 1422; the Takeda Science Foundation; a Banyu Foundation Research Grant; and the Vehicle Racing Commemorative Foundation.	Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Nishida H, 2012, HYPERTENSION, V60, P981, DOI 10.1161/HYPERTENSIONAHA.112.201509; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Ohta A, 2009, HUM MOL GENET, V18, P3978, DOI 10.1093/hmg/ddp344; Talati G, 2010, BIOCHEM BIOPH RES CO, V393, P844, DOI 10.1016/j.bbrc.2010.02.096; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Zeniya M, 2013, HYPERTENSION, V62, P872, DOI 10.1161/HYPERTENSIONAHA.113.01543; Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wu GJ, 2013, FEBS LETT, V587, P1717, DOI 10.1016/j.febslet.2013.04.032; Takahashi D, 2013, BIOCHEM BIOPH RES CO, V437, P457, DOI 10.1016/j.bbrc.2013.06.104; Susa K, 2012, CLIN EXP NEPHROL, V16, P530, DOI 10.1007/s10157-012-0590-x; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Saritas T, 2013, J AM SOC NEPHROL, V24, P407, DOI 10.1681/ASN.2012040404; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Oi K, 2012, BIOL OPEN, V1, P120, DOI 10.1242/bio.2011048; Orlov SN, 2012, ANN MED, V44, pS111, DOI 10.3109/07853890.2011.653395; Pan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053950; Sohara E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024277; Takahashi D, 2014, BIOSCIENCE REP, V34, P195, DOI 10.1042/BSR20140047; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yadav A, 2010, AM J PHYSIOL-CELL PH, V299, pC488, DOI 10.1152/ajpcell.00424.2009; Yu KY, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0416-y	33	0	0	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	2015	26	9					2129	2138		10.1681/ASN.2014070639		10	Urology & Nephrology	Urology & Nephrology	CQ4NR	WOS:000360582100010		
J	Imasaka, K; Tayama, E; Tomita, Y				Imasaka, Ken-ichi; Tayama, Eiki; Tomita, Yukihiro			Left ventricular performance early after repair for posterior mitral leaflet prolapse: Chordal replacement versus leaflet resection	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article						left ventricular performance; mitral valve repair; chordal replacement; leaflet resection	POLYTETRAFLUOROETHYLENE ARTIFICIAL GRAFTS; VALVE REPAIR; SURGICAL-CORRECTION; ATRIAL-FIBRILLATION; MASS REGRESSION; EXTENSIVE USE; REGURGITATION; SURGERY; EFFICIENCY; RECOMMENDATIONS	Objective: To review hemodynamic performance early after valve repair with chordal replacement versus leaflet resection for posterior mitral leaflet prolapse. Methods: Between April 2006 and September 2014, 72 consecutive patients underwent valve repair with chordal replacement (30 patients) or leaflet resection (42 patients) for isolated posterior mitral leaflet prolapse. Left ventricular ejection fraction, end-systolic elastance, effective arterial elastance, and ventricular efficiency were noninvasively measured by echocardiography and analyzed preoperatively and similar to 1 month postoperatively. Mitral valve repair was accomplished in all patients, and no regurgitation (including trivial) was observed postoperatively. Results: Chordal replacement resulted in significantly less reduction in left ventricular ejection fraction, and significantly greater increase in end-systolic elastance than leaflet resection (left ventricular ejection fraction, 4.8% vs 16.7% relative decrease [P = .005] and end-systolic elastance, 19.0% vs -1.3% relative increase [P = .012]). Despite comparable preoperative ventricular efficiency between the groups, the postoperative ventricular efficiency in the chordal replacement group was superior to that in the leaflet resection group (ventriculoarterial coupling, 32.0% vs 89.3% relative increase [P = .007] and ratio of stroke work to pressure-volume area, 4.3% vs 13.4% relative decrease [P = .008]). In multivariate analysis, operative technique was a significant determinant of left ventricular ejection fraction and ratio of stroke work to pressure-volume area (P = .030 and P = .030, respectively). Conclusions: Chordal replacement might provide patients undergoing valve repair for posterior mitral leaflet prolapse with better postoperative ventricular performance than leaflet resection. Longer follow-up is required to compare long-term outcomes.	[Imasaka, Ken-ichi; Tayama, Eiki; Tomita, Yukihiro] Natl Hosp Org, Kyushu Med Ctr, Dept Cardiovasc Surg, Clin Res Inst, Fukuoka 8128582, Japan	Tomita, Y (reprint author), Natl Hosp Org, Kyushu Med Ctr, Dept Cardiovasc Surg, Chuo Ku, 1-8-1 Jigyo Hama, Fukuoka 8128582, Japan.	ytomita@kyumed.jp					Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Suri RM, 2008, J THORAC CARDIOV SUR, V136, P442, DOI 10.1016/j.jtcvs.2007.10.067; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; SUGA H, 1990, PHYSIOL REV, V70, P247; CARPENTIER AF, 1995, ANN THORAC SURG, V60, P1177, DOI 10.1016/0003-4975(95)00753-8; BURKHOFF D, 1986, AM J PHYSIOL, V250, P1021; David TE, 2013, J THORAC CARDIOV SUR, V145, P1563, DOI 10.1016/j.jtcvs.2012.05.030; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Tomita Y, 2005, SURG TODAY, V35, P812, DOI 10.1007/s00595-005-3043-2; Braunberger E., 2001, CIRCULATION S1, V104, P18; David T E, 1989, J Card Surg, V4, P286, DOI 10.1111/j.1540-8191.1989.tb00291.x; Dreyfus GD, 2006, J HEART VALVE DIS, V15, P528; Dubrey SW, 1997, J AM SOC ECHOCARDIOG, V10, P67, DOI 10.1016/S0894-7317(97)80034-X; Gazoni LM, 2007, ANN THORAC SURG, V83, P1658, DOI 10.1016/j.athoracsur.2007.01.028; Goldfine H, 1998, J AM COLL CARDIOL, V31, P180, DOI 10.1016/S0735-1097(97)00453-1; Imasaka K, 2013, J HEART VALVE DIS, V22, P804; Imasaka K, 2013, J THORAC CARDIOV SUR, V146, P61, DOI 10.1016/j.jtcvs.2012.05.056; Johnston DR, 2010, J THORAC CARDIOVASC, V89, P1385; Kerr AJ, 2001, AM J CARDIOL, V87, P1116, DOI 10.1016/S0002-9149(01)01475-8; Manabe S, 2013, CIRC J, V77, P2038, DOI 10.1253/circj.CJ-12-1600; NOZAWA T, 1988, CIRCULATION, V77, P1116; Padala M, 2009, J THORAC CARDIOV SUR, V138, P309, DOI 10.1016/j.jtcvs.2009.01.031; Quintana E, 2014, J THORAC CARDIOV SUR, V148, P2752, DOI 10.1016/j.jtcvs.2014.07.029; Salvador L, 2008, J THORAC CARDIOV SUR, V135, P1280, DOI 10.1016/j.jtcvs.2007.12.026; Shafii AE, 2012, AM J CARDIOL, V110, P403, DOI 10.1016/j.amjcard.2012.03.041; STARLING MR, 1994, AM HEART J, V127, P1324, DOI 10.1016/0002-8703(94)90052-3; STARLING MR, 1995, CIRCULATION, V92, P811; Stulak JM, 2011, J THORAC CARDIOV SUR, V141, P122, DOI 10.1016/j.jtcvs.2010.08.068; Suri RM, 2009, J THORAC CARDIOV SUR, V137, P1071, DOI 10.1016/j.jtcvs.2008.10.026; Tanoue Y, 2001, CIRCULATION, V103, P2176; Tomita Y, 2002, EUR J CARDIO-THORAC, V21, P27, DOI 10.1016/S1010-7940(01)00990-3; Tomita Y, 1997, ANN THORAC SURG, V64, P1831, DOI 10.1016/S0003-4975(97)01070-9; Tomita Y, 2004, ANN THORAC SURG, V78, P815, DOI 10.1016/j.athoracsur.2004.03.036	35	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	SEP	2015	150	3					538	545		10.1016/j.jtcvs.2015.06.022		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ6AE	WOS:000360686000041		
J	Fukui, T; Tabata, M; Morita, S; Takanashi, S				Fukui, Toshihiro; Tabata, Minoru; Morita, Satoshi; Takanashi, Shuichiro			Gender differences in patients undergoing surgery for acute type A aortic dissection	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article						aorta; aortic dissection; aortic surgery; sex; surgery	CORONARY-ARTERY-BYPASS; OPERATIVE MORTALITY; INTERNATIONAL REGISTRY; SEX-DIFFERENCES; OUTCOMES; WOMEN; REPAIR; MANAGEMENT; MALPERFUSION; SOCIETY	Objectives: The impact of gender on preoperative characteristics and postoperative outcomes in patients undergoing surgery for acute type A aortic dissection rarely has been investigated. Methods: We reviewed the records of 504 patients (245 women and 259 men) who underwent surgery for acute type A aortic dissection between August 2006 and December 2013. Women were older (71.5 vs 59.7 years; P < .001) and smaller (body surface area 1.5 vs 1.9 m(2); P < .001) than men. Early and long-term outcomes were compared between men and women. Results: Operative mortality (< 30 days) was similar between the groups (4.5% vs 5.8%; P = .646). Multivariable logistic regression analysis demonstrated that myocardial ischemia (odds ratio [OR], 5.48; 95% confidence interval [CI], 2.00-15.00; P < .001), neurologic ischemia (OR, 6.64; 95% CI, 2.26-19.48; P < .001), and shock/tamponade (OR, 3.74; 95% CI, 1.49-9.40; P = .005) were independent predictors of operative mortality. At 5 years, there was no significant difference in survival between the groups (80.1% vs 89.3%; P = .067). Cox regression analysis demonstrated that myocardial ischemia (hazard ratio [HR], 2.40; 95% CI, 1.21-4.74; P = .012), nonprescription of beta-blockers at discharge (HR, 4.27; 95% CI, 2.43-7.50; P < .001), and nonprescription of angiotensin II receptor blockers at discharge (HR, 2.39; 95% CI, 1.14-5.01; P = .021) were independent predictors of late mortality. Female gender was not an independent predictor of operative and late mortality. Conclusions: There are no differences in early and long-term outcomes between male and female patients undergoing surgery for acute type A aortic dissection.	[Fukui, Toshihiro; Tabata, Minoru; Takanashi, Shuichiro] Sakakibara Heart Inst, Dept Cardiovasc Surg, Fuchu, Tokyo 1830003, Japan; [Tabata, Minoru] Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Cardiovasc Surg, Chiba, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan	Fukui, T (reprint author), Sakakibara Heart Inst, Dept Cardiovasc Surg, 3-16-1 Asahi Cho, Fuchu, Tokyo 1830003, Japan.	tfukui.cvs@gmail.com					Alam M, 2013, AM J CARDIOL, V112, P309, DOI 10.1016/j.amjcard.2013.03.034; FISHER LD, 1982, J THORAC CARDIOV SUR, V84, P334; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133; Nienaber CA, 2004, CIRCULATION, V109, P3014, DOI 10.1161/01.CIR.0000130644.78677.2C; Edwards FH, 1998, ANN THORAC SURG, V66, P125, DOI 10.1016/S0003-4975(98)00358-0; Zierer A, 2007, ANN THORAC SURG, V84, P479, DOI 10.1016/j.athoracsur.2007.03.084; Matsushita A, 2014, J THORAC CARDIOV SUR, V147, P290, DOI 10.1016/j.jtcvs.2012.11.007; Zitser-Gurevich Y, 2002, J THORAC CARDIOV SUR, V123, P517, DOI 10.1067/mtc.2002.120012; Mehta RH, 2002, CIRCULATION, V105, P200, DOI 10.1161/hc0202.102246; Groenink M, 2013, EUR HEART J, V34, P3491, DOI 10.1093/eurheartj/eht334; Hogue CW, 2001, CIRCULATION, V103, P2133; Gilon D, 2009, AM J CARDIOL, V103, P1029, DOI 10.1016/j.amjcard.2008.12.013; Mehta RH, 2002, J AM COLL CARDIOL, V40, P685, DOI 10.1016/S0735-1097(02)02005-3; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6; Januzzi JL, 2004, J AM COLL CARDIOL, V43, P665, DOI 10.1016/j.jacc.2003.08.054; Suzuki T, 2012, AM J CARDIOL, V109, P122, DOI 10.1016/j.amjcard.2011.08.012; Bekkers JA, 2013, EUR J CARDIO-THORAC, V43, P389, DOI 10.1093/ejcts/ezs342; Braverman AC, 2010, CIRCULATION, V122, P184, DOI 10.1161/CIRCULATIONAHA.110.958975; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Bukkapatnam RN, 2010, AM J CARDIOL, V105, P339, DOI 10.1016/j.amjcard.2009.09.035; COSGROVE DM, 1984, J THORAC CARDIOV SUR, V88, P673; Ehrlich M, 1998, CIRCULATION, V98, pII294; Geirsson A, 2007, ANN THORAC SURG, V84, P1955, DOI 10.1016/j.athoracsur.2007.07.017; Guru V, 2004, J THORAC CARDIOV SUR, V127, P1158, DOI 10.1016/j.jtcvs.2003.12.008; HANNAN EL, 1992, AM HEART J, V123, P866, DOI 10.1016/0002-8703(92)90689-S; Huynh TTT, 2013, J VASC SURG, V57, p11S, DOI 10.1016/j.jvs.2012.08.126; Kawahito K, 2003, ANN THORAC SURG, V76, P1471, DOI 10.1016/S0003-4975(03)00899-3; Kruger T, 2012, BRIT J SURG, V99, P1331, DOI 10.1002/bjs.8840; Matsuyama S, 2012, J THORAC CARDIOV SUR, V143, P1377, DOI 10.1016/j.jtcvs.2011.07.016; Melby SJ, 2013, J CLIN HYPERTENS, V15, P63, DOI 10.1111/jch.12024; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Okita Yutaka, 2015, Gen Thorac Cardiovasc Surg, V63, P185, DOI 10.1007/s11748-014-0476-9; Shimokawa T, 2008, ANN THORAC SURG, V85, P1619, DOI 10.1016/j.athoracsur.2008.01.048; SVENSSON LG, 1990, CIRCULATION, V82, P24; Weintraub WS, 1993, CIRCULATION, V88, pI179	35	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	SEP	2015	150	3					581	587		10.1016/j.jtcvs.2015.06.031		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ6AE	WOS:000360686000049		
J	Kishimoto, Y; Kato, T; Ito, M; Azuma, Y; Fukasawa, Y; Ohno, K; Kojima, S				Kishimoto, Yasuaki; Kato, Taichi; Ito, Mikako; Azuma, Yoshiteru; Fukasawa, Yoshie; Ohno, Kinji; Kojima, Seiji			Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article						pulmonary arterial hypertension; molecular hydrogen; NFAT; STAT3; reactive oxygen species	ARTERIAL-HYPERTENSION; MICE; SURVIVAL; INFLAMMATION; CHEMOKINES; REGISTRY; HYPOXIA; DISEASE; SYSTEM; CELLS	Objective: The pathogenesis of pulmonary arterial hypertension (PAH) involves reactive oxygen species and inflammation. Beneficial effects of molecular hydrogen, which exerts both anti-inflammatory and antioxidative effects, have been reported for various pathologic conditions. We therefore hypothesized that molecular hydrogen would improve monocrotaline (MCT)-induced PAH in rats. Methods: Nineteen male Sprague-Dawley rats (body weight: 200-300 g) were divided into groups, receiving: (1) MCT + hydrogen-saturated water (group H); (2) MCT + dehydrogenized water (group M); or (3) saline + dehydrogenized water (group C). Sixteen days after substance administration, we evaluated hemodynamics, harvested the lungs and heart, and performed morphometric analysis of the pulmonary vasculature. Macrophage infiltration, antiproliferating cell nuclear antigen-positive cells, 8-hydroxy-deoxyguanosine (8-OHdG)positive cells, and expressions of phosphorylated signal transducers and activators of transcription-3 (STAT3) and nuclear factor of activated T-cells (NFAT) were evaluated immunohistochemically. Stromal cell-derived factor-1 and monocyte chemoattractant protein-1 expressions were evaluated by quantitative reverse-transcription polymerase chain reaction. Results: Pulmonary arterial hypertension was significantly exacerbated in group M compared to group C, but was significantly improved in group H. Vascular density was significantly reduced in group M, but not in group H. Adventitial macrophages, antiproliferating cell nuclear antigen - and 8-OHdG-positive cells, and stromal cell-derived factor-1 and monocyte chemoattractant protein-1 expressions were significantly increased in group M, but improved in group H. Expressions of phosphorylated STAT3 and NFAT were up-regulated in group M, but improved in group H. Conclusions: Molecular hydrogen ameliorates MCT-induced PAH in rats by suppressing macrophage accumulation, reducing oxidative stress and modulating the STAT3/NFAT axis.	[Kishimoto, Yasuaki; Kato, Taichi; Azuma, Yoshiteru; Fukasawa, Yoshie; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4668550, Japan; [Ito, Mikako; Azuma, Yoshiteru; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4668550, Japan	Kato, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Pediat, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ktaichi@med.nagoya-u.ac.jp			JSPS KAKENHI Grant [21790981]	This work was supported by JSPS KAKENHI Grant Number 21790981.	Bowers R, 2004, AM J RESP CRIT CARE, V169, P764, DOI 10.1164/rccm.200301-147OC; Dorfmuller P, 2007, HUM PATHOL, V38, P893, DOI 10.1016/j.humpath.2006.11.022; Tanaka E, 2002, J RHEUMATOL, V29, P282; Paulin R, 2011, CIRCULATION, V123, P1205, DOI 10.1161/CIRCULATIONAHA.110.963314; Dumitrascu R, 2011, EUR RESPIR J, V37, P1104, DOI 10.1183/09031936.00126010; TUDER RM, 1994, AM J PATHOL, V144, P275; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Li FY, 2013, FOOD CHEM TOXICOL, V61, P248, DOI 10.1016/j.fct.2013.10.004; Courboulin A, 2012, EUR RESPIR J, V40, P618, DOI 10.1183/09031936.00084211; Ohno K, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/353152; He B, 2013, MOL BIOL REP, V40, P5513, DOI 10.1007/s11033-013-2653-9; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Sahara M, 2007, CIRCULATION, V115, P509, DOI 10.1161/CIRCULATIONAHA.106.655837; Olive M, 2008, J CLIN INVEST, V118, P2050, DOI 10.1172/JCI31244; Fagan KA, 2004, AM J PHYSIOL-LUNG C, V287, pL656, DOI 10.1152/ajplung.00090.2003; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599; Schober A, 2007, THROMB HAEMOSTASIS, V97, P730, DOI 10.1160/TH07-02-0085; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Price LC, 2011, EUR RESPIR J, V37, P813, DOI 10.1183/09031936.00028310; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Mitani Y, 2008, J THORAC CARDIOV SUR, V136, P142, DOI 10.1016/j.jtcvs.2007.10.061; Barst RJ, 2012, CIRCULATION, V125, P113, DOI 10.1161/CIRCULATIONAHA.111.026591; Quarck R, 2009, J AM COLL CARDIOL, V53, P1211, DOI 10.1016/j.jacc.2008.12.038; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Ramiro-Diaz JM, 2013, AM J PHYSIOL-LUNG C, V304, pL613, DOI 10.1152/ajplung.00408.2012; Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104; Hamidi SA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-141; Ito Mikako, 2011, Med Gas Res, V1, P24, DOI 10.1186/2045-9912-1-24; Ito Mikako, 2012, Med Gas Res, V2, P15, DOI 10.1186/2045-9912-2-15; Ohta S, 2014, PHARMACOL THERAPEUT, V144, P1, DOI 10.1016/j.pharmthera.2014.04.006; Perez-Vizcaino F, 2010, RESP PHYSIOL NEUROBI, V174, P212, DOI 10.1016/j.resp.2010.08.009; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Wang Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-26	35	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	SEP	2015	150	3					645	654		10.1016/j.jtcvs.2015.05.052		10	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ6AE	WOS:000360686000061		
J	Nishimori, H; Yamamoto, M; Orihashi, K				Nishimori, Hideaki; Yamamoto, Masaki; Orihashi, Kazumasa			CEREBRAL INFARCTION OCCURS PARTICULARLY IN PATIENTS WITH PORCELAIN AORTA	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Letter									[Nishimori, Hideaki; Yamamoto, Masaki; Orihashi, Kazumasa] Kochi Univ, Sch Med, Dept Surg 2, Nankoku, Kochi, Japan	Nishimori, H (reprint author), Kochi Univ, Sch Med, Dept Surg 2, Nankoku, Kochi, Japan.						Idrees J, 2015, J THORAC CARDIOV SUR, V149, P131, DOI 10.1016/j.jtcvs.2014.09.035; LeMaire SA, 2015, J THORAC CARDIOV SUR, V149, P134, DOI 10.1016/j.jtcvs.2014.10.024; Nishi H, 2010, INTERACT CARDIOV TH, V10, P18, DOI 10.1510/icvts.2009.216242	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	SEP	2015	150	3					744	745		10.1016/j.jtcvs.2015.05.041		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ6AE	WOS:000360686000097		
J	Chen, F; Takahagi, A; Sakamoto, K; Date, H				Chen, Fengshi; Takahagi, Akihiro; Sakamoto, Kazuhisa; Date, Hiroshi			Lung autotransplantation technique for postpneumonectomy-like syndrome	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material									[Chen, Fengshi; Takahagi, Akihiro; Date, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto 6068507, Japan; [Sakamoto, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto 6068507, Japan	Date, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hdate@kuhp.kyoto-u.ac.jp					Chen FS, 2004, YONSEI MED J, V45, P1107; Lee Y, 2008, J THORAC CARDIOV SUR, V136, P780, DOI 10.1016/j.jtcvs.2007.12.035; Shen KR, 2008, J THORAC CARDIOV SUR, V135, P1210, DOI 10.1016/j.jtcvs.2007.11.022; van Maurik AFMM, 2007, J THORAC CARDIOV SUR, V134, P608, DOI 10.1016/j.jtcvs.2007.05.014; Veronesi G, 2002, ANN ONCOL, V13, P1945, DOI 10.1093/annonc/mdf310	5	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	SEP	2015	150	3					E45	E47		10.1016/j.jtcvs.2015.06.048		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ6AE	WOS:000360686000009		
J	Hosoyama, K; Kawamoto, S; Motoyoshi, N; Saiki, Y				Hosoyama, Katsuhiro; Kawamoto, Shunsuke; Motoyoshi, Naotaka; Saiki, Yoshikatsu			Intraoperative vacuum-assisted closure following in situ graft replacement for an infected thoracic aortic graft	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material							BLOOD-FLOW		[Hosoyama, Katsuhiro; Kawamoto, Shunsuke; Motoyoshi, Naotaka; Saiki, Yoshikatsu] Kobe Univ, Div Cardiovasc Surg, Dept Surg, Kobe, Hyogo 657, Japan	Saiki, Y (reprint author), Tohoku Univ, Grad Sch Med, Div Cardiovasc Surg, Aoba Ku, 1-1 Seiryocho, Sendai, Miyagi, Japan.	yoshisaiki@med.tohoku.ac.jp					Wackenfors A, 2004, WOUND REPAIR REGEN, V12, P600, DOI 10.1111/j.1067-1927.2004.12602.x; Petzina R, 2006, EUR J CARDIO-THORAC, V30, P85, DOI 10.1016/j.ejcts.2006.04.009; Coselli JS, 1999, ANN THORAC SURG, V67, P1990, DOI 10.1016/S0003-4975(99)00355-0; Coselli JS, 1999, ANN THORAC SURG, V67, P1997; Saiki Yoshikatsu, 2008, Interact Cardiovasc Thorac Surg, V7, P712, DOI 10.1510/icvts.2008.176727; Suzuki Tomoyuki, 2015, Gen Thorac Cardiovasc Surg, V63, P86, DOI 10.1007/s11748-014-0451-5	6	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	SEP	2015	150	3					E36	E38		10.1016/j.jtcvs.2015.05.061		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ6AE	WOS:000360686000005		
J	Okita, Y				Okita, Yutaka			An intimal cylinder in the descending aorta	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material									[Okita, Yutaka] Kobe Univ, Dept Surg, Div Cardiovasc Surg, Kobe, Hyogo 657, Japan	Okita, Y (reprint author), Dept Surg, Div Cardiovasc Surg, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yokita@med.kobe-u.ac.jp					Kim SY, 2015, J THORAC CARDIOV SUR, V150, pE33, DOI 10.1016/j.jtcvs.2015.05.033	1	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	SEP	2015	150	3					E35	E36		10.1016/j.jtcvs.2015.06.043		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ6AE	WOS:000360686000004		
J	Travis, WD; Brambilla, E; Nicholson, AG; Yatabe, Y; Austin, JHM; Beasley, MB; Chirieac, LR; Dacic, S; Duhig, E; Flieder, DB; Geisinger, K; Hirsch, FR; Ishikawa, Y; Kerr, KM; Noguchi, M; Pelosi, G; Powell, CA; Tsao, MS; Wistuba, I				Travis, William D.; Brambilla, Elisabeth; Nicholson, Andrew G.; Yatabe, Yasushi; Austin, John H. M.; Beasley, Mary Beth; Chirieac, Lucian. R.; Dacic, Sanja; Duhig, Edwina; Flieder, Douglas B.; Geisinger, Kim; Hirsch, Fred R.; Ishikawa, Yuichi; Kerr, Keith M.; Noguchi, Masayuki; Pelosi, Giuseppe; Powell, Charles A.; Tsao, Ming Sound; Wistuba, Ignacio		WHO Panel	The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification	JOURNAL OF THORACIC ONCOLOGY			English	Review						WHO classification; Lung tumors; Lung cancer; Lung adenocarcinoma; Squamous cell carcinoma; Small cell carcinoma; Large cell carcinoma; Carcinoid	ERDHEIM-CHESTER-DISEASE; RESPIRATORY SOCIETY CLASSIFICATION; SQUAMOUS-CELL-CARCINOMA; NUT MIDLINE CARCINOMA; PROPOSED IASLC/ATS/ERS CLASSIFICATION; MICRONODULAR PNEUMOCYTE HYPERPLASIA; PULMONARY SCLEROSING HEMANGIOMA; EGFR-MUTATION-ANALYSIS; STAGE-I DISEASE; INTERNATIONAL-ASSOCIATION	The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura, Thymus and Heart has just been published with numerous important changes from the 2004 WHO classification. The most significant changes in this edition involve (1) use of immunohistochemistry throughout the classification, (2) a new emphasis on genetic studies, in particular, integration of molecular testing to help personalize treatment strategies for advanced lung cancer patients, (3) a new classification for small biopsies and cytology similar to that proposed in the 2011 Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, (4) a completely different approach to lung adenocarcinoma as proposed by the 2011 Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, (5) restricting the diagnosis of large cell carcinoma only to resected tumors that lack any clear morphologic or immunohistochemical differentiation with reclassification of the remaining former large cell carcinoma subtypes into different categories, (6) reclassifying squamous cell carcinomas into keratinizing, nonkeratinizing, and basaloid subtypes with the nonkeratinizing tumors requiring immunohistochemistry proof of squamous differentiation, (7) grouping of neuroendocrine tumors together in one category, (8) adding NUT carcinoma, (9) changing the term sclerosing hemangioma to sclerosing pneumocytoma, (10) changing the name hamartoma to pulmonary hamartoma, (11) creating a group of PEComatous tumors that include (a) lymphangioleiomyomatosis, (b) PEComa, benign (with clear cell tumor as a variant) and (c) PEComa, malignant, (12) introducing the entity pulmonary myxoid sarcoma with an EWSR1-CREB1 translocation, (13) adding the entities myoepithelioma and myoepithelial carcinomas, which can show EWSR1 gene rearrangements, (14) recognition of usefulness of WWTR1-CAMTA1 fusions in diagnosis of epithelioid hemangioendotheliomas, (15) adding Erdheim-Chester disease to the lymphoproliferative tumor, and (16) a group of tumors of ectopic origin to include germ cell tumors, intrapulmonary thymoma, melanoma and meningioma.	[Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Brambilla, Elisabeth] Univ Grenoble 1, CHU Albert Michallon, Dept Anat & Cytol Pathol, INSERM,U823,Inst Albert Bonniot, Grenoble, France; [Nicholson, Andrew G.] Royal Brompton Hosp, Dept Pathol, London SW3 6LY, England; [Yatabe, Yasushi] Aichi Canc Ctr, Dept Pathol, Nagoya, Aichi 464, Japan; [Austin, John H. M.] Columbia Univ, Med Ctr, Dept Radiol, New York, NY USA; [Beasley, Mary Beth] Ichan Sch Med Mt Sinai, Dept Pathol, New York, NY USA; [Chirieac, Lucian. R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Dacic, Sanja] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Duhig, Edwina] John Flynn Hosp, Sullivan Nicolaides Pathol, Tugun, Qld, Australia; [Flieder, Douglas B.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Geisinger, Kim] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Hirsch, Fred R.] Univ Colorado, Canc Ctr UCHSC, Aurora, CO USA; [Ishikawa, Yuichi] JFCR Canc Inst, Dept Pathol, Tokyo, Japan; [Kerr, Keith M.] Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland; [Noguchi, Masayuki] Univ Tsukuba, Inst Basic Med Sci, Dept Pathol, Tsukuba, Ibaraki 305, Japan; [Pelosi, Giuseppe] Ist Nazl Tumori, Dept Pathol & Lab Med, I-20133 Milan, Italy; [Powell, Charles A.] Ichan Sch Med Mt Siai, Div Pulm Crit Care & Sleep Med, New York, NY USA; [Tsao, Ming Sound] Princess Margaret Hosp, Dept Pathol, Toronto, ON M4X 1K9, Canada; [Wistuba, Ignacio] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Travis, WD (reprint author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA.	travisw@mskcc.org	POWELL, CHARLES/C-8663-2011	POWELL, CHARLES/0000-0003-3509-891X			Anderson T, 2015, AM J SURG PATHOL, V39, P132, DOI 10.1097/PAS.0000000000000346; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; Cavalli G, 2013, ANN RHEUM DIS, V72, P1691, DOI 10.1136/annrheumdis-2012-202542; [Anonymous], 2014, NATURE, V511, P543; Rossi G, 2014, VIRCHOWS ARCH, V464, P61, DOI 10.1007/s00428-013-1501-6; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Errani C, 2011, GENE CHROMOSOME CANC, V50, P644, DOI 10.1002/gcc.20886; Kadota K, 2012, MODERN PATHOL, V25, P1117, DOI 10.1038/modpathol.2012.58; Holst VA, 1997, AM J SURG PATHOL, V21, P801, DOI 10.1097/00000478-199707000-00008; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Travis WD, 1998, AM J SURG PATHOL, V22, P934, DOI 10.1097/00000478-199808000-00003; Tsuta K, 2013, LUNG CANCER, V81, P371, DOI 10.1016/j.lungcan.2013.06.012; Hornick JL, 2003, AM J SURG PATHOL, V27, P1183, DOI 10.1097/00000478-200309000-00001; Maruyama H, 2001, MODERN PATHOL, V14, P609, DOI 10.1038/modpathol.3880359; Pelosi G, 2012, J THORAC ONCOL, V7, P281, DOI 10.1097/JTO.0b013e31823815d3; Pelosi G, 2012, LUNG CANCER, V77, P507, DOI 10.1016/j.lungcan.2012.05.093; Ou SHI, 2009, J THORAC ONCOL, V4, P1202, DOI 10.1097/JTO.0b013e3181b28fb9; Chetritt J, 1999, HUM PATHOL, V30, P1093, DOI 10.1016/S0046-8177(99)90228-9; Warth A, 2015, J THORAC ONCOL, V10, P638, DOI 10.1097/JTO.0000000000000490; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Nicholson AG, 2010, J THORAC ONCOL, V5, P436, DOI 10.1097/JTO.0b013e3181c6ed9b; Martignoni G, 2010, ARCH PATHOL LAB MED, V134, P33, DOI 10.1043/2008-0542-RAR1.1; Girard N, 2009, AM J SURG PATHOL, V33, P1752, DOI 10.1097/PAS.0b013e3181b8cf03; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Nonaka D, 2012, AM J SURG PATHOL, V36, P895, DOI 10.1097/PAS.0b013e3182498f2b; Italiano A, 2009, INT J CANCER, V125, P2479, DOI 10.1002/ijc.24610; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Warth A, 2015, AM J SURG PATHOL, V39, P793, DOI 10.1097/PAS.0000000000000409; [Anonymous], 2015, CANC DISCOV, V5, pOF1; Thway K, 2012, AM J SURG PATHOL, V36, pE1, DOI 10.1097/PAS.0b013e31825485c5; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Warth A, 2012, VIRCHOWS ARCH, V461, P185, DOI 10.1007/s00428-012-1263-6; Woo T, 2012, PATHOL INT, V62, P785, DOI 10.1111/pin.12016; Kadota K, 2015, J THORAC ONCOL, V10, P806, DOI 10.1097/JTO.0000000000000486; Loo PS, 2010, J THORAC ONCOL, V5, P442, DOI 10.1097/JTO.0b013e3181d40fac; Arnaud L, 2010, ARTHRITIS RHEUM-US, V62, P3504, DOI 10.1002/art.27672; Chang YL, 2011, ANN SURG ONCOL, V18, P2952, DOI 10.1245/s10434-011-1621-7; Nakatani Y, 2002, MODERN PATHOL, V15, P617, DOI 10.1038/modpathol.3880575; Chan ACL, 2000, AM J SURG PATHOL, V24, P1531, DOI 10.1097/00000478-200011000-00009; Vencio EF, 2007, AM J SURG PATHOL, V31, P319, DOI 10.1097/01.pas.0000213366.33627.a0; Antonescu CR, 2013, GENE CHROMOSOME CANC, V52, P775, DOI 10.1002/gcc.22073; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Rekhtman N, 2013, MODERN PATHOL, V26, P511, DOI 10.1038/modpathol.2012.195; Pelosi G, 2005, AM J SURG PATHOL, V29, P179, DOI 10.1097/01.pas.0000149690.75462.29; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; Schwartz BE, 2011, CANCER RES, V71, P2686, DOI 10.1158/0008-5472.CAN-10-3513; Yamaguchi Y, 2010, J THORAC ONCOL, V5, P1361, DOI 10.1097/JTO.0b013e3181eaf2f3; Haack H, 2009, AM J SURG PATHOL, V33, P984, DOI 10.1097/PAS.0b013e318198d666; Bauer DE, 2012, CLIN CANCER RES, V18, P5773, DOI 10.1158/1078-0432.CCR-12-1153; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P685, DOI 10.5858/arpa.2012-0264-RA; Hysi I, 2011, INTERACT CARDIOV TH, V13, P226, DOI 10.1510/icvts.2011.270934; Russell PA, 2011, J THORAC ONCOL, V6, P1496, DOI 10.1097/JTO.0b013e318221f701; Yendamuri S, 2012, SURGERY, V152, P397, DOI 10.1016/j.surg.2012.05.007; Thway K, 2011, AM J SURG PATHOL, V35, P1722, DOI 10.1097/PAS.0b013e318227e4d2; Herbst RS, 2015, CLIN CANCER RES, V21, P1514, DOI 10.1158/1078-0432.CCR-13-3473; McCormack FX, 2012, AM J RESP CRIT CARE, V186, P1210, DOI 10.1164/rccm.201205-0848OE; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Lim HJ, 2013, CHEST, V144, P1291, DOI 10.1378/chest.12-2987; Lee HY, 2014, AM J ROENTGENOL, V202, pW224, DOI 10.2214/AJR.13.11819; BRAMBILLA E, 1992, HUM PATHOL, V23, P993, DOI 10.1016/0046-8177(92)90260-A; DALCIN P, 1993, GENE CHROMOSOME CANC, V8, P131; Song Z, 2013, EJSO-EUR J SURG ONC, V39, P1262, DOI 10.1016/j.ejso.2013.08.026; Flieder DB, 1997, AM J SURG PATHOL, V21, P1242, DOI 10.1097/00000478-199710000-00017; Pelosi G, 2014, J THORAC ONCOL, V9, P273, DOI 10.1097/JTO.0000000000000092; Gong L, 2009, PATHOL RES PRACT, V205, P601, DOI 10.1016/j.prp.2009.02.004; Bagan P, 2006, ANN THORAC SURG, V82, P2010, DOI 10.1016/j.athoracsur.2006.06.068; Turner BM, 2012, ARCH PATHOL LAB MED, V136, P163, DOI 10.5858/arpa.2011-0320-OA; Kadota K, 2014, MODERN PATHOL, V27, P690, DOI 10.1038/modpathol.2013.188; Dacic S, 2002, AM J SURG PATHOL, V26, P510, DOI 10.1097/00000478-200204000-00015; Takahashi M, 2014, J THORAC CARDIOV SUR, V147, P54, DOI 10.1016/j.jtcvs.2013.08.058; Niho S, 1998, AM J PATHOL, V152, P1065; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P668, DOI 10.5858/arpa.2012-0263-RA; Thunnissen E, 2012, MODERN PATHOL, V25, P1574, DOI 10.1038/modpathol.2012.106; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Taira T, 2012, LUNG CANCER, V76, P423, DOI 10.1016/j.lungcan.2011.11.010; Antonescu CR, 2010, GENE CHROMOSOME CANC, V49, P1114, DOI 10.1002/gcc.20819; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Girard N, 2009, CLIN CANCER RES, V15, P5184, DOI 10.1158/1078-0432.CCR-09-0594; Yanagawa N, 2014, ANN THORAC SURG, V98, P453, DOI 10.1016/j.athoracsur.2014.04.108; Caplin ME, 2015, ANN ONCOL, V26, P1604, DOI 10.1093/annonc/mdv041; Duhig EE, 2015, J THORAC ONCOL, V10, P673, DOI 10.1097/JTO.0000000000000446; Sekine S, 2003, J PATHOL, V200, P214, DOI 10.1002/path.1352; Barletta JA, 2010, CANCER-AM CANCER SOC, V116, P659, DOI 10.1002/cncr.24831; Hwang DH, 2014, ARCH PATHOL LAB MED, V138, P626, DOI 10.5858/arpa.2013-0179-OA; Yanagawa N, 2013, J THORAC ONCOL, V8, P612, DOI 10.1097/JTO.0b013e318287c3eb; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Travis WD, 2010, J THORAC ONCOL, V5, P411, DOI 10.1097/JTO.0b013e3181d57f6e; GAFFEY MJ, 1991, AM J SURG PATHOL, V15, P644, DOI 10.1097/00000478-199107000-00005; Nitadori J, 2013, JNCI-J NATL CANCER I, V105, P1212, DOI 10.1093/jnci/djt166; Mendlick MR, 2001, AM J SURG PATHOL, V25, P684, DOI 10.1097/00000478-200105000-00019; Lau K, 2011, CHEST, V140, P1312, DOI 10.1378/chest.11-0039; Barnes L., 2005, PATHOLOGY GENETICS H; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Bodner SM, 1996, HUM PATHOL, V27, P1117, DOI 10.1016/S0046-8177(96)90302-0; Brambilla C, 2014, CLIN CANCER RES, V20, P5777, DOI 10.1158/1078-0432.CCR-14-0459; Brun AL, 2010, EUR RADIOL, V20, P2579, DOI 10.1007/s00330-010-1830-7; Cha MJ, 2014, J THORAC CARDIOV SUR, V147, P921, DOI 10.1016/j.jtcvs.2013.09.045; Chen YB, 2014, AM J MED SCI, V347, P50, DOI 10.1097/MAJ.0b013e318295c821; Clinical Lung Cancer Genome Project (CLCGP), 2013, SCI TRANSL MED, V5; D'Armiento J, 2007, CANCER RES, V67, P1902, DOI 10.1158/0008-5472.CAN-06-1122; Devouassoux-Shisheboran M, 2000, AM J SURG PATHOL, V24, P906, DOI 10.1097/00000478-200007000-00002; Diamond EL, 2014, BLOOD, V124, P483, DOI 10.1182/blood-2014-03-561381; Edwards SL, 2000, J CLIN PATHOL, V53, P537, DOI 10.1136/jcp.53.7.537; Fernandez-Cuesta L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4518; Fletcher CDM, 2013, WHO CLASSIFICATION T, P208; FLETCHER JA, 1995, GENE CHROMOSOME CANC, V12, P220, DOI 10.1002/gcc.2870120310; Fritz AG, 2000, INT CLASSIFICATION D; Gaffey MJ, 1997, SEMIN DIAGN PATHOL, V14, P222; Girard N, 2010, CHEST, V137, P46, DOI 10.1378/chest.09-0325; Haroche J, 2015, J CLIN ONCOL, V33, P411, DOI 10.1200/JCO.2014.57.1950; Haroche J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0412-0; Isaka T, 2014, LUNG CANCER, V85, P40, DOI 10.1016/j.lungcan.2014.03.023; Kadota K, 2015, AM J SURG PATHOL; Kadota K, 2015, CHEST; Kadota K, 2014, J THORAC ONCOL, V9, P1126, DOI 10.1097/JTO.0000000000000253; Kadota K, 2014, AM J SURG PATHOL, V38, P448, DOI 10.1097/PAS.0000000000000134; Kaira K, 2010, J THORAC ONCOL, V5, P460, DOI 10.1097/JTO.0b013e3181ce3e3c; Kim DJ, 2003, ANN THORAC SURG, V76, P1833, DOI 10.1016/S0003-4975(03)01296-7; Klempner SJ, 2015, CLIN LUNG CANC; Kourda Jihene, 2010, Cases J, V3, P25, DOI 10.1186/1757-1626-3-25; Lantuejoul S, 1997, MODERN PATHOL, V10, P1001; Lawson K, 2012, EUR RESPIR J, V40, P1578, DOI 10.1183/09031936.00076411; Lee S, 2011, J CANCER RES CLIN, V137, P1203, DOI 10.1007/s00432-011-0986-0; Leone A, 2011, INT J CANCER, V128, P732, DOI 10.1002/ijc.25335; Lewis DR, 2014, CANCER-AM CANCER SOC, V120, P2883, DOI 10.1002/cncr.28749; Loukeri AA, 2015, CLIN LUNG CANCER, V16, P15, DOI 10.1016/j.cllc.2014.07.001; Macher-Goeppinger S, 2011, J CLIN PATHOL, V64, P349, DOI 10.1136/jcp.2010.085696; Mackinnon AC, 2014, MODERN PATHOL, V27, P1063, DOI 10.1038/modpathol.2013.227; Masuya D, 2005, EUR J CARDIO-THORAC, V28, P775, DOI 10.1016/j.ejcts.2005.08.003; Moro-Sibilot D, 2008, EUR RESPIR J, V31, P854, DOI 10.1183/09031936.00058507; Murphy SJ, 2014, J CLIN ONCOL, V32, P4050, DOI 10.1200/JCO.2014.56.7644; Nakazato Y, 2013, J THORAC ONCOL, V8, P736, DOI 10.1097/JTO.0b013e318288dbd8; Nakazato Y, 2010, CANCER-AM CANCER SOC, V116, P2011, DOI 10.1002/cncr.24948; (NGM) CLCGPCNGM, 2013, SCI TRANSL MED, V5; Nicholson AG, 1999, HISTOPATHOLOGY, V35, P313; Onozato ML, 2013, AM J SURG PATHOL, V37, P287, DOI 10.1097/PAS.0b013e31826885fb; Pardo J, 2008, DIAGN MOL PATHOL, V17, P151, DOI 10.1097/PDM.0b013e31815d05b3; Patel NR, 2015, HISTOPATHOLOGY; Pelosi G, 2004, MODERN PATHOL, V17, P538, DOI 10.1038/modpathol.3800058; Pileri SA, 2004, HISTOPATHOLOGY, V44, P156, DOI 10.1111/j.1365-2559.2004.01788.x; Rush WL, 2000, MODERN PATHOL, V13, P747, DOI 10.1038/modpathol.3880130; Sarkaria IS, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-27; Sigel CS, 2012, CANCER CYTOPATHOL, V120, P35, DOI 10.1002/cncy.20185; Tanas MR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002409; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Thway K, 2012, AM J SURG PATHOL, V36, P883, DOI 10.1097/PAS.0b013e31824b1ee0; TOMASHEFSKI JF, 1982, AM J SURG PATHOL, V6, P531, DOI 10.1097/00000478-198209000-00005; Toyokawa G, 2013, LUNG CANCER, V81, P491, DOI 10.1016/j.lungcan.2013.06.013; Travis W, 2004, PATHOLOGY GENETICS T; Travis WD, 2015, WHO CLASSIFICATION T; Travis WD, 1999, COUNTRIES HISTOLOGIC; Tsao MS, 2015, J CLIN ONCOL; Tzoulis Charalampos, 2015, BMC Res Notes, V8, P171, DOI 10.1186/s13104-015-1135-7; Ujiie H, 2015, J CLIN ONCO IN PRESS; von der Thusen JH, 2013, J THORAC ONCOL, V8, P37, DOI 10.1097/JTO.0b013e318276274e; Walts AE, 2012, MODERN PATHOL, V25, P1258, DOI 10.1038/modpathol.2012.81; Wang LC, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-10; World Health Organization, 1967, HIST TYP LUNG TUM; World Health Organization, 1981, HIST TYP LUNG TUM; Xiao S, 1997, AM J PATHOL, V150, P901; Xue XY, 2013, J INT MED RES, V41, P1779, DOI 10.1177/0300060513504707	163	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	SEP	2015	10	9					1243	1260		10.1097/JTO.0000000000000630		18	Oncology; Respiratory System	Oncology; Respiratory System	CQ1NW	WOS:000360365400003		
J	Kadota, K; Nitadori, J; Ujiie, H; Buitrago, DH; Woo, KM; Sima, CS; Travis, WD; Jones, DR; Adusumilli, PS				Kadota, Kyuichi; Nitadori, Jun-ichi; Ujiie, Hideki; Buitrago, Daniel H.; Woo, Kaitlin M.; Sima, Camelia S.; Travis, William D.; Jones, David R.; Adusumilli, Prasad S.			Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma Tumor-Infiltrating CD10(+) Neutrophil/CD20(+) Lymphocyte Ratio as an Independent Prognostic Factor	JOURNAL OF THORACIC ONCOLOGY			English	Article						Tumor infiltrating lymphocytes; Immune response; Non-small-cell lung cancer; Survival	CD8(+) T-CELLS; COLORECTAL-CANCER; NEUTROPHIL/LYMPHOCYTE RATIO; PRETREATMENT NEUTROPHIL; PREOPERATIVE NEUTROPHIL; CURATIVE RESECTION; COMPETING RISK; SURVIVAL; RECURRENCE; MODEL	Introduction: We previously reported the prognostic significance of the lung adenocarcinoma immune microenvironment. In this study, we preformed comprehensive analysis of immune markers and their associations with prognosis in patients with lung squamous cell carcinoma. Methods: We reviewed surgically resected, solitary lung squamous cell carcinoma patients (n = 485; 1999-2009) who were randomly split into a training cohort (n = 331) and validation cohort (n = 154). We constructed tissue microarrays and performed immunostaining for CD3, CD45RO, CD8, CD4, FoxP3, CD20, CD68, CXCL12, CXCR4, CCR7, interleukin-7 receptor, and interleukin-12 receptor 2. Overall survival (OS) was analyzed using the log-rank test and the Cox proportional hazards model. Results: Analysis of single immune cell infiltration revealed that high tumor-infiltrating CD10(+) neutrophils were associated with worse prognoses in the training cohort (p = 0.021). Analysis of biologically relevant immune cell combinations identified that patients with high CD10(+) neutrophil and low CD20(+) lymphocyte had a significantly worse OS (5-year OS, 42%) than those with other combinations of CD10 and CD20 (5-year OS, 62%; p < 0.001); this was confirmed in the validation cohort (p = 0.032). For the multivariate analysis, high CD10/low CD20 immune cell infiltration was an independent predictor of OS in both the training cohort (hazard ratio = 1.61, p = 0.006) and the validation cohort (hazard ratio = 1.75; p = 0.043). Conclusion: High CD10(+)/low CD20(+) immune cell infiltration ratio is a significant prognostic factor of lung squamous cell carcinoma. Immunomodulatory therapy of tumor-specific neutrophil and B-lymphocyte responses may have applicability in the treatment of lung squamous cell carcinoma.	[Kadota, Kyuichi; Nitadori, Jun-ichi; Ujiie, Hideki; Buitrago, Daniel H.; Jones, David R.; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, New York, NY 10065 USA; [Kadota, Kyuichi; Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Kadota, Kyuichi] Kagawa Univ, Dept Diagnost Pathol, Fac Med, Takamatsu, Kagawa 760, Japan; [Nitadori, Jun-ichi] Univ Tokyo, Dept Thorac Surg, Tokyo, Japan; [Woo, Kaitlin M.; Sima, Camelia S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA	Adusumilli, PS (reprint author), Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10065 USA.	adusumip@mskcc.org			National Institutes of Health [R21 CA164568-01A1, R21 CA164585-01A1, U54 CA137788, P30 CA008748]; U.S. Department of Defense [LC110202]	The authors thank Joe Dycoco of the Memorial Sloan Kettering Cancer Center (MSK) Thoracic Surgery Service for assisting with the Thoracic Service of the Department of Surgery's Lung Cancer Database; Irina Linkov of the MSK Pathology Core Facility for technical assistance with immunohistochemistry; and Alex Torres of the MSK Thoracic Surgery Service for his editorial assistance. This work is supported by grants from the National Institutes of Health (R21 CA164568-01A1, R21 CA164585-01A1, U54 CA137788, and P30 CA008748); and the U.S. Department of Defense (LC110202).	Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Khanh DT, 2011, CANCER SCI, V102, P1724, DOI 10.1111/j.1349-7006.2011.01987.x; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Mano Y, 2013, ANN SURG, V258, P301, DOI 10.1097/SLA.0b013e318297ad6b; Tomita M, 2011, ANTICANCER RES, V31, P2995; Jablonska J, 2010, J CLIN INVEST, V120, P1151, DOI 10.1172/JCI37223; Trojan A, 2004, LUNG CANCER-J IASLC, V44, P143, DOI 10.1016/j.lungcan.2003.11.004; Petersen RP, 2006, CANCER, V107, P2866, DOI 10.1002/cncr.22282; Gondo T, 2012, UROLOGY, V79, P1085, DOI 10.1016/j.urology.2011.11.070; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Suzuki K, 2011, CLIN CANCER RES, V17, P5247, DOI 10.1158/1078-0432.CCR-10-2805; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Mishalian I, 2013, CANCER IMMUNOL IMMUN, V62, P1745, DOI 10.1007/s00262-013-1476-9; Wu QD, 2001, AM J PHYSIOL-CELL PH, V280, pC814; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Yao YW, 2013, CANCER IMMUNOL IMMUN, V62, P471, DOI 10.1007/s00262-012-1347-9; Wakabayashi O, 2003, CANCER SCI, V94, P1003, DOI 10.1111/j.1349-7006.2003.tb01392.x; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Smelt SC, 2000, J IMMUNOL, V164, P3681; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Hicks AM, 2006, P NATL ACAD SCI USA, V103, P7753, DOI 10.1073/pnas.0602382103; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.3.CO;2-F; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221; Kondratieva TK, 2010, J IMMUNOL, V184, P1227, DOI 10.4049/jimmunol.0902011; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Horne ZD, 2011, J SURG RES, V171, P1, DOI 10.1016/j.jss.2011.03.068; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Chappell R, 2012, CLIN CANCER RES, V18, P2127, DOI 10.1158/1078-0432.CCR-12-0455; Edge SB, 2009, AJCC CANC STAGING MA, P253; Eruslanov EB, 2014, J CLIN INVEST, V124, P5466, DOI [10.1172/JCI77053, 10.1172/JCI7053]; Ilie M, 2012, CANCER-AM CANCER SOC, V118, P1726, DOI 10.1002/cncr.26456; Jankova L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-442; Kadota K, 2015, ANN SURG ONCOL; Lee MC, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.967142; Suzuki K, 2011, CANCER IMMUNOL IMMUN, V60, P1721, DOI 10.1007/s00262-011-1073-8; Szkandera J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078225; Ujiie H, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1009285	54	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	SEP	2015	10	9					1301	1310		10.1097/JTO.0000000000000617		10	Oncology; Respiratory System	Oncology; Respiratory System	CQ1NW	WOS:000360365400009		
J	Vansteenkiste, JF; Canon, JL; De Braud, F; Grossi, F; De Pas, T; Gray, JE; Su, WC; Felip, E; Yoshioka, H; Gridelli, C; Dy, GK; Thongprasert, S; Reck, M; Aimone, P; Vidam, GA; Roussou, P; Wang, YA; Di Tomaso, E; Soria, JC				Vansteenkiste, Johan F.; Canon, Jean-Luc; De Braud, Filippo; Grossi, Francesco; De Pas, Tommaso; Gray, Jhanelle E.; Su, Wu-Chou; Felip, Enriqueta; Yoshioka, Hiroshige; Gridelli, Cesare; Dy, Grace K.; Thongprasert, Sumitra; Reck, Martin; Aimone, Paola; Vidam, Gena Atalla; Roussou, Pantelia; Wang, Ying A.; Di Tomaso, Emmanuelle; Soria, Jean-Charles			Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer Results from the Phase II BASALT-1 Study	JOURNAL OF THORACIC ONCOLOGY			English	Article						Buparlisib; BKM120; PI3K pathway activation; Squamous NSCLC; Nonsquamous NSCLC	PIK3CA MUTATIONS; OPPORTUNITIES; CHALLENGES; INHIBITORS; DOCETAXEL; CARCINOMA; ERLOTINIB; TUMORS; TRIAL	Introduction: The phosphatidylinositol 3-kinase (PI3K) pathway promotes tumor growth and treatment resistance in non-small cell lung cancer (NSCLC). The aim of the open-label, two-stage, Phase II study BASALT-1 (NCT01820325) was to investigate the pan-PI3K inhibitor buparlisib (BKM120) in patients with PI3K pathway-activated, relapsed NSCLC. Methods: After prescreening for PI3K pathway activation, patients with PI3K pathway-activated, metastatic, squamous or nonsquamous NSCLC, who had relapsed after prior systemic antineoplastic therapy, were enrolled. In Stage 1, patients received single-agent buparlisib (100mg/day). A futility analysis was performed independently in each histology group, based on the 12-week progression-free survival rate for the first 30 patients treated in each group being less than 50%. Exploratory biomarker analyses were performed in archival tissue samples and circulating tumor DNA (ctDNA). Results: Of 1242 prescreened patients, 13.5% exhibited PI3K pathway activation. As of June 5, 2014, 63 patients (30 squamous and 33 nonsquamous) were treated in Stage 1. The 12-week progression-free survival rates were 23.3% (95% confidence interval: 9.9-42.3) and 20.0% (95% confidence interval: 7.7-38.6) in the squamous and nonsquamous groups, respectively. Stage 2 was therefore not initiated in either group. PI3K pathway mutations in ctDNA were more concordant with metastatic tissue than with primary biopsies. Conclusions: Despite preselecting patients for targeted treatment, BASALT-1 did not meet its primary objective during Stage 1. PI3K pathway activation can be detected using ctDNA, but may not be the main oncogenic driver in NSCLC. Combinations of PI3K inhibitors with other agents may demonstrate greater efficacy than monotherapy.	[Vansteenkiste, Johan F.] Univ Hosp KU Leuven, Leuven, Belgium; [Canon, Jean-Luc] Grand Hop Charleroi, Charleroi, Belgium; [De Braud, Filippo] Fdn IRCCS, Ist Nazl Tumori, Milan, Italy; [Grossi, Francesco] AOU San Martino IST, Ist Nazl Ric Canc, Genoa, Italy; [De Pas, Tommaso] European Inst Oncol, Milan, Italy; [Gray, Jhanelle E.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Su, Wu-Chou] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Felip, Enriqueta] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain; [Yoshioka, Hiroshige] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan; [Gridelli, Cesare] SG Moscati Hosp, Avellino, Italy; [Dy, Grace K.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Thongprasert, Sumitra] Chiang Mai Univ, Chiang Mai 50000, Thailand; [Reck, Martin] German Ctr Lung Res DZL, ARCN, LungenClin Grosshansdorf, Grosshansdorf, Germany; [Aimone, Paola; Roussou, Pantelia] Novartis Pharma AG, Basel, Switzerland; [Vidam, Gena Atalla] Novartis Pharmaceut, E Hanover, NJ USA; [Wang, Ying A.; Di Tomaso, Emmanuelle] Novartis Inst BioMed Res, Cambridge, MA USA; [Soria, Jean-Charles] Gustave Roussy Canc Campus, Villejuif, France; [Soria, Jean-Charles] Univ Paris 11, Villejuif, France	Vansteenkiste, JF (reprint author), Katholieke Univ Leuven, Univ Hosp Leuven, Campus Gasthuisberg,Herestr 49, B-3000 Leuven, Belgium.	johan.vansteenkiste@uzleuven.be			Novartis Pharmaceuticals	The authors thank the patients who took part in the trial and their families, as well as the staff who assisted with the study at each site. This study was sponsored by Novartis Pharmaceuticals, who also provided financial support for medical editorial assistance. We thank Nadia Solovieff and Mike Morrissey (Novartis) for assistance with NGS experiments, and Nirmal Jethwa, PhD (Articulate Science Ltd.) for medical editorial assistance with this manuscript.	Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Leighl NB, 2012, CURR ONCOL, V19, pS52, DOI 10.3747/co.19.1114; Rodon J, 2014, INVEST NEW DRUG, V32, P670, DOI 10.1007/s10637-014-0082-9; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Marsit CJ, 2005, HUM PATHOL, V36, P768, DOI 10.1016/j.humpath.2005.05.006; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Perez-Moreno P, 2012, CLIN CANCER RES, V18, P2443, DOI 10.1158/1078-0432.CCR-11-2370; Jin G, 2010, LUNG CANCER, V69, P279, DOI 10.1016/j.lungcan.2009.11.012; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Burger M, 2011, CANC RES S, V70, P4498, DOI DOI 10.1158/1538-7445.AM10-4498; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dy GK, 2013, J THORAC ONCOL S2, V8; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Goss G, 2014, ANN ONCOL S4, V25; Howlader N, 2011, SEER CANC STAT REV 1, P19; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Koul D, 2010, CANC RES S8, V70; Maira S-M, 2010, CANC RES S8, V70; National Comprehensive Cancer Network Inc, NCCN CLIN PRACT GUID; Schnell C SF, 2010, CANCER RES, V70, P4472, DOI 10.1158/1538-7445.AM10-4472; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Zito CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031331	32	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	SEP	2015	10	9					1319	1327		10.1097/JTO.0000000000000607		9	Oncology; Respiratory System	Oncology; Respiratory System	CQ1NW	WOS:000360365400011		
J	Kojima, H; Watanabe, R; Isaka, M; Shimizu, R; Kayata, H; Miyata, N; Maniwa, T; Takahashi, S; Ito, I; Kameya, T; Funai, K; Ohde, Y; Nakajima, T				Kojima, Hideaki; Watanabe, Reiko; Isaka, Mitsuhiro; Shimizu, Reiko; Kayata, Hiroyuki; Miyata, Naoko; Maniwa, Tomohiro; Takahashi, Shoji; Ito, Ichiro; Kameya, Toru; Funai, Kazuhito; Ohde, Yasuhisa; Nakajima, Takashi			High-Grade Neuroendocrine Carcinoma with Bronchial Intraepithelial Tumor Spread Possibly a New Histologic Feature of Large-Cell Neuroendocrine Carcinoma	JOURNAL OF THORACIC ONCOLOGY			English	Article						High-grade neuroendocrine carcinoma; Large-cell neuroendocrine carcinoma; Bronchial intraepithelial tumor spread; Bronchus	LUNG-CARCINOMA	Introduction: During surgical resection of a peripherally located high-grade neuroendocrine carcinoma (HGNEC), we unexpectedly discovered prominent bronchial intraepithelial tumor spread up to the surgical end of the bronchus. Because bronchial intraepithelial tumor spread of peripherally located HGNEC has been rarely reported, we conducted a retrospective analysis at our hospital. Methods: We histologically reviewed surgically resected HGNEC cases to assess bronchial intraepithelial spread of tumor cells. HGNECs with bronchial intraepithelial tumor spread were further studied by immunohistochemistry for neuroendocrine markers, and their clinicopathological characteristics were evaluated. Results: Of 1778 cases of surgically resected lung cancer in our hospital, 47 cases of HGNEC were evaluated. Bronchial intraepithelial tumor spread was observed in nine cases (19.1%); eight of these cases were large-cell neuroendocrine carcinoma (LCNEC) or small-cell lung carcinoma with an LCNEC component. Moreover, bronchial intraepithelial tumor spread was continuous from the primary tumor to the resected end of the bronchus in four cases, and all these cases had an LCNEC component. Furthermore, HGNEC with bronchial intraepithelial tumor spread was associated with a higher recurrence rate than no bronchial intraepithelial tumor spread. Conclusion: The results of this study suggest that bronchial intraepithelial tumor spread is commonly observed in cases of peripherally located HGNEC and may be a unique form of tumor invasion, especially tumors with LCNEC morphology. Therefore, surgeons and pathologists should be cognizant of bronchial intraepithelial tumor spread in peripherally located HGNEC, as well as its potential role as an indicator of HGNEC aggressiveness.	[Kojima, Hideaki; Isaka, Mitsuhiro; Shimizu, Reiko; Kayata, Hiroyuki; Miyata, Naoko; Maniwa, Tomohiro; Takahashi, Shoji; Ohde, Yasuhisa] Shizuoka Canc Ctr, Div Thorac Surg, Nagaizumi, Shizuoka, Japan; [Watanabe, Reiko; Ito, Ichiro; Kameya, Toru; Nakajima, Takashi] Shizuoka Canc Ctr, Div Pathol, Nagaizumi, Shizuoka, Japan; [Funai, Kazuhito] Hamamatsu Univ Sch Med, Dept Surg 1, Hamamatsu, Shizuoka 4313192, Japan	Kojima, H (reprint author), Shizuoka Canc Ctr, Div Thorac Surg, 411-8777,Shimonagakubo 1007, Nagaizumi, Shizuoka, Japan.	h.kojima@scchr.jp					Nicholson SA, 2002, AM J SURG PATHOL, V26, P1184, DOI 10.1097/01.PAS.0000022995.91977.CD; Junker K, 2000, J CANCER RES CLIN, V126, P361, DOI 10.1007/PL00008483; Rosen Y, 2011, INT J SURG PATHOL, V19, P538, DOI 10.1177/1066896911408722; Travis W, 2004, PATHOLOGY GENETICS T; Travis WDCTCB., 1999, WHO INT HISTOLOGICAL	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	SEP	2015	10	9					1337	1340		10.1097/JTO.0000000000000616		4	Oncology; Respiratory System	Oncology; Respiratory System	CQ1NW	WOS:000360365400013		
J	Nakamura, M; Wang, YQ; Wang, C; Oh, D; Yin, WH; Kimura, T; Miyazaki, K; Abe, K; Mercuri, M; Lee, LH; Segers, A; Buller, H				Nakamura, M.; Wang, Y. Q.; Wang, C.; Oh, D.; Yin, W. -H.; Kimura, T.; Miyazaki, K.; Abe, K.; Mercuri, M.; Lee, L. H.; Segers, A.; Bueller, H.			Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						edoxaban; safety; treatment efficacy; venous thromboembolism; warfarin	ATRIAL-FIBRILLATION; STROKE PREVENTION; WARFARIN; THERAPY; ANTICOAGULATION; EPIDEMIOLOGY; POPULATION; THROMBOSIS; INTENSITY; MORTALITY	BackgroundDirect oral anticoagulants have been evaluated for their efficacy and safety in the treatment of venous thromboembolism (VTE), which comprises deep vein thrombosis and pulmonary embolism. The randomized, double-blind Hokusai-VTE trial demonstrated that 60mg of edoxaban once daily following initial heparin treatment is non-inferior to heparin overlapped with and followed by warfarin for the treatment of VTE, and is associated with significantly fewer bleeding events. ObjectivesTo assess the efficacy and safety of edoxaban versus warfarin among East Asian patients enrolled in the Hokusai-VTE trial. Patients/methodsThe Hokusai-VTE trial enrolled 8292 patients from 439 centers worldwide, including 1109 patients from Japan, China, Korea, and Taiwan. The primary efficacy and safety outcomes were symptomatic recurrent VTE and clinically relevant bleeding, respectively. ResultsIn the overall East Asian population, the primary efficacy outcome of symptomatic recurrent VTE occurred in 16 of 563 (2.8%) patients in the edoxaban group versus 24 of 538 (4.5%) patients in the warfarin group (hazard ratio [HR]0.64; 95% confidence interval [CI]0.34-1.19; P=0.1601). The primary safety outcome of clinically relevant bleeding occurred in 56 of 563 (9.9%) patients inthe edoxaban group versus 93 of 538 (17.3%) patients in the warfarin group (HR0.56; 95%CI0.40-0.78; P<0.001). ConclusionsEdoxaban is an effective and safer alternative to warfarin in East Asian patients with acute VTE who require anticoagulant therapy, consistent with overall study findings from the Hokusai-VTE trial.	[Nakamura, M.] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 5148507, Japan; [Wang, Y. Q.] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Wang, C.] Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [Wang, C.] Capital Med Univ, Dept Resp Med, Beijing, Peoples R China; [Wang, C.] China Japan Friendship Hosp, Beijing, Peoples R China; [Oh, D.] CHA Univ, CHA Bundang Med Ctr, Gyeongghi Do, South Korea; [Yin, W. -H.] Cheng Hsin Gen Hosp, Ctr Heart, Tokyo, Japan; [Yin, W. -H.] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Kimura, T.] Daiichi Sankyo Co Ltd, Clin Planning Dept, Tokyo, Japan; [Miyazaki, K.] Daiichi Sankyo Co Ltd, Asia Dev Dept, Tokyo, Japan; [Abe, K.] Daiichi Sankyo Co Ltd, Clin Data & Biostat Dept, Tokyo, Japan; [Mercuri, M.] Daiichi Sankyo Pharma Dev, Clin Dev Dept, Edison, NJ USA; [Lee, L. H.] Singapore Gen Hosp, Dept Hematol, Singapore, Singapore; [Segers, A.] ITREAS, Brugg, Switzerland; [Bueller, H.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands	Nakamura, M (reprint author), Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	mashio@clin.medic.mie-u.ac.jp					Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Ayala CN, 2002, STROKE, V33, P1197, DOI 10.1161/01.STR.0000015028.52.771.D1; Lee CH, 2010, J THROMB HAEMOST, V8, P1515, DOI 10.1111/j.1538-7836.2010.03873.x; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Van Spall HGC, 2012, CIRCULATION, V126, P2309, DOI 10.1161/CIRCULATIONAHA.112.101808; Wong KSL, 2014, STROKE, V45, P1739, DOI 10.1161/STROKEAHA.113.002968; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; Jang MJ, 2011, J THROMB HAEMOST, V9, P85, DOI 10.1111/j.1538-7836.2010.04108.x; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Bang Oh Young, 2014, J Stroke, V16, P73, DOI 10.5853/jos.2014.16.2.73; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Japanese Circulation Society Joint Working Group, 2011, CIRC J, V75, P1258; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Lertkiatmongkol P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074053; Liu H. S. Y., 2002, Hong Kong Medical Journal, V8, P400; You JHS, 2005, BRIT J CLIN PHARMACO, V59, P582, DOI 10.1111/j.1365-2125.2005.02361.x	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	SEP	2015	13	9					1606	1614		10.1111/jth.13055		9	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CQ7FM	WOS:000360768400010		
J	Yoshimura, Y; Sakamoto, Y; Kwangyeol, L; Amano, Y; Tachikawa, N				Yoshimura, Yukihiro; Sakamoto, Yohei; Kwangyeol, Lee; Amano, Yuichiro; Tachikawa, Natsuo			Round Pneumonia With Murine Typhus After Travel to Indonesia	JOURNAL OF TRAVEL MEDICINE			English	Article									[Yoshimura, Yukihiro; Sakamoto, Yohei; Kwangyeol, Lee; Amano, Yuichiro; Tachikawa, Natsuo] Yokohama Municipal Citizens Hosp, Dept Infect Dis, Yokohama, Kanagawa 2408555, Japan	Yoshimura, Y (reprint author), Yokohama Municipal Citizens Hosp, Dept Infect Dis, Hodogaya Ku, 56 Okazawa Cho, Yokohama, Kanagawa 2408555, Japan.	yymole@gmail.com					Durning SJ, 2003, CHEST, V124, P372, DOI 10.1378/chest.124.1.372; DUMLER JS, 1991, JAMA-J AM MED ASSOC, V266, P1365, DOI 10.1001/jama.266.10.1365; Civen R, 2008, CLIN INFECT DIS, V46, P913, DOI 10.1086/527443; Velasco-Tirado V, 2012, ENFERM INFEC MICR CL, V30, P427, DOI 10.1016/j.eimc.2012.02.008	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1195-1982	1708-8305		J TRAVEL MED	J. Travel Med.	SEP-OCT	2015	22	5					353	354		10.1111/jtm.12226		2	Medicine, General & Internal	General & Internal Medicine	CQ7EU	WOS:000360766600012		
J	Liu, ZM; Kato, A; Oyama, M; Kozuka-Hata, H; Arii, J; Kawaguchi, Y				Liu, Zhuoming; Kato, Akihisa; Oyama, Masaaki; Kozuka-Hata, Hiroko; Arii, Jun; Kawaguchi, Yasushi			Role of Host Cell p32 in Herpes Simplex Virus 1 De-Envelopment during Viral Nuclear Egress	JOURNAL OF VIROLOGY			English	Article							TEGUMENT PROTEIN VP13/14; INFECTED-CELLS; GLOBULAR HEADS; RNA-BINDING; KINASE-C; SUBSTRATE-SPECIFICITY; MITOCHONDRIAL P-32; VIRION ENVELOPE; SPLICING FACTOR; GENE-PRODUCT	To clarify the function(s) of the herpes simplex virus 1 (HSV-1) major virion structural protein UL47 (also designated VP13/14), we screened cells overexpressing UL47 for UL47-binding cellular proteins. Tandem affinity purification of transiently expressed UL47 coupled with mass spectrometry-based proteomics technology and subsequent analyses showed that UL47 interacted with cell protein p32 in HSV-1-infected cells. Unlike in mock-infected cells, p32 accumulated at the nuclear rim in HSV-1-infected cells, and this p32 recruitment to the nuclear rim required UL47. p32 formed a complex(es) with HSV-1 proteins UL31, UL34, Us3, UL47, and/or ICP22 in HSV-1-infected cells. All these HSV-1 proteins were previously reported to be important for HSV-1 nuclear egress, in which nucleocapsids bud through the inner nuclear membrane (primary envelopment) and the enveloped nucleocapsids then fuse with the outer nuclear membrane (de-envelopment). Like viral proteins UL31, UL34, Us3, and UL47, p32 was detected in primary enveloped virions. p32 knockdown reduced viral replication and induced membranous invaginations adjacent to the nuclear rim containing primary enveloped virions and aberrant localization of UL31 and UL34 in punctate structures at the nuclear rim. These effects of p32 knockdown were reduced in the absence of UL47. Therefore, the effects of p32 knockdown in HSV-1 nuclear egress were similar to those of the previously reported mutation(s) in HSV-1 regulatory proteins for HSV-1 de-envelopment during viral nuclear egress. Collectively, these results suggested that p32 regulated HSV-1 de-envelopment and replication in a UL47-dependent manner. IMPORTANCE In this study, we have obtained data suggesting that (i) the HSV-1 major virion structural protein UL47 interacted with host cell protein p32 and mediated the recruitment of p32 to the nuclear rim in HSV-1-infected cells; (ii) p32 was a component of the HSV-1 nuclear egress complex (NEC), whose core components were UL31 and UL34; and (iii) p32 regulated HSV-1 de-envelopment during viral nuclear egress. It has been reported that p32 was a component of human cytomegalovirus NEC and was required for efficient disintegration of nuclear lamina, which has been thought to facilitate HSV-1 primary envelopment during viral nuclear egress. Thus, p32 appeared to be a core component of herpesvirus NECs, like UL31 and UL34 homologs in other herpesviruses, and to play multiple roles in herpesvirus nuclear egress.	[Liu, Zhuoming; Kato, Akihisa; Arii, Jun; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan; [Liu, Zhuoming; Kato, Akihisa; Arii, Jun; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Int Res Ctr Infect Dis, Tokyo, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo, Japan	Kawaguchi, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan.	ykawagu@ims.u-tokyo.ac.jp			Funding Program for Next Generation World-Leading Researchers; Japan Society for the Promotion of Science (JSPS); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan; Takeda Science Foundation	This study was supported by the Funding Program for Next Generation World-Leading Researchers, Grants for Scientific Research from the Japan Society for the Promotion of Science (JSPS), a contract research fund for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), a grant for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan, and a grant from the Takeda Science Foundation.	Rubinstein DB, 2004, INT J CANCER, V110, P741, DOI 10.1002/ijc.20105; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; PURVES FC, 1986, BIOCHIM BIOPHYS ACTA, V889, P208, DOI 10.1016/0167-4889(86)90106-0; Scholtes LD, 2010, J VIROL, V84, P7642, DOI 10.1128/JVI.00277-10; Wisner TW, 2009, J VIROL, V83, P3115, DOI 10.1128/JVI.01462-08; Matthews DA, 1998, J GEN VIROL, V79, P1677; Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; Milbradt J, 2014, MOL CELL PROTEOMICS, V13, P2132, DOI 10.1074/mcp.M113.035782; Shu M, 2013, P NATL ACAD SCI USA, V110, pE1669, DOI 10.1073/pnas.1305475110; Liang XZ, 2004, J VIROL, V78, P12416, DOI 10.1128/JVI.78.22.12416-12427.2004; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Maruzuru Y, 2014, J VIROL, V88, P7445, DOI 10.1128/JVI.01057-14; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; Hall KT, 2002, J VIROL, V76, P11612, DOI 10.1128/JVI.76.2211612-11612.2002; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Ryckman BJ, 2004, J VIROL, V78, P399, DOI 10.1128/JVI.78.1.399-412.2004; Liu ZM, 2014, J VIROL, V88, P4657, DOI 10.1128/JVI.00137-14; Mou F, 2009, J VIROL, V83, P5181, DOI 10.1128/JVI.00090-09; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; LEADER DP, 1993, PHARMACOL THERAPEUT, V59, P343, DOI 10.1016/0163-7258(93)90075-O; Mou F, 2007, J VIROL, V81, P6459, DOI 10.1128/JVI.00380-07; van Leeuwen HC, 2001, J CELL SCI, V114, P2115; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Kawaguchi Y, 1997, J VIROL, V71, P7328; Wang Y, 2014, J BIOL CHEM, V289, P35795, DOI 10.1074/jbc.M114.603845; Mettenleiter TC, 2013, CELL MICROBIOL, V15, P170, DOI 10.1111/cmi.12044; LEADER DP, 1991, BIOCHIM BIOPHYS ACTA, V1091, P426, DOI 10.1016/0167-4889(91)90210-O; Roller RJ, 2000, J VIROL, V74, P117; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; ZHANG Y, 1991, J VIROL, V65, P829; Kato A, 2005, J VIROL, V79, P9325, DOI 10.1128/JVI.79.14.9325-9331.2005; Sugimoto K, 2008, J VIROL, V82, P5198, DOI 10.1128/JVI.02681-07; Mou F, 2008, J VIROL, V82, P8094, DOI 10.1128/JVI.00874-08; Chang YE, 1997, J VIROL, V71, P8307; Donnelly M, 2001, J VIROL, V75, P2566, DOI 10.1128/JVI.75.6.2566-2574.2001; Kato A, 2011, J VIROL, V85, P9599, DOI 10.1128/JVI.00845-11; Morimoto T, 2009, J VIROL, V83, P11624, DOI 10.1128/JVI.00993-09; Murata T, 2000, J GEN VIROL, V81, P401; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Arii J, 2009, J VIROL, V83, P4520, DOI 10.1128/JVI.02601-08; Beatch MD, 2005, J VIROL, V79, P10807, DOI 10.1128/JVI.79.16.10807-10820.2005; Berro R, 2006, J VIROL, V80, P3189, DOI 10.1128/JVI.80.7.3.189-3204.2006; Bigalke JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5131; Brokstad KA, 2001, BIOCHEM BIOPH RES CO, V281, P1161, DOI 10.1006/bbrc.2001.4473; Bruni R, 1996, P NATL ACAD SCI USA, V93, P10423, DOI 10.1073/pnas.93.19.10423; Bryant HE, 2000, J VIROL, V74, P11322, DOI 10.1128/JVI.74.23.11322-11328.2000; Dobrikova E, 2010, J VIROL, V84, P270, DOI 10.1128/JVI.01740-09; Donnelly M, 2007, J VIROL, V81, P2283, DOI 10.1128/JVI.01677-06; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Kato A, 2014, J VIROL, V88, P7776, DOI 10.1128/JVI.00603-14; Lim BL, 1998, GENE, V209, P229, DOI 10.1016/S0378-1119(98)00055-9; Lu PD, 1999, CLIN IMMUNOL, V90, P360, DOI 10.1006/clim.1998.4660; LUO Y, 1994, J VIROL, V68, P3850; Maruzuru Y, 2013, J VIROL, V87, P9323, DOI 10.1128/JVI.01581-13; Robles-Flores M, 2002, J BIOL CHEM, V277, P5247, DOI 10.1074/jbc.M109333200; Roizman B, 2013, FIELDS VIROLOGY, V2, P1823; SIMOS G, 1994, FEBS LETT, V346, P225, DOI 10.1016/0014-5793(94)00479-X; Suppiah S, 2012, J GEN VIROL, V93, P807, DOI 10.1099/vir.0.038901-0; Tikoo S, 2013, ADV VIROL, V2013; Van Scoy S, 2000, VIROLOGY, V275, P145, DOI 10.1006/viro.2000.0508; YU L, 1995, J VIROL, V69, P3017	69	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	SEP	2015	89	17					8982	8998		10.1128/JVI.01220-15		17	Virology	Virology	CQ6GZ	WOS:000360703900029		
J	Shigemura, T; Shiohara, M; Kato, M; Furuta, S; Kaneda, K; Morishita, K; Hasegawa, H; Fujii, M; Gorlach, A; Koike, K; Kamata, T				Shigemura, Tomonari; Shiohara, Masaaki; Kato, Masayoshi; Furuta, Shuichi; Kaneda, Kazuko; Morishita, Kazuhiro; Hasegawa, Hiroo; Fujii, Masahiro; Gorlach, Agnes; Koike, Kenichi; Kamata, Tohru			Superoxide-Generating Nox5 alpha Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype	JOURNAL OF VIROLOGY			English	Article							NF-KAPPA-B; JAK-STAT PATHWAY; CONSTITUTIVE ACTIVATION; HTLV-I; NADPH OXIDASE; GROWTH-FACTOR; EXPRESSION; PROTEIN; PROLIFERATION; LYMPHOCYTES	Human T-cell leukemia virus type 1 (HTLV-1) is associated with adult T-cell leukemia (ATL) and transforms T cells in vitro. To our knowledge, the functional role of reactive oxygen species (ROS)-generating NADPH oxidase 5 (Nox5) in HTLV-1 transformation remains undefined. Here, we found that Nox5 alpha expression was upregulated in 88% of 17 ATL patient samples but not in normal peripheral blood T cells. Upregulation of the Nox5 alpha variant was transcriptionally sustained by the constitutive Janus family tyrosine kinase (Jak)-STAT5 signaling pathway in interleukin-2 (IL-2)-independent HTLV-1-transformed cell lines, including MT1 and MT2, whereas it was transiently induced by the IL-2-triggered Jak-STAT5 axis in uninfected T cells. A Nox inhibitor, diphenylene iodonium, and antioxidants such as N-acetyl cysteine blocked proliferation of MT1 and MT2 cells. Ablation of Nox5 alpha by small interfering RNAs abrogated ROS production, inhibited cellular activities, including proliferation, migration, and survival, and suppressed tumorigenicity in immunodeficient NOG mice. The findings suggest that Nox5 alpha is a key molecule for redox-signal-mediated maintenance of the HTLV-1 transformation phenotype and could be a potential molecular target for therapeutic intervention in cancer development. IMPORTANCE HTLV-1 is the first human oncogenic retrovirus shown to be associated with ATL. Despite the extensive study over the years, the mechanism underlying HTLV-1-induced cell transformation is not fully understood. In this study, we addressed the expression and function of ROS-generating Nox family genes in HTLV-1-transformed cells. Our report provides the first evidence that the upregulated expression of Nox5 alpha is associated with the pathological state of ATL peripheral blood mononuclear cells and that Nox5 alpha is an integral component of the Jak-STAT5 signaling pathway in HTLV-1-transformed T cells. Nox5 alpha-derived ROS are critically involved in the regulation of cellular activities, including proliferation, migration, survival, and tumorigenicity, in HTLV-1-transformed cells. These results indicate that Nox5 alpha-derived ROS are functionally required for maintenance of the HTLV-1 transformation phenotype. The finding provides new insight into the redox-dependent mechanism of HTLV-1 transformation and raises an intriguing possibility that Nox5 alpha serves as a potential molecular target to treat HTLV-1-related leukemia.	[Shigemura, Tomonari; Shiohara, Masaaki; Koike, Kenichi] Shinshu Univ, Grad Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Kato, Masayoshi; Furuta, Shuichi; Kamata, Tohru] Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, Matsumoto, Nagano 390, Japan; [Kaneda, Kazuko; Morishita, Kazuhiro] Miyazaki Univ, Fac Med, Div Tumor & Cellular Biochem, Miyazaki, Japan; [Hasegawa, Hiroo] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 852, Japan; [Fujii, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, Niigata, Japan; [Gorlach, Agnes] Tech Univ Munich, German Heart Ctr Munich, Dept Pediat Cardiol & Congenital Heart Dis, Expt & Mol Pediat Cardiol, D-80290 Munich, Germany	Kamata, T (reprint author), Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, Matsumoto, Nagano 390, Japan.	tohru_kamata@med.miyazaki-u.ac.jp			Japan Society for Promotion of Science [22300328, 21591357]; Ministry of Science and Culture of Japan [18012019]	Financial support for this work was provided by Grants-in-Aid for Scientific Research for Japan Society for Promotion of Science (22300328 [to T.K.] and 21591357 [to M.S.]) and a Grant on Cancer Research in Applied Areas from the Ministry of Science and Culture of Japan (18012019 [to T.K.]).	Nicot C, 2001, BLOOD, V98, P823, DOI 10.1182/blood.V98.3.823; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; GRASSMANN R, 1992, J VIROL, V66, P4570; Mori N, 1999, BLOOD, V93, P2360; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; TAGAYA Y, 1989, EMBO J, V8, P757; Shuai K, 1996, ONCOGENE, V13, P247; Takemoto S, 1997, P NATL ACAD SCI USA, V94, P13897, DOI 10.1073/pnas.94.25.13897; Komatsu D, 2008, ONCOGENE, V27, P4724, DOI 10.1038/onc.2008.102; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; BelAiba RS, 2007, FREE RADICAL BIO MED, V42, P446, DOI 10.1016/j.freeradbiomed.2006.10.054; POPOVIC M, 1983, P NATL ACAD SCI-BIOL, V80, P5402, DOI 10.1073/pnas.80.17.5402; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Kamiguti AS, 2005, J IMMUNOL, V175, P8424; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Dewan MZ, 2003, J VIROL, V77, P5286, DOI 10.1128/JVI.77.9.5286-5294.2003; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Shi SR, 2011, J HISTOCHEM CYTOCHEM, V59, P13, DOI 10.1369/jhc.2010.957191; Burchill MA, 2003, J IMMUNOL, V171, P5853; Hall WW, 2005, ONCOGENE, V24, P5965, DOI 10.1038/sj.onc.1208975; JANIK P, 1975, CANCER RES, V35, P3698; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Mulloy JC, 1998, J VIROL, V72, P4408; Silic-Benussi M, 2010, BLOOD, V116, P54, DOI 10.1182/blood-2009-07-235861; Sun SC, 1999, ONCOGENE, V18, P1401, DOI 10.1038/sj.onc.1202430; Tomita M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-22; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282; XU X, 1995, J CLIN INVEST, V96, P1548, DOI 10.1172/JCI118193	42	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	SEP	2015	89	17					9080	9089		10.1128/JVI.00983-15		10	Virology	Virology	CQ6GZ	WOS:000360703900037		
J	Yokosawa, N; Yokota, S; Kubota, T; Fujii, N				Yokosawa, Noriko; Yokota, Shin-ichi; Kubota, Toru; Fujii, Nobuhiro			C-Terminal Region of STAT-1 alpha Is Not Necessary for Its Ubiquitination and Degradation Caused by Mumps Virus V Protein (vol 76, pg 12683, 2002)	JOURNAL OF VIROLOGY			English	Correction									[Yokosawa, Noriko; Yokota, Shin-ichi; Kubota, Toru; Fujii, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Microbiol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Yokosawa, N (reprint author), Sapporo Med Univ, Sch Med, Dept Microbiol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan.						Yokosawa N, 2002, J VIROL, V76, P12683, DOI 10.1128/JVI.76.24.12683-12690.2002	1	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	SEP	2015	89	17					9142	9142		10.1128/JVI.00715-15		1	Virology	Virology	CQ6GZ	WOS:000360703900046		
J	Kaneko, M; Hirano, S; Tateya, I; Kishimoto, Y; Hiwatashi, N; Fujiu-Kurachi, M; Ito, J				Kaneko, Mami; Hirano, Shigeru; Tateya, Ichiro; Kishimoto, Yo; Hiwatashi, Nao; Fujiu-Kurachi, Masako; Ito, Juichi			Multidimensional Analysis on the Effect of Vocal Function Exercises on Aged Vocal Fold Atrophy	JOURNAL OF VOICE			English	Article						Aged vocal fold atrophy; Voice therapy; Vocal function exercises; Multidimensional analysis	GROWTH-FACTOR THERAPY; VOICE DISORDERS; CLINICAL-TRIAL; CANINE MODEL; OLDER-ADULTS	Objectives. Age-related voice change is characterized as weak, harsh, and breathy. These changes are caused by histologic alteration of the lamina propria of the vocal fold mucosa as well as atrophy of the thyroarytenoid muscle. Several therapeutic strategies involving laryngeal framework surgery and injection laryngoplasty have been tried, but effects have been limited. Vocal function exercises (VFE) have been used to treat age-related vocal fold atrophy although the effectiveness has been shown with limited analysis. The present study aims to determine the effectiveness of VFE for the treatment of aged atrophy using multidimensional analysis. Study Design. This is a retrospective study. Methods. Sixteen patients with vocal fold atrophy aged 65-81 years underwent voice therapy using VFE. Six patients with vocal fold atrophy aged 65-85 years were involved as a historical control group. The grade, roughness, breathiness, asthenia, strain (GRBAS) scale, stroboscopic examinations, aerodynamic assessment, acoustic analysis, and Voice Handicap Index-10 (VHI-10) were performed before and after VFE. Normalized mucosal wave amplitude (NMWA), normalized glottal gap (NGG), and bowing index (BI) were measured by image analysis during stroboscopic examinations. Results. After VFE, significant improvements were shown in GRBAS, maximum phonation time, jitter, NMWA, NGG, and VHI-10 although BI has not changed significantly. There were no significant improvements in the historical control. Conclusions. The data suggest that VFE produces significant improvement in subjective, objective, and patient self-evaluation and deserves further attention as a treatment for aged atrophy of the vocal fold. It was also suggested that VFE does not improve the vocal fold bowing but may improve muscular function during voicing.	[Kaneko, Mami; Hirano, Shigeru; Tateya, Ichiro; Kishimoto, Yo; Hiwatashi, Nao; Ito, Juichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068507, Japan; [Fujiu-Kurachi, Masako] Niigata Univ, Rehabil Grad Sch, Dept Eating Disorder & Dysphagia, Niigata, Japan	Hirano, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kyoto 6068507, Japan.	hirano@ent.kuhp.kyoto-u.ac.jp			Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) [10-05]	This study was supported by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO ID: 10-05).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Sauder C, 2010, ANN OTO RHINOL LARYN, V119, P460; Omori K, 1997, ANN OTO RHINOL LARYN, V106, P544; STEMPLE JC, 1994, J VOICE, V8, P271, DOI 10.1016/S0892-1997(05)80299-1; Gartner-Schmidt J, 2011, LARYNGOSCOPE, V121, P585, DOI 10.1002/lary.21122; Ohno S, 2011, ANN OTO RHINOL LARYN, V120, P401; Roy N, 2007, LARYNGOSCOPE, V117, P628, DOI 10.1097/MLG.0b013e3180306da1; Rosen CA, 2000, J VOICE, V14, P619, DOI 10.1016/S0892-1997(00)80017-X; Rosen CA, 2004, LARYNGOSCOPE, V114, P1549, DOI 10.1097/00005537-200409000-00009; Hirano S, 2012, LARYNGOSCOPE, V122, P327, DOI 10.1002/lary.22393; Roy N, 2001, J SPEECH LANG HEAR R, V44, P286, DOI 10.1044/1092-4388(2001/023); SHIPP T, 1969, J SPEECH HEAR RES, V12, P703; Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15; Suehiro A, 2010, ACTA OTO-LARYNGOL, V130, P844, DOI 10.3109/00016480903426618; Colton RH, 2006, UNDERSTANDING VOICE, V3rd, P498; Etter NM, 2013, J VOICE, V27, P61, DOI 10.1016/j.jvoice.2012.07.002; Gorman S, 2008, LARYNGOSCOPE, V118, P1900, DOI 10.1097/MLG.0b013e31817f9822; Gray SD, 2000, OTOLARYNG CLIN N AM, V33, P679, DOI 10.1016/S0030-6665(05)70237-1; HARTMAN DE, 1979, J COMMUN DISORD, V12, P53, DOI 10.1016/0021-9924(79)90021-2; Hirano M, 1981, CLIN EXAMINATION VOI; Hirano M., 1985, SPEECH SCI, P1; Hirano S, 2004, ANN OTO RHINOL LARYN, V113, P777; Jacobson BH, 1997, AM J SPEECH-LANG PAT, V6, P66; Lu FL, 1998, ANN OTO RHINOL LARYN, V107, P113; Luschei ES, 1999, J NEUROPHYSIOL, V81, P2131; Mueller Peter B., 1997, Seminars in Speech and Language, V18, P159, DOI 10.1055/s-2008-1064070; Ramig LO, 2001, FOLIA PHONIATR LOGO, V53, P252, DOI 10.1159/000052680; Sabol JW, 1995, J VOICE, V8, P927; Siracusa Maria das Graças de Paiva, 2011, J Soc Bras Fonoaudiol, V23, P27, DOI 10.1590/S2179-64912011000100008; Slavit DH, 1999, ENT-EAR NOSE THROAT, V78, P505; Stemple JC, 2010, CLIN VOICE PATHOLOGY, P245; TUCKER HM, 1988, ANN OTO RHINOL LARYN, V97, P534; Verdolini K, 2001, Logoped Phoniatr Vocol, V26, P37, DOI 10.1080/140154301300109125	33	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0892-1997	1873-4588		J VOICE	J. Voice	SEP	2015	29	5					638	644		10.1016/j.jvoice.2014.10.017		7	Otorhinolaryngology	Otorhinolaryngology	CQ4EI	WOS:000360556700019		
J	Shindo, Y; Ito, R; Kobayashi, D; Ando, M; Ichikawa, M; Goto, Y; Fukui, Y; Iwaki, M; Okumura, J; Yamaguchi, I; Yagi, T; Tanikawa, Y; Sugino, Y; Shindoh, J; Ogasawara, T; Nomura, F; Saka, H; Yamamoto, M; Taniguchi, H; Suzuki, R; Saito, H; Kawamura, T; Hasegawa, Y				Shindo, Yuichiro; Ito, Ryota; Kobayashi, Daisuke; Ando, Masahiko; Ichikawa, Motoshi; Goto, Yasuhiro; Fukui, Yasutaka; Iwaki, Mai; Okumura, Junya; Yamaguchi, Ikuo; Yagi, Tetsuya; Tanikawa, Yoshimasa; Sugino, Yasuteru; Shindoh, Joe; Ogasawara, Tomohiko; Nomura, Fumio; Saka, Hideo; Yamamoto, Masashi; Taniguchi, Hiroyuki; Suzuki, Ryujiro; Saito, Hiroshi; Kawamura, Takashi; Hasegawa, Yoshinori		Cent Japan Lung Study Grp	Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study	LANCET INFECTIOUS DISEASES			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CARE-ASSOCIATED PNEUMONIA; PREDICTION RULE; INTENSIVE-CARE; SEPTIC SHOCK; HEALTH; SEPSIS; STRATIFICATION; VALIDATION; GUIDELINES	Background Appropriate initial antibiotics are essential for the treatment of infectious diseases. However, some patients with pneumonia might develop adverse outcomes, despite receiving appropriate initial antibiotics. We aimed to clarify the risk factors for 30-day mortality in patients who received appropriate initial antibiotics and to identify potential candidates who would benefit from adjunctive therapy. Methods From March 15, to Dec 22, 2010, we did a prospective, observational study at ten medical institutions in hospitalised patients (aged >= 20 years) with pneumonia. We did a multivariable logistic regression analysis to calculate odds ratios (ORs) and 95% CI to assess the risk factors for 30-day mortality. This study was registered with the University Medical Information Network in Japan, number UMIN000003306. Findings The 30-day mortality was 11% (61 of 579 patients) in the appropriate initial antibiotic treatment group and 17% (29 of 168) in the inappropriate initial antibiotic treatment group. Albumin concentration of less than 30 mg/L (adjusted OR 3.39, 95% CI 1.83-6.28), non-ambulatory status (3.34, 1.84-6.05), pH of less than 7.35 (3.13, 1.52-6.42), respiration rate of at least 30 breaths per min (2.33, 1.28-4.24), and blood urea nitrogen of at least 7.14 mmol/L (2.20, 1.13-4.30) were independent risk factors in patients given appropriate initial antibiotic treatment. The 30-day mortality was 1% (one of 126 patients), 1% (two of 168), 17% (23 of 137), 22% (20 of 89), and 44% (14 of 32) for patients with no, one, two, three, and four or five risk factors, respectively. Interpretation Patients with two or more risk factors were at a higher risk of death during the 30 days assessed than were individuals with no or one risk factor, despite appropriate initial antibiotic treatment. Therefore, adjunctive therapy might be important for improving outcomes in patients with two or more risk factors.	[Shindo, Yuichiro] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4668550, Japan; [Shindo, Yuichiro; Ito, Ryota; Kobayashi, Daisuke; Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4668550, Japan; [Ito, Ryota; Nomura, Fumio] Japanese Red Cross Nagoya Daiichi Hosp, Dept Resp Med, Nagoya, Aichi, Japan; [Kobayashi, Daisuke; Taniguchi, Hiroyuki] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Ichikawa, Motoshi; Tanikawa, Yoshimasa] Toyota Kosei Hosp, Dept Resp Med & Allergy, Toyota, Japan; [Ichikawa, Motoshi] Gifu Prefectural Tajimi Hosp, Dept Resp Med, Tajimi, Japan; [Goto, Yasuhiro; Yamamoto, Masashi] Nagoya Ekisaikai Hosp, Dept Resp Med, Nagoya, Aichi, Japan; [Goto, Yasuhiro] Fujita Hlth Univ, Dept Internal Med, Div Resp Med & Clin Allergy, Toyoake, Aichi, Japan; [Fukui, Yasutaka; Suzuki, Ryujiro] Toyohashi Municipal Hosp, Dept Resp Med, Toyohashi, Aichi, Japan; [Iwaki, Mai; Ogasawara, Tomohiko] Nagoya Daini Red Cross Hosp, Dept Resp Med, Nagoya, Aichi, Japan; [Okumura, Junya; Sugino, Yasuteru] Toyota Mem Hosp, Dept Resp Med, Toyota, Japan; [Yamaguchi, Ikuo] Toyohashi Municipal Hosp, Dept Cent Lab, Toyohashi, Aichi, Japan; [Yagi, Tetsuya] Nagoya Univ Hosp, Dept Infect Dis, Nagoya, Aichi, Japan; [Shindoh, Joe] Ogaki Municipal Hosp, Dept Resp Med, Ogaki, Japan; [Saka, Hideo] Nagoya Med Ctr, Natl Hosp Org, Dept Resp Med, Nagoya, Aichi, Japan; [Saito, Hiroshi] Aichi Hosp, Aichi Canc Ctr, Dept Resp Med, Okazaki, Aichi, Japan; [Kawamura, Takashi] Kyoto Univ, Hlth Serv, Kyoto, Japan	Shindo, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Resp Med, Inst Adv Res,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	yshindo@med.nagoya-u.ac.jp			Central Japan Lung Study Group	Central Japan Lung Study Group.	Agresti A, 2012, CLASSIFICATION TREE, V3rd, P574; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Tumbarello M, 2013, INTENS CARE MED, V39, P682, DOI 10.1007/s00134-013-2828-9; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Wunderink RG, 2013, AM J RESP CRIT CARE, V188, P896, DOI 10.1164/rccm.201308-1536ED; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Spellberg B, 2008, CLIN INFECT DIS, V47, pS249, DOI 10.1086/591411; Stiller K, 2013, CHEST, V144, P825, DOI 10.1378/chest.12-2930; Shindo Y, 2009, CHEST, V135, P633, DOI 10.1378/chest.08-1357; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P1145, DOI 10.1016/j.jclinepi.2009.12.004; Casaer MP, 2008, CRIT CARE, V12, DOI 10.1186/cc6945; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Espana PP, 2006, AM J RESP CRIT CARE, V174, P1249, DOI 10.1164/rccm.200602-177OC; European Society of Clinical Microbiology and Infectious Diseases, CLIN BREAKP; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Menard S, 2001, APPL LOGISTIC REGRES, P12; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125; Moro-Garcia MA, 2012, AGE, V34, P479, DOI 10.1007/s11357-011-9240-6; Musher DM, 2014, NEW ENGL J MED, V371, P1619, DOI 10.1056/NEJMra1312885; Renaud B, 2009, CRIT CARE, V13, DOI 10.1186/cc7781; Richards Guy, 2011, J Intensive Care Med, V26, P34, DOI 10.1177/0885066610383949; Rivadeneira DE, 2001, SURGERY, V129, P617, DOI 10.1067/msy.2001.112963; Shindo Y, 2008, RESPIROLOGY, V13, P731, DOI 10.1111/j.1440-1843.2008.01329.x; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WHO, GLOB HLTH OBS GHO CA; Wunderink RG, 2012, SEMIN RESP CRIT CARE, V33, P311, DOI 10.1055/s-0032-1315643	39	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1473-3099	1474-4457		LANCET INFECT DIS	Lancet Infect. Dis.	SEP	2015	15	9					1055	1065		10.1016/S1473-3099(15)00151-6		11	Infectious Diseases	Infectious Diseases	CQ4AZ	WOS:000360547800033		
J	Ogita, M; Tsuchida, S; Aoki, A; Satoh, M; Kado, S; Sawabe, M; Nanbara, H; Kobayashi, H; Takeuchi, Y; Mizutani, K; Sasaki, Y; Nomura, F; Izumi, Y				Ogita, Mayumi; Tsuchida, Sachio; Aoki, Akira; Satoh, Mamoru; Kado, Sayaka; Sawabe, Masanori; Nanbara, Hiromi; Kobayashi, Hiroaki; Takeuchi, Yasuo; Mizutani, Koji; Sasaki, Yoshiyuki; Nomura, Fumio; Izumi, Yuichi			Increased cell proliferation and differential protein expression induced by low-level Er:YAG laser irradiation in human gingival fibroblasts: proteomic analysis	LASERS IN MEDICAL SCIENCE			English	Article						Er:YAG laser; Galectin-7; Gingival fibroblasts; Low-level laser therapy; Proteomics	PERIODONTAL-DISEASE; GENE-EXPRESSION; EPITHELIAL-CELLS; GALECTIN-7; 14-3-3-SIGMA; ACTIVATION; DISCOVERY; MIGRATION; STRESS; REPAIR	Erbium-doped yttrium aluminum garnet (Er:YAG) laser treatment has demonstrated favorable wound healing effect after periodontal therapy. One of the reasons may be the positive biological effect of the low-level laser on the irradiated tissues, although the mechanism remains unclear. The aim of this study was to investigate the effect of low-level Er:YAG laser irradiation on cell proliferation and laser-induced differential expression of proteins in human gingival fibroblasts (HGFs) by proteomic analysis. In the first experiment, HGFs were exposed to low-level Er:YAG laser irradiation and the laser-induced cell proliferation and damage were evaluated on day 3. In the second experiment, proteomic analysis was performed on day 1 after irradiation. The peptides prepared from HGFs were analyzed by a hybrid ion trap-Fourier transform mass spectrometer, Mascot search engine, and UniProtKB database. A significant increase in cell proliferation without cell damage after irradiation was observed. Among the total identified 377 proteins, 59 proteins, including galectin-7, which was associated with the process of wound healing, were upregulated and 15 proteins were downregulated in laser-treated HGFs. In the third experiment, the increase in messenger RNA (mRNA) and protein expression of galectin-7 in the irradiated HGFs was validated by various analytical techniques. In addition, the effect of recombinant human galectin-7 on the modulation of HGFs proliferation was confirmed. The results indicate that low-level Er:YAG laser irradiation can promote HGF proliferation and induce a significant change in protein expression and the upregulation of galectin-7 expression may partly contribute to the increase in cell proliferation.	[Ogita, Mayumi; Aoki, Akira; Satoh, Mamoru; Nanbara, Hiromi; Kobayashi, Hiroaki; Takeuchi, Yasuo; Mizutani, Koji; Izumi, Yuichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Bunkyo Ku, Tokyo 1138549, Japan; [Tsuchida, Sachio; Satoh, Mamoru; Nomura, Fumio] Chiba Univ, Grad Sch Med, Dept Mol Diag F8, Chiba 2608670, Japan; [Kado, Sayaka] Chiba Univ, Ctr Chem Anal, Chiba 2608670, Japan; [Sasaki, Yoshiyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial & Neck Reconstruct, Maxillofacial Orthognath,Bunkyo Ku, Tokyo 1138549, Japan; [Ogita, Mayumi; Izumi, Yuichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program,Bunkyo Ku, Tokyo 1138549, Japan	Tsuchida, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	acna4827@chiba-u.jp; aoperi@tmd.ac.jp			Global Center of Excellence Program of the International Research Center for Molecular Science in Tooth and Bone Diseases at TMDU - Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [22392308, 23463212]	This study was partially supported by the grant of the Global Center of Excellence Program of the International Research Center for Molecular Science in Tooth and Bone Diseases at TMDU funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the grant of Grants-in-Aid for Scientific Research (C) (no. 22392308 and no. 23463212 for A. A.) from the Japan Society for the Promotion of Science. We would like to acknowledge Dr. Kengo Iwasaki and Dr. Yoichi Taniguchi at TMDU for their kind advices and supports.	Abiko Yoshimitsu, 2004, J Oral Sci, V46, P19, DOI 10.2334/josnusd.46.19; Yu W, 1997, PHOTOCHEM PHOTOBIOL, V66, P866, DOI 10.1111/j.1751-1097.1997.tb03239.x; Berbee JFP, 2010, J LIPID RES, V51, P1943, DOI 10.1194/jlr.M006809; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Pourzarandian A, 2005, J PERIODONTOL, V76, P187, DOI 10.1902/jop.2005.76.2.187; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Peplow PV, 2011, PHOTOMED LASER SURG, V29, P285, DOI 10.1089/pho.2010.2846; Tsuchida S, 2013, PROTEOMICS, V13, P2339, DOI 10.1002/pmic.201200510; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; Ejiri K, 2014, LASER MED SCI, V29, P1339, DOI 10.1007/s10103-013-1292-7; Zhang YO, 2003, J INVEST DERMATOL, V120, P849, DOI 10.1046/j.1523-1747.2003.12133.x; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Abe D, 2011, J PERIODONTAL RES, V46, P345, DOI 10.1111/j.1600-0765.2011.01349.x; McKnight H, 2014, J PERIODONTOL, V85, P810, DOI 10.1902/jop.2013.130161; Aoki A, 2004, PERIODONTOL 2000, V36, P59, DOI 10.1111/j.1600-0757.2004.03679.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Chan TA, 1999, NATURE, V401, P616; Shefer G, 2001, J CELL PHYSIOL, V187, P73, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1053>3.0.CO;2-9; Cao ZY, 2003, ARCH OPHTHALMOL-CHIC, V121, P82; MESTER E, 1985, LASER SURG MED, V5, P31, DOI 10.1002/lsm.1900050105; Crespi R, 2007, J PERIODONTOL, V78, P1195, DOI 10.1902/jop.2007.060460; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Lubart R, 2005, PHOTOMED LASER SURG, V23, P3, DOI 10.1089/pho.2005.23.3; Tsuchida S, 2012, PROTEOMICS, V12, P2190, DOI 10.1002/pmic.201100655; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Aleksic V, 2010, LASER MED SCI, V25, P559, DOI 10.1007/s10103-010-0761-5; Schwarz F, 2001, J PERIODONTOL, V72, P361, DOI 10.1902/jop.2001.72.3.361; Fukuhara E, 2006, CALCIFIED TISSUE INT, V79, P443, DOI 10.1007/s00223-006-0072-9; MORIMOTO Y, 1994, LASER SURG MED, V15, P191, DOI 10.1002/lsm.1900150207; Campbell L, 2013, J INVEST DERMATOL, V133, P2461, DOI 10.1038/jid.2013.164; Ara T, 2009, J PERIODONTAL RES, V44, P21, DOI 10.1111/j.1600-0765.2007.01041.x; Bertoldi C, 2013, J CLIN PERIODONTOL, V40, P573, DOI 10.1111/jcpe.12050; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Cho SB, 2013, ACTA DERM-VENEREOL, V93, P669, DOI 10.2340/00015555-1583; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; Gillett GT, 1996, ANN HUM GENET, V60, P201, DOI 10.1111/j.1469-1809.1996.tb00423.x; Ishikawa I, 2000, PERIODONTOLOGY, V50, P90, DOI DOI 10.1111/J.1600-0757.2008.00283.X; Kampfer H, 2003, J INVEST DERMATOL, V121, P1544, DOI 10.1046/j.1523-1747.2003.12610.x; Oda S, 2000, PERIODONTOLOGY, V36, P45; Ohshiro T, 1991, J Clin Laser Med Surg, V9, P267; Rondanino C, 2011, AM J PHYSIOL-RENAL, V301, pF622, DOI 10.1152/ajprenal.00134.2011; Saussez S, 2006, CELL MOL LIFE SCI, V63, P686, DOI 10.1007/s00018-005-5458-8; Sawabe M, 2015, LASER MED SCI, V30, P875, DOI 10.1007/s10103-013-1478-z; SEIFERT GJ, 1992, EUR J CELL BIOL, V59, P138; THOMPSON HW, 1991, INVEST OPHTH VIS SCI, V32, P433; Witte MB, 2002, J SURG RES, V105, P35, DOI 10.1006/jsre.2002.6443	49	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	SEP	2015	30	7					1855	1866		10.1007/s10103-014-1691-4		12	Engineering, Biomedical; Surgery	Engineering; Surgery	CQ8NA	WOS:000360863300006		
J	Kanda, S; Horinouchi, H; Fujiwara, Y; Nokihara, H; Yamamoto, N; Sekine, I; Kunitoh, H; Kubota, K; Tamura, T; Ohe, Y				Kanda, Shintaro; Horinouchi, Hidehito; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Sekine, Ikuo; Kunitoh, Hideo; Kubota, Kaoru; Tamura, Tomohide; Ohe, Yuichiro			Cytotoxic chemotherapy may overcome the development of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) therapy	LUNG CANCER			English	Article						Non-small cell lung cancer; Epidermal growth factor receptor mutation; Tyrosine kinase inhibitor; Gefitinib; Chemotherapy; Cisplatin; Docetaxel	CELL LUNG-CANCER; PHASE-III TRIAL; RESOLUTION MELTING ANALYSIS; 1ST-LINE TREATMENT; OPEN-LABEL; CARBOPLATIN-PACLITAXEL; PLUS CISPLATIN; GENE-MUTATIONS; GEFITINIB; ERLOTINIB	Objectives: In the first-line treatment of non-small cell lung cancer (NSCLC) harboring EGFR mutations, epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) has been shown to yield a longer progression-free survival (PFS) rate than platinum-doublet chemotherapy; however, after the initial response, most patients develop resistance to the EGFR-TKIs. We hypothesized that the insertion of platinum-doublet chemotherapy after the initial response to EGFR-TKIs might prevent the emergence of acquired resistance to EGFR-TKIs and prolong survival. Methods: We carried out a phase II study of the following first-line treatment for patients with advanced NSCLC harboring EGFR mutations. Gefitinib (250 mg) was administered on days 1-56. Then, after a two-week drug-free period, three cycles of cisplatin (80 mg/m(2)) and docetaxel (60 mg/m(2)) were administered on days 71, 92, and 113. Thereafter, gefitinib was re-started on day 134 and continued until disease progression. The primary endpoint was the two-year PFS rate. Results: A total of 34 patients were enrolled. Of the 33 eligible patients and 12 achieved a two-year PFS. Thus, this therapeutic strategy met the criterion for usefulness. The 1-, 2-, 3-, and 5-year PFS rates were 67.0%, 40.2%, 36.9%, and 22.0%, respectively, and the median PFS was 19.5 months. The 1-, 2-, 3- and 5-year survival rates were 90.6%, 71.9%, 64.8%, and 36.5% respectively, and the median survival time was 48.0 months. Conclusion: These results indicate that the insertion of platinum-doublet chemotherapy might prevent the development of acquired resistance to EGFR-TKIs in patients with advanced NSCLC harboring EGFR mutations. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kanda, Shintaro; Horinouchi, Hidehito; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Ohe, Yuichiro] Natl Canc Ctr, Dept Thorac Oncol, Tokyo 1040045, Japan; [Sekine, Ikuo] Chiba Canc Ctr, Div Resp Med, Chiba 2608717, Japan; [Kunitoh, Hideo] Japanese Red Cross Med Ctr, Dept Internal Med, Div Chemotherapy, Tokyo, Japan; [Kubota, Kaoru] Nippon Med Sch, Dept Internal Med, Div Pulm Med Infect & Oncol, Tokyo 113, Japan; [Tamura, Tomohide] St Lukes Int Hosp, Thorac Ctr, Tokyo, Japan	Kanda, S (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	skanda@ncc.go.jp			National Cancer Center Research and Development Fund [26-A-4]	This study was supported in part by a National Cancer Center Research and Development Fund (26-A-4).	Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Takano T, 2007, CLIN CANCER RES, V13, P5385, DOI 10.1158/1078-0432.CCR-07-0627; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Janne PA, 2012, J CLIN ONCOL, V30, P2063, DOI 10.1200/JCO.2011.40.1315; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Hirsch FR, 2011, J CLIN ONCOL, V29, P3567, DOI 10.1200/JCO.2010.34.4929; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Douillard JY, 2007, J THORAC ONCOL, V2, P939, DOI 10.1097/JTO.0b013e318153fa2b; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Bai H, 2012, J CLIN ONCOL, V30, P3077, DOI 10.1200/JCO.2011.39.3744; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Kubota K, 2004, J CLIN ONCOL, V22, P254, DOI 10.1200/JCO.2004.06.114; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Riely GJ, 2007, CLIN CANCER RES, V13, P5150, DOI 10.1158/1078-0432.CCR-07-0560; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Chaft JE, 2011, CLIN CANCER RES, V17, P6298, DOI 10.1158/1078-0432.CCR-11-1468; Engleman J.A., 2007, SCIENCE, V316, P1039; Fukui T, 2008, CLIN CANCER RES, V14, P4751, DOI 10.1158/1078-0432.CCR-07-5207; Kimura T., 2004, P AM SOC CLIN ONCO B, V23; Mitsudomi T., 2012, J CLIN ONCOL S, V30; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Piperdi B., 2004, P AM SOC CLIN ONCOL, V23; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yamaguchi H, 2013, CLIN CANCER RES, V19, P845, DOI 10.1158/1078-0432.CCR-12-2621; Zhou C, 2012, J CLIN ONCOL S, V30	42	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	SEP	2015	89	3					287	293		10.1016/j.lungcan.2015.06.016		7	Oncology; Respiratory System	Oncology; Respiratory System	CQ3OX	WOS:000360513200011		
J	Nishiyama, A; Katakami, N; Yoshioka, H; Iwasaku, M; Korogi, Y; Hata, A; Takeshita, J; Otsuka, K; Nishino, K; Uchida, J; Okuyama, T; Namba, Y; Mori, M; Fujita, S; Morita, S				Nishiyama, Akihiro; Katakami, Nobuyuki; Yoshioka, Hiroshige; Iwasaku, Masahiro; Korogi, Yohei; Hata, Akito; Takeshita, Jumpei; Otsuka, Kojiro; Nishino, Kazumi; Uchida, Junji; Okuyama, Takako; Namba, Yoshinobu; Mori, Masahide; Fujita, Shiro; Morita, Satoshi			Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer	LUNG CANCER			English	Article						EGFR mutation-negative; Non-squamous non-small-cell lung cancer; Erlotinib; Pemetrexed; Docetaxel; Performance status; Second-line treatment	OPEN-LABEL; PHASE-III; 1ST-LINE TREATMENT; CHEMOTHERAPY; MULTICENTER; TRIAL; CTONG-0802; CISPLATIN; THERAPY; NSCLC	Objective: Several guidelines recommend erlotinib, pemetrexed, or docetaxel for second-line chemotherapy in patients with advanced non-squamous non-small-cell lung cancer (NSCLC). The aim of this study was to retrospectively evaluate the efficacy of erlotinib, pemetrexed, and docetaxel in epidermal growth factor receptor (EGFR) mutation-negative patients with previously treated advanced non-squamous NSCLC. Materials and methods: We analyzed the efficacy of these agents in patients with previously treated advanced non-squamous NSCLC who had EGFR wild-type tumors, performance status (PS) of 0, 1, or 2 and received erlotinib, pemetrexed, or docetaxel between December 2007 and September 2011. Variability among patient backgrounds was evaluated using propensity scores to assess comparability. The efficacy of these agents was evaluated in patient subgroups with low variability. Results: The propensity scores showed that the backgrounds of the groups that received second-line therapy with each agent had low variability and were adequate for comparison. Patients were divided into the PS0/1 and PS2 groups for analysis. The median progression-free survival (PFS) in patients treated with erlotinib was 2.8 months in the PS0/1 group, as compared with 1.0 month in the PS0/1/2 group and 0.90 months in the PS2 group. PFS in PS0/1 patients who received erlotinib was comparable to that in PS0/1 patients who received pemetrexed (2.5 months) or docetaxel (1.9 months). Overall survival (OS) in erlotinib-, pemetrexed-, and docetaxel-treated PS0/1 patients was 16.1, 7.4 and 10.0 months, respectively. The study had limited power to detect differences in PFS and OS because of the small sample size. Conclusions: Erlotinib appears to be a useful second-line option in PS0/1 patients with EGFR mutation-negative advanced non-squamous NSCLC given its mild adverse effects. The results should be carefully interpreted because of the small sample size, limited power, and retrospective nature of the study. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nishiyama, Akihiro; Yoshioka, Hiroshige; Iwasaku, Masahiro; Korogi, Yohei] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan; [Katakami, Nobuyuki; Hata, Akito; Takeshita, Jumpei; Fujita, Shiro] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo 6500047, Japan; [Otsuka, Kojiro] Kobe City Med Ctr Gen Hosp, Div Pulm Med, Kobe, Hyogo, Japan; [Nishino, Kazumi; Uchida, Junji; Okuyama, Takako] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Osaka, Japan; [Namba, Yoshinobu; Mori, Masahide] Natl Hosp Org Toneyama Natl Hosp, Dept Thorac Oncol, Toyonaka, Osaka, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto 6068501, Japan	Katakami, N (reprint author), Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	kabu568459@yahoo.co.jp			Foundation for Biomedical Research and Innovation	Nobuyuki Katakami received honoraria from Chugai Pharmaceutical Company, Novartis Pharmaceutical Company, Lilly Pharmaceutical Company, Taiho Pharmaceutical Company, Pfizer Pharmaceutical Company, Daiichi Sankyo Pharmaceutical Company, Shionogi Pharmaceutical Company, and Sanofi Pharmaceutical Company. Hiroshige Yoshioka received honoraria from Chugai Pharmaceutical Company, Lilly Pharmaceutical Company, Sanofi Pharmaceutical Company, and AstraZeneca Pharmaceutical Company. Kazumi Nishino has received honorarium from Chugai Pharmaceutical Company. Satoshi Morita received support for travel and fees for participation from the Foundation for Biomedical Research and Innovation, as well as honoraria from Chugai Pharmaceutical Company. The other authors have declared no conflicts of interest.	Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Peters S, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds226; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Kawaguchi T, 2014, J CLIN ONCOL, V32, P1902, DOI 10.1200/JCO.2013.52.4694; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Chen G, 2013, ANN ONCOL, V24, P1615, DOI 10.1093/annonc/mdt012; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Yoshioka H, 2010, J THORAC ONCOL, V5, P99, DOI 10.1097/JTO.0b013e3181c20063; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924; Azzoli CG, 2011, J CLIN ONCOL, V29, P4725, DOI 10.1200/JCO.2011.40.5571; Gaofeng P., 2013, TARGET ONCOL, V8, P107; Garassino M.C., 2013, LANCET ONCOL, V22; National Comprehensive Cancer Network, 2013, NCCN PRACT GUID ONC	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	SEP	2015	89	3					301	305		10.1016/j.lungcan.2015.06.017		5	Oncology; Respiratory System	Oncology; Respiratory System	CQ3OX	WOS:000360513200013		
J	Kadota, K; Buitrago, D; Lee, MC; Villena-Vargas, J; Sima, CS; Jones, DR; Travis, WD; Adusumilli, PS				Kadota, Kyuichi; Buitrago, Daniel; Lee, Ming-Ching; Villena-Vargas, Jonathan; Sima, Camelia S.; Jones, David R.; Travis, William D.; Adusumilli, Prasad S.			Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma	LUNG CANCER			English	Article						Adenocarcinoma; Lung; CD10; Histology; Recurrence	INTERNATIONAL ASSOCIATION; INDEPENDENT PREDICTOR; COLORECTAL-CANCER; CLASSIFICATION; CELLS; CARCINOMA; SOCIETY; SUBGROUPS; LYMPHOMA; SURVIVAL	Objective: CD10 (neutral endopeptidase) is expressed in various normal and tumor cells, and its biological function can be controlled through enzymatic activity and signaling pathways. We investigated whether CD10 expression predicted disease recurrence and whether it correlated with histologic subtypes of stage I lung adenocarcinoma. Materials and methods: We reviewed tumor slides of resected pathologic stage I lung adenocarcinomas (1995-2009). Tumors were classified according to the IASLC/ATS/ERS classification. CD10 immunohistochemistry was performed using tissue microarrays (n = 915). We combined the intensity (0-3) and distribution scores (0-2) for CD10 to create a total score (0-5). Risk of recurrence was estimated using competing risks methods. Results: In the training cohort (n = 313), risk of recurrence of patients with high tumoral CD10 (score >1, n = 57) was significantly higher (5-year cumulative incidence of recurrence [CIR], 37%) than in those with low CD10 (score <= 1; n = 256; 5-year CIR, 16%; P < 0.001); this finding was confirmed in the validation cohort (n = 602, P=0.036). High tumoral CD10 was associated with higher risk of recurrence in acinar (P= 0.007) and papillary predominant tumors (P= 0.022). High tumoral CD10 was most frequently identified in micropapillary predominant (41%) and solid predominant tumors (34%). On multivariate analysis of intermediate-grade tumors, high tumoral CD10 remained a significant independent risk factor of recurrence (hazard ratio, 1.88; P=0.025). Conclusion: In stage I lung adenocarcinoma, tumoral CD10 correlated with high-grade histology and was an independent predictor of recurrence in intermediate-grade tumors. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kadota, Kyuichi; Buitrago, Daniel; Lee, Ming-Ching; Villena-Vargas, Jonathan; Jones, David R.; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, New York, NY 10065 USA; [Kadota, Kyuichi; Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Kadota, Kyuichi] Kagawa Univ, Fac Med, Dept Diagnost Pathol, Takamatsu, Kagawa 760, Japan; [Sima, Camelia S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA; [Lee, Ming-Ching] Inst Clin Med, Taipei, Taiwan; [Lee, Ming-Ching] Natl Yang Ming Univ, Taipei 112, Taiwan	Adusumilli, PS (reprint author), Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10065 USA.	adusumip@mskcc.org			National Institutes of Health [R21 CA164568-01A1, R21 CA164585-01A1, U54 CA137788, P50 CA086438-13]; U.S. Department of Defense [PR101053, LC110202]; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center	This work is supported by grants from the National Institutes of Health (R21 CA164568-01A1, R21 CA164585-01A1, U54 CA137788, and P50 CA086438-13), the U.S. Department of Defense (PR101053 and LC110202), and the Mr. William H. Goodwin and Mrs. Alice Goodwin, the Commonwealth Foundation for Cancer Research, and the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center.	Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Khanh DT, 2011, CANCER SCI, V102, P1724, DOI 10.1111/j.1349-7006.2011.01987.x; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Kadota K, 2012, MODERN PATHOL, V25, P1117, DOI 10.1038/modpathol.2012.58; Kadota K, 2013, CANCER-AM CANCER SOC, V119, P931, DOI 10.1002/cncr.27863; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Fleischmann A, 2011, VIRCHOWS ARCH, V458, P741, DOI 10.1007/s00428-011-1084-z; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; Kuniyasu H, 2010, GUT, V59, P348, DOI 10.1136/gut.2009.178376; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; Fukusumi T, 2014, BRIT J CANCER, V111, P506, DOI 10.1038/bjc.2014.289; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Morisaki N, 2010, J BIOL CHEM, V285, P39819, DOI 10.1074/jbc.M110.161547; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Biasoli I, 2005, HISTOPATHOLOGY, V46, P328, DOI 10.1111/j.1365-2559.2005.02099.x; Bilalovic N, 2004, AM J CLIN PATHOL, V121, P34, DOI 10.1309/TNKL7GDC66R9WPV5; Dall'Era Marc A, 2007, BMC Urol, V7, P3, DOI 10.1186/1471-2490-7-3; Desmedt C, 2012, CLIN CANC RES; Edge SB, 2009, AJCC CANC STAGING MA, P253; Gurel D, 2012, PATHOL ONCOL RES, V18, P153, DOI 10.1007/s12253-011-9421-8; Kadota K, 2015, ANN SURG ONCOL; Kim HS, 2010, HISTOPATHOLOGY, V56, P708, DOI 10.1111/j.1365-2559.2010.03534.x; Kristiansen G, 2002, ANAL CELL PATHOL, V24, P41; Leithner K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-40; McIntosh GG, 1999, AM J PATHOL, V154, P77, DOI 10.1016/S0002-9440(10)65253-4; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ono S, 2012, CHEST; SHIPP MA, 1993, BLOOD, V82, P1052; Tokuhara T, 2001, Jpn J Thorac Cardiovasc Surg, V49, P489, DOI 10.1007/BF02919543; Turner AJ, 1997, FASEB J, V11, P355; Vansteenkiste J, 2013, ANN ONCOL SUPPL 6, V24, pvi89, DOI DOI 10.1093/ANN0NC/MDT241	35	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	SEP	2015	89	3					329	336		10.1016/j.lungcan.2015.06.003		8	Oncology; Respiratory System	Oncology; Respiratory System	CQ3OX	WOS:000360513200017		
J	Yamanishi, T; Kaga, K; Fuse, M; Shibata, C; Uchiyama, T				Yamanishi, Tomonori; Kaga, Kanya; Fuse, Miki; Shibata, Chiharu; Uchiyama, Tomoyuki			Neuromodulation for the Treatment of Lower Urinary Tract Symptoms	LUTS-LOWER URINARY TRACT SYMPTOMS			English	Review						electrical; lower urinary tract symptoms; magnetic; neuromodulation; overactive bladder	TIBIAL NERVE-STIMULATION; GENUINE STRESS-INCONTINENCE; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; FUNCTIONAL MAGNETIC STIMULATION; FLOOR ELECTRICAL-STIMULATION; OVERACTIVE BLADDER SYNDROME; NEUROGENIC DETRUSOR OVERACTIVITY; 1-YEAR FOLLOW-UP; PELVIC FLOOR	Neuromodulation therapy incorporates electrical stimulation to target specific nerves that control lower urinary tract symptoms (LUTS). The objectives of this article are to review the mechanism of action, the type of neuromodulation, and the efficacy of neuromodulation mainly according to the results of randomized controlled trials. Neuromodulation includes pelvic floor electrical stimulation (ES) using vaginal, anal and surface electrodes, interferential therapy (IF), magnetic stimulation (MS), percutaneous tibial nerve stimulation, and sacral nerve stimulation (SNS). The former four stimulations are used for external periodic (short-term) stimulation, and SNS are used for internal, chronic (long-term) stimulation. All of these therapies have been reported to be effective for overactive bladder or urgency urinary incontinence. Pelvic floor ES, IF, and MS have also been reported to be effective for stress urinary incontinence. The mechanism of neuromodulation for overactive bladder has been reported to be the reflex inhibition of detrusor contraction by the activation of afferent fibers by three actions, i.e., the activation of hypogastric nerve, the direct inhibition of the pelvic nerve within the sacral cord and the supraspinal inhibition of the detrusor reflex. The mechanism of neuromodulation for stress incontinence is contraction of the pelvic floor muscles through an effect on the muscle fibers as well as through the stimulation of pudendal nerves. Overall, cure and improvement rates of these therapies for urinary incontinence are 30-50, and 60-90% respectively. MS has been considered to be a technique for stimulating nervous system noninvasively. SNS is indicated for patients with refractory overactive bladder and urinary retention.	[Yamanishi, Tomonori; Kaga, Kanya; Fuse, Miki; Shibata, Chiharu; Uchiyama, Tomoyuki] Dokkyo Med Univ, Continence Ctr, Dept Urol, Tochgi, Japan	Yamanishi, T (reprint author), Dokkyo Med Univ, Continence Ctr, Dept Urol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	yamanish@dokkyomed.ac.jp					Abel I, 1996, NEUROUROL URODYNAM, V15, P283; ALEXANDER S, 1970, British Journal of Urology, V42, P184, DOI 10.1111/j.1464-410X.1970.tb10020.x; Almeida FG, 2004, J UROLOGY, V171, P1571, DOI 10.1097/01.ju.0000117791.72151.f8; Amuzu BJ, 1998, CLIN OBSTET GYNECOL, V41, P702, DOI 10.1097/00003081-199809000-00026; Yamanishi T, 2000, J UROLOGY, V163, P456, DOI 10.1016/S0022-5347(05)67899-8; Suzuki T, 2007, NEUROUROL URODYNAM, V26, P767, DOI 10.1002/nau.20423; Yamanishi T, 2010, J UROLOGY, V184, P2007, DOI 10.1016/j.juro.2010.06.103; Sherburn M, 2011, NEUROUROL URODYNAM, V30, P317, DOI 10.1002/nau.20968; Yamanishi T, 2000, UROLOGY, V56, P777, DOI 10.1016/S0090-4295(00)00779-2; Abrams P, 2006, INT J UROL, V13, P692, DOI 10.1111/j.1442-2042.2006.01387.x; Ward KL, 2008, BJOG-INT J OBSTET GY, V115, P226, DOI 10.1111/j.1471-0528.2007.01548.x; Peters KM, 2009, J UROLOGY, V182, P1055, DOI 10.1016/j.juro.2009.05.045; Brubaker L, 1997, AM J OBSTET GYNECOL, V177, P536, DOI 10.1016/S0002-9378(97)70142-X; Schreiner L, 2010, INT UROGYNECOL J, V21, P1065, DOI 10.1007/s00192-010-1165-6; Yokoyama T, 2004, INT J UROL, V11, P602, DOI 10.1111/j.1442-2042.2004.00857.x; Peters KM, 2010, J UROLOGY, V183, P1438, DOI 10.1016/j.juro.2009.12.036; Bradshaw HD, 2003, BJU INT, V91, P810, DOI 10.1046/j.1464-410X.2003.04235.x; Goode PS, 2003, JAMA-J AM MED ASSOC, V290, P345, DOI 10.1001/jama.290.3.345; Mattiasson A, 2010, BJU INT, V105, P1126, DOI 10.1111/j.1464-410X.2009.08910.x; Wille S, 2003, J UROLOGY, V170, P490, DOI 10.1097/01.ju.0000076141.33973.75; Kaya S, 2011, CLIN REHABIL, V25, P327, DOI 10.1177/0269215510385481; Nuhoglu B, 2006, INT UROGYNECOL J, V17, P204, DOI 10.1007/s00192-005-1370-x; McClurg D, 2006, NEUROUROL URODYNAM, V25, P337, DOI 10.1002/nau.20209; OLAH KS, 1990, AM J OBSTET GYNECOL, V162, P87; Siddiqui NY, 2010, NEUROUROL URODYNAM, V29, pS18, DOI 10.1002/nau.20786; Yoong W, 2010, BJU INT, V106, P1673, DOI 10.1111/j.1464-410X.2010.09461.x; Hohenfellner M, 1998, J UROLOGY, V160, P821, DOI 10.1016/S0022-5347(01)62795-2; Ugurlucan FG, 2013, GYNECOL OBSTET INVES, V75, P46, DOI 10.1159/000343756; BARKER AT, 1987, NEUROSURGERY, V20, P100; Fujishiro T, 2002, J UROLOGY, V168, P1036, DOI 10.1097/01.ju.0000025868.08859.9e; Kabay SC, 2009, NEUROUROL URODYNAM, V28, P62, DOI 10.1002/nau.20593; McFarlane JP, 1997, BRIT J UROL, V80, P734, DOI 10.1046/j.1464-410X.1997.00446.x; Klingler HC, 2000, UROLOGY, V56, P766, DOI 10.1016/S0090-4295(00)00727-5; Wang AC, 2004, UROLOGY, V63, P61, DOI 10.1016/j.urology.2003.08.047; Oerlemans DJAJ, 2008, NEUROUROL URODYNAM, V27, P28, DOI 10.1002/nau.20459; Galloway NTM, 1999, UROLOGY, V53, P1108, DOI 10.1016/S0090-4295(99)00037-0; Smith JJ, 1996, J UROLOGY, V155, P127, DOI 10.1016/S0022-5347(01)66567-4; Kabay SC, 2008, UROLOGY, V71, P641, DOI 10.1016/j.urology.2007.11.135; Fujishiro T, 2000, J UROLOGY, V164, P1277, DOI 10.1016/S0022-5347(05)67155-8; Yamanishi T, 2014, INT J UROL, V21, P395, DOI 10.1111/iju.12289; Yamanishi T, 2008, INT J UROL, V15, P665, DOI 10.1111/j.1442-2042.2008.02080.x; Yamanishi T, 2000, UROLOGY, V55, P353, DOI 10.1016/S0090-4295(99)00476-8; MCGUIRE EJ, 1983, J UROLOGY, V129, P78; But I, 2005, J UROLOGY, V173, P1644, DOI 10.1097/01.ju.0000157336.87781.32; Amaro JL, 2006, ACTA OBSTET GYN SCAN, V85, P619, DOI 10.1080/00016340500495058; Berghmans LCM, 1998, BRIT J UROL, V82, P181; Spinelli M, 2003, J UROLOGY, V170, P1905, DOI 10.1097/01.ju.0000092634.64580.9a; Ogah J, 2011, NEUROUROL URODYNAM, V30, P284, DOI 10.1002/nau.20980; HAHN I, 1991, NEUROUROL URODYNAM, V10, P545, DOI 10.1002/nau.1930100604; Moore KN, 1999, BJU INT, V83, P57, DOI 10.1046/j.1464-410X.1999.00894.x; HOFBAUER J, 1990, Z UROL NEPHROL, V83, P249; Finazzi-Agro E, 2010, J UROLOGY, V184, P2001, DOI 10.1016/j.juro.2010.06.113; Berghmans B, 2002, EUR UROL, V41, P581, DOI 10.1016/S0302-2838(02)00178-1; Arruda RM, 2008, INT UROGYNECOL J, V19, P1055, DOI 10.1007/s00192-008-0586-y; Bent AE, 1993, INT UROGYNECOL J, V4, P9, DOI 10.1007/BF00372801; Berghmans B, 2005, INCONTINENCE EDITION, V2005, P855; Blowman C, 1991, PHYSIOTHERAPY, V10, P661; Bo K, 1998, ACTA OBSTET GYN SCAN, V77, P3; Bower WF, 1998, J UROLOGY, V160, P2133, DOI 10.1016/S0022-5347(01)62259-6; Bratt H, 1998, ACTA OBSTET GYN SCAN, V77, P22; BRODAK PP, 1993, NEUROUROL URODYNAM, V12, P533, DOI 10.1002/nau.1930120603; CALDWELL K P, 1963, Lancet, V2, P174; Chandi DD, 2003, BJU INT, V63, P539; Ruiz BC, 2004, EUR UROL, V45, P65, DOI 10.1016/j.eururo.2003.08.012; Cooperberg MR, 2005, UROL CLIN N AM, V32, P71, DOI 10.1016/j.ucl.2004.09.007; Dougall DS, 1985, PHYSIOTHERAPY, V71, P135; EARDLEY I, 1990, J UROLOGY, V144, P948; ERIKSEN BC, 1989, UROL INT, V44, P90; FALL M, 1985, NEUROUROL URODYNAM, V4, P329, DOI 10.1002/nau.1930040410; Fall M, 1998, ACTA OBSTET GYN SCAN, V77, P16; FRANKLIN BA, 1990, OBSTET GYN CLIN N AM, V17, P817; Franzen K, 2010, INT UROGYNECOL J, V21, P1517, DOI 10.1007/s00192-010-1213-2; Gallo ML, 1997, NEUROUROL URODYNAM, V16, P167, DOI 10.1002/(SICI)1520-6777(1997)16:3<167::AID-NAU6>3.0.CO;2-C; Geirsson G, 1997, NEUROUROL URODYNAM, V16, P559, DOI 10.1002/(SICI)1520-6777(1997)16:6<559::AID-NAU6>3.0.CO;2-D; Govier RE, 2001, J UROLOGY, V165, P1193; Green RJG, 1988, PHYSIOTHERAPY, V74, P161; Ishikawa N, 1998, MED BIOL ENG COMPUT, V36, P704, DOI 10.1007/BF02518872; Jeyaseelan SM, 2000, CLIN REHABIL, V14, P631, DOI 10.1191/0269215500cr372oa; Kohli N, 2002, CLIN OBSTET GYNECOL, V45, P218, DOI 10.1097/00003081-200203000-00023; Kulseng-Hanssen S, 1998, ACTA OBSTET GYN SCAN, V77, P12; Leong RK, 2011, NEUROUROL URODYNAM, V30, P1249, DOI 10.1002/nau.20979; Levin PJ, 2012, INT UROGYNECOL J, V23, P1591, DOI 10.1007/s00192-012-1712-4; LI JS, 1992, J UROLOGY, V148, P949; Lin V W, 1997, J Spinal Cord Med, V20, P218; Lin VWH, 1997, NEUROUROL URODYNAM, V16, P305, DOI 10.1002/(SICI)1520-6777(1997)16:4<305::AID-NAU6>3.0.CO;2-I; Luber KM, 1997, NEUROUROL URODYNAM, V16, P543, DOI 10.1002/(SICI)1520-6777(1997)16:6<543::AID-NAU4>3.0.CO;2-E; McClurg D, 2008, NEUROUROL URODYNAM, V27, P231, DOI 10.1002/nau.20486; McQuire W A, 1975, Physiotherapy, V61, P305; Miller K, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P265, DOI 10.1007/BF01901503; MOORE T, 1967, BRIT MED J, V3, P150; MORRISON JFB, 1995, NEUROSCI RES, V23, P195, DOI 10.1016/0168-0102(95)00942-M; Okada N, 1998, BRIT J UROL, V81, P560; Ozdedeli S, 2010, CLIN REHABIL, V24, P342, DOI 10.1177/0269215509346092; Pelliccioni G, 2006, NEUROUROL URODYNAM, V25, P788, DOI 10.1002/nau.20215; PLEVNIK S, 1986, WORLD J UROL, V4, P24, DOI 10.1007/BF00326737; PLEVNIK S, 1979, UROLOGY, V14, P638, DOI 10.1016/0090-4295(79)90545-4; Primus G, 1996, NEUROUROL URODYNAM, V15, P187, DOI 10.1002/(SICI)1520-6777(1996)15:3<187::AID-NAU3>3.0.CO;2-B; Reitz A, 2004, NEUROUROL URODYNAM, V23, P148, DOI 10.1002/nau.20014; Richardson DA, 1996, UROLOGY, V48, P110, DOI 10.1016/S0090-4295(96)00090-8; Sancaktar M, 2010, GYNECOL ENDOCRINOL, V26, P729, DOI 10.3109/09513591003649815; SAND PK, 1995, AM J OBSTET GYNECOL, V173, P72, DOI 10.1016/0002-9378(95)90172-8; Scheepens WA, 2001, EUR UROL, V40, P434, DOI 10.1159/000049812; Schultz-Lampel D, 1998, WORLD J UROL, V16, P301, DOI 10.1007/s003450050071; SCOTT RS, 1979, AM J OBSTET GYNECOL, V135, P663; Shafik A, 1999, UROLOGY, V54, P368, DOI 10.1016/S0090-4295(99)00083-7; Shaker HS, 1998, J UROLOGY, V159, P1516, DOI 10.1097/00005392-199805000-00028; Shaker HS, 1998, J UROLOGY, V159, P1476, DOI 10.1097/00005392-199805000-00017; SHEPHERD AM, 1984, BRIT J UROL, V56, P644, DOI 10.1111/j.1464-410X.1984.tb06136.x; Sheriff MKM, 1996, BRIT J UROL, V78, P39, DOI 10.1046/j.1464-410X.1996.00358.x; Siegel S, 2015, NEUROUROL URODYNAM, V34, P224, DOI 10.1002/nau.22544; Soomro NA, 2001, J UROLOGY, V166, P146, DOI 10.1016/S0022-5347(05)66096-X; Souto SC, 2013, WORLD J UROL, V32, P179; Spinelli M, 2005, WORLD J UROL, V23, P225, DOI 10.1007/s00345-005-0502-8; Spruijt J, 2003, ACTA OBSTET GYN SCAN, V82, P1043, DOI 10.1034/j.1600-0412.2003.00130.x; SUSSET J, 1995, J UROLOGY, V153, P1461, DOI 10.1016/S0022-5347(01)67433-0; Suzuki T, 1994, UROL SURG, V7, P529; SWITZER D, 1988, IRISH MED J, V81, P30; vansKerrebroek PE, 2007, J UROLOGY, V178, P2029; Voorham-van der Zalm Petra J, 2006, BJU Int, V97, P1035, DOI 10.1111/j.1464-410X.2006.06131.x; Walsh IK, 1999, EUR UROL, V35, P192, DOI 10.1159/000019846; Wang AC, 2006, UROLOGY, V68, P999, DOI 10.1016/j.urology.2006.05.038; Weil EHJ, 1998, WORLD J UROL, V16, P313, DOI 10.1007/s003450050074; White WM, 2009, UROLOGY, V73, P731, DOI 10.1016/j.urology.2008.11.047; Williams KS, 2006, BJU INT, V98, P1043, DOI 10.1111/j.1464-410X.2006.06484.x; WILSON PD, 1987, BRIT J OBSTET GYNAEC, V94, P575, DOI 10.1111/j.1471-0528.1987.tb03153.x; Yalcin OT, 1998, ACTA OBSTET GYN SCAN, V77, P341, DOI 10.1034/j.1600-0412.1998.770317.x; Yamanishi T, 1997, J UROLOGY, V158, P2127, DOI 10.1016/S0022-5347(01)68176-X; Yamanishi T, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P281, DOI 10.1007/BF01901508; YAMANISHI T, 1994, J UROLOGY, V151, P1066; Yamanishi T, 2001, WORLD J UROL, V19, P299, DOI 10.1007/s003450100226; Yamanishi T, 1999, NEUROUROL URODYNAM, V18, P505, DOI 10.1002/(SICI)1520-6777(1999)18:5<505::AID-NAU13>3.0.CO;2-8; Yamanishi T, 2000, J UROLOGY, V164, P1686, DOI 10.1016/S0022-5347(05)67083-8; Yamanishi T, 1999, UROLOGY, V54, P652, DOI 10.1016/S0090-4295(99)00194-6; Yasuda K, 1994, UROL SURG, V7, P297; Yasuda K, 1993, INT UROGYNECOL J, V4, P146, DOI 10.1007/BF00571623; Yokoyama T, 2004, UROLOGY, V63, P264, DOI 10.1016/j.urology.2003.09.024	136	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-5664	1757-5672		LUTS	LUTS	SEP	2015	7	3					121	132		10.1111/luts.12087		12	Urology & Nephrology	Urology & Nephrology	CQ8KI	WOS:000360856200001		
J	Furuta, A; Suzuki, Y; Kimura, S; Asano, K; Egawa, S; Yoshimura, N				Furuta, Akira; Suzuki, Yasuyuki; Kimura, Shouji; Asano, Kouji; Egawa, Shin; Yoshimura, Naoki			Noradrenergic Mechanisms Controlling Urethral Smooth and Striated Muscle Function in Urethral Continence Reflex in Rats	LUTS-LOWER URINARY TRACT SYMPTOMS			English	Article						alpha adrenoceptor; norepinephrine; smooth muscle; striated muscle; urethral continence reflex	LOWER URINARY-TRACT; INDUCED STRESS CONDITION; CLOSURE MECHANISMS; REUPTAKE INHIBITOR; ANESTHETIZED CAT; FEMALE RATS; INCONTINENCE; WOMEN; NOREPINEPHRINE; POTENTIATION	ObjectivesTo investigate the role of noradrenergic pathways in the urethral continence reflex during abdominal compression in rats. MethodsUnder urethane anesthesia, urethral baseline pressure (UBP) and urethral pressure response (UPR) during momentary abdominal compression using a 100 g weight was measured using a transurethral microtransducer-tipped catheter placed at the middle urethra in Sprague-Dawley female rats. Following intravenous (i.v.) application of hexamethonium or -bungarotoxin to block urethral smooth or striated muscle function, respectively, the effects of terazosin, an (1)-adrenoceptor (AR) antagonist (0.3 mg/kg, i.v.), medetomidine, an (2)-AR agonist (0.3 mg/kg, i.v.) or nisoxetine, a norepinephrine reuptake inhibitor (1 mg/kg, i.v.) followed by terazosin on UBP and UPR were examined. ResultsAfter hexamethonium pretreatment, terazosin did not alter UBP or UPR, whereas medetomidine significantly decreased UPR by 28% without UBP changes. Nisoxetine significantly increased UPR by 64%, which was eliminated by terazosin, but UBP was not altered by nisoxetine. After -bungarotoxin pretreatment, UBP and UPR were significantly decreased by terazosin or medetomidine. Nisoxetine induced significant increases in UBP and UPR by 16 and 15%, respectively, which were antagonized by terazosin. ConclusionThese results suggest that: the baseline activity and reflex contraction of urethral smooth muscle are decreased by (1)-AR inhibition or (2)-AR stimulation; the reflex contraction of urethral striated muscle is decreased by (2)-AR stimulation, but not by (1)-AR inhibition; and nisoxetine increases baseline and reflex activity of smooth muscle in addition to striated muscle reflex activity by (1)-AR stimulation. These findings will be useful to understand nerve-mediated urethral closure mechanisms.	[Furuta, Akira; Kimura, Shouji; Asano, Kouji; Egawa, Shin] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan; [Suzuki, Yasuyuki] Tokyo Rehabil Hosp, Dept Urol, Tokyo, Japan; [Yoshimura, Naoki] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA USA	Furuta, A (reprint author), 3-25-8 Nishi Shinbashi Minato Ku, Tokyo 1058461, Japan.	a-furuta@rf7.so-net.ne.jp			Japan Society for the Promotion of Science [22591802]	Our research has been supported by Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (22591802).	Wilson L, 2001, OBSTET GYNECOL, V98, P398, DOI 10.1016/S0029-7844(01)01464-8; ANDERSON RS, 1983, J UROLOGY, V130, P727; Kawasaki Y, 2003, ANESTHESIOLOGY, V98, P682, DOI 10.1097/00000542-200303000-00016; Choo GY, 2012, INT NEUROUROL J, V16, P47, DOI 10.5213/inj.2012.16.1.47; Norton P, 2006, LANCET, V367, P57, DOI 10.1016/S0140-6736(06)67925-7; DeLancey JOL, 2010, NEUROUROL URODYNAM, V29, pS13, DOI 10.1002/nau.20888; Chang HY, 2006, AM J PHYSIOL-REG I, V291, pR224, DOI 10.1152/ajpregu.00780.2005; DANUSER H, 1995, J UROLOGY, V153, P1308, DOI 10.1016/S0022-5347(01)67591-8; DANUSER H, 1995, J PHARMACOL EXP THER, V274, P820; Danuser H, 1996, BRIT J PHARMACOL, V118, P150; Furuta A, 2011, INT UROGYNECOL J, V22, P963, DOI 10.1007/s00192-011-1403-6; Furuta A, 2009, J UROLOGY, V181, P1467, DOI 10.1016/j.juro.2008.11.008; Kaiho Y, 2007, AM J PHYSIOL-RENAL, V292, pF639, DOI 10.1152/ajprenal.00226.2006; Kamo I, 2004, AM J PHYSIOL-RENAL, V287, pF434, DOI 10.1152/ajprenal.00038.2004; Kamo I, 2003, AM J PHYSIOL-REG I, V285, pR356, DOI 10.1152/ajpregu.00010.2003.; Kamo I, 2006, J UROLOGY, V176, P2711, DOI 10.1016/j.juro.2006.07.139; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; Li XH, 2001, J PHARMACOL EXP THER, V299, P939; Liao JM, 2007, AM J PHYSIOL-RENAL, V292, pF1791, DOI 10.1152/ajprenal.00443.2006; Miyazaki T, 1998, BRAIN RES, V790, P170, DOI 10.1016/S0006-8993(97)01549-7; Miyazato M, 2008, AM J PHYSIOL-RENAL, V295, pF264, DOI 10.1152/ajprenal.90241.2008; Radley SC, 2001, NEUROUROL URODYNAM, V20, P43, DOI 10.1002/1520-6777(2001)20:1<43::AID-NAU6>3.0.CO;2-F; Takamatsu I, 2008, ANESTHESIOLOGY, V108, P94; Thor KB, 2004, INT J GYNECOL OBSTET, V86, pS38, DOI 10.1016/j.ijgo.2004.04.028; THOR KB, 1995, J PHARMACOL EXP THER, V274, P1014; WATANABE H, 1979, J ANAT, V128, P873	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-5664	1757-5672		LUTS	LUTS	SEP	2015	7	3					155	161		10.1111/luts.12065		7	Urology & Nephrology	Urology & Nephrology	CQ8KI	WOS:000360856200006		
J	Sato, K; Kobayashi, S; Kusakari, M; Watahiki, S; Oikawa, M; Hoshiba, T; Tanaka, M				Sato, Kazuhiro; Kobayashi, Shingo; Kusakari, Miho; Watahiki, Shogo; Oikawa, Masahiko; Hoshiba, Takashi; Tanaka, Masaru			The Relationship Between Water Structure and Blood Compatibility in Poly(2-methoxyethyl Acrylate) (PMEA) Analogues	MACROMOLECULAR BIOSCIENCE			English	Article						biomaterial; blood compatibility; intermediate water; protein adsorption; water structure	DIFFERENTIAL SCANNING CALORIMETRY; PROTEIN ADSORPTION; POLY(ETHYLENE GLYCOL); PLATELET-ADHESION; PLASMA-PROTEINS; DRUG-DELIVERY; POLYMERS; SURFACE; MECHANISM; SYSTEMS	Six types of poly(2-methoxyethyl acrylate) (PMEA) analogues were synthesized and the water structure in the hydrated polymers was characterized using differential scanning calorimetry (DSC). The hydrated PMEA analogues exhibited the different amounts of intermediate water. Non-thrombogenicity evaluation was performed on PMEA analogues for platelet adhesion and protein adsorption. Platelet adhesion was suppressed on PMEA analogues. In addition, the protein adsorption and deformation were suppressed by increasing the amount of intermediate water. This study demonstrates that the amount of intermediate water might play a key role in expressing the blood compatibility of polymeric materials.	[Sato, Kazuhiro; Kobayashi, Shingo; Kusakari, Miho; Watahiki, Shogo; Oikawa, Masahiko; Hoshiba, Takashi; Tanaka, Masaru] Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan; [Hoshiba, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Kobayashi, Shingo; Tanaka, Masaru] Kyushu Univ, Inst Mat Chem & Engn, Nishi Ku, Fukuoka 8190395, Japan	Tanaka, M (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	tanaka@yz.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for Next Generation World-Leading Researchers (NEXT Program, Japan)	This work is supported by Grants-in-Aid and Special Coordination Funds for Promoting Science and Technology of Ministry of Education, Culture, Sports, Science and Technology, Japan. We gratefully acknowledge the financial support from the Funding Program for Next Generation World-Leading Researchers (NEXT Program, Japan).	Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039; Balakrishnan B, 2005, BIOMATERIALS, V26, P3495, DOI 10.1016/j.biomaterials.2004.09.032; Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381; Riedel T, 2013, LANGMUIR, V29, P3388, DOI 10.1021/la304886r; Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008; Kawai K, 2006, BIOPHYS J, V90, P3732, DOI 10.1529/biophysj.105.075986; Xuan J, 2012, LANGMUIR, V28, P16463, DOI 10.1021/la303946b; Huang L, 2001, J POLYM SCI POL PHYS, V39, P496, DOI 10.1002/1099-0488(20010301)39:5<496::AID-POLB1023>3.0.CO;2-H; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; Cavadas M, 2011, NANOMED-NANOTECHNOL, V7, P730, DOI 10.1016/j.nano.2011.04.006; Hayashi T, 2012, PHYS CHEM CHEM PHYS, V14, P10196, DOI 10.1039/c2cp41236e; Jin J, 2013, LANGMUIR, V29, P6624, DOI 10.1021/la4017239; Lutz JF, 2007, MACROMOLECULES, V40, P8540, DOI 10.1021/ma7021474; Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088; Hatakeyma T, 2007, THERMOCHIM ACTA, V465, P59, DOI 10.1016/j.tca.2007.09.005; Chen CY, 2013, BIOMATERIALS, V34, P4501, DOI 10.1016/j.biomaterials.2013.02.049; Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9; Tanaka M, 2010, J BIOMAT SCI-POLYM E, V21, P1849, DOI 10.1163/092050610X517220; Morita S, 2007, LANGMUIR, V23, P3750, DOI 10.1021/la0625998; Morita S, 2014, LANGMUIR, V30, P10698, DOI 10.1021/la502550d; Hatakeyama H, 1998, THERMOCHIM ACTA, V308, P3, DOI 10.1016/S0040-6031(97)00325-0; Ayako O., 2005, ADV MATER, V17, P2329; BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406; Djikaev YS, 2010, ADV COLLOID INTERFAC, V154, P77, DOI 10.1016/j.cis.2010.01.009; Gemmei-Ide M, 2012, J PHYS CHEM B, V116, P1850, DOI 10.1021/jp211473p; Harris JM., 1992, POLYETHYLENE GLYCOL; Hatakeyama T, 2010, ACTA BIOMATER, V6, P2077, DOI 10.1016/j.actbio.2009.12.018; Kishi A., 2008, J APPL POLYM SCI, V111, P476; Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706; Medel S, 2011, J POLYM SCI POL CHEM, V49, P690, DOI 10.1002/pola.24480; Miwa Y, 2010, J BIOMAT SCI-POLYM E, V21, P1911, DOI 10.1163/092050610X489682; Nagasaki Y, 2011, POLYM J, V43, P949, DOI 10.1038/pj.2011.93; Nishinari K, 1997, COLLOID POLYM SCI, V275, P1078, DOI 10.1007/s003960050186; Sefcik LS, 2013, CELL MOL BIOENG, V6, P287, DOI 10.1007/s12195-013-0286-7; Tsuruta T, 2010, J BIOMAT SCI-POLYM E, V21, P1831, DOI 10.1163/092050610X488269; Vogler A. E., 2009, BIOMATERIALS, V30, P1857; Wei-Bor T., 1999, J BIOMED MATER RES, V44, P130; Wei-Hsuan K., 2011, BIOMACROMOLECULES, V12, P4348; YAMADANOSAKA A, 1990, J APPL POLYM SCI, V39, P2443, DOI 10.1002/app.1990.070391117; ZHANG ZL, 1983, PHYSIOL CHEM PHYS, V15, P407	40	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	SEP	2015	15	9					1296	1303		10.1002/mabi.201500078		8	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	CQ6NN	WOS:000360721300013		
J	Anetai, Y; Sumida, I; Takahashi, Y; Yagi, M; Ota, S; Mizuno, H; Ogawa, K				Anetai, Yusuke; Sumida, Iori; Takahashi, Yutaka; Yagi, Masashi; Ota, Seiichi; Mizuno, Hirokazu; Ogawa, Kazuhiko			Reference respiratory waveforms by minimum jerk model analysis	MEDICAL PHYSICS			English	Article						CyberKnife; Synchrony; respiratory tracking; respiratory training; respiratory monitoring; respiratory coaching; gated radiotherapy	TUMOR-TRACKING SYSTEM; MOTION COMPENSATION; GATED RADIOTHERAPY; LUNG-TUMORS; ACCURACY; REPRODUCIBILITY	Purpose: CyberKnife (R) robotic surgery system has the ability to deliver radiation to a tumor subject to respiratory movements using Synchrony (R) mode with less than 2 mm tracking accuracy. However, rapid and rough motion tracking causes mechanical tracking errors and puts mechanical stress on the robotic joint, leading to unexpected radiation delivery errors. During clinical treatment, patient respiratory motions are much more complicated, suggesting the need for patient-specific modeling of respiratory motion. The purpose of this study was to propose a novel method that provides a reference respiratory wave to enable smooth tracking for each patient. Methods: The minimum jerk model, which mathematically derives smoothness by means of jerk, or the third derivative of position and the derivative of acceleration with respect to time that is proportional to the time rate of force changed was introduced to model a patient-specific respiratory motion wave to provide smooth motion tracking using CyberKnife (R). To verify that patient-specific minimum jerk respiratory waves were being tracked smoothly by Synchrony (R) mode, a tracking laser projection from CyberKnife (R) was optically analyzed every 0.1 s using a webcam and a calibrated grid on a motion phantom whose motion was in accordance with three pattern waves (cosine, typical free-breathing, and minimum jerk theoretical wave models) for the clinically relevant superior-inferior directions from six volunteers assessed on the same node of the same isocentric plan. Results: Tracking discrepancy from the center of the grid to the beam projection was evaluated. The minimum jerk theoretical wave reduced the maximum-peak amplitude of radial tracking discrepancy compared with that of the waveforms modeled by cosine and typical free-breathing model by 22% and 35%, respectively, and provided smooth tracking for radial direction. Motion tracking constancy as indicated by radial tracking discrepancy affected by respiratory phase was improved in the minimum jerk theoretical model by 7.0% and 13% compared with that of the waveforms modeled by cosine and free-breathing model, respectively. Conclusions: The minimum jerk theoretical respiratory wave can achieve smooth tracking by CyberKnife (R) and may provide patient-specific respiratory modeling, which may be useful for respiratory training and coaching, as well as quality assurance of the mechanical CyberKnife (R) robotic trajectory. (C) 2015 American Association of Physicists in Medicine.	[Anetai, Yusuke; Sumida, Iori; Takahashi, Yutaka; Yagi, Masashi; Mizuno, Hirokazu; Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka 5650871, Japan; [Ota, Seiichi] Osaka Univ Hosp, Dept Med Technol, Suita, Osaka 5650871, Japan	Anetai, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	anetai@radonc.med.osaka-u.ac.jp			JSPS [23003]; Japan Society for the Promotion of Science [23390300, 21791194]; Ministry of Health, Labor, and Welfare of Japan [H22-3rd Term Cancer Control-General-043]	This study was supported by the JSPS Core-to-Core Program (No. 23003), Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (No. 23390300), Grant-in-Aid for Young Scientists (B) (No. 21791194), and Grant-in-Aid for Cancer Research (H22-3rd Term Cancer Control-General-043) from the Ministry of Health, Labor, and Welfare of Japan.	Shirato H, 2000, INT J RADIAT ONCOL, V48, P1187, DOI 10.1016/S0360-3016(00)00748-3; Luo LH, 2010, J ZHEJIANG UNIV-SC A, V11, P191, DOI 10.1631/jzus.A0900374; Berbeco RI, 2005, PHYS MED BIOL, V50, P3655, DOI 10.1088/0031-9155/50/16/001; Dieterich S, 2011, MED PHYS, V38, P2914, DOI 10.1118/1.3579139; Seppenwoolde Y, 2007, MED PHYS, V34, P2774, DOI 10.1118/1.2739811; Ozhasoglu C, 2008, MED DOSIM, V33, P117, DOI 10.1016/j.meddos.2008.02.004; Weichert F, 2013, SENSORS-BASEL, V13, P6380, DOI 10.3390/s130506380; Neicu T, 2006, PHYS MED BIOL, V51, P617, DOI 10.1088/0031-9155/51/3/010; Hoogeman M, 2009, INT J RADIAT ONCOL, V74, P297, DOI 10.1016/j.ijrobp.2008.12.041; Hoisak JDP, 2004, INT J RADIAT ONCOL, V60, P1298, DOI 10.1016/j.ijrobp.2004.07.681; [Anonymous], 2010, KUKA SYST SOFTW 5 5; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Depuydt T, 2011, RADIOTHER ONCOL, V98, P365, DOI 10.1016/j.radonc.2011.01.015; Dieterich S., 2004, CYBERKNIFE SYNCHRONY; FLASH T, 1985, J NEUROSCI, V5, P1688; Haasbeek CJA, 2008, INT J RADIAT ONCOL, V71, P1118, DOI 10.1016/j.ijrobp.2007.11.061; Hiraoka T., 2005, P 12 WORLD C INT TRA, P3416; Inoue M., 2011, MED PHYS, V38, P3623; Kini Vijay R, 2003, Med Dosim, V28, P7, DOI 10.1016/S0958-3947(02)00136-X; Kroger T., 2011, INT C ROB AUT; Masselli GMP, 2009, MED PHYS, V36, P1467, DOI 10.1118/1.3098942; Nakamura M, 2011, INT J RADIAT ONCOL, V79, P1565, DOI 10.1016/j.ijrobp.2010.05.046; Ozhasoglu C, 2002, INT J RADIAT ONCOL, V52, P1389, DOI 10.1016/S0360-3016(01)02789-4; Pantelis E, 2009, J INSTRUM, V4, DOI 10.1088/1748-0221/4/05/P05009; Sahih A., 2006, IAR ANN M; Venkat RB, 2008, PHYS MED BIOL, V53, P197	26	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	SEP	2015	42	9					5066	5074		10.1118/1.4927557		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CQ5LG	WOS:000360645000009		
J	Matsumura, A; Yusa, K; Kanai, T; Mizota, M; Ohno, T; Nakano, T				Matsumura, Akihiko; Yusa, Ken; Kanai, Tatsuaki; Mizota, Manabu; Ohno, Tatsuya; Nakano, Takashi			Evaluation of an empirical monitor output estimation in carbon ion radiotherapy	MEDICAL PHYSICS			English	Article						carbon ion radiotherapy; monitor units; field effect	BRAGG PEAK FIELDS; IRRADIATION SYSTEM; UNIT CALCULATIONS; THERAPY; RANGE; BEAMS; DESIGN; HIMAC	Purpose: A conventional broad beam method is applied to carbon ion radiotherapy at Gunma University Heavy Ion Medical Center. According to this method, accelerated carbon ions are scattered by various beam line devices to form 3D dose distribution. The physical dose per monitor unit (d/MU) at the isocenter, therefore, depends on beam line parameters and should be calibrated by a measurement in clinical practice. This study aims to develop a calculation algorithm for d/MU using beam line parameters. Methods: Two major factors, the range shifter dependence and the field aperture effect, are measured via PinPoint chamber in a water phantom, which is an identical setup as that used for monitor calibration in clinical practice. An empirical monitor calibration method based on measurement results is developed using a simple algorithm utilizing a linear function and a double Gaussian pencil beam distribution to express the range shifter dependence and the field aperture effect. Results: The range shifter dependence and the field aperture effect are evaluated to have errors of 0.2% and 0.5%, respectively. The proposed method has successfully estimated d/MU with a difference of less than 1% with respect to the measurement results. Taking the measurement deviation of about 0.3% into account, this result is sufficiently accurate for clinical applications. Conclusions: An empirical procedure to estimate d/MU with a simple algorithm is established in this research. This procedure allows them to use the beam time for more treatments, quality assurances, and other research endeavors. (C) 2015 American Association of Physicists in Medicine.	[Matsumura, Akihiko; Yusa, Ken; Kanai, Tatsuaki; Ohno, Tatsuya; Nakano, Takashi] Gunma Univ, Gunma Univ Heavy Ion Med Ctr, Maebashi, Gunma 3718511, Japan; [Mizota, Manabu] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 2638555, Japan	Matsumura, A (reprint author), Gunma Univ, Gunma Univ Heavy Ion Med Ctr, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	matchan.akihiko@gunma-u.ac.jp					Akagi T, 2006, PHYS MED BIOL, V51, P1919, DOI 10.1088/0031-9155/51/7/020; Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104; Kanai T, 1997, RADIAT RES, V147, P78, DOI 10.2307/3579446; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Torikoshi M, 2007, J RADIAT RES, V48, pA15, DOI 10.1269/jrr.48.A15; Hsi WC, 2009, MED PHYS, V36, P634, DOI 10.1118/1.3056466; Inaniwa T, 2009, MED PHYS, V36, P2889, DOI 10.1118/1.3140586; Kooy HM, 2005, PHYS MED BIOL, V50, P5847, DOI 10.1088/0031-9155/50/24/006; Kooy HM, 2003, PHYS MED BIOL, V48, P2797, DOI 10.1088/0031-9155/48/17/305; Kusano Y, 2007, MED PHYS, V34, P4016, DOI 10.1118/1.2779126; Lin LY, 2014, J APPL CLIN MED PHYS, V15, P297; Mizota M., 2012, JPN J MED PHYS S3, V32, P93; Noda K, 2007, J RADIAT RES, V48, pA43, DOI 10.1269/jrr.48.A43; Ohno Tatsuya, 2013, EPMA J, V4, P9, DOI 10.1186/1878-5085-4-9; Ohno Tatsuya, 2011, Cancers (Basel), V3, P4046, DOI 10.3390/cancers3044046; Sahoo N, 2008, MED PHYS, V35, P5088, DOI 10.1118/1.2992055; Sakama M, 2012, PHYS MED BIOL, V57, P6615, DOI 10.1088/0031-9155/57/20/6615; Tajiri M, 2013, MED PHYS, V40, DOI 10.1118/1.4812426	18	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	SEP	2015	42	9					5188	5194		10.1118/1.4928145		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CQ5LG	WOS:000360645000020		
J	Nakada, K; Taguchi, K; Fung, GSK; Amaya, K				Nakada, Kento; Taguchi, Katsuyuki; Fung, George S. K.; Amaya, Kenji			Joint estimation of tissue types and linear attenuation coefficients for photon counting CT	MEDICAL PHYSICS			English	Article						computed tomography; iterative reconstruction; maximum a posteriori estimation; coupled Markov random field	STATISTICAL IMAGE-RECONSTRUCTION; RAY COMPUTED-TOMOGRAPHY; SPECTRAL CT; ENERGY; DETECTORS	Purpose: Newly developed spectral computed tomography (CT) such as photon counting detector CT enables more accurate tissue-type identification through material decomposition technique. Many iterative reconstruction methods, including those developed for spectral CT, however, employ a regularization term whose penalty transition is designed using pixel value of CT image itself. Similarly, the tissue-type identification methods are then applied after reconstruction; thus, it is impossible to take into account probability distribution obtained from projection likelihood. The purpose of this work is to develop comprehensive image reconstruction and tissue-type identification algorithm which improves quality of both reconstructed image and tissue-type map. Methods: The authors propose a new framework to jointly perform image reconstruction, material decomposition, and tissue-type identification for photon counting detector CT by applying maximum a posteriori estimation with voxel-based latent variables for the tissue types. The latent variables are treated using a voxel-based coupled Markov random field to describe the continuity and discontinuity of human organs and a set of Gaussian distributions to incorporate the statistical relation between the tissue types and their attenuation characteristics. The performance of the proposed method is quantitatively compared to that of filtered backprojection and a quadratic penalized likelihood method by 100 noise realization. Results: Results showed a superior trade-off between image noise and resolution to current reconstruction methods. The standard deviation (SD) and bias of reconstructed image were improved from quadratic penalized likelihood method: bias, -0.9 vs -0.1 Hounsfield unit (HU); SD, 46.8 vs 27.4 HU. The accuracy of tissue-type identification was also improved from quadratic penalized likelihood method: 80.1% vs 86.9%. Conclusions: The proposed method makes it possible not only to identify tissue types more accurately but also to reconstruct CT images with decreased noise and enhanced sharpness owing to the information about the tissue types. (C) 2015 American Association of Physicists in Medicine.	[Nakada, Kento; Amaya, Kenji] Tokyo Inst Technol, Sch Informat Sci & Engn, Dept Mech & Environm Informat, Meguro Ku, Tokyo 1528550, Japan; [Taguchi, Katsuyuki; Fung, George S. K.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Med Imaging Phys, Baltimore, MD 21287 USA	Taguchi, K (reprint author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Med Imaging Phys, Baltimore, MD 21287 USA.	nakada.k.ac@a.mei.titech.ac.jp; ktaguchi@jhmi.edu; gfung2@jhmi.edu; kamaya@a.mei.titech.ac.jp					Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Elbakri IA, 2002, IEEE T MED IMAGING, V21, P89, DOI 10.1109/42.993128; Taguchi K, 2013, MED PHYS, V40, DOI 10.1118/1.4820371; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Roessl E, 2007, PHYS MED BIOL, V52, P4679, DOI 10.1088/0031-9155/52/15/020; Sukovic P, 2000, IEEE T MED IMAGING, V19, P1075, DOI 10.1109/42.896783; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Fessler JA, 2002, P SOC PHOTO-OPT INS, V4684, P38, DOI 10.1117/12.467189; Wang XL, 2011, MED PHYS, V38, P1534, DOI 10.1118/1.3553401; Taguchi K, 2011, MED PHYS, V38, P1089, DOI 10.1118/1.3539602; ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; Segars WP, 2010, MED PHYS, V37, P4902, DOI 10.1118/1.3480985; BESAG J, 1986, J ROY STAT SOC B MET, V48, P259; Bishop C.M., 2006, PATTERN RECOGNITION, V4; Cammin J, 2014, MED PHYS, V41, DOI 10.1118/1.4866890; FESSLER JA, 1994, IEEE T MED IMAGING, V13, P290, DOI 10.1109/42.293921; Hasegawa R, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.093802; Kohler T., 2009, P FULL 3D, V3D, P263; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Li S. Z., 2009, MARKOV RANDOM FIELD, V26; Long Y, 2014, IEEE T MED IMAGING, V33, P1614, DOI 10.1109/TMI.2014.2320284; Schirra CO, 2013, IEEE T MED IMAGING, V32, P1249, DOI 10.1109/TMI.2013.2250991; White G. R. D. R., 1992, 46 ICRU, V46	24	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	SEP	2015	42	9					5329	5341		10.1118/1.4927261		13	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CQ5LG	WOS:000360645000033		
J	Matsubara, H; Matsufuji, N; Tsuji, H; Yamamoto, N; Karasawa, K; Nakajima, M; Takahashi, W; Karube, M				Matsubara, H.; Matsufuji, N.; Tsuji, H.; Yamamoto, N.; Karasawa, K.; Nakajima, M.; Takahashi, W.; Karube, M.			Objective assessment in digital images of skin erythema caused by radiotherapy	MEDICAL PHYSICS			English	Article						skin erythema; skin toxicity; image processing; independent component analysis; particle therapy	TISSUE; COLOR	Purpose: Skin toxicity caused by radiotherapy has been visually classified into discrete grades. The present study proposes an objective and continuous assessment method of skin erythema in digital images taken under arbitrary lighting conditions, which is the case for most clinical environments. The purpose of this paper is to show the feasibility of the proposed method. Methods: Clinical data were gathered from six patients who received carbon beam therapy for lung cancer. Skin condition was recorded using an ordinary compact digital camera under unfixed lighting conditions; a laser Doppler flowmeter was used to measure blood flow in the skin. The photos and measurements were taken at 3 h, 30, and 90 days after irradiation. Images were decomposed into hemoglobin and melanin colors using independent component analysis. Pixel values in hemoglobin color images were compared with skin dose and skin blood flow. The uncertainty of the practical photographic method was also studied in nonclinical experiments. Results: The clinical data showed good linearity between skin dose, skin blood flow, and pixel value in the hemoglobin color images; their correlation coefficients were larger than 0.7. It was deduced from the nonclinical that the uncertainty due to the proposed method with photography was 15%; such an uncertainty was not critical for assessment of skin erythema in practical use. Conclusions: Feasibility of the proposed method for assessment of skin erythema using digital images was demonstrated. The numerical relationship obtained helped to predict skin erythema by artificial processing of skin images. Although the proposed method using photographs taken under unfixed lighting conditions increased the uncertainty of skin information in the images, it was shown to be powerful for the assessment of skin conditions because of its flexibility and adaptability. (C) 2015 American Association of Physicists in Medicine.	[Matsubara, H.; Matsufuji, N.; Tsuji, H.; Yamamoto, N.; Karasawa, K.; Nakajima, M.; Karube, M.] Natl Inst Radiol Sci, Chiba 2638555, Japan; [Takahashi, W.] Tokyo Univ Hosp, Dept Radiol, Tokyo 1138655, Japan	Matsubara, H (reprint author), Natl Inst Radiol Sci, Chiba 2638555, Japan.	matubara@nirs.go.jp					Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Setaro M, 2002, SKIN RES TECHNOL, V8, P84, DOI 10.1034/j.1600-0846.2002.00328.x; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; HIRAOKA M, 1993, PHYS MED BIOL, V38, P1859, DOI 10.1088/0031-9155/38/12/011; Torikoshi M, 2007, J RADIAT RES, V48, pA15, DOI 10.1269/jrr.48.A15; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; Yoshida EJ, 2011, MED PHYS, V38, P5747, DOI 10.1118/1.3633942; Inomata Taisuke, 1995, Nippon Acta Radiologica, V55, P58; KASHIMA S, 1993, JPN J APPL PHYS 1, V32, P2177, DOI 10.1143/JJAP.32.2177; LAHTI A, 1993, ARCH DERMATOL RES, V285, P278, DOI 10.1007/BF00371596; Mattsson U., 1997, SKIN RES TECHNOL, V3, P53, DOI 10.1111/j.1600-0846.1997.tb00161.x; Santa G. A., 2009, MED PHYS, V36, P4519; Tsumura N, 2003, ACM T GRAPHIC, V22, P770, DOI 10.1145/882262.882344; Wengstrom Y, 2004, RADIOTHER ONCOL, V72, P191, DOI 10.1016/j.radonc.2004.04.011	14	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	SEP	2015	42	9					5568	5577		10.1118/1.4928890		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CQ5LG	WOS:000360645000054		
J	Fisher, JC				Fisher, James C.			The ex turpi causa principle in Hounga and Servier	MODERN LAW REVIEW			English	Article						Hounga v Allen; Servier v Apotex; illegality; ex turpi causa		In Hounga v Allen the majority of the Supreme Court employed a test for the application of the ex turpi causa defence involving the balancing of public policy arguments for and against allowing the defence. Although this has attracted some early academic support, this note will argue it is inconsistent with authority and principle. The later decision in Servier v Apotex does not address the Hounga decision directly but strongly endorses a more conservative approach to the ex turpi causa principle. The resulting tension between these two Supreme Court decisions is likely further to destabilise the law in this area. This note advances arguments in favour of the Servier approach, summarises both decisions in terms of their consistency with authority and considers the ways in which Servier may have limited the effects of Hounga.	Univ Tokyo, Law, Tokyo 1138654, Japan	Fisher, JC (reprint author), Univ Tokyo, Law, Tokyo 1138654, Japan.						Bogg A., OXFORD HUMAN RIGHTS; Bogg A., 2013, LQR, V129, P12; Bogg A., UK CONSTITUTIONAL LA	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0026-7961	1468-2230		MOD LAW REV	Mod. Law Rev.	SEP	2015	78	5					854	870		10.1111/1468-2230.12146		17	Law	Government & Law	CQ7FW	WOS:000360769400006		
J	Schlitter, AM; Jang, KT; Kloppel, G; Saka, B; Hong, SM; Choi, H; Offerhaus, GJ; Hruban, RH; Zen, Y; Konukiewitz, B; Regel, I; Allgauer, M; Balci, S; Basturk, O; Reid, MD; Esposito, I; Adsay, V				Schlitter, Anna Melissa; Jang, Kee-Taek; Kloeppel, Guenter; Saka, Burcu; Hong, Seung-Mo; Choi, Hyejeong; Offerhaus, George Johan; Hruban, Ralph H.; Zen, Yoh; Konukiewitz, Bjoern; Regel, Ivonne; Allgaeuer, Michael; Balci, Serdar; Basturk, Olca; Reid, Michelle D.; Esposito, Irene; Adsay, Volkan			Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases	MODERN PATHOLOGY			English	Article							PAPILLARY MUCINOUS NEOPLASMS; PANCREATIC INTRAEPITHELIAL NEOPLASIA; RENAL-CELL CARCINOMA; TUBULOCYSTIC CARCINOMA; TUBULAR NEOPLASMS; INVASIVE TUMOR; BILIARY-TRACT; FOLLOW-UP; BREAST; CANCER	Intraductal tubulopapillary neoplasm is a well-established entity in the pancreas. A similar, if not identical, tumor occurs also in the biliary tract. We conducted a multicenter study of 20 such lesions, focusing on their clinicopathologic characteristics and molecular profile. Biliary intraductal tubulopapillary neoplasms were seen in patients in their 60s (mean 62 years). The tumors were intrahepatic 70%, extrahepatic 10%, and perihilar 20%; mean tumor size was 6.9 cm. Histologically, all intraductal tubulopapillary neoplasms showed, in addition to their typical tubular pattern, solid areas (70%) or abortive papillae (50%). Necrosis was common (85%), predominantly focal (40%), and with 'comedocarcinoma-like pattern' in 40%. Immunohistochemically, these neoplasms were characterized by the expression of MUC1 (80%) and MUC6 (30%) and by the absence of MUC2 and MUC5AC. Associated invasive carcinomas were present in 16 (80%), mainly conventional tubular adenocarcinoma (50%). The molecular alterations observed included CDKN2A/p16 (intraductal components 44%, invasive 33%) and TP53 (intraductal components 17%, invasive 9%). Mutations in KRAS (intraductal 6%, invasive 0%), PIK3CA (intraductal 6%, invasive 0%), and loss of SMAD4/DPC4 (intraductal 7%, invasive 0%) were rare. No alterations/mutations were identified in IDH1/2, BRAF, GNAS, EGFR, HER2, and beta-catenin. Follow-up information was available for 17 patients (85%) with mean follow-up 44 months. Overall combined survival rates showed favorable prognosis: 1 year 100%, 3 years 90%, and 5 years 90%. In conclusion, despite the relatively high incidence of invasive carcinoma (80%), available follow-up suggests that biliary intraductal tubulopapillary neoplasms have an indolent behavior. Molecular analyses highlight the low prevalence of alterations of common oncogenic signaling pathways in intraductal tubulopapillary neoplasm. Further studies using whole-exome sequencing are required to discover yet unknown molecular changes and to understand the carcinogenesis of intraductal tubulopapillary neoplasms.	[Schlitter, Anna Melissa; Kloeppel, Guenter; Konukiewitz, Bjoern; Allgaeuer, Michael] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany; [Jang, Kee-Taek] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Saka, Burcu; Choi, Hyejeong; Balci, Serdar; Reid, Michelle D.; Adsay, Volkan] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Hong, Seung-Mo] Univ Ulsan, Coll Med, Dept Pathol, Ulsan Univ Hosp, Seoul, South Korea; [Offerhaus, George Johan] Univ Med Ctr, Dept Pathol, Utrecht, Netherlands; [Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Zen, Yoh] Kobe Univ, Dept Diagnost Pathol, Kobe, Hyogo 657, Japan; [Regel, Ivonne] Tech Univ Munich, Dept Surg, D-80290 Munich, Germany; [Basturk, Olca] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Esposito, Irene] Med Univ Innsbruck, Inst Pathol, A-6020 Innsbruck, Austria	Adsay, V (reprint author), Emory Univ Hosp, Anat Pathol, 1364 Clifton Rd NE,Room H-180B, Atlanta, GA 30322 USA.	volkan.adsay@emory.edu			Ilke and Mirkan Aydin family; NIH [CA62924]	We would like to thank Rhonda Everett for her expertize in the organization and preparation of this manuscript and Susanne Plaschke for excellent technical assistance. This study was supported in part by a fund recruited and donated by the Ilke and Mirkan Aydin family, and by NIH Grant CA62924.	Adsay NV, 2002, MODERN PATHOL, V15, P1087, DOI 10.1097/01.MP.0000028647.98725.8B; Adsay NV, 2010, PATHOLOGY GENETICS T, P304; Albores-Saavedra J, 2010, WHO CLASSIFICATION T, P266; Amin MB, 2009, AM J SURG PATHOL, V33, P384, DOI 10.1097/PAS.0b013e3181872d3f; Tefferi A, 2010, LEUKEMIA, V24, P1302, DOI 10.1038/leu.2010.113; Voss JS, 2013, HUM PATHOL, V44, P1216, DOI 10.1016/j.humpath.2012.11.006; Basturk O, 2010, AM J SURG PATHOL, V34, P364, DOI 10.1097/PAS.0b013e3181cf8bb6; Zen Y, 2011, MODERN PATHOL, V24, P1079, DOI 10.1038/modpathol.2011.71; Nassar H, 2006, AM J SURG PATHOL, V30, P501, DOI 10.1097/00000478-200604000-00011; Rocha FG, 2012, HEPATOLOGY, V56, P1352, DOI 10.1002/hep.25786; Rakha EA, 2011, AM J SURG PATHOL, V35, P1093, DOI 10.1097/PAS.0b013e31821b3f65; Yang XJ, 2008, AM J SURG PATHOL, V32, P177, DOI 10.1097/PAS.0b013e318150df1d; Luttges J, 2001, AM J SURG PATHOL, V25, P942; Katabi N, 2012, AM J SURG PATHOL, V36, P1647, DOI 10.1097/PAS.0b013e3182684d4f; Zabron A, 2013, DIS MODEL MECH, V6, P281, DOI 10.1242/dmm.010561; Ohike N, 2010, AM J SURG PATHOL, V34, P1731, DOI 10.1097/PAS.0b013e3181f8ff05; Zen Y, 2012, HUM PATHOL, V43, P440, DOI 10.1016/j.humpath.2011.03.013; Liau JY, 2014, MODERN PATHOL, V27, P1163, DOI 10.1038/modpathol.2013.241; Zen Y, 2007, MODERN PATHOL, V20, P701, DOI 10.1038/modpathol.3800788; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Adsay V, 2012, AM J SURG PATHOL, V36, P1279, DOI 10.1097/PAS.0b013e318262787c; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Wynveen CA, 2011, AM J SURG PATHOL, V35, P1, DOI 10.1097/PAS.0b013e3181fbe20a; Amato E, 2014, J PATHOL, V233, P217, DOI 10.1002/path.4344; Yamaguchi H, 2011, AM J SURG PATHOL, V35, P1812, DOI 10.1097/PAS.0b013e31822769a0; Zen Y, 2006, J HEPATOL, V44, P350, DOI 10.1016/j.jhep.2005.09.025; Mayo SC, 2011, HPB, V13, P473, DOI 10.1111/j.1477-2574.2011.00326.x; Yamaguchi H, 2013, J PATHOL, V231, P335, DOI 10.1002/path.4242; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Noel MS, 2013, ONCOTARGETS THER, V6, P1545, DOI 10.2147/OTT.S32545; Balci S, 2014, MOD PATHOL, V27, p446A; Bettstetter M, 2013, HUM PATHOL, V44, P829, DOI 10.1016/j.humpath.2012.08.005; Bhanot U, 2015, MODERN PATHOL, V28, p1761A; Collins LC, 2006, AM J SURG PATHOL, V30, P1002, DOI 10.1097/00000478-200608000-00011; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Esposito I, 2004, VIRCHOWS ARCH, V444, P447, DOI 10.1007/s00428-004-0984-6; Gonzalez RS, 2015, HISTOPATHOLOGY, DOI [10.1111/his.12725, DOI 10.1111/HIS.12725]; Jang KT, 2013, MODERN PATHOL, V26, p404A; Klimstra DS, 2007, MODERN PATHOL, V20, p285A; Kloppel G, 2014, SEMIN DIAGN PATHOL, V31, P452, DOI 10.1053/j.semdp.2014.08.005; Kloppel G, 2013, BEST PRACT RES CL GA, V27, P285, DOI 10.1016/j.bpg.2013.04.002; Königsrainer Ingmar, 2008, Pancreas, V36, P92, DOI 10.1097/MPA.0b013e318149f536; Nakanuma Y, 2014, HISTOL HISTOPATHOL, V29, P1; Nakanuma Y, 2010, WHO CLASSIFICATION T, P217; Nakanuma Y, 2010, PATHOL INT, V60, P419, DOI 10.1111/j.1440-1827.2010.02543.x; Park HJ, 2010, PATHOL INT, V60, P630, DOI 10.1111/j.1440-1827.2010.02572.x; Schlitter AM, 2014, MODERN PATHOL, V27, P73, DOI 10.1038/modpathol.2013.112; Trkova M, 2006, CANCER LETT, V242, P68, DOI 10.1016/j.canlet.2005.10.036; UNGER P, 1992, NEW YORK STATE J MED, V92, P18	50	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	SEP	2015	28	9					1249	1264		10.1038/modpathol.2015.61		16	Pathology	Pathology	CQ5RV	WOS:000360664200009		
J	Murata, M; Hasegawa, K; Kanazawa, I; Fukasaka, J; Kochi, K; Shimazu, R				Murata, Miho; Hasegawa, Kazuko; Kanazawa, Ichiro; Fukasaka, Junichi; Kochi, Kenji; Shimazu, Rieko		Japan Zonisamide PD Study Group	Zonisamide Improves Wearing- Off in Parkinson's Disease: A Randomized, Double- Blind Study	MOVEMENT DISORDERS			English	Article						levodopa; Parkinson's disease; randomized controlled trial; zonisamide; wearing-off	GENOME-WIDE ASSOCIATION; VARIANTS; PROTEIN; CLONING; PARK16; LOCUS; RISK	Background: Previously, we reported 50 mg/ d zonisamide improved wearing- off without increasing dyskinesia in patients with Parkinson's disease ( PD). Methods: To determine the efficacy of zonisamide for treatment of " off" time in PD patients, we conducted a multicenter, randomized, double- blind, parallel- group, placebo- controlled study in Japan. Patients with PD and wearing- off received placebo for 4 weeks and then were treated for 12 weeks with zonisamide 25 or 50 mg/ d or placebo, in addition to their previous therapy. The primary endpoint was the change from baseline in daily " off" time as determined by patients' diaries at the final assessment. Secondary endpoints included changes from baseline in the total scores of the Unified Parkinson's Disease Rating Scale Parts I, II, III, and IV, the dyskinesia duration, and PDQ- 39 score. Results: Of 422 patients enrolled, 389 ( 131 for placebo, 130 for zonisamide 25 mg, and 128 for zonisamide 50 mg) were randomized, and 354 ( 120, 119, and 115, respectively) completed the study. The " off" time significantly reduced by 0.71960.179 h for zonisamide, 50 mg compared with placebo ( 0.01160.173 h, P50.005). Although the incidence of somnolence was higher for zonisamide ( 3.1% for zonisamide 25 mg, 6.3% for zonisamide 50 mg) than for placebo ( 2.3%), the incidences of the other adverse events, including dyskinesia or hallucination, for both zonisamide treatments were comparable to those for placebo. Conclusion: The study provides evidence that confirms the efficacy of zonisamide 50 mg/ d for reduction in " off" time in PD patients with wearing- off phenomena. (C) 2015 International Parkinson and Movement Disorder Society	[Murata, Miho] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan; [Hasegawa, Kazuko] Sagamihara Natl Hosp, Dept Neurol, Kanagawa, Japan; [Kanazawa, Ichiro] Int Univ Hlth & Welf Grad Sch, Tokyo, Japan; [Fukasaka, Junichi; Kochi, Kenji; Shimazu, Rieko] Sumitomo Dainippon Pharma Co Ltd, Tokyo, Japan	Murata, M (reprint author), 4-1-1,Ogawa Higashi, Kodaira, Tokyo 1878551, Japan.	mihom@ncnp.go.jp			Sumitomo Dainippon Pharma Co., Ltd.	This study was supported by Sumitomo Dainippon Pharma Co., Ltd.	Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Chang XL, 2011, AM J MED GENET B, V156B, P334, DOI 10.1002/ajmg.b.31167; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Tan EK, 2010, NEUROLOGY, V75, P508, DOI 10.1212/WNL.0b013e3181eccfcd; Ramirez A, 2011, PARKINSONISM RELAT D, V17, P70, DOI 10.1016/j.parkreldis.2010.09.002; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Tucci A, 2010, EUR J HUM GENET, V18, P1356, DOI 10.1038/ejhg.2010.125; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Ostvold AC, 2001, EUR J BIOCHEM, V268, P2430, DOI 10.1046/j.1432-1327.2001.02120.x; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Chang KH, 2013, NEUROBIOL AGING, V34, p[2442, e2445]; desRijk MC, 2000, NEUROLOGY, V54, pS21; GARRUTO RM, 1985, NEUROLOGY, V35, P193; Li HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075041; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Shimizu F, 1997, CYTOGENET CELL GENET, V77, P261, DOI 10.1159/000134591; Teo YY, 2010, GENET EPIDEMIOL, V34, P34, DOI 10.1002/gepi.20432; Teo YY, 2009, GENET EPIDEMIOL, V33, P128, DOI 10.1002/gepi.20366	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	SEP	2015	30	10					1343	1350		10.1002/mds.26286		8	Clinical Neurology	Neurosciences & Neurology	CQ7CD	WOS:000360759500039		
J	Miyamoto, R; Kawarai, T; Oki, R; Matsumoto, S; Izumi, Y; Kaji, R				Miyamoto, Ryosuke; Kawarai, Toshitaka; Oki, Ryosuke; Matsumoto, Shinichi; Izumi, Yuishin; Kaji, Ryuji			Lack of C9orf72 Expansion in 406 Sporadic and Familial Cases of Idiopathic Dystonia in Japan	MOVEMENT DISORDERS			English	Letter							HUNTINGTON-DISEASE; CONTROLLED-TRIAL; ETHYL-EPA	BackgroundIt has been suggested that treatment with ethyl-eicosapentaenoic acid (EPA) may improve motor function in patients with Huntington's disease (HD) with cytosine-adenine-guanine repeat numbers of <45. MethodsThis multicenter, randomized, double-blind, placebo-controlled 6-month trial compared the effects of ethyl-EPA versus placebo on 290 subjects with mild-to-moderate HD. The primary endpoint was the change from baseline to 6 months in the Total Motor Score 4 (TMS-4) component of the Unified Huntington's Disease Rating Scale (UHDRS). Secondary endpoints included change from baseline in UHDRS subscores and Clinical Global Impression (CGI). ResultsNo significant differences in TMS-4 scores were noted between treatment groups. Similarly, there were no significant differences between groups on any of the UHDRS subscores or CGI scores. ConclusionEthyl-EPA was not beneficial in patients with HD during 6 months of placebo-controlled evaluation. (c) 2015 International Parkinson and Movement Disorder Society	[Miyamoto, Ryosuke; Kawarai, Toshitaka; Oki, Ryosuke; Izumi, Yuishin; Kaji, Ryuji] Univ Tokushima, Dept Clin Neurosci, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Miyamoto, Ryosuke; Kaji, Ryuji] Ijinkai Takeda Gen Hosp, Movement Disorders Clin, Kyoto, Japan; [Matsumoto, Shinichi] Shinko Hosp, Dept Neurol, Kobe, Hyogo, Japan	Miyamoto, R (reprint author), Univ Tokushima, Dept Clin Neurosci, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.						[Anonymous], 2008, ARCH NEUROL, V65, P1582; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006455.pub2; Murck H, 2007, BRAIN RES BULL, V72, P159, DOI 10.1016/j.brainresbull.2006.10.020; Puri BK, 2005, NEUROLOGY, V65, P286, DOI 10.1212/01.wnl.0000169025.09670.6d; Siesling S, 1997, MOVEMENT DISORD, V12, P229, DOI 10.1002/mds.870120214	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	SEP	2015	30	10					1430	1431		10.1002/mds.26310		2	Clinical Neurology	Neurosciences & Neurology	CQ7CD	WOS:000360759500052		
J	Liu, JZ; van Sommeren, S; Huang, HL; Ng, SC; Alberts, R; Takahashi, A; Ripke, S; Lee, JC; Jostins, L; Shah, T; Abedian, S; Cheon, JH; Cho, J; Daryani, NE; Franke, L; Fuyuno, Y; Hart, A; Juyal, RC; Juyal, G; Kim, WH; Morris, AP; Poustchi, H; Newman, WG; Midha, V; Orchard, TR; Vahedi, H; Sood, A; Sung, JJY; Malekzadeh, R; Westra, HJ; Yamazaki, K; Yang, SK; Barrett, JC; Franke, A; Alizadeh, BZ; Parkes, M; Thelma, BK; Daly, MJ; Kubo, M; Anderson, CA; Weersma, RK				Liu, Jimmy Z.; van Sommeren, Suzanne; Huang, Hailiang; Ng, Siew C.; Alberts, Rudi; Takahashi, Atsushi; Ripke, Stephan; Lee, James C.; Jostins, Luke; Shah, Tejas; Abedian, Shifteh; Cheon, Jae Hee; Cho, Judy; Daryani, Naser E.; Franke, Lude; Fuyuno, Yuta; Hart, Ailsa; Juyal, Ramesh C.; Juyal, Garima; Kim, Won Ho; Morris, Andrew P.; Poustchi, Hossein; Newman, William G.; Midha, Vandana; Orchard, Timothy R.; Vahedi, Homayon; Sood, Ajit; Sung, Joseph J. Y.; Malekzadeh, Reza; Westra, Harm-Jan; Yamazaki, Keiko; Yang, Suk-Kyun; Barrett, Jeffrey C.; Franke, Andre; Alizadeh, Behrooz Z.; Parkes, Miles; Thelma, B. K.; Daly, Mark J.; Kubo, Michiaki; Anderson, Carl A.; Weersma, Rinse K.		Int Multiple Sclerosis Genetics Co; Int IBD Genetics Consortium	Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; KAPPA-B-ZETA; ULCERATIVE-COLITIS; CROHNS-DISEASE; JAPANESE POPULATION; COMPLEX DISEASES; METAANALYSIS; VARIANTS; STRATIFICATION; ARCHITECTURE	Ulcerative colitis and Crohn's disease are the two main forms of inflammatory bowel disease (IBD). Here we report the first transancestry association study of IBD, with genome-wide or Immunochip genotype data from an extended cohort of 86,640 European individuals and Immunochip data from 9,846 individuals of East Asian, Indian or Iranian descent. We implicate 38 loci in IBD risk for the first time. For the majority of the IBD risk loci, the direction and magnitude of effect are consistent in European and non-European cohorts. Nevertheless, we observe genetic heterogeneity between divergent populations at several established risk loci driven by differences in allele frequency (NOD2) or effect size (TNFSF15 and ATG16L1) or a combination of these factors (IL23R and IRGM). Our results provide biological insights into the pathogenesis of IBD and demonstrate the usefulness of trans-ancestry association studies for mapping loci associated with complex diseases and understanding genetic architecture across diverse populations.	[Liu, Jimmy Z.; Shah, Tejas; Barrett, Jeffrey C.; Anderson, Carl A.] Wellcome Trust Sanger Inst, Hinxton, England; [van Sommeren, Suzanne; Alberts, Rudi; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [van Sommeren, Suzanne; Franke, Lude; Westra, Harm-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Huang, Hailiang; Ripke, Stephan; Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Analyt & Translat Genet Unit, Boston, MA USA; [Ng, Siew C.; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, LKS Inst Hlth Sci,State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Takahashi, Atsushi] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Lee, James C.; Parkes, Miles] Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge, England; [Jostins, Luke] Univ Oxford, Wellcome Trust Ctr Human Genet, Headington, England; [Abedian, Shifteh; Poustchi, Hossein; Vahedi, Homayon; Malekzadeh, Reza] Shariati Hosp, Digest Dis Res Inst, Tehran, Iran; [Cheon, Jae Hee; Kim, Won Ho] Yonsei Univ, Coll Med, Dept Gastroenterol & Hepatol, Seoul, South Korea; [Cho, Judy] Mt Sinai Hosp, Icahn Sch Med, New York, NY 10029 USA; [Daryani, Naser E.] Emam Hosp, Dept Gastroenterol, Tehran, Iran; [Fuyuno, Yuta; Yamazaki, Keiko; Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Hart, Ailsa] St Marks Hosp, Inflammatory Bowel Dis Unit, Harrow, Middx, England; [Juyal, Ramesh C.] Natl Inst Immunol, New Delhi 110067, India; [Juyal, Garima; Thelma, B. K.] Univ Delhi, Dept Genet, New Delhi, India; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Newman, William G.] Univ Manchester, Manchester Ctr Genom Med, Manchester, Lancs, England; [Newman, William G.] Cent Manchester Univ Hosp Natl Hlth Serv NHS Fdn, Manchester, Lancs, England; [Midha, Vandana; Sood, Ajit] Dayanand Med Coll & Hosp, Dept Med, Ludhiana, Punjab, India; [Orchard, Timothy R.] St Marys Hosp, Dept Gastroenterol & Hepatol, London, England; [Yang, Suk-Kyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Hepatol, Seoul, South Korea; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	Anderson, CA (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	carl.anderson@sanger.ac.uk; r.k.weersma@umcg.nl	Ng, Siew Chien/N-4733-2015	Ng, Siew Chien/0000-0002-6850-4454	Netherlands Organization for Scientific Research (NWO) [016.136.308]; Broad Medical Research Program of the Broad Foundation [IBD-0318]; Netherlands Organization for Scientific Research (NWO), through NWO VENI grant [916.10.135]; NWO VIDI grant [917.14.374]; European Community's Health Seventh Framework Programme [259867]; Department of Biotechnology of the government of India (New Delhi, India) [BT/01/COE/07/UDSC/2008]; Tehran University of Medical Sciences, Iran; National Association for Colitis and Crohn's Disease; Wellcome Trust; Medical Research Council UK; Peninsular College of Medicine and Dentistry, Exeter; National Institute for Health Research (NIHR) Biomedical Research Centre; Wellcome Trust [WT098017, 098051]	R.K.W. is supported by a VIDI grant (016.136.308) from the Netherlands Organization for Scientific Research (NWO) and the Broad Medical Research Program of the Broad Foundation (IBD-0318). L.F. is supported by the Netherlands Organization for Scientific Research (NWO), through NWO VENI grant 916.10.135 and NWO VIDI grant 917.14.374. The research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement 259867. T.B.K. is supported by Centre of Excellence grant BT/01/COE/07/UDSC/2008 from the Department of Biotechnology of the government of India (New Delhi, India). The collection of Iranian samples has been supported by the Tehran University of Medical Sciences, Iran. UK case collections were supported by the National Association for Colitis and Crohn's Disease, the Wellcome Trust, the Medical Research Council UK and the Peninsular College of Medicine and Dentistry, Exeter. We also acknowledge National Institute for Health Research (NIHR) Biomedical Research Centre awards to Guy's and St Thomas' NHS Trust/King's College London and to Addenbrooke's Hospital/University of Cambridge School of Clinical Medicine. A.P.M. is supported by the Wellcome Trust under award WT098017. J.Z.L., T.S., J.C.B. and C.A.A. are supported by the Wellcome Trust (098051).	Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/nmeth.1785, 10.1038/NMETH.1785]; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Yang SK, 2014, GUT, V63, P80, DOI 10.1136/gutjnl-2013-305193; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710; Juyal G, 2015, GUT, V64, P571, DOI 10.1136/gutjnl-2013-306625; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Ng SC, 2013, GASTROENTEROLOGY, V145, P158, DOI 10.1053/j.gastro.2013.04.007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Miyake T, 2010, P NATL ACAD SCI USA, V107, P17680, DOI 10.1073/pnas.1012977107; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Beigel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093498; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Duarte JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079819; *ENCODE PROJ CONS, 2011, PLOS BIOL, V0009; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fukaya T, 2012, P NATL ACAD SCI USA, V109, P11288, DOI 10.1073/pnas.1202208109; Juyal G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016565; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Li Ying, 2011, Cell, V147, P629, DOI 10.1016/j.cell.2011.09.025; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Schramm K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093844; Serfling E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-16; Varona R, 2003, EUR J IMMUNOL, V33, P2937, DOI 10.1002/eji.200324347; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579	53	8	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					979	+		10.1038/ng.3359		11	Genetics & Heredity	Genetics & Heredity	CQ1XQ	WOS:000360394100007		
J	Nakamura, H; Arai, Y; Totoki, Y; Shirota, T; Elzawahry, A; Kato, M; Hama, N; Hosoda, F; Urushidate, T; Ohashi, S; Hiraoka, N; Ojima, H; Shimada, K; Okusaka, T; Kosuge, T; Miyagawa, S; Shibata, T				Nakamura, Hiromi; Arai, Yasuhito; Totoki, Yasushi; Shirota, Tomoki; Elzawahry, Asmaa; Kato, Mamoru; Hama, Natsuko; Hosoda, Fumie; Urushidate, Tomoko; Ohashi, Shoko; Hiraoka, Nobuyoshi; Ojima, Hidenori; Shimada, Kazuaki; Okusaka, Takuji; Kosuge, Tomoo; Miyagawa, Shinichi; Shibata, Tatsuhiro			Genomic spectra of biliary tract cancer	NATURE GENETICS			English	Article							HEPATOCELLULAR-CARCINOMA; MUTATIONAL LANDSCAPE; PATTERN DISCOVERY; PD-1 BLOCKADE; CHOLANGIOCARCINOMA; IDENTIFICATION; FUSIONS; IMMUNOTHERAPY; GALLBLADDER; SIGNATURES	The incidence of biliary tract cancer (BTC), including intrahepatic (ICC) and extrahepatic (ECC) cholangiocarcinoma and gallbladder cancer, has increased globally; however, no effective targeted molecular therapies have been approved at the present time. Here we molecularly characterized 260 BTCs and uncovered spectra of genomic alterations that included new potential therapeutic targets. Gradient spectra of mutational signatures with a higher burden of the APOBEC-associated mutation signature were observed in gallbladder cancer and ECC. Thirty-two significantly altered genes, including ELF3, were identified, and nearly 40% of cases harbored targetable genetic alterations. Gene fusions involving FGFR2 and PRKACA or PRKACB preferentially occurred in ICC and ECC, respectively, and the subtype-associated prevalence of actionable growth factor-mediated signals was noteworthy. The subgroup with the poorest prognosis had significant enrichment of hypermutated tumors and a characteristic elevation in the expression of immune checkpoint molecules. Accordingly, immune-modulating therapies might also be potentially promising options for these patients.	[Nakamura, Hiromi; Arai, Yasuhito; Totoki, Yasushi; Shirota, Tomoki; Elzawahry, Asmaa; Hama, Natsuko; Hosoda, Fumie; Ohashi, Shoko; Shibata, Tatsuhiro] Natl Canc Ctr, Div Canc Genom, Tokyo, Japan; [Shirota, Tomoki; Miyagawa, Shinichi] Shinshu Univ, Sch Med, Dept Surg 1, Matsumoto, Nagano 390, Japan; [Kato, Mamoru] Natl Canc Ctr, Dept Bioinformat, Tokyo, Japan; [Urushidate, Tomoko; Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan; [Hiraoka, Nobuyoshi; Ojima, Hidenori] Natl Canc Ctr, Div Pathol, Tokyo, Japan; [Hiraoka, Nobuyoshi; Ojima, Hidenori] Natl Canc Ctr, Clin Labs, Tokyo, Japan; [Ojima, Hidenori] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Shimada, Kazuaki; Kosuge, Tomoo] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Surg, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan	Shibata, T (reprint author), Natl Canc Ctr, Div Canc Genom, Tokyo, Japan.	tashibat@ncc.go.jp			Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer), National Cancer Center Research and Development Funds [26-A-5]; MEXT [26461040]; Yasuda Medical Foundation; National Cancer Center Research and Development Fund, Japan	This study was supported by Grants-in-Aid from the Ministry of Health, Labour and Welfare and the Japan Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer), National Cancer Center Research and Development Funds (26-A-5), MEXT KAKENHI (grant 26461040) and the Yasuda Medical Foundation. The National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan. The supercomputing resource 'SHIROKANE' was provided by the Human Genome Center, The University of Tokyo.	Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Misra S, 2003, LANCET ONCOL, V4, P167, DOI 10.1016/S1470-2045(03)01021-0; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li ML, 2014, NAT GENET, V46, P872, DOI 10.1038/ng.3030; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Pilarski R, 2014, GENE CHROMOSOME CANC, V53, P177, DOI 10.1002/gcc.22129; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Arai Y, 2014, HEPATOLOGY, V59, P1427, DOI 10.1002/hep.26890; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Kirschner LS, 2000, NAT GENET, V26, P89; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Patel T, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-10; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Babur O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0612-6; Breast Cancer Linkage Consortium, 1999, J NATL CANCER I, V91, P1310; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498	42	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1003	+		10.1038/ng.3375		11	Genetics & Heredity	Genetics & Heredity	CQ1XQ	WOS:000360394100010		
J	Lenz, TL; Deutsch, AJ; Han, B; Hu, XL; Okada, Y; Eyre, S; Knapp, M; Zhernakova, A; Huizinga, TWJ; Abecasis, G; Becker, J; Boeckxstaens, GE; Chen, WM; Franke, A; Gladman, DD; Gockel, I; Gutierrez-Achury, J; Martin, J; Nair, RP; Nothen, MM; Onengut-Gumuscu, S; Rahman, P; Rantapaa-Dahlqvist, S; Stuart, PE; Tsoi, LC; van Heel, DA; Worthington, J; Wouters, MM; Klareskog, L; Elder, JT; Gregersen, PK; Schumacher, J; Rich, SS; Wijmenga, C; Sunyaev, SR; Bakker, PIW; Raychaudhuri, S				Lenz, Tobias L.; Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Eyre, Stephen; Knapp, Michael; Zhernakova, Alexandra; Huizinga, Tom W. J.; Abecasis, Goncalo; Becker, Jessica; Boeckxstaens, Guy E.; Chen, Wei-Min; Franke, Andre; Gladman, Dafna D.; Gockel, Ines; Gutierrez-Achury, Javier; Martin, Javier; Nair, Rajan P.; Noethen, Markus M.; Onengut-Gumuscu, Suna; Rahman, Proton; Rantapaa-Dahlqvist, Solbritt; Stuart, Philip E.; Tsoi, Lam C.; van Heel, David A.; Worthington, Jane; Wouters, Mira M.; Klareskog, Lars; Elder, James T.; Gregersen, Peter K.; Schumacher, Johannes; Rich, Stephen S.; Wijmenga, Cisca; Sunyaev, Shamil R.; de Bakker, Paul I. W.; Raychaudhuri, Soumya			Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SEROPOSITIVE RHEUMATOID-ARTHRITIS; CELIAC-DISEASE; PREFERENTIAL TRANSMISSION; HETEROZYGOTE ADVANTAGE; SHARED EPITOPE; GENETIC RISK; MHC; SUSCEPTIBILITY; ASSOCIATION	Human leukocyte antigen (HLA) genes confer substantial risk for autoimmune diseases on a log-additive scale. Here we speculated that differences in autoantigen-binding repertoires between a heterozygote's two expressed HLA variants might result in additional non-additive risk effects. We tested the non-additive disease contributions of classical HLA alleles in patients and matched controls for five common autoimmune diseases: rheumatoid arthritis (n(cases) = 5,337), type 1 diabetes (T1D; n(cases) = 5,567), psoriasis vulgaris (n(cases) = 3,089), idiopathic achalasia (n(cases) = 727) and celiac disease (ncases = 11,115). In four of the five diseases, we observed highly significant, non-additive dominance effects (rheumatoid arthritis, P = 2.5 x 10(-12); T1D, P = 2.4 x 10(-10); psoriasis, P = 5.9 x 10(-6); celiac disease, P = 1.2 x 10(-87)). In three of these diseases, the non-additive dominance effects were explained by interactions between specific classical HLA alleles (rheumatoid arthritis, P = 1.8 x 10(-3); T1D, P = 8.6 x 10(-27); celiac disease, P = 6.0 x 10(-100)). These interactions generally increased disease risk and explained moderate but significant fractions of phenotypic variance (rheumatoid arthritis, 1.4%; T1D, 4.0%; celiac disease, 4.1%) beyond a simple additive model.	[Lenz, Tobias L.; Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Sunyaev, Shamil R.; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Lenz, Tobias L.; Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Sunyaev, Shamil R.; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [Lenz, Tobias L.] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Evolutionary Immunogen, Plon, Germany; [Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Sunyaev, Shamil R.; Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Deutsch, Aaron J.; Hu, Xinli] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Han, Buhm] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Eyre, Stephen; Worthington, Jane; Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Musculoskeletal Res, Arthrit Res UK Ctr Genet & Genom, Manchester, Lancs, England; [Eyre, Stephen; Worthington, Jane] Cent Manchester Univ Hosp Natl Hlth Serv NHS Fdn, Natl Inst Hlth Res NIHR Manchester Musculoskeleta, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Knapp, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Zhernakova, Alexandra; Gutierrez-Achury, Javier; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Huizinga, Tom W. J.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Abecasis, Goncalo; Tsoi, Lam C.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Abecasis, Goncalo; Tsoi, Lam C.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Becker, Jessica; Noethen, Markus M.; Schumacher, Johannes] Univ Bonn, Inst Human Genet, Bonn, Germany; [Becker, Jessica; Noethen, Markus M.; Schumacher, Johannes] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Boeckxstaens, Guy E.; Wouters, Mira M.] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Leuven, Belgium; [Chen, Wei-Min; Onengut-Gumuscu, Suna; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Gladman, Dafna D.] Univ Toronto, Dept Med, Div Rheumatol, Toronto, ON, Canada; [Gladman, Dafna D.] Univ Toronto, Toronto Western Res Inst, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada; [Gladman, Dafna D.] Univ Toronto, Toronto Western Res Inst, Toronto, ON, Canada; [Gockel, Ines] Univ Hosp Leipzig, Dept Visceral Transplant Thorac & Vasc Surg, Leipzig, Germany; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Nair, Rajan P.; Stuart, Philip E.; Elder, James T.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Rahman, Proton] Mem Univ Newfoundland, Dept Med, St John, NF, Canada; [Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Rheumatol, Umea, Sweden; [van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Klareskog, Lars; Raychaudhuri, Soumya] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Klareskog, Lars; Raychaudhuri, Soumya] Karolinska Univ Hosp Solna, Stockholm, Sweden; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; [Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands	Lenz, TL (reprint author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	pdebakker@umcutrecht.nl; soumya@broadinstitute.org	Lenz, Tobias/D-1387-2009; Wouters, Mira/K-1371-2013; 	Lenz, Tobias/0000-0002-7203-0044; Zhernakova, Alexandra/0000-0002-4574-0841	German Research Foundation (DFG) [LE 2593/1-1, LE 2593/2-1, GO 1795/1-1, KN 378/2-1, SCHU 1596/5-1]; US National Institutes of Health [1R01AR062886, R01AR065183, 1R01AR063759-01A1, 5U01GM092691, 1UH2AR067677-01]; IMI (European Union); Netherlands Organization for Scientific Research (Vernieuwingsimpuls VIDI Award NWO project) [016.126.354]; Instituto de Salud Carlos III [RD12/0009]; Alfried Krupp von Bohlen und Halbach-Stiftung	This project was supported by grants from the German Research Foundation (DFG; LE 2593/1-1 and LE 2593/2-1 (T.L.L.), GO 1795/1-1 (I.G.), KN 378/2-1 (M.K.) and SCHU 1596/5-1 (J.S.)), by grants from the US National Institutes of Health (1R01AR062886 (P.I.W.d.B.), R01AR065183 (J.T.E.), 1R01AR063759-01A1 (S.R.), 5U01GM092691 (S.R.) and 1UH2AR067677-01 (S.R.)), by the IMI (European Union)-funded program BTCure (L.K.) and by the Netherlands Organization for Scientific Research (Vernieuwingsimpuls VIDI Award NWO project 016.126.354 (P.I.W.d.B.)). Sample collection for J.M. was supported by a grant from the Instituto de Salud Carlos III (RD12/0009). M.M.N. received support for this work from the Alfried Krupp von Bohlen und Halbach-Stiftung and is a member of the DFG-funded Excellence Cluster ImmunoSensation.	Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Koeleman BPC, 2004, GENES IMMUN, V5, P381, DOI 10.1038/sj.gene.6364106; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Bronson PG, 2009, DIABETES OBES METAB, V11, P74, DOI 10.1111/j.1463-1326.2008.01006.x; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; Lenz TL, 2011, EVOLUTION, V65, P2380, DOI 10.1111/j.1558-5646.2011.01288.x; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Thursz MR, 1997, NAT GENET, V17, P11, DOI 10.1038/ng0997-11; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Woelfing B, 2009, PHILOS T R SOC B, V364, P117, DOI 10.1098/rstb.2008.0174; Rich SS, 2006, ANN NY ACAD SCI, V1079, P1, DOI 10.1196/annals.1375.001; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Gutierrez-Achury J, 2015, NAT GENET, V47, P577, DOI 10.1038/ng.3268; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Gockel I, 2014, NAT GENET, V46, P901, DOI 10.1038/ng.3029; MACGREGOR A, 1995, J RHEUMATOL, V22, P1032; Klareskog L, 2013, ADV IMMUNOL, V118, P129, DOI 10.1016/B978-0-12-407708-9.00003-0; Thomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Miyadera H, 2015, J CLIN INVEST, V125, P275, DOI 10.1172/JCI74961; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Balding D.J., 2007, HDB STAT GENETICS; Clop A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071690; Dean M, 2002, ANNU REV GENOM HUM G, V3, P263, DOI 10.1146/annurev.genom.3.022502.103149; Gjuvsland AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009379; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Hu X., 2015, NAT GENET, V47, P888; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kwan S.H., 2007, STAT GENETICS GENE M, P17; Lipsitch Marc, 2003, BMC Med Genet, V4, P2, DOI 10.1186/1471-2350-4-2; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Sasaki T, 1999, J HUM GENET, V44, P318, DOI 10.1007/s100380050168; Tsai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00321; VADHEIM CM, 1986, NEW ENGL J MED, V315, P1314, DOI 10.1056/NEJM198611203152103; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131	51	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1085	+		10.1038/ng.3379		8	Genetics & Heredity	Genetics & Heredity	CQ1XQ	WOS:000360394100021		
J	Kiyonaka, S; Sakaguchi, R; Hamachi, I; Morii, T; Yoshizaki, T; Mori, Y				Kiyonaka, Shigeki; Sakaguchi, Reiko; Hamachi, Itaru; Morii, Takashi; Yoshizaki, Takenao; Mori, Yasuo			Validating subcellular thermal changes revealed by fluorescent thermosensors	NATURE METHODS			English	Letter							ACTIVE-TRANSPORT; HEAT-PRODUCTION; CELLS; RATS		[Kiyonaka, Shigeki; Hamachi, Itaru; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Dept Technol & Ecol, Kyoto, Japan; [Sakaguchi, Reiko] Kyoto Univ, Inst Integrated Cell Mat Sci, World Premier Int Res Initiat, Kyoto, Japan; [Morii, Takashi] Kyoto Univ, Inst Adv Energy, Uji, Kyoto, Japan; [Yoshizaki, Takenao] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto, Japan	Kiyonaka, S (reprint author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan.	mori@sbchem.kyoto-u.ac.jp					Kiyonaka S, 2013, NAT METHODS, V10, P1232, DOI [10.1038/nmeth.2690, 10.1038/NMETH.2690]; Sakaguchil R, 2015, CURR OPIN BIOTECH, V31, P57, DOI 10.1016/j.copbio.2014.07.013; Baffou G, 2014, NAT METHODS, V11, P899, DOI 10.1038/nmeth.3073; Lervik A, 2010, PHYS CHEM CHEM PHYS, V12, P1610, DOI 10.1039/b918607g; Bedeaux D, 2008, PHYS CHEM CHEM PHYS, V10, P7304, DOI 10.1039/b810374g; CLARK DG, 1986, BIOCHEM J, V235, P337; HANSEN ES, 1986, BIOSCIENCE REP, V6, P31, DOI 10.1007/BF01145176; Kondepudi D., 1998, MODERN THERMODYNAMIC, P333; Lervik A, 2013, EUR BIOPHYS J BIOPHY, V42, P321, DOI 10.1007/s00249-012-0877-6; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	SEP	2015	12	9					801	802				2	Biochemical Research Methods	Biochemistry & Molecular Biology	CQ4PI	WOS:000360586700004		
J	Suzuki, M; Zeeb, V; Arai, S; Oyama, K; Ishiwata, S				Suzuki, Madoka; Zeeb, Vadim; Arai, Satoshi; Oyama, Kotaro; Ishiwata, Shin'ichi			The 10(5) gap issue between calculation and measurement in single-cell thermometry	NATURE METHODS			English	Letter							LIVING CELLS; TEMPERATURE		[Suzuki, Madoka; Arai, Satoshi; Ishiwata, Shin'ichi] Waseda Biosci Res Inst Singapore WABIOS, Singapore, Singapore; [Suzuki, Madoka; Ishiwata, Shin'ichi] Waseda Univ, Org Univ Res Initiat, Tokyo, Japan; [Zeeb, Vadim] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Russia; [Zeeb, Vadim; Oyama, Kotaro; Ishiwata, Shin'ichi] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Phys, Tokyo, Japan	Suzuki, M (reprint author), Waseda Biosci Res Inst Singapore WABIOS, Singapore, Singapore.	suzu_mado@aoni.waseda.jp; ishiwata@waseda.jp					Takei Y, 2014, ACS NANO, V8, P198, DOI 10.1021/nn405456e; Yang JM, 2011, ACS NANO, V5, P5067, DOI 10.1021/nn201142f; Johannessen EA, 2002, ANAL CHEM, V74, P2190, DOI 10.1021/ac011028b; Sato MK, 2014, BIOPHYS J, V106, P2458, DOI 10.1016/j.bpj.2014.04.044; Baffou G, 2014, NAT METHODS, V11, P899, DOI 10.1038/nmeth.3073; Arai S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06701	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	SEP	2015	12	9					802	803				3	Biochemical Research Methods	Biochemistry & Molecular Biology	CQ4PI	WOS:000360586700005		
J	Kuruma, Y; Ueda, T				Kuruma, Yutetsu; Ueda, Takuya			The PURE system for the cell-free synthesis of membrane proteins	NATURE PROTOCOLS			English	Article							IN-VITRO; PURIFIED COMPONENTS; EXPRESSION SYSTEM; FOF1-ATP SYNTHASE; F1F0-ATP SYNTHASE; EPSILON-SUBUNIT; ATP SYNTHASE; TRANSLATION; COMPLEXES; SELECTION	Cell-free gene expression systems are biotechnological tools for the in vitro production of proteins of interest. The addition of membrane vesicles (liposomes) enables the production of membrane proteins, including those in large-molecular-weight complexes, such as the SecYEG translocon or ATP synthase. Here we describe a protocol for the cell-free synthesis of membrane proteins using the protein synthesis using recombinant elements (PURE) system, and for subsequent quantification of products and analyses of membrane localization efficiency, product orientation in the membrane and complex formation in the membrane. In addition, measurements of ATP synthase activity are used as an example to demonstrate the functional nature of the cell-free synthesized proteins. This protocol allows the rapid production and the detailed analysis of membrane proteins, and the complete process from template DNA preparation to activity measurement can be accomplished within 1 d. In contrast to alternative methods using living cells, this protocol can also help to prevent the difficulties in membrane protein purification and the risks of protein aggregation during reconstitution into lipid membranes.	[Kuruma, Yutetsu] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 152, Japan; [Kuruma, Yutetsu; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba, Japan	Kuruma, Y (reprint author), Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 152, Japan.	kuruma@elsi.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology;  [26119704];  [26103511]	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (grant numbers 26119704 and 26103511 to Y.K.) and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, to T.U. We thank T. Suzuki of Waseda University for valuable advice about F<INF>o</INF>F<INF>1</INF>-ATP synthase, H. Matsubayashi for the SecYEG translocon data and T. Kanamori of GeneFrontier for providing the PURE system.	Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; Swartz J, 2006, J IND MICROBIOL BIOT, V33, P476, DOI 10.1007/s10295-006-0127-y; Soga H, 2014, ACS SYNTH BIOL, V3, P372, DOI 10.1021/sb400094c; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Mikami S, 2008, PROTEIN EXPRES PURIF, V62, P190, DOI 10.1016/j.pep.2008.09.002; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; Fujiwara K, 2013, NUCLEIC ACIDS RES, V41, P7176, DOI 10.1093/nar/gkt489; Kuruma Y, 2009, BBA-BIOMEMBRANES, V1788, P567, DOI 10.1016/j.bbamem.2008.10.017; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; Matsubayashi H, 2014, ANGEW CHEM INT EDIT, V53, P7535, DOI 10.1002/anie.201403929; Kuruma Y, 2012, BIOCHEM J, V442, P631, DOI 10.1042/BJ20111284; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Carlson ED, 2012, BIOTECHNOL ADV, V30, P1185, DOI 10.1016/j.biotechadv.2011.09.016; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Fujii S, 2014, NAT PROTOC, V9, P1578, DOI 10.1038/nprot.2014.107; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Asahara H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq377; Chizzolini F, 2014, ACS SYNTH BIOL, V3, P363, DOI 10.1021/sb4000977; Ezure T, 2010, METHODS MOL BIOL, V607, P31, DOI 10.1007/978-1-60327-331-2_4; Fillingame RH, 2000, J EXP BIOL, V203, P9; Kalmbach R, 2007, J MOL BIOL, V371, P639, DOI 10.1016/j.jmb.2007.05.087; Kuruma Y, 2010, METHODS MOL BIOL, V607, P161, DOI 10.1007/978-1-60327-331-2_14; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; Sambrook J., 2012, MOL CLONING LAB MANU; Schuler Mary A, 2013, Methods Mol Biol, V974, P415, DOI 10.1007/978-1-62703-275-9_18; Shimizu Y, 2014, METHODS MOL BIOL, V1118, P275, DOI 10.1007/978-1-62703-782-2_19; Shimizu Y, 2010, METHODS MOL BIOL, V607, P11, DOI 10.1007/978-1-60327-331-2_2; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Terada T, 2014, METHODS MOL BIOL, V1091, P151, DOI 10.1007/978-1-62703-691-7_10; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007	38	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	SEP	2015	10	9					1328	1344		10.1038/nprot.2015.082		17	Biochemical Research Methods	Biochemistry & Molecular Biology	CQ3HQ	WOS:000360493200006		
J	Fujii, T; Matsuda, S; Tejedor, ML; Esaki, T; Sakane, I; Mizuno, H; Tsuyama, N; Masujima, T				Fujii, Takashi; Matsuda, Shuichi; Tejedor, Monica Lorenzo; Esaki, Tsuyoshi; Sakane, Iwao; Mizuno, Hajime; Tsuyama, Naohiro; Masujima, Tsutomu			Direct metabolomics for plant cells by live single-cell mass spectrometry	NATURE PROTOCOLS			English	Article							MOLECULAR ANALYSIS; TRANSCRIPTOME ANALYSIS; MALDI-MS; IN-VIVO; EXPRESSION; PROTEOMICS; VIDEO; DYNAMICS; GENOMICS; NEURONS	Live single-cell mass spectrometry (live MS) provides a mass spectrum that shows thousands of metabolite peaks from a single live plant cell within minutes. By using an optical microscope, a cell is chosen for analysis and a metal-coated nanospray microcapillary tip is used to remove the cell's contents. After adding a microliter of ionization solvent to the opposite end of the tip, the trapped contents are directly fed into the mass spectrometer by applying a high voltage between the tip and the inlet port of the spectrometer to induce nanospray ionization. Proteins are not detected because of insufficient sensitivity. Metabolite peaks are identified by exact mass or tandem mass spectrometry (MS/MS) analysis, and isomers can be separated by combining live MS with ion-mobility separation. By using this approach, spectra can be acquired in 10 min. In combination with metabolic maps and/or molecular databases, the data can be annotated into metabolic pathways; the data analysis takes 30 min to 4 h, depending on the MS/MS data availability from databases. This method enables the analysis of a number of metabolites from a single cell with rapid sampling at sub-attomolar-level sensitivity.	[Fujii, Takashi; Matsuda, Shuichi; Tejedor, Monica Lorenzo; Mizuno, Hajime; Tsuyama, Naohiro; Masujima, Tsutomu] Hiroshima Univ, Graduated Sch Biomed Sci, Lab Mol Med & Devices, Hiroshima, Japan; [Fujii, Takashi; Matsuda, Shuichi; Esaki, Tsuyoshi; Sakane, Iwao; Mizuno, Hajime; Tsuyama, Naohiro; Masujima, Tsutomu] RIKEN, Quantitat Biol Ctr, Lab Single Cell Mass Spectrometry, Suita, Osaka, Japan	Masujima, T (reprint author), Hiroshima Univ, Graduated Sch Biomed Sci, Lab Mol Med & Devices, Hiroshima, Japan.	masujima@riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant for Development of Systems and Technology for Advanced Measurement and Analysis by the Japan Science and Technology Agency (JST)	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant for Development of Systems and Technology for Advanced Measurement and Analysis by the Japan Science and Technology Agency (JST). We thank A. Makarov (Thermo Scientific) for his kind support in instrumentation using Orbitrap/MS, K. Karasawa (AB Sciex) for support in data analysis, P. Karagiannis (QBiC, RIKEN) for helping with the English in this manuscript and all students (Hiroshima University) and staff (QBiC, RIKEN) who have engaged in this live MS project.	Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Li LJ, 2000, TRENDS BIOTECHNOL, V18, P151, DOI 10.1016/S0167-7799(00)01427-X; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Dai SJ, 2012, MOL CELL PROTEOMICS, V11, P1622, DOI 10.1074/mcp.R112.021550; Neugebauer U, 2010, J BIOPHOTONICS, V3, P579, DOI 10.1002/jbio.201000020; Stender AS, 2013, CHEM REV, V113, P2469, DOI 10.1021/cr300336e; Lanni EJ, 2012, J PROTEOMICS, V75, P5036, DOI 10.1016/j.jprot.2012.03.017; Shrestha B, 2009, ANAL CHEM, V81, P8265, DOI 10.1021/ac901525g; Sanchez-Freire V, 2012, NAT PROTOC, V7, P829, DOI 10.1038/nprot.2012.021; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Rubakhin SS, 2008, ANAL CHEM, V80, P7128, DOI 10.1021/ac8010389; Pinaud R, 2008, NAT PROTOC, V3, P1370, DOI 10.1038/nprot.2008.115; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Amantonico A, 2010, ANAL CHEM, V82, P7394, DOI 10.1021/ac1015326; Rubakhin SS, 2013, CURR OPIN BIOTECH, V24, P95, DOI 10.1016/j.copbio.2012.10.021; Lin YQ, 2011, ANAL CHEM, V83, P4369, DOI 10.1021/ac2009838; [Anonymous], 2007, [Masujima, T., Tsuyama, N. & Mizuno, H, US patent application], Patent No. [12/ 739660, 12739660]; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/nmeth.1315, 10.1038/NMETH.1315]; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/nmeth.1557, 10.1038/NMETH.1557]; Tsuyama N, 2008, ANAL SCI, V24, P559, DOI 10.2116/analsci.24.559; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Masujima T, 2009, ANAL SCI, V25, P953; Rinke C, 2014, NAT PROTOC, V9, P1038, DOI 10.1038/nprot.2014.067; Schroeder T, 2011, NAT METHODS, V8, pS30, DOI [10.1038/nmeth.1577, 10.1038/NMETH.1577]; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Mizuno H, 2008, J MASS SPECTROM, V43, P1692, DOI 10.1002/jms.1460; Lapainis T, 2009, ANAL CHEM, V81, P5858, DOI 10.1021/ac900936g; Svatos A, 2011, ANAL CHEM, V83, P5037, DOI 10.1021/ac2003592; Bjarnholt N, 2014, NAT PROD REP, V31, P818, DOI 10.1039/c3np70100j; Esumi S, 2006, NAT PROTOC, V1, P2143, DOI 10.1038/nprot.2006.343; Fujii T., 2014, P 62 ASMS C; Geigl B.J., 2007, NAT PROTOC, V2, P3173; Gholipour Y, 2008, J AM SOC MASS SPECTR, V19, P1841, DOI 10.1016/j.jasms.2008.08.006; Jayaraman D, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00044; JIMENEZ CR, 1994, J NEUROCHEM, V62, P404; Jones M.A., 2014, ELIFE, V3; Kellogg A.R., 2014, NAT PROTOC, V9, P1713; Lange BM, 2005, CURR OPIN PLANT BIOL, V8, P236, DOI 10.1016/j.pbi.2005.03.015; Li M.Q., 2011, CURR OPIN BIOTECH, V23, P56; Masujima T, 1999, ANAL CHIM ACTA, V400, P33, DOI 10.1016/S0003-2670(99)00704-7; Masujima T, 2006, NANOMEDICINE-UK, V1, P331, DOI 10.2217/17435889.1.3.331; Masujima T., 2007, EU- PAT, Patent No. 2216396; Masujima T., 2007, Patent nos. JP-PAT, Patent No. 5317983; Masujima T., 2007, China- PAT, Patent No. 1369602; Matsuda S., 2013, P 61 ASMS C; Misra B.B., 2014, TRENDS PLANT SCI, V14, P1360; Sakane I., 2013, P 61 ASMS C; Sirikatitham A, 2007, RAPID COMMUN MASS SP, V21, P385, DOI 10.1002/rcm.2842; Tejedor L.M., 2009, ANAL SCI, V25, P1053; Tejedor L.M., 2012, ANAL CHEM, V84, P5221; Thurber GM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2506; Urban L.P., 2011, ANAL CHEM, V83, P1843; Wong K.F., 2014, NAT PROTOC, V9, P1170; Young W.J., 2012, NAT PROTOC, V7, P80; Zenobi R., 2011, SCIENCE, V342, P1201; Zhang I.J., 2012, ANALYST, V137, P3091; Zrazhevskiy P, 2013, NAT PROTOC, V8, P1852, DOI 10.1038/nprot.2013.112	62	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	SEP	2015	10	9					1445	1456		10.1038/nprot.2015.084		12	Biochemical Research Methods	Biochemistry & Molecular Biology	CQ3HQ	WOS:000360493200013		
J	Schwab, S; Koenig, T; Morishima, Y; Dierks, T; Federspiel, A; Jann, K				Schwab, Simon; Koenig, Thomas; Morishima, Yosuke; Dierks, Thomas; Federspiel, Andrea; Jann, Kay			Discovering frequency sensitive thalamic nuclei from EEG microstate informed resting state fMRI	NEUROIMAGE			English	Article						EEG microstates; EEG topography; Thalamus; fMRI; Resting-state	SPONTANEOUS BRAIN ACTIVITY; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; ELECTROPHYSIOLOGICAL SIGNATURES; 1ST-EPISODE SCHIZOPHRENIA; PREFRONTAL CORTEX; TOPOGRAPHY; DYNAMICS; PHASE	Microstates (MS), the fingerprints of the momentarily and time-varying states of the brain derived from electro-encephalography (EEG), are associated with the resting state networks (RSNs). However, using MS fluctuations along different EEG frequency bands to model the functional MRI (fMRI) signal has not been investigated so far, or elucidated the role of the thalamus as a fundamental gateway and a putative key structure in cortical functional networks. Therefore, in the current study, we used MS predictors in standard frequency bands to predict blood oxygenation level dependent (BOLD) signal fluctuations. We discovered that multivariate modeling of BOLD-fMRI using six EEG-MS classes in eight frequency bands strongly correlated with thalamic areas and large-scale cortical networks. Thalamic nuclei exhibited distinct patterns of correlations for individual MS that were associated with specific EEG frequency bands. Anterior and ventral thalamic nuclei were sensitive to the beta frequency band, medial nuclei were sensitive to both alpha and beta frequency bands, and posterior nuclei such as the pulvinar were sensitive to delta and theta frequency bands. These results demonstrate that EEG-MS informed fMRI can elucidate thalamic activity not directly observable by EEG, which may be highly relevant to understand the rapid formation of thalamocortical networks. (C) 2015 Elsevier Inc. All rights reserved.	[Schwab, Simon; Koenig, Thomas; Morishima, Yosuke; Dierks, Thomas; Federspiel, Andrea] Univ Hosp Psychiat, Dept Psychiat Neurophysiol, CH-3000 Bern 60, Switzerland; [Schwab, Simon; Koenig, Thomas; Morishima, Yosuke; Dierks, Thomas; Federspiel, Andrea] Univ Bern, Bern, Switzerland; [Schwab, Simon; Koenig, Thomas; Morishima, Yosuke; Dierks, Thomas; Federspiel, Andrea] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland; [Morishima, Yosuke] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Jann, Kay] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	Schwab, S (reprint author), Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bolligenstr 111, CH-3000 Bern 60, Switzerland.	schwab@puk.unibe.ch	Dierks, Thomas/B-7092-2012; Morishima, Yosuke/K-8258-2013; 	Dierks, Thomas/0000-0002-4173-5308; Morishima, Yosuke/0000-0001-9363-697X; Schwab, Simon/0000-0002-1588-2689	Swiss National Science Foundation (SNSF) [136249, 33CM30-124114]	This research was supported in part by two grants from the Swiss National Science Foundation (SNSF) to Thomas Koenig (Sinergia #136249), and Kay Jann (SPUM #33CM30-124114).	Koenig T, 2001, NEUROIMAGE, V14, P383, DOI 10.1006/nimg.2001.0825; Kindler J, 2011, CLIN NEUROPHYSIOL, V122, P1179, DOI 10.1016/j.clinph.2010.10.042; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Koenig T, 2002, NEUROIMAGE, V16, P41, DOI 10.1006/nimg.2002.1070; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Lehmann D, 2005, PSYCHIAT RES-NEUROIM, V138, P141, DOI 10.1016/j.pscychresns.2004.05.007; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Koenig T, 1999, EUR ARCH PSY CLIN N, V249, P205, DOI 10.1007/s004060050088; Nair A, 2013, BRAIN, V136, P1942, DOI 10.1093/brain/awt079; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Yuan H, 2012, NEUROIMAGE, V60, P2062, DOI 10.1016/j.neuroimage.2012.02.031; Koenig T, 2001, SCHIZOPHR RES, V50, P55, DOI 10.1016/S0920-9964(00)00154-7; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; Reep RL, 2009, NEUROBIOL LEARN MEM, V91, P104, DOI 10.1016/j.nlm.2008.08.010; Calderone DJ, 2014, TRENDS COGN SCI, V18, P300, DOI 10.1016/j.tics.2014.02.005; Liu ZM, 2012, NEUROIMAGE, V63, P1060, DOI 10.1016/j.neuroimage.2012.08.025; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Musso F, 2010, NEUROIMAGE, V52, P1149, DOI 10.1016/j.neuroimage.2010.01.093; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Kamishina H, 2009, BRAIN RES, V1264, P39, DOI 10.1016/j.brainres.2009.01.024; Strik WK, 1997, PSYCHIAT RES-NEUROIM, V75, P183, DOI 10.1016/S0925-4927(97)00054-1; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449; LEHMANN D, 1987, ELECTROEN CLIN NEURO, V67, P271, DOI 10.1016/0013-4694(87)90025-3; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Koenig T, 2005, PHILOS T ROY SOC B, V360, P1015, DOI 10.1098/rstb.2005.1649; Nishida K, 2013, CLIN NEUROPHYSIOL, V124, P1106, DOI 10.1016/j.clinph.2013.01.005; Andreou C, 2014, SCHIZOPHR RES, V152, P513, DOI 10.1016/j.schres.2013.12.008; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Jann K, 2008, NEUROIMAGE, V42, P635, DOI 10.1016/j.neuroimage.2008.05.001; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kikuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022912; Kottlow M, 2012, CLIN NEUROPHYSIOL, V123, P1536, DOI 10.1016/j.clinph.2011.12.019; Liu ZM, 2014, CEREB CORTEX, V24, P3080, DOI 10.1093/cercor/bht164; Lopes da Silva F., 1991, ELECTROENCEPHALOGRAP, V79, P81; Lopes da Silva F.H., 1973, CLIN NEUROPHYSIOL, V35, P627, DOI DOI 10.1016/0013-4694(73)90216-2; Schwab S., 2013, P INT SOC MAG RESON, V21, P3246; Stevens A, 1996, EUR ARCH PSY CLIN N, V246, P310, DOI 10.1007/BF02189024; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106	59	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	SEP	2015	118						368	375		10.1016/j.neuroimage.2015.06.001		8	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CQ5GB	WOS:000360630200035		
J	Kajihara, T; Anwar, MN; Kawasaki, M; Mizuno, Y; Nakazawa, K; Kitajo, K				Kajihara, Takafumi; Anwar, Muhammad Nabeel; Kawasaki, Masahiro; Mizuno, Yuji; Nakazawa, Kimitaka; Kitajo, Keiichi			Neural dynamics in motor preparation: From phase-mediated global computation to amplitude-mediated local computation	NEUROIMAGE			English	Article							HUMAN-BRAIN ACTIVITY; NEURONAL OSCILLATIONS; ALPHA-BAND; SELECTIVE ATTENTION; CORTICAL NETWORKS; VISUAL-ATTENTION; PREMOTOR THEORY; WORKING-MEMORY; SYNCHRONIZATION; CORTEX	Oscillatory activity plays a critical role in the brain. Here, we illustrate the dynamics of neural oscillations in the motor system of the brain. We used a non-directional cue to instruct participants to prepare a motor response with either the left or the right hand and recorded electroencephalography during the preparation of the response. Consistent with previous findings, the amplitude of alpha-band (8-14 Hz) oscillations significantly decreased over the motor region contralateral to the hand prepared for the response. Prior to this decrease, there were a number of inter-regional phase synchronies at lower frequencies (2-4 Hz; delta band). Cross-frequency coupling was quantified to further explore the direct link between alpha amplitudes and delta synchrony. The cross-frequency coupling of showed response-specific modulation, whereby the motor region contralateral to the preparation hand exhibited an increase in coupling relative to the baseline. The amplitude of alpha oscillations had an unpreferred and a preferred delta phase, in which the amplitude was modulated negatively and positively, respectively. Given the amplitude of alpha-band oscillations decreased over the analyzed period, the alpha amplitude might be down-regulated by the phase-amplitude coupling, although we do not have direct evidence for that. Taken together, these results show global-to-local computation in the motor system, which started from inter-regional delta phase synchrony and ended at an effector-specific decrease in the amplitude of alpha-band oscillations, with phase-amplitude coupling connecting both computations. (C) 2015 The Authors. Published by Elsevier Inc.	[Kajihara, Takafumi; Anwar, Muhammad Nabeel; Kawasaki, Masahiro; Mizuno, Yuji; Kitajo, Keiichi] RIKEN Brain Sci Inst, RIKEN BSI TOYOTA Collaborat Ctr, Rhythm Based Brain Informat Proc Unit, Wako, Saitama 3510198, Japan; [Kajihara, Takafumi; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Anwar, Muhammad Nabeel] Natl Univ Sci & Technol NUST, Sch Mech & Mfg Engn, Islamabad 44000, Pakistan; [Kawasaki, Masahiro] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3050006, Japan; [Kawasaki, Masahiro; Kitajo, Keiichi] RIKEN Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama 3510198, Japan; [Mizuno, Yuji; Kitajo, Keiichi] Tokyo Univ Agr & Technol, Grad Sch Engn, Tokyo 1830057, Japan; [Mizuno, Yuji] Japan Soc Promot Sci, Tokyo 1020083, Japan	Kitajo, K (reprint author), RIKEN Brain Sci Inst, RIKEN BSI TOYOTA Collaborat Ctr, Rhythm Based Brain Informat Proc Unit, Wako, Saitama 3510198, Japan.	kkitajo@brain.riken.jp			junior research associate program, RIKEN; Toyota Motor Corporation; Japan Science and Technology (JST) PRESTO	This study was supported by junior research associate program, RIKEN, by a research grant from Toyota Motor Corporation, and by a fund from the Japan Science and Technology (JST) PRESTO. We thank Kazutoshi Kudo, Masahiro Shinya, Yuka Okazaki, and Yutaka Uno for advice and comments.	Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Rodriguez E, 1999, NATURE, V397, P430; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Haegens S, 2011, J NEUROSCI, V31, P5197, DOI 10.1523/JNEUROSCI.5199-10.2011; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Kawasaki M, 2010, EUR J NEUROSCI, V31, P1683, DOI 10.1111/j.1460-9568.2010.07217.x; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Smith DT, 2012, NEUROPSYCHOLOGIA, V50, P1104, DOI 10.1016/j.neuropsychologia.2012.01.025; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Gould IC, 2011, J NEUROPHYSIOL, V105, P1318, DOI 10.1152/jn.00653.2010; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; ARROYO S, 1993, ELECTROEN CLIN NEURO, V87, P76, DOI 10.1016/0013-4694(93)90114-B; BURGESS AP, 1999, HANDB EL CL, V6, P139; BUZSAKI G., 2009, RHYTHMS BRAIN; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Katnani HA, 2013, J NEUROSCI, V33, P10057, DOI 10.1523/JNEUROSCI.0850-13.2013; Kawasaki M., 2014, FRONT PSYCHOL, V5; Kawasaki M., 2014, FRONT HUM NEUROSCI, V8; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Ledberg A, 2007, CEREB CORTEX, V17, P44, DOI 10.1093/cercor/bhj123; Mazaheri A, 2006, P NATL ACAD SCI USA, V103, P2948, DOI 10.1073/pnas.0505785103; Perrin F., 1988, ELECTROENCEPHALOGRAP, V72, P184; Worden M. S., 2000, J NEUROSCI, V20, P1	58	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	SEP	2015	118						445	455		10.1016/j.neuroimage.2015.05.032		11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CQ5GB	WOS:000360630200043		
J	Kobashi, H; Kamiya, K; Igarashi, A; Miyake, T; Shimizu, K				Kobashi, Hidenaga; Kamiya, Kazutaka; Igarashi, Akihito; Miyake, Toshiyuki; Shimizu, Kimiya			Intraocular Scattering after Instillation of Diquafosol Ophthalmic Solution	OPTOMETRY AND VISION SCIENCE			English	Article							HIGHER-ORDER ABERRATIONS; DOUBLE-PASS INSTRUMENT; WAVE-FRONT SENSOR; EYE WORKSHOP 2007; BREAK-UP TIME; DRY EYE; TEAR-FILM; SERIAL MEASUREMENTS; QUALITY; TETRASODIUM	Purpose To assess the changes in intraocular scattering before and after instillation of diquafosol ophthalmic solution in patients with short tear breakup time (TBUT) dry eye. Methods We prospectively examined 20 eyes of 20 short TBUT dry eye patients (study group) and age-matched 20 eyes of 20 healthy subjects (control group). Intraocular scattering was measured as the objective scattering index (OSI) at 0.5-second intervals over 10 seconds without blinking. Patients were instructed to start topical administration of 3% diquafosol ophthalmic solution six times daily for 4 weeks. Results The OSI significantly deteriorated after 7.0 seconds compared with the initial value of OSI after the blinking in the study group. The OSI was also significantly higher in the study group than in the control group at 4.5 to 10.0 seconds after the blinking (p < 0.05). We found significant improvements 2 weeks after treatment not only in TBUT (p < 0.001) but also in the mean OSI, the OSI change rate, and the slope of the linear regression line of the OSI within 10 seconds (p < 0.001, p = 0.003, and p = 0.002, respectively). We also found significant improvements 4 weeks after treatment in these variables. Conclusions Intraocular scattering deteriorates significantly with time in patients with short TBUT dry eye. Diquafosol ophthalmic solution exhibits an improvement not only in TBUT but also in intraocular scattering, indicating that diquafosol is also effective for improving the optical quality of the eye.	[Kobashi, Hidenaga; Kamiya, Kazutaka; Igarashi, Akihito; Miyake, Toshiyuki; Shimizu, Kimiya] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa 2288555, Japan	Kobashi, H (reprint author), Kitasato Univ, Sch Med, Dept Ophthalmol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2288555, Japan.	himon@hotmail.co.jp					Montes-Mico R, 2004, OPHTHALMOLOGY, V111, P758, DOI 10.1016/j.ophtha.2003.06.027; Benito A, 2011, J CATARACT REFR SURG, V37, P1481, DOI 10.1016/j.jcrs.2011.03.036; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; TODA I, 1993, ACTA OPHTHALMOL, V71, P347; Thibos LN, 1999, OPTOMETRY VISION SCI, V76, P817, DOI 10.1097/00006324-199912000-00016; Bron AJ, 2007, OCUL SURF, V5, P108; Dougherty BE, 2011, INVEST OPHTH VIS SCI, V52, P8630, DOI 10.1167/iovs.11-8027; TODA I, 1995, OPHTHALMOLOGY, V102, P302; Kaido M, 2013, J OCUL PHARMACOL TH, V29, P595, DOI 10.1089/jop.2012.0246; Kamiya K, 2012, EYE, V26, P1363, DOI 10.1038/eye.2012.166; Nichols KK, 2004, EXPERT OPIN INV DRUG, V13, P47, DOI 10.1517/eoid.13.1.47.25281; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P1615, DOI 10.1167/iovs.05-0017; Vilaseca M, 2010, OPTOMETRY VISION SCI, V87, P675, DOI 10.1097/OPX.0b013e3181ea1ad3; Diaz-Douton F, 2006, INVEST OPHTH VIS SCI, V47, P1710, DOI 10.1167/iovs.05-1049; Tauber J, 2004, CORNEA, V23, P784, DOI 10.1097/01.ico.0000133993.14768.a9; Koh S, 2008, CORNEA, V27, P275, DOI 10.1097/ICO.0b013e31815be9c8; Fujihara T, 2001, INVEST OPHTH VIS SCI, V42, P96; Murakami T, 2004, OPHTHAL RES, V36, P89, DOI 10.1159/000076887; Koh S, 2002, AM J OPHTHALMOL, V134, P115, DOI 10.1016/S0002-9394(02)01430-7; Montes-Mico R, 2004, INVEST OPHTH VIS SCI, V45, P1752, DOI 10.1167/iovs.03-0839; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; Lemp MA, 2007, OCUL SURF, V5, P75; Matsumoto Y, 2012, OPHTHALMOLOGY, V119, P1954, DOI 10.1016/j.ophtha.2012.04.010; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Dartt DA, 2002, PROG RETIN EYE RES, V21, P555, DOI 10.1016/S1350-9462(02)00038-1; Diaz-Valle D, 2012, J CATARACT REFR SURG, V38, P1192, DOI 10.1016/j.jcrs.2012.02.040; Kobashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082427; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; Koh S, 2014, ACTA OPHTHALMOL, V92, pe671, DOI 10.1111/aos.12443; Koh S, 2006, INVEST OPHTH VIS SCI, V47, P3318, DOI 10.1167/iovs.06-0018; Lemp Michael A., 1995, CLAO Journal, V21, P221; SHIMMURA S, 1995, BRIT J OPHTHALMOL, V79, P1007, DOI 10.1136/bjo.79.11.1007	32	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	SEP	2015	92	9					E303	E309		10.1097/OPX.0000000000000490		7	Ophthalmology	Ophthalmology	CQ5IE	WOS:000360636200015		
J	Ogura, I; Kawashima, Y; Muramatsu, T; Ito, K; Kaneda, T				Ogura, Ichiro; Kawashima, Yusuke; Muramatsu, Teruaki; Ito, Kotaro; Kaneda, Takashi			Characteristic computed tomographic findings of midface fractures relative to the cause of injury: a fall or violence	ORAL RADIOLOGY			English	Article						Computed tomography; Midfacial fractures; Falls; Violence; Radiography	MAXILLOFACIAL FRACTURES; FACIAL TRAUMA; MANDIBULAR CONDYLAR; DOMESTIC VIOLENCE; DIAGNOSIS; CT	The aim of this study was to investigate the characteristic computed tomography (CT) findings of midface fractures in regard to falls and violence as their etiologies. A prospective study was performed in 104 patients with midface fractures resulting from falls or violence and who underwent 64-slice multidetector CT. The midface fracture locations were classified as Le Fort I-III, isolated anterior maxillary sinus, isolated zygomatic arch, zygomaticomaxillary complex, and blowout fractures. Statistical analysis to study the relation between the cause of the fractures (falls or violence) and their locations was performed using Fisher's exact test. A value of p < 0.05 was considered to be statistically significant. The proportions of fractures resulting from falls and violence, respectively, were 70.2 and 29.8 % of all midface fractures. When these categories were further examined, 77.3 and 22.7 % of zygomaticomaxillary complex fractures, respectively (p = 0.047), resulted from falls and violence, as did 43.8 and 56.2 % of isolated anterior maxillary sinus fractures (p = 0.018). This study suggests that zygomaticomaxillary complex midface fractures as seen on CT are more often caused by a fall, whereas midface isolated anterior maxillary sinus fractures are more often seen on CT images after an act of violence.	[Ogura, Ichiro; Kawashima, Yusuke; Muramatsu, Teruaki; Ito, Kotaro; Kaneda, Takashi] Nihon Univ, Sch Dent Matsudo, Dept Radiol, Matsudo, Chiba 2718587, Japan	Ogura, I (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Radiol, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	ogura.ichirou@nihon-u.ac.jp					Perciaccante VJ, 1999, J ORAL MAXIL SURG, V57, P760, DOI 10.1016/S0278-2391(99)90808-X; Schuknecht B, 2005, EUR RADIOL, V15, P560, DOI 10.1007/s00330-004-2631-7; Iida S, 2001, INT J ORAL MAX SURG, V30, P286, DOI 10.1054/ijom.2001.0056; Boeddinghaus R, 2008, EUR J RADIOL, V66, P396, DOI 10.1016/j.ejrad.2007.11.019; Yamamoto K, 2011, J ORAL MAXIL SURG, V69, P2204, DOI 10.1016/j.joms.2011.02.115; Yamamoto K, 2010, J ORAL MAXIL SURG, V68, P1602, DOI 10.1016/j.joms.2009.09.029; Chu ZG, 2011, J CRANIO MAXILL SURG, V39, P503, DOI 10.1016/j.jcms.2010.10.022; Hashemi HM, 2011, DENT TRAUMATOL, V27, P385, DOI 10.1111/j.1600-9657.2011.01016.x; Hopper RA, 2006, RADIOGRAPHICS, V26, P783, DOI 10.1148/rg.263045710; Imholz B, 2014, OR SURG OR MED OR PA, V117, P690, DOI 10.1016/j.oooo.2014.03.010; Matsumoto K, 2013, ORAL RADIOL, V29, P80, DOI 10.1007/s11282-012-0100-6; Ogura I, 2012, DENTOMAXILLOFAC RAD, V41, P392, DOI 10.1259/dmfr/67127210; Ogura I, 2014, JPN DENT SCI REV, V50, P86; Ogura I, 2014, EUR RADIOL, V24, P902, DOI 10.1007/s00330-013-3085-6; Patel R, 2012, SEMIN ULTRASOUND CT, V33, P410, DOI 10.1053/j.sult.2012.06.005; Salonen EM, 2010, DENTOMAXILLOFAC RAD, V39, P107, DOI 10.1259/dmfr/67015359; Salonen EM, 2008, EMERG RADIOL, V14, P241; Salonen EM, 2007, ACTA RADIOL, V48, P449, DOI 10.1080/02841850701199959; Simonds JS, 2011, AM J NEURORADIOL, V32, P468, DOI 10.3174/ajnr.A2337; Smith HL, 2013, DENT TRAUMATOL, V29, P313, DOI 10.1111/edt.12006; Sohns JM, 2013, CLIN IMAG, V37, P728, DOI 10.1016/j.clinimag.2012.11.002	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0911-6028	1613-9674		ORAL RADIOL	Oral Radiol.	SEP	2015	31	3					149	154		10.1007/s11282-014-0195-z		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ7CB	WOS:000360759300003		
J	Sisounthone, J; Ejima, K; Nakajima, I; Honda, K; Hosono, S; Vongsa, S; Matsumoto, K; Kuwata, F; Aboshi, H; Sidaphone, B; Lyvongsa, A; Ngonephady, S; Sitthiphanh, A; Otsuka, K; Katsumata, A; Fujita, H				Sisounthone, Johnny; Ejima, Ken-ichiro; Nakajima, Ichiro; Honda, Kazuya; Hosono, Shigeharu; Vongsa, Souksavanh; Matsumoto, Kunihito; Kuwata, Fumiyuki; Aboshi, Hirofumi; Sidaphone, Bounnhong; Lyvongsa, Akao; Ngonephady, Sengphouvanh; Sitthiphanh, Aloungnadeth; Otsuka, Kichibe; Katsumata, Akitoshi; Fujita, Hiroshi			Application of telemedicine to assess mandibular cortical width on panoramic images of dental patients in the Lao People's Democratic Republic	ORAL RADIOLOGY			English	Article						Mandibular cortical width; Osteoporosis; Laos; OSTEODENT; Telemedicine system	BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; DIAGNOSING OSTEOPOROSIS; OSTEODENT PROJECT; RADIOGRAPHS; PERFORMANCE	Mandibular cortical width (MCW) reference standards for osteoporosis screening have not yet been established in Laos, where panoramic radiography has recently been introduced. The present study was designed to determine the average MCW in Laotian people using panoramic radiography via telemedicine. MCW was measured in 519 patients who underwent diagnostic panoramic radiography at a Laos university. Images were transferred to a Japanese university using a telemedicine system. MCW was measured with a computer-aided diagnostic system and was classified by gender, age, and thickness according to OSTEODENT reference standards. The overall average MCW was 3.70-3.83 mm in men and 3.54 mm in females. The Mann-Whitney U test showed a statistically significant difference (P = 0. 04). MCW increased with age: 2.89 mm at age 0-19 years and 4.25 mm at > 60 years. The rate by gender for a parts per thousand currency sign3 mm cortical thickness of MCW was 34.1 % in men and 48.6 % in females. The average MCW was 3.50 mm in the 20-44 year age group and 3.88 mm in the 45-70 year age group. The connection for teleconferencing and data transmission went smoothly. This study used panoramic radiography to determine average MCW in Laotian people for the first time. MCW was thicker in males than in females and increased with age. Use of the telemedicine system will contribute to further developments in oral and maxillofacial radiology in Laos.	[Sisounthone, Johnny; Vongsa, Souksavanh; Sidaphone, Bounnhong; Lyvongsa, Akao; Ngonephady, Sengphouvanh; Sitthiphanh, Aloungnadeth] Univ Hlth Sci, Fac Dent, Viangchan, Laos; [Ejima, Ken-ichiro; Honda, Kazuya; Matsumoto, Kunihito] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chiyoda Ku, Tokyo 1018310, Japan; [Ejima, Ken-ichiro; Honda, Kazuya; Matsumoto, Kunihito] Nihon Univ, Sch Dent, Dent Res Ctr, Div Adv Dent Treatment, Tokyo 1018310, Japan; [Nakajima, Ichiro] Nihon Univ, Sch Dent, Dept Community Dent, Tokyo 1018310, Japan; [Nakajima, Ichiro; Kuwata, Fumiyuki] Nihon Univ, Sch Dent, Dent Res Ctr, Div Dent Educ, Tokyo 1018310, Japan; [Hosono, Shigeharu] Nihon Univ, Sch Med, Dept Pediat, Tokyo 1018310, Japan; [Kuwata, Fumiyuki] Nihon Univ, Sch Dent, Dept Chem, Tokyo 1018310, Japan; [Aboshi, Hirofumi] Nihon Univ, Sch Dent, Dept Legal Med, Tokyo 1018310, Japan; [Otsuka, Kichibe] Nihon Univ, Sch Dent, Dept Biochem, Tokyo 1018310, Japan; [Otsuka, Kichibe] Nihon Univ, Sch Dent, Dent Res Ctr, Div Funct Morphol, Tokyo 1018310, Japan; [Katsumata, Akitoshi] Asahi Univ, Sch Dent, Dept Oral Radiol, Gifu, Japan; [Fujita, Hiroshi] Gifu Univ, Grad Sch Med, Dept Intelligent Image Informat, Div Regenerat & Adv Med Sci, Gifu, Japan	Ejima, K (reprint author), Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	ejima.ken-ichiro@nihon-u.ac.jp			Nihon University President Grant Initiative; Sato Fund, Nihon University School of Dentistry	This work was supported by the Nihon University President Grant Initiative and a grant from the Sato Fund, Nihon University School of Dentistry.	Alexander BT, 2014, CLIN THER IN PRESS; Neves FS, 2012, OSTEOPOROSIS INT, V23, P2037, DOI 10.1007/s00198-011-1810-z; Arifin AZ, 2006, OSTEOPOROSIS INT, V17, P753, DOI 10.1007/s00198-005-0045-2; Taguchi A, 2003, J BONE MINER RES, V18, P1689, DOI 10.1359/jbmr.2003.18.9.1689; TAGUCHI A, 1995, ORAL SURG ORAL MED O, V80, P612, DOI 10.1016/S1079-2104(05)80158-1; Karayianni K, 2007, BONE, V40, P223, DOI 10.1016/j.bone.2006.07.025; Devlin H, 2007, ORAL SURG ORAL MED O, V104, P821, DOI 10.1016/j.tripleo.2006.12.027; PECK WA, 1993, AM J MED, V94, P646; Hekmatin E, 2013, J RES MED SCI, V18, P951; Horner K, 2002, J DENT, V30, P171, DOI 10.1016/S0300-5712(02)00010-6; Mochizuki N, 2014, ORAL RADIOL, V30, P160, DOI 10.1007/s11282-013-0155-z; Morita I, 2009, ORAL SURG ORAL MED O, V108, P777, DOI 10.1016/j.tripleo.2009.03.043; Muramatsu C, 2013, INT J COMPUT ASS RAD, V8, P877, DOI 10.1007/s11548-012-0800-8; Nakamoto T, 2003, OSTEOPOROSIS INT, V14, P659, DOI 10.1007/s00198-003-1419-y; Nicopoulou-Karayianni K, 2009, J CLIN PERIODONTOL, V36, P190, DOI 10.1111/j.1600-051X.2008.01365.x; Ramesh Aruna, 2013, Imaging Sci Dent, V43, P235, DOI 10.5624/isd.2013.43.4.235; Taguchi A, 2010, ORAL DIS, V16, P316, DOI 10.1111/j.1601-0825.2009.01615.x; Taguchi A, 2008, BONE, V43, P209, DOI 10.1016/j.bone.2008.03.014; Viengsakhone L, 2010, NAGOYA J MED SCI, V72, P51; Konstantinos VZ, 2007, MATURITAS, V58, P226, DOI 10.1016/j.maturitas.2007.08.014	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0911-6028	1613-9674		ORAL RADIOL	Oral Radiol.	SEP	2015	31	3					155	159		10.1007/s11282-015-0198-4		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ7CB	WOS:000360759300004		
J	Iikubo, M; Kamio, T; Hashimoto, N; Nishioka, T; Wakoh, M; Sano, T; Igarashi, C; Kobayashi, K; Seki, K; Katsumata, A; Ariji, E; Sasano, T; Sakamoto, M; Kojima, I				Iikubo, Masahiro; Kamio, Takashi; Hashimoto, Naoya; Nishioka, Takashi; Wakoh, Mamoru; Sano, Tsukasa; Igarashi, Chinami; Kobayashi, Kaoru; Seki, Kenji; Katsumata, Akitoshi; Ariji, Eiichiro; Sasano, Takashi; Sakamoto, Maya; Kojima, Ikuho			Comparison of bisecting and parallel intraoral radiography and cone-beam computed tomography for detecting various horizontal angle root fractures	ORAL RADIOLOGY			English	Article						Root fractures; Intraoral radiography; CBCT	DENTAL USE; ACCURACY; TEETH; CT	The aim of this study was to compare cone-beam computed tomography (CBCT) with intraoral radiography (parallel and bisecting techniques) for their detection capabilities of various horizontal angle root fractures in human teeth. Eighty-one extracted human upper central incisors were divided into three groups: (1) right-angle group (n = 27), in which a groove was formed perpendicular to the long axis of the root at the middle of the root; (2) 75-degree group (n = 27), which was grooved at 75A degrees in the cervical third of the root; and (3) 55-degree group (n = 27), which was grooved at 55A degrees in the middle third of the root. In an additional control group (n = 9), the teeth remained without grooves. The specimens were examined by the above-mentioned three imaging techniques by seven oral radiologists, and the grooves were visualized as radiolucent lines traversing the roots. The detection sensitivities for the parallel technique and CBCT were significantly greater than those for the bisecting technique for the right-angle and 75-degree groups, whereas the bisecting technique and CBCT showed significantly greater detection sensitivities than the parallel technique for the 55-degree group. There were no significant differences in specificity among the three imaging techniques. CBCT demonstrated high diagnostic accuracy for teeth with root fractures at any angle. When fracture lines are not located clearly by intraoral radiography at only one projection angle, additional intraoral radiography with different angles can improve detection.	[Iikubo, Masahiro; Hashimoto, Naoya; Nishioka, Takashi; Sasano, Takashi; Sakamoto, Maya; Kojima, Ikuho] Tohoku Univ, Grad Sch Dent, Dept Oral Diag, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kamio, Takashi; Wakoh, Mamoru] Tokyo Dent Coll, Dept Oral & Maxillofacial Radiol, Chiyoda Ku, Tokyo 1010061, Japan; [Sano, Tsukasa; Seki, Kenji] Showa Univ, Sch Dent, Dept Radiol, Tokyo 1428555, Japan; [Igarashi, Chinami; Kobayashi, Kaoru] Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Radiol & Diag, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan; [Katsumata, Akitoshi] Asahi Univ, Sch Dent, Dept Oral Radiol, Mizuho 5010296, Japan; [Ariji, Eiichiro] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chikusa Ku, Nagoya, Aichi 4648651, Japan	Iikubo, M (reprint author), Tohoku Univ, Grad Sch Dent, Dept Oral Diag, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	machapy@dent.tohoku.ac.jp		Katsumata, Akitoshi/0000-0001-5281-5234; Kamio, Takashi/0000-0002-2559-7443; Kojima, Ikuho/0000-0001-9660-8245	Japanese Association for Dental Science [2011B-5]	We are grateful to Prof. Tomohiro Okano (Department of Radiology, Showa University School of Dentistry) for critical reading of the manuscript and constructive advice. This work was supported in part by a Grant-in-Aid for Project Research (No. 2011B-5) from the Japanese Association for Dental Science	Hashimoto K, 2007, DENTOMAXILLOFAC RAD, V36, P465, DOI 10.1259/dmfr/22818643; Costa FF, 2011, J ENDODONT, V37, P1456, DOI 10.1016/j.joen.2011.05.040; Bornstein MM, 2009, DENT TRAUMATOL, V25, P571, DOI 10.1111/j.1600-9657.2009.00833.x; Iikubo M, 2009, ORAL SURG ORAL MED O, V108, pE70, DOI 10.1016/j.tripleo.2009.07.009; Katsumata A, 2006, ORAL SURG ORAL MED O, V101, P652, DOI 10.1016/j.tripleo.2005.07.027; Arai Y, 1999, DENTOMAXILLOFAC RAD, V28, P245, DOI 10.1038/sj.dmfr.4600448; Flores MT, 2007, DENT TRAUMATOL, V23, P66, DOI 10.1111/j.1600-9657.2007.00592.x; Caliskan MK, 1996, ENDOD DENT TRAUMATOL, V12, P129; DEGERING CI, 1970, ORAL SURG ORAL MED O, V30, P213, DOI 10.1016/0030-4220(70)90364-6; Farman TT, 2000, DENTOMAXILLOFAC RAD, V29, P41, DOI 10.1038/sj.dmfr.4600499; Higashi T, 1979, ORAL RADIOLOGY; Honda K, 2000, JPN J TOMOGR, V27, P193; Kamburoglu K, 2009, DENT TRAUMATOL, V25, P256, DOI 10.1111/j.1600-9657.2009.00770.x; Nair MK, 2002, DENTOMAXILLOFAC RAD, V31, P299, DOI 10.1038/sj.dmfr.4600712; Nakagawa Y, 2002, INT J ORAL MAX SURG, V31, P322, DOI 10.1054/ijom.2001.0222	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0911-6028	1613-9674		ORAL RADIOL	Oral Radiol.	SEP	2015	31	3					173	180		10.1007/s11282-015-0201-0		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ7CB	WOS:000360759300007		
J	Yoshida, H; Yasuda, N; Hayashi, T; Tsuji, K; Wato, M; Gamoh, S; Shimizutani, K; Tanaka, A; Masaki, Y; Morita, S				Yoshida, Hiroaki; Yasuda, Norihiro; Hayashi, Teruyoshi; Tsuji, Kaname; Wato, Masahiro; Gamoh, Shoko; Shimizutani, Kimishige; Tanaka, Akio; Masaki, Yasufumi; Morita, Shosuke			A case of probable IgG4-related disease involving the unilateral trigeminal nerve of the cheek region	ORAL RADIOLOGY			English	Article						Immunoglobulin G (IgG); Immunoglobulin G4 (IgG4); Trigeminal nerve computed tomography (CT); Magnetic resonance imaging (MRI); Positron emission tomography (PET)	CHRONIC SCLEROSING DACRYOADENITIS; INFLAMMATORY PSEUDOTUMOR; SYSTEMIC-DISEASE; PLASMA-CELLS; PANCREATITIS; SPECTRUM	Immunoglobulin G4 (IgG4)-related disease comprises a recently recognized systemic syndrome characterized by mass-forming lesions that are found mainly in exocrine tissue and consist of lymphoplasmacytic infiltrates and sclerosis. There are numerous IgG4-positive plasma cells in the affected tissues, and the serum IgG4 level is increased in patients. The subject was a 77-year-old man with pathologically provable IgG4-related disease involving the unilateral trigeminal nerve in the left cheek region. A tumor-like lesion measuring 40 x 15 x 15 mm in the soft tissues of the left cheek was observed on computed tomography and magnetic resonance imaging, and extended along the infraorbital nerves to the anterior region of the maxilla. The mass was hypointense on T2-weighted images and showed mild contrast enhancement. Positron emission tomography showed accumulation in the left cheek (SUVmax: 3.9). Lymphoid follicles of various sizes surrounded by fibrosis were seen in the resected tumor. Immunostaining for IgG and IgG4 showed diffuse distribution of IgG- and IgG4-positive plasma cells in the interfollicular area, and the ratio of IgG4-positive plasma cells to IgG-positive plasma cells was 59 %. IgG4-related disease of the head and neck may be suggested by the combination of clinical signs and symptoms and radiologic findings of an infiltrative mass lesion. Although a definitive diagnosis cannot presently be obtained using IgG4-related disease comprehensive diagnostic criteria, we concluded that the present case was IgG4-related disease based on the good clinical course.	[Yoshida, Hiroaki; Yasuda, Norihiro; Hayashi, Teruyoshi; Tsuji, Kaname; Morita, Shosuke] Osaka Dent Univ, Dept Oral & Maxillofacial Surg 1, Chuo Ku, Osaka 5400008, Japan; [Wato, Masahiro; Tanaka, Akio] Osaka Dent Univ, Dept Oral Pathol, Osaka 5400008, Japan; [Gamoh, Shoko; Shimizutani, Kimishige] Osaka Dent Univ, Dept Oral Radiol, Osaka 5400008, Japan; [Masaki, Yasufumi] Kanazawa Med Univ, Dept Hematol & Immunol, Kanazawa, Ishikawa, Japan	Yoshida, H (reprint author), Osaka Dent Univ, Dept Oral & Maxillofacial Surg 1, Chuo Ku, 1-5-17 Otemae, Osaka 5400008, Japan.	hiro-y@cc.osaka-dent.ac.jp					Kase S, 2013, ANTICANCER RES, V33, P2779; Takahira M, 2007, ARCH OPHTHALMOL-CHIC, V125, P1575, DOI 10.1001/archopht.125.11.1575; Zen Y, 2005, HUM PATHOL, V36, P710, DOI 10.1016/j.humpath.2005.05.011; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Ishida M, 2009, PATHOL INT, V59, P670, DOI 10.1111/j.1440-1827.2009.02425.x; Sato Y, 2008, PATHOL INT, V58, P465, DOI 10.1111/j.1440-1827.2008.02257.x; Cheuk W, 2007, AM J SURG PATHOL, V31, P643, DOI 10.1097/01.pas.0000213445.08902.11; Wong S, 2007, HUM PATHOL, V38, P1720, DOI 10.1016/j.humpath.2007.06.011; Wallace ZS, 2012, SURV OPHTHALMOL, V57, P26, DOI 10.1016/j.survophthal.2011.07.004; Mehta M, 2009, ARCH PATHOL LAB MED, V133, P1251, DOI 10.1043/1543-2165-133.8.1251; Zen Y, 2004, AM J SURG PATHOL, V28, P1193, DOI 10.1097/01.pas.0000136449.37936.6c; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Katsura M, 2011, AJNR Am J Neuroradiol, V32, pE150, DOI 10.3174/ajnr.A2256; Kitagawa S, 2005, AM J SURG PATHOL, V29, P783, DOI 10.1097/01.pas.0000164031.59940.fc; Kojima Masaru, 2010, J Clin Exp Hematop, V50, P39; Masaki Yasufumi, 2011, J Clin Exp Hematop, V51, P13; Romano A, 2012, DENTOMAXILLOFAC RAD, V41, P432, DOI 10.1259/dmfr/43068020; Sato Y, 2010, J CLIN EXP HEMATOP, V52, P51; Sato Y, 2010, PATHOL INT, V60, P247, DOI 10.1111/j.1440-1827.2010.02524.x; Sumi T, 2012, ORAL RADIOL, V28, P140, DOI 10.1007/s11282-012-0085-1; Taniguchi T, 2004, GUT, V53, P770; Yamamoto M, 2006, MOD RHEUMATOL, V16, P335	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0911-6028	1613-9674		ORAL RADIOL	Oral Radiol.	SEP	2015	31	3					193	198		10.1007/s11282-014-0190-4		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ7CB	WOS:000360759300010		
J	Kumahashi, N; Sward, P; Larsson, S; Lohmander, LS; Frobell, R; Struglics, A				Kumahashi, N.; Sward, P.; Larsson, S.; Lohmander, L. S.; Frobell, R.; Struglics, A.			Type II collagen C2C epitope in human synovial fluid and serum after knee injury - associations with molecular and structural markers of injury	OSTEOARTHRITIS AND CARTILAGE			English	Article						Biomarkers; Collagen; C2C; Knee injury; Synovial fluid	ANTERIOR CRUCIATE LIGAMENT; AGGRECAN ARGS FRAGMENTS; PROTEOGLYCAN FRAGMENTS; JOINT FLUID; RADIOGRAPHIC PROGRESSION; INFLAMMATORY ARTHRITIS; CARTILAGE TURNOVER; OSTEOARTHRITIS; BIOMARKERS; BONE	Purpose: Investigate in a cross-sectional study time-dependent changes of synovial fluid type II collagen epitope C2C concentrations after knee injury and correlate to other joint injury biomarkers. Methods: Synovial fluid samples were aspirated between 0 days and 7 years after injury (n = 235). Serum was collected from 71 of the knee injured patients. Synovial fluid from 8 knee-healthy subjects was used as reference. C2C was quantified by immunoassay and structural injury was determined from magnetic resonance images (MRI) of the injured knee acquired 1-38 days after injury (n = 98). Additional joint injury biomarker results were from earlier investigations of the same samples. Results: Synovial fluid C2C concentrations were higher in injured knees than in knees of reference subjects from 1 day up to 7 years after injury. C2C concentrations in synovial fluid and serum were correlated (r = 0.403, P < 0.001). In synovial fluid from subjects early after injury (0-33 days), C2C concentrations were correlated with cross-linked C-telopeptide of type II collagen (r = 0.444, P = 0.003), ARGS-aggrecan (r = 0.337, P < 0.001), osteocalcin (r = 0.345, P < 0.001), osteopontin (r = 0.371, P < 0.001) and IL-8 (r = -0.385, P < 0.001), but not with structural joint injury as visualized on MRI. Conclusion: The increased levels of synovial fluid C2C after injury, together with the associations seen with several other injury-related biomarkers, suggest that an acute knee injury is associated with an immediate and sustained local degradation of type II collagen. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Kumahashi, N.; Sward, P.; Larsson, S.; Lohmander, L. S.; Frobell, R.; Struglics, A.] Lund Univ, Dept Clin Sci Lund, Orthopaed, Lund, Sweden; [Kumahashi, N.] Shimane Univ, Dept Orthopaed, Izumo, Shimane 6938501, Japan; [Lohmander, L. S.] Univ Southern Denmark, Res Unit Musculoskeletal Funct & Physiotherapy, Odense, Denmark; [Lohmander, L. S.] Univ Southern Denmark, Dept Orthopaed & Traumatol, Odense, Denmark	Kumahashi, N (reprint author), Shimane Univ, Sch Med, Dept Orthoped, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	n-kuma@med.shimane-u.ac.jp			Swedish Research Council; Crafoord Foundation; Faculty of Medicine Lund University; Thelma Zoegas fund; King Gustaf V 80-year Birthday Fund; Kock Foundation; Swedish Rheumatism Association; Alfred Osterlunds Foundation; Swedish National Centre for Research in Sports	Funding for this work was provided as project grants from the Swedish Research Council (RF), the Crafoord Foundation (AS, RF), the Faculty of Medicine Lund University (AS, RF), Thelma Zoegas fund (RF), the King Gustaf V 80-year Birthday Fund (AS), the Kock Foundation (AS), the Swedish Rheumatism Association (AS), the Alfred Osterlunds Foundation (AS) and the Swedish National Centre for Research in Sports (PS).	Irie K, 2003, KNEE, V10, P93, DOI 10.1016/S0968-0160(02)00083-2; Simkin PA, 2011, J RHEUMATOL, V38, P2635, DOI 10.3899/jrheum.110785; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Sward P, 2012, OSTEOARTHR CARTILAGE, V20, P1302, DOI 10.1016/j.joca.2012.07.021; Mullan RH, 2007, ARTHRITIS RHEUM, V56, P2919, DOI 10.1002/art.22843; Struglics A, 2011, OSTEOARTHR CARTILAGE, V19, P1047, DOI 10.1016/j.joca.2011.05.006; Frobell RB, 2008, OSTEOARTHR CARTILAGE, V16, P829, DOI 10.1016/j.joca.2007.11.003; Lohmander LS, 2003, ARTHRITIS RHEUM, V48, P3130, DOI 10.1002/art.11326; Matyas JR, 2004, ARTHRITIS RHEUM, V50, P543, DOI 10.1002/art.20027; Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P181; LOHMANDER LS, 1994, ANN RHEUM DIS, V53, P8, DOI 10.1136/ard.53.1.8; Pan J, 2012, BONE, V51, P212, DOI 10.1016/j.bone.2011.11.030; Ivaska KK, 2004, J BIOL CHEM, V279, P18361, DOI 10.1074/jbc.M314324200; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; DeSilva B, 2003, PHARM RES, V20, P1885, DOI 10.1023/B:PHAM.0000003390.51761.3d; Svoboda SJ, 2013, AM J SPORT MED, V41, P2108, DOI 10.1177/0363546513494180; Mazzuca SA, 2006, J RHEUMATOL, V33, P1147; Yoshida H, 2013, OSTEOARTHR CARTILAGE, V21, P831, DOI 10.1016/j.joca.2013.03.009; Lohmander LS, 1999, ARTHRITIS RHEUM, V42, P534, DOI 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J; Higuchi H, 2006, INT ORTHOP, V30, P43, DOI 10.1007/s00264-005-0023-5; Sward P, 2014, AM J SPORT MED, V42, P1096, DOI 10.1177/0363546514524924; Cibere J, 2009, ARTHRITIS RHEUM-US, V60, P1372, DOI 10.1002/art.24473; Cahue S, 2007, OSTEOARTHR CARTILAGE, V15, P819, DOI 10.1016/j.joca.2007.01.016; Catterall JB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3216; DAHLBERG L, 1992, ACTA ORTHOP SCAND, V63, P417, DOI 10.3109/17453679209154758; Eckstein F, 2015, ARTHRITIS RHEUMATOL, V67, P152, DOI 10.1002/art.38881; Jayadev C, 2012, J IMMUNOL METHODS, V386, P22, DOI 10.1016/j.jim.2012.08.012; JUBB RW, 1980, J PATHOL, V130, P159, DOI 10.1002/path.1711300304; Kijowski R, 2012, RADIOLOGY, V264, P531, DOI 10.1148/radiol.12112171; King KB, 2004, MAGN RESON IMAGING, V22, P1117, DOI 10.1016/j.mri.2004.08.001; Kojima T, 2001, ARTHRITIS RHEUM, V44, P120, DOI 10.1002/1529-0131(200101)44:1<120::AID-ANR16>3.0.CO;2-X; Kojima T, 2008, MENOPAUSE, V15, P133, DOI 10.1097/gme.0b013e318054e2ce; Larsson S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2735; Larsson S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3217; LOHMANDER LS, 1989, ARTHRITIS RHEUM, V32, P1434, DOI 10.1002/anr.1780321113; Poole AR, 2004, J IMMUNOL METHODS, V294, P145, DOI 10.1016/j.jim.2004.09.005; Price JS, 1999, ARTHRITIS RHEUM, V42, P2390, DOI 10.1002/1529-0131(199911)42:11<2390::AID-ANR18>3.0.CO;2-9; Trumble TN, 2009, OSTEOARTHR CARTILAGE, V17, P371, DOI 10.1016/j.joca.2008.07.014	39	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	SEP	2015	23	9					1506	1512		10.1016/j.joca.2015.04.022		7	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CQ5ON	WOS:000360655000009		
J	Park, Y; Hosomichi, J; Ge, C; Xu, J; Franceschi, R; Kapila, S				Park, Y.; Hosomichi, J.; Ge, C.; Xu, J.; Franceschi, R.; Kapila, S.			Immortalization and characterization of mouse temporomandibular joint disc cell clones with capacity for multi-lineage differentiation	OSTEOARTHRITIS AND CARTILAGE			English	Article						TMJ disc; Fibrocartilage cells; Immortalization; Fibroblast-like cell clones; Chondrocyte-like cell clones; Multi-lineage potential	RABBIT CRANIOMANDIBULAR JOINT; GROWTH-FACTORS; PROTEOGLYCAN EXPRESSION; IDENTIFICATION; DISORDERS; SYMPTOMS; ELEMENT; MATRIX; GENE; PAIN	Objective: Despite the importance of temporomandibular joint (TMJ) disc in normal function and disease, studying the responses of its cells has been complicated by the lack of adequate characterization of the cell subtypes. The purpose of our investigation was to immortalize, clone, characterize and determine the multi-lineage potential of mouse TMJ disc cells. Design: Cells from 12-week-old female mice were cultured and immortalized by stable transfection with human telomerase reverse transcriptase (hTERT). The immortalized cell clones were phenotyped for fibroblast-or chondrocyte-like characteristics and ability to undergo adipocytic, osteoblastic and chondrocytic differentiation. Results: Of 36 isolated clones, four demonstrated successful immortalization and maintenance of stable protein expression for up to 50 passages. Two clones each were initially characterized as fibroblast-like and chondrocyte-like on the basis of cell morphology and growth rate. Further the chondrocyte-like clones had higher mRNA expression levels of cartilage oligomeric matrix protein (COMP) (>3.5-fold), collagen X (>11-fold), collagen II expression (2-fold) and collagen II: I ratio than the fibroblast-like clones. In contrast, the fibroblast-like clones had higher mRNA expression level of vimentin (>1.5-fold), and fibroblastic specific protein 1 (>2.5-fold) than the chondrocyte-like clones. Both cell types retained multi-lineage potential as demonstrated by their capacity to undergo robust adipogenic, osteogenic and chondrogenic differentiation. Conclusions: These studies are the first to immortalize TMJ disc cells and characterize chondrocyte-like and fibroblast-like clones with retained multi-differentiation potential that would be a valuable resource in studies to dissect the behavior of specific cell types in health and disease and for tissue engineering. (C) 2015 The Authors.	[Park, Y.; Hosomichi, J.; Xu, J.; Kapila, S.] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA; [Hosomichi, J.] Tokyo Med & Dent Univ, Grad Sch, Dept Orthodont Sci, Tokyo, Japan; [Ge, C.; Franceschi, R.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	Kapila, S (reprint author), Univ Michigan, 1011 North Univ Ave, Ann Arbor, MI 48109 USA.	skapila@umich.edu			National Institutes of Health/National Institute of Dental and Craniofacial Research [R01 DE018455, K12 DE023574]	This study was supported by grants R01 DE018455 and K12 DE023574 from the National Institutes of Health/National Institute of Dental and Craniofacial Research. We wish to thank Dr Takayuki Hayami for his help with the statistical analyses.	Almarza AJ, 2006, ARCH ORAL BIOL, V51, P215, DOI 10.1016/j.archoralbio.2005.07.002; MILLS DK, 1988, ARCH ORAL BIOL, V33, P195, DOI 10.1016/0003-9969(88)90045-3; Santos KCP, 2013, J ORAL MAXIL SURG, V71, P1504, DOI 10.1016/j.joms.2013.04.033; Almarza AJ, 2005, ANN BIOMED ENG, V33, P943, DOI 10.1007/s10439-005-3311-8; Kalpakci KN, 2011, J DENT RES, V90, P193, DOI 10.1177/0022034510381501; DWORKIN SF, 1990, J AM DENT ASSOC, V120, P273; Detamore MS, 2003, J BIOMECH ENG-T ASME, V125, P558, DOI 10.1115/1.1589778; Zaucke F, 2001, BIOCHEM J, V358, P17, DOI 10.1042/0264-6021:3580017; MILAM SB, 1991, J ORAL MAXIL SURG, V49, P381, DOI 10.1016/0278-2391(91)90376-W; Kalpakci KN, 2011, ACTA BIOMATER, V7, P1710, DOI 10.1016/j.actbio.2010.12.015; Detamore MS, 2006, J ORAL MAXIL SURG, V64, P243, DOI 10.1016/j.joms.2005.10.009; Allen KD, 2008, J DENT RES, V87, P180; Detamore MS, 2003, J ORAL MAXIL SURG, V61, P494, DOI 10.1053/joms.2003.50096; Landesberg R, 1996, ARCH ORAL BIOL, V41, P761, DOI 10.1016/S0003-9969(96)00068-4; Mao JJ, 1998, J DENT RES, V77, P1520; Allen KD, 2007, TISSUE ENG, V13, P101, DOI 10.1089/ten.2006.0094; Beek M, 2001, J DENT RES, V80, P1913; Nakano T, 1996, ARCH ORAL BIOL, V41, P845, DOI 10.1016/S0003-9969(96)00040-4; Beek M, 2001, J DENT RES, V80, P876; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tanaka E, 2006, J ORAL MAXIL SURG, V64, P1221, DOI 10.1016/j.joms.2006.04.017; NAKANO T, 1989, ARCH ORAL BIOL, V34, P749, DOI 10.1016/0003-9969(89)90082-4; Ahmad N, 2012, MOL CELL ENDOCRINOL, V363, P46, DOI 10.1016/j.mce.2012.07.006; Almarza AJ, 2004, TISSUE ENG, V10, P1787, DOI 10.1089/ten.2004.10.1787; MILLS DK, 1994, J ORAL MAXIL SURG, V52, P1279, DOI 10.1016/0278-2391(94)90051-5; Allen KD, 2006, TISSUE ENG, V12, P1183, DOI 10.1089/ten.2006.12.1183; Benjamin M, 2004, INT REV CYTOL, V233, P1, DOI 10.1016/S0074-7696(04)33001-9; Berkovitz BKB, 2000, ARCH ORAL BIOL, V45, P987, DOI 10.1016/S0003-9969(00)00067-4; Carini Francesco, 2007, Italian Journal of Anatomy and Embryology, V112, P267; Cortés Daniel, 2011, Cranio, V29, P117; Detamore MS, 2004, ARCH ORAL BIOL, V49, P577, DOI 10.1016/j.archoralbio.2004.01.015; Eberhard L, 2013, DENTOMAXILLOFAC RAD, V42, P201; Garzon I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051961; KAPILA S, 1995, J DENT RES, V74, P1328; Leonandi R, 2012, ARCH ORAL BIOL, V57, P614, DOI 10.1016/j.archoralbio.2011.12.004; LIPTON JA, 1993, J AM DENT ASSOC, V124, P115; Manfredini D, 2004, Minerva Stomatol, V53, P429; Mills David K., 1994, Journal of Orofacial Pain, V8, P136; NAGY NB, 1992, ARCH ORAL BIOL, V37, P271, DOI 10.1016/0003-9969(92)90049-E; Nakao Y, 2015, J DENT RES, V94, P93, DOI 10.1177/0022034514553816; Ohrbach R, 2011, J PAIN, V12, pT27, DOI 10.1016/j.jpain.2011.09.001; Okada H, 1998, AM J PHYSIOL-RENAL, V275, pF306; Plesh O, 2005, J OROFAC PAIN, V19, P65; Rees LA, 1954, BRIT DENT J, V96, P125; Scapino RP, 1996, ARCH ORAL BIOL, V41, P1039, DOI 10.1016/S0003-9969(96)00079-9; Segu M, 2011, MINERVA STOMATOL, V60, P349; Sindelar BJ, 2000, ARCH BIOCHEM BIOPHYS, V379, P64, DOI 10.1006/abbi.2000.1855; Sperber GH, 2001, CRANIOFACIAL DEV; Wang LM, 2009, ARCH ORAL BIOL, V54, P1, DOI 10.1016/j.archoralbio.2008.06.002; Wang W, 2009, OSTEOARTHR CARTILAGE, V17, P646, DOI 10.1016/j.joca.2008.09.015	50	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	SEP	2015	23	9					1532	1542		10.1016/j.joca.2015.04.006		11	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CQ5ON	WOS:000360655000012		
J	Iijima, H; Aoyama, T; Ito, A; Yamaguchi, S; Nagai, M; Tajino, J; Zhang, X; Kuroki, H				Iijima, H.; Aoyama, T.; Ito, A.; Yamaguchi, S.; Nagai, M.; Tajino, J.; Zhang, X.; Kuroki, H.			Effects of short-term gentle treadmill walking on subchondral bone in a rat model of instability-induced osteoarthritis	OSTEOARTHRITIS AND CARTILAGE			English	Article						Osteoarthritis; Bone mu CT; Exercise; Osteoclasts; Subchondral bone cyst	ARTICULAR-CARTILAGE; EXERCISE; OSTEOCLASTOGENESIS; HISTOPATHOLOGY; DEGENERATION; DESTRUCTION; PROGRESSION; ALENDRONATE; PREVENTION; DAMAGE	Objective: Subchondral bone cyst (SBC) growth, caused by osteoclast activity during early knee osteoarthritis (OA) pathogenesis, should be treated to prevent further progressions of OA. In the present study, we evaluated the effects of gentle treadmill walking on subchondral bone and cartilage changes in an experimental rat model of destabilized medial meniscus (DMM). Method: Twelve-week-old Wistar rats underwent DMM surgery in their right knee and sham surgery in their left knee and were assigned to either the sedentary group or walking group (n = 42/group). Animals in the walking group were subjected to treadmill exercise 2 days after surgery, which included walking for 12 m/min, 30 min/day, 5 days/week for 1, 2, and 4 week(s). Subchondral bone and cartilage changes were evaluated by micro-CT analysis, histological analysis, and biomechanical analysis. Results: Treadmill walking had a tendency to suppress SBC growth, which was confirmed by micro-CT (P = 0.06) and positive staining for tartrate-resistant acid phosphatase (TRAP) activity for the osteoclast number per bone surface (P = 0.09) 4 weeks after surgery. These changes coincide with the prevention of cartilage degeneration as evaluated by the Osteoarthritis Research Society International (OARSI) score (P < 0.05) and biomechanically softening (P < 0.05). Furthermore, treadmill walking could suppressed increasing osteocyte deaths (P < 0.01), which was positively correlated with the OARSI score (r = 0.77; P < 0.01). Conclusion: These results indicate biomechanical and biological links exist between cartilage and subchondral bone; preventive effects of treadmill walking on subchondral bone deterioration might be partly explained by the chondroprotective effects. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Iijima, H.; Ito, A.; Yamaguchi, S.; Nagai, M.; Tajino, J.; Zhang, X.; Kuroki, H.] Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci, Kyoto 6068501, Japan; [Aoyama, T.] Kyoto Univ, Grad Sch Med, Dept Dev & Rehabil Motor Funct, Human Hlth Sci, Kyoto 6068501, Japan	Kuroki, H (reprint author), 53 Shogoin,Sakyo Ku, Kyoto 6068507, Japan.	iijima.hirotaka.75s@st.kyoto-u.ac.jp; aoyama.tomoki.4e@kyoto-u.ac.jp; ito.akira.27n@st.kyoto-u.ac.jp; yamaguchi.shouki.26n@st.kyoto-u.ac.jp; nagai.momoko.36v@st.kyoto-u.ac.jp; tajino.junichi.57z@st.kyoto-u.ac.jp; zhang.xiangkai.48v@st.kyoto-u.ac.jp; kuroki.hiroshi.6s@kyoto-u.ac.jp			JSPS KAKENHI [25242055, 25560258]	This study was supported in part by a JSPS KAKENHI Grant-in-Aid for Scientific Research (A) (no. 25242055) and a JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research (no. 25560258).	Jaiprakash A, 2012, INT J BIOL SCI, V8, P406, DOI 10.7150/ijbs.4221; Siebelt M, 2014, BONE, V66, P163, DOI 10.1016/j.bone.2014.06.009; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Botter SM, 2009, OSTEOARTHR CARTILAGE, V17, P636, DOI 10.1016/j.joca.2008.09.018; McErlain DD, 2008, OSTEOARTHR CARTILAGE, V16, P458, DOI 10.1016/j.joca.2007.08.006; Bloecker K, 2013, OSTEOARTHR CARTILAGE, V21, P419, DOI 10.1016/j.joca.2012.11.015; Botter SM, 2008, OSTEOARTHR CARTILAGE, V16, P506, DOI 10.1016/j.joca.2007.08.005; Westacott CI, 1997, ARTHRITIS RHEUM, V40, P1282, DOI 10.1002/1529-0131(199707)40:7<1282::AID-ART13>3.0.CO;2-E; Hayami T, 2004, ARTHRITIS RHEUM, V50, P1193, DOI 10.1002/art.20124; Iijima H, 2014, OSTEOARTHR CARTILAGE, V22, P1036, DOI 10.1016/j.joca.2014.05.009; Cifuentes DJ, 2010, OSTEOARTHR CARTILAGE, V18, P1088, DOI 10.1016/j.joca.2010.04.004; Galois L, 2004, OSTEOARTHR CARTILAGE, V12, P779, DOI 10.1016/j.joca.2004.06.008; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.20883; Franciozi CES, 2013, OSTEOARTHR CARTILAGE, V21, P965, DOI 10.1016/j.joca.2013.04.007; Norrdin RW, 1998, BONE, V22, P133, DOI 10.1016/S8756-3282(97)00253-6; Ni GX, 2013, BIOMED RES INT, DOI 10.1155/2013/172392; Botter SM, 2011, ARTHRITIS RHEUM-US, V63, P2690, DOI 10.1002/art.30307; Maurel DB, 2011, BONE, V49, P543, DOI 10.1016/j.bone.2011.06.001; Boudenot A, 2014, OSTEOARTHR CARTILAGE, V22, P1176, DOI 10.1016/j.joca.2014.05.020; Cao L, 2006, J BIOMECH ENG-T ASME, V128, P766, DOI 10.1115/1.2246237; Chang TK, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-185; Cox LGE, 2011, BONE, V49, P762, DOI 10.1016/j.bone.2011.06.028; DISHMAN RK, 1988, PHYSIOL BEHAV, V43, P541, DOI 10.1016/0031-9384(88)90206-5; Fonseca H, 2011, CALCIFIED TISSUE INT, V88, P443, DOI 10.1007/s00223-011-9476-2; Iijima H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-101; Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI [10.1359/jbmr.080207, 10.1359/JBMR.080207]; Lane NE, 2010, ANN NY ACAD SCI, V1192, P81, DOI 10.1111/j.1749-6632.2009.05228.x; Martinez-Calatrava MJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3884; McErlain DD, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3727; Shimizu S, 2007, ARTHRITIS RHEUM, V56, P3358, DOI 10.1002/art.22941; Siebelt M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4461; Yamaguchi S, 2013, J ORTHOP RES, V31, P1026, DOI 10.1002/jor.22332; Yuan XL, 2014, OSTEOARTHR CARTILAGE, V22, P1077, DOI 10.1016/j.joca.2014.05.023	36	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	SEP	2015	23	9					1563	1574		10.1016/j.joca.2015.04.015		12	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CQ5ON	WOS:000360655000015		
J	Kamiyama, R; Mitani, H; Yonekawa, H; Fukushima, H; Sasaki, T; Shimbashi, W; Seto, A; Koizumi, Y; Ebina, A; Kawabata, K				Kamiyama, Ryosuke; Mitani, Hiroki; Yonekawa, Hiroyuki; Fukushima, Hirofumi; Sasaki, Toru; Shimbashi, Wataru; Seto, Akira; Koizumi, Yuh; Ebina, Aya; Kawabata, Kazuyoshi			A Clinical Study of Pharyngolaryngectomy with Total Esophagectomy: Postoperative Complications, Countermeasures, and Prognoses	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						hypopharyngeal cancer; esophagectomy; complications; mortality	SQUAMOUS-CELL CARCINOMA; CANCER; HYPOPHARYNX; CHEMORADIOTHERAPY; RESECTION; CHEMOTHERAPY; ESOPHAGUS; TRENDS; HEAD	Objective Patients with advanced hypopharyngeal or cervical esophageal cancer have a comparatively high risk of also developing thoracic esophageal cancer. Pharyngolaryngectomy with total esophagectomy is highly invasive, and few reports about it exist. We examined the postoperative complications and respective countermeasures and prognoses of patients who underwent pharyngolaryngectomy with total esophagectomy. Study Design Case series with chart review. Setting Department of Head and Neck Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Japan. Subjects and Methods We examined the postoperative complications and respective countermeasures and prognoses of 40 patients who underwent pharyngolaryngectomy with total esophagectomy in our hospital. Results Postoperative complications were observed in 23 patients (57.5%) and consisted of 8 groups: tracheal region necrosis in 5 patients; neck abscess formation/wound infection in 5; fistula in 4; tracheostomy suture leakage in 2; ileus in 2; lymphorrhea in 2; pulmonary complications in 2; and other complications, including hemothorax, tracheoinnominate artery fistula, temporary cardiac arrest due to intraoperative mediastinum operation, methicillin-resistant Staphylococcus aureus enteritis, and sepsis, in 1 patient each. A lethal complicationbrachiocephalic vein hemorrhage due to tracheostomy suture leakage and hemorrhagic shock due to tracheoinnominate artery fistulaoccurred in 2 (5%) patients. The crude 5-year survival rate was 48.6%. Conclusions Serious postoperative complications were related to tracheostomaplasty. Although pharyngolaryngectomy with total esophagectomy is highly invasive, we believe that our outlined treatment method is the most appropriate for cases of advanced hypopharyngeal or cervical esophageal cancer that also requires concurrent surgery for esophageal cancer.	[Kamiyama, Ryosuke; Mitani, Hiroki; Yonekawa, Hiroyuki; Fukushima, Hirofumi; Sasaki, Toru; Shimbashi, Wataru; Seto, Akira; Koizumi, Yuh; Ebina, Aya; Kawabata, Kazuyoshi] Japanese Fdn Canc Res, Dept Head & Neck Oncol, Canc Inst Hosp, Tokyo 1358550, Japan	Kamiyama, R (reprint author), Japanese Fdn Canc Res, Dept Head & Neck Oncol, Canc Inst Hosp, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	ryosuke.kamiyama@jfcr.or.jp					Ohtsu A, 1999, J CLIN ONCOL, V17, P2915; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Ferahkose Z, 2008, DIS ESOPHAGUS, V21, P340, DOI 10.1111/j.1442-2050.2007.00781.x; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Muto M, 2002, CARCINOGENESIS, V23, P1759, DOI 10.1093/carcin/23.10.1759; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Suzuki G, 2014, ANTICANCER RES, V34, P1989; Orringer MB, 2007, ANN SURG, V246, P363, DOI 10.1097/SLA.0b013e31814697f2; Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002; Triboulet JP, 2001, ARCH SURG-CHICAGO, V136, P1164, DOI 10.1001/archsurg.136.10.1164; LEFEBVRE JL, 1987, HEAD NECK-J SCI SPEC, V10, P14, DOI 10.1002/hed.2890100104; Chou SH, 2010, WORLD J SURG, V34, P1832, DOI 10.1007/s00268-010-0595-0; Chu PY, 2004, J LARYNGOL OTOL, V118, P443; Dudhat SB, 1999, EUR J SURG ONCOL, V25, P82, DOI 10.1053/ejso.1998.0605; Elias D, 1998, ANN SURG ONCOL, V5, P511, DOI 10.1007/BF02303643; Hoffman HT, 1997, LARYNGOSCOPE, V107, P1005, DOI 10.1097/00005537-199708000-00001; International Union Against Cancer (UICC), 2009, TNM CLASSIFICATION M; Ishi H, 2012, J JPN BRONCHOESOPHAG, V63, P443; Lindenmann J, 2008, ANN THORAC SURG, V85, P354, DOI 10.1016/j.athoracsur.2007.06.044; Nishimaki T, 2002, INT SURG, V87, P38; Shuangba He, 2011, Am J Otolaryngol, V32, P275, DOI 10.1016/j.amjoto.2010.05.002; Taguchi T, 2014, CANCER CHEMOTH PHARM, V73, P1147, DOI 10.1007/s00280-014-2448-2; Tanaka S, 2005, JAPANESE J HEAD NECK, V31, P548; VANDENBROUCK C, 1987, HEAD NECK-J SCI SPEC, V10, P4, DOI 10.1002/hed.2890100103; Wei WI, 1998, HEAD NECK-J SCI SPEC, V20, P240, DOI 10.1002/(SICI)1097-0347(199805)20:3<240::AID-HED9>3.0.CO;2-0	26	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	SEP	2015	153	3					392	399		10.1177/0194599815591965		8	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CQ5SP	WOS:000360666300011		
J	Yamamoto, N; Okuyama, H; Hiraumi, H; Sakamoto, T; Matsuura, H; Ito, J				Yamamoto, Norio; Okuyama, Hideaki; Hiraumi, Harukazu; Sakamoto, Tatsunori; Matsuura, Hitomi; Ito, Juichi			The Outcome of Cochlear Implantation for Mitochondrial Disease Patients With Syndromic Hearing Loss	OTOLOGY & NEUROTOLOGY			English	Article						Cochlear implantation; Cognitive problem; Long-term outcome; Mitochondrial disease; Syndromic deafness	KEARNS-SAYRE-SYNDROME; MELAS-SYNDROME; MUTATION; DEAFNESS	Objectives To evaluate the outcome and to confirm the validity of cochlear implantation for syndromic deafness in patients with mitochondrial disease. Study Design Retrospective case review. Setting Tertiary referral center. Patients We reviewed medical charts of 367 cochlear implantation cases at Kyoto University Hospital between 1987 and 2012. We identified five patients with syndromic mitochondrial disease who underwent cochlear implantation surgery. The mean age of the patients (four women and one man) when they underwent surgeries was 44.4 years (range, 30-64 yr; median, 41 yr). Interventions Therapeutic and rehabilitative. Main Outcome Measure In four of five patients, speech perception performance was measured using Japanese vowels, consonant-vowel syllables, and short sentences. Results Only 1.4% (5 of 367) of cochlear implantation cases at Kyoto University Hospital underwent cochlear implantation surgery because of syndromic mitochondrial diseases. Four of those patients showed significantly improved speech perception outcomes, and the beneficial effects of the intervention continued long after surgery. One patient could not perform speech perception test presumably because of poor cognitive function. Conclusion Mitochondrial disease patients who underwent cochlear implantation surgery sustained gains in hearing performance even long after surgery. A single patient showed poor postoperative speech perception associated with cognitive problems. Cochlear implantation for mitochondrial disease patients seems to be a viable treatment option in the absence of significant cognitive impairment.	[Yamamoto, Norio; Hiraumi, Harukazu; Sakamoto, Tatsunori; Matsuura, Hitomi; Ito, Juichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Kyoto, Japan; [Okuyama, Hideaki] Tenri Hosp, Dept Otolaryngol, Tenri, Nara 632, Japan	Yamamoto, N (reprint author), 54 Shogoin Kawahara Cho,Sakyo Ku, Kyoto, Kyoto 6060815, Japan.	yamamoto@ent.kuhp.kyoto-u.ac.jp	Sakamoto, Tatsunori/N-3046-2015; 	Sakamoto, Tatsunori/0000-0001-6669-7013; , Norio/0000-0001-8924-0710	JSPS KAKENHI [24592545]; Ministry of Education, Culture, Sports, Science and Technology in Japan [23229009]; Japan Society for the Promotion of Science	This project was supported by JSPS KAKENHI (a Grant-in-Aid for Scientific Research [C] [24592545] to N.Y. and a Grant-in-Aid for Scientific Research [S] [23229009] to J.I.) from the Ministry of Education, Culture, Sports, Science and Technology in Japan and by the Japan Society for the Promotion of Science.	Tono T, 1998, AM J OTOL, V19, P754; Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82; Fricker RM, 2002, ANESTHESIOLOGY, V97, P1635, DOI 10.1097/00000542-200212000-00044; Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012; Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Counter PR, 2001, J LARYNGOL OTOL, V115, P730; Cullington HE, 1999, J LARYNGOL OTOL, V113, P353; ELVERLAND HH, 1991, AM J OTOL, V12, P459; Hill D, 2001, J NEUROL NEUROSUR PS, V71, P281, DOI 10.1136/jnnp.71.2.281; Hiraumi H, 2007, ACTA OTO-LARYNGOL, V127, P17, DOI 10.1080/03655230601065225; Karkos PD, 2005, EUR ARCH OTO-RHINO-L, V262, P322, DOI 10.1007/s00405-004-0817-x; Lerman J, 2011, BRIT J ANAESTH, V107, P79, DOI 10.1093/bja/aer335; Li JN, 2011, ACTA OTO-LARYNGOL, V131, P1012, DOI 10.3109/00016489.2011.579623; Mancuso M, 2004, ACTA NEUROL SCAND, V110, P72, DOI 10.1111/j.1600-0404.2004.00254.x; Nishizaki K, 1999, ACTA OTO-LARYNGOL, P34; Pijl S, 2008, EAR HEARING, V29, P472, DOI 10.1097/01.aud.0000310791.83193.62; Raut V, 2002, J LARYNGOL OTOL, V116, P373; Rosenthal EL, 1999, AM J OTOL, V20, P187; Rosenthal EL, 1999, AM J OTOL, V20, P190; Scarpelli M., 2012, GENET RES INT, V2012; Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313; Ulubil SA, 2006, J LARYNGOL OTOL, V120, P230, DOI 10.1017/S002221510500318X; Yamaguchi T, 1997, ADV OTO-RHINO-LARYNG, V52, P321; Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010; Yasumura S, 2003, ACTA OTO-LARYNGOL, V123, P55, DOI 10.1080/0036554021000028081; Zwirner P, 2001, LARYNGOSCOPE, V111, P515, DOI 10.1097/00005537-200103000-00024	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	SEP	2015	36	8					E129	E133		10.1097/MAO.0000000000000817		5	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CQ3FX	WOS:000360488500002		
J	Sugimoto, DT				Sugimoto, David T.			STRATIGRAPHY OF TEL 'EN GEV, ISRAEL: CORRELATION AMONG THREE ARCHAEOLOGICAL MISSIONS	PALESTINE EXPLORATION QUARTERLY			English	Article						Tel 'En Gev; stratigraphy; Iron Age; Geshur; Aram	EXCAVATIONS; GESHUR; GALILEE	Archaeological excavations have been conducted at Tel 'En Gev, Israel, by three archaeological missions: a group of Israeli archaeologists headed by B. Mazar (1961), the Japanese Archaeological Project in the Biblical Land (1990-2004), and Keio University, Japan (2009-2011). Mazar and others detected five Iron Age strata in the 'lower city' and four in the 'upper city'. On the other hand, the Japanese mission found only two strata from the Iron Age and one each for Persian, Hellenistic, and Early Roman periods, while Keio University uncovered three Iron Age strata and one Persian-Hellenistic stratum. Therefore, until date, no coherent timeframe has been established for the site. In this paper, the evidence gathered by the three groups will be examined and compared to reconstruct a coherent picture of the historical development of Tel 'En Gev.	Keio Univ, Tokyo, Japan	Sugimoto, DT (reprint author), Keio Univ, Tokyo, Japan.	dt-cedar@keio.jp					Aharoni Yohanan, 1979, LAND BIBLE HIST GEOG; Albright W. F., 1943, BASOR, V89, P7; Na'aman N, 2002, ISRAEL EXPLOR J, V52, P200; Na'aman N, 2012, SCAND J OLD TESTAM, V26, P88, DOI 10.1080/09018328.2012.704198; Arav R., 2008, NEW ENCY ARCHAEOLOGI, V5, P1611; Arav R., 2004, BETHSAIDA CITY N SHO, V3; Arav R, 2000, ISRAEL EXPLOR J, V50, P47; Arav R., 1995, BETHSAIDA CITY N SHO, V1; Arie E., 2008, TEL AVIV, V35, P6; Dothan M., 1975, ERLSR, V12, P63; Fritz V., 1999, TEL AVIV, V26, P92; Fritz V, 2002, Z DEUT PALASTINA-VER, V118, P2; Hafporsson S., 2006, CONIETANEA BIBLIA OL, V54; Hasegawa S, 2012, VETUS TESTAMENTUM, V62, P501, DOI 10.1163/156853312X645272; Kochavi M., 1998, JUSTITIA SUPPLEMENT, P25; Kochavi M., 2008, NEW ENCY ARCHAEOLOGI, V5, P1756; Kochavi M., 1993, NEW ENCY ARCHAEOLOGI, V2, P551; KOCHAVI M, 1991, ISRAEL EXPLOR J, V41, P180; Kochavi M., 1992, BAR, V18-4, p[30, 84]; Lipinski E., 2000, ORIENTALIA LOVANIENS, V100; Mazar A., 2005, BIBLE RADIOCARBON DA, P15; Mazar B., 1961, JBL, V80, P16, DOI 10.2307/3264563; Mazar B., 1984, IEJ, V14, P1; Munger S, 2011, NEAR EAST ARCHAEOL, V74, P68; Munger S., 2013, ARAMAEANS CHALDEANS, P149; Pakkala J., 2013, SCANDINAVIAN J OLD T, V27, P226; Pakkala J, 2010, SCAND J OLD TESTAM, V24, P155, DOI 10.1080/09018328.2010.527071; Rapuano Y., 2001, HADASHOT ARKHELOGYOT, V113; Sugimoto D. T., 2012, SHIGAKU, V81, P191; Sugimoto D. T., 2009, TELEN GEV 1998 2004, P29; Sugimoto D. T., 2010, HADASHOT ARKHEOLOGIY, V122; Sugimoto D. T., 2005, B SOC NEAR E STUDIES, V48, P1; Sugimoto D. T., 2015, ORIENT, V50, P91; Sugimoto D. T., 2010, SHIGAKU, V79, P87; Sugimoto DT, 2014, ISRAEL EXPLOR J, V64, P9; Sugimoto D.T., 2011, SHIGAKU, V80, P71; Tsukimoto A., 2009, TELEN GEV E SHORE SE	37	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0031-0328	1743-1301		PALEST EXPLOR Q	Palest. Explor. Q.	SEP	2015	147	3					195	219		10.1179/1743130114Y.0000000014		25	Archaeology; History	Archaeology; History	CQ4RZ	WOS:000360593600004		
J	Honma, N; Hosoi, T; Arai, T; Takubo, K				Honma, Naoko; Hosoi, Takayuki; Arai, Tomio; Takubo, Kaiyo			Estrogen and cancers of the colorectum, breast, and lung in postmenopausal women	PATHOLOGY INTERNATIONAL			English	Review						breast cancer; colorectal cancer; elderly; lung cancer; postmenopausal	HORMONE REPLACEMENT THERAPY; BODY-MASS INDEX; RECEPTOR-BETA; REPEAT POLYMORPHISM; PLUS PROGESTIN; COLON-CANCER; ER-BETA; RISK; CARCINOMA; SURVIVAL	As estrogens play an important role in maintaining physiological function in various organs, the estrogen decrease after menopause is thought to cause various diseases frequently observed in postmenopausal or elderly women. With the aging of society and a decrease in infectious or vascular diseases, neoplasms have now become the most frequent cause of death in Japan. Cancers of the colorectum, breast, and lung have been rapidly increasing both in incidence and death, especially among postmenopausal women. Interestingly, all three of these cancers are associated with estrogens. In premenopausal women, ovarian estrogens plays major roles in the female reproductive organs through the classic estrogen receptor, ER-. In postmenopausal women, however, estrogens produced/activated by peripherally localized estrogen-metabolizing enzymes such as aromatase, which converts androgen into estrogens, are thought to play physiologically and pathobiologically important roles in various organs through second ER, namely ER-, distributing systemically. In this article, the association of estrogens with these cancers in postmenopausal or elderly women are reviewed, especially focusing on the role of ER- and peripheral estrogen metabolism. The possibility of prevention or treatment of these diseases through estrogenic control is also discussed.	[Honma, Naoko; Takubo, Kaiyo] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Hosoi, Takayuki] Kenkoin Med Corp, Kenkoin Clin, Inst Prevent Med, Tokyo, Japan; [Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan	Honma, N (reprint author), Toho Univ, Sch Med, Dept Pathol, Ota Ku, 21-16 Omori Nishi, Tokyo 1438540, Japan.	naoko.honma@med.toho-u.ac.jp			JSPS/MEXT KAKENHI [17590324, 19590376, 22590328, 25460429]; Ministry of Health, Labour and Welfare of Japan [17-7]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This review was made possible by the support of JSPS/MEXT KAKENHI (17590324, 19590376, 22590328, 25460429), and Grant-in-Aid for Cancer Research no. 17-7 from the Ministry of Health, Labour and Welfare of Japan, and The Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank all our collaborative researchers who were involved in our studies.	ADAMI HO, 1989, INT J CANCER, V44, P833, DOI 10.1002/ijc.2910440515; Beral V, 2002, LANCET, V360, P942, DOI 10.1016/S0140-6736(02)11032-4; [Anonymous], 2013, CANC STAT JAP 2013; Crivellari D, 2007, J CLIN ONCOL, V25, P1882, DOI 10.1200/JCO.2006.10.2079; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Honma N, 2003, HISTOPATHOLOGY, V42, P120, DOI 10.1046/j.1365-2559.2003.01542.x; Rudolph A, 2013, CANCER RES, V73, P3306, DOI 10.1158/0008-5472.CAN-12-4051; Honma N, 2013, INT J CANCER, V132, P951, DOI 10.1002/ijc.27688; Ganti AK, 2006, J CLIN ONCOL, V24, P59, DOI 10.1200/JCO.2005.02.9827; Sasano H, 2009, PATHOL INT, V59, P777, DOI 10.1111/j.1440-1827.2009.02444.x; Zervoudakis A, 2011, J NATL CANCER I, V103, P826, DOI 10.1093/jnci/djr101; Wong NACS, 2005, J PATHOL, V207, P53, DOI 10.1002/path.1807; Gunter MJ, 2008, CANCER RES, V68, P329, DOI 10.1158/0008-5472.CAN-07-2946; Honma N, 2011, CANCER SCI, V102, P1848, DOI 10.1111/j.1349-7006.2011.02018.x; Mah V, 2011, LUNG CANCER, V74, P318, DOI 10.1016/j.lungcan.2011.03.009; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Iwasaki M, 2008, J CLIN ONCOL, V26, P1677, DOI 10.1200/JCO.2007.13.9964; CALLE EE, 1995, J NATL CANCER I, V87, P517, DOI 10.1093/jnci/87.7.517; Ogawa S, 1998, NUCLEIC ACIDS RES, V26, P3505, DOI 10.1093/nar/26.15.3505; Simon MS, 2012, J CLIN ONCOL, V30, P3983, DOI 10.1200/JCO.2012.42.7732; Chlebowski RT, 2010, J NATL CANCER I, V102, P1413, DOI 10.1093/jnci/djq285; ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618; Wisnivesky JP, 2007, J CLIN ONCOL, V25, P1705, DOI 10.1200/JCO.2006.08.1455; Lim WY, 2012, AM J EPIDEMIOL, V175, P492, DOI 10.1093/aje/kwr332; Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555; TAIOLI E, 1994, J NATL CANCER I, V86, P869, DOI 10.1093/jnci/86.11.869; Traynor AM, 2009, LUNG CANCER, V64, P51, DOI 10.1016/j.lungcan.2008.07.002; Slattery ML, 2001, CANCER RES, V61, P126; Clendenen TV, 2009, CANCER EPIDEM BIOMAR, V18, P275, DOI 10.1158/1055-9965.EPI-08-0777; Honma N, 2008, J CLIN ONCOL, V26, P3727, DOI 10.1200/JCO.2007.14.2968; Mahabir S, 2006, CANCER EPIDEM BIOMAR, V15, P2502, DOI 10.1158/1055-9965.EPI-06-0499; Sato R, 2009, CANCER RES, V69, P914, DOI 10.1158/0008-5472.CAN-08-0906; Arai T, 2010, GERIATR GERONTOL INT, V10, pS207, DOI 10.1111/j.1447-0594.2010.00590.x; Barone M, 2008, GENES NUTR, V3, P7, DOI 10.1007/s12263-008-0081-6; Bouchardy C, 2011, CANCER-AM CANCER SOC, V117, P1288, DOI 10.1002/cncr.25638; Burns TF, 2014, LUNG CANC MANAG, V3, P43; Chakraborty S, 2014, EXPERT REV RESP MED, V4, P509; Dhebri AR, 2012, BMJ CASE REP; Honma N, 2006, J CLIN ENDOCR METAB, V91, P607, DOI 10.1210/jc.2005-1967; Honma Naoko, 2014, Nihon Rinsho, V72, P49; Honma N, 2011, HISTOPATHOLOGY, V59, P216, DOI 10.1111/j.1365-2559.2011.03914.x; Kawai Hideki, 2014, World J Clin Oncol, V5, P1020, DOI 10.5306/wjco.v5.i5.1020; Kennelly R, 2008, LANCET ONCOL, V9, P385, DOI 10.1016/S1470-2045(08)70100-1; Limsui D, 2012, GUT, V61, P1299, DOI 10.1136/gutjnl-2011-300719; Lonning PE, 2009, J STEROID BIOCHEM, V117, P31, DOI 10.1016/j.jsbmb.2009.06.005; MALUF HM, 1995, AM J SURG PATHOL, V19, P1237, DOI 10.1097/00000478-199511000-00003; MILLER WR, 1982, CANCER RES, V42, P3365; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321; Rudolph A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-817; Shimazu T, 2011, CANCER EPIDEM BIOMAR, V20, P419, DOI 10.1158/1055-9965.EPI-10-1025; Slattery ML, 2005, CANCER EPIDEM BIOMAR, V14, P2936, DOI 10.1158/1055-9965.EPI-05-0514; Tsukamoto K, 1998, J HUM GENET, V43, P73, DOI 10.1007/s100380050043; Verma MK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-167; Verma MK, 2012, LIFE SCI, V91, P800, DOI 10.1016/j.lfs.2012.08.029; Yamashita A, 1994, J JAP SOC CLIN SURG, V55, P2726	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	SEP	2015	65	9					451	459		10.1111/pin.12326		9	Pathology	Pathology	CQ7EO	WOS:000360766000001		
J	Koshi, H; Sano, T; Handa, T; Yanagawa, T; Saitou, K; Nagamori, S; Kanai, Y; Takagishi, K; Oyama, T				Koshi, Hiromi; Sano, Takaaki; Handa, Tadashi; Yanagawa, Takashi; Saitou, Kenichi; Nagamori, Shushi; Kanai, Yoshikatsu; Takagishi, Kenji; Oyama, Tetsunari			L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors	PATHOLOGY INTERNATIONAL			English	Article						bone tumors; CD98; L-type amino acid transporter-1; immunohistochemistry; soft tissue tumors	CELL LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; HEAVY-CHAIN; 1 LAT1; SYSTEM; PET; ACTIVATION; CARCINOMA; SARCOMA	L-type amino acid transporter-1 (LAT1) is expressed in many cancers. We examined LAT1 and CD98 expression immunohistochemically in surgically resected specimens of various bone and soft tissue tumors. Out of 226 cases, 79 (35%) were LAT1(+) and 95 (42%) were CD98(+). In bone tumors, LAT1 was highly expressed in osteoblastoma (89%), chondrosarcoma (50%), and osteosarcoma (60%); in soft tissue tumors, LAT1 was highly expressed in rhabdomyosarcoma (80%), synovial sarcoma (63%), Ewing's sarcoma (60%), epithelioid sarcoma (100%) and angiosarcoma (100%). In malignant soft tissue tumors, LAT1 expression was associated with higher histological grade. High CD98 expression was seen in many bone tumors of intermediate and high malignancy. Among soft tissue tumors, CD98 was expressed in tendon sheath giant cell tumor and malignant peripheral nerve sheath tumor (57%), Ewing's sarcoma (50%) and undifferentiated sarcoma (64%). Some of the malignant soft tissue tumors expressed both LAT1 and CD98. This study showed that LAT1 and CD98 was expressed in many malignant and intermediate bone tumors, and some malignant soft tissue tumors.	[Koshi, Hiromi; Sano, Takaaki; Handa, Tadashi; Oyama, Tetsunari] Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Maebashi, Gumma 3718511, Japan; [Koshi, Hiromi; Yanagawa, Takashi; Saitou, Kenichi; Takagishi, Kenji] Gunma Univ, Grad Sch Med, Dept Orthoped Surg, Maebashi, Gumma 3718511, Japan; [Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Pharmacol, Osaka, Japan	Koshi, H (reprint author), Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	m11702013@gunma-u.ac.jp					Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Guillou L, 1997, J CLIN ONCOL, V15, P350; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Nobusawa A, 2013, EUR J NUCL MED MOL I, V40, P1692, DOI 10.1007/s00259-013-2477-9; Tomiyoshi K, 1997, NUCL MED COMMUN, V18, P169, DOI 10.1097/00006231-199702000-00013; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Inoue T, 1999, J NUCL MED, V40, P399; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Kaira K, 2009, LUNG CANCER, V66, P120, DOI 10.1016/j.lungcan.2008.12.015; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; Nakanishi K, 2007, VIRCHOWS ARCH, V451, P681, DOI 10.1007/s00428-007-0457-9; Kaira K, 2012, BRIT J CANCER, V107, P632, DOI 10.1038/bjc.2012.310; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Edge SB, 2010, AJCC CANC STAGING MA; Fletcher Ch, 2013, WHO CLASSIFICATION T; Imai H, 2009, HISTOPATHOLOGY, V54, P804, DOI 10.1111/j.1365-2559.2009.03300.x; Kim CS, 2008, BIOL PHARM BULL, V31, P1096, DOI 10.1248/bpb.31.1096; Kim SG, 2006, ANTICANCER RES, V26, P1989; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Ohkame H, 2001, J SURG ONCOL, V78, P265, DOI 10.1002/jso.1165; Segawa A, 2013, MOL CLIN ONCOL, V1, P274; Watanabe H, 2000, EUR J NUCL MED, V27, P1509, DOI 10.1007/s002590000344	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	SEP	2015	65	9					460	467		10.1111/pin.12323		8	Pathology	Pathology	CQ7EO	WOS:000360766000002		
J	Konishi, E; Nakashima, Y; Mano, M; Tomita, Y; Nagasaki, I; Kubo, T; Araki, N; Haga, H; Toguchida, J; Ueda, T; Sakuma, T; Imahori, M; Morii, E; Yoshikawa, H; Tsukamoto, Y; Futani, H; Wakasa, K; Hoshi, M; Hamada, S; Takeshita, H; Inoue, T; Aono, M; Kawabata, K; Murata, H; Katsura, K; Urata, Y; Ueda, H; Yanagisawa, A				Konishi, Eiichi; Nakashima, Yasuaki; Mano, Masayuki; Tomita, Yasuhiko; Nagasaki, Ikumitsu; Kubo, Toshikazu; Araki, Nobuhito; Haga, Hironori; Toguchida, Junya; Ueda, Takafumi; Sakuma, Toshiko; Imahori, Masaya; Morii, Eiichi; Yoshikawa, Hideki; Tsukamoto, Yoshitane; Futani, Hiroyuki; Wakasa, Kenichi; Hoshi, Manabu; Hamada, Shinshichi; Takeshita, Hideyuki; Inoue, Takeshi; Aono, Masanari; Kawabata, Kenji; Murata, Hiroaki; Katsura, Kanade; Urata, Yoji; Ueda, Hideki; Yanagisawa, Akio			Primary central chondrosarcoma of long bone, limb girdle and trunk: Analysis of 174 cases by numerical scoring on histology	PATHOLOGY INTERNATIONAL			English	Article						grade; pathology; prognosis; primary central chondrosarcoma; statistical analysis	PROGNOSTIC-FACTORS; RELIABILITY; DIAGNOSIS; SURVIVAL	The aims of this study were: (i) to elucidate clinicopathological characteristics of pcCHS of long bones (L), limb girdles (LG) and trunk (T) in Japan; (ii) to investigate predictive pathological findings for outcome of pcCHS of L, LG and T, objectively; and (iii) to elucidate a discrepancy of grade between biopsy and resected specimens. Clinicopathological profiles of 174 pcCHS (79 male, 95 female), of L, LG, and T were retrieved. For each case, a numerical score was given to 18 pathological findings. The average age was 50.5 years (15-80 years). Frequently involved sites were femur, humerus, pelvis and rib. The 5-year and 10-year disease-specific survival (DSS) rates [follow-up: 1-258 months (average 65.5)] were 87.0% and 80.4%, respectively. By Cox hazards analysis on pathological findings, age, sex and location, histologically higher grade and older age were unfavorable predictors, and calcification was a favorable predictor in DSS. The histological grade of resected specimen was higher than that of biopsy in 37.7% (26/69 cases). In conclusion, higher histological grade and older age were predictors for poor, but calcification was for good prognosis. Because there was a discrepancy in grade between biopsy and resected specimens, comprehensive evaluation is necessary before definitive operation for pcCHS.	[Konishi, Eiichi; Yanagisawa, Akio] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Pathol, Kyoto, Kyoto 6028566, Japan; [Nagasaki, Ikumitsu] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Math, Kyoto, Kyoto 6028566, Japan; [Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Orthoped, Kyoto, Kyoto 6028566, Japan; [Nakashima, Yasuaki; Haga, Hironori] Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto 6068501, Japan; [Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068501, Japan; [Katsura, Kanade] Japanese Red Cross Kyoto Daini Hosp, Dept Pathol, Kyoto, Japan; [Urata, Yoji] Japanese Red Cross Kyoto Daiichi Hosp, Dept Pathol, Kyoto, Japan; [Ueda, Hideki] Japanese Red Cross Kyoto Daiichi Hosp, Dept Orthoped Surg, Kyoto, Japan; [Mano, Masayuki] Osaka Natl Hosp, Dept Pathol, Osaka, Japan; [Ueda, Takafumi] Osaka Natl Hosp, Dept Orthopaed Surg, Osaka, Japan; [Tomita, Yasuhiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka, Japan; [Araki, Nobuhito] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Orthoped Surg, Osaka, Japan; [Wakasa, Kenichi] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka, Japan; [Hoshi, Manabu] Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan; [Inoue, Takeshi] Osaka City Gen Hosp, Dept Pathol, Osaka, Japan; [Aono, Masanari] Osaka City Gen Hosp, Dept Orthoped Surg, Osaka, Japan; [Sakuma, Toshiko] Hyogo Canc Ctr, Dept Pathol, Akashi, Hyogo, Japan; [Imahori, Masaya] Hyogo Canc Ctr, Dept Orthoped Surg, Akashi, Hyogo, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan; [Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan; [Tsukamoto, Yoshitane] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Futani, Hiroyuki] Hyogo Coll Med, Dept Orthopaed Surg, Nishinomiya, Hyogo 6638501, Japan; [Hamada, Shinshichi] Otsu Municipal Hosp, Dept Pathol, Otsu, Shiga, Japan; [Takeshita, Hideyuki] Otsu Municipal Hosp, Dept Orthoped Surg, Otsu, Shiga, Japan; [Kawabata, Kenji] Matsushita Mem Hosp, Dept Pathol, Moriguchi, Osaka, Japan; [Murata, Hiroaki] Matsushita Mem Hosp, Dept Orthoped Surg, Moriguchi, Osaka, Japan	Konishi, E (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med, Dept Pathol, Kamigyo Ku, Kawaramachi Hirokoji, Kyoto, Kyoto 6028566, Japan.	konie@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25462349]	The study was partly funded by Ministry of Education, Culture, Sports, Science and Technology, Japan (EK, MM, HT and AY, Grant no. 25462349).	Lee FY, 1999, J BONE JOINT SURG AM, V81A, P326; Fiorenza F, 2002, J BONE JOINT SURG BR, V84B, P93, DOI 10.1302/0301-620X.84B1.11942; HENDERSON ED, 1963, J BONE JOINT SURG AM, V45, P1450; LIU J, 1987, CANCER, V59, P1376, DOI 10.1002/1097-0142(19870401)59:7<1376::AID-CNCR2820590725>3.0.CO;2-F; Mavrogenis AF, 2012, ORTHOPEDICS, V35, pE379, DOI 10.3928/01477447-20120222-30; Andreou D, 2011, ACTA ORTHOP, V82, P749, DOI 10.3109/17453674.2011.636668; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; GITELIS S, 1981, J BONE JOINT SURG AM, V63, P1248; EVANS HL, 1977, CANCER, V40, P818, DOI 10.1002/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B; Eefting D, 2009, AM J SURG PATHOL, V33, P50, DOI 10.1097/PAS.0b013e31817eec2b; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; MANKIN HJ, 1980, J BONE JOINT SURG AM, V62, P160; Bjornsson J, 1998, CANCER, V83, P2105; Giuffrida AY, 2009, J BONE JOINT SURG AM, V91A, P1063, DOI 10.2106/JBJS.H.00416; PRITCHARD DJ, 1980, CANCER, V45, P149, DOI 10.1002/1097-0142(19800101)45:1<149::AID-CNCR2820450125>3.0.CO;2-A; Angelini A, 2012, J SURG ONCOL, V106, P929, DOI 10.1002/jso.23173; Chagin Andrei S, 2007, Pediatr Endocrinol Rev, V4, P329; DAHLIN DC, 1956, J BONE JOINT SURG AM, V38, P1025; Fletcher Ch, 2013, WHO CLASSIFICATION T; Jones KB, 2007, J BONE JOINT SURG AM, V89A, P2113, DOI 10.2106/JBJS.F.01530; MIRRA JM, 1985, CLIN ORTHOP RELAT R, P214; ONEAL LW, 1952, CANCER, V5, P551, DOI 10.1002/1097-0142(195205)5:3<551::AID-CNCR2820050317>3.0.CO;2-Z; Riedel RF, 2009, CURR TREAT OPTION ON, V10, P94, DOI 10.1007/s11864-009-0088-2; Rizzo M, 2001, CLIN ORTHOP RELAT R, P224; SANERKIN NG, 1980, CANCER, V45, P582, DOI 10.1002/1097-0142(19800201)45:3<582::AID-CNCR2820450326>3.0.CO;2-#; SCHILLER AL, 1985, SEMIN DIAGN PATHOL, V2, P42; The Japanese Orthopaedic Association Committee of Tumors, 2000, GEN RUL CLIN PATH ST, V3rd; Unni KK, 2010, DAHLINS BONE TUMORS	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	SEP	2015	65	9					468	475		10.1111/pin.12324		8	Pathology	Pathology	CQ7EO	WOS:000360766000003		
J	Yoshida, M; Ichikawa, A; Miyoshi, H; Kiyasu, J; Kimura, Y; Niino, D; Ohshima, K				Yoshida, Maki; Ichikawa, Ayako; Miyoshi, Hiroaki; Kiyasu, Junichi; Kimura, Yoshizo; Niino, Daisuke; Ohshima, Koichi			Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma	PATHOLOGY INTERNATIONAL			English	Article						BCL2; Burkitt lymphoma; double-hit lymphoma; MYC	B-CELL LYMPHOMA	Translocations involving MYC are highly characteristic for Burkitt lymphoma (BL). BCL2 expression has also been found previously in about 10 to 20% of BL cases, and BCL2 translocation is a major mechanism for the deregulation of BCL2 expression in non-Hodgkin lymphomas. However, we know little about the incidence of MYC/BCL2 double-hit (DH) in BL. We examined BL cases to determine how frequently they contained BCL2 translocations in combination with MYC translocations using fluorescence in situ hybridization. We also determined the effect of BCL2 expression on clinical outcomes of BL. BCL2 translocations were detected in 3.5% (2/57 cases) of the cases, and BCL2 expression was detected in 33%. Two cases with BCL2 translocation also showed BCL2 expression. The incidence of BCL2 expression was significantly higher in patients 16 years of age and older (46%) than in patients under 16 years of age (6%). Among patients 16 years of age and older, we did not detect significant differences in overall survival with respect to BCL2 expression status. In conclusion, BCL2 translocation is a rare cytogenetic abnormality in BL, and BL probably accounts for only a small fraction of MYC/BCL2 DH lymphomas. BCL2 expression in BL is probably not associated with BCL2 translocations.	[Yoshida, Maki; Ichikawa, Ayako; Miyoshi, Hiroaki; Kiyasu, Junichi; Kimura, Yoshizo; Niino, Daisuke; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan	Yoshida, M (reprint author), Kurume Univ, Sch Med, Dept Pathol, Asahimachi 67, Kurume, Fukuoka 8300011, Japan.	yoshida_maki@med.kurume-u.ac.jp					Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Mounier N, 2003, BLOOD, V101, P4279, DOI 10.1182/blood-2002-11-3442; Johnson NA, 2009, BLOOD, V114, P2273, DOI 10.1182/blood-2009-03-212191; Georgious P, 2001, BRIT J HAEMATOL, V113, P383; Jaffe E, 2008, WHO CLASSIFICATION T, P267; McClure RE, 2005, AM J SURG PATHOL, V29, P1652, DOI 10.1097/01.pas.0000180442.87022.08; Monni O, 1997, BLOOD, V90, P1168; Nakamura N, 2002, MODERN PATHOL, V15, P771, DOI 10.1097/01.MP.0000019577.73786.64; Nomura Y, 2008, CANCER SCI, V99, P1564, DOI 10.1111/j.1349-7006.2008.00851.x; Weremowicz S, 2007, CURR PROTOC HUM GENE, pChapter 8	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	SEP	2015	65	9					486	489		10.1111/pin.12333		4	Pathology	Pathology	CQ7EO	WOS:000360766000005		
J	Sentani, K; Ogawa, I; Uraoka, N; Ikeda, M; Hayashi, N; Hattori, T; Hattori, Y; Oue, N; Takata, T; Yasui, W				Sentani, Kazuhiro; Ogawa, Ikuko; Uraoka, Naohiro; Ikeda, Masayuki; Hayashi, Naoki; Hattori, Takuya; Hattori, Yui; Oue, Naohide; Takata, Takashi; Yasui, Wataru			High-grade epithelial-myoepithelial carcinoma of the parotid gland with mucous cell differentiation	PATHOLOGY INTERNATIONAL			English	Article						epithelial-myoepithelial carcinoma; high-grade; mucous cell differentiation; parotid gland	SALIVARY-GLANDS; IMMUNOHISTOCHEMICAL ANALYSIS; TUMORS; TRANSFORMATION; VARIANT	Epithelial-myoepithelial carcinoma (EMC) is a rare salivary gland tumor with a low-grade malignancy, and EMC with high-grade histopathological features is exceedingly rare. Furthermore, EMC with intracellular mucin is also extremely rare. We report an uncommon case of a high-grade EMC of the parotid gland with mucous cell differentiation in a 66-year old Japanese woman who noticed a right palpable parotid mass increasing in size within a one-year period. The cytological specimen showed a focally biphasic structure and included isolated or discohesive piled-up clusters with hyaline globules surrounded by neoplastic cells with nuclear atypia. The gross examination revealed a relatively well-demarcated, multinodular gray-whitish and solid mass. Histologically, the tumor consisted of variably sized solid nests or trabeculae with central necrosis and increased mitotic activity, and invaded into adjacent skeletal muscles. Immunohistochemically, the biphasic ductal and myoepithelial differentiation of this tumor confirmed the diagnosis of high-grade EMC. Furthermore, numerous small nests with d-PAS and alcian blue-positive mucous cells predominated in about 5% of the whole tumor, and these mucous cells were encompassed by neoplastic myoepithelial cells. We should recognize this variant of EMC because we can't rule out the possibility of EMC even in the presence of mucous cells.	[Sentani, Kazuhiro; Uraoka, Naohiro; Hattori, Takuya; Hattori, Yui; Oue, Naohide; Yasui, Wataru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima 7348551, Japan; [Takata, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348551, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Ikeda, Masayuki; Hayashi, Naoki] Miyoshi Cent Hosp, Hiroshima, Japan	Yasui, W (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	wyasui@hiroshima-u.ac.jp					Alos L, 1999, VIRCHOWS ARCH, V434, P291, DOI 10.1007/s004280050344; Seethala RR, 2007, AM J SURG PATHOL, V31, P44, DOI 10.1097/01.pas.0000213314.74423.d8; Hornick JL, 2003, AM J SURG PATHOL, V27, P1183, DOI 10.1097/00000478-200309000-00001; Shinozaki A, 2008, AM J SURG PATHOL, V32A, P913, DOI 10.1097/PAS.0b013e318160852a; Ohtomo R, 2013, MODERN PATHOL, V26, P1041, DOI 10.1038/modpathol.2013.54; Miliauskas JR, 2003, DIAGN CYTOPATHOL, V28, P163, DOI 10.1002/dc.10253; Baker AR, 2013, INT J SURG PATHOL, V21, P514, DOI 10.1177/1066896912468153; FONSECA I, 1993, VIRCHOWS ARCH A, V422, P389, DOI 10.1007/BF01605458; Fonseca I, 2005, WHO CLASSIFICATION T, P225; Fonseca I, 2000, AM J SURG PATHOL, V24, P469, DOI 10.1097/00000478-200003000-00018; Kusafuka K, 2008, ORAL SURG ORAL MED O, V106, P85, DOI 10.1016/j.tripleo.2008.01.013; Lima Francisco Jadson, 2012, Open Dent J, V6, P111, DOI 10.2174/1874210601206010111; Nagao T., 2013, HEAD NECK PATHOL S1, V7, P37, DOI [10.1007/s12105-013-0458-8, DOI 10.1007/S12105-013-0458-8]; Ng WK, 1999, ACTA CYTOL, V43, P675; Park JO, 2011, J LARYNGOL OTOL, V125, P1286, DOI 10.1017/S0022215111002222; Roy P, 2010, AM J SURG PATHOL, V34, P1258, DOI 10.1097/PAS.0b013e3181e366d2; Seethala RR, 2009, ARCH PATHOL LAB MED, V133, P950, DOI 10.1043/1543-2165-133.6.950; Seethala RR, 2013, HEAD NECK PATHOL, V7, P77; Suzuki T, 2010, ACTA CYTOL, V54, P605; vansTongeren J, 2009, EUR ARCH OTO-RHINO-L, V266, P1495; Yang S, 2012, INT J ORAL MAX SURG, V41, P810, DOI 10.1016/j.ijom.2011.12.012	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	SEP	2015	65	9					490	494		10.1111/pin.12315		5	Pathology	Pathology	CQ7EO	WOS:000360766000006		
J	Makise, N; Morikawa, T; Takeshima, Y; Fujimura, T; Homma, Y; Fukayama, M				Makise, Naohiro; Morikawa, Teppei; Takeshima, Yuta; Fujimura, Tetsuya; Homma, Yukio; Fukayama, Masashi			Urinary bladder urothelial carcinoma with concurrent plasmacytoid and micropapillary differentiations: A report of two cases with an emphasis on serum carbohydrate antigen 19-9	PATHOLOGY INTERNATIONAL			English	Article						biomarkers; CA19-9 antigen; E-cadherin; HER2; immunohistochemistry; prognosis	POOR-PROGNOSIS; CANCER; VARIANT	We report two cases of urinary bladder urothelial carcinoma (UC). In both, histological examination of a transurethral resection specimen of the bladder tumor revealed UC with plasmacytoid and micropapillary differentiations. In Case 1, residual plasmacytoid UC deeply invaded the extravesical fat tissue of the radical cystectomy specimen, and metastatic carcinoma was found in almost all the dissected lymph nodes. Despite adjuvant chemotherapy and radiotherapy, the patient died 25 months postdiagnosis. Elevated serum carbohydrate antigen 19-9 (CA19-9) returned to near normal levels after radical cystectomy, but they increased shortly before death. In Case 2, no residual carcinoma was found in the radical cystectomy specimen or lymph nodes. Postoperative serum CA19-9 was maintained at normal levels, and the patient remains alive without recurrence or metastasis. Although plasmacytoid and micropapillary UC are known aggressive variants of UC, plasmacytoid UC may be more aggressive. Serum CA19-9 could serve as a useful biomarker to monitor progression of plasmacytoid UC.	[Makise, Naohiro; Morikawa, Teppei; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan; [Takeshima, Yuta; Fujimura, Tetsuya; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1130033, Japan	Morikawa, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tmorikawa-tky@umin.ac.jp					Ahmadi H, 2014, UROL ONCOL-SEMIN ORI, V32, P648, DOI 10.1016/j.urolonc.2014.01.019; Sashide K, 2004, UROL INT, V72, P112, DOI 10.1159/000075963; Shah RB, 2013, UROL ONCOL-SEMIN ORI, V31, P1650, DOI 10.1016/j.urolonc.2012.04.009; Demirovic A, 2010, TUMORI, V96, P358; Sato K, 2009, PATHOL RES PRACT, V205, P189, DOI 10.1016/j.prp.2008.09.004; Shimada K, 2010, CANCER SCI, V101, P155, DOI 10.1111/j.1349-7006.2009.01379.x; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Kamat AM, 2007, CANCER, V110, P62, DOI 10.1002/cncr.22756; Amin MB, 2009, MODERN PATHOL, V22, pS96, DOI 10.1038/modpathol.2009.26; Dayyani F, 2013, J UROLOGY, V189, P1656, DOI 10.1016/j.juro.2012.11.084; Hayashi T, 2011, INT J CLIN ONCOL, V16, P759, DOI 10.1007/s10147-011-0240-4; Ichimura T, 2014, ANN SURG ONCOL, V16, P759; Keck B, 2014, UROL ONCOL-SEMIN ORI, V32, P1234, DOI 10.1016/j.urolonc.2014.06.016; Keck B, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-71; Lopez-Beltran A, 2009, HUM PATHOL, V40, P1023, DOI 10.1016/j.humpath.2009.01.001; Mai KT, 2006, EUR UROL, V50, P1111, DOI 10.1016/j.eururo.2005.12.047; Monn MF, 2015, UROL ONCOL, V33, P18; Nigwekar P, 2009, AM J SURG PATHOL, V33, P417, DOI 10.1097/PAS.0b013e318186c45e; Peck Joshua R, 2012, Exp Hematol Oncol, V1, P16, DOI 10.1186/2162-3619-1-16; Shimada K, 2006, UROLOGY, V68, P891	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	SEP	2015	65	9					495	500		10.1111/pin.12314		6	Pathology	Pathology	CQ7EO	WOS:000360766000007		
J	Takayama, S; Maeda, T; Nishihara, M; Kanazawa, A; Chong, HS; Oka, H; Hirota, S; Ishikawa, O				Takayama, Shouichi; Maeda, Tamaki; Nishihara, Masayoshi; Kanazawa, Akifumi; Chong, Hyon Su; Oka, Hiroshi; Hirota, Seiichi; Ishikawa, Osamu			A case of intraductal tubulopapillary neoplasm of pancreas with severe calcification, a potential pitfall in diagnostic imaging	PATHOLOGY INTERNATIONAL			English	Article						adenocarcinoma; calcification; intraductal tubulopapillary neoplasm; macrophages; osteopontin; pancreatic neoplasms; pancreaticoduodenectomy; preoperative images	PSAMMOMA BODIES; OSTEOPONTIN	We experienced a case of intraductal tubulopapillary neoplasms (ITPN) of the pancreas with severe calcification, which complicated image diagnosis. A pancreas head tumor was detected in a Japanese female in her 50s. Early enhancement by contrast-enhanced CT and coarse calcification suggested a neuroendocrine tumor, although the obstruction and dilation of the main pancreatic duct appeared to be an intraductal tumor. An endoscopic ultrasound-guided fine needle aspiration biopsy specimen revealed adenocarcinoma tissue. Pancreaticoduodenectomy was performed, and the patient has been well without evidence of recurrence for over 10 months. Pathological examination on the resected specimen revealed that the tumor showed papillary and tubulo-cribriform growth patterns. Together with typical immunohistochemical results, the final diagnosis of ITPN was made. Characteristically, this case showed extensive calcification of both psammoma body-type and non psammoma body-type with foamy macrophage aggregation. This is the first report of ITPN with two types of calcification and macrophage. Since calcification might be one of the characteristic histological findings in ITPN as shown in our case, the possibility of ITPN should be also considered when calcification is detected in pancreatic lesions by various imaging modalities.	[Takayama, Shouichi; Nishihara, Masayoshi; Kanazawa, Akifumi; Chong, Hyon Su; Oka, Hiroshi] Moriguchi Keijinkai Hosp, Dept Surg, Moriguchi, Osaka, Japan; [Maeda, Tamaki] Moriguchi Keijinkai Hosp, Dept Pathol, Moriguchi, Osaka, Japan; [Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Ishikawa, Osamu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan	Maeda, T (reprint author), 2-47-12 Yagumohigashi Machi, Moriguchi, Osaka 5700021, Japan.	tamaki@art.osaka-med.ac.jp					Adsay NV, 2010, PATHOLOGY GENETICS T, P304; Ahls MG, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-11; Yamaguchi H, 2009, AM J SURG PATHOL, V33, P1164, DOI 10.1097/PAS.0b013e3181a162e5; Tajiri T, 2012, PATHOL RES PRACT, V208, P691, DOI 10.1016/j.prp.2012.09.002; HIROTA S, 1993, AM J PATHOL, V143, P1003; Kasugai H, 2013, J NIPPON MED SCH, V80, P224; Jokoji R, 2012, PATHOL INT, V62, P339, DOI 10.1111/j.1440-1827.2012.02791.x; Bhuva N, 2011, BMJ CASE REP, DOI [10.1136/bcr.09.2011.4777., DOI 10.1136/BCR.09.2011.4777]; Furuhata A, 2014, DIAGN CYTOPATHOL, V42, P314, DOI 10.1002/dc.23083; GILKS CB, 1990, INT J GYNECOL PATHOL, V9, P110, DOI 10.1097/00004347-199004000-00002; Japanese Pancreas Society, 2009, GEN RUL STUD PANCR C; Matsuda M, 2014, PANCREAS, V29, P729; Matsushita K, 2013, JPN J GASTROENTEROL, V46, P196; Motosugi U, 2012, J COMPUT ASSIST TOMO, V36, P710, DOI 10.1097/RCT.0b013e31826d1fc8; Ohike Nobuyuki, 2008, JOP, V9, P335; Takahashi T, 2011, PATHOL INT, V61, P603, DOI 10.1111/j.1440-1827.2011.02705.x; Tunio GM, 1998, ARCH PATHOL LAB MED, V122, P1087; WARNER TFCS, 1980, ARCH PATHOL LAB MED, V104, P432; Zhen-Zhong D, 2009, BMJ CASE REP, DOI [10.1136/bcr.10.2008.1063., DOI 10.1136/BCR.10.2008.1063]	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	SEP	2015	65	9					501	506		10.1111/pin.12322		6	Pathology	Pathology	CQ7EO	WOS:000360766000008		
J	Yoshida, M; Okita, H; Tanimoto, T; Bitoh, Y; Fukuzawa, H; Yokoi, A; Kozaki, A; Kawasaki, K; Akasaka, Y				Yoshida, Makiko; Okita, Hajime; Tanimoto, Terutaka; Bitoh, Yuko; Fukuzawa, Hiroaki; Yokoi, Akiko; Kozaki, Aiko; Kawasaki, Keiichiro; Akasaka, Yoshinobu			Congenital mesoblastic nephroma with focal anaplastic lesion	PATHOLOGY INTERNATIONAL			English	Letter							CLEAR-CELL SARCOMA; WILMS-TUMOR; PROGNOSTIC-FACTOR; EXPRESSION; KIDNEY		[Yoshida, Makiko] Kobe Childrens Hosp, Dept Pathol, Kobe, Hyogo, Japan; [Tanimoto, Terutaka; Bitoh, Yuko; Fukuzawa, Hiroaki; Yokoi, Akiko] Kobe Childrens Hosp, Dept Pediat Surg, Kobe, Hyogo, Japan; [Kozaki, Aiko; Kawasaki, Keiichiro] Kobe Childrens Hosp, Dept Oncol, Kobe, Hyogo, Japan; [Akasaka, Yoshinobu] Kobe Childrens Hosp, Dept Radiol, Kobe, Hyogo, Japan; [Okita, Hajime] Natl Ctr Child Hlth & Dev, Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan	Yoshida, M (reprint author), Kobe Childrens Hosp, Dept Pathol, Kobe, Hyogo, Japan.						Alavi Samin, 2013, Ecancermedicalscience, V7, P311, DOI 10.3332/ecancer.2013.311; Vujanic GM, 2007, AM J SURG PATHOL, V31, P1459; Argani P, 2000, AM J SURG PATHOL, V24, P4, DOI 10.1097/00000478-200001000-00002; Chi HT, 2012, BIOCHEM BIOPH RES CO, V429, P87, DOI 10.1016/j.bbrc.2012.10.087; Argani P, 2004, PATHOLOGY GENETICS T, P60; Beniers AJMC, 2001, INT J ONCOL, V18, P133; Jadali F, 2011, IRAN J KIDNEY DIS, V5, P149; Murphy WM, 2004, AFIP ATLAS TUMOR PAT, P57; Perlman EJ, 2004, PATHOLOGY GENETICS T, P48; Tanaka Y, 2013, LAB INVEST, V93, p252A	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	SEP	2015	65	9					507	509		10.1111/pin.12293		3	Pathology	Pathology	CQ7EO	WOS:000360766000009		
J	Kimura, S; Yanagisawa, M; Fujita, Y; Sakihara, S; Hisaoka, M; Kurose, A				Kimura, Sotai; Yanagisawa, Michiro; Fujita, Yuki; Sakihara, Satoru; Hisaoka, Masanori; Kurose, Akira			A case of phosphaturic mesenchymal tumor of the pelvis with vascular invasion	PATHOLOGY INTERNATIONAL			English	Letter							OSTEOMALACIA; VARIANT		[Kimura, Sotai; Kurose, Akira] Hirosaki Univ, Grad Sch Med, Dept Anat Pathol, Hirosaki, Aomori, Japan; [Yanagisawa, Michiro; Fujita, Yuki] Hirosaki Univ, Grad Sch Med, Dept Orthoped Surg, Hirosaki, Aomori, Japan; [Sakihara, Satoru] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan; [Hisaoka, Masanori] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Oncol, Kitakyushu, Fukuoka 807, Japan	Kimura, S (reprint author), Hirosaki Univ, Grad Sch Med, Dept Anat Pathol, Hirosaki, Aomori, Japan.						Uchihashi K, 2013, HUM PATHOL, V44, P2614, DOI 10.1016/j.humpath.2013.04.027; Ogose A, 2001, SKELETAL RADIOL, V30, P99; Folpe AL, 2004, AM J SURG PATHOL, V28, P1, DOI 10.1097/00000478-200401000-00001; Fatani HA, 2013, ANN DIAGN PATHOL, V17, P319, DOI 10.1016/j.anndiagpath.2012.06.005; Seijas R, 2009, ARCH ORTHOP TRAUM SU, V129, P533, DOI 10.1007/s00402-008-0808-2; Uramoto N, 2009, AURIS NASUS LARYNX, V36, P104, DOI 10.1016/j.anl.2008.01.003; Morimoto T, 2014, ONCOL LETT, V8, P67, DOI 10.3892/ol.2014.2081; FIRTH RG, 1985, AM J MED, V78, P669, DOI 10.1016/0002-9343(85)90411-5	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	SEP	2015	65	9					510	512		10.1111/pin.12295		3	Pathology	Pathology	CQ7EO	WOS:000360766000010		
J	Fleischer, DM; Sicherer, S; Greenhawt, M; Campbell, D; Chan, E; Muraro, A; Halken, S; Katz, Y; Ebisawa, M; Eichenfield, L; Sampson, H; Lack, G; Du Toit, G; Roberts, G; Bahnson, H; Feeney, M; Hourihane, J; Spergel, J; Young, M; As'aad, A; Allen, K; Prescott, S; Kapur, S; Saito, H; Agache, I; Akdis, CA; Arshad, H; Beyer, K; Dubois, A; Eigenmann, P; Fernandez-Rivas, M; Grimshaw, K; Hoffman-Sommergruber, K; Host, A; Lau, S; O'Mahony, L; Mills, C; Papadopoulos, N; Venter, C; Agmon-Levin, N; Kessel, A; Antaya, R; Drolet, B; Rosenwasser, L				Fleischer, David M.; Sicherer, Scott; Greenhawt, Matthew; Campbell, Dianne; Chan, Edmond; Muraro, Antonella; Halken, Susanne; Katz, Yitzhak; Ebisawa, Motohiro; Eichenfield, Lawrence; Sampson, Hugh; Lack, Gideon; Du Toit, George; Roberts, Graham; Bahnson, Henry; Feeney, Mary; Hourihane, Jonathan; Spergel, Jonathan; Young, Michael; As'aad, Amal; Allen, Katrina; Prescott, Susan; Kapur, Sandeep; Saito, Hirohisa; Agache, Ioana; Akdis, Cezmi A.; Arshad, Hasan; Beyer, Kirsten; Dubois, Anthony; Eigenmann, Philippe; Fernandez-Rivas, Monserrat; Grimshaw, Kate; Hoffman-Sommergruber, Karin; Host, Arne; Lau, Susanne; O'Mahony, Liam; Mills, Clare; Papadopoulos, Nikolaus; Venter, Carina; Agmon-Levin, Nancy; Kessel, Aaron; Antaya, Richard; Drolet, Beth; Rosenwasser, Lanny			Consensus Communication on Early Peanut Introduction and the Prevention of Peanut Allergy in High-risk Infants	PEDIATRICS			English	Article						allergy prevention; complementary feeding; peanut allergy	FOOD ALLERGY; NUTRITIONAL INTERVENTIONS; CHILDREN; PREVALENCE; DISEASE	The purpose of this brief communication is to highlight emerging evidence to existing guidelines regarding potential benefits of supporting early, rather than delayed, peanut introduction during the period of complementary food introduction in infants. This document should be considered as interim guidance based on consensus among the following organizations: American Academy of Allergy, Asthma & Immunology, American Academy of Pediatrics, American College of Allergy, Asthma & Immunology, Australasian Society of Clinical Immunology and Allergy, Canadian Society of Allergy and Clinical Immunology, European Academy of Allergy and Clinical Immunology, Israel Association of Allergy and Clinical Immunology, Japanese Society for Allergology, Society for Pediatric Dermatology, and World Allergy Organization. More formal guidelines regarding early-life, complementary feeding practices and the risk of allergy development will follow in the next year from the National Institute of Allergy and Infectious Diseases-sponsored Working Group and the European Academy of Allergy and Clinical Immunology.	[Fleischer, David M.; Hourihane, Jonathan; Spergel, Jonathan; Young, Michael] Amer Acad Allergy Asthma & Immunol, Milwaukee, WI 53202 USA; [Sicherer, Scott] Amer Acad Pediat, Elk Grove Village, IL USA; [Greenhawt, Matthew; As'aad, Amal] Amer Coll Allergy Asthma & Immunol, New York, NY USA; [Campbell, Dianne; Allen, Katrina; Prescott, Susan] Australasian Soc Clin Immunol & Allergy, Sydney, NSW, Australia; [Chan, Edmond; Kapur, Sandeep] Canadian Soc Allergy & Clin Immunol, London, England; [Muraro, Antonella; Halken, Susanne; Du Toit, George; Roberts, Graham; Agache, Ioana; Akdis, Cezmi A.; Arshad, Hasan; Beyer, Kirsten; Dubois, Anthony; Eigenmann, Philippe; Fernandez-Rivas, Monserrat; Grimshaw, Kate; Hoffman-Sommergruber, Karin; Host, Arne; Lau, Susanne; O'Mahony, Liam; Mills, Clare; Papadopoulos, Nikolaus; Venter, Carina] European Acad Allergy & Clin Immunol, Zurich, Switzerland; [Katz, Yitzhak; Agmon-Levin, Nancy; Kessel, Aaron] Israel Assoc Allergy & Clin Immunol, Tel Hashomer, Israel; [Ebisawa, Motohiro; Saito, Hirohisa] Japanese Soc Allergol, Tokyo, Japan; [Eichenfield, Lawrence; Antaya, Richard; Drolet, Beth] Soc Pediat Dermatol, Indianapolis, IN USA; [Sampson, Hugh; Lack, Gideon; Feeney, Mary; Rosenwasser, Lanny] World Allergy Org, London, England; [Bahnson, Henry] Rho Fed Syst Div Inc, Chapel Hill, NC USA	Fleischer, DM (reprint author), Amer Acad Allergy Asthma & Immunol, Milwaukee, WI 53202 USA.	david.fleischer@childrenscolorado.org					Muraro A, 2014, ALLERGY, V69, P590, DOI 10.1111/all.12398; Chan ES, 2013, PAED CHILD HEALT-CAN, V18, P545; de Silva D, 2014, ALLERGY, V69, P581, DOI 10.1111/all.12334; Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x; Amoah AS, 2013, J ALLERGY CLIN IMMUN, V132, P639, DOI 10.1016/j.jaci.2013.04.023; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Fleischer DM, 2013, J ALLER CL IMM-PRACT, V1, P29, DOI 10.1016/j.jaip.2012.09.003; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Soller L, 2012, J ALLERGY CLIN IMMUN, V130, P986, DOI 10.1016/j.jaci.2012.06.029; Australasian Society of Clinical Immunology and Allergy (ASCIA), ASCIA INF FEED ADV; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850	14	0	0	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2015	136	3					600	604		10.1542/peds.2015-2394		5	Pediatrics	Pediatrics	CQ6IN	WOS:000360708100054		
J	Hara, S; Komagata, K				Hara, Shinjiro; Komagata, Keita			Selective-area growth and magnetic reversals of ferromagnetic nanoclusters on semiconducting substrate for magnetic logic applications	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						bottom-up formation; ferromagnetic nanoclusters; magnetic logic operation; magnetic reversal; metal-organic vapor phase epitaxy	VAPOR-PHASE EPITAXY; QUANTUM CELLULAR-AUTOMATA; MNAS NANOCLUSTERS; TUNNEL-JUNCTIONS; SHIFT REGISTER; GAAS NANOWIRES; MAGNETORESISTANCE; DEPENDENCE; DEVICES; MOVPE	The use of selective-area metal-organic vapor phase epitaxy, which is our bottom-up formation approach, to fabricate MnAs nanocluster composite arrays in which two nanoclusters are formed in close proximity at an angle of 120 degrees and with a spatial gap of around 20nm on GaAs (111)B substrates is reported in this paper. The magnetic reversals of the nanoclusters in the composite arrays are observed depending on the strengths and directions of the applied external magnetic fields at room temperature. The applied external magnetic fields for the magnetic reversals in one of the nanoclusters in the composites are possibly from 750 to 1000Gauss (G). The characterization results obtained using magnetic force microscopy show that the magnetic reversals in the nanoclusters are independently controlled in nanocluster composites. Finally, we discuss the designing of the nanocluster size, shape, and arrangement to control the magnetization directions in the nanoclusters in the composites for possible application to magnetic logic operations based on the results of the magnetic reversals in the nanoclusters.	[Hara, Shinjiro; Komagata, Keita] Hokkaido Univ, Res Ctr Integrated Quantum Elect, Sapporo, Hokkaido 0608628, Japan	Hara, S (reprint author), Hokkaido Univ, Res Ctr Integrated Quantum Elect, North 13 West 8, Sapporo, Hokkaido 0608628, Japan.	hara@rciqe.hokudai.ac.jp			Japan Science and Technology Agency (JST); (KAKENHI) from the Japan Society for the Promotion of Science (JSPS) [23360129]	The authors thank Prof. P. J. Klar, Dr. M. T. Elm, M. Fischer, Prof. T. Fukui, and Prof. J. Motohisa for stimulating and fruitful discussions, and S. Sakita, H. Fujimagari, H. Kato, R. Kodaira, S. Ito, K. Morita, M. Yatago, Y. Kobayashi, Dr. Y. Kohashi, and Dr. T. Sato for supporting the MOVPE growth experiments. This work was financially supported in part by a grant for Precursory Research for Embryonic Science and Technology (PRESTO) from the Japan Science and Technology Agency (JST), and Grants-in-Aid for Scientific Research (B) (KAKENHI Grant number 23360129) and Challenging Exploratory Research (KAKENHI Grant number 25600034) from the Japan Society for the Promotion of Science (JSPS).	Allwood DA, 2002, SCIENCE, V296, P2003, DOI 10.1126/science.1070595; Annunziata A. J., 2011, P IEDM; Senevirathne K, 2009, ACS NANO, V3, P1129, DOI 10.1021/nn900194f; Cowburn RP, 2000, SCIENCE, V287, P1466, DOI 10.1126/science.287.5457.1466; Ito S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3157275; Choi HJ, 2005, ADV MATER, V17, P1351, DOI 10.1002/adma.200401706; Elm MT, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035309; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Tomioka K, 2008, NANO LETT, V8, P3475, DOI 10.1021/nl802398j; Heiliger C, 2010, IEEE T MAGN, V46, P1702, DOI 10.1109/TMAG.2010.2041194; Noborisaka J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2035332; Ikejiri K, 2007, J CRYST GROWTH, V298, P616, DOI 10.1016/j.jcrysgro.2006.10.179; Imre A, 2006, SCIENCE, V311, P205, DOI 10.1126/science.1120506; Ney A, 2003, NATURE, V425, P485, DOI 10.1038/nature02014; Csaba G, 2002, IEEE T NANOTECHNOL, V1, P209, DOI 10.1109/TNANO.2002.807380; Elm MT, 2014, ADV MATER, V26, P8079, DOI 10.1002/adma.201403136; Elm MT, 2010, J APPL PHYS, V107, DOI 10.1063/1.3275427; Parish MCB, 2003, APPL PHYS LETT, V83, P2046, DOI 10.1063/1.1608492; Fischer M, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906036; Hara S, 2008, J CRYST GROWTH, V310, P2390, DOI 10.1016/j.jcrysgro.2007.12.026; Sato T, 2008, J CRYST GROWTH, V310, P2359, DOI 10.1016/j.jcrysgro.2007.12.048; Ding Y, 2007, NANO LETT, V7, P3598, DOI 10.1021/nl071651x; Hai PN, 2009, NATURE, V458, P489, DOI 10.1038/nature07879; Hua B, 2009, NANO LETT, V9, P112, DOI 10.1021/nl802636b; Ikejiri K, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/26/265604; Tanaka T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.025003; Hai PN, 2010, NAT NANOTECHNOL, V5, P593, DOI [10.1038/nnano.2010.130, 10.1038/NNANO.2010.130]; Hubner W, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184431; Hara S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2349309; Elm MT, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.235305; Allwood DA, 2005, SCIENCE, V309, P1688, DOI 10.1126/science.1108813; Borschel C, 2011, NANO LETT, V11, P3935, DOI 10.1021/nl2021653; Daweritz L, 2004, J APPL PHYS, V96, P5056, DOI 10.1063/1.1790576; Engel-Herbert R, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2171790; Engel-Herbert R, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.104441; Garcia V, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.246802; GOODENOU.JB, 1967, PHYS REV, V157, P389, DOI 10.1103/PhysRev.157.389; Guslienko KY, 1999, APPL PHYS LETT, V75, P394, DOI 10.1063/1.124386; Haque SA, 2004, J MAGN MAGN MATER, V282, P380, DOI 10.1016/j.jmmm.2004.04.088; Hara S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PE01; Hayashi M, 2008, SCIENCE, V320, P209, DOI 10.1126/science.1154587; Ishikawa F, 2003, JPN J APPL PHYS 2, V42, pL918, DOI 10.1143/JJAP.42.L918; Kaganer VM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045305; Kim HS, 2009, CHEM MATER, V21, P1137, DOI 10.1021/cm8033388; Kitauchi Y, 2010, NANO LETT, V10, P1699, DOI 10.1021/nl1000407; Kobayashi Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.045001; Komagata K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GH01; Pampuch P., 2003, PHYS REV LETT, V91; Salles BR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3309421; Ramlan DG, 2006, NANO LETT, V6, P50, DOI 10.1021/nl0519276; Ramsteiner M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.081304; Rudolph A, 2009, NANO LETT, V9, P3860, DOI 10.1021/nl9020717; Saha D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358944; Sugahara S, 2002, APPL PHYS LETT, V80, P1969, DOI 10.1063/1.1461425; Takagaki Y, 2008, Journal of Physics: Condensed Matter, V20, DOI 10.1088/0953-8984/20/22/225007; Takagaki Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125324; Thomas L., 2011, P IEDM; Wolff MFH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/5/055602; Yatago M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BH01; Zhang Y, 2014, J APPL PHYS, V115, DOI 10.1063/1.4865884	60	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	SEP	2015	252	9					1925	1933		10.1002/pssb.201552083		9	Physics, Condensed Matter	Physics	CQ5UM	WOS:000360671200002		
J	Nakagomi, S; Kaneko, S; Kokubun, Y				Nakagomi, Shinji; Kaneko, Satoru; Kokubun, Yoshihiro			Crystal orientations of beta-Ga2O3 thin films formed on n-plane sapphire substrates	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						crystals; Ga2O3; sapphire; thin films	MOLECULAR-BEAM EPITAXY; SINGLE-CRYSTALS; C-PLANE; GROWTH	We have used X-ray pole figure analysis to study crystal orientations of -Ga2O3 thin films deposited on (113) n-plane sapphire substrates by gallium evaporation in oxygen plasma. The films were strongly (-201)-oriented. However, the (-201) plane of -Ga2O3 on the (113) n-plane sapphire was inclined along the (110) a-plane. Crystals of (-201)-oriented -Ga2O3 exhibit a threefold symmetry in which the -Ga2O3 crystal is rotated by increments of 120 degrees from the direction of the c-axis on the a-plane of sapphire. The crystal orientation of -Ga2O3 was explained by comparing oxygen atom arrangements on the -Ga2O3 plane in three different configurations and on the (113) n-plane sapphire substrates.	[Nakagomi, Shinji; Kokubun, Yoshihiro] Ishinomaki Senshu Univ, Fac Sci & Engn, Dept Informat Technol & Elect, Ishinomaki, Miyagi 9868580, Japan; [Kaneko, Satoru] Kanagawa Ind Technol Ctr, Ebina, Kanagawa 2430435, Japan	Nakagomi, S (reprint author), Ishinomaki Senshu Univ, Fac Sci & Engn, Dept Informat Technol & Elect, Ishinomaki, Miyagi 9868580, Japan.	nakagomi@isenshu-u.ac.jp	Kaneko, Satoru/E-4842-2011	Kaneko, Satoru/0000-0003-0823-1666			Sasaki K, 2013, J CRYST GROWTH, V378, P591, DOI 10.1016/j.jcrysgro.2013.02.015; Sasaki K, 2013, IEEE ELECTR DEVICE L, V34, P493, DOI 10.1109/LED.2013.2244057; Aida H, 2008, JPN J APPL PHYS, V47, P8506, DOI 10.1143/JJAP.47.8506; Nakagomi S, 2012, J CRYST GROWTH, V349, P12, DOI 10.1016/j.jcrysgro.2012.04.006; Scholz F, 2014, J CRYST GROWTH, V405, P97, DOI 10.1016/j.jcrysgro.2014.08.006; Villora EG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164407; Kokubun Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2432946; Villora EG, 2004, J CRYST GROWTH, V270, P420, DOI 10.1016/j.jcrysgro.2004.06.027; Higashiwaki M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3674287; Oshima T, 2007, JPN J APPL PHYS 1, V46, P7217, DOI 10.1143/JJAP.46.7217; Goriki N, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JB31; Nakagomi S., 2011, SENSOR LETT, V9, P35; Nakagomi S, 2013, PHYS STATUS SOLIDI A, V210, P1738, DOI 10.1002/pssa.201329040; Nakagomi S, 2015, PHYS STATUS SOLIDI B, V252, P612, DOI 10.1002/pssb.201451456; Nakagomi S, 2013, SENSOR ACTUAT B-CHEM, V187, P413, DOI 10.1016/j.snb.2013.01.020; Nakasu T., 2014, 61 SPRING M JAP SOC; Ohira S., 2005, J JPN ASS CRYST GROW, V32, P10; Okada N, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/2/024003; Oshima T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011202; Suzuki R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3574911	20	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	SEP	2015	252	9					2117	2122		10.1002/pssb.201552168		6	Physics, Condensed Matter	Physics	CQ5UM	WOS:000360671200030		
J	Tousen, Y; Ishiwata, H; Ishimi, Y; Ikegami, S				Tousen, Yuko; Ishiwata, Hajimu; Ishimi, Yoshiko; Ikegami, Sachie			Equol, a Metabolite of Daidzein, Is More Efficient than Daidzein for Bone Formation in Growing Female Rats	PHYTOTHERAPY RESEARCH			English	Article						equol; daidzein; soy isoflavone; bone mineral density; bone formation	SPRAGUE-DAWLEY RATS; ESTROGEN-RECEPTOR; SOY ISOFLAVONES; DIETARY EQUOL; MICE; DIFFERENTIATION; PHYTOESTROGENS; HORMONE; DENSITY; BREAST	Few studies have examined the effects of isoflavones and particularly equol, a metabolite of the isoflavone daidzein, on bone formation during the growth period in animals. The present study investigated the effects of orally administered daidzein or equol on bone formation and bone mineral density in growing female rats. Female Sprague-Dawley rats, aged 3 weeks, were divided into four groups (n = 8 per group) as follows: rats were orally administered a corn oil, 8 mg/day of daidzein, 4 mg/day of equol or 8 mg/day of equol in corn oil for 4 weeks. Daidzein and equol increased the bone mineral density of growing female rats by stimulating bone formation without exhibiting a substantial effect on the weight of their reproductive organs. Bone growth caused by increased bone mineralizing surface and bone formation rate in rats administered with equol was approximately twice that of rats administered with daidzein. These results suggest that equol might be more efficient than daidzein for bone formation in growing female rats. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Tousen, Yuko; Ishimi, Yoshiko] Natl Inst Hlth & Nutr, Dept Food Funct & Labeling, Shinjuku Ku, Tokyo 1628636, Japan; [Ishiwata, Hajimu] Seitoku Univ, Dept Human Nutr, Mastudo, Chiba 2718555, Japan; [Ikegami, Sachie] Otsuma Womans Univ, Dept Home Econ, Chiyoda Ku, Tokyo 1028357, Japan	Tousen, Y (reprint author), Natl Inst Hlth & Nutr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	tousen@nih.go.jp			general incorporated association of the Otsuma Kotaka memorial for academic research	This study was supported by a grant from the general incorporated association of the Otsuma Kotaka memorial for academic research (2007). Excellent technical assistance was provided by Chiharu Yamazaki. We thank Mr Hisashi Murayama (Hard Tissue Research Team, Kureha Chemical Industry Co) for his assistance with the histological analyses.	Roghani M, 2013, PHYTOTHER RES, V27, P112, DOI 10.1002/ptr.4699; REEVES PG, 1993, J NUTR, V123, P1939; Setchell KDR, 2002, J NUTR, V132, P3577; Taku K, 2011, MATURITAS, V70, P333, DOI 10.1016/j.maturitas.2011.09.001; Romano B, 2013, PHYTOTHER RES, V27, P1588, DOI 10.1002/ptr.5023; Jefferson WN, 2002, BIOL REPROD, V67, P1285, DOI 10.1095/biolreprod.102.005371; Compston JE, 2001, PHYSIOL REV, V81, P419; Tousen Y, 2011, MENOPAUSE, V18, P563, DOI 10.1097/gme.0b013e3181f85aa7; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Wang J, 2014, GENET MOL RES, V13, P5055, DOI 10.4238/2014.July.4.21; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Bonnelye E, 2005, J CLIN ENDOCR METAB, V90, P3115, DOI 10.1210/jc.2004-2168; Fujioka M, 2004, J NUTR, V134, P2623; Gamache PH, 1998, P SOC EXP BIOL MED, V217, P274; Ishimi Y, 2010, J NUTR, V140, p1373S, DOI 10.3945/jn.110.124842; Kang J, 2012, INT J MOL SCI, V13, P6747, DOI 10.3390/ijms13066747; Kim H, 2015, J BONE MINER METAB, V33, P30, DOI 10.1007/s00774-014-0567-9; Magee PJ, 2004, BRIT J NUTR, V91, P513, DOI 10.1079/BJN20031075; Mathey J, 2007, OSTEOPOROSIS INT, V18, P671, DOI 10.1007/s00198-007-0351-y; Peterson CA, 2008, ANN NUTR METAB, V52, P48, DOI 10.1159/000118630; PRUITT LA, 1992, J BONE MINER RES, V7, P179; Rachon D, 2007, MATURITAS, V58, P308, DOI 10.1016/j.maturitas.2007.09.005; Rachon D, 2007, CLIMACTERIC, V10, P416, DOI 10.1080/13697130701624757; Root Allen W, 2002, Adolesc Med, V13, P53; Schmitt E, 2001, TOXICOL IN VITRO, V15, P433, DOI 10.1016/S0887-2333(01)00048-0; Schwen RJ, 2012, FOOD CHEM TOXICOL, V50, P1741, DOI 10.1016/j.fct.2012.02.039; Selvaraj V, 2004, BIOL REPROD, V71, P966, DOI 10.1095/biolreprod.104.029512; Setchell KD, 2001, J AM COLL NUTR, V20, P354; Zaineddin AK, 2012, NUTR CANCER, V64, P652, DOI 10.1080/01635581.2012.683227	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	SEP	2015	29	9					1349	1354		10.1002/ptr.5387		6	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ8FY	WOS:000360843100010		
J	Wu, S; Clevenger, JP; Sun, L; Visa, S; Kamiya, Y; Jikumaru, Y; Blakeslee, J; van der Knaap, E				Wu, Shan; Clevenger, Josh P.; Sun, Liang; Visa, Sofia; Kamiya, Yuji; Jikumaru, Yusuke; Blakeslee, Joshua; van der Knaap, Esther			The control of tomato fruit elongation orchestrated by sun, ovate and fs8.1 in a wild relative of tomato	PLANT SCIENCE			English	Article						Tomato; Near isogenic lines; Fruit shape; SUN; OVATE; fs8.1	ARABIDOPSIS-THALIANA; BAYESIAN CLASSIFICATION; FLOWER DEVELOPMENT; SHAPE VARIATION; MAJOR QTL; GENE; LEAF; MORPHOGENESIS; CYTOKININ; EXTENSION	Within the cultivated tomato germplasm, sun, ovate and fs8.I are the three predominant QTLs controlling fruit elongation. Although SUN and OVATE have been cloned, their role in plant growth and development are not well understood. To compare and contrast the effects of the three QTLs in a homogeneous background, we developed near isogenic lines (NILs) in the wild species Solanum pimpinellifolium LA1589 background. We carried out detailed morphological characterization of reproductive and vegetative organs in the single, double and triple NILs and determined the epistatic interactions of the three loci affecting fruit shape. The phenotypic evaluations demonstrated that the three loci regulate unique aspects of ovary and fruit elongation and in different temporal manners. The strongest effect on organ shape was caused by sun. In addition to fruit shape, sun also affected leaf and sepal elongation and stem thickness. The synergistic interaction between sun and ovate or fs8.1 suggested that the pathways involving SUN, OVATE and the gene(s) underlying fs8.1 may converge at a common node. The results of an extensive profiling analysis suggested that the degree of fruit elongation was not related to the accumulation of any of the classical hormones. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Wu, Shan; Clevenger, Josh P.; Sun, Liang; Blakeslee, Joshua; van der Knaap, Esther] Ohio State Univ, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Visa, Sofia] Coll Wooster, Dept Math & Comp Sci, Wooster, OH 44691 USA; [Kamiya, Yuji; Jikumaru, Yusuke] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	van der Knaap, E (reprint author), Ohio State Univ, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	vanderknaap.1@osu.edu	Kamiya, Yuji/F-9420-2010	Kamiya, Yuji/0000-0003-4415-520X	National Science Foundation [IOS 0922661]	This work was supported by National Science Foundation IOS 0922661. We thank Drs. J.C. Jang, M.L. Jones, R.S. Lamb and E.J. Stockinger for helpful comments.	Achcar F, 2009, NUCLEIC ACIDS RES, V37, pW63, DOI 10.1093/nar/gkp430; Alonso-Cantabrana H, 2007, DEVELOPMENT, V134, P2663, DOI 10.1242/DEV.02864; Molesini B, 2009, PLANT PHYSIOL, V149, P534, DOI 10.1104/pp.108.131367; Coen E, 2001, CR ACAD SCI III-VIE, V324, P523, DOI 10.1016/S0764-4469(01)01321-X; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Rodriguez GR, 2013, HEREDITY, V111, P256, DOI 10.1038/hdy.2013.45; COCKERHAM CC, 1954, GENETICS, V39, P859; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Marsch-Martinez N, 2012, PLANT J, V72, P222, DOI 10.1111/j.1365-313X.2012.05062.x; Ostergaard L, 2009, CURR OPIN PLANT BIOL, V12, P36, DOI 10.1016/j.pbi.2008.09.011; Novak O, 2012, PLANT J, V72, P523, DOI 10.1111/j.1365-313X.2012.05085.x; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Brioudes F, 2009, PLANT J, V60, P1070, DOI 10.1111/j.1365-313X.2009.04023.x; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Pelaz S, 2001, CURR BIOL, V11, P182, DOI 10.1016/S0960-9822(01)00024-0; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Ito T, 2007, PLANT CELL, V19, P3516, DOI 10.1105/tpc.107.055467; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Wu S, 2011, PLANT PHYSIOL, V157, P1175, DOI 10.1104/pp.111.181065; Goethe J.W., 1970, ITALIAN JOURNEY; Gonzalo MJ, 2008, THEOR APPL GENET, V116, P647, DOI 10.1007/s00122-007-0698-7; Grandilio S, 1996, MOL BREEDING, V2, P251, DOI 10.1007/BF00564202; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Jiang N, 2009, PLANT J, V60, P181, DOI 10.1111/j.1365-313X.2009.03946.x; Ku HM, 2000, THEOR APPL GENET, V101, P873, DOI 10.1007/s001220051555; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Rodriguez GR, 2010, J VIS EXP, V16, P37; Sea M., 2011, METHOD MOL BIOL, V773, P99; Visa S, 2014, EUPHYTICA, V200, P429, DOI 10.1007/s10681-014-1179-0; Welty N, 2007, CAN J BOT, V85, P111, DOI 10.1139/B06-154; Xiao H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-49; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101	38	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	SEP	2015	238						95	104		10.1016/j.plantsci.2015.05.019		10	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CQ3NY	WOS:000360510500010		
J	Sakai, H; Iwai, T; Matsubara, C; Usui, Y; Okamura, M; Yatou, O; Terada, Y; Aoki, N; Nishida, S; Yoshida, KT				Sakai, Hiroaki; Iwai, Toru; Matsubara, Chie; Usui, Yuto; Okamura, Masaki; Yatou, Osamu; Terada, Yasuko; Aoki, Naohiro; Nishida, Sho; Yoshida, Kaoru T.			A decrease in phytic acid content substantially affects the distribution of mineral elements within rice seeds	PLANT SCIENCE			English	Article						Low phytic acid grains; Mineral elements; Mutant; Oryza sativa L.; Phosphorus; Seed storage substances	3-PHOSPHATE SYNTHASE GENE; ORYZA-SATIVA L.; INOSITOL PHOSPHATE; NUTRIENT ELEMENTS; TRANSGENIC RICE; SOYBEAN SEEDS; GRAIN TISSUES; BARLEY-GRAIN; WILD-TYPE; PHOSPHORUS	Phytic acid (myo-inositol hexakisphosphate; InsP(6)) is the storage compound of phosphorus and many mineral elements in seeds. To determine the role of InsP6 in the accumulation and distribution of mineral elements in seeds, we performed fine mappings of mineral elements through synchrotron-based X-ray microfluorescence analysis using developing seeds from two independent low phytic acid (lpa) mutants of rice (Oryza sativa L.). The reduced InsP6 in lpa seeds did not affect the translocation of mineral elements from vegetative organs into seeds, because the total amounts of phosphorus and the other mineral elements in lpa seeds were identical to those in the wild type (WT). However, the reduced InsP6 caused large changes in mineral localization within lpa seeds. Phosphorus and potassium in the aleurone layer of lpa greatly decreased and diffused into the endosperm. Zinc and copper, which were broadly distributed from the aleurone layer to the inner endosperm in the WT, were localized in the narrower space around the aleurone layer in lpa mutants. We also confirmed that similar distribution changes occurred in transgenic rice with the lpa phenotype. Using these results, we discussed the role of InsP6 in the dynamic accumulation and distribution patterns of mineral elements during seed development. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Sakai, Hiroaki] Univ Tokyo, Fac Agr, Bunkyo Ku, Tokyo 113, Japan; [Iwai, Toru; Matsubara, Chie; Usui, Yuto; Okamura, Masaki; Aoki, Naohiro; Nishida, Sho; Yoshida, Kaoru T.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Yatou, Osamu] NARO Agr Res Ctr, Crop Dev Div, Niigata, Japan; [Terada, Yasuko] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan	Yoshida, KT (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	ayosida@mail.ecc.u-tokyo.ac.jp		Sakai, Hiroaki/0000-0002-5480-2354	Japan Advanced Plant Science Network	The ICP-OES analysis was supported by Japan Advanced Plant Science Network. The mu-XRF analysis was performed at the BL37XU in the SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2010B1695 and No. 2013B1209). The authors are grateful to Dr. M. Takahashi, Ms. H. Aihara, Mr. N. Morishita, Mr. Y. Tagashira, Mr. G. Hayakawa, and the members of Laboratory of Plant Nutrition and Physiology, Utsunomiya University for the technical assistance for the mu-XRF analysis. We are grateful to Ms. T. Shimizu for her help in rough mapping of lpa2623 mutant.	Bohn L, 2008, J ZHEJIANG UNIV-SC B, V9, P165, DOI 10.1631/jzus.B0710640; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Shi JR, 2005, PLANT J, V42, P708, DOI 10.1111/j.1365-313X.2005.02412.x; Mendoza C, 1998, AM J CLIN NUTR, V68, P1123; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Iwai T, 2012, PLANT PHYSIOL, V160, P2007, DOI 10.1104/pp.112.206573; Liu JC, 2004, SEED SCI RES, V14, P109, DOI 10.1079/SSR2004160; Kuwano M, 2009, PLANT BIOTECHNOL J, V7, P96, DOI 10.1111/j.1467-7652.2008.00375.x; Larson SR, 1998, THEOR APPL GENET, V97, P141, DOI 10.1007/s001220050878; Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012; Guttieri M, 2004, CROP SCI, V44, P418; Xu XH, 2009, THEOR APPL GENET, V119, P75, DOI 10.1007/s00122-009-1018-1; Lombi E, 2009, NEW PHYTOL, V184, P193, DOI 10.1111/j.1469-8137.2009.02912.x; Raboy V, 2000, PLANT PHYSIOL, V124, P355, DOI 10.1104/pp.124.1.355; Bohn L, 2007, J AGR FOOD CHEM, V55, P7547, DOI 10.1021/jf071191t; Lin L, 2005, CAN J BOT, V83, P131, DOI 10.1139/B04-146; Yoshida KT, 1999, PLANT PHYSIOL, V119, P65, DOI 10.1104/pp.119.1.65; Hitz WD, 2002, PLANT PHYSIOL, V128, P650, DOI 10.1104/pp.128.2.650; Rose TJ, 2010, FIELD CROP RES, V119, P154, DOI 10.1016/j.fcr.2010.07.004; Shi JR, 2003, PLANT PHYSIOL, V131, P507, DOI 10.1104/pp.014258; Bryant RJ, 2005, CEREAL CHEM, V82, P517, DOI 10.1094/CC-82-0517; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Holm PB, 2002, J NUTR, V132, p514S; Hoshikawa K., 1990, MORPHOLOGY, V1, P273; Kim SI, 2008, THEOR APPL GENET, V117, P769, DOI 10.1007/s00122-008-0818-z; Kuwano M, 2009, PLANT CELL PHYSIOL, V50, P1387, DOI 10.1093/pcp/pcp071; Kuwano M, 2006, MOL BREEDING, V18, P263, DOI 10.1007/s11032-006-9038-x; Larson SR, 2000, CROP SCI, V40, P1397; Liu K, 2007, J AGR FOOD CHEM, V55, P4453, DOI 10.1021/jf0637776; Liu QL, 2007, THEOR APPL GENET, V114, P803, DOI 10.1007/s00122-006-0478-9; Lott JNA, 1984, SEED PHYSL, V1, P139; Lott J.N.A., 1995, SEED DEV GERMINATION, P215; Ockenden I, 2004, PLANT SCI, V167, P1131, DOI 10.1016/j.plantsci.2004.06.008; OGAWA M, 1979, PLANT CELL PHYSIOL, V20, P19; Okamura M, 2013, FUNCT PLANT BIOL, V40, P1137, DOI 10.1071/FP13105; Persson DP, 2009, METALLOMICS, V1, P418, DOI 10.1039/b905688b; Raboy V., 2006, INOSITOL PHOSPHATES, P111; Rasmussen SK, 1998, HEREDITAS, V129, P107, DOI 10.1111/j.1601-5223.1998.00107.x; Ren XL, 2007, FOOD CHEM, V102, P1400, DOI 10.1016/j.foodchem.2006.05.065; Veum TL, 2002, J ANIM SCI, V80, P2663	40	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	SEP	2015	238						170	177		10.1016/j.plantsci.2015.06.006		8	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CQ3NY	WOS:000360510500017		
J	Wakimura, Y; Wang, W; Itoh, S; Okazaki, M; Takakuda, K				Wakimura, Yuki; Wang, Wei; Itoh, Soichiro; Okazaki, Mutsumi; Takakuda, Kazuo			An Experimental Study to Bridge a Nerve Gap with a Decellularized Allogeneic Nerve	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							REGENERATION; MATRIX; RECONSTRUCTION; ALLOGRAFTS; SCAFFOLD; ORGANS; GRAFT; TUBES	Background: The authors evaluated the efficacy of decellularized nerve as a scaffold for nerve regeneration. Methods: Sciatic nerves harvested from Sprague-Dawley rats were decellularized in combination with sodium dodecyl sulfate and Triton X-100, and examined with scanning electron microscopy and immunofluorescence staining. A graft into the sciatic nerve in Wistar rats was performed with the decellularized Sprague-Dawley rat sciatic nerves [allograft: 10 mm long (n = 3) for short term and 15 mm long (n = 5) for long term]. As a control, a portion of sciatic nerve of Wistar rats was cut, reversed, and resutured in situ [autograft: 10 mm long (n = 3) and 15 mm long (n = 5) for different terms, respectively]. Samples were harvested 4 weeks postoperatively and prepared for immunohistochemistry. Von Frey hair test, static toe spread factor measurement, and electrophysiologic and histomorphologic analyses were carried out to evaluate nerve recovery 24 weeks postoperatively. Results: Scanning electron microscopic images revealed the honeycomb structure, and immunohistology showed that the three-dimensional structure of the basal lamina column on which cell adhesion molecules are integrated is preserved through the decellularization protocols. Limited ED1-positive macrophage invasion was found through the decellularized sciatic nerves, suggesting that antigenicity remained more or less after this treatment. Nevertheless, NF160-positive axons accompanied by S100-positive Schwann cells penetrated through the decellularized sciatic nerves. Sciatic nerve function had recovered, and there were no significant differences in the electrophysiologic and histomorphologic recovery in the groups. Conclusion: These results suggest that the decellularized allogeneic nerve is a suitable scaffold to bridge a nerve gap.	Tokyo Med & Dent Univ, Plast & Reconstruct Surg, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; Kawakita Gen Hosp, Dept Orthoped Surg, Tokyo, Japan	Wang, W (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.	wangmech@tmd.ac.jp			Japan Society for the Promotion of Science [24791901]	This study is supported in part by a Grant-in-Aid for young scientists B (24791901) of the Japan Society for the Promotion of Science.	Brooks DN, 2012, MICROSURG, V32, P1, DOI 10.1002/micr.20975; Wang W, 2008, J BIOMED MATER RES A, V85A, P919, DOI 10.1002/jbm.a.31522; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; He M, 2013, TISSUE ENG PART B-RE, V19, P194, DOI [10.1089/ten.TEB.2012.0340, 10.1089/ten.teb.2012.0340]; [Anonymous], 2011, COMMITTEE UPDATE GUI, V8th; Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Weber B, 2011, SEMIN IMMUNOPATHOL, V33, P307, DOI 10.1007/s00281-011-0258-8; Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220; Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Furkan E, 2009, HAND NY, V4, P245; Itoh S, 2008, SURFACE DESIGN MODIF, P205; Itoh S, 1996, MICROSURG, V17, P525, DOI 10.1002/(SICI)1098-2752(1996)17:10<525::AID-MICR1>3.3.CO;2-V	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	SEP	2015	136	3					319E	327E		10.1097/PRS.0000000000001556		9	Surgery	Surgery	CQ5ZU	WOS:000360685000001		
J	Hirano, M; Satake, W; Ihara, K; Tsuge, I; Kondo, S; Saida, K; Betsui, H; Okubo, K; Sakamoto, H; Ueno, S; Ikuno, Y; Ishihara, R; Iwahashi, H; Ohishi, M; Mano, T; Yamashita, T; Suzuki, Y; Nakamura, Y; Kusunoki, S; Toda, T				Hirano, Makito; Satake, Wataru; Ihara, Kenji; Tsuge, Ikuya; Kondo, Shuji; Saida, Ken; Betsui, Hiroyuki; Okubo, Kazuhiro; Sakamoto, Hikaru; Ueno, Shuichi; Ikuno, Yasushi; Ishihara, Ryu; Iwahashi, Hiromi; Ohishi, Mitsuru; Mano, Toshiyuki; Yamashita, Toshihide; Suzuki, Yutaka; Nakamura, Yusaku; Kusunoki, Susumu; Toda, Tatsushi			The First Nationwide Survey and Genetic Analyses of Bardet-Biedl Syndrome in Japan	PLOS ONE			English	Article							MUTATIONS; DIAGNOSIS; PATIENT; BBS1	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities. The causative genes have been identified as BBS1-19. In Western countries, this disease is often reported, but remains undiagnosed in many patients until later in life, while only a few patients with no mutations identified have been reported in Japan. We thus conducted the first nationwide survey of BBS in Japan by sending questionnaires to 2,166 clinical departments with board-certified specialists and found 7 patients with clinically definite BBS. We performed exome analyses combined with analyses of mRNA and protein in these patients. We identified 2 novel mutations in the BBS5 gene (p.R89X and IVS7-27 T>G) in 2 sibling patients. The latter mutation that resided far from the authentic splicing site was associated with skipping of exon 8. We also found 3 previously reported mutations in the BBS2 (p.R413X and p.R480X) and BBS7 (p.C243Y) genes in 2 patients. To our knowledge, a nationwide survey of BBS has not been reported in any other country. In addition, this is the first study to identify genetic alterations in Japanese patients with BBS. Our results indicate that BBS in Japan is genetically heterogeneous and at least partly shares genetic features with BBS in other countries.	[Hirano, Makito; Sakamoto, Hikaru; Ueno, Shuichi; Nakamura, Yusaku] Kinki Univ, Sakai Hosp, Fac Med, Dept Neurol, Sakai, Osaka, Japan; [Hirano, Makito; Ueno, Shuichi; Kusunoki, Susumu] Kinki Univ, Fac Med, Dept Neurol, Osakasayama, Japan; [Satake, Wataru; Toda, Tatsushi] Kobe Univ, Div Neurol Mol Brain Sci, Grad Sch Med, Kobe, Hyogo 657, Japan; [Ihara, Kenji; Okubo, Kazuhiro] Kyushu Univ, Grad Sch Med, Dept Pediat, Fukuoka 812, Japan; [Tsuge, Ikuya] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi, Japan; [Kondo, Shuji] Univ Tokushima, Dept Pediat, Tokushima 770, Japan; [Saida, Ken] Natl Ctr Child Hlth & Dev, Dept Nephrol, Tokyo, Japan; [Betsui, Hiroyuki] Haga Red Cross Hosp, Dept Pediat, Mooka, Tochigi, Japan; [Ikuno, Yasushi] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan; [Ishihara, Ryu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan; [Iwahashi, Hiromi] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan; [Ohishi, Mitsuru] Osaka Univ, Dept Geriatr Med, Grad Sch Med, Suita, Osaka, Japan; [Mano, Toshiyuki] Osaka Med Ctr, Dept Pediat Neurol, Izumi, Japan; [Mano, Toshiyuki] Res Inst Maternal & Child Hlth, Izumi, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Hirano, M (reprint author), Kinki Univ, Sakai Hosp, Fac Med, Dept Neurol, Sakai, Osaka, Japan.	hirano_makito@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25461297]; Health and Labour Science Research Grants (Research in Intractable Diseases) [10103346]	MH recieved Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25461297) and Health and Labour Science Research Grants (Research in Intractable Diseases, 10103346).	Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Yamada K, 2000, PEDIATR NEUROSURG, V33, P323, DOI 10.1159/000055979; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Hirano Makito, 2011, Clin Med Insights Case Rep, V4, P17, DOI 10.4137/CCRep.S6622; Iannello S, 2002, Obes Rev, V3, P123, DOI 10.1046/j.1467-789X.2002.00055.x; NAKAMURA F, 1990, J GASTROEN HEPATOL, V5, P206, DOI 10.1111/j.1440-1746.1990.tb01826.x; Saida K, 2014, BRAIN DEV-JPN, V36, P721, DOI 10.1016/j.braindev.2013.10.013; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Tonomura Y, 2009, CLIN NEUROL NEUROSUR, V111, P102, DOI 10.1016/j.clineuro.2008.08.008; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136317	10.1371/journal.pone.0136317		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ2NK	WOS:000360437700038		
J	Itoh, M; Nakayama, K; Noguchi, R; Kamohara, K; Furukawa, K; Uchihashi, K; Toda, S; Oyama, J; Node, K; Morita, S				Itoh, Manabu; Nakayama, Koichi; Noguchi, Ryo; Kamohara, Keiji; Furukawa, Kojirou; Uchihashi, Kazuyoshi; Toda, Shuji; Oyama, Jun-ichi; Node, Koichi; Morita, Shigeki			Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae	PLOS ONE			English	Article							VASCULAR GRAFTS; BLOOD-VESSEL; IN-VITRO; CELLS; REVASCULARIZATION; ACCESS; MICROTISSUES; EXPRESSION; GENERATION; PROSTHESES	Background Small caliber vascular prostheses are not clinically available because synthetic vascular prostheses lack endothelial cells which modulate platelet activation, leukocyte adhesion, thrombosis, and the regulation of vasomotor tone by the production of vasoactive substances. We developed a novel method to create scaffold-free tubular tissue from multicellular spheroids (MCS) using a "Bio-3D printer"-based system. This system enables the creation of pre-designed three-dimensional structures using a computer controlled robotics system. With this system, we created a tubular structure and studied its biological features. Methods and Results Using a "Bio-3D printer," we made scaffold-free tubular tissues (inner diameter of 1.5 mm) from a total of 500 MCSs (2.5x 10(4) cells per one MCS) composed of human umbilical vein endothelial cells (40%), human aortic smooth muscle cells (10%), and normal human dermal fibroblasts (50%). The tubular tissues were cultured in a perfusion system and implanted into the abdominal aortas of F344 nude rats. We assessed the flow by ultrasonography and performed histological examinations on the second (n = 5) and fifth (n = 5) day after implantation. All grafts were patent and remodeling of the tubular tissues (enlargement of the lumen area and thinning of the wall) was observed. A layer of endothelial cells was confirmed five days after implantation. Conclusions The scaffold-free tubular tissues made of MCS using a Bio-3D printer underwent remodeling and endothelialization. Further studies are warranted to elucidate the underlying mechanism of endothelialization and its function, as well as the long-term results.	[Itoh, Manabu; Noguchi, Ryo; Kamohara, Keiji; Furukawa, Kojirou; Morita, Shigeki] Saga Univ, Fac Med, Dept Thorac & Cardiovasc Surg, Saga 840, Japan; [Nakayama, Koichi] Saga Univ, Fus Grad Sch Sci & Engn, Biomed Engn Course Adv Technol, Saga 840, Japan; [Oyama, Jun-ichi; Node, Koichi] Saga Univ, Fac Med, Dept Cardiovasc Med, Saga 840, Japan; [Uchihashi, Kazuyoshi; Toda, Shuji] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga 840, Japan	Morita, S (reprint author), Saga Univ, Fac Med, Dept Thorac & Cardiovasc Surg, Saga 840, Japan.	moritash@cc.saga-u.ac.jp			Science and Technology Grants for Scientific Research (JP) Grant [25293298, 50555084]	This work was supported by Science and Technology Grants for Scientific Research (JP) Grant Nos. 25293298 and 50555084.	Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017; Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; L'Heureux N, 1998, FASEB J, V12, P47; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Ao PY, 2000, EUR J VASC ENDOVASC, V20, P241, DOI 10.1053/ejvs.2000.1177; Kelm JM, 2006, TISSUE ENG, V12, P2151, DOI 10.1089/ten.2006.12.2151; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; Daenens K, 2009, J VASC SURG, V49, P1210, DOI 10.1016/j.jvs.2008.12.009; Hodges TC, 1997, J VASC SURG, V26, P1009, DOI 10.1016/S0741-5214(97)70014-4; Steffens L, 2009, J CELL MOL MED, V13, P3380, DOI 10.1111/j.1582-4934.2008.00418.x; Faries PL, 2000, J VASC SURG, V32, P1080, DOI 10.1067/mva.2000.111279; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Watanabe T, 2011, J BIOMED MATER RES B, V98B, P120, DOI 10.1002/jbm.b.31841; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013; Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654; Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828; Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; TOMIZAWA Y, 1995, ARTIF ORGANS, V19, P39, DOI 10.1111/j.1525-1594.1995.tb02242.x; Ferrari ER, 2006, CURR OPIN CARDIOL, V21, P584; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelm JM, 2010, J BIOTECHNOL, V148, P46, DOI 10.1016/j.jbiotec.2010.03.002; Kelm JM, 2005, J BIOTECHNOL, V118, P213, DOI 10.1016/j.jbiotec.2005.03.016; Layer PG, 2002, TRENDS NEUROSCI, V25, P131, DOI 10.1016/S0166-2236(00)02036-1; Mancuso L, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045011; Nakayama K, 2013, BIOFABRICATION: MICRO- AND NANO-FABRICATION, PRINTING, PATTERNING, AND ASSEMBLIES, P1; Nemeno-Guanzon JG, 2012, J BIOMED BIOTECHNOL, V2012, DOI [10.1155/2012/956345, DOI 10.1155/2012/956345]; Rosas SE, 2003, J VASC SURG, V37, P1036, DOI 10.1067/mva.2003.257; Sanchez-Bustamante CD, 2008, TISSUE ENG PT A, V14, P1969, DOI 10.1089/ten.tea.2007.0302; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Yamanami M, 2013, J ARTIF ORGANS, V16, P59, DOI 10.1007/s10047-012-0676-y; Yamanami M, 2010, J BIOMED MATER RES B, V92B, P156, DOI 10.1002/jbm.b.31501	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136681	10.1371/journal.pone.0136681		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ2NK	WOS:000360437700057		
J	Nakayama, A; Morita, H; Nakao, T; Yamaguchi, T; Sumida, T; Ikeda, Y; Kumagai, H; Motozawa, Y; Takahashi, T; Imaizumi, A; Hashimoto, T; Nagai, R; Komuro, I				Nakayama, Atsuko; Morita, Hiroyuki; Nakao, Tomoko; Yamaguchi, Toshihiro; Sumida, Tomokazu; Ikeda, Yuichi; Kumagai, Hidetoshi; Motozawa, Yoshihiro; Takahashi, Tsukasa; Imaizumi, Atsushi; Hashimoto, Tadashi; Nagai, Ryozo; Komuro, Issei			A Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling	PLOS ONE			English	Article							HUMAN HYPERTROPHIC CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; OXIDATIVE STRESS; HEART-FAILURE; GENE-EXPRESSION; NADPH OXIDASE; MOUSE MODEL; TGF-BETA; RATS; FIBROBLASTS	Oxidative stress has been implicated in cardiac remodeling (cardiac fibrosis and hypertrophy), which impairs cardiac function and metabolism; therefore, it is anticipated antioxidative compounds will have protective properties against cardiac remodeling. Luteolin (3',4',5,7-tetrahydroxyflavone), a widely distributed flavonoid found in many herbal extracts including celery, green pepper, perilla leaves and seeds, and chamomile, is a known to be a potent antioxidant and was previously demonstrated to exert an antifibrotic effect in the lungs and the liver. In this study, we clearly demonstrate that oral pretreatment with the higher-luteolin diet (0.035% (wt/wt)) protected against cardiac fibrosis and hypertrophy as well as a hyperoxidative state in Ang II-infused rats. In cardiac tissue, increased gene expression levels of TGF beta 1, CTGF, Nox2, Nox4, ANP, and BNP induced by Ang II were restored by oral pretreatment of this high-luteolin diet. In cultured rat cardiac fibroblasts, H2O2-induced TGF beta 1 expression and the phosphorylation of JNK were suppressed by luteolin pretreatment. In conclusion, food-derived luteolin has protective actions against Ang II-induced cardiac remodeling, which could be mediated through attenuation of oxidative stress.	[Nakayama, Atsuko; Nakao, Tomoko; Yamaguchi, Toshihiro; Sumida, Tomokazu; Ikeda, Yuichi; Kumagai, Hidetoshi; Motozawa, Yoshihiro; Nagai, Ryozo; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Morita, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Translat Res Healthcare & Clin Sci, Tokyo, Japan; [Takahashi, Tsukasa; Imaizumi, Atsushi; Hashimoto, Tadashi] Theravalues Corp, Tokyo, Japan	Morita, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Translat Res Healthcare & Clin Sci, Tokyo, Japan.	hmrt-tky@umin.net			Theravalues Corporation (Tokyo, Japan)	This research is supported by the Theravalues Corporation (Tokyo, Japan). The funder provided support in the form of salaries for authors TT, AI, TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Liao PH, 2011, CIRC J, V75, P443, DOI 10.1253/circj.CJ-10-0381; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.000017264.66561.3D; Swynghedauw B, 1999, PHYSIOL REV, V79, P215; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Domitrovic R, 2009, TOXICOL APPL PHARM, V241, P311, DOI 10.1016/j.taap.2009.09.001; Zhang W, 2012, CLIN EXP PHARMACOL P, V39, P429, DOI 10.1111/j.1440-1681.2012.05692.x; Zannad F, 2000, CIRCULATION, V102, P2700; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007.; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Zhao WY, 2008, MOL CELL BIOCHEM, V317, P43, DOI 10.1007/s11010-008-9803-8; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Chen CY, 2010, J AGR FOOD CHEM, V58, P11653, DOI 10.1021/jf1031668; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Brilla CG, 2000, CIRCULATION, V102, P1388; Ando C, 2009, FEBS LETT, V583, P3649, DOI 10.1016/j.febslet.2009.10.045; Zhang P, 2011, AM J PHYSIOL-HEART C, V301, pH147, DOI 10.1152/ajpheart.00026.2011; Lim DS, 2001, CIRCULATION, V103, P789; Diez J, 2001, CURR OPIN CARDIOL, V16, P328, DOI 10.1097/00001573-200111000-00003; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Marian AJ, 2006, J AM COLL CARDIOL, V47, P827, DOI 10.1016/j.jacc.2005.10.041; Brilla CG, 2000, CARDIOVASC RES, V47, P1, DOI 10.1016/S0008-6363(00)00092-4; Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0; Okada H, 2005, CIRCULATION, V111, P2430, DOI 10.1161/01.CIR.0000165066.71481.8E; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Ago T, 2011, CIRC J, V75, P1791, DOI 10.1253/circj.CJ-11-0388; Cheng TH, 2003, J AM COLL CARDIOL, V42, P1845, DOI 10.1016/j.jacc.2003.06.010; Díez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Juric D, 2007, AM J PHYSIOL-HEART C, V292, pH2138, DOI 10.1152/ajpheart.00852.2006; Li LP, 2013, PHARMAZIE, V68, P195, DOI 10.1691/ph.2013.2744; Lombardi R, 2009, CIRCULATION, V119, P1398, DOI 10.1161/CIRCULATIONAHA.108.790501; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Sia YT, 2002, CIRCULATION, V105, P2549, DOI 10.1161/01.CIR.0000016721.84535.00; Sumitomo-Ueda Y, 2010, HYPERTENSION, V56, P430, DOI 10.1161/HYPERTENSIONAHA.110.152207; Werner Christian M, 2008, Ther Adv Cardiovasc Dis, V2, P167, DOI 10.1177/1753944708091777; Yu CM, 2001, J AM COLL CARDIOL, V38, P1207, DOI 10.1016/S0735-1097(01)01518-2	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137106	10.1371/journal.pone.0137106		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ2NK	WOS:000360437700097		
J	Saito, Y; Fujiwara, T; Ohashi, K; Okitsu, Y; Fukuhara, N; Onishi, Y; Ishizawa, K; Harigae, H				Saito, Yo; Fujiwara, Tohru; Ohashi, Keiichi; Okitsu, Yoko; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo			High-Throughput siRNA Screening to Reveal GATA-2 Upstream Transcriptional Mechanisms in Hematopoietic Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; ENDOTHELIAL-CELLS; APLASTIC-ANEMIA; GENE-EXPRESSION; DIFFERENTIATION; DEFICIENCY; MUTATIONS; CITED2; IDENTIFICATION	Hematopoietic stem cells can self-renew and differentiate into all blood cell types. The transcription factor GATA-2 is expressed in both hematopoietic stem and progenitor cells and is essential for cell proliferation, survival, and differentiation. Recently, evidence from studies of aplastic anemia, MonoMAC syndrome, and lung cancer has demonstrated a mechanistic link between GATA-2 and human pathophysiology. GATA-2-dependent disease processes have been extensively analyzed; however, the transcriptional mechanisms upstream of GATA-2 remain less understood. Here, we conducted high-throughput small-interferingRNA (siRNA) library screening and showed that YN-1, a human erythroleukemia cell line, expressed high levels of GATA-2 following the activation of the hematopoietic-specific 1S promoter. As transient luciferase reporter assay in YN-1 cells revealed the highest promoter activity in the 1S promoter fused with GATA-2 intronic enhancer (+9.9 kb/1S); therefore, we established a cell line capable of stably expressing +9.9 kb/1S-Luciferase. Subsequently, we screened 995 transcription factor genes and revealed that CITED2 acts as a GATA-2 activator in human hematopoietic cells. These results provide novel insights into and further identify the regulatory mechanism of GATA-2.	[Saito, Yo; Fujiwara, Tohru; Ohashi, Keiichi; Okitsu, Yoko; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Mol Hematol Oncol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Ishizawa, Kenichi] Yamagata Univ, Dept Hematol & Cell Therapy, Fac Med, Yamagata 990, Japan	Harigae, H (reprint author), Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 980, Japan.	harigae@med.tohoku.ac.jp			KANAE Foundation for the Promotion of Medical Science; Sanofi KK; Chugai Pharmaceutical Co., Ltd.	This study was supported by KANAE Foundation for the Promotion of Medical Science (TF) (http://www.kanae-zaidan.com) which receives financial support from Sanofi KK, and by a research grant from Chugai Pharmaceutical Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanalkumar R, 2014, P NATL ACAD SCI USA, V111, pE1091, DOI 10.1073/pnas.1400065111; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Guiu J, 2013, J EXP MED, V210, P71, DOI 10.1084/jem.20120993; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zeng WH, 2004, BLOOD, V103, P325, DOI 10.1182/blood-2003-02-0490; Lim KC, 2000, NAT GENET, V25, P209; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Kamata M, 2014, HAEMATOLOGICA, V99, P1686, DOI 10.3324/haematol.2014.105692; Tsai FY, 1997, BLOOD, V89, P3636; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Cortes-Lavaud X, 2012, BLOOD, V120; Ding XL, 2012, STEM CELLS DEV, V21, P121, DOI 10.1089/scd.2010.0539; ENDO K, 1993, BRIT J HAEMATOL, V85, P653, DOI 10.1111/j.1365-2141.1993.tb03205.x; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Fujimaki S, 2001, BRIT J HAEMATOL, V113, P52, DOI 10.1046/j.1365-2141.2001.02736.x; Fujiwara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040959; Fujiwara T, 2014, ANN HEMATOL, V93, P1515, DOI 10.1007/s00277-014-2090-4; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; KOEFFLER HP, 1980, BLOOD, V56, P265; Korthuis PM, 2015, LEUKEMIA, V29, P625, DOI 10.1038/leu.2014.259; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Moriguchi T, 2014, INT J HEMATOL, V100, P417, DOI 10.1007/s12185-014-1568-0; Orkin SH, 2008, CELL, V20, P712; Pan XQ, 2000, J BIOCHEM-TOKYO, V127, P105; Snow JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001103; Snow JW, 2011, BLOOD, V117, P4769, DOI 10.1182/blood-2010-10-313031; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137079	10.1371/journal.pone.0137079		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ2NK	WOS:000360437700090		
J	Watanabe, E; Kiyono, K; Hayano, J; Yamamoto, Y; Inamasu, J; Yamamoto, M; Ichikawa, T; Sobue, Y; Harada, M; Ozaki, Y				Watanabe, Eiichi; Kiyono, Ken; Hayano, Junichiro; Yamamoto, Yoshiharu; Inamasu, Joji; Yamamoto, Mayumi; Ichikawa, Tomohide; Sobue, Yoshihiro; Harada, Masehide; Ozaki, Yukio			Multiscale Entropy of the Heart Rate Variability for the Prediction of an Ischemic Stroke in Patients with Permanent Atrial Fibrillation	PLOS ONE			English	Article							RISK STRATIFICATION SCHEMES; VENTRICULAR RESPONSE; MYOCARDIAL-INFARCTION; APPROXIMATE ENTROPY; CIRCADIAN VARIATION; MORNING INCREASE; TIME-SERIES; THROMBOEMBOLISM; ANTICOAGULATION; MORTALITY	Background Atrial fibrillation (AF) is a significant risk factor for ischemic strokes, and making a robust risk stratification scheme would be important. Few studies have examined whether nonlinear dynamics of the heart rate could predict ischemic strokes in AF. We examined whether a novel complexity measurement of the heart rate variability called multiscale entropy (MSE) was a useful risk stratification measure of ischemic strokes in patients with permanent AF. Methods and Results We examined 173 consecutive patients (age 69 +/- 11 years) with permanent AF who underwent 24-hour Holter electrocardiography from April 2005 to December 2006. We assessed several frequency ranges of the MSE and CHA(2)DS(2)-VASc score (1 point for congestive heart failure, hypertension, diabetes, vascular disease, an age 65 to 74 years, and a female sex and 2 points for an age >= 75 years and a stroke or transient ischemic attack). We found 22 (13%) incident ischemic strokes during a mean follow up of 3.8-years. The average value of the MSE in the very-low frequency subrange (90-300 s, MeanEn(VLF2)) was significantly higher in patients who developed ischemic strokes than in those who did not (0.68 +/- 0.15 vs. 0.60 +/- 0.14, P<0.01). There was no significant difference in the C-statistic between the CHA(2)DS(2)-VASc score and MeanEn(VLF2) (0.56; 95% confidence interval, 0.43-0.69 vs. 0.66; 95% confidence interval, 0.53-0.79). After an adjustment for the age, CHA(2)DS(2)-VASc score, and antithrombotic agent, a Cox hazard regression model revealed that the MeanEn(VLF2) was an independent predictor of an ischemic stroke (hazard ratio per 1-SD increment, 1.80; 95% confidence interval, 1.17-2.07, P<0.01). Conclusion The MeanEn(VLF2) in 24-hour Holter electrocardiography is a useful risk stratification measure of ischemic strokes during the long-term follow-up in patients with permanent AF.	[Watanabe, Eiichi; Yamamoto, Mayumi; Ichikawa, Tomohide; Sobue, Yoshihiro; Harada, Masehide; Ozaki, Yukio] Fujita Hlth Univ, Sch Med, Dept Cardiol, Toyoake, Aichi 47011, Japan; [Kiyono, Ken] Osaka Univ, Grad Sch Engn Sci, Div Bioengn, Toyonaka, Osaka 560, Japan; [Hayano, Junichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Med Educ, Nagoya, Aichi, Japan; [Yamamoto, Yoshiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan; [Inamasu, Joji] Fujita Hlth Univ, Sch Med, Dept Neurosurg, Toyoake, Aichi 47011, Japan	Watanabe, E (reprint author), Fujita Hlth Univ, Sch Med, Dept Cardiol, Toyoake, Aichi 47011, Japan.	enwatan@fujita-hu.ac.jp			Japan Society for the Promotion of Science KAKENHI; Suzuken Memorial Foundation	This study was supported in part by the Japan Society for the Promotion of Science KAKENHI (to EW, KK) (http://www.e-rad.go.jp/kenkyu/index.html) and the Suzuken Memorial Foundation (to EW) (http://www.suzukenzaidan.or.jp/).	MARLER JR, 1989, STROKE, V20, P473; MILLARCRAIG MW, 1978, LANCET, V1, P795; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Yamada A, 2000, CIRCULATION, V102, P300; Khaykin Y, 2011, EUROPACE, V13, P1797, DOI 10.1093/europace/eur203; Hayano J, 1997, AM J PHYSIOL-HEART C, V273, pH2811; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; CHISHAKI AS, 1991, AM HEART J, V121, P820, DOI 10.1016/0002-8703(91)90194-M; Huikuri HV, 2000, CIRCULATION, V101, P47; Costa M, 2002, COMPUT CARDIOL, V29, P137; ANAN T, 1990, J ELECTROCARDIOL, V23, P243, DOI 10.1016/0022-0736(90)90163-V; VANDENBERG MP, 1994, CLIN SCI, V86, P531; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; MARSHALL J, 1977, STROKE, V8, P230; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Taylor JA, 1998, CIRCULATION, V98, P547; Hayano J, 1998, J AM COLL CARDIOL, V31, P158, DOI 10.1016/S0735-1097(97)00429-4; CHORRO FJ, 1990, AM J PHYSIOL, V259, pH1015; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Costa Madalena, 2005, Phys Rev E Stat Nonlin Soft Matter Phys, V71, P021906, DOI 10.1103/PhysRevE.71.021906; EHRLY A M, 1973, Biorheology, V10, P577; Fuster V, 2006, CIRCULATION, V114, P700; Ho YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018699; Olesen JB, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d124; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Schurmann J., 1996, PATTERN CLASSIFICATI; Camm AJ, 1996, CIRCULATION, V93, P1043	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137144	10.1371/journal.pone.0137144		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ2NK	WOS:000360437700099		
J	Kusunoki, S; Mizuta, R; Hosaka, M				Kusunoki, Shoji; Mizuta, Ryo; Hosaka, Masahiro			Future changes in precipitation intensity over the Arctic projected by a global atmospheric model with a 60-km grid size	POLAR SCIENCE			English	Article						The Arctic; Precipitation intensity; Polar amplification; Global atmospheric model; Water vapor transport	SEA-SURFACE TEMPERATURE; BAIU RAIN BAND; CLIMATE MODELS; EXTRATROPICAL CYCLONES; WARMER CLIMATE; ICE; CIRCULATION; RESOLUTION; EXTREMES; BUDGET	Future changes in precipitation intensity over the Arctic were calculated based on three- member ensemble simulations using a global atmospheric model with a high horizontal resolution (60-km grid) for the period 1872-2099 (228 years). During 1872-2005, the model was forced with observed historical sea surface temperature (SST) data, while during 2006-2099, boundary SST data were estimated using the multi-model ensemble (MME) of the Coupled Model Intercomparison Project, Phase 3 (CMIP3) model, assuming the A1B emission scenario. The annual mean precipitation (PAVE), the simple daily precipitation intensity index (SDII), and the maximum 5-day precipitation total (R5d) averaged over the Arctic increased monotonically towards the end of the 21st century. Over the Arctic, the conversion rate from water vapor to precipitation per one degree temperature increase is larger for PAVE than for R5d, which is opposite to the tropics and mid-latitudes. The increases in PAVE, SDII, and R5d can be partly attributed to an increase in water vapor associated with increasing temperatures, and to an increase in the horizontal transport of water vapor from low to high latitudes associated with transient eddies. (C) 2015 The Authors. Published by Elsevier B.V. and NIPR.	[Kusunoki, Shoji; Mizuta, Ryo; Hosaka, Masahiro] Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan	Kusunoki, S (reprint author), Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	skusunoki@mri-jma.go.jp			SOUSEI program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Arctic Climate Change Research Project - MEXT	This work was conducted under the framework of the Development of Basic Technology for Risk Information on Climate Change supported by the SOUSEI program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The work was also supported by the "Arctic Climate Change Research Project" within the framework of the GREen Network of Excellence (GRENE) Program sponsored by MEXT. We thank two anonymous reviewers for valuable comments and suggestions that greatly improved the manuscript.	Kusunoki S, 2011, CLIM DYNAM, V37, P2481, DOI 10.1007/s00382-011-1000-x; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Sugi M, 2002, J METEOROL SOC JPN, V80, P249, DOI 10.2151/jmsj.80.249; Kattsov VM, 2007, J HYDROMETEOROL, V8, P571, DOI 10.1175/JHM575.1; Sugi M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053360; Cassano JJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000332; Murakami H, 2012, J CLIMATE, V25, P3237, DOI 10.1175/JCLI-D-11-00415.1; Jakobson E, 2010, INT J CLIMATOL, V30, P2175, DOI 10.1002/joc.2039; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Zappa G, 2013, J CLIMATE, V26, P5846, DOI 10.1175/JCLI-D-12-00573.1; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Bintanja R, 2014, NATURE, V509, P479, DOI 10.1038/nature13259; Frich P, 2002, CLIMATE RES, V19, P193, DOI 10.3354/cr019193; Bengtsson L, 2009, J CLIMATE, V22, P2276, DOI 10.1175/2008JCLI2678.1; Groves DG, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001191; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Dai A, 2006, J CLIMATE, V19, P4605, DOI 10.1175/JCLI3884.1; Endo H, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017874; Rawlins MA, 2010, J CLIMATE, V23, P5715, DOI 10.1175/2010JCLI3421.1; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; TIEDTKE M, 1989, MON WEATHER REV, V117, P1779, DOI 10.1175/1520-0493(1989)117<1779:ACMFSF>2.0.CO;2; Bengtsson L, 2007, TELLUS A, V59, P539, DOI 10.1111/j.1600-0870.2007.00251.x; Emori S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023272; Mizuta R, 2011, J CLIMATE, V24, P6456, DOI 10.1175/2011JCLI3969.1; Kusunoki S, 2006, J METEOROL SOC JPN, V84, P581, DOI 10.2151/jmsj.84.581; Bengtsson L, 1996, TELLUS A, V48, P57, DOI 10.1034/j.1600-0870.1996.00004.x; Bengtsson L, 2011, TELLUS A, V63, P907, DOI 10.1111/j.1600-0870.2011.00534.x; Deser C, 2012, CLIM DYNAM, V38, P527, DOI 10.1007/s00382-010-0977-x; Griggs D.J., 2001, CLIM CHANG 2001 SCI, P881; Kamiguchi K, 2006, SOLA, V2, P64, DOI 10.2151/sola.2006-017; Kattsov VM, 2007, IZV ATMOS OCEAN PHY+, V43, P142, DOI 10.1134/S0001433807020028; Kim S., 2010, ANN J HYDRAULIC ENG, V54, P127; Kug JS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043673; Kusunoki S, 2013, J GEOPHYS RES-ATMOS, V118, P11007, DOI 10.1002/jgrd.50877; Kusunoki S, 2008, SOLA, V4, P85, DOI 10.2151/sola.2008-022; Meehl GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023680; Mizuta R., 2012, J METEOROL SOC JPN A, V90A, P213; Mizuta R., 2008, TECH REP METEOR RES, V56, P28; Nakicenovic N., 2000, SPECIAL REPORT EMISS, P599; Nishii K., 2014, CLIM DYNAM, V44, P1311; Oort A. H., 1992, PHYS CLIMATE; Oshima K, 2004, POLAR METEOROL GLACI, V18, P30; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; Screen JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051598; Serreze M. C., 2005, CAMBRIDGE ATMOS SPAC; Shibata K., 2005, PAP METEOROL GEOPHYS, V55, P75, DOI DOI 10.2467/MRIPAPERS.55.75; Skific N, 2009, J CLIMATE, V22, P5115, DOI 10.1175/2009JCLI2829.1; Pavelsky TM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007230; Solomons S., 2007, CLIM CHANG 2007 PHYS, P996; Sorteberg A, 2008, TELLUS A, V60, P570, DOI 10.1111/j.1600-0870.2008.00314.x; Stocker TF, 2013, CLIM CHANG 2013 PHYS, P1535, DOI DOI 10.1017/CBO9781107415324; Walsh JE, 2013, POLAR SCI, V7, P188, DOI 10.1016/j.polar.2013.05.002; WILKS D. S., 2011, STAT METHODS ATMOSPH; Yoshimura H., 2014, MON WEA REV, V143, P597; Yukimoto S., 2011, TECH REP METEOROL RE, V64, P88; Zwiers F. W., 1999, STAT ANAL CLIMATE RE	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-9652	1876-4428		POLAR SCI	Polar Sci.	SEP	2015	9	3					277	292		10.1016/j.polar.2015.08.001		16	Ecology; Geosciences, Multidisciplinary	Environmental Sciences & Ecology; Geology	CQ4HK	WOS:000360565200001		
J	Ojima, M; Takahashi, KT; Tanimura, A; Odate, T; Fukuchi, M				Ojima, Motoha; Takahashi, Kunio T.; Tanimura, Atsushi; Odate, Tsuneo; Fukuchi, Mitsuo			Spatial distribution of micro- and meso-zooplankton in the seasonal ice zone of east Antarctica during 1983-1995	POLAR SCIENCE			English	Article						Seasonal ice zone; Distribution patterns; Micro- and meso-zooplankton	FORAMINIFER NEOGLOBOQUADRINA-PACHYDERMA; COMMUNITY STRUCTURE; SOUTHERN-OCEAN; SEA ICE; DISTRIBUTION PATTERNS; ABUNDANCE; COPEPODS; PLANKTON; SUMMER; MACROZOOPLANKTON	Historically, most studies about the geographic distribution of zooplankton in the Southern Ocean have been focused on the macro-sized zooplankton (2-20 mm), such as the Antarctic krill and larger-sized copepods. On the other hand, despite the high abundance and biomass, the distribution patterns of micro- (20-200 mu m) and meso-sized (200 mu m-2 mm) zooplankton communities are little understood. In this study, we investigated the distribution patterns of larger micro-zooplankton (100-200 mu m) and meso-zooplankton communities in the seasonal ice zone in the Cosmonaut Sea near Syowa Station and examined the effects of environmental factors and water properties on these communities. The investigation was based on samples collected with 100 mm mesh nets, which are appropriate to estimate the quantitative abundance and community structure of micro- and meso-zooplankton species between 1983 and 1995. Cluster analysis of the samples revealed that the distribution of macro-zooplankton species was influenced by the temperature and salinity of ocean fronts. Among the meso-zooplankton, cyclopoid and small calanoid copepods tended to be ubiquitously distributed. However, among the micro-zooplankton, the distributions of foraminiferans and tintinnids were associated with sea ice extent. The distribution of micro- and meso-zooplankton communities could be used to estimate the impact of environmental changes on the marine ecosystem in the Southern Ocean. (C) 2015 Elsevier B.V. and NIPR. All rights reserved.	[Ojima, Motoha; Takahashi, Kunio T.; Tanimura, Atsushi; Odate, Tsuneo; Fukuchi, Mitsuo] Grad Univ Adv Studies SOKENDAI, Tachikawa, Tokyo 1908518, Japan; [Takahashi, Kunio T.; Tanimura, Atsushi; Odate, Tsuneo; Fukuchi, Mitsuo] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan	Ojima, M (reprint author), Grad Univ Adv Studies SOKENDAI, 10-3 Midori Cho, Tachikawa, Tokyo 1908518, Japan.	ojima.motoha@nipr.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI grant [23310013]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 23310013. We would like to thank the officers and crew of the icebreakers Fuji and Shirase 5002 and the expedition members of the Japanese Antarctic Research Expedition (JARE) cruises for collecting the zooplankton samples and environmental data.	Alder A. V., 1999, S ATLANTIC ZOOPLANKT, P321; Alder V. A., 1995, THESIS U BUCNOS AIRE, P1; Zamora-Terol S, 2013, MAR ECOL PROG SER, V483, P85, DOI 10.3354/meps10288; Calbet A, 2005, J PLANKTON RES, V27, P1195, DOI 10.1093/plankt/fbi081; Dubischar CD, 2002, DEEP-SEA RES PT II, V49, P3871, DOI 10.1016/S0967-0645(02)00115-7; Makabe R, 2012, J PLANKTON RES, V34, P432, DOI 10.1093/plankt/fbs014; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Takahashi KT, 2010, POLAR SCI, V4, P317, DOI 10.1016/j.polar.2010.05.002; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Ojima M, 2013, POLAR BIOL, V36, P1293, DOI 10.1007/s00300-013-1348-y; SPINDLER M, 1986, POLAR BIOL, V5, P185, DOI 10.1007/BF00441699; Beaumont KL, 1997, ANTARCT SCI, V9, P121; Atkinson A, 2000, POLAR BIOL, V23, P46, DOI 10.1007/s003000050007; Chiba S, 2001, MAR ECOL PROG SER, V216, P95, DOI 10.3354/meps216095; DIECKMANN GS, 1991, J FORAMIN RES, V21, P182; FUKUCHI M, 1985, B MAR SCI, V37, P518; Tanimura A, 2008, ANTARCT SCI, V20, P365, DOI 10.1017/S0954102008000928; Nielsen TG, 1996, MAR ECOL PROG SER, V139, P79, DOI 10.3354/meps139079; Atkinson A, 1998, J MARINE SYST, V15, P289, DOI 10.1016/S0924-7963(97)00081-X; BANSE K, 1982, LIMNOL OCEANOGR, V27, P1059; Beers J. R., 1970, B SCRIPPS I OCEANOGR, V17, P67; Bibik V. A., 1988, INTERDISCIPLINARY IN, P16; Clarke R. K., 1993, MARINE ECOLOGY PROGR, V92, P205; Fukuchi M., 1981, MEM NATL I POLAR R E, V34, P37; Hoshiai T, 1989, P NIPR S POLAR BIOL, V2, P61; Hoshiai T., 1981, NATL I POLAR RES MEM, V34, P44; Hosie GW, 2000, DEEP-SEA RES PT II, V47, P2437, DOI 10.1016/S0967-0645(00)00031-X; Hosie Graham W., 1997, Proceedings of the NIPR Symposium on Polar Biology, V10, P90; Hunt BPV, 2007, DEEP-SEA RES PT I, V54, P1042, DOI 10.1016/j.dsr.2007.04.002; Metz C., 1996, BER POLARFORSCH, V207, P1; Stevens CJ, 2015, POLAR BIOL, V38, P275, DOI 10.1007/s00300-014-1583-x; Swadling KM, 2010, DEEP-SEA RES PT II, V57, P887, DOI 10.1016/j.dsr2.2008.10.041; Turner J., 2011, CLIMATE CHANGE POLAR; Yamada S., 1992, NANKYOKU SHIRYO ANTA, V36, P60	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-9652	1876-4428		POLAR SCI	Polar Sci.	SEP	2015	9	3					319	326		10.1016/j.polar.2015.05.002		8	Ecology; Geosciences, Multidisciplinary	Environmental Sciences & Ecology; Geology	CQ4HK	WOS:000360565200004		
J	Li, HX; Terao, A; Sugiyama, H				Li, Huaxia; Terao, Akihiro; Sugiyama, Hiroyuki			Application of tabular contact search method to multibody gear dynamics simulation with tooth surface imperfections	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART K-JOURNAL OF MULTI-BODY DYNAMICS			English	Article						Multibody dynamics; gear dynamics; gear tooth contact; contact search; tooth surface imperfection	SYSTEMS; ELEMENT; SPUR	In this investigation, an integrated numerical procedure for multibody gear dynamics simulation is developed using the tabular contact search method. Existing online contact search algorithms, which are widely used in multibody dynamics simulation, lead to extensive computational burden if detailed tooth surface geometry described by CAD or measured data points are considered with geometric imperfections. In the numerical procedure developed in this study, the contact geometry analysis based on the nonconformal contact condition is performed using the detailed tooth surface description prior to the dynamic simulation, and then the contact point as well as the tooth geometry at the contact point stored in the look-up contact tables are used to determine mesh forces in the multibody gear dynamics simulation. This allows for detecting multi-point contact without any iterative procedures, and the contact point on the back side of the tooth can also be considered by switching look-up contact tables in a straightforward manner. Furthermore, it is demonstrated that discontinuous contact event caused by the tooth surface imperfection can be predicted using a combined nodal and nonconformal contact search algorithm developed in this study. Several numerical examples are presented in order to demonstrate the use of the numerical procedure developed in this investigation.	[Li, Huaxia; Sugiyama, Hiroyuki] Univ Iowa, Dept Mech & Ind Engn, Iowa City, IA 52242 USA; [Terao, Akihiro] Tokyo Univ Sci, Dept Mech Engn, Tokyo 162, Japan	Sugiyama, H (reprint author), Univ Iowa, 2416C Seamans Ctr, Iowa City, IA 52242 USA.	hiroyuki-sugiyama@uiowa.edu			National Science Foundation [EPSC-1101284]	This research was supported by the National Science Foundation Grant Number EPSC-1101284.	Sainsot P, 2004, J MECH DESIGN, V126, P748, DOI 10.1115/1.1758252; Cardona A, 1997, INT J NUMER METH ENG, V40, P357, DOI 10.1002/(SICI)1097-0207(19970130)40:2<357::AID-NME71>3.3.CO;2-G; Cornell RW, 1981, J MECH DESIGN, V103, P447; Ebrahimi S, 2006, MULTIBODY SYST DYN, V16, P55, DOI 10.1007/s11044-006-9021-7; Haug E. J., 1989, COMPUTER AIDED KINEM; Houser DR, 1996, SEM 14 INT MOD AN C; Kahraman A, 1994, J MECH DESIGN, V116, P71; Karagiannis I, 2012, MECH MACH THEORY, V48, P94, DOI 10.1016/j.mechmachtheory.2011.08.012; KIN V, 1994, J MECH DESIGN, V116, P738, DOI 10.1115/1.2919444; Lee CH, 2012, P AS C MULT DYN SHAN; Litvin F. L., 2004, GEAR GEOMETRY APPL T; Mohammadpour M, 2014, J VIB ACOUST, V136, DOI 10.1115/1.4027403; OZGUVEN HN, 1988, J SOUND VIB, V121, P383; Palermo A, 2013, MECH MACH THEORY, V62, P13, DOI 10.1016/j.mechmachtheory.2012.11.006; Parker RG, 2000, J MECH DESIGN, V122, P305; Piegl L., 1996, NURBS BOOK; Shabana A.A., 2008, RAILROAD VEHICLE DYN; Shabana A.A., 2010, COMPUTATIONAL DYNAMI; Sheng S., 2012, NRELTP500054530; Shikin E. V., 1995, HDB SPLINES USER; Sugiyama H, 2013, INT J RAILWAY TECHNO, V4, P85; Sugiyama H, 2012, MULTIBODY SYST DYN, V27, P55, DOI 10.1007/s11044-011-9252-0; Sugiyama H., 2009, J COWT NONLINEAR DYN, V4, P1; TAVAKOLI MS, 1986, J MECH TRANSM-T ASME, V108, P86; VIJAYAKAR S, 1991, INT J NUMER METH ENG, V31, P525, DOI 10.1002/nme.1620310308; Wang J., 2003, APPL MECH REV, V56, P309, DOI 10.1115/1.1555660; Zhang Y, 1994, J MECH DESIGN, V116, P738; Ziegler P, 2009, P ECCOMAS THEM C MUL	28	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1464-4193	2041-3068		P I MECH ENG K-J MUL	Proc. Inst. Mech Eng Pt K-J Multi-Body Dyn.	SEP	2015	229	3					274	290		10.1177/1464419314561090		17	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CQ1YV	WOS:000360397400004		
J	Chiba, S; Suzuki, N				Chiba, Sotaro; Suzuki, Nobuhiro			Highly activated RNA silencing via strong induction of dicer by one virus can interfere with the replication of an unrelated virus	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						RNA silencing; dicer; argonaute; virus; Cryphonectria parasitica	CHESTNUT BLIGHT FUNGUS; DOUBLE-STRANDED-RNA; ROOT-ROT FUNGUS; PROTOTYPIC HYPOVIRUS CHV1-EP713; ROSELLINIA-NECATRIX; CRYPHONECTRIA-PARASITICA; ANTIVIRAL DEFENSE; PROTEASE P-29; PHYTOPATHOGENIC FUNGUS; CROSS-PROTECTION	Viruses often coinfect single host organisms in nature. Depending on the combination of viruses in such coinfections, the interplay between them may be synergistic, apparently neutral with no effect on each other, or antagonistic. RNA silencing is responsible for many cases of interference or cross-protection between viruses, but such antagonistic interactions are usually restricted to closely related strains of the same viral species. In this study, we present an unprecedented example of RNA silencing-mediated one-way interference between unrelated viruses in a filamentous model fungus, Cryphonectria parasitica. The replication of Rosellinia necatrix victorivirus 1 (RnVV1; Totiviridae) was strongly impaired by coinfection with the prototypic member of the genus Mycoreovirus (MyRV1) or a mutant of the prototype hypovirus (Cryphonectria hypovirus 1, CHV1) lacking the RNA silencing suppressor (CHV1-Delta p69). This interference was associated with marked transcriptional induction of key genes in antiviral RNA silencing, dicer-like 2 (dcl2) and argonaute-like 2 (agl2), following MyRV1 or CHV1-Delta p69 infection. Interestingly, the inhibition of RnVV1 replication was reproduced when the levels of dcl2 and agl2 transcripts were elevated by transgenic expression of a hairpin construct of an endogenous C. parasitica gene. Disruption of dcl2 completely abolished the interference, whereas that of agl2 did not always lead to its abolishment, suggesting more crucial roles of dcl2 in antiviral defense. Taken altogether, these results demonstrated the susceptible nature of RnVV1 to the antiviral silencing in C. parasitica activated by distinct viruses or transgene-derived double-stranded RNAs and provide insight into the potential for broad-spectrum virus control mediated by RNA silencing.	[Chiba, Sotaro; Suzuki, Nobuhiro] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	Suzuki, N (reprint author), Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan.	nsuzuki@okayama-u.ac.jp	Suzuki, Nobuhiro/B-2517-2011		Yomogi Inc.; Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [25252011]	We are grateful to Drs. Donald L. Nuss, Bradley I. Hillman, Satoko Kanematsu, and Dae-Hyuk Kim for the generous gift of the fungal strains (EP155, Delta dcl2, Delta agl2, Cp9B21, W1029, and CpMK1-KO). We thank Drs. Ida Bagus Andika, Liying Sun, and Hideki Kondo for plasmid pCPXHY2-CpMK1-IR and their helpful comments on the manuscript. This study was supported in part by Yomogi Inc. and a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI 25252011 to N.S.).	Andika IB, 2015, PLANT J, V81, P781, DOI 10.1111/tpj.12770; Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010; Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Suzuki N, 2004, J GEN VIROL, V85, P3437, DOI 10.1099/vir.0.80293-0; Wickner RB, 2013, ADV VIRUS RES, V86, P1, DOI 10.1016/B978-0-12-394315-6.00001-5; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Hillman BI, 2004, ADV VIRUS RES, V63, P423, DOI 10.1016/S0065-3527(04)63007-7; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Ziebell H, 2010, ADV VIRUS RES, V76, P211, DOI 10.1016/S0065-3527(10)76006-1; Ratcliff FG, 1999, PLANT CELL, V11, P1207; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Csorba T, 2015, VIROLOGY, V479, P85, DOI 10.1016/j.virol.2015.02.028; Drinnenberg IA, 2011, SCIENCE, V333, P1592, DOI 10.1126/science.1209575; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; Cao MJ, 2014, P NATL ACAD SCI USA, V111, P14613, DOI 10.1073/pnas.1407131111; Kondo H, 2013, ADV VIRUS RES, V86, P177, DOI 10.1016/B978-0-12-394315-6.00007-6; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Kosaka Y, 2006, PLANT DIS, V90, P67, DOI 10.1094/PD-90-0067; CHOI GH, 1992, SCIENCE, V257, P800, DOI 10.1126/science.1496400; Chiba S, 2013, J VIROL, V87, P6727, DOI 10.1128/JVI.00557-13; Chiba S, 2013, J VIROL, V87, P2330, DOI 10.1128/JVI.02835-12; CRAVEN MG, 1993, J VIROL, V67, P6513; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Eusebio-Cope A, 2015, VIROLOGY, V477, P164, DOI 10.1016/j.virol.2014.09.024; Eusebio-Cope A, 2015, NUCLEIC ACIDS RES, V43, P3802, DOI 10.1093/nar/gkv239; Garbutt JS, 2012, INSECT BIOCHEM MOLEC, V42, P621, DOI 10.1016/j.ibmb.2012.05.001; Hillman BI, 2004, J VIROL, V78, P892, DOI 10.1128/JVI.78.2.892-898.2004; Himeno M, 2010, VIROLOGY, V396, P69, DOI 10.1016/j.virol.2009.10.008; KOONIN EV, 1991, P NATL ACAD SCI USA, V88, P10647, DOI 10.1073/pnas.88.23.10647; Liu JS, 2014, J INSECT PHYSIOL, V66, P10, DOI 10.1016/j.jinsphys.2014.05.008; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; Nuss DL, 2011, ADV VIRUS RES, V80, P25, DOI 10.1016/B978-0-12-385987-7.00002-6; Park SM, 2004, MOL MICROBIOL, V51, P1267, DOI 10.1046/j.1365-2958.2004.03919.x; Segers GC, 2006, EUKARYOT CELL, V5, P896, DOI 10.1128/EC.00373-05; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; SHAPIRA R, 1991, EMBO J, V10, P731; Shivaprasad PV, 2008, NUCLEIC ACIDS RES, V36, P5896, DOI 10.1093/nar/gkn590; Sun LY, 2006, J GEN VIROL, V87, P3703, DOI 10.1099/vir0.82213-0; Sun LY, 2008, RNA, V14, P2557, DOI 10.1261/rna.1125408; Sun QH, 2009, P NATL ACAD SCI USA, V106, P17927, DOI 10.1073/pnas.0907552106; Suzuki N, 2002, J VIROL, V76, P7747, DOI 10.1128/JVI.76.15.7747-7759.2002; Suzuki N, 1999, J VIROL, V73, P9478; Suzuki N, 2003, J VIROL, V77, P11697, DOI 10.1128/JVI.77.21.11697-11707.2003; Wickner RB, 2011, FAMILY TOTIVIRIDAE V, P639; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Yaegashi H, 2013, FEMS MICROBIOL ECOL, V83, P49, DOI 10.1111/j.1574-6941.2012.01454.x; Yaegashi H, 2013, VIROLOGY, V444, P409, DOI 10.1016/j.virol.2013.07.010; Zhang DX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108653; Zhang XM, 2008, P NATL ACAD SCI USA, V105, P16749, DOI 10.1073/pnas.0807225105	58	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 1	2015	112	35					E4911	E4918		10.1073/pnas.1509151112		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1TV	WOS:000360383200014		
J	Ozawa, M; Kob, W; Ikeda, A; Miyazaki, K				Ozawa, Misaki; Kob, Walter; Ikeda, Atsushi; Miyazaki, Kunimasa			Reply to Chakrabarty et al.: Particles move even in ideal glasses	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Letter									[Ozawa, Misaki; Miyazaki, Kunimasa] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan; [Kob, Walter] Univ Montpellier I, Lab Charles Coulomb, UMR 5221, F-34090 Montpellier, France; [Kob, Walter] CNRS, F-34090 Montpellier, France; [Ikeda, Atsushi] Kyoto Univ, Fukui Inst Fundamental Chem, Kyoto 6068103, Japan	Kob, W (reprint author), Univ Montpellier I, Lab Charles Coulomb, UMR 5221, F-34090 Montpellier, France.	walter.kob@univ-montp2.fr	Ikeda, Atsushi/G-5210-2011	Ikeda, Atsushi/0000-0003-3107-374X			Cammarota C, 2012, P NATL ACAD SCI USA, V109, P8850, DOI 10.1073/pnas.1111582109; Ozawa M, 2015, P NATL ACAD SCI USA, V112, P6914, DOI 10.1073/pnas.1500730112; Chakrabarty S, 2015, P NATL ACAD SCI USA, V112, pE4819, DOI 10.1073/pnas.1512745112	3	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 1	2015	112	35					E4821	E4822		10.1073/pnas.1513323112		2	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1TV	WOS:000360383200002		
J	Woerman, AL; Stohr, J; Aoyagi, A; Rampersaud, R; Krejciova, Z; Watts, JC; Ohyama, T; Patel, S; Widjaja, K; Oehler, A; Sanders, DW; Diamond, MI; Seeley, WW; Middleton, LT; Gentleman, SM; Mordes, DA; Sudhof, TC; Giles, K; Prusiner, SB				Woerman, Amanda L.; Stoehr, Jan; Aoyagi, Atsushi; Rampersaud, Ryan; Krejciova, Zuzana; Watts, Joel C.; Ohyama, Takao; Patel, Smita; Widjaja, Kartika; Oehler, Abby; Sanders, David W.; Diamond, Marc I.; Seeley, William W.; Middleton, Lefkos T.; Gentleman, Steve M.; Mordes, Daniel A.; Suedhof, Thomas C.; Giles, Kurt; Prusiner, Stanley B.			Propagation of prions causing synucleinopathies in cultured cells	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						alpha-synuclein; multiple system atrophy; neurodegeneration; strains; Parkinson's disease	MULTIPLE SYSTEM ATROPHY; PATHOLOGICAL ALPHA-SYNUCLEIN; GLIAL CYTOPLASMIC INCLUSIONS; SPORADIC PARKINSONS-DISEASE; A-BETA PRIONS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LEWY BODIES; IN-VIVO; STRAINS	Increasingly, evidence argues that many neurodegenerative diseases, including progressive supranuclear palsy (PSP), are caused by prions, which are alternatively folded proteins undergoing self-propagation. In earlier studies, PSP prions were detected by infecting human embryonic kidney (HEK) cells expressing a tau fragment [TauRD(LM)] fused to yellow fluorescent protein (YFP). Here, we report on an improved bioassay using selective precipitation of tau prions from human PSP brain homogenates before infection of the HEK cells. Tau prions were measured by counting the number of cells with TauRD(LM)-YFP aggregates using confocal fluorescence microscopy. In parallel studies, we fused alpha-synuclein to YFP to bioassay alpha-synuclein prions in the brains of patients who died of multiple system atrophy (MSA). Previously, MSA prion detection required similar to 120 d for transmission into transgenic mice, whereas our cultured cell assay needed only 4 d. Variation in MSA prion levels in four different brain regions from three patients provided evidence for three different MSA prion strains. Attempts to demonstrate alpha-synuclein prions in brain homogenates from Parkinson's disease patients were unsuccessful, identifying an important biological difference between the two synucleinopathies. Partial purification of tau and alpha-synuclein prions facilitated measuring the levels of these protein pathogens in human brains. Our studies should facilitate investigations of the pathogenesis of both tau and alpha-synuclein prion disorders as well as help decipher the basic biology of those prions that attack the CNS.	[Woerman, Amanda L.; Stoehr, Jan; Aoyagi, Atsushi; Rampersaud, Ryan; Krejciova, Zuzana; Watts, Joel C.; Patel, Smita; Widjaja, Kartika; Giles, Kurt; Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Stoehr, Jan; Watts, Joel C.; Seeley, William W.; Giles, Kurt; Prusiner, Stanley B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Aoyagi, Atsushi; Ohyama, Takao] Daiichi Sankyo Co Ltd, Tokyo 1408710, Japan; [Oehler, Abby; Seeley, William W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Sanders, David W.; Diamond, Marc I.] Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Middleton, Lefkos T.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Ageing Res Unit, London SW7 2AZ, England; [Gentleman, Steve M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Neuroinflammat & Neurodegenerat, London SW7 2AZ, England; [Mordes, Daniel A.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Prusiner, Stanley B.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Prusiner, SB (reprint author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	stanley@ind.ucsf.edu			National Institutes of Health (NIH) [AG002132, AG010770, AG021601, AG031220]; Rainwater Charitable Foundation; Sherman Fairchild Foundation; Dana Foundation; Mary Jane Brinton Fund; NIH [AG023501, AG19724]; Tau Consortium; Consortium for Frontotemporal Dementia Research; Parkinson's UK, a charity registered in England [948776]; Parkinson's UK, a charity registered in Wales [948776]; Parkinson's UK, a charity registered in Scotland [SC037554]; University of Miami Brain Endowment Bank	This work was supported by grants from the National Institutes of Health (NIH) (AG002132, AG010770, AG021601, and AG031220) as well as the Rainwater Charitable Foundation, the Sherman Fairchild Foundation, the Dana Foundation, and the Mary Jane Brinton Fund. PSP tissue samples were received from the University of California, San Francisco Neurodegenerative Disease Brain Bank, which is supported by the NIH (AG023501 and AG19724 to W.W.S.), the Tau Consortium, and the Consortium for Frontotemporal Dementia Research. Additional tissue samples were supplied by the neuropathology core of the Massachusetts Alzheimer's Disease Research Center (AG005134); the Parkinson's UK Tissue Bank at Imperial College London, funded by Parkinson's UK, a charity registered in England and Wales (948776) and in Scotland (SC037554); and the University of Miami Brain Endowment Bank. DNA for WT and A53T mutated human a-synuclein was kindly provided by Dr. Robert Nussbaum. We thank the Hunter's Point animal facility staff for their assistance with animal experiments and Marta Gavidia for mouse genotyping. Additional thanks to Dr. Joel Gever for optimizing the cell assay conditions and to Ana Serban for the production of the K18 fragment of tau and the anti-Tau-12 antibody.	Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Baba M, 1998, AM J PATHOL, V152, P879; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Alafuzoff I, 2009, ACTA NEUROPATHOL, V117, P635, DOI 10.1007/s00401-009-0523-2; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Spillantini MG, 1998, NEUROSCI LETT, V251, P205; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Kim EJ, 2012, CEREB CORTEX, V22, P251, DOI 10.1093/cercor/bhr004; BUTLER DA, 1988, J VIROL, V62, P1558; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Stohr J, 2014, P NATL ACAD SCI USA, V111, P10329, DOI 10.1073/pnas.1408968111; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Murray ME, 2015, BRAIN, V138, P1370, DOI 10.1093/brain/awv050; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Barghorn Stefan, 2005, Methods Mol Biol, V299, P35; Barmada SJ, 2005, J NEUROSCI, V25, P5824, DOI 10.1523/JNEUROSCI.1192-05.2005; Bian JF, 2006, BIOCHEM BIOPH RES CO, V340, P894, DOI 10.1016/j.bbrc.2005.12.085; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; CHANDLER RL, 1963, LANCET, V2, P1165; Fahn S, 2011, PRINCIPLES PRACTICE; Fernagut PO, 2005, MOVEMENT DISORD, V20, pS57, DOI 10.1002/mds.20541; Forster E, 1912, PATHOLOGISCHE ANAT H, P920; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Levine DJ, 2015, ACS CHEM BIOL, V10, P1269, DOI 10.1021/cb5006239; National Research Council, 2011, GUIDE CARE USE LAB A; Parkinson J, 1817, ESSAY SHAKING PALSY; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prusiner SB, 2014, MADNESS AND MEMORY; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Wenning GK, 2001, CNS DRUGS, V15, P839, DOI 10.2165/00023210-200115110-00003	75	2	2	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 1	2015	112	35					E4949	E4958		10.1073/pnas.1513426112		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CQ1TV	WOS:000360383200018		
J	Tachimori, H; Takeshima, T; Kono, T; Akazawa, M; Zhao, XH				Tachimori, Hisateru; Takeshima, Tadashi; Kono, Toshiaki; Akazawa, Masato; Zhao, Xianghua			Statistical aspects of psychiatric inpatient care in Japan: Based on a comprehensive nationwide survey of psychiatric hospitals conducted from 1996 to 2012	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Review						discharge rate for long-term patients; discharge rate for newly admitted patients; policy evaluation; psychiatric hospital; psychiatric inpatient care; statistical survey		The aim of this review is to clarify the state of psychiatric admissions and discharges in Japan using statistical data collected from 1996 to 2012. We performed a secondary analysis of nationwide data on psychiatric hospitals, which are collected yearly by the Ministry of Health, Labour and Welfare. The latest national figures for indices defined in the Reform Vision of Mental Health and Welfare' (originally released in 2004) were 70.9% for discharge rate for newly admitted patients' and 23.3% for discharge rate for long-term patients', which have target rates of 76% and 29%, respectively. The national discharge rate for newly admitted patients was roughly on the increase, but appeared to reach a plateau in recent years. [Correction added on 17 July 2015, after first online publication: 'on the decline' has been corrected to 'on the increase' in the sentence above.] The national discharge rate for long-term patients was higher in 2012 than in 1999 and appeared to increase throughout the 2000s, although not enough to reach the target. Some improvements in the discharge rate for newly admitted patients indicated some progress in mental health reform, although problems should continue to be addressed in order to reach the targets. As for discharge rates of long-term admissions in local communities, some problems still remain to be solved in order to achieve the goals of the reform vision.	[Tachimori, Hisateru; Takeshima, Tadashi; Kono, Toshiaki; Akazawa, Masato; Zhao, Xianghua] Natl Ctr Neurol & Psychiat, Dept Mental Hlth Policy & Evaluat, Natl Inst Mental Hlth, Kodaira, Tokyo 1878553, Japan	Tachimori, H (reprint author), Natl Ctr Neurol & Psychiat, Dept Mental Hlth Policy & Evaluat, Natl Inst Mental Hlth, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878553, Japan.	tachi@ncnp.go.jp			Health and Labour Science Research Grants [H24-Seishin-Ippan-008, H21-Kokoro-Ippan-009, H18-Kokoro-Ippan-007]	This work was supported by Health and Labour Science Research Grants (H24-Seishin-Ippan-008, H21-Kokoro-Ippan-009, and H18-Kokoro-Ippan-007). The authors do not have any conflicts of interest to declare.	[Labour and Welfare Headquarters for Mental Health and Welfare of the Ministry of Health], 2004, SEISH HOK IR FUK KAI; [Labour and Welfare National Institute of Mental Health National Center of Neurology and Psychiatry Mental Health and Disability Health Division of the Ministry of Health], 1996, SEISH HOK FUK SIR; OECD, 2014, OECD HLTH STAT 2014; OECD, 2014, OECD HLTH STAT; R CORE TEAM, 2014, LANG ENV STAT COMP; Sessions organized by the Social Welfare and War Victims Relief Bureau of the Ministry of Health Labour and Welfare, 2009, SEISH HOK IR FUK SAR	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	SEP	2015	69	9					512	522		10.1111/pcn.12297		11	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CQ7UV	WOS:000360811400002		
J	Kanehara, A; Umeda, M; Kawakami, N				Kanehara, Akiko; Umeda, Maki; Kawakami, Norito		World Mental Hlth Japan Survey Grp	Barriers to mental health care in Japan: Results from the World Mental Health Japan Survey	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						barriers to mental health care; epidemiologic study; mental health service use; sociodemographic correlates; stigma	HELP-SEEKING; PUBLIC BELIEFS; UNITED-STATES; DISORDERS; AUSTRALIA; SERVICES; STIGMA; PREVALENCE; COUNTRIES; ATTITUDES	AimsThe reasons for accessing and maintaining access to mental health services in Japan may be different to those in other countries. Using the World Health Organization World Mental Health Japan survey data, this study investigated the prevalence of sociodemographic correlates of barriers for the use of, reasons for delayed access to, and reasons for dropping out from mental health care in a Japanese community-based sample. MethodsAn interview survey was conducted with a random sample of residents living in 11 communities across Japan during the years 2002-2006. Data from 4130 participants were analyzed. ResultsThe most frequently reported reason for not seeking mental health care was a low perceived need (63.9%). The most common reason for delaying access to help was the wish to handle the problem on one's own (68.8%), while the most common reason for dropping out of care was also a low perceived need (54.2%). Being a woman and of younger age were key sociodemographic barriers to the use of mental health services. ConclusionsLow perceived need was a major reason for not seeking, delay in using, and dropout from mental health services in Japan. In addition, low perceived need and structural barriers were more frequently reported than attitudinal barriers, with the exception of a desire to handle the problem on one's own. These findings suggest that improving therapist-patient communication and quality of mental health care, as well as mental health literacy education in the community, might improve access to care in Japan.	[Kanehara, Akiko; Umeda, Maki; Kawakami, Norito; World Mental Hlth Japan Survey Grp] Univ Tokyo, Sch Publ Hlth, Dept Mental Hlth, Tokyo 1130033, Japan	Kawakami, N (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Mental Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nkawakami@m.u-tokyo.ac.jp			Japan Ministry of Health, Labour, and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; US National Institute of Mental Health [R01MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R01-TW006481]; Pan American Health Organization; Eli Lilly and Company; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb	The authors declare that they have no competing interests. The World Mental Health Japan (WMHJ) survey was supported by a Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour, and Welfare. The WMH Japan 2002-2004 Survey was carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. We also thank the WMH staff for assistance with instrumentation, fieldwork, and data analysis. These activities were supported by the US National Institute of Mental Health (R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R01-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, and Bristol-Myers Squibb. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/publications.php.	Jagdeo A, 2009, CAN J PSYCHIAT, V54, P757; Thompson A, 2004, SOC PSYCH PSYCH EPID, V39, P810, DOI 10.1007/s00127-004-0816-7; Mackenzie CS, 2006, AGING MENT HEALTH, V10, P574, DOI 10.1080/13607860600641200; Olfson M, 2009, PSYCHIAT SERV, V60, P898, DOI 10.1176/appi.ps.60.7.898; Andrade LH, 2014, PSYCHOL MED, V44, P1303, DOI 10.1017/S0033291713001943; WELLS JE, 1994, SOC PSYCH PSYCH EPID, V29, P155; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Wang JL, 2007, MED CARE, V45, P224, DOI 10.1097/01.mlr.0000244506.86885.a5; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Prins M, 2011, SOC PSYCH PSYCH EPID, V46, P1033, DOI 10.1007/s00127-010-0266-3; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Oshima I, 2003, BRIT J PSYCHIAT, V183, P50, DOI 10.1192/bjp.183.1.50; Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x; Griffiths KM, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-21; Ito H, 2005, BRIT J PSYCHIAT, V187, P243, DOI 10.1192/bjp.187.3.243; Jorm AF, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-12; Kido Y, 2013, PSYCHIAT CLIN NEUROS, V67, P101, DOI 10.1111/pcn.12008; Kisely S, 2006, BRIT J PSYCHIAT, V189, P79, DOI 10.1192/bjp.bp.105.019869; Knapp M, 2003, BRIT J PSYCHIAT, V183, P477, DOI 10.1192/bjp.183.6.477; Mojtabai R, 2010, SOC PSYCH PSYCH EPID, V45, P705, DOI 10.1007/s00127-009-0109-2; Nakane Y, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-33; Wang PS, 2000, MED CARE, V38, P926, DOI 10.1097/00005650-200009000-00006	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	SEP	2015	69	9					523	533		10.1111/pcn.12267		11	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CQ7UV	WOS:000360811400003		
J	Nishio, A; Yamamoto, M; Ueki, H; Watanabe, T; Matsuura, K; Tamura, O; Uehara, R; Shioiri, T				Nishio, Akihiro; Yamamoto, Mayumi; Ueki, Hirofumi; Watanabe, Takahiro; Matsuura, Kenshin; Tamura, Osamu; Uehara, Ryosuke; Shioiri, Toshiki			Prevalence of mental illness, intellectual disability, and developmental disability among homeless people in Nagoya, Japan: A case series study	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						developmental disability; homeless; intellectual disabilities; mental illness; Wechsler Adult Intelligence Scale Third Edition	GERMANY; HEALTH	AimWhile it has been reported that the prevalence of mental illness is higher in homeless people than in the national population, few studies have investigated the prevalence of intellectual and developmental disability among the homeless. In this study, we conducted a survey to comprehensively assess these mental problems among homeless people in Nagoya, Japan. MethodsThe subjects were 18 homeless men. Mental illness was diagnosed with semi-structured interviews conducted by psychiatrists. We used the Wechsler Adult Intelligence Scale III to diagnose intellectual disability. Discrepancies between Wechsler Adult Intelligence Scale III subtest scores were used as criteria for developmental disability. ResultsEleven of the 18 participants were diagnosed with mental illness: six with mood disorder, two with psychotic disorder, and six with alcohol problems. The mean IQ of all subjects was 83.427.4. The 95% confidence interval (CI) was 96.2-69.1. Seven participants were found to have intellectual disability. Three men showed discrepancies of more than 10 between subtest scores, and all of them were diagnosed with a mental illness. We divided the participants into four groups: those with mental illness only; those with intellectual disability only; those with both problems; and those without diagnosis. The men with intellectual disability only were significantly younger and had been homeless since a younger age than the other groups. Participants diagnosed with a mental illness had been homeless for longer than those without mental health problems. ConclusionAlthough the sample size was limited, this study revealed the high prevalence of mental illness and intellectual disability, 61% (95%CI, 35-83%) and 39% (95%CI, 17-64%), respectively, in homeless people in Nagoya, Japan.	[Nishio, Akihiro; Yamamoto, Mayumi] Gifu Univ, Hlth Adm Ctr, Gifu 5011193, Japan; [Nishio, Akihiro; Ueki, Hirofumi; Shioiri, Toshiki] Gifu Univ, Dept Psychopathol, Div Neurosci, Grad Sch Med, Gifu 5011193, Japan; [Yamamoto, Mayumi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan; [Watanabe, Takahiro] Midori Hosp, Gifu, Japan; [Matsuura, Kenshin] Kanazawa Johoku Hosp, Kanazawa, Ishikawa, Japan; [Tamura, Osamu] Hokkaido Labor Hosp, Sapporo, Hokkaido, Japan; [Uehara, Ryosuke] Yoshida Hosp, Nara, Japan	Nishio, A (reprint author), Gifu Univ, Hlth Adm Ctr, 1-1 Yanagido, Gifu 5011193, Japan.	a_nishio@gifu-u.ac.jp			Japan Federation of Democratic Medical Institute; Institute of Nonprofit Health Care Cooperation	We would like to express our appreciation to the staff of the non-profit organization Sasashima Support Center and Sasashima Clinic and the psychiatrists, clinical psychologists, certified social workers, and nurses who cooperated on this survey. The authors declare that they have no conflict of interest. Our survey was financed by the Japan Federation of Democratic Medical Institute and Institute of Nonprofit Health Care Cooperation.	Fichter MM, 2001, ACTA PSYCHIAT SCAND, V103, P94, DOI 10.1034/j.1600-0447.2001.00217.x; NAKANE Y, 1992, SCHIZOPHRENIA BULL, V18, P75; Edidin JP, 2012, CHILD PSYCHIAT HUM D, V43, P354, DOI 10.1007/s10578-011-0270-1; Rohde P, 1999, J ADOLESCENCE, V22, P319, DOI 10.1006/jado.1999.0224; Mercier C, 2011, J INTELL DISABIL RES, V55, P441, DOI 10.1111/j.1365-2788.2010.01366.x; Salize HJ, 2002, ADDICTION, V97, P1593, DOI 10.1046/j.1360-0443.2002.00235.x; [Anonymous], 2001, WHO COMPOSITE INT DI; Langle G, 2005, SOC PSYCH PSYCH EPID, V40, P382, DOI 10.1007/s00127-005-0902-5; City of Nagoya, 2012, FACT FIND HOM PERS L, P12; Dairoku H, 2008, JAPAN PSYCHOL ASS M, P433; Dunne E, 2012, Ir Med J, V105, P71; Epstein J, 2012, CONNERS ADULT ADHD D; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fukue T, 2013, JPN J GEN HOSP PSYCH, V25, P55; Ministry of Health Labour and Welfare in Japan, 2000, COMPR SURV CHILDR PE; Morikawa Suimei, 2011, Nihon Koshu Eisei Zasshi, V58, P331; Oakes Peter M, 2008, J Intellect Disabil, V12, P325, DOI 10.1177/1744629508100496; Ohota T, 2011, PSYCHIAT NEUROL JPN, V113, P1137; Van Straaten B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086112; Wechsler D, 1997, WECHSLER ADULT INTEL; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	SEP	2015	69	9					534	542		10.1111/pcn.12265		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CQ7UV	WOS:000360811400004		
J	Nakagawa, A; Williams, A; Sado, M; Oguchi, Y; Mischoulon, D; Smith, F; Mimura, M; Sato, Y				Nakagawa, Atsuo; Williams, Aya; Sado, Mitsuhiro; Oguchi, Yoshiyo; Mischoulon, David; Smith, Felicia; Mimura, Masaru; Sato, Yuji			Comparison of treatment selections by Japanese and US psychiatrists for major depressive disorder: A case vignette study	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						Japan; major depressive disorder; medical education; psychiatric residency; USA	SYSTEMATIC ANALYSIS; BENZODIAZEPINE USE; GLOBAL BURDEN; ANTIDEPRESSANTS; INJURIES; DISEASES	AimsA review of the published work on treatments for major depressive disorder suggests that there is an alarming gap between guideline recommendations and actual clinical practices worldwide. The purpose of this study was to compare early-career psychiatrists' selections of treatment for mild to moderate major depression in Japan and the USA. MethodsThe authors surveyed 120 early-career psychiatrists from two residency programs in Japan and the USA using web-based questionnaires. In response to two case vignettes of mild to moderate major depression, the subjects selected treatment modalities and first- and second-line pharmacotherapy. ResultsEighty-one psychiatrists (68%) returned surveys, of whom 42 (52%) were Japanese and 39 (48%) American. Fewer Japanese subjects selected psychotherapy than Americans. The Japanese psychiatrists favored benzodiazepine monotherapy for the treatment of mild depression, whereas the American psychiatrists favored antidepressant monotherapy. For the initial treatment of moderate depression, approximately half of the Japanese selected antidepressant monotherapy, and a quarter selected benzodiazepine monotherapy, whereas the Americans unanimously selected selective serotonin reuptake inhibitors monotherapy. As a second-line strategy, the Japanese were more likely to augment medication and less likely to increase dosage for moderate depression than their American counterparts. ConclusionsDifferences were found between the treatment selections of early-career psychiatrists in Japan and the USA, despite comparable guidelines and postgraduate training. The results suggest that the gap between guidelines and practice may also be shaped by physician workload, attitudes toward side-effects, and the sociocultural contexts in which clinical decisions are made.	[Nakagawa, Atsuo; Williams, Aya; Sato, Yuji] Keio Univ, Clin Res Ctr, Sch Med, Tokyo 1608582, Japan; [Sado, Mitsuhiro; Oguchi, Yoshiyo; Mimura, Masaru] Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo 1608582, Japan; [Mischoulon, David; Smith, Felicia] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Nakagawa, A (reprint author), Keio Univ, Clin Res Ctr, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	anakagawa@z2.keio.jp			Health Labor Sciences Research Grant from the Japanese Ministry of Health, Labour, and Welfare [H25-Seishin-Shitei-011, H26-Seishin-Shitei-001]	This study was made possible by a Health Labor Sciences Research Grant (H25-Seishin-Shitei-011, H26-Seishin-Shitei-001) from the Japanese Ministry of Health, Labour, and Welfare. The authors would also like to thank Dr Nhi-Ha Trinh and Dr Justin Chen from the MGH Depression Clinical and Research Program for their contributions to the study design and recruitment. The authors report no conflict of interest.	American Board of Psychiatry and Neurology, 2011, PSYCH COR COMP OUTL; American Psychiatric Association, 2010, PRACT GUID TREATM PA; Lai IC, 2011, J CLIN PHARM THER, V36, P577, DOI 10.1111/j.1365-2710.2010.01213.x; Duhoux A, 2009, SOC PSYCH PSYCH EPID, V44, P385, DOI 10.1007/s00127-008-0444-8; Sanyal C, 2011, CAN J PSYCHIAT, V56, P667; Onishi Y, 2013, CLIN DRUG INVEST, V33, P597, DOI 10.1007/s40261-013-0104-y; Pfeiffer PN, 2011, J CLIN PSYCHOPHARM, V31, P360, DOI 10.1097/JCP.0b013e318217b4c4; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Valenstein M, 2004, AM J PSYCHIAT, V161, P654, DOI 10.1176/appi.ajp.161.4.654; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P11; Chen SY, 2010, GEN HOSP PSYCHIAT, V32, P360, DOI 10.1016/j.genhosppsych.2010.03.007; Fujisawa D, 2006, CURRENT STATUS DISSE; Furukawa T, 2000, COCHRANE DB SYST REV; IBM Corporation, 2013, IBM SPSS STAT WIND V; Marcus M, DEPRESSION A GLOBAL; Medscape, 2013, PSYCH COMP REP 2013; Ministry of Health Labour and Welfare, OV MED SERV REG JAP; Morris-Yates A, 2012, PSYCHIAT WORK LOAD S; National Institute for Health and Care Excellence, 2009, DEPR AD TREATM MAN D; Qualtrics, QUALTR SEC STAT; Qualtrics, QUATLR ONL SURV SOFT; Shirasaka T, 2011, SEISHIN SHINKEIGAKU, V65, pSS30; Taylor D, 2012, MAUDSLEY PRESCRIBING; Trivedi Madhukar H, 2007, CNS Spectr, V12, P1; Umene-Nakano Wakako, 2011, Seishin Shinkeigaku Zasshi, V113, P271; Verger P, 2008, CAN J PSYCHIAT, V53, P94; Warden Diane, 2007, Curr Psychiatry Rep, V9, P449, DOI 10.1007/s11920-007-0061-3	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	SEP	2015	69	9					553	562		10.1111/pcn.12273		10	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CQ7UV	WOS:000360811400006		
J	Hayashi, N; Igarashi, M; Imai, A; Yoshizawa, Y; Asamura, K; Ishikawa, Y; Tokunaga, T; Ishimoto, K; Tatebayashi, Y; Kumagai, N; Ishii, H; Okazaki, Y				Hayashi, Naoki; Igarashi, Miyabi; Imai, Atsushi; Yoshizawa, Yuka; Asamura, Kaori; Ishikawa, Yoichi; Tokunaga, Taro; Ishimoto, Kayo; Tatebayashi, Yoshitaka; Kumagai, Naoki; Ishii, Hidetoki; Okazaki, Yuji			Pathways from life-historical events and borderline personality disorder to symptomatic disorders among suicidal psychiatric patients: A study of structural equation modeling	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						borderline personality disorder; childhood and adolescent maltreatment; psychiatric admission; psychiatric diagnosis; suicidal behavior	MAJOR DEPRESSIVE DISORDER; DELIBERATE SELF-HARM; CHILDHOOD EXPERIENCES; ANXIETY DISORDERS; POSTTRAUMATIC-STRESS; RISK-FACTORS; BEHAVIOR; PSYCHOPATHOLOGY; COMORBIDITY; ADVERSITIES	AimsSuicidal behavior (SB) is a major mental health problem. The research has identified many factors related to SB, such as problems in the developmental period and psychiatric and personality disorders. However, the interrelation of these factors has not been clearly delineated. MethodsThe subjects were 155 patients consecutively admitted with SB to a psychiatric center in Tokyo. Structured interviews, including the Structured Clinical Interview for DSM-IV (SCID)-I and SCID-II, were conducted to determine characteristics of the SB-related factors. To illustrate their interrelation, this study applied the technique of structural equation modeling. The latent constructs of life-historical events, borderline personality disorder (BPD) features and three symptomatic disorders (depression, anxiety disorders and substance dependence) were aligned in the chronological order of their manifestation, and connected one another within the model. Indicator variables of life-historical events were maltreatment in the developmental period and early onset of problematic behaviors. Indicators of BPD features and symptomatic disorders included the scales composed of the items in the SCID-I and II. ResultsThe constructed model with favorable goodness-of-fit indices confirmed that BPD features had a mediating role in which they were influenced by life-historical events, and exerted an influence on the symptomatic disorders. Outside the BPD-mediating paths, the model suggested three clinically interpretable links between life-historical events and symptomatic disorders. ConclusionsThe model of this study demonstrated the pathways from life-historical events and BPD to symptomatic disorders, and indicated a generating process of psychiatric comorbidity among suicidal patients. The wide-range view this study portrayed has important clinical implications, and deserves further substantiation by future studies.	[Hayashi, Naoki] Teikyo Univ, Dept Psychiat, Sch Med, Tokyo 1738606, Japan; [Igarashi, Miyabi] Tokyo Metropolitan Chubu Comprehens Ctr Mental Hl, Tokyo, Japan; [Imai, Atsushi; Tokunaga, Taro; Ishimoto, Kayo; Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo, Japan; [Ishikawa, Yoichi] Kitanomaru Clin, Tokyo, Japan; [Tatebayashi, Yoshitaka] Tokyo Metropolitan Inst Med Sci, Affect Disorders Res Team, Tokyo, Japan; [Kumagai, Naoki] Tokyo Govt Bur Social Welf & Publ Hlth, Tokyo, Japan; [Yoshizawa, Yuka] Osaka Prefectural Tondabayashi Hlth Ctr, Osaka, Japan; [Ishii, Hidetoki] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Okazaki, Yuji] Michinoo Hosp, Nagasaki, Japan	Hayashi, N (reprint author), Teikyo Univ, Dept Psychiat, Sch Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738606, Japan.	nhayashi55@nifty.com			Japanese Ministry of Health, Labor and Welfare [H19, H20-Kokoro-Japan 012]; Tokyo Metropolitan Hospital Management Office [H21, H22 Rinsho-kenkyu-hi]	The present study was supported by grants-in-aid from the Japanese Ministry of Health, Labor and Welfare (H19, H20-Kokoro-Japan 012) and the Tokyo Metropolitan Hospital Management Office (H21, H22 Rinsho-kenkyu-hi). The authors declare that they have no competing interests.	Zanarini MC, 2000, PSYCHIAT CLIN N AM, V23, P89, DOI 10.1016/S0193-953X(05)70145-3; Molnar BE, 2001, AM J PUBLIC HEALTH, V91, P753, DOI 10.2105/AJPH.91.5.753; Gunderson JG, 2004, J CLIN PSYCHIAT, V65, P1049; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; Black DW, 2004, J PERS DISORD, V18, P226, DOI 10.1521/pedi.18.3.226.35445; Johnson JG, 2002, ARCH GEN PSYCHIAT, V59, P741, DOI 10.1001/archpsyc.59.8.741; Zanarini MC, 2006, J PERS DISORD, V20, P9, DOI 10.1521/pedi.2006.20.1.9; Haukka J, 2008, AM J EPIDEMIOL, V167, P1155, DOI 10.1093/aje/kwn017; Yen S, 2003, J ABNORM PSYCHOL, V112, P375, DOI 10.1037/0021-843X.112.3.375; Turnbull DL, 2013, J NERV MENT DIS, V201, P130, DOI 10.1097/NMD.0b013e31827f6449; Zanarini MC, 1997, AM J PSYCHIAT, V154, P1101; Sanislow CA, 2002, AM J PSYCHIAT, V159, P284, DOI 10.1176/appi.ajp.159.2.284; SOLOFF PH, 1983, COMPR PSYCHIAT, V24, P574, DOI 10.1016/0010-440X(83)90026-3; Nepon J, 2010, DEPRESS ANXIETY, V27, P791, DOI 10.1002/da.20674; Walter M, 2009, ADDICTION, V104, P97, DOI 10.1111/j.1360-0443.2008.02413.x; Bohnert ASB, 2010, DRUG ALCOHOL DEPEN, V110, P183, DOI 10.1016/j.drugalcdep.2010.03.010; Brodsky BS, 2008, PSYCHIAT CLIN N AM, V31, P223, DOI 10.1016/j.psc.2008.02.002; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Nevitt J, 2001, STRUCT EQU MODELING, V8, P353, DOI 10.1207/S15328007SEM0803_2; Widom CS, 1999, AM J PSYCHIAT, V156, P1223; Bruffaerts R, 2010, BRIT J PSYCHIAT, V197, P20, DOI 10.1192/bjp.bp.109.074716; Fliege H, 2009, J PSYCHOSOM RES, V66, P477, DOI 10.1016/j.jpsychores.2008.10.013; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561; Haw C, 2001, BRIT J PSYCHIAT, V178, P48, DOI 10.1192/bjp.178.1.48; BOLLEN KA, 1992, SOCIOL METHOD RES, V21, P205, DOI 10.1177/0049124192021002004; Corbitt EM, 1996, J AFFECT DISORDERS, V39, P61, DOI 10.1016/0165-0327(96)00023-7; De Leo DBS, 2004, SUICIDAL BEHAV, P11; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; First M., 1997, USERS GUIDE STRUCTUR; First MB, 1997, STRUCTURED CLIN INTE; Gorman J M, 1996, Depress Anxiety, V4, P160, DOI 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J; Gunnell D, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2278; Hawgood J, 2008, CURR OPIN PSYCHIATR, V21, P51, DOI 10.1097/YCO.0b013e3282f2309d; Hayashi N, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-186; Hayashi N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-109; HERPERTZ S, 1995, ACTA PSYCHIAT SCAND, V91, P57, DOI 10.1111/j.1600-0447.1995.tb09743.x; LINKS PS, 1995, J NERV MENT DIS, V183, P582, DOI 10.1097/00005053-199509000-00004; Lonnqvist J, 2009, OXFORD TXB SUICIDOLO, P275; Sharp C, 2012, J PERS DISORD, V26, P927, DOI 10.1521/pedi.2012.26.6.927; Silverman MH, 2012, J PERS DISORD, V26, P804; Soderberg S, 2001, NORD J PSYCHIAT, V55, P163, DOI 10.1080/08039480152036038; Stanley B, 2009, OXFORD TXB SUICIDOLO, P287; Troister Talia, 2008, Curr Psychiatry Rep, V10, P60, DOI 10.1007/s11920-008-0011-8	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	SEP	2015	69	9					563	571		10.1111/pcn.12280		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CQ7UV	WOS:000360811400007		
J	Ojio, Y; Yonehara, H; Taneichi, S; Yamasaki, S; Ando, S; Togo, F; Nishida, A; Sasaki, T				Ojio, Yasutaka; Yonehara, Hiromi; Taneichi, Setsuko; Yamasaki, Syudo; Ando, Shuntaro; Togo, Fumiharu; Nishida, Atsushi; Sasaki, Tsukasa			Effects of school-based mental health literacy education for secondary school students to be delivered by school teachers: A preliminary study	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						adolescent; health education; mental health; program evaluation; schools	YOUNG-PEOPLE; HELP-SEEKING; INTERVENTIONS; STIGMA; PROGRAM; DISORDERS; KNOWLEDGE; ATTITUDES; ILLNESS; IMPACT	AimsImproving knowledge and beliefs about mental health (or mental health literacy [MHL]) may promote appropriate help-seeking by adolescents who are suffering from mental health problems. We developed a concise, school-staff-led MHL program and examined its effects. MethodsThe participants comprised 118 grade-9 students (61 boys and 57 girls). The program consisted of two 50-min sessions, and was given by a schoolteacher. The effects of the program were evaluated before, immediately after and 3 months after the program, using a self-report questionnaire. ResultsKnowledge of mental health/illnesses and desirable behavior for help-seeking were significantly improved immediately after (post-test, P<0.001, and P<0.001, respectively) and 3 months after the program (3-month follow up, P<0.001 and P<0.001, respectively), compared with the test before the delivery of the program (pre-test, Wilcoxon signed rank test). Proportions of the correct diagnoses of vignette cases of major depression and schizophrenia were significantly (P<0.001) elevated from 38.3% and 19.1% (pre-test) to 94.7% and 93.6% (post-test), and 91.5% and 86.2% (3-month follow up). Intentions to seek help and to provide peers with help with mental health problems were also significantly (P<0.001) elevated at post-test and at 3 months compared with the pre-test. ConclusionsA concise, school-staff-led program may have a significant effect on the improvement of MHL in secondary school students.	[Ojio, Yasutaka; Taneichi, Setsuko; Togo, Fumiharu; Sasaki, Tsukasa] Univ Tokyo, Dept Phys & Hlth Educ, Tokyo 1130033, Japan; [Yonehara, Hiromi] Univ Tokyo, Secondary Sch, Fac Educ, Tokyo 1130033, Japan; [Yamasaki, Syudo; Ando, Shuntaro; Nishida, Atsushi] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo 113, Japan	Sasaki, T (reprint author), Univ Tokyo, Grad Sch Educ, Lab Hlth Educ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sasaki@p.u-tokyo.ac.jp			Kitano Foundation of Lifelong Integrated Education; Center for Excellence in School Education; Mental Health Okamoto Memorial Foundation; Toyota Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [23118004]	This research was funded through grants from the Kitano Foundation of Lifelong Integrated Education, the Center for Excellence in School Education, The Mental Health Okamoto Memorial Foundation, The Toyota Foundation, and the Ministry of Education, Culture, Sports, Science and Technology of Japan, Scientific Research Grant on Innovative Area (23118004; Adolescent Mind & Self-Regulation). We are grateful also to research assistants, in particular Mr Junichi Katori, for his cooperation with this study. The authors declare no conflicts of interest. The authors are solely responsible for the content and writing of the paper.	Wei YF, 2013, EARLY INTERV PSYCHIA, V7, P109, DOI 10.1111/eip.12010; Clement S, 2012, BRIT J PSYCHIAT, V201, P57, DOI 10.1192/bjp.bp.111.093120; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Jorm AF, 2012, AM PSYCHOL, V67, P231, DOI 10.1037/a0025957; Rusch N, 2011, PSYCHIAT SERV, V62, P675, DOI 10.1176/appi.ps.62.6.675; Han SS, 2005, J ABNORM CHILD PSYCH, V33, P665, DOI 10.1007/s10802-005-7646-2; Santor DA, 2007, J AM ACAD CHILD PSY, V46, P50, DOI 10.1097/01.chi.0000242247.45915.ee; Pinfold V, 2003, BRIT J PSYCHIAT, V182, P342, DOI 10.1192/bjp.182.4.342; Rahman A, 1998, LANCET, V352, P1022, DOI 10.1016/S0140-6736(98)02381-2; Jorm AF, 1997, MED J AUSTRALIA, V166, P182; Bagnell AL, 2013, CHILD ADOL PSYCH CL, V21, P81; Clement S., 2014, PSYCHOL MED, V26, P1, DOI DOI 10.1017/S0033291714000129; Corrigan PW, 2012, BRIT J PSYCHIAT, V201, P7, DOI 10.1192/bjp.bp.111.103382; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Jones P., 2013, BRIT J PSYCHIAT S54, V202, P5; Jorm F, 2010, BMC PSYCHIATRY, V10, P51; Kutcher S., 2013, ADV SCH MENT HLTH PR, V6, P83; McLuckie A, 2014, BMC PSYCHIATRY, V14, P1694; Naylor PB, 2009, BRIT J PSYCHIAT, V194, P365, DOI 10.1192/bjp.bp.108.053058; Ojio Y, 2013, JPN J SCH HLTH, V55, P325; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; PETCHERS MK, 1988, HOSP COMMUNITY PSYCH, V39, P1102; Rickwood DJ, 2005, AUSTR E J ADV MENTAL, V4, P3, DOI DOI 10.5172/JAMH.4.3.218; Yamaguchi S, 2011, PSYCHIAT CLIN NEUROS, V65, P405, DOI 10.1111/j.1440-1819.2011.02239.x; Yamaguchi S, 2013, J NERV MENT DIS, V201, P490, DOI 10.1097/NMD.0b013e31829480df	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	SEP	2015	69	9					572	579		10.1111/pcn.12320		8	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CQ7UV	WOS:000360811400008		
J	Sugimoto, T; Umeda, M; Shinozaki, T; Naruse, T; Miyamoto, Y				Sugimoto, Takashi; Umeda, Maki; Shinozaki, Tomohiro; Naruse, Takashi; Miyamoto, Yuki			Sources of perceived social support associated with reduced psychological distress at 1 year after the Great East Japan Earthquake: Nationwide cross-sectional survey in 2012	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						community integration; disaster; mental health; residence characteristics; social support	NIIGATA-CHUETSU EARTHQUAKE; SURVIVORS; HEALTH; POPULATION; RECOVERY; DISASTER; PERFORMANCE; DISORDERS; ANXIETY; STRESS	AimLack of social support has been associated with a higher level of psychological distress after disasters, but its relative associations with sources of support such as neighbors, friends, family, and others, are underreported. The present study assessed the associations of social support with psychological distress according to support source among the general population 1 year after the Great East Japan Earthquake. MethodsAn online survey was completed by a Japanese national sample of 10469 participants in 2012, from which 8777 were analyzed. Psychological distress was measured using the Kessler Psychological Distress Scale (K6), and the associations between social support from family, friends, or neighbors and psychological distress score were estimated using a proportional odds model. This model was separately fitted for house-damage certification from the disaster (573 participants were certified, 8204 were uncertified). ResultsPrevalence of K613 points was 8.4% for house-damage certified and 9.0% for uncertified participants. K65 points was observed among 49.9% of the house-damaged certified group and in 47.7% of the uncertified group. Lack of support from family, friends, and neighbors was similarly associated with higher K6 score among house-damage certified and uncertified participants. Similar patterns were observed from participants who received house-damage certificates and those who did not experience damage to their homes. ConclusionEnhancing perceived sources of social support among the general population, not limited to people with house damage, can be an effective way to reduce psychological distress following a disaster.	[Sugimoto, Takashi] Univ Tokyo, Grad Sch Publ Policy, Dept Hlth Technol Assessment & Publ Policy, Tokyo 1130033, Japan; [Shinozaki, Tomohiro] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo 1130033, Japan; [Naruse, Takashi] Univ Tokyo, Dept Community Hlth Nursing, Tokyo 1130033, Japan; [Miyamoto, Yuki] Univ Tokyo, Grad Sch Med, Dept Psychiat Nursing, Tokyo 1130033, Japan; [Umeda, Maki] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	Sugimoto, T (reprint author), Univ Tokyo, Grad Sch Publ Policy, Dept Hlth Technol Assessment & Publ Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	t-sugimoto@pp.u-tokyo.ac.jp					FIORE J, 1986, AM J COMMUN PSYCHOL, V14, P93, DOI 10.1007/BF00923252; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Onder E, 2006, SOC PSYCH PSYCH EPID, V41, P868, DOI 10.1007/s00127-006-0107-6; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Rubin GJ, 2012, BRIT J PSYCHIAT, V201, P400, DOI 10.1192/bjp.bp.112.111575; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Michel PO, 2011, EUR PSYCHIAT, V26, P436, DOI 10.1016/j.eurpsy.2010.09.009; Watanabe C, 2004, J TRAUMA STRESS, V17, P63, DOI 10.1023/B:JOTS.0000014678.79875.30; Norris FH, 1996, J PERS SOC PSYCHOL, V71, P498, DOI 10.1037/0022-3514.71.3.498; Oyama Mari, 2012, Environmental Health and Preventive Medicine, V17, P118, DOI 10.1007/s12199-011-0225-y; Livanou M, 2005, EUR PSYCHIAT, V20, P137, DOI 10.1016/j.eurpsy.2004.06.025; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Arnberg FK, 2012, J TRAUMA STRESS, V25, P721, DOI 10.1002/jts.21758; BARRERA M, 1986, AM J COMMUN PSYCHOL, V14, P413, DOI 10.1007/BF00922627; Bland SH, 1997, J NERV MENT DIS, V185, P188, DOI 10.1097/00005053-199703000-00008; BLUMENTHAL JA, 1987, PSYCHOSOM MED, V49, P331; Brymer M., 2006, PSYCHOL 1 AID FIELD; Chang MC, 2012, PSYCHIAT QUART, V83, P481, DOI 10.1007/s11126-012-9216-4; Kawakami N, 2007, RES REGARDING STAT I, P13; Kilic C, 2006, ACTA PSYCHIAT SCAND, V114, P194, DOI 10.1111/j.1600-0447.2006.00786.x; Kuwabara H, 2008, PSYCHIAT CLIN NEUROS, V62, P503, DOI 10.1111/j.1440-1819.2008.01842.x; Matsuoka Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-249; Montazeri A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-4; Nakamura K, 2014, J EPIDEMIOL, V24, P125, DOI 10.2188/jea.JE20130097; Nishi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035248; Norris CM, 2006, J CLIN EPIDEMIOL, V59, P448, DOI 10.1016/j.jclinepi.2005.09.007; R Core Team, 2013, R LANG ENV STAT COMP; Ripley BD, 2002, MODERN APPL STAT S; Sawa M, 2013, J AFFECT DISORDERS, V148, P413, DOI 10.1016/j.jad.2012.11.011; Shindo M, 2012, PSYCHIAT CLIN NEUROS, V66, P454, DOI 10.1111/j.1440-1819.2012.02366.x; Sugimoto Takashi, 2013, Interact J Med Res, V2, pe31, DOI 10.2196/ijmr.2585; Thomas W, 2013, VGAM VECTOR GEN LINE; Wahlstrom L, 2013, INT J SOC PSYCHIATR, V59, P40, DOI 10.1177/0020764011423174; Zhang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046449	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	SEP	2015	69	9					580	586		10.1111/pcn.12235		7	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CQ7UV	WOS:000360811400009		
J	Inoue, K; Inoue, K; Suda, S; Shioda, K; Kobayashi, T; Kishi, K; Kato, S				Inoue, Kana; Inoue, Koju; Suda, Shiro; Shioda, Katsutoshi; Kobayashi, Toshiyuki; Kishi, Koichiro; Kato, Satoshi			Differences in vulnerability to traumatic stress among patients with psychiatric disorders: One-year follow-up study after the Great East Japan Earthquake	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						disaster; Great East Japan Earthquake; longitudinal study; post-traumatic stress disorders; psychiatric patient	TERRORIST ATTACKS; EVENT SCALE; INDIVIDUALS; SURVIVORS; TURKEY; IMPACT	AimsThe aim of this study was to evaluate differences in vulnerability to traumatic stress and the 1-year course of post-traumatic stress symptoms among patients with pre-existing psychiatric disorders after the Great East Japan Earthquake. MethodsThe Impact of Event Scale-Revised (IES-R) was used to assess post-traumatic stress symptoms in 612 patients with schizophrenic (ICD-10 F2; n=163), mood (F3; n=299), or neurotic disorders (F4; n=150) at 1-4 months and again at 13-16 months after the disaster (retention rate: 68%). ResultsThe mean IES-R total score for all diagnostic groups was 18.6 at index and 13.4 at follow up. The mean IES-R total score for patients with neurotic disorders (22.5) was significantly higher than that of patients with mood disorders (18.1) and schizophrenic disorders (15.9). At follow up, these scores decreased for all groups and inter-group differences were not observed. ConclusionsVulnerability to traumatic stress after a disaster was most severe in patients with neurotic disorders, followed by mood disorders, and, lastly, schizophrenic disorders. This difference among the three diagnostic groups was not found 1 year after the disaster.	[Inoue, Kana; Inoue, Koju; Suda, Shiro; Shioda, Katsutoshi; Kobayashi, Toshiyuki; Kato, Satoshi] Jichi Med Univ, Dept Psychiat, Shimotsuke, Tochigi 3290498, Japan; [Kishi, Koichiro] Int Univ Hlth & Welf, Ctr Informat Educ, Tochigi, Japan	Inoue, K (reprint author), Jichi Med Univ, Dept Psychiat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	inouecana@gmail.com					Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Salcioglu E, 2003, J NERV MENT DIS, V191, P154, DOI 10.1097/00005053-200303000-00003; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Ahern J, 2002, PSYCHIATRY, V65, P289, DOI 10.1521/psyc.65.4.289.20240; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Chubb HL, 1996, BRIT J PSYCHIAT, V169, P430, DOI 10.1192/bjp.169.4.430; Franklin CL, 2002, J NERV MENT DIS, V190, P833, DOI 10.1097/00005053-200212000-00005; National Police Agency, SIT DAM GREAT E JAP; Nishi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035248; Stratta P, 2010, AM J PSYCHIAT, V167, P352, DOI 10.1176/appi.ajp.2009.09081173; Tochigi Prefecture, SIT DAM GREAT E JAP; Usui C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4310; Weiss D. S., 2004, ASSESSING PSYCHOL TR, V2, P168, DOI DOI 10.1007/978-0-387-70990-1_10; World Health Organization, 1993, ICD 10 CLASS MENT BE	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	SEP	2015	69	9					587	595		10.1111/pcn.12282		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CQ7UV	WOS:000360811400010		
J	Inoue, K; Fujita, Y; Miyaoka, T; Ezoe, S; Horiguchi, J				Inoue, Ken; Fujita, Yasuyuki; Miyaoka, Tsuyoshi; Ezoe, Satoko; Horiguchi, Jun			Importance of measures to prevent suicides related to the Great East Japan Earthquake among women	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter									[Inoue, Ken; Fujita, Yasuyuki] Shimane Univ, Fac Med, Dept Publ Hlth, Izumo, Shimane, Japan; [Miyaoka, Tsuyoshi; Horiguchi, Jun] Shimane Univ, Fac Med, Dept Psychiat, Izumo, Shimane, Japan; [Ezoe, Satoko] Shimane Univ, Hlth Serv Ctr Izumo, Izumo, Shimane, Japan	Inoue, K (reprint author), Shimane Univ, Fac Med, Dept Publ Hlth, Izumo, Shimane, Japan.	ke-inoue@med.shimane-u.ac.jp					Fukunaga T, 2011, BR J PSYCHIAT, V2012; Kokai M, 2004, PSYCHIAT CLIN NEUROS, V58, P110, DOI 10.1111/j.1440-1819.2003.01203.x; Kumar S, 2001, LANCET, V357, P447, DOI 10.1016/S0140-6736(00)04028-9; National Police Agency, 2011, TOH PAC OC EARTHQ DA; National Police Agency, STATISTICS	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	SEP	2015	69	9					596	596		10.1111/pcn.12288		1	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CQ7UV	WOS:000360811400011		
J	Trendafilov, NT; Adachi, K				Trendafilov, Nickolay T.; Adachi, Kohei			Sparse Versus Simple Structure Loadings	PSYCHOMETRIKA			English	Article						principal component analysis; factor analysis; orthogonal and oblique rotations; sparseness-inducing constraints; LASSO constraints; projected gradients	PRINCIPAL COMPONENT ANALYSIS; ROTATION	The component loadings are interpreted by considering their magnitudes, which indicates how strongly each of the original variables relates to the corresponding principal component. The usual ad hoc practice in the interpretation process is to ignore the variables with small absolute loadings or set to zero loadings smaller than some threshold value. This, in fact, makes the component loadings sparse in an artificial and a subjective way. We propose a new alternative approach, which produces sparse loadings in an optimal way. The introduced approach is illustrated on two well-known data sets and compared to the existing rotation methods.	[Trendafilov, Nickolay T.] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Adachi, Kohei] Osaka Univ, Suita, Osaka 565, Japan	Trendafilov, NT (reprint author), Open Univ, Dept Math & Stat, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	Nickolay.Trendafilov@open.ac.uk			Leverhulme Trust, UK [RPG-2013-211]	This work is supported by a grant RPG-2013-211 from The Leverhulme Trust, UK.	Absil PA, 2008, OPTIMIZATION ALGORITHMS ON MATRIX MANIFOLDS, P1; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430; Shen HP, 2008, J MULTIVARIATE ANAL, V99, P1015, DOI 10.1016/j.jmva.2007.06.007; Trendafilov NT, 2014, COMPUTATION STAT, V29, P431, DOI 10.1007/s00180-013-0434-5; CADIMA J, 1995, J APPL STAT, V22, P203, DOI 10.1080/757584614; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Jolliffe IT, 2003, J COMPUT GRAPH STAT, V12, P531, DOI 10.1198/1061860032148; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Browne MW, 2001, MULTIVAR BEHAV RES, V36, P111, DOI 10.1207/S15327906MBR3601_05; Harman H. H, 1976, MODERN FACTOR ANAL; Jennrich R. I., 2007, FACTOR ANAL 100 HIST, P315; Jennrich RI, 2004, PSYCHOMETRIKA, V69, P257, DOI 10.1007/BF02295943; Jennrich RI, 2006, PSYCHOMETRIKA, V71, P173, DOI 10.1007/s11336-003-1136-B; Jennrich RI, 2001, PSYCHOMETRIKA, V66, P289, DOI 10.1007/BF02294840; Jolliffe I., 2002, PRINCIPAL COMPONENT; Mackey L., 2009, P ADV NEUR INF PROC, V21, P1017; Mulaik S. A., 2010, FDN FACTOR ANAL; The MathWorks Inc, 2011, MATLAB R2011A; Thurstone L. L., 1947, MULTIPLE FACTOR ANAL; Thurstone LL, 1935, THE VECTORS OF MIND; Trendafilov NT, 2006, J COMPUT GRAPH STAT, V15, P628, DOI 10.1198/106186006X130828	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3123	1860-0980		PSYCHOMETRIKA	Psychometrika	SEP	2015	80	3					776	790		10.1007/s11336-014-9416-y		15	Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Psychology, Mathematical	Mathematics; Mathematical Methods In Social Sciences; Psychology	CQ4IR	WOS:000360568800014		
J	Zhao, Y; Jin, SF; Yue, WY				Zhao, Yuan; Jin, Shunfu; Yue, Wuyi			An Adjustable Channel Bonding Strategy in Centralized Cognitive Radio Networks and its Performance Optimization	QUALITY TECHNOLOGY AND QUANTITATIVE MANAGEMENT			English	Article						Adjustable transmission rate; channel bonding; cognitive radio networks; Markov chain; optimal strategy; priority queue	QUEUE	One form of spectrum enhancement technologies for cognitive radio networks is a channel bonding strategy, with which a network user can utilize multiple idle channels as one bonding channel. In this paper, we propose an adjustable channel bonding strategy for centralized cognitive radio networks. The main idea is that the number of channels to be aggregated is set according to the number of packets remaining in the system dynamically. Based on the working principle of the proposed adjustable channel bonding strategy, we present a discrete-time priority queueing model with an adjustable transmission rate for this network system. By constructing a two-dimensional Markov chain, we give the transition probability matrix of the Markov chain and obtain the steady-state distribution of the system model. Accordingly, we derive the formulas for the blocking rate, the normalized throughput, the average latency of the Secondary Users (SUs) and the closed channel ratio. Moreover, we provide numerical experiments to investigate the influence of the buffer capacity of the SUs on different performance measures. Finally, with regard to the joining of an SU packet as a trial, we give the Nash equilibrium strategy and socially optimal strategy for the SUs, and propose a reasonable admission fee in order to oblige the SU packets to adopt the socially optimal strategy	[Zhao, Yuan; Jin, Shunfu] Yanshan Univ, Sch Informat Sci & Engn, Qinhuangdao, Peoples R China; [Zhao, Yuan; Jin, Shunfu] Yanshan Univ, Key Lab Comp Virtual Technol & Syst Integrat Hebe, Qinhuangdao, Peoples R China; [Zhao, Yuan] Northeastern Univ Qinhuangdao, Sch Comp & Commun Engn, Qinhuangdao, Peoples R China; [Yue, Wuyi] Konan Univ, Dept Intelligence & Informat, Kobe, Hyogo, Japan	Jin, SF (reprint author), Yanshan Univ, Sch Informat Sci & Engn, Qinhuangdao, Peoples R China.	jsf@ysn.edu.cn			National Natural Science Foundation [61472342, 11201408]; Hebei Province Natural Science Foundation, China [F2012203093, A2012203124, A2013203148]; MEXT, Japan	This work was supported in part by National Natural Science Foundation (No. 61472342, No. 11201408), Hebei Province Natural Science Foundation (No. F2012203093, No. A2012203124, No. A2013203148), China and was supported in part by MEXT, Japan.	Do CT, 2012, IEEE COMMUN LETT, V16, P1944, DOI 10.1109/LCOMM.2012.111412.120830; Zhang X, 2011, IEEE J-STSP, V5, P110, DOI 10.1109/JSTSP.2010.2091941; Marinho J, 2012, WIREL NETW, V18, P147, DOI 10.1007/s11276-011-0392-1; Li HS, 2011, IEEE T WIREL COMMUN, V10, P1656, DOI 10.1109/TWC.2011.030411.101220; Do CT, 2012, IEICE T COMMUN, VE95B, P1978, DOI 10.1587/transcom.E95.B.1978; Garhwal A., 2011, INT J NEXT GENERATIO, V3, P15; Hassin R., 2003, QUEUE NOT QUEUE EQUI; Kaur P., 2011, INT J ENG TECHNOLOGY, V3, P96; Nguyen-Thanh N., 2014, IEICE T COMMUN, VE97-B, P359, DOI DOI 10.1587/TRANSC0M.E97.B.359; Takahashi Y., 2012, P 7 INT C QUEUEING T, P1; Tian N, 2006, INT SER OPER RES MAN, V93, P1, DOI 10.1007/978-0-387-33723-4; Zhao Y, 2013, PAC J OPTIM, V9, P679	12	0	0	NCTU-NATIONAL CHIAO TUNG UNIV PRESS	TAICHUNG	NO 100, WENHWA RD, TAICHUNG, 40724 ROC, TAIWAN	1684-3703	1811-4857		QUAL TECHNOL QUANT M	Qual. Technol. Quant. Manag.	SEP	2015	12	3					293	312				20	Engineering, Industrial; Operations Research & Management Science; Statistics & Probability	Engineering; Operations Research & Management Science; Mathematics	CQ7HV	WOS:000360774500002		
J	Saffer, Z; Yue, WY				Saffer, Zsolt; Yue, Wuyi			M/G/1 Multiple Vacation Model with Balking for a Class of Disciplines	QUALITY TECHNOLOGY AND QUANTITATIVE MANAGEMENT			English	Article						Balking; M/G/1; queueing theory; vacation model	EQUILIBRIUM JOINING PROBABILITIES; WORKLOAD DEPENDENT BALKING; M/PH/1 QUEUES; BUSY PERIOD; SERVICE; TIMES	In this paper an M/G/1 multiple vacation model with balking is considered. In this model the probability of joining to the system upon arrival depends on the number of customers at previous (customer or vacation) start epoch. The distribution of the joining probabilities is general, i.e. it is not limited to any class of distributions. The model enables a wide range of service disciplines including the exhaustive, the non-exhaustive, the semi-exhaustive, the gated, the G-limited and the E-limited ones. We establish stationary relationships between the number of customers in the system at different characteristic epochs. This leads to a system of linear equations for the stationary number of customers in terms of unknown probabilities. We provide the solution for these unknown probabilities on discipline specific way for all the above listed disciplines. Additionally the stability, the special case of state independent joining probabilities and the numerical solution are also discussed.	[Saffer, Zsolt] Budapest Univ Technol & Econ, Dept Networked Syst & Serv, Budapest, Hungary; [Yue, Wuyi] Konan Univ, Dept Intelligence & Informat, Kobe, Hyogo, Japan	Saffer, Z (reprint author), Budapest Univ Technol & Econ, Dept Networked Syst & Serv, Budapest, Hungary.	safferzs@hit.bme.hu			Hungarian Government through OTKA [K101150]	This work is supported by the Hungarian Government through the OTKA K101150 project.	WOLFF RW, 1982, OPER RES, V30, P223, DOI 10.1287/opre.30.2.223; Thomo L, 1997, NONLINEAR ANAL-THEOR, V30, P2025, DOI 10.1016/S0362-546X(97)00017-5; Borst SC, 1997, OPER RES, V45, P536, DOI 10.1287/opre.45.4.536; Boxma O, 2010, J APPL PROBAB, V47, P130; EISENBER.M, 1972, OPER RES, V20, P440, DOI 10.1287/opre.20.2.440; Kerner Y, 2011, GAME ECON BEHAV, V71, P521, DOI 10.1016/j.geb.2010.06.002; Kleinrock L., 1975, QUEUING SYSTEMS, V1; KUEHN PJ, 1979, AT&T TECH J, V58, P671; Liang J. Y., 2012, MECH MATER, V198-199, P732; Liu LQ, 2006, QUEUEING SYST, V52, P251, DOI 10.1007/s11134-006-6084-3; Liu LQ, 2008, QUEUEING SYST, V59, P37, DOI 10.1007/s11134-008-9074-9; Qi H., 2008, J COMPUTATIONAL INFO, V4, P2245; Tian N., 2010, 5 INT C QUEUEING THE; Yue C., 2009, ADV QUEUEING THEORY, P103, DOI 10.1007/978-0-387-09703-9_6; Yue D., 2006, 6 INT S OP RES ITS A; Zhang F, 2013, J IND MANAG OPTIM, V9, P901, DOI 10.3934/jimo.2013.9.901	16	0	0	NCTU-NATIONAL CHIAO TUNG UNIV PRESS	TAICHUNG	NO 100, WENHWA RD, TAICHUNG, 40724 ROC, TAIWAN	1684-3703	1811-4857		QUAL TECHNOL QUANT M	Qual. Technol. Quant. Manag.	SEP	2015	12	3					383	407				25	Engineering, Industrial; Operations Research & Management Science; Statistics & Probability	Engineering; Operations Research & Management Science; Mathematics	CQ7HV	WOS:000360774500008		
J	Shultz, J				Shultz, John			ASCETIC PRACTICES IN JAPANESE RELIGION.	RELIGIOUS STUDIES REVIEW			English	Book Review									[Shultz, John] Kansai Gaidai Univ, Hirakata, Osaka, Japan	Shultz, J (reprint author), Kansai Gaidai Univ, Hirakata, Osaka, Japan.						LOBETTI TF, 2014, ASCETIC PRACTICES JA	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0319-485X	1748-0922		RELIG STUD REV	Relig. Stud. Rev.	SEP	2015	41	3					127	128		10.1111/rsr.12241_6		2	Religion	Religion	CQ7CE	WOS:000360759600087		
J	Zhang, ZY; Yang, YQ; Hamada, H				Zhang, Zhiyuan; Yang, Yuqiu; Hamada, Hiroyuki			The effects of open holes on the fracture behaviors and mechanical properties of glass fiber mat composites	SCIENCE AND ENGINEERING OF COMPOSITE MATERIALS			English	Article						characteristic distance; finite element; glass fiber chopped mat; notched strength	REINFORCED POLYPROPYLENE; BOLTED-JOINTS; STRENGTH	In this paper, composite specimens were fabricated from a glass fiber chopped strand mat and unsaturated polyester resin using the hand lay-up method. To evaluate the effects of open holes on the mechanical properties, different factors, including the volume fraction of glass fiber and material thickness were investigated. Both the unnotched strength of smooth specimens and the notched strength of specimens with holes, increased as volume fraction increased, but the trends were different. For notched specimens with closer volume fractions, increased thickness or width-to-depth ratio led to a lower resistance on the open hole. In investigating the fracture behaviors of notched specimens, two different fracture areas were distinguished: parallel areas and fan-shaped areas. The length of each parallel area was measured. To evaluate the material properties, characteristic distance was calculated using linear elastic methods in finite element software (MSC-Marc, MSC Software Corporation, Tokyo, Japan). The results revealed that characteristic distance has a good correspondence with parallel area length.	[Yang, Yuqiu] Donghua Univ, Shanghai 201620, Peoples R China; [Zhang, Zhiyuan; Hamada, Hiroyuki] Kyoto Inst Technol, Sakyo Ku, Kyoto 6068585, Japan	Yang, YQ (reprint author), Donghua Univ, Shanghai 201620, Peoples R China.	amy_yuqiu_yang@dhu.edu.cn					Alaattin A., 2008, COMPOS STRUCT, V85, P59; Amit Y, 2006, THESIS WICHITA STATE; WHITNEY JM, 1974, J COMPOS MATER, V8, P253, DOI 10.1177/002199837400800303; O'Higgins RM, 2008, COMPOS SCI TECHNOL, V68, P2770, DOI 10.1016/j.compscitech.2008.06.003; Mohan NS, 2007, J MATER PROCESS TECH, V186, P265, DOI 10.1016/j.jmatprotec.2006.12.043; KIM JK, 1995, J COMPOS MATER, V29, P982; Wolfrath J, 2005, POLYM COMPOSITE, V26, P361, DOI 10.1002/pc.20110; Green BG, 2007, COMPOS PART A-APPL S, V38, P867, DOI 10.1016/j.compositesa.2006.07.008; Aytac G, 2010, POLYM COMPOSITE, V31, P173; CHANG FK, 1984, J COMPOS MATER, V18, P290, DOI 10.1177/002199838401800307; Kaleemulla KM, 2009, J ENG SCI TECHNOL, V2, P91; Karger-Kocsis J, 1994, COMPOS MAT, V30, P8; KARGERKOCSIS J, 1993, J POLYM B, V31, P235; Laurent D, 2001, MATER SCI FORUM, V404, P43; Lindhagen J, 1997, POLYM COMPOSITE, V18, P40, DOI 10.1002/pc.10259; Massimo D, 2009, APPL COMPOS MATER, V16, P297; Mendoza J, 2011, JOM, V63, P43; Orifici AC, 2010, 27 C INT COUNC AER S; Pakdil M, 2009, INDIAN J ENG MATER S, V16, P79; Davim JP, 2004, COMPOS SCI TECHNOL, V64, P289, DOI 10.1016/S0266-3538(03)00253-7; Ryosuke M, 2008, COMPOS PART A-APPL S, V39, P154; Tsotsis TK, 1999, POLYM DEGRAD STABIL, V64, P207, DOI 10.1016/S0141-3910(98)00190-6; Wang WC, 1996, COMPOS STRUCT, V34, P91, DOI 10.1016/0263-8223(95)00135-2; Weimer C, 2000, COMPOS PART A-APPL S, V31, P1269, DOI 10.1016/S1359-835X(00)00074-9	24	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0792-1233	2191-0359		SCI ENG COMPOS MATER	Sci. Eng. Compos. Mater.	SEP	2015	22	5					555	564		10.1515/secm-2014-0069		10	Materials Science, Composites	Materials Science	CQ8UH	WOS:000360884500012		
J	Takahashi, T; Thornton, B; Ohki, K; Sakka, T				Takahashi, Tomoko; Thornton, Blair; Ohki, Koichi; Sakka, Tetsuo			Calibration-free analysis of immersed brass alloys using long-ns-duration pulse laser-induced breakdown spectroscopy with and without correction for nonstoichiometric ablation	SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY			English	Article						Laser-induced breakdown spectroscopy (LIBS); Calibration-free LIBS; Liquid-phase laser ablation; Quantitative analysis; Long-pulse laser	QUANTITATIVE ELEMENTAL ANALYSIS; CHEMICAL-ANALYSIS; SPECTRAL-LINES; SINGLE-PULSE; SAMPLES; PLASMA; UNDERWATER; WATER; EMISSION; LIQUIDS	Long-ns-duration, single pulse laser-induced breakdown spectroscopy CUBS) is known tote an effective method to observe well resolved spectra from samples immersed in water at high hydrostatic pressures. The aim of this study is to investigate whether the signals obtained using this method are suitable for quantitative analysis of chemical composition. Six certified brass alloys consisting of copper (Cu), zinc (Zn) and lead (Pb) were measured underwater using a laser pulse of duration 250 ns, and their compositions were determined using calibration-free LIBS (CF-LIBS) and corrected CF-LIBS (CCF-LIBS) methods. The mass fractions of Cu and Zn calculated using CF-LIBS showed better agreement with the certified values than those determined using CCF-LIBS, with relative errors of Cu 4.2 +/- 3.3% and Zn 72 +/- 6.4%. From the results, it can be said that the difference of preferential evaporation and ablation among elements does not need to be considered for underwater measurements with the long-pulse LIBS setup used in this work. While the results indicate that the CF-LIBS method can be applied for in situ quantitative analysis of major elements with concentrations > similar to 10%, the mass fractions determined for Pb, with concentrations < 5 % had large relative errors, suggesting that an alternative method is required to quantify minor elements. (C) 2015 The Authors. Published by Elsevier B.V.	[Takahashi, Tomoko; Thornton, Blair] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Ohki, Koichi] OK Lab Co Ltd, Tokyo 1810013, Japan; [Sakka, Tetsuo] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan	Takahashi, T (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan.	takahas@iis.u-tokyo.ac.jp			Japanese Ministry of Education	This project is funded by the Japanese Ministry of Education under the 'Program for the development of fundamental tools for the utilization of marine resources'.	Pichahchy AE, 1997, SPECTROCHIM ACTA B, V52, P25, DOI 10.1016/S0584-8547(96)01575-3; Sakka T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2172235; Saeki M, 2014, J NUCL SCI TECHNOL, V51, P930, DOI 10.1080/00223131.2014.917996; Ciucci A, 1999, APPL SPECTROSC, V53, P960, DOI 10.1366/0003702991947612; Salle B, 2006, SPECTROCHIM ACTA B, V61, P301, DOI 10.1016/j.sab.2006.02.003; Thornton B, 2014, SPECTROCHIM ACTA B, V97, P7, DOI 10.1016/j.sab.2014.04.008; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Thornton B, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.102402; De Giacomo A, 2011, J PHYS CHEM C, V115, P5123, DOI 10.1021/jp109389c; De Giacomo A, 2007, SPECTROCHIM ACTA B, V62, P721, DOI 10.1016/j.sab.2007.06.008; De Giacomo A, 2006, ANAL BIOANAL CHEM, V385, P303, DOI 10.1007/s00216-006-0323-7; Sakka T, 2009, APPL SURF SCI, V255, P9576, DOI 10.1016/j.apsusc.2009.04.086; Lednev VN, 2008, LASER PHYS, V18, P850, DOI 10.1134/S1054660X08070086; Eppler AS, 1996, APPL SPECTROSC, V50, P1175, DOI 10.1366/0003702963905123; Whitehouse AI, 2001, SPECTROCHIM ACTA B, V56, P821, DOI 10.1016/S0584-8547(01)00232-4; Dimitrijevic MS, 1999, ASTRON ASTROPHYS SUP, V140, P193, DOI 10.1051/aas:1999417; Cristoforetti G, 2010, SPECTROCHIM ACTA B, V65, P86, DOI 10.1016/j.sab.2009.11.005; Bleiner D, 2006, J ANAL ATOM SPECTROM, V21, P910, DOI 10.1039/b602800d; Colao F, 2004, J ANAL ATOM SPECTROM, V19, P502, DOI 10.1039/b315488b; Cremers D.A., 2006, HDB LASER INDUCED BR, P109; De Giacomo A, 2004, SPECTROCHIM ACTA B, V59, P1431, DOI 10.1016/j.sab.2004.07.002; Fornarini L, 2005, SPECTROCHIM ACTA B, V60, P1186, DOI 10.1016/j.sab.2005.06.008; Hahn David W, 2010, Appl Spectrosc, V64, P335, DOI 10.1366/000370210793561691; Hanif M, 2011, OPT LASER ENG, V49, P1456, DOI 10.1016/j.optlaseng.2011.06.013; Haynes W.M., 2012, CRC HDB CHEM PHYS, P12; Hermann J, 2010, SPECTROCHIM ACTA B, V65, P636, DOI 10.1016/j.sab.2010.03.015; Herrera KK, 2009, J ANAL ATOM SPECTROM, V24, P413, DOI 10.1039/b820493d; Huddlestone R.H., 1965, SPECTRAL INTENSITIES, P201; Lazic V, 2005, SPECTROCHIM ACTA B, V60, P1014, DOI 10.1016/j.sab.2005.06.014; Meslin P.-Y., 2013, SCIENCE, V341; NYGA R, 1993, OPT LETT, V18, P747, DOI 10.1364/OL.18.000747; Pandhija S, 2009, APPL PHYS B-LASERS O, V94, P545, DOI 10.1007/s00340-008-3343-5; Sakka T, 2014, SPECTROCHIM ACTA B, V97, P94, DOI 10.1016/j.sab.2014.05.009; Sakka T, 2007, CHEM LETT, V36, P508, DOI 10.1246/cl.2007.508; Shah ML, 2012, APPL OPTICS, V51, P4612, DOI 10.1364/AO.51.004612; Shaikh NM, 2006, J PHYS D APPL PHYS, V39, P1384, DOI 10.1088/0022-3727/39/7/008; Smith P.L, 2014, KURUCZ ATOMIC LINE D; Takahashi T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.042403; Thornton B, 2015, DEEP-SEA RES PT I, V95, P20, DOI 10.1016/j.dsr.2014.10.006; Thornton B., 2012, P IEEE OC 12 HAMPT R; Thornton B, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.022702; Thornton B, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.082401; Tognoni E, 2010, SPECTROCHIM ACTA B, V65, P1, DOI 10.1016/j.sab.2009.11.006	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0584-8547			SPECTROCHIM ACTA B	Spectroc. Acta Pt. B-Atom. Spectr.	SEP 1	2015	111						8	14		10.1016/j.sab.2015.06.009		7	Spectroscopy	Spectroscopy	CQ7HS	WOS:000360774200002		
J	Fehlings, MG; Ibrahim, A; Tetreault, L; Albanese, V; Alvarado, M; Arnold, P; Barbagallo, G; Bartels, R; Bolger, C; Defino, H; Kale, S; Massicotte, E; Moraes, O; Scerrati, M; Tan, G; Tanaka, M; Toyone, T; Yukawa, Y; Zhou, Q; Zileli, M; Kopjar, B				Fehlings, Michael G.; Ibrahim, Ahmed; Tetreault, Lindsay; Albanese, Vincenzo; Alvarado, Manuel; Arnold, Paul; Barbagallo, Giuseppe; Bartels, Ronald; Bolger, Ciaran; Defino, Helton; Kale, Shashank; Massicotte, Eric; Moraes, Osmar; Scerrati, Massimo; Tan, Gamaliel; Tanaka, Masato; Toyone, Tomoaki; Yukawa, Yasutsugu; Zhou, Qiang; Zileli, Mehmet; Kopjar, Branko			A Global Perspective on the Outcomes of Surgical Decompression in Patients With Cervical Spondylotic Myelopathy	SPINE			English	Article						cervical spondylotic myelopathy; surgery; international; outcomes; safety; modified Japanese Orthopaedic Association Scale; Nurick score; Neck Disability Index; 30-m walking test; Short-Form-36; complications; prospective cohort; multicenter	POSTERIOR LONGITUDINAL LIGAMENT; NECK DISABILITY INDEX; NATURAL-HISTORY; OSSIFICATION; SPINE; DISORDER; RECOVERY; VALIDITY	Study Design. Prospective, multicenter international cohort. Objective. To evaluate outcomes of surgical decompression for cervical spondylotic myelopathy (CSM) at a global level. Summary of Background Data. CSM is a degenerative spine disease and the most common cause of spinal cord dysfunction worldwide. Surgery is increasingly recommended as the preferred treatment strategy for CSM to improve neurological and functional status and quality of life. The outcomes of surgical intervention for CSM have never been evaluated at an international level. Methods. Between October 2007 and January 2011, 479 symptomatic patients with image evidence of CSM were enrolled in the prospective, multicenter AOSpine CSM-International study from 16 global sites. Preoperative and postoperative clinical status, functional impairment, and quality of life were evaluated using the modified Japanese Orthopaedic Assessment Scale, Nurick Scale, Neck Disability Index, and Short-Form-36v2. Preoperative and 12- and 24-month postoperative outcomes were compared using mixed-model analysis of covariance for repeated measurements. Results. The study cohort consisted of 310 males and 169 females, with a mean age of 56.37 11.91 years. There were significant differences in age, etiology, and surgical approaches between the regions. At 24 months postoperatively, the mean modified Japanese Orthopaedic Assessment Scale score improved from 12.50 (95% confidence interval [CI], 12.24-12.76) to 14.90 (95% CI, 14.64-15.16); the Neck Disability Index improved from 36.38 (95% CI, 34.33-38.43) to 23.20 (95% CI, 21.24-25.15); and the SF36v2 Physical Component Score and Mental Composite Score improved from 34.28 (95% CI, 33.46-35.10) to 40.76 (95% CI, 39.71-41.81) and 39.45 (95% CI, 38.25-40.64) to 46.24 (95% CI, 44.94-47.55), respectively. The rate of neurological complications was 3.13%. Conclusion. Surgical decompression for CSM is safe and results in improved functional status and quality of life in patients around the world, irrespective of differences in medical systems and sociocultural determinants of health. Level of Evidence: 3	[Fehlings, Michael G.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Ibrahim, Ahmed; Tetreault, Lindsay; Massicotte, Eric] Toronto Western Hosp, Dept Surg, Toronto, ON M5T 2S8, Canada; [Albanese, Vincenzo; Barbagallo, Giuseppe] Univ Hosp Catania, Dept Neurosurg, Catania, Italy; [Alvarado, Manuel] Hosp San Juan Dios, Caracas, Venezuela; [Arnold, Paul] Univ Kansas, Dept Neurosurg, Kansas City, KS USA; [Bartels, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, NL-6525 ED Nijmegen, Netherlands; [Bolger, Ciaran] Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland; [Defino, Helton] Univ Sao Paulo, Fac Med, BR-14049 Ribeirao Preto, Brazil; [Kale, Shashank] All India Inst Med Sci, Dept Neurosurg, New Delhi, India; [Moraes, Osmar] Hosp Santa Marcelina, Dept Neurosurg, Santa Marcelina, Brazil; [Scerrati, Massimo] Univ Politecn Marche, Dept Neurosurg, Ancona, Italy; [Tan, Gamaliel] Tan Tock Seng Hosp, Dept Orthopaed, Singapore, Singapore; [Tanaka, Masato] Okayama Univ, Dept Orthoped Surg, Okayama 7008530, Japan; [Toyone, Tomoaki] Teikyo Univ, Sch Med, Dept Orthopaed Surg, Tokyo 173, Japan; [Yukawa, Yasutsugu] Chubu Rosai Hosp, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Zhou, Qiang] Third Mil Med Univ, Dept Orthoped, Chongqing, Peoples R China; [Zileli, Mehmet] Ege Univ, Dept Neurosurg, Izmir, Turkey; [Kopjar, Branko] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA	Fehlings, MG (reprint author), Toronto Western Hosp, Div Neurosurg, 399 Bathurst St,Ste 4WW-449, Toronto, ON M5T 2S8, Canada.	michael.fehlings@uhn.ca	Bartels, R.H.M.A./L-4184-2015		AOSpine International funds	AOSpine International funds were received to support this work.	GORE DR, 1986, SPINE, V11, P521, DOI 10.1097/00007632-198607000-00003; CLARKE E, 1956, BRAIN, V79, P483, DOI 10.1093/brain/79.3.483; Tetreault LA, 2014, WORLD NEUROSURG, V81, P623, DOI 10.1016/j.wneu.2013.09.023; Kalsi-Ryan S, 2013, NEUROSCIENTIST, V19, P409, DOI 10.1177/1073858412467377; Cheung WY, 2008, INT ORTHOP, V32, P273, DOI 10.1007/s00264-006-0315-4; Al-Tamimi YZ, 2013, EUR SPINE J, V22, P2552, DOI 10.1007/s00586-013-2965-4; Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33; Kadanka Z, 2011, EUR SPINE J, V20, P1533, DOI 10.1007/s00586-011-1811-9; SADASIVAN KK, 1993, YALE J BIOL MED, V66, P235; Chagas H, 2005, SURG NEUROL, V64, pS30, DOI 10.1016/j.surneu.2005.02.016; NURICK S, 1972, BRAIN, V95, P101, DOI 10.1093/brain/95.1.101; BENZEL EC, 1991, J SPINAL DISORD, V4, P286; Young BA, 2009, SPINE J, V9, P802, DOI 10.1016/j.spinee.2009.06.002; Kadanka Z, 2002, SPINE, V27, P2205, DOI 10.1097/01.BRS.0000029255.77224.BB; Carreon LY, 2010, SPINE J, V10, P469, DOI 10.1016/j.spinee.2010.02.007; EBERSOLD MJ, 1995, J NEUROSURG, V82, P745, DOI 10.3171/jns.1995.82.5.0745; Fehlings MG, 2012, J NEUROSURG-SPINE, V17, P89, DOI 10.3171/2012.6.AOSPINE111069; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Inamasu J, 2006, NEUROSURGERY, V58, P1027, DOI 10.1227/01.NEU.0000215867.87770.73; Matz PG, 2009, J NEUROSURG-SPINE, V11, P104, DOI 10.3171/2009.1.SPINE08716; SYMON L, 1967, NEUROLOGY, V17, P117; Chiles BW, 1999, NEUROSURGERY, V44, P762, DOI 10.1097/00006123-199904000-00041; OHTSUKA K, 1987, ARCH ORTHOP TRAUM SU, V106, P89, DOI 10.1007/BF00435420; Gok B, 2008, J NEUROSURG-SPINE, V9, P152, DOI 10.3171/SPI/2008/9/8/152; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.2307/2290705; Chiles BW, 1999, NEUROSURGERY, V44, P769; Fehlings MG, 2013, SPINE, V38, pS1, DOI 10.1097/BRS.0b013e3182a7e9e0; Handa Y, 2002, J NEUROSURG, V96, P173, DOI 10.3171/spi.2002.96.2.0173; Harrell FE, 2001, REGRESSION MODELING; Jayakumar PN, 1996, CLIN NEUROL NEUROSUR, V98, P142, DOI 10.1016/0303-8467(96)00004-2; Kadanka Z, 2002, SPINE, V27, P2210; Karadimas SK, 2013, SPINE, V38, pS21, DOI 10.1097/BRS.0b013e3182a7f2c3; Kong LD, 2013, EXP THER MED, V6, P852, DOI 10.3892/etm.2013.1224; Latimer M, 2002, BRIT J NEUROSURG, V16, P545; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Nikolaidis I, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001466.pub3; Ono K, 1999, CLIN ORTHOP RELAT R, P18; Rhee JM, 2013, SPINE, V38, pS55, DOI 10.1097/BRS.0b013e3182a7f41d; Rubin DB, 1989, MULTIPLE IMPUTATION; Schafer J. L., 1997, ANAL INCOMPLETE MULT; Singh A, 1999, LANCET, V354, P370, DOI 10.1016/S0140-6736(98)10199-X; Singh Anoushka, 2015, Eur Spine J, V24 Suppl 2, P209, DOI 10.1007/s00586-013-2935-x; Suri Ashish, 2003, Spine J, V3, P33, DOI 10.1016/S1529-9430(02)00448-5; Tetreault Lindsay A, 2015, Eur Spine J, V24 Suppl 2, P236, DOI 10.1007/s00586-013-2658-z; TROJAN DA, 1992, AM J MED, V92, P296, DOI 10.1016/0002-9343(92)90080-U	47	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	SEP 1	2015	40	17					1322	1328		10.1097/BRS.0000000000000988		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CQ5QW	WOS:000360661500002		
J	Yamao, Y; Takagi, Y; Kawauchi, T; Arakawa, Y; Takayama, M; Miyamoto, S				Yamao, Yukihiro; Takagi, Yasushi; Kawauchi, Takeshi; Arakawa, Yoshiki; Takayama, Motohiro; Miyamoto, Susumu			Surgical Management of Recurrent Spontaneous Spinal Epidural Hematoma With 3 Episodes	SPINE			English	Article						recurrent spontaneous spinal epidural hematoma; posterior venous plexus; cervicothoracic region; laminectomy	OF-THE-LITERATURE; ETIOLOGY	Study design. A case report. Objective. We report a case of spontaneous spinal epidural hematoma with 3 bleeding episodes and discuss the surgical management of recurrent spontaneous spinal epidural hematoma. Summary of Background Data. Spontaneous spinal epidural hematoma is a rare condition that causes spinal cord compression and neurological deficits. However, the cause of bleeding remains unclear and recurrent bleeding is very seldom reported. Methods. A 39-year-old female patient was referred to Kyoto University hospital with sudden back and right upper extremity pain. She was also treated conservatively at the local hospital 19 and 4 months previously because of same episodes. Magnetic resonance images demonstrated right spinal epidural hematoma at the C6-T1 level. In the first 2 episodes, magnetic resonance images revealed spinal epidural hematomas at exactly the same level. Results. In the third episode, the patient's neurological condition was not worse than it had been in the first 2 episodes, and we initially managed her conservatively. To identify the cause of the hematoma, surgery was performed 15 days after the third onset. Microscopic examination revealed the development of a venous plexus around the old hematoma in the dorsal epidural space. The patient was discharged without any further neurological deficits, and recurrent bleeding has not occurred for 6 months after surgery. Conclusion. This is the first report of operative and histological observation of recurrent spontaneous spinal epidural hematoma caused by a posterior venous plexus. In a case of recurrent spontaneous spinal epidural hematoma, surgery might be necessary to prevent further hematomas. Level of Evidence: N/A	[Yamao, Yukihiro; Takagi, Yasushi; Kawauchi, Takeshi; Arakawa, Yoshiki; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Takayama, Motohiro] Otsu Municipal Hosp, Dept Neurosurg, Otsu, Shiga, Japan	Takagi, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	ytakagi@kuhp.kyoto-u.ac.jp					Abram HS, 2007, PEDIATR NEUROL, V36, P177, DOI 10.1016/j.pediatrneurol.2006.09.009; LAWTON MT, 1995, J NEUROSURG, V83, P1, DOI 10.3171/jns.1995.83.1.0001; Groen RJM, 2004, ACTA NEUROCHIR, V146, P103, DOI 10.1007/s00701-003-0160-9; GROEN RJM, 1990, J NEUROL SCI, V98, P121, DOI 10.1016/0022-510X(90)90253-J; BEATTY RM, 1984, J NEUROSURG, V61, P143, DOI 10.3171/jns.1984.61.1.0143; HERNANDEZ D, 1982, ANN NEUROL, V11, P623, DOI 10.1002/ana.410110611; Chen CJ, 1997, NEURORADIOLOGY, V39, P737; Hsieh CT, 2006, AM J EMERG MED, V24, P736, DOI 10.1016/j.ajem.2006.01.025; Jain RS, 2014, AM J EMERG MED, V32; Pecha MD, 1998, ARCH PHYS MED REHAB, V79, P460, DOI 10.1016/S0003-9993(98)90151-4; Groen RJM, 1996, NEUROSURGERY, V39, P494, DOI 10.1097/00006123-199609000-00012; Zhong WY, 2011, J CLIN NEUROSCI, V18, P1490, DOI 10.1016/j.jocn.2011.02.039	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	SEP 1	2015	40	17					E996	E998		10.1097/BRS.0000000000001017		3	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CQ5RF	WOS:000360662500008		
J	Yoshihara, H; Yoneoka, D				Yoshihara, Hiroyuki; Yoneoka, Daisuke			Re: "Comparison of In-hospital Morbidity and Mortality Rates Between Anterior and Nonanterior Approach Procedures for Thoracic Disc Herniation" by Yoshihara et al.	SPINE			English	Letter									[Yoshihara, Hiroyuki] Suny Downstate Med Ctr, Dept Orthopaed Surg & Rehabil Med, Brooklyn, NY 11203 USA; [Yoneoka, Daisuke] Grad Univ Adv Studies, Sch Adv Sci, Dept Stat Sci, Tokyo, Japan	Yoshihara, H (reprint author), Suny Downstate Med Ctr, Dept Orthopaed Surg & Rehabil Med, Brooklyn, NY 11203 USA.						CARSON J, 1971, J NEUROL NEUROSUR PS, V34, P68, DOI 10.1136/jnnp.34.1.68; Yoshihara H, 2014, SPINE, V39, pE728, DOI 10.1097/BRS.0000000000000322	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	SEP 1	2015	40	17					E1001	E1001		10.1097/BRS.0000000000001028		1	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CQ5RF	WOS:000360662500010		
J	Yotsukura, M; Kinoshita, T; Kohno, M; Asakura, K; Kamiyama, I; Emoto, K; Hayashi, Y; Ohtsuka, T				Yotsukura, Masaya; Kinoshita, Tomonari; Kohno, Mitsutomo; Asakura, Keisuke; Kamiyama, Ikuo; Emoto, Katsura; Hayashi, Yuichiro; Ohtsuka, Takashi			Survival predictors after resection of lung metastases of head or neck cancers	THORACIC CANCER			English	Article						Cancer survival; head and neck cancer; pulmonary metastasis	SQUAMOUS-CELL CARCINOMA; PULMONARY METASTASES; SURGICAL RESECTION; TUMORS	BackgroundPulmonary metastasectomies are performed for a variety of cancers, though few reports have examined their merit for head and neck cancers. This study examined the relationship between clinical and pathological characteristics and survival after resection of lung metastases of these cancers. MethodsBetween 1986 and 2013, 34 patients presenting with pulmonary metastases of primary head or neck cancers underwent surgical resections at our institution. We retrospectively analyzed their clinical and pathological characteristics and the patients' survival after metastasectomy in search of adverse prognostic factors. ResultsThe primary sites of cancer were: the tongue in eight patients, the pharynx and salivary glands each in seven, the larynx in five, and miscellaneous sites in seven patients. Squamous cell carcinoma (SCC) was present in 19, adenoid cystic carcinomas in 10, and other diagnoses in five patients. The median disease-free interval (DFI) between the initial surgery and the metastasectomies was 40 months. The overall five-year survival rate was 57.9%, and median survival time was 77 months. By single variable analysis, a DFI of 26 months, age 60 years, and histology of SCC were predictors; by multiple variable analysis, a short DFI (P = 0.018) and older age (P = 0.046) remained independent predictors of poor clinical outcomes. ConclusionsYoung age and a long DFI are factors in favor of pulmonary metastasectomy after surgical treatment of primary head or neck cancers.	[Yotsukura, Masaya; Kinoshita, Tomonari; Kohno, Mitsutomo; Asakura, Keisuke; Kamiyama, Ikuo; Ohtsuka, Takashi] Keio Univ, Sch Med, Div Gen Thorac Surg, Dept Surg, Tokyo 1608582, Japan; [Emoto, Katsura; Hayashi, Yuichiro] Keio Univ Hosp, Dept Pathol, Tokyo, Japan	Kohno, M (reprint author), Keio Univ, Sch Med, Div Gen Thorac Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kohno@a3.keio.jp					Winter H, 2008, ANN SURG ONCOL, V15, P2915, DOI 10.1245/s10434-008-0001-4; Yano T, 2009, SURG TODAY, V39, P91, DOI 10.1007/s00595-008-3820-9; Ferlito A, 2001, ORL J OTO-RHINO-LARY, V63, P63, DOI 10.1159/000055711; Chen F, 2008, WORLD J SURG, V32, P1657, DOI 10.1007/s00268-008-9631-8; Daiko H, 2010, JPN J CLIN ONCOL, V40, P639, DOI 10.1093/jjco/hyq023; FINLEY RK, 1992, AM J SURG, V164, P594, DOI 10.1016/S0002-9610(05)80714-7; Haro A, 2010, INTERACT CARDIOV TH, V10, P700, DOI 10.1510/icvts.2009.219766; Liu D, 1999, ANN SURG ONCOL, V6, P572, DOI 10.1007/s10434-999-0572-8; MAZER TM, 1988, AM J SURG, V156, P238, DOI 10.1016/S0002-9610(88)80282-4; Nibu K, 1997, AM J OTOLARYNG, V18, P391, DOI 10.1016/S0196-0709(97)90059-4; Shiono S, 2009, ANN THORAC SURG, V88, P856, DOI 10.1016/j.athoracsur.2009.04.040; Wedman J, 1996, HEAD NECK-J SCI SPEC, V18, P311	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7706	1759-7714		THORAC CANCER	Thorac. Cancer	SEP	2015	6	5					579	583		10.1111/1759-7714.12225		5	Oncology; Respiratory System	Oncology; Respiratory System	CQ6XD	WOS:000360746400004		
J	Tomizawa, K; Suda, K; Takemoto, T; Iwasaki, T; Sakaguchi, M; Kuwano, H; Mitsudomi, T				Tomizawa, Kenji; Suda, Kenichi; Takemoto, Toshiki; Iwasaki, Takuya; Sakaguchi, Masahiro; Kuwano, Hiroyuki; Mitsudomi, Tetsuya			Progression after spontaneous regression in lung large cell neuroendocrine carcinoma: Report of a curative resection	THORACIC CANCER			English	Article						Lung large cell neuroendocrine carcinoma; progression; spontaneous regression	CANCER; REMISSION	We present the first reported case of lung large cell neuroendocrine carcinoma (LCNEC) with spontaneous regression followed by progression. An 85-year-old woman presented with a 2.8-cm nodule in the right upper lung lobe on chest computed tomography. After four months, the tumor decreased to 1.8cm and remained unchanged in size for the next three months, but it grew to 8.6cm and invaded the mediastinal fat tissue after approximately one year. Ultrasound echo-guided percutaneous biopsy revealed the tumor to be LCNEC. The patient underwent a right upper lobectomy with lymph node dissection. She had a good postoperative course with no complications. Physicians and surgeons should be aware that radiographic regression of a pulmonary nodule does not necessarily exclude the possibility of lung cancer.	[Tomizawa, Kenji; Suda, Kenichi; Takemoto, Toshiki; Iwasaki, Takuya; Sakaguchi, Masahiro; Mitsudomi, Tetsuya] Kinki Univ, Div Thorac Surg, Dept Surg, Osaka 5898511, Japan; [Tomizawa, Kenji; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma, Japan	Mitsudomi, T (reprint author), Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, 377-2 Ohno Higashi, Osaka 5898511, Japan.	mitsudom@surg.med.kindai.ac.jp					CHALLIS GB, 1990, ACTA ONCOL, V29, P545; COLE WH, 1981, J SURG ONCOL, V17, P201, DOI 10.1002/jso.2930170302; Kappauf H, 1997, ANN ONCOL, V8, P1031, DOI 10.1023/A:1008209618128; Mizuno T, 2011, CHEST, V140, P527, DOI 10.1378/chest.10-2564; Choi SM, 2013, AM J RESP CRIT CARE, V188, pE5, DOI 10.1164/rccm.201208-1417IM; Furukawa M, 2011, ANN THORAC CARDIOVAS, V17, P577, DOI 10.5761/atcs.cr.10.01638; Gladwish A, 2010, BMJ CASE REP, V2010; Haruki T, 2010, SURG TODAY, V40, P1155, DOI 10.1007/s00595-009-4195-2; Hwang Eu Dong, 2013, Tuberc Respir Dis (Seoul), V75, P214, DOI 10.4046/trd.2013.75.5.214; Ono K, 1996, J CLIN IMMUNOL, V16, P334, DOI 10.1007/BF01541669; Pujol JL, 2007, J THORAC ONCOL, V2, P168	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7706	1759-7714		THORAC CANCER	Thorac. Cancer	SEP	2015	6	5					655	658		10.1111/1759-7714.12201		4	Oncology; Respiratory System	Oncology; Respiratory System	CQ6XD	WOS:000360746400015		
J	Orita, M; Iyama, K; Hayashida, N; Mitsutake, N; Suzuki, S; Yamashita, S; Takamura, N				Orita, Makiko; Iyama, Keita; Hayashida, Naomi; Mitsutake, Norisato; Suzuki, Shinichi; Yamashita, Shunichi; Takamura, Noboru			Implication of Nitrate in Drinking Water in Kawauchi Village, Fukushima	THYROID			English	Letter							THYROID-CANCER; ACCIDENT; RISK		[Orita, Makiko; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 8528523, Japan; [Iyama, Keita; Mitsutake, Norisato; Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Disaster Med, Nagasaki 8528523, Japan; [Hayashida, Naomi] Nagasaki Univ, Grad Sch Biomed Sci, Div Strateg Collaborat Res, Atom Bomb Dis Inst,Ctr Promot Collaborat Res Radi, Nagasaki 8528523, Japan; [Suzuki, Shinichi] Fukushima Med Univ, Dept Thyroid & Endocrinol, Sch Med, Fukushima, Japan	Takamura, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Atom Bomb Dis Inst, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	takamura@nagasaki-u.ac.jp		Mitsutake, Norisato/0000-0002-2744-8046			Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Cardis E, 2005, J NATL CANCER I, V97, P724; Ward MH, 2010, EPIDEMIOLOGY, V21, P389, DOI 10.1097/EDE.0b013e3181d6201d; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	SEP 1	2015	25	9					1064	1065		10.1089/thy.2015.0161		2	Endocrinology & Metabolism	Endocrinology & Metabolism	CQ0VB	WOS:000360314600014		
J	Kurokawa, S; Hajika, M; Shibuya, T				Kurokawa, Shunji; Hajika, Makita; Shibuya, Tomoko			Canopy height-to-row spacing ratio as a simple and practical onsite index to determine the time for terminating Ipomoea coccinea control in the Japanese soybean-growing systems	WEED BIOLOGY AND MANAGEMENT			English	Article						decision support system; invasive weed; light; red morning glory; soybean	CORN ZEA-MAYS; GLYCINE-MAX; MORNINGGLORY IPOMOEA; CRITICAL PERIOD; WEED-CONTROL; LACUNOSA INTERFERENCE; FIELD COMPETITION; GROWTH; HEDERACEA; GLORY	In order to determine the time for terminating Ipomoea coccinea control in Japanese soybean-growing systems, the relationship between the relative photosynthetic photon flux density at the emergence time of I.coccinea seedlings and their fate in competition with a Japanese determinate soybean cultivar, Hatayutaka, was investigated. A 2 year field study was conducted, in which I.coccinea was seeded at 0, 5 and 7 weeks after seeding of the soybean in 2010 and once per week between 0 and 7 weeks after seeding in 2011, while soybean was seeded in six plots at three different seeding times and two different row-spacing arrangements with the same intrarow spacing. The results showed that the I.coccinea seedlings that emerged at a relative photosynthetic photon flux density of <49% grew weak or died. At this value, the canopy height-to-row spacing ratio of soybean was very stable, regardless of the row spacing, in both study years. This ratio was also stable when tested on 11 different soybean cultivars that covered all cultivation areas of Japan and had various growth speeds during the early growing period. A canopy height-to-row spacing ratio of 1.0 could be a simple and practical onsite index for determining the time to terminate I.coccinea control in Japanese soybean-growing systems.	[Kurokawa, Shunji; Shibuya, Tomoko] NARO Agr Res Ctr, Crop Prod Syst Div, Tsukuba, Ibaraki 3058666, Japan; [Hajika, Makita] NARO Inst Crop Sci, Field Crop Res Div, Tsukuba, Ibaraki, Japan	Kurokawa, S (reprint author), NARO Agr Res Ctr, 3-1-1 Kannondai, Tsukuba, Ibaraki 3058666, Japan.	shunji@affrc.go.jp					Dalley CD, 2004, WEED TECHNOL, V18, P177, DOI 10.1614/02-150B; PREECE MA, 1978, ANN HUM BIOL, V5, P1, DOI 10.1080/03014467800002601; MURDOCK EC, 1986, WEED SCI, V34, P711; VANACKER RC, 1993, WEED SCI, V41, P194; CORDES RC, 1984, WEED SCI, V32, P364; CROWLEY RH, 1978, WEED SCI, V26, P484; Endo Ikuma, 2010, Research Bulletin of the Aichi-ken Agricultural Research Center, P51; Fukumi N., 2005, J WEED SCI TECHNOL S, V50, P46; Halford C, 2001, WEED TECHNOL, V15, P737, DOI 10.1614/0890-037X(2001)015[0737:CPOWCI]2.0.CO;2; Hiraiwa K., 2005, J WEED SCI TECHNOL S, V50, P50; Hiraiwa Kaku, 2007, Research Bulletin of the Aichi-ken Agricultural Research Center, P25; HOWE OW, 1987, WEED SCI, V35, P185; Jones C. A., 2010, Journal - American Society of Sugar Cane Technologists, V30, P11; Jones C. A., 2009, Journal - American Society of Sugar Cane Technologists, V29, P25; MOSIER DG, 1995, WEED SCI, V43, P239; Norsworthy JK, 2004, WEED SCI, V52, P802, DOI 10.1614/WS-03-165R; OLIVER LR, 1976, WEED SCI, V24, P482; ONOFRI A, 2005, ITAL J AGROMETEOROL, V3, P40; R Core Team, 2012, R LANG ENV STAT COMP; SNAYDON RW, 1989, J APPL ECOL, V26, P1043, DOI 10.2307/2403711; Umemoto M., 2013, AGR RES SERIES NARO, P69; Vega CRC, 2003, ANN BOT-LONDON, V91, P795, DOI 10.1093/aob/mcg081; Venable W.N., 2002, MODERN APPL STAT S; Watanabe H., 2010, J WEED SCI TECHNOL S, V55, P55; WHIGHAM DF, 1984, J ECOL, V72, P721, DOI 10.2307/2259527; Yasuda K., 2007, J WEED SCI TECHNOL S, V52, P32	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-6162	1445-6664		WEED BIOL MANAG	Weed Biol. Manag.	SEP	2015	15	3					113	121		10.1111/wbm.12074		9	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CQ8FZ	WOS:000360843200003		
J	Sakamoto, R; Okumiya, K; Wang, HX; Dai, QX; Fujisawa, M; Wada, T; Imai, H; Kimura, Y; Ishimoto, Y; Fukutomi, E; Chen, WL; Sasiwongsaroj, K; Kato, E; Ge, RL; Matsubayashi, K				Sakamoto, Ryota; Okumiya, Kiyohito; Wang, Hongxin; Dai, Qingxiang; Fujisawa, Michiko; Wada, Taizo; Imai, Hissei; Kimura, Yumi; Ishimoto, Yasuko; Fukutomi, Eriko; Chen, Wingling; Sasiwongsaroj, Kwanchit; Kato, Emiko; Ge, Ri-Li; Matsubayashi, Kozo			Oxidized Low Density Lipoprotein Among the Elderly in Qinghai-Tibet Plateau	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						Oxidative stress; Ox-LDL; High altitude; Elderly people; Tibetan; Han	HIGH-ALTITUDE HYPOXIA; OXIDATIVE STRESS; NITRIC-OXIDE; HEMOGLOBIN CONCENTRATION; ATHEROSCLEROSIS; ADAPTATION; HYPERTENSION; HIGHLANDERS; LDL; ASSOCIATION	Objective.-Several environmental factors including hypoxia have been reported to contribute to oxidative stress in individuals living in the highlands. However, little is known about the role of oxidized low-density lipoprotein (ox-LDL) among community-dwelling elderly in the Qinghai-Tibet plateau. Methods.-The study population comprised 168 community-dwelling elderly subjects aged 60 years or older (male to female ratio, 70:98; mean age, 65.8 years) living in Haiyan County, located 3000 to 3200 m above sea level, 30 km northwest of Xining, Qinghai. The subjects were volunteers who joined a Comprehensive Geriatric Assessment. Plasma ox-LDL was measured in 168 community-dwelling elderly subjects aged 60 years or older (23 Tibetans and 145 Hans) with a monoclonal antibody-based enzyme-linked immunosorbent assay. Results.-Mean ox-LDL level was higher among Tibetan elderly than Han elderly (Tibetan, 79.0 +/- 29.6 U/L; Han, 62.8 +/- 23.5 U/L; P = .003). Tibetan ethnicity was significantly associated with ox-LDL levels after adjusting for LDL cholesterol levels. In addition, high ox-LDL levels (>= 70 U/L) were significantly associated with a homeostasis model assessment insulin resistance index of at least 1.6 (odds ratio [On 2.82; 95% confidence interval [95% CI], 1.11 to 7.15; P = .029) and ankle brachial pressure index of less than 1.0 (OR, 4.85; 95% CI, 1.14 to 10.00; P = .028), after adjusting for age, sex, and ethnicity. Conclusions.-Our findings support the hypothesis that ox-LDL levels are higher among Tibetan elderly highlanders compared with those among Han elderly. As ox-LDL levels can affect insulin resistance and arteriosclerosis, further research is needed to determine how oxidative stress influences the health situation among elderly individuals at high altitudes.	[Sakamoto, Ryota] Hakubi Ctr Adv Res, Kyoto, Japan; [Sakamoto, Ryota; Okumiya, Kiyohito; Fujisawa, Michiko; Wada, Taizo; Kimura, Yumi; Ishimoto, Yasuko; Fukutomi, Eriko; Sasiwongsaroj, Kwanchit; Kato, Emiko; Matsubayashi, Kozo] Ctr Southeast Asian Studies, Kyoto, Japan; [Imai, Hissei; Chen, Wingling; Matsubayashi, Kozo] Kyoto Univ, Sch Publ Hlth, Dept Field Med, Kyoto 6068501, Japan; [Sakamoto, Ryota; Okumiya, Kiyohito] Res Inst Humanity & Nat, Kyoto, Japan; [Wang, Hongxin; Dai, Qingxiang] Qinghai Univ, Affiliated Hosp, Qinghai, Peoples R China; [Ge, Ri-Li] Qinghai Univ, Res Ctr High Altitude Med, Qinghai, Peoples R China	Sakamoto, R (reprint author), Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, 46 Shimoadachi Cho, Kyoto 6068501, Japan.	sakamoto65@cseas.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [3-4 FR]	This research was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology for the Research Institute for Humanity and Nature (3-4 FR): Human Life, Aging, and Disease in High-Altitude Environments: Physio-medical, Ecological and Cultural Adaptation in "Highland Civilizations."	Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Dosek A, 2007, RESP PHYSIOL NEUROBI, V158, P128, DOI 10.1016/j.resp.2007.03.013; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayr M, 2006, J AM COLL CARDIOL, V47, P2436, DOI 10.1016/j.jacc.2006.03.024; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Holvoet P, 2007, ATHEROSCLEROSIS, V194, P245, DOI 10.1016/j.atherosclerosis.2006.08.002; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Nedeljkovic ZS, 2003, POSTGRAD MED J, V79, P195, DOI 10.1136/pmj.79.930.195; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Peng YJ, 2011, P NATL ACAD SCI USA, V108, P3065, DOI 10.1073/pnas.1100064108; West JB, 2004, ANN INTERN MED, V141, P789; Beall CM, 2000, HUM BIOL, V72, P201; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Holvoet P, 2003, ARTERIOSCL THROM VAS, V23, P1444, DOI 10.1161/01.ATV.0000080379.05071.22; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Askew EW, 2002, TOXICOLOGY, V180, P107, DOI 10.1016/S0300-483X(02)00385-2; Aronovitch Y, 2007, FREE RADICAL BIO MED, V42, P1317, DOI 10.1016/j.freeradbiomed.2007.01.017; Beleznai T, 2011, AM J PHYSIOL-HEART C, V300, pH777, DOI 10.1152/ajpheart.00831.2010; Berger KI, 1998, ENCY OCCUPATIONAL HL, P375; Garruto RM, 2003, AM J PHYS ANTHROPOL, V122, P171, DOI 10.1002/ajpa.10283; Gonzales GF, 2009, AM J PHYSIOL-REG I, V297, pR1477, DOI 10.1152/ajpregu.00275.2009; Hininger I, 1997, EUR J CLIN NUTR, V51, P601, DOI 10.1038/sj.ejcn.1600451; Hoit BD, 2005, J APPL PHYSIOL, V99, P1796, DOI 10.1152/japplphysiol.00205.2005; Hulthe J, 2002, ARTERIOSCL THROM VAS, V22, P1162, DOI 10.1161/01.ATV.0000021150.63480.CD; Martarelli D, 2011, J SPORT MED PHYS FIT, V51, P299; MAZZONE T, 1983, P NATL ACAD SCI-BIOL, V80, P5094, DOI 10.1073/pnas.80.16.5094; Okumiya K, 2010, J AM GERIATR SOC, V58, P1193, DOI 10.1111/j.1532-5415.2010.02862.x; Pfeiffer JM, 1999, WILD ENVIRON MED, V10, P66, DOI 10.1580/1080-6032(1999)010[0066:EOASOU]2.3.CO;2; Sakamoto R, 2009, GERIATR GERONTOL INT, V9, P352, DOI 10.1111/j.1447-0594.2009.00544.x; Schmidt MC, 2002, WILD ENVIRON MED, V13, P94, DOI 10.1580/1080-6032(2002)013[0094:OSIHTI]2.0.CO;2; Villafuerte FC, 2004, J APPL PHYSIOL, V96, P1581, DOI 10.1152/japplphysiol.00328.2003	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1080-6032	1545-1534		WILD ENVIRON MED	Wildern. Environ. Med.	SEP	2015	26	3					343	349				7	Public, Environmental & Occupational Health; Sport Sciences	Public, Environmental & Occupational Health; Sport Sciences	CQ7JX	WOS:000360781100009		
J	Borlongan, AM				Borlongan, Ariane MaCalinga			English today: Introducing the varieties of English around the world	WORLD ENGLISHES			English	Book Review									[Borlongan, Ariane MaCalinga] Tokyo Univ Foreign Studies, Fuchu, Tokyo, Japan	Borlongan, AM (reprint author), Tokyo Univ Foreign Studies, 3-11-1 Asahi Cho, Fuchu, Tokyo, Japan.	arianemacalingaborlongan@yahoo.com					LEITNER G, 2012, ENGLISH TODAY INTRO	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0883-2919	1467-971X		WORLD ENGLISH	World Englishes	SEP	2015	34	3					510	512		10.1111/weng.12177		3	Linguistics; Language & Linguistics	Linguistics	CQ4OD	WOS:000360583400014		
J	Nozawa, M; Hara, I; Matsuyama, H; Iki, M; Nagao, K; Nishioka, T; Komura, T; Esa, A; Uejima, S; Imanishi, M; Uekado, Y; Ogawa, T; Kajikawa, H; Uemura, H				Nozawa, Masahiro; Hara, Isao; Matsuyama, Hideyasu; Iki, Masayuki; Nagao, Kazuhiro; Nishioka, Tsukasa; Komura, Takahiro; Esa, Atsunobu; Uejima, Shigeya; Imanishi, Masaaki; Uekado, Yasunari; Ogawa, Takatoshi; Kajikawa, Hiroshi; Uemura, Hirotsugu			Significance of baseline bone markers on disease progression and survival in hormone-sensitive prostate cancer with bone metastasis	WORLD JOURNAL OF UROLOGY			English	Article						Bisphosphonate; Bone marker; Bone metastasis; Predictive marker; Prognostic factor; Prostate cancer	ANDROGEN-DEPRIVATION THERAPY; SKELETAL-RELATED EVENTS; MESENCHYMAL TRANSITION; METABOLIC MARKERS; ZOLEDRONIC ACID; LUNG-CANCER; MEN; TRIAL; COMPLICATIONS; PREDICTORS	This study evaluated the baseline patient characteristics associated with the time to biochemical progression and overall survival in patients who participated in a phase II trial on zoledronic acid combined with the initial androgen-deprivation therapy for treatment-na < ve bone-metastatic prostate cancer. Patients received zoledronic acid 4 mg intravenously every 4 weeks for up to 24 months, concomitantly started with bicalutamide 80 mg orally every day and goserelin acetate 10.8 mg subcutaneously every 12 weeks. A total of 53 Japanese patients were enrolled between July 2008 and April 2010, and 52 patients were evaluable. Median follow-up period was 41.6 months. Updated median time to biochemical progression was 25.9 months (95 % confidence interval 14.5-49.9). Higher serum bone-specific alkaline phosphatase was an independent risk factor for time to biochemical progression based on multivariate analysis (hazard ratio 6.51; 95 % confidence interval 2.71-15.62; P < 0.001). Median time to biochemical progression for patients with serum bone-specific alkaline phosphatase level higher than 26 mu g/L was 12.7 months. Multivariate analysis indicated that higher serum C-terminal telopeptide of type I collagen independently increased the risk of death (hazard ratio 9.62; 95 % confidence interval 2.11-43.89; P = 0.003). Median overall survival for patients with serum C-terminal telopeptide of type I collagen level higher than 8.0 ng/ml was 31.1 months. Baseline bone markers can be useful as predictors for disease progression and survival time in patients with bone metastasis from treatment-na < ve prostate cancer treated with upfront zoledronic acid concomitantly started with androgen-deprivation therapy.	[Nozawa, Masahiro; Uemura, Hirotsugu] Kinki Univ, Dept Urol, Fac Med, Osaka 5898511, Japan; [Hara, Isao] Wakayama Med Univ, Dept Urol, Wakayama, Japan; [Matsuyama, Hideyasu; Nagao, Kazuhiro] Yamaguchi Univ, Grad Sch Med, Dept Urol, Ube, Yamaguchi 755, Japan; [Iki, Masayuki] Kinki Univ, Fac Med, Dept Publ Hlth, Osaka, Japan; [Nishioka, Tsukasa] Kinki Univ, Fac Med, Sakai Hosp, Dept Urol, Sakai, Osaka, Japan; [Komura, Takahiro] Naga Hosp, Dept Urol, Kinokawa, Japan; [Esa, Atsunobu] NTT Osaka Hosp, Dept Urol, Osaka, Japan; [Uejima, Shigeya] Natl Hosp Org, Osaka Minami Med Ctr, Dept Urol, Kawachi Nagano, Japan; [Imanishi, Masaaki] Tondabayashi Hosp, Dept Urol, Tondabayashi, Japan; [Uekado, Yasunari] Wakayama Rosai Hosp, Dept Urol, Wakayama, Japan; [Ogawa, Takatoshi] Kainan Municipal Hosp, Dept Urol, Kainan, Japan; [Kajikawa, Hiroshi] Izumiotsu Municipal Hosp, Dept Urol, Izumiotsu, Japan	Nozawa, M (reprint author), Kinki Univ, Dept Urol, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	nozawa06@med.kindai.ac.jp					Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Tombal B, 2014, LANCET ONCOL, V15, P592, DOI 10.1016/S1470-2045(14)70129-9; Brown JE, 2005, J NATL CANCER I, V97, P59, DOI 10.1093/jnci/dji002; Aruga A, 1997, BRIT J CANCER, V76, P760, DOI 10.1038/bjc.1997.458; Sathiakumar N, 2011, PROSTATE CANCER P D, V14, P177, DOI 10.1038/pcan.2011.7; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Norgaard M, 2010, J UROLOGY, V184, P162, DOI 10.1016/j.juro.2010.03.034; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Coleman RE, 2004, ONCOLOGIST, V9, P14, DOI 10.1634/theoncologist.9-90004-14; Cook RJ, 2006, CLIN CANCER RES, V12, P3361, DOI 10.1158/1078-0432.CCR-06-0269; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Oefelein MG, 2002, J UROLOGY, V168, P1005, DOI 10.1097/01.ju.0000024395.86788.cc; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Saad F, 2002, J NATL CANCER I, V94, P1458; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Berruti A, 1999, CLIN CHEM, V45, P1240; Lara PN, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju013; Maeda H, 1997, J UROLOGY, V157, P539, DOI 10.1016/S0022-5347(01)65196-6; Nozawa M, 2014, INT J CLIN ONCOL, V19, P693, DOI 10.1007/s10147-013-0604-z; Smith MR, 2007, UROLOGY, V70, P315, DOI 10.1016/j.urology.2007.03.071; Sweeney Christopher J, 2006, Clin Adv Hematol Oncol, V4, P588	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	SEP	2015	33	9					1263	1268		10.1007/s00345-014-1431-1		6	Urology & Nephrology	Urology & Nephrology	CQ3NM	WOS:000360509100008		
J	Tokiwa, H				Tokiwa, Hiroaki			Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category -Foreword-	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									Rikkyo Univ, Dept Chem, Res Ctr Smart Mol, Toshima Ku, Tokyo 1718501, Japan	Tokiwa, H (reprint author), Rikkyo Univ, Dept Chem, Res Ctr Smart Mol, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	tokiwa@rikkyo.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1001	1002				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900001		
J	Shimano, H				Shimano, Hitoshi			SREBP-1c and Elov16 as Targets for Obesity-related Disorders	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						Elov16; sterol regulatory element-binding protein; poly-unsaturated fatty acids	ELEMENT-BINDING PROTEIN-1; RECEPTOR-DEFICIENT MICE; FATTY-ACID; ATHEROSCLEROSIS; ELONGASE; PROMOTER; LIVER; GENE	Recent studies suggest that chronic local inflammation and cellular stresses are the key steps in organ defects in obesity-related diseases such as atherosclerosis, diabetes, and fatty liver. We have shown that an excess energy state activates sterol regulatory element-binding protein (SREBP) -1c, a master transcription factor for fatty acid synthesis causing the accumulation of lipids leading to fatty liver, insulin resistance, insulin secretion defects, and dyslipidemia and we clarified their molecular mechanisms. Recently, we shifted focus to the quality aspect of accumulated lipids. It has long been known that saturated and poly-unsaturated fatty acids are atherogenic and anti-atherogenic, respectively. Besides desaturation, we found that the chain-length of fatty acids is another important factor. Elov16 that we have cloned as an SREBP-1 target is a fatty acid elongase that catalises the last step of fatty acid synthesis. Elov16 KO mice exhibit obesity and fatty liver on a high energy diet, but unexpectedly were immune to insulin resistance (Nat. Med., 13, 2007, Matsuzaka et al.), atherosclerosis (Arterioscler. Thromb. Vasc. Biol., 31, 2011, Saito et al.) and non-alcoholic steatohepatitis (NASH) pathology including liver damage, ROS, and fibrosis (Hepatology, 56, 2012, Matsuzaka et al.). Elov16 is crucial for protection against lung fibrosis (Nat. Commun., 4, 2013, Sunaga et al.). These data implicate that fatty acid composition is a new therapeutic target for a variety of chronic metabolic diseases. In this symposium review, a novel strategy for the prevention of life-related diseases will be discussed in the standpoint of application of wet-dry fusion strategies for theoretical and medicinal chemistry.	Univ Tsukuba, Fac Med, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 3058575, Japan	Shimano, H (reprint author), Univ Tsukuba, Fac Med, Dept Internal Med Endocrinol & Metab, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hshimano@md.tsukuba.ac.jp					Matsuzaka T, 2009, J MOL MED-JMM, V87, P379, DOI 10.1007/s00109-009-0449-0; Karasawa T, 2011, ARTERIOSCL THROM VAS, V31, P1788, DOI 10.1161/ATVBAHA.110.219659; Takahashi A, 2005, DIABETES, V54, P492; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x; Saito R, 2011, ARTERIOSCL THROM VAS, V31, P1973, DOI 10.1161/ATVBAHA.110.221663; Matsuzaka T, 2002, J LIPID RES, V43, P911; Nakakuki M, 2014, J BIOCHEM, V155, P301, DOI 10.1093/jb/mvu019; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; Shimano H., 2014, J CLIN EXP MED, V248, P1184; Shimano H, 2012, PROG LIPID RES, V51, P267, DOI 10.1016/j.plipres.2011.12.004; Sunaga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3563	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1003	1009				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900002		
J	Noda, T				Noda, Takeshi			Genome Packaging Mechanism of Influenza A Virus	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						influenza A virus; genome packaging; electron microscopic analysis	RIBONUCLEOPROTEIN COMPLEXES; RNA SEGMENTS; VIRIONS	The influenza A virus genome consists of eight-segmented, single-stranded, negative-sense RNAs. Each genomic viral RNA segment (vRNA) encodes different viral proteins that are necessary for efficient virus replication, and forms a ribonucleoprotein complex (RNP) together with viral nucleoproteins and an RNA polymerase complex. Later in infection, progeny virions, which are released from the plasma membrane of the infected cell, must incorporate the eight separate vRNAs to be infectious. However, the mechanism by which the segmented vRNAs are incorporated into each progeny virion remains unclear. To elucidate the genome packaging mechanism of influenza A virus, we examined the architecture of RNPs within progeny virions using several electron microscopic analyses. We demonstrated that each progeny virion incorporates eight RNPs arranged in a specific pattern, in which seven RNPs surround the central one. Such characteristic arrangement is found in all influenza A virus strains tested here, suggesting that the mechanism by which well-organized eight RNPs is incorporated into virion is common to influenza A viruses. In addition, there seem to be physical interactions among the eight RNPs via nucleic acid-like structures, suggesting that there are specific interactions among the eight vRNAs in the form of RNPs. These results indicate that influenza A virion selectively packages a complete set of eight separate vRNAs.	Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Div Ultrastructural Virol,Minato Ku, Tokyo 1088639, Japan	Noda, T (reprint author), Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Div Ultrastructural Virol,Minato Ku, 6-1 Shirokanedai, Tokyo 1088639, Japan.	t-noda@ims.u-tokyo.ac.jp					Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; HIRST GK, 1973, VIROLOGY, V56, P620, DOI 10.1016/0042-6822(73)90063-9; COMPANS RW, 1972, J VIROL, V10, P795; Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; ENAMI M, 1991, VIROLOGY, V185, P291, DOI 10.1016/0042-6822(91)90776-8; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3766.2005; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; Muramoto Y, 2006, J VIROL, V80, P2318, DOI 10.1128/JVI.80.5.2318-2325.2006; Noda T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1647	10	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1011	1013				3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900003		
J	Igarashi, M				Igarashi, Manabu			Antiviral Drugs Targeting Influenza Virus Surface Proteins: A Computational Structural Biology Approach	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						influenza virus; molecular dynamics; docking; homology modeling; anti-influenza drug; monoclonal antibody	A VIRUSES; ANTIINFLUENZA ACTIVITY; NEUTRALIZING ANTIBODIES; VIRAL HEMAGGLUTININ; FUSION INHIBITOR; HUMAN INFECTION; IDENTIFICATION; STACHYFLIN; H5N1; RESISTANCE	For the prevention and control of infectious viral diseases, vaccines and antiviral drugs targeting viral proteins are of great importance. Amino acid substitutions in viral proteins occasionally cause the emergence of antibody-escape and drug-resistant mutants. With regard to this, we have studied the proteins of several viruses, especially the influenza A virus, by using techniques of computational chemistry and biology such as molecular modeling, molecular docking, and molecular dynamics simulations. Influenza A virus is a zoonotic pathogen that is transmitted from animals to humans. This virus has two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA). The HA of influenza viruses plays a key role in the initiation of viral infection. And HA is also the major target of antibodies that neutralize viral infectivity. Some amino acid substitutions in the antigenic epitope on HA could decrease the interaction between HA and antibodies, leading to the generation of antigenic variants with novel antigenic structures of HA. In addition, HA protein seems to be a favorable target for anti-influenza drugs, but effective HA inhibitors have not been developed due to the emergence of drug-resistant viruses with amino acid substitutions on the HA. To understand how amino acid substitutions affect changes in drug susceptibility, we have been computationally analyzing the three-dimensional structures of influenza virus proteins. In this paper, we review the results obtained through our current analysis.	Hokkaido Univ Res Ctr Zoonosis Control, Div Global Epidemiol, Kita Ku, Sapporo, Hokkaido 0010020, Japan	Igarashi, M (reprint author), Hokkaido Univ Res Ctr Zoonosis Control, Div Global Epidemiol, Kita Ku, Kita-20,Nishi-10, Sapporo, Hokkaido 0010020, Japan.	igarashi@czc.hokudai.ac.jp					Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Plotch SJ, 1999, J VIROL, V73, P140; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Luo GX, 1997, J VIROL, V71, P4062; Yoshimoto J, 1999, ARCH VIROL, V144, P865, DOI 10.1007/s007050050552; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; WEBSTER RG, 1992, MICROBIOL REV, V56, P152; Sun J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00038; Takano R, 2013, J INFECT DIS, V207, P89, DOI 10.1093/infdis/jis633; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; HAY AJ, 1985, EMBO J, V4, P3021; Feng F, 2010, BIOORG MED CHEM LETT, V20, P3772, DOI 10.1016/j.bmcl.2010.04.060; Kilbourne Edwin D., 1997, Journal of Infectious Diseases, V176, pS29, DOI 10.1086/514171; Le QM, 2005, NATURE, V438, P754, DOI 10.1038/438754b; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Motohashi Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-118; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Yagi S, 1999, PHARMACEUT RES, V16, P1041, DOI 10.1023/A:1018983715982; Yanagita H, 2012, ACS CHEM BIOL, V7, P552, DOI 10.1021/cb200332k; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yoshimoto J, 2000, J PHARM PHARMACOL, V52, P1247, DOI 10.1211/0022357001777225; Yoshimoto J, 2000, MICROBIOL IMMUNOL, V44, P677	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1015	1021				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900004		
J	Hata, S				Hata, Saori			Molecular Pathogenesis of Sporadic Alzheimer's Disease (AD) and Pharmaceutical Research to Develop a Biomarker for AD Diagnosis	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						Alzheimer's disease (AD); biomarker; alcadein	AMYLOID-BETA-PROTEIN; GAMMA-SECRETASE; PRECURSOR PROTEIN; ALCADEIN-ALPHA; CLEAVAGE; PLASMA; METABOLISM; TRANSPORT; FRAGMENT	Alzheimer's disease (AD) is the most common senile dementia. One of the pathological characteristics of AD is the appearance of senile plaques composed of amyloid-beta (A beta) depositions. A beta is generated by consecutive cleavages of A beta precursor protein (APP) by beta- and gamma-secretases. The common pathogenesis for familial AD (FAD) is believed to involve misprocessing of APP by gamma-secretase, resulting in increased A beta 42 peptide deposition. However, little is known about gamma-secretase function in sporadic AD (SAD), which is the major type of AD. This may be because A beta 42 peptide has highly aggregative properties; therefore it is not easy to estimate the quantitative alteration of net A beta 42 in SAD patients. Alcadein is a family of neural type I membrane proteins. Processing of Alcadein by APP alpha- and gamma-secretases results in secretion of non-aggregative peptide, p3-Alc, into CSF and blood. The C-terminuses of A beta and p3-Alc are altered by FAD-linked genetic mutations in catalytic components of gamma-secretase, in association with an increase in minor A beta and p3-Alc species. Thus p3-Ales are expected to behave as useful indicators of gamma-secretase dysfunction in SAD brain. Quantitative and qualitative analyses of p3-Ales raise the possibility that gamma-secretase dysfunction may exist even in the absence of genetic mutations. p3-Ale peptides may be a novel biomarker for AD and an indicator of gamma-secretase dysfunction for drug development.	Hokkaido Univ, Fac Pharmaceut Sci, Lab Neurosci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hata, S (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Neurosci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	shata@pharm.hokudai.ac.jp					Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Hata S, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-16; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Hata S, 2011, ANN NEUROL, V69, P1026, DOI 10.1002/ana.22343; Kamogawa K, 2012, J ALZHEIMERS DIS, V31, P421, DOI 10.3233/JAD-2012-120601; Konno T, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-76; Omori C, 2014, J ALZHEIMERS DIS, V39, P861, DOI 10.3233/JAD-131610; Piao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062431; Takei N, 2015, J BIOL CHEM, V290, P987, DOI 10.1074/jbc.M114.599852; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243	14	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1023	1027				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900005		
J	Sato, K				Sato, Katsuhiko			Development of Functional Multilayer Nanofilms and Microcapsules Based on Layer-by-Layer Deposition Techniques	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						layer-by-layer (LbL) film; microcapsule; glucose response; phenylboronic acid	CONCANAVALIN-A; HYDROGEN-PEROXIDE; THIN-FILMS; 2-IMINOBIOTIN-LABELED POLY(ETHYLENEIMINE); ELECTROCHEMICAL BIOSENSORS; INDUCED DISINTEGRATION; ASSEMBLIES; BINDING; GLYCOGEN; RELEASE	Functional multilayer thin films have been prepared by layer-by-layer (LbL) deposition for the development of sensors, separators, and drug delivery systems. In particular, glucose-sensitive LbL films have been widely studied for use as glucose sensors and in glucose-triggered drug delivery systems. In this work, I report on glucose-sensitive LbL films that consist of concanavalin A (ConA), phenylboronic acid (PBA), and glucose oxidase (GOx). ConA/glycogen LbL films were prepared by LbL deposition of ConA and glycogen through a lectin-sugar interaction. Similarly, PBA-modified poly (amidoamine) dendrimer/poly (vinyl alcohol) (PVA) LbL films were prepared through cyclic boronate ester bonds. Both types of films decomposed in the presence of glucose, by the competitive binding of glucose, although these LbL films did not show a satisfactory response to millimolar concentrations of glucose under physiological conditions. PBA-modified poly (allylamine hydrochloride) and PVA films were prepared on a GOx-modified quartz slide. The LbL film was stable over a wide pH range, from 3.0 to 9.0, in the absence of glucose. In contrast, the film decomposed upon exposure to 0.1-10 mm glucose solutions for 60 min at pH 7.4. The glucose-induced decomposition of the film can be explained by the scission of the carbon-boron bond of the PBA residues by hydrogen peroxide, which was produced through the GOx-catalyzed oxidation of glucose. These results suggest this multilayer film may be useful for the development of glucose-sensitive drug delivery systems.	Tohoku Unicer, Grad Sch Pharmaceut Sci, Aoba Ku, Sedai 9808578, Japan	Sato, K (reprint author), Tohoku Unicer, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sedai 9808578, Japan.	satok@rn.tohoku.ac.jp					Watahiki R, 2014, J MATER CHEM B, V2, P5809, DOI 10.1039/c4tb00676c; Lux CD, 2012, J AM CHEM SOC, V134, P15758, DOI 10.1021/ja303372u; Tong WJ, 2008, J MATER CHEM, V18, P3799, DOI 10.1039/b805717f; Broaders KE, 2011, J AM CHEM SOC, V133, P756, DOI 10.1021/ja110468v; Zhao W, 2006, ELECTROANAL, V18, P1737, DOI 10.1002/elan.200603630; Inoue H, 2005, BIOMACROMOLECULES, V6, P27, DOI 10.1021/bm0495856; Song CC, 2013, MACROMOLECULES, V46, P8416, DOI 10.1021/ma401656t; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Hashide R, 2012, COLLOID SURFACE B, V89, P242, DOI 10.1016/j.colsurfb.2011.09.023; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Ibey BL, 2005, ANAL CHEM, V77, P7039, DOI 10.1021/ac0507901; SCHWARZ FP, 1993, J BIOL CHEM, V268, P7668; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Sato K, 2005, LANGMUIR, V21, P797, DOI 10.1021/la048059x; Wang ZP, 2008, CHEM MATER, V20, P4194, DOI 10.1021/cm8003358; Sato K, 2011, ADV DRUG DELIVER REV, V63, P809, DOI 10.1016/j.addr.2011.03.015; Sato K, 2013, MOLECULES, V18, P8440, DOI 10.3390/molecules18078440; Hayashida O, 2003, CHEM LETT, V32, P632; Shibata H, 2010, P NATL ACAD SCI USA, V107, P17894, DOI 10.1073/pnas.1006911107; Takahashi S, 2012, ANAL BIOANAL CHEM, V402, P1749, DOI 10.1007/s00216-011-5317-4; Sato K, 2014, LANGMUIR, V30, P9247, DOI 10.1021/la501750s; Asher SA, 2003, J AM CHEM SOC, V125, P3322, DOI 10.1021/ja021037h; Borges J, 2014, CHEM REV, V114, P8883, DOI 10.1021/cr400531v; Endo Y, 2011, J COLLOID INTERF SCI, V360, P519, DOI 10.1016/j.jcis.2011.04.104; Kawanishi T, 2004, J FLUORESC, V14, P499, DOI 10.1023/B:JOFL.0000039338.16715.48; MANDAL DK, 1994, BIOCHEMISTRY-US, V33, P1149, DOI 10.1021/bi00171a014; Mercato L. L., 2014, ADV COLLOID INTERFAC, V207, P139; Pingarron JM, 2008, ELECTROCHIM ACTA, V53, P5848, DOI 10.1016/j.electacta.2008.03.005; Sato K, 2006, ANAL BIOANAL CHEM, V386, P1899, DOI 10.1007/s00216-006-0779-5; Sato K, 2006, BIOMACROMOLECULES, V7, P3302, DOI 10.1021/bm060819q; Sato K, 2014, POLYMERS-BASEL, V6, P2157, DOI 10.3390/polym6082157; Sato K, 2003, LANGMUIR, V19, P7406, DOI 10.1021/la030163b; Sato K, 2010, POLYM BULL, V65, P807, DOI 10.1007/s00289-010-0278-x; Sato K, 2006, ANAL BIOANAL CHEM, V384, P1297, DOI 10.1007/s00216-005-0279-z; Sato K, 2012, POLYM BULL, V68, P891, DOI 10.1007/s00289-011-0670-1; Sato K, 2014, J COLLOID INTERF SCI, V432, P92, DOI 10.1016/j.jcis.2014.06.039; Sato K, 2009, J NANOSCI NANOTECHNO, V9, P386, DOI 10.1166/jnn.2009.J037; Tomita S, 2008, J COLLOID INTERF SCI, V326, P35, DOI 10.1016/j.jcis.2008.06.054	40	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1029	1035				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900006		
J	Ikemura, K				Ikemura, Kenji			Molecular Biological Analysis of Factors Influencing Pharmacokinetics to Achieve Personalized Pharmacotherapy	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						liver ischemia-reperfusion (I/R); pharmacokinetics; P-glycoprotein (P-gp); microRNA; CYP3A; organic cation transporter 2	LIVER ISCHEMIA-REPERFUSION; INTESTINAL EPITHELIAL-CELLS; DECREASED ORAL ABSORPTION; P-GLYCOPROTEIN; DRUG TRANSPORTERS; CYCLOSPORINE-A; CIMETIDINE; BIOAVAILABILITY; METABOLISM; MECHANISMS	Large individual variations in drug efficacy and safety could be explained in part by pharmacokinetics regulated by drug transporters and drug-metabolizing enzymes. However, expression and/or function of these proteins often fluctuate in pathological conditions, causing individual pharmacokinetic variability. To achieve a personalized pharmacotherapy after liver transplantation, our group has been investigating the pharmacokinetics of drugs and factors causing its variation based on molecular biological analysis using rats with liver ischemia-reperfusion (I/R) injury as a model for injuries immediately after liver transplantation. The first finding is that the oral bioavailability of cyclosporine A (CsA), which is an immunosuppressant, was decreased by increased first-pass metabolism due to elevated CYP3A and P-glycoprotein (P-gp) specifically in the upper small intestine after liver I/R. Expression of CYP3A in the small intestine was also elevated through transcriptional regulation by endogenous bile acids, whereas expression and function of intestinal P-gp were increased by post-transcriptional regulation via microRNA-145. Next, the pharmacokinetics of a cationic drug, cimetidine, which is eliminated from the kidney, and the expressional variation of drug transporters in the kidney after liver I/R were examined. Liver I/R decreased tubular secretion of cimetidine, mainly because of decreased expression of rat organic cation transporter 2 in the kidney. These findings provide useful information on the etiology of liver I/R injury and appropriate use of immunosuppressants and drugs eliminated from the kidney after liver transplantation.	Mie Univ Hosp, Dept Pharm, Tsu, Mie 5148507, Japan	Ikemura, K (reprint author), Mie Univ Hosp, Dept Pharm, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	ikemurak@clin.medic.mie-u.ac.jp					Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Ikemura K, 2013, MOL PHARMACOL, V83, P399, DOI 10.1124/mol.112.081844; Ikemura K, 2014, PHARMACOL THERAPEUT, V143, P217, DOI 10.1016/j.pharmthera.2014.03.002; Tsuda M, 2009, J PHARMACOL EXP THER, V329, P185, DOI 10.1124/jpet.108.147918; WU CY, 1995, CLIN PHARMACOL THER, V58, P492, DOI 10.1016/0009-9236(95)90168-X; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Masuda S, 2006, PHARMACOL THERAPEUT, V112, P184, DOI 10.1016/j.pharmthera.2006.04.006; HEBERT MF, 1992, CLIN PHARMACOL THER, V52, P453; Tahara H, 2005, J PHARMACOL EXP THER, V315, P337, DOI 10.1124/jpet.105.088104; Braun N, 2003, TRANSPLANT P, V35, P1458, DOI 10.1016/S0041-1345(03)00486-x; GONZALEZMARTIN G, 1985, INT J CLIN PHARM TH, V23, P355; Ikemura K, 2009, EXPERT OPIN DRUG MET, V5, P907, DOI 10.1517/17425250903008525; Ikemura K, 2012, EUR J PHARMACOL, V690, P192, DOI 10.1016/j.ejphar.2012.06.031; Ikemura K, 2013, DRUG METAB PHARMACOK, V28, P504, DOI 10.2133/dmpk.DMPK-13-RG-021; Ikemura K, 2009, J PHARMACOL EXP THER, V328, P249, DOI 10.1124/jpet.108.145581; Kaplan B, 1999, TRANSPLANTATION, V67, P333, DOI 10.1097/00007890-199901270-00026; Tanaka Y, 2007, MOL PHARMACOL, V71, P817, DOI 10.1124/mol.106.029033	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1037	1041				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900007		
J	Hayama, T				Hayama, Tadashi			Development of Selective LC Analysis Method for Biogenic and Related Compounds Based on a Fluorous Affinity Technique	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						perfluoroalkyl; fluorous derivatization; biogenic compound; LC	CHROMATOGRAPHY/TANDEM MASS-SPECTROMETRY; DERIVATIZATION; AMINES	A separation-oriented derivatization method combined with LC has been developed for the selective analysis of biogenic and related compounds. In this method, we utilized a specific affinity between perfluoroalkyl-containing compounds, i.e., 'fluorous' compounds (fluorophilicity). Our strategy involves the derivatization of target analytes with perfluoroalkyl reagents, followed by selective retention of the derivatives with a perfluoroalkyl-modified stationary phase LC column. The perfluoroalkylated derivatives are strongly retained on the column owing to their fluorophilicity, whereas non-derivatized species, such as sample matrices, are hardly retained. Therefore, utilizing this derivatization method, target analytes can be determined selectively without interference from matrices. This method has been successfully applied to the LC analysis of some biogenic and related compounds in complex biological samples.	Fukuoka Univ, Fac Pharmaceut Sci, Johnan Ku, Fukuoka 8140180, Japan	Hayama, T (reprint author), Fukuoka Univ, Fac Pharmaceut Sci, Johnan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	thayama@fukuoka-u.ac.jp					Hayama T, 2010, RAPID COMMUN MASS SP, V24, P2868, DOI 10.1002/rcm.4710; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Sakaguchi Y, 2011, J CHROMATOGR A, V1218, P5581, DOI 10.1016/j.chroma.2011.05.076; Hayama T, 2012, ANAL CHEM, V84, P8407, DOI 10.1021/ac3020092; Pucci V, 2009, J PHARMACEUT BIOMED, V50, P867, DOI 10.1016/j.jpba.2009.05.037; Curran DP, 2008, SCIENCE, V321, P1645, DOI 10.1126/science.1158721; Davies NM, 1997, CLIN PHARMACOKINET, V32, P268, DOI 10.2165/00003088-199732040-00002; Gladysz J.A., 2004, HDB FLUOROUS CHEM; Sakaguchi Y, 2014, RAPID COMMUN MASS SP, V28, P2481, DOI 10.1002/rcm.7042; Sakaguchi Y, 2011, J PHARMACEUT BIOMED, V55, P176, DOI 10.1016/j.jpba.2011.01.011; Shinkai N, 2008, J PHARM PHARMACOL, V60, P71, DOI 10.1211/jpp.60.1.009; Uneyama K., 2006, ORGANOFLUORINE CHEM	12	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1043	1048				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900008		
J	Murata, I; Arai, N; Fukushima, A; Saito, A; Inoue, Y; Kimura, M; Kanamoto, I				Murata, Isamu; Arai, Narutoshi; Fukushima, Aishi; Saito, Astuko; Inoue, Yutaka; Kimura, Masayuki; Kanamoto, Ikuo			Study of Preparation and Utility of Suppository Containing Carbamazepine Tablet for Hospital Use in Rabbits	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						carbamazepine (CBZ); suppository; cancer-related neuropathic pain; pharmacokinetics	PAIN	Cancer patients often report a decreased quality of life due to cancer-related pain, especially neuropathic pain, which is difficult to manage and often develops resistance to morphine. Thus a supplementary analgesic can play an important role in the treatment of cancer-related pain. Carbamazepine (CBZ), for example, can be effective, but only if the patient can take medication orally because it is limited to oral administration. In this study we investigated the efficacy of a suppository containing CBZ tablet in hospital preparations. We selected a base for the suppository of either polyethylene glycol (P), Witepsol VOSCO (R) H-15 (H), or Witepsol VOSCO (R) S-55 (S). Six to eight in vitro and in vivo groups were divided randomly based on route of administration and treatment: intravenous (i. v.), per os (p.o.), and intrarectal administration (i.r.) (composed of CBZ powder and tablet formulations, CBZp and CBZt) prepared in either a base of P, H, or S (CBZp/P, CBZp/H, CBZp/S, CBZt/P, CBZt/H, and CBZt/S). The hardness levels of the CBZt suppository group were significantly lower than the CBZp suppository group. The drug release profiles of the CBZt suppository group were high in order of P, H, and S; there were no significant differences between these groups and the CBZp suppository group. The maximum drug concentration time levels of the CBZt suppository group significantly increased compared with the p. o. group. These two groups had equivalent maximum drug concentration and bioavailability levels. These results suggest that a suppository containing CBZ tablet can be useful for hospital preparations.	[Murata, Isamu; Fukushima, Aishi; Saito, Astuko; Inoue, Yutaka; Kimura, Masayuki; Kanamoto, Ikuo] Josai Univ, Fac Pharmaceut Sci, Lab Drug Safety Management, Sakado, Saitama 3500295, Japan; [Arai, Narutoshi] Saitama Int Med Ctr, Dept Pharm, Hidaka, Saitama 3501298, Japan	Murata, I (reprint author), Josai Univ, Fac Pharmaceut Sci, Lab Drug Safety Management, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.	ismurata@josai.ac.jp					Hidaka N, 2006, BIOL PHARM BULL, V29, P705, DOI 10.1248/bpb.29.705; Fujishima I., 2006, NAIFUKUYAKU KEIKANTO, V2nd; Gallagher RM, 2006, CLIN J PAIN, V22, pS2, DOI 10.1097/01.ajp.0000193827.07453.d6; Health Labour and Welfare Statistics Association, 2010, KOK NO DOUK 2010 201, P30; Iseki Masako, 2006, Folia Pharmacologica Japonica, V128, P326, DOI 10.1254/fpj.128.326; Japanese Society for Palliative Medicine, 2000, EV BAS MED NI NOTT G, P5; Kanamoto I., 1991, JPN J CLIN PHARM THE, V22, P489; Kanamoto I., 1998, JPN J HOSP PHARM, V24, P150; Kato Jitsu, 2010, Nichidai Igaku Zasshi, V69, P170; Muranishi S., 1985, ZAZAI SEIZAI KARA RI; Nakayama A., 2009, JPN J PHARM HLTH CAR, V35, P343; SHINODA M, 1995, BIOL PHARM BULL, V18, P1289; SUMI M, 1987, YAKUGAKU ZASSHI, V107, P984; Tsunetou S., 1999, SAISHINKANWAIRYOUGAK, P11; Unotoro J., 2009, J JAPANESE COLL SURG, V34, P1102; World Health Organization (WHO), 1996, CHAG DIS PROGR EL TR, V2nd, P12; Yamashita Chikamasa, 2011, Yakuzaigaku, V71, P126	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1049	1055				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900009		
J	Nanaumi, Y; Onda, M; Tsubota, K; Tanaka, R; Mukai, Y; Matoba, S; Tanaka, Y; Arakawa, Y				Nanaumi, Yoko; Onda, Mitsuko; Tsubota, Kenichi; Tanaka, Rie; Mukai, Yusuke; Matoba, Syunya; Tanaka, Yuka; Arakawa, Yukio			Effectiveness of Pharmacists' Comprehensive Assessment of Medication Profiles in Dementia Patients	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			English	Article						dementia; home care; community pharmacy; comprehensive assessment; medication profiling	DRUG-RELATED PROBLEMS; REVIEWS; DISEASE; CARE	In Japan the prevalence of dementia has increased considerably, and pharmacists are involved in addressing these patients' medication-related problems. Here, we determined whether pharmacists' comprehensive assessment of medication profiles could reduce the burden of dementia patients' medication-related problems. In this historical cohort study 120 community pharmacies were randomly selected, and participating pharmacists completed questionnaires concerning comprehensive assessment of patient medication profiles, using a "start" questionnaire for patients prescribed medication prior to or during the study period and a "follow-up" questionnaire for patients who subsequently visited pharmacies for prescriptions. Numbers and details of problems and solutions implemented by pharmacists and identified in the start and follow-up questionnaires were compared. Changes in start and follow-up scores were also compared between patients whose problems were identified by pharmacists (identified group) and those whose problems were not (non-identified group). Data were collected for 349 patients issued medication by 60 pharmacies. The most common medication-related problems identified in the start survey were key person's understanding of donepezil (60 cases) and other dementia treatments (60 cases), and adherence to treatment (53 cases). Solutions implemented by pharmacists included gathering information regarding drug administration and dementia awareness from the key person and providing pharmaceutical counseling and instruction. Subsequently, problems related to understanding of dementia treatment, understanding donepezil, and adherence were resolved by 70.0%, 65.0%, and 58.5%, respectively. Pharmacists' comprehensive assessment of medication profiles could effectively solve dementia patients' medication-related problems.	[Nanaumi, Yoko] Adv Pharma Res Off, Nara 6310805, Japan; [Onda, Mitsuko; Tsubota, Kenichi; Tanaka, Rie; Mukai, Yusuke; Matoba, Syunya; Tanaka, Yuka; Arakawa, Yukio] Osaka Univ Pharmaceut Sci, Clin Lab Pract Pharm, Takatsuki, Osaka 5691094, Japan	Onda, M (reprint author), Adv Pharma Res Off, 3-6-2 Ukyo, Nara 6310805, Japan.	onda@gly.oups.ac.jp					Ahmad A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-133; Hugtenburg JG, 2009, PHARM WORLD SCI, V31, P630, DOI 10.1007/s11096-009-9314-z; Homma A, 2009, DEMENT GERIATR COGN, V27, P232, DOI 10.1159/000203887; Asada T, HLTH LABOR SCI RES G; Belle SH, 2004, AM J GERIAT PSYCHIAT, V12, P250, DOI 10.1176/appi.ajgp.12.3.250; Black Sandra E, 2004, CMAJ, V171, P1174, DOI 10.1503/cmaj.1041615; Cotrell Victoria, 2006, J Gerontol Soc Work, V47, P31, DOI 10.1300/J083v47n03_03; Felkey B G, 1995, Am Pharm, VNS35, P42; Felkey B., 1995, AM PHARM, V35, p52 ; Jurkowski C.A., 1998, AM J MED, V104, p39S; Jurkowski Claire L., 1998, American Journal of Medicine, V104, p13S, DOI 10.1016/S0002-9343(98)00023-0; Lewis NJW, 2008, J AM PHARM ASSOC, V48, P171, DOI 10.1331/JAPhA.2008.07141; Massey Angela L, 2005, Consult Pharm, V20, P514, DOI 10.4140/TCP.n.2005.514; Mirt J., 1996, J AM PHARM ASSOC, VNS36, P249; Molinuevo JL, 2012, REV NEUROLOGIA, V54, P65; Nanaumi Y., 2012, PHARM PHARM, V3, P368; National Institute of Population and Social Security Research, POP PROJ JAP JAN 201; Ocaña Gloria García, 2007, Rev Enferm, V30, P59; Rantucci M., 2002, PHARM PRACT MISSISSA, V18, P25; Roughead EE, 2011, J CLIN PHARM THER, V36, P27, DOI 10.1111/j.1365-2710.2009.01149.x; Sen-Roy S, 2002, PHARM PRACT MISSISSA, V18, pC1; Slattum Patricia W, 2004, Consult Pharm, V19, P352, DOI 10.4140/TCP.n.2004.352; Stafford AC, 2009, PHARM WORLD SCI, V31, P216, DOI 10.1007/s11096-009-9287-y; Takasaki Y., 2008, JPN J CANC CHEMOT S1, V35, P91; Triller DM, 2007, AM J HEALTH-SYST PH, V64, P2244, DOI 10.2146/ajhp050492; Willis JS, 2011, J COMMUN HEALTH, V36, P1027, DOI 10.1007/s10900-011-9405-3	26	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1057	1067				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900010		
J	Senaha, H; Myotoku, M; Tomida, Y; Murayama, Y; Nakanishi, A; Iwamoto, C; Tagawa, M; Hata, A; Kokado, M; Obata, A; Kawaguchi, S				Senaha, Hiromasa; Myotoku, Michiaki; Tomida, Yumi; Murayama, Yoko; Nakanishi, Akiko; Iwamoto, Chiaki; Tagawa, Miyuki; Hata, Akiko; Kokado, Mai; Obata, Ayaka; Kawaguchi, Shunichi			Changes in Medical Safety Interventions Conducted by Ward-based Pharmacists since the Introduction of Their Services in Complex Medical Ward	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			English	Article						medical safety; ward; risk avoidance; pharmacist's round; interest of patient		Despite an increase in the number of reports on medical safety interventions conducted by ward-based pharmacists, only a few reports have classified intervention cases in detail. We classified and compared the types of medical safety intervention conducted by ward-based pharmacists since the introduction of their services. The interventions were classified into: cases that were identified by pharmacists or through asking questions about physicians' prescriptions before dispensing medications (active interventions); and those in which pharmacy technicians could contribute to medical safety by receiving inquiries from patients or healthcare providers (passive interventions). The numbers of the two types of intervention were compared. The number of interventions significantly increased after the introduction of ward-based clinical pharmacy services. Especially, the numbers of cases identified during ward rounds conducted by ward-based pharmacists (active interventions) and those identified by receiving inquiries from physicians or nurses (passive interventions) significantly increased, possibly because the collection of patient information was performed more efficiently by conducting ward rounds, and an environment where physicians and nurses can easily make inquiries to pharmacists was established after increasing the time pharmacists spend on hospital wards. The results demonstrate that the introduction of ward-based clinical pharmacy services has improved communication with patients, facilitated information-sharing among physicians, nurses, and other healthcare providers, contributed to the safer management of pharmaceutical operations, and increased interest of patients.	[Senaha, Hiromasa; Tomida, Yumi; Murayama, Yoko; Nakanishi, Akiko; Iwamoto, Chiaki; Tagawa, Miyuki; Hata, Akiko; Kokado, Mai; Obata, Ayaka; Kawaguchi, Shunichi] Municipal Ikeda Hosp, Dept Pharm, Ikeda, Osaka 5638510, Japan; [Myotoku, Michiaki] Osaka Ohtani Univ, Fac Pharm, Lab Pract Pharm & Pharmaceut Care, Tondabayashi, Osaka 5848540, Japan	Senaha, H (reprint author), Municipal Ikeda Hosp, Dept Pharm, 3-1-18 Jonan, Ikeda, Osaka 5638510, Japan.	hiromasa-senaha@hosp.ikeda.osaka.jp					Adachi K., 2014, JPN J PHARM HLTH CAR, V40, P8; Kori T., 2008, JPN J PHARM HLTH CAR, V34, P426; Kumakura Y., 2014, JPN J PHARM HLTH CAR, V40, P1; Nakagawa Y., 2014, J JPN SOC HOSP PHARM, V50, P71; Nakamura T., 2009, J JPN SOC HOSP PHARM, V45, P1119; Nozawa A., 2009, JPN J PHARM HLTH CAR, V35, P892; Sekimoto H, 2010, JPN J PHARM HLTH CAR, V36, P171; Yoshida Y., 2011, J JPN SOC HOSP PHARM, V37, P591	8	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1069	1076				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900011		
J	Takahashi, K; Suda, Y; Kawaguchi, H; Nakamura, Y; Kawabata, S; Kawakami, N; Nishikawa, T; Nagayama, K				Takahashi, Katsuyuki; Suda, Yasuki; Kawaguchi, Hiroshi; Nakamura, Yasutaka; Kawabata, Shiho; Kawakami, Noriko; Nishikawa, Takeshi; Nagayama, Katsuya			Introduction of a Clinical Research Experience Program in Hospital Practical Training for Pharmacy Students and Its Evaluation	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						clinical research; long-term clinical training; model core curriculum		Long-term clinical training based on a model core curriculum was conducted to nurture highly competent pharmacists in the clinical field. Pharmacists' responsibilities are expanding, and a system has been developed to help pharmacists gain accreditation, identify specialties, and improve their training. However, this system requires research competency. Therefore clinical research should be considered a part of clinical training to encourage high competency among pharmacists. Because the model core curriculum does not include a section on clinical research. Osaka City University Hospital introduced a hands-on clinical research experience program and evaluated its usefulness. A significant improvement in the level of knowledge and awareness of clinical research was seen among students who underwent the clinical research experience program. In addition, the level of student satisfaction was higher. These findings suggest that a clinical research experience program may be useful to nurture a greater awareness of clinical research and knowledge acquisition among pharmacists.	[Takahashi, Katsuyuki; Suda, Yasuki; Kawaguchi, Hiroshi; Nakamura, Yasutaka; Kawabata, Shiho; Kawakami, Noriko; Nishikawa, Takeshi; Nagayama, Katsuya] Osaka City Univ Hosp, Dept Pharm, Abeno Ku, Osaka 5458586, Japan	Takahashi, K (reprint author), Osaka City Univ Hosp, Dept Pharm, Abeno Ku, 1-5-7 Asahimachi, Osaka 5458586, Japan.	k.taka@med.osaka-cu.ac.jp					Kawazoe H., 2013, JPN J PHARM HLTH CAR, V39, P733; Koshiishi T., 2012, JPN J PHARM PALLIAT, V5, P49; Nagasato A., 2013, J JPN SOC HOSP PHARM, V49, P861; Science Council of Japan, YAK NO SHOK TO SHAK; Suemaru K, 2008, YAKUGAKU ZASSHI, V128, P1839, DOI 10.1248/yakushi.128.1839; Tanaka M., 2007, JPN J PHARM HLTH CAR, V33, P318	6	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	2015	135	9					1077	1082				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ4TQ	WOS:000360597900012		
J	Kuribayashi, R; Matsuhama, M; Mikami, K				Kuribayashi, Ryosuke; Matsuhama, Maki; Mikami, Kenichi			Regulation of Generic Drugs in Japan: the Current Situation and Future Prospects	AAPS JOURNAL			English	Article						approval review; generic drug; Japan; PMDA		Generic drugs are interchangeable with original proprietary drugs, as they have the same active pharmaceutical ingredients, dosage forms, strength, quality, indications, effects, directions, and dosage. The cost of generic drugs is lower than original drugs, because the developmental cost is lower. The expansion of medical expenses is an important issue in many countries, including Japan, the USA, and Europe, and promotion of generic drugs has been demanded to solve this issue in Japan. Generic drug approval review in Japan is conducted by the Pharmaceuticals and Medical Devices Agency ( PMDA), which reviews the equivalence of the original drugs from the viewpoint of quality, efficacy, and safety, based on documentation submitted by the generic drug applicants. However, the details of the generic drug review in Japan have not been reported. In this report, we introduce the application types, the number of applications and approvals, and the review timeline of generic drugs in Japan. In addition, we discuss recent consultations and future prospects.	[Kuribayashi, Ryosuke; Matsuhama, Maki; Mikami, Kenichi] Pharmaceut & Med Devices Agcy, Off Gener Drugs, Chiyoda Ku, Tokyo 1000013, Japan	Kuribayashi, R (reprint author), Pharmaceut & Med Devices Agcy, Off Gener Drugs, Chiyoda Ku, 3-3-2 Kasumigaseki, Tokyo 1000013, Japan.	kuribayashi-ryosuke@pmda.go.jp					Davit B, 2013, AAPS J, V15, P974, DOI 10.1208/s12248-013-9499-x; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; EMA, 2009, GUID REQ CLIN DOC OR; FDA, 2013, GEN DRUG US FEE ACT, pP1; FDA, 2014, GUID IND ANDA SUBM A; FDA, 2013, GUID FLUT P IN PRESS; ICH harmonised tripartite guideline, 2004, ICH HARM TRIP GUID O; IMS Institute For Healthcare Iinformatics, 2013, AV COSTS US HEALTHC; IMSHEALTH, 2009, GEN MED ESS CONTR LO; MHLW, 2012, PROM US GEN DRUGS; Ortman J. M., 2014, AGING NATION OLDER P; PMDA MHLW, 2014, MIDT PLAN PHARM MED; Simon-Kucher& PartnersHealthcare Insights, 2013, REC DEV GLOB PRIC MA	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1550-7416			AAPS J	AAPS J.	SEP	2015	17	5					1312	1316		10.1208/s12248-015-9777-x		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CQ1NN	WOS:000360364500025		
J	Mia, MB; Nishijima, J; Fujimitsu, Y				Mia, Md. Bodruddoza; Nishijima, Jun; Fujimitsu, Yasuhiro			Monitoring heat flow before and after eruption of Kuju fumaroles in 1995 using Landsat TIR images	ACTA GEODAETICA ET GEOPHYSICA			English	Article						Landsat TM TIR data; Radiant heat flux; Heat discharge rates; Kuju fumaroles	VOLCANO; JAPAN; KYUSHU	The Kuju fumaroles in central Kyushu, Japan began to erupt as phreatic in nature on 11 October 1995. To infer the thermal activity, main objectives were to monitor the radiative heat flux (RHF) before and after eruption of Kuju fumaroles in 1995 using 4 sets of Landsat TM thermal infrared data from 1990 to 1996; and to calculate and monitor the heat discharge rate (HDR) after multiplying RHF using a relationship coefficient between RHF and HDR, derived from two previous studies. The RHF was estimated by using the Stefan-Boltzmann equation for heat flow where we applied satellite image-derived spectral emissivity and land surface temperature. An increasing trend of total radiant heat flux was obtained of about 22-39 MW before the Kuju fumaroles eruption from 1990 to 1994 and a declining trend total RHF of about 37-11 MW after eruption from 1995 to 1996. RHF was strongly correlated with land surface temperature (LST) above ambient in our study. Spatial distribution of RHF also showed a similar trend of total RHF. After using this relationship coefficient, we obtained the HDR from our study area about 144.64, 249.74, 239.67 and 68.54 MW in 1990, 1994, 1995 and 1996, respectively. The HDR was much higher before eruption in October 11, 1995 than that of after the eruption in our study. Fumaroles area also showed an abrupt increase of bared land and no vegetation just after eruption within the thematic map in 1995. Statistics of LST and RHF also showed evidences of heat loss activity before and after eruption in 1995. In conclusion, we infer from this study that Landsat TM thermal infrared images are fully competent to monitor thermal activity from any active volcano fumaroles for future eruption.	[Mia, Md. Bodruddoza] Univ Dhaka, Dept Geol, Fac Earth & Environm Sci, Dhaka 1000, Bangladesh; [Nishijima, Jun; Fujimitsu, Yasuhiro] Kyushu Univ, Lab Geotherm, Dept Earth Resources Engn, Fac Engn, Fukuoka 8190395, Japan	Mia, MB (reprint author), Univ Dhaka, Dept Geol, Fac Earth & Environm Sci, Dhaka 1000, Bangladesh.	bodruddoza.geo@gmail.com			GCOE of Kyushu university; Japan government (MEXT)	Authors would like to acknowledge their sincere gratitude to GCOE of Kyushu university financial support of this work. They also acknowledged USGS archive to provide satellite images with free of cost. The first author would also like to show his sincere gratefulness to Japan government (MEXT) PhD scholarship during this work.	Mia MB, 2012, J VOLCANOL GEOTH RES, V235, P1, DOI 10.1016/j.jvolgeores.2012.05.005; Savage SL, 2010, GISCI REMOTE SENS, V47, P460, DOI 10.2747/1548-1603.47.4.460; Valor E, 1996, REMOTE SENS ENVIRON, V57, P167, DOI 10.1016/0034-4257(96)00039-9; Mia MB, 2012, J EARTH SYST SCI, V121, P1049, DOI 10.1007/s12040-012-0211-9; Harris AJL, 2009, B VOLCANOL, V71, P441, DOI 10.1007/s00445-008-0236-8; EHARA S, 1992, J VOLCANOL GEOTH RES, V54, P107, DOI 10.1016/0377-0273(92)90117-V; Ehara S, 2005, P WROLD GEOTH C 2005; Kamata H, 1997, J VOLCANOL GEOTH RES, V76, P163, DOI 10.1016/S0377-0273(96)00076-5; Mia MB, 2011, J ADV SCI ENG RES, V1, P177; Mia MB, 2013, PROCEDIA EARTH PLANE, V6, P114; Mia MB, 2012, P SPIE ASIA PAC REM; Nakaboh M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016047; NASA, 2009, LANDS 7 SCI DAT US H; Qin Z, 2001, INT J REMOTE SENS, V22, P3719, DOI 10.1080/01431160010006971; Yamasaki T, 1970, GEOTHERMICS, V2, P197, DOI DOI 10.1016/0375-6505(70)90020-9	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2213-5812	2213-5820		ACTA GEOD GEOPHYS	Acta Geod. Geophys.	SEP	2015	50	3					295	305		10.1007/s40328-014-0075-3		11	Geochemistry & Geophysics	Geochemistry & Geophysics	CQ0LH	WOS:000360286900003		
J	Shi, Y; Xu, PL				Shi, Yun; Xu, Peiliang			Comparing the estimates of the variance of unit weight in multiplicative error models	ACTA GEODAETICA ET GEOPHYSICA			English	Article						Multiplicative error models; Bias-corrected weighted LS method; Variance of unit weight	SPECKLE; LIDAR; ADJUSTMENT; NOISE	Multiplicative error models should become more and more important in geodesy, since modern measurement technology on the basis of electromagnetic wave has clearly demonstrated that measurements of this type contain two types of random errors: fixed random errors and baseline-length dependent random errors. Although a number of the estimators of the variance of unit weight are derived from the least-squares-based adjustment methods for multiplicative error models recently, we know very little about their statistical performances. We first derive the variances of the estimates of the variance of unit weight in multiplicative error models. We find that the second order term of random errors will not affect the unbiasedness of an estimate of the variance of unit weight, if such a term is generated from the nonlinearity of models and/or least-squares-based nonlinear objective functions. The result is surprising, since the second order term of random errors has been well known to create the biases in both the estimate of parameters and the measurement corrections in the literature of nonlinear adjustment and nonlinear regression. Simulations are carried out to confirm the statistical analysis and to numerically compare the performances of different estimates of the variance of unit weight in multiplicative error models. From the simulation results, we recommend the estimate of the variance of unit weight with the bias-corrected weighted LS solution, followed by the two estimates with the ordinary LS solutions and the first estimate with the weighted LS solution.	[Shi, Yun] Xian Univ Sci & Technol, Sch Geomat, Xian 710054, Peoples R China; [Xu, Peiliang] Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto 6110011, Japan	Xu, PL (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto 6110011, Japan.	shiyun0908@hotmail.com; pxu@rcep.dpri.kyoto-u.ac.jp			Chinese National Science Foundation [41204006, 41020144004];  [C25400449]	This work is partially supported by the Chinese National Science Foundation (Projects Nos. 41204006 and 41020144004) and a Grant-in-Aid for Scientific Research C25400449.	ULABY FT, 1986, IEEE T GEOSCI REMOTE, V24, P235, DOI 10.1109/TGRS.1986.289643; GOODMAN JW, 1976, J OPT SOC AM, V66, P1145, DOI 10.1364/JOSA.66.001145; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.1093/biomet/61.3.439; Xu PL, 2006, J GEODESY, V80, P69, DOI 10.1007/s00190-006-0032-1; FLAMANT PH, 1984, APPL OPTICS, V23, P1412; Gui QM, 1995, J PLA I SURVEING MAP, V3, P227; Heyde C.C., 1997, QUASI LIKELIHOOD ITS; Koch K.-R, 1999, PARAMETER ESTIMATION; Nelder J., 1989, GEN LINEAR MODELS; Searle S.R., 1971, LINEAR MODELS; Shi Y, 2014, SENSORS-BASEL, V14, P1249, DOI 10.3390/s140101249; WANG JY, 1992, APPL OPTICS, V31, P801, DOI 10.1364/AO.31.000801; Xu PL, 2009, GEOPHYS J INT, V179, P182, DOI 10.1111/j.1365-246X.2009.04280.x; Xu PL, 2013, J GEODESY, V87, P629, DOI 10.1007/s00190-013-0635-2; Xu PL, 1999, INT J REMOTE SENS, V20, P2577, DOI 10.1080/014311699211949; Xu PL, 2000, COMMUN STAT-SIMUL C, V29, P83, DOI 10.1080/03610910008813603	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2213-5812	2213-5820		ACTA GEOD GEOPHYS	Acta Geod. Geophys.	SEP	2015	50	3					353	363		10.1007/s40328-014-0096-y		11	Geochemistry & Geophysics	Geochemistry & Geophysics	CQ0LH	WOS:000360286900007		
J	Verma, A; Kumar, A				Verma, Archana; Kumar, Alok			Sudden unexpected death in epilepsy: some approaches for its prevention and medico-legal consideration	ACTA NEUROLOGICA BELGICA			English	Review						Epilepsy; Sudden unexpected death; Unexplained death; Forensic autopsy; Antiepileptic drugs (AEDs); SUDEP	UNEXPLAINED DEATH; RISK-FACTORS; NERVE-STIMULATION; MORTALITY; SURGERY; SUDEP; CARBAMAZEPINE; COHORT; DEFINITIONS; PERSPECTIVE	Worldwide, mortality associated with epilepsy is a matter of grave concern. The mortality rate in epileptic population is two to three times more than that of the general population. Sudden unexplained death in epilepsy, better known as sudden unexpected death in epilepsy (SUDEP), is a mysterious and rare condition, in which typically young or middle-aged people with epilepsy die without a clearly defined cause. At times, this may raise a strong suspicion of foul play and raise several medico-legal issues. There may be several different underlying mechanisms but most research has focused on seizure-related cerebral and respiratory depression, cardiac arrhythmia and autonomic dysfunction. In recent years, some significant risk factors have been recognized and strategies have been suggested that could be useful in prevention of SUDEP. Present communication provides some of the updates on new advances in prevention of SUDEP as well as highlights related medico-legal issues.	[Verma, Archana] Japan Epilepsy Res Fdn, Natl Epilepsy Ctr, Shizuoka Inst Epilepsy & Neurol Disorders, Aoi Ku, Shizuoka 4208688, Japan; [Kumar, Alok] Rural Inst Med Sci & Res, Forens Med & Toxicol, Saifai, Etawah, India	Verma, A (reprint author), Japan Epilepsy Res Fdn, Natl Epilepsy Ctr, Shizuoka Inst Epilepsy & Neurol Disorders, Aoi Ku, Urushiyama 886, Shizuoka 4208688, Japan.	archanashiva2010@rediffmail.com					Annegers JF, 1997, EPILEPSIA, V38, pS9, DOI 10.1111/j.1528-1157.1997.tb06137.x; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; Kloster R, 1999, J NEUROL NEUROSUR PS, V67, P439, DOI 10.1136/jnnp.67.4.439; Walczak TS, 2001, NEUROLOGY, V56, P519; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Surges R, 2010, EPILEPSIA, V51, P738, DOI 10.1111/j.1528-1167.2010.02571.x; Sperling MR, 2005, EPILEPSIA, V46, P49, DOI 10.1111/j.1528-1167.2005.00410.x; Sillanpaa M, 2010, NEW ENGL J MED, V363, P2522, DOI 10.1056/NEJMoa0911610; Ficker DM, 1998, NEUROLOGY, V51, P1270; Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1; Hesdorffer DC, 2011, EPILEPSIA, V52, P1150, DOI 10.1111/j.1528-1167.2010.02952.x; Ardesch JJ, 2007, CLIN NEUROL NEUROSUR, V109, P849, DOI 10.1016/j.clineuro.2007.07.024; Nilsson L, 2003, EPILEPSIA, V44, P575, DOI 10.1046/j.1528-1157.2003.03302.x; Persson H, 2003, EPILEPSY RES, V57, P69, DOI 10.1016/j.eplepsyres.2003.10.012; NASHEF L, 1995, EPILEPSIA, V36, P1187, DOI 10.1111/j.1528-1157.1995.tb01061.x; DASHEIFF RM, 1991, J CLIN NEUROPHYSIOL, V8, P216, DOI 10.1097/00004691-199104000-00010; Ragsdale DS, 2008, BRAIN RES REV, V58, P149, DOI 10.1016/j.brainresrev.2008.01.003; Hitiris N, 2007, EPILEPSY BEHAV, V10, P138, DOI 10.1016/j.yebeh.2006.11.010; So EL, 2009, EPILEPSIA, V50, P917, DOI 10.1111/j.1528-1167.2008.01906.x; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; Langan Y, 2005, NEUROLOGY, V64, P1131; Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; Hesdorffer DC, 2012, EPILEPSIA, V53, P249, DOI 10.1111/j.1528-1167.2011.03354.x; Faingold CL, 2011, EPILEPSY BEHAV, V22, P186, DOI 10.1016/j.yebeh.2011.06.015; Tomson T, 2005, EPILEPSIA, V46, P54, DOI 10.1111/j.1528-1167.2005.00411.x; Ryvlin P, 2013, EPILEPSIA, V54, P23, DOI 10.1111/epi.12180; Hennessy MJ, 1999, NEUROLOGY, V53, P1276; Leestma JE, 1997, EPILEPSIA, V38, pS63, DOI 10.1111/j.1528-1157.1997.tb06132.x; LUND A, 1985, ACTA NEUROL SCAND, V72, P444; Nilsson I, 1999, LANCET, V353, P888; Ryvlin P, 2009, EPILEPSIA, V50, P60; Schnabel R, 1997, SEIZURE, V6, P327, DOI 10.1016/S1059-1311(97)80083-0; Terra VC, 2012, SEIZURE-EUR J EPILEP, V21, P649, DOI 10.1016/j.seizure.2012.06.012; Timmings PL, 1998, SEIZURE-EUR J EPILEP, V7, P289, DOI 10.1016/S1059-1311(98)80020-4; Tomson T, 1998, THER DRUG MONIT, V20, P309, DOI 10.1097/00007691-199806000-00011	37	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	SEP	2015	115	3					207	212		10.1007/s13760-014-0362-3		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CP9LB	WOS:000360214500001		
J	Yokota, H; Kakutani, M; Miyamae, S; Yonezawa, T				Yokota, Hiroshi; Kakutani, Miho; Miyamae, Seisuke; Yonezawa, Taiji			Blooming artery sign in proximal posterior inferior cerebellar artery dissection	ACTA NEUROLOGICA BELGICA			English	Editorial Material						Posterior inferior cerebellar artery dissection; Blooming effect; Magnetic resonance imaging; Gradient echo image; Ischemia; Subarachnoid hemorrhage	ISCHEMIC-STROKE		[Yokota, Hiroshi; Kakutani, Miho; Miyamae, Seisuke; Yonezawa, Taiji] Osaka Police Hosp, Dept Neurosurg, Tennouji Ku, Osaka 5430035, Japan	Yokota, H (reprint author), Osaka Police Hosp, Dept Neurosurg, Tennouji Ku, Kitayama Cho 10-31, Osaka 5430035, Japan.	hyokota0001@gmail.com					Kern R, 2013, CEREBROVASC DIS, V35, P402, DOI 10.1159/000351753; Park MG, 2014, J STROKE CEREBROVASC, V23, P1865, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.023; Rovira A, 2004, RADIOLOGY, V232, P466, DOI 10.1148/radiol.2322030273; Ishihara H, 2013, J NEUROINTERV SURG, V5, P557, DOI 10.1136/neurintsurg-2012-010500; Takumi I, 2007, SURG NEUROL, V68, P103, DOI 10.1016/j.surneu.2006.08.063; Yamaura A, 1998, SURG CEREB STROKE, V26, P79	6	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	SEP	2015	115	3					371	373		10.1007/s13760-014-0401-0		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CP9LB	WOS:000360214500025		
J	Yokota, H; Ida, Y				Yokota, Hiroshi; Ida, Yuki			Ongoing intracerebral and intraventricular hemorrhages from ruptured anterior communicating artery aneurysm demonstrated by CT angiography	ACTA NEUROLOGICA BELGICA			English	Editorial Material						Anterior communicating artery aneurysm; Computed tomographic angiography; Extravasation; Intraventricular hemorrhage			[Yokota, Hiroshi; Ida, Yuki] Nabari City Hosp, Dept Neurosurg, Nabari, Mie 5180481, Japan	Yokota, H (reprint author), Nabari City Hosp, Dept Neurosurg, 1-178 Yurigaoka Nishi, Nabari, Mie 5180481, Japan.	hyokota0001@gmail.com					Tsuang FY, 2012, J NEUROSURG, V116, P1244, DOI 10.3171/2012.2.JNS111175; MOHR G, 1983, J NEUROSURG, V58, P482, DOI 10.3171/jns.1983.58.4.0482; Hashiguchi A, 2007, NEUROSURG REV, V30, P151, DOI 10.1007/s10143-007-0068-6; Im SH, 2007, CLIN NEUROL NEUROSUR, V109, P299, DOI 10.1016/j.clineuro.2006.11.008; INAGAWA T, 1990, SURG NEUROL, V33, P117, DOI 10.1016/0090-3019(90)90020-P; Scholtes F, 2011, J NEUROSURG, V115, P617, DOI 10.3171/2011.4.JNS101629	6	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	SEP	2015	115	3					375	377		10.1007/s13760-014-0386-8		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CP9LB	WOS:000360214500026		
J	Kim, DY; Cho, SH; Takabayashi, T; Schleimer, RP				Kim, Dong-Young; Cho, Seong H.; Takabayashi, Tetsuji; Schleimer, Robert P.			Chronic Rhinosinusitis and the Coagulation System	ALLERGY ASTHMA & IMMUNOLOGY RESEARCH			English	Review						Rhinosinusitis; nasal polyps; coagulation; fibrinolysis; tissue plasminogen activator; factor XIIIa	PLASMINOGEN ACTIVATION SYSTEM; FACTOR-XIII-A; ALLERGIC-ASTHMA; PLATELET ACTIVATION; NASAL POLYPS; MACROPHAGE ACTIVATION; FIBRIN DEPOSITION; THROMBIN ACTIVITY; UPPER AIRWAYS; MOUSE MODELS	Chronic rhinosinusitis (CRS) is one of the most common chronic diseases in adults and severely affects quality of life in patients. Although various etiologic and pathogenic mechanisms of CRS have been proposed, the causes of CRS remain uncertain. Abnormalities in the coagulation cascade may play an etiologic role in many diseases, such as asthma and other inflammatory conditions. While studies on the relationship between asthma and dysregulated coagulation have been reported, the role of the coagulation system in the pathogenesis of CRS has only been considered following recent reports. Excessive fibrin deposition is seen in nasal polyp (NP) tissue from patients with chronic rhinosinusitis with nasal polyp (CRSwNP) and is associated with activation of thrombin, reduction of tissue plasminogen activator (t-PA) and upregulation of coagulation factor XIII-A (FXIII-A), all events that can contribute to fibrin deposition and crosslinking. These findings were reproduced in a murine model of NP that was recently established. Elucidation of the mechanisms of fibrin deposition may enhance our understanding of tissue remodeling in the pathophysiology of NP and provide new targets for the treatment of CRSwNP.	[Kim, Dong-Young; Cho, Seong H.; Takabayashi, Tetsuji; Schleimer, Robert P.] Northwest Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL 60611 USA; [Kim, Dong-Young] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Cho, Seong H.] Kyung Hee Univ, Sch Med, Dept Med, Div Rheumatol, Seoul, South Korea; [Takabayashi, Tetsuji] Univ Fukui, Dept Sensory & Locomotor Med, Div Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan	Schleimer, RP (reprint author), Northwest Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, 240 E Huron, Chicago, IL 60611 USA.	rpschleimer@northwestern.edu	Cho, Seong/I-7102-2015		NIH [R37HL068546, U19AI106683]; NIAID [1K23AI110731-01]; Ernest S. Bazley Foundation	This work was supported by R37HL068546 and U19AI106683 from the NIH, NIAID 1K23AI110731-01, and Ernest S. Bazley Foundation.	Adany R, 2003, CELL MOL LIFE SCI, V60, P1049, DOI 10.1007/s00018-003-2178-9; Takabayashi T, 2013, AM J RESP CRIT CARE, V187, P49, DOI 10.1164/rccm.201207-1292OC; Takabayashi T, 2013, J ALLERGY CLIN IMMUN, V132, P584, DOI 10.1016/j.jaci.2013.02.003; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Xiao W, 2005, CHEST, V128, P2316, DOI 10.1378/chest.128.4.2316; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Schuliga M, 2013, CURR OPIN PHARMACOL, V13, P386, DOI 10.1016/j.coph.2013.05.014; Shimizu S, 2011, AM J RHINOL ALLERGY, V25, P7, DOI 10.2500/ajra.2011.25.3535; YAMAMOTO H, 1993, J ALLERGY CLIN IMMUN, V91, P79, DOI 10.1016/0091-6749(93)90299-U; Pawliczak R, 2005, CURR ALLERGY ASTHM R, V5, P463, DOI 10.1007/s11882-005-0027-7; Gabazza EC, 1999, LUNG, V177, P253, DOI 10.1007/PL00007645; Wagers SS, 2004, J CLIN INVEST, V114, P104, DOI 10.1172/JC1200419569; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Van Bruaene Nicholas, 2009, J Allergy Clin Immunol, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Gabazza EC, 2004, INT J HEMATOL, V79, P117, DOI 10.1532/IJH97.03165; Lee SH, 2012, AM J RESP CELL MOL, V46, P842, DOI 10.1165/rcmb.2011-0369OC; Feistritzer C, 2004, INT ARCH ALLERGY IMM, V135, P12, DOI 10.1159/000080037; Terada M, 2004, AM J RESP CRIT CARE, V169, P373, DOI 10.1164/rccm.200308-1156OC; Cho S, 2011, ANN ALLERG ASTHMA IM, V106, P371, DOI 10.1016/j.anai.2010.12.021; Schleimer Robert P, 2009, Proc Am Thorac Soc, V6, P288, DOI 10.1513/pats.200808-088RM; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Mercer PF, 2009, AM J RESP CRIT CARE, V179, P414, DOI 10.1164/rccm.200712-1827OC; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; Wygrecka M, 2008, THROMB HAEMOSTASIS, V99, P494, DOI 10.1160/TH07-11-0666; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Schenone M, 2004, CURR OPIN HEMATOL, V11, P272, DOI 10.1097/01.moh.0000130308.37353.d4; Shinagawa K, 2007, AM J RESP CRIT CARE, V175, P136, DOI 10.1164/rccm.200608-1097OC; Ciprandi G, 2012, ALLERGY ASTHMA IMMUN, V4, P171, DOI 10.4168/aair.2012.4.4.171; Schouten M, 2009, J THROMB HAEMOST, V7, P1592, DOI 10.1111/j.1538-7836.2009.03523.x; Seshadri S, 2012, ALLERGY, V67, P920, DOI 10.1111/j.1398-9995.2012.02848.x; Lambrecht BN, 2013, NEW ENGL J MED, V369, P1964, DOI 10.1056/NEJMcibr1311045; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Kanazawa H, 2007, CHEST, V132, P1169, DOI 10.1378/chest.07-0945; Oh CK, 2002, BIOCHEM BIOPH RES CO, V294, P1155, DOI 10.1016/S0006-291X(02)00577-6; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053; Levi M, 2003, CRIT CARE MED, V31, pS238, DOI 10.1097/01.CCM.0000057849.53689.65; Bachert Claus, 2002, Curr Allergy Asthma Rep, V2, P252, DOI 10.1007/s11882-002-0027-9; Bagoly Z, 2012, THROMB RES, V129, pS77, DOI 10.1016/j.thromres.2012.02.040; Cho SH, 2001, J ALLERGY CLIN IMMUN, V108, P212, DOI 10.1067/mai.2001.117260; Del Rosso M, 2008, FRONT BIOSCI-LANDMRK, V13, P4667, DOI 10.2741/3032; DERRICK EK, 1993, HISTOPATHOLOGY, V22, P157, DOI 10.1111/j.1365-2559.1993.tb00095.x; Epstein MM, 2004, INT ARCH ALLERGY IMM, V133, P84, DOI 10.1159/000076131; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; GABAZZA EC, 1994, THROMB HAEMOSTASIS, V71, P199; GRESELE P, 1993, J ALLERGY CLIN IMMUN, V91, P894, DOI 10.1016/0091-6749(93)90347-I; Hauck RW, 1999, AM J PHYSIOL-LUNG C, V277, pL22; Hayashi S, 2006, PHARMACOLOGY, V76, P46, DOI 10.1159/000089718; Hogan KA, 2002, THROMB HAEMOSTASIS, V87, P563; HUDSON M, 1992, BLOOD COAGUL FIBRIN, V3, P773, DOI 10.1097/00001721-199212000-00011; Katona E, 2001, J IMMUNOL METHODS, V258, P127, DOI 10.1016/S0022-1759(01)00479-3; Kim DW, 2011, AM J RHINOL ALLERGY, V25, pE255, DOI 10.2500/ajra.2011.25.3727; KNAUER KA, 1981, NEW ENGL J MED, V304, P1404, DOI 10.1056/NEJM198106043042307; Komerup KN, 2007, PLATELETS, V18, P319; Kowal K, 2006, CLIN EXP ALLERGY, V36, P426, DOI 10.1111/j.1365-2222.2006.02446.x; Lee SY, 2014, ALLERGY ASTHMA IMMUN, V6, P310, DOI 10.4168/aair.2014.6.4.310; Meltzer EO, 2004, OTOLARYNG HEAD NECK, V131, pS1, DOI 10.1016/j.otohns.2004.09.067; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; NEALE TJ, 1988, LANCET, V2, P421; Nesheim M, 2003, CHEST, V124, p33S, DOI 10.1378/chest.124.3_suppl.33S; Perrio MJ, 2007, CLIN EXP ALLERGY, V37, P1688, DOI 10.1111/j.1365-2222.2007.02829.x; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Shimizu S, 2008, CLIN IMMUNOL, V129, P365, DOI 10.1016/j.clim.2008.07.020; Shimizu S, 2000, AM J PHYSIOL-LUNG C, V279, pL503; Shinagawa K, 2009, AM J PHYSIOL-LUNG C, V296, pL763, DOI 10.1152/ajplung.90638.2008; Torocsik D, 2010, THROMB HAEMOSTASIS, V104, P709, DOI 10.1160/TH09-11-0805; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21	71	0	0	KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY	JONGNO-GU	RM 1705, KUMHO BLDG 327-2, CHANGSINDONG, JONGNO-GU, SEOUL 110-540, SOUTH KOREA	2092-7355	2092-7363		ALLERGY ASTHMA IMMUN	Allergy Asthma Immunol. Res.	SEP	2015	7	5					421	430		10.4168/aair.2015.7.5.421		10	Allergy; Immunology	Allergy; Immunology	CQ0AX	WOS:000360258100002		
J	Iriyama, N; Fujisawa, S; Yoshida, C; Wakita, H; Chiba, S; Okamoto, S; Kawakami, K; Takezako, N; Kumagai, T; Inokuchi, K; Ohyashiki, K; Taguchi, J; Yano, S; Igarashi, T; Kouzai, Y; Morita, S; Sakamoto, J; Sakamaki, H				Iriyama, Noriyoshi; Fujisawa, Shin; Yoshida, Chikashi; Wakita, Hisashi; Chiba, Shigeru; Okamoto, Shinichiro; Kawakami, Kimihiro; Takezako, Naoki; Kumagai, Takashi; Inokuchi, Koiti; Ohyashiki, Kazuma; Taguchi, Jun; Yano, Shingo; Igarashi, Tadahiko; Kouzai, Yasuji; Morita, Satoshi; Sakamoto, Junichi; Sakamaki, Hisashi			Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study	AMERICAN JOURNAL OF HEMATOLOGY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; LARGE GRANULAR LYMPHOCYTOSIS; KINASE INHIBITOR THERAPY; 3-YEAR FOLLOW-UP; NATURAL-KILLER; NK CELLS; IMATINIB; NILOTINIB; INCREASE; JAPAN	Dasatinib is one of the key treatment options for chronic myeloid leukemia (CML) patients. Increase in lymphocyte counts has been known to be predictive of a good treatment response under dasatinib treatment as a second line therapy. However, clinical significance of lymphocyte dynamics in the upfront setting has yet to be clarified. To investigate the significance of lymphocyte dynamics in newly diagnosed chronic phase (CP)-CML, patient data of D-First study ( NCT01464411) were analyzed. Fifty-two CML-CP patients enrolled to this study were treated with dasatinib (100 mgday(-1)) and all were followed-up for 18 months. The incidence of lymphocyosis was observed in 14 (27%), but it was not associated with deep molecular response achievement. However, natural killer (NK) cell or cytotoxic T lymphocyte (CTL) counts at 1 month were significantly higher in patients with deep molecular response (DMR) by 18 months compared to those without DMR. When the patients were divided into two groups according to those calculated thresholds by receiver operating characteristic curve (407/L for NK cells and 347/L for CTLs), the cumulative DMR rates by 18 months were significantly better in higher value group compared to lower value group. In contrast, regulatory T cell counts were significantly lower at 12 and 15 months in patients achieved DMR. These results suggest the presence of dual effects of dasatinib on immune system through the cytotoxic lymphocytes activation and Treg deregulation in different periods in newly diagnosed CML-CP. Am. J. Hematol. 90:819-824, 2015. (c) 2015 Wiley Periodicals, Inc.	[Iriyama, Noriyoshi] Nihon Univ, Sch Med, Div Hematol & Rheumatol, Dept Med, Tokyo 1738610, Japan; [Fujisawa, Shin] Yokohama City Univ, Dept Hematol, Med Ctr, Kanagawa, Japan; [Yoshida, Chikashi] Natl Hosp Org, Dept Hematol, Mito Med Ctr, Ibaraki, Japan; [Wakita, Hisashi] Narita Red Cross Hosp, Div Hematol & Oncol, Japanese Red Cross Soc, Narita, Japan; [Chiba, Shigeru] Univ Tsukuba, Fac Med, Dept Hematol, Ibaraki, Japan; [Okamoto, Shinichiro] Keio Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo, Japan; [Kawakami, Kimihiro] Kagawa Prefectural Cent Hosp, Dept Hematol & Clin Oncol, Kagawa, Japan; [Takezako, Naoki] Natl Hosp Org, Dept Hematol, Disaster Med Ctr, Tokyo, Japan; [Kumagai, Takashi] Ohme Municipal Gen Hosp, Dept Hematol, Tokyo, Japan; [Inokuchi, Koiti] Nippon Med Sch, Dept Internal Med, Div Hematol, Tokyo 113, Japan; [Ohyashiki, Kazuma] Tokyo Med Univ, Dept Hematol, Tokyo 1608402, Japan; [Taguchi, Jun] Japanese Red Cross Shizuoka Hosp, Dept Hematol, Shizuoka, Japan; [Yano, Shingo] Jikei Univ, Sch Med, Div Clin Oncol & Hematol, Dept Internal Med, Tokyo, Japan; [Igarashi, Tadahiko] Gunma Prefectural Canc Ctr, Div Hematol & Oncol, Gunma, Japan; [Kouzai, Yasuji] Tokyo Metropolitan Tama Synth Med Ctr, Dept Hematol, Tokyo, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Sakamoto, Junichi] Tokai Cent Hosp, Gifu, Japan; [Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan	Iriyama, N (reprint author), Nihon Univ, Sch Med, Div Hematol & Rheumatol, Dept Med,Itabashi ku, 30-1 Oyaguchi Kami Cho, Tokyo 1738610, Japan.	iriyama.noriyoshi@nihon-u.ac.jp			Epidemiological and Clinical Research Information Network (ECRIN)	Contract grant sponsor: Epidemiological and Clinical Research Information Network (ECRIN).	Yoshida C, 2012, INT J CLIN ONCOL, V17, P584, DOI 10.1007/s10147-011-0328-x; Rohon P, 2010, EUR J HAEMATOL, V85, P387, DOI 10.1111/j.1600-0609.2010.01501.x; Nagata Y, 2010, INT J HEMATOL, V91, P799, DOI 10.1007/s12185-010-0565-1; Powers JJ, 2011, LEUKEMIA LYMPHOMA, V52, P668, DOI 10.3109/10428194.2010.550074; Kumagai T, 2014, INT J HEMATOL, V99, P41, DOI 10.1007/s12185-013-1483-9; Yanada M, 2006, J CLIN ONCOL, V24, P460, DOI 10.1200/JCO.2005.03.2177; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Salih J, 2010, INT J CANCER, V127, P2119, DOI 10.1002/ijc.25233; Kreutzman A, 2010, BLOOD, V116, P772, DOI 10.1182/blood-2009-12-256800; Iriyama N, 2015, AM J HEMATOL, V90, P282, DOI 10.1002/ajh.23923; Kantarjian H, 2011, J CLIN ONCOL, V29, P3173, DOI 10.1200/JCO.2010.33.4169; Jabbour E, 2014, BLOOD, V123, P494, DOI 10.1182/blood-2013-06-511592; Tanaka H, 2012, INT J HEMATOL, V96, P308, DOI 10.1007/s12185-012-1132-8; Larson RA, 2012, LEUKEMIA, V26, P2197, DOI 10.1038/leu.2012.134; Kim DH, 2009, HAEMATOL-HEMATOL J, V94, P135, DOI 10.3324/haematol.13151; Tauchi T, 2011, LEUKEMIA RES, V35, P585, DOI 10.1016/j.leukres.2010.10.027; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46; Hassold N, 2012, INT J CANCER, V131, pE916, DOI 10.1002/ijc.27537; Inokuchi Koiti, 2014, J Clin Exp Hematop, V54, P197; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lee SJ, 2011, AM J HEMATOL, V86, P346, DOI 10.1002/ajh.21980; OSHIMI K, 1993, LEUKEMIA, V7, P782; Paydas S, 2014, CRIT REV ONCOL HEMAT, V89, P242, DOI 10.1016/j.critrevonc.2013.10.005; Tanaka J, 2012, BLOOD, V119, P6175, DOI 10.1182/blood-2012-03-416800; Uchiyama T, 2013, HEMATOL ONCOL, V31, P156, DOI 10.1002/hon.2034	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	SEP	2015	90	9					819	824		10.1002/ajh.24096		6	Hematology	Hematology	CP9MI	WOS:000360218000026		
J	Yamamoto, T; Shoji, S; Yamakawa, T; Wada, A; Suzuki, K; Iseki, K; Tsubakihara, Y				Yamamoto, Tadashi; Shoji, Shigeichi; Yamakawa, Tomoyuki; Wada, Atsushi; Suzuki, Kazuyuki; Iseki, Kunitoshi; Tsubakihara, Yoshiharu			Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients	AMERICAN JOURNAL OF KIDNEY DISEASES			English	Article						Predialysis pH; postdialysis pH; serum bicarbonate; metabolic acidosis; acid-base status; all-cause mortality; cardiovascular mortality; hemodialysis; dialysate bicarbonate; end-stage renal disease (ESRD); renal replacement therapy; Japanese Renal Data Registry (JRDR)	CHRONIC KIDNEY-DISEASE; ACID-BASE-BALANCE; METABOLIC-ACIDOSIS; DIALYSIS OUTCOMES; SERUM BICARBONATE; PRACTICE PATTERNS; ASSOCIATION; CALCIFICATION; NUTRITION; NORMALIZATION	Background: To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design: An observational study including cross-sectional and 1-year analyses. Setting & Participants: Data from the renal registry of the Japanese Society of Dialysis Therapy (20082009), including 15,132 dialysis patients 16 years or older. Predictor: Predialysis pH <7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or >= 7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level <18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or >= 26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH < 7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or >= 7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or >= 28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). Outcomes: All-cause and cardiovascular (CV) mortality during the 1-year follow-up. Measurements: HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate. Results: Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH >= 7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH < 7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH >= 7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause andCVmortality was observed. Limitations: Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths. Conclusions: Predialysis pH >= 7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre-and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients. (C) 2015 by the National Kidney Foundation, Inc.	[Yamamoto, Tadashi; Shoji, Shigeichi; Yamakawa, Tomoyuki] Shirasagi Hosp, Kidney Ctr, Osaka 5460002, Japan; [Wada, Atsushi; Suzuki, Kazuyuki; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan	Yamamoto, T (reprint author), Shirasagi Hosp, Kidney Ctr, 7-11-23 Kumata, Osaka 5460002, Japan.	yamamoto@shirasagi-hp.or.jp					AHMAD S, 1980, T AM SOC ART INT ORG, V26, P318; Bray SH, 1996, AM J KIDNEY DIS, V28, P700, DOI 10.1016/S0272-6386(96)90251-6; Wu DY, 2006, CLIN J AM SOC NEPHRO, V1, P70, DOI 10.2215/CJN.00010505; de Solis AJ, 2009, J NEPHROL, V22, P647; ENGLAND BK, 1991, AM J PHYSIOL, V260, pC277; Kirschbaum B, 2000, AM J KIDNEY DIS, V35, P1068, DOI 10.1016/S0272-6386(00)70041-2; SYMRENG T, 1992, KIDNEY INT, V41, P1064, DOI 10.1038/ki.1992.162; Bommer J, 2004, AM J KIDNEY DIS, V44, P661, DOI 10.1053/j.ajkd.2004.06.008; Vashistha T, 2013, CLIN J AM SOC NEPHRO, V8, P254, DOI 10.2215/CJN.05780612; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Lomashvili K, 2006, KIDNEY INT, V69, P1464, DOI 10.1038/sj.ki.5000297; Bailey JL, 2006, J AM SOC NEPHROL, V17, P1388, DOI 10.1681/ASN.2004100842; Hood VL, 1998, NEW ENGL J MED, V339, P819; Tentori F, 2013, AM J KIDNEY DIS, V62, P738, DOI 10.1053/j.ajkd.2013.03.035; Uribarri J, 1999, AM J KIDNEY DIS, V34, P493, DOI 10.1016/S0272-6386(99)70077-6; Ohtake T, 2010, HEMODIAL INT, V14, P218, DOI 10.1111/j.1542-4758.2009.00423.x; Graham KA, 1997, J AM SOC NEPHROL, V8, P632; Chiu YW, 2010, SEMIN DIALYSIS, V23, P411, DOI 10.1111/j.1525-139X.2010.00749.x; Iseki K, 2011, NEPHROL DIAL TRANSPL, V26, P963, DOI 10.1093/ndt/gfq507; Kirschbaum B, 2003, CLIN CHIM ACTA, V336, P109, DOI 10.1016/S0009-8981(03)00333-4; Lofberg E, 1997, CLIN NEPHROL, V48, P230; Matsuoka Mitsuteru, 2004, Clin Exp Nephrol, V8, P54, DOI 10.1007/s10157-003-0260-0; Mehrotra R, 2009, AM J CLIN NUTR, V90, P1532, DOI 10.3945/ajcn.2009.28285; National Kidney Foundation, 2001, AM J KIDNEY DIS S, V35, pS1; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Noh U-Seok, 2007, Electrolyte Blood Press, V5, P95, DOI 10.5049/EBP.2007.5.2.95; OETTINGER CW, 1993, J AM SOC NEPHROL, V3, P1804; Soudan Khaldoun, 2006, Hemodial Int, V10, P209, DOI 10.1111/j.1542-4758.2006.00096.x; Stein A, 1997, KIDNEY INT, V52, P1089, DOI 10.1038/ki.1997.433; Voss D, 2007, AUST FAM PHYSICIAN, V36, P253; Yildiz A, 2004, NEPHROL DIAL TRANSPL, V19, P885, DOI 10.1093/ndt/gfh001	31	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0272-6386	1523-6838		AM J KIDNEY DIS	Am. J. Kidney Dis.	SEP	2015	66	3					469	478		10.1053/j.ajkd.2015.04.014		10	Urology & Nephrology	Urology & Nephrology	CP8BG	WOS:000360115400020		
J	Maeda, Y; Kuroda, S; Ganzorig, K; Wazen, R; Nanci, A; Tanaka, E				Maeda, Yuichi; Kuroda, Shingo; Ganzorig, Khaliunaa; Wazen, Rima; Nanci, Antonio; Tanaka, Eiji			Histomorphometric analysis of overloading on palatal tooth movement into the maxillary sinus	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							ANTERIOR OPEN-BITE; TITANIUM SCREW ANCHORAGE; HEAVY ORTHODONTIC FORCES; MICROCOMPUTED-TOMOGRAPHY; PHYSICAL-PROPERTIES; SKELETAL ANCHORAGE; ROOT CEMENTUM; BONE; MODEL; ADULT	Introduction: Our objective was to evaluate the effect of overloading on the palatal movement of the maxillary molar. Methods: The maxillary first molars of male C57BI/6 mice were moved palatally with loads of 10 or 30 g for 14 days, and the amount of tooth movement was longitudinally measured on microcomputed tomography images. Bone remodeling around the molar root with the 30-g load was evaluated at days 3, 5, 7, and 14 after the start of tooth movement using histomorphometry and immunodetection of bone-restricted interferon inducible transmembrane-like protein, a novel marker of active bone formation. Results: In the 10-g load group, the amount of tooth movement increased dramatically between days 5 and 7 and increased gradually thereafter. Tooth movement at days 5 and 7 was significantly lower in the 30-g-load group than in the 10-g load group; however, the total tooth movement at 14 days was similar in the 2 groups. An orthodontic load of 30 g stimulated bone formation on the sinus wall, but bone resorption on the periodontal ligament side was delayed because of hyalinization, which means that strong force application did not accelerate tooth movement. Moreover, some root resorption was induced by the excessive force. Conclusions: Root penetration into the sinus and bone height reduction do not occur because new bone formation on the maxillary sinus is induced before bone resorption on the periodontal side, even though an excessive orthodontic force is applied. However, an excessive force can induce root resorption.	[Maeda, Yuichi; Ganzorig, Khaliunaa] Univ Tokushima, Grad Sch Oral Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima 7708504, Japan; [Kuroda, Shingo; Tanaka, Eiji] Univ Tokushima, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Grad Sch, Tokushima 7708504, Japan; [Wazen, Rima; Nanci, Antonio] Univ Montreal, Fac Dent, Lab Study Calcified Tissues & Biomat, Montreal, PQ, Canada; [Tanaka, Eiji] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Kuroda, S (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	kuroda@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25463185]	Supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (number 25463185).	Ren YJ, 2004, AM J ORTHOD DENTOFAC, V125, P71, DOI 10.1016/j.ajodo.2003.02.005; Harris DA, 2006, AM J ORTHOD DENTOFAC, V130, P639, DOI 10.1016/j.ajodo.2005.01.029; KING GJ, 1991, AM J ORTHOD DENTOFAC, V99, P456, DOI 10.1016/S0889-5406(05)81579-3; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, P550, DOI 10.1016/j.ajodo.2006.12.001; Taddei SRD, 2012, J BIOMECH, V45, P2729, DOI 10.1016/j.jbiomech.2012.09.006; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI [10.1359/jbmr.080412, 10.1359/JBMR.080412]; Umemori M, 1999, AM J ORTHOD DENTOFAC, V115, P166, DOI 10.1016/S0889-5406(99)70345-8; Yamada K, 2009, ANGLE ORTHOD, V79, P78, DOI 10.2319/020408-68.1; WEHRBEIN H, 1995, AM J ORTHOD DENTOFAC, V107, P360, DOI 10.1016/S0889-5406(95)70088-9; Kuroda S, 2004, ANGLE ORTHOD, V74, P558; Weltman B, 2010, AM J ORTHOD DENTOFAC, V137, P462, DOI 10.1016/j.ajodo.2009.06.021; Krishnan V, 2009, J DENT RES, V88, P597, DOI 10.1177/0022034509338914; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V132, P599, DOI 10.1016/j.ajodo.2005.11.046; Barbagallo LJ, 2008, AM J ORTHOD DENTOFAC, V133, P218, DOI 10.1016/j.ajodo.2006.01.043; Brudvik P, 1993, Eur J Orthod, V15, P249; Chan E K M, 2004, Orthod Craniofac Res, V7, P64, DOI 10.1111/j.1601-6343.2004.00280.x; CHURCHES AE, 1982, CLIN ORTHOP RELAT R, P265; Graber TM, 2005, ORTHODONTICS CURRENT; Kuroda S, 2011, EUR CELLS MATER, V22, P56; Kuroda S, 2013, CLIN ORAL INVEST, V17, P131, DOI 10.1007/s00784-012-0686-4; Lazarus S, 2014, OSTEOPOROSIS INT, V25, P399, DOI 10.1007/s00198-013-2465-8; Lindskog-Stokland B, 1993, Eur J Orthod, V15, P89; Oh H, 2014, AM J ORTHOD DENTOFAC, V146, P493, DOI 10.1016/j.ajodo.2014.03.025; Patoine A, 2014, J BONE MINER RES, V29, P2004, DOI 10.1002/jbmr.2243; Pavlin D, 2000, CLIN ORTHOD RES, V3, P55, DOI 10.1034/j.1600-0544.2000.030202.x; Re S, 2001, CLIN ORTHOD RES, V4, P177, DOI 10.1034/j.1600-0544.2001.040308.x; RYGH P, 1973, ACTA ODONTOL SCAND, V31, P109, DOI 10.3109/00016357309004617; Sakai D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024847; Sakai Y, 2009, J DENT RES, V88, P345, DOI 10.1177/0022034509334649; Von Bohl M, 2004, ANGLE ORTHOD, V74, P16; WEHRBEIN H, 1990, Fortschritte der Kieferorthopaedie, V51, P345, DOI 10.1007/BF02167543	31	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	SEP	2015	148	3					423	430		10.1016/j.ajodo.2015.04.032		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ4BS	WOS:000360549800015		
J	Ishida, T; Ikemoto, S; Ono, T				Ishida, Takayoshi; Ikemoto, Shigehiro; Ono, Takashi			Nasomaxillary hypoplasia with a congenitally missing tooth treated with LeFort II osteotomy, autotransplantation, and nickel-titanium alloy wire	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							MATURE PERMANENT INCISORS; OBSTRUCTIVE SLEEP-APNEA; ROOT RESORPTION; DISTRACTION OSTEOGENESIS; PERIODONTAL-LIGAMENT; ZYGOMATIC ANCHORAGE; MAXILLARY OSTEOTOMY; FACIAL PALSY; REPLANTATION; MALOCCLUSION	Introduction: In some skeletal Class III adult patients with nasomaxillary hypoplasia, the LeFort I osteotomy provides insufficient correction. This case report describes a 20-year-old woman with a combination of nasomaxillary hypoplasia and a protrusive mandible with a congenitally missing mandibular second premolar. Methods: We performed a LeFort II osteotomy for maxillary advancement. Autotransplantation of a tooth was also performed; the donor tooth was used to replace the missing permanent tooth. To increase the chance of success, we applied light continuous force with an improved superelastic nickel-titanium alloy wire technique before extraction and after transplantation. Results: The patient's profile and malocclusion were corrected, and the autotransplanted tooth functioned well. The postero-occlusal relationships were improved, and ideal overbite and overjet relationships were achieved. Conclusions: The methods used in this case represent a remarkable treatment.	[Ishida, Takayoshi; Ono, Takashi] Tokyo Med Dent Univ, Grad Sch, Dept Orofacial Dev & Funct, Div Oral Hlth Sci, Tokyo 1138549, Japan	Ishida, T (reprint author), Tokyo Med Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	takaorts@tmd.ac.jp					ANDREASEN JO, 1980, SWED DENT J, V4, P231; ANDREASEN JO, 1980, SWED DENT J, V4, P135; ANDREASEN JO, 1981, INT J ORAL MAXILLOF, V10, P54, DOI 10.1016/S0300-9785(81)80008-7; Andreasen J O, 1981, J Endod, V7, P294, DOI 10.1016/S0099-2399(81)80095-7; ANDREASEN JO, 1981, ACTA ODONTOL SCAND, V39, P1; ANDREASEN JO, 1981, ACTA ODONTOL SCAND, V39, P15; Horiuchi Y, 2008, AM J ORTHOD DENTOFAC, V133, pS121, DOI 10.1016/j.ajodo.2006.12.012; KUFNER J, 1971, J ORAL SURG, V29, P549; GUYER EC, 1986, ANGLE ORTHOD, V56, P7; Lye KW, 2008, J ORAL MAXIL SURG, V66, P968, DOI 10.1016/j.joms.2007.11.031; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; BELL WH, 1975, J ORAL SURG, V33, P412; Suzaki Y, 2008, ANGLE ORTHOD, V78, P495, DOI 10.2319/020207-51.1; Kim SG, 2007, J ORAL MAXIL SURG, V65, P2438, DOI 10.1016/j.joms.2007.05.030; Axhausen G., 1934, DTSCH ZAHN MUND KIEF, V1, P334; Bagheri SC, 2005, J ORAL MAXIL SURG, V63, P1123, DOI 10.1016/j.joms.2005.04.003; Battagel J M, 1993, Eur J Orthod, V15, P347; CHAN GK, 1974, AM J ORTHOD DENTOFAC, V65, P152, DOI 10.1016/0002-9416(74)90176-6; CONVERSE JM, 1970, PLAST RECONSTR SURG, V45, P527, DOI 10.1097/00006534-197006000-00001; DEVRIES K, 1993, J CRANIO MAXILL SURG, V21, P50, DOI 10.1016/S1010-5182(05)80147-7; ELLIS E, 1984, J ORAL MAXIL SURG, V42, P295, DOI 10.1016/0278-2391(84)90109-5; EPKER BN, 1975, J ORAL SURG, V33, P491; Lew K K, 1993, Br J Orthod, V20, P19; Fujita K, 2008, ORTHOD WAVES, V67, P128, DOI 10.1016/j.odw.2008.02.003; Fusetti M, 2012, ACTA OTORHINOLARYNGO, V32, P320; Hara S, 2013, J ORAL MAXIL SURG, V71, pE93, DOI 10.1016/j.joms.2012.10.007; Ishida T, 2013, AM J ORTHOD DENTOFAC, V144, P583, DOI 10.1016/j.ajodo.2012.10.028; Ishida T, 2014, ANGLE ORTHOD, V84, P919, DOI 10.2319/010414-13.1; Ishikawa F, 1957, J JPN ORTHOD SOC, V16, P4; JACKSON IT, 1983, J ORAL MAXIL SURG, V41, P103, DOI 10.1016/0278-2391(83)90216-1; HENDERSO.D, 1973, BRIT J ORAL SURG, V11, P77, DOI 10.1016/0007-117X(73)90022-X; Kanno T, 2008, J ORAL MAXIL SURG, V66, P1833, DOI 10.1016/j.joms.2007.10.013; Kanno Z, 2007, ANGLE ORTHOD, V77, P549, DOI 10.2319/061206-236; KELLER EE, 1987, J ORAL MAXIL SURG, V45, P223; Kohno T, 2002, J Orthod, V29, P129, DOI 10.1093/ortho/29.2.129; Li K., 2000, SLEEP BREATH, V4, P137, DOI 10.1055/s-2000-11564; Lim HH, 1998, KOREAN J ORTHOD, V28, P189; LOSKEN HW, 1988, S AFR J SURG, V26, P88; Miura F, 1960, J JPN ORTHOD SOC, V19, P40; Otsubo K., 1993, J JPN DENT MAT, V12, P521; Otsubo K, 1994, J JPN ORTHOD SOC, V53, P641; Park JW, 2011, ORAL SURG ORAL MED O, V111, P24, DOI 10.1016/j.tripleo.2010.03.045; Sakamoto T, 1959, J JAPANESE ORTHODONT, V18, P1; Sakashita H, 1996, INT J ORAL MAX SURG, V25, P182, DOI 10.1016/S0901-5027(96)80025-7; STEINHAUSER EW, 1980, J MAXILLOFAC SURG, V8, P258, DOI 10.1016/S0301-0503(80)80112-3; Tonogi M, 2007, JPN J JAW DEFORM, V17, P9; Wassmund M., 1935, LEHRBUCH PRAKTISCHEN, V1; Watanabe K, 2012, AM J ORTHOD DENTOFAC, V142, P698, DOI 10.1016/j.ajodo.2012.07.007	48	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	SEP	2015	148	3					479	492		10.1016/j.ajodo.2014.10.036		14	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CQ4BS	WOS:000360549800021		
J	Nogi, Y; Watanabe, M; Suzuki, K; Ohkuma, Y				Nogi, Yasuyuki; Watanabe, Masayuki; Suzuki, Kiyomitsu; Ohkuma, Yasunori			Method of measuring dielectric constant using an oscilloscope	AMERICAN JOURNAL OF PHYSICS			English	Article							PARALLEL-PLATE CAPACITOR	A simple relationship determining the dielectric constant of a material inserted in a parallel-plate capacitor is formulated from Gauss's law for a uniform electric field and the continuity condition of electric flux at the boundary of the material. The relationship suggests that the dielectric constant can be determined from the dependence of the charge stored on the capacitor on the thicknesses of the material and the air layer between the plates. A uniform field is created by applying an ac voltage to the plates, which includes a guard ring. The stored charge is estimated by using an oscilloscope to measure the voltage across a resistor inserted between the power supply and the capacitor. The results of the measurement are given for planar materials such as soda-lime glass, Bakelite, acrylic glass, and Teflon with a thickness of 0.5-1 cm. (C) 2015 American Association of Physics Teachers.	[Nogi, Yasuyuki; Watanabe, Masayuki; Suzuki, Kiyomitsu] Nihon Univ, Coll Sci & Technol, Tokyo 1018308, Japan; [Ohkuma, Yasunori] Nihon Univ, Coll Ind Technol, Chiba 2758576, Japan	Nogi, Y (reprint author), Nihon Univ, Coll Sci & Technol, Tokyo 1018308, Japan.	ya.nogi@nifty.com					Parker GW, 2002, AM J PHYS, V70, P502, DOI 10.1119/1.1463738; Grove TT, 2005, AM J PHYS, V73, P52, DOI 10.1119/1.1794757; CARLSON GT, 1994, AM J PHYS, V62, P1099, DOI 10.1119/1.17668; Clipper Controls, DIEL CONST VAR MAT; DISTASIO M, 1979, AM J PHYS, V47, P440, DOI 10.1119/1.11802; Feynman R, 1964, FEYNMAN LECT PHYS, V2; GINGLE A, 1975, AM J PHYS, V43, P161, DOI 10.1119/1.9883; Gray D. E., 1963, AM I PHYS HDB, V2nd; KAKIMOTO A, 1977, REV SCI INSTRUM, V48, P1570, DOI 10.1063/1.1134946; Landau L D, 1984, ELECTRODYNAMICS CONT; Maxwell J. C., 1873, TREATISE ELECT MAGNE, V1; METZ RN, 1973, AM J PHYS, V41, P1170, DOI 10.1119/1.1987509; Nogi Y, 2013, AM J PHYS, V81, P359, DOI 10.1119/1.4793439; Straulino S, 2009, Physics Education, V44, DOI 10.1088/0031-9120/44/3/011; West R. C., 2005, CRC HDB CHEM PHYS, V86th	15	0	0	AMER ASSOC PHYSICS TEACHERS AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0002-9505	1943-2909		AM J PHYS	Am. J. Phys.	SEP	2015	83	9					782	786		10.1119/1.4922233		5	Education, Scientific Disciplines; Physics, Multidisciplinary	Education & Educational Research; Physics	CQ1VS	WOS:000360388900008		
J	Igoh, A; Doi, Y; Sakurada, K				Igoh, Akihisa; Doi, Yusuke; Sakurada, Koichi			Identification and evaluation of potential forensic marker proteins in vaginal fluid by liquid chromatography/mass spectrometry	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Vaginal fluid identification; Liquid chromatography/electrospray ionization time-of-flight mass spectrometry; Peptide mass fingerprinting; Forensic science; Protein markers	ACID-BINDING-PROTEIN; COMPREHENSIVE PROTEOMIC ANALYSIS; SQUAMOUS-CELL CARCINOMA; E-FABP; EXPRESSION; SPRR3; BIOMARKERS; SCIENCE; CLONING; FAMILY	Vaginal fluid is one of the most common body fluids found at crime scenes. Discriminating vaginal fluid from other body fluids is important in forensic science; however, few potential protein markers have been reported to date. Proteomic methods for identifying protein markers have gained attention, although few reports have applied this technology to forensic protein markers. Therefore, to identify characteristic vaginal proteins, we examined various body fluids (nasal secretions, saliva, urine, semen, vaginal fluids, and sweat) using liquid chromatography/electrospray ionization time-of-flight mass spectrometry and peptide mass fingerprinting. We identified three components (average molecular mass values 17,237 +/- 2, 18,063 +/- 2, and 15,075 +/- 1) detectable only in vaginal samples: two human small proline-rich protein 3 (SPRR3) isoforms and a human fatty acid-binding protein 5 (FABP5) with an acetylated (+42) N-terminal region lacking the initiator methionine residue (-131). Using ELISA, these yielded markedly high average values in vaginal fluids. The mass spectra of these proteins were not detected in infant saliva but were detected in the vaginal fluid throughout the menstrual cycle. The results of forensic analysis (detection limit, mixed body fluid samples, casework samples, and blind samples) suggest that these proteins are potential forensic markers. In conclusion, high SPRR3 and FABP5 expression levels, which may be used as potential markers for vaginal fluid identification in forensic science, were detected in vaginal fluids from healthy adults.	[Igoh, Akihisa; Doi, Yusuke] Forens Sci Lab Okayama Prefectural Police HQ, Kita Ku, Okayama 7000816, Japan; [Doi, Yusuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Legal Med, Kita Ku, Okayama 7008558, Japan; [Sakurada, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Dent, Bunkyo Ku, Tokyo 1138510, Japan	Igoh, A (reprint author), Forens Sci Lab Okayama Prefectural Police HQ, Kita Ku, 1-3-2 Tondacho, Okayama 7000816, Japan.	op-qphif108@pref.okayama.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25933002]	We wish to thank the volunteers who kindly donated samples for this study. We also wish to thank Dr. Osamu Noguchi and Mr. Atsushi Yokoyama, Forensic Science Laboratory of Okayama Prefectural Police H.Q., for technical advice. This study was partially supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25933002.	Abraham JM, 1996, CELL GROWTH DIFFER, V7, P855; Akutsu T, 2010, INT J LEGAL MED, V124, P493, DOI 10.1007/s00414-009-0391-2; Akutsu T, 2010, J FORENSIC SCI, V55, P742, DOI 10.1111/j.1556-4029.2010.01325.x; Van Steendam K, 2013, INT J LEGAL MED, V127, P287, DOI 10.1007/s00414-012-0747-x; Zhang Y, 2008, INT J CANCER, V122, P260, DOI 10.1002/ijc.23104; MADSEN P, 1992, J INVEST DERMATOL, V99, P299, DOI 10.1111/1523-1747.ep12616641; Sakurada K, 2010, FORENSIC SCI INT, V194, P80, DOI 10.1016/j.forsciint.2009.10.015; Brettell TA, 2011, ANAL CHEM, V83, P4539, DOI 10.1021/ac201075e; Yan WH, 2009, PROTEOM CLIN APPL, V3, P116, DOI 10.1002/prca.200800140; Liu RZ, 2011, AM J PATHOL, V178, P997, DOI 10.1016/j.ajpath.2010.11.075; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; SIEGENTHALER G, 1993, BIOCHEM BIOPH RES CO, V190, P482, DOI 10.1006/bbrc.1993.1073; Dasari S, 2007, J PROTEOME RES, V6, P1258, DOI 10.1021/pr0605419; Chen BS, 2000, CARCINOGENESIS, V21, P2147, DOI 10.1093/carcin/21.12.2147; Cho DH, 2010, MOL MED, V16, P271, DOI 10.2119/molmed.2009.00187; de Simao AT, 2011, EXP MOL PATHOL, V91, P584, DOI [10.1016/j.yexmp.2011.06.006, DOI 10.1016/J.YEXMP.2011.06.006]; Doi M, 2014, FORENSIC SCI INT-GEN, V12, P93, DOI 10.1016/j.fsigen.2014.05.005; Donfack J, 2015, FORENSIC SCI INT-GEN, V16, P112, DOI 10.1016/j.fsigen.2014.12.008; Gravett MG, 2007, J PROTEOME RES, V6, P89, DOI 10.1021/pr060149v; ITOH Y, 1990, FORENSIC SCI INT, V47, P79, DOI 10.1016/0379-0738(90)90287-9; Kim JC, 2012, BREAST CANCER RES TR, V133, P909, DOI 10.1007/s10549-011-1868-5; Liu QY, 2014, ONCOL LETT, V7, P427, DOI 10.3892/ol.2013.1736; Manconi B, 2010, BIOCHEM BIOPH RES CO, V398, P477, DOI 10.1016/j.bbrc.2010.06.103; Nakazono T, 2002, J FORENSIC SCI, V47, P568; Pereira L, 2007, J PROTEOME RES, V6, P1269, DOI 10.1021/pr0605421; Schwebke JR, 1999, J INFECT DIS, V180, P1632, DOI 10.1086/315065; STOWELL LI, 1991, FORENSIC SCI INT, V50, P125, DOI 10.1016/0379-0738(91)90141-5; Uma RS, 2007, ORAL ONCOL, V43, P27, DOI 10.1016/j.oraloncology.2005.12.024; Virkler K, 2010, ANAL BIOANAL CHEM, V396, P525, DOI 10.1007/s00216-009-3207-9; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17	30	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	SEP	2015	407	23					7135	7144		10.1007/s00216-015-8877-x		10	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CQ2EL	WOS:000360412100022		
J	Miyamoto, Y; Suzuki, D; Esaka, F; Magara, M				Miyamoto, Yutaka; Suzuki, Daisuke; Esaka, Fumitaka; Magara, Masaaki			Accurate purification age determination of individual uranium-plutonium mixed particles	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Age determination; Isotope ratio; Ion-chromatography; Safeguards; ICP-MS; Uraniumand plutoniummixed oxide (MOX)	IONIZATION MASS-SPECTROMETRY; ISOTOPE RATIO ANALYSIS; ENVIRONMENTAL-SAMPLES; NUCLEAR FORENSICS; SAFEGUARDS	Age of individual uranium-plutonium (U/Pu) mixed particles with various U/Pu atomic ratios (1-70) were determined by inductively coupled plasma mass spectrometry. Micron-sized particles were prepared from U and Pu certified reference materials. The Pu reference was stored for 4-6 years since the last purification (July 14, 2008). The Pu purification age was obtained from the Am-241/Pu-241 ratio which was calculated from the product of three measured ratios of Pu and Am isotopes in the eluted fractions. These ratios were measured by a high-resolution inductively coupled plasma mass spectrometer equipped with a desolvation system. Femto-gram to pico-gram quantities of Am, U, and Pu in a sample solution were sequentially separated on a small anion-exchange column. The Am-241/Pu-241 ratio was accurately determined by spiking pure Am-243 into the sample solution. The average determined age for the particles for the five independent U/Pu ratios was in good agreement with the expected age with high accuracy (difference age 0.27 years) and high precision (standard deviation 0.44 years). The described analytical technique can serve as an effective tool for nuclear safeguards and environmental radiochemistry.	[Miyamoto, Yutaka; Suzuki, Daisuke; Esaka, Fumitaka; Magara, Masaaki] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Miyamoto, Y (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan.	miyamoto.yutaka@jaea.go.jp			Nuclear Regulation Authority, Japan	This work was financially supported by the Nuclear Regulation Authority, Japan. The authors would like to thank Mr. N. Kohno for the particle production, Mr. T. Onodera and Ms. R. Usui for the chemical treatments, and Mr. Y. Takahashi for the ICP-MS measurements.	Esaka F, 2010, TALANTA, V83, P569, DOI 10.1016/j.talanta.2010.10.009; Alvarado JAC, 2011, RADIOCHIM ACTA, V99, P121, DOI 10.1524/ract.2011.1803; Wallenius M, 2001, RADIOCHIM ACTA, V89, P55, DOI 10.1524/ract.2001.89.1.055; Wallenius M, 2000, FRESEN J ANAL CHEM, V366, P234, DOI 10.1007/s002160050046; Mayer K, 2013, CHEM REV, V113, P884, DOI 10.1021/cr300273f; Chen Y, 2009, J RADIOANAL NUCL CH, V281, P675, DOI 10.1007/s10967-009-0056-0; Donohue DL, 1998, J ALLOY COMPD, V271, P11, DOI 10.1016/S0925-8388(98)00015-2; Esaka F., 2011, MASS SPECTROM LETT, V2, P80; Esaka F, 2015, J RADIOANAL NUCL CH, V306, P393, DOI 10.1007/s10967-015-4113-6; Martin MJ, 2005, NUCL DATA SHEETS, V106, P89, DOI 10.1016/j.nds.2005.10.004; Miyamoto Y, 2013, RADIOCHIM ACTA, V101, P745, DOI 10.1524/ract.2013.2079; Nygren U, 2007, J RADIOANAL NUCL CH, V272, P45, DOI 10.1007/s10967-006-6780-9; Shinonaga T, 2009, SPECTROCHIM ACTA B, V64, P95, DOI 10.1016/j.sab.2008.10.044; Spencer KJ, 2009, J RADIOANAL NUCL CH, V282, P549, DOI 10.1007/s10967-009-0287-0; Sturm M, 2014, J RADIOANAL NUCL CH, V302, P399, DOI 10.1007/s10967-014-3294-8; Suzuki D, 2015, APPL RADIAT ISOTOPES, V96, P52, DOI 10.1016/j.apradiso.2014.11.012; Usuda S, 2010, J NUCL RADIOCHEM SCI, V11, pA5; Usuda S, 2006, INT J ENVIRON AN CH, V86, P663, DOI 10.1080/03067310600583733; Wallenius M, 2011, J RADIOANAL NUCL CHE, V99, P121; Wellum R, 2009, J ANAL ATOM SPECTROM, V24, P801, DOI 10.1039/b819584f; Yoshimochi H, 2004, J NUCL SCI TECHNOL, V41, P850, DOI 10.3327/jnst.41.850; Zhang HT, 2008, RADIOCHIM ACTA, V96, P327, DOI 10.1524/ract.2008.1499	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	SEP	2015	407	23					7165	7173		10.1007/s00216-015-8880-2		9	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CQ2EL	WOS:000360412100025		
J	Ichijo, H; Toyama, T				Ichijo, Hiroyuki; Toyama, Tomoko			Axons from the medial habenular nucleus are topographically sorted in the fasciculus retroflexus	ANATOMICAL SCIENCE INTERNATIONAL			English	Article						Fasciculus retroflexus; Interpeduncular; nucleus; Medial habenular nucleus; Topographic map; Transgenic mice	SUBSTANCE-P; RAT; PATHWAY; CONNECTIONS; PATTERNS; GROWTH; GENE; FEAR	We generated transgenic mice lines with a construct consisting of the zif268/egr1 promoter and the gene for the normal long-life yellow fluorescent protein (Venus) with a membrane localization sequence. One of the lines exhibited topographic labeling in the medial habenular nucleus (MHb) during postnatal development, which confirmed the previous findings that the medial, lateral, and dorsal areas of MHb project to the ventral, dorsal, and lateral parts of the interpeduncular nucleus, respectively. In addition, the membranous localization of the labeling allowed us to observe spacial arrangement of the labeled axons in the fasciculus retroflexus (FR) in the transgenic mice. Here, we report topographic sorting of the MHb axons in the FR. At postnatal day (P) 5 and P10, the labeled axons from the medial MHb were fasciculated and ran through the narrow path in the core of the FR. At P24, the labeled axons from the medial and dorsal MHb were fasciculated and ran through the broad path in the FR core. No labeling occurred in the lateral MHb throughout development; correspondingly, parts of the FR core remained unlabeled. The results indicated that the axons from the medial and dorsal areas of the MHb are grouped together in the FR of this transgenic line and are sorted out from the axons from the lateral MHb.	[Ichijo, Hiroyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Anat, Toyama 9300194, Japan; [Ichijo, Hiroyuki; Toyama, Tomoko] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Div Biomed Sci, Tsukuba, Ibaraki 3058575, Japan	Ichijo, H (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Anat, Sugitani 2630, Toyama 9300194, Japan.	ichijo@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [13210021, 21220009]; University of Tsukuba in Tsukuba, Japan	We thank Dr. M. Hamada and Prof. S. Takahashi for generating the transgenic mice. This work was supported by Grants-in-Aid for the 21st Century COE Program and for Scientific Research on Priority Areas (C)-Advanced Brain Science Project (13210021) and for Scientific Research (S) (21220009) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and for the Research Projects from the University of Tsukuba in Tsukuba, Japan.	CONTESTABILE A, 1987, NEUROSCIENCE, V21, P253, DOI 10.1016/0306-4522(87)90337-X; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; Stein I, 1998, MOL CELL BIOL, V18, P3112; Okamoto H, 2012, DEV NEUROBIOL, V72, P386, DOI 10.1002/dneu.20913; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Yamaguchi T, 2013, NEURON, V78, P537, DOI 10.1016/j.neuron.2013.02.035; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; Kim U, 2005, J COMP NEUROL, V483, P236, DOI 10.1002/cne.20410; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Geisler S, 2003, J COMP NEUROL, V458, P78, DOI 10.1002/cne.10566; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Quina LA, 2009, J NEUROSCI, V29, P14309, DOI 10.1523/JNEUROSCI.2430-09.2009; CUELLO AC, 1978, BRAIN RES, V149, P413; Ichijo H, 1999, DEV BRAIN RES, V117, P199, DOI 10.1016/S0165-3806(99)00126-1; IWAHORI N, 1993, ANAT EMBRYOL, V187, P523, DOI 10.1007/BF00214430; MROZ EA, 1976, BRAIN RES, V113, P597, DOI 10.1016/0006-8993(76)90061-5; SAKAMOTO KM, 1991, ONCOGENE, V6, P867	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1447-6959	1447-073X		ANAT SCI INT	Anat. Sci. Int.	SEP	2015	90	4					229	234		10.1007/s12565-014-0252-z		6	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CQ0PL	WOS:000360298800005		
J	Hirayanagi, Y; Qu, N; Hirai, S; Naito, M; Terayama, H; Hayashi, S; Hatayama, N; Kuramasu, M; Ogawa, Y; Itoh, M				Hirayanagi, Yoshie; Qu, Ning; Hirai, Shuichi; Naito, Munekazu; Terayama, Hayato; Hayashi, Shogo; Hatayama, Naoyuki; Kuramasu, Miyuki; Ogawa, Yuki; Itoh, Masahiro			Busulfan pretreatment for transplantation of rat spermatogonia differentially affects immune and reproductive systems in male recipient mice	ANATOMICAL SCIENCE INTERNATIONAL			English	Article						Immunity; Spermatogenesis; Testis; Immune privilege; Immune-competent	GERM-CELL TRANSPLANTATION; SPERMATOGENESIS FOLLOWING TRANSPLANTATION; MOUSE TESTES; STEM-CELLS; ELONGATE SPERMATIDS; BONE-MARROW; EXPRESSION; MYLERAN; IRRADIATION	Testicular cell transplantation has generally been performed by using immune-deficient recipient mice to investigate the biology of spermatogonial stem cells (SSCs), the production of transgenic animals, and restoration of fertility. Recently, we demonstrated that rat spermatogenesis can occur in the seminiferous tubules of immune-competent recipient mice via pretreatment with busulfan (Myleran, 1, 4-butanediol methanesulfonate, 40 mg/kg) after transplantation of rat SSCs. However, considering the immunosuppressive effect of busulfan, there is a possibility that busulfan itself causes immune suppression in immune-competent recipient mice. The aim of this study was to determine the effects of busulfan on the immune system and spermatogenesis in immune-competent recipient mice. The results showed that at 60 days after busulfan treatment, just the same time as the transplantation, the recovery could be seen in the immune system including cell counts and functions of T and B lymphocytes in the spleen, but the spermatogenesis was more compromised. This study demonstrated that after busulfan pretreatment the immune system in immune-competent recipient mice had recovered by the time that rat spermatogenesis could occur in the murine testis. It became clear that xenogenic spermatogenesis can be tolerated in seminiferous tubules in the testes of immune-competent mice.	[Hirayanagi, Yoshie; Qu, Ning; Hirai, Shuichi; Hayashi, Shogo; Hatayama, Naoyuki; Kuramasu, Miyuki; Ogawa, Yuki; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Tokyo 1608402, Japan; [Naito, Munekazu] Aichi Med Univ, Dept Anat, Nagakute, Aichi 4801195, Japan; [Terayama, Hayato] Tokai Univ, Sch Med, Dept Anat, Isehara, Kanagawa 2591193, Japan	Qu, N (reprint author), Tokyo Med Univ, Dept Anat, Tokyo 1608402, Japan.	quning@tokyo-med.ac.jp	Hayashi, Shogo/K-7268-2015	Hayashi, Shogo/0000-0003-0302-7658	Ministry of Education, Science, Sports and Culture, Japan [24590243]	This study was supported by a Grant-in-Aid for General Scientific Research (24590243) from the Ministry of Education, Science, Sports and Culture, Japan. We would also like to thank Mr. Shinichi Kawata for the excellent secretarial and technical assistance.	Choi YJ, 2004, FEBS LETT, V575, P41, DOI 10.1016/j.febslet.2004.08.034; Ploemacher RE, 2004, BIOL BLOOD MARROW TR, V10, P236, DOI 10.1016/j.bbmt.2003.11.004; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Jonsson CK, 1999, ENDOCRINOLOGY, V140, P3755, DOI 10.1210/en.140.8.3755; Itoh M, 2005, J REPROD IMMUNOL, V67, P57, DOI 10.1016/j.jri.2005.06.007; DOWN JD, 1991, BLOOD, V77, P661; Sofikitis N, 2003, HUM REPROD UPDATE, V9, P291, DOI 10.1093/humupd/dmg015; BARKER CF, 1977, ADV IMMUNOL, V25, P1; de Jonge ME, 2005, CLIN PHARMACOKINET, V44, P1135, DOI 10.2165/00003088-200544110-00003; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3<270::AID-MRD9>3.0.CO;2-Z; GALTON DAG, 1958, ANN NY ACAD SCI, V68, P967, DOI 10.1111/j.1749-6632.1958.tb42652.x; Guest I, 2000, IMMUNOPHARMACOLOGY, V46, P103, DOI 10.1016/S0162-3109(99)00168-X; Guitton N, 2000, INT J ANDROL, V23, P332, DOI 10.1046/j.1365-2605.2000.00248.x; Haddad S, 1997, ULTRASOUND MED BIOL, V23, P1421, DOI 10.1016/S0301-5629(97)00185-3; Jopling C, 2001, BRIT J HAEMATOL, V113, P970, DOI 10.1046/j.1365-2141.2001.02825.x; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P1801, DOI 10.1095/biolreprod.102.012575; KENIS Y, 1956, REV FR ETUD CLIN BIO, V1, P435; KYLE RA, 1961, BLOOD, V18, P497; MADDOCKS S, 1990, J REPROD IMMUNOL, V18, P9, DOI 10.1016/0165-0378(90)90021-W; MAGUIRE SM, 1993, MOL CELL ENDOCRINOL, V94, P79, DOI 10.1016/0303-7207(93)90054-N; McKinnell C, 1997, INT J ANDROL, V20, P171; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Qu N, 2012, REPROD FERT DEVELOP, V24, P337, DOI 10.1071/RD10349; Russell LD, 1996, J ANDROL, V17, P615; VANKEULE.CJ, 1974, CELL TISSUE KINET, V7, P549; VANKEULEN CJG, 1975, CELL TISSUE KINET, V8, P543; Zhang Z, 2003, BIOL REPROD, V68, P961, DOI 10.1095/biolreprod.102.009480	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1447-6959	1447-073X		ANAT SCI INT	Anat. Sci. Int.	SEP	2015	90	4					264	274		10.1007/s12565-014-0261-y		11	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CQ0PL	WOS:000360298800010		
J	Takezawa, K; Kageyama, I				Takezawa, Kojiro; Kageyama, Ikuo			Nerve fiber analysis on the morphology of the lingual nerve	ANATOMICAL SCIENCE INTERNATIONAL			English	Article						Nerve fiber analysis; Chorda tympani; Sublingual ganglion; Submandibular ganglion; Lingual nerve		The route of fine fascicles of nerve fibers in the lingual nerve was clarified. Contemporary anatomy textbooks describe the lingual nerve as supplying sensory innervation to the mucous membrane of the presulcal part of the tongue, the floor and side wall of the mouth, and the mandibular gums. In addition to receiving the chorda tympani and a branch of the inferior alveolar nerve, the lingual nerve is connected to the submandibular ganglion by a few branches. It carries preganglionic fibers from the chorda tympani and postganglionic fibers from the submandibular ganglion to the submandibular and sublingual glands. The branch from the mylohyoid nerve is described as a sensory nerve. However, we observed that this branch was directly connected to the submandibular ganglion. Furthermore, the branch from the submandibular ganglion innervated thin membranous tissue that originated in the petrous part of the temporal bone and inserted into the lateral surface of the superior constrictor. These branches have not been described in the anatomy textbooks and literature. Therefore, we studied the morphological features of the lingual nerve and discovered the route of fine fascicles of nerve fibers in the lingual nerve. These findings will likely improve the neurological and physiological understanding of the function of the lingual nerve.	[Takezawa, Kojiro; Kageyama, Ikuo] Nippon Dent Univ, Sch Life Dent Niigata, Dept Anat, Chuo Ku, Niigata 9518580, Japan	Takezawa, K (reprint author), Nippon Dent Univ, Sch Life Dent Niigata, Dept Anat, Chuo Ku, 1-8 Hamaura Cho, Niigata 9518580, Japan.	takezawa@ngt.ndu.ac.jp					Eric ES, 1989, J ORAL MAXILLOFAC SU, V47, P931; GOMEZ H, 1961, ANAT REC, V139, P69, DOI 10.1002/ar.1091390110; Gray H., 1980, GRAYS ANATOMY; Hollinshead WH, 1967, TXB OF ANATOMY; Lockhart RD, 1959, ANATOMY HUMANBODY; Quain J, 1909, QUAINS ELEMENTS AN 2, V3; Rauber A, 1898, LEHRBUCH ANATOMIE ME; Saigusa H, 2006, SURG RADIOL ANAT, V28, P59, DOI 10.1007/s00276-005-0037-0; Sobotta J, 1962, ATLAS ANATOMIE MENSC; Takezawa K, 2012, ANAT SCI INT, V87, P136, DOI 10.1007/s12565-012-0135-0; Toldt H, 1969, ANATOMISCHER ATLAS, V3	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1447-6959	1447-073X		ANAT SCI INT	Anat. Sci. Int.	SEP	2015	90	4					298	302		10.1007/s12565-014-0267-5		5	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CQ0PL	WOS:000360298800013		
J	Ishizawa, A; Tateishi, S; Zhou, M; Suzuki, R; Abe, H				Ishizawa, Akimitsu; Tateishi, Sayaka; Zhou, Ming; Suzuki, Ryoji; Abe, Hiroshi			A study of fundamental courses in the great cardiac vein	ANATOMICAL SCIENCE INTERNATIONAL			English	Article						Human heart; Anomalous great cardiac vein; Fundamental courses	HUMAN HEART; ARTERIES; SYSTEM	We studied an extremely rare great cardiac vein anomaly in a 65-year-old woman during dissection practice at the Akita University School of Medicine (2013). The great cardiac vein has two main roots, one accompanied by a left marginal vein that pours into the coronary sinus, and the other ascending along the anterior interventricular sulcus from the apex, and running over the circumflex branch of the left coronary artery. It then runs along the atrial side of the transverse sinus of the pericardium, and drains directly into the superior vena cava. No anastomosis between these veins was evident. The great cardiac vein might originate from two venous systems, one in the posterior wall of the left ventricle, and the other running along the anterior interventricular sulcus. These venous systems flow in the venous network of the left edge of the coronary sulcus. The former venous system always selected the course, which went to the coronary sinus in the venous network. The latter system may drain into one of the following four courses: the first one contacts the former course; the second passes to the transverse sinus of the pericardium and flows to the (right) superior vena cava; the third passes between a pulmonary trunk and ascending aorta from the dorsum of the pulmonary trunk, turns around in a ventral aspect, and then flows into the left superior vena cava; and the fourth flows to the anterior cardiac vein. The first of these belongs to the normal great cardiac vein, but the others are anomalous.	[Ishizawa, Akimitsu; Tateishi, Sayaka; Zhou, Ming; Suzuki, Ryoji; Abe, Hiroshi] Akita Univ, Grad Sch Med, Dept Anat, Akita 0108543, Japan	Ishizawa, A (reprint author), Akita Univ, Grad Sch Med, Dept Anat, 1-1-1 Hondo, Akita 0108543, Japan.	ishizawa@med.akita-u.ac.jp					Aikawa E, 1984, CELL, V16, P316; Aikawa E, 1982, EXPERIENTIA, V38, P815; Ho SY, 2009, CLIN ANAT, V22, P52, DOI 10.1002/ca.20634; Bernanke David H., 2002, Anatomical Record, V269, P198, DOI 10.1002/ar.10139; Ishizawa A, 2014, ANAT SCI INT, V89, P183, DOI 10.1007/s12565-013-0221-y; Ishizawa A, 2007, ACTA ANAT NIP S, V82, P178; Ishizawa A, 2007, ANAT SCI INT, V82, P242, DOI 10.1111/j.1447-073x.2007.00165.x; Kawashima T, 2003, ANN ANAT, V185, P535, DOI 10.1016/S0940-9602(03)80122-X; Ludinghausen M, 1989, GEGENBAUR MORPH JB, V135, P475; Ludinghausen M, 1987, SURG RADIOL ANAT, V9, P159, DOI 10.1007/BF02086601; Peeters MPFMV, 1997, DEV DYNAM, V208, P338; Peeters MPFMV, 1997, CARDIOVASC RES, V36, P101	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1447-6959	1447-073X		ANAT SCI INT	Anat. Sci. Int.	SEP	2015	90	4					303	307		10.1007/s12565-014-0268-4		5	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CQ0PL	WOS:000360298800014		
J	Gautam, S; Kim, T; Shoda, T; Sen, S; Deep, D; Luthra, R; Ferreira, MT; Pinho, MG; Spiegel, DA				Gautam, Samir; Kim, Taehan; Shoda, Takuji; Sen, Sounok; Deep, Deeksha; Luthra, Ragini; Ferreira, Maria Teresa; Pinho, Mariana G.; Spiegel, David A.			An Activity-Based Probe for Studying Crosslinking in Live Bacteria	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						bacteria; biosensors; crosslinking; fluorescent probes; peptidoglycans	PENICILLIN-BINDING PROTEINS; CELL-WALL SYNTHESIS; STAPHYLOCOCCUS-AUREUS; PEPTIDOGLYCAN BIOSYNTHESIS; BACILLUS-SUBTILIS; DIVISION; REVEAL; RESISTANT; PBP2; TRANSPEPTIDASE	Penicillin-binding proteins (PBPs) catalyze the crosslinking of peptidoglycan (PG), an essential process for bacterial growth and survival, and a common antibiotic target. Yet, despite its importance, little is known about the spatiotemporal aspects of crosslinkinglargely because of a lack of experimental tools for studying the reaction in live bacteria. Here we introduce such a tool: an activity-based probe that enables visualization and relative quantitation of crosslinking in vivo. In Staphylococcus aureus, we show that fluorescent mimics of the natural substrate of PBPs (PG stem peptide) are covalently incorporated into the cell wall, installing fluorophores in place of natural crosslinks. These fluorescent stem peptide mimics (FSPMs) are selectively recognized by a single PBP in S. aureus: PBP4. Thus, we were able to use FSPM pulse-labeling to localize PBP4 activity in live cells, showing that it is recruited to the septum in a manner dependent on wall teichoic acid.	[Gautam, Samir] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Gautam, Samir; Kim, Taehan; Shoda, Takuji; Sen, Sounok; Deep, Deeksha; Luthra, Ragini; Spiegel, David A.] Yale Univ, Dept Chem, New Haven, CT 06511 USA; [Shoda, Takuji] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Sen, Sounok] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sen, Sounok] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ferreira, Maria Teresa; Pinho, Mariana G.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal	Spiegel, DA (reprint author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06511 USA.	david.spiegel@yale.edu			Camille and Henry Dreyfus Foundation; Novartis; Alfred P. Sloan Foundation [BR2011-117]; NIH [1DP2OD002913-01]; NIH MSTP [T32GM07205]	This work was supported by a Camille and Henry Dreyfus Foundation New Faculty Award (to D.A.S.), a Novartis Early Career Award in Organic Chemistry (to D.A.S.), an Alfred P. Sloan Foundation Fellowship (BR2011-117 to D.A.S.), an NIH New Innovator Award (1DP2OD002913-01 to D.A.S.), and an NIH MSTP training grant (T32GM07205 to S.G.). We appreciate Dr. Thihan Padukkavidana's helpful suggestions in the preparation of this manuscript and Ambrose Cheung's generosity in sharing the S. aureus PBP mutant strains. D.A.S. is a paid consultant for Bristol-Myers Squibb.	Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; Foss MH, 2011, BIOCHEMISTRY-US, V50, P7719, DOI 10.1021/bi200940d; Kocaoglu O, 2012, ACS CHEM BIOL, V7, P1746, DOI 10.1021/cb300329r; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Banerjee R, 2013, EUR J CLIN MICROBIOL, V32, P827, DOI 10.1007/s10096-013-1817-9; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Sauvage E, 2007, J MOL BIOL, V371, P528, DOI 10.1016/j.jmb.2007.05.071; Lebar MD, 2014, J AM CHEM SOC, V136, P10874, DOI 10.1021/ja505668f; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; Gautam S, 2015, J AM CHEM SOC, V137, P7441, DOI 10.1021/jacs.5b02972; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Polk RE, 2011, CLIN INFECT DIS, V53, P1100, DOI 10.1093/cid/cir672; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Alvarez L, 2014, MICROB DRUG RESIST, V20, P190, DOI 10.1089/mdr.2014.0047; Gautam S, 2013, TRENDS BIOTECHNOL, V31, P258, DOI 10.1016/j.tibtech.2013.01.012; GEORGOPAPADAKOU NH, 1982, ANTIMICROB AGENTS CH, V22, P172; KOZARICH JW, 1978, J BIOL CHEM, V253, P1272; Kuru E., 2012, ANGEW CHEM, V124, P12687; Nelson JW, 2010, ACS CHEM BIOL, V5, P1147, DOI 10.1021/cb100195d; Pereira SFF, 2009, MOL MICROBIOL, V72, P895, DOI 10.1111/j.1365-2958.2009.06687.x; Pereira SFF, 2007, J BACTERIOL, V189, P3525, DOI 10.1128/JB.00044-07; Pinho MG, 2000, J BACTERIOL, V182, P1074, DOI 10.1128/JB.182.4.1074-1079.2000	30	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	SEP 1	2015	54	36					10492	10496		10.1002/anie.201503869		5	Chemistry, Multidisciplinary	Chemistry	CQ0UL	WOS:000360312800014		
J	Endo, M; Takeuchi, Y; Suzuki, Y; Emura, T; Hidaka, K; Wang, F; Willner, I; Sugiyama, H				Endo, Masayuki; Takeuchi, Yosuke; Suzuki, Yuki; Emura, Tomoko; Hidaka, Kumi; Wang, Fuan; Willner, Itamar; Sugiyama, Hiroshi			Single-Molecule Visualization of the Activity of a Zn2+-Dependent DNAzyme	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						DNA origami; DNA structures; DNAzymes; high-speed atomic force microscopy; single-molecule imaging	STRAND DISPLACEMENT CASCADES; CATALYTIC BEACON SENSOR; LOGIC GATES; DNA NANOSTRUCTURE; HEMIN/G-QUADRUPLEX; RATIONAL DESIGN; NUCLEIC-ACIDS; ORIGAMI; ENZYME; BIOMOLECULES	We demonstrate the single-molecule imaging of the catalytic reaction of a Zn2+-dependent DNAzyme in a DNA origami nanostructure. The single-molecule catalytic activity of the DNAzyme was examined in the designed nanostructure, a DNA frame. The DNAzyme and a substrate strand attached to two supported dsDNA molecules were assembled in the DNA frame in two different configurations. The reaction was monitored by observing the configurational changes of the incorporated DNA strands in the DNA frame. This configurational changes were clearly observed in accordance with the progress of the reaction. The separation processes of the dsDNA molecules, as induced by the cleavage by the DNAzyme, were directly visualized by high-speed atomic force microscopy (AFM). This nanostructure-based AFM imaging technique is suitable for the monitoring of various chemical and biochemical catalytic reactions at the single-molecule level.	[Endo, Masayuki; Sugiyama, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Takeuchi, Yosuke; Suzuki, Yuki; Emura, Tomoko; Hidaka, Kumi; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Endo, Masayuki; Sugiyama, Hiroshi] CREST Japan Sci & Technol Agcy JST, Chiyoda Ku, Tokyo 1020075, Japan; [Wang, Fuan; Willner, Itamar] Hebrew Univ Jerusalem, Inst Chem, Minerva Ctr Biohybrid Complex Syst, IL-91904 Jerusalem, Israel	Endo, M (reprint author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Yoshida Ushinomiyacho, Kyoto 6068501, Japan.	endo@kuchem.kyoto-u.ac.jp; willnea@vms.huji.ac.il; hs@kuchem.kyoto-u.ac.jp	Suzuki, Yuki/H-9950-2015; Sugiyama, Hiroshi/C-7687-2011; Endo, Masayuki/J-5874-2014		MEXT [24104002]; JSPS [15H03837, 24225005, 26620133]; Israel Science Foundation; Sekisui Chemical; Kurata Memorial Hitachi Science and Technology Foundation; Core Research for Evolutional Science and Technology (CREST) of JST	This research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas ("Molecular Robotics", grant number 24104002) from MEXT, Core Research for Evolutional Science and Technology (CREST) of JST, and JSPS KAKENHI (grant numbers 15H03837, 24225005, 26620133). I.W. is supported by the Israel Science Foundation. Financial support through research grants to M.E. from Sekisui Chemical and the Kurata Memorial Hitachi Science and Technology Foundation is also acknowledged.	Adar R, 2004, P NATL ACAD SCI USA, V101, P9960, DOI 10.1073/pnas.0400731101; Willner I, 2008, CHEM SOC REV, V37, P1153, DOI 10.1039/b718428j; Endo M, 2012, ANGEW CHEM INT EDIT, V51, P10518, DOI 10.1002/anie.201205247; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Fan CH, 2003, P NATL ACAD SCI USA, V100, P9134, DOI 10.1073/pnas.1633515100; Wang L, 2012, ACS NANO, V6, P6659, DOI [10.1021/nn300997f, 10.1021/nn300992f]; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Rajendran A, 2013, J AM CHEM SOC, V135, P1117, DOI 10.1021/ja310454k; Wilking M, 2013, ORG BIOMOL CHEM, V11, P6940, DOI 10.1039/c3ob41366g; Ge BX, 2010, ANGEW CHEM INT EDIT, V49, P9965, DOI 10.1002/anie.201004946; Sannohe Y, 2010, J AM CHEM SOC, V132, P16311, DOI 10.1021/ja1058907; Padirac A, 2013, CURR OPIN BIOTECH, V24, P575, DOI 10.1016/j.copbio.2012.11.011; Andreasson J, 2007, J PHYS CHEM C, V111, P14274, DOI 10.1021/jp074429p; Breaker RR, 1997, NAT BIOTECHNOL, V15, P427, DOI 10.1038/nbt0597-427; Wang F, 2011, J AM CHEM SOC, V133, P17149, DOI 10.1021/ja2076789; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Freeman R, 2013, ACS APPL MATER INTER, V5, P2815, DOI 10.1021/am303189h; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Gu HZ, 2013, J AM CHEM SOC, V135, P9121, DOI 10.1021/ja403585e; Endo M, 2010, ANGEW CHEM INT EDIT, V49, P9412, DOI 10.1002/anie.201003604; Endo M, 2014, ACCOUNTS CHEM RES, V47, P1645, DOI 10.1021/ar400299m; Lu CH, 2013, NANO LETT, V13, P1298, DOI 10.1021/nl400078g; Rajendran A, 2014, ANGEW CHEM INT EDIT, V53, P4107, DOI 10.1002/anie.201308903; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Pelossof G, 2012, ANAL CHEM, V84, P3703, DOI 10.1021/ac3002269; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Gerasimova YV, 2010, CHEM BIOL, V17, P104, DOI 10.1016/j.chembiol.2010.02.003; Moshe M, 2009, NANO LETT, V9, P1196, DOI 10.1021/nl803887y; Wang ZG, 2013, ACS NANO, V7, P1591, DOI 10.1021/nn305424e; Lederman H, 2006, BIOCHEMISTRY-US, V45, P1194, DOI 10.1021/bi051871u; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Du Y, 2013, ACCOUNTS CHEM RES, V46, P203, DOI 10.1021/ar300011g; Rajendran A, 2014, CHEM REV, V114, P1493, DOI 10.1021/cr300253x; Suzuki Y, 2014, J AM CHEM SOC, V136, P211, DOI 10.1021/ja408656y; Teller C, 2009, ANAL CHEM, V81, P9114, DOI 10.1021/ac901773b; Wang F, 2014, CHEM REV, V114, P2881, DOI 10.1021/cr400354z; Liu J, 2007, J AM CHEM SOC, V129, P9838, DOI 10.1021/ja0717358; Endo M, 2010, J AM CHEM SOC, V132, P1592, DOI 10.1021/ja907649w; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Golub E, 2011, ANGEW CHEM INT EDIT, V50, P11710, DOI 10.1002/anie.201103853; Rajendran A, 2012, ANGEW CHEM INT EDIT, V51, P874, DOI 10.1002/anie.201102113; Shimron S, 2011, CHEM COMMUN, V47, P8787, DOI 10.1039/c1cc12795k; Elbaz J, 2010, CHEM COMMUN, V46, P1209, DOI 10.1039/b919417g; Picuri JM, 2009, J AM CHEM SOC, V131, P9368, DOI 10.1021/ja902490x; Endo M, 2013, CHEM-EUR J, V19, P16887, DOI 10.1002/chem.201303830; Orbach R, 2014, CHEM SCI, V5, P3381, DOI 10.1039/c4sc00914b; Orbach R, 2012, P NATL ACAD SCI USA, V109, P21228, DOI 10.1073/pnas.1219672110; Liu XQ, 2013, NANO LETT, V13, P219, DOI 10.1021/nl303894h; Liu JW, 2007, P NATL ACAD SCI USA, V104, P2056, DOI 10.1073/pnas.0607875104; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; BREAKER RR, 1994, TRENDS BIOTECHNOL, V12, P268, DOI 10.1016/0167-7799(94)90138-4; Endo M., 2012, ANGEW CHEM, V124, P10670; Endo M., 2010, ANGEW CHEM, V122, P9602, DOI 10.1002/ange.201003604; Ge B., 2010, ANGEW CHEM, V122, P10161, DOI 10.1002/ange.201004946; Gianneschi N. C., 2007, ANGEW CHEM, V119, P4029, DOI 10.1002/ange.200700047; Gianneschi NC, 2007, ANGEW CHEM INT EDIT, V46, P3955, DOI 10.1002/anie.200700047; Golub E., 2011, ANGEW CHEM, V123, P11914; Joyce G. F., 2007, ANGEW CHEM, V119, P6540, DOI 10.1002/ange.200701369; Orbach R, 2012, CHEM-EUR J, V18, P14689, DOI 10.1002/chem.201201995; Rajendran A., 2012, ANGEW CHEM, V124, P898, DOI DOI 10.1002/ANGE.201102113; Rajendran A., 2014, ANGEW CHEM, V126, P4275; Zhong Z., 2013, J AM CHEM SOC, V135, P1934; Zhou M., 2010, ANGEW CHEM, V122, P2213; Zhou MG, 2010, ANGEW CHEM INT EDIT, V49, P2167, DOI 10.1002/anie.200907082	66	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	SEP 1	2015	54	36					10550	10554		10.1002/anie.201504656		5	Chemistry, Multidisciplinary	Chemistry	CQ0UL	WOS:000360312800026		
J	Miyamura, H; Sonoyama, A; Hayrapetyan, D; Kobayashi, S				Miyamura, Hiroyuki; Sonoyama, Arisa; Hayrapetyan, Davit; Kobayashi, Shu			Self-Assembled Nanocomposite Organic Polymers with Aluminum and Scandium as Heterogeneous Water-Compatible Lewis Acid Catalysts	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						aluminum; CC coupling; heterogeneous catalysis; Lewis acids; scandium	ALDOL REACTION; AQUEOUS-MEDIA; SILICA; HYDROXYMETHYLATION; FORMALDEHYDE; CHEMISTRY; ALKOXIDES; COMPLEX; GREEN	While water-compatible Lewis acids have great potential as accessible and environmentally benign catalysts for various organic transformations, efficient immobilization of such Lewis acids while keeping high activity and without leaching of metals even under aqueous conditions is a challenging task. Self-assembled nanocomposite catalysts of organic polymers, carbon black, aluminum reductants, and scandium salts as heterogeneous water-compatible Lewis acid catalysts are described. These catalysts could be successfully applied to various CC bond-forming reactions without leaching of metals. Scanning transmission electron microscopy analyses revealed that the nanocomposite structure of Al and Sc was fabricated in these heterogeneous catalysts. It is noted that Al species, which are usually decomposed rapidly in the presence of water, are stabilized under aqueous conditions.	[Miyamura, Hiroyuki; Sonoyama, Arisa; Hayrapetyan, Davit; Kobayashi, Shu] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Kobayashi, S (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	shu_kobayashi@chem.s.u-tokyo.ac.jp	Miyamura, Hiroyuki/E-9166-2012; Kobayashi, Shu/E-9214-2012	Miyamura, Hiroyuki/0000-0002-0028-773X; 	JSPS; Global COE Program; University of Tokyo; MEXT (Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research from JSPS, the Global COE Program, the University of Tokyo, and MEXT (Japan). We also thank Noriaki Kuramitsu (University of Tokyo) for STEM and EDS analysis.	Abraham S, 2006, TETRAHEDRON, V62, P1474, DOI 10.1016/j.tet.2005.11.023; Tsubogo T, 2013, ANGEW CHEM INT EDIT, V52, P6590, DOI 10.1002/anie.201210066; Cozzi F, 2006, ADV SYNTH CATAL, V348, P1367, DOI 10.1002/adsc.200606096; Ishikawa S, 2004, J AM CHEM SOC, V126, P12236, DOI 10.1021/ja047896i; Kaneda K, 2006, B CHEM SOC JPN, V79, P981, DOI 10.1246/bcsj.79.981; Gu YL, 2006, ANGEW CHEM INT EDIT, V45, P7217, DOI 10.1002/anie.200603070; Doherty S, 2008, ADV SYNTH CATAL, V350, P295, DOI 10.1002/adsc.200700425; Kitanosono T, 2013, ADV SYNTH CATAL, V355, P3095, DOI 10.1002/adsc.201300798; Ohshima T, 2002, J AM CHEM SOC, V124, P14546, DOI 10.1021/ja028457r; Kobayashi S, 2010, CHEM REC, V10, P271, DOI 10.1002/tcr.201000026; Miyamura H, 2014, ACCOUNTS CHEM RES, V47, P1054, DOI 10.1021/ar400224f; Kirschning A, 2006, CHEM-EUR J, V12, P5972, DOI 10.1002/chem.200600236; Corma A, 2006, ADV SYNTH CATAL, V348, P1391, DOI 10.1002/adsc.200606192; Shintaku H, 2014, ACS CATAL, V4, P1198, DOI 10.1021/cs401149n; Gu YL, 2009, ADV SYNTH CATAL, V351, P817, DOI 10.1002/adsc.200900043; Corma A, 2003, CHEM REV, V103, P4307, DOI 10.1021/cr030680z; Liu Y, 2013, INORG CHEM, V52, P10286, DOI 10.1021/ic400598x; Burke MD, 2003, SCIENCE, V302, P613, DOI 10.1126/science.1089946; Kobayashi S, 2002, CHEM REV, V102, P2227, DOI 10.1021/cr010289i; Vickerstaffe E, 2004, J COMB CHEM, V6, P332, DOI 10.1021/cc049977g; Torii H, 2004, ANGEW CHEM INT EDIT, V43, P1983, DOI 10.1002/anie.200352724; Akiyama R, 2009, CHEM REV, V109, P594, DOI 10.1021/cr800529d; Sheldon RA, 1998, ACCOUNTS CHEM RES, V31, P485, DOI 10.1021/ar9700163; Kobayashi S, 2006, CHEM-EUR J, V12, P5954, DOI 10.1002/chem.200600385; Kobayashi S, 1998, J AM CHEM SOC, V120, P8287, DOI 10.1021/ja980715q; Kobayashi S, 2013, ALDRICHIM ACTA, V46, P3; Turevskaya EP, 2000, POLYHEDRON, V19, P705, DOI 10.1016/S0277-5387(00)00312-0; Campana AG, 2007, J ORG CHEM, V72, P8127, DOI 10.1021/jo701354c; Dhakshinamoorthy A, 2013, CATAL SCI TECHNOL, V3, P2509, DOI 10.1039/c3cy00350g; Gu Y., 2006, ANGEW CHEM, V118, P7375, DOI DOI 10.1002/ANGE.200603070; Kobayashi S, 1999, EUR J ORG CHEM, P15; KOBAYASHI S, 1991, CHEM LETT, P2187, DOI 10.1246/cl.1991.2187; Kuwano R, 1998, CHEM COMMUN, P71, DOI 10.1039/a706662g; MEHROTRA RC, 1968, CHEM COMMUN, P469, DOI 10.1039/c19680000469; Shiina J, 2007, EUR J ORG CHEM, P5190, DOI 10.1002/ejoc.200700522; Takeuchi M, 2005, J AM CHEM SOC, V127, P13096, DOI 10.1021/ja053176f; Torii H., 2004, ANGEW CHEM, V116, P2017, DOI 10.1002/ange.200352724; Tsubogo T., 2013, ANGEW CHEM, V125, P6722; Yoo WJ, 2011, J AM CHEM SOC, V133, P3095, DOI 10.1021/ja110142y; Zhang F, 2013, GREEN CHEM, V15, P2865, DOI 10.1039/c3gc41020j	40	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	SEP 1	2015	54	36					10559	10563		10.1002/anie.201503874		5	Chemistry, Multidisciplinary	Chemistry	CQ0UL	WOS:000360312800028		
J	Zavorotynska, O; Deledda, S; Li, GQ; Matsuo, M; Orimo, S; Hauback, BC				Zavorotynska, Olena; Deledda, Stefano; Li, Guanqiao; Matsuo, Motoaki; Orimo, Shin-ichi; Hauback, Bjorn C.			Isotopic Exchange in Porous and Dense Magnesium Borohydride	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						gas-solid exchange; hydrogen isotope exchange; magnesium borohydride; Raman spectroscopy	HYDROGEN STORAGE; COMPLEX HYDRIDES; MG(BH4)(2); STABILITY; DEUTERIUM; ALKALI	Magnesium borohydride (Mg(BH4)(2)) is one of the most promising complex hydrides presently studied for energy-related applications. Many of its properties depend on the stability of the BH4- anion. The BH4- stability was investigated with respect to HD exchange. Insitu Raman measurements on high-surface-area porous Mg(BH4)(2) in 0.3MPa D-2 have shown that the isotopic exchange at appreciable rates occurs already at 373K. This is the lowest exchange temperature observed in stable borohydrides. Gas-solid isotopic exchange follows the BH4-+(DBH3D-)-B-.+H-. mechanism at least at the initial reaction steps. Exsitu deuteration of porous Mg(BH4)(2) and its dense-phase polymorph indicates that the intrinsic porosity of the hydride is the key behind the high isotopic exchange rates. It implies that the solid-state H(D) diffusion is considerably slower than the gas-solid HD exchange reaction at the surface and it is a rate-limiting steps for hydrogen desorption and absorption in Mg(BH4)(2.</IN)	[Zavorotynska, Olena; Deledda, Stefano; Hauback, Bjorn C.] Inst Energy Technol, Dept Phys, N-2027 Kjeller, Norway; [Li, Guanqiao; Matsuo, Motoaki; Orimo, Shin-ichi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Orimo, Shin-ichi] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Hauback, BC (reprint author), Inst Energy Technol, Dept Phys, POB 40, N-2027 Kjeller, Norway.	bjorn.hauback@ife.no	ORIMO, Shin-ichi/A-4971-2011; Zavorotynska, Olena/O-9975-2015	ORIMO, Shin-ichi/0000-0002-4216-0446; 	ERA NET CONCERT-Japan iTHEUS project; European Fuel Cells and Hydrogen Joint Undertaking under the collaborative project "BOR4STORE" [303428]; JSPS [25220911, 26820311]; ICC-IMR of Tohoku University	This work was funded by the ERA NET CONCERT-Japan iTHEUS project, and by the European Fuel Cells and Hydrogen Joint Undertaking (http://www.fch-ju.eu) under the collaborative project "BOR4STORE" (Grant agreement No. 303428). Partial financial support from JSPS KAKENHI (Grant Nos. 25220911, 26820311), JSPS Fellows, and the Integrated Project of ICC-IMR of Tohoku University is gratefully acknowledged.	MESMER RE, 1962, J AM CHEM SOC, V84, P2039, DOI 10.1021/ja00870a005; Ban V, 2014, J PHYS CHEM C, V118, P23402, DOI 10.1021/jp507286m; Soloveichik GL, 2009, INT J HYDROGEN ENERG, V34, P916, DOI 10.1016/j.ijhydene.2008.11.016; Zavorotynska O, 2011, J PHYS CHEM C, V115, P18890, DOI 10.1021/jp2058244; Orimo SI, 2007, CHEM REV, V107, P4111, DOI 10.1021/cr0501846; Ozolins V, 2009, J AM CHEM SOC, V131, P230, DOI 10.1021/ja8066429; Her JH, 2007, ACTA CRYSTALLOGR B, V63, P561, DOI 10.1107/S0108768107022665; Li HW, 2011, ENERGIES, V4, P185, DOI 10.3390/en4010185; Riktor MD, 2007, J MATER CHEM, V17, P4939, DOI 10.1039/b712750b; George L, 2010, INT J HYDROGEN ENERG, V35, P5454, DOI 10.1016/j.ijhydene.2010.03.078; Filinchuk Y, 2011, ANGEW CHEM INT EDIT, V50, P11162, DOI 10.1002/anie.201100675; Remhof A, 2014, J MATER CHEM A, V2, P7244, DOI 10.1039/c4ta00644e; Nakamori Y, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045126; van Setten MJ, 2009, J MATER CHEM, V19, P7081, DOI 10.1039/b908821k; BROWN WG, 1952, J AM CHEM SOC, V74, P1343, DOI 10.1021/ja01125a506; Cerny R, 2007, ANGEW CHEM INT EDIT, V46, P5765, DOI 10.1002/anie.200700773; Paskevicius M, 2012, J PHYS CHEM C, V116, P15231, DOI 10.1021/jp302898k; Chong M, 2011, CHEM COMMUN, V47, P1330, DOI 10.1039/c0cc03461d; Ley MB, 2014, MATER TODAY, V17, P122, DOI 10.1016/j.mattod.2014.02.013; Renaudin G, 2004, J ALLOY COMPD, V375, P98, DOI 10.1016/j.jallcom.2003.11.018; van Setten MJ, 2008, CHEM MATER, V20, P4952, DOI 10.1021/cm800358k; Borgschulte A, 2011, FARADAY DISCUSS, V151, P213, DOI 10.1039/c0fd00011f; Borgschulte A, 2012, ENERG ENVIRON SCI, V5, P6823, DOI 10.1039/c2ee02975h; Cerny R., 2007, ANGEW CHEM, V119, DOI 10.1002/ange.200700773; Chong M, 2015, INORG CHEM, V54, P4120, DOI 10.1021/acs.inorgchem.5b00373; Filinchuk Y., 2011, ANGEW CHEM, V123, P11358, DOI DOI 10.1002/ANGE.201100675; Gremaud R., 2009, PHYS REV B, V80, P1; Gremaud R, 2011, J PHYS CHEM C, V115, P2489, DOI 10.1021/jp107266d; Gribov EN, 2010, PHYS CHEM CHEM PHYS, V12, P6474, DOI 10.1039/c002031c; Hagemann H, 2010, J PHYS CHEM C, V114, P10045, DOI 10.1021/jp101484f; Matsurtaga T, 2008, RENEW ENERG, V33, P193, DOI 10.1016/j.renene.2007.05.004; Nakamoto K., 2008, INFRARED RAMAN SPECT, P204; Parker SF, 2010, COORDIN CHEM REV, V254, P215, DOI 10.1016/j.ccr.2009.06.016; Remhof A, 2010, Z PHYS CHEM, V224, P263, DOI 10.1524/zpch.2010.6104	34	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	SEP 1	2015	54	36					10592	10595		10.1002/anie.201502699		4	Chemistry, Multidisciplinary	Chemistry	CQ0UL	WOS:000360312800035		
J	Chen, FK; Hong, YS; Shimizu, S; Kim, D; Tanaka, T; Osuka, A				Chen, Fengkun; Hong, Yong Seok; Shimizu, Soji; Kim, Dongho; Tanaka, Takayuki; Osuka, Atsuhiro			Synthesis of a Tetrabenzotetraaza[8]circulene by a "Fold-In" Oxidative Fusion Reaction	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						aromaticity; circulenes; cyclooctatetraene; fused-ring systems; pyrroles	PLANAR ANTIAROMATIC CYCLOOCTATETRAENES; INDEPENDENT CHEMICAL-SHIFTS; PORPHYRIN SHEET; AROMATICITY; CORE; NICS	Tetrabenzotetraaza[8]circulene (1) has been synthesized in good yield by a fold-in oxidative fusion reaction of a 1,2-phenylene-bridged cyclic tetrapyrrole. X-ray diffraction analysis of 1 has revealed a planar square structure with a central cyclooctatetraene (COT) core that shows little alternation of the bond lengths. Despite these structural features, 1 shows aromatic-like character, such as sharp absorption bands, high fluorescence quantum yields (phi(F)=0.55 in THF), and a single exponential fluorescence decay with (F)=3.8ns. These observations indicate a dominant contribution of an [8]radialene-like conjugation and hence aromatic character of the local aromatic segments in 1.	[Chen, Fengkun; Tanaka, Takayuki; Osuka, Atsuhiro] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Hong, Yong Seok; Kim, Dongho] Yonsei Univ, Spect Lab Funct Elect Syst, Seoul 120749, South Korea; [Hong, Yong Seok; Kim, Dongho] Yonsei Univ, Dept Chem, Seoul 120749, South Korea; [Shimizu, Soji] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Fukuoka 8190395, Japan	Kim, D (reprint author), Yonsei Univ, Spect Lab Funct Elect Syst, Seoul 120749, South Korea.	dongho@yonsei.ac.kr; taka@kuchem.kyoto-u.ac.jp; osuka@kuchem.kyoto-u.ac.jp			JSPS KAKENHI [25220802, 25620031, 20705446]; Global Research Laboratory (GRL) Program - Ministry of Science, ICT and Future, Korea [2013K1A1A2A02050183]	The work at Kyoto was supported by JSPS KAKENHI (Grant Numbers 25220802, 25620031, and 20705446). The work at Yonsei was supported by the Global Research Laboratory (GRL) Program funded by the Ministry of Science, ICT and Future, Korea (2013K1A1A2A02050183). We thank Prof. Dr. Hiromitsu Maeda and Dr. Yuya Bando (Ritsumeikan University) for MALDI-TOF MS measurements.	Nakamura Y, 2006, J AM CHEM SOC, V128, P4119, DOI 10.1021/ja057812l; Tanaka T, 2015, CHEM SOC REV, V44, P943, DOI 10.1039/c3cs60443h; Baryshnikov GV, 2014, PHYS CHEM CHEM PHYS, V16, P15367, DOI 10.1039/c4cp00860j; Dadvand A, 2008, CHEM COMMUN, P5354, DOI 10.1039/b809259a; Mysliwiec D, 2013, ANGEW CHEM INT EDIT, V52, P1713, DOI 10.1002/anie.201208547; Chernichenko KY, 2006, ANGEW CHEM INT EDIT, V45, P7367, DOI 10.1002/anie.200602190; Sakamoto Y, 2013, J AM CHEM SOC, V135, P14074, DOI 10.1021/ja407842z; Plesner M, 2015, ORG BIOMOL CHEM, V13, P5937, DOI 10.1039/c5ob00676g; Chen ZF, 2005, CHEM REV, V105, P3842, DOI 10.1021/cr030088+; Nobusue S, 2015, ANGEW CHEM INT EDIT, V54, P2090, DOI 10.1002/anie.201410791; Grzybowski M, 2013, ANGEW CHEM INT EDIT, V52, P9900, DOI 10.1002/anie.201210238; Nakamura Y, 2008, TETRAHEDRON, V64, P11433, DOI 10.1016/j.tet.2008.08.072; Feng CN, 2013, ANGEW CHEM INT EDIT, V52, P7791, DOI 10.1002/anie.201303875; Miller RW, 2014, CHEM-EUR J, V20, P3705, DOI 10.1002/chem.201304657; Ohmae T, 2010, J AM CHEM SOC, V132, P1066, DOI 10.1021/ja908161r; Nielsen CB, 2010, CHEM-EUR J, V16, P13030, DOI 10.1002/chem.201002261; Chandra B, 2013, ORG LETT, V15, P306, DOI 10.1021/ol3032158; Hensel T, 2013, CHEM-EUR J, V19, P17097, DOI 10.1002/chem.201303194; Nakamura Y, 2007, CHEM-ASIAN J, V2, P860, DOI 10.1002/asia.200700112; Kondratowicz M, 2014, CHEM-EUR J, V20, P14981, DOI 10.1002/chem.201404470; Seven O, 2012, CHEM-EUR J, V18, P11284, DOI 10.1002/chem.201201547; Tsuda A, 2001, SCIENCE, V293, P79, DOI 10.1126/science.1059552; Nielsen CB, 2013, CHEM-EUR J, V19, P3898, DOI 10.1002/chem.201203113; Schleyer PV, 1996, J AM CHEM SOC, V118, P6317, DOI 10.1021/ja960582d; Aita K, 2013, ORG LETT, V15, P3522, DOI 10.1021/ol401125f; Brock-Nannestad T, 2011, EUR J ORG CHEM, P6320, DOI 10.1002/ejoc.201100966; Chernichenko K. Y., 2006, ANGEW CHEM, V118, P7527, DOI 10.1002/ange.200602190; ERDTMAN H, 1968, CHEM COMMUN, P773, DOI 10.1039/c19680000773; ERDTMAN H, 1970, TETRAHEDRON LETT, P3389; Eskildsen J, 2000, EUR J ORG CHEM, P1637; Feng C.-H., 2013, ANGEW CHEM, V125, P7945; Grzybowski M., 2013, ANGEW CHEM, V52, P9900; Haley M. M., 2006, CARBON RICH COMPOUND; Lim JM, 2009, CHEM COMMUN, P261, DOI 10.1039/b810718a; MARKL G, 1994, ANGEW CHEM INT EDIT, V33, P1151, DOI 10.1002/anie.199411511; Markl G., 1994, ANGEW CHEM, V106, P1211, DOI 10.1002/ange.19941061107; Mullen K., 2006, ORGANIC LIGHT EMITTI; Muller T. J. J., 2007, FUNCTIONAL ORGANIC M; Mysliwiec D., 2013, ANGEW CHEM, V125, P1757; Nobusue S., 2015, ANGEW CHEM, V127, P2118; Pawlicki M., 2015, ANGEW CHEM, V127, P1926; Pawlicki M, 2015, ANGEW CHEM INT EDIT, V54, P1906, DOI 10.1002/anie.201410595; Rathore R, 2004, TETRAHEDRON LETT, V45, P5267, DOI 10.1016/j.tetlet.2004.05.019; Shimizu M, 2011, TETRAHEDRON, V67, P8014, DOI 10.1016/j.tet.2011.08.019; VOGEL E, 1990, ANGEW CHEM INT EDIT, V29, P1387, DOI 10.1002/anie.199013871; Vogel E., 1990, ANGEW CHEM, V102, P1431, DOI 10.1002/ange.19901021206; Xiong XD, 2015, CHEM-ASIAN J, V10, P969, DOI 10.1002/asia.201403028	47	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	SEP 1	2015	54	36					10639	10642		10.1002/anie.201505124		4	Chemistry, Multidisciplinary	Chemistry	CQ0UL	WOS:000360312800046		
J	Swarnakar, AK; Hering-Junghans, C; Nagata, K; Ferguson, MJ; McDonald, R; Tokitoh, N; Rivard, E				Swarnakar, Anindya K.; Hering-Junghans, Christian; Nagata, Koichi; Ferguson, Michael J.; McDonald, Robert; Tokitoh, Norihiro; Rivard, Eric			Encapsulating Inorganic Acetylene, HBNH, Using Flanking Coordinative Interactions	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION			English	Article						boron; carbenes; donor-acceptor systems; multiple bonds; nitrogen	N-HETEROCYCLIC CARBENE; BORON-NITRIDE; MAIN-GROUP; COUPLING-CONSTANTS; RING-EXPANSION; CHEMISTRY; REACTIVITY; COMPLEX; BONDS; AMINOBORANES	A stable donor-acceptor coordination complex of the elusive parent inorganic iminoborane HBNH (a structural analogue of acetylene) is reported. This species was generated via thermally induced N-2 elimination/1,2-H migration from a hydrido(azido)borane adduct NHCBH2N3 (NHC=N-heterocyclic carbene) in the presence of a fluorinated triarylborane. The mechanism of this process was also investigated by computational and isotopic labeling studies. This transformation represents a new and potentially modular route to unsaturated inorganic building blocks for advanced material synthesis.	[Swarnakar, Anindya K.; Hering-Junghans, Christian; Ferguson, Michael J.; McDonald, Robert; Rivard, Eric] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Nagata, Koichi; Tokitoh, Norihiro] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Rivard, E (reprint author), Univ Alberta, Dept Chem, 11227 Saskatchewan Dr, Edmonton, AB T6G 2G2, Canada.	erivard@ualberta.ca			NSERC of Canada; Canada Foundation for Innovation (CFI); Alexander von Humboldt Foundation; Japan Society for the Promotion of Science (JSPS)	This work was supported by the NSERC of Canada (Discovery Grant for E.R) and the Canada Foundation for Innovation (CFI). C.H.-J. acknowledges the Alexander von Humboldt Foundation for a Feodor Lynen Postdoctoral Fellowship, while K.N. thanks the Japan Society for the Promotion of Science (JSPS) for a PhD fellowship. We also thank Dr. Tapas Purkait, Olena Shynkaruk, and William Torres Delgado for experimental assistance, Compute Canada for providing computational resources, and Prof. Alex Brown and Dr. Urmi Bhusan Bhakta for helpful discussions.	Albertin G, 2008, INORG CHEM, V47, P742, DOI 10.1021/ic701907y; Al-Rafia S. M. I., 2011, ANGEW CHEM, V123, P8504; Al-Rafia SMI, 2011, ANGEW CHEM INT EDIT, V50, P8354, DOI 10.1002/anie.201103576; Krieg M, 2015, ANGEW CHEM INT EDIT, V54, P8284, DOI 10.1002/anie.201412165; Vogel U, 2001, ANGEW CHEM INT EDIT, V40, P4409, DOI 10.1002/1521-3773(20011203)40:23<4409::AID-ANIE4409>3.0.CO;2-F; Braunschweig H, 2015, ANGEW CHEM INT EDIT, V54, P1662, DOI 10.1002/anie.201409699; PAETZOLD P, 1982, CHEM BER-RECL, V115, P2819, DOI 10.1002/cber.19821150813; Fischer RC, 2010, CHEM REV, V110, P3877, DOI 10.1021/cr100133q; Yamaguchi T, 2010, J AM CHEM SOC, V132, P14061, DOI 10.1021/ja107160g; PAETZOLD P, 1991, PURE APPL CHEM, V63, P345, DOI 10.1351/pac199163030345; Braunschweig H, 2010, CHEM REV, V110, P3924, DOI 10.1021/cr900333n; Rokade BV, 2012, J ORG CHEM, V77, P5364, DOI 10.1021/jo3008258; Liu L, 2014, SCIENCE, V343, P163, DOI 10.1126/science.1246137; PAETZOLD P, 1979, CHEM BER-RECL, V112, P3811, DOI 10.1002/cber.19791121207; Leitao EM, 2013, NAT CHEM, V5, P817, DOI [10.1038/nchem.1749, 10.1038/NCHEM.1749]; Pyykko P, 2009, CHEM-EUR J, V15, P12770, DOI 10.1002/chem.200901472; Wrackmeyer B, 2007, Z NATURFORSCH B, V62, P220; Stock A, 1926, BER DTSCH CHEM GES, V59, P2210, DOI 10.1002/cber.19260590906; Rivard E, 2014, DALTON T, V43, P8577, DOI 10.1039/c4dt00481g; Malcolm AC, 2012, INORG CHEM, V51, P12905, DOI 10.1021/ic3018997; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Schulz A, 2010, CHEM-EUR J, V16, P7276, DOI 10.1002/chem.201000289; Al-Rafia SMI, 2012, CHEM-EUR J, V18, P13810, DOI 10.1002/chem.201202195; PAETZOLD P, 1987, ADV INORG CHEM RAD, V31, P123, DOI 10.1016/S0898-8838(08)60223-8; Hamilton CW, 2009, CHEM SOC REV, V38, P279, DOI 10.1039/b800312m; AXENROD T, 1971, J AM CHEM SOC, V93, P6536, DOI 10.1021/ja00753a035; Dahcheh F, 2014, ANGEW CHEM INT EDIT, V53, P13159, DOI 10.1002/anie.201408371; Filippou AC, 2014, ANGEW CHEM INT EDIT, V53, P565, DOI 10.1002/anie.201308433; Solovyev A, 2010, J AM CHEM SOC, V132, P15072, DOI 10.1021/ja107025y; Ghadwal RS, 2013, ACCOUNTS CHEM RES, V46, P444, DOI 10.1021/ar300196u; Stubbs NE, 2013, CHEM COMMUN, V49, P9098, DOI 10.1039/c3cc44373f; Kolychev EL, 2012, CHEM-EUR J, V18, P16938, DOI 10.1002/chem.201202840; PAINE RT, 1990, CHEM REV, V90, P73, DOI 10.1021/cr00099a004; Al-Rafia SMI, 2011, J AM CHEM SOC, V133, P777, DOI 10.1021/ja1106223; Braunschweig H., 2015, ANGEW CHEM, V127, P1682; Dahcheh F., 2014, ANGEW CHEM, V126, P13375; Dahcheh F, 2015, CHEM-EUR J, V21, P199, DOI 10.1002/chem.201405887; Filippou A. C., 2014, ANGEW CHEM, V126, P576; Filthaus M, 2012, ORGANOMETALLICS, V31, P3894, DOI 10.1021/om300063y; Fox AR, 2009, J AM CHEM SOC, V131, P5716, DOI 10.1021/ja8095812; Krieg M., 2015, ANGEW CHEM, V127, P8402; Liu H, 2015, ANGEW CHEM INT EDIT, V54, P7051, DOI 10.1002/anie.201502023; Liu H., 2015, ANGEW CHEM, V127, P7157; LORY ER, 1973, J AM CHEM SOC, V95, P1766, DOI 10.1021/ja00787a012; Lummis P. A., 2014, ANGEW CHEM, V126, P9501; Lummis PA, 2014, ANGEW CHEM INT EDIT, V53, P9347, DOI 10.1002/anie.201404611; Matus MH, 2009, J PHYS CHEM C, V113, P16553, DOI 10.1021/jp905318y; Momeni MR, 2015, PHYS CHEM CHEM PHYS, V17, P16525, DOI 10.1039/c5cp01993a; Noth H., 1988, ANGEW CHEM, V100, P1664, DOI 10.1002/ange.19881001205; NOTH H, 1988, ANGEW CHEM INT EDIT, V27, P1603, DOI 10.1002/anie.198816031; Purkait TK, 2015, NANOSCALE, V7, P2241, DOI 10.1039/c4nr05125d; Rupar PA, 2007, ORGANOMETALLICS, V26, P4109, DOI 10.1021/om7006198; Stephan DW, 2015, ACCOUNTS CHEM RES, V48, P306, DOI 10.1021/ar500375j; Sundaram R, 2015, J PHYS CHEM C, V119, P3253, DOI 10.1021/jp512753n; THOMPSON CA, 1995, J AM CHEM SOC, V117, P10125, DOI 10.1021/ja00145a029; Vogel U., 2001, ANGEW CHEM, V113, P4541, DOI 10.1002/1521-3757(20011203)113:23<4541::AID-ANGE4541>3.0.CO;2-U; Zhang FT, 2010, J PHYS CHEM A, V114, P12148, DOI 10.1021/jp107210d	57	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1433-7851	1521-3773		ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit.	SEP 1	2015	54	36					10666	10669		10.1002/anie.201504867		4	Chemistry, Multidisciplinary	Chemistry	CQ0UL	WOS:000360312800052		
J	Nitta, T; Yamashiro, Y; Hattori, Y; Ezumi, T; Nishioka, M; Nakamura, J				Nitta, Takenori; Yamashiro, Yasuhiro; Hattori, Yukio; Ezumi, Tomoko; Nishioka, Mituaki; Nakamura, Junji			The interference by HbF on HbA1c (BM Test HbA1c) measurement in enzymatic method	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article						Glycated hemoglobin; enzymatic methods; hemoglobin	FETAL-HEMOGLOBIN; VARIANTS; ANALYZER; ASSAYS	Background High performance liquid chromatography and immunological and enzymatic methods are known as the methods for HbA1c measurement. However, the differences in the principles of the methods may cause slight discrepancies, which become problems especially in the regions where hemoglobinopathies that have high HbF concentrations are commonly seen. In this report, we discuss the effect of HbF on the HbA1c measurement by the enzymatic method (BM Test HbA1c) which can be applied to automatic analyzer of high sample throughput. Methods Thirty-five samples (HbF concentration: between 1.4 and 90.1%) and 68 samples (HbF concentration: <1.0%) were analyzed by high performance liquid chromatography (Tosoh G8) and BM Test HbA1c. The results by BM Test HbA1c were compared with those by the high performance liquid chromatography and International Federation of Clinical Chemistry reference method. Results The high and positive correlation coefficient was demonstrated between the enzymatic and International Federation of Clinical Chemistry methods for the samples with normal HbF concentration. The samples with high HbF concentration exhibited high and positive correlation coefficient, although the figure is lower than that of the normal HbF concentration group. Conclusions BM Test HbA1c revealed a high and positive correlation with high performance liquid chromatography and International Federation of Clinical Chemistry reference methods. However, the HbA1c values by BM Test HbA1c and high performance liquid chromatography method were lower than those by International Federation of Clinical Chemistry reference method when the HbF concentration was high. BM Test HbA1c had some deviation from the International Federation of Clinical Chemistry reference method, while no significant interference was seen when the HbF values were less than 15%. When HbF is higher than 15%, however, the interpretation of HbA1c by BM Test may require some special consideration.	[Nitta, Takenori; Yamashiro, Yasuhiro; Hattori, Yukio] Yamaguchi Univ, Grad Sch Med, Dept Hlth Sci, Ube, Yamaguchi 7558505, Japan; [Ezumi, Tomoko; Nishioka, Mituaki; Nakamura, Junji] Yamaguchi Univ, Dept Clin Lab, Ube, Yamaguchi, Japan	Nitta, T (reprint author), Yamaguchi Univ, Grad Sch Med, I-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	s002ur@yamaguchi-u.ac.jp					Shu I, 2012, CLIN CHIM ACTA, V413, P1712, DOI 10.1016/j.cca.2012.05.017; Abadie JM, 2008, ANN CLIN LAB SCI, V38, P31; Bry L, 2001, CLIN CHEM, V47, P153; Gomi K., 2014, Seibutsu-kogaku Kaishi, V92, P62; Hattori Y, 2006, INT MED J, V13, P83; Lee SC, 2011, CLIN BIOCHEM, V44, P1338, DOI 10.1016/j.clinbiochem.2011.08.907; Little RR, 2012, CLIN CHEM, V58, P945, DOI 10.1373/clinchem.2012.181933; Matsumoto H, 2013, ANN CLIN BIOCHEM, V50, P443, DOI 10.1177/0004563213476859; Rohlfing Curt L, 2008, Am J Clin Pathol, V129, P811, DOI 10.1309/YFVTUD0GHJF7D16H	9	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	SEP	2015	52	5					569	575		10.1177/0004563214568872		7	Medical Laboratory Technology	Medical Laboratory Technology	CQ0WE	WOS:000360317700006		
J	Maekawa, M; Shimada, M; Ohno, K; Togawa, M; Nittono, H; Iida, T; Hofmann, AF; Goto, J; Yamaguchi, H; Mano, N				Maekawa, Masamitsu; Shimada, Miki; Ohno, Kousaku; Togawa, Masami; Nittono, Hiroshi; Iida, Takashi; Hofmann, Alan F.; Goto, Junichi; Yamaguchi, Hiroaki; Mano, Nariyasu			Focused metabolomics using liquid chromatography/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann-Pick disease type C and 3-hydroxysteroid dehydrogenase deficiency	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article						Conjugated cholesterol metabolites; focused metabolomics; 3-hydroxysteroid dehydrogenase deficiency; liquid chromatography; electrospray ionization tandem mass spectrometry; Niemann-Pick disease type C	BILE-ACID 3-SULFATES; 5-BETA-REDUCTASE DEFICIENCY; N-ACETYLGLUCOSAMINIDES; CHEMICAL-SYNTHESIS; INBORN ERROR; IDENTIFICATION; HEPATITIS; SULFATES; STEROIDS; MICROSOMES	Background Various conjugated cholesterol metabolites are excreted in urine of the patients with metabolic abnormalities and hepatobiliary diseases. We aimed to examine the usefulness of precursor ion scan and neutral loss scan for the characterization of conjugated cholesterol metabolites in urine. Methods A mixture of authentic standards of conjugated cholesterol metabolites was used for investigating the performance of the present method. The urine of patients with Niemann-Pick diseases type C and 3-hydroxysteroid dehydrogenase deficiency were analysed by precursor ion scan of m/z 97, 74, and 124. Results A precursor ion scan of m/z 97 was effective for identifying conjugates with ester sulphates on hydroxyl groups whereas ester sulphates on phenolic alcohols were signalled by a neutral loss scan of 80 Da. Monosaccharide-conjugated cholesterol metabolites were signalled by a precursor ion scan of m/z 113. Although precursor ion scan of m/z 74 and 124 was effective for finding glycine- and taurine-conjugated metabolites, high intensity of product ions (m/z 74 and 124) disturbed measurement of other multiply conjugated metabolites. The urine samples contained many conjugated cholesterol metabolites, and there were several disease-specific intense peaks. We found several unknown intense peaks with three known peaks in urine of the Niemann-Pick type C patient. In the patient with 3-hydroxysteroid dehydrogenase deficiency, intense peaks that were tentatively identified as 5-cholenoic acid sulphates and their glycine and taurine conjugates were present. Conclusion The method should lead to the discovery of new urinary biomarkers for these disturbances of cholesterol catabolism and transport.	[Maekawa, Masamitsu; Shimada, Miki; Goto, Junichi; Yamaguchi, Hiroaki; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharmaceut Sci, Sendai, Miyagi 9808574, Japan; [Ohno, Kousaku; Togawa, Masami] Tottori Univ, Fac Med, Tottori 680, Japan; [Nittono, Hiroshi] Junshin Clin Bile Acid Inst, Tokyo, Japan; [Iida, Takashi] Nihon Univ, Coll Humanities & Sci, Tokyo, Japan; [Hofmann, Alan F.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	Mano, N (reprint author), Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, I-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mano@hosp.tohoku.ac.jp			KAKENHI [22659007]	This study was supported in part by KAKENHI (Grant-in Aid for Challenging Exploratory Research: 22659007).	FALANY CN, 1994, J BIOL CHEM, V269, P19375; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Griffiths WJ, 2010, J LIPID RES, V51, P23, DOI 10.1194/jlr.R001941-JLR200; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; SETCHELL KDR, 1988, J CLIN INVEST, V82, P2148, DOI 10.1172/JCI113837; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Maekawa M, 2014, STEROIDS, V80, P80, DOI 10.1016/j.steroids.2013.11.016; Alvelius G, 2001, J LIPID RES, V42, P1571; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Muto A, 2012, J CHROMATOGR B, V900, P24, DOI 10.1016/j.jchromb.2012.05.023; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Mitamura K, 2007, J CHROMATOGR B, V855, P88, DOI 10.1016/j.jchromb.2007.02.010; CLAYTON PT, 1987, J CLIN INVEST, V79, P1031, DOI 10.1172/JCI112915; GOTO J, 1980, CHEM PHARM BULL, V28, P1258; GOTO J, 1978, CLIN CHIM ACTA, V87, P141; Goto J, 1998, STEROIDS, V63, P180, DOI 10.1016/S0039-128X(97)00160-8; GOTO J, 1979, CHEM PHARM BULL, V27, P1402; Goto T, 2005, STEROIDS, V70, P185, DOI 10.1016/j.steroids.2004.12.006; Goto T, 2007, J CHROMATOGR B, V846, P69, DOI 10.1016/j.jchromb.2006.08.013; Higashi T, 2007, J PHARMACEUT BIOMED, V43, P1782, DOI 10.1016/j.jpba.2006.12.029; ICHIMIYA H, 1991, J LIPID RES, V32, P829; IIDA T, 1995, J LIPID RES, V36, P628; Iida T, 2006, STEROIDS, V71, P18, DOI 10.1016/j.steroids.2005.07.008; Ikegawa S, 1997, J MASS SPECTROM, V32, P401, DOI 10.1002/(SICI)1096-9888(199704)32:4<401::AID-JMS488>3.3.CO;2-5; Kakiyama G, 2005, CHEM PHYS LIPIDS, V134, P141, DOI 10.1016/j.chemphyslip.2005.01.002; MARSCHALL HU, 1989, J BIOL CHEM, V264, P12989; MATERN H, 1984, P NATL ACAD SCI-BIOL, V81, P7036, DOI 10.1073/pnas.81.22.7036; MATERN S, 1984, J CLIN INVEST, V74, P402, DOI 10.1172/JCI111435; NIWA T, 1992, STEROIDS, V57, P522; PALMER RH, 1967, P NATL ACAD SCI USA, V58, P1047, DOI 10.1073/pnas.58.3.1047; Schwarz M, 2000, J CLIN INVEST, V106, P1175, DOI 10.1172/JCI10902; Vanier MT, 1998, BRAIN PATHOL, V8, P163	32	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	SEP	2015	52	5					576	587		10.1177/0004563214568871		12	Medical Laboratory Technology	Medical Laboratory Technology	CQ0WE	WOS:000360317700007		
J	Shrestha, R; Hui, SP; Imai, H; Hashimoto, S; Uemura, N; Takeda, S; Fuda, H; Suzuki, A; Yamaguchi, S; Hirano, K; Chiba, H				Shrestha, Rojeet; Hui, Shu-Ping; Imai, Hiromitsu; Hashimoto, Satoru; Uemura, Naoto; Takeda, Seiji; Fuda, Hirotoshi; Suzuki, Akira; Yamaguchi, Satoshi; Hirano, Ken-ichi; Chiba, Hitoshi			Plasma capric acid concentrations in healthy subjects determined by high-performance liquid chromatography	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article						High-performance liquid chromatography; plasma capric acid; medium-chain triglycerides	MEDIUM-CHAIN TRIGLYCERIDES; FREE FATTY-ACIDS; ENERGY-EXPENDITURE; DECANOIC ACIDS; TRIACYLGLYCEROLS; LIPIDS; SERUM; 2-NITROPHENYLHYDRAZIDES; METABOLISM; DISEASE	Background Capric acid (FA10:0, decanoic acid) is a medium-chain fatty acid abundant in tropical oils such as coconut oil, whereas small amounts are present in milk of goat, cow, and human. Orally ingested FA10:0 is transported to the liver and quickly burnt within it. Only few reports are available for FA10:0 concentrations in human plasma. Methods Fasting (n=5, male/female=3/2, age 319.3 years old) and non-fasting (n=106, male/female=44/62, age 21.93.2 years old) blood samples were collected from apparently healthy Japanese volunteers. The total FA10:0 in the plasma were measured by high-performance liquid chromatography after derivatization with 2-nitrophenylhydrazine followed by UV detection. Results Inter and intra-assay coefficient of variation of FA10:0 assay at three different concentrations ranged in 1.7-3.9 and 1.3-5.4%, respectively, with an analytical recovery of 95.2-104.0%. FA10:0 concentration was below detection limit (0.1 mu mol/L) in each fasting human plasma. FA10:0 was not detected in 50 (47.2%) of 106 non-fasting blood samples, while 29 (27.4%) plasma samples contained FA10:0 less than or equal to 0.5 mu mol/L (0.4 +/- 0.1), and 27 (25.5%) contained it at more than 0.5 mu mol/L (0.9 +/- 0.3). Conclusion A half of the non-fasting plasma samples contained detectable FA10:0. This simple, precise, and accurate high-performance liquid chromatography method might be useful for monitoring plasma FA10:0 during medium-chain triglycerides therapy.	[Shrestha, Rojeet; Hui, Shu-Ping; Takeda, Seiji; Fuda, Hirotoshi; Chiba, Hitoshi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0600812, Japan; [Imai, Hiromitsu] Oita Univ Hosp, Clin Pharmacol Ctr, Oita, Japan; [Hashimoto, Satoru; Uemura, Naoto] Oita Univ, Fac Med, Dept Clin Pharmacol & Therapeut, Oita 87011, Japan; [Suzuki, Akira; Yamaguchi, Satoshi; Hirano, Ken-ichi] Osaka Univ, Grad Sch Med, Lab Cardiovasc Dis Novel Noninvas & Nutr Therapeu, Osaka, Japan; [Suzuki, Akira; Yamaguchi, Satoshi; Hirano, Ken-ichi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan	Hui, SP (reprint author), Hokkaido Univ, Fac Hlth Sci, Kita 12,Nishi 5, Sapporo, Hokkaido 0600812, Japan.	keino@hs.hokudai.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Center of Innovation Program from Japan Science and Technology Agency, JST; Japan Society for the Promotion of Science, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was financially supported by research grants for rare and intractable disease from the Ministry of Health, Labor, and Welfare of Japan, partially supported by the Center of Innovation Program from Japan Science and Technology Agency, JST, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan, partially by the Regional Innovation Strategy Support Program, Sapporo Health Innovation "Smart-H," of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	HAIDUKEWYCH D, 1982, CLIN CHEM, V28, P642; BACH AC, 1982, AM J CLIN NUTR, V36, P950; Ronis MJJ, 2013, EXP BIOL MED, V238, P151, DOI 10.1258/ebm.2012.012303; Han JR, 2007, METABOLISM, V56, P985, DOI 10.1016/j.metabol.2007.03.005; Labarthe F, 2008, CARDIOVASC DRUG THER, V22, P97, DOI 10.1007/s10557-008-6084-0; Tsuji H, 2001, J NUTR, V131, P2853; Marten B, 2006, INT DAIRY J, V16, P1374, DOI 10.1016/j.idairyj.2006.06.015; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; JENSEN RG, 1992, ANNU REV NUTR, V12, P417, DOI 10.1146/annurev.nutr.12.1.417; Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007; St-Onge MP, 2003, OBES RES, V11, P395, DOI 10.1038/oby.2003.53; Brondz I, 2002, ANAL CHIM ACTA, V465, P1, DOI 10.1016/S0003-2670(01)01467-2; DEAN HG, 1989, CLIN CHEM, V35, P1945; GREENBER.NJ, 1969, NEW ENGL J MED, V280, P1045, DOI 10.1056/NEJM196905082801906; HILAIRE N, 1995, J BIOL CHEM, V270, P27027; HILL JO, 1990, J LIPID RES, V31, P407; JEBENS E, 1992, SCAND J CLIN LAB INV, V52, P717, DOI 10.3109/00365519209115517; Jensen RG, 2002, J DAIRY SCI, V85, P295; Kiziltunc A, 1998, CLIN CHEM LAB MED, V36, P83, DOI 10.1515/CCLM.1998.015; Lima ES, 2002, ANAL CHIM ACTA, V465, P81; Miwa H, 2002, ANAL CHIM ACTA, V465, P237, DOI 10.1016/S0003-2670(01)01582-3; MIWA H, 1985, J CHROMATOGR, V321, P165, DOI 10.1016/S0021-9673(01)90433-9; MIWA H, 1987, J CHROMATOGR-BIOMED, V421, P33, DOI 10.1016/0378-4347(87)80376-6; ONKENHOUT W, 1995, CLIN CHEM, V41, P1467; Terada S, 2012, NUTRITION, V28, P92, DOI 10.1016/j.nut.2011.04.008; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; VICI CD, 1988, CLIN CHIM ACTA, V172, P233, DOI 10.1016/0009-8981(88)90328-2	27	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	SEP	2015	52	5					588	596		10.1177/0004563215569081		9	Medical Laboratory Technology	Medical Laboratory Technology	CQ0WE	WOS:000360317700008		
J	Nakashima, M; Saitsu, H; Takei, N; Tohyama, J; Kato, M; Kitaura, H; Shiina, M; Shirozu, H; Masuda, H; Watanabe, K; Ohba, C; Tsurusaki, Y; Miyake, N; Zheng, YJ; Sato, T; Takebayashi, H; Ogata, K; Kameyama, S; Kakita, A; Matsumoto, N				Nakashima, Mitsuko; Saitsu, Hirotomo; Takei, Nobuyuki; Tohyama, Jun; Kato, Mitsuhiro; Kitaura, Hiroki; Shiina, Masaaki; Shirozu, Hiroshi; Masuda, Hiroshi; Watanabe, Keisuke; Ohba, Chihiro; Tsurusaki, Yoshinori; Miyake, Noriko; Zheng, Yingjun; Sato, Tatsuhiro; Takebayashi, Hirohide; Ogata, Kazuhiro; Kameyama, Shigeki; Kakita, Akiyoshi; Matsumoto, Naomichi			Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb	ANNALS OF NEUROLOGY			English	Article							DEVELOPMENTAL BRAIN MALFORMATIONS; MAMMALIAN TARGET; POINT MUTATIONS; GROWTH-CONTROL; RAPAMYCIN; ACTIVATION; EPILEPSY; PATHWAY; CANCER; SPECTRUM	ObjectiveFocal cortical dysplasia (FCD) type IIb is a cortical malformation characterized by cortical architectural abnormalities, dysmorphic neurons, and balloon cells. It has been suggested that FCDs are caused by somatic mutations in cells in the developing brain. Here, we explore the possible involvement of somatic mutations in FCD type IIb. MethodsWe collected a total of 24 blood-brain paired samples with FCD, including 13 individuals with FCD type IIb, 5 with type IIa, and 6 with type I. We performed whole-exome sequencing using paired samples from 9 of the FCD type IIb subjects. Somatic MTOR mutations were identified and further investigated using all 24 paired samples by deep sequencing of the entire gene's coding region. Somatic MTOR mutations were confirmed by droplet digital polymerase chain reaction. The effect of MTOR mutations on mammalian target of rapamycin (mTOR) kinase signaling was evaluated by immunohistochemistry and Western blotting analyses of brain samples and by in vitro transfection experiments. ResultsWe identified four lesion-specific somatic MTOR mutations in 6 of 13 (46%) individuals with FCD type IIb showing mutant allele rates of 1.11% to 9.31%. Functional analyses showed that phosphorylation of ribosomal protein S6 in FCD type IIb brain tissues with MTOR mutations was clearly elevated, compared to control samples. Transfection of any of the four MTOR mutants into HEK293T cells led to elevated phosphorylation of 4EBP, the direct target of mTOR kinase. InterpretationWe found low-prevalence somatic mutations in MTOR in FCD type IIb, indicating that activating somatic mutations in MTOR cause FCD type IIb. Ann Neurol 2015;78:375-386	[Nakashima, Mitsuko; Saitsu, Hirotomo; Ohba, Chihiro; Tsurusaki, Yoshinori; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Takei, Nobuyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan; [Tohyama, Jun] Nishi Niigata Chuo Natl Hosp, Dept Child Neurol, Niigata, Japan; [Kato, Mitsuhiro] Showa Univ, Sch Med, Dept Pediat, Tokyo 142, Japan; [Kitaura, Hiroki; Zheng, Yingjun; Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 2360004, Japan; [Shirozu, Hiroshi; Masuda, Hiroshi; Kameyama, Shigeki] Nishi Niigata Chuo Natl Hosp, Epilepsy Ctr, Dept Funct Neurosurg, Niigata, Japan; [Watanabe, Keisuke; Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Sato, Tatsuhiro] Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Tokyo 108, Japan	Matsumoto, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; Strategic Research Program for Brain Sciences; Collaborative Research Project of the Brain Research Institute; University of Niigata; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan; a Grant-in-Aid for Scientific Research (A), (B), and (C); a Grant-in-Aid for Exploratory Research from the Japan Society for the Promotion of Science; the Takeda Science Foundation; the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; the Strategic Research Program for Brain Sciences; and the Collaborative Research Project of the Brain Research Institute, the University of Niigata, and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Abecasis GR, 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Schick V, 2007, EPILEPSIA, V48, P65, DOI 10.1111/j.1528-1167.2007.01291.x; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Marin-Valencia I, 2014, EPILEPSIA, V55, P970, DOI 10.1111/epi.12650; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Ljungberg MC, 2006, ANN NEUROL, V60, P420, DOI 10.1002/ana.20949; Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Miyahara H, 2013, BRAIN PATHOL, V23, P254, DOI 10.1111/j.1750-3639.2012.00634.x; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Scheffer IE, 2014, ANN NEUROL, V75, P782, DOI 10.1002/ana.24126; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Schick V, 2006, ACTA NEUROPATHOL, V112, P715, DOI 10.1007/s00401-006-0128-y; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Lim JS, 2015, NAT MED, V21, P395, DOI 10.1038/nm.3824; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; D'Gama AM, 2015, ANN NEUROL, V77, P720, DOI 10.1002/ana.24357; Eguchi S, 2006, GENES CELLS, V11, P757, DOI 10.1111/j.1365-2443.2006.00977.x; Baulac S, 2015, ANN NEUROL, V77, P675, DOI 10.1002/ana.24368; Jansen LA, 2015, BRAIN, V138, P1613, DOI 10.1093/brain/awv045; Takei N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00028; Sisodiyo SM, 2009, LANCET NEUROL, V8, P830, DOI 10.1016/S1474-4422(09)70201-7; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	42	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	SEP	2015	78	3					375	386		10.1002/ana.24444		12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CP9MQ	WOS:000360218800005		
J	Gowen, BB; Sefing, EJ; Westover, JB; Smee, DF; Hagloch, J; Furuta, Y; Hall, JO				Gowen, Brian B.; Sefing, Eric J.; Westover, Jonna B.; Smee, Donald F.; Hagloch, Joseph; Furuta, Yousuke; Hall, Jeffery O.			Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever	ANTIVIRAL RESEARCH			English	Article						Favipiravir; T-705; Arenavirus; Pharmacokinetics; Infection	EBOLA-VIRUS INFECTION; IN-VIVO ACTIVITIES; RIFT-VALLEY FEVER; ALDEHYDE OXIDASE; RNA-POLYMERASE; MOUSE MODEL; PATHOGENESIS; VITRO; RIBAVIRIN; EFFICACY	Favipiravir (T-705) is a new anti-influenza drug approved for human use in Japan and progressing through Phase 3 clinical trials in the U.S. In addition to its potent inhibitory effects against influenza virus infection, the compound has been shown to be broadly active against RNA viruses from 9 different families, including the Arenaviridae. Several members of the Arenaviridae family of viruses are significant human pathogens that cause viral hemorrhagic fever, a severe systemic syndrome where vascular leak is a cardinal feature. Because arenaviral infections are unlikely to be diagnosed and treated until the illness has progressed to a more advanced state, it is important to understand the effects of the disease state on favipiravir pharmacokinetics (PK) and biodistribution to help guide therapeutic strategy. During acute arenavirus infection in hamsters, we found reduced plasma favipiravir concentrations and altered kinetics of absorption, elimination and time to maximum drug concentration. Imaddition, the amounts of the favipiravir M1 primary metabolite were higher in the infected animals, suggesting that favipiravir metabolism may favor the formation of this inactive metabolite during viral infection. We also discovered differences in favipiravir and M1 PK parameters associated with arenavirus infection in a number of hamster tissues. Finally, analysis at the individual animal level demonstrated a correlation between reduced plasma favipiravir concentration with increased disease burden as reflected by weight loss and viral load. Our study is the first to show the impact of active viral infection and disease on favipiravir PK and biodistribution, highlighting the need to consider alterations in these parameters when treating individuals with viral hemorrhagic fever of arenavirus or other etiology. (C) 2015 Elsevier B.V. All rights reserved.	[Gowen, Brian B.; Sefing, Eric J.; Westover, Jonna B.; Smee, Donald F.; Hagloch, Joseph; Hall, Jeffery O.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Furuta, Yousuke] Toyama Chem Co Ltd, Res Labs, Toyama, Japan	Gowen, BB (reprint author), Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	brian.gowen@usu.edu; jeffery.hall@usu.edu			National Institutes of Health [U54 AI-065357]	This work was supported by a sub-award to B.B.G. as part of National Institutes of Health Grant U54 AI-065357 (Rocky Mountain RCE; J. Belisle, Principal Investigator).	Ueda O, 2005, DRUG METAB DISPOS, V33, P1312, DOI 10.1124/dmd.105.005306; Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Smither SJ, 2014, ANTIVIR RES, V104, P153, DOI 10.1016/j.antiviral.2014.01.012; Grant A, 2012, VIRUSES-BASEL, V4, P2317, DOI 10.3390/v4102317; Rocha-Pereira J, 2012, BIOCHEM BIOPH RES CO, V424, P777, DOI 10.1016/j.bbrc.2012.07.034; Pryde DC, 2010, J MED CHEM, V53, P8441, DOI 10.1021/jm100888d; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; Sangawa H, 2013, ANTIMICROB AGENTS CH, V57, P5202, DOI 10.1128/AAC.00649-13; Treitel M, 2012, CLIN PHARMACOKINET, V51, P619, DOI 10.2165/11633440-000000000-00000; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Baranovich T, 2013, J VIROL, V87, P3741, DOI 10.1128/JVI.02346-12; Mendenhall M, 2011, ANTIMICROB AGENTS CH, V55, P782, DOI 10.1128/AAC.01219-10; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Scharton D, 2014, ANTIVIR RES, V104, P84, DOI 10.1016/j.antiviral.2014.01.016; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; Buchmeier MJ, 2001, FIELDS VIROLOGY, P1635; Caroline AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002790; Cass LMR, 1999, CLIN PHARMACOKINET, V36, P1, DOI 10.2165/00003088-199936001-00001; Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209; FABRE J, 1976, Clinical Pharmacokinetics, V1, P99, DOI 10.2165/00003088-197601020-00002; Gordon AH, 1940, BIOCHEM J, V34, P764; Gowen BB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-240; Gowen BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003725; Gowen BB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002614; Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347; Kobayashi O., 2011, INT C ANT AG CHEM CH; Marty F.M., 2013, J INFECT DIS; Moraz ML, 2011, EXPERT REV ANTI-INFE, V9, P49, DOI [10.1586/eri.10.142, 10.1586/ERI.10.142]; REED L. J., 1938, AMER JOUR HYG, V27, P493; NIAID, 2015, BIOD EM INF DIS; Oestereich L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002804; Yun NE, 2012, VIRUSES-BASEL, V4, P2031, DOI 10.3390/v4102031	34	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	SEP	2015	121						132	137		10.1016/j.antiviral.2015.07.003		6	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	CQ3OI	WOS:000360511500015		
J	Mitsuda, Y; Miyako, I				Mitsuda, Yuri; Miyako, Ishiuchi			Ishiuchi Miyako	APERTURE			English	Editorial Material									[Mitsuda, Yuri] Kawamura Mem DIG Museum Art, Sakura, Chiba, Japan	Mitsuda, Y (reprint author), Kawamura Mem DIG Museum Art, Sakura, Chiba, Japan.							0	0	0	APERTURE	NEW YORK	20 EAST 23RD ST, NEW YORK, NY 10010 USA	0003-6420			APERTURE	Aperture	FAL	2015		220					122	135				14	Art	Art	CQ0AS	WOS:000360257600013		
J	Bagryanskaya, E; Lee, HI; Rudowicz, C; Ohta, H				Bagryanskaya, Elena; Lee, Hong-In; Rudowicz, Czeslaw; Ohta, Hitoshi			Modern Trends in the Development of EPR/ESR	APPLIED MAGNETIC RESONANCE			English	Editorial Material									[Bagryanskaya, Elena] Novosibirsk Organ Chem Inst, Novosibirsk 630090, Russia; [Lee, Hong-In] Kyungpook Natl Univ, Dept Chem, Taegu 702701, South Korea; [Rudowicz, Czeslaw] West Pomeranian Univ Technol Szczecin, Inst Phys, PL-70310 Szczecin, Poland; [Ohta, Hitoshi] Kobe Univ, Mol Photosci Res Ctr, Kobe, Hyogo 6578501, Japan	Ohta, H (reprint author), Kobe Univ, Mol Photosci Res Ctr, Kobe, Hyogo 6578501, Japan.	hohta@kobe-u.ac.jp						0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					965	966		10.1007/s00723-015-0719-7		2	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800001		
J	Ando, T; Yonamoto, Y				Ando, Takahiro; Yonamoto, Yoshiki			In Situ EPR Detection of Reactive Oxygen Species in Adherent Cells Using Polylysine-Coated Glass Plate	APPLIED MAGNETIC RESONANCE			English	Article							HUMAN-ENDOTHELIAL-CELLS; OXIDATIVE STRESS; CANCER-CELLS; SPIN TRAPS; SUPEROXIDE; ADHESION; SURFACES; ROS; RADICALS; GLUTATHIONE	In conventional electron paramagnetic resonance (EPR) experiments, it is a common procedure to use a cell suspension after detachment to measure reactive oxygen species (ROS) generated in the cell. However, to elucidate redox signaling transduction between the cells, the sample should be under cell culture conditions. Here, we propose an in situ EPR detection methodology of ROS produced in adherent cells. A quartz glass plate was coated with poly-l-lysine (PLL) to improve the adhesion efficiency of cultured cells. Using mouse fibroblasts and human malignant epithelial cells (HeLa) on the glass sheet (approximately 6.5 x 10(4) adherent cells per sheet), remarkable increases in the relative EPR signal intensities of spin adducts related to superoxide radicals were observed 1 h after addition of a redox-active compound (pyocyanin) and a spin trap to the culture medium. There was no disturbing effect on the EPR signals with the PLL-coated glass plate alone. The intensity of EPR signals in HeLa cells without exogenous pyocyanin was statistically significantly higher than that of the control, implying intrinsically larger amounts of ROS in cancer cells than those in non-malignant ones. Moreover, an optically transparent holder for supporting the cell-adhered glass substrate enabled both EPR detection of ROS and microscopic observation, where more than 88 % of cell viability was maintained. These findings demonstrated that the proposed in situ EPR methodology would be useful for measuring ROS generated under cell culture conditions.	[Ando, Takahiro; Yonamoto, Yoshiki] Hitachi Ltd, Yokohama Res Lab, Totsuka Ku, Yokohama, Kanagawa 2440817, Japan	Ando, T (reprint author), Hitachi Ltd, Yokohama Res Lab, Totsuka Ku, 292 Yoshida Cho, Yokohama, Kanagawa 2440817, Japan.	takahiro.ando.dc@hitachi.com					Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Durackova Z, 2010, PHYSIOL RES, V59, P459; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Shi HL, 2005, ARCH BIOCHEM BIOPHYS, V437, P59, DOI 10.1016/j.abb.2005.02.028; Eaton SS, 2012, J MAGN RESON, V223, P151, DOI 10.1016/j.jmr.2012.07.025; Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6; Hawkins CL, 2014, BBA-GEN SUBJECTS, V1840, P708, DOI 10.1016/j.bbagen.2013.03.034; Sun XX, 2013, J BIOL CHEM, V288, P8826, DOI 10.1074/jbc.M112.429316; Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E; Khan N, 2003, FREE RADICAL BIO MED, V34, P1473, DOI 10.1016/S0891-5849(03)00182-5; VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2; Takeshita K, 2004, J RADIAT RES, V45, P373, DOI 10.1269/jrr.45.373; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.0.CO;2-6; TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; FINKELSTEIN E, 1982, MOL PHARMACOL, V21, P262; Brieger K., 2012, SWISS MED WKLY, V142, P13659, DOI DOI 10.4414/SMW.2012.13659; Danhier P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053324; EDELMAN GM, 1984, P NATL ACAD SCI-BIOL, V81, P1460, DOI 10.1073/pnas.81.5.1460; Gardner PR, 1996, ARCH BIOCHEM BIOPHYS, V333, P267, DOI 10.1006/abbi.1996.0390; Kingshott P, 2011, CURR OPIN CHEM BIOL, V15, P667, DOI 10.1016/j.cbpa.2011.07.012; Kohno M, 2010, J CLIN BIOCHEM NUTR, V47, P1, DOI 10.3164/jcbn.10-13R; Muller M, 2002, FREE RADICAL BIO MED, V33, P1527, DOI 10.1016/S0891-5849(02)01087-0; Nakagawa H, 2000, FEBS LETT, V471, P187, DOI 10.1016/S0014-5793(00)01398-3; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; Osterloh K, 2002, AM J PHYSIOL-HEART C, V283, pH398, DOI 10.1152/ajpheart.00558.2001; Rahal A, 2014, BIOMED RES INT, DOI 10.1155/2014/761264; Saito K, 2009, FREE RADICAL RES, V43, P668, DOI 10.1080/10715760902988850; Shin CS, 2011, NANOSCI NANOTECH LET, V3, P561, DOI 10.1166/nnl.2011.1206; Stanczyk Malgorzata, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P15; Subczynski Witold K., 2005, V23, P229, DOI 10.1007/0-387-26741-7_10; Swartz H.M., 1998, EPR STUDIES CELLS TI, P451; TANIGAWA T, 1995, FREE RADICAL RES, V22, P361, DOI 10.3109/10715769509145648; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Utsumi H, 2003, ARCH BIOCHEM BIOPHYS, V416, P1, DOI 10.1016/S0003-9861(03)00285-6; Zhu CP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05029	43	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					977	986		10.1007/s00723-015-0688-x		10	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800003		
J	Kawasaki, K; Sakurai, T; Ohmichi, E; Okubo, S; Ohta, H; Matsubayashi, K; Uwatoko, Y				Kawasaki, Kohei; Sakurai, Takahiro; Ohmichi, Eiji; Okubo, Susumu; Ohta, Hitoshi; Matsubayashi, Kazuyuki; Uwatoko, Yoshiya			Development of High-Pressure ESR System Using Micro-coil	APPLIED MAGNETIC RESONANCE			English	Article							CELL	We have developed the high-pressure electron spin resonance (ESR) system using a micro-coil in the frequency region up to around 2 GHz and potentially 10 GHz. The hybrid-type piston-cylinder pressure cell whose maximum pressure reaches 4 GPa was used. In this study, we obtained ESR spectra at 2.3 GPa successfully, which can never be obtained by the single-layer piston-cylinder pressure cell. The minimum detectable spin number was estimated to be the order of 10(12) spins/G. Moreover, it is shown that the sensitivity can be improved by two orders of magnitude using the field modulation technique. This high-pressure ESR technique is a promising one to achieve the sensitivity and the high pressure simultaneously.	[Kawasaki, Kohei; Ohmichi, Eiji; Ohta, Hitoshi] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Sakurai, Takahiro] Kobe Univ, Ctr Supports Res & Educ Act, Kobe, Hyogo 6578501, Japan; [Okubo, Susumu; Ohta, Hitoshi] Kobe Univ, Mol Photosci Res Ctr, Kobe, Hyogo 6578051, Japan; [Matsubayashi, Kazuyuki; Uwatoko, Yoshiya] Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan	Sakurai, T (reprint author), Kobe Univ, Ctr Supports Res & Educ Act, Kobe, Hyogo 6578501, Japan.	tsakurai@kobe-u.ac.jp			Japan Society for the Promotion of Science [25400341]	This research was partially supported by Grants-in-Aid for Scientific Research (C) (No. 25400341) from Japan Society for the Promotion of Science.	SMITH TF, 1967, PHYS REV, V159, P353, DOI 10.1103/PhysRev.159.353; Sakurai T, 2012, J MAGN RESON, V223, P41, DOI 10.1016/j.jmr.2012.07.020; Uwatoko Y, 2003, PHYSICA B, V329, P1658, DOI 10.1016/S0921-4526(02)02449-3; SAKAI N, 1985, REV SCI INSTRUM, V56, P726, DOI 10.1063/1.1138215; MAHDJOUR H, 1986, REV SCI INSTRUM, V57, P1100, DOI 10.1063/1.1138664; Sakurai T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2746818; Sienkiewicz A, 2005, J MAGN RESON, V177, P261, DOI 10.1016/j.jmr.2005.08.002	7	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					987	992		10.1007/s00723-015-0650-y		6	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800004		
J	Yoshizawa, D; Kida, T; Nakatsuji, S; Iritani, K; Halim, M; Takeuchi, T; Hagiwara, M				Yoshizawa, D.; Kida, T.; Nakatsuji, S.; Iritani, K.; Halim, M.; Takeuchi, T.; Hagiwara, M.			High-Field Multi-Frequency ESR in the Rare-Earth Spinel Compound CdYb2S4	APPLIED MAGNETIC RESONANCE			English	Article							ICE	We have performed electron spin resonance (ESR) measurements in the low temperature magnetic-ordered state of polycrystalline samples of CdYb2S4. This material is one of the rare-earth spinel compounds in which Yb3+ ions form the pyrochlore lattice, and consequently, CdYb2S4 possesses anomalous properties caused by geometrical frustration and anisotropic terms. Some ESR signals have been detected, and their resonance fields are well-fitted by linear lines in the frequency vs. magnetic-field plane. One of the ESR modes appears to intersect the origin of this plane, suggesting a nearly gapless feature in the magnetically ordered state of this material. Two additional ESR modes appear above H (c) = 2.6 T, indicating that there is a field-induced phase transition at H (c). Given the nearly gapless feature of CdYb2S4, we expect that the ground state of CdYb2S4 must be either the Palmer-Chalker state or the psi (2) state.	[Yoshizawa, D.; Kida, T.; Hagiwara, M.] Osaka Univ, Grad Sch Sci, Ctr Adv High Magnet Field Sci, Osaka 5600043, Japan; [Nakatsuji, S.; Iritani, K.; Halim, M.] Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan; [Nakatsuji, S.] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; [Takeuchi, T.] Osaka Univ, Low Temp Ctr, Osaka 5600043, Japan	Hagiwara, M (reprint author), Osaka Univ, Grad Sch Sci, Ctr Adv High Magnet Field Sci, Osaka 5600043, Japan.	hagiwara@ahmf.sci.osaka-u.ac.jp			JSPS [25707030]; PRESTO; JST, Japan	We thank Kalro Penc, Collin Broholm, Oleg Tchernyshyov, and Kenta Kimura for fruitful discussions. This work was partially supported by Grants-in-Aid (No. 25707030) from JSPS, and by PRESTO, JST, Japan.	Savary L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.167201; Guitteny S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.134408; Fennell T, 2009, SCIENCE, V326, P415, DOI 10.1126/science.1177582; Snyder J, 2001, NATURE, V413, P48, DOI 10.1038/35092516; Machida Y, 2010, NATURE, V463, P210, DOI 10.1038/nature08680; Ross KA, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021002; Ishikawa JJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245109; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Iritani K., PREPRINT; Kimura K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2914; Quilliam JA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.097201; Sosin SS, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.094428	12	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					993	996		10.1007/s00723-015-0651-x		4	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800005		
J	Sakai, T; Hijii, K; Okubo, S; Ohta, H; Nakano, H; Miyashita, S				Sakai, Tru; Hijii, Keigo; Okubo, Susumu; Ohta, Hitoshi; Nakano, Hiroki; Miyashita, Seiji			Possible Singlet--Triplet Transition of ESR in the Kagome-Lattice Antiferromagnet	APPLIED MAGNETIC RESONANCE			English	Article							DIMENSIONAL S=1 ANTIFERROMAGNET; SPIN GAP EXCITATIONS; HEISENBERG-ANTIFERROMAGNET; SYSTEM SRCU2(BO3)(2); GROUND-STATE; HALDANE-GAP; MAGNETIZATION; FIELD; NENP; CUGEO3	The S = 1/2 kagome-lattice antiferromagnet is investigated by the numerical diagonalization of 18-spin finite-size cluster. The matrix elements proportional to the intensity of the singlet--triplet electron spin resonance (ESR) transition are calculated in the presence of the Dzyaloshinsky--Moriya interaction. Some angle-dependent selection rules are also proposed. The present result would be useful to examine whether the kagome-lattice antiferromagnet has a spin gap or not, with the ESR experiment.	[Sakai, Tru] SPring 8, JAEA, Sayo, Japan; [Hijii, Keigo; Okubo, Susumu; Ohta, Hitoshi] Kobe Univ, Mol Photosci Res Ctr, Kobe, Hyogo 657, Japan; [Nakano, Hiroki] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Japan; [Miyashita, Seiji] Univ Tokyo, Dept Phys, Tokyo 113, Japan	Sakai, T (reprint author), SPring 8, JAEA, Sayo, Japan.	sakai@spring8.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23340109, 24540348, 26400387]; MEXT; Computational Materials Science Initiative, Japan	This work has been partly supported by Grants-in-Aids for Scientific Research (B) (no. 23340109) and (C) (nos. 24540348 and 26400387) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). We further thank the Supercomputer Center, Institute for Solid State Physics, University of Tokyo; the Cyberscience Center, Tohoku University; and the Computer Room, Yukawa Institute for Theoretical Physics, Kyoto University; the Department of Simulation Science, National Institute for Fusion Science; Center for Computational Materials Science, Institute for Materials Research, Tohoku University; Supercomputing Division, Information Technology Center, The University of Tokyo for computational facilities. This work was partly supported by the Strategic Programs for Innovative Research, MEXT, and the Computational Materials Science Initiative, Japan. The authors would like to express their sincere thanks to the staff members of the Center for Computational Materials Science of the Institute for Materials Research, Tohoku University for their continuous support of the SR16000 supercomputing facilities.	AJIRO Y, 1989, PHYS REV LETT, V63, P1424, DOI 10.1103/PhysRevLett.63.1424; Nojiri H, 1999, J PHYS SOC JPN, V68, P2906, DOI 10.1143/JPSJ.68.2906; KATSUMATA K, 1989, PHYS REV LETT, V63, P86, DOI 10.1103/PhysRevLett.63.86; Sakai T, 2000, J PHYS SOC JPN, V69, P3521, DOI 10.1143/JPSJ.69.3521; Okamoto Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.033701; Evenbly G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.187203; Iqbal Y, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.100404; HALDANE FDM, 1983, PHYS REV LETT, V50, P1153, DOI 10.1103/PhysRevLett.50.1153; Yoshida H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.043704; Yan SM, 2011, SCIENCE, V332, P1173, DOI 10.1126/science.1201080; Ran Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117205; Cepas O, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.140405; LU W, 1991, PHYS REV LETT, V67, P3716, DOI 10.1103/PhysRevLett.67.3716; Kageyama H, 1999, PHYS REV LETT, V82, P3168, DOI 10.1103/PhysRevLett.82.3168; Cepas O, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.167205; Jiang HC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117203; Nakano H, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.053704; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; HASE M, 1993, PHYS REV LETT, V70, P3651, DOI 10.1103/PhysRevLett.70.3651; Iqbal Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.020407; Lauchli A. M., 2011, PHYS REV B, V83, P21241; Nojiri H, 1999, J PHYS SOC JPN, V68, P3417, DOI 10.1143/JPSJ.68.3417; PALME W, 1993, INT J MOD PHYS B, V7, P1016, DOI 10.1142/S0217979293002195; RICE TM, 1993, EUROPHYS LETT, V23, P445, DOI 10.1209/0295-5075/23/6/011; Sakai T., 2003, J PHYS SOC JPN, V72, P53; SAKAI T, 1994, J PHYS SOC JPN, V63, P867, DOI 10.1143/JPSJ.63.867; Shores P., 2005, J AM CHEM SOC, V127, P13462; Sindzingre P, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/27009	28	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					997	1002		10.1007/s00723-015-0652-9		6	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800006		
J	Okutani, A; Kimura, S; Takeuchi, T; Hagiwara, M				Okutani, A.; Kimura, S.; Takeuchi, T.; Hagiwara, M.			High-Field Multi-Frequency ESR in the Quasi-1D S=1/2 Ising-Like Antiferromagnet BaCo2V2O8 in a Transverse Field	APPLIED MAGNETIC RESONANCE			English	Article								We have performed high-field multi-frequency electron spin resonance (ESR) measurements of a single crystal of the S = 1/2 quasi one-dimensional (1D) Ising-like antiferromagnet BaCo2V2O8 at 1.5 K in magnetic fields of up to 14 T applied along [110] and [100] directions. Two main ESR branches, which are ascending and descending with increasing magnetic fields, are observed from 400 GHz at zero magnetic field in both cases. The low ESR mode shows a softening near 10 T for H || [100], while no softening was observed below 14 T for H || [110]. This difference in the magnetic excitations may explain the distinct phase diagrams for these two directions.	[Okutani, A.; Hagiwara, M.] Osaka Univ, Grad Sch Sci, Ctr Adv High Magnet Field Sci, Osaka 5600043, Japan; [Kimura, S.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Takeuchi, T.] Osaka Univ, Low Temp Ctr, Osaka 5600043, Japan	Hagiwara, M (reprint author), Osaka Univ, Grad Sch Sci, Ctr Adv High Magnet Field Sci, Osaka 5600043, Japan.	hagiwara@ahmf.sci.osaka-u.ac.jp	Kimura, Shojiro/A-8874-2011		MEXT, Japan [24340073, 242440590, 25246006]	This work is partly supported by Grants-in-Aid for Scientific Research (nos. 24340073, 242440590 and 25246006) from the MEXT, Japan.	He ZZ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.172403; Zhao ZY, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.134412; WICHMANN R, 1986, Z ANORG ALLG CHEM, V534, P153, DOI 10.1002/zaac.19865340320; Kimura S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.207201; He Z, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2189913; ISHIMURA N, 1980, PROG THEOR PHYS, V63, P743, DOI 10.1143/PTP.63.743; Kimura S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.033706; Kimura S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.087602; MORI S, 1994, J PHYS SOC JPN, V63, P3474, DOI 10.1143/JPSJ.63.3474; Niesen SK, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.224413; Yamaguchi H, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.033701	11	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					1003	1006		10.1007/s00723-015-0655-6		4	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800007		
J	Sakurai, T; Matsui, R; Kawasaki, K; Okubo, S; Ohta, H; Matsubayashi, K; Uwatoko, Y; Kudo, K; Koike, Y				Sakurai, Takahiro; Matsui, Ryosuke; Kawasaki, Kohei; Okubo, Susumu; Ohta, Hitoshi; Matsubayashi, Kazuyuki; Uwatoko, Yoshiya; Kudo, Kazutaka; Koike, Yoji			Development of High-Pressure and Multi-Frequency ESR System and Its Application to Quantum Spin System	APPLIED MAGNETIC RESONANCE			English	Article							PHASE-TRANSITIONS; SRCU2(BO3)(2)	We have developed a high-pressure and multi-frequency electron spin resonance (ESR) system in the submillimeter wave region. The pressure is generated by the piston-cylinder pressure cell whose inner parts are all made of ceramics. The requirements for the inner parts of the pressure cell are toughness and transmission in the submillimeter wave region and they enable us to observe the transmitted light through a sample subjected to high pressure. It was found that both properties can be achieved by the combination of the inner parts made of the ZrO2-based ceramic and the Al2O3 ceramic. For the Shastry-Sutherland compound SrCu2(BO3)(2), we observed the direct ESR transition from the singlet ground state to the first excited triplet sates at 1.5 GPa successfully in the frequency region from 300 to 700 GHz.	[Sakurai, Takahiro] Kobe Univ, Ctr Supports Res & Educ Act, Kobe, Hyogo 6578501, Japan; [Matsui, Ryosuke; Kawasaki, Kohei; Ohta, Hitoshi] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Okubo, Susumu; Ohta, Hitoshi] Kobe Univ, Mol Photosci Res Ctr, Kobe, Hyogo 6578051, Japan; [Matsubayashi, Kazuyuki; Uwatoko, Yoshiya] Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan; [Kudo, Kazutaka] Okayama Univ, Dept Phys, Okayama 7008530, Japan; [Koike, Yoji] Tohoku Univ, Dept Appl Phys, Sendai, Miyagi 9808579, Japan	Sakurai, T (reprint author), Kobe Univ, Ctr Supports Res & Educ Act, Kobe, Hyogo 6578501, Japan.	tsakurai@kobe-u.ac.jp	KUDO, Kazutaka/B-1468-2011		Japan Society for the Promotion of Science [25400341]	This research was partially supported by Grants-in-Aid for Scientific Research (C) (No. 25400341) from Japan Society for the Promotion of Science.	Sakurai T, 2012, J MAGN RESON, V223, P41, DOI 10.1016/j.jmr.2012.07.020; Fujimoto K, 2013, APPL MAGN RESON, V44, P893, DOI 10.1007/s00723-013-0441-2; Kageyama H, 2003, PHYSICA B, V329, P1020, DOI 10.1016/S0921-4526(02)02222-6; Nojiri H, 2003, J PHYS SOC JPN, V72, P3243, DOI 10.1143/JPSJ.72.3243; Cepas O, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.167205; Haravifard S, 2012, P NATL ACAD SCI USA, V109, P2286, DOI 10.1073/pnas.1114464109; Ohta H., 2003, J PHYS SOC JPN SB, V72; Sakurai T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2746818; Sakurai T, 2009, J PHYS CONF SER, V150, DOI 10.1088/1742-6596/150/4/042171	9	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					1007	1012		10.1007/s00723-015-0660-9		6	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800008		
J	Nakajima, A; Yamaguchi, T; Yamashita, T; Kawai, K; Miyake, Y; Kanaori, K; Tajima, K				Nakajima, Akira; Yamaguchi, Tomoko; Yamashita, Tomoyuki; Kawai, Kiyoshi; Miyake, Yusuke; Kanaori, Kenji; Tajima, Kunihiko			Quantitative Spin-trapping ESR Investigation of Alkoxyl Radical Derived from AAPH: Development of a Flow-injection Spin-trapping ESR System for the Oxygen Radical Absorbance Capacity Assay	APPLIED MAGNETIC RESONANCE			English	Article							SUPEROXIDE; ANTIOXIDANTS; ELIMINATE	A flow-injection electron spin resonance (ESR) system was developed for the quantitative detection of an alkoxyl radical (RO center dot, R = C(CH3)(2)-C(+NH2Cl-)NH2) derived from AAPH (2,2'-azobis(2,4-amidinopropane) dihydrochloride) by thermal decomposition. Optimal measurement conditions for the system were examined, and it was found that the control of the radical formation by quenching in an ice-water vessel should be effective to obtain the stable and accurate results. The system was applied for the estimation of the alkoxyl radical-elimination ability and the oxygen radical absorbance capacity values of selected biosubstances, such as Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), caffeic acid, 4-hydroxycinnamic acid, epinephrine, rutin, (+)-catechin, l-tryptophane, and d-mannitol. As the rate constant for the reaction between alkoxyl radical and substrate, k (S), could not be unequivocally determined, the defined value, gamma (50) = k (S)/k (1), (k (1), the rate constant for the reaction between alkoxyl radical and spin trap) was used as a reaction parameter of substrate for alkoxyl radical. The flow-injection electron spin resonance system using alkoxyl radical elimination gave valid gamma (50) values for biosubstances, and the system should be a valuable method for the evaluation of the antioxidant ability.	[Nakajima, Akira] Miyazaki Univ, Dept Biotechnol, Frontier Sci Res Ctr, Kiyotake, Miyazaki 8891692, Japan; [Yamashita, Tomoyuki; Kawai, Kiyoshi; Miyake, Yusuke; Kanaori, Kenji; Tajima, Kunihiko] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Yamaguchi, Tomoko] Kyoto Inst Technol, Venture Lab, Sakyo Ku, Kyoto 6068585, Japan	Tajima, K (reprint author), Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.	tajima@kit.ac.jp					Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R; Werber J, 2011, J PHARM SCI-US, V100, P3307, DOI 10.1002/jps.22578; Kohri S, 2009, ANAL BIOCHEM, V386, P167, DOI 10.1016/j.ab.2008.12.022; CHIGNELL CF, 1994, PHOTOCHEM PHOTOBIOL, V59, P5, DOI 10.1111/j.1751-1097.1994.tb04994.x; BUETTNER GR, 1990, FREE RADICAL RES COM, V10, P11, DOI 10.3109/10715769009145928; Cao GH, 1999, METHOD ENZYMOL, V299, P50; FINKELSTEIN E, 1979, MOL PHARMACOL, V16, P676; JANZEN EG, 1990, J AM CHEM SOC, V112, P8279, DOI 10.1021/ja00179a010; Krainev A. G., 1996, J CHEM SOC PERK T, V2, P747; Nakajima A, 2013, BIOSCI BIOTECH BIOCH, V77, P324, DOI 10.1271/bbb.120749; Nakajima A, 2013, APPL MAGN RESON, V44, P997, DOI 10.1007/s00723-013-0463-9; Nakajima A, 2012, ANAL BIOANAL CHEM, V403, P1961, DOI 10.1007/s00216-012-6021-8; Sakurai Y, 2014, CHEM LETT, V43, P527, DOI 10.1246/cl.131111; Wahl R. U. R., 1998, J CHEM SOC PERK T, V2, P2009; Watanabe R. K., 2008, CHEM LETT, V37, P612	16	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					1013	1022		10.1007/s00723-015-0664-5		10	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800009		
J	Kimura, S; Watanabe, K; Kashiwagi, T; Yamaguchi, H; Hagiwara, M; Honda, Z				Kimura, S.; Watanabe, K.; Kashiwagi, T.; Yamaguchi, H.; Hagiwara, M.; Honda, Z.			High-Field ESR Measurements of the Spin-Gap System in Polarized Microwaves	APPLIED MAGNETIC RESONANCE			English	Article								We have performed high-field electron spin resonance (ESR) measurements of the isolated antiferromagnetic dimer system Na2Co2(C2O4)(3)(H2O)(2) by illuminating circularly polarized microwaves at 162 GHz. Different from a usual ESR signal by the magnetic dipole transition, the resonance signal, coming from the direct transition between the singlet and triplet states in this compound, is suggested to show absence of circular dichroism. From this curious behavior, we consider that the direct transition in Na2Co2(C2O4)(3)(H2O)(2) is driven by oscillating electric fields of microwaves. We propose that the spin current mechanism is responsible to induce a finite probability for the electric-dipole-active transition between the singlet and the triplet states in Na2Co2(C2O4)(3)(H2O)(2).	[Kimura, S.; Watanabe, K.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kashiwagi, T.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Yamaguchi, H.] Osaka Prefecture Univ, Coll Integrated Arts & Sci, Sakai, Osaka 5888531, Japan; [Hagiwara, M.] Osaka Univ, Grad Sch Sci, Ctr Adv High Magnet Field Sci, Osaka 5600043, Japan; [Honda, Z.] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	Kimura, S (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	shkimura@imr.tohoku.ac.jp	Watanabe, Kazuo/C-2819-2011; Kimura, Shojiro/A-8874-2011		 [24340073];  [26620055]	This work is partly supported by Grant-in-Aid for Scientific Research B (Grant No. 24340073) and for Challenging Exploratory Research (Grant No. 26620055).	Wang Z, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174406; Cepas O, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024404; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Kimura S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.060413; MITRA PP, 1994, PHYS REV LETT, V72, P912, DOI 10.1103/PhysRevLett.72.912; Nakagawa Y, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.124708; Price DJ, 2000, J CHEM SOC DALTON, P3566, DOI 10.1039/b005494l; Sakai, 2003, J PHYS SOC JPN, V72, P53	8	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					1035	1039		10.1007/s00723-015-0661-8		5	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800011		
J	Ikeda, S; Hara, S; Sakurai, T; Okubo, S; Ohta, H; Sakurai, H				Ikeda, Shohei; Hara, Shigeo; Sakurai, Takahiro; Okubo, Susumu; Ohta, Hitoshi; Sakurai, Hiroya			High-field ESR Measurements of YCrO3	APPLIED MAGNETIC RESONANCE			English	Article							SUBMILLIMETER; EPR	High-field electron spin resonance measurements of perovskite compound YCrO3 powder have been performed to obtain the magnetic anisotropy. Isotropic absorption lines of electron paramagnetic resonance, which can be described as single Lorentzian shape, are observed. The g value of paramagnetic state is estimated to be 1.983 at 265 K. Magnitude of D vector of Dzyaloshinskii-Moriya interaction is estimated to be 0.36 K from Moriya's formula using the obtained g value. Powder patterns of antiferromagnetic resonance (AFMR) with large antiferromagnetic gaps are observed below T (N) = 140 K. Two antiferromagnetic gaps at zero field have been estimated to be 181 GHz (6.5 T) and 338 GHz (12.1 T), and a spin flop transition field have been estimated to be 3.5 T from widely observed frequency-field diagram at 1.9 K. Although obtained AFMR modes seem to be typical AFMR modes of two sublattice antiferromagnet with triaxial magnetic anisotropy, the obtained zero-field gap is twice as large as the obtained spin flop transition field which suggests the unconventional antiferromagnetic order.	[Ikeda, Shohei] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Hara, Shigeo; Sakurai, Takahiro] Kobe Univ, Ctr Supports Res & Educ Act, Kobe, Hyogo 6578501, Japan; [Okubo, Susumu; Ohta, Hitoshi] Kobe Univ, Mol Photosci Reserch Ctr, Kobe, Hyogo 6578501, Japan; [Sakurai, Hiroya] Natl Inst Mat Sacience, Tsukuba, Ibaraki 3050047, Japan	Ikeda, S (reprint author), Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan.	gya6o00@gmail.com; hrsgo@crystal.kobe-u.ac.jp; tsakurai@kobe-u.ac.jp; sokubo@kobe-u.ac.jp; hohta@kobe-u.ac.jp; sakurai.hiroya@nims.go.jp					Abragam A, 1970, ELECT PARAMAGNETIC R; MOTOKAWA M, 1991, INT J INFRARED MILLI, V12, P149, DOI 10.1007/BF01009889; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; MORIYA T, 1960, PHYS REV, V120, P91, DOI 10.1103/PhysRev.120.91; Duran A, 2010, J SOLID STATE CHEM, V183, P1863, DOI 10.1016/j.jssc.2010.06.001; Kimura S, 1996, INT J INFRARED MILLI, V17, P833, DOI 10.1007/BF02101391; Nakagawa N, 1998, INT J INFRARED MILLI, V19, P167, DOI 10.1023/A:1022511405901; Ohta H, 2006, J PHYS CONF SER, V51, P611, DOI 10.1088/1742-6596/51/1/140; OHTA H, 1993, J PHYS SOC JPN, V62, P785, DOI 10.1143/JPSJ.62.785; Ramesha K, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/10/102202; Serrao C. R., 2005, Physical Review B (Condensed Matter and Materials Physics), V72, DOI 10.1103/PhysRevB.72.220101	11	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	SEP	2015	46	9					1053	1058		10.1007/s00723-015-0663-6		6	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CQ3NA	WOS:000360507800013		
J	Kurniawan, KH; Pardede, M; Hedwig, R; Abdulmadjid, SN; Lahna, K; Idris, N; Jobiliong, E; Suyanto, H; Suliyanti, MM; Tjia, MO; Lie, TJ; Lie, ZS; Kurniawan, DP; Kagawa, K				Kurniawan, Koo Hendrik; Pardede, Marincan; Hedwig, Rinda; Abdulmadjid, Syahrun Nur; Lahna, Kurnia; Idris, Nasrullah; Jobiliong, Eric; Suyanto, Hery; Suliyanti, Maria Margaretha; Tjia, May On; Lie, Tjung Jie; Lie, Zener Sukra; Kurniawan, Davy Putra; Kagawa, Kiichiro			Practical and highly sensitive elemental analysis for aqueous samples containing metal impurities employing electrodeposition on indium-tin oxide film samples and laser-induced shock wave plasma in low-pressure helium gas	APPLIED OPTICS			English	Article							INDUCED BREAKDOWN SPECTROSCOPY; LIBS	We have conducted an experimental study exploring the possible application of laser-induced breakdown spectroscopy (LIBS) for practical and highly sensitive detection of metal impurities in water. The spectrochemical measurements were carried out by means of a 355 nm Nd-YAG laser within N2 and He gas at atmospheric pressures as high as 2 kPa. The aqueous samples were prepared as thin films deposited on indium-tin oxide (ITO) glass by an electrolysis process. The resulting emission spectra suggest that concentrations at parts per billion levels may be achieved for a variety of metal impurities, and it is hence potentially feasible for rapid inspection of water quality in the semiconductor and pharmaceutical industries, as well as for cooling water inspection for possible leakage of radioactivity in nuclear power plants. In view of its relative simplicity, this LIBS equipment offers a practical and less costly alternative to the standard use of inductively coupled plasma-mass spectrometry (ICP-MS) for water samples, and its further potential for in situ and mobile applications. (C) 2015 Optical Society of America	[Kurniawan, Koo Hendrik; Tjia, May On; Lie, Tjung Jie; Lie, Zener Sukra; Kurniawan, Davy Putra; Kagawa, Kiichiro] Res Ctr Maju Makmur Mandiri Fdn, Jakarta 11630, Indonesia; [Pardede, Marincan] Univ Pelita Harapan, Dept Elect Engn, Tangerang 15811, Indonesia; [Hedwig, Rinda] Bina Nusantara Univ, Dept Comp Engn, Jakarta 14810, Indonesia; [Abdulmadjid, Syahrun Nur; Lahna, Kurnia; Idris, Nasrullah] Syiah Kuala Univ, Fac Math & Nat Sci, Dept Phys, Banda Aceh 23111, Nad, Indonesia; [Jobiliong, Eric] Univ Pelita Harapan, Dept Ind Engn, Tangerang 15811, Indonesia; [Suyanto, Hery] Udayana Univ, Fac Math & Nat Sci, Dept Phys, Denpasar 80361, Bali, Indonesia; [Suliyanti, Maria Margaretha] Indonesia Inst Sci, Res Ctr Phys, Kawasan PUSPIPTEK, Tangerang Selatan 15314, Banten, Indonesia; [Tjia, May On] Bandung Inst Technol, Fac Math & Nat Sci, Phys Magnetism & Photon Grp, Bandung 40132, Indonesia; [Kagawa, Kiichiro] Fukui Sci Educ Acad, Fukui 9100804, Japan	Kurniawan, KH (reprint author), Res Ctr Maju Makmur Mandiri Fdn, 40-80 Srengseng Raya, Jakarta 11630, Indonesia.	kurnia18@cbn.net.id	Hedwig, Rinda/C-7769-2015	Hedwig, Rinda/0000-0002-4189-5205			Hahn DW, 2012, APPL SPECTROSC, V66, P347, DOI 10.1366/11-06574; Lazic V, 2014, SPECTROCHIM ACTA B, V101, P288, DOI 10.1016/j.sab.2014.09.006; Pardede M, 2001, APPL SPECTROSC, V55, P1229, DOI 10.1366/0003702011953243; Fortes FJ, 2010, SPECTROCHIM ACTA B, V65, P975, DOI 10.1016/j.sab.2010.11.009; Radziemski L, 2013, SPECTROCHIM ACTA B, V87, P3, DOI 10.1016/j.sab.2013.05.013; Hahn David W, 2010, Appl Spectrosc, V64, P335, DOI 10.1366/000370210793561691; Hedwig R, 2006, SPECTROCHIM ACTA B, V61, P1285, DOI 10.1016/j.sab.2006.10.012; Kurniawan KH, 2014, APPL SPECTROSC REV, V49, P323, DOI 10.1080/05704928.2013.825267; Samu Jarvinen T., 2014, SPECTROCHIM ACTA B, V99, P9; Winefordner D., 2004, J ANAL ATOM SPECTROM, V19, P1061	10	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	SEP 1	2015	54	25					7592	7597		10.1364/AO.54.007592		6	Optics	Optics	CQ1GB	WOS:000360344200020		
J	Tan, H; Oishi, T; Tanaka, A; Doerffer, R				Tan, Hiroyuki; Oishi, Tomohiko; Tanaka, Akihiko; Doerffer, Roland			Accurate estimation of the backscattering coefficient by light scattering at two backward angles	APPLIED OPTICS			English	Article							COASTAL WATERS; OCEAN WATERS; VOLUME; SEA; PHYTOPLANKTON; DISTRIBUTIONS; POLARIZATION; PARTICLES; DIRECTION	Backscattering coefficients are frequently estimated from light scattering at one backward angle multiplied by a conversion factor. We determined that the shapes of the volume scattering functions (VSFs), particularly for scattering angles larger than 170 degrees, cause significant variations in the conversion factor at 120 degrees. Our approach uses the ratio of scattering at 170 degrees and at 120 degrees, which is a good indicator of the shape differences of the VSFs for most oceanic waters and wavelengths in the visible range. The proposed method provides significant accuracy improvement in the determination of the backscattering coefficients with a prediction error of 3% of the mean. (C) 2015 Optical Society of America	[Tan, Hiroyuki] Marine Engn & Technol Serv, Kitakyushu, Fukuoka, Japan; [Tan, Hiroyuki; Oishi, Tomohiko; Tanaka, Akihiko] Tokai Univ, Sch Marine Sci & Technol, Shizuoka, Japan; [Tan, Hiroyuki; Doerffer, Roland] Helmholtz Zentrum Geesthacht, Inst Coastal Res, D-21502 Geesthacht, Germany	Tan, H (reprint author), Marine Engn & Technol Serv, Ohiraki 3-8-12, Kitakyushu, Fukuoka, Japan.	hiro@ko-marine.com			German Academic Exchange Service (Deutsche Akademische Austauschdienst Dienst) [A0604137]; Japan Society for the Promotion of Science (JSPS) [15K05290]	German Academic Exchange Service (Deutsche Akademische Austauschdienst Dienst) (A0604137); Japan Society for the Promotion of Science (JSPS) (15K05290).	Sullivan JM, 2009, APPL OPTICS, V48, P6811, DOI 10.1364/AO.48.006811; FOURNIER GR, 1994, P SOC PHOTO-OPT INS, V2258, P194, DOI 10.1117/12.190063; Freda W, 2012, OCEANOLOGIA, V54, P355, DOI 10.5697/oc.54-3.355; BRICAUD A, 1986, APPL OPTICS, V25, P571; Boss E, 2001, APPL OPTICS, V40, P5503, DOI 10.1364/AO.40.005503; Tan H, 2013, OPT EXPRESS, V21, P18697, DOI 10.1364/OE.21.018697; GORDON HR, 1975, APPL OPTICS, V14, P417, DOI 10.1364/AO.14.000417; Zhang XD, 2012, APPL OPTICS, V51, P5085, DOI 10.1364/AO.51.005085; Berthon JF, 2007, APPL OPTICS, V46, P5189, DOI 10.1364/AO.46.005189; Sokolov A, 2010, OPT EXPRESS, V18, P4615, DOI 10.1364/OE.18.004615; Gilerson AA, 2013, APPL OPTICS, V52, P8685, DOI 10.1364/AO.52.008685; Aas E, 1996, J PLANKTON RES, V18, P2223, DOI 10.1093/plankt/18.12.2223; OISHI T, 1990, APPL OPTICS, V29, P4658, DOI 10.1364/AO.29.004658; Chami M, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003230; Tonizzo A, 2009, OPT EXPRESS, V17, P5666, DOI 10.1364/OE.17.005666; Zhang XD, 2011, APPL OPTICS, V50, P1240, DOI 10.1364/AO.50.001240; ULLOA O, 1994, APPL OPTICS, V33, P7070, DOI 10.1364/AO.33.007070; Maffione RA, 1997, APPL OPTICS, V36, P6057, DOI 10.1364/AO.36.006057; Volten H, 1998, LIMNOL OCEANOGR, V43, P1180; Randolph K, 2014, J GEOPHYS RES-OCEANS, V119, P757, DOI 10.1002/2013JC009227; Sullivan JM, 2005, APPL OPTICS, V44, P1667, DOI 10.1364/AO.44.001667; Babin M, 2003, LIMNOL OCEANOGR, V48, P843; Czerski H., 2011, J GEOPHYS RES, V116; Jerlov NG, 1976, MARINE OPTICS; Jodai Y., 1996, P SOC PHOTO-OPT INS, V2963, P461; Lee ME, 2003, OCEANS 2003 MTS/IEEE: CELEBRATING THE PAST...TEAMING TOWARD THE FUTURE, P2835; Mankovsky V. I., 2002, P OCEANS 2002 MTS IE, V4, P2368; Mankovsky V. I., 2002, IEEE INT GEOSC REM S; Mishchenko MI, 2000, LIGHT SCATTERING NON; Mobley C. D., 1994, LIGHT WATER RAD TRAN; Morel A., 1974, OPTICAL ASPECTS OCEA; Morel A., 1973, AGARD LECT SER, V61; Petzold T. J., 1972, 7278 ISO; Sullivan J., 2013, LIGHT SCATTERING REV, V7, P189; Twardowski M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007347; van de Hulst H. C., 1957, LIGHT SCATTERING SMA; Whitmire L., 2010, OPT EXPRESS, V18, P15073; You Y, 2011, APPL OPTICS, V50, P4873, DOI 10.1364/AO.50.004873; Zhang XD, 2014, OPT EXPRESS, V22, P31329, DOI 10.1364/OE.22.031329	39	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	SEP 1	2015	54	25					7718	7733		10.1364/AO.54.007718		16	Optics	Optics	CQ1GB	WOS:000360344200035		
J	Kuznetsov, I; Mukhin, I; Vadimova, O; Palashov, O; Ueda, K				Kuznetsov, Ivan; Mukhin, Ivan; Vadimova, Olga; Palashov, Oleg; Ueda, Ken-ichi			Thermal effects in Yb:YAG single-crystal thin-rod amplifier	APPLIED OPTICS			English	Article							YB-YAG; HEAT-GENERATION; LASER-BEAM; TEMPERATURE; DISKS	This work presents a new design for the laser gain module based on a ytterbium-doped yttrium aluminum garnet (Yb:YAG) single-crystal thin rod. Thermal effects (temperature, phase, and polarization distortion of laser radiation) and small signal gain are investigated both experimentally and theoretically. We then analyzed the influence of thermal effects and amplified spontaneous emission on the power scaling of the laser based on the gain module. A small signal gain as high as 3.3 per pass was experimentally achieved. (C) 2015 Optical Society of America	[Kuznetsov, Ivan; Mukhin, Ivan; Vadimova, Olga; Palashov, Oleg; Ueda, Ken-ichi] Russian Acad Sci, Inst Appl Phys, Nizhnii Novgorod 603950, Russia; [Palashov, Oleg] Lobachevsky State Univ Nizhny Novgorod, Nizhnii Novgorod 603950, Russia; [Ueda, Ken-ichi] Univ Electrocommun, Inst Laser Sci, Chou Ku, Tokyo 1828585, Japan	Kuznetsov, I (reprint author), Russian Acad Sci, Inst Appl Phys, 46 Ulyanov Str, Nizhnii Novgorod 603950, Russia.	ivanushka911@yandex.ru			Mega-grant of the Government of the Russian Federation [14.B25.31.0024]; Ministry of Education; Science of Russian Federation; Nizhny Novgorod State University [02.B.44.21.0003]	Mega-grant of the Government of the Russian Federation (14.B25.31.0024); Ministry of Education and Science of Russian Federation and Nizhny Novgorod State University (02.B.44.21.0003).	Anashkina E, 2010, J OPT SOC AM B, V27, P363, DOI 10.1364/JOSAB.27.000363; Schulz M, 2012, OPT EXPRESS, V20, P5038, DOI 10.1364/OE.20.005038; Zaouter Y, 2011, OPT LETT, V36, P748, DOI 10.1364/OL.36.000748; Delen X, 2012, OPT LETT, V37, P2898, DOI 10.1364/OL.37.002898; Delen X, 2013, OPT LETT, V38, P109, DOI 10.1364/OL.38.000109; Vadimova OL, 2013, QUANTUM ELECTRON+, V43, P201, DOI 10.1070/QE2013v043n03ABEH015064; Sato Y, 2009, OPT MATER, V31, P720, DOI 10.1016/j.optmat.2008.10.040; Arzakantsyan M, 2012, OPT MATER EXPRESS, V2, P1219; Sato Y, 2014, OPT MATER EXPRESS, V4, P876, DOI 10.1364/OME.4.000876; Mukhin IB, 2011, QUANTUM ELECTRON+, V41, P1045, DOI [10.1070/QE2011v041n11ABEH014575, 10.1070/QE2011v041n11ABEH14575]; Creath K., 1988, Progress in optics. Vol.XXVI, DOI 10.1016/S0079-6638(08)70178-1; Eichhorn M, 2009, APPL PHYS B-LASERS O, V94, P451, DOI 10.1007/s00340-008-3292-z; FAN TY, 1993, IEEE J QUANTUM ELECT, V29, P1457, DOI 10.1109/3.234394; Fourmigue J. M., 2014, LASER OPTICS 2014, pTuSy1; Koechner W., 1999, SOLID STATE LASER EN; Kuznetsov Ivan I., 2014, IEEE Journal of Quantum Electronics, V50, DOI 10.1109/JQE.2013.2297743; Larionov M., 2014, ADV SOLID STATE LASE; Liu Q, 2007, J OPT SOC AM B, V24, P2081, DOI 10.1364/JOSAB.24.002081; Potemkin AK, 2005, QUANTUM ELECTRON+, V35, P1042, DOI 10.1070/QE2005v035n11ABEH01288; SUMIDA DS, 1994, OSA PROC, V20, P100; Vyatkin AG, 2009, QUANTUM ELECTRON+, V39, P814, DOI 10.1070/QE2009v039n09ABEH014039	21	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	SEP 1	2015	54	25					7747	7752		10.1364/AO.54.007747		6	Optics	Optics	CQ1GB	WOS:000360344200038		
J	Hayashida, H; Dolan, NJ; Hounsome, C; Alajmi, N; Bishop, NC				Hayashida, Harumi; Dolan, Nicola J.; Hounsome, Charlotte; Alajmi, Nawal; Bishop, Nicolette C.			Salivary SIgA responses to acute moderate-vigorous exercise in monophasic oral contraceptive users	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM			English	Article						oral contraceptive cycle; upper respiratory symptoms; aerobic exercise; estrogen; monophasic combined oral contraceptives	MUCOSAL IMMUNITY; MENSTRUAL-CYCLE; SEX-DIFFERENCES; IGA; GENDER; PERFORMANCE; EXPRESSION; SWIMMERS; PHASE	The purpose of this study was to examine the effect of oral contraceptive (OC) use on salivary secretory immunoglobulin A (SIgA) levels at rest and in response to an acute bout of moderate-vigorous exercise during 2 phases of the 4-week OC cycle corresponding to different phases of the synthetic menstrual cycle. Ten healthy active females completed a cycling at 70% peak oxygen uptake for 45 min at 2 time points of an OC cycle: during the equivalent in time to the mid-follicular phase (day 8 +/- 2) and the mid-luteal phase (day 20 +/- 2). Timed unstimulated saliva samples were obtained before, immediately postexercise, and 1 h postexercise and analyzed for salivary SIgA. Salivary SIgA secretion rate was 26% (95% confidence limits (CI) 6-46) lower at postexercise compared with pre-exercise during the synthetic follicular phase (p = 0.019) but no differences were observed during the synthetic luteal trial. Saliva flow rate was 11% (95% CI, 8-30) lower at postexercise compared with pre-exercise (main effect for time; p = 0.025). In conclusion, the pattern of salivary SIgA secretion rate response to moderate-vigorous exercise varies across the early and late phases of a monophasic OC cycle, with a transient reduction in salivary SIgA responses during the synthetic follicular phase. These findings indicate that monophasic OC use should be considered when assessing mucosal immune responses to acute exercise.	[Hayashida, Harumi; Dolan, Nicola J.; Hounsome, Charlotte; Alajmi, Nawal; Bishop, Nicolette C.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England	Hayashida, H (reprint author), Tokoha Univ, Fac Hlth Promot Sci, Kita Ku, 1230 Miyakodacho, Hamamatsu, Shizuoka 4312102, Japan.	h-hayashida@fuji.waseda.jp					Allgrove JE, 2009, INT J SPORT NUTR EXE, V19, P209; Cha HR, 2011, J IMMUNOL, V187, P3044, DOI 10.4049/jimmunol.1100402; Fahlman MM, 2005, MED SCI SPORT EXER, V37, P374, DOI 10.1249/01.MSS.0000155432.67020.88; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA479, DOI 10.1016/j.autrev.2011.11.022; Neville V, 2008, MED SCI SPORT EXER, V40, P1228, DOI 10.1249/MSS.0b013e31816be9c3; Bishop NC, 2009, FRONT BIOSCI, V14, P4444, DOI 10.2741/3540; Morgado JP, 2014, J SPORT SCI MED, V13, P708; Franklin RD, 1999, J REPROD IMMUNOL, V42, P93, DOI 10.1016/S0165-0378(98)00086-2; Burrows M, 2007, SPORTS MED, V37, P557, DOI 10.2165/00007256-200737070-00001; Gleeson M, 2012, SCAND J MED SCI SPOR, V22, P410, DOI 10.1111/j.1600-0838.2010.01272.x; He CS, 2014, EXERC IMMUNOL REV, V20, P8; Safaeian M, 2009, J INFECT DIS, V199, P455, DOI 10.1086/596060; Bennell K, 1999, BRIT J SPORT MED, V33, P231; Burrows M, 2002, J SPORT SCI, V20, P339, DOI 10.1080/026404102753576116; Cohen J., 1988, STAT POWER ANAL BEHA, P380; Cole AS, 1988, BIOCH ORAL BIOL; Diebel ME, 2011, J TRAUMA, V71, P474, DOI 10.1097/TA.0b013e318228239d; Gillum T, 2014, EXERC IMMUNOL REV, V20, P23; Gleeson M, 2011, EXERC IMMUNOL REV, V17, P122; Guttmacher Institute, 2013, CONTR US US; HSCIC, 2013, NHS CONTR SERV ENGL; Pyne DB, 2001, MED SCI SPORT EXER, V33, P348, DOI 10.1097/00005768-200103000-00002; ROSATO R, 1995, MOL CELL ENDOCRINOL, V110, P81, DOI 10.1016/0303-7207(95)03519-D; Timmons BW, 2005, J APPL PHYSIOL, V99, P979, DOI 10.1152/japplphysiol.00171.2005	24	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1715-5312	1715-5320		APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	SEP	2015	40	9					863	867		10.1139/apnm-2014-0468		5	Nutrition & Dietetics; Physiology; Sport Sciences	Nutrition & Dietetics; Physiology; Sport Sciences	CQ1QV	WOS:000360374300001		
J	Hishikawa, K; Goishi, K; Fujiwara, T; Kaneshige, M; Ito, Y; Sago, H				Hishikawa, Kenji; Goishi, Keiji; Fujiwara, Takeo; Kaneshige, Masao; Ito, Yushi; Sago, Haruhiko			Pulmonary air leak associated with CPAP at term birth resuscitation	ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION			English	Article							END-EXPIRATORY PRESSURE; NEONATAL PNEUMOTHORAX; NEWBORN-INFANTS; PRETERM INFANTS; WEIGHT INFANTS; DELIVERY; INTUBATION; RISK	Objective The Japan Resuscitation Council (JRC) Guidelines 2010 for neonatal resuscitation introduced continuous positive airway pressure (CPAP) in delivery room. The present study evaluated the effect of CPAP for pulmonary air leak at term birth. Design, setting and patients This retrospective single-centre study used the data of term neonates who were born without major congenital anomalies at our centre between 2008 and 2009, and between 2011 and 2012. Interventions Resuscitation according to the JRC Guidelines 2010. Main outcome measures We examined the association between the JRC Guidelines 2010, CPAP by face mask and pulmonary air leak. Results A total of 5038 infants were analysed. The frequency of CPAP by face mask increased after the update of the JRC Guidelines in 2010 (1.7% vs 11.1%; p<0.001). Pulmonary air leak increased at early term (37 weeks: 1.0% vs 3.5%, p=0.02; 38 weeks: 0.7% vs 2.2%, p=0.02). While adjusting for confounders, the JRC Guidelines 2010 was associated with pulmonary air leak in early-term neonates (37 weeks: adjusted OR (aOR) 4.37; 95% CI 1.40 to 17.45; 38 weeks: aOR 2.80; 95% CI 1.04 to 8.91), but this association disappeared while adjusting for face mask CPAP additionally (37 weeks: aOR 1.90; 95% CI 0.47 to 8.71; 38 weeks: aOR 1.66; 95% CI 0.54 to 5.77). Conclusions Following the update of the JRC guidelines on neonatal resuscitation, we observed an increased use of CPAP via face mask, which was associated with a higher prevalence of pulmonary air leak in early-term neonates in our centre.	[Hishikawa, Kenji; Goishi, Keiji; Kaneshige, Masao; Ito, Yushi] Natl Ctr Child Hlth & Dev, Div Neonatol, Ctr Maternal Fetal Neonatal & Reprod Med, Setagaya Ku, Tokyo 1578535, Japan; [Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Dev Social Med, Tokyo, Japan; [Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo 1578535, Japan	Hishikawa, K (reprint author), Natl Ctr Child Hlth & Dev, Div Neonatol, Ctr Maternal Fetal Neonatal & Reprod Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	hishikawa.k1234@gmail.com					Zanardo V, 2007, J PEDIATR-US, V150, P252, DOI 10.1016/j.jpeds.2006.12.008; Sengupta S, 2013, JAMA PEDIATR, V167, P1053, DOI 10.1001/jamapediatrics.2013.2581; Lindner W, 1999, PEDIATRICS, V103, P961, DOI 10.1542/peds.103.5.961; Wiswell TE, 2011, RESP CARE, V56, P1360, DOI 10.4187/respcare.01433; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Zanardo V, 2004, ACTA PAEDIATR, V93, P643, DOI 10.1080/08035250410026671; Probyn ME, 2004, PEDIATR RES, V56, P198, DOI 10.1203/01.PDR.0000132752.94155.13; Finer NN, 2004, PEDIATRICS, V114, P651, DOI 10.1542/peds.2004-0394; PALMEKILANDER C, 1992, ACTA PAEDIATR, V81, P739, DOI 10.1111/j.1651-2227.1992.tb12094.x; International Liaison Committee on Resuscitation, 2005, RESUSCITATION, V67, P293; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Saugstad OD, 1998, EUR J PEDIATR, V157, pS11, DOI 10.1007/PL00014284; Finer NN, 2010, NEW ENGL J MED, V362, P1970; Tamura M, JRC GUIDELINES 2010; te Pas AB, 2007, PEDIATRICS, V120, P936, DOI 10.1542/peds.2007-2440; Trevisanuto D, 2005, J PERINAT MED, V33, P449, DOI 10.1515/JPM.2005.079; Wiswell TE, 2011, RESP CARE, V56, P1367	17	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1359-2998	1468-2052		ARCH DIS CHILD-FETAL	Arch. Dis. Child.-Fetal Neonatal Ed.	SEP	2015	100	5					F382	F387		10.1136/archdischild-2014-307891		6	Pediatrics	Pediatrics	CQ2ZA	WOS:000360470000004		
J	Kuwata, R; Sugiyama, H; Yonemitsu, K; Dung, NV; Terada, Y; Taniguchi, M; Shimoda, H; Takano, A; Maeda, K				Kuwata, Ryusei; Sugiyama, Hiroki; Yonemitsu, Kenzo; Nguyen Van Dung; Terada, Yutaka; Taniguchi, Masayasu; Shimoda, Hiroshi; Takano, Ai; Maeda, Ken			Isolation of Japanese encephalitis virus and a novel insect-specific flavivirus from mosquitoes collected in a cowshed in Japan	ARCHIVES OF VIROLOGY			English	Article							PIPIENS DIPTERA-CULICIDAE; QUANG BINH VIRUS; CULEX-FLAVIVIRUS; GENETIC-CHARACTERIZATION; YUNNAN PROVINCE; TRANSMISSION; CHINA; GENOTYPE; TRITAENIORHYNCHUS; PSEUDOVISHNUI	Cattle do not generally appear to develop severe viremia when infected with Japanese encephalitis virus (JEV), and they can be infected without showing clinical signs. However, two cattle in Japan recently died from JEV infection. In this study, we investigated the presence of different species of mosquitoes and flavivirus in a cowshed in the southwest region of Japan. In this cowshed, the two most common species of mosquitoes collected were Culex tritaeniorhynchus (including Culex pseudovishnui) and Anopheles sinensis. We performed virus isolation from the collected mosquitoes and obtained two flaviviruses: JEV and a novel insect-specific flavivirus, tentatively designated Yamadai flavivirus (YDFV). Phylogenetic analysis revealed that all three JEV isolates belonged to JEV genotype I and were closely related to a JEV strain that was isolated from the brains of cattle exhibiting neurological symptoms in Japan. Genetic characterization of YDFV revealed that the full genome RNA (10,863 nucleotides) showed homology with the Culex-associated insect-specific flaviviruses Quang Binh virus (79 % identity) and Yunnan Culex flavivirus (78 % identity), indicating that YDFV is a novel insect-specific flavivirus.	[Kuwata, Ryusei; Sugiyama, Hiroki; Yonemitsu, Kenzo; Nguyen Van Dung; Terada, Yutaka; Shimoda, Hiroshi; Takano, Ai; Maeda, Ken] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Microbiol, Yamaguchi 7538515, Japan; [Taniguchi, Masayasu] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Theriogenol, Yamaguchi 7538515, Japan	Maeda, K (reprint author), Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Microbiol, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	kmaeda@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology TOKUBETSUKEIHI; Yamaguchi University; Japanese Ministry of Health, Labor and Welfare [H25-Shinko-Ippan-006]; Japan Society for the Promotion of Science (KAKEN) [25893151]	The authors would like to thank Norio Kamura and the staff of the Experimental Farm of Yamaguchi University for their assistance in arranging field work. This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology TOKUBETSUKEIHI to Dr. Masahiro Fujishima, Yamaguchi University, and Grants-in-Aid from the Japanese Ministry of Health, Labor and Welfare (H25-Shinko-Ippan-006), and the Japan Society for the Promotion of Science (KAKEN Grant No. 25893151).	Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474; Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0; Machado DC, 2012, INTERVIROLOGY, V55, P475, DOI 10.1159/000337166; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034; Parreira R, 2012, VIRUS RES, V167, P152, DOI 10.1016/j.virusres.2012.04.010; Shimoda H, 2010, EMERG INFECT DIS, V16, P1137, DOI 10.3201/eid1607.091757; Zuo SQ, 2014, VIRUS RES, V180, P31, DOI 10.1016/j.virusres.2013.12.005; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1; Blitvich BJ, 2009, J MED ENTOMOL, V46, P934, DOI 10.1603/033.046.0428; Goenaga S, 2014, J MED ENTOMOL, V51, P900; Lim SI, 2007, J VET SCI, V8, P45; Morales-Betoulle ME, 2008, J MED ENTOMOL, V45, P1187, DOI 10.1603/0022-2585(2008)45[1187:CFIFMI]2.0.CO;2; Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Nabeshima T, 2010, FUTURE VIROL, V5, P343, DOI 10.2217/FVL.10.21; Schuh AJ, 2014, J VIROL, V88, P4522, DOI 10.1128/JVI.02686-13; Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039; Kuno G, 1998, J VIROL, V72, P73; Katayama T, 2013, J CLIN MICROBIOL, V51, P3448, DOI 10.1128/JCM.00737-13; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Farfan-Ale JA, 2010, VECTOR-BORNE ZOONOT, V10, P777, DOI 10.1089/vbz.2009.0196; Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043; Clements AN, 1999, BIOL MOSQUITOES SENS, P480; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Felsenstein J., 2005, PHYLIP PHYLOGENY INF; Feng Y, 2012, JPN J INFECT DIS, V65, P215; ILKAL MA, 1988, T ROY SOC TROP MED H, V82, P628, DOI 10.1016/0035-9203(88)90536-6; Kamimura K, 1968, MED ENTOMOL ZOOL, V19, P15; Kato N, 2014, BMC VET RES, V10, P63; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712; Liu H, 2013, VECTOR-BORNE ZOONOT, V13, P41, DOI 10.1089/vbz.2012.1016; Liu XB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-221; Lutomiah Joel J.L., 2007, Journal of Insect Science (Tucson), V7, P1, DOI 10.1673/031.007.5501; MOURYA DT, 1991, INDIAN J MED RES-A, V93, P250; NAIK PS, 1990, INDIAN J MED RES-A, V91, P331; Obara M, 2011, AM J TROP MED HYG, V84, P695, DOI 10.4269/ajtmh.2011.10-0188; Obara-Nagoya M, 2013, J MED ENTOMOL, V50, P300, DOI 10.1603/ME12159; Ohno Y, 2009, J VET MED SCI, V71, P1035, DOI 10.1292/jvms.71.1035; Philip SP, 2000, ICMR B, V30, P37; Saiyasombat R, 2010, ARCH VIROL, V155, P983, DOI 10.1007/s00705-010-0665-5; Sakai T, 1989, PREV VET MED, V116, P325; Takasaki T, 2009, IASR, V30, P156; Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449; Thenmozhi V, 2006, TROP MED INT HEALTH, V11, P288, DOI 10.1111/j.1365-3156.2006.01567.x; Wada Y, 1971, MED ENTOMOL ZOOL, V22, P24	49	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	SEP	2015	160	9					2151	2159		10.1007/s00705-015-2488-x		9	Virology	Virology	CQ3NC	WOS:000360508000002		
J	Fukuma, A; Tani, H; Taniguchi, S; Shimojima, M; Saijo, M; Fukushi, S				Fukuma, Aiko; Tani, Hideki; Taniguchi, Satoshi; Shimojima, Masayuki; Saijo, Masayuki; Fukushi, Shuetsu			Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein	ARCHIVES OF VIROLOGY			English	Article							RESPIRATORY-SYNDROME CORONAVIRUS; DIPEPTIDYL PEPTIDASE 4; RIFT-VALLEY FEVER; FUNCTIONAL RECEPTOR; DROMEDARY CAMELS; ANTIBODIES; SUSCEPTIBILITY; PNEUMONIA; BINDING; MODEL	Middle East respiratory syndrome (MERS) coronavirus (Co-V) contains a single spike (S) protein, which binds to a receptor molecule, dipeptidyl peptidase 4 (DPP4; also known as CD26), and serves as a neutralizing antigen. Pseudotyped viruses are useful for measuring neutralization titers against highly infectious viruses as well as for studying their mechanism of entry. In this study, we constructed a series of cytoplasmic deletion mutants of MERS-CoV S and compared the efficiency with which they formed pseudotypes with vesicular stomatitis virus. A pseudotype bearing an S protein with the C-terminal 16 amino acids deleted (MERSpv-St16) reached a maximum titer that was approximately tenfold higher than that of a pseudotype bearing a non-truncated full-length S protein. Using MERSpv-St16, we demonstrated the inability of rat DPP4 to serve as a functional receptor for MERS-CoV, suggesting that rats are not susceptible to MERS-CoV infection. This study provides novel information that enhances our understanding of the host range of MERS-CoV.	[Fukuma, Aiko; Tani, Hideki; Taniguchi, Satoshi; Shimojima, Masayuki; Saijo, Masayuki; Fukushi, Shuetsu] Natl Inst Infect Dis, Dept Virol 1, Tokyo 2080011, Japan	Fukushi, S (reprint author), Natl Inst Infect Dis, Dept Virol 1, 4-7-1 Gakuen, Tokyo 2080011, Japan.	fukushi@nih.go.jp			Ministry of Health, Labor, and Welfare of Japan [H25 Shinko-Ippan-008]; JSPS KAKENHI [26450418]	We thank Dr. Bart Haagmans and Dr. Ron Fouchier, Erasmus Medical Center, Rotterdam, The Netherlands, for providing MERS-CoV, and Dr. Kazuo Ohnishi, National Institute of Infectious Diseases, for providing a monoclonal antibody for MERS-CoV S protein. We also thank Dr. Shutoku Matsuyama and Dr. Masato Tashiro, National Institute of Infectious Diseases, for experimental support and helpful discussions. This work was supported in part by a grant-in-aid from the Ministry of Health, Labor, and Welfare of Japan (H25 Shinko-Ippan-008) and JSPS KAKENHI Grant Number 26450418.	Fukushi S, 2012, J VIROL METHODS, V180, P68, DOI 10.1016/j.jviromet.2011.12.013; Cockrell AS, 2014, J VIROL, V88, P5195, DOI 10.1128/JVI.03764-13; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92; Raj VS, 2014, J VIROL, V88, P1834, DOI 10.1128/JVI.02935-13; Munster VJ, 2013, NEW ENGL J MED, V368, P1560, DOI 10.1056/NEJMc1215691; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14; Barlan A, 2014, J VIROL, V88, P4953, DOI 10.1128/JVI.00161-14; Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Ogino M, 2003, CLIN DIAGN LAB IMMUN, V10, P154, DOI 10.1128/CDLI.10.1.154-160.2003; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Abroug F, 2014, EMERG INFECT DIS, V20, P1527, DOI 10.3201/eid2009.140378; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Bosch BJ, 2013, CELL RES, V23, P1069, DOI 10.1038/cr.2013.108; Bukbuk DN, 2014, T ROY SOC TROP MED H, V108, P768, DOI 10.1093/trstmh/tru163; Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250; Fanoy Ewout B, 2014, Emerg Themes Epidemiol, V11, P16, DOI 10.1186/1742-7622-11-16; Fukushi S, 2005, J GEN VIROL, V86, P2269, DOI 10.1099/vir.080955-0; Nowotny N, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.16.20781; Kraaij-Dirkzwager M, 2014, EURO SURVEILL, V19; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Muller M. A., 2012, MBIO, V3; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Tsiodras S, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.16.20782; Zhao GY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-266; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111	27	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	SEP	2015	160	9					2293	2300		10.1007/s00705-015-2506-z		8	Virology	Virology	CQ3NC	WOS:000360508000015		
J	Iijima, H; Fukutani, N; Aoyama, T; Fukumoto, T; Uritani, D; Kaneda, E; Ota, K; Kuroki, H; Matsuda, S				Iijima, Hirotaka; Fukutani, Naoto; Aoyama, Tomoki; Fukumoto, Takahiko; Uritani, Daisuke; Kaneda, Eishi; Ota, Kazuo; Kuroki, Hiroshi; Matsuda, Shuichi			Clinical Phenotype Classifications Based on Static Varus Alignment and Varus Thrust in Japanese Patients With Medial Knee Osteoarthritis	ARTHRITIS & RHEUMATOLOGY			English	Article							POPULATION-BASED COHORT; ADDUCTION MOMENT; RISK-FACTORS; PAIN; PROGRESSION; GAIT; MALALIGNMENT; DISEASE; ASSOCIATION; EXERCISE	Objective. To investigate the association between knee pain during gait and 4 clinical phenotypes based on static varus alignment and varus thrust in patients with medial knee osteoarthritis (OA). Methods. Patients in an orthopedic clinic (n=266) diagnosed as having knee OA (Kellgren/Lawrence [K/L] grade >= 1) were divided into 4 phenotype groups according to the presence or absence of static varus alignment and varus thrust (dynamic varus): no varus (n=173), dynamic varus (n=17), static varus (n=50), and static varus+dynamic varus (n=26). The knee range of motion, spatiotemporal gait parameters, visual analog scale scores for knee pain, and scores on the Japanese Knee Osteoarthritis Measure were used to assess clinical outcomes. Multiple logistic regression analyses identified the relationship between knee pain during gait and the 4 phenotypes, adjusted for possible risk factors, including age, sex, body mass index, K/L grade, and gait velocity. Results. Multiple logistic regression analysis showed that varus thrust without varus alignment was associated with knee pain during gait (odds ratio [OR] 3.30, 95% confidence interval [95% CI] 1.08-12.4), and that varus thrust combined with varus alignment was strongly associated with knee pain during gait (OR 17.1, 95% CI 3.19-320.0). Sensitivity analyses applying alternative cutoff values for defining static varus alignment showed comparable results. Conclusion. Varus thrust with or without static varus alignment was associated with the occurrence of knee pain during gait. Tailored interventions based on individual malalignment phenotypes may improve clinical outcomes in patients with knee OA.	[Iijima, Hirotaka; Fukutani, Naoto; Aoyama, Tomoki; Kuroki, Hiroshi; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Kyoto 6068507, Japan; [Fukumoto, Takahiko; Uritani, Daisuke] Kio Univ, Nara, Japan; [Kaneda, Eishi] Nozomi Orthopaed Clin, Hiroshima, Japan; [Ota, Kazuo] Ota Orthopaed Clin, Kyoto, Japan	Aoyama, T (reprint author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 53 Shogoin, Kyoto 6068507, Japan.	aoyama.tomoki.4e@kyoto-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare	Supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science, and Technology, and the Ministry of Health, Labor, and Welfare.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Felson DT, 2010, OSTEOARTHR CARTILAGE, V18, P601, DOI 10.1016/j.joca.2010.01.007; Thorstensson CA, 2007, OSTEOARTHR CARTILAGE, V15, P1163, DOI 10.1016/j.joca.2007.03.012; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Bennell KL, 2014, ARTHRITIS RHEUMATOL, V66, P950, DOI 10.1002/art.38317; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Knoop J, 2011, ARTHRIT CARE RES, V63, P1535, DOI 10.1002/acr.20571; Hinman RS, 2007, RHEUMATOLOGY, V46, P1057, DOI 10.1093/rheumatology/kem114; Bennell KL, 2010, ANN RHEUM DIS, V69, P1151, DOI 10.1136/ard.2009.118182; Shull PB, 2013, J ORTHOP RES, V31, P1020, DOI 10.1002/jor.22340; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Driban JB, 2010, CLIN RHEUMATOL, V29, P123, DOI 10.1007/s10067-009-1301-1; Hayashi D, 2012, OSTEOARTHR CARTILAGE, V20, P1227, DOI 10.1016/j.joca.2012.07.020; Cerejo R, 2002, ARTHRITIS RHEUM, V46, P2632, DOI 10.1002/art.10530; Suzuki T, 2013, KNEE SURG SPORT TR A, V21, P2584, DOI 10.1007/s00167-013-2508-x; Robbins SM, 2011, ARTHRIT CARE RES, V63, P991, DOI 10.1002/acr.20476; Tanamas S, 2009, ARTHRIT RHEUM-ARTHR, V61, P459, DOI 10.1002/art.24336; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006; Moyer RF, 2013, ARCH PHYS MED REHAB, V94, P103, DOI 10.1016/j.apmr.2012.09.004; Messier SP, 2014, OSTEOARTHR CARTILAGE, V22, P912, DOI 10.1016/j.joca.2014.05.013; Jones RK, 2013, GAIT POSTURE, V37, P368, DOI 10.1016/j.gaitpost.2012.08.002; Akai M, 2005, J RHEUMATOL, V32, P1524; Lim BW, 2008, ARTHRIT RHEUM-ARTHR, V59, P943, DOI 10.1002/art.23823; Barrios JA, 2010, J BIOMECH, V43, P2208, DOI 10.1016/j.jbiomech.2010.03.040; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpian.2003.09.004; Barrios JA, 2009, CLIN BIOMECH, V24, P850, DOI 10.1016/j.clinbiomech.2009.07.016; Kuroyanagi Y, 2012, KNEE, V19, P130, DOI 10.1016/j.knee.2010.12.007; Kraus VB, 2005, ARTHRITIS RHEUM, V52, P1730, DOI 10.1002/art.21100; Niu J, 2009, ARTHRIT RHEUM-ARTHR, V61, P329, DOI 10.1002/art.24337; Bennell KL, 2015, ARTHRIT CARE RES, V67, P1281, DOI 10.1002/acr.22558; Chang A, 2004, ARTHRITIS RHEUM, V50, P3897, DOI 10.1002/art.20657; Chang AH, 2013, OSTEOARTHR CARTILAGE, V21, P1668, DOI [10.1016/j.joca.2013.08.007, 10.1016/j.joca2013.08.007]; Fantini PCH, 2012, J ORTHOP RES, V30, P1125; Foroughi N, 2010, KNEE, V17, P210, DOI 10.1016/j.knee.2009.09.006; Henriksen M, 2012, KNEE, V19, P392, DOI 10.1016/j.knee.2011.07.003; Hunt MA, 2011, ARTHRIT CARE RES, V63, P293, DOI 10.1002/acr.20341; Lo GH, 2012, ARTHRITIS RHEUM-US, V64, P2252, DOI 10.1002/art.34422; McDaniel G, 2010, OSTEOARTHR CARTILAGE, V18, P273, DOI 10.1016/j.joca.2009.10.005; Muraki S, 2012, ARTHRITIS RHEUM-US, V64, P1447, DOI 10.1002/art.33508; Thorp LE, 2010, J MUSCULOSKEL NEURON, V10, P166; White DK, 2013, ARTHRIT CARE RES, V65, P187, DOI 10.1002/acr.21816	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	SEP	2015	67	9					2354	2362		10.1002/art.39224		9	Rheumatology	Rheumatology	CQ1SP	WOS:000360379500008		
J	Taniguchi, Y; Ogata, K; Yoshimatsu, R; Yamagami, T; Terada, Y				Taniguchi, Yoshinori; Ogata, Koji; Yoshimatsu, Rika; Yamagami, Takuji; Terada, Yoshio			Polyarteritis Nodosa of the Iliopsoas Muscle	ARTHRITIS & RHEUMATOLOGY			English	Editorial Material							VASCULITIS		[Taniguchi, Yoshinori; Ogata, Koji; Yoshimatsu, Rika; Yamagami, Takuji; Terada, Yoshio] Kochi Med Sch, Nanko Ku, Kochi, Japan	Taniguchi, Y (reprint author), Kochi Med Sch, Nanko Ku, Kochi, Japan.						Hernandez-Rodriguez J, 2008, CURR OPIN RHEUMATOL, V20, P40, DOI 10.1097/BOR.0b013e3282f176a0; Khellaf M, 2007, ANN RHEUM DIS, V66, P554, DOI 10.1136/ard.2006.065110	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	SEP	2015	67	9					2426	2426		10.1002/art.39206		1	Rheumatology	Rheumatology	CQ1SP	WOS:000360379500016		
J	Suyama, Y; Kishimoto, M; Nozaki, T; Deshpande, GA; Okada, M				Suyama, Yasuhiro; Kishimoto, Mitsumasa; Nozaki, Taiki; Deshpande, Gautam A.; Okada, Masato			Acute calcific tendinitis of the longus colli muscle	ARTHRITIS & RHEUMATOLOGY			English	Editorial Material									[Suyama, Yasuhiro; Kishimoto, Mitsumasa; Nozaki, Taiki; Okada, Masato] St Lukes Int Hosp, Tokyo, Japan; [Suyama, Yasuhiro; Kishimoto, Mitsumasa; Nozaki, Taiki; Okada, Masato] St Lukes Int Univ, Tokyo, Japan; [Deshpande, Gautam A.] St Lukes Life Sci Inst, Tokyo, Japan	Suyama, Y (reprint author), St Lukes Int Hosp, Tokyo, Japan.						Zibis AH, 2013, EUR SPINE J, V22, pS434, DOI 10.1007/s00586-012-2584-5; Desmots F, 2013, Diagn Interv Imaging, V94, P470, DOI 10.1016/j.diii.2012.09.006; Park R, 2010, SEMIN ARTHRITIS RHEU, V39, P504, DOI 10.1016/j.semarthrit.2009.04.002	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	SEP	2015	67	9					2446	2446		10.1002/art.39184		1	Rheumatology	Rheumatology	CQ1SP	WOS:000360379500019		
J	Akiyama, M; Suzuki, K; Yamaoka, K; Yasuoka, H; Takeshita, M; Kaneko, Y; Kondo, H; Kassai, Y; Miyazaki, T; Morita, R; Yoshimura, A; Takeuchi, T				Akiyama, Mitsuhiro; Suzuki, Katsuya; Yamaoka, Kunihiro; Yasuoka, Hidekata; Takeshita, Masaru; Kaneko, Yuko; Kondo, Harumi; Kassai, Yoshiaki; Miyazaki, Takahiro; Morita, Rimpei; Yoshimura, Akihiko; Takeuchi, Tsutomu			Brief Report Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease	ARTHRITIS & RHEUMATOLOGY			English	Article							SJOGRENS-SYNDROME; CRITERIA	Objective. To elucidate the pathologic role of follicular helper T (Tfh) cells and their subsets in active, untreated IgG4-related disease. Methods. Fifteen patients with active, untreated, biopsy-proven IgG4-related disease, 24 patients with primary Sjogren's syndrome (SS), 12 patients with allergic rhinitis, and 23 healthy controls were evaluated. Tfh cells were defined as CD3+CD4+CXCR5+CD45RA- cells. Circulating Tfh cell subsets among CXCR5+CD45RA-CD4+ T cells were defined as Tfh17 cells (CXCR3-CCR6+), Tfh1 cells (CXCR3+CCR6-), or Tfh2 cells (CXCR3-CCR6-). CD19+CD20-CD27+CD38+ cells were defined as plasmablasts. Serum cytokine levels (interleukin-4 [IL-4], IL-10, IL-21, and IL-33) were measured by cytometric bead array or enzyme-linked immunosorbent assay. Results. Patients with IgG4-related disease had significantly increased levels of Tfh2 cells compared to healthy controls or patients with primary SS or allergic rhinitis. Increased Tfh2 levels were strongly associated with increased serum IgG4 levels and the IgG4:IgG ratio in IgG4-related disease. A positive correlation was observed between Tfh2 counts, plasmablast counts, and serum IL-4 levels. Interestingly, levels of plasmablasts and serum IL-4 and IgG4 decreased after treatment with glucocorticoids, whereas no obvious change was observed in Tfh2 cell counts. Conclusion. The Tfh2 cell count was specifically increased in IgG4-related disease and was correlated with elevated serum levels of IgG4 and IL-4 and plasmablast counts. Tfh2 cells were the only component that was not affected by glucocorticoid treatment, suggesting that Tfh2 cells are the cell type implicated in IgG4-related disease.	[Akiyama, Mitsuhiro; Suzuki, Katsuya; Yamaoka, Kunihiro; Yasuoka, Hidekata; Takeshita, Masaru; Kaneko, Yuko; Kondo, Harumi; Morita, Rimpei; Yoshimura, Akihiko; Takeuchi, Tsutomu] Keio Univ, Sch Med, Tokyo, Japan; [Kassai, Yoshiaki; Miyazaki, Takahiro] Takeda Pharmaceut Co, Tokyo, Japan	Takeuchi, T (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol,Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	tsutake@z5.keio.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	Keio University; Takeda Pharmaceutical Company, Japan; Pfizer Japan; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma; Takeda Pharmaceutical; GlaxoSmithKline; Nippon Shinyaku; Eli Lilly Japan K.K.; Janssen Pharmaceutical K.K.; Eisai; Astellas Pharma; Actelion Pharmaceuticals; AbbVie; Bristol-Myers K.K.; Kissei; Santen Pharmaceutical; Taisho Toyama Pharmaceutical; UCB; Teijin Pharma; SymBio Pharmaceuticals; Celltrion; Daiichi Sankyo; Asahi Kasei Pharma; Nippon Kayaku; AstraZeneca K.K.; Novartis Pharma K.K.	Supported by an institutional research grant from Keio University and by Takeda Pharmaceutical Company, Japan.; Dr. Yamaoka has received consulting fees, speaking fees, and/or honoraria from Pfizer Japan, Chugai Pharmaceutical, Mitsubishi Tanabe Pharma, Takeda Pharmaceutical, GlaxoSmithKline, Nippon Shinyaku, Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Eisai, Astellas Pharma, and Actelion Pharmaceuticals (less than $10,000 each). Dr. Kaneko has received consulting fees, speaking fees, and/or honoraria from AbbVie, Astellas Pharma, Chugai Pharmaceutical, Bristol-Myers K.K., Eisai, Kissei, Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma, Pfizer Japan, Santen Pharmaceutical, Taisho Toyama Pharmaceutical, and UCB (less than $10,000 each). Dr. Takeuchi has received consulting fees, speaking fees, and/or honoraria from Pfizer Japan, Santen Pharmaceutical, Takeda Pharmaceutical, Teijin Pharma, Taisho Toyama Pharmaceutical, SymBio Pharmaceuticals, and Celltrion (less than $10,000 each) and from Astellas Pharma, Bristol-Myers K.K., Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Mitsubishi Tanabe Pharma, AbbVie, Asahi Kasei Pharma, Janssen Pharmaceutical K.K., Takeda Pharmaceutical, Nippon Kayaku, AstraZeneca K.K., Eli Lilly Japan K.K., and Novartis Pharma K.K. (more than $10,000 each).	Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Kanari H, 2010, INT ARCH ALLERGY IMM, V152, P47, DOI 10.1159/000312125; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Scadding GK, 2008, CLIN EXP ALLERGY, V38, P19, DOI 10.1111/j.1365-2222.2007.02888.x; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Maehara T, 2012, ANN RHEUM DIS, V71, P2011, DOI 10.1136/annrheumdis-2012-201477; Carruthers MN, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/259408; Wallace ZS, 2015, ANN RHEUM DIS, V74, P190, DOI 10.1136/annrheumdis-2014-205233	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	SEP	2015	67	9					2476	2481		10.1002/art.39209		6	Rheumatology	Rheumatology	CQ1SP	WOS:000360379500024		
J	Endo, T; Ito, K; Morimoto, J; Kanayama, M; Ota, D; Ikesue, M; Kon, S; Takahashi, D; Onodera, T; Iwasaki, N; Uede, T				Endo, Tsutomu; Ito, Koyu; Morimoto, Junko; Kanayama, Masashi; Ota, Daichi; Ikesue, Masahiro; Kon, Shigeyuki; Takahashi, Daisuke; Onodera, Tomohiro; Iwasaki, Norimasa; Uede, Toshimitsu			Syndecan 4 Regulation of the Development of Autoimmune Arthritis in Mice by Modulating B Cell Migration and Germinal Center Formation	ARTHRITIS & RHEUMATOLOGY			English	Article							COLLAGEN-INDUCED ARTHRITIS; T-CELLS; RHEUMATOID-ARTHRITIS; LYMPH-NODES; FACTOR-I; DENDRITIC CELLS; LYMPHOCYTES; ANTIBODIES; ORGANIZATION; MOBILIZATION	Objective. Syndecan 4 has been implicated as a critical mediator of inflammatory responses because of its functions as a coreceptor and reservoir for growth factors and chemokines. Although syndecan 4 is known to be expressed on B cells, its role in immune responses remains unclear. The purpose of this study was to investigate the contribution of syndecan 4 to the development of immune arthritis in murine models. Methods. The clinical severity of 3 immunopathologically distinct models, collagen-induced arthritis (CIA), antigen-induced arthritis (AIA), and collagen antibody-induced arthritis (CAIA), was evaluated in wild-type (WT) mice and in syndecan 4-deficient (Sdc4(-/-)) mice. Germinal center (GC) formation, B cell profiles, humoral immune responses, and B cell migration were analyzed during the course of CIA. Results. Sdc4(-/-) mice were resistant to the induction of CIA, which is T cell and B cell dependent, but AIA and CAIA, which are T cell dependent and T cell independent, respectively, occurred with equal frequency in WT mice and Sdc4(-/-) mice. Furthermore, Sdc4(-/-) mice had reduced numbers of B cells and deficient GC formation in draining lymph nodes (DLNs) during the course of CIA, resulting in reduced production of collagen-specific autoantibodies. Compared with B cells from WT mice, B cells from Sdc4(-/-) mice showed reduced chemotactic migration toward stromal cell-derived factor 1 (SDF-1) and reduced SDF-1-mediated Akt phosphorylation. Consistent with these findings, in vivo transfer experiments showed that fewer Sdc4(-/-) B cells than WT B cells were found in and around the follicles in the DLNs. Conclusion. Our findings suggest that syndecan 4 contributes to the development of CIA by promoting GC formation and autoantibody production through its regulation of SDF-1-mediated B cell migration.	[Endo, Tsutomu; Ito, Koyu; Morimoto, Junko; Kanayama, Masashi; Ota, Daichi; Ikesue, Masahiro; Uede, Toshimitsu] Inst Med Genet, Sapporo, Hokkaido, Japan; [Endo, Tsutomu; Ito, Koyu; Morimoto, Junko; Kanayama, Masashi; Ota, Daichi; Ikesue, Masahiro; Uede, Toshimitsu] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0600815, Japan; [Kon, Shigeyuki] Hokkaido Univ, Gradu Sch Pharmaceut Sci, Sapporo, Hokkaido 0600815, Japan; [Takahashi, Daisuke; Onodera, Tomohiro; Iwasaki, Norimasa] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0600815, Japan	Uede, T (reprint author), Hokkaido Univ, Inst Med Genet, Dept Matrix Med, Kita Ku, Kita-15 Nishi-7, Sapporo, Hokkaido 0600815, Japan.	uedetoshimitsu@icloud.com			Japan Society for the Promotion of Science [23659703]	Supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant 23659703).	Arai J, 2000, EUR J HAEMATOL, V64, P323, DOI 10.1034/j.1600-0609.2000.90147.x; STUART JM, 1983, J EXP MED, V158, P378, DOI 10.1084/jem.158.2.378; Pan M, 2004, J CLIN IMMUNOL, V24, P481, DOI 10.1023/B:JOCI.0000040919.16739.44; Leavenworth JW, 2011, P NATL ACAD SCI USA, V108, P14584, DOI 10.1073/pnas.1112188108; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Yanaba K, 2007, J IMMUNOL, V179, P1369; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Nandakumar KS, 2004, ARTHRITIS RES THER, V6, pR544, DOI 10.1186/ar1217; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Cohen SB, 2006, ARTHRITIS RHEUM, V54, P2793, DOI 10.1002/art.22025; Cho YG, 2007, AUTOIMMUN REV, V7, P65, DOI 10.1016/j.autrev.2007.08.001; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Weyand CM, 2003, ANN NY ACAD SCI, V987, P140; Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Charnaux N, 2005, FEBS J, V272, P1937, DOI 10.1111/j.1742-4658.2005.04624.x; Coelho FM, 2013, BLOOD, V121, P4101, DOI 10.1182/blood-2012-10-465336; Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Hamon M, 2004, GLYCOBIOLOGY, V14, P311, DOI 10.1093/glycob/cwh038; Kanayama M, 2009, J IMMUNOL, V182, P8015, DOI 10.4049/jimmunol.0900725; Kanayama M, 2011, J IMMUNOL, V187, P5851, DOI 10.4049/jimmunol.1101524; Kaneider NC, 2005, THROMB HAEMOSTASIS, V93, P1120, DOI 10.1160/TH04-11-0763; Leavenworth JW, 2013, J CLIN INVEST, V123, P1382, DOI 10.1172/JCI66938; Mullazehi M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3825; Peng SB, 2005, MOL CANCER RES, V3, P227; Pohlers D, 2004, CLIN EXP IMMUNOL, V135, P409, DOI 10.1111/j.1365-2249.2004.02381.x; Tanaka D, 2006, IMMUNOLOGY, V119, P195, DOI 10.1111/j.1365-2567.2006.02424.x; Vicente-Manzanares M, 1999, J IMMUNOL, V163, P4001; Yamashita Y, 1999, J IMMUNOL, V162, P5940	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	SEP	2015	67	9					2512	2522		10.1002/art.39193		11	Rheumatology	Rheumatology	CQ1SP	WOS:000360379500031		
J	Hamaguchi, Y; Kuwana, M; Fujimoto, M				Hamaguchi, Yasuhito; Kuwana, Masataka; Fujimoto, Manabu			Anti-RNA polymerase II antibodies in a US cohort of systemic sclerosis patients: comment on the article by Hamaguchi et al Reply	ARTHRITIS & RHEUMATOLOGY			English	Letter							SERUM ANTINUCLEAR ANTIBODIES		[Hamaguchi, Yasuhito] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Tokyo, Japan; [Fujimoto, Manabu] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Fujimoto, Manabu] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Hamaguchi, Y (reprint author), Kanazawa Univ, Kanazawa, Ishikawa, Japan.						Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; KUWANA M, 1994, ARTHRITIS RHEUM, V37, P902, DOI 10.1002/art.1780370619; Sobanski V, 2014, ARTHRITIS RHEUMATOL, V66, P407, DOI 10.1002/art.38219; Hamaguchi Y, 2008, BRIT J DERMATOL, V158, P487, DOI 10.1111/j.1365-2133.2007.08392.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	SEP	2015	67	9					2548	2548		10.1002/art.39201		1	Rheumatology	Rheumatology	CQ1SP	WOS:000360379500035		
